PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, Y; Chin, RK; Christiansen, P; Sun, Y; Tumanov, AV; Wang, J; Chervonsky, AV; Fu, YX				Lee, Youjin; Chin, Robert K.; Christiansen, Peter; Sun, Yonglian; Tumanov, Alexel V.; Wang, Jing; Chervonsky, Alexander V.; Fu, Yang-Xin			Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NONOBESE DIABETIC MICE; TNF FAMILY MEMBER; TRANSGENIC MICE; DENDRITIC CELLS; NOD MICE; ECTOPIC EXPRESSION; AUTOIMMUNE-DISEASE; HOMING CHEMOKINES; FACTOR-ALPHA	The development of spontaneous insulin-dependent diabetes mellitus is preceded by the organization of tertiary lymphoid organ (TLO) in situ, but its role in the development of tissue destruction and the cytokines that control such structures have not been fully defined. We have now observed that TNF superfamily 14 (TNFSF14) is upregulated in aged nonobese diabetic (NOD) pancreas with the appearance of TLO. Blockade of TNFSF14 signaling caused a substantial reduction in the expression of lymphotoxin beta receptor (LT beta R)-controlled migration factors within the islets and disrupts organization of tertiary structures, leading to prevention of diabetes. Consistently, enhancing LT beta R signaling by transgenic expression of TNFSF14 in the islets of NOD mice rapidly promoted de novo formation of local TLO, resulting in diabetes, even in the absence of draining lymph nodes (LN). Thus, the TNFSF14-LT beta R pathway appears to be critical in the development and maintenance of TLO for the onset of diabetes.	Univ Chicago, Comm Immunol, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Fu, YX (corresponding author), Univ Chicago, Comm Immunol, Dept Pathol, 5841 S Maryland,Room J541,MC3083, Chicago, IL 60637 USA.	yfu@uchicago.edu	Wang, Jing Hong/M-7813-2015	Wang, Jing Hong/0000-0003-4343-2527; Chervonsky, Alexander/0000-0001-7547-871X; Tumanov, Alexei/0000-0001-6042-0152; fu, yang-xin/0000-0001-8441-6617	NICHD NIH HHS [HD062026] Funding Source: Medline; NIDDK NIH HHS [DK58897] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058897] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Browning JL, 1997, J IMMUNOL, V159, P3288; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chen SC, 2002, J IMMUNOL, V168, P1001, DOI 10.4049/jimmunol.168.3.1001; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Drayton DL, 2002, ADV EXP MED BIOL, V512, P43; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gommerman JL, 2003, J CLIN INVEST, V112, P755, DOI 10.1172/JCI200318648; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Jaakkola I, 2003, EUR J IMMUNOL, V33, P3255, DOI 10.1002/eji.200324405; Levisetti MG, 2004, DIABETES, V53, P3115, DOI 10.2337/diabetes.53.12.3115; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Ruddle NH, 1999, IMMUNOL RES, V19, P119, DOI 10.1007/BF02786481; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Wang J, 2002, EUR J IMMUNOL, V32, P1969, DOI 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M; Wang J, 2001, J IMMUNOL, V167, P5099, DOI 10.4049/jimmunol.167.9.5099; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Yang XG, 1997, T NONFERR METAL SOC, V7, P1	45	111	117	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					499	509		10.1016/j.immuni.2006.06.016	http://dx.doi.org/10.1016/j.immuni.2006.06.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16934497	Bronze			2022-12-18	WOS:000240862200017
J	Hua, ZC; Sohn, SJ; Kang, CH; Cado, D; Winoto, A				Hua, ZC; Sohn, SJ; Kang, CH; Cado, D; Winoto, A			A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region	IMMUNITY			English	Article							INDUCED APOPTOSIS; T-CELLS; ACTIVATION; FADD; PROLIFERATION; FADD/MORT1; INDUCTION; CASPASES; DFADD; MICE	FADD is an adaptor known to transmit apoptotic signals from members of the tumor necrosis factor receptor family. We show here that FADD has a domain implicated in cell proliferation. Mice bearing the Asp mutation in the serine 191 phosphorylation site are runted and anemic and display splenomegaly. Apoptosis is unimpaired in these mice, but they exhibit many immune developmental problems indicative of proliferative defects. Mutant FADD T cells are defective in cell cycle progression, suggesting that regulation of phosphorylation at serine 191 is essential for growth/proliferation. Remarkably, serine 191 is conserved among mammalian FADD proteins, but this C-terminal region is absent in lower organisms, suggesting that FADD acquired a domain during evolution, rendering it a "proliferation-apoptosis coupler" that balances cell proliferation and apoptosis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; Nanjing Univ, Inst Mol & Cell Biol, Nanjing 210093, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Nanjing University; Nanjing University	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 469 LSA, Berkeley, CA 94720 USA.	winoto@uclink4.berkeley.edu			NCI NIH HHS [CA75162] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075162] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams JM, 2002, CELL, V110, P403, DOI 10.1016/S0092-8674(02)00904-2; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Elkon KB, 1999, J EXP MED, V190, P1725, DOI 10.1084/jem.190.12.1725; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	32	111	112	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2003	18	4					513	521		10.1016/S1074-7613(03)00083-9	http://dx.doi.org/10.1016/S1074-7613(03)00083-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705854	Bronze			2022-12-18	WOS:000182353900007
J	Hailman, E; Burack, WR; Shaw, AS; Dustin, ML; Allen, PM				Hailman, E; Burack, WR; Shaw, AS; Dustin, ML; Allen, PM			Immature CD4(+)CD8(+) thymocytes form a multifocal immunological synapse with sustained tyrosine phosphorylation	IMMUNITY			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; T-CELLS; INDUCED APOPTOSIS; CLONAL DELETION; TCR; ACTIVATION; MATURE; COMPLEXES; ADHESION	The immunological synapse formed during mature T cell activation consists of a central cluster of TCR and MHC molecules surrounded by a ring of LFA-1 and ICAM-1. We examined synapse formation in thymocytes undergoing activation in a lipid bilayer system by following the movement of fluorescent MHC and ICAM-1 molecules, Immature CD4(+)CD8(+) thymocytes formed a decentralized synapse with multiple foci of MHC accumulation corresponding to areas of exclusion of ICAM-1. The MHC clusters and ICAM-1 holes were mobile and transient and correlated with active and sustained signaling, as shown by staining with antibodies against phosphotyrosine and activated Lck. Our findings show that signaling in immature thymocytes can result from a novel, multifocal pattern of receptor accumulation.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Washington University (WUSTL); New York University	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	allen@immunology.wustl.edu	Dustin, Michael/AAM-4611-2020	Shaw, Andrey/0000-0001-5685-0272; Dustin, Michael/0000-0003-4983-6389				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 1996, J IMMUNOL, V157, P2014; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN DR, 1994, CURR OPIN IMMUNOL, V6, P476, DOI 10.1016/0952-7915(94)90130-9; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; KEARSE KP, 1993, P NATL ACAD SCI USA, V90, P2438, DOI 10.1073/pnas.90.6.2438; Kersh GJ, 1998, J IMMUNOL, V161, P585; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PAGE DM, 1993, J IMMUNOL, V151, P1868; Peterson DA, 1999, J IMMUNOL, V162, P3117; Prockop S, 2000, SEMIN IMMUNOL, V12, P435, DOI 10.1006/smim.2000.0267; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki G, 1999, J IMMUNOL, V162, P5981; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; Vidal K, 1999, J IMMUNOL, V163, P4811; Wang AQ, 1998, ACTA MECH SOLIDA SIN, V11, P95; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Williams O, 1998, P NATL ACAD SCI USA, V95, P5706, DOI 10.1073/pnas.95.10.5706; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	54	111	113	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2002	16	6					839	848		10.1016/S1074-7613(02)00326-6	http://dx.doi.org/10.1016/S1074-7613(02)00326-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121665	Bronze			2022-12-18	WOS:000176534000009
J	Yang, WC; Collette, Y; Nunes, Y; Olive, D				Yang, WC; Collette, Y; Nunes, Y; Olive, D			Tec kinases: A family with multiple roles in immunity	IMMUNITY			English	Review							BRUTONS-TYROSINE-KINASE; X-LINKED AGAMMAGLOBULINEMIA; PLECKSTRIN HOMOLOGY DOMAIN; B-CELL DEVELOPMENT; T-CELLS; SH2 DOMAIN; RECEPTOR ENGAGEMENT; PH DOMAIN; PROTEIN; ACTIVATION		Univ Mediterranee, INSERM, U119, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Olive, D (corresponding author), Univ Mediterranee, INSERM, U119, F-13009 Marseille, France.		NUNES, Jacques A/F-4952-2013; Yang, Wen-Chin/D-3441-2015; COLLETTE, Yves/F-2270-2013	NUNES, Jacques A/0000-0003-4865-0400; Yang, Wen-Chin/0000-0001-6410-2581; COLLETTE, Yves/0000-0001-5359-7099				Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; Cariappa A, 1999, J IMMUNOL, V162, P4417; Collette Y, 1997, EUR J IMMUNOL, V27, P3283, DOI 10.1002/eji.1830271227; Debnath J, 1999, MOL CELL BIOL, V19, P1498; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hirata M, 1998, JPN J PHARMACOL, V76, P255, DOI 10.1254/jjp.76.255; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; Kashiwakura J, 1999, J EXP MED, V190, P1147, DOI 10.1084/jem.190.8.1147; Kawakami Y, 1999, J LEUKOCYTE BIOL, V65, P286, DOI 10.1002/jlb.65.3.286; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; King PD, 1997, J IMMUNOL, V158, P580; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Maas A, 1999, J IMMUNOL, V162, P6526; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Mano H, 1999, INT J HEMATOL, V69, P6; Marengere LEM, 1997, J IMMUNOL, V159, P3220; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Merkel AL, 1999, CYTOGENET CELL GENET, V84, P132, DOI 10.1159/000015240; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Pawson T, 1997, NATURE, V385, P582, DOI 10.1038/385582b0; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Satterthwaite AB, 1998, J EXP MED, V188, P833, DOI 10.1084/jem.188.5.833; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Shan XC, 1999, J BIOL CHEM, V274, P29323, DOI 10.1074/jbc.274.41.29323; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VIHINEN M, 1994, BIOCHEM BIOPH RES CO, V205, P1270, DOI 10.1006/bbrc.1994.2802; Woodland RT, 1996, J IMMUNOL, V156, P2143; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang WC, 1999, EUR J IMMUNOL, V29, P1842, DOI 10.1002/(SICI)1521-4141(199906)29:06<1842::AID-IMMU1842>3.0.CO;2-D; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; ZHU QL, 1994, J EXP MED, V180, P461, DOI 10.1084/jem.180.2.461	58	111	116	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					373	382		10.1016/S1074-7613(00)80189-2	http://dx.doi.org/10.1016/S1074-7613(00)80189-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795735	Bronze			2022-12-18	WOS:000086757300002
J	Bevan, MJ				Bevan, MJ			In thymic selection, peptide diversity gives and takes away	IMMUNITY			English	Article							POSITIVE SELECTION; THYMOCYTES				Bevan, MJ (corresponding author), UNIV WASHINGTON,DEPT IMMUNOL,HOWARD HUGHES MED INST,SEATTLE,WA 98195, USA.							Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; MERKENSCHLAGER M, 1997, IN PRESS J EXP MED; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	15	111	116	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					175	178		10.1016/S1074-7613(00)80520-8	http://dx.doi.org/10.1016/S1074-7613(00)80520-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285402	Bronze			2022-12-18	WOS:A1997XT49200001
J	Ping, DS; Jones, PL; Boss, JM				Ping, DS; Jones, PL; Boss, JM			TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; ZINC FINGER PROTEIN; FACTOR-ALPHA; INFLAMMATORY CYTOKINES; SUPEROXIDE-DISMUTASE; ACTIVATION; BINDING; EXPRESSION; CELLS	In vivo genomic footprinting (IVGF) was used to examine regulatory site occupancy during the activation of the murine inflammatory response gene MCP-1/JE by TNF. In response to TNF, both promoter distal and proximal regulatory regions became occupied in vivo. EMSA analysis showed that while some of the factors involved in expression, including NF-kappa B, were translocated to the nucleus following TNF treatment, others were already present and able to bind DNA in vitro. Protein kinase inhibitor studies showed that protein phosphorylation was required for TNF activation but not factor assembly. These studies provide evidence for a multistep model of TNF-mediated gene regulation involving chromatin accessibility, transcription factor complex assembly, and protein phosphorylation.			Ping, DS (corresponding author), EMORY UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,ATLANTA,GA 30322, USA.				NCI NIH HHS [CA47953] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047953] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; BEUTLER B, 1993, CRIT CARE MED, V21, pS423; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; CAO XM, 1992, J BIOL CHEM, V267, P1345; CERAMI A, 1992, CLIN IMMUNOL IMMUNOP, V62, pS3, DOI 10.1016/0090-1229(92)90035-M; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; CREASEY AA, 1987, CANCER RES, V47, P145; FRETER RR, 1995, MOL CELL BIOL, V15, P315, DOI 10.1128/MCB.15.1.315; GORDON HM, 1992, J IMMUNOL, V148, P4021; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HANAZAWA S, 1994, J BIOL CHEM, V269, P21379; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P1243, DOI 10.1093/nar/19.6.1243; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; JOHN S, 1995, MOL CELL BIOL, V15, P1786; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kronke M, 1992, Immunol Ser, V56, P189; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MANTOVANI A, 1993, ADV EXP MED BIOL, V351, P47; MATTILA P, 1992, SCAND J IMMUNOL, V36, P159, DOI 10.1111/j.1365-3083.1992.tb03087.x; MEICHLE A, 1990, J BIOL CHEM, V265, P8339; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; MUELLER PR, 1994, CURRENT PROTOCOLS MO; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; RILEY JL, 1993, J IMMUNOL, V151, P6942; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Sambrook J, 1989, MOL CLONING LAB MANU; SATRIANO JA, 1993, J IMMUNOL, V150, P1971; SCHATTNER A, 1994, CLIN IMMUNOL IMMUNOP, V70, P177, DOI 10.1006/clin.1994.1027; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, P1, DOI 10.1002/clc.4960141302; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SIDHU RS, 1993, PHARMACOL THERAPEUT, V57, P79, DOI 10.1016/0163-7258(93)90037-E; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SPANA C, 1990, GENE DEV, V4, P1505, DOI 10.1101/gad.4.9.1505; TAKESHITA A, 1995, J IMMUNOL, V155, P419; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TIMMERS HT, 1990, NUCLEIC ACIDS RES, V18, P23, DOI 10.1093/nar/18.1.23; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; UEDA A, 1994, J IMMUNOL, V153, P2052; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WANG AM, 1985, SCIENCE, V228, P149, DOI 10.1126/science.3856324; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703	61	111	115	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1996	4	5					455	469		10.1016/S1074-7613(00)80412-4	http://dx.doi.org/10.1016/S1074-7613(00)80412-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630731	Bronze			2022-12-18	WOS:A1996UM67800005
J	PUDDINGTON, L; OLSON, S; LEFRANCOIS, L				PUDDINGTON, L; OLSON, S; LEFRANCOIS, L			INTERACTIONS BETWEEN STEM-CELL FACTOR AND C-KIT ARE REQUIRED FOR INTESTINAL IMMUNE-SYSTEM HOMEOSTASIS	IMMUNITY			English	Article							DENDRITIC EPIDERMAL-CELLS; TYROSINE KINASE RECEPTOR; THYMIC STROMAL CELLS; W-MUTANT MICE; INTRAEPITHELIAL LYMPHOCYTES; T-CELLS; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; GAMMA-DELTA; LANGERHANS CELLS	Interactions between stem cell factor (SCF) and its receptor, c-Kit, are important for development of hematopoietic, melanocytes, and germ cells. T lymphocytes appeared normal in c-Kit (W/W-v) or SCF (SI/SId) mutant mice, except for those residing within the intestinal epithelium, the intraepithelial lymphocytes (IEL). Normally, IEL are composed of equal numbers of cells with alpha beta or gamma delta T cell receptors. In mutant mice, beginning at 6-8 weeks of age, the number of gamma delta IEL decreased, whereas alpha beta IEL increased. The latter was due largely to an increased CD4(+)CD8(+) TCR alpha beta subset, suggesting that these cells may be intermediates in the alpha beta IEL lineage. c-Kit or SCF was expressed by IEL or intestinal epithelial cells, respectively, indicating a potential for direct intercellular interaction. This possibility was supported by reconstitution studies that demonstrated that c-Kit mutations directly affected IEL. Thus, SCF-c-Kit interactions are important for homeostasis of the intestinal immune compartment.			PUDDINGTON, L (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT MED,DIV RHEUMAT DIS,FARMINGTON,CT 06030, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135917, R01AI035917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 35917] Funding Source: Medline; NIDDK NIH HHS [DK45260] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; BANDEIRA A, 1990, P NATL ACAD SCI USA, V88, P43; BERGSTRESSER PR, 1984, METHOD ENZYMOL, V108, P683; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRUCE J, 1981, J IMMUNOL, V127, P2496; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; DEGEUS B, 1990, EUR J IMMUNOL, V20, P291, DOI 10.1002/eji.1830200210; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; GALY AHM, 1993, THYMUS, V22, P13; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; GUYGRAND D, 1992, EUR J IMMUNOL, V22, P505, DOI 10.1002/eji.1830220232; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HARRISON DE, 1991, EXP HEMATOL, V19, P374; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEFRANCOIS L, 1994, J IMMUNOL, V153, P987; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; LEFRANCOIS L, 1990, CELL, V63, P333, DOI 10.1016/0092-8674(90)90166-C; LEFRANCOIS L, 1994, MUCOSAL IMMUNOLOGY I, P61; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIN T, 1993, EUR J IMMUNOL, V23, P1968, DOI 10.1002/eji.1830230836; MAEDA H, 1992, DEVELOPMENT, V116, P369; MOSLEY RL, 1990, J IMMUNOL, V145, P1369; MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WOLF SS, 1992, IMMUNOLOGY, V77, P362; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	47	111	112	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					733	739		10.1016/S1074-7613(94)80015-4	http://dx.doi.org/10.1016/S1074-7613(94)80015-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7534619				2022-12-18	WOS:A1994PX64800003
J	Scott, CL; T'Jonck, W; Martens, L; Todorov, H; Sichien, D; Soen, B; Bonnardel, J; De Prijck, S; Vandamme, N; Cannoodt, R; Saelens, W; Vanneste, B; Toussaint, W; De Bleser, P; Takahashi, N; Vandenabeele, P; Henri, S; Pridans, C; Hume, DA; Lambrecht, BN; De Baetselier, P; Milling, SWF; Van Ginderachter, JA; Malissen, B; Berx, G; Beschin, A; Saeys, Y; Guilliams, M				Scott, Charlotte L.; T'Jonck, Wouter; Martens, Liesbet; Todorov, Helena; Sichien, Dorine; Soen, Bieke; Bonnardel, Johnny; De Prijck, Sofie; Vandamme, Niels; Cannoodt, Robrecht; Saelens, Wouter; Vanneste, Bavo; Toussaint, Wendy; De Bleser, Pieter; Takahashi, Nozomi; Vandenabeele, Peter; Henri, Sandrine; Pridans, Clare; Hume, David A.; Lambrecht, Bart N.; De Baetselier, Patrick; Milling, Simon W. F.; Van Ginderachter, Jo A.; Malissen, Bernard; Berx, Geert; Beschin, Alain; Saeys, Yvan; Guilliams, Martin			The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; RESIDENT MACROPHAGES; IN-VIVO; MOUSE; HOMEOSTASIS; MONOCYTES; MICE; DIFFERENTIATION; EXPRESSION	Heterogeneity between different macrophage populations has become a defining feature of this lineage. However, the conserved factors defining macrophages remain largely unknown. The transcription factor ZEB2 is best described for its role in epithelial to mesenchymal transition; however, its role within the immune system is only now being elucidated. We show here that Zeb2 expression is a conserved feature of macrophages. Using Clec4f-cre, Itgax-cre, and Fcgr1-cre mice to target five different macrophage populations, we found that loss of ZEB2 resulted in macrophage disappearance from the tissues, coupled with their subsequent replenishment from bone-marrow precursors in open niches. Mechanistically, we found that ZEB2 functioned to maintain the tissue-specific identities of macrophages. In Kupffer cells, ZEB2 achieved this by regulating expression of the transcription factor LXR alpha, removal of which recapitulated the loss of Kupffer cell identity and disappearance. Thus, ZEB2 expression is required in macrophages to preserve their tissue-specific identities.	[Scott, Charlotte L.; T'Jonck, Wouter; Sichien, Dorine; Bonnardel, Johnny; De Prijck, Sofie; Vanneste, Bavo; Guilliams, Martin] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [T'Jonck, Wouter; Martens, Liesbet; Todorov, Helena; Sichien, Dorine; Soen, Bieke; Bonnardel, Johnny; De Prijck, Sofie; Vandamme, Niels; Cannoodt, Robrecht; Saelens, Wouter; Vanneste, Bavo; De Bleser, Pieter; Takahashi, Nozomi; Vandenabeele, Peter; Berx, Geert; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Scott, Charlotte L.; Milling, Simon W. F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Martens, Liesbet; Todorov, Helena; Cannoodt, Robrecht; Saelens, Wouter; De Bleser, Pieter; Saeys, Yvan] VIB UGent Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Soen, Bieke; Vandamme, Niels; Berx, Geert] VIB UGent Ctr Inflammat Res, Mol & Cellular Oncol Lab, Ghent, Belgium; [Toussaint, Wendy; Lambrecht, Bart N.] VIB Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium; [Toussaint, Wendy; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, Ghent, Belgium; [Takahashi, Nozomi; Vandenabeele, Peter] VIB UGent Ctr Inflammat Res, Lab Mol Signaling & Cell Death, Ghent, Belgium; [Henri, Sandrine; Malissen, Bernard] Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pridans, Clare] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Hume, David A.] Univ Queensland, Translat Res Inst, Mater Res, Brisbane, Qld 4102, Australia; [De Baetselier, Patrick; Van Ginderachter, Jo A.; Beschin, Alain] VIB UGent Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium; [De Baetselier, Patrick; Van Ginderachter, Jo A.; Beschin, Alain] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Malissen, Bernard] Aix Marseille Univ, Ctr Immunophenom, INSERM, CNRS, F-13288 Marseille, France; [Saeys, Yvan] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Glasgow; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Edinburgh; Mater Research; University of Queensland; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Ghent University	Scott, CL; Guilliams, M (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium.; Scott, CL; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	charlotte.scott@irc.vib-ugent.be; martin.guilliams@irc.vib-ugent.be	Pridans, Clare/AAF-9953-2020; Hume, David/N-6702-2019; Beschin, Alain/L-2154-2014; Henri, Sandrine/O-3045-2016; T'Jonck, Wouter/AAY-1476-2021; De Bleser, Pieter/AAB-2968-2021; Lambrecht, Bart N/K-2484-2014; Saelens, Wouter/I-6197-2019; Saeys, Yvan/C-1311-2009; Vandenabeele, Peter/AAD-5793-2022; Van Ginderachter, Jo A/H-5473-2013; Guilliams, Martin/N-7803-2013; Malissen, Bernard/AAK-4659-2020	Pridans, Clare/0000-0001-9423-557X; Beschin, Alain/0000-0001-8478-6941; T'Jonck, Wouter/0000-0002-9390-525X; Lambrecht, Bart N/0000-0003-4376-6834; Saelens, Wouter/0000-0002-7114-6248; Saeys, Yvan/0000-0002-0415-1506; Vandenabeele, Peter/0000-0002-6669-8822; Van Ginderachter, Jo A/0000-0002-4442-7474; Guilliams, Martin/0000-0003-3525-7570; Cannoodt, Robrecht/0000-0003-3641-729X; Malissen, Bernard/0000-0003-1340-9342; HENRI, Sandrine/0000-0002-8980-9193; Vanneste, Bavo/0000-0002-4152-5634; T'Jonck, Wouter/0000-0002-7494-1458; Berx, Geert/0000-0001-5770-2458; Martens, Liesbet/0000-0001-9180-7456; Takahashi, Nozomi/0000-0002-3751-4203; Todorov, Helena/0000-0002-1594-8609; Bonnardel, Johnny/0000-0003-2359-3438; Hume, David/0000-0002-2615-1478; Sichien, Dorine/0000-0002-7298-3005	Marie Curie IEF; Sir Henry Wellcome Postdoctoral Fellowship; PHENOMIN; ERC [322465]; FWO; EOS [30826052 MODEL-IDI]; GOA-Ghent University grant; GOA-Ghent University; ERC;  [BOF16/MET_V/007]	Marie Curie IEF(European Commission); Sir Henry Wellcome Postdoctoral Fellowship; PHENOMIN; ERC(European Research Council (ERC)European Commission); FWO(FWO); EOS; GOA-Ghent University grant; GOA-Ghent University; ERC(European Research Council (ERC)European Commission); 	We thank K. Vergote, G. Blanke, and J. Taminau for genotyping, the Flow Cytometry Core Facility for assistance, and A. Mowat for critical reading of the manuscript. This study benefitted from data assembled by the Immgen Consortium. We would also like to thank VIB TechWatch and the Single Cell Accelerator program for supporting the 10x genomics platform. We thank F. Fiore, A. Adda-Benatia, and F. Danjan for construction of the Fcgr1-IRES-iCre-TEAL mice and A. Baranska for her initial characterization of the Fcgr1-cre line (data not shown). C.L.S. is supported by a Marie Curie IEF and a Sir Henry Wellcome Postdoctoral Fellowship. B.M. is supported by PHENOMIN and ERC (FP7/2007-2013 grant no 322465), P.V. is supported by FWO, EOS (30826052 MODEL-IDI), and Methusalem (BOF16/MET_V/007), G.B. is supported by an FWO and a GOA-Ghent University grant. Y.S. is supported by the FWO and is a Marylou Ingram Scholar. M.G. is supported by an FWO, a GOA-Ghent University, and an ERC Consolidator grant.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; HUME DA, 1988, J IMMUNOL, V141, P3405; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lynch R. W., 2018, J LEUKOCYTE BIOL, V95, P2157; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	41	110	110	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					312	+		10.1016/j.immuni.2018.07.004	http://dx.doi.org/10.1016/j.immuni.2018.07.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30076102	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000442354500016
J	Li, J; Lee, Y; Li, YJ; Jiang, Y; Lu, HP; Zang, WJ; Zhao, XH; Liu, LG; Chen, Y; Tan, HD; Yang, ZY; Zhang, MQ; Mak, TW; Ni, L; Dong, C				Li, Jing; Lee, Younghee; Li, Yanjian; Jiang, Yu; Lu, Huiping; Zang, Wenjuan; Zhao, Xiaohong; Liu, Liguo; Chen, Yang; Tan, Haidong; Yang, Zhiying; Zhang, Michael Q.; Mak, Tak W.; Ni, Ling; Dong, Chen			Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8(+) T Cells	IMMUNITY			English	Article							FAMILY-MEMBER; EXHAUSTION; B7-H4; RECEPTORS; SURVIVAL; PATHWAYS; CANCER	The molecular mechanisms whereby CD8(+) T cells become "exhausted" in the tumor microenvironment remain unclear. Programmed death ligand-1 (PD-L1) is upregulated on tumor cells and PD-1-PD-L1 blockade has significant efficacy in human tumors; however, most patients do not respond, suggesting additional mechanisms underlying T cell exhaustion. B7 superfamily member 1 (B7S1), also called B7-H4, B7x, or VTCN1, negatively regulates T cell activation. Here we show increased B7S1 expression on myeloid cells from human hepatocellular carcinoma correlated with CD8(+) T cell dysfunction. B7S1 inhibition suppressed development of murine tumors. Putative B7S1 receptor was co-expressed with PD-1 but not T cell immunoglobulin and mucin-domain containing-3 (Tim-3) at an activated state of early tumor-infiltrating CD8(+) T cells, and B7S1 promoted T cell exhaustion, possibly through Eomes overexpression. Combinatorial blockade of B7S1 and PD-1 synergistically enhanced anti-tumor immune responses. Collectively, B7S1 initiates dysfunction of tumor-infiltrating CD8(+) T cells and may be targeted for cancer immunotherapy.	[Li, Jing; Jiang, Yu; Lu, Huiping; Zang, Wenjuan; Zhao, Xiaohong; Ni, Ling; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Li, Jing; Jiang, Yu; Lu, Huiping; Zang, Wenjuan; Zhao, Xiaohong; Ni, Ling; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lee, Younghee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Li, Yanjian; Chen, Yang; Zhang, Michael Q.] MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Li, Yanjian; Chen, Yang; Zhang, Michael Q.] TNLIST, Bioinformat Div, Beijing 100084, Peoples R China; [Li, Yanjian; Chen, Yang; Zhang, Michael Q.] TNLIST, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China; [Li, Yanjian; Chen, Yang; Zhang, Michael Q.] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Liu, Liguo; Tan, Haidong; Yang, Zhiying] China Japan Friendship Hosp, Dept Hepatobiliary Surg, Beijing 100029, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Dallas, TX 75080 USA; [Mak, Tak W.] Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada; [Mak, Tak W.] Univ Hlth Network, Toronto, ON M5G 2C1, Canada; [Dong, Chen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; China-Japan Friendship Hospital; University of Texas System; University of Texas Dallas; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009; Yang, Zhiying/AGK-0941-2022	dong, chen/0000-0002-0084-9130; Yang, Zhiying/0000-0001-9787-9266; Li, Jing/0000-0002-9285-9423	Beijing Municipal Science and Technology [Z171100000417005]; National Natural Science Foundation of China (NSFC) [81502462, 31671384]	Beijing Municipal Science and Technology; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Beijing Municipal Science and Technology (grant number Z171100000417005 to C.D.) and from The National Natural Science Foundation of China (NSFC) (grant number 81502462 to L.N., 31671384 to M.Q.Z.). C.D. is a Bayer Chair Professor at Tsinghua University. We thank Dr. Haiyan Liu for providing Hepa1-6 cell line.	Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chen C, 2012, J IMMUNOTHER, V35, P354, DOI 10.1097/CJI.0b013e31824212c4; Chen LJ, 2011, CANCER IMMUNOL IMMUN, V60, P1047, DOI 10.1007/s00262-011-1017-3; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Giordano M, 2015, EMBO J, V34, P2042, DOI 10.15252/embj.201490786; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Jiang JT, 2010, CANCER IMMUNOL IMMUN, V59, P1707, DOI 10.1007/s00262-010-0900-7; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Li J, 2017, CURR OPIN IMMUNOL, V45, P37, DOI 10.1016/j.coi.2017.01.001; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Quandt D, 2011, CLIN CANCER RES, V17, P3100, DOI 10.1158/1078-0432.CCR-10-2268; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Xu H, 2016, ONCOL LETT, V11, P1841, DOI 10.3892/ol.2016.4128; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	32	110	116	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					773	+		10.1016/j.immuni.2018.03.018	http://dx.doi.org/10.1016/j.immuni.2018.03.018			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29625896	Bronze			2022-12-18	WOS:000430198900022
J	Czimmerer, Z; Daniel, B; Horvath, A; Ruckerl, D; Nagy, G; Kiss, M; Peloquin, M; Budai, MM; Cuaranta-Monroy, I; Simandi, Z; Steiner, L; Nagy, B; Poliska, S; Banko, C; Bacso, Z; Schulman, IG; Sauer, S; Deleuze, JF; Allen, JE; Benko, S; Nagy, L				Czimmerer, Zsolt; Daniel, Bence; Horvath, Attila; Ruckerl, Dominik; Nagy, Gergely; Kiss, Mate; Peloquin, Matthew; Budai, Marietta M.; Cuaranta-Monroy, Ixchelt; Simandi, Zoltan; Steiner, Laszlo; Nagy, Bela, Jr.; Poliska, Szilard; Banko, Csaba; Bacso, Zsolt; Schulman, Ira G.; Sauer, Sascha; Deleuze, Jean-Francois; Allen, Judith E.; Benko, Szilvia; Nagy, Laszlo			The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages	IMMUNITY			English	Article							SUPER-ENHANCERS; HUMAN GENOME; CHROMATIN; IMMUNITY; BINDING; CELLS; EXPRESSION; PRINCIPLES; RECEPTORS; DISEASES	The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding remains limited regarding the molecular determinants of repression. Here we show that IL-4-activated STAT6 transcription factor is required for the direct transcriptional repression of a large number of genes during in vitro and in vivo alternative macrophage polarization. Repression results in decreased line-age-determining transcription factor, p300, and RNA polymerase II binding followed by reduced enhancer RNA expression, H3K27 acetylation, and chromatin accessibility. The repressor function of STAT6 is HDAC3 dependent on a subset of IL-4-repressed genes. In addition, STAT6-repressed enhancers show extensive overlap with the NF-kappa B p65 cistrome and exhibit decreased responsiveness to lipopolysaccharide after IL-4 stimulus on a subset of genes. As a consequence, macrophages exhibit diminished inflammasome activation, decreased IL-1 beta production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes an alternative polarization-specific epigenenomic signature resulting in dampened macrophage responsiveness to inflammatory stimuli.	[Czimmerer, Zsolt; Horvath, Attila; Nagy, Gergely; Kiss, Mate; Cuaranta-Monroy, Ixchelt; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary; [Daniel, Bence; Peloquin, Matthew; Simandi, Zoltan; Nagy, Laszlo] Sanford Burnham Prebys Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA; [Ruckerl, Dominik; Allen, Judith E.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Budai, Marietta M.; Benko, Szilvia] Univ Debrecen, Dept Physiol, Fac Med, Debrecen, Hungary; [Steiner, Laszlo] UD Genomed Med Genom Technol Ltd, Debrecen, Hungary; [Nagy, Bela, Jr.] Univ Debrecen, Dept Lab Med, Fac Med, Debrecen, Hungary; [Poliska, Szilard] Univ Debrecen, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Fac Med, Debrecen, Hungary; [Banko, Csaba; Bacso, Zsolt] Univ Debrecen, Dept Biophys & Cell Biol, Fac Med, Debrecen, Hungary; [Schulman, Ira G.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, Wurzburg, Germany; [Sauer, Sascha] Max Delbruck Ctr Mol Med BIMSB & BIH, Berlin, Germany; [Deleuze, Jean-Francois] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Nagy, Laszlo] Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Debrecen, Hungary	University of Debrecen; Sanford Burnham Prebys Medical Discovery Institute; University of Manchester; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Virginia; Max Planck Society; University of Wurzburg; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Debrecen	Nagy, L (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary.; Nagy, L (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA.; Nagy, L (corresponding author), Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Debrecen, Hungary.	lnagy@sbpdiscovery.org	Cuaranta, Ixchelt/G-9574-2018; Nagy, Gergely/F-7670-2017; Horvath, Attila/AAA-9075-2020; Allen, Judith E/C-9198-2011; Kiss, Máté/HDL-8582-2022; Bacso, Zsolt/A-3615-2009; Nagy, Laszlo/A-3814-2008; SIMANDI, Zoltan/A-9619-2012	Cuaranta, Ixchelt/0000-0001-7801-7695; Nagy, Gergely/0000-0002-3273-731X; Allen, Judith E/0000-0002-3829-066X; Bacso, Zsolt/0000-0001-6885-3796; Nagy, Laszlo/0000-0001-6653-2155; SIMANDI, Zoltan/0000-0001-8894-1259; Ruckerl, Dominik/0000-0002-0206-1451; Kiss, Mate/0000-0002-5649-0382; Horvath, Attila/0000-0002-6127-8925	Hungarian Scientific Research Fund [K100196, K111941, K116855, K109429]; SBP Medical Discovery Institute; European Sequencing and Genotyping Infrastructure (European Commission, FP7) [26205]; Analytical Genomics Core Facility at the SBP; European Union; European Social Fund; State of Hungary [TAMOP 4.2.4.A/2-11-1-2012-0001]; American Heart Association (AHA) postdoctoral fellowship [17POST33660450]; Medical Research Council UK [MR/K01207X/1]; Bolyai and a Szodoray Postdoctoral Fellowship; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4]; MRC [MR/K01207X/1, MR/K01207X/2] Funding Source: UKRI; Medical Research Council [MR/K01207X/1, MR/K01207X/2] Funding Source: researchfish	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); SBP Medical Discovery Institute; European Sequencing and Genotyping Infrastructure (European Commission, FP7); Analytical Genomics Core Facility at the SBP; European Union(European Commission); European Social Fund(European Social Fund (ESF)); State of Hungary; American Heart Association (AHA) postdoctoral fellowship(American Heart Association); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bolyai and a Szodoray Postdoctoral Fellowship; New National Excellence Program of the Ministry of Human Capacities; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Ms. Cseh, Szalka, Kriston, and Beladi for technical assistance and Dr. Szatmari and members of the Nagy laboratory for discussions and comments on the manuscript. This work was supported by the Hungarian Scientific Research Fund (K100196, K111941, and K116855 to L.N. and K109429 to S.B.) and by SBP Medical Discovery Institute to L. N. Library preparation and bioinformatic analysis were performed at the Genomic Medicine and Bioinformatic Core Facility of the University of Debrecen. RNA sequencing was performed at the Centre National de Genotypage (CNG) Evry, by S. McGinn, A. Boland, D. Lechner, and M.T. Bihoreau and supported by the European Sequencing and Genotyping Infrastructure (funded by the European Commission, FP7/2007-2013) under no. 26205 (ESGI) to L. N., and also at the Analytical Genomics Core Facility at the SBP. Z.C. was supported by funding from the European Union, the European Social Fund, and the State of Hungary (TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program''), B.D. by the American Heart Association (AHA) postdoctoral fellowship (17POST33660450), J.E.A. by the Medical Research Council UK (MR/K01207X/1), S.B. by a Bolyai and a Szodoray Postdoctoral Fellowship, and M.M.B. by the UNKP-17-4 New National Excellence Program of the Ministry of Human Capacities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barta E., 2011, EMBNET J, V17; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Fort MM, 2001, J IMMUNOL, V166, P2793, DOI 10.4049/jimmunol.166.4.2793; GANDINO L, 1990, EXP CELL RES, V188, P192, DOI 10.1016/0014-4827(90)90159-8; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Johnston CJC, 2015, JOVE-J VIS EXP, DOI 10.3791/52412; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ruckerl D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006233; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schmidt SF, 2015, GENOME RES, V25, P1281, DOI 10.1101/gr.188300.114; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thomas GD, 2012, BLOOD, V120, pE93, DOI 10.1182/blood-2012-07-442640; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Yan Q, 2012, P NATL ACAD SCI USA, V109, P14140, DOI 10.1073/pnas.1119842109; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	110	118	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					75	+		10.1016/j.immuni.2017.12.010	http://dx.doi.org/10.1016/j.immuni.2017.12.010			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343442	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-18	WOS:000422751600012
J	Warnatsch, A; Tsourouktsoglou, TD; Branzk, N; Wang, Q; Reincke, S; Herbst, S; Gutierrez, M; Papayannopoulos, V				Warnatsch, Annika; Tsourouktsoglou, Theodora-Dorita; Branzk, Nora; Wang, Qian; Reincke, Susanna; Herbst, Susanne; Gutierrez, Maximiliano; Papayannopoulos, Venizelos			Reactive Oxygen Species Localization Programs Inflammation to Clear Microbes of Different Size	IMMUNITY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; CHRONIC GRANULOMATOUS-DISEASE; NF-KAPPA-B; CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; CYTOKINE PRODUCTION; IN-VIVO; ACTIVATION; RECOGNITION; MYELOPEROXIDASE	How the number of immune cells recruited to sites of infection is determined and adjusted to differences in the cellular stoichiometry between host and pathogen is unknown. Here, we have uncovered a role for reactive oxygen species (ROS) as sensors of microbe size. By sensing the differential localization of ROS generated in response to microbes of different size, neutrophils tuned their interleukin (IL)-1 beta expression via the selective oxidation of NF-kappa B, in order to implement distinct inflammatory programs. Small microbes triggered ROS intracellularly, suppressing IL-1 beta expression to limit neutrophil recruitment as each phagocyte eliminated numerous pathogens. In contrast, large microbes triggered ROS extracellularly, amplifying IL-1 beta expression to recruit numerous neutrophils forming cooperative clusters. Defects in ROS-mediated microbe size sensing resulted in large neutrophil infiltrates and clusters in response to small microbes that contribute to inflammatory disease. These findings highlight the impact of ROSlocalization on signal transduction.	[Warnatsch, Annika; Tsourouktsoglou, Theodora-Dorita; Branzk, Nora; Wang, Qian; Reincke, Susanna; Papayannopoulos, Venizelos] Francis Crick Inst, Antimicrobial Def Lab, 1 Midland Rd, London NW1 1AT, England; [Herbst, Susanne; Gutierrez, Maximiliano] Francis Crick Inst, Host Pathogen Interact TB Lab, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute; Francis Crick Institute	Papayannopoulos, V (corresponding author), Francis Crick Inst, Antimicrobial Def Lab, 1 Midland Rd, London NW1 1AT, England.	veni.p@crick.ac.uk		Gutierrez, Maximiliano/0000-0003-3199-0337; Warnatsch, Annika/0000-0003-2013-1625; Papayannopoulos, Venizelos/0000-0002-3741-8190; Branzk, Nora/0000-0002-5707-855X; Reincke, Susanna/0000-0003-2286-5761	Francis Crick Institute from the UK Medical Research Council [MC_UP_1202/13, FC001129, MC_UP_1202/11, FC001092]; Cancer Research UK [FC001129, FC001092]; Wellcome Trust [FC001129, FC001092]; MRC [MC_UP_1202/13, MC_UP_1202/11] Funding Source: UKRI; Medical Research Council [MC_UP_1202/11, MC_UP_1202/13] Funding Source: researchfish; The Francis Crick Institute [10129, 10092] Funding Source: researchfish	Francis Crick Institute from the UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank B. Stockinger, G. Kassiotis, and D. Anastasiou for comments, H. Aegerter for help with BCG S. pneumoniae, and P. Thorpe and E. Herrero-Serrano for S. cerevisiae strains. This work was supported by the Francis Crick Institute which receives its core funding from the UK Medical Research Council (MC_UP_1202/13, FC001129, MC_UP_1202/11, FC001092), Cancer Research UK (FC001129, FC001092), and the Wellcome Trust (FC001129, FC001092).	Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bagaitkar J, 2015, BLOOD, V126, P2724, DOI 10.1182/blood-2015-05-644773; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Caffrey AK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004625; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; DEVALON ML, 1987, INFECT IMMUN, V55, P2398, DOI 10.1128/IAI.55.10.2398-2403.1987; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Han W, 2013, J IMMUNOL, V190, P4786, DOI 10.4049/jimmunol.1201809; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Huang XF, 2015, CELL REP, V12, P1120, DOI 10.1016/j.celrep.2015.07.021; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Kashem SW, 2015, IMMUNITY, V42, P356, DOI 10.1016/j.immuni.2015.01.008; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Malachowa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158293; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Plato A, 2015, SEMIN IMMUNOPATHOL, V37, P97, DOI 10.1007/s00281-014-0462-4; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	53	110	115	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					421	432		10.1016/j.immuni.2017.02.013	http://dx.doi.org/10.1016/j.immuni.2017.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28314592	Green Published, hybrid			2022-12-18	WOS:000396818100014
J	Conde, P; Rodriguez, M; van der Touw, W; Jimenez, A; Burns, M; Miller, J; Brahmachary, M; Chen, HM; Boros, P; Rausell-Palamos, F; Yun, TJ; Riquelme, P; Rastrojo, A; Aguado, B; Stein-Streilein, J; Tanaka, M; Zhou, L; Zhang, JF; Lowary, TL; Ginhoux, F; Park, CG; Cheong, C; Brody, J; Turley, SJ; Lira, SA; Bronte, V; Gordon, S; Heeger, PS; Merad, M; Hutchinson, J; Chen, SH; Ochando, J				Conde, Patricia; Rodriguez, Mercedes; van der Touw, William; Jimenez, Ana; Burns, Matthew; Miller, Jennifer; Brahmachary, Manisha; Chen, Hui-ming; Boros, Peter; Rausell-Palamos, Francisco; Yun, Tae Jin; Riquelme, Paloma; Rastrojo, Alberto; Aguado, Begona; Stein-Streilein, Joan; Tanaka, Masato; Zhou, Lan; Zhang, Junfeng; Lowary, Todd L.; Ginhoux, Florent; Park, Chae Gyu; Cheong, Cheolho; Brody, Joshua; Turley, Shannon J.; Lira, Sergio A.; Bronte, Vincenzo; Gordon, Siamon; Heeger, Peter S.; Merad, Miriam; Hutchinson, James; Chen, Shu-Hsia; Ochando, Jordi			DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance	IMMUNITY			English	Article							REGULATORY T-CELLS; MOUSE DC-SIGN; DENDRITIC CELL; SUPPRESSOR-CELLS; INFLAMMATORY MONOCYTES; DIFFERENTIATION; ANTIGEN; EXPRESSION; RECEPTOR; GLYCOSYLATION	Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T cell immunity and promoted CD4(+)Foxp3(+) Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages in vivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.	[Conde, Patricia; Burns, Matthew; Heeger, Peter S.; Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10129 USA; [Rodriguez, Mercedes] Inst Salud Carlos III, Ctr Nacl Microbiol, Immunol Trasplantes, Madrid 28220, Spain; [van der Touw, William; Jimenez, Ana; Miller, Jennifer; Chen, Hui-ming; Brody, Joshua; Merad, Miriam; Chen, Shu-Hsia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10129 USA; [Brahmachary, Manisha] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10129 USA; [Boros, Peter] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10129 USA; [Rausell-Palamos, Francisco] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10129 USA; [Yun, Tae Jin; Cheong, Cheolho] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Riquelme, Paloma; Hutchinson, James] Univ Hosp Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Rastrojo, Alberto; Aguado, Begona] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Stein-Streilein, Joan] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Lab Immune Regulat, Tokyo 1920392, Japan; [Zhou, Lan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Junfeng; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Zhang, Junfeng; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Park, Chae Gyu] Yonsei Univ, Coll Med, Immunol Lab, Seoul 120752, South Korea; [Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02284 USA; [Lira, Sergio A.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10129 USA; [Bronte, Vincenzo] Verona Univ Hosp, I-37129 Verona, Italy; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England	Icahn School of Medicine at Mount Sinai; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Regensburg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Harvard University; Harvard Medical School; Schepens Eye Research Institute; Tokyo University of Pharmacy & Life Sciences; Case Western Reserve University; University of Alberta; University of Alberta; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yonsei University; Yonsei University Health System; Harvard University; Dana-Farber Cancer Institute; Icahn School of Medicine at Mount Sinai; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Oxford	Ochando, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10129 USA.	jordi.ochando@mssm.edu	Hutchinson, James Alexander/H-3401-2019; Aguado, Begoña/R-4496-2019; Ochando, Jordi/B-6219-2008; Rastrojo, Alberto/N-4607-2014; Bronte, Vincenzo/K-7902-2016; ROMAN, paTRICIA CONDE-SAN/AAA-7525-2020; Ochando, jordi/ABE-2358-2020; Lowary, Todd L/F-9608-2019	Hutchinson, James Alexander/0000-0002-1199-4210; Ochando, Jordi/0000-0001-7037-1681; Rastrojo, Alberto/0000-0003-4381-7267; Bronte, Vincenzo/0000-0002-3741-5141; Ochando, jordi/0000-0001-7037-1681; Lowary, Todd L/0000-0002-8331-8211; Park, Chae Gyu/0000-0003-1906-1308; Aguado, Begona/0000-0003-4043-6944; Conde, Patricia/0000-0002-9346-305X	COST Action: Action to Focus and Accelerate Cell Tolerogenic Therapies (A FACTT) [BM1305]; Mount Sinai Recanati/Miller Transplantation Institute developmental funds; AST/Pfizer Basic Science Faculty Development Grant; Ministerio de Educacion y Ciencia [SAF2010-15062, SAF2013-48834-R]; Fundacion Mutua Madrilena grant; NATIONAL CANCER INSTITUTE [R01CA109322, R01CA173861, R01CA190400, R01CA127483] Funding Source: NIH RePORTER	COST Action: Action to Focus and Accelerate Cell Tolerogenic Therapies (A FACTT); Mount Sinai Recanati/Miller Transplantation Institute developmental funds; AST/Pfizer Basic Science Faculty Development Grant; Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andres Hidalgo (Centro Nacional de Investigaciones Cardiovasculares, ISCIII) and Emmanuel Gautier (Department of Pathology & Immunology, Washington University) for critical review of the manuscript. We acknowledge the technical contributions of the Flow Cytometry, Microsurgery, and the Biorepository/Pathology Centers of Research Excellence at Mount Sinai, and the Alberta Glycomics Centre for their help on the LNFPIII synthesis. Acknowledgments to Marcy Kuentzel and Sridar Chittur at the University of Albany Center for Functional Genomics Microarray Core facility for their assistance in generating the microarray data. This work was supported by the COST Action BM1305: Action to Focus and Accelerate Cell Tolerogenic Therapies (A FACTT), the Mount Sinai Recanati/Miller Transplantation Institute developmental funds, AST/Pfizer Basic Science Faculty Development Grant, Ministerio de Educacion y Ciencia SAF2010-15062, SAF2013-48834-R, and Fundacion Mutua Madrilena grants to J.O. A portion of this work appears as part of the doctoral thesis of P.C.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bronte V, 1998, J IMMUNOL, V161, P5313; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Cai MC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-103; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Garcia-Vallejo JJ, 2014, J EXP MED, V211, P1457, DOI 10.1084/jem.20122192; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Gorbachev AV, 2004, J IMMUNOL, V173, P2443, DOI 10.4049/jimmunol.173.4.2443; GREGORY SH, 1992, J IMMUNOL, V149, P188; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; JUTILA MA, 1988, EUR J IMMUNOL, V18, P1819, DOI 10.1002/eji.1830181125; Li GL, 2004, BIOCHEM BIOPH RES CO, V322, P637, DOI 10.1016/j.bbrc.2004.07.172; Li GL, 2005, J IMMUNOL, V174, P4706, DOI 10.4049/jimmunol.174.8.4706; LOKESHWAR BL, 1988, J IMMUNOL, V141, P483; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Parker KH, 2014, CANCER RES, V74, P5723, DOI 10.1158/0008-5472.CAN-13-2347; Garcia MR, 2010, J CLIN INVEST, V120, P2486, DOI 10.1172/JCI41628; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Sudo T, 1995, ONCOGENE, V11, P2469; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zhang W, 2008, TRANSPLANTATION, V86, P1125, DOI 10.1097/TP.0b013e318186fccd	54	110	115	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1143	1158		10.1016/j.immuni.2015.05.009	http://dx.doi.org/10.1016/j.immuni.2015.05.009			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26070485	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000356362800018
J	Lee, JY; Skon, CN; Lee, YJ; Oh, S; Taylor, JJ; Malhotra, D; Jenkins, MK; Rosenfeld, MG; Hogquist, KA; Jameson, SC				Lee, June-Yong; Skon, Cara N.; Lee, You Jeong; Oh, Soohwan; Taylor, Justin J.; Malhotra, Deepali; Jenkins, Marc K.; Rosenfeld, M. Geoffrey; Hogquist, Kristin A.; Jameson, Stephen C.			The Transcription Factor KLF2 Restrains CD4(+) T Follicular Helper Cell Differentiation	IMMUNITY			English	Article							KRUPPEL-LIKE FACTOR-2; L-SELECTIN; NEGATIVE REGULATOR; GERMINAL-CENTERS; MEMORY; RECEPTOR; EFFECTOR; BCL6; EXPRESSION; EGRESS	T follicular helper (Tfh) cells are essential for efficient B cell responses, yet the factors that regulate differentiation of this CD4(+) T cell subset are incompletely understood. Here we found that the KLF2 transcription factor serves to restrain Tfh cell generation. Induced KLF2 deficiency in activated CD4(+) T cells led to increased Tfh cell generation and B cell priming, whereas KLF2 overexpression prevented Tfh cell production. KLF2 promotes expression of the trafficking receptor S1PR1, and S1PR1 downregulation is essential for efficient Tfh cell production. However, KLF2 also induced expression of the transcription factor Blimp-1, which repressed transcription factor Bcl-6 and thereby impaired Tfh cell differentiation. Furthermore, KLF2 induced expression of the transcription factors T-bet and GATA3 and enhanced Th1 differentiation. Hence, our data indicate KLF2 is pivotal for coordinating CD4(+) T cell differentiation through two distinct and complementary mechanisms: via control of T cell localization and by regulation of lineage-defining transcription factors.	[Lee, June-Yong; Skon, Cara N.; Lee, You Jeong; Taylor, Justin J.; Malhotra, Deepali; Jenkins, Marc K.; Hogquist, Kristin A.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55414 USA; [Lee, June-Yong; Skon, Cara N.; Lee, You Jeong; Hogquist, Kristin A.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA; [Taylor, Justin J.; Malhotra, Deepali; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55414 USA; [Oh, Soohwan; Rosenfeld, M. Geoffrey] Howard Hughes Med Inst, Chevy Chase, MD USA; [Oh, Soohwan; Rosenfeld, M. Geoffrey] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of California System; University of California San Diego	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55414 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013; Jenkins, Marc K/G-1063-2012; Lee, You Jeong/T-6086-2019	Jameson, Stephen C/0000-0001-9137-1146; Jenkins, Marc K/0000-0001-8009-7655; Skon-Hegg, Cara/0000-0003-0703-3553; Lee, June-Yong/0000-0002-4476-725X; Malhotra, Deepali/0000-0002-8215-7639	NIH [R37 AI38903]; NATIONAL CANCER INSTITUTE [T32CA009138, P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039560, R37AI038903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Hugh Rosen (Research Institute of Scripps Clinic) for S1PR1-GFP reporter mice; Kathy Pape, and Jessica Yang (UMN) for practical advice; Phil Nance and Shane Crotty (LIAI, La Jolla) for reagents and wise suggestions, and the Jamequist lab for intellectual input. This work was supported by NIH award R37 AI38903 (to SCJ).	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Pabbisetty SK, 2014, P NATL ACAD SCI USA, V111, P9579, DOI 10.1073/pnas.1323493111; PALIARD X, 1988, J IMMUNOL, V141, P849; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097953; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Zachariah Marcus A, 2009, F1000 Biol Rep, V1, P60, DOI 10.3410/B1-60; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	57	110	115	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					252	264		10.1016/j.immuni.2015.01.013	http://dx.doi.org/10.1016/j.immuni.2015.01.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692701	Green Accepted, Bronze			2022-12-18	WOS:000349916400010
J	Yamashita, M; Hirahara, K; Shinnakasu, R; Hosokawa, H; Norikane, S; Kimura, MY; Hasegawa, A; Nakayama, T				Yamashita, Masakatsu; Hirahara, Kiyoshi; Shinnakasu, Ryo; Hosokawa, Hiroyuki; Norikane, Satoko; Kimura, Motoko Y.; Hasegawa, Akihiro; Nakayama, Toshinori			Crucial role of MLL for the maintenance of memory T helper type 2 cell responses	IMMUNITY			English	Article							11Q23 CHROMOSOMAL TRANSLOCATIONS; TRANSCRIPTION FACTOR GATA-3; HISTONE METHYLTRANSFERASE; DROSOPHILA-TRITHORAX; MAMMALIAN TRITHORAX; GENE-EXPRESSION; DYNAMIC CHANGES; ACUTE LEUKEMIAS; MUTANT MICE; TH2 CELLS	The Mixed-Lineage Leukemia (MLL) gene, a mammalian homolog of the Drosophila trithorax, is implicated in regulating the maintenance of Hox gene expression and hematopoiesis. The physiological functions of MLL in the immune system remain largely unknown. Although MLL+/- CD4 T cells differentiate normally into antigen-specific effector Th1/Th2 cells in vitro, the ability of memory Th2 cells to produce Th2 cyto-kines was selectively reduced. Furthermore, histone modifications at the Th2 cytokine gene loci were not properly maintained in MLL+/- memory Th2 cells. The reduced expression of MLL in memory Th2 cells resulted in decreased GATA3 expression accompanied with impaired GATA3 locus histone modifications. The direct association of MLL with the GATA3 locus and the Th2 cytokine gene loci was demonstrated. Memory Th2 cell-dependent allergic airway inflammation was decreased in MLL+/- Th2 cell-transferred mice. Thus, a crucial role for MLL in the maintenance of memory Th2 cell function is indicated.	Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan	Chiba University	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017; Hirahara, Kiyoshi/E-2460-2017	Nakayama, Toshinori/0000-0002-1434-2007; Hirahara, Kiyoshi/0000-0002-9128-9449; Hosokawa, Hiroyuki/0000-0002-9592-2889				Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kamata T, 2003, J CLIN INVEST, V111, P109, DOI 10.1172/JCI200315719; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	58	110	113	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					611	622		10.1016/j.immuni.2006.03.017	http://dx.doi.org/10.1016/j.immuni.2006.03.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713978	Bronze			2022-12-18	WOS:000237970100017
J	Tudor, KSRS; Payne, KJ; Yamashita, Y; Kincade, PW				Tudor, KSRS; Payne, KJ; Yamashita, Y; Kincade, PW			Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; HEAT-STABLE ANTIGEN; INTERLEUKIN-7 RECEPTOR; SURFACE ANTIGENS; NATURAL-KILLER; MOUSE; IDENTIFICATION; PROGENITORS; EXPRESSION	Most lineage marker-negative (Lin(-))TdT(+) cells from murine marrow lack CD34 but display c-kit at low density as well as IL-7R alpha and FIk-2/FIt-3 receptors. Single cells with these characteristics generated CD45RA(+)CD19(-) as well as CD19(+) lymphocytes in culture. CD45RA+CD19- marrow cells were resolved into three nonoverlapping subsets. One subset, lacking DX5 and Ly-6C antigens, yielded CD19(+) cells in culture. Further analysis demonstrated CD24 on most Lin(-)TdT(+) cells and all CD45R(+)CD19(-)DX5(-)Ly-6C(-) cells. Mac-1/CD11b was absent from these two subsets of B lineage precursors, while IL-7R alpha was retained during subsequent differentiation to a CD19(+) and stromal cell-independent stage. These findings contrast with previous descriptions of B lymphocyte precursors and suggest a sequence of early differentiation events.	Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu	Payne, Kimberly/AAS-6814-2020	Payne, Kimberly/0000-0002-7025-5821	NIAID NIH HHS [AI-33085, AI-20069] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033085, R01AI020069, R37AI020069] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; ANTICA M, 1994, BLOOD, V84, P111; BANCHEREAU J, 1992, ADV IMMUNOL, V52, P125, DOI 10.1016/S0065-2776(08)60876-7; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; BRIGHTMAN BK, 1995, CELL IMMUNOL, V160, P297, DOI 10.1016/0008-8749(95)80041-G; Chappel MS, 1996, J EXP MED, V184, P1639, DOI 10.1084/jem.184.5.1639; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYASHI SI, 1990, J EXP MED, V171, P1683, DOI 10.1084/jem.171.5.1683; Hirayama F, 1999, BLOOD, V93, P4187, DOI 10.1182/blood.V93.12.4187.412k07_4187_4195; Hough MR, 1996, J IMMUNOL, V156, P479; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Hunte BE, 1998, EUR J IMMUNOL, V28, P3850; KINCADE PW, 1981, J IMMUNOL, V127, P2262; KINCADE PW, 2000, IN PRESS IMMUNOL REV; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LeBein TW, 1998, CURR OPIN IMMUNOL, V10, P188, DOI 10.1016/S0952-7915(98)80248-3; LEE RE, 1989, J CLIN ONCOL, V7, P7, DOI 10.1200/JCO.1989.7.1.7; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Liu Yongde, 1994, COSTIMULATORY PATHWA, P41; Lu LW, 1998, EUR J IMMUNOL, V28, P1755, DOI 10.1002/(SICI)1521-4141(199806)28:06<1755::AID-IMMU1755>3.0.CO;2-3; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; MILLER BA, 1985, J IMMUNOL, V134, P3286; MONTECINORODRIGUEZ E, 1994, HYBRIDOMA, V13, P175, DOI 10.1089/hyb.1994.13.175; Moore TA, 1996, J IMMUNOL, V157, P2366; MORELAND K, 1996, AM STUD INT, V34, P88; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Ortiz M, 1999, IMMUNITY, V10, P173, DOI 10.1016/S1074-7613(00)80018-7; Osmond D G, 1990, Semin Immunol, V2, P173; PARK YH, 1989, EUR J IMMUNOL, V19, P2139, DOI 10.1002/eji.1830191125; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rebel VI, 1996, EXP HEMATOL, V24, P638; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROLINK A, 1993, CURR OPIN IMMUNOL, V5, P207, DOI 10.1016/0952-7915(93)90006-E; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Ryan DH, 1997, BLOOD, V89, P929, DOI 10.1182/blood.V89.3.929; Schlueter AJ, 1997, J IMMUNOL, V158, P4211; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519	44	110	110	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2000	12	3					335	345		10.1016/S1074-7613(00)80186-7	http://dx.doi.org/10.1016/S1074-7613(00)80186-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755620	Bronze			2022-12-18	WOS:000086292100011
J	Paz, P; Brouwenstijn, N; Perry, R; Shastri, N				Paz, P; Brouwenstijn, N; Perry, R; Shastri, N			Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; IMMUNODOMINANT VIRAL PEPTIDE; TAP; TRANSPORTER; MOLECULES; PROTEASOME; PROTEINS; CELLS; TRANSLOCATION; GENERATION	The antigen processing pathway generates the peptides displayed by MHC I molecules on the cell surface. Whether these peptides are generated in the cytosol or from longer intermediates transported into the ER is unclear, because peptides other than those bound to MHC I have been difficult to find. Using a novel assay, we show that N-terminally extended antigenic analogs were associated with high-molecular weight material in the cytosol and were transported by TAP. In the ER, a nonapeptide was predominant that was converted to the final octapeptide only in presence of the appropriate MHC I molecule. The existence of extended peptides and their MHC I-dependent trimming suggest a mechanism for efficiently satisfying the distinct sequence preferences of polymorphic MHC I molecules.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu						ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; DICK LR, 1994, J IMMUNOL, V152, P3884; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Monaco JJ, 1995, ANNU REV GENET, V29, P729, DOI 10.1146/annurev.ge.29.120195.003501; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEISIG A, 1995, J IMMUNOL, V154, P1273; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; OTSU M, 1995, J BIOL CHEM, V270, P14958, DOI 10.1074/jbc.270.25.14958; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; Serwold T, 1999, J IMMUNOL, V162, P4712; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; VANBLEEK GM, 1990, NATURE, V348, P213; YellenShaw AJ, 1997, J EXP MED, V186, P1655, DOI 10.1084/jem.186.10.1655; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	39	110	113	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					241	251		10.1016/S1074-7613(00)80099-0	http://dx.doi.org/10.1016/S1074-7613(00)80099-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485659	Bronze			2022-12-18	WOS:000082383400013
J	VILLANUEVA, MS; FISCHER, P; FEEN, K; PAMER, EG				VILLANUEVA, MS; FISCHER, P; FEEN, K; PAMER, EG			EFFICIENCY OF MHC CLASS-I ANTIGEN-PROCESSING - A QUANTITATIVE-ANALYSIS	IMMUNITY			English	Article							CYTOTOXIC LYMPHOCYTES-T; GRAM-POSITIVE BACTERIA; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; MAMMALIAN-CELLS; IAP GENE; PEPTIDES; IDENTIFICATION; IMMUNITY; MOLECULE	Listeria monocytogenes is an intracellular pathogen that secretes proteins into host cell cytosol. One such protein, the murein hydrolase p60, is processed by the host cell into the nonamer peptide p60 217-225 and presented to cytotoxic T lymphocytes by the H-2K(d) MHC class I molecule. Using strains of L. monocytogenes that secrete different amounts of p60, we show that the rate of p60 217-225 production is proportional to the quantity of intracellular antigen. The appearance of p60 217-225 is coupled to the degradation of newly synthesized p60. By accounting for the rate of intracellular antigen secretion and degradation, we estimate that approximately 35 p60 molecules are degraded to produce one p60 217-225 epitope. These findings provide an estimate of the efficiency of antigen processing and shed light on the capacity of the MHC class I antigen processing pathway to accommodate foreign antigens.			VILLANUEVA, MS (corresponding author), YALE UNIV,SCH MED,INFECT DIS SECT,CLIN INVEST LAB 803,333 CEDAR ST,NEW HAVEN,CT 06520, USA.							ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; BERCHE P, 1987, J IMMUNOL, V138, P2266; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; BISHOP DK, 1987, J IMMUNOL, V139, P2005; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BRUNT LM, 1990, J IMMUNOL, V145, P3540; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; EISENLOHR LC, 1992, J EXP MED, V175, P481, DOI 10.1084/jem.175.2.481; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; GENTSCHEV I, 1992, INFECT IMMUN, V60, P5091, DOI 10.1128/IAI.60.12.5091-5098.1992; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KAUFMANN SHE, 1988, J IMMUNOL, V140, P3173; KOHLER S, 1991, J BACTERIOL, V173, P4668; KUHN M, 1989, INFECT IMMUN, V57, P55, DOI 10.1128/IAI.57.1.55-61.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; PAMER EG, 1993, CURR OPIN IMMUNOL, V5, P492, DOI 10.1016/0952-7915(93)90028-Q; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Tilney Lewis G., 1993, Trends in Microbiology, V1, P25, DOI 10.1016/0966-842X(93)90021-I; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TRIEUCUOT P, 1987, FEMS MICROBIOL LETT, V48, P289, DOI 10.1016/0378-1097(87)90178-9; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; WIPKE BT, 1993, EUR J IMMUNOL, V23, P2005, DOI 10.1002/eji.1830230842; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993	40	110	112	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					479	489		10.1016/1074-7613(94)90090-6	http://dx.doi.org/10.1016/1074-7613(94)90090-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7534616				2022-12-18	WOS:A1994PK17100005
J	CROOKS, MEC; LITTMAN, DR				CROOKS, MEC; LITTMAN, DR			DISRUPTION OF T-LYMPHOCYTE POSITIVE AND NEGATIVE SELECTION IN MICE LACKING THE CD8 BETA-CHAIN	IMMUNITY			English	Article								The CD4 and CD8 coreceptors have been shown to play significant roles in the differentiation and activation of helper and cytotoxic T lymphocytes (CTLs), respectively. Coordinate binding of coreceptor and T cell receptor (TCR) to the same major histocompatibility complex (MHC) molecule and coreceptor interaction with the tyrosine kinase p56(lck) are required for effective signaling. Whereas CD4 is a monomer, CD8 consists of either alpha alpha homodimers or alpha beta heterodimers. Signaling properties of CD8 have been ascribed to the alpha chain, which binds to both the MHC class I and to p56(lck), respectively. To study CD8 beta specifically, we have generated mice defective in its expression. We observe a significant reduction in the numbers of CD8(+) T cells, but these cells have normal CTL activity. By breeding CD8 beta(null) mice with animals expressing a class I-specific TCR transgene, we show that CD8 beta plays a significant role in both positive and negative selection of developing thymocytes.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	CROOKS, MEC (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT IMMUNOL & MICROBIOL, SAN FRANCISCO, CA 94143 USA.				PHS HHS [R01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADLRICH CJ, 1991, NATURE, V352, P718; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CRISPE IN, 1987, J IMMUNOL, V138, P2013; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P212, DOI 10.1002/eji.1830230133; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; INGOLD AL, 1991, NATURE, V352, P721, DOI 10.1038/352721a0; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; KILLEEN N, 1993, PHILOS T ROY SOC B, V342, P25, DOI 10.1098/rstb.1993.0131; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; KRUISBEEK AM, 1992, CURRENT PROTOCOLS IM; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; NAKAYAMA K, 1989, J IMMUNOL, V142, P2540; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; OROURKE AM, 1993, IMMUNOL TODAY, V14, P183; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; PARNES JR, 1989, ADV IMMUNOL, V44, P265; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SCHILHAM MW, 1993, EUR J IMMUNOL, V23, P1299, DOI 10.1002/eji.1830230617; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TORRESNAGEL N, 1992, EUR J IMMUNOL, V22, P2841, DOI 10.1002/eji.1830221113; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WALLACE VA, 1993, CURR OPIN IMMUNOL, V5, P235, DOI 10.1016/0952-7915(93)90010-P; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; WUNDERLICH J, 1992, CURRENT PROTOCOLS IM; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	55	110	110	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1994	1	4					277	285						9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889415				2022-12-18	WOS:A1994PK16600005
J	CHEN, CY; NABAVI, N				CHEN, CY; NABAVI, N			IN-VITRO INDUCTION OF T-CELL ANERGY BY BLOCKING B7 AND EARLY T-CELL COSTIMULATORY MOLECULE ETC-1 B7-2	IMMUNITY			English	Article							CYTOKINE GENE-EXPRESSION; CTLA-4 COUNTER-RECEPTOR; ANTIGEN PRESENTATION; ACCESSORY CELLS; LYMPHOCYTES-T; ACTIVATION; CD28; INTERLEUKIN-2; LIGAND; PROLIFERATION	APC-associated B7 and ETC-1/B7-2 are two major costimulatory molecules for full activation of T lymphocytes during auto- and allogeneic immune responses. In this report, we further examine the role of the two molecules in murine CD4(+) T cell activation and anergy development. As suggested in antibody blocking studies, optimal activation of CD4(+) T eels in response to anti-CD3 stimulation requires collaborative signaling through the two molecules. Simultaneous blockade of B7 and ETC-1/B7-2 renders CD4(+) T cells unresponsive to anti-CD3 restimulation. PCR analysis and cytokine reconstitution studies show that the observed unresponsiveness is correlated to a significant reduction of Th1- type cytokine production, suggesting B7 and ETC-1/B7-2-mediated costimulatory signaling may be specifically active in regulation of the function of the Th1 subset.			CHEN, CY (corresponding author), HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT INFLAMMAT & AUTOIMMUNE DIS,NUTLEY,NJ 07110, USA.							AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; CHEN C, 1994, IN PRESS J IMMUNOL; CHEN CY, 1994, J IMMUNOL, V152, P2105; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; DAMLE NK, 1992, J IMMUNOL, V148, P1985; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; GERMANN T, 1993, EUR J IMMUNOL, V23, P1762, DOI 10.1002/eji.1830230805; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JENKINS MK, 1987, IMMUNOL REV, V95, P113, DOI 10.1111/j.1600-065X.1987.tb00502.x; KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759; KRIEGER JI, 1985, J IMMUNOL, V135, P2937; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MUELLER DL, 1989, J IMMUNOL, V142, P2617; MURRAY LJ, 1990, EUR J IMMUNOL, V20, P163, DOI 10.1002/eji.1830200124; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; SVETIC A, 1991, J IMMUNOL, V147, P2391; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; VANSEVENTER GA, 1991, J EXP MED, V174, P901, DOI 10.1084/jem.174.4.901; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; VANSEVENTER GA, 1991, CURR OPIN IMMUNOL, V3, P294, DOI 10.1016/0952-7915(91)90027-X; WEAVER CT, 1990, IMMUNOL TODAY, V11, P49; WONG HL, 1988, CELL IMMUNOL, V111, P39, DOI 10.1016/0008-8749(88)90049-4	40	110	118	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					147	154		10.1016/1074-7613(94)90108-2	http://dx.doi.org/10.1016/1074-7613(94)90108-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7534198				2022-12-18	WOS:A1994PK16200007
J	Seidman, JS; Troutman, TD; Sakai, M; Gola, A; Spann, NJ; Bennett, H; Bruni, CM; Ouyang, ZY; Li, RZ; Sun, XL; Vu, BT; Pasillas, MP; Ego, KM; Gosselin, D; Link, VM; Chong, LW; Evans, RM; Thompson, BM; McDonald, JG; Hosseini, M; Witztum, JL; Germain, RN; Glass, CK				Seidman, Jason S.; Troutman, Ty D.; Sakai, Mashito; Gola, Anita; Spann, Nathanael J.; Bennett, Hunter; Bruni, Cassi M.; Ouyang, Zhengyu; Li, Rick Z.; Sun, Xiaoli; Vu, BaoChau T.; Pasillas, Martina P.; Ego, Kaori M.; Gosselin, David; Link, Verena M.; Chong, Ling-Wa; Evans, Ronald M.; Thompson, Bonne M.; McDonald, Jeffrey G.; Hosseini, Mojgan; Witztum, Joseph L.; Germain, Ronald N.; Glass, Christopher K.			Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis	IMMUNITY			English	Article							FATTY LIVER-DISEASE; MACROPHAGES; FIBROSIS; LINEAGE; RESOLUTION; ENHANCERS; MONOCYTES; SELECTION; PATHWAYS; REVEALS	Tissue-resident and recruited macrophages contribute to both host defense and pathology. Multiple macrophage phenotypes are represented in diseased tissues, but we lack deep understanding of mechanisms controlling diversification. Here, we investigate origins and epigenetic trajectories of hepatic macrophages during diet-induced non-alcoholic steatohepatitis (NASH). The NASH diet induced significant changes in Kupffer cell enhancers and gene expression, resulting in partial loss of Kupffer cell identity, induction of Trem2 and Cd9 expression, and cell death, Kupffer cell loss was compensated by gain of adjacent monocyte-derived macrophages that exhibited convergent epigenomes, transcriptomes, and functions. NASH-induced changes in Kupffer cell enhancers were driven by AP-1 and EGR that reprogrammed LXR functions required for Kupffer cell identity and survival to instead drive a scar-associated macrophage phenotype. These findings reveal mechanisms by which disease-associated environmental signals instruct resident and recruited macrophages to acquire distinct gene expression programs and corresponding functions.	[Seidman, Jason S.; Troutman, Ty D.; Sakai, Mashito; Spann, Nathanael J.; Bennett, Hunter; Bruni, Cassi M.; Ouyang, Zhengyu; Li, Rick Z.; Vu, BaoChau T.; Pasillas, Martina P.; Ego, Kaori M.; Link, Verena M.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Troutman, Ty D.; Sun, Xiaoli; Witztum, Joseph L.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gola, Anita; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20189 USA; [Gosselin, David] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Link, Verena M.] Ludwig Maximilian Univ Munich, Fac Biol, Div Evolutionary Biol, Munich, Germany; [Chong, Ling-Wa; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Thompson, Bonne M.; McDonald, Jeffrey G.] UT Southwestern Med Ctr, Ctr Human Nutr, Dallas, TX USA; [Hosseini, Mojgan] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Laval University; University of Munich; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Troutman, TD; Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Troutman, TD; Glass, CK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	ttroutman@health.ucsd.edu; ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021; Germain, Ronald/ABE-7090-2020	Glass, Christopher/0000-0003-4344-3592; Evans, Ronald/0000-0002-9986-5965; Sakai, Mashito/0000-0002-4908-2727; Thompson, Bonne/0000-0001-7563-8330; Chong, Ling Wa/0000-0002-8571-5413; Troutman, Ty/0000-0001-8925-8080; Bennett, Hunter/0000-0002-8495-1545	NIH [DK091183, HL088083, DK063491, GM085764, 5T32DK007541]; Fondation Leducq [16CVD01]; American Heart Association Fellowship [16PRE30980030]; NRSA [T32CA009523]; Manpei Suzuki Diabetes Foundation of Tokyo, Japan; Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan; American Heart Association [18POST34060088]; Intramural Research program of NIAID, NIH;  [P30 DK063491];  [T32DK007044]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association Fellowship(American Heart Association); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation of Tokyo, Japan; Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan; American Heart Association(American Heart Association); Intramural Research program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; 	These studies were supported by NIH grants DK091183, HL088083, DK063491, and GM085764 and Fondation Leducq grant 16CVD01. J.S.S. was supported by American Heart Association Fellowship 16PRE30980030 and NIH Predoctoral Training grant 5T32DK007541. T.D.T. was supported by P30 DK063491, T32DK007044, and NRSA T32CA009523. M.S. was supported by the Manpei Suzuki Diabetes Foundation of Tokyo, Japan and the Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan. X.S. was supported by the American Heart Association grant 18POST34060088. This work was also supported in part by the Intramural Research program of NIAID, NIH.	Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eichenfield DZ, 2016, ELIFE, V5, DOI 10.7554/eLife.13024; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haas JT, 2016, ANNU REV PHYSIOL, V78, P181, DOI 10.1146/annurev-physiol-021115-105331; Hall D, 2010, J BIOL CHEM, V285, P31011, DOI 10.1074/jbc.M110.127159; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Heinz S, 2018, CELL, V174, P1522, DOI 10.1016/j.cell.2018.07.047; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Holtman IR, 2017, J CLIN INVEST, V127, P3220, DOI 10.1172/JCI90604; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiss M, 2018, CELL IMMUNOL, V330, P188, DOI 10.1016/j.cellimm.2018.02.008; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krenkel O, 2018, HEPATOLOGY, V67, P1270, DOI 10.1002/hep.29544; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Love M.I., 2014, GASTROENTEROLOGY, V15, P550; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Muse ED, 2018, P NATL ACAD SCI USA, V115, pE4680, DOI 10.1073/pnas.1714518115; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pirzgalska RM, 2018, CELL IMMUNOL, V330, P183, DOI 10.1016/j.cellimm.2018.04.014; Poussin C, 2011, DIABETES, V60, P2216, DOI 10.2337/db11-0338; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Rinella ME, 2016, NAT REV GASTRO HEPAT, V13, P196, DOI 10.1038/nrgastro.2016.3; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Shook BA, 2018, SCIENCE, V362, P909, DOI 10.1126/science.aar2971; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	71	109	110	5	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1057	+		10.1016/j.immuni.2020.04.001	http://dx.doi.org/10.1016/j.immuni.2020.04.001			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32362324	Bronze, Green Accepted			2022-12-18	WOS:000541890000018
J	Lim, HY; Lim, SY; Tan, CK; Thiam, CH; Goh, CC; Carbajo, D; Chew, SHS; See, P; Chakarov, S; Wang, XN; Lim, LH; Johnson, LA; Lum, J; Fong, CY; Bongso, A; Biswas, A; Goh, C; Evrard, M; Yeo, KP; Basu, R; Wang, JK; Tan, Y; Jain, R; Tikoo, S; Choong, C; Weninger, W; Poidinger, M; Stanley, RE; Collin, M; Tan, NS; Ng, LG; Jackson, DG; Ginhoux, F; Angeli, V				Lim, Hwee Ying; Lim, Sheau Yng; Tan, Chek Kun; Thiam, Chung Hwee; Goh, Chi Ching; Carbajo, Daniel; Chew, Samantha Hui Shang; See, Peter; Chakarov, Svetoslav; Wang, Xiao Nong; Lim, Li Hui; Johnson, Louise A.; Lum, Josephine; Fong, Chui Yee; Bongso, Ariff; Biswas, Arijit; Goh, Chern; Evrard, Maximilien; Yeo, Kim Pin; Basu, Ranu; Wang, Jun Kit; Tan, Yingrou; Jain, Rohit; Tikoo, Shweta; Choong, Cleo; Weninger, Wolfgang; Poidinger, Michael; Stanley, Richard E.; Collin, Matthew; Tan, Nguan Soon; Ng, Lai Guan; Jackson, David G.; Ginhoux, Florent; Angeli, Veronique			Hyaluronan ReceptorLYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen	IMMUNITY			English	Article							ENDOTHELIAL RECEPTOR LYVE-1; GENE-EXPRESSION; DENDRITIC CELLS; LYVE-1-POSITIVE MACROPHAGES; MATRIX METALLOPROTEINASES; CIRCULATING MONOCYTES; CARDIAC MACROPHAGES; TISSUE; MICE; ATHEROSCLEROSIS	The maintenance of appropriate arterial tone is critically important for normal physiological arterial function. However, the cellular and molecular mechanisms remain poorly defined. Here, we have shown that in the mouse aorta, resident macrophages prevented arterial stiffness and collagen deposition in the steady state. Using phenotyping, transcriptional profiling, and targeted deletion of Csf1r, we have demonstrated that these macrophages-which are a feature of blood vessels invested with smooth muscle cells (SMCs) in both mouse and human tissues-expressed the hyaluronan (HA) receptor LYVE-l. Furthermore, we have shown they possessed the unique ability to modulate collagen expression in SMCs by matrix metalloproteinase MMP-9-dependent proteolysis through engagement of LYVE-1 with the HA pericellular matrix of SMCs. Our study has unveiled a hitherto unknown homeostatic contribution of arterial LYVE-1(+) macrophages through the control of collagen production by SMCs and has identified a function of LYVE-1 in leukocytes.	[Lim, Hwee Ying; Lim, Sheau Yng; Thiam, Chung Hwee; Chew, Samantha Hui Shang; Lim, Li Hui; Goh, Chern; Yeo, Kim Pin; Angeli, Veronique] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol & Immunol,Immunol Programme, Singapore 117597, Singapore; [Tan, Chek Kun; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Goh, Chi Ching; Carbajo, Daniel; See, Peter; Chakarov, Svetoslav; Lum, Josephine; Evrard, Maximilien; Tan, Yingrou; Poidinger, Michael; Ng, Lai Guan; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Wang, Xiao Nong; Collin, Matthew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Johnson, Louise A.; Jackson, David G.] Univ Oxford, John Radcliff Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Fong, Chui Yee; Bongso, Ariff; Biswas, Arijit] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; [Basu, Ranu; Stanley, Richard E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY 10461 USA; [Wang, Jun Kit; Choong, Cleo] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639977, Singapore; [Jain, Rohit; Tikoo, Shweta; Weninger, Wolfgang] Centenary Inst, Newtown, NSW 2050, Australia; [Tan, Nguan Soon] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Tan, Nguan Soon] KK Womens & Children Hosp, Singapore 229899, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Newcastle University - UK; University of Oxford; National University of Singapore; Yeshiva University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Sydney; Centenary Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); KK Women's & Children's Hospital	Angeli, V (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol & Immunol,Immunol Programme, Singapore 117597, Singapore.	micva@nus.edu.sg	Evrard, Maximilien/L-3886-2019; Ng, Lai Guan/N-6980-2019; Jain, Rohit/O-2015-2019; Ng, Lai Guan/E-5673-2011; Tikoo, Shweta/AAX-1902-2021; Lim, Hwee Ying/Q-1463-2019; Tan, Nguan Soon/A-2220-2011; Chakarov, Svetoslav/AAC-9283-2019; Wang, Jun Kit/K-2309-2019	Evrard, Maximilien/0000-0002-2105-1160; Ng, Lai Guan/0000-0003-1905-3586; Jain, Rohit/0000-0002-4905-462X; Ng, Lai Guan/0000-0003-1905-3586; Tikoo, Shweta/0000-0001-5850-8075; Lim, Hwee Ying/0000-0003-3991-7855; Tan, Nguan Soon/0000-0003-0136-7341; Chakarov, Svetoslav/0000-0002-0665-5417; Wang, Jun Kit/0000-0001-7003-6592; , david/0000-0002-4133-9364; Johnson, Louise/0000-0001-6667-8912; See, Peter/0000-0003-4428-7763; Poidinger, Michael/0000-0002-1047-2277	NMRC [CBRGnov094]; NRF; UK Medical research Council; EMBO YIP; SIgN core funding; Singapore NRF Senior Investigatorship [NRFI2017-02]; MRC [MC_UU_00008/2, MC_UU_12010/2] Funding Source: UKRI	NMRC(National Medical Research Council, Singapore); NRF; UK Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO YIP(European Molecular Biology Organization (EMBO)); SIgN core funding; Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Shortman for critical discussion, Y.H. Lee, Y.S. Yip, and Y.L. Chua for technical assistance, and G.H. Teo and P.E. Hutchinson from Flow Cytometry Lab and E. Koh from Advanced Imaging core facility (Life Science Institute, Immunology programme, NUS) for sharing their expertise. This work was supported by NMRC (CBRGnov094) and NRF grants to V.A., UK Medical research Council funding to D.G.J., and EMBO YIP, SIgN core funding, and Singapore NRF Senior Investigatorship (NRFI2017-02) to F.G.	Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Castro MM, 2011, PHARMACOL RES, V64, P567, DOI 10.1016/j.phrs.2011.04.002; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Faraco G, 2016, J CLIN INVEST, V126, P4674, DOI 10.1172/JCI86950; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He HH, 2016, ARTERIOSCL THROM VAS, V36, P2203, DOI 10.1161/ATVBAHA.116.307592; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jackson DG, 2018, MATRIX BIOL; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Nadal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035253; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palombo C, 2016, VASC PHARMACOL, V77, P1, DOI 10.1016/j.vph.2015.11.083; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Simons M, 2015, CIRC RES, V116, P1712, DOI 10.1161/CIRCRESAHA.116.302953; Swirski FK, 2016, TRENDS IMMUNOL, V37, P32, DOI 10.1016/j.it.2015.11.004; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P2162, DOI 10.1167/iovs.06-0783; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yu Q, 2000, GENE DEV, V14, P163; Yvonnick B, 2014, BLOOD PRESSURE ARTER, P63, DOI DOI 10.1007/978-1-4471-5198-2	46	109	111	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					326	+		10.1016/j.immuni.2018.06.008	http://dx.doi.org/10.1016/j.immuni.2018.06.008			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30566884	Green Submitted, Bronze			2022-12-18	WOS:000442354500017
J	Sabatel, C; Radermecker, C; Fievez, L; Paulissen, G; Chakarov, S; Fernandes, C; Olivier, S; Toussaint, M; Pirottin, D; Xiao, X; Quatresooz, P; Sirard, JC; Cataldo, D; Gillet, L; Bouabe, H; Desmet, CJ; Ginhoux, F; Marichal, T; Bureau, F				Sabatel, Catherine; Radermecker, Coraline; Fievez, Laurence; Paulissen, Genevieve; Chakarov, Svetoslav; Fernandes, Claudia; Olivier, Sabine; Toussaint, Marie; Pirottin, Dimitri; Xiao, Xue; Quatresooz, Pascale; Sirard, Jean-Claude; Cataldo, Didier; Gillet, Laurent; Bouabe, Hicham; Desmet, Christophe J.; Ginhoux, Florent; Marichal, Thomas; Bureau, Fabrice			Exposure to Bacterial CpG DNA Protects from Airway Allergic Inflammation by Expanding Regulatory Lung Interstitial Macrophages	IMMUNITY			English	Article							DENDRITIC CELLS; INHALED ANTIGEN; BONE-MARROW; CIRCULATING MONOCYTES; MURINE MODEL; RECEPTOR 4; IN-VIVO; ASTHMA; ACTIVATION; OLIGODEOXYNUCLEOTIDES	Living in a microbe-rich environment reduces the risk of developing asthma. Exposure of humans or mice to unmethylated CpG DNA (CpG) from bacteria reproduces these protective effects, suggesting a major contribution of CpG to microbe-induced asthma resistance. However, how CpG confers protection remains elusive. We found that exposure to CpG expanded regulatory lung interstitial macrophages (IMs) from monocytes infiltrating the lung or mobilized from the spleen. Trafficking of IM precursors to the lung was independent of CCR2, a chemokine receptor required for monocyte mobilization from the bone marrow. Using a mouse model of allergic airway inflammation, we found that adoptive transfer of IMs isolated from CpG-treated mice recapitulated the protective effects of CpG when administered before allergen sensitization or challenge. IM-mediated protection was dependent on IL-10, given that Il10(-/-) CpG-induced IMs lacked regulatory effects. Thus, the expansion of regulatory lung IMs upon exposure to CpG might underlie the reduced risk of asthma development associated with a microbe-rich environment.	[Sabatel, Catherine; Radermecker, Coraline; Fievez, Laurence; Paulissen, Genevieve; Fernandes, Claudia; Olivier, Sabine; Pirottin, Dimitri; Desmet, Christophe J.; Marichal, Thomas; Bureau, Fabrice] Univ Liege, GIGA Res, Lab Cellular & Mol Immunol, B-4000 Liege, Belgium; [Sabatel, Catherine; Radermecker, Coraline; Pirottin, Dimitri; Xiao, Xue; Gillet, Laurent; Marichal, Thomas; Bureau, Fabrice] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Chakarov, Svetoslav; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Toussaint, Marie] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London W2 1PG, England; [Xiao, Xue; Gillet, Laurent] Univ Liege, Lab Immunol Vaccinol, Fundamental & Appl Res Anim & Hlth, B-4000 Liege, Belgium; [Quatresooz, Pascale] Univ Liege, Dept Human Histol, Ctr Rech Prot Pr, B-4000 Liege, Belgium; [Sirard, Jean-Claude] Univ Lille, CHU Lille, Inst Pasteur Lille, INSERM,U1019,CNRS,UMR8204,Ctr Infect & Immun Lill, F-59000 Lille, France; [Cataldo, Didier] Univ Liege, GIGA Res, Lab Tumor & Dev Biol, B-4000 Liege, Belgium; [Bouabe, Hicham] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Bureau, Fabrice] Walloon Excellence Life Sci & Biotechnol, Wallonia, Belgium	University of Liege; University of Liege; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Imperial College London; University of Liege; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; University of Liege; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; WELBIO	Marichal, T; Bureau, F (corresponding author), Univ Liege, GIGA Res, Lab Cellular & Mol Immunol, B-4000 Liege, Belgium.; Marichal, T; Bureau, F (corresponding author), Univ Liege, Fac Vet Med, B-4000 Liege, Belgium.; Bureau, F (corresponding author), Walloon Excellence Life Sci & Biotechnol, Wallonia, Belgium.	t.marichal@ulg.ac.be; fabrice.bureau@ulg.ac.be	Sirard, Jean-Claude/B-5932-2011; Cataldo, Didier/GPG-3453-2022; Chakarov, Svetoslav/AAC-9283-2019	Sirard, Jean-Claude/0000-0001-9854-4652; Chakarov, Svetoslav/0000-0002-0665-5417; , Xue (River)/0000-0003-1384-9954; Gillet, Laurent/0000-0002-1047-2525	F.R.S.-FNRS [CR-2012S-01R]; Belgian Program on Interuniversity Attraction Poles (IUAP; T-TIME) [P7/39]; Action de Recherche Concertee de la Federation Wallonie-Bruxelles de Belgique [2/07-03-ITPKC]; FRFS-WELBIO [CR-2012S-01R]; Acteria Foundation	F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Program on Interuniversity Attraction Poles (IUAP; T-TIME); Action de Recherche Concertee de la Federation Wallonie-Bruxelles de Belgique; FRFS-WELBIO(WELBIO); Acteria Foundation	We thank Dr. Francois Trottein (Institut Pasteur de Lille) for providing Influenza A virus; Prof. Hans Nauwynck (Ghent University) for advice; Dr. Natalia Kosovilka from the Stanford PAN facility; Dr. Sandra Ormenese and Raafat Stephan from the Cell Imaging and Flow Cytometry GIGA Platform; Dr. Pierre Drion and other staff members from the Mouse Facility and Transgenics GIGA Platform; Dr. Chantal Humblet from the GIGA Immunohistology Platform; and Raja Fares, Cedric Francois, and Ilham Sbai for excellent technical and secretarial assistance. The Laboratory of Cellular and Molecular Immunology is supported by the F.R.S.-FNRS for the FRFS-WELBIO under grant CR-2012S-01R, by the Belgian Program on Interuniversity Attraction Poles (IUAP; T-TIME; P7/39), and by an "Action de Recherche Concertee de la Federation Wallonie-Bruxelles de Belgique" (12/07-03-ITPKC). C.S. and C.R. are research fellows of the F.R.S.-FNRS, L.F. is supported by the FRFS-WELBIO (CR-2012S-01R), T.M. is supported by the Acteria Foundation, and C.D. and T.M. are research associates of the F.R.S.-FNRS.	Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Beeh KM, 2013, J ALLERGY CLIN IMMUN, V131, P866, DOI 10.1016/j.jaci.2012.12.1561; Bouabe H, 2011, J IMMUNOL, V187, P3165, DOI 10.4049/jimmunol.1101477; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Broide D, 1998, J IMMUNOL, V161, P7054; Chen L, 2006, J IMMUNOL, V177, P2373, DOI 10.4049/jimmunol.177.4.2373; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; Kline JN, 1998, J IMMUNOL, V160, P2555; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Mesnil C, 2016, J CLIN INVEST, V126, P3279, DOI 10.1172/JCI85664; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Roy SR, 2003, J ALLERGY CLIN IMMUN, V112, P571, DOI 10.1067/mai.2003.1711; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Smit LAM, 2009, AM J RESP CRIT CARE, V179, P363, DOI 10.1164/rccm.200810-1533OC; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sur S, 1999, J IMMUNOL, V162, P6284; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; von Mutius E, 2016, J ALLERGY CLIN IMMUN, V137, P680, DOI 10.1016/j.jaci.2015.12.1301	48	109	114	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					457	473		10.1016/j.immuni.2017.02.016	http://dx.doi.org/10.1016/j.immuni.2017.02.016			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329706	Bronze			2022-12-18	WOS:000396818100017
J	Alloatti, A; Kotsias, F; Pauwels, AM; Carpier, JM; Jouve, M; Timmerman, E; Pace, L; Vargas, P; Maurin, M; Gehrmann, U; Joannas, L; Vivar, OI; Lennon-Dumenil, AM; Savina, A; Gevaert, K; Beyaert, R; Hoffmann, E; Amigorena, S				Alloatti, Andres; Kotsias, Fiorella; Pauwels, Anne-Marie; Carpier, Jean-Marie; Jouve, Mabel; Timmerman, Evy; Pace, Luigia; Vargas, Pablo; Maurin, Mathieu; Gehrmann, Ulf; Joannas, Leonel; Vivar, Omar I.; Lennon-Dumenil, Ana-Maria; Savina, Ariel; Gevaert, Kris; Beyaert, Rudi; Hoffmann, Eik; Amigorena, Sebastian			Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens	IMMUNITY			English	Article							PRESENTING CELLS; ACTIVATION; MATURATION; PH; CROSSPRESENTATION; PHAGOCYTOSIS; COMPARTMENT; CAPTURE; LIGANDS; TLR	The initiation of cytotoxic immune responses by dendritic cells (DCs) requires the presentation of antigenic peptides derived from phagocytosed microbes and infected or dead cells to CD8(+) T cells, a process called cross-presentation. Antigen cross-presentation by non-activated DCs, however, is not sufficient for the effective induction of immune responses. Additionally, DCs need to be activated through innate receptors, like Toll-like receptors (TLRs). During DC maturation, cross-presentation efficiency is first upregulated and then turned off. Here we show that during this transient phase of enhanced cross-presentation, phago-lysosome fusion was blocked by the topological re-organization of lysosomes into perinuclear clusters. LPS-induced lysosomal clustering, inhibition of phago-lysosome fusion and enhanced cross-presentation, all required expression of the GTPase Rab34. We conclude that TLR4 engagement induces a Rab34-dependent re-organization of lysosomal distribution that delays antigen degradation to transiently enhance cross- presentation, thereby optimizing the priming of CD8(+) T cell responses against pathogens.	[Alloatti, Andres; Kotsias, Fiorella; Carpier, Jean-Marie; Pace, Luigia; Vargas, Pablo; Maurin, Mathieu; Gehrmann, Ulf; Joannas, Leonel; Vivar, Omar I.; Lennon-Dumenil, Ana-Maria; Savina, Ariel; Hoffmann, Eik; Amigorena, Sebastian] INSERM U932, Inst Curie, F-75248 Paris 05, France; [Kotsias, Fiorella] Univ Buenos Aires, Fac Vet Sci, Dept Virol, RA-1427 Buenos Aires, DF, Argentina; [Pauwels, Anne-Marie; Beyaert, Rudi; Hoffmann, Eik] VIB, Unit Mol Signal Transduct Inflammat, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Pauwels, Anne-Marie; Beyaert, Rudi; Hoffmann, Eik] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Jouve, Mabel] Inst Curie, UMR3215, F-75248 Paris 05, France; [Timmerman, Evy; Gevaert, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Timmerman, Evy; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Vargas, Pablo] Inst Curie, CNRS UMR 144, F-75248 Paris 05, France; [Savina, Ariel] Roche SAS, F-92650 Boulogne, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Buenos Aires; Flanders Institute for Biotechnology (VIB); Ghent University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Hoffmann, E (corresponding author), INSERM U932, Inst Curie, F-75248 Paris 05, France.	eik.hoffmann@irc.vib-ugent.be; sebastian.amigorena@curie.fr	Lennon-Dumenil, Ana-Maria/I-6716-2016; Hoffmann, Eik/Y-2297-2019; Beyaert, Rudi/B-2589-2009; Vargas, Pablo/L-9858-2017; Hoffmann, Eik/T-5428-2018; VARGAS, Pablo/HHM-4543-2022; Gevaert, Kris/D-6489-2017; Alloatti, Andres/P-3021-2016; Gevaert, Kris/AAE-4212-2019	Hoffmann, Eik/0000-0003-4224-1091; Vargas, Pablo/0000-0002-6475-494X; Hoffmann, Eik/0000-0003-4224-1091; VARGAS, Pablo/0000-0002-6475-494X; Gevaert, Kris/0000-0002-4237-0283; Alloatti, Andres/0000-0003-0555-0653; Gevaert, Kris/0000-0002-4237-0283; Jouve San Roman, Mabel Juana/0000-0002-3115-4681; Beyaert, Rudi/0000-0002-5704-582X; Amigorena, Sebastian/0000-0001-8583-8416	French National Research Agency through the "Investments for the Future'' program (France-BioImaging) [ANR-10-INSB-04, ANR-11-LABX-0043]; CelTisPhyBio Labex, IDEX PSL [ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL]; European Research Council [340046]; La Ligue Nationale contre le Cancer [EL2014.LNCC/SA]; Fonds Wetenschappelijk Onderzoek (FWO); "Interuniversity Attraction Poles'' (IAP7); Ghent University "Concerted Research Actions'' (GOA); Ghent University "Group-ID MRP"; EMBO long-term fellowship [ALTF 883-2011]; FWO [11W8415N, 1526615N]; La Ligue contre le Cancer; Fondation Recherche Medicale [SPF20101221176]; omics@VIB program (Marie Curie FP7 People)	French National Research Agency through the "Investments for the Future'' program (France-BioImaging)(French National Research Agency (ANR)); CelTisPhyBio Labex, IDEX PSL; European Research Council(European Research Council (ERC)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); "Interuniversity Attraction Poles'' (IAP7); Ghent University "Concerted Research Actions'' (GOA); Ghent University "Group-ID MRP"(Ghent University); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); FWO(FWO); La Ligue contre le Cancer(Ligue nationale contre le cancer); Fondation Recherche Medicale; omics@VIB program (Marie Curie FP7 People)	We are grateful to J. Magalhaes, A. Zamaleeva, A. Goncalves, G. Van Isterdael for technical assistance and B. Lambrecht, H. Hammad, M. Guillams for scientific discussions. We acknowledge the PICT-IBiSA@Pasteur microscopy facility (Institute Curie, Paris), the Bio Imaging Core (VIB, Ghent), and the flow cytometry facilities at Institute Curie and the IRC. This work was supported by the French National Research Agency through the "Investments for the Future'' program (France-BioImaging, ANR-10-INSB-04), ANR-11-LABX-0043 and by the CelTisPhyBio Labex (No ANR-10-LBX-0038), part of the IDEX PSL (ANR-10-IDEX-0001-02 PSL). We are grateful to the financial support by the European Research Council (2013-AdG No 340046 DCBIOX), La Ligue Nationale contre le Cancer (EL2014.LNCC/SA), Fonds Wetenschappelijk Onderzoek (FWO), the "Interuniversity Attraction Poles'' (IAP7), Ghent University "Concerted Research Actions'' (GOA) and "Group-ID MRP.'' A.A. was supported by an EMBO long-term fellowship (ALTF 883-2011), A.-M.P. by an FWO fellowship (11W8415N), J.-M.C. by a fellowship of La Ligue contre le Cancer, and E.H. by fellowships of Fondation Recherche Medicale (SPF20101221176), the omics@VIB program (co-financed by the Marie Curie FP7 People Cofund) and an FWO grant (1526615N).	Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hoffmann TK, 2001, J IMMUNOTHER, V24, P162, DOI 10.1097/00002371-200103000-00011; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kasmapour B, 2012, P NATL ACAD SCI USA, V109, P20485, DOI 10.1073/pnas.1206811109; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vega-Ramos J, 2014, J IMMUNOL, V193, P3851, DOI 10.4049/jimmunol.1303215; Wagner CS, 2012, J IMMUNOL, V188, P686, DOI 10.4049/jimmunol.1102214; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zou LY, 2009, P NATL ACAD SCI USA, V106, P15801, DOI 10.1073/pnas.0905684106	36	109	112	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1087	1100		10.1016/j.immuni.2015.11.006	http://dx.doi.org/10.1016/j.immuni.2015.11.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682983	Bronze, Green Published			2022-12-18	WOS:000366846600013
J	Neumann, K; Castineiras-Vilarino, M; Hockendorf, U; Hannesschlager, N; Lemeer, S; Kupka, D; Meyermann, S; Lech, M; Anders, HJ; Kuster, B; Busch, DH; Gewies, A; Naumann, R; Gross, O; Ruland, J				Neumann, Konstantin; Castineiras-Vilarino, Mercedes; Hoeckendorf, Ulrike; Hannesschlaeger, Nicole; Lemeer, Simone; Kupka, Danny; Meyermann, Svenia; Lech, Maciej; Anders, Hans-Joachim; Kuster, Bernhard; Busch, Dirk H.; Gewies, Andreas; Naumann, Ronald; Gross, Olaf; Ruland, Juergen			Clec12a Is an Inhibitory Receptor for Uric Acid Crystals that Regulates Inflammation in Response to Cell Death	IMMUNITY			English	Article							INDUCED NEUTROPHIL ACTIVATION; MONOSODIUM URATE CRYSTALS; LECTIN RECEPTORS; DENDRITIC CELLS; MICL CLEC12A; IDENTIFICATION; RECOGNITION; INVOLVEMENT; MECHANISM; ISCHEMIA	Recognition of cell death by the innate immune system triggers inflammatory responses. However, how these reactions are regulated is not well understood. Here, we identify the inhibitory C-type lectin receptor Clec12a as a specific receptor for dead cells. Both human and mouse Clec12a could physically sense uric acid crystals (monosodium urate, MSU), which are key danger signals for cell-death-induced immunity. Clec12a inhibited inflammatory responses to MSU in vitro, and Clec12a-deficient mice exhibited hyperinflammatory responses after being challenged with MSU or necrotic cells and after radiation-induced thymocyte killing in vivo. Thus, we identified a negative regulatory MSU receptor that controls noninfectious inflammation in response to cell death that has implications for autoimmunity and inflammatory disease.	[Neumann, Konstantin; Castineiras-Vilarino, Mercedes; Hoeckendorf, Ulrike; Hannesschlaeger, Nicole; Kupka, Danny; Meyermann, Svenia; Gewies, Andreas; Gross, Olaf; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany; [Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Lehrstuhl Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Lech, Maciej; Anders, Hans-Joachim] Klinikum Univ Munchen LMU, Med Klin & Poliklin 4, D-80336 Munich, Germany; [Busch, Dirk H.] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany; [Naumann, Ronald] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Max Planck Society	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany.	jruland@lrz.tum.de	Anders, Hans-Joachim/ABD-6247-2021; Neumann, Konstantin/AAD-5056-2019; Gross, Olaf/E-4570-2010; Ruland, Jürgen/Q-6680-2018; Lech, Maciej/AAJ-7899-2021; Kuster, Bernhard/Q-6031-2016; Lemeer, Simone/I-4363-2016	Neumann, Konstantin/0000-0002-5527-2834; Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Lech, Maciej/0000-0002-4293-2733; Kuster, Bernhard/0000-0002-9094-1677; kupka, danny/0000-0002-6125-4114; Anders, Hans-Joachim/0000-0003-2434-2956; Gewies, Andreas/0000-0002-7606-6482; Hockendorf, Ulrike/0000-0002-8218-3343	Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network; SFB grants from Deutsche Forschungsgemeinschaft; ERC	Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network; SFB grants from Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank Carsten Watzl and the University of Heidelberg for providing the ILZ expression vector. O.G. is funded by the Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network. This work was supported by SFB grants from Deutsche Forschungsgemeinschaft and an ERC Advanced Grant to J.R.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200; Barabe F, 1998, FASEB J, V12, P209, DOI 10.1096/fasebj.12.2.209; Bot A, 1996, J IMMUNOL, V157, P3436; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; CHERIAN PV, 1986, ULTRASTRUCT PATHOL, V10, P209, DOI 10.3109/01913128609032219; Chessa TAM, 2010, BLOOD, V116, P6027, DOI 10.1182/blood-2010-08-300889; de Hoef DLV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055584; Desaulniers P, 2001, J LEUKOCYTE BIOL, V70, P659; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gagne V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4250; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Landis RC, 2002, ARTHRITIS RHEUM, V46, P3026, DOI 10.1002/art.10614; Lassen S, 2010, J IMMUNOL, V185, P1976, DOI 10.4049/jimmunol.0904207; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Sancho D, 2013, CURR OPIN IMMUNOL, V25, P46, DOI 10.1016/j.coi.2012.12.007; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schiltz C, 2002, ARTHRITIS RHEUM, V46, P1643, DOI 10.1002/art.10326; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Stark S, 2005, J IMMUNOL METHODS, V296, P149, DOI 10.1016/j.jim.2004.11.010; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612; Uchimura E, 2000, J LEUKOCYTE BIOL, V67, P780, DOI 10.1002/jlb.67.6.780; Watzl C., 2006, PRODUCTION USE TRIME; Wevers BA, 2013, FUTURE MICROBIOL, V8, P839, DOI 10.2217/fmb.13.56; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	48	109	111	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					389	399		10.1016/j.immuni.2013.12.015	http://dx.doi.org/10.1016/j.immuni.2013.12.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24631154	Bronze			2022-12-18	WOS:000333422300012
J	Lu, TT; Onizawa, M; Hammer, GE; Turer, EE; Yin, Q; Damko, E; Agelidis, A; Shifrin, N; Advincula, R; Barrera, J; Malynn, BA; Wu, H; Ma, A				Lu, Timothy T.; Onizawa, Michio; Hammer, Gianna E.; Turer, Emre E.; Yin, Qian; Damko, Ermelinda; Agelidis, Alexander; Shifrin, Nataliya; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Wu, Hao; Ma, Averil			Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme	IMMUNITY			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS; POLYUBIQUITIN-BINDING; LINEAR POLYUBIQUITIN; RHEUMATOID-ARTHRITIS; EDITING ENZYME; ACTIVATION; ALPHA; TNF	A20 is an anti-inflammatory protein linked to multiple human autoimmune diseases and lymphomas. A20 possesses a deubiquitinating motif and a zinc finger, ZF4, that binds ubiquitin and supports its E3 ubiquitin ligase activity. To understand how these activities mediate A20's physiological functions, we generated two lines of gene-targeted mice, abrogating either A20's deubiquitinating activity (Tnfaip3(OTU) mice) or A20's ZF4 (Tnfaip3(ZF4) mice). Both Tnfaip3(OTU) and Tnfaip3(ZF4) mice exhibited increased responses to TNF and sensitivity to colitis. A20's C103 deubiquitinating motif restricted both K48- and K63-linked ubiquitination of receptor interacting protein 1 (RIP1). A20's ZF4 was required for recruiting A20 to ubiquitinated RIP1. A20 OTU proteins and A20(ZF4) proteins complemented each other to regulate RIP1 ubiquitination and NF kappa B signaling normally in compound mutant Tnfaip3(OTU/ZF4) cells. This complementation involved homodimerization of A20 proteins, and we have defined an extensive dimerization interface in A20. These studies reveal how A20 proteins collaborate to restrict TNF signaling.	[Lu, Timothy T.; Onizawa, Michio; Hammer, Gianna E.; Turer, Emre E.; Agelidis, Alexander; Shifrin, Nataliya; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Yin, Qian; Damko, Ermelinda; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu		Agelidis, Alex/0000-0002-6582-1630; Hammer, Gianna/0000-0001-6959-858X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939, P30DK026743, T32DK007007] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045937] Funding Source: Medline; NIDDK NIH HHS [R01 DK071939, T32 DK007007, P30 DK026743] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247	43	109	112	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					896	905		10.1016/j.immuni.2013.03.008	http://dx.doi.org/10.1016/j.immuni.2013.03.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23602765	Green Accepted, Bronze			2022-12-18	WOS:000330942500009
J	Pratama, A; Ramiscal, RR; Silva, DG; Das, SK; Athanasopoulos, V; Fitch, J; Botelho, NK; Chang, PP; Hu, X; Hogan, JJ; Mana, P; Bernal, D; Korner, H; Yu, D; Goodnow, CC; Cook, MC; Vinuesa, CG				Pratama, Alvin; Ramiscal, Roybel R.; Silva, Diego G.; Das, Souvik K.; Athanasopoulos, Vicki; Fitch, Jessica; Botelho, Natalia K.; Chang, Pheh-Ping; Hu, Xin; Hogan, Jennifer J.; Mana, Paula; Bernal, David; Korner, Heinrich; Yu, Di; Goodnow, Christopher C.; Cook, Matthew C.; Vinuesa, Carola G.			Roquin-2 Shares Functions with Its Paralog Roquin-1 in the Repression of mRNAs Controlling T Follicular Helper Cells and Systemic Inflammation	IMMUNITY			English	Article							STRESS GRANULES; ARTHRITIS; ACCUMULATION; AUTOIMMUNITY; MACROPHAGES; FAMILY; ALPHA; LEADS	Accumulation of T follicular helper (Tfh) cells and proinflammatory cytokines drive autoantibody-mediated diseases. The RNA-binding protein Roquin-1 (Rc3h1) represses the inducible costimulator ICOS and interferon-gamma (IFN-gamma) in T cells to prevent Tfh cell accumulation. Unlike Rc3h1(san) mice with a mutation in the ROQ domain of Roquin-1, mice lacking the protein, paradoxically do not display increased Tfh cells. Here we have analyzed mice with mutations that eliminate the RING domain from Roquin-1 or its paralog, Roquin-2 (Rc3h2). RING or ROQ mutations both disrupted Icos mRNA regulation by Roquin-1, but, unlike the ROQ mutant that still occupied mRNA-regulating stress granules, RING-deficient Roquin-1 failed to localize to stress granules and allowed Roquin-2 to compensate in the repression of ICOS and Tfh cells. These paralogs also targeted tumor necrosis factor (TNF) in nonlymphoid cells, ameliorating autoantibody-induced arthritis. The Roquin family emerges as a posttranscriptional brake in the adaptive and innate phases of antibody responses.	[Pratama, Alvin; Ramiscal, Roybel R.; Silva, Diego G.; Das, Souvik K.; Athanasopoulos, Vicki; Fitch, Jessica; Botelho, Natalia K.; Chang, Pheh-Ping; Hu, Xin; Hogan, Jennifer J.; Mana, Paula; Bernal, David; Yu, Di; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 0200, Australia; [Goodnow, Christopher C.; Cook, Matthew C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 0200, Australia; [Cook, Matthew C.] Australian Natl Univ, John Curtin Sch Med Res, ANU Med Sch, Canberra, ACT 0200, Australia; [Korner, Heinrich] Menzies Res Inst, Hobart, Tas 7000, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; University of Tasmania; Menzies Institute for Medical Research	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 0200, Australia.	carola.vinuesa@anu.edu.au	Silva, Diego/GRF-5446-2022; Korner, Heinrich/D-9970-2014; Cook, matthew/F-4151-2019; Goodnow, Christopher C/V-8108-2018; Yu, Di/C-2163-2009; Vinuesa, Carola G/B-1108-2010	Korner, Heinrich/0000-0003-4610-2814; Cook, matthew/0000-0002-3331-9363; Goodnow, Christopher C/0000-0001-5296-6155; Yu, Di/0000-0003-1721-8922; Vinuesa, Carola G/0000-0001-9799-0298; Chang, Pheh Ping/0000-0002-3395-4746; Athanasopoulos, Vicki/0000-0002-5764-5948; Das, Souvik/0000-0002-2178-1382; Ramiscal, Roy/0000-0002-5718-6294; Fitch, Jessica/0000-0002-8758-1359; Bernal-Estevez, David Andres/0000-0002-7330-0333	Elizabeth Blackburn NH&MRC Senior Research Fellowship; NH and MRC program	Elizabeth Blackburn NH&MRC Senior Research Fellowship; NH and MRC program(National Health and Medical Research Council (NHMRC) of Australia)	We thank Professor Paul Waring and the Australian Phenomics Network, University of Melbourne, for the histopathology analysis of the Rc3h1<SUP>san/san</SUP> Rc3h2<SUP>rin/rin</SUP> mice. We thank Anne Prins for histology slides preparation. We thank the ACRF Biomolecular Resource Facility and the Microscopy and Cytometry Resource Facility, John Curtin School of Medical Research for technical support. This work was funded by an Elizabeth Blackburn NH&MRC Senior Research Fellowship to C. G. V. and NH and MRC program and project grants to C. G. V., M. C. C. and C.C.G.	Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chang PP, 2012, J IMMUNOL, V189, P701, DOI 10.4049/jimmunol.1102432; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Orme J, 2012, AUTOIMMUN REV, V11, P365, DOI 10.1016/j.autrev.2011.10.010; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Peschon JJ, 1998, J IMMUNOL, V160, P943; Saxena R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3378; Siess DC, 2000, J BIOL CHEM, V275, P33655, DOI 10.1074/jbc.M004461200; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	23	109	115	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					669	680		10.1016/j.immuni.2013.01.011	http://dx.doi.org/10.1016/j.immuni.2013.01.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23583642	Bronze			2022-12-18	WOS:000330942100010
J	Biburger, M; Aschermann, S; Schwab, I; Lux, A; Albert, H; Danzer, H; Woigk, M; Dudziak, D; Nimmerjahn, F				Biburger, Markus; Aschermann, Susanne; Schwab, Inessa; Lux, Anja; Albert, Heike; Danzer, Heike; Woigk, Melissa; Dudziak, Diana; Nimmerjahn, Falk			Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo	IMMUNITY			English	Article							FC-GAMMA-RIV; THROMBOCYTOPENIC PURPURA; MONOCLONAL-ANTIBODY; PLATELET KINETICS; IMMUNE-COMPLEXES; DENDRITIC CELLS; BONE-MARROW; MAST-CELLS; T-CELLS; RECEPTOR	Immunoglobulin G (IgG) antibodies confer protection against pathogenic microorganisms, serve as therapeutics in tumor therapy, and are involved in destruction of healthy tissues during autoimmune diseases. Understanding the molecular pathways and effector cell types involved in antibody-mediated effector functions is a prerequisite to modulate these activities. In this study we used two independent model systems to identify innate immune effector cells required for IgG activity in vivo. We first defined the precise repertoire of receptors for the IgG Fc fragment (Fc gamma R) on innate immune effector cells in the blood and on tissue-resident macrophage populations. Despite expression of relevant activating Fc gamma Rs on various phagocyte populations, our data indicate that the majority of these cell types are dispensable for IgG activity in vivo. In contrast, IgG-dependent effector functions were selectively impaired in animals lacking the CX(3)CR1(hi)Ly6C(lo) CD11c(int) monocyte subset, which expressed the full set of Fc gamma Rs required for IgG activity.	[Biburger, Markus; Aschermann, Susanne; Schwab, Inessa; Lux, Anja; Albert, Heike; Danzer, Heike; Woigk, Melissa; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Chair Genet, D-91058 Erlangen, Germany; [Dudziak, Diana] Univ Erlangen Nurnberg, Dept Dermatol, Nikolaus Fiebiger Ctr Mol Med, Lab DC Biol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Nimmerjahn, F (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Chair Genet, Erwin Rommel Str 3, D-91058 Erlangen, Germany.	fnimmerj@biologie.uni-erlangen.de	Nimmerjahn, Falk/J-4986-2013; Biburger, Markus/H-6380-2017; Dudziak, Diana/B-2432-2017	Biburger, Markus/0000-0002-9177-8402; Dudziak, Diana/0000-0001-9358-134X; Lux, Anja/0000-0001-9475-2147; Nimmerjahn, Falk/0000-0002-5418-316X	German Research Foundation [SFB 643]; Emmy-Noether programme [DU548 2-1]; Bavarian Genome Research Network (BayGene)	German Research Foundation(German Research Foundation (DFG)); Emmy-Noether programme(German Research Foundation (DFG)); Bavarian Genome Research Network (BayGene)	This study was supported by the German Research Foundation (SFB 643 to F.N. and D.D.), the Emmy-Noether programme (DU548 2-1; D.D.), and the Bavarian Genome Research Network (BayGene to F.N. and D.D.). We are grateful to N. van Roijen for clodronate liposomes, M. Mack (University Hospital Regensburg, Germany) for the CCR2 antibody, T. Winkler (University of Erlangen) for the CD20-IgG2a antibody), T. Malek (University of Miami) for the 1A8 hybridoma, and J. Ravetch (Rockefeller University, New York), U. Schleicher (Department of Microbiology at the University Hospital of Erlangen), and D. Littman (Skirball Institute, New York) for mice.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baudino L, 2008, J IMMUNOL, V180, P1948, DOI 10.4049/jimmunol.180.3.1948; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Biburger M, 2010, ANN HEMATOL, V89, pS25, DOI 10.1007/s00277-010-0915-3; Bussel J, 2006, SEMIN HEMATOL, V43, pS3, DOI 10.1053/j.seminhematol.2006.04.009; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cines DB, 2005, ANNU REV MED, V56, P425, DOI 10.1146/annurev.med.56.082103.104644; CLARKSON SB, 1986, J EXP MED, V164, P474, DOI 10.1084/jem.164.2.474; Coetzee LM, 2000, THROMB HAEMOSTASIS, V83, P148; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giorgini A, 2008, J IMMUNOL, V181, P8745, DOI 10.4049/jimmunol.181.12.8745; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamaguchi Y, 2006, J EXP MED, V203, P743, DOI 10.1084/jem.20052283; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; HEYNS ADP, 1980, BRIT J HAEMATOL, V44, P269, DOI 10.1111/j.1365-2141.1980.tb01209.x; Hirano M, 2007, NAT IMMUNOL, V8, P762, DOI 10.1038/ni1477; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Meyer D, 1998, BLOOD, V92, P3997, DOI 10.1182/blood.V92.11.3997.423k52_3997_4002; MIZUTANI H, 1992, THROMB HAEMOSTASIS, V67, P563; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Nimmerjahn F, 2010, P NATL ACAD SCI USA, V107, P19396, DOI 10.1073/pnas.1014515107; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Santiago-Raber ML, 2011, J AUTOIMMUN, V37, P171, DOI 10.1016/j.jaut.2011.05.015; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; SCHMIDT KG, 1985, SCAND J HAEMATOL, V34, P47; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; SPRAGUE CC, 1952, JAMA-J AM MED ASSOC, V150, P1193, DOI 10.1001/jama.1952.03680120029009; STRATTON JR, 1989, J NUCL MED, V30, P629; Syed SN, 2009, EUR J IMMUNOL, V39, P3343, DOI 10.1002/eji.200939884; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Weng WK, 2004, J CLIN ONCOL, V22, P4717, DOI 10.1200/JCO.2004.06.003; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	56	109	110	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					932	944		10.1016/j.immuni.2011.11.009	http://dx.doi.org/10.1016/j.immuni.2011.11.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22169040	Bronze			2022-12-18	WOS:000298777300012
J	Lennon, GP; Bettini, M; Burton, AR; Vincent, E; Arnold, PY; Santamaria, P; Vignali, DAA				Lennon, Greig P.; Bettini, Maria; Burton, Amanda R.; Vincent, Erica; Arnold, Paula Y.; Santamaria, Pere; Vignali, Dario A. A.			T Cell Islet Accumulation in Type 1 Diabetes Is a Tightly Regulated, Cell-Autonomous Event	IMMUNITY			English	Article							RECEPTOR RETROGENIC MICE; MHC CLASS-I; INSULITIS; PEPTIDE; CLONES; MOUSE; AUTOIMMUNITY; INFLAMMATION; RECRUITMENT; EXPRESSION	Type 1 diabetes is a T cell-mediated autoimmune disease, characterized by lymphocytic infiltration of the pancreatic islets. It is currently thought that islet antigen specificity is not a requirement for islet entry and that diabetogenic T cells can recruit a heterogeneous bystander T cell population. We tested this assumption directly by generating T cell receptor (TCR) retrogenic mice expressing two different T cell populations. By combining diabetogenic and nondiabetogenic or nonautoantigen-specific T cells, we demonstrate that by stander T cells cannot accumulate in the pancreatic islets. Autoantigen-specific T cells that accumulate in islets, but do not cause diabetes, were also unaffected by the presence of diabetogenic T cells. Additionally, 67% of TCRs cloned from nonobese diabetic (NOD) islet-infiltrating CD4(+) T cells were able to mediate cell-autonomous islet infiltration and/or diabetes when expressed in retrogenic mice. Therefore, islet entry and accumulation appears to be a cell-autonomous and tightly regulated event and is governed by islet antigen specificity.	[Lennon, Greig P.; Bettini, Maria; Burton, Amanda R.; Vincent, Erica; Arnold, Paula Y.; Vignali, Dario A. A.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Santamaria, Pere] Univ Calgary, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; [Santamaria, Pere] Univ Calgary, Dept Microbiol & Infect Dis, Inst Inflammat Infect & Immun, Fac Med, Calgary, AB T2N 4N1, Canada	St Jude Children's Research Hospital; University of Calgary; University of Calgary	Vignali, DAA (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Santamaria, Pere/ABF-6823-2021	Bettini, Maria/0000-0002-6415-7731	Juvenile Diabetes Research Foundation International [1-2004-141, 1-2006-847]; NIH [AI072239]; St. Jude Cancer Center [CA-21765]; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072239] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Jude Cancer Center(St. Jude Medical); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank T. DiLorenzo and D. Serreze for reagents, K. Forbes and T. Moore for mouse colony management, the Vignali lab for assistance with harvesting bone marrow and helpful discussions, R. Cross and Y. He for single-cell sorting, and J. Houston in the St. Jude Flow Cytometry Facility for help running samples on the LSRII. D.A.A.V. is supported by funds from the Juvenile Diabetes Research Foundation International (1-2004-141 [The Robert and Janice Compton Research Grant, In Honor of Elizabeth S. Compton] and 1-2006-847), the NIH (AI072239), the St. Jude Cancer Center Support CORE grant (CA-21765), and the American Lebanese Syrian Associated Charities (ALSAC). P.S. is supported by the Canadian Institutes of Health Research and is a Scientist of the Alberta Heritage Foundation for Medical Research.	Arnold PY, 2004, J IMMUNOL, V173, P3103, DOI 10.4049/jimmunol.173.5.3103; Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; Bridgett M, 1998, DIABETES, V47, P1848, DOI 10.2337/diabetes.47.12.1848; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Cantagrel A, 1998, Int Rev Immunol, V17, P323, DOI 10.3109/08830189809054409; Carvalho-Pinto C, 2004, EUR J IMMUNOL, V34, P548, DOI 10.1002/eji.200324285; Chaparro RJ, 2008, J IMMUNOL METHODS, V335, P106, DOI 10.1016/j.jim.2008.03.007; Christen U, 2004, J CLIN INVEST, V113, P74, DOI 10.1172/JCI200417005; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Hamilton-Williams EE, 2003, P NATL ACAD SCI USA, V100, P6688, DOI 10.1073/pnas.1131954100; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Hill NJ, 2003, J IMMUNOL, V170, P1649, DOI 10.4049/jimmunol.170.4.1649; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Morimoto J, 2004, J IMMUNOL, V173, P7017, DOI 10.4049/jimmunol.173.11.7017; Pauza ME, 2004, DIABETES, V53, P978, DOI 10.2337/diabetes.53.4.978; Peterson JD, 1998, CELL IMMUNOL, V189, P92, DOI 10.1006/cimm.1998.1377; Rhode A, 2005, J IMMUNOL, V175, P3516, DOI 10.4049/jimmunol.175.6.3516; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Sercarz EE, 2000, J AUTOIMMUN, V14, P275, DOI 10.1006/jaut.2000.0380; Suri A, 2004, EUR J IMMUNOL, V34, P447, DOI 10.1002/eji.200324599; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wen L, 1998, J CLIN INVEST, V102, P947, DOI 10.1172/JCI2723; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yamanouchi J, 2003, J IMMUNOL, V171, P6900, DOI 10.4049/jimmunol.171.12.6900	31	109	114	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					643	653		10.1016/j.immuni.2009.07.008	http://dx.doi.org/10.1016/j.immuni.2009.07.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818656	Bronze, Green Accepted			2022-12-18	WOS:000271403900015
J	Koga, K; Takaesu, G; Yoshida, R; Nakaya, M; Kobayashi, T; Kinjyo, I; Yoshimura, A				Koga, Keiko; Takaesu, Giichi; Yoshida, Ryoko; Nakaya, Mako; Kobayashi, Takashi; Kinjyo, Ichiko; Yoshimura, Akihiko			Cyclic Adenosine Monophosphate Suppresses the Transcription of Proinflammatory Cytokines via the Phosphorylated c-Fos Protein	IMMUNITY			English	Article							IMMUNE-RESPONSES; B P65; KINASE; ACTIVATION; BINDING; DEGRADATION; MACROPHAGES; FAMILY; CELLS; GENE	Intracellular cyclic adenosine monophosphate (cAMP) suppresses innate immunity by inhibiting proinflammatory cytokine production from monocytic cells. Enhanced expression of interleukin-10 (IL-10) has been suggested to be the mechanism of suppression. However, cAMP is still capable of suppressing production of the cytokines; TINIF-alpha and IL-12 in IL-10-deficient dendritic cells (DCs). Here, we demonstrated that the transcription factor c-Fos was responsible for the cAMP-mediated suppression of inflammatory cytokine production. c-Fos accumulated at high amounts in response to cAMP and lipopolysaccharide (LIPS). Overexpression of c-Fos suppressed LPS-induced cytokine production, whereas cAMP-mediated suppression of TNF-alpha and IL-12 was impaired in Fos(-/-) DCs or in RAW264.7 cells treated with c-Fos SiRNA. c-Fos physically interacted with p65 protein and reduced the recruitment of p65 to the Tnf promoter. Multiple sites of c-Fos were phosphorylated by the IKK beta protein. Thus, we propose that c-Fos is a substrate of IKK beta and is responsible for the immunosuppressive effect of cAMP.	[Koga, Keiko; Takaesu, Giichi; Yoshida, Ryoko; Nakaya, Mako; Kobayashi, Takashi; Yoshimura, Akihiko] Kyushu Univ, Div Mol & Cellular Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Yoshida, Ryoko; Kinjyo, Ichiko; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Kyushu University; Keio University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Kyushu Univ, Div Mol & Cellular Immunol, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Takaesu, Giichi/0000-0002-1581-1055; Kinjyo, Ichiko/0000-0001-7051-3790	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Astellas Foundation for Research on Metabolic Disorders; Japan Intractable Disease Research Foundation; Mochica Memorial Foundation; Naito Memorial Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Astellas Foundation for Research on Metabolic Disorders; Japan Intractable Disease Research Foundation; Mochica Memorial Foundation; Naito Memorial Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Fund	We thank K. Takeda (Osaka University) for providing II10<SUP>-/-</SUP> and STAT3-flox mice; S. Okada (Kumamoto University) for Fos<SUP>-/-</SUP> mice; Y. Nakabeppu (Kyushu University) for c-Fos, FosB, and Fral cDNAs; and T. Ishitani (Kyushu University) for GST-IKBa plasmid. We also thank T. Yoshioka, M. Ohtsu, K. Fukidome, and M. Asakawa for technical assistance and N. Soma and Y. Nishi for manuscript preparation. This study was supported by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Astellas Foundation for Research on Metabolic Disorders; the Japan Intractable Disease Research Foundation; the Mochica Memorial Foundation; the Naito Memorial Foundation; and the Princess Takamatsu Cancer Research Fund.	Akasaki Y, 2004, J IMMUNOL, V173, P4352, DOI 10.4049/jimmunol.173.7.4352; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Coronella-Wood J, 2004, J BIOL CHEM, V279, P33567, DOI 10.1074/jbc.M404013200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; DENT G, 1994, AM J RESP CELL MOL, V10, P565, DOI 10.1165/ajrcmb.10.5.8179921; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Hanada T, 2005, J IMMUNOL, V174, P4325, DOI 10.4049/jimmunol.174.7.4325; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; JAIN JN, 1993, J IMMUNOL, V151, P837; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; KUPRASH DV, 1995, ONCOGENE, V11, P97; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Mason NJ, 2004, INFECT IMMUN, V72, P5662, DOI 10.1128/IAI.72.10.5662-5667.2004; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pozo D, 2003, TRENDS MOL MED, V9, P211, DOI 10.1016/S1471-4914(03)00049-2; PULGKROGER A, 2001, BLOOD, V98, P2175; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; Rowe J, 1997, AM J RESP CELL MOL, V17, P218, DOI 10.1165/ajrcmb.17.2.2722; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shiraishi H, 2008, INT IMMUNOL, V20, P1219, DOI 10.1093/intimm/dxn078; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0	50	109	110	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					372	383		10.1016/j.immuni.2008.12.021	http://dx.doi.org/10.1016/j.immuni.2008.12.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19285436	Bronze			2022-12-18	WOS:000264405500010
J	Subbarao, K; Murphy, BR; Fauci, AS				Subbarao, K; Murphy, BR; Fauci, AS			Development of effective vaccines against pandemic influenza	IMMUNITY			English	Editorial Material							VIRUS; EVOLUTION; H2N2	A key strategy to protect humans against an influenza pandemic is the development of an effective vaccine. However, the development of effective pandemic vaccines poses both practical and immunological challenges.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov		Subbarao, Kanta/0000-0003-1713-3056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000933, ZIAAI000997, Z01AI000997, Z01AI000933] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], FIELDS VIROLOGY; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Luke CJ, 2006, EMERG INFECT DIS, V12, P66, DOI 10.3201/eid1201.051147; Murphy BR, 2001, FIELDS VIROLOGY, P435; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513	17	109	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					5	9		10.1016/j.immuni.2005.12.005	http://dx.doi.org/10.1016/j.immuni.2005.12.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413916	Bronze			2022-12-18	WOS:000234850200003
J	Zajonc, DM; Crispin, MDM; Bowden, TA; Young, DC; Cheng, TY; Hu, JD; Costello, CE; Rudd, PM; Dwek, RA; Miller, MJ; Brenner, MB; Moody, DB; Wilson, IA				Zajonc, DM; Crispin, MDM; Bowden, TA; Young, DC; Cheng, TY; Hu, JD; Costello, CE; Rudd, PM; Dwek, RA; Miller, MJ; Brenner, MB; Moody, DB; Wilson, IA			Molecular mechanism of lipopeptide presentation by CD1a	IMMUNITY			English	Article							T-CELL RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; PROTEIN MODELS; LIPID ANTIGEN; NKT CELLS; REFINEMENT; PROGRAM; SIDEROPHORES; GLYCOLIPIDS	CD1a is expressed on Langerhans cells (LCs) and dendritic cells (DCs), where it mediates T cell recognition of glycolipid and lipopeptide antigens that contain either one or two alkyl chains. We demonstrate here that CD1a-restricted T cells can discriminate the peptide component of didehydroxymycobactin lipopeptides. Structure analysis of CD1a cocrystallized with a synthetic mycobactin lipopeptide at 2.8 Angstrom resolution further reveals that the single alkyl chain is inserted deep within the A' pocket of the groove, whereas its two peptidic branches protrude along the F' pocket to the outer, alpha-helical surface of CD1a for recognition by the TCR. Remarkably, the cyclized lysine branch of the peptide moiety lies in the shallow F' pocket in a conformation that closely mimics that of the alkyl chain in the CD1a-sulfatide structure. Thus, this structural study illustrates how a single chain lipid can be presented by CD1 and that the peptide moiety of the lipopeptide is recognized by the TCR.	Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; Boston Univ, Sch Med, Mass Spectrometry Resource, Boston, MA 02118 USA; Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England	Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Notre Dame; Boston University; University of Oxford	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Bowden, Thomas/0000-0002-8066-8785; Costello, Catherine/0000-0003-1594-5122	NCI NIH HHS [CA58896] Funding Source: Medline; NCRR NIH HHS [RR10888] Funding Source: Medline; NIAID NIH HHS [AI054193, AI28973, AI49313, AI30988] Funding Source: Medline; NIAMS NIH HHS [AR48632] Funding Source: Medline; NIGMS NIH HHS [GM62116] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, R01AI030988, R37AI028973, R01AI054193, R01AI028973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; DeLano W. L, 2002, PYMOL MOL GENETICS G; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2001, CURR OPIN IMMUNOL, V13, P471, DOI 10.1016/S0952-7915(00)00243-0; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hu JD, 1997, J AM CHEM SOC, V119, P3462, DOI 10.1021/ja963968x; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Quadri LEN, 2000, MOL MICROBIOL, V37, P1, DOI 10.1046/j.1365-2958.2000.01941.x; Rosat JP, 1999, J IMMUNOL, V162, P366; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; SNOW GA, 1969, BIOCHEM J, V115, P1031, DOI 10.1042/bj1151031; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOODRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	54	109	112	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					209	219		10.1016/j.immuni.2004.12.009	http://dx.doi.org/10.1016/j.immuni.2004.12.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723809	Bronze			2022-12-18	WOS:000227509600007
J	Krauss, S; Brand, MD; Buttgereit, F				Krauss, S; Brand, MD; Buttgereit, F			Signaling takes a breath - New quantitative perspectives on bioenergetics and signal transduction	IMMUNITY			English	Article							CALCINEURIN	Immune cells are in constant need of energy for both basic housekeeping and specific immune functions. Increased energy demand during lymphocyte stimulation is coordinated by signal transduction pathways. This review explores the interface between lymphocyte signaling and energy metabolism. In particular, it discusses recent work that allows weighing signaling routes with respect to their role in the regulation of energy metabolism during lymphocyte activation.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MRC, Dynn Human Nutr Unit, Cambridge CB2 2XY, England; Humboldt Univ, Charite Univ Hosp, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krauss, S (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, 99 Brookline Ave, Boston, MA 02215 USA.	skrauss@caregroup.harvard.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Buttgereit, Frank/0000-0003-2534-550X				[Anonymous], 1999, CLIN EXP IMMUNOL, V118, P1; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Buttgereit F, 2000, IMMUNOL TODAY, V21, P192; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; FELLD A, 1997, UNDERSTANDING CONTRO; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Judd B A, 2000, Rev Immunogenet, V2, P164; Kavanagh NI, 2000, BBA-BIOENERGETICS, V1457, P57, DOI 10.1016/S0005-2728(00)00054-2; Krauss S, 2000, FASEB J, V14, P2581, DOI 10.1096/fj.00-0064com; Krauss S, 1999, BBA-BIOENERGETICS, V1412, P129, DOI 10.1016/S0005-2728(99)00058-4; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mishra N, 2000, J IMMUNOL, V165, P2830, DOI 10.4049/jimmunol.165.5.2830; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Reiter TA, 1999, J BIOL INORG CHEM, V4, P632, DOI 10.1007/s007750050387; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0	21	109	110	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					497	502		10.1016/S1074-7613(01)00205-9	http://dx.doi.org/10.1016/S1074-7613(01)00205-9			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672532	Bronze			2022-12-18	WOS:000171757800001
J	Sarukhan, A; Garcia, C; Lanoue, A; von Boehmer, H				Sarukhan, A; Garcia, C; Lanoue, A; von Boehmer, H			Allelic inclusion of T cell receptor alpha genes poses an autoimmune hazard due to low-level expression of autospecific receptors	IMMUNITY			English	Article							TRANSGENIC MICE; BETA-GENES; V-ALPHA; TOLERANCE; ANTIGEN; EXCLUSION; CHAINS; REARRANGEMENT; REPERTOIRE; INDUCTION	Organ-specific autoimmune disease can be caused by alpha beta T cells that have escaped self-tolerance induction. Here we show that one of the causes of escape from self-tolerance is the coexpression of two different T cell receptors by the same cell, which can occur in up to 30% of all T cells in normal mice and can lead to low-level surface expression of an autospecific TCR. We found that double receptor-expressing T cells can escape tolerance even to ubiquitously expressed antigens but can nevertheless induce autoimmune diabetes when the relevant protein is expressed in pancreatic tissue. Such diabetogenic T cells are absent, however, among T cells expressing the autospecific TCR as the sole receptor.	Inst Necker, INSERM 373, F-75730 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	von Boehmer, H (corresponding author), Inst Necker, INSERM 373, 156 Rue Vaugirad, F-75730 Paris, France.	vonboehm@infobiogen.fr	Cordier, Corinne/F-9966-2018	Cordier, Corinne/0000-0003-4799-6143; Sarukhan, Adelaida/0000-0003-3747-6304				Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Conrad B, 1997, CELL, V90, P303, DOI 10.1016/S0092-8674(00)80338-4; DEGERMANN S, 1994, EUR J IMMUNOL, V24, P3155, DOI 10.1002/eji.1830241236; FAVEEUW C, 1995, J IMMUNOL METHODS, V187, P163, DOI 10.1016/0022-1759(95)00180-I; FOERSTER I, 1995, IMMUNITY, V2, P573; GUERDER S, 1994, IMMUNITY, V1, P155; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HEATH WR, 1993, J EXP MED, V178, P1807, DOI 10.1084/jem.178.5.1807; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; MAROLLEAU JP, 1988, CELL, V55, P291, DOI 10.1016/0092-8674(88)90052-9; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; RITCHIE KA, 1984, NATURE, V312, P517, DOI 10.1038/312517a0; SAITO T, 1989, J IMMUNOL, V143, P3379; Sarukhan A, 1998, EMBO J, V17, P71, DOI 10.1093/emboj/17.1.71; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VACCHIO MS, 1993, J IMMUNOL, V151, P1322; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; YASUNAMI R, 1988, EUR J IMMUNOL, V18, P481, DOI 10.1002/eji.1830180325; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	36	109	110	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					563	570		10.1016/S1074-7613(00)80561-0	http://dx.doi.org/10.1016/S1074-7613(00)80561-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620677	Bronze			2022-12-18	WOS:000073885400004
J	Aichele, P; BrduschaRiem, K; Oehen, S; Odermatt, B; Zinkernagel, RM; Hengartner, H; Pircher, H				Aichele, P; BrduschaRiem, K; Oehen, S; Odermatt, B; Zinkernagel, RM; Hengartner, H; Pircher, H			Peptide antigen treatment of naive and virus-immune mice: Antigen-specific tolerance versus immunopathology	IMMUNITY			English	Article							T-CELL TOLERANCE; MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; GLUTAMIC-ACID DECARBOXYLASE; VESICULAR STOMATITIS-VIRUS; MLSA-ENCODED ANTIGENS; TRANSGENIC MICE; SELF-TOLERANCE	Peptide-specific down-regulation of T cell responses may represent a powerful tool to intervene in autoimmune diseases or graft rejections. It is therefore important to know whether peptide treatment tolerizes both naive and antigen-experienced memory T lymphocytes. Here we show that a major histocompatibility complex class I binding peptide, derived from the glycoprotein (GP33 peptide) of lymphocytic choriomeningitis virus (LCMV), specifically tolerized naive cytotoxic T lymphocytes (CTL) when administered three times intraperitoneally in incomplete Freund's adjuvants. However, in the presence of GP33-specific memory CTL in LCMV-primed mice, the same treatment had a general immunosuppressive effect on unrelated third-party antigen-specific T cell responses and caused severe immunopathological damage to the spleen.			Aichele, P (corresponding author), UNIV ZURICH, DEPT PATHOL, INST EXPT IMMUNOL, CH-8091 ZURICH, SWITZERLAND.							AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; Aichele P, 1996, IMMUNOL REV, V152, P21, DOI 10.1111/j.1600-065X.1996.tb00909.x; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; ALSABBAGH A, 1994, EUR J IMMUNOL, V24, P2104, DOI 10.1002/eji.1830240926; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; BLACKMAN MA, 1990, NATURE, V345, P540, DOI 10.1038/345540a0; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; BURSTEIN HJ, 1993, J EXP MED, V177, P457, DOI 10.1084/jem.177.2.457; CHARAN S, 1986, J IMMUNOL, V136, P3057; CHEN YH, 1995, J IMMUNOL, V155, P910; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DRESSER DW, 1962, IMMUNOLOGY, V5, P378; DUTZ JP, 1992, INT IMMUNOL, V4, P571, DOI 10.1093/intimm/4.5.571; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GUERDER S, 1995, J IMMUNOL, V155, P5167; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HOYNE GF, 1993, J EXP MED, V178, P1783, DOI 10.1084/jem.178.5.1783; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KHOURY SJ, 1990, CELL IMMUNOL, V131, P302, DOI 10.1016/0008-8749(90)90256-Q; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KYBURZ D, 1993, J IMMUNOL, V150, P5051; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LANIER LL, 1995, J IMMUNOL, V154, P97; LEHMANNGRUBE F, 1971, VIROL MONOGR, V10, P1; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCCAREN LC, 1959, J EXP MED, V109, P475; METZLER B, 1993, INT IMMUNOL, V5, P1159, DOI 10.1093/intimm/5.9.1159; MILLER A, 1991, CURR OPIN IMMUNOL, V3, P936, DOI 10.1016/S0952-7915(05)80017-2; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; MILLER A, 1993, J IMMUNOL, V151, P7307; MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.iy.10.040192.000411; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; MOSKOPHIDIS D, 1993, EUR J IMMUNOL, V23, P3306, DOI 10.1002/eji.1830231237; MOSKOPHIDIS D, 1987, EUR J IMMUNOL, V17, P937, DOI 10.1002/eji.1830170707; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MOSS DJ, 1991, J EXP MED, V173, P681, DOI 10.1084/jem.173.3.681; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OKI A, 1985, J EXP MED, V161, P897, DOI 10.1084/jem.161.5.897; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; PEMBERTON RM, 1990, IMMUNOLOGY, V70, P223; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; RAJEWSKY K, 1974, EUR J IMMUNOL, V4, P120, DOI 10.1002/eji.1830040211; RAMMENSEE HG, 1993, CURR OPIN IMMUNOL, V5, P35, DOI 10.1016/0952-7915(93)90078-7; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RIA F, 1990, NATURE, V343, P381, DOI 10.1038/343381a0; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROMBALL CG, 1993, J EXP MED, V178, P1637, DOI 10.1084/jem.178.5.1637; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SCHILD H, 1990, SCIENCE, V247, P1587, DOI 10.1126/science.2321019; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; SCHULZ M, 1989, EUR J IMMUNOL, V19, P1657, DOI 10.1002/eji.1830190921; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; VANBLEEK GM, 1990, NATURE, V348, P213; VIDARD L, 1994, P NATL ACAD SCI USA, V91, P5627, DOI 10.1073/pnas.91.12.5627; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; ZINKERNAGEL RM, 1985, J EXP MED, V162, P2125, DOI 10.1084/jem.162.6.2125	91	109	110	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1997	6	5					519	529		10.1016/S1074-7613(00)80340-4	http://dx.doi.org/10.1016/S1074-7613(00)80340-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175830	Bronze			2022-12-18	WOS:A1997XB81900003
J	Oakes, SA; Candotti, F; Johnston, JA; Chen, YQ; Ryan, JJ; Taylor, N; Liu, XW; Hennighausen, L; Notarangelo, LD; Paul, WE; Blaese, RM; OShea, JJ				Oakes, SA; Candotti, F; Johnston, JA; Chen, YQ; Ryan, JJ; Taylor, N; Liu, XW; Hennighausen, L; Notarangelo, LD; Paul, WE; Blaese, RM; OShea, JJ			Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways	IMMUNITY			English	Article							RECEPTOR-GAMMA-CHAIN; JAK-3 JANUS KINASE; B-CELLS; TYROSINE PHOSPHORYLATION; FUNCTIONAL COMPONENT; MYELOID CELLS; BETA-CHAIN; INTERLEUKIN-2; ACTIVATION; INSULIN	Both IL-2 and IL-4 bind to receptors containing the common gamma chain and JAK3. Although JAK3 is required for proper lymphoid development, the precise roles of this kinase in IL-2 and IL-4 signaling in lymphocytes have not been defined. Here, we have studied IL-2 and IL-4 signaling in B cell lines lacking JAK3. Although IL-2-induced phosphorylation of IL-2R beta, JAK1, and STAT5 all required the presence of JAK3, IL-4-mediated phosphorylation of JAK1, STAT6, and insulin receptor substrates 1 and 2 did not. However, IL-4-induced effects were clearly improved following JAK3 expression. These data indicate that IL-4 signaling occurs in the absence of of JAK3, but is comparatively inefficient. These findings may help in understanding the pathogenesis of the immunodeficiency that occurs with mutations of JAK3 and may suggest a mechanism for the pleiotropic effects of IL-4.	NIH, NATL CTR HUMAN GENOME RES, CLIN GENE THERAPY BRANCH, BETHESDA, MD 20892 USA; HOWARD HUGHES MED INST, NIH, RES SCHOLARS PROGRAM, BETHESDA, MD 20892 USA; NIAID, IMMUNOL LAB, NIH, BETHESDA, MD 20892 USA; NIDDKD, BIOCHEM & METAB LAB, NIH, BETHESDA, MD 20892 USA; CHILDRENS HOSP LOS ANGELES, DIV RES IMMUNOL & BONE MARROW TRANSPLANTAT, LOS ANGELES, CA 90027 USA; UNIV BRESCIA, DEPT PEDIAT, I-25123 BRESCIA, ITALY; NIAMSD, NIH, ARTHRIT & RHEUMATISM BRANCH, LYMPHOCYTE CELL BIOL SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's Hospital Los Angeles; University of Brescia; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)			Taylor, Naomi/H-4016-2014; Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Hennighausen, Lothar/0000-0001-8319-9841; Candotti, Fabio/0000-0001-6399-6042	Telethon [A.042] Funding Source: Medline	Telethon(Fondazione Telethon)		ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Callard RE, 1996, IMMUNOL TODAY, V17, P108, DOI 10.1016/0167-5699(96)80600-1; Candotti F, 1996, J EXP MED, V183, P2687, DOI 10.1084/jem.183.6.2687; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CONRAD DH, 1987, J IMMUNOL, V139, P2290; FENGHAO X, 1995, J CLIN INVEST, V96, P907, DOI 10.1172/JCI118138; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Izuhara K, 1996, J BIOL CHEM, V271, P619, DOI 10.1074/jbc.271.2.619; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KEEGAN AD, 1995, P NATL ACAD SCI USA, V92, P7681, DOI 10.1073/pnas.92.17.7681; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MATTHEWS DJ, 1995, BLOOD, V85, P38, DOI 10.1182/blood.V85.1.38.bloodjournal85138; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schnyder B, 1996, BLOOD, V87, P4286, DOI 10.1182/blood.V87.10.4286.bloodjournal87104286; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TORTOLANI PJ, 1995, J IMMUNOL, V155, P5220; WANG LM, 1995, STEM CELLS, V13, P360, DOI 10.1002/stem.5530130407; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WELHAM MJ, 1995, J BIOL CHEM, V270, P12286, DOI 10.1074/jbc.270.20.12286; WHITE MF, 1994, J BIOL CHEM, V269, P1; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	52	109	116	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1996	5	6					605	615		10.1016/S1074-7613(00)80274-5	http://dx.doi.org/10.1016/S1074-7613(00)80274-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986719	Bronze			2022-12-18	WOS:A1996WA65100010
J	RUDENSKY, AY; MARIC, M; EASTMAN, S; SHOEMAKER, L; DEROOS, PC; BLUM, JS				RUDENSKY, AY; MARIC, M; EASTMAN, S; SHOEMAKER, L; DEROOS, PC; BLUM, JS			INTRACELLULAR ASSEMBLY AND TRANSPORT OF ENDOGENOUS PEPTIDE-MHC CLASS-II COMPLEXES	IMMUNITY			English	Article							B-CELL INTERACTION; INVARIANT CHAIN; T-CELLS; ANTIGEN PRESENTATION; LYMPHOCYTES-B; MOLECULES; IMMUNOGLOBULIN; COMPARTMENT; SELF; EXPRESSION	To define the intracellular site of assembly of endogenous peptide-MHC class II complexes, an immunochemical approach was undertaken employing a monoclonal antibody specific for an endogenous peptide-class II complex in combination with subcellular fractionation. Here, we show that newly synthesized MHC class II molecules, upon exit from the Golgi, are delivered into a dense endocytic compartment (MIIC) distinct from late endosomes and lysosomes. Endogenous peptide-class II complexes are initially formed in this compartment and subsequently traffic through late endosomal vesicles prior to cell surface expression. Exogenous antigen delivered via immunoglobulin receptors is targeted to MIIC en route to lysosomes after passing through early and late endosomes. Processing of an endocytosed antigen was observed in this compartment. Our results suggest a specific role for MIIC in the processing of endogenous and exogenous proteins as well as the assembly of peptide-MHC class II complexes.	UNIV WASHINGTON,SCH MED,DEPT IMMUNOL,SEATTLE,WA 98195; VIRGINIA MASON RES CTR,SEATTLE,WA 98101	University of Washington; University of Washington Seattle; Virginia Mason Medical Center	RUDENSKY, AY (corresponding author), UNIV WASHINGTON,SCH MED,HOWARD HUGHES MED INST,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033418, R01AI034206, R29AI034206] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34206, AI33418] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; COLLINS DS, 1991, J IMMUNOL, V147, P4054; CONRAD PJ, 1984, J IMMUNOL, V132, P662; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; HARDING CV, 1993, J IMMUNOL, V151, P3988; HUGIN AW, 1991, SCIENCE, V252, P424, DOI 10.1126/science.1850169; HUMBERT M, 1993, EUR J IMMUNOL, V23, P3158, DOI 10.1002/eji.1830231218; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MURPHY DB, 1992, J IMMUNOL, V148, P3483; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; QUI Y, 1994, J CELL BIOL, V124, P595; RATH S, 1992, EUR J IMMUNOL, V22, P2121, DOI 10.1002/eji.1830220824; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; RUDENSKY AY, 1990, EUR J IMMUNOL, V20, P1691, DOI 10.1002/eji.1830200811; RUDENSKY AY, 1989, EUR J IMMUNOL, V19, P1677, DOI 10.1002/eji.1830190923; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; WEISS S, 1989, P NATL ACAD SCI USA, V86, P282, DOI 10.1073/pnas.86.1.282; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; ZACHGO S, 1992, J CELL SCI, V103, P811	37	109	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					585	594		10.1016/1074-7613(94)90048-5	http://dx.doi.org/10.1016/1074-7613(94)90048-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600287				2022-12-18	WOS:A1994PN12700007
J	Nagashima, H; Mahlakoiv, T; Shih, HY; Davis, FP; Meylan, F; Huang, YF; Harrison, OJ; Yao, C; Mikami, Y; Urban, JF; Caron, KM; Belkaid, Y; Kanno, Y; Artis, D; O'Shea, JJ				Nagashima, Hiroyuki; Mahlakoiv, Tanel; Shih, Han-Yu; Davis, Fred P.; Meylan, Francoise; Huang, Yuefeng; Harrison, Oliver J.; Yao, Chen; Mikami, Yohei; Urban, Joseph F., Jr.; Caron, Kathleen M.; Belkaid, Yasmine; Kanno, Yuka; Artis, David; O'Shea, John J.			Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation	IMMUNITY			English	Article							NEURONAL REGULATION; IMMUNE-SYSTEM; GENE; PROLIFERATION; INHIBITION	Innate lymphocytes maintain tissue homeostasis at mucosal barriers, with group 2 innate lymphoid cells (ILC2s) producing type 2 cytokines and controlling helminth infection. While the molecular understanding of ILC2 responses has advanced, the complexity of microenvironmental factors impacting ILC2s is becoming increasingly apparent. Herein, we used single-cell analysis to explore the diversity of gene expression among lung lymphocytes during helminth infection. Following infection, we identified a subset of ILC2s that preferentially expressed Il5-encoding interleu kin (IL)-5, together with Ca/ca-encoding calcitonin gene-related peptide (CGRP) and its cognate receptor components. CGRP in concert with IL-33 and neuromedin U (NMU) supported IL-5 but constrained IL-13 expression and ILC2 proliferation. Without CGRP signaling, ILC2 responses and worm expulsion were enhanced. Collectively, these data point to CGRP as a context-dependent negative regulatory factor that shapes innate lymphocyte responses to alarmins and neuropeptides during type 2 innate immune responses.	[Nagashima, Hiroyuki; Shih, Han-Yu; Davis, Fred P.; Meylan, Francoise; Yao, Chen; Mikami, Yohei; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Mahlakoiv, Tanel; Artis, David] Cornell Univ, JiII Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA; [Huang, Yuefeng] NIAID, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Harrison, Oliver J.; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Caron, Kathleen M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Huang, Yuefeng] Columbia Univ, Vagelos Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Chapel Hill; Columbia University	Kanno, Y; O'Shea, JJ (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.; Artis, D (corresponding author), Cornell Univ, JiII Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.	kannoy@mail.nih.gov; dartis@med.cornell.edu; john.oshea@nih.gov	MIKAMI, YOHEI/GRJ-8133-2022; Kanno, Yuka/B-5802-2013; Nagashima, Hiroyuki/AAL-3128-2021	MIKAMI, YOHEI/0000-0001-5104-4415; Kanno, Yuka/0000-0001-5668-9319; Nagashima, Hiroyuki/0000-0001-8405-6746; Yao, Chen/0000-0001-6852-5661; Caron, Kathleen/0000-0002-7033-9232; Shih, Han-Yu/0000-0002-7525-5433; Urban, Joseph/0000-0002-1590-8869; Artis, David/0000-0002-1753-4100	Intramural Research Programs of NIAMS; NIAID; National Institutes of Health [AI074878, AI095466, AI095608, AI102942]; Burroughs Wellcome Fund; Crohn's & Colitis Foundation; Cure for IBD; Rosanne H. Silberman Foundation; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, R01AI102942, ZIAAI001132, R01AI074878, U01AI095608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation; Cure for IBD; Rosanne H. Silberman Foundation; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of Molecular Immunology and Inflammation Branch (NIAMS) for input and support. We thank S. Dell'Orso, G. Gutierrez-Cruz, and F. Naz (Genome Analysis Core Facility, NIAMS); J. Simone, J. Lay, and K. Tinsley (Flow Cytometry Section, NIAMS); H-W. Sun and S.R. Brooks (Biodata Mining and Discovery Section, NIAMS); E. Ralston and A. Kenea (Light Imaging Section, NIAMS); and L. Samsel and P. J. McCoy (Flow Cytometry Core, NHLBI) for their technical support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS and NIAID. Research in the Artis laboratory is supported by the National Institutes of Health (AI074878, AI095466, AI095608, and AI102942), the Burroughs Wellcome Fund, the Crohn's & Colitis Foundation, Cure for IBD, and the Rosanne H. Silberman Foundation. H. N. was supported by the JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH. T.M. was supported by the Crohn's & Colitis Foundation.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOUDARD F, 1991, J NEUROSCI RES, V29, P29, DOI 10.1002/jnr.490290104; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ikutani M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90721; Klose CSN, 2019, CURR OPIN IMMUNOL, V56, P94, DOI 10.1016/j.coi.2018.11.002; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; Lu JT, 1999, MOL CELL NEUROSCI, V14, P99, DOI 10.1006/mcne.1999.0767; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mitsikostas DD, 2017, CURR OPIN NEUROL, V30, P272, DOI 10.1097/WCO.0000000000000438; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagashima H, 2018, J ALLERGY CLIN IMMUN, V141, P1939, DOI 10.1016/j.jaci.2018.01.028; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Price R, 2016, EURASIP J AUDIO SPEE, P1, DOI 10.1186/s13636-016-0088-7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Team R.C, 2015, R LANG ENV STAT COMP; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; UMEDA Y, 1988, BIOCHEM BIOPH RES CO, V154, P227, DOI 10.1016/0006-291X(88)90674-2; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Walter S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0476-1; WEINSTEIN JN, 1994, STEM CELLS, V12, P13, DOI 10.1002/stem.5530120106; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	108	109	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					682	+		10.1016/j.immuni.2019.06.009	http://dx.doi.org/10.1016/j.immuni.2019.06.009			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31353223	Green Accepted, Bronze			2022-12-18	WOS:000490141700014
J	Agudo, J; Park, ES; Rose, SA; Alibo, E; Sweeney, R; Dhainaut, M; Kobayashi, KS; Sachidanandam, R; Baccarini, A; Merad, M; Brown, BD				Agudo, Judith; Park, Eun Sook; Rose, Samuel A.; Alibo, Eziwoma; Sweeney, Robert; Dhainaut, Maxime; Kobayashi, Koichi S.; Sachidanandam, Ravi; Baccarini, Alessia; Merad, Miriam; Brown, Brian D.			Quiescent Tissue Stem Cells Evade Immune Surveillance	IMMUNITY			English	Article							MHC CLASS-I; T-CELLS; FUNCTIONALLY DISTINCT; SOMATIC MUTATIONS; SMALL-INTESTINE; SELF-RENEWAL; NICHE; VIVO; PRIVILEGE; CANCER	Stem cells are critical for the maintenance of many tissues, but whether their integrity is maintained in the face of immunity is unclear. Here we found that cycling epithelial stem cells, including Lgr(5+) intestinal stem cells, as well as ovary and mammary stem cells, were eliminated by activated T cells, but quiescent stem cells in the hair follicle and muscle were resistant to T cell killing. Immune evasion was an intrinsic property of the quiescent stem cells resulting from systemic downregulation of the antigen presentation machinery, including MHC class I and TAP proteins, and is mediated by the transactivator NLRC5. This process was reversed upon stem cell entry into the cell cycle. These studies identify a link between stem cell quiescence, antigen presentation, and immune evasion. As cancer-initiating cells can derive from stem cells, these findings may help explain how the earliest cancer cells evade immune surveillance.	[Agudo, Judith; Alibo, Eziwoma; Dhainaut, Maxime; Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Agudo, Judith; Park, Eun Sook; Rose, Samuel A.; Alibo, Eziwoma; Sweeney, Robert; Dhainaut, Maxime; Baccarini, Alessia; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Sachidanandam, Ravi; Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Kobayashi, Koichi S.] Hokkaido Univ, Fac Med, Sapporo, Hokkaido 0608638, Japan; [Sachidanandam, Ravi; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Hokkaido University; Icahn School of Medicine at Mount Sinai	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	brian.brown@mssm.edu	sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Dhainaut, Maxime/0000-0003-3832-7095; Rose, Samuel/0000-0001-9701-0050; Kobayashi, Koichi/0000-0003-2930-0114	NIH [R01AI104848, R01AI113221, R21OD020185, R01DK106593]; Robin Chemers Neustein Award; Juvenile Diabetes Research Foundation (JDRF) [3-2013-92]; NATIONAL CANCER INSTITUTE [R01CA190400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, T32AI007605, R01AI113221, U24AI118644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK106593] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD020185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robin Chemers Neustein Award; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Marc Feldmann (U. Oxford), Daniel Schramek (U. Toronto), Ken Lau (Vanderbilt), Adeeb Rahman (Icahn School of Medicine), and Robert Krauss, Mark Lebwohl, and Emma Guttman (Mount Sinai) for helpful discussions and Albert Ruzo for technical assistance. B.D.B. and M.M. were supported by NIH R01AI104848, R01AI113221, R21OD020185, and R01DK106593. J.A. was supported by the Robin Chemers Neustein Award and a Juvenile Diabetes Research Foundation (JDRF) postdoctoral fellowship (3-2013-92).	Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Busch K, 2016, CURR OPIN HEMATOL, V23, P295, DOI 10.1097/MOH.0000000000000250; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chidgey AP, 2008, CELL STEM CELL, V3, P357, DOI 10.1016/j.stem.2008.09.011; Clevers H, 2015, SCIENCE, V350, P1319, DOI 10.1126/science.aad7016; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Li N, 2016, GASTROENTEROLOGY, V151, P298, DOI 10.1053/j.gastro.2016.04.049; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Ng A, 2014, NAT CELL BIOL, V16, P745, DOI 10.1038/ncb3000; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; PIONTEK GE, 1985, J IMMUNOL, V135, P4281; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Quarta M, 2016, NAT BIOTECHNOL, V34, P752, DOI 10.1038/nbt.3576; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Stucci S, 2017, ONCOL LETT, V14, P5671, DOI 10.3892/ol.2017.6919; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Tang Chad, 2013, Methods Mol Biol, V1029, P17, DOI 10.1007/978-1-62703-478-4_2; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang L, 2016, SCIENCE, V351, P613, DOI 10.1126/science.aad5440; WESTGATE GE, 1991, J INVEST DERMATOL, V97, P417, DOI 10.1111/1523-1747.ep12481002; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wood KJ, 2016, TRENDS IMMUNOL, V37, P5, DOI 10.1016/j.it.2015.11.005; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	59	108	109	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					271	+		10.1016/j.immuni.2018.02.001	http://dx.doi.org/10.1016/j.immuni.2018.02.001			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466757	Bronze, Green Accepted			2022-12-18	WOS:000425507800013
J	Kaufmann, SHE; Dorhoi, A				Kaufmann, Stefan H. E.; Dorhoi, Anca			Molecular Determinants in Phagocyte-Bacteria Interactions	IMMUNITY			English	Review							NEUTROPHIL EXTRACELLULAR TRAPS; NITRIC-OXIDE SYNTHASE; STAPHYLOCOCCUS-AUREUS; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; PSEUDOMONAS-AERUGINOSA; SUPPRESSOR-CELLS; EPITHELIAL-CELLS; ALVEOLAR MACROPHAGES; INTERFERON-GAMMA	Phagocytes are crucial for host defense against bacterial pathogens. As first demonstrated by Metchnikoff, neutrophils and mononuclear phagocytes share the capacity to engulf, kill, and digest microbial invaders. Generally, neutrophils focus on extracellular, and mononuclear phagocytes on intracellular, pathogens. Reciprocally, extracellular pathogens often capitalize on hindering phagocytosis and killing of phagocytes, whereas intracellular bacteria frequently allow their engulfment and then block intracellular killing. As foreseen by Metchnikoff, phagocytes become highly versatile by acquiring diverse phenotypes, but still retaining some plasticity. Further, phagocytes engage in active crosstalk with parenchymal and immune cells to promote adjunctive reactions, including inflammation, tissue healing, and remodeling. This dynamic network allows the host to cope with different types of microbial invaders. Here we present an update of molecular and cellular mechanisms underlying phagocyte functions in antibacterial defense. We focus on four exemplary bacteria ranging from an opportunistic extracellular to a persistent intracellular pathogen.	[Kaufmann, Stefan H. E.; Dorhoi, Anca] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE; Dorhoi, A (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de; dorhoi@mpiib-berlin.mpg.de			European Union (EU) [HEALTH-F4-2011-280873, HEALTH-F3-2012-305279]; EU [643381]; Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety project BioVacSafe (IMI JU) [115308]; Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety project PreDICT-TB [115337]; Bill AMP; Melinda Gates Foundation Grand Challenges (BMGF GC) in Global Health Program [BMGF GC6-2013, OPP 1055806, OPP 1065330]; Bundesministerium fur Bildung und Forschung (BMBF) [03ZZ0806A]; BMBF Infect ERA project Anti-Bacterial Immune Regulation (ABIR) [031A404]; Institut Merieux Research Program (Starting grant); Else Kroner-Fresenius-Stiftung [2015_A69]	European Union (EU)(CGIAREuropean Commission); EU(European Commission); Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety project BioVacSafe (IMI JU); Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety project PreDICT-TB; Bill AMP; Melinda Gates Foundation Grand Challenges (BMGF GC) in Global Health Program; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF Infect ERA project Anti-Bacterial Immune Regulation (ABIR); Institut Merieux Research Program (Starting grant); Else Kroner-Fresenius-Stiftung	The authors thank Diane Schad for help preparing the figures and Mary Louise Grossman for excellent help preparing the manuscript. Work in S.H.E.K.'s lab is supported by the European Union's Seventh Framework Programme (EU FP7) projects ADITEC (HEALTH-F4-2011-280873) and TANDEM (HEALTHF-3-2012-305279); by the EU Horizon 2020 project TBVAC 2020 (Grant no. 643381); by the Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety projects BioVacSafe (IMI JU) (Grant no. 115308) and PreDICT-TB (Grant no. 115337); by the Bill & Melinda Gates Foundation Grand Challenges (BMGF GC) in Global Health Program (BMGF GC6-2013, #OPP 1055806 and #OPP 1065330); by the Bundesministerium fur Bildung und Forschung (BMBF) project inVAC (grant no. 03ZZ0806A); and by the BMBF Infect ERA project Anti-Bacterial Immune Regulation (ABIR) (Grant no. 031A404). A.D. is supported by the Institut Merieux Research Program (Starting grant) and the Else Kroner-Fresenius-Stiftung (Grant no. 2015_A69). The authors apologize to the investigators whose work could not be cited due to length limitations.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Andrews T, 2003, CLIN MICROBIOL REV, V16, P597, DOI 10.1128/CMR.16.4.597-621.2003; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Arnett E, 2014, J IMMUNOL, V192, P234, DOI 10.4049/jimmunol.1301302; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Beaumont PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099029; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; BoseDasgupta S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003879; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Carr KD, 2011, EUR J IMMUNOL, V41, P2666, DOI 10.1002/eji.201041363; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; Dorhoi A., 2015, SEMIN IMMUNOPATHOL; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Duque-Correa MA, 2014, P NATL ACAD SCI USA, V111, pE4024, DOI 10.1073/pnas.1408839111; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; El Daker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123772; Faure E, 2014, AM J RESP CRIT CARE, V189, P799, DOI 10.1164/rccm.201307-1358OC; Flannagan R. S., 2015, CELL MICROBIOL; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Heim CE, 2015, J LEUKOCYTE BIOL, V98, P1003, DOI 10.1189/jlb.4VMA0315-125RR; Heim CE, 2014, J IMMUNOL, V192, P3778, DOI 10.4049/jimmunol.1303408; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; HUIZINGA TWJ, 1990, J IMMUNOL, V144, P1432; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Johnson EE, 2010, FEMS IMMUNOL MED MIC, V58, P138, DOI 10.1111/j.1574-695X.2009.00622.x; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jubrail J, 2016, CELL MICROBIOL, V18, P80, DOI 10.1111/cmi.12485; Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Kitur K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004820; Knaul JK, 2014, AM J RESP CRIT CARE, V190, P1053, DOI 10.1164/rccm.201405-0828OC; Ko YP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003816; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Li CW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003918; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Lugo-Villarino G, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018549; Maertzdorf J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018531; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Melehani JH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004970; Metschnikoff E, 1884, ALLG WEIN MED ZTG, V27, P307; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muller S, 2014, FASEB J, V28, P162, DOI 10.1096/fj.13-232272; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Ng HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106813; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Ong CWM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004917; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schnupf P, 2007, INFECT IMMUN, V75, P5135, DOI 10.1128/IAI.00164-07; Scordo JM, 2016, J INNATE IMMUN, V8, P3, DOI 10.1159/000439275; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Simeone R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004650; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Skabytska Y, 2014, IMMUNITY, V41, P762, DOI 10.1016/j.immuni.2014.10.009; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Spaan AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6438; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Tebartz C, 2015, J IMMUNOL, V194, P1100, DOI 10.4049/jimmunol.1400196; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Wang GX, 2012, J IMMUNOL, V188, P5829, DOI 10.4049/jimmunol.1102620; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Williams MA, 2012, TRENDS IMMUNOL, V33, P488, DOI 10.1016/j.it.2012.04.007; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004; Wong KW, 2013, J INFECT DIS, V208, P109, DOI 10.1093/infdis/jit097; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yeremeev V, 2015, TUBERCULOSIS, V95, P447, DOI 10.1016/j.tube.2015.03.007; Yokoyama R, 2012, INFECT IMMUN, V80, P2816, DOI 10.1128/IAI.00399-12; Yoshikawa Y, 2009, AUTOPHAGY, V5, P1220, DOI 10.4161/auto.5.8.10177; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; Zumla A, 2015, NAT REV DRUG DISCOV, V14, P511, DOI 10.1038/nrd4696	146	108	115	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					476	491		10.1016/j.immuni.2016.02.014	http://dx.doi.org/10.1016/j.immuni.2016.02.014			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982355	Green Submitted, Bronze			2022-12-18	WOS:000372784200004
J	Taylor, A; Harker, JA; Chanthong, K; Stevenson, PG; Zuniga, EI; Rudd, CE				Taylor, Alison; Harker, James A.; Chanthong, Kittiphat; Stevenson, Philip G.; Zuniga, Elina I.; Rudd, Christopher E.			Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; PROTEIN-TYROSINE KINASE; INHIBITORY RECEPTOR PD-1; IN-VIVO; SIGNAL-TRANSDUCTION; INTERLEUKIN-2 PRODUCTION; DISEASE PROGRESSION; NEGATIVE REGULATION; PROGRAMMED DEATH-1; CD4 RECEPTOR	Despite the importance of the co-receptor PD-1 in T cell immunity, the upstream signaling pathway that regulates PD-1 expression has not been defined. Glycogen synthase kinase 3 (GSK-3, isoforms alpha and beta) is a serine-threonine kinase implicated in cellular processes. Here, we identified GSK-3 as a key up-stream kinase that regulated PD-1 expression in CD8(+) T cells. GSK-3 siRNA downregulation, or inhibition by small molecules, blocked PD-1 expression, resulting in increased CD8(+) cytotoxic T lymphocyte (CTL) function. Mechanistically, GSK-3 inactivation increased Tbx21 transcription, promoting enhanced T-bet expression and subsequent suppression of Pdcd1 (encodes PD-1) transcription in CD8(+) CTLs. Injection of GSK-3 inhibitors in mice increased in vivo CD8(+) OT-I CTL function and the clearance of murine gamma-herpesvirus 68 and lymphocytic choriomeningitis clone 13 and reversed T cell exhaustion. Our findings identify GSK-3 as a regulator of PD-1 expression and demonstrate the applicability of GSK-3 inhibitors in the modulation of PD-1 in immunotherapy.	[Taylor, Alison; Chanthong, Kittiphat; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England; [Harker, James A.; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England; [Stevenson, Philip G.] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Clin Med Virol Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Stevenson, Philip G.] Univ Queensland, Brisbane, Qld 4072, Australia	University of Cambridge; University of California System; University of California San Diego; University of Cambridge; Royal Children's Hospital Brisbane; University of Queensland; University of Queensland	Rudd, CE (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021; Taylor, Alison/ABE-5809-2021; Stevenson, Philip g/F-9688-2014	Rudd, Christopher E/0000-0001-5295-9019; Stevenson, Philip g/0000-0002-3520-5060; Taylor, Alison/0000-0003-2295-2611; Harker, James/0000-0002-0301-6898	Wellcome Trust [092627/Z/10/Z]; Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute (New York); Leukemia and Lymphoma Society Scholar Award; NIH [AI081923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081923] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute (New York); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C.E.R. was supported by Wellcome Trust 092627/Z/10/Z, J.A.H. by an Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute (New York), and E.I.Z. by a Leukemia and Lymphoma Society Scholar Award and a grant from the NIH AI081923. We thank Dr. Graham Lord (King's College London) for the kind gift of the Ifng CNS-12 promoter.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; BURGESS KE, 1991, EUR J IMMUNOL, V21, P1663, DOI 10.1002/eji.1830210712; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dong HD, 1999, NAT MED, V5, P1365; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Grakoui A, 2006, J HEPATOL, V45, P468, DOI 10.1016/j.jhep.2006.07.009; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Li CY, 2015, EMBO MOL MED, V7, P754, DOI 10.15252/emmm.201404578; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Milho R, 2009, J GEN VIROL, V90, P21, DOI 10.1099/vir.0.006569-0; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Palmer BE, 2013, J IMMUNOL, V190, P211, DOI 10.4049/jimmunol.1201108; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schroeder JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058501; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Smith X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004018; Song M, 2009, BIOCHEM BIOPH RES CO, V381, P491, DOI 10.1016/j.bbrc.2009.02.069; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wacker Michael J, 2005, J Biomol Tech, V16, P266; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wood JE, 2006, J BIOL CHEM, V281, P32385, DOI 10.1074/jbc.M604878200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	89	108	117	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					274	286		10.1016/j.immuni.2016.01.018	http://dx.doi.org/10.1016/j.immuni.2016.01.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885856	Green Published, hybrid			2022-12-18	WOS:000370294000011
J	Kim, TS; Gorski, SA; Hahn, S; Murphy, KM; Braciale, TJ				Kim, Taeg S.; Gorski, Stacey A.; Hahn, Steven; Murphy, Kenneth M.; Braciale, Thomas J.			Distinct Dendritic Cell Subsets Dictate the Fate Decision between Effector and Memory CD8(+) T Cell Differentiation by a CD24-Dependent Mechanism	IMMUNITY			English	Article							INFLUENZA-VIRUS INFECTION; GLYCATION END-PRODUCTS; HEAT-STABLE ANTIGEN; EXPRESSION; ACTIVATION; RESPONSES; RECEPTOR; CD24; RAGE; LUNG	The contribution of different DC subsets to effector and memory CD8(+) T cell generation during infection and the mechanism by which DCs controls these fate decisions is unclear. Here we demonstrated that the CD103(+) and CD11b(hi) migratory respiratory DC (RDC) subsets after influenza virus infection activated naive virus-specific CD8(+) T cells differentially. CD103(+) RDCs supported the generation of CD8(+) T effector (Teff) cells, which migrate from lymph nodes to the infected lungs. In contrast, migrant CD11b(hi) RDCs activated CD8(+) T cells characteristic of central memory CD8(+) T (CD8(+) Tcm) cells including retention within the draining lymph nodes. CD103(+) RDCs expressed CD24 at an elevated level, contributing to the propensity of this DC subpopulation to support CD8(+) Teff cell differentiation. Mechanistically, CD24 was shown to regulate CD8(+) T cell activation through HMGB1-mediated engagement of T cell RAGE. Thus, there is distribution of labor among DC subsets in regulating CD8(+) T cell differentiation.	[Kim, Taeg S.; Gorski, Stacey A.; Hahn, Steven; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Gorski, Stacey A.; Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	University of Virginia; University of Virginia; University of Virginia; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	tjb2r@virginia.edu			National Institutes of Health [R01 AI-15608, U19 AI-83024, R01 HL-33391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, T32AI007496, U19AI083024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Small for excellent technical assistance and members of the T.J.B. laboratory for insightful comments and helpful discussions. We also would like to thank V. Engelhard, T. Bender, and V. Laubach (University of Virginia, VA) for reagents and technical advice. This study is supported by the National Institutes of Health (R01 AI-15608, U19 AI-83024, and R01 HL-33391 to T.J.B.).	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Askew D, 2008, IMMUNOLOGY, V123, P447, DOI 10.1111/j.1365-2567.2007.02711.x; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2002, IMMUNOL CELL BIOL, V80, P463, DOI 10.1046/j.1440-1711.2002.01116.x; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Fahl SP, 2009, J IMMUNOL, V183, P5582, DOI 10.4049/jimmunol.0901187; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; He Y, 2013, CANCER RES, V73, P629, DOI 10.1158/0008-5472.CAN-12-2704; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; Moser B, 2007, AM J TRANSPLANT, V7, P293, DOI 10.1111/j.1600-6143.2006.01617.x; Moser B, 2007, J IMMUNOL, V179, P8051, DOI 10.4049/jimmunol.179.12.8051; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu Y, 1998, J EXP MED, V187, P1151, DOI 10.1084/jem.187.7.1151	38	108	108	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					400	413		10.1016/j.immuni.2014.02.004	http://dx.doi.org/10.1016/j.immuni.2014.02.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24631155	Green Accepted, Bronze			2022-12-18	WOS:000333422300013
J	Marangoni, F; Murooka, TT; Manzo, T; Kim, EY; Carrizosa, E; Elpek, NM; Mempel, TR				Marangoni, Francesco; Murooka, Thomas T.; Manzo, Teresa; Kim, Edward Y.; Carrizosa, Esteban; Elpek, Natalie M.; Mempel, Thorsten R.			The Transcription Factor NFAT Exhibits Signal Memory during Serial T Cell Interactions with Antigen-Presenting Cells	IMMUNITY			English	Article							DENDRITIC CELLS; IN-VIVO; LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; STROMAL CELLS; CUTTING EDGE; CA2+ SIGNALS; STOP SIGNAL; ACTIVATION; TUMOR	Interactions with antigen-presenting cells (APCs) interrupt T cell migration through tissues and trigger signaling pathways that converge on the activation of transcriptional regulators, including nuclear factor of activated T cells (NFAT), which control T cell function and differentiation. Both stable and unstable modes of cognate T cell-APC interactions have been observed in vivo, but the functional significance of unstable, serial contacts has remained unclear. Here we used multiphoton intravital microscopy in lymph nodes and tumors to show that while NFAT nuclear import was fast (t(1/2) (max)similar to 1 min), nuclear export was slow (t(1/2)similar to 20 min) in T cells. During delayed export, nuclear NFAT constituted a short-term imprint of transient TCR signals and remained transcriptionally active for the T cell tolerance gene Egr2, but not for the effector gene Ifng, which required continuous TCR triggering for expression. This provides a potential mechanistic basis for the observation that a predominance of unstable APC interactions correlates with the induction of T cell tolerance.	[Marangoni, Francesco; Murooka, Thomas T.; Manzo, Teresa; Kim, Edward Y.; Carrizosa, Esteban; Elpek, Natalie M.; Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Marangoni, Francesco; Murooka, Thomas T.; Kim, Edward Y.; Carrizosa, Esteban; Mempel, Thorsten R.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mempel, TR (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	tmempel@mgh.harvard.edu	Manzo, Teresa/AAC-3398-2019; Marangoni, Francesco/I-9087-2012	Manzo, Teresa/0000-0001-8552-3625; Marangoni, Francesco/0000-0002-2490-849X; Murooka, Thomas/0000-0002-3030-2726	NIH [AI073457, CA150975, AI0178897, AI097052]; Dana Foundation; MGH Fund for Medical Discovery Fellowship; MGH ECOR Tosteson Postdoctoral Fellowship Award; NATIONAL CANCER INSTITUTE [R01CA150975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007387, R56AI097052, P01AI078897, K99AI073457, R00AI073457, R01AI097052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; MGH Fund for Medical Discovery Fellowship; MGH ECOR Tosteson Postdoctoral Fellowship Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Jose Aramburu, Ulrich von Andrian, Shiv Pillai, James Moon, and Anjana Rao for helpful suggestions and critical reading of the manuscript, as well as Harald von Boehmer, Jose Aramburu, Vigo Heissmeyer, Roberto Bonasio, Sean Megason, Paul Allen, and Jason McCarthy for providing key reagents. We are indebted to Julia Kahn from the laboratory of Dai Fukumura for technical advice. T. R. M. was supported by NIH grants AI073457, CA150975, AI0178897, and AI097052 as well as a grant by the Dana Foundation. F. M. was supported by an MGH Fund for Medical Discovery Fellowship. T. T. M. was supported by the MGH ECOR Tosteson Postdoctoral Fellowship Award.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Clark CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018916; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Frey AB, 2008, IMMUNOL REV, V222, P192, DOI 10.1111/j.1600-065X.2008.00606.x; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Pulecio J, 2010, J EXP MED, V207, P2719, DOI 10.1084/jem.20100007; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586	48	108	109	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					237	249		10.1016/j.immuni.2012.09.012	http://dx.doi.org/10.1016/j.immuni.2012.09.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23313588	Green Accepted, Bronze			2022-12-18	WOS:000330940800007
J	Jiang, N; Huang, J; Edwards, LJ; Liu, BY; Zhang, Y; Beal, CD; Evavold, BD; Zhu, C				Jiang, Ning; Huang, Jun; Edwards, Lindsay J.; Liu, Baoyu; Zhang, Yan; Beal, Carrie D.; Evavold, Brian D.; Zhu, Cheng			Two-Stage Cooperative T Cell Receptor-Peptide Major Histocompatibility Complex-CD8 Trimolecular Interactions Amplify Antigen Discrimination	IMMUNITY			English	Article							LIGAND-BINDING; CD8 CORECEPTOR; ACTIVATION; TCR; KINETICS; AFFINITY; RECRUITMENT; LCK; MICROCLUSTERS; RECOGNITION	The T cell receptor (TCR) and CD8 bind peptide-major histocompatibility complex (pMHC) glycoproteins to initiate adaptive immune responses, yet the trimolecular binding kinetics at the T cell membrane is unknown. By using a micropipette adhesion frequency assay, we show that this kinetics has two stages. The first consists of TCR-dominant binding to agonist pMHC. This triggers a second stage consisting of a step increase in adhesion after a one second delay. The second-stage binding requires Src family kinase activity to initiate CD8 binding to the same pMHC engaged by the TCR. This induced trimeric-cooperative interaction enhances adhesion synergistically to favor potent ligands, which further amplifies discrimination. Our data reveal a TCR-CD8 positive-feedback loop involved in initial signaling steps that is sensitive to a single pMHC is rapid, reversible, synergistic, and peptide discriminative.	[Jiang, Ning; Huang, Jun; Liu, Baoyu; Zhang, Yan; Zhu, Cheng] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Edwards, Lindsay J.; Beal, Carrie D.; Evavold, Brian D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Huang, Jun/E-8472-2010; Beal, Cara D/D-1138-2016; Jiang, Ning/M-5448-2017; Zhu, Cheng/A-5724-2011; Liu, Baoyu/C-4911-2009	Beal, Cara D/0000-0002-9219-2120; Jiang, Ning/0000-0003-1103-5922; Liu, Baoyu/0000-0002-0798-6314; Evavold, Brian/0000-0002-3561-3494	NIH [AI38282, AI060799, AI056017]; National Multiple Sclerosis Society [RG4047-A-3]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060799, R21AI056017, R29AI038282, R01AI038282, R01AI060799, R56AI038282, R01AI056017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Sambhara for providing F5 T cells, N.R. Gascoigne for providing CD8<SUP>+</SUP>TCR<SUP>-</SUP> OT1 hybridoma, J. Altman for providing the H-2K<SUP>b</SUP>alpha 3A2 construct, H. He for experimental advice, V. Zarnitsyna for helping with the PP2 inhibition experiment, J. Lou for structural analysis, J. Plowden and F. Zhang for technical assistance, and the NIH Tetramer Core Facility at Emory University for providing MHC monomers. This work was supported by NIH grants AI38282 and AI060799 (to C.Z.) and by NIH grant AI056017 and National Multiple Sclerosis Society Grant RG4047-A-3 (to B.D.E.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Campanelli R, 2002, INT IMMUNOL, V14, P39, DOI 10.1093/intimm/14.1.39; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Devine L, 2004, IMMUNOL LETT, V93, P123, DOI 10.1016/j.imlet.2004.02.002; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Ford ML, 2003, J IMMUNOL, V171, P1247, DOI 10.4049/jimmunol.171.3.1247; Gakamsky DM, 2005, BIOPHYS J, V89, P2121, DOI 10.1529/biophysj.105.061671; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Holman PO, 2005, J IMMUNOL, V174, P3986, DOI 10.4049/jimmunol.174.7.3986; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kerry SE, 2003, J IMMUNOL, V171, P4493, DOI 10.4049/jimmunol.171.9.4493; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pecht I, 2005, FEBS LETT, V579, P3336, DOI 10.1016/j.febslet.2005.04.025; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabatino JJ, 2008, J IMMUNOL, V180, P4451, DOI 10.4049/jimmunol.180.7.4451; Smyth LA, 2002, EUR J IMMUNOL, V32, P3386, DOI 10.1002/1521-4141(2002012)32:12<3386::AID-IMMU3386>3.0.CO;2-E; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Thome M, 1996, EUR J IMMUNOL, V26, P2093, DOI 10.1002/eji.1830260920; TOMONARI K, 1990, INT IMMUNOL, V2, P1189, DOI 10.1093/intimm/2.12.1189; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wooldridge L, 2003, J IMMUNOL, V171, P6650, DOI 10.4049/jimmunol.171.12.6650; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zamoyska R, 2007, IMMUNITY, V27, P421, DOI 10.1016/j.immuni.2007.08.009; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	50	108	109	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					13	23		10.1016/j.immuni.2010.12.017	http://dx.doi.org/10.1016/j.immuni.2010.12.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21256056	Green Accepted, Bronze			2022-12-18	WOS:000287336600006
J	Basso, K; Sumazin, P; Morozov, P; Schneider, C; Maute, RL; Kitagawa, Y; Mandelbaum, J; Haddad, J; Chen, CZ; Califano, A; Dalla-Favera, R				Basso, Katia; Sumazin, Pavel; Morozov, Pavel; Schneider, Christof; Maute, Roy L.; Kitagawa, Yukiko; Mandelbaum, Jonathan; Haddad, Joseph, Jr.; Chen, Chang-Zheng; Califano, Andrea; Dalla-Favera, Riccardo			Identification of the Human Mature B Cell miRNome	IMMUNITY			English	Article							POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; MICRORNAS; BIOGENESIS; MECHANISMS; MIRBASE; TARGETS	The full set of microRNAs (miRNAs) in the human genome is not known. Because presently known miRNAs have been identified by virtue of their abundant expression in a few cell types, many tissue-specific miRNAs remain unrevealed. To understand the role of miRNAs in B cell function and lymphoma-genesis, we generated short-RNA libraries from normal human B cells at different stages of development (naive, germinal center, memory) and from a Burkitt lymphoma cell line. A combination of cloning and computational analysis identified 178 miRNAs (miRNome) expressed in normal and/or transformed B cell libraries. Most notably, the B cell miRNome included 75 miRNAs which to our knowledge have not been previously reported and of which 66 have been validated by RNA blot and/or RT-PCR analyses. Numerous miRNAs were expressed in a stage- or transformation-specific fashion in B cells, suggesting specific functional or pathologic roles. These results provide a resource for studying the role of miRNAs in B cell development, immune function, and lymphomagenesis.	[Basso, Katia; Schneider, Christof; Maute, Roy L.; Kitagawa, Yukiko; Mandelbaum, Jonathan; Califano, Andrea; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Basso, Katia; Schneider, Christof; Maute, Roy L.; Kitagawa, Yukiko; Mandelbaum, Jonathan; Califano, Andrea; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Sumazin, Pavel; Morozov, Pavel; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY 10032 USA; [Haddad, Joseph, Jr.] Columbia Univ, Dept Otolaryngol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Basso, Katia] Univ Padua, Dept Pediat, I-35100 Padua, Italy; [Schneider, Christof] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Chen, Chang-Zheng] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Padua; Ulm University; Stanford University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rd10@columbia.edu	Califano, Andrea/F-7239-2012; Sumazin, Pavel/AAE-6607-2020; Morozov, Pavel/GQP-7206-2022	Sumazin, Pavel/0000-0002-1215-4977; Chen, Chang-Zheng/0000-0002-1620-242X; Califano, Andrea/0000-0003-4742-3679	Department of Health and Human Services; National Cancer Institute; National Centers for Biomedical Computing NIH Roadmap Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	Department of Health and Human Services; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Centers for Biomedical Computing NIH Roadmap Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to G. Liu and J. Chau for initial suggestions on generation and computational analysis of short-RNA libraries, respectively. We thank A. Ambesi for technical consultation. C.S. is supported by a Fellowship of the Mildred Scheel Stiftung fur Krebsforschung. R.L.M. is supported by a grant from the Department of Health and Human Services. This study was supported by grants to R.D.-F., A.C., and C.-Z.C. from the National Cancer Institute (N and the National Institute forAllergy and Infectious Diseases (NIAID) and by the National Centers for Biomedical Computing NIH Roadmap Initiative.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Davison A., 1997, BOOTSTRAP METHODS TH, V94; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harrell F. E., 2001, REGRESSION MODELING; Hartigan J.A., 1975, CLUSTERING ALGORITHM; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	41	108	110	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					744	752		10.1016/j.immuni.2009.03.017	http://dx.doi.org/10.1016/j.immuni.2009.03.017			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19446474	Green Accepted, Bronze			2022-12-18	WOS:000266356900016
J	Lybarger, L; Wang, XL; Harris, MR; Virgin, HW; Hansen, TH				Lybarger, L; Wang, XL; Harris, MR; Virgin, HW; Hansen, TH			Virus subversion of the MHC class I peptide-loading complex	IMMUNITY			English	Article							LEUKEMIA-ASSOCIATED-PROTEIN; MONOCLONAL-ANTIBODIES; DOWN-REGULATION; HERPESVIRUS K3; ALPHA-2 DOMAIN; CELL-SURFACE; MOLECULES; ANTIGEN; MOUSE; TAPASIN	Many viral proteins modulate class I expression, yet, in general, their mechanisms of specific class I recognition are poorly understood. The mK3 protein of gamma(2)-Herpesvirus 68 targets the degradation of nascent class I molecules via the ubiquitin/proteasome pathway. Here, we identify cellular components of the MHC class I assembly machinery, TAP and tapasin, that are required for mK3 function. mK3 failed to regulate class I in TAP-or tapasin-deficient cells, and mK3 interacted with TAP/tapasin, even in the absence of class I. Expression of mK3 resulted in the ubiquitination of TAP/tapasin-associated class 1, and mutants of class I incapable of TAP/tapasin interaction were unaffected by mK3. Thus, mK3 subverts TAP/tapasin to specifically target class I molecules for destruction.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hansen, TH (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	hansen@genetics.wustl.edu		Virgin, Herbert/0000-0001-8580-7628	NATIONAL CANCER INSTITUTE [R55CA074730, R01CA074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687, R01AI042793, R01AI045019, R21AI042793, T32AI007163] Funding Source: NIH RePORTER; NCI NIH HHS [CA 74730] Funding Source: Medline; NIAID NIH HHS [AI 42793, AI 19687, AI 45019, T32 AI 07163] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; Haque M, 2001, J GEN VIROL, V82, P1175, DOI 10.1099/0022-1317-82-5-1175; Harris MR, 2001, J IMMUNOL, V166, P6686, DOI 10.4049/jimmunol.166.11.6686; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Margetic D, 1999, INTERNET J CHEM, V2; Means RE, 2002, EMBO J, V21, P1638, DOI 10.1093/emboj/21.7.1638; Nicholas J, 1997, J VIROL, V71, P1963, DOI 10.1128/JVI.71.3.1963-1974.1997; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; OZATO K, 1980, J IMMUNOL, V124, P533; OZATO K, 1980, J IMMUNOL, V125, P2473; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; PRETELL J, 1979, VIROLOGY, V97, P32, DOI 10.1016/0042-6822(79)90370-2; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VANSANTEN VL, 1991, J VIROL, V65, P5211, DOI 10.1128/JVI.65.10.5211-5224.1991; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; YU LLY, 2002, J VIROL, V76, P2796; Yu YYL, 1999, J IMMUNOL, V163, P4427	51	108	111	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					121	130		10.1016/S1074-7613(02)00509-5	http://dx.doi.org/10.1016/S1074-7613(02)00509-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530981	Bronze			2022-12-18	WOS:000180860600012
J	Takaki, S; Sauer, K; Iritani, BM; Chien, S; Ebihara, Y; Tsuji, K; Takatsu, K; Perlmutter, RM				Takaki, S; Sauer, K; Iritani, BM; Chien, S; Ebihara, Y; Tsuji, K; Takatsu, K; Perlmutter, RM			Control of B cell production by the adaptor protein Lnk: Definition of a conserved family of signal-modulating proteins	IMMUNITY			English	Article							MICE LACKING; SH2 DOMAINS; C-CBL; PLECKSTRIN HOMOLOGY; ANTIGEN-RECEPTOR; PDGF RECEPTOR; APS; IDENTIFICATION; LYMPHOCYTES; SUBSTRATE	Lnk is an SH2 domain-containing adaptor protein expressed preferentially in lymphocytes. To illuminate the importance of Lnk, we generated Ink(-/-) mice. Whereas T cell development was unaffected, pre-B and immature B cells accumulated in the spleens. In the bone marrow, B-lineage cells were proportionately increased, reflecting enhanced production of pro-B cells that resulted in part from hypersensitivity of precursors to SCF, the ligand for c-kit. Hence, Lnk ordinarily acts to regulate B cell production. Further characterization of Ink(-/-) mice also revealed that full-length Lnk is a 68 kDa protein containing a conserved proline-rich region and a PH domain. Lnk is a representative of a multigene adaptor protein family whose members act, by analogy with Lnk, to modulate intracellular signaling.	Univ Tokyo, Inst Med Sci, Dept Immunol, Tokyo 108, Japan; Univ Tokyo, Inst Med Sci, Dept Clin Oncol, Tokyo 108, Japan; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Merck Res Labs, Rahway, NJ 07065 USA	University of Tokyo; University of Tokyo; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Merck & Company	Perlmutter, RM (corresponding author), Univ Tokyo, Inst Med Sci, Dept Immunol, 4-6-1 Shirokanedai, Tokyo 108, Japan.	roger_perlmutter@merck.com		Iritani, Brian/0000-0003-1903-7850	NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001445] Funding Source: NIH RePORTER; NCRR NIH HHS [T32 RR007019, T32 RR07019] Funding Source: Medline; NIAID NIH HHS [K08 AI001445-05, K08 AI001445-04, K08 AI001445-06] Funding Source: Medline; PHS HHS [1 K08 AJ01445-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed Z, 1999, BIOCHEM J, V341, P665, DOI 10.1042/0264-6021:3410665; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Birge RB, 1996, GENES CELLS, V1, P595, DOI 10.1046/j.1365-2443.1996.00258.x; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Farrar MA, 1998, BBA-REV CANCER, V1377, pF35, DOI 10.1016/S0304-419X(97)00038-3; Ghia P, 1998, IMMUNOL TODAY, V19, P480, DOI 10.1016/S0167-5699(98)01330-9; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; Iseki M, 2000, BIOCHEM BIOPH RES CO, V272, P45, DOI 10.1006/bbrc.2000.2736; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Killeen N, 1998, CURR OPIN IMMUNOL, V10, P360, DOI 10.1016/S0952-7915(98)80176-3; Kotani K, 1998, BIOCHEM J, V335, P103, DOI 10.1042/bj3350103; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Mayumi M, 1995, CRIT REV IMMUNOL, V15, P255, DOI 10.1615/CritRevImmunol.v15.i3-4.40; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moodie SA, 1999, J BIOL CHEM, V274, P11186, DOI 10.1074/jbc.274.16.11186; MORRISSEY PJ, 1991, J IMMUNOL, V147, P561; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NORVELL A, 1995, J IMMUNOL, V154, P4404; Norvell A, 1996, J IMMUNOL, V156, P1328; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Riedel H, 1997, J BIOCHEM-TOKYO, V122, P1105; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Takaki S, 1997, J BIOL CHEM, V272, P14562, DOI 10.1074/jbc.272.23.14562; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; UEHARA S, 1994, INT IMMUNOL, V6, P1937, DOI 10.1093/intimm/6.12.1937; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; Yokouchi M, 1999, ONCOGENE, V18, P759, DOI 10.1038/sj.onc.1202326; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	48	108	112	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					599	609		10.1016/S1074-7613(00)00060-1	http://dx.doi.org/10.1016/S1074-7613(00)00060-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114373	Green Accepted, Bronze			2022-12-18	WOS:000165598500003
J	FORSTER, I; HIROSE, R; ARBEIT, JM; CLAUSEN, BE; HANAHAN, D				FORSTER, I; HIROSE, R; ARBEIT, JM; CLAUSEN, BE; HANAHAN, D			LIMITED CAPACITY FOR TOLERIZATION OF CD4(+) T-CELLS SPECIFIC FOR A PANCREATIC BETA-CELL NEO-ANTIGEN	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; NEGATIVE SELECTION; SPONTANEOUS AUTOIMMUNITY; PERIPHERAL TOLERANCE; ALPHA; EXPRESSION; THYMOCYTES; INDUCTION; LINES	Mice transgenic for SV40 T antigen (Tag) under control of the rat insulin promoter (RIP) develop two alternative immunological phenotypes: tolerance or autoimmunity towards Tag. We utilized the T cell receptor (TCR) genes expressed in a Tag-specific CD4+ cell from an autoimmune RIP-Tag mouse to generate two lines of TCR transgenic mice in which either 10% or 90% of peripheral T cells express the transgenic TCR. Where cross-bred to the tolerant RIP1-Tag2 line, mice from the low frequency TCR line showed partial deletion of peripheral Tag-specific T cells and nonresponsiveness of those that remained. In contrast, crossbred mice in which transgenic T cells comprised a majority of the T cell population were nontolerant both in vivo and in vitro. Thus, tolerization of CD4+ T cells specific fora rare self-antigen may fail if too many autoreactive T cells develop.	UNIV COLOGNE, INST GENET, D-50931 COLOGNE, GERMANY; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HORMONE RES INST, SAN FRANCISCO, CA 94143 USA	University of Cologne; University of California System; University of California San Francisco; University of California System; University of California San Francisco			CLAUSEN, Björn Erik/A-8229-2010; Förster, Irmgard/P-8545-2016	CLAUSEN, Björn Erik/0000-0002-2484-7842; Förster, Irmgard/0000-0002-7644-5642				ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FIELDS LE, 1992, P NATL ACAD SCI USA, V89, P5730, DOI 10.1073/pnas.89.13.5730; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEIGER T, 1992, P NATL ACAD SCI USA, V89, P2985, DOI 10.1073/pnas.89.7.2985; GEIGER T, 1993, J IMMUNOL, V151, P7030; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOMER RJ, 1993, INT IMMUNOL, V5, P1495, DOI 10.1093/intimm/5.12.1495; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; KANAGAWA O, 1988, J IMMUNOL METHODS, V110, P169; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MARSHAKROTHSTEIN A, 1979, J IMMUNOL, V122, P2491; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SKOWRONSKI J, 1990, P NATL ACAD SCI USA, V87, P7487, DOI 10.1073/pnas.87.19.7487; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; WHITE J, 1989, J IMMUNOL, V143, P1822; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	58	108	109	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1995	2	6					573	585		10.1016/1074-7613(95)90002-0	http://dx.doi.org/10.1016/1074-7613(95)90002-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796292	Bronze			2022-12-18	WOS:A1995RE53800003
J	Chun, E; Lavoie, S; Fonseca-Pereira, D; Bae, S; Michaud, M; Hoveyda, HR; Fraser, GL; Comeau, CAG; Glickman, JN; Fuller, MH; Layden, BT; Garrett, WS				Chun, Eunyoung; Lavoie, Sydney; Fonseca-Pereira, Diogo; Bae, Sena; Michaud, Monia; Hoveyda, Hamid R.; Fraser, Graeme L.; Comeau, Carey Ann Gallini; Glickman, Jonathan N.; Fuller, Miles H.; Layden, Brian T.; Garrett, Wendy S.			Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity	IMMUNITY			English	Article							CHAIN FATTY-ACIDS; T-BET DEFICIENCY; HOST-DEFENSE; MICROBIOTA; INFLAMMATION; DRIVES; IL-22; TIME	Group 3 innate lymphoid cells (ILC3s) sense environmental signals that are critical for gut homeostasis and host defense. However, the metabolite-sensing G-protein-coupled receptors that regulate colonic ILC3s remain poorly understood. We found that colonic ILC3s expressed Ffar2, a microbial metabolite-sensing receptor, and that Ffar2 agonism promoted ILC3 expansion and function. Deficiency of Ffar2 in ILC3s decreased their in situ proliferation and ILC3-derived interleukin-22 (IL-22) production. This led to impaired gut epithelial function characterized by altered mucus-associated proteins and antimicrobial peptides and increased susceptibility to colonic injury and bacterial infection. Ffar2 increased IL-22(+) CCR6(+) ILC3s and influenced ILC3 abundance in colonic lymphoid tissues. Ffar2 agonism differentially activated AKT or ERK signaling and increased ILC3-derived IL-22 via an AKT and STAT3 axis. Our findings suggest that Ffar2 regulates colonic ILC3 proliferation and function, and they identify an ILC3-receptor signaling pathway modulating gut homeostasis and pathogen defense.	[Chun, Eunyoung; Lavoie, Sydney; Fonseca-Pereira, Diogo; Bae, Sena; Michaud, Monia; Comeau, Carey Ann Gallini; Garrett, Wendy S.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Chun, Eunyoung; Lavoie, Sydney; Fonseca-Pereira, Diogo; Bae, Sena; Michaud, Monia; Comeau, Carey Ann Gallini; Garrett, Wendy S.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hoveyda, Hamid R.] Euroscreen SA, B-6041 Gosselies, Belgium; [Fraser, Graeme L.] EPICS SA, B-6041 Gosselies, Belgium; [Glickman, Jonathan N.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Glickman, Jonathan N.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Fuller, Miles H.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Layden, Brian T.] Univ Illinois, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA; [Layden, Brian T.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Garrett, Wendy S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Garrett, WS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Garrett, WS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	wgarrett@hsph.harvard.edu	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Garrett, Wendy/0000-0002-5092-0150	NIH [R01CA154426, R01-DK104927]; U.S. Department of Veterans Affairs merit award [I01-BX003382-01A1]; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grant R01CA154426. B.T.L. is supported by NIH grant R01-DK104927 and U.S. Department of Veterans Affairs merit award I01-BX003382-01A1. We thank the BPF Next-Gen Sequencing Core Facility at Harvard Medical School. We thank L. Ricci for preparing the graphical abstract. We thank the Garrett Laboratory for helpful discussions and manuscript review.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Bhinder G, 2013, JOVE-J VIS EXP, DOI 10.3791/50222; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Crepin VF, 2016, NAT PROTOC, V11, P1851, DOI 10.1038/nprot.2016.100; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Di Luccia B., 2019, J EXP MED; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Emgard J, 2018, IMMUNITY, V48, P120, DOI 10.1016/j.immuni.2017.11.020; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Forbes S, 2015, DIABETES, V64, P3763, DOI 10.2337/db15-0481; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hoveyda H., 2011, International Patent Application, Patent No. [WO 2011/076732 A1, 2011076732]; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kim SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02729-6; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Withers DR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01298; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	64	107	112	9	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					871	+		10.1016/j.immuni.2019.09.014	http://dx.doi.org/10.1016/j.immuni.2019.09.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31628054	Bronze, Green Accepted			2022-12-18	WOS:000497811300011
J	Zheng, Y; Han, GW; Abagyan, R; Wu, BL; Stevens, RC; Cherezov, V; Kufareva, I; Handel, TM				Zheng, Yi; Han, Gye Won; Abagyan, Ruben; Wu, Beili; Stevens, Raymond C.; Cherezov, Vadim; Kufareva, Irina; Handel, Tracy M.			Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV	IMMUNITY			English	Article							AMINO-TERMINAL DOMAIN; HIGH-AFFINITY BINDING; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; N-TERMINUS; RANTES; CORECEPTOR; CXCR4; GP120; PEPTIDES	CCR5 is the primary chemokine receptor utilized by HIV to infect leukocytes, whereas CCR5 ligands inhibit infection by blocking CCR5 engagement with HIV gp120. To guide the design of improved therapeutics, we solved the structure of CCR5 in complex with chemokine antagonist [5P7]CCL5. Several structural features appeared to contribute to the anti-HIV potency of [5P7]CCL5, including the distinct chemokine orientation relative to the receptor, the near-complete occupancy of the receptor binding pocket, the dense network of intermolecular hydrogen bonds, and the similarity of binding determinants with the FDA-approved HIV inhibitor Maraviroc. Molecular modeling indicated that HIV gp120 mimicked the chemokine interaction with CCR5, providing an explanation for the ability of CCR5 to recognize diverse ligands and gp120 variants. Our findings reveal that structural plasticity facilitates receptor- chemokine specificity and enables exploitation by HIV, and provide insight into the design of small molecule and protein inhibitors for HIV and other CCR5-mediated diseases.	[Zheng, Yi; Abagyan, Ruben; Kufareva, Irina; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Han, Gye Won; Cherezov, Vadim] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; University of Southern California; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Southern California; University of Southern California	Kufareva, I; Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ikufareva@ucsd.edu; thandel@ucsd.edu	Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022; zheng, yi/G-1917-2016	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; zheng, yi/0000-0002-4871-0779	National Institutes of Health [R01 AI118985, R01 GM117424, R21 AI121918, R21 AI122211, R01 GM071872]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; US Department of Energy (DOE) Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985, R21AI121918, R01AI037113, R21AI122211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117424, R01GM071872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Qin for help during early stages of the project, M. Gustavsson and T. Kawamura for helpful suggestions, A. Ishchenko, H. Zhang, and M. Audet for help with FRAP experiments and X-ray data collection, R. Sanishvili, N. Venugopalan, and staff at beamline 23ID at GM/CA CAT Advanced Photon Source. Funding was provided by National Institutes of Health grants R01 AI118985, R01 GM117424, R21 AI121918, R21 AI122211, and R01 GM071872. GM/CA@APS has been funded from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated by Argonne National Laboratory under contract number DE-AC02-06CH11357. R.A. has an equity interest in Molsoft. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cerini F, 2016, PROTEIN EXPRES PURIF, V119, P1, DOI 10.1016/j.pep.2015.10.011; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choi WT, 2012, J VIROL, V86, P10218, DOI 10.1128/JVI.00353-12; Cimbro R, 2016, EBIOMEDICINE, V10, P45, DOI 10.1016/j.ebiom.2016.06.037; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Dalton JAR, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0567-3; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dorgham K, 2016, METHOD ENZYMOL, V570, P47, DOI 10.1016/bs.mie.2015.09.014; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Hall SE, 2009, MOL PHARMACOL, V75, P1325, DOI 10.1124/mol.108.053470; Hanes MS, 2015, J BIOL CHEM, V290, P22385, DOI 10.1074/jbc.M115.675108; Howard OMZ, 1999, J BIOL CHEM, V274, P16228, DOI 10.1074/jbc.274.23.16228; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jin J, 2014, J BIOL CHEM, V289, P19042, DOI 10.1074/jbc.M114.559831; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; Martin-Blondel G, 2016, NAT REV NEUROL, V12, P95, DOI 10.1038/nrneurol.2015.248; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navenot JM, 2001, J MOL BIOL, V313, P1181, DOI 10.1006/jmbi.2001.5086; Nedellec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022020; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roche M, 2016, CURR TOP MED CHEM, V16, P1091, DOI 10.2174/1568026615666150901114724; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Stepanov S, 2011, ACTA CRYSTALLOGR D, V67, P176, DOI 10.1107/S0907444910053916; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Swinney DC, 2014, BRIT J PHARMACOL, V171, P3364, DOI 10.1111/bph.12683; Tam K, 2016, MBIO, V7, DOI 10.1128/mBio.02024-16; Tamamis P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05447; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605	68	107	110	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1005	+		10.1016/j.immuni.2017.05.002	http://dx.doi.org/10.1016/j.immuni.2017.05.002			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636951	Green Accepted, Bronze			2022-12-18	WOS:000403665900014
J	Shimokawa, C; Kanaya, T; Hachisuka, M; Ishiwata, K; Hisaeda, H; Kurashima, Y; Kiyono, H; Yoshimoto, T; Kaisho, T; Ohno, H				Shimokawa, Chikako; Kanaya, Takashi; Hachisuka, Masami; Ishiwata, Kenji; Hisaeda, Hajime; Kurashima, Yosuke; Kiyono, Hiroshi; Yoshimoto, Tomohiro; Kaisho, Tsuneyasu; Ohno, Hiroshi			Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth Infections	IMMUNITY			English	Article							FACTOR SPI-B; HEMATOPOIETIC STEM; TYPE-2 IMMUNITY; TRANSCRIPTION; PU.1; EXPRESSION; DIFFERENTIATION; INFLAMMATION; ACTIVATION; RESPONSES	Mast cells are important for eradication of intestinal nematodes; however, their precise mechanisms of action have remained elusive, especially in the early phase of infection. We found that Spi-B-deficient mice had increased numbers of mast cells and rapidly expelled the Heligmosomoides polygyrus (Hp) nematode. This was accompanied by induction of interleukin-13 (IL-13)-producing group 2 innate lymphoid cells (ILC2) and goblet cell hyperplasia. Immediately after Hp infection, mast cells were rapidly activated to produce IL-33 in response to ATP released from apoptotic intestinal epithelial cells. In vivo inhibition of the P2X7 ATP receptor rendered the Spi-B-deficient mice susceptible to Hp, concomitant with elimination of mast cell activation and IL-13-producing ILC2 induction. These results uncover a previously unknown role for mast cells in innate immunity in that activation of mast cells by ATP orchestrates the development of a protective type 2 immune response, in part by producing IL-33, which contributes to ILC2 activation.	[Shimokawa, Chikako; Kanaya, Takashi; Hachisuka, Masami; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Kanaya, Takashi; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Div Immunobiol, Dept Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Ishiwata, Kenji] Jikei Univ, Dept Trop Med, Sch Med, Tokyo 1058461, Japan; [Hisaeda, Hajime] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma 3718511, Japan; [Kurashima, Yosuke; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Yoshimoto, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Lab Allerg Dis, Nishinomiya, Hyogo 6638501, Japan; [Yoshimoto, Tomohiro] Hyogo Coll Med, Dept Immunol, Nishinomiya, Hyogo 6638501, Japan; [Kaisho, Tsuneyasu] Wakayama Med Univ, Inst Adv Med, Dept Immunol, Wakayama 6418509, Japan	RIKEN; Yokohama City University; Jikei University; Gunma University; University of Tokyo; Hyogo College of Medicine; Hyogo College of Medicine; Wakayama Medical University	Ohno, H (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan.; Ohno, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Div Immunobiol, Dept Med Life Sci, Yokohama, Kanagawa 2300045, Japan.	hiroshi.ohno@riken.jp	Kiyono, Hiroshi/AAC-6735-2022	Kanaya, Takashi/0000-0002-9863-1673	Japan Society for the Promotion of Science [26870849, 24249029]; Ohyama Health Foundation; Grants-in-Aid for Scientific Research [15H05274] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ohyama Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Zijin Guo, Ms. Sayuri Sakakibara, Naoko Tachibana, and Mr. Tatsuya Tanigaki for technical support; Dr. Shigeo Koyasu, Dr. Kazuyo Moro, and Dr. Naoko Satoh-Takayama for critical reading of the manuscript; and Dr. Peter D. Burrows for English editing. We are grateful to Dr. Hiroyuki Miyoshi (Keio University) for providing lentiviral vectors and to Dr. Atsushi Miyawaki (RIKEN) for Venus cDNA. This work was supported in part by Grants-in-Aid for Young Scientists (B) (26870849 to C.S.) and Scientific Research (A) (24249029 to H.O.) from the Japan Society for the Promotion of Science and Grant-in-Aid for Academic Research by Ohyama Health Foundation to C.S.	Akiyama N, 2014, J EXP MED, V211, P2425, DOI 10.1084/jem.20141207; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Coppin E, 2016, J IMMUNOL, V196, P4110, DOI 10.4049/jimmunol.1501037; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Hashimoto K, 2009, PARASITE IMMUNOL, V31, P457, DOI 10.1111/j.1365-3024.2009.01123.x; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Horsnell WGC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003662; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kanaya Takashi, 2014, Biosci Microbiota Food Health, V33, P91, DOI [10.12938/bmfh.33.91, 10.12938/bmfh.2013-024]; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Kuhl C, 2005, MOL CELL BIOL, V25, P8592, DOI 10.1128/MCB.25.19.8592-8606.2005; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Le H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00104; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Luis TC, 2012, LEUKEMIA, V26, P86, DOI 10.1038/leu.2011.260; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Sibilano R, 2014, EUR J IMMUNOL, V44, P2558, DOI 10.1002/eji.201444546; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; SUWA H, 1995, INT IMMUNOL, V7, P1441, DOI 10.1093/intimm/7.9.1441; Tetsutani K, 2009, EUR J IMMUNOL, V39, P2822, DOI 10.1002/eji.200939433; Tung HY, 2014, J INTERF CYTOK RES, V34, P141, DOI 10.1089/jir.2012.0066; Vanderford DA, 2010, EXP DERMATOL, V19, P518, DOI 10.1111/j.1600-0625.2009.01032.x; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	47	107	109	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					863	+		10.1016/j.immuni.2017.04.017	http://dx.doi.org/10.1016/j.immuni.2017.04.017			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514691	Bronze			2022-12-18	WOS:000401316300020
J	Witherden, DA; Watanabe, M; Garijo, O; Rieder, SE; Sarkisyan, G; Cronin, SJF; Verdino, P; Wilson, IA; Kumanogoh, A; Kikutani, H; Teyton, L; Fischer, WH; Havran, WL				Witherden, Deborah A.; Watanabe, Megumi; Garijo, Olivia; Rieder, Stephanie E.; Sarkisyan, Gor; Cronin, Shane J. F.; Verdino, Petra; Wilson, Ian A.; Kumanogoh, Atsushi; Kikutani, Hitoshi; Teyton, Luc; Fischer, Wolfgang H.; Havran, Wendy L.			The CD100 Receptor Interacts with Its Plexin B2 Ligand to Regulate Epidermal gamma delta T Cell Function	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; IV SEMAPHORIN CD100; DENDRITIC CELLS; WOUND REPAIR; ACTIN CYTOSKELETON; SURFACE MOLECULE; NERVOUS-SYSTEM; ACTIVATION; MIGRATION; ADHESION	gamma delta T cells respond rapidly to keratinocyte damage, providing essential contributions to the skin wound healing process. The molecular interactions regulating their response are unknown. Here, we identify a role for interaction of plexin B2 with the CD100 receptor in epithelial repair. In vitro blocking of plexin B2 or CD100 inhibited gamma delta T cell activation. Furthermore, CD100 deficiency in vivo resulted in delayed repair of cutaneous wounds due to a disrupted gamma delta T cell response to keratinocyte damage. Ligation of CD100 in gamma delta T cells induced cellular rounding via signals through ERK kinase and cofilin. Defects in this rounding process were evident in the absence of CD100-mediated signals, thereby providing a mechanistic explanation for the defective wound healing in CD100-deficient animals. The discovery of immune functions for plexin B2 and CD100 provides insight into the complex cell-cell interactions between epithelial resident gamma delta T cells and the neighboring cells they support.	[Witherden, Deborah A.; Watanabe, Megumi; Garijo, Olivia; Rieder, Stephanie E.; Sarkisyan, Gor; Cronin, Shane J. F.; Teyton, Luc; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Kikutani, Hitoshi] Osaka Univ, Dept Mol Immunol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kikutani, Hitoshi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Fischer, Wolfgang H.] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Osaka University; Osaka University; Osaka University; Salk Institute	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	havran@scripps.edu		Lipton, Stuart/0000-0002-3490-1259	NIH [AI36964, AI32751, AI52257, AI42266, CA58896, RR022988, NS057096]; Leukemia and Lymphoma Society; Vincent J. Coates Foundation; Grants-in-Aid for Scientific Research [20229007] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052257, R37AI042266, R01AI032751, R29AI032751, R01AI042266, R21AI032751, R01AI036964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Vincent J. Coates Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Park and W. Low for MS analysis and M. Svoboda, K. Podshivalova, and M. Haynes for technical assistance, K. Cheung for help with bone marrow chimeras, R. Bos and L. Sherman for clone 4 TCR transgenic mice and HA peptide, and C. Surh for C57BL/6 congenic mice. N. Gascoigne, J. Jameson, M. McHeyzer-Williams, T. Meehan, and D. Nemazee provided critical reading of the manuscript. This work was supported by NIH grants AI36964, AI32751, and AI52257 (W.L.H.); NIH grants AI42266 and CA58896 (I.A.W); and The Leukemia and Lymphoma Society (S.E.R.). The Mass Spectrometry Facility at the Salk Institute is supported by grants from the NIH (RR022988 and NS057096) and the Vincent J. Coates Foundation. This is manuscript number 18711 from The Scripps Research Institute.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Artigiani S, 2003, J BIOL CHEM, V278, P10094, DOI 10.1074/jbc.M210156200; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Cox EP., 1927, J PALEONTOL, V1, P179, DOI DOI 10.2307/1298056; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Elhabazi A, 1997, J BIOL CHEM, V272, P23515, DOI 10.1074/jbc.272.38.23515; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Grose R, 2002, DEVELOPMENT, V129, P2303; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HEEG K, 1985, J IMMUNOL METHODS, V77, P237, DOI 10.1016/0022-1759(85)90036-5; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; Komori HK, 2012, J IMMUNOL, V188, P2972, DOI 10.4049/jimmunol.1100887; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kumanogoh A, 2010, P JPN ACAD B-PHYS, V86, P611, DOI 10.2183/pjab.86.611; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Moretti S, 2006, CURR NEUROVASC RES, V3, P295, DOI 10.2174/156720206778792939; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Perala N, 2011, DIFFERENTIATION, V81, P81, DOI 10.1016/j.diff.2010.10.001; Redmond WL, 2008, J IMMUNOL, V180, P5275, DOI 10.4049/jimmunol.180.8.5275; SAMSTAG Y, 1991, J IMMUNOL, V147, P788; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Schaffer M, 1998, BRIT J SURG, V85, P444; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; WAN LSC, 1994, DRUG DEV IND PHARM, V20, P2551, DOI 10.3109/03639049409042659; WAN LSC, 1993, INT J PHARM, V96, P59, DOI 10.1016/0378-5173(93)90212-X; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006; Zielonka M, 2010, EXP CELL RES, V316, P2477, DOI 10.1016/j.yexcr.2010.05.007	64	107	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					314	325		10.1016/j.immuni.2012.05.026	http://dx.doi.org/10.1016/j.immuni.2012.05.026			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22902232	Bronze, Green Accepted			2022-12-18	WOS:000308261800015
J	Mallevaey, T; Clarke, AJ; Scott-Browne, JP; Young, MH; Roisman, LC; Pellicci, DG; Patel, O; Vivian, JP; Matsuda, JL; McCluskey, J; Godfrey, DI; Marrack, P; Rossjohn, J; Gapin, L				Mallevaey, Thierry; Clarke, Andrew J.; Scott-Browne, James P.; Young, Mary H.; Roisman, Laila C.; Pellicci, Daniel G.; Patel, Onisha; Vivian, Julian P.; Matsuda, Jennifer L.; McCluskey, James; Godfrey, Dale I.; Marrack, Philippa; Rossjohn, Jamie; Gapin, Laurent			A Molecular Basis for NKT Cell Recognition of CD1d-Self-Antigen	IMMUNITY			English	Article							KILLER T-CELLS; STRUCTURAL BASIS; CUTTING EDGE; RECEPTOR; CD1D; ACTIVATION; GLYCOLIPIDS; REPERTOIRE; COMPLEX; SELF	The antigen receptor for natural killer T cells (NKT TCR) binds CD1d-restricted microbial and self-lipid antigens, although the molecular basis of self-CD1d recognition is unclear. Here, we have characterized NKT TCR recognition of CD1d molecules loaded with 0 natural self-antigens (Ags) and report the 2.3 angstrom resolution structure of an autoreactive NKT TCR-phosphatidylinositol-CD1d complex. NKT TCR recognition of self- and foreign antigens was underpinned by a similar mode of germline-encoded recognition of CD1d. However, NKT TCR autoreactivity is mediated by unique sequences within the non-germline-encoded CDR3 beta loop encoding for a hydrophobic motif that promotes self-association with CD1d. Accordingly, NKT cell autoreactivity may arise from the inherent affinity of the interaction between CD1d and the NKT TCR, resulting in the recognition of a broad range of CD1d-restricted self-antigens. This demonstrates that multiple self-antigens can be recognized in a similar manner by autoreactive NKT TCRs.	[Clarke, Andrew J.; Roisman, Laila C.; Patel, Onisha; Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Prot Crystallog Unit, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia; [Mallevaey, Thierry; Scott-Browne, James P.; Young, Mary H.; Matsuda, Jennifer L.; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Sch Med & Natl Jewish Hlth, Dept Immunol, Denver, CO 80206 USA; [Pellicci, Daniel G.; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Marrack, Philippa] Univ Colorado Denver, Howard Hughes Med Inst, Denver, CO 80220 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Med, Denver, CO 80220 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Denver, CO 80220 USA	Monash University; University of Colorado System; University of Colorado Denver; University of Melbourne; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Prot Crystallog Unit, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamie.rossjohn@monash.edu; gapinl@njhealth.org	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Roisman, Laila C./P-9129-2019; Mallevaey, Thierry/AAH-4499-2020; Roisman, Laila/D-1827-2010; Pellicci, Daniel/AAX-8539-2020; Marrack, Philippa/AHE-6316-2022	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Roisman, Laila C./0000-0001-8455-9327; Roisman, Laila/0000-0001-8455-9327; Vivian, Julian/0000-0002-9400-4437; Marrack, Philippa/0000-0003-1883-3687; Patel, Onisha/0000-0001-6701-7139; Godfrey, Dale/0000-0002-3009-5472; Pellicci, Daniel/0000-0001-5305-2398	National Institutes of Health [AI076463, AI078246, AI187785, T32 AI07405]; Howard Hughes Medical Institute; Cancer Council of Victoria; National Health and Medical Research Council of Australia; NHMRC; Australian Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076463, R56AI078246, R01AI018785, T32AI007405, P01AI022295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (AI076463 and AI078246 to L.G. and AI187785 to P.M.), NIH training grant T32 AI07405 to J.P.S.-B. and M.H.Y.; Howard Hughes Medical Institute (P.M.); the Cancer Council of Victoria, and the National Health and Medical Research Council of Australia. D.I.G. is supported by an NHMRC fellowship; J.R. is supported by an Australian Research Council Federation Fellowship. T.M., A.J.C., JR., and L.G. designed the experiments, did the experimental work, analyzed the experiments, and prepared the manuscript. D.G.P., O.P., J.L.M., M.H.Y., DIG., J.M., L.C.R., J.P.V., and P.M. provided intellectual insight and crystallographic data. T.M., J.P.S.-B., D.I.G., P.M., JR., and L.G. devised the project and wrote the manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P501; Bellone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008646; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Brossay L, 1998, J IMMUNOL, V160, P3681; Brossay L, 1998, J IMMUNOL, V161, P5124; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Li YS, 2009, J PROTEOME RES, V8, P2740, DOI 10.1021/pr801040h; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Muindi K, 2010, P NATL ACAD SCI USA, V107, P3052, DOI 10.1073/pnas.0915056107; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Park SH, 1998, J IMMUNOL, V160, P3128; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Skold M, 2005, J IMMUNOL, V175, P3584, DOI 10.4049/jimmunol.175.6.3584; Swann JB, 2007, CURR TOP MICROBIOL, V314, P293; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	107	107	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					315	326		10.1016/j.immuni.2011.01.013	http://dx.doi.org/10.1016/j.immuni.2011.01.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21376640	Green Accepted, Bronze			2022-12-18	WOS:000289014500008
J	Cho, JH; Kim, HO; Surh, CD; Sprent, J				Cho, Jae-Ho; Kim, Hee-Ok; Surh, Charles D.; Sprent, Jonathan			T Cell Receptor-Dependent Regulation of Lipid Rafts Controls Naive CD8(+) T Cell Homeostasis	IMMUNITY			English	Article							SENSORY ADAPTATION; IL-2 RECEPTOR; MEMORY; PROLIFERATION; SIGNAL; DIFFERENTIATION; ANTIGEN; HELP; LOCALIZATION; ACTIVATION	T cell receptor (TCR) contact with self ligands keeps T cells alive and is shown here to cause naive CD8(+), but not CD4(+), T cells to be hypersensitive to certain gamma(c) cytokines, notably interleukin (IL)-2, IL-15, and IL-7. Hypersensitivity of CD8(+) T cells to IL-2 was dependent on a low-level TCR signal, associated with high expression of CD5 and GM1, a marker for lipid rafts, and was abolished by disruption of lipid rafts. By contrast, CD4(+) T cells expressed low amounts of GM1 and were unresponsive to IL-2. Physiologically, sensitivity to IL-7 and IL-15 maintains survival of resting CD8(+) T cells, whereas sensitivity to IL-2 may be irrelevant for normal homeostasis but crucial for the immune response. Thus, TCR contact with antigen upregulates GM1 and amplifies responsiveness of naive CD8(+) T cells to IL-2, thereby making the cells highly sensitive to exogenous IL-2 from CD4(+) T helper cells.	[Cho, Jae-Ho; Kim, Hee-Ok; Sprent, Jonathan] St Vincents Hosp, Garvan Inst Med Res, Immunol & Inflammat Program, Darlinghurst, NSW 2010, Australia; [Surh, Charles D.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Sprent, Jonathan] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Cho, Jae-Ho; Surh, Charles D.; Sprent, Jonathan] POSTECH, WCU IBB Program, Pohang, South Korea	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Scripps Research Institute; University of New South Wales Sydney; Pohang University of Science & Technology (POSTECH)	Sprent, J (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Immunol & Inflammat Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	j.sprent@garvan.org.au	Cho, Jae Ho/K-9519-2014	Cho, Jae Ho/0000-0003-3658-4354	NIH (USA); NHMRC (Australia); KOSEF (Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045809, R01AI064586, R01AI075164] Funding Source: NIH RePORTER	NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); KOSEF (Korea)(Korea Science and Engineering Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Basten, C. King, K. Webster, R. Kohler, and M. Palendira for helpful comments and suggestions; A. Hong for mice genotyping; R. Brink and C. Mackay for OT-II mice; I. Hwang (The Scripps Research Institute) for 2C.Cd28<SUP>-/-</SUP> and 2C.Itgar<SUP>-/-</SUP> mice; C. Brownlee, Y. Sontani, and J. Darakdjian of the Garvan Flow Cytometry Core Facility for cell sorting; W. Hughes of the Garvan Pieter Huveneers Molecular Imaging Unit for confocal imaging; and the Garvan Biological Testing Facility for animal care. This work was supported by grants from the NIH (USA), NHMRC (Australia), and KOSEF (Korea).	Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bodnar A, 2008, IMMUNOL LETT, V116, P117, DOI 10.1016/j.imlet.2007.12.014; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; CAI ZL, 1994, J EXP MED, V179, P2005, DOI 10.1084/jem.179.6.2005; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; COELHO VD, 2004, BMC IMMUNOL, V5, P2; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Goebel J, 2002, J LEUKOCYTE BIOL, V72, P199; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Guimond M, 2005, J IMMUNOTHER, V28, P289, DOI 10.1097/01.cji.0000165356.03924.e7; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kim K, 2009, J BIOL CHEM, V284, P22149, DOI 10.1074/jbc.M109.000752; Malek TR, 2002, TRENDS IMMUNOL, V23, P465, DOI 10.1016/S1471-4906(02)02308-6; Marmor MD, 2001, BLOOD, V98, P1489, DOI 10.1182/blood.V98.5.1489; Marquez ME, 2005, J IMMUNOL, V175, P7388, DOI 10.4049/jimmunol.175.11.7388; MINAMI Y, 1993, EMBO J, V12, P759, DOI 10.1002/j.1460-2075.1993.tb05710.x; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Udaka K, 1996, J IMMUNOL, V157, P670; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhao JM, 1999, J BIOL CHEM, V274, P13744, DOI 10.1074/jbc.274.20.13744	47	107	109	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					214	226		10.1016/j.immuni.2009.11.014	http://dx.doi.org/10.1016/j.immuni.2009.11.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20137986	Green Accepted, Bronze			2022-12-18	WOS:000275346000011
J	Lauritsen, JPH; Wong, GW; Lee, SY; Lefebvre, JM; Ciofani, M; Rhodes, M; Kappes, DJ; Zuniga-Pflucker, JC; Wiest, DL				Lauritsen, Jens Peter Holst; Wong, Gladys W.; Lee, Sang-Yun; Lefebvre, Juliette M.; Ciofani, Maria; Rhodes, Michele; Kappes, Dietmar J.; Zuniga-Pflucker, Juan Carlos; Wiest, David L.			Marked Induction of the Helix-Loop-Helix Protein Id3 Promotes the gamma delta T Cell Fate and Renders Their Functional Maturation Notch Independent	IMMUNITY			English	Article							ALPHA-BETA; PRE-TCR; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; TRANSGENIC MICE; IGE PRODUCTION; LINEAGE FATE; E2A PROTEINS; IN-VIVO; GENE	alpha beta and gamma delta T cells arise from a common thymocyte progenitor during development in the thymus. Emerging evidence suggests that the pre-T cell receptor (pre-TCR) and gamma delta T cell receptor (gamma delta TCR) play instructional roles in specifying the alpha beta and gamma delta T-lineage fates, respectively. Nevertheless, the signaling pathways differentially engaged to specify fate and promote the development of these lineages remain poorly understood. Here, we show that differential activation of the extracellular signal-related kinase (ERK)-early growth response gene (Egr)-inhibitor of DNA binding 3 (Id3) pathway plays a defining role in this process. In particular, Id3 expression served to regulate adoption of the gamma delta fate. Moreover, Id3 was both necessary and sufficient to enable gamma delta-lineage cells to differentiate independently of Notch signaling and become competent IFN gamma-producing effectors. Taken together, these findings identify Id3 as a central player that controls both adoption of the gamma delta fate and its maturation in the thymus.	[Wong, Gladys W.; Ciofani, Maria; Zuniga-Pflucker, Juan Carlos] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Lauritsen, Jens Peter Holst; Lee, Sang-Yun; Lefebvre, Juliette M.; Rhodes, Michele; Kappes, Dietmar J.; Wiest, David L.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Wong, Gladys W.; Ciofani, Maria; Zuniga-Pflucker, Juan Carlos] Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fox Chase Cancer Center; University of Toronto	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jczp@sri.utoronto.ca; david.wiest@fccc.edu	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Ciofani, Maria/0000-0001-6472-5260; Wiest, David/0000-0002-0792-3188	NIH [AI081314, P01CA06927, P30-DK-50306]; Canadian Institute of Health Research [CIHR-MOP42387]; Canada Research Chair in Developmental Immunology; Fox Chase Cancer Plain and Fancy and Greenwald Postdoctoral Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Immunology(Canada Research Chairs); Fox Chase Cancer Plain and Fancy and Greenwald Postdoctoral Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Singer and M.K. Anderson for critically reviewing the manuscript. We acknowledge the following core facilities at Fox Chase Cancer Center: Cell Culture, DNA Sequencing, DNA Synthesis, Flow Cytometry, and Laboratory Animal. We acknowledge the Sunnybrook Research Institute Centre for Cytometry and Scanning Microscopy and the Division of Comparative Research. This work was supported by NIH grants (D.L.W.) AI081314, NIH core grant P01CA06927, Center grant no. P30-DK-50306, and an appropriation from the Commonwealth of Pennsylvania; and by a grant (J.C.Z.-P.) from the Canadian Institute of Health Research (CIHR-MOP42387). J.C.Z.-P. is supported by a Canada Research Chair in Developmental Immunology. G.W.W. and M.C. were supported by a CIHR Scholarship. J.P.L. and S.Y.L. were supported by the Fox Chase Cancer Plain and Fancy and Greenwald Postdoctoral Fellowships, respectively.	Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Deed RW, 1997, MOL CELL BIOL, V17, P6815, DOI 10.1128/MCB.17.12.6815; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Garcia-Peydro M, 2003, BLOOD, V102, P2444, DOI 10.1182/blood-2002-10-3261; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Haks MC, 2003, J IMMUNOL, V170, P2853, DOI 10.4049/jimmunol.170.6.2853; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hernandez-Hoyos G, 2003, SEMIN CELL DEV BIOL, V14, P121, DOI 10.1016/S1084-9521(02)00180-5; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Koltsova EK, 2007, J IMMUNOL, V179, P4694, DOI 10.4049/jimmunol.179.7.4694; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Lees RK, 2001, EUR J IMMUNOL, V31, P2901, DOI 10.1002/1521-4141(2001010)31:10<2901::AID-IMMU2901>3.0.CO;2-#; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PEREIRA P, 1992, EMBO J, V11, P25, DOI 10.1002/j.1460-2075.1992.tb05023.x; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Ueda-Hayakawa I, 2009, J IMMUNOL, V182, P5306, DOI 10.4049/jimmunol.0804249; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023	47	107	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					565	575		10.1016/j.immuni.2009.07.010	http://dx.doi.org/10.1016/j.immuni.2009.07.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833086	Green Accepted, Bronze			2022-12-18	WOS:000271403900008
J	Sekimata, M; Perez-Melgosa, M; Miller, SA; Weinmann, AS; Sabo, PJ; Sandstrom, R; Dorschner, MO; Stamatoyannopoulos, JA; Wilson, CB				Sekimata, Masayuki; Perez-Melgosa, Mercedes; Miller, Sara A.; Weinmann, Amy S.; Sabo, Peter J.; Sandstrom, Richard; Dorschner, Michael O.; Stamatoyannopoulos, John A.; Wilson, Christopher B.			CCCTC-Binding Factor and the Transcription Factor T-bet Orchestrate T Helper 1 Cell-Specific Structure and Function at the Interferon-gamma Locus	IMMUNITY			English	Article							CHROMOSOME CONFORMATION CAPTURE; CYTOKINE GENE-EXPRESSION; IN-VIVO; CTCF; CHROMATIN; GENOME; LONG; DIFFERENTIATION; ELEMENTS; ASSOCIATION	How cell type-specific differences in chromatin conformation are achieved and their contribution to gene expression are incompletely understood. Here we identify a cryptic upstream orchestrator of interferon-gamma (IFNG) transcription, which is embedded within the human IL26 gene, compromised of a single CCCTC-binding factor (CTCF) binding site and retained in all mammals, even surviving near-complete evolutionary deletion of the equivalent gene encoding IL-26 in rodents. CTCF and cohesins occupy this element in vivo in a cell type-nonspecific manner. This element is juxtaposed to two other sites located within the first intron and downstream of Ifng, where CTCF, cohesins, and the transcription factor T-bet bind in a T helper 1 (Th1) cell-specific manner. These interactions, close proximity of other elements within the locus to each other and to the gene encoding interferon-gamma, and robust murine Ifng expression are dependent on CTCF and T-bet. The results demonstrate that cooperation between architectural (CTCF) and transcriptional enhancing (T-bet) factors and the elements to which they bind is required for proper Th1 cell-specific expression of Ifng.	[Sabo, Peter J.; Sandstrom, Richard; Dorschner, Michael O.; Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Sekimata, Masayuki; Perez-Melgosa, Mercedes; Weinmann, Amy S.; Wilson, Christopher B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Miller, Sara A.] Univ Washington, Sch Med, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Wilson, Christopher B.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; chris.wilson@gatesfoundation.org		Sandstrom, Richard/0000-0002-3356-1547	NIH [R01-AI071282, R01-HD18184, N01-AI40069, U54-HG004592, R01-GM71923, R01-GM71852, R01-AI061061, GMT3207270]; American Cancer Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018184] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061061, N01AI040069, R01AI071272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071852, R01GM071923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Orkin and G. Blobel for providing G1E cells, M. Merkenschlager for useful discussions, A. Chaudhry for the retroviral construct, and A. Brasfield for animal care. This work was supported in part by funding from NIH grants R01-AI071282 (C.B.W.), R01-HD18184 (C.B.W.), N01-AI40069 (C.B.W. and J.A.S.), U54-HG004592 (J.A.S.), R01-GM71923 (J.A.S.), R01-GM71852 (J.A.S.), and R01-AI061061 (A.S.W.), by the American Cancer Society (A.S.W.), and by NIH predoctoral training grant GMT3207270 (S.A.M.).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Apostolou E, 2008, MOL CELL, V29, P154, DOI 10.1016/j.molcel.2008.01.008; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Sekimata M, 2004, NUCLEIC ACIDS RES, V32, P590, DOI 10.1093/nar/gkh249; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	54	107	108	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					551	564		10.1016/j.immuni.2009.08.021	http://dx.doi.org/10.1016/j.immuni.2009.08.021			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818655	Green Accepted, Bronze			2022-12-18	WOS:000271403900007
J	Harwood, NE; Batista, FD				Harwood, Naomi E.; Batista, Facundo D.			New insights into the early molecular events underlying B cell activation	IMMUNITY			English	Review							IMMUNOLOGICAL-SYNAPSE FORMATION; FOLLICULAR DENDRITIC CELL; MEMBRANE-BOUND ANTIGEN; RESPONSES IN-VIVO; LYMPH-NODE; T-CELLS; IMMUNE-SYNAPSE; LIPID RAFTS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION	The appropriate activation of B cells is critical for the development and operation of immune responses and is dependent on the extensive coordination of intra- and intercellular communications in response to antigen stimulation. An accurate description of the B cell-activation process requires investigation of these interactions within their correct cellular context both at high resolution and in real time. Here, we discuss a number of recent studies that have offered insight into the early molecular events of B cell activation. We suggest that segregation within the B cell membrane triggers localized cytoskeleton reorganisation and signaling, allowing the formation of B cell receptor (BCR) microclusters. These BCR microclusters are the sites for the coordinated recruitment of the signalosome and are propagated during B cell spreading. We discuss the recent identification of a critical role for CD19 in the B cell response to membrane-bound antigen and suggest a mechanism involving BCR microclusters by which it mediates its stimulatory function. Finally, we consider research that has taken advantage of recent technological advances in multiphoton microscopy that have allowed its application to the investigation of the dynamics of membrane-bound antigen presentation and subsequent B cell activation in lymph nodes in vivo.	[Harwood, Naomi E.; Batista, Facundo D.] Can Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, London WC2A 3PX, England		Batista, FD (corresponding author), Can Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk						Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Brezski RJ, 2007, J IMMUNOL, V179, P4464, DOI 10.4049/jimmunol.179.7.4464; Brooks SR, 2004, J IMMUNOL, V172, P7556, DOI 10.4049/jimmunol.172.12.7556; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Chakraborty AK, 2003, NAT IMMUNOL, V4, P933, DOI 10.1038/ni1003-933; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fournier E, 2003, CURR BIOL, V13, P1858, DOI 10.1016/j.cub.2003.09.034; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujimoto M, 1999, IMMUNITY, V11, P191, DOI 10.1016/S1074-7613(00)80094-1; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRAY D, 1991, INT IMMUNOL, V3, P141, DOI 10.1093/intimm/3.2.141; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Guermonprez P, 1998, J IMMUNOL, V161, P4542; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Han A, 2003, IMMUNITY, V19, P621, DOI 10.1016/S1074-7613(03)00275-9; Hao JJ, 2004, J BIOL CHEM, V279, P33413, DOI 10.1074/jbc.M313564200; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; KOSCO MH, 1988, J IMMUNOL, V140, P354; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Krummel MF, 2007, CURR OPIN IMMUNOL, V19, P460, DOI 10.1016/j.coi.2007.06.006; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li XL, 1997, J IMMUNOL, V158, P5649; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Reth M, 2000, IMMUNOL REV, V176, P10; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Sato S, 1997, J IMMUNOL, V159, P3278; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Schneckenburger H, 2005, CURR OPIN BIOTECH, V16, P13, DOI 10.1016/j.copbio.2004.12.004; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sohn HW, 2008, J IMMUNOL, V180, P793, DOI 10.4049/jimmunol.180.2.793; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Treanor B, 2007, CURR OPIN IMMUNOL, V19, P476, DOI 10.1016/j.coi.2007.05.009; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wu JH, 1996, J IMMUNOL, V157, P3404; Wykes M, 1998, J IMMUNOL, V161, P1313; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	121	107	110	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					609	619		10.1016/j.immuni.2008.04.007	http://dx.doi.org/10.1016/j.immuni.2008.04.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482567	Bronze			2022-12-18	WOS:000256003900008
J	Stolen, CM; Marttila-Ichihara, F; Koskinen, K; Yegutkin, GG; Turja, R; Bono, P; Skurnik, M; Hanninen, A; Jalkanen, S; Salmi, M				Stolen, CM; Marttila-Ichihara, F; Koskinen, K; Yegutkin, GG; Turja, R; Bono, P; Skurnik, M; Hanninen, A; Jalkanen, S; Salmi, M			Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo	IMMUNITY			English	Article							VASCULAR ADHESION PROTEIN-1; PERIVASCULAR BASEMENT-MEMBRANE; CONTAINING MONOAMINE-OXIDASE; SENSITIVE AMINE OXIDASE; L-SELECTIN; TRANSENDOTHELIAL MIGRATION; LYMPH-NODES; P-SELECTIN; INFLAMMATION; PECAM-1	Leukocyte migration from the blood to tissues is a prerequisite for normal immune responses. We produced mice deficient in an endothelial cell-surface oxidase (amine oxidase, copper containing-3 [AOC3], also known as vascular adhesion protein-1 [VAP-1]) and found that this enzyme is needed for leukocyte extravasation in vivo. Real-time imaging shows that AOC3 mediates slow rolling, firm adhesion, and transmigration of leukocytes in vessels at inflammatory sites and lymphoid tissues. Absence of AOC3 results in reduced lymphocyte homing into lymphoid organs and in attenuated inflammatory response in peritonitis. These data alter the paradigm of leukocyte extravasation cascade by providing the first physiological proof for the concept that endothelial cell surface enzymes regulate the development of inflammatory reactions in vivo and suggest that this enzyme should be useful as an anti-inflammatory target.	Turku Univ, Dept Med Microbiol, Medicity Res Lab, FIN-20520 Turku, Finland; Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland	University of Turku; University of Helsinki	Salmi, M (corresponding author), Turku Univ, Dept Med Microbiol, Medicity Res Lab, FIN-20520 Turku, Finland.	marko.salmi@utu.fi	Yegutkin, Gennady G./K-3815-2014; Skurnik, Mikael/I-8477-2019	Yegutkin, Gennady G./0000-0001-6684-7982; Skurnik, Mikael/0000-0001-8791-9260				BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Boyle JS, 1997, P NATL ACAD SCI USA, V94, P14626, DOI 10.1073/pnas.94.26.14626; CHASSANDE O, 1994, J BIOL CHEM, V269, P14484; Cronin CN, 1998, GENE, V220, P71, DOI 10.1016/S0378-1119(98)00416-8; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Duncan GS, 1999, J IMMUNOL, V162, P3022; Hanninen A, 1998, J IMMUNOL, V160, P6018; Imamura Y, 1998, GENOMICS, V51, P293, DOI 10.1006/geno.1998.5357; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Jalkanen S, 2001, EMBO J, V20, P3893, DOI 10.1093/emboj/20.15.3893; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Lechner F, 2000, J INFECT DIS, V182, P978, DOI 10.1086/315765; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; O'Sullivan J, 2003, BBA-PROTEINS PROTEOM, V1647, P367, DOI 10.1016/S1570-9639(03)00096-7; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Puri KD, 1996, J BIOL CHEM, V271, P5404, DOI 10.1074/jbc.271.10.5404; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1997, J EXP MED, V186, P589, DOI 10.1084/jem.186.4.589; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Smith A, 1998, PHARM SCI TECHNOL TO, V1, P188, DOI 10.1016/S1461-5347(98)00057-1; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Zhang XP, 1996, GENE, V179, P279, DOI 10.1016/S0378-1119(96)00387-3	43	107	123	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					105	115		10.1016/j.immuni.2004.12.006	http://dx.doi.org/10.1016/j.immuni.2004.12.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664163	Bronze			2022-12-18	WOS:000226682900011
J	Emambokus, NR; Frampton, J				Emambokus, NR; Frampton, J			The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis	IMMUNITY			English	Article							INTRAEMBRYONIC HEMOGENIC SITES; BONE-MARROW STROMA; STEM-CELLS; INTEGRIN EXPRESSION; ADHESION RECEPTORS; DIRECT-CONTACT; GENE; FIBRONECTIN; MOUSE; DIFFERENTIATION	The alpha integrin GPIIb is a marker of hematopoietic progenitors. Using a marking strategy based on Cre-IoxP technology to trace the fate of GPIIb-expressing cells, we show that GPIIb is expressed during early definitive embryonic hematopoiesis. However, the marked fetal population is distinct from the hematopoietic cells that predominate in the adult, suggesting that at least two waves of progenitors arise concurrently or consecutively in the fetus. Furthermore, using an inactivated allele of gpIIb, we provide evidence for a functional role of GPIIb on progenitors. We observe an increase in hematopoietic progenitors in the yolk sac, fetal liver, and bone marrow, an effect which may, in part, be explained by loss of binding to fibronectin.	John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Emambokus, NR (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.							Anzai N, 1999, BLOOD, V93, P3317, DOI 10.1182/blood.V93.10.3317.410k12_3317_3326; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; BERRIDGE MV, 1985, BLOOD, V66, P76; Buckley CD, 1998, MOL MEMBR BIOL, V15, P167, DOI 10.3109/09687689709044318; Corbel C, 2002, DEV BIOL, V243, P301, DOI 10.1006/dbio.2001.0553; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DEBILI N, 1992, BONE MARROW TRANSPL, V9, P11; Debili N, 2001, BLOOD, V97, P2023, DOI 10.1182/blood.V97.7.2023; DENARIER E, 1993, BIOCHEM BIOPH RES CO, V195, P1360, DOI 10.1006/bbrc.1993.2193; DEXTER TM, 1990, CIBA F SYMP, V148, P76; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; FRASER JK, 1986, BLOOD, V68, P762; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GINSBERG MH, 1995, THROMB HAEMOSTASIS, V74, P352; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hogan BLM, 1994, MANIPULATING MOUSE E; Hurley RW, 1997, EXP HEMATOL, V25, P321; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KALUZHNY Y, 2001, TRANSCRIPTION FACTOR, P31; KERST JM, 1993, BLOOD, V81, P344; Lemischka I R, 1991, Semin Immunol, V3, P349; Manaia A, 2000, DEVELOPMENT, V127, P643; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Ody C, 1999, BLOOD, V93, P2898; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Prosper F, 2001, J LEUKOCYTE BIOL, V69, P307; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; TILL J, 1961, RADIAT RES, V14, P1419; TRONIKLEROUX D, 1995, J EXP MED, V181, P2141, DOI 10.1084/jem.181.6.2141; Tropel P, 1997, BLOOD, V90, P2995, DOI 10.1182/blood.V90.8.2995; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Verfaillie CATHERINE M., 1999, Hematology, V4, P321; Verfaillie CM, 1998, BLOOD, V92, P2609, DOI 10.1182/blood.V92.8.2609; VERFAILLIE CM, 1992, BLOOD, V79, P2821; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; Verfaillie CM, 1996, LEUKEMIA, V10, P498; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wang MWJ, 1998, CELL GROWTH DIFFER, V9, P105; WEINSTEIN R, 1989, BLOOD, V73, P111; WILLIAMS DA, 1993, BLOOD, V81, P3169; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105	53	107	110	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					33	45		10.1016/S1074-7613(03)00173-0	http://dx.doi.org/10.1016/S1074-7613(03)00173-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871637	Bronze			2022-12-18	WOS:000184260400006
J	Richie, LI; Ebert, PJR; Wu, LC; Krummel, MF; Owen, JJT; Davis, MM				Richie, LI; Ebert, PJR; Wu, LC; Krummel, MF; Owen, JJT; Davis, MM			Imaging synapse formation during thymocyte selection: Inability of CD3 zeta to form a stable central accumulation during negative selection	IMMUNITY			English	Article							T-CELL-RECEPTOR; POSITIVE SELECTION; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; CD4; ACTIVATION; MICE; COSTIMULATION; TRANSDUCTION; SEGREGATION	TCR signaling can result in cell fates ranging from activation to tolerance to apoptosis. Organization of molecules in an "immunological synapse" between mature T cells and APCs correlates with the strength of TCR signaling. To investigate synapse formation during thymic selection, we have established a reaggregate system in which molecular recruitment of GFP fusion proteins to thymocyte:stromal cell interfaces can be visualized in real time. We demonstrate that negative selection is associated with efficient conjugate formation and rapid recruitment of p56(lck) and CD3zeta to an immunological synapse. Interestingly, CD3zeta-GFP does not accumulate at the center of the synapse, as in mature T cells, but at the periphery across a wide range of ligand densities. This implicates differences in synapse geometry in initiation of alternate signals downstream of the TCR.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Ehrlich, Lauren/0000-0002-1697-1755; Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052116] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Baldwin KK, 1999, J IMMUNOL, V163, P689; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BONOMO A, 1993, J EXP MED, V177, P1153, DOI 10.1084/jem.177.4.1153; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; DESTGROTH BF, 1993, MOL MECH IMMUNOLOGIC, P123; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HO WYW, 1995, THESIS STANFORD U PA; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; JANEWAY C, 1992, Current Biology, V2, P26, DOI 10.1016/0960-9822(92)90419-B; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; JONES LA, 1993, INT IMMUNOL, V5, P503, DOI 10.1093/intimm/5.5.503; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Kersh GJ, 2000, J IMMUNOL, V164, P5675, DOI 10.4049/jimmunol.164.11.5675; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; Kisielow P, 1990, Semin Immunol, V2, P35; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LO D, 1986, IMMUNOL RES, V5, P221, DOI 10.1007/BF02919203; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; OWENS T, 1987, P NATL ACAD SCI USA, V84, P9209, DOI 10.1073/pnas.84.24.9209; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; SPEISER DE, 1989, J EXP MED, V170, P2165, DOI 10.1084/jem.170.6.2165; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Travers H, 2001, J IMMUNOL METHODS, V253, P209, DOI 10.1016/S0022-1759(01)00391-X; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Vacchino JF, 2001, J IMMUNOL, V166, P6680, DOI 10.4049/jimmunol.166.11.6680; Volkmann A, 1997, J IMMUNOL, V158, P693; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015	44	107	110	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					595	606		10.1016/S1074-7613(02)00299-6	http://dx.doi.org/10.1016/S1074-7613(02)00299-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970882	Bronze			2022-12-18	WOS:000175109600010
J	Lagasse, E; Shizuru, JA; Uchida, N; Tsukamoto, A; Weissman, IL				Lagasse, E; Shizuru, JA; Uchida, N; Tsukamoto, A; Weissman, IL			Toward regenerative medicine	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; BONE-MARROW TRANSPLANTATION; COMMON MYELOID PROGENITOR; METASTATIC BREAST-CANCER; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; IN-VIVO; PERIPHERAL-BLOOD; MULTIPLE-MYELOMA; IRRADIATED MICE		SternCells, Sunnyvale, CA 94085 USA; Stanford Univ, Sch Med, Div Bone Marrow Transplantat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol & Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Lagasse, E (corresponding author), SternCells, 525 Del Rey Ave,Suite C, Sunnyvale, CA 94085 USA.							Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; ANTIN JH, 1993, BLOOD, V82, P2273; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BENNETT M, 1987, ADV IMMUNOL, V41, P333, DOI 10.1016/S0065-2776(08)60034-6; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bisgaard HC, 1996, CLIN LAB MED, V16, P325, DOI 10.1016/S0272-2712(18)30272-5; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; CIVIN CI, 1984, J IMMUNOL, V133, P167; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; CUDKOWICZ G, 1971, J EXP MED, V134, P83, DOI 10.1084/jem.134.1.83; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gandy KL, 1998, TRANSPLANTATION, V65, P295, DOI 10.1097/00007890-199802150-00001; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hill B, 1996, EXP HEMATOL, V24, P936; IKEHARA S, 1985, P NATL ACAD SCI USA, V82, P2483, DOI 10.1073/pnas.82.8.2483; Ito M, 1999, Biol Blood Marrow Transplant, V5, P357, DOI 10.1016/S1083-8791(99)70012-1; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KAUFMAN CL, 1994, BLOOD, V84, P2436; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MARTIN PJ, 1990, BONE MARROW TRANSPL, V6, P283; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MURRAY L, 1995, BLOOD, V85, P368; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Shizuru JA, 2000, P NATL ACAD SCI USA, V97, P9555, DOI 10.1073/pnas.170279297; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; TILL J, 1961, RADIAT RES, V14, P1419; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tricot G, 1998, BLOOD, V91, P4489, DOI 10.1182/blood.V91.12.4489.412k11_4489_4495; TRUITT RL, 1996, GRAFT VS HOST DIS, P385; TSUKAMOTO A, 1995, HEMATOPOIETIC STEM C, P85; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; UCHIDA N, 1994, BLOOD, V83, P3758; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; VERDONCK LF, 1994, BLOOD, V83, P3090, DOI 10.1182/blood.V83.10.3090.3090; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	75	107	117	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					425	436		10.1016/S1074-7613(01)00123-6	http://dx.doi.org/10.1016/S1074-7613(01)00123-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336688	Bronze			2022-12-18	WOS:000168246700010
J	Correia-Neves, M; Waltzinger, C; Mathis, D; Benoist, C				Correia-Neves, M; Waltzinger, C; Mathis, D; Benoist, C			The shaping of the T cell repertoire	IMMUNITY			English	Article							MHC CLASS-II; POSITIVE SELECTION; THYMIC SELECTION; TRANSGENIC MICE; AMINO-ACIDS; RECEPTOR; ALPHA; PEPTIDE; TCR; COMPLEX	By combining a TCR beta transgene with a TCR alpha minilocus comprised of a single V and two J gene segments, we engineered a mouse line exhibiting ample but focused Ton diversity, restricted to CDR3 alpha. Using single-cell PCR and high-throughput sequencing, we have exploited this system to scrutinize T cell repertoire selection and evolution. Some striking observations emerged: (1)thymic selection produces a repertoire that is very "bumpy," with marked overrepresentation of a subset of sequences; (2) MHC class I- and class II-restricted TCRs can be distinguished by minute, single-residue changes in CDR3 alpha; and (3) homeostatic expansion and survival in the periphery can markedly remold the postselection repertoire, likely reflecting variability in the potential of cells displaying different TCRs to respond to homeostatic cues.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Benoist, C (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Strasbourg, France.		Correia-Neves, Margarida/AAH-4636-2020; Correia-Neves, Margarida/C-9122-2009	Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BILL J, 1990, J MOL CELL IMMUNOL, V4, P269; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; Correia-Neves M, 1999, J IMMUNOL, V163, P5471; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dunger A, 1996, DIABETES, V45, P183, DOI 10.2337/diabetes.45.2.183; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1990, J IMMUNOL, V145, P1324; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; OKAZAKI K, 1988, EMBO J, V7, P1669, DOI 10.1002/j.1460-2075.1988.tb02994.x; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Penit C, 1997, J IMMUNOL, V159, P4848; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Sim BC, 1998, IMMUNOL TODAY, V19, P276, DOI 10.1016/S0167-5699(98)01257-2; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TOMONARI K, 1988, IMMUNOGENETICS, V28, P455, DOI 10.1007/BF00355379; Tuaillon N, 1998, P NATL ACAD SCI USA, V95, P1703, DOI 10.1073/pnas.95.4.1703; VITIELLO A, 1996, J IMMUNOL, V157, P555; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Wallace ME, 2000, IMMUNITY, V12, P547, DOI 10.1016/S1074-7613(00)80206-X; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; Zinkernagel RM, 1997, IMMUNOL TODAY, V18, P14, DOI 10.1016/S0167-5699(97)80008-4	46	107	111	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2001	14	1					21	32		10.1016/S1074-7613(01)00086-3	http://dx.doi.org/10.1016/S1074-7613(01)00086-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163227	Bronze			2022-12-18	WOS:000166513800003
J	Ye, SK; Maki, K; Kitamura, T; Sunaga, S; Akashi, K; Domen, J; Weissman, IL; Honjo, T; Ikuta, K				Ye, SK; Maki, K; Kitamura, T; Sunaga, S; Akashi, K; Domen, J; Weissman, IL; Honjo, T; Ikuta, K			Induction of germline transcription in the TCR gamma locus by Stat5: Implications for accessibility control by the IL-7 receptor	IMMUNITY			English	Article							T-CELL RECEPTOR; V-J RECOMBINATION; INTERLEUKIN-7 RECEPTOR; DEFICIENT MICE; GENE REARRANGEMENT; TARGETED DELETION; ALPHA-CHAIN; BCL-2; EXPRESSION; LYMPHOPOIESIS	IL-7 receptor (IL-7R) plays critical roles in lymphocyte development by promoting survival and proliferation and by inducing V(D)J recombination in TCR and Ig loci. Here, we demonstrate that IL-7R-activated Stat5 binds to consensus motifs in the 5' regions of J gamma segments and induces germline transcripts. We also show that a constitutively active form of Stat5 restores V-J recombination of TCR gamma genes and partially rescues T cell development from IL-7R(-/-) T cell precursors, especially in favor of gamma delta T cells. Therefore, this study reveals a potential role of Stat5 in T cell development and also implies that IL-7R may control the accessibility of the TCR gamma locus through Stat5-induced germline transcription.	Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan; Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1080071, Japan; Tokyo Univ Hosp, Dept Hematol & Oncol, Tokyo 1138655, Japan; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Kyoto University; University of Tokyo; University of Tokyo; Stanford University; Stanford University	Ikuta, K (corresponding author), Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan.	ikuta@mfour.med.kyoto-u.ac.jp	Kitamura, Toshio/AAA-2071-2021; Ye, Sang Kyu/J-2768-2012; Honjo, Tasuku/N-4470-2016	Ikuta, Koichi/0000-0003-1319-1021				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Candeias S, 1997, IMMUNOL LETT, V57, P9, DOI 10.1016/S0165-2478(97)00062-X; Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; IKUTA K, 1986, J EXP MED, V164, P428, DOI 10.1084/jem.164.2.428; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Sunaga S, 1997, J IMMUNOL, V158, P4223; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; vanderPlas DC, 1996, LEUKEMIA, V10, P1317; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; WAKAO H, 1992, J BIOL CHEM, V267, P16365; WEINSTEIN Y, 1989, J EXP MED, V169, P2059, DOI 10.1084/jem.169.6.2059; WEINSTEIN Y, 1995, EUR CYTOKINE NETW, V6, P97; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	38	107	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					213	223		10.1016/S1074-7613(00)80096-5	http://dx.doi.org/10.1016/S1074-7613(00)80096-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485656	Bronze			2022-12-18	WOS:000082383400010
J	Plebanski, M; Flanagan, KL; Lee, EAM; Reece, WHH; Hart, K; Gelder, C; Gillespie, G; Pinder, M; Hill, AVS				Plebanski, M; Flanagan, KL; Lee, EAM; Reece, WHH; Hart, K; Gelder, C; Gillespie, G; Pinder, M; Hill, AVS			Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum	IMMUNITY			English	Article							CIRCUMSPOROZOITE PROTEIN; RECEPTOR ANTAGONISTS; IMMUNIZED VOLUNTEER; BERGHEI INFECTION; PERIPHERAL-BLOOD; PEPTIDE LIGAND; MURINE MALARIA; WEST-AFRICA; CS PROTEIN; IFN-GAMMA	The immunodominant CD4 T cell epitope region, Th2R, of the circumsporozoite protein of Plasmodium falciparum is highly polymorphic. Such variation might be utilized by the parasite to escape from or interfere with CD4 T cell effector functions. Here, we show that costimulation with naturally occurring altered peptide ligands (APL) can induce a rapid change from IFN gamma production to the immunosuppresive mediator interleukin 10 (IL-10). This mechanism may contribute to the low levels of T cell responses observed to this pathogen in malaria-endemic areas.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Inst Mol Med, Oxford OX3 9DU, England; Cardiff Univ, Dept Med, Cardiff CF4 4XX, S Glam, Wales; MRC Labs, Fajara, Gambia	University of Oxford; Cardiff University; MRC Laboratory Molecular Biology	Plebanski, M (corresponding author), Austin & Repatriat Med Ctr, Austin Res Inst, Infect Dis Unit, Melbourne, Vic 3084, Australia.	mplebans@ari.unimelb.edu.au	Plebanski, Magdalena/AAU-3144-2021; HILL, Adrian V>S>/C-1306-2008	Flanagan, Katie/0000-0002-1575-1953	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AIDOO M, 1995, LANCET, V345, P1003, DOI 10.1016/S0140-6736(95)90754-8; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; DAVENPORT MP, 1995, IMMUNOGENETICS, V42, P392; DAVENPORT MP, 1995, IMMUNOL TODAY, V16, P432, DOI 10.1016/0167-5699(95)80020-4; DAVENPORT MP, 1995, P NATL ACAD SCI USA, V92, P6567, DOI 10.1073/pnas.92.14.6567; DELACRUZ VF, 1987, J BIOL CHEM, V262, P11935; DOOLAN DL, 1993, INT IMMUNOL, V5, P37, DOI 10.1093/intimm/5.1.37; DOOLAN DL, 1994, PARASITE IMMUNOL, V16, P129, DOI 10.1111/j.1365-3024.1994.tb00332.x; Doolan DL, 1997, PHILOS T R SOC B, V352, P1361, DOI 10.1098/rstb.1997.0121; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; ESPOSITO F, 1992, IMMUNOL LETT, V33, P187, DOI 10.1016/0165-2478(92)90046-Q; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; HO M, 1988, J IMMUNOL, V141, P2755; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOLLSBERG P, 1995, P NATL ACAD SCI USA, V92, P4036, DOI 10.1073/pnas.92.9.4036; Hussell T, 1996, J GEN VIROL, V77, P2447, DOI 10.1099/0022-1317-77-10-2447; HVIID L, 1991, FEMS MICROBIOL IMMUN, V76, P219, DOI 10.1016/0378-1097(91)90070-Q; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; LIMA POD, 1994, J EXP MED, V179, P1297; LOCKYER MJ, 1989, MOL BIOCHEM PARASIT, V37, P275, DOI 10.1016/0166-6851(89)90159-X; MAHANTY S, 1995, PARASITE IMMUNOL, V17, P385, DOI 10.1111/j.1365-3024.1995.tb00906.x; MARSH K, 1988, T ROY SOC TROP MED H, V82, P532, DOI 10.1016/0035-9203(88)90495-6; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MORENO A, 1991, INT IMMUNOL, V3, P997, DOI 10.1093/intimm/3.10.997; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MOSS PAH, 1995, P NATL ACAD SCI USA, V92, P5773, DOI 10.1073/pnas.92.13.5773; NARDIN EH, 1989, SCIENCE, V246, P1603, DOI 10.1126/science.2480642; O'Garra A, 1997, CURR OPIN IMMUNOL, V9, P872, DOI 10.1016/S0952-7915(97)80192-6; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PLEBANSKI M, 1995, EUR J IMMUNOL, V25, P1783, DOI 10.1002/eji.1830250645; Plebanski M, 1998, EUR J IMMUNOL, V28, P4345, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;4345::AID-IMMU4345&gt;3.0.CO;2-P; Plebanski M, 1997, J IMMUNOL, V158, P2849; RENIA L, 1993, J IMMUNOL, V150, P1471; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; TakitaSonoda Y, 1996, EXP PARASITOL, V84, P223, DOI 10.1006/expr.1996.0108; TIROUVANZIAM UB, 1995, J IMMUNOL, V154, P3922; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; Wang RB, 1996, J IMMUNOL, V157, P4061; WANGOO A, 1990, APMIS, V98, P407, DOI 10.1111/j.1699-0463.1990.tb01051.x; WEISS WR, 1993, J IMMUNOL, V151, P2690; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; Winkler S, 1999, J INFECT DIS, V179, P209, DOI 10.1086/314571; ZEVERING Y, 1994, EUR J IMMUNOL, V24, P1418, DOI 10.1002/eji.1830240627	60	107	107	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					651	660		10.1016/S1074-7613(00)80064-3	http://dx.doi.org/10.1016/S1074-7613(00)80064-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403640	Bronze			2022-12-18	WOS:000081209600003
J	Powis, SJ; Young, LL; Joly, E; Barker, PJ; Richardson, L; Brandt, RP; Melief, CJ; Howard, JC; Butcher, GW				Powis, SJ; Young, LL; Joly, E; Barker, PJ; Richardson, L; Brandt, RP; Melief, CJ; Howard, JC; Butcher, GW			The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER	IMMUNITY			English	Article							ANTIGEN PRESENTATION; LINKED TRANSPORTER; LYMPHOCYTES-T; MOLECULE; CELLS; TRANSLOCATION; REGION; PROTEIN; GENE	Functional polymorphism in the rat peptide transporter associated with antigen processing (TAP) changes the peptide pool available for binding and presentation by a class I MHC allele, RT1.A(a). The peptide binding motif for RT1.A(a), determined by stabilization with synthetic peptides, included a strong preference for arginine at the peptide C terminus. Analysis of natural peptides bound to RT1.A(a) by both pool sequencing and anhydrotrypsin chromatography revealed that TAP polymorphism determined the presence or absence of arginine as the peptide C-terminal residue. This result highlights the in vivo impact of TAP-peptide selectivity, and provides evidence against a high rate of generation of new C termini by protease activity in the endoplasmic reticulum.	BABRAHAM INST,MICROCHEM FACIL,CAMBRIDGE CB2 4AT,ENGLAND; UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND; UNIV LEIDEN HOSP,DEPT IMMUNOHEMATOL,2300 RC LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,BLOODBANK,2300 RC LEIDEN,NETHERLANDS; UNIV COLOGNE,INST GENET,COLOGNE,GERMANY	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Dundee; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Cologne	Powis, SJ (corresponding author), BABRAHAM INST,DEPT IMMUNOL,IMMUNOGENET LAB,CAMBRIDGE CB2 4AT,ENGLAND.		Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681; Powis, Simon/0000-0003-4218-2984; Howard, Jonathan/0000-0003-2756-5143				BUTCHER GW, 1987, J IMMUNOGENET, V14, P163; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; HAMMOND SA, 1993, NATURE, V364, P158, DOI 10.1038/364158a0; HARLOW E, 1988, ANTIBODIES LABORATOR; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4; JOLY E, 1994, IMMUNOGENETICS, V40, P45, DOI 10.1007/BF00163963; JOLY E, 1995, IMMUNOGENETICS, V41, P326, DOI 10.1007/BF00172159; LIVINGSTONE AM, 1991, IMMUNOGENETICS, V34, P157, DOI 10.1007/BF00205818; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; POWIS SJ, 1991, J EXP MED, V173, P913, DOI 10.1084/jem.173.4.913; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; POWIS SJ, 1993, TRANSPLANT P, V25, P2752; RADA C, 1990, P NATL ACAD SCI USA, V87, P2167, DOI 10.1073/pnas.87.6.2167; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; THORPE CJ, 1995, IMMUNOGENETICS, V41, P329; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANBLEEK GM, 1990, NATURE, V348, P213; WILLIAMS RM, 1980, LEUKEMIA RES, V4, P261, DOI 10.1016/0145-2126(80)90086-7; YANG Y, 1992, J BIOL CHEM, V267, P11669; YOKOSAWA H, 1979, ANAL BIOCHEM, V98, P198, DOI 10.1016/0003-2697(79)90726-7	38	107	110	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					159	165		10.1016/S1074-7613(00)80680-9	http://dx.doi.org/10.1016/S1074-7613(00)80680-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624806	Bronze			2022-12-18	WOS:A1996TX22500006
J	Gavin, MA; Bevan, MJ				Gavin, MA; Bevan, MJ			Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire	IMMUNITY			English	Article							RECEPTOR ALPHA-CHAIN; MICE; SITE; IDENTIFICATION; RESISTANCE; EPITOPE; GENES; TDT	Making use of mice deficient for terminal deoxynucleotidyl transferase (TdT) expression and a random peptide library, we have examined the diversity and peptide specificity of the neonatal T cell repertoire specific for a single H-2D(b)-restricted peptide. Consistent with the predicted decrease in repertoire diversity, polyclonal CTL lines and individual clones from different TdT(0) mice are more similar to each other than those from different wild-type mice in terms of their fingerprints of cross-reactivity to the library and their TCR sequences. We have also found that several TdT(0) CTL clones cross-react with many more library peptides than wild-type CTL clones. In a few instances, the degree of peptide promiscuity correlates with TCR sequence characteristics such as N region addition and homology-directed recombination, but not CDR3 loop length. Based on epitope titrations for each clone, TCR affinity for antigen is consistently high; thus, this reduced specificity for peptide may coincide with an accentuated affinity for the alpha helices of the MHC. Peptide promiscuity in the neonate may allow the relatively small numbers of T cells in the periphery to protect against a broader range of pathogens.			Gavin, MA (corresponding author), UNIV WASHINGTON,HOWARD HUGHES MED INST,DEPT IMMUNOL,SEATTLE,WA 98195, USA.				NIAID NIH HHS [AI-19335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335, R37AI019335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; BOGUE M, 1992, P NATL ACAD SCI USA, V89, P11011, DOI 10.1073/pnas.89.22.11011; BOGUE M, 1991, EMBO J, V10, P3647, DOI 10.1002/j.1460-2075.1991.tb04931.x; BONOMO A, 1995, IMMUNOL TODAY, V16, P61, DOI 10.1016/0167-5699(95)80089-1; BONOMO A, 1994, J IMMUNOL, V152, P1509; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; DORIT RL, 1995, CURRENT PROTOCOLS MO; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEENEY AJ, 1991, J EXP MED, V174, P115, DOI 10.1084/jem.174.1.115; GAVIN MA, 1994, EUR J IMMUNOL, V24, P2124, DOI 10.1002/eji.1830240929; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GILFILLAN S, 1995, EUR J IMMUNOL, V25, P3115, DOI 10.1002/eji.1830251119; HEUER J, 1991, J IMMUNOL, V146, P775; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; IWASHIRO M, 1993, J VIROL, V67, P4533, DOI 10.1128/JVI.67.8.4533-4542.1993; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; NALEFSKI EA, 1992, J EXP MED, V175, P1553, DOI 10.1084/jem.175.6.1553; RIGGS PD, 1992, CURRENT PROTOCOLS MO; RUEFFJUY D, 1991, INT IMMUNOL, V3, P683, DOI 10.1093/intimm/3.7.683; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; WITHER J, 1991, J IMMUNOL, V146, P3513; YAGUE J, 1988, NUCLEIC ACIDS RES, V16, P11355, DOI 10.1093/nar/16.23.11355	33	107	110	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					793	800		10.1016/1074-7613(95)90068-3	http://dx.doi.org/10.1016/1074-7613(95)90068-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777724	Bronze			2022-12-18	WOS:A1995TM02300013
J	Smith, LK; Boukhaled, GM; Condotta, SA; Mazouz, S; Guthmiller, JJ; Vijay, R; Butler, NS; Bruneau, J; Shoukry, NH; Krawczyk, CM; Richer, MJ				Smith, Logan K.; Boukhaled, Giselle M.; Condotta, Stephanie A.; Mazouz, Sabrina; Guthmiller, Jenna J.; Vijay, Rahul; Butler, Noah S.; Bruneau, Julie; Shoukry, Naglaa H.; Krawczyk, Connie M.; Richer, Martin J.			Interleukin-10 Directly Inhibits CD8(+) T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; TUMOR-INFILTRATING LYMPHOCYTES; C VIRUS-INFECTION; HEPATITIS-C; IN-VIVO; IL-10; RECEPTOR; TCR; AVIDITY; PERSISTENCE	Chronic viral infections remain a global health concern. The early events that facilitate viral persistence have been linked to the activity of the immunoregulatory cytokine IL-10. However, the mechanisms by which IL-10 facilitates the establishment of chronic infection are not fully understood. Herein, we demonstrated that the antigen sensitivity of CD8(+) T cells was decreased during chronic infection and that this was directly mediated by IL-10. Mechanistically, we showed that IL-10 induced the expression of Mgat5, a glycosyltransferase that enhances N-glycan branching on surface glycoproteins. Increased N-glycan branching on CD8(+) T cells promoted the formation of a galectin 3-mediated membrane lattice, which restricted the interaction of key glycoproteins, ultimately increasing the antigenic threshold required for T cell activation. Our study identified a regulatory loop in which IL-10 directly restricts CD8(+) T cell activation and function through modification of cell surface glycosylation allowing the establishment of chronic infection.	[Smith, Logan K.; Condotta, Stephanie A.; Krawczyk, Connie M.; Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Smith, Logan K.; Condotta, Stephanie A.; Richer, Martin J.] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Boukhaled, Giselle M.; Krawczyk, Connie M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Physiol, Montreal, PQ, Canada; [Mazouz, Sabrina; Bruneau, Julie; Shoukry, Naglaa H.] CRCHUM, Montreal, PQ, Canada; [Mazouz, Sabrina] Univ Montreal, Dept Microbiol Immunol & Infectiol, Montreal, PQ, Canada; [Guthmiller, Jenna J.; Butler, Noah S.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Vijay, Rahul; Butler, Noah S.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Bruneau, Julie] Univ Montreal, Dept Family Med & Emergency Med, Montreal, PQ, Canada; [Shoukry, Naglaa H.] Univ Montreal, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Iowa; Universite de Montreal; Universite de Montreal	Richer, MJ (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Richer, MJ (corresponding author), McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada.	martin.j.richer@mcgill.ca		Butler, Noah/0000-0002-1429-0796; Mazouz, Sabrina/0000-0002-0090-3299; Boukhaled, Giselle/0000-0002-6567-6234	McGill Faculty of Medicine; NSERC [RGPIN-2016-04713]; FRQS [32807]; CIHR [PJT-152903, MOP-126184, MOP-133680]; NIH/NIAID [R01AI125446, R01AI127481]; FRQS AIDS and Infectious Disease Network (Reseau SIDA-MI); CIHR; FRQS; Canadian Network on Hepatitis C (CanHepC); joint initiative of the CIHR [NHC-142832]; Public Health Agency of Canada; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125446, R01AI127481] Funding Source: NIH RePORTER; Alberta Innovates [201201140] Funding Source: researchfish	McGill Faculty of Medicine; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQS; CIHR(Canadian Institutes of Health Research (CIHR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FRQS AIDS and Infectious Disease Network (Reseau SIDA-MI); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS; Canadian Network on Hepatitis C (CanHepC); joint initiative of the CIHR(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alberta Innovates	We would like to thank Camille Stegen for flow cytometry assistance. We would also like to thank Jeff Nolz (Oregon Health & Science University) and members of the Richer Lab for discussion and critical comments on the manuscript. This work was supported by startup funds from the McGill Faculty of Medicine and grants from NSERC (RGPIN-2016-04713), FRQS (32807), and CIHR (PJT-152903) to M.J.R., grants from NIH/NIAID (R01AI125446 and R01AI127481) to N.S.B., and a grant from CIHR (MOP-126184) to C.M.K. The Montreal hepatitis C cohort is supported by grants CIHR (MOP-133680) and FRQS AIDS and Infectious Disease Network (Reseau SIDA-MI) to J.B. and N.H.S. M.J.R. is supported by a New Investigator Salary Award from CIHR and a Chercheurs-Boursiers Junior 1 salary award from FRQS. L.K.S. is supported by a Canada Graduate Scholarship-Master's award from CIHR. S.M. is supported by a doctoral fellowship from the Canadian Network on Hepatitis C (CanHepC). CanHepC is funded by a joint initiative of the CIHR (NHC-142832) and the Public Health Agency of Canada.	Abdel-Hakeem MS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006191; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Alexander-Miller MA, 2005, IMMUNOL RES, V31, P13, DOI 10.1385/IR:31:1:13; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bian YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026466; Borger JG, 2014, IMMUNOL LETT, V157, P16, DOI 10.1016/j.imlet.2013.11.005; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Frebel H, 2010, EUR J IMMUNOL, V40, P654, DOI 10.1002/eji.200940102; Grebely J, 2013, INT J EPIDEMIOL, V42, P1649, DOI 10.1093/ije/dys167; Grigorian Ani, 2011, ISRN Neurol, V2011, P374314, DOI 10.5402/2011/374314; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Kobayashi F, 1996, PARASITOL RES, V82, P385, DOI 10.1007/s004360050133; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Kwon DS, 2010, EUR CYTOKINE NETW, V21, P208, DOI 10.1684/ecn.2010.0201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mannino MH, 2015, CANCER LETT, V367, P103, DOI 10.1016/j.canlet.2015.07.009; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Perica K, 2012, BIOPHYS J, V103, P1890, DOI 10.1016/j.bpj.2012.09.011; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZJ, 2015, CANCER RES, V75, P1635, DOI 10.1158/0008-5472.CAN-14-3016; Vigano S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/153863; Walker LJ, 2010, CLIN EXP IMMUNOL, V159, P245, DOI 10.1111/j.1365-2249.2009.04047.x; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	55	106	108	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					299	+		10.1016/j.immuni.2018.01.006	http://dx.doi.org/10.1016/j.immuni.2018.01.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29396160	Green Accepted, Bronze			2022-12-18	WOS:000425507800015
J	Cao, W; Yang, YQ; Wang, ZY; Liu, AL; Fang, L; Wu, FL; Hong, J; Shi, YF; Leung, S; Dong, C; Zhang, JWZ				Cao, Wei; Yang, Yiqing; Wang, Zhengyi; Liu, Ailian; Fang, Lei; Wu, Fenglan; Hong, Jian; Shi, Yufang; Leung, Stewart; Dong, Chen; Zhang, Jingwu Z.			Leukemia Inhibitory Factor Inhibits T Helper 17 Cell Differentiation and Confers Treatment Effects of Neural Progenitor Cell Therapy in Autoimmune Disease	IMMUNITY			English	Article							EMBRYONIC STEM-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ROR-GAMMA-T; MULTIPLE-SCLEROSIS; INFLAMMATION; T(H)17; STAT3; LIF; DEMYELINATION; EXPRESSION	Neural progenitor cell (NPC) therapy is considered a promising treatment modality for multiple sclerosis (MS), potentially acting through neural repair. Here, we showed that intravenous administration of NPCs ameliorated experimental autoimmune encephalomyelitis (EAE) by selectively inhibiting pathogenic T helper 17 (Th17) cell differentiation. Leukemia inhibitory factor (LIF) produced by NPCs was responsible for the observed EAE suppression. Through the inducible LIE receptor expression, LIE inhibited the differentiation of Th17 cells in EAE mice and that from MS subjects. At the molecular level, LIF exerted an opposing effect on interleukin 6 (IL-6)-induced signal transducer and activator of transcription 3 (STAT3) phosphorylation required for Th17 cell differentiation by triggering a signaling cascade that activated extracellular signal-regulated MAP kinase (ERK) and upregulated suppressor of cytokine signaling 3 (SOCS3) expression. This study reveals a critical role for LIF in regulating Th17 cell differentiation and provides insights into the mechanisms of action of NPC therapy in MS.	[Cao, Wei; Yang, Yiqing; Wang, Zhengyi; Zhang, Jingwu Z.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Cao, Wei; Yang, Yiqing; Wang, Zhengyi; Zhang, Jingwu Z.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Liu, Ailian; Fang, Lei; Wu, Fenglan; Leung, Stewart; Zhang, Jingwu Z.] GlaxoSmithKline Res & Dev Ctr, Dept Neuroimmunol, Shanghai 201203, Peoples R China; [Hong, Jian] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Shi, Yufang] Chinese Acad Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; GlaxoSmithKline; Baylor College of Medicine; Chinese Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhang, JWZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China.	jingwu.z.zang@gsk.com	Hu, Jialei/A-3926-2015; dong, chen/B-3181-2009; Shi, Yufang/AAE-4431-2020	dong, chen/0000-0002-0084-9130; Shi, Yufang/0000-0001-8964-319X				Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Clahsen T, 2005, CELL SIGNAL, V17, P559, DOI 10.1016/j.cellsig.2004.09.016; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Forrai A, 2006, STEM CELLS, V24, P604, DOI 10.1634/stemcells.2005-0323; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Makar TK, 2008, J NEUROL SCI, V270, P70, DOI 10.1016/j.jns.2008.02.011; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marriott MP, 2008, GLIA, V56, P686, DOI 10.1002/glia.20646; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Setati MM, 2010, IUBMB LIFE, V62, P61, DOI 10.1002/iub.283; Slaets H, 2008, PROTEOMICS, V8, P1237, DOI 10.1002/pmic.200700641; Slaets H, 2010, TRENDS MOL MED, V16, P493, DOI 10.1016/j.molmed.2010.08.007; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu C, 2007, J CELL PHYSIOL, V213, P161, DOI 10.1002/jcp.21105; Yu YQ, 2009, MOL CELL BIOCHEM, V320, P101, DOI 10.1007/s11010-008-9911-5	44	106	113	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					273	284		10.1016/j.immuni.2011.06.011	http://dx.doi.org/10.1016/j.immuni.2011.06.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21835648	Bronze			2022-12-18	WOS:000294387900016
J	Farlik, M; Reutterer, B; Schindler, C; Greten, F; Vogl, C; Muller, M; Decker, T				Farlik, Matthias; Reutterer, Benjamin; Schindler, Christian; Greten, Florian; Vogl, Claus; Mueller, Mathias; Decker, Thomas			Nonconventional Initiation Complex Assembly by STAT and NF-kappa B Transcription Factors Regulates Nitric Oxide Synthase Expression	IMMUNITY			English	Article							RNA-POLYMERASE-II; INNATE IMMUNITY; IFN-GAMMA; TARGETED DISRUPTION; BACTERIAL LIGANDS; INTERFERON-GAMMA; GENE-EXPRESSION; TERMINAL DOMAIN; INDUCTION; BETA	Transcriptional regulation of the Nos2 gene encoding inducible nitric oxide synthase (iNOS) requires type I interferon (IFN-I) signaling and additional signals emanating from pattern recognition receptors. Here we showed sequential and cooperative contributions of the transcription factors ISGF3 (a complex containing STAT1, STAT2, and IRF9 subunits) and NF-kappa B to the transcriptional induction of the Nos2 gene in macrophages infected with the intracellular bacterial pathogen Listeria monocytogenes. NF-kappa B preceded ISGF3 at the Nos2 promoter and generated a transcriptional memory effect by depositing basal transcription factor TFIIH with the associated CDK7 kinase for serine 5 phosphorylation of the RNA polymerase II (pol II) carboxyterminal domain (CTD). Subsequent to TFIIH deposition by NF-kappa B, ISGF3 attracted the pol II enzyme and phosphorylation at CTD S5 occurred. Thus, STATs and NF-kappa B cooperate through pol II promoter recruitment and the phosphorylation of its CTD, respectively, as a prerequisite for productive elongation of iNOS mRNA.	[Farlik, Matthias; Reutterer, Benjamin; Decker, Thomas] Univ Vienna, Dept Genet Microbiol & Immunobiol, Max F Perutz Labs, A-1030 Vienna, Austria; [Schindler, Christian] Columbia Univ, Dept Microbiol, New York, NY 10032 USA; [Schindler, Christian] Columbia Univ, Dept Med, New York, NY 10032 USA; [Greten, Florian] Tech Univ Munich, Klinikum Rechts Isar, D-81675 Munich, Germany; [Vogl, Claus; Mueller, Mathias] Univ Vet Med, Inst Genet & Anim Breeding, A-1210 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Columbia University; Columbia University; Technical University of Munich; University of Veterinary Medicine Vienna	Decker, T (corresponding author), Univ Vienna, Dept Genet Microbiol & Immunobiol, Max F Perutz Labs, Dr Bohr Gasse 9-4, A-1030 Vienna, Austria.	thomas.decker@univie.ac.at	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080; Muller, Mathias/0000-0002-7879-3552	Austrian Research Foundation (FWF) [SFB-28, P20522-B05]; Austrian Science Fund (FWF) [F 2803, F 2808] Funding Source: researchfish	Austrian Research Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. Nakasato and T. Taniguchi for providing bone marrow from Irf9-deficient mice. We thank A. Jamieson and P. Kovarik for critical reading of our manuscript. This work was funded by the Austrian Research Foundation (FWF) through grants SFB-28 (to M.M. and T.D.) and P20522-B05 (to T.D.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; Gao JJ, 1998, J IMMUNOL, V161, P4803; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Harada H, 1996, GENES CELLS, V1, P995, DOI 10.1046/j.1365-2443.1996.870287.x; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Plumlee CR, 2009, J BIOL CHEM, V284, P30058, DOI 10.1074/jbc.M109.018283; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spink J, 1997, J BIOL CHEM, V272, P24417, DOI 10.1074/jbc.272.39.24417; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zwaferink H, 2008, INFECT IMMUN, V76, P1649, DOI 10.1128/IAI.01251-07	53	106	108	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					25	34		10.1016/j.immuni.2010.07.001	http://dx.doi.org/10.1016/j.immuni.2010.07.001			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20637660	Green Published, hybrid			2022-12-18	WOS:000280418100007
J	Wang, L; Wildt, KF; Castro, E; Xiong, Y; Feigenbaum, L; Tessarollo, L; Bosselut, R				Wang, Lie; Wildt, Kathryn F.; Castro, Ehydel; Xiong, Yumei; Feigenbaum, Lionel; Tessarollo, Lino; Bosselut, Remy			The Zinc Finger Transcription Factor Zbtb7b Represses CD8-Lineage Gene Expression in Peripheral CD4(+) T Cells	IMMUNITY			English	Article							CD4-CD8 LINEAGE DIFFERENTIATION; IFN-GAMMA PRODUCTION; HELPER TYPE-1 CELLS; IN-VIVO; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; POSITIVE SELECTION; RUNX PROTEINS; REGULATES CD4; FACTOR GATA-3	How CD4-CD8 differentiation is maintained in mature T cells is largely unknown. The present study has examined the role in this process of the zinc finger protein Zbtb7b, a critical factor for the commitment of MHC II-restricted thymocytes to the CD4(+) lineage. We showed that Zbtb7b acted in peripheral CD4(+) T cells to suppress CD8-lineage gene expression, including that of CD8 and cytotoxic effector genes perforin and Granzyme B, and was important for the proper repression of interferon-gamma (IFN-gamma) during effector differentiation. The inappropriate expression of IFN-gamma by Zbtb7b-deficient CD4(+) T cells required the activities of Eomesodermin and Runx transcription factors. Runx activity was needed for Granzyme B expression, indicating that Runx proteins control expression of the cytotoxic program. We conclude that a key function of Zbtb7b in the mature CD4(+) T cell compartment is to repress CD8-lineage gene expression.	[Wang, Lie; Wildt, Kathryn F.; Castro, Ehydel; Xiong, Yumei; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI SAIC, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, CCR, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov			Intramural Research Program of the National Cancer Institute; Center for Cancer Research, NIH; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Southon for ES cell recombination; G. Sanchez for mouse technical assistance; B. Taylor and S. Banerjee for expert cell sorting; S. Reiner, B. Paul, and J. Zhu for reagents; S.R. Jenkinson and J. Zhu for helpful discussions and T cell activation protocols; and J. Ashwell, Y. Belkaid, and S. Reiner for reading the manuscript. This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Christen U, 2004, IMMUNOL RES, V30, P309, DOI 10.1385/IR:30:3:309; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; ROY M, 1993, J IMMUNOL, V151, P2497; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Singer A, 2004, ADV IMMUNOL, V83, P91; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	54	106	109	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 19	2008	29	6					876	887		10.1016/j.immuni.2008.09.019	http://dx.doi.org/10.1016/j.immuni.2008.09.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19062319	Bronze, Green Accepted			2022-12-18	WOS:000262012400008
J	Klemke, M; Wabnitz, GH; Funke, F; Funk, B; Kirchgessner, H; Samstag, Y				Klemke, Martin; Wabnitz, Guido H.; Funke, Faustina; Funk, Beate; Kirchgessner, Henning; Samstag, Yvonne			Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; ACTIVATION; ARTHRITIS; DEPHOSPHORYLATION; PHOSPHORYLATION; IDENTIFICATION; COSTIMULATION; CYTOSKELETON; EXPRESSION	Oxidative stress leads to impaired T cell activation. A central integrator of T cell activation is the actin-remodelling protein cofilin. Cofilin is activated through dephosphorylation at Ser3. Activated cofilin enables actin dynamics through severing and depolymerization of F-actin. Binding of cofilin to actin is required for formation of the immune synapse and T cell activation. Here, we showed that oxidatively stressed human T cells were impaired in chemotaxis- and costimulation-induced F-actin modulation. Although cofilin was dephosphorylated, steady-state F-actin levels increased under oxidative stress conditions. Mass spectrometry revealed that cofilin itself was a target for oxidation. Cofilin oxidation induced formation of an intramolecular disulfide bridge and loss of its Ser3 phosphorylation. Importantly, dephosphorylated oxidized cofilin, although still able to bind to F-actin, did not mediate F-actin depolymerization. Impairing actin dynamics through oxidation of cofilin provides a molecular explanation for the T cell hyporesponsiveness caused by oxidative stress.	[Klemke, Martin; Wabnitz, Guido H.; Funke, Faustina; Funk, Beate; Kirchgessner, Henning; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Klemke, M (corresponding author), Heidelberg Univ, Inst Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	klemke@uni-heidelberg.de		Wabnitz, Guido/0000-0001-5101-9885	Deutsche Forschungsgerneinschaft [SFB405/A4, DFG SA 393/3-3]	Deutsche Forschungsgerneinschaft(German Research Foundation (DFG))	We thank T. Weschenfelder for excellent technical assistance. This work Was supported by grants from the Deutsche Forschungsgerneinschaft (SFB405/A4 and DFG SA 393/3-3).	Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.3.CO;2-L; MIZUNO K, 1994, ONCOGENE, V9, P1605; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; PIRZER UC, 1990, EUR J IMMUNOL, V20, P2339, DOI 10.1002/eji.1830201025; QIAO L, 1993, GASTROENTEROLOGY, V105, P814, DOI 10.1016/0016-5085(93)90899-N; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; SAMSTAG Y, 1991, J IMMUNOL, V147, P788; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Schmielau J, 2001, CLIN CANCER RES, V7, p933S; Schmielau J, 2001, CANCER RES, V61, P4756; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	34	106	113	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					404	413		10.1016/j.immuni.2008.06.016	http://dx.doi.org/10.1016/j.immuni.2008.06.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18771940	Bronze			2022-12-18	WOS:000259708900011
J	Luckashenak, N; Schroeder, S; Endt, K; Schmidt, D; Mahnke, K; Bachmann, MF; Marconi, P; Deeg, CA; Brocker, T				Luckashenak, Nancy; Schroeder, Samira; Endt, Katrin; Schmidt, Darja; Mahnke, Karsten; Bachmann, Martin F.; Marconi, Peggy; Deeg, Cornelia A.; Brocker, Thomas			Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo	IMMUNITY			English	Article							RESTRICTED CROSS-PRESENTATION; VIRUS-LIKE PARTICLES; DRAINING LYMPH-NODE; MHC CLASS-I; APOPTOTIC CELLS; HOMEOSTATIC PROLIFERATION; SELF-ANTIGEN; REQUIRES PRESENTATION; PERIPHERAL TOLERANCE; EPITHELIAL-CELLS	Immature dendritic cells (DCs) sample tissue-specific antigens (TSAs) and process them for "cross-presentation" via major histocompatibility complex (MHC) class I and 11 molecules. Findings with adoptively transferred T cell receptor (TCR)-transgenic CD8(+) T cells in transgenic mice expressing model TSA indicate that this process contributes to tolerance induction of CD8+ T cells, a phenomenon termed "crosstolerance." However, up to now it has been unknown whether "crosstolerance" can also control autoimmune T cells specific for physiological nontransgenic TSA. Here, we showed that a DC-specific deficiency in uptake of apoptotic material inhibits crosspresentation in vivo. This defect allowed the accumulation of fully functional auto-reactive CD8+ T cells that could be activated for autoimmune attack in peripheral lymphoid organs. Thus, our data demonstrate the importance of crosstolerance induction by DCs as a vital instrument for controlling self-reactive T cells from the peripheral repertoire and preventing autoimmune disease.	[Luckashenak, Nancy; Schroeder, Samira; Endt, Katrin; Schmidt, Darja; Brocker, Thomas] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Mahnke, Karsten] Univ Heidelberg, Dept Dermatol, D-69115 Heidelberg, Germany; [Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Schlieren Zuerich, Switzerland; [Marconi, Peggy] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Deeg, Cornelia A.] Univ Munich, Inst Physiol & Physiol Chem, D-80538 Munich, Germany	University of Munich; Ruprecht Karls University Heidelberg; University of Ferrara; University of Munich	Brocker, T (corresponding author), Univ Munich, Inst Immunol, D-80336 Munich, Germany.	tbrocker@med.uni-muenchen.de	Marconi, Peggy/K-7733-2016; Deeg, Cornelia A/G-4940-2010; Deeg, Cornelia/U-4216-2019	Deeg, Cornelia A/0000-0003-0375-3190; Marconi, Peggy C. R./0000-0003-3488-0491; Brocker, Thomas/0000-0001-7060-5433				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; BUHLMANN JE, 2007, SCIENCE, V316, P612; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Faideau B, 2006, J IMMUNOL, V177, P53, DOI 10.4049/jimmunol.177.1.53; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Garcia CA, 2005, J IMMUNOL, V175, P2111, DOI 10.4049/jimmunol.175.4.2111; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauterbach H, 2004, J VIROL, V78, P4020, DOI 10.1128/JVI.78.8.4020-4028.2004; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Roth E, 2002, J IMMUNOL, V168, P5124, DOI 10.4049/jimmunol.168.10.5124; Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Storni T, 2004, J IMMUNOL, V172, P6129, DOI 10.4049/jimmunol.172.10.6129; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Vezys V, 2002, J IMMUNOL, V169, P6677, DOI 10.4049/jimmunol.169.12.6677; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	71	106	107	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					521	532		10.1016/j.immuni.2008.02.018	http://dx.doi.org/10.1016/j.immuni.2008.02.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18387832	Bronze			2022-12-18	WOS:000254939400013
J	Li, X; Wang, S; Qi, J; Echtenkamp, SF; Chatterjee, R; Wang, M; Boons, GJ; Dziarski, R; Gupta, D				Li, Xinna; Wang, Shiyong; Qi, Jin; Echtenkamp, Stephen F.; Chatterjee, Rohini; Wang, Mu; Boons, Geert-Jan; Dziarski, Roman; Gupta, Dipika			Zebrafish peptidoglycan recognition proteins are bactericidal amidases essential for defense against bacterial infections	IMMUNITY			English	Article							L-ALANINE AMIDASE; GRAM-NEGATIVE BACTERIA; POSITIVE BACTERIA; IMMUNE-RESPONSES; RECEPTOR; PGRP; IDENTIFICATION; EXPRESSION; SYSTEM; FAMILY	Peptidoglycan recognition proteins (PGRPs) are structurally conserved through evolution, but their functions in innate immunity are different in invertebrates and vertebrates. We asked what the functions of PGRPs in fish are and whether they are indispensable for defense against infection because fish are the first vertebrates that developed adaptive immunity, but they still rely solely on innate immunity during early development of embryos. We identified and cloned three zebrafish PGRPs and showed that they are highly expressed in eggs, developing embryos, and adult tissues that contact external environment. Zebrafish PGRPs have both peptidoglycan-lytic amidase activity and broad-spectrum bactericidal activity, which is a unique feature. Furthermore, we demonstrated that in the developing zebrafish embryo, one of these PGRPs is essential for defense and survival during bacterial infections. These data demonstrate an absolute requirement for innate immunity in defense against infections in fish embryos and for a PGRP protein for survival in vertebrates.	Indiana Univ, Sch Med, Gary, IN 46408 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Indiana University System; Indiana University Northwest; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Georgia; University of Georgia	Gupta, D (corresponding author), Indiana Univ, Sch Med, Gary, IN 46408 USA.	dgupta@iun.edu	Boons, Geert-Jan P H/J-3211-2016	Boons, Geert-Jan P H/0000-0003-3111-5954	NIAID NIH HHS [R01 AI028797-14, R01 AI028797, U01 AI056395, AI56395, U01 AI056395-05, AI28797] Funding Source: Medline; NIGMS NIH HHS [R01 GM065248-04, GM065248, R01 GM061761, R01 GM065248] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056395, R01AI028797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761, R01GM065248] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Li XN, 2006, J BIOL CHEM, V281, P20738, DOI 10.1074/jbc.M601017200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Sang YM, 2005, INFECT IMMUN, V73, P7133, DOI 10.1128/IAI.73.11.7133-7141.2005; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Wang HT, 2005, INFECT IMMUN, V73, P7216, DOI 10.1128/IAI.73.11.7216-7225.2005; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhang YO, 2005, BBA-PROTEINS PROTEOM, V1752, P34, DOI 10.1016/j.bbapap.2005.07.001	42	106	113	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					518	529		10.1016/j.immuni.2007.07.020	http://dx.doi.org/10.1016/j.immuni.2007.07.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892854	Bronze, Green Accepted			2022-12-18	WOS:000249843400017
J	Tanaka, S; Tsukada, J; Suzuki, W; Hayashi, K; Tanigaki, K; Tsuji, M; Inoue, H; Honjo, T; Kubo, M				Tanaka, Shinya; Tsukada, Jun; Suzuki, Wataru; Hayashi, Katsuhiko; Tanigaki, Kenji; Tsuji, Masayuki; Inoue, Hiromasa; Honjo, Tasuku; Kubo, Masato			The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells	IMMUNITY			English	Article							CYTOKINE GENE-EXPRESSION; IL-4 GENE; IN-VIVO; COORDINATE REGULATOR; TRANSCRIPTION; DIFFERENTIATION; GATA-3; POLARIZATION; DELETION; ALLELES	Epigenetic changes in chromatin structure at the T helper (Th2) locus correlate with interukin-4 (IL-4) and IL-13 expression during Th2 differentiation. By using a transgenic green fluorescence protein (GFP) reporter system, we show that conserved noncoding sequence-2 (CNS-2), located downstream of the 114 locus, is a constitutively active enhancer in NKT cells as well as in a subset of CD44(hi) memory phenotype CD4(+) T cells. CNS-2 enhancer activity and initial IL-4 expression in CD44(hi) CD4(+) T cells were abolished in mice with a CD4-specific deletion of the transcriptional mediator of Notch signalling, Rbp-j. Depletion of CNS-2 active CD4(+) T cells markedly decreased Th2 differentiation from naive CD4(+) T cells and antigen-specific IgE production after in vivo priming. These findings indicate that Notch-regulated CNS-2 enhancer controls initial IL-4 expression In NKT and memory phenotype CD4(+) T cells and that CNS-2 active CD44(hi) memory phenotype T cells are important in facilitating Th2 differentiation of naive CD4(+) T cells in allergic responses.	RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa 2300045, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Cambridge CB2 1QN, England; Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Higashi Ku, Fukuoka 8128582, Japan	RIKEN; Tokyo University of Science; University of Cambridge; Kyoto University; Kyushu University	Kubo, M (corresponding author), RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Suehiro Cho 1-7-22, Yokohama, Kanagawa 2300045, Japan.	raysolfc@rcai.riken.jp	Kubo, Masato/A-5918-2016; Honjo, Tasuku/N-4470-2016					Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Kato H, 1997, DEVELOPMENT, V124, P4133; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nakayama T, 2001, INT ARCH ALLERGY IMM, V124, P38, DOI 10.1159/000053663; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tough DF, 2000, VACCINE, V18, P1642, DOI 10.1016/S0264-410X(99)00500-9; Yagi R, 2002, INT IMMUNOL, V14, P1, DOI 10.1093/intimm/14.1.1; Yamada S, 2006, INT IMMUNOL, V18, P335, DOI 10.1093/intimm/dxh372; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	44	106	111	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					689	701		10.1016/j.immuni.2006.04.009	http://dx.doi.org/10.1016/j.immuni.2006.04.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782026	Bronze			2022-12-18	WOS:000238592200008
J	Schaerli, P; Willimann, K; Ebert, LM; Walz, A; Moser, B				Schaerli, P; Willimann, K; Ebert, LM; Walz, A; Moser, B			Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation	IMMUNITY			English	Article							HUMAN DENDRITIC CELLS; COLONY-STIMULATING FACTOR; CLASS-II TRANSPORT; CHEMOKINE RECEPTOR; LYMPH-NODE; IN-VIVO; MONOCYTES; TISSUE; EXPRESSION; PROTEIN	Dendritic cells (DCs) are major constituents of peripheral tissues, where they control immunity to foreign and self-antigens. The process of continuous DC renewal under homeostatic conditions is largely undefined. Here, we demonstrate that CD14(+) DC precursors, either derived from CD34(+) hematopoietic progenitor cells or isolated from blood, were attracted by the chemokine CXCL14, which is constitutively produced in healthy skin and other epithelial tissues. In a tissue model we show that human epidermal equivalents profoundly affected CD14(+) DC precursors, including their supra-basal positioning and survival as well as their differentiation into Langerhans cell-like cells with potent antigen-presentation functions. Our model assigns unprecedented roles to CXCL14 and epidermal tissue as attractant and niche of differentiation, respectively, in the renewal of Langerhans cells under steady-state conditions.	Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Moser, B (corresponding author), Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland.	bernhard.moser@izb.unibe.ch	Ebert, Lisa/B-9530-2013	Ebert, Lisa/0000-0002-8041-9666; Moser, Bernhard/0000-0002-4354-4572				Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Jaksits S, 1999, J IMMUNOL, V163, P4869; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Limat A, 2002, CELLS TISSUES ORGANS, V172, P79, DOI 10.1159/000065615; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Novak N, 2003, J ALLERGY CLIN IMMUN, V111, P38, DOI 10.1067/mai.2003.2; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Proksch E, 1996, BRIT J DERMATOL, V134, P630, DOI 10.1046/j.1365-2133.1996.66828.x; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; ROMANI N, 1989, J INVEST DERMATOL, V93, P600, DOI 10.1111/1523-1747.ep12319727; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Schaerli P, 2005, IMMUNOL RES, V31, P57, DOI 10.1385/IR:31:1:57; SCHULER G, 1985, J INVEST DERMATOL, V85, pS99, DOI 10.1111/1523-1747.ep12275566; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Strunk D, 1996, BLOOD, V87, P1292, DOI 10.1182/blood.V87.4.1292.bloodjournal8741292; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.3.CO;2-H; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Yang D, 1999, J IMMUNOL, V163, P1737	51	106	110	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					331	342		10.1016/j.immuni.2005.08.012	http://dx.doi.org/10.1016/j.immuni.2005.08.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169505	Bronze			2022-12-18	WOS:000232382500011
J	Cupedo, T; Jansen, W; Kraal, G; Mebius, RE				Cupedo, T; Jansen, W; Kraal, G; Mebius, RE			Induction of secondary and tertiary lymphoid structures in the skin	IMMUNITY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; TUMOR-NECROSIS-FACTOR; PEYERS PATCH ORGANOGENESIS; CXC CHEMOKINE RECEPTOR-5; B-CELL; T-CELLS; GENE-EXPRESSION; GERMINAL CENTER; RHEUMATOID SYNOVITIS; CHRONIC INFLAMMATION	During embryogenesis a developmental program leading to the formation of lymph nodes and Peyer's patches is initiated. We now show that lymph node-like structures as well as tertiary lymphoid structures can ectopically be induced by intradermal injection of newborn lymph node-derived cells. ICAM-1/VCAM-1-expressing stromal organizers, follicular dendritic cells, lymphatic endothelium, and HEVs in these structures are of donor origin, while all hematopoietic cells are host derived. Formation depends on lymphotoxin-expressing donor cells, whereas further organization requires lymphotoxin-expressing recipient cells. While induced secondary lymphoid structures develop a normal cellular architecture, the degree of organization in tertiary structures is correlated to the immune activation status of the host. These results indicate that the cellular and molecular requirements for the establishment of lymph nodes and tertiary structures are remarkably similar and that hyperactivated lymphocytes can fulfill the role of lymphoid tissue inducer cells during inflammatory responses.	VU Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mebius, RE (corresponding author), VU Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	r.mebius@vumc.nl	Cupedo, Tom/GQQ-0614-2022	Mebius, Reina/0000-0003-0451-7464				Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cuff CA, 1998, J IMMUNOL, V161, P6853; Cupedo T, 2003, SEMIN IMMUNOL, V15, P243, DOI 10.1016/j.smim.2003.08.002; Cupedo T, 2002, IMMUNOL REV, V189, P41, DOI 10.1034/j.1600-065X.2002.18905.x; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Han SH, 2001, ARTHRITIS RHEUM, V44, P1438, DOI 10.1002/1529-0131(200106)44:6<1438::AID-ART239>3.0.CO;2-Q; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Kang YM, 2002, J EXP MED, V195, P1325, DOI 10.1084/jem.20011565; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Liu YJ, 1996, INT REV CYTOL, V166, P139, DOI 10.1016/S0074-7696(08)62508-5; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Page G, 2002, J IMMUNOL, V168, P5333, DOI 10.4049/jimmunol.168.10.5333; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Sacca R, 1998, J IMMUNOL, V160, P485; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883	52	106	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					655	667		10.1016/j.immuni.2004.09.006	http://dx.doi.org/10.1016/j.immuni.2004.09.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539152	Bronze			2022-12-18	WOS:000225365000007
J	Davidson, D; Shi, XC; Zhang, SH; Wang, H; Nemer, M; Ono, N; Ohno, SJ; Yanagi, Y; Veillette, A				Davidson, D; Shi, XC; Zhang, SH; Wang, H; Nemer, M; Ono, N; Ohno, SJ; Yanagi, Y; Veillette, A			Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation	IMMUNITY			English	Article							T-CELL DEVELOPMENT; SIGNAL-TRANSDUCTION; MICE DEFICIENT; SLAM FAMILY; SH2 DOMAIN; RECEPTOR; DISEASE; RESPONSES; DIFFERENTIATION; RESPONSIVENESS	SAP is an adaptor mutated in X-linked lymphoproliferative disease. It plays a critical role in T helper 2 (T(H)2) cytokine production. This function was suggested to reflect the capacity of SAP to associate with SLAM family receptors and enable tyrosine phosphorylation signaling by these receptors through SAP-mediated recruitment of Src-related kinase FynT. Here, we addressed by genetic means the importance of the SAP-FynT interaction in normal T cell functions. By creating a mouse in which the FynT binding site of SAP was inactivated in the germ line (sap(R78A) mouse) and by analyzing mice lacking SAP, FynT or SLAM, evidence was obtained that the SAP-FynT cascade is indeed crucial for normal T(H)2 functions in vitro and in vivo. These data imply that SAP is necessary for T(H)2 cytokine regulation primarily as a result of its capacity to recruit FynT. They also establish a previously unappreciated role for FynT in SAP-dependent T(H)2 cytokine regulation.	Clin Res Inst Montreal, Oncol Mol Lab, Quebec City, PQ H2W 1R7, Canada; Inst Montreal, Lab Cardiac Growth, Quebec City, PQ H2W 1RL, Canada; McGill Univ, Dept Microbiol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Immunol, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan; Inst Montreal, Differentiat Clin Res, Montreal, PQ H2W 1R7, Canada; McGill Univ, Dept Immunol, Montreal, PQ H3G 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Kyushu University; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Oncol Mol Lab, Quebec City, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca		Yanagi, Yusuke/0000-0001-7815-1667; ONO, NOBUYUKI/0000-0003-0709-4858; Wang, Hao/0000-0003-1537-661X				APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Castro AG, 1999, J IMMUNOL, V163, P5860; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Eberl G, 1999, J IMMUNOL, V163, P4091; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Latour S, 2003, IMMUNOL REV, V192, P212, DOI 10.1034/j.1600-065X.2003.00023.x; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Veillette A, 2004, J EXP MED, V199, P1175, DOI 10.1084/jem.20040588; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P336, DOI 10.1016/S0952-7915(03)00037-2; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504	36	106	111	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					707	717		10.1016/j.immuni.2004.10.005	http://dx.doi.org/10.1016/j.immuni.2004.10.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539156	Bronze			2022-12-18	WOS:000225365000011
J	Mayerova, D; Parke, EA; Bursch, LS; Odumade, OA; Hogquist, KA				Mayerova, D; Parke, EA; Bursch, LS; Odumade, OA; Hogquist, KA			Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state	IMMUNITY			English	Article							REGIONAL LYMPH-NODES; DENDRITIC CELLS; CROSS-PRESENTATION; IN-VIVO; PERIPHERAL TOLERANCE; POSITIVE SELECTION; EFFECTOR FUNCTION; LEISHMANIA-MAJOR; EPITHELIAL-CELLS; BONE-MARROW	TCR transgenic mice that express a peptide antigen in keratinocytes develop a lethal CD8 T cell-dependent autoimmune disease. We employed an adoptive transfer system to understand this disease and show that transfer of low numbers of naive CD8 T cells into peptide transgenic mice caused chronic skin disease. The antigen-presenting cell that initiated this response was the epidermal Langerhans cell. Naive CD8 T cells proliferated extensively, migrated to tissues, developed effector function, and were capable of making a recall response. These features are very different from the abortive activation of CD8 T cells that occurred in response to the same antigen presented by APC from other tissues. Furthermore, tolerance was dominant when the antigen was presented by both Langerhans cells and other APC. These data suggest that Langerhans cells do not have tolerogenic properties in the steady state.	Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, 312 Church St SE, Minneapolis, MN 55455 USA.	hogqu001@gold.tc.umn.edu		Hogquist, Kristin/0000-0001-9963-5687				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; BERGSTRESSER PR, 1980, J INVEST DERMATOL, V74, P77, DOI 10.1111/1523-1747.ep12519909; BLANK C, 1993, J INFECT DIS, V167, P418, DOI 10.1093/infdis/167.2.418; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; BORKOWSKI TA, 1994, EUR J IMMUNOL, V24, P2767, DOI 10.1002/eji.1830241129; Borkowski TA, 1997, J CLIN INVEST, V100, P575, DOI 10.1172/JCI119567; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Kurts C, 2000, J MOL MED, V78, P326, DOI 10.1007/s001090000108; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Lucas A, 2002, NAT IMMUNOL, V3, P1125, DOI 10.1038/ni1202-1125; Mayerova D, 2004, J IMMUNOL, V172, P851, DOI 10.4049/jimmunol.172.2.851; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McGargill MA, 2002, J IMMUNOL, V169, P2141, DOI 10.4049/jimmunol.169.4.2141; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Randolph GJ, 2002, J EXP MED, V196, P413, DOI 10.1084/jem.20021240; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Saeki H, 1999, J IMMUNOL, V162, P2472; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanski HE, 2001, J IMMUNOL, V166, P6602, DOI 10.4049/jimmunol.166.11.6602; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger B, 1999, Adv Immunol, V71, P229; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yoshino M, 2003, INT IMMUNOL, V15, P773, DOI 10.1093/intimm/dxg075	59	106	106	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					391	400		10.1016/j.immuni.2004.07.019	http://dx.doi.org/10.1016/j.immuni.2004.07.019			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357950	Bronze			2022-12-18	WOS:000224034900010
J	Li, LQ; Lee, HH; Bell, JJ; Gregg, RK; Ellis, JS; Gessner, A; Zaghouani, H				Li, LQ; Lee, HH; Bell, JJ; Gregg, RK; Ellis, JS; Gessner, A; Zaghouani, H			IL-4 utilizes an alternative receptor to drive apoptosis of Th2 cells and skews neonatal immunity toward Th2	IMMUNITY			English	Article							T-CELLS; IN-VIVO; DENDRITIC CELLS; NEWBORN MICE; B-CELLS; RESPONSES; EXPRESSION; TOLERANCE; INDUCTION; EXPOSURE	Primary neonatal Th1 cells develop alongside of Th2 upon priming of the newborn but undergo apoptosis upon recall with antigen. These Th1 cells were isolated, and their death was correlated with elevated IL-13Ralpha1 chain expression. Strikingly, neutralization of Th2s' IL-4 reduced apoptosis, sustained recall responses, and the live Th1 cells displayed a decrease in IL-13Ralpha1 expression. Blockade of IL-13Ralpha1 or IL-4Ralpha also restores recall and secondary Th1 responses. Adult T cells primed within the neonatal environment did not upregulate IL-13Ralpha1 chain or undergo apoptosis and developed recall Th1 responses. These observations indicate that developmental expression of IL-13Ralpha1 along with IL-4Ra provides a receptor through which IL-4 induces death of Th1 cells and skews neonatal immunity toward Th2.	Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany	University of Missouri System; University of Missouri Columbia; University of Erlangen Nuremberg	Zaghouani, H (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, M616 Med Sci Bldg, Columbia, MO 65212 USA.	zaghouanih@health.missouri.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048541] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48541] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adkins B, 1998, J IMMUNOL, V160, P4217; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; BILLINGHAM R, 1956, P ROY SOC LONDON, V239, P44; CHEN NX, 1995, TRANSPLANTATION, V59, P933, DOI 10.1097/00007890-199504150-00002; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; GAMMON G, 1986, NATURE, V319, P413, DOI 10.1038/319413a0; Garza KM, 1997, IMMUNITY, V6, P89, DOI 10.1016/S1074-7613(00)80245-9; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Huang H, 1998, J EXP MED, V187, P1305, DOI 10.1084/jem.187.8.1305; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Li LQ, 2001, J IMMUNOL, V167, P2585, DOI 10.4049/jimmunol.167.5.2585; Lomo J, 1996, CANCER RES, V56, P40; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Min B, 1998, J EXP MED, V188, P2007, DOI 10.1084/jem.188.11.2007; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morel PA, 1998, CRIT REV IMMUNOL, V18, P275, DOI 10.1615/CritRevImmunol.v18.i4.10; Moser JM, 2001, J EXP MED, V193, P595, DOI 10.1084/jem.193.5.595; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Obiri NI, 1997, J IMMUNOL, V158, P756; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pack CD, 2001, J IMMUNOL, V167, P4187, DOI 10.4049/jimmunol.167.8.4187; POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674; Poudrier J, 2000, EUR J IMMUNOL, V30, P3157, DOI 10.1002/1521-4141(200011)30:11<3157::AID-IMMU3157>3.0.CO;2-H; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Schnare M, 1998, J IMMUNOL, V161, P3484; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Singh RR, 1996, J EXP MED, V183, P1613, DOI 10.1084/jem.183.4.1613; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753	36	106	113	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					429	440		10.1016/S1074-7613(04)00072-X	http://dx.doi.org/10.1016/S1074-7613(04)00072-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084272	Bronze			2022-12-18	WOS:000221442800009
J	Pham, LV; Tamayo, AT; Yoshimura, LC; Lo, P; Terry, N; Reid, PS; Ford, RJ				Pham, LV; Tamayo, AT; Yoshimura, LC; Lo, P; Terry, N; Reid, PS; Ford, RJ			A CD40 signalosome anchored in lipid rafts leads to constitutive activation of NF-kappa B and autonomous cell growth in B cell lymphomas	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; RECEPTOR-ASSOCIATED FACTOR-2; T-CELL; FOLLICULAR LYMPHOMA; TNF RECEPTOR; IKK-GAMMA; LIGAND; KINASE; COMPLEX; PROLIFERATION	B cell lineage non-Hodgkin's lymphomas (NHL-B) are neoplastic B cells that show dysregulated B lymphocyte growth characteristics. Unlike normal B cells, aggressive NHL-B cells show constitutive expression of nuclear NF-kappaB by maintaining an assembled, scaffold-like signaling platform, called a Signalosome within the lipid raft microdomain, extending from the cell membrane. The CD40 Signalosome appears to be initiated through autochthonous production and cognate binding of CD154 (CD40L, gp39) to CD40 by the lymphoma cell. Constitutive expression of NF-kappaB in NHL-B can be downregulated by treatment with antibodies to CD40 or CD154 that disrupt Signalosomes, inhibit lymphoma cell growth, and induce cell death. CD40 Signalosomes may provide a potentially vulnerable target for therapeutic intervention in NHL-B cells.	Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ford, RJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.				NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Andersen NS, 2000, BLOOD, V96, P2219; ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; BURDIN N, 1995, J IMMUNOL, V154, P2533; CASTLE BE, 1993, J IMMUNOL, V151, P1777; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; CLEARY ML, 1984, P NATL ACAD SCI-BIOL, V81, P593, DOI 10.1073/pnas.81.2.593; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; COIFFIER B, 1991, J CLIN ONCOL, V9, P211, DOI 10.1200/JCO.1991.9.2.211; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; FORD RJ, 1990, BLOOD, V75, P1311; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gaspari AA, 1996, EUR J IMMUNOL, V26, P1371, DOI 10.1002/eji.1830260629; Gordon J, 2000, IMMUNOLOGY, V100, P269, DOI 10.1046/j.1365-2567.2000.00074.x; Grammer AC, 1999, J IMMUNOL, V163, P4150; GRAMMER AC, 1995, J IMMUNOL, V154, P4996; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsing Y, 1997, J IMMUNOL, V159, P4898; JOENSUU H, 1990, CANCER, V65, P2564, DOI 10.1002/1097-0142(19900601)65:11<2564::AID-CNCR2820651128>3.0.CO;2-P; Kaleem Z, 2001, AM J CLIN PATHOL, V115, P136; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klaus GGB, 1999, INT IMMUNOL, V11, P71, DOI 10.1093/intimm/11.1.71; Klein G, 1999, CURR TOP MICROBIOL, V246, P161; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Mori N, 1999, BLOOD, V93, P2360; NAKASHATRI H, 1997, MOL CELL BIOL, V17, P3629; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; PEARSONWHITE S, 1995, BLOOD, V86, P2146, DOI 10.1182/blood.V86.6.2146.bloodjournal8662146; Planken EV, 1996, LEUKEMIA, V10, P488; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; Schattner EJ, 1998, BLOOD, V91, P2689, DOI 10.1182/blood.V91.8.2689.2689_2689_2697; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STEVENSON FK, 1993, BLOOD, V82, P224, DOI 10.1182/blood.V82.1.224.bloodjournal821224; Sundaresan A, 1997, CELL GROWTH DIFFER, V8, P1071; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Visser HPJ, 2000, LEUKEMIA, V14, P1483, DOI 10.1038/sj.leu.2401829; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang DK, 1997, BRIT J HAEMATOL, V97, P409, DOI 10.1046/j.1365-2141.1997.422688.x; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Younes A, 1999, INT J BIOL MARKER, V14, P135, DOI 10.1177/172460089901400303; ZELENETZ AD, 1992, J EXP MED, V176, P1137, DOI 10.1084/jem.176.4.1137; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	59	106	111	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					37	50		10.1016/S1074-7613(01)00258-8	http://dx.doi.org/10.1016/S1074-7613(01)00258-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825564	Bronze			2022-12-18	WOS:000173575700005
J	Nagata, K; Nakamura, T; Kitamura, F; Kuramochi, S; Taki, S; Campbell, KS; Karasuyama, H				Nagata, K; Nakamura, T; Kitamura, F; Kuramochi, S; Taki, S; Campbell, KS; Karasuyama, H			The Ig alpha/Ig beta heterodimer on mu-negative ProB cells is competent for transducing signals to induce early B cell differentiation	IMMUNITY			English	Review							SURROGATE LIGHT-CHAIN; IMMUNOGLOBULIN HEAVY-CHAIN; EPIDERMAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; DEFICIENT MUTANT MICE; MOUSE BONE-MARROW; PRE-B; T-CELL; ANTIGEN-RECEPTOR; TYROSINE KINASE	The immunoglobulin alpha (Ig alpha)/Ig beta heterodimer was detected on the surface of mu-negative proB cell lines in association with calnexin. The cross-linking of Ig beta on proB cells freshly isolated from bone marrow of recombination activating gene (RAG)-2-deficient mice induced a rapid and transient tyrosine-phosphorylation of Ig alpha as well as an array of intracellular proteins including Syk, PI3-kinase, Vav, and SLP-76. It also elicited the phosphorylation and activation of a MAP kinase ERK but not JNK/SAPK or p38. When RAG-2-deficient mice were treated with anti-Ig beta monoclonal antibody, developmentally arrested proB cells were induced to differentiate to the small preB cell stage as observed when the mu transgene was expressed in RAG-P-deficient mice. Thus, the cross-linking of Ig beta on proB cells appears to elicit differentiation signals analogous to those delivered by the preB cell receptor in normal B cell development.	TOKYO METROPOLITAN INST MED SCI,DEPT IMMUNOL,TOKYO 113,JAPAN; UNIV TOKYO,INST MED SCI,DEPT INFECT DIS & APPL IMMUNOL,TOKYO 108,JAPAN; UNIV TOKYO,FAC MED,DEPT IMMUNOL,TOKYO 113,JAPAN; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; University of Tokyo			Karasuyama, Hajime/A-7966-2011; Campbell, Kerry S./T-1381-2019	Karasuyama, Hajime/0000-0003-0689-0836; Taki, Shinsuke/0000-0001-5143-3496				ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; BALTIMORE D, 1979, IMMUNOL REV, V48, P3, DOI 10.1111/j.1600-065X.1979.tb00296.x; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COLLINS TL, 1997, TODAY, V18, P221; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DELUCA D, 1995, J IMMUNOL METHODS, V178, P13, DOI 10.1016/0022-1759(94)00236-P; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GOLD MR, 1992, J IMMUNOL, V148, P2012; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARDY RR, 1986, P NATL ACAD SCI USA, V83, P1438, DOI 10.1073/pnas.83.5.1438; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hobert O, 1996, MOL CELL BIOL, V16, P3066; HOBERT O, 1994, J BIOL CHEM, V269, P20225; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Horne MC, 1996, IMMUNITY, V4, P145, DOI 10.1016/S1074-7613(00)80679-2; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Jenkinson E J, 1990, Semin Immunol, V2, P51; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOYAMA M, 1997, IN PRESS INT IMMUNOL; Krop I, 1996, J IMMUNOL, V157, P48; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; Kuwahara K, 1996, INT IMMUNOL, V8, P1273, DOI 10.1093/intimm/8.8.1273; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; Meffre E, 1996, EUR J IMMUNOL, V26, P2172, DOI 10.1002/eji.1830260932; Milili M, 1996, EUR J IMMUNOL, V26, P63, DOI 10.1002/eji.1830260110; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; Moriguchi T, 1996, Adv Pharmacol, V36, P121, DOI 10.1016/S1054-3589(08)60579-7; NAKAMURA T, 1993, INT IMMUNOL, V5, P1309, DOI 10.1093/intimm/5.10.1309; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NOMURA J, 1991, INT IMMUNOL, V3, P117, DOI 10.1093/intimm/3.2.117; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; Papavasiliou F, 1996, J EXP MED, V184, P2025, DOI 10.1084/jem.184.5.2025; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; Papavasiliou F, 1997, CURR OPIN IMMUNOL, V9, P233, DOI 10.1016/S0952-7915(97)80141-0; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; PILLAI S, 1988, CURR TOP MICROBIOL, V137, P136; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RAMOSMORALES F, 1994, ONCOGENE, V9, P1917; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Romero F, 1996, MOL CELL BIOL, V16, P37; ROSENBERG N, 1994, SEMIN CANCER BIOL, V5, P95; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; Sanz E, 1996, J EXP MED, V183, P2693, DOI 10.1084/jem.183.6.2693; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SHAPIRO AM, 1993, MOL CELL BIOL, V13, P5679, DOI 10.1128/MCB.13.9.5679; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; WADA I, 1991, J BIOL CHEM, V266, P19599; WARNER NL, 1979, IMMUNOL REV, V48, P197, DOI 10.1111/j.1600-065X.1979.tb00304.x; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WIEST DL, 1994, J EXP MED, V180, P1375, DOI 10.1084/jem.180.4.1375; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; YAGITA H, 1989, P NATL ACAD SCI USA, V86, P645, DOI 10.1073/pnas.86.2.645; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; YE ZS, 1994, P NATL ACAD SCI USA, V91, P12629, DOI 10.1073/pnas.91.26.12629; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; Young F, 1997, IMMUNITY, V6, P23, DOI 10.1016/S1074-7613(00)80239-3; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	113	106	107	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					559	570		10.1016/S1074-7613(00)80377-5	http://dx.doi.org/10.1016/S1074-7613(00)80377-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354476	Bronze			2022-12-18	WOS:A1997YD59300012
J	Turpen, JB; Kelley, CM; Mead, PE; Zon, LI				Turpen, JB; Kelley, CM; Mead, PE; Zon, LI			Bipotential primitive-definitive hematopoietic progenitors in the vertebrate embryo	IMMUNITY			English	Article							FETAL LIVER HEMATOPOIESIS; XENOPUS-LAEVIS; YOLK-SAC; STEM-CELLS; TRANSCRIPTION FACTOR; PARAAORTIC SPLANCHNOPLEURA; MOUSE EMBRYOS; MICE LACKING; GENE; EXPRESSION	Two regions of the vertebrate embryo, the blood islands and the dorsal lateral plate (DLP), participate in early hematopoietic development. In Xenopus, primitive erythrocytes are derived solely from the ventral blood islands (VBI), while definitive hematopoietic cells such as lymphocytes are derived from both VBI and DLP. We have utilized a transplantation technique to demonstrate in vivo that all hematopoietic cells (embryonic, fetal, or adult) originate from Ventral mesoderm. Reciprocal grafts between VBI and DLP demonstrated that both regions are bipotential with respect to primitive and definitive hematopoiesis. Commitment of the VBI to primitive erythropoiesis and restriction of the DLP to definitive hematopoiesis occurs during neurula stages. Thus, hematopoietic development involves the induction of the blood program on the ventral axis of the embryo followed by environmentally regulated specification to the primitive or definitive lineages.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; UNIV NEBRASKA,MED CTR,DEPT CELL BIOL & ANAT,OMAHA,NE 68198	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Nebraska System; University of Nebraska Medical Center			Kelley, Clair M/O-2688-2015		NHLBI NIH HHS [HL48801] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMARAVADI L, 1994, ONCOGENE, V9, P971; BECHTOLD TE, 1992, J IMMUNOL, V148, P2975; BELL SE, 1991, EUR J IMMUNOL, V21, P2931, DOI 10.1002/eji.1830211206; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; CHEN XD, 1995, J IMMUNOL, V154, P2557; CORMIER F, 1988, DEVELOPMENT, V102, P279; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DEPARIS P, 1975, J EMBRYOL EXP MORPH, V33, P665; Dieterlen-Lievre F, 1993, SEMIN DEV BIOL, V4, P325; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; FLEISHMAN R, 1982, CELL, V30, P352; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; IKUTA K, 1993, SEMIN DEV BIOL, V4, P371; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; KAU CL, 1983, J IMMUNOL, V131, P2262; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; LASSILA O, 1978, NATURE, V272, P353, DOI 10.1038/272353a0; LASSILA O, 1982, BLOOD, V59, P377; MAENO M, 1985, DEV GROWTH DIFFER, V27, P137; MARTIN C, 1978, CELL DIFFER DEV, V7, P115, DOI 10.1016/0045-6039(78)90012-X; Mead PE, 1996, NATURE, V382, P357, DOI 10.1038/382357a0; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MELCHERS F, 1991, ADV EXP MED BIOL, V229, P201; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAITO M, 1990, J LEUKOCYTE BIOL, V48, P27, DOI 10.1002/jlb.48.1.27; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RICH IN, 1976, BLUT, V33, P171, DOI 10.1007/BF00995998; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TURPEN J, 1981, DEV BIOL, V104, P99; TURPEN J, 1982, DEV BIOL, V104, P138; WEBER R, 1991, DEVELOPMENT, V112, P1021; WEISSMANN I, 1978, COLD SPRING HARB SYM, V5, P33; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	50	106	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					325	334		10.1016/S1074-7613(00)80354-4	http://dx.doi.org/10.1016/S1074-7613(00)80354-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324353	Bronze			2022-12-18	WOS:A1997XY83000002
J	Tooze, RM; Doody, GM; Fearon, DT				Tooze, RM; Doody, GM; Fearon, DT			Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin	IMMUNITY			English	Article							B-CELL ACTIVATION; TYROSINE-PHOSPHATASE 1C; ANTIGEN RECEPTOR; TRANSCRIPTIONAL ACTIVATION; T-LYMPHOCYTES; RAS/RAF-1/MEK/MAPK CASCADE; CYCLOSPORIN-A; CROSS-LINKING; SIGNAL; PHOSPHORYLATION	The signaling pathways linked to membrane immunoglobulin (mig) that are regulated by the coreceptors CD19 and CD22 are not known. The mitogen-activated protein (MAP) kinases ERK2, JNK, and p38 couple extracellular signals to transcriptional responses. The capacity of mig to activate these MAP kinases is synergistically amplified by coligating CD19, and this effect requires that CD19 be juxtaposed to mig. CD22 suppresses MAP kinase activation when cross-linked to mig alone or to the coligated complex of mig and CD19. Separate ligation and sequestration of CD22 from mig enhances MAP kinase activation, probably reflecting release of mig from constitutive down-regulation. Thus, CD19 and CD22 have counterregulatory effects on MAP kinase activation by mig, which are dependent on their proximity to the antigen receptor.			Tooze, RM (corresponding author), UNIV CAMBRIDGE, SCH CLIN MED, DEPT MED, WELLCOME TRUST IMMUNOL UNIT, CAMBRIDGE CB2 2SP, ENGLAND.		Doody, Gina/AAN-8246-2021	Doody, Gina/0000-0003-0665-6759; Tooze, Reuben/0000-0003-2915-7119	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Carter RH, 1997, J IMMUNOL, V158, P3062; CARTER RH, 1991, J IMMUNOL, V147, P3663; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; CASILLAS A, 1991, J BIOL CHEM, V266, P19088; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DONGWORTH DW, 1982, EUR J IMMUNOL, V12, P1018, DOI 10.1002/eji.1830121207; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HRLOW E, 1988, ANTIBODIES LAB MANUA; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kashiwada M, 1996, EUR J IMMUNOL, V26, P1451, DOI 10.1002/eji.1830260708; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KOZONO Y, 1995, EUR J IMMUNOL, V25, P1013, DOI 10.1002/eji.1830250423; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Li YY, 1996, J IMMUNOL, V157, P1440; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MURAGUCHI A, 1983, J EXP MED, V158, P690, DOI 10.1084/jem.158.3.690; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; PEZZUTTO A, 1987, J IMMUNOL, V138, P2793; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; POWELL LD, 1994, J BIOL CHEM, V269, P10628; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; SGROI D, 1993, J BIOL CHEM, V268, P7011; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Sutherland CL, 1996, J IMMUNOL, V157, P3381; TORDAI A, 1994, J BIOL CHEM, V269, P7538; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VANNOESEL CJM, 1993, INT IMMUNOL, V5, P699; WENG WK, 1994, J BIOL CHEM, V269, P32514; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	69	106	108	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1997	7	1					59	67		10.1016/S1074-7613(00)80510-5	http://dx.doi.org/10.1016/S1074-7613(00)80510-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252120	Bronze			2022-12-18	WOS:A1997XN69300006
J	IVASHKIV, LB				IVASHKIV, LB			CYTOKINES AND STATS - HOW CAN SIGNALS ACHIEVE SPECIFICITY	IMMUNITY			English	Article							TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; ACTIVATION; KINASE				IVASHKIV, LB (corresponding author), CORNELL UNIV,GRAD SCH MED SCI,HOSP SPECIAL SURG,DEPT MED,GRAD PROGRAM IMMUNOL,NEW YORK,NY 10021, USA.							AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FELDMAN GM, 1995, J IMMUNOL, V154, P318; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IGARASHI K, 1993, MOL CELL BIOL, V13, P3984, DOI 10.1128/MCB.13.7.3984; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEHMANN J, 1994, J IMMUNOL, V153, P165; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; ROTHMAN P, 1994, IMMUNITY, V1, P457, DOI 10.1016/1074-7613(94)90088-4; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; SENGUPTA TK, 1995, J EXP MED, V181, P1015, DOI 10.1084/jem.181.3.1015; SHUAI K, 1992, SCIENCE, V259, P1808; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; WEN Z, 1995, IN PRESS CELL; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	32	106	109	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					1	4		10.1016/1074-7613(95)90152-3	http://dx.doi.org/10.1016/1074-7613(95)90152-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621070	hybrid			2022-12-18	WOS:A1995RK86800001
J	LIVAK, F; PETRIE, HT; CRISPE, IN; SCHATZ, DG				LIVAK, F; PETRIE, HT; CRISPE, IN; SCHATZ, DG			IN-FRAME TCR DELTA-GENE REARRANGEMENTS PLAY A CRITICAL ROLE IN THE ALPHA-BETA/GAMMA-DELTA T-CELL LINEAGE DECISION	IMMUNITY			English	Article							RECEPTOR-GAMMA-DELTA; THYMOCYTE DEVELOPMENT; V(D)J RECOMBINATION; IMMATURE THYMOCYTES; TRANSGENIC MICE; LYMPHOCYTES-T; CHAIN GENES; BETA-CHAIN; 95 KB; EXPRESSION	Using a quantitative multiprobe Southern blot analysis, we demonstrate the surprising result that a significant proportion of alpha beta T cells and thymocytes retain T cell receptor delta locus sequences. A substantial portion of the retained delta locus is in a fully V-to-D-to-J rearranged configuration and 20% of these delta rearrangements are functional, significantly less than the 33% predicted for random gene rearrangements. Our observations are in conflict with the idea that ap and gamma delta T cells derive from distinct precursors and suggest that commitment of a common precursor to the gamma delta lineage depends upon expression of a ya T cell receptor. We propose that the intrathymic T cell lineage decision is determined by a competition between the production of functional gamma delta and beta-pre-T cell receptor complexes.	YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520	Yale University	LIVAK, F (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,333 CEDAR ST,NEW HAVEN,CT 06520, USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NIAID NIH HHS [AI32524, T32-AI07019] Funding Source: Medline; NIGMS NIH HHS [GM37758] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032524, T32AI007019] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BONNEVILLE M, 1989, NATURE, V342, P931, DOI 10.1038/342931a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CRON RQ, 1988, J IMMUNOL, V141, P1074; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ELLIOTT JF, 1988, NATURE, V331, P627; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; HAAS W, 1992, CURR OPIN IMMUNOL, V4, P147, DOI 10.1016/0952-7915(92)90004-X; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; HELD W, 1990, EUR J IMMUNOL, V20, P2133, DOI 10.1002/eji.1830200936; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; KORMAN AJ, 1989, P NATL ACAD SCI USA, V86, P267, DOI 10.1073/pnas.86.1.267; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; LEW AM, 1986, SCIENCE, V234, P1401, DOI 10.1126/science.3787252; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LINDSTEN T, 1987, J EXP MED, V166, P761, DOI 10.1084/jem.166.3.761; LUCAS B, 1993, J IMMUNOL, V151, P4574; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER S, 1994, EUR J IMMUNOL, V24, P145; OBRIEN RL, 1992, P NATL ACAD SCI USA, V89, P4348, DOI 10.1073/pnas.89.10.4348; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKAZAKI K, 1988, EMBO J, V7, P1669, DOI 10.1002/j.1460-2075.1988.tb02994.x; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TAKAGAKI Y, 1989, J IMMUNOL, V142, P2112; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; TATSUMI Y, 1993, J IMMUNOL, V151, P3030; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; THOMPSON SD, 1991, EUR J IMMUNOL, V21, P1939, DOI 10.1002/eji.1830210824; TODA M, 1988, J MOL BIOL, V202, P219, DOI 10.1016/0022-2836(88)90453-6; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WANG K, 1994, GENOMICS, V20, P419, DOI 10.1006/geno.1994.1196; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0; WINOTO A, 1991, CURR OPIN IMMUNOL, V3, P199, DOI 10.1016/0952-7915(91)90050-B; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844	66	106	106	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					617	627		10.1016/1074-7613(95)90006-3	http://dx.doi.org/10.1016/1074-7613(95)90006-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796295	hybrid			2022-12-18	WOS:A1995RE53800007
J	ERNST, P; SMALE, ST				ERNST, P; SMALE, ST			COMBINATORIAL REGULATION OF TRANSCRIPTION .2. THE IMMUNOGLOBULIN-MU HEAVY-CHAIN GENE	IMMUNITY			English	Review							HELIX-LOOP-HELIX; CELL-TYPE SPECIFICITY; PROTEIN-BINDING SITES; DNASE-I SENSITIVITY; FUNCTIONAL-ANALYSIS; ENHANCER ELEMENT; TRANSGENIC MICE; LEUCINE-ZIPPER; LYMPHOID-CELLS; IGH ENHANCER				ERNST, P (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,HOWARD HUGHES MED INST,INST MOLEC BIOL,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90095, USA.			Ernst, Patricia/0000-0001-7638-2939	NCI NIH HHS [CA09120] Funding Source: Medline; NIDDK NIH HHS [DK43726] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043726, R29DK043726] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANNWEILER A, 1992, NUCLEIC ACIDS RES, V20, P1503, DOI 10.1093/nar/20.7.1503; ANNWEILER A, 1994, NUCLEIC ACIDS RES, V22, P4250, DOI 10.1093/nar/22.20.4250; ARTANDI SE, 1994, MOL CELL BIOL, V14, P7704, DOI 10.1128/MCB.14.12.7704; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; CALAME K, 1995, IMMUNOGLOBULIN GENES; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; ERNST P, 1995, IMMUNITY, V2, P311, DOI 10.1016/1074-7613(95)90139-6; FELDHAUS AL, 1993, EMBO J, V12, P2763, DOI 10.1002/j.1460-2075.1993.tb05937.x; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; FORD AM, 1992, P NATL ACAD SCI USA, V89, P3423; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GARCIA JV, 1986, NATURE, V322, P383, DOI 10.1038/322383a0; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; GEORGIEV GP, 1969, J THEOR BIOL, V25, P473, DOI 10.1016/S0022-5193(69)80034-2; GIERER A, 1973, COLD SPRING HARB SYM, V38, P951, DOI 10.1101/SQB.1974.038.01.097; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JACOBS Y, 1993, MOL CELL BIOL, V13, P7321, DOI 10.1128/MCB.13.12.7321; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; KADESCH T, 1986, NUCLEIC ACIDS RES, V14, P8209, DOI 10.1093/nar/14.20.8209; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KILEDJIAN M, 1988, MOL CELL BIOL, V8, P145, DOI 10.1128/MCB.8.1.145; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; LIBERMANN TA, 1993, MOL CELL BIOL, V13, P5957, DOI 10.1128/MCB.13.10.5957; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P3155, DOI 10.1128/MCB.10.6.3155; LOPEZ M, 1994, MOL CELL BIOL, V14, P3292, DOI 10.1128/MCB.14.5.3292; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, IN PRESS MOL CELL BI, V15; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MATHER EL, 1983, P NATL ACAD SCI-BIOL, V80, P4689, DOI 10.1073/pnas.80.15.4689; MELCHERS F, 1980, EUR J IMMUNOL, V10, P679, DOI 10.1002/eji.1830100905; MILLER AE, 1992, IMMUNOGENETICS, V35, P24, DOI 10.1007/BF00216623; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NELSEN B, 1990, MOL CELL BIOL, V10, P3145, DOI 10.1128/MCB.10.6.3145; NELSEN B, 1992, INT REV CYTOL, V133, P121, DOI 10.1016/S0074-7696(08)61859-8; PEREZMUTUL J, 1988, NUCLEIC ACIDS RES, V16, P6085, DOI 10.1093/nar/16.13.6085; PERRY RP, 1979, CELL, V18, P1333, DOI 10.1016/0092-8674(79)90243-5; PFISTERER P, 1994, EMBO J, V13, P1654, DOI 10.1002/j.1460-2075.1994.tb06429.x; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; RADOMSKA HS, 1994, IMMUNITY, V1, P623, DOI 10.1016/1074-7613(94)90034-5; RAYNAL MC, 1989, P NATL ACAD SCI USA, V86, P8024, DOI 10.1073/pnas.86.20.8024; RIVERA RR, 1993, MOL CELL BIOL, V13, P7163, DOI 10.1128/MCB.13.11.7163; ROMAN C, 1992, MOL CELL BIOL, V12, P817, DOI 10.1128/MCB.12.2.817; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; RUEZINSKY D, 1991, GENE DEV, V5, P29, DOI 10.1101/gad.5.1.29; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHNEIKERT J, 1992, ONCOGENE, V7, P249; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHEN LY, 1993, MOL CELL BIOL, V13, P3530, DOI 10.1128/MCB.13.6.3530; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STORB U, 1981, BIOCHEMISTRY-US, V20, P990, DOI 10.1021/bi00507a053; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TSAO BP, 1988, NUCLEIC ACIDS RES, V16, P3239, DOI 10.1093/nar/16.8.3239; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WASYLYK C, 1986, EMBO J, V5, P553, DOI 10.1002/j.1460-2075.1986.tb04246.x; WEINBERGER J, 1988, MOL CELL BIOL, V8, P988, DOI 10.1128/MCB.8.2.988; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YUAN D, 1992, J IMMUNOL, V148, P3652; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	103	106	106	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					427	438		10.1016/1074-7613(95)90024-1	http://dx.doi.org/10.1016/1074-7613(95)90024-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749979	Bronze			2022-12-18	WOS:A1995QZ43000001
J	Ma, XC; Zou, F; Yu, F; Li, R; Yuan, YC; Zhang, YW; Zhang, XT; Deng, JY; Chen, T; Song, Z; Qiao, YD; Zhan, YK; Liu, J; Zhang, JS; Zhang, X; Peng, ZL; Li, YZ; Lin, YT; Liang, LT; Wang, GW; Chen, YS; Chen, QE; Pan, T; He, X; Zhang, H				Ma, Xiancai; Zou, Fan; Yu, Fei; Li, Rong; Yuan, Yaochang; Zhang, Yiwen; Zhang, Xiantao; Deng, Jieyi; Chen, Tao; Song, Zheng; Qiao, Yidan; Zhan, Yikang; Liu, Jun; Zhang, Junsong; Zhang, Xu; Peng, Zhilin; Li, Yuzhuang; Lin, Yingtong; Liang, Liting; Wang, Guanwen; Chen, Yingshi; Chen, Qier; Pan, Ting; He, Xin; Zhang, Hui			Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses	IMMUNITY			English	Article							SARS-COV; CELL; PROTEIN; DESIGN; MEMORY; TARGET; MERS	Various vaccine strategies have been proposed in response to the global COVID-19 pandemic, each with unique strategies for eliciting immune responses. Here, we developed nanoparticle vaccines by covalently conjugating the self-assembled 24-mer ferritin to the receptor binding domain (RBD) and/or heptad repeat (HR) subunits of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) spike (S) protein. Compared to monomer vaccines, nanoparticle vaccines elicited more robust neutralizing antibodies and cellular immune responses. RBD and RBD-HR nanoparticle vaccinated hACE2 transgenic mice vaccinated with RBD and/or RBD-HR nanoparticles exhibited reduced viral load in the lungs after SARS-CoV-2 challenge. RBD-HR nanoparticle vaccines also promoted neutralizing antibodies and cellular immune responses against other coronaviruses. The nanoparticle vaccination of rhesus macaques induced neutralizing antibodies, and T and B cell responses prior to boost immunization; these responses persisted for more than three months. RBD- and HR-based nanoparticles thus present a promising vaccination approach against SARS-CoV-2 and other coronaviruses.	[Ma, Xiancai; Li, Rong; Yuan, Yaochang; Zhang, Yiwen; Zhang, Xiantao; Deng, Jieyi; Chen, Tao; Song, Zheng; Qiao, Yidan; Zhan, Yikang; Liu, Jun; Zhang, Xu; Peng, Zhilin; Li, Yuzhuang; Lin, Yingtong; Chen, Yingshi; Chen, Qier; Pan, Ting; He, Xin; Zhang, Hui] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Zhongshan Sch Med,Key Lab Trop Dis Control, Engn Res Ctr Gene Vaccine,Minist Educ,Inst Human, Guangzhou 510080, Guangdong, Peoples R China; [Zou, Fan; Liu, Jun; Liang, Liting] Qianyang Biomed Res Inst, Guangzhou 510063, Guangdong, Peoples R China; [Yu, Fei; Zhang, Junsong; Wang, Guanwen] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangzhou 510080, Guangdong, Peoples R China; [Pan, Ting] Sun Yat Sen Univ Shenzhen, Ctr Infect & Immun Study, Sch Med, Shenzhen 518107, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Zhang, H (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Zhongshan Sch Med,Key Lab Trop Dis Control, Engn Res Ctr Gene Vaccine,Minist Educ,Inst Human, Guangzhou 510080, Guangdong, Peoples R China.	zhangh92@mail.sysu.edu.cn	Chen, Yingshi/GLT-9645-2022	Chen, Yingshi/0000-0002-5391-5103; Zhang, Yiwen/0000-0002-5232-0335; Ma, Xiancai/0000-0002-4934-4221; He, Xin/0000-0002-2131-2092; Yu, Fei/0000-0003-1546-9365	National Special Research Program of China for Important Infectious Diseases [2018ZX10302103, 2017ZX10202102]; Special 2019-nCoV Program of Natural Science Foundation of China (NSFC) [82041002]; Special 2019-nCoV Project of National Key Research and Development Program of China [2020YFC0841400]; Important Key Program of NSFC [81730060]; Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou [201803040002]; National Postdoctoral Program for Innovative Talents; General Program of China Postdoctoral Science Foundation [BX20190398, 2019M663215]; Pearl River S&T Nova Program of Guangzhou [201806010118]; Special 2019-nCoV Project of Research and Development Program of Guangdong [2020B111123001]	National Special Research Program of China for Important Infectious Diseases; Special 2019-nCoV Program of Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special 2019-nCoV Project of National Key Research and Development Program of China; Important Key Program of NSFC; Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou; National Postdoctoral Program for Innovative Talents; General Program of China Postdoctoral Science Foundation; Pearl River S&T Nova Program of Guangzhou; Special 2019-nCoV Project of Research and Development Program of Guangdong	This work was supported by the National Special Research Program of China for Important Infectious Diseases (2018ZX10302103 and 2017ZX10202102), the Special 2019-nCoV Program of Natural Science Foundation of China (NSFC) (82041002), the Special 2019-nCoV Project of National Key Research and Development Program of China (2020YFC0841400), the Special 2019-nCoV Project of Research and Development Program of Guangdong (2020B111123001), the Important Key Program of NSFC (81730060), and the Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou (201803040002) to H.Z. This work was also supported by the National Postdoctoral Program for Innovative Talents and the General Program of China Postdoctoral Science Foundation (BX20190398 and 2019M663215) to X.M. This work was also supported by the Pearl River S&T Nova Program of Guangzhou (201806010118) to T.P.	Ahmed SF, 2020, NAT PROTOC, V15, P2141, DOI 10.1038/s41596-020-0358-9; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.1101/2020.04.10.036418]; Case JB, 2020, CELL HOST MICROBE, V28, P465, DOI 10.1016/j.chom.2020.07.018; Chattopadhyay Saborni, 2017, Nanotheranostics, V1, P244, DOI 10.7150/ntno.19796; Dai LP, 2020, CELL, V182, P722, DOI 10.1016/j.cell.2020.06.035; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Erasmus JH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc9396; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Godavarthy A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134010; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Hassan AO, 2020, CELL, V183, P169, DOI 10.1016/j.cell.2020.08.026; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jackson L. A., 2020, NEW ENGLAND J MED; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Li SW, 2020, ECOTOX ENVIRON SAFE, V201, DOI 10.1016/j.ecoenv.2020.110801; Liu BF, 2020, CELL MOL IMMUNOL, V17, P1098, DOI 10.1038/s41423-020-00528-0; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Palm AKE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01787; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Ravichandran S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3539; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Shi XJ, 2020, PROTEIN SCI, V29, P1924, DOI 10.1002/pro.3913; Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19; Shin MD, 2020, NAT NANOTECHNOL, V15, P646, DOI 10.1038/s41565-020-0737-y; Smatti MK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02991; Tian J.-H., 2020, SARS COV 2 SPIKE GLY, DOI [10.1101/2020.06.29, DOI 10.1101/2020.06.29]; Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Wang N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00298; Wang WJ, 2020, NAT NANOTECHNOL, V15, P406, DOI 10.1038/s41565-020-0648-y; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Yang JY, 2020, NATURE, V586, P572, DOI 10.1038/s41586-020-2599-8; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang NN, 2020, CELL, V182, P1271, DOI 10.1016/j.cell.2020.07.024; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	58	105	108	12	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1315	+		10.1016/j.immuni.2020.11.015	http://dx.doi.org/10.1016/j.immuni.2020.11.015			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33275896	Green Published, Bronze			2022-12-18	WOS:000599363300018
J	Remmerie, A; Martens, L; Thone, T; Castoldi, A; Seurinck, R; Pavie, B; Roels, J; Vanneste, B; De Prijck, S; Vanhockerhout, M; Latib, MBA; Devisscher, L; Hoorens, A; Bonnardel, J; Vandamme, N; Kremer, A; Borghgraef, P; Van Vlierberghe, H; Lippens, S; Pearce, E; Saeys, Y; Scott, CL				Remmerie, Anneleen; Martens, Liesbet; Thone, Tinne; Castoldi, Angela; Seurinck, Ruth; Pavie, Benjamin; Roels, Joris; Vanneste, Bavo; De Prijck, Sofie; Vanhockerhout, Mathias; Latib, Mushida Binte Abdul; Devisscher, Lindsey; Hoorens, Anne; Bonnardel, Johnny; Vandamme, Niels; Kremer, Anna; Borghgraef, Peter; Van Vlierberghe, Hans; Lippens, Saskia; Pearce, Edward; Saeys, Yvan; Scott, Charlotte L.			Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver	IMMUNITY			English	Article							STEATOHEPATITIS; FIBROSIS; INFLAMMATION; SIGNATURES; STEATOSIS; NETWORK; DISEASE; MODEL	Metabolic-associated fatty liver disease (MAFLD) represents a spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Hepatic macrophages, specifically Kupffer cells (KCs), are suggested to play important roles in the pathogenesis of MAFLD through their activation, although the exact roles played by these cells remain unclear. Here, we demonstrated that KCs were reduced in MAFLD being replaced by macrophages originating from the bone marrow. Recruited macrophages existed in two subsets with distinct activation states, either closely resembling homeostatic KCs or lipid-associated macrophages (LAMs) from obese adipose tissue. Hepatic LAMs expressed Osteopontin, a biomarker for patients with NASH, linked with the development of fibrosis. Fitting with this, LAMs were found in regions of the liver with reduced numbers of KCs, characterized by increased Desmin expression. Together, our data highlight considerable heterogeneity within the macrophage pool and suggest a need for more specific macrophage targeting strategies in MAFLD.	[Remmerie, Anneleen; Martens, Liesbet; Thone, Tinne; Vanneste, Bavo; De Prijck, Sofie; Vanhockerhout, Mathias; Latib, Mushida Binte Abdul; Scott, Charlotte L.] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Remmerie, Anneleen; Martens, Liesbet; Thone, Tinne; Pavie, Benjamin; Vanneste, Bavo; De Prijck, Sofie; Vanhockerhout, Mathias; Latib, Mushida Binte Abdul; Bonnardel, Johnny; Kremer, Anna; Borghgraef, Peter; Lippens, Saskia; Scott, Charlotte L.] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium; [Martens, Liesbet; Thone, Tinne; Vanneste, Bavo; De Prijck, Sofie; Vanhockerhout, Mathias; Latib, Mushida Binte Abdul; Bonnardel, Johnny] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Castoldi, Angela; Pearce, Edward] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Seurinck, Ruth; Roels, Joris; Vandamme, Niels; Saeys, Yvan] VIB UGent Ctr Inflammat Res, Data Min & Modelling Biomed, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Seurinck, Ruth; Roels, Joris; Vandamme, Niels; Saeys, Yvan] Univ Ghent, Fac Sci, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Pavie, Benjamin; Kremer, Anna; Borghgraef, Peter; Lippens, Saskia] VIB UGent Ctr Inflammat Res, VIB BioImaging Core, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Devisscher, Lindsey] Univ Ghent, Fac Med & Hlth Sci, Dept Basic & Appl Med Sci, Ghent, Belgium; [Hoorens, Anne] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium; [Van Vlierberghe, Hans] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Pearce, Edward] Univ Freiburg, Freiburg, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Max Planck Society; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Freiburg	Scott, CL (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium.; Scott, CL (corresponding author), Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium.	charlotte.scott@irc.vib-ugent.be	Devisscher, Lindsey/AAD-5969-2021; Castoldi, Angela/K-1889-2015; Saeys, Yvan/C-1311-2009	Devisscher, Lindsey/0000-0003-4862-9580; Saeys, Yvan/0000-0002-0415-1506; Lippens, Saskia/0000-0002-8261-3462; Vanneste, Bavo/0000-0002-4152-5634; Castoldi, Angela/0000-0002-8434-7989; Pavie, Benjamin/0000-0002-0249-3844; Remmerie, Anneleen/0000-0001-5433-2316; Martens, Liesbet/0000-0001-9180-7456; Van Vlierberghe, Hans/0000-0003-0647-9238; Bonnardel, Johnny/0000-0003-2359-3438	ERC [851908]; FWO	ERC(European Research Council (ERC)European Commission); FWO(FWO)	We thank the IRC flow cytometry core facility, Gert Van Isterdael, and Julie Van Duyse for assistance. We also thank Dr Wouter Saelens and Jana Roels for discussions and Profs Martin Guilliams and Allan Mowat for critically reading the manuscript. We also thank VIB Tech Watch, the VIB Single-cell accelerator program, and Martin Guilliams for their help in establishing the CITE-Seq protocols. Finally, we thank the staff of the VIB-UGent animal house. A.R. is supported through her role as a junior assistant to the Department of Biomedical Molecular Biology, Ghent University. C.L.S. is a Francqui Foundation Professor, and her lab is supported by an ERC starting grant (MyeFattyLiver, #851908) and FWO project grants.	Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; BALLARDINI G, 1988, VIRCHOWS ARCH B, V56, P45, DOI 10.1007/BF02890000; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bhattacharjee J, 2017, HEPATOL COMMUN, V1, P299, DOI 10.1002/hep4.1041; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Coombes JD, 2016, BBA-MOL BASIS DIS, V1862, P135, DOI 10.1016/j.bbadis.2015.10.028; Devisscher L, 2017, CELL IMMUNOL, V322, P74, DOI 10.1016/j.cellimm.2017.10.006; Diggins KE, 2017, NAT METHODS, V14, P275, DOI [10.1038/NMETH.4149, 10.1038/nmeth.4149]; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7; Ghazarian M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7616; Glass O, 2018, HEPATOL COMMUN, V2, P1344, DOI 10.1002/hep4.1237; Haas JT, 2019, NAT METAB, V1, P604, DOI 10.1038/s42255-019-0076-1; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Honda M, 2020, J CELL COMMUN SIGNAL, V14, P223, DOI 10.1007/s12079-020-00554-7; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kim BM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25699-9; Kirovski G, 2010, INT J CLIN EXP PATHO, V3, P675; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lun Aaron T L, 2016, F1000Res, V5, P2122; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Morgantini C, 2019, NAT METAB, V1, P445, DOI 10.1038/s42255-019-0044-9; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Pont F, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz601; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Reid DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159524; Remmerie A, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00259; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Seth D, 2014, WORLD J GASTROENTERO, V20, P13088, DOI 10.3748/wjg.v20.i36.13088; Sethunath D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197242; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Tran S., 2020, IMMUNITY; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Ydens E, 2020, NAT NEUROSCI, V23, P676, DOI 10.1038/s41593-020-0618-6	60	105	105	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					641	+		10.1016/j.immuni.2020.08.004	http://dx.doi.org/10.1016/j.immuni.2020.08.004			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32888418	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000569806100018
J	Harris, NL; Loke, P				Harris, Nicola L.; Loke, P'ng			Recent Advances in Type-2-Cell-Mediated Immunity: Insights from Helminth Infection	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; TISSUE-RESIDENT MACROPHAGES; TYPE-2 IMMUNITY; MAST-CELLS; TRICHINELLA-SPIRALIS; PROTECTIVE IMMUNITY; LUNG INFLAMMATION; IL-13 PRODUCTION; DENDRITIC CELLS	Type-2-cell-mediated immune responses play a critical role in mediating both host-resistance and disease-tolerance mechanisms during helminth infections. Recently, type 2 cell responses have emerged as major regulators of tissue repair and metabolic homeostasis even under steady-state conditions. In this review, we consider how studies of helminth infection have contributed toward our expanding cellular and molecular understanding of type-2-cell-mediated immunity, as well as new areas such as the microbiome. By studying how these successful parasites form chronic infections without overt pathology, we are gaining additional insights into allergic and inflammatory diseases, as well as normal physiology.	[Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Loke, P'ng] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; New York University	Harris, NL (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	Loke, Png/X-2278-2019; Harris, Nicola Laraine/E-5342-2019	Harris, Nicola Laraine/0000-0003-2922-0210	European Research Council (ERC) under the European Union's Seventh Framework Programme; ERC [310948]; National Institutes of Health [AI133977, HL084312, AI093811, AI094166, DK103788]; Department of Defense [PR151468P1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094166, R01AI133977, R01AI093811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103788] Funding Source: NIH RePORTER	European Research Council (ERC) under the European Union's Seventh Framework Programme(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP/2007-2013) and ERC grant agreement no. 310948 awarded to N.L.H. and from grants from the National Institutes of Health (AI133977, HL084312, AI093811, AI094166, and DK103788) and the Department of Defense (PR151468P1) to P.L.	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; APPLETON JA, 1984, SCIENCE, V226, P70, DOI 10.1126/science.6474191; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bieren JEV, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003771; Blankenhaus B, 2011, J IMMUNOL, V186, P4295, DOI 10.4049/jimmunol.1001920; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bouchery T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7970; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002883; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Brunet LR, 1997, J IMMUNOL, V159, P777; Cadman ET, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003988; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; CHANDRASHEKAR R, 1990, INT J PARASITOL, V20, P725, DOI 10.1016/0020-7519(90)90005-8; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dubey LK, 2016, CELL REP, V15, P1527, DOI 10.1016/j.celrep.2016.04.023; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Girgis NM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004080; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Gouon-Evans V, 2002, BREAST CANCER RES, V4, P155, DOI 10.1186/bcr441; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Harris NL, 2011, TRENDS PARASITOL, V27, P288, DOI 10.1016/j.pt.2011.03.010; Hasnain SZ, 2013, INT J BIOCHEM CELL B, V45, P364, DOI 10.1016/j.biocel.2012.10.011; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hayes KS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005708; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hewitson JP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004676; Hewitson JP, 2014, EXPERT REV VACCINES, V13, P473, DOI 10.1586/14760584.2014.893195; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005347; Huang L, 2015, J IMMUNOL, V194, P283, DOI 10.4049/jimmunol.1402219; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Jackson-Jones LH, 2016, EUR J IMMUNOL, V46, P2311, DOI 10.1002/eji.201646442; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Knott ML, 2007, INT J PARASITOL, V37, P1367, DOI 10.1016/j.ijpara.2007.04.006; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Monin L, 2015, J CLIN INVEST, V125, P4699, DOI 10.1172/JCI77378; Moretti S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14017; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nascimento M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004282; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Okada H, 2013, ENDOCR J, V60, P1241, DOI 10.1507/endocrj.EJ13-0312; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Parkins J J, 1989, Nutr Res Rev, V2, P227, DOI 10.1079/NRR19890016; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qualls JE, 2016, SEMIN IMMUNOPATHOL, V38, P139, DOI 10.1007/s00281-015-0534-0; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Rangan KJ, 2016, SCIENCE, V353, P1434, DOI 10.1126/science.aaf3552; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Ruckerl D, 2014, IMMUNOL REV, V262, P113, DOI 10.1111/imr.12221; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shea-Donohue T, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12422; Shen SW, 2015, PARASITE IMMUNOL, V37, P333, DOI 10.1111/pim.12187; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Strandmark J, 2017, MUCOSAL IMMUNOL, V10, P661, DOI 10.1038/mi.2016.93; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Torow N, 2017, MUCOSAL IMMUNOL, V10, P5, DOI 10.1038/mi.2016.81; Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Van de Velde LA, 2017, J BIOL CHEM, V292, P15, DOI 10.1074/jbc.M116.766238; van der Werf N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003215; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wiria AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054855; Wong CK, 2007, IMMUNOL LETT, V112, P82, DOI 10.1016/j.imlet.2007.07.002; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	153	105	108	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1024	1036		10.1016/j.immuni.2017.11.015	http://dx.doi.org/10.1016/j.immuni.2017.11.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262347	Bronze			2022-12-18	WOS:000418486500009
J	Renoux, VM; Zriwil, A; Peitzsch, C; Michaelsson, J; Friberg, D; Soneji, S; Sitnicka, E				Renoux, Virginie M.; Zriwil, Alya; Peitzsch, Claudia; Michaelsson, Jakob; Friberg, Danielle; Soneji, Shamit; Sitnicka, Ewa			Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; NK CELLS; DENDRITIC CELLS; BONE-MARROW; INNATE; DIFFERENTIATION; DISTINCT; MOUSE; INDUCTION; ORIGIN	Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+) CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy.	[Renoux, Virginie M.; Zriwil, Alya; Peitzsch, Claudia; Soneji, Shamit; Sitnicka, Ewa] Lund Univ, Lund Res Ctr Stem Cell Biol & Cell Therapy, S-22184 Lund, Sweden; [Zriwil, Alya; Soneji, Shamit; Sitnicka, Ewa] Lund Univ, Dept Lab Med, Div Mol Hematol, S-22184 Lund, Sweden; [Michaelsson, Jakob] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden; [Friberg, Danielle] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Otorhinolaryngol, S-14186 Stockholm, Sweden; [Friberg, Danielle] Karolinska Inst, CLINTEC, S-14186 Stockholm, Sweden	Lund University; Lund University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sitnicka, E (corresponding author), Lund Univ, Lund Res Ctr Stem Cell Biol & Cell Therapy, S-22184 Lund, Sweden.	ewa.sitnicka@med.lu.se	Peitzsch, Claudia/J-9792-2016; Peitzsch, Claudia/AAM-1517-2020	Peitzsch, Claudia/0000-0002-5247-908X; Peitzsch, Claudia/0000-0002-5247-908X; Zriwil, Alya/0000-0001-6262-7253; Friberg, Danielle/0000-0001-8327-1292	Swedish Research Council; AFA Foundation; Swedish Cancer Foundation; Lund University Hospital; Hemato-Linne and StemTherapy program; Swedish Pediatric Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Foundation; Swedish Cancer Foundation; Lund University Hospital; Hemato-Linne and StemTherapy program; Swedish Pediatric Cancer Foundation	The authors thank Lilian Wittmann, Aurelie Baudet, Jonas Larsson, Carmen Flores Bjurstrom, and Karl Johan Malmberg for the technical assistance, critical reagents, discussions, and expert advice. We are thankful to David Bryder for critically reading and commenting on the manuscript. This work was supported by the Swedish Research Council, the AFA Foundation, the Swedish Cancer Foundation, the ALF Clinical Research Award from Lund University Hospital, and the Hemato-Linne and StemTherapy program. E.S. has an Associate Professor Position supported by the Swedish Pediatric Cancer Foundation.	Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Charoudeh HN, 2010, BLOOD, V116, P183, DOI 10.1182/blood-2009-10-247130; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ivarsson MA, 2013, J CLIN INVEST, V123, P3889, DOI 10.1172/JCI68989; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Medvinsky A., 2008, CURR PROTOC STEM CEL, V2; Miller JS, 2013, HEMATOL-AM SOC HEMAT, P247, DOI 10.1182/asheducation-2013.1.247; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Moroso V, 2011, EUR J IMMUNOL, V41, P3340, DOI 10.1002/eji.201141760; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park CY, 2008, NAT PROTOC, V3, P1932, DOI 10.1038/nprot.2008.194; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; PUNNONEN J, 1992, J IMMUNOL, V148, P3398; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Res P, 1996, BLOOD, V87, P5196, DOI 10.1182/blood.V87.12.5196.bloodjournal87125196; Roy A, 2012, P NATL ACAD SCI USA, V109, P17579, DOI 10.1073/pnas.1211405109; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Tang YJ, 2012, BLOOD, V120, P63, DOI 10.1182/blood-2011-02-337980; Vosshenrich CAJ, 2013, CURR OPIN IMMUNOL, V25, P130, DOI 10.1016/j.coi.2013.02.002; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005	43	105	109	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					394	407		10.1016/j.immuni.2015.07.011	http://dx.doi.org/10.1016/j.immuni.2015.07.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287684	Bronze, Green Published			2022-12-18	WOS:000360101200020
J	Surace, L; Lysenko, V; Fontana, AO; Cecconi, V; Janssen, H; Bicvic, A; Okoniewski, M; Pruschy, M; Dummer, R; Neefjes, J; Knuth, A; Gupta, A; van den Broek, M				Surace, Laura; Lysenko, Veronika; Fontana, Andrea Orlando; Cecconi, Virginia; Janssen, Hans; Bicvic, Antonela; Okoniewski, Michal; Pruschy, Martin; Dummer, Reinhard; Neefjes, Jacques; Knuth, Alexander; Gupta, Anurag; van den Broek, Maries			Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response	IMMUNITY			English	Article							LOCAL RADIATION-THERAPY; PRIMARY BRAIN-TUMORS; T-CELL RESPONSES; DENDRITIC CELLS; IFN-GAMMA; MOLECULAR-MECHANISMS; APOPTOTIC CELLS; EFFECTOR-CELLS; CANCER; ACTIVATION	Radiotherapy induces DNA damage and cell death, but recent data suggest that concomitant immune stimulation is an integral part of the therapeutic action of ionizing radiation. It is poorly understood how radiotherapy supports tumor-specific immunity. Here we report that radiotherapy induced tumor cell death and transiently activated complement both in murine and human tumors. The local production of pro-inflammatory anaphylatoxins C3a and C5a was crucial to the tumor response to radiotherapy and concomitant stimulation of tumor-specific immunity. Dexamethasone, a drug frequently given during radiotherapy, limited complement activation and the anti-tumor effects of the immune system. Overall, our findings indicate that anaphylatoxins are key players in radiotherapy-induced tumor-specific immunity and the ensuing clinical responses.	[Surace, Laura; Lysenko, Veronika; Cecconi, Virginia; Bicvic, Antonela; Gupta, Anurag; van den Broek, Maries] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Fontana, Andrea Orlando; Pruschy, Martin] Univ Zurich Hosp, Dept RadioOncol, CH-8091 Zurich, Switzerland; [Janssen, Hans; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands; [Okoniewski, Michal] Swiss Fed Inst Technol, ID Sci IT Serv, CH-8092 Zurich, Switzerland; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Knuth, Alexander] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Netherlands Cancer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	van den Broek, M (corresponding author), Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	vandenbroek@immunology.uzh.ch	Lysenko, Veronika/O-5965-2016; knuth, alexander/H-2608-2014; van den Broek, Maries/L-6532-2019; Neefjes, Jacques J.C./H-8780-2017; van den Broek, Maries/G-4128-2016	Lysenko, Veronika/0000-0002-2011-5070; knuth, alexander/0000-0002-9318-2784; Neefjes, Jacques J.C./0000-0001-6763-2211; Pruschy, Martin/0000-0002-3124-9015; surace, laura/0000-0001-8152-0611; van den Broek, Maries/0000-0002-9489-3692; Bicvic, Antonela/0000-0002-4999-9439; Gupta, Anurag/0000-0001-6850-3489; Fontana, Andrea Orlando/0000-0001-5058-0013	Swiss National Science Foundation (SNSF); Vontobel Foundation Zurich; University Research Priority Program (URPP) "Translational Cancer Research"	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Vontobel Foundation Zurich; University Research Priority Program (URPP) "Translational Cancer Research"	We thank Melody Swartz (EPFL Lausanne, Switzerland) for providing the B16F10-OVA cell line; Jovan Pavlovic (Institute of Medical Virology, University of Zurich) for providing antibodies against JAK and STAT; James Di Santo (Department of Immunology, Institute Pasteur, Paris) for providing anti-NK1.1 antibody; Claudia Matter (Clinic for Oncology, University Hospital Zurich, Switzerland) and Karina Silina (Institute of Experimental Immunology, University of Zurich) for technical assistance; personnel from the Biologisches Zentrallabor (University Hospital of Zurich) for expert animal care; Alessandra Curioni-Fontecedro (Clinic for Oncology, University Hospital of Zurich) for helpful discussion; and Burkhard Becher, Christian Munz, Ali Bransi (Institute of Experimental Immunology, University of Zurich), Sabine Werner (Institute of Cell Biology, ETH, Zurich), Stefano Ferrari (Institute of Molecular Cancer Research, University of Zurich), Mark Robert Nicolls (Department of Medicine, Stanford Medicine), and John Lambris (Department of Pathology, University of Pennsylvania) for scientific support and critically reading the manuscript. This work was financially supported by the Swiss National Science Foundation (SNSF), the Vontobel Foundation Zurich, and the University Research Priority Program (URPP) "Translational Cancer Research."	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Baudino L, 2014, P NATL ACAD SCI USA, V111, P1503, DOI 10.1073/pnas.1316877111; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen GB, 2011, J BIOL CHEM, V286, P34941, DOI 10.1074/jbc.M111.286427; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Elvington M, 2014, CELL REP, V8, P818, DOI 10.1016/j.celrep.2014.06.051; ENGELMAN RM, 1995, ANN THORAC SURG, V60, P801, DOI 10.1016/0003-4975(95)00211-3; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Farrar CA, 2014, CURR OPIN ORGAN TRAN, V19, P8, DOI 10.1097/MOT.0000000000000037; Favaudon V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008973; Formenti SC, 2012, INT J RADIAT ONCOL, V84, P879, DOI 10.1016/j.ijrobp.2012.06.020; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Fukuoka Y, 2013, J IMMUNOL, V191, P1827, DOI 10.4049/jimmunol.1202889; Godau J, 2004, J IMMUNOL, V173, P3437, DOI 10.4049/jimmunol.173.5.3437; Gupta A, 2012, J IMMUNOL, V189, P558, DOI 10.4049/jimmunol.1200563; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hempen C, 2002, SUPPORT CARE CANCER, V10, P322, DOI 10.1007/s00520-001-0333-0; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627; Hughes MA, 2005, INT J RADIAT ONCOL, V62, P1423, DOI 10.1016/j.ijrobp.2004.12.085; Keller AM, 2008, IMMUNITY, V29, P934, DOI 10.1016/j.immuni.2008.10.009; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Li K, 2007, MOL IMMUNOL, V44, P3866, DOI 10.1016/j.molimm.2007.06.006; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Ma YT, 2010, SEMIN IMMUNOL, V22, P113, DOI 10.1016/j.smim.2010.03.001; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Merrick A, 2005, BRIT J CANCER, V92, P1450, DOI 10.1038/sj.bjc.6602518; PACKARD BD, 1983, INFECT IMMUN, V40, P1011, DOI 10.1128/IAI.40.3.1011-1014.1983; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Qing XP, 2012, EUR J IMMUNOL, V42, P1723, DOI 10.1002/eji.201142290; Quartier P, 2005, EUR J IMMUNOL, V35, P252, DOI 10.1002/eji.200425497; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roumenina LT, 2011, J IMMUNOL, V187, P4369, DOI 10.4049/jimmunol.1101749; Schmudde I, 2013, SEMIN IMMUNOL, V25, P2, DOI 10.1016/j.smim.2013.04.009; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma A, 2013, CLIN CANCER RES, V19, P4843, DOI 10.1158/1078-0432.CCR-13-0352; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Sun SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026838; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Verbrugge I, 2014, RADIAT RES, V182, P219, DOI 10.1667/RR13511.1; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298	65	105	110	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					767	777		10.1016/j.immuni.2015.03.009	http://dx.doi.org/10.1016/j.immuni.2015.03.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25888260	Bronze			2022-12-18	WOS:000353347500021
J	Nelson, RW; Beisang, D; Tubo, NJ; Dileepan, T; Wiesner, DL; Nielsen, K; Wuthrich, M; Klein, BS; Kotov, DI; Spanier, JA; Fife, BT; Moon, JJ; Jenkins, MK				Nelson, Ryan W.; Beisang, Daniel; Tubo, Noah J.; Dileepan, Thamotharampillai; Wiesner, Darin L.; Nielsen, Kirsten; Wuethrich, Marcel; Klein, Bruce S.; Kotov, Dmitri I.; Spanier, Justin A.; Fife, Brian T.; Moon, James J.; Jenkins, Marc K.			T Cell Receptor Cross-Reactivity between Similar Foreign and Self Peptides Influences Naive Cell Population Size and Autoimmunity	IMMUNITY			English	Article							CLASS-II; REPERTOIRE DIVERSITY; PRECURSOR FREQUENCY; RESPONSES; EPITOPE; CD4; BINDING; MYELIN; SPECIFICITY; SELECTION	T cell receptor (TCR) cross-reactivity between major histocompatibility complex II (MHCII)-binding self and foreign peptides could influence the naive CD4(+) T cell repertoire and autoimmunity. We found that nonamer peptides that bind to the same MHCII molecule only need to share five amino acids to cross-react on the same TCR. This property was biologically relevant because systemic expression of a self peptide reduced the size of a naive cell population specific for a related foreign peptide by deletion of cells with cross-reactive TCRs. Reciprocally, an incompletely deleted naive T cell population specific for a tissue-restricted self peptide could be triggered by related microbial peptides to cause autoimmunity. Thus, TCR cross-reactivity between similar self and foreign peptides can reduce the size of certain foreign peptide-specific T cell populations and might allow T cell populations specific for tissue-restricted self peptides to cause autoimmunity after infection.	[Nelson, Ryan W.; Tubo, Noah J.; Dileepan, Thamotharampillai; Kotov, Dmitri I.; Spanier, Justin A.; Fife, Brian T.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Nelson, Ryan W.; Beisang, Daniel; Tubo, Noah J.; Dileepan, Thamotharampillai; Wiesner, Darin L.; Nielsen, Kirsten; Kotov, Dmitri I.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Wuethrich, Marcel; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Spanier, Justin A.; Fife, Brian T.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Moon, James J.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02129 USA; [Moon, James J.] Harvard Univ, Sch Med, Boston, MA 02129 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; Fife, Brian/D-2042-2013; moon, james/F-1031-2014	Jenkins, Marc K/0000-0001-8009-7655; Nelson, Ryan/0000-0003-2327-9481; Spanier, Justin/0000-0002-3282-4499; Kotov, Dmitri/0000-0001-7843-1503; Fife, Brian/0000-0001-9826-5637; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996; Nielsen, Kirsten/0000-0002-2318-168X; moon, james/0000-0001-8071-1491	NIH [T32 GM008244, F30 DK093242, UL1 TR000114, R01 AI107020, R01 AI080275, R01 AI105816, R01 AI040996, R01 AI093553, P01 AI035296, R37 AI027998, R01 AI039614, R01 AI103760]; William F. Milton Fund; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027998, U19AI095261, R01AI103760, R01AI093553, R21AI105816, R01AI035681, R01AI040996, R01AI107020, R01AI039614, T32AI007313, R01AI080275, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007203, P30DK043351, F30DK093242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William F. Milton Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Walter and A. Quade for technical assistance, S. McSorley for the Aasf:I-A<SUP>b</SUP>, RplF:I-A<SUP>b</SUP>, and PmpG1:I-A<SUP>b</SUP> tetramers, and all members of the Jenkins Laboratory for helpful discussions. Grants from the NIH (T32 GM008244 and F30 DK093242 to R.W.N., UL1 TR000114 to D. B., R01 AI107020 to J. J. M., R01 AI080275 to K.N., R01 AI105816 and R01 AI040996 to B. S. K., R01 AI093553 to M. W., P01 AI035296 to B. T. F., and R37 AI027998, R01 AI039614, P01 AI035296, and R01 AI103760 to M. K. J.) and the William F. Milton Fund (to J. J. M.) supported this work.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Campion SL, 2014, J EXP MED, V211, P1273, DOI 10.1084/jem.20130555; Chu HH, 2010, J IMMUNOL, V185, P4705, DOI 10.4049/jimmunol.1002276; Cong YZ, 1996, EUR J IMMUNOL, V26, P2587, DOI 10.1002/eji.1830261108; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Flesch IEA, 2010, J IMMUNOL, V184, P45, DOI 10.4049/jimmunol.0900999; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; HOYNE GF, 1994, IMMUNOLOGY, V83, P190; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Legoux F, 2010, J IMMUNOL, V184, P6731, DOI 10.4049/jimmunol.1000295; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Lucca LE, 2014, J IMMUNOL, V193, P3267, DOI 10.4049/jimmunol.1400523; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maybeno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043481; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Painter CA, 2012, IMMUNOL REV, V250, P144, DOI 10.1111/imr.12003; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Sant AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00340; Schmidt J, 2011, J VIROL, V85, P5232, DOI 10.1128/JVI.00093-11; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Stewart-Jones GB, 2012, P NATL ACAD SCI USA, V109, pE3483, DOI 10.1073/pnas.1207896109; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tan ACL, 2011, J IMMUNOL, V187, P1895, DOI 10.4049/jimmunol.1100664; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	51	105	108	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					95	107		10.1016/j.immuni.2014.12.022	http://dx.doi.org/10.1016/j.immuni.2014.12.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25601203	Green Accepted, Bronze			2022-12-18	WOS:000348197500014
J	Dong, ZJ; Davidson, D; Perez-Quintero, LA; Kurosaki, T; Swat, W; Veillette, A				Dong, Zhongjun; Davidson, Dominique; Perez-Quintero, Luis Alberto; Kurosaki, Tomohiro; Swat, Wojciech; Veillette, Andre			The Adaptor SAP Controls NK Cell Activation by Regulating the Enzymes Vav-1 and SHIP-1 and by Enhancing Conjugates with Target Cells	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; NATURAL-KILLER-CELLS; SIGNAL-TRANSDUCTION; GENE-PRODUCT; PHOSPHOLIPASE C-GAMMA-2; CYTOKINE REGULATION; ANTIGEN RECEPTOR; INFECTED-CELLS; KINASE FYN; SLAM	The adaptor SAP, mutated in X-linked lymphoproliferative disease, has critical roles in multiple immune cell types. Among these, SAP is essential for the ability of natural killer (NK) cells to eliminate abnormal hematopoietic cells. Herein, we elucidated the molecular and cellular bases of this activity. SAP enhanced NK cell responsiveness by a dual molecular mechanism. It coupled SLAM family receptors to the kinase Fyn, which triggered the exchange factor Vav-1 and augmented NK cell activation. SAP also prevented the inhibitory function of SLAM family receptors. This effect was Fyn independent and correlated with uncoupling of SLAM family receptors from the lipid phosphatase SHIP-1. Both mechanisms cooperated to enable conjugate formation with target cells and to stimulate cytotoxicity and cytokine secretion by NK cells. These data showed that SAP secures NK cell activation by a dichotomous molecular mechanism, which is required for conjugate formation. These findings may have implications for the role of SAP in other immune cell types.	[Dong, Zhongjun; Davidson, Dominique; Perez-Quintero, Luis Alberto; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Dong, Zhongjun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Perez-Quintero, Luis Alberto; Veillette, Andre] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3G 1Y6, Canada; [Kurosaki, Tomohiro] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Turumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan; [Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Tsinghua University; McGill University; RIKEN; Osaka University; Washington University (WUSTL); Universite de Montreal	Dong, ZJ (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	dongzj@mail.tsinghua.edu.cn; veillea@ircm.qc.ca	Kurosaki, Tomohiro/D-1306-2009; Quintero, Luis Alberto Perez/P-2013-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Quintero, Luis Alberto Perez/0000-0002-7036-8762	Canadian Institutes of Health Research (CIHR); Canadian Cancer Society Research Institute	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We thank S. Latour and M. Cruz for discussions, N. Wu for help with quantitation, and L. Yin for sharing the SAP-deficient mouse. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Cancer Society Research Institute to A.V. Z.D. was recipient of a fellowship from CIHR, and A.V. holds the Canada Research Chair in Signaling in the Immune System and was an International Scholar of the Howard Hughes Medical Institute.	Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; HATA A, 1994, MOL CELL BIOL, V14, P7306, DOI 10.1128/MCB.14.11.7306; Hoffmann SC, 2011, J IMMUNOL, V186, P2757, DOI 10.4049/jimmunol.1002867; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Lowin-Kropf B, 2002, EUR J IMMUNOL, V32, P773, DOI 10.1002/1521-4141(200203)32:3<773::AID-IMMU773>3.0.CO;2-U; Mesecke S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001325; Mikhalap SV, 2004, BLOOD, V104, P4063, DOI 10.1182/blood-2004-04-1273; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Osman MS, 2007, J IMMUNOL, V178, P1261, DOI 10.4049/jimmunol.178.3.1261; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Stewart MP, 1996, J IMMUNOL, V156, P1810; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wahle JA, 2007, J IMMUNOL, V179, P8009, DOI 10.4049/jimmunol.179.12.8009; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	58	105	109	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					974	985		10.1016/j.immuni.2012.03.023	http://dx.doi.org/10.1016/j.immuni.2012.03.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22683124	Bronze			2022-12-18	WOS:000306097100015
J	Zou, Z; Shin, SW; Alvarez, KS; Kokoza, V; Raikhell, AS				Zou, Zhen; Shin, Sang Woon; Alvarez, Kanwal S.; Kokoza, Vladimir; Raikhell, Alexander S.			Distinct Melanization Pathways in the Mosquito Aedes aegypti	IMMUNITY			English	Article							HOLOTRICHIA-DIOMPHALIA LARVAE; PRO-PHENOL-OXIDASE; MANDUCA-SEXTA; ANOPHELES-GAMBIAE; SERINE-PROTEASE; TOLL PATHWAY; PROPHENOLOXIDASE ACTIVATION; PROTEOLYTIC CASCADE; PLASMODIUM-BERGHEI; INNATE IMMUNITY	Serine protease cascades are involved in blood coagulation and immunity. In arthropods, they regulate melanization, which plays an important role in immune defense and wound healing. However, the mechanisms underlying melanization pathways are not completely characterized. We found that in the mosquito Aedes aegypti, there are two distinct melanization activation pathways carried out by different modules of serine proteases and their specific inhibitors serpins. Immune melanization proteases (IMP-1 and IMP-2) and Serpin-1 mediate hemolymph prophenoloxidase cleavage and immune response against the malaria parasite. Tissue melanization, exemplified by the formation of melanotic tumors, is controlled by tissue melanization protease (CLIPB8), IMP-1, and Serpin-2. In addition, serine proteases CLIPB5 and CLIPB29 are involved in activation of Toll pathway by fungal infection or by infection-independent manner, respectively. Serpin-2 is implicated in the latter activation of Toll pathway. This study revealed the complexity underlying melanization and Toll pathway in mosquitoes.	[Zou, Zhen; Shin, Sang Woon; Alvarez, Kanwal S.; Kokoza, Vladimir; Raikhell, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Zou, Zhen; Shin, Sang Woon; Alvarez, Kanwal S.; Kokoza, Vladimir; Raikhell, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Shin, SW (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	sang.shin@ucr.edu; alexander.raikhel@ucr.edu	Alvarez, Kanwal/AAQ-6451-2020; zou, zhen/C-6134-2016	zou, zhen/0000-0003-3550-7656; Shin, Sang Woon/0000-0001-9467-0803	NIH/NIAID [RO1 AI059492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059492] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Jiang for helpful suggestions in preparing the manuscript. This work was supported by NIH/NIAID grant RO1 AI059492.	Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; ASPIN A, 1995, P NATL ACAD SCI USA, V92, P939; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; Hillyer JF, 2005, J HISTOCHEM CYTOCHEM, V53, P689, DOI 10.1369/jhc.4A6564.2005; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wagenaar-Bos IGA, 2006, IMMUNOL ALLERGY CLIN, V26, P615, DOI 10.1016/j.iac.2006.08.004; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	48	105	118	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					41	53		10.1016/j.immuni.2009.11.011	http://dx.doi.org/10.1016/j.immuni.2009.11.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152169	Bronze			2022-12-18	WOS:000274119900010
J	Green, RS; Stone, EL; Tenno, M; Lehtonen, E; Farquhar, MG; Marth, JD				Green, Ryan S.; Stone, Erica L.; Tenno, Mari; Lehtonen, Eero; Farquhar, Marilyn G.; Marth, Jamey D.			Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis	IMMUNITY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; BONE-MARROW-TRANSPLANTATION; MANNAN-BINDING LECTINS; TOTAL-BODY IRRADIATION; ALPHA-MANNOSIDASE-II; ANEMIA TYPE-II; MICE DEFICIENT; IN-VIVO; RECEPTOR; EXPRESSION	Autoimmune diseases are prevalent and often life-threatening syndromes, yet the pathogenic triggers and mechanisms involved remain mostly unresolved. Protein asparagine linked(N-) glycosylation produces glycan structures that substantially differ among the extracellular compartments of evolutionarily divergent organisms. Alpha-mannosidase-II (alpha M-II) deficiency diminishes complex-type N-glycan branching in vertebrates and induces an autoimmune disease in mice similar to human systemic lupus erythematosus. We found that disease pathogenesis provoking glomerulonephritis and kidney failure was nonhematopoietic in origin, independent of complement C3 and the adaptive immune system, mitigated by intravenous administration of immunoglobulin-G, and linked to chronic activation of the innate immune system. N-glycans produced in alpha M-II deficiency bear immune-stimulatory mannose-dependent ligands for innate immune lectin receptors, disrupting the phylogenic basis of this glycomic recognition mechanism. Thus, mammalian N-glycan branching safeguards against the formation of an endogenous immunologic signal of nonself that can provoke a sterile inflammatory response in the pathogenesis of autoimmune disease.	Univ Calif San Diego, Dept Cell & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif San Diego, Dept Cell & Mol Med, La Jolla, CA 92093 USA.	jmarth@ucsd.edu	Lehtonen, Eero/AGJ-4027-2022	Lehtonen, Eero/0000-0002-8218-635X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017724, R01DK048247, R01DK017724] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48247, DK17724] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; DOWN JD, 1991, BLOOD, V77, P661; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FORTIER AH, 1994, CURRENT PROTOCOLS IM; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Hasegawa H, 2003, ARTHRITIS RHEUM, V48, P2555, DOI 10.1002/art.11231; Ikehara S, 1998, ACTA HAEMATOL-BASEL, V99, P116, DOI 10.1159/000040826; Iolascon A, 1997, BLOOD, V90, P4197, DOI 10.1182/blood.V90.10.4197; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jorgensen TN, 2004, CURR OPIN IMMUNOL, V16, P787, DOI 10.1016/j.coi.2004.09.013; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kim HL, 2002, AM J KIDNEY DIS, V40, P1146, DOI 10.1053/ajkd.2002.36858; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lanzara C, 2003, BLOOD CELL MOL DIS, V30, P22, DOI 10.1016/S1079-9796(03)00009-3; LARGEN PJ, 1995, EXP NEPHROL, V3, P34; Lauwerys B, 2005, LUPUS, V14, P2, DOI 10.1191/0961203305lu2052oa; Liu H, 2001, SCAND J IMMUNOL, V53, P489, DOI 10.1046/j.1365-3083.2001.00908.x; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Oates JC, 2006, CLIN IMMUNOL, V121, P243, DOI 10.1016/j.clim.2006.06.001; Ott VL, 2001, J ALLERGY CLIN IMMUN, V108, pS95, DOI 10.1067/mai.2001.117822; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; ROVIN BH, 1994, LAB INVEST, V71, P536; ROY DC, 1990, BLOOD, V75, P296; SASTRY R, 1995, MAMM GENOME, V6, P103, DOI 10.1007/BF00303252; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; SHEPHERD VL, 1985, J BIOL CHEM, V260, P160; Sherer Y, 2006, AUTOIMMUN REV, V5, P153, DOI 10.1016/j.autrev.2005.09.002; Shimizu S, 2004, RHEUMATOLOGY, V43, P1121, DOI 10.1093/rheumatology/keh277; STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; TACHTMAN H, 2004, SEMIN NEPHROL, V24, P324; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; VARKL A, 1980, J BIOL CHEM, V225, P10847; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zoja C, 1997, J AM SOC NEPHROL, V8, P720	53	105	109	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					308	320		10.1016/j.immuni.2007.06.008	http://dx.doi.org/10.1016/j.immuni.2007.06.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17681821	Bronze, Green Published			2022-12-18	WOS:000249056300016
J	Oliver, PM; Cao, X; Worthen, GS; Shi, PJ; Briones, N; MacLeod, M; White, J; Kirby, P; Kappler, J; Marrack, P; Yang, BL				Oliver, Paula M.; Cao, Xiao; Scott Worthen, George; Shi, Peijun; Briones, Natalie; MacLeod, Megan; White, Janice; Kirby, Patricia; Kappler, John; Marrack, Philippa; Yang, Baoli			Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation	IMMUNITY			English	Article							EPITHELIAL NA+ CHANNEL; WW DOMAINS; AIRWAY INFLAMMATION; IN-VIVO; NEDD4; TARGET; FAMILY; IDENTIFICATION; MICE; PHOSPHORYLATION	Nedd4 family interacting protein-1 (Ndfip1) is a protein whose only known function is that it binds Nedd4, a HECT-type E3 ubiquitin ligase. Here we show that mice lacking Ndfip1 developed severe inflammation of the skin and lung and died prematurely. This condition was due to a defect in Ndfip1(-/-) T cells. Ndfip1(-/-) cells were activated, and they proliferated and adopted a T helper 2 (Th2) phenotype more readily than did their Ndfip1(+/+) counterparts. This phenotype resembled that of Itchy mutant mice, suggesting that Ndfip1 might affect the function of Itch, an E3 ubiquitin ligase. We show that T cell activation promoted both Ndfip1 expression and its association with Itch. In the absence of Ndfip1, JunB half-life was prolonged after T cell activation. Thus, in the absence of Ndfip1, Itch is inactive and JunB accumulates. As a result, T cells produce Th2 cytokines and promote Th2-mediated inflammatory disease.	Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA	University of Iowa; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Yang, BL (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA.	baoli-yang@uiowa.edu	Marrack, Philippa/AHE-6316-2022	BRIONES, NATALIE/0000-0002-8342-9552; MacLeod, Megan/0000-0003-1843-8580; Marrack, Philippa/0000-0003-1883-3687	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI052225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK052617] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL105834] Funding Source: Medline; NIAID NIH HHS [R01 AI052225, AI-52225, P01 AI022295, AI-22295] Funding Source: Medline; NIDDK NIH HHS [P50 DK052617-100007, P50 DK52617, P50 DK052617] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; DELPRETE G, 1992, ALLERGY, V47, P450; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Heissmeyer Vigo, 2005, Novartis Found Symp, V267, P165; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; HUSTAD CM, 1995, GENETICS, V140, P255; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kurakin A, 2002, J BIOMOL STRUCT DYN, V19, P1015, DOI 10.1080/07391102.2002.10506805; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu PJ, 1999, NATURE, V399, P784; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; RICCI M, 1994, J INVEST ALLERG CLIN, V4, P214; ROMAGNANI S, 1991, INT ARCH ALLER A IMM, V94, P133, DOI 10.1159/000235344; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schaefer BC, 2001, ANAL BIOCHEM, V297, P86, DOI 10.1006/abio.2001.5327; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858	45	105	113	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					929	940		10.1016/j.immuni.2006.10.012	http://dx.doi.org/10.1016/j.immuni.2006.10.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17137798	Bronze, Green Accepted			2022-12-18	WOS:000243087500012
J	Rivera, A; Ro, G; Van Epps, HL; Simpson, T; Leiner, I; Sant'Angelo, DB; Pamer, EG				Rivera, Amariliz; Ro, Grace; Van Epps, Heather L.; Simpson, Tyler; Leiner, Ingrid; Sant'Angelo, Derek B.; Pamer, Eric G.			Innate immune activation and CD4(+) T cell priming during respiratory fungal infection	IMMUNITY			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; MYELOID DIFFERENTIATION FACTOR-88; IFN-GAMMA PRODUCTION; TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNITY; FUMIGATUS CONIDIA; DENDRITIC CELLS; IN-VIVO; MICE; MYD88	Aspergillus fumigatus is a mold that causes a spectrum of diseases, including lethal lung infections in immunocompromised humans and allergic asthma in atopic individuals. T helper 1 (Th1) CD4(+)T cells protect against invasive A. fumigatus infections whereas Th2 CD4(+) T cells exacerbate asthma upon inhalation of A. fumigatus spores. Herein, we demonstrate that A. fumigatus-specific T cells were rapidly primed in lymph nodes draining the lung and fully differentiated into interferon-gamma (IFN-gamma)-producing Th1 CD4(+) T cells upon arrival in the airways. T-bet induction in A. fumigatus-specific CD4(+) T cells was enhanced by MyD88-mediated signals in draining lymph nodes, but T cell proliferation, trafficking, and Th1 differentiation in the airways were Toll-like receptor (TLR) and MyD88 independent. Our studies demonstrate that CD4(+) T cell differentiation during respiratory fungal infection occurs incrementally, with TLR-mediated signals in the lymph node enhancing the potential for IFN-gamma production whereas MyD88-independent signals promote Th1 differentiation in the lung.	Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Program Immunol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Program Immunol, 1275 York Ave,Box 9, New York, NY 10021 USA.	pamere@mskcc.org			NATIONAL CANCER INSTITUTE [K01CA117914] Funding Source: NIH RePORTER; NCI NIH HHS [CA09149, K01 CA117914-01A1] Funding Source: Medline; NIAID NIH HHS [R01-AI0677359] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Blease K, 2001, J IMMUNOL, V167, P6583, DOI 10.4049/jimmunol.167.11.6583; Cenci E, 1997, INFECT IMMUN, V65, P564, DOI 10.1128/IAI.65.2.564-570.1997; Cenci E, 2000, J IMMUNOL, V165, P381, DOI 10.4049/jimmunol.165.1.381; Cockrill BA, 1999, ANNU REV MED, V50, P303, DOI 10.1146/annurev.med.50.1.303; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Drennan MB, 2005, J IMMUNOL, V175, P2501, DOI 10.4049/jimmunol.175.4.2501; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; GOODLEY JM, 1994, J HOSP INFECT, V26, P27, DOI 10.1016/0195-6701(94)90076-0; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hogaboam CM, 2005, MED MYCOL, V43, pS197, DOI 10.1080/13693780400025211; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Kursar M, 2004, INT IMMUNOL, V16, P415, DOI 10.1093/intimm/dxh047; Kurup VP, 1997, ALLERGY, V52, P1215, DOI 10.1111/j.1398-9995.1997.tb02526.x; Lambrecht BN, 2000, CLIN EXP ALLERGY, V30, P214; Latge JP, 2002, CURR OPIN MICROBIOL, V5, P355, DOI 10.1016/S1369-5274(02)00343-0; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marr KA, 2003, INFECT IMMUN, V71, P5280, DOI 10.1128/IAI.71.9.5280-5286.2003; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Mencacci A, 2001, BLOOD, V97, P1483, DOI 10.1182/blood.V97.5.1483; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Perruccio K, 2005, BLOOD, V106, P4397, DOI 10.1182/blood-2005-05-1775; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Rivera A, 2005, INFECT IMMUN, V73, P7170, DOI 10.1128/IAI.73.11.7170-7179.2005; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Van Epps HL, 2003, ANTIMICROB AGENTS CH, V47, P1818, DOI 10.1128/AAC.47.6.1818-1823.2003; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730	51	105	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					665	675		10.1016/j.immuni.2006.08.016	http://dx.doi.org/10.1016/j.immuni.2006.08.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17027299	Bronze			2022-12-18	WOS:000241481500017
J	Vilcek, J				Vilcek, Jan			Fifty years of interferon research: Aiming at a moving target	IMMUNITY			English	Editorial Material							DOUBLE-STRANDED-RNA; SYSTEMIC LUPUS-ERYTHEMATOSUS; HUMAN FIBROBLAST INTERFERON; HUMAN-LEUKOCYTE INTERFERON; TOLL-LIKE RECEPTORS; LISTERIA-MONOCYTOGENES; AUTOIMMUNE-DISEASES; POSITIVE FEEDBACK; RIG-I; ALPHA	Nearly half a century has passed since the first published description of interferons (IFNs). This commentary introduces the four accompanying review articles on type I IFN research and attempts to relate how the field of IFN research has been changing during its history.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Vilcek, J (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1St Ave, New York, NY 10016 USA.	jan.vilcek@med.nyu.edu						AGUET M, 1982, VIROLOGY, V117, P541, DOI 10.1016/0042-6822(82)90497-4; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BRANCA AA, 1981, NATURE, V294, P768, DOI 10.1038/294768a0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; FRIEDMAN RM, 1967, SCIENCE, V156, P1760, DOI 10.1126/science.156.3783.1760; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; GRESSER I, 1975, NATURE, V258, P76, DOI 10.1038/258076a0; GRESSER I, 1969, P NATL ACAD SCI USA, V63, P51, DOI 10.1073/pnas.63.1.51; HAVELL EA, 1975, P NATL ACAD SCI USA, V72, P2185, DOI 10.1073/pnas.72.6.2185; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; HO M, 1964, SCIENCE, V146, P1472, DOI 10.1126/science.146.3650.1472; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HOOKS JJ, 1982, ARTHRITIS RHEUM, V25, P396, DOI 10.1002/art.1780250406; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KERR IM, 1974, NATURE, V250, P57, DOI 10.1038/250057a0; KLEINSCHMIDT WJ, 1964, P NATL ACAD SCI USA, V52, P741, DOI 10.1073/pnas.52.3.741; KNIGHT E, 1980, SCIENCE, V207, P525, DOI 10.1126/science.7352259; LEBLEU B, 1976, P NATL ACAD SCI USA, V73, P3107, DOI 10.1073/pnas.73.9.3107; LINDAHL P, 1976, P NATL ACAD SCI USA, V73, P1284, DOI 10.1073/pnas.73.4.1284; LINDAHL P, 1972, P NATL ACAD SCI USA, V69, P721, DOI 10.1073/pnas.69.3.721; LOCKART RZ, 1973, INTERFERONS INTERFER, P11; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MERIGAN T C, 1973, Lancet, V1, P563; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; PAUCKER K, 1962, VIROLOGY, V17, P324, DOI 10.1016/0042-6822(62)90123-X; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; RIVIERE Y, 1977, P NATL ACAD SCI USA, V74, P2135, DOI 10.1073/pnas.74.5.2135; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SKURKOVICH SV, 1975, ANN ALLERGY, V35, P356; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stewart W, 1979, INTERFERON SYSTEM; STINEBRING WR, 1964, NATURE, V204, P712, DOI 10.1038/204712a0; SUELTENFUSS EA, 1962, SCIENCE, V139, P595; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; TANIGUCHI T, 1979, P JPN ACAD B-PHYS, V55, P464, DOI 10.2183/pjab.55.464; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VILCEK J, 1984, PROG MED VIROL, V30, P62; VILCEK J, 1970, ARCH INTERN MED, V126, P69, DOI 10.1001/archinte.126.1.69; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; ZOON KC, 1980, SCIENCE, V207, P527, DOI 10.1126/science.7352260	63	105	118	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					343	348		10.1016/j.immuni.2006.08.008	http://dx.doi.org/10.1016/j.immuni.2006.08.008			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979566	Bronze			2022-12-18	WOS:000240862200001
J	Moita, LF; Wang-Sattler, R; Michel, K; Zimmermann, T; Blandin, S; Levashina, EA; Kafatos, FC				Moita, LF; Wang-Sattler, R; Michel, K; Zimmermann, T; Blandin, S; Levashina, EA; Kafatos, FC			In vivo identification of novel regulators and conserved pathways of phagocytosis in A-gambiae	IMMUNITY			English	Article							MOSQUITO ANOPHELES-GAMBIAE; COMPLEMENT-LIKE PROTEIN; CELL CORPSE ENGULFMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; IMMUNE-RESPONSE; DROSOPHILA; RECEPTOR; GENES	Anopheles gambiae uses effective immune responses, including phagocytosis, to fight microbial infection. We have developed a semiquantitative phagocytosis test and used it in conjunction with dsRNA gene silencing to test the in vivo roles of 71 candidate genes in phagocytosis of Escherichia coli and Staphylococcus aureus. Here, we show that inactivation of 26 genes changes the phagocytic activity by more than 45% and that two pathways similar to those that mediate apoptotic cell removal in Caenorhabditis elegans are used in A. gambiae for phagocytosis of microorganisms. Simultaneous inactivation of the identified regulators of phagocytosis and conserved components defining each signaling pathway permitted provisional assignment of the novel regulators to one or the other pathway. Pathway inactivation enhances at least three times the ability of E. coli and S. aureus to proliferate in the mosquito. Interestingly, mosquito survival is not compromised even if both pathways are perturbed simultaneously.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Moita, LF (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	lferreiramoita@partners.org; f.kafatos@imperial.ac.uk	Blandin, Stephanie/I-2786-2016; Moita, Luis F./L-1296-2013; Blandin, Stephanie/ABH-2267-2021; Michel, Kristin/F-3400-2011; Moita, Luis/HCI-2793-2022; Wang-Sattler, Rui/B-5354-2014	Blandin, Stephanie/0000-0003-4566-1200; Moita, Luis F./0000-0003-0707-315X; Blandin, Stephanie/0000-0003-4566-1200; Moita, Luis/0000-0003-0707-315X; Wang-Sattler, Rui/0000-0002-8794-8229; Levashina, Elena/0000-0003-4605-906X				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; ELLIS RE, 1991, GENETICS, V129, P79; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; FOLEY E, 2004, PLOS BIOL, V2; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 2001, CELL DEATH DIFFER, V8, P564, DOI 10.1038/sj.cdd.4400850; Guy GR, 2002, CELL SIGNAL, V14, P11, DOI 10.1016/S0898-6568(01)00227-3; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; Kuang B, 2000, DEVELOPMENT, V127, P1517; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vizioli J, 2001, INSECT BIOCHEM MOLEC, V31, P241, DOI 10.1016/S0965-1748(00)00143-0; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	37	105	110	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2005	23	1					65	73		10.1016/j.immuni.2005.05.006	http://dx.doi.org/10.1016/j.immuni.2005.05.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039580	Bronze			2022-12-18	WOS:000231024800009
J	West, AP; Herr, AB; Bjorkman, PJ				West, AP; Herr, AB; Bjorkman, PJ			The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A(2) receptor homolog	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYSTEINE-RICH DOMAIN; I-RELATED RECEPTOR; CRYSTAL-STRUCTURE; MANNOSE RECEPTOR; MAMMARY-GLAND; SEDIMENTATION-VELOCITY; SECRETORY COMPONENT; MEMBRANE-RECEPTOR; HUMAN PLACENTA	In mammals, IgG is transferred from mother to young by the MHC-related receptor FcRn, which binds IgG in acidic endosomes and releases it at basic pH into blood. Maternal IgY, the avian counterpart of IgG, is transferred to embryos across yolk sac membranes. We affinity-purified the chicken yolk sac IgY receptor (FcRY) and sequenced its gene. FcRY is unrelated to MHC molecules but is a homolog of the mammalian phospholipase A(2) receptor. Analytical ultracentrifugation and truncation experiments suggest that FcRY forms a compact structure containing an IgY binding site at acidic pH but undergoes a conformational change at basic pH that disrupts the site. FcRY is thus unrelated to mammalian FcRn in both its structure and mechanism for pH-dependent binding, illustrating distinct routes utilized by evolution to transfer antibodies.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	NIAID NIH HHS [2 R01 AI041239-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041239] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adamski FM, 2000, MOL IMMUNOL, V37, P435, DOI 10.1016/S0161-5890(00)00065-1; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cianga P, 1999, EUR J IMMUNOL, V29, P2515, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2515::AID-IMMU2515&gt;3.0.CO;2-D; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; GUILLEMOT F, 1989, TRENDS GENET, V5, P300, DOI 10.1016/0168-9525(89)90112-1; Hanasaki K, 1999, ARCH BIOCHEM BIOPHYS, V372, P215, DOI 10.1006/abbi.1999.1511; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kacskovics I, 2000, J IMMUNOL, V164, P1889, DOI 10.4049/jimmunol.164.4.1889; Karaca K, 1997, HYBRIDOMA, V16, P545, DOI 10.1089/hyb.1997.16.545; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Leach JL, 1996, J IMMUNOL, V157, P3317; LINDEN CD, 1978, J CELL SCI, V33, P317; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mayer B, 2002, IMMUNOLOGY, V107, P288, DOI 10.1046/j.1365-2567.2002.01514.x; Mohammed SM, 1998, IMMUNOTECHNOLOGY, V4, P115, DOI 10.1016/S1380-2933(98)00013-X; Morrison SL, 2002, MOL IMMUNOL, V38, P619, DOI 10.1016/S0161-5890(01)00095-5; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; PARVARI R, 1988, EMBO J, V7, P739, DOI 10.1002/j.1460-2075.1988.tb02870.x; PEPPARD JV, 1986, EUR J IMMUNOL, V16, P225, DOI 10.1002/eji.1830160303; RIVERACALZADA A, 2003, 4 EMBO, P807; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; Schnulle PM, 2003, VET IMMUNOL IMMUNOP, V91, P227, DOI 10.1016/S0165-2427(02)00294-5; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Tanford C., 1961, PHYS CHEM MACROMOLEC; TRESSLER RL, 1987, J BIOL CHEM, V262, P15406; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; WIELAND WH, 2004, IN PRESS BIOCH J; [No title captured]	53	105	109	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					601	610		10.1016/S1074-7613(04)00113-X	http://dx.doi.org/10.1016/S1074-7613(04)00113-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142528	Bronze			2022-12-18	WOS:000221631900010
J	Park, BY; Kim, YK; Shin, JW; Lee, S; Cho, KM; Fruh, K; Lee, S; Ahn, KS				Park, BY; Kim, YK; Shin, JW; Lee, S; Cho, KM; Fruh, K; Lee, S; Ahn, KS			Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion	IMMUNITY			English	Article							CELL-LINE .220; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; HEAVY-CHAINS; SURFACE EXPRESSION; REVEALS POLYMORPHISM; QUALITY-CONTROL; E3/19K PROTEIN; LUMINAL DOMAIN; CUTTING EDGE	The immune evasion protein US3 of human cytomegalovirus binds to and arrests MHC class I molecules in the endoplasmic reticulum (ER). However, substantial amounts of class I molecules still escape US3-mediated ER retention, suggesting that not all class I alleles are affected equally by US3. Here, we identify tapasin inhibition as the mechanism of MHC retention by US3. US3 directly binds tapasin and inhibits tapasin-dependent peptide loading, thereby preventing the optimization of the peptide repertoire presented by class I molecules. Due to the allelic specificity of tapasin toward class I molecules, US3 affects only class I alleles that are dependent on tapasin for peptide loading and surface expression. Accordingly, tapasin-independent class I alleles selectively escape to the cell surface.	Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; Oregon Hlth Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA	Korea University; Oregon Health & Science University	Ahn, KS (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea.	ksahn@korea.ac.kr	Lee, Sungwook/K-3697-2013	CHO, KWANGMIN/0000-0001-6764-1425; Frueh, Klaus/0000-0001-8014-3877				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; BEIER DC, 1994, J IMMUNOL, V152, P3862; Beissbarth T, 2000, EUR J IMMUNOL, V30, P1203, DOI 10.1002/(SICI)1521-4141(200004)30:4<1203::AID-IMMU1203>3.0.CO;2-L; Bennett EM, 1999, J IMMUNOL, V162, P5049; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURGERT HG, 1987, EMBO J, V6, P2019, DOI 10.1002/j.1460-2075.1987.tb02466.x; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dedier S, 2000, J BIOL CHEM, V275, P27055; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; FRUH K, 1992, J BIOL CHEM, V267, P22131; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Gruhler A, 2000, TRAFFIC, V1, P318, DOI 10.1034/j.1600-0854.2000.010405.x; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Jun Y, 2000, J IMMUNOL, V164, P805, DOI 10.4049/jimmunol.164.2.805; Lee S, 2003, J VIROL, V77, P2147, DOI 10.1128/JVI.77.3.2147-2156.2003; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Machold RP, 1997, J EXP MED, V185, P363, DOI 10.1084/jem.185.2.363; Neisig A, 1996, J IMMUNOL, V156, P3196; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Park B, 2003, J BIOL CHEM, V278, P14337, DOI 10.1074/jbc.M212882200; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	50	105	108	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					71	85		10.1016/S1074-7613(03)00355-8	http://dx.doi.org/10.1016/S1074-7613(03)00355-8			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738766	Bronze			2022-12-18	WOS:000221442200008
J	Blanchard, N; Di Bartolo, V; Hivroz, C				Blanchard, N; Di Bartolo, V; Hivroz, C			In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; TOXIC LYMPHOCYTES-T; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; TARGET-CELLS; CYTOSKELETAL POLARIZATION; PKC-THETA; ACTIVATION; RECEPTOR; MEMBRANE	Recognition by T cells of their ligands at the surface of antigen-presenting cells (APCs) leads to T cell activation, polarization of the T cell toward the APC, and formation of an immune synapse. Using ZAP-70-deficient T cells expressing zeta-GFP, we show that ZAP-70 signaling drives the TCR-dependent reorientation of the microtubule-organizing center thus leading to relocation of a zeta-GFP(+) intracellular compartment close to the APC. ZAP-70 is also necessary to supply the synapse with the signaling molecules PKC-theta and LAT. In contrast, ZAP-70 is not required for clustering of zeta-GFP and CD2 or exclusion of CD45 and CD43 from the synapse. These data show that ZAP-70-dependent signaling is required for formation of a functional immune synapse.	Inst Curie, INSERM, U520, F-75005 Paris, France; Inst Pasteur, Mol Immunol Unit, F-75724 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hivroz, C (corresponding author), Inst Curie, INSERM, U520, 12 Rue Lhomond, F-75005 Paris, France.		Di Bartolo, Vincenzo/AAL-6834-2020; Blanchard, Nicolas/AAD-6601-2020; Hivroz, Claire/H-2711-2014; Blanchard, Nicolas/I-5255-2014	Di Bartolo, Vincenzo/0000-0002-5453-947X; Blanchard, Nicolas/0000-0002-4924-2161; Hivroz, Claire/0000-0002-6794-2890; Blanchard, Nicolas/0000-0002-4924-2161				Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Donnadieu E, 2001, J IMMUNOL, V166, P5540, DOI 10.4049/jimmunol.166.9.5540; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; HIVROZ C, 1994, CURR BIOL, V4, P731, DOI 10.1016/S0960-9822(00)00162-7; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1984, J IMMUNOL, V133, P2762; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Meinl E, 2000, J IMMUNOL, V165, P3578, DOI 10.4049/jimmunol.165.7.3578; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; RYSER JE, 1982, J IMMUNOL, V128, P1159; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	49	105	107	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					389	399		10.1016/S1074-7613(02)00421-1	http://dx.doi.org/10.1016/S1074-7613(02)00421-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387734	Bronze			2022-12-18	WOS:000178667100001
J	Nelms, KA; Goodnow, CC				Nelms, KA; Goodnow, CC			Genome-wide ENU mutagenesis to reveal immune regulators	IMMUNITY			English	Review							ETHYLNITROSOUREA MUTAGENESIS; MOUSE SPERMATOGONIA; LOCUS TEST; T-REGION; B-CELLS; GENE; DROSOPHILA; MUTATIONS; TOLERANCE; MUTANT	A complete list of molecular components for immune system function is now available with the completion of the human and mouse genome sequences. However, identification and functional annotation of genes involved in immunological processes require a discovery methodology that can efficiently and broadly analyze the complex interplay of these components in vivo. Our recent experience indicates that genome-wide chemical mutagenesis in the mouse is an extremely powerful methodology for the identification of genes required for complex immunological processes.	John Curtin Sch Med Res, Med Genome Ctr, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Nelms, KA (corresponding author), John Curtin Sch Med Res, Med Genome Ctr, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				BODE VC, 1988, GENETICS, V118, P299; BODE VC, 1984, GENETICS, V108, P457; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; FAVOR J, 1991, MUTAT RES, V249, P293, DOI 10.1016/0027-5107(91)90003-7; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Glynne RJ, 2000, CURR OPIN IMMUNOL, V12, P210, DOI 10.1016/S0952-7915(99)00076-X; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; HARDING CO, 1992, P NATL ACAD SCI USA, V89, P2644, DOI 10.1073/pnas.89.7.2644; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Klopp N, 1998, GENOMICS, V52, P152, DOI 10.1006/geno.1998.5417; LEWIS SE, 1991, MUTAT RES, V249, P311, DOI 10.1016/0027-5107(91)90005-9; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RINCHIK EM, 1990, P NATL ACAD SCI USA, V87, P896, DOI 10.1073/pnas.87.3.896; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Townsend SE, 2001, J IMMUNOL METHODS, V249, P137, DOI 10.1016/S0022-1759(00)00352-5; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	35	105	107	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		409	418		10.1016/S1074-7613(01)00199-6	http://dx.doi.org/10.1016/S1074-7613(01)00199-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567631	Bronze			2022-12-18	WOS:000171211800008
J	Spiliotis, ET; Osorio, M; Zuniga, MC; Edidin, M				Spiliotis, ET; Osorio, M; Zuniga, MC; Edidin, M			Selective export of MHC class I molecules from the ER after their dissociation from TAP	IMMUNITY			English	Article							INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; ANTIGEN PRESENTATION; BINDING; ASSOCIATION; COMPLEXES; CALNEXIN; GLYCOPROTEIN; TRAFFICKING	It has been assumed that upon dissociation from TAP, MHC class I molecules exit the ER by nonselective bulk flow. We now show that exit must occur by association with cargo receptors. Inconsistent with exit by bulk flow, loading of MHC class I molecules with high-affinity peptides triggers dissociation from TAP but has no effect on rates of ER-to-Golgi transport. Moreover, peptide-loaded MHC class I molecules accumulate at ER exit sites from which TAP molecules are excluded. Consistent with receptor-mediated exit, ER-to-Golgi transport of MHC class I molecules is independent of their cytoplasmic tails, which themselves lack ER export motifs. In addition, we show that MHC class I molecules associate with the putative cargo receptor BAP31.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA	Johns Hopkins University; University of California System; University of California Santa Cruz	Edidin, M (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	edidin@jhu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014584, R01AI014584] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14584] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BECK JC, 1986, J IMMUNOL, V137, P916; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; CAPPS GG, 1993, J BIOL CHEM, V268, P21263; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GRANT B, 1998, JAVA REP, V3, P6; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1; Kulig K, 1998, J EXP MED, V187, P865, DOI 10.1084/jem.187.6.865; Lewis SE, 1996, MOL HUM REPROD, V2, P873, DOI 10.1093/molehr/2.11.873; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; MACHOLD RP, 1995, J EXP MED, V181, P1111, DOI 10.1084/jem.181.3.1111; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Neisig A, 1998, J IMMUNOL, V160, P171; Ng FWH, 1998, J BIOL CHEM, V273, P3140, DOI 10.1074/jbc.273.6.3140; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; OZATO K, 1980, J IMMUNOL, V124, P533; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Shugrue CA, 1999, J CELL SCI, V112, P4547; SOLHEIM JC, 1993, J IMMUNOL, V151, P5387; Stephens DJ, 2000, J CELL SCI, V113, P2177; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Udaka K, 1996, J IMMUNOL, V157, P670; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; WILLIAMS DB, 1985, J CELL BIOL, V101, P725, DOI 10.1083/jcb.101.3.725; WILLIAMS DB, 1988, J BIOL CHEM, V263, P4549; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; ZUNIGA MC, 1983, CELL, V34, P535, DOI 10.1016/0092-8674(83)90386-0	46	105	107	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2000	13	6					841	851		10.1016/S1074-7613(00)00081-9	http://dx.doi.org/10.1016/S1074-7613(00)00081-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163199	Bronze			2022-12-18	WOS:000166142300009
J	Wang, RK; Zhang, Q; Ge, JW; Ren, WL; Zhang, R; Lan, J; Ju, B; Su, B; Yu, FT; Chen, P; Liao, HY; Feng, YM; Li, XM; Shi, XL; Zhang, Z; Zhang, FJ; Ding, Q; Zhang, T; Wang, XQ; Zhang, LQ				Wang, Ruoke; Zhang, Qi; Ge, Jiwan; Ren, Wenlin; Zhang, Rui; Lan, Jun; Ju, Bin; Su, Bin; Yu, Fengting; Chen, Peng; Liao, Huiyu; Feng, Yingmei; Li, Xuemei; Shi, Xuanling; Zhang, Zheng; Zhang, Fujie; Ding, Qiang; Zhang, Tong; Wang, Xinquan; Zhang, Linqi			Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species	IMMUNITY			English	Article							COCKTAIL; SYSTEM; BRAZIL	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge during the global pandemic and may facilitate escape from current antibody therapies and vaccine protection. Here we showed that the South African variant B.1.351 was the most resistant to current monoclonal antibodies and convalescent plasma from coronavirus disease 2019 (COVID-19)-infected individuals, followed by the Brazilian variant P.1 and the United Kingdom variant B.1.1.7. This resistance hierarchy corresponded with Y144del and 242-244del mutations in the N-terminal domain and K417N/T, E484K, and N501Y mutations in the receptor-binding domain (RBD) of SARS-CoV-2. Crystal structure analysis of the B.1.351 triple mutant (417N-484K-501Y) RBD complexed with the monoclonal antibody P2C-1F11 revealed the molecular basis for antibody neutralization and escape. B.1.351 and P.1 also acquired the ability to use mouse and mink ACE2 receptors for entry. Our results demonstrate major antigenic shifts and potential broadening of the host range for B.1.351 and P.1 variants, which poses serious challenges to current antibody therapies and vaccine protection.	[Wang, Ruoke; Zhang, Qi; Zhang, Rui; Chen, Peng; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, NexVac Res Ctr, Comprehens AIDS Res Ctr,Sch Med, Ctr Infect Dis Res,Beijing Adv Innovat Ctr Struct, Beijing 100084, Peoples R China; [Wang, Ruoke] Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Ge, Jiwan; Lan, Jun; Wang, Xinquan] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol,Key Lab Prot, Beijing Frontier Res Ctr Biol Struct,Minist Educ, Collaborat Innovat Ctr Biotherapy,Sch Life Sci, Beijing 100084, Peoples R China; [Ren, Wenlin; Ding, Qiang] Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing 100084, Peoples R China; [Ren, Wenlin; Ding, Qiang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Ju, Bin; Zhang, Zheng] Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Inst Hepatol, Shenzhen 518112, Guangdong, Peoples R China; [Ju, Bin; Zhang, Zheng] Southern Univ Sci & Technol, Affiliated Hosp 2, Sch Med, Shenzhen 518112, Guangdong, Peoples R China; [Su, Bin; Liao, Huiyu; Feng, Yingmei; Li, Xuemei; Zhang, Tong] Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China; [Yu, Fengting; Zhang, Fujie] Capital Med Univ, Beijing Ditan Hosp, Clin & Res Ctr Infect Dis, 8 Jing Shun Dong Jie, Chaoyang 100015, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Inst Biopharmaceut & Hlth Engn, Shenzhen 518055, Peoples R China; [Zhang, Linqi] Inst Biomed Hlth Technol & Engn, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Southern University of Science & Technology; Southern University of Science & Technology; Capital Medical University; Capital Medical University; Tsinghua University; Shenzhen Bay Laboratory	Zhang, LQ (corresponding author), Tsinghua Univ, NexVac Res Ctr, Comprehens AIDS Res Ctr,Sch Med, Ctr Infect Dis Res,Beijing Adv Innovat Ctr Struct, Beijing 100084, Peoples R China.; Wang, XQ (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol,Key Lab Prot, Beijing Frontier Res Ctr Biol Struct,Minist Educ, Collaborat Innovat Ctr Biotherapy,Sch Life Sci, Beijing 100084, Peoples R China.; Zhang, T (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Inst Biopharmaceut & Hlth Engn, Shenzhen 518055, Peoples R China.; Zhang, LQ (corresponding author), Inst Biomed Hlth Technol & Engn, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China.	zt_doc@ccmu.edu.cn; xinquanwang@mail.tsinghua.edu.cn; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; Zhang, Tong/HGC-1090-2022	Chen, Peng/0000-0002-9041-8392	National Key Plan for Scientific Research and Development of China [2020YFC0848800, 2020YFC0849900]; National Natural Science Foundation [81530065, 91442127, 32000661]; Beijing Municipal Science and Technology Commission [D171100000517, Z201100005420019]; Science and Technology Innovation Committee of Shenzhen Municipality [202002073000002]; COVID-19 Science and Technology Project of Beijing Hospitals Authority [YGZX-C1]; Beijing Advanced Innovation Center for Structural Biology; Tsinghua University Scientific Research Program [20201080053, 2020Z99CFG004]; Tencent Foundation; Shuidi Foundation; National Science Fund for Distinguished Young Scholars [82025022]; China Postdoctoral Science Foundation [2020T130062ZX]; TH Capital	National Key Plan for Scientific Research and Development of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Science and Technology Innovation Committee of Shenzhen Municipality; COVID-19 Science and Technology Project of Beijing Hospitals Authority; Beijing Advanced Innovation Center for Structural Biology; Tsinghua University Scientific Research Program; Tencent Foundation; Shuidi Foundation; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); TH Capital	We acknowledge the work and contributions of all health care providers from Beijing Youan Hospital, Beijing Ditan Hospital, and Shenzhen Third People's Hospital. We also thank affected individuals for their active participation. This study was supported by the National Key Plan for Scientific Research and Development of China (2020YFC0848800 and 2020YFC0849900), the National Natural Science Foundation (81530065, 91442127, and 32000661), the Beijing Municipal Science and Technology Commission (D171100000517 and Z201100005420019), and the Science and Technology Innovation Committee of Shenzhen Municipality (202002073000002). It is also supported by funds from the COVID-19 Science and Technology Project of Beijing Hospitals Authority (YGZX-C1), the Beijing Advanced Innovation Center for Structural Biology, the Tsinghua University Scientific Research Program (20201080053 and 2020Z99CFG004), the Tencent Foundation, the Shuidi Foundation, the TH Capital and the National Science Fund for Distinguished Young Scholars (82025022), and the China Postdoctoral Science Foundation (2020T130062ZX). The funders had no role in study design, data collection, analysis, and interpretation or writing of the report. We thank the SSRF BL17U1 beamline for data collection and processing.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Callaway E, 2021, NATURE, V589, P500, DOI 10.1038/d41586-021-00121-z; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; CERUTTI G, 2021, BIORXIV; Chan KK, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abf1738, 10.1101/2020.10.18.344622]; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Du S, 2020, CELL, V183, P1013, DOI 10.1016/j.cell.2020.09.035; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujino T, 2021, EMERG INFECT DIS, V27, P1243, DOI 10.3201/eid2704.210138; Ge JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20501-9; GISAID, 2021, COVID 19 VIR GEN AN; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hou Yixuan J, 2020, bioRxiv, DOI 10.1101/2020.09.28.317685; Huang BY, 2021, LANCET MICROBE, V2, pE285, DOI 10.1016/S2666-5247(21)00082-3; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Johnson & Johnson, 2021, JOHNS JOHNS COVID 19; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kupferschmidt K, 2021, SCIENCE, V371, P9, DOI 10.1126/science.371.6524.9; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Liu YH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025373118; Maggi F, 2021, EMERG INFECT DIS, V27, P1249, DOI 10.3201/eid2704.210183; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munnink Bas B. Oude, 2021, Science (Washington D C), V371, P172, DOI 10.1126/science.abe5901; Novavax, 2021, NOV COVID 19 VACC DE; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, 2020, INV NOV SARS COV 2 V, V5; Rathnasinghe Raveen, 2021, medRxiv, DOI 10.1101/2021.01.19.21249592; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sun S., 2020, CHARACTERIZATION STR, DOI 10.1101/2020.11.10.377333; Suryadevara Naveenchandra, 2021, bioRxiv, DOI [10.1016/j.cell.2021.03.029, 10.1101/2021.01.19.427324]; Tegally H, 2021, NAT MED, V27, P440, DOI 10.1038/s41591-021-01255-3; Tian F., 2021, MUTATION N501Y RBD S, DOI [10.1101/2021.02.14.431117, DOI 10.1101/2021.02.14.431117]; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Wang Pengfei, 2021, bioRxiv, DOI 10.1101/2021.01.25.428137; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Wu SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17972-1; Xia SL, 2021, LANCET INFECT DIS, V21, P39, DOI 10.1016/S1473-3099(20)30831-8; Yu F, 2019, J APPL CRYSTALLOGR, V52, P472, DOI 10.1107/S1600576719001183; Yuan Meng, 2021, bioRxiv, DOI [10.1126/science.abh1139, 10.1101/2021.02.16.430500]; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	67	104	106	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1611	+		10.1016/j.immuni.2021.06.003	http://dx.doi.org/10.1016/j.immuni.2021.06.003		JUL 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34166623	Bronze, Green Published			2022-12-18	WOS:000672812100021
J	Madore, C; Yin, ZR; Leibowitz, J; Butovsky, O				Madore, Charlotte; Yin, Zhuoran; Leibowitz, Jeffrey; Butovsky, Oleg			Microglia, Lifestyle Stress, and Neurodegeneration	IMMUNITY			English	Review							CHAIN FATTY-ACIDS; INTESTINAL BACTERIAL OVERGROWTH; AMYOTROPHIC-LATERAL-SCLEROSIS; LOW-GRADE INFLAMMATION; ALZHEIMERS-DISEASE; GUT-MICROBIOTA; APOLIPOPROTEIN-E; AMYLOID-BETA; MEDITERRANEAN DIET; MULTIPLE-SCLEROSIS	Recent years have witnessed a revolution in our understanding of microglia biology, including their major role in the etiology and pathogenesis of neurodegenerative diseases. Technological advances have enabled the identification of microglial signatures in health and disease, including the development of new models to investigate and manipulate human microglia in vivo in the context of disease. In parallel, genetic association studies have identified several gene risk factors associated with Alzheimer's disease that are specifically or highly expressed by microglia in the central nervous system (CNS). Here, we discuss evidence for the effect of stress, diet, sleep patterns, physical activity, and microbiota composition on microglia biology and consider how lifestyle might influence an individual's predisposition to neurodegenerative diseases. We discuss how different lifestyles and environmental factors might regulate microglia, potentially leading to increased susceptibility to neurodegenerative disease, and we highlight the need to investigate the contribution of modern environmental factors on microglia modulation in neurodegeneration.	[Madore, Charlotte; Yin, Zhuoran; Leibowitz, Jeffrey; Butovsky, Oleg] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Butovsky, Oleg] Harvard Med Sch, Evergrande Ctr Immunol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Butovsky, O (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA.; Butovsky, O (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA.	obutovsky@rics.bwh.harvard.edu	Stefanadis, Christodoulos/ABH-2232-2020; Madore, Charlotte/AAK-8735-2021; Butovsky, Oleg/ABG-9086-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Madore, Charlotte/0000-0002-0704-6496; Butovsky, Oleg/0000-0003-0186-8867	NIH National Institute of Neurological Disorders and Stroke [R01 NS088137, R21 NS104609, R21 NS101673]; National Institute on Aging (NIA) [R01 AG051812, R01 AG054672]; National Eye Institute [R01 EY027921]; National Multiple Sclerosis Society [5092A1]; National Health and Medical Research Council Australia [RG180378]; Nancy Davis Foundation Faculty Award; Cure Alzheimer's Fund Award; Amyotrophic Lateral Sclerosis Association; Sanofi	NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Nancy Davis Foundation Faculty Award; Cure Alzheimer's Fund Award; Amyotrophic Lateral Sclerosis Association; Sanofi	O.B. is supported by the NIH National Institute of Neurological Disorders and Stroke (R01 NS088137, R21 NS104609, and R21 NS101673), National Institute on Aging (NIA; R01 AG051812 and R01 AG054672), and National Eye Institute (R01 EY027921); the National Multiple Sclerosis Society (5092A1); National Health and Medical Research Council Australia (RG180378); a Nancy Davis Foundation Faculty Award; a Cure Alzheimer's Fund Award; the Amyotrophic Lateral Sclerosis Association; and Sanofi.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Alkadhi KA, 2015, MOL NEUROBIOL, V52, P93, DOI 10.1007/s12035-014-8839-x; Alkadhi Karim A, 2012, Front Biosci (Elite Ed), V4, P214; Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Altmeppen HC, 2013, FEBS J, V280, P4338, DOI 10.1111/febs.12196; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Uranga JA, 2016, PHARMACOL REP, V68, P816, DOI 10.1016/j.pharep.2016.05.002; Baldy C, 2018, EXP PHYSIOL, V103, P1192, DOI 10.1113/EP087088; Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Banqueri M, 2019, STRESS, V22, P563, DOI 10.1080/10253890.2019.1604666; Barrientos RM, 2011, J NEUROSCI, V31, P11578, DOI 10.1523/JNEUROSCI.2266-11.2011; Bartels C, 2018, AM J PSYCHIAT, V175, P232, DOI 10.1176/appi.ajp.2017.17040404; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bisht K, 2018, NEUROBIOL STRESS, V9, P9, DOI 10.1016/j.ynstr.2018.05.003; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Blacher E, 2019, NATURE, V572, P474, DOI 10.1038/s41586-019-1443-5; Bonanni L, 2018, J ALZHEIMERS DIS, V63, P203, DOI 10.3233/JAD-171134; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brown BM, 2016, SLEEP, V39, P1063, DOI 10.5665/sleep.5756; Brown DG, 2019, ELIFE, V8, DOI 10.7554/eLife.47117; Buettner D, 2016, AM J LIFESTYLE MED, V10, P318, DOI 10.1177/1559827616637066; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001; Caraci F, 2018, PHARMACOL RES, V130, P374, DOI 10.1016/j.phrs.2018.02.007; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Carson R, 2016, STEROIDS, V114, P25, DOI 10.1016/j.steroids.2016.05.012; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chen WW, 2016, BIOMED REP, V4, P403, DOI 10.3892/br.2016.607; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; Chuang YF, 2016, MOL PSYCHIATR, V21, P910, DOI 10.1038/mp.2015.129; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cope EC, 2018, J NEUROSCI, V38, P8889, DOI 10.1523/JNEUROSCI.0789-18.2018; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cowan CSM, 2019, DEV COGN NEUROS-NETH, V37, DOI 10.1016/j.dcn.2019.100627; Cronin P, 2017, ALZHEIMERS DEMENT, V13, P689, DOI 10.1016/j.jalz.2016.10.003; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; da Silva SG, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-61; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davis C, 2015, NUTRIENTS, V7, P9139, DOI 10.3390/nu7115459; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Delpech JC, 2016, BRAIN BEHAV IMMUN, V57, P79, DOI 10.1016/j.bbi.2016.06.006; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dodiya HB, 2019, J EXP MED, V216, P1542, DOI 10.1084/jem.20182386; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; DRASAR BS, 1973, P NUTR SOC, V32, P49, DOI 10.1079/PNS19730014; Duffy JF, 2015, SLEEP MED CLIN, V10, P423, DOI 10.1016/j.jsmc.2015.08.002; Dumaine JE, 2015, AM J PHYSIOL-REG I, V308, pR1062, DOI 10.1152/ajpregu.00049.2015; Eidson LN, 2019, BRAIN BEHAV IMMUN, V81, P305, DOI 10.1016/j.bbi.2019.06.027; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fasano A, 2013, MOVEMENT DISORD, V28, P1241, DOI 10.1002/mds.25522; Fastame MC, 2015, AGING MENT HEALTH, V19, P698, DOI 10.1080/13607863.2014.962003; Fastame MC, 2014, AGING MENT HEALTH, V18, P648, DOI 10.1080/13607863.2013.866635; Fastame MC, 2014, PSYCHOL HEALTH MED, V19, P127, DOI 10.1080/13548506.2013.802360; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Fernandes NC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0553-3; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2016, PSYCHONEUROENDOCRINO, V66, P82, DOI 10.1016/j.psyneuen.2016.01.006; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Forsythe P, 2014, ADV EXP MED BIOL, V817, P115, DOI 10.1007/978-1-4939-0897-4_5; Fox M, 2013, J ALZHEIMERS DIS, V37, P809, DOI 10.3233/JAD-130152; Frank MG, 2014, PSYCHONEUROENDOCRINO, V40, P191, DOI 10.1016/j.psyneuen.2013.11.006; Frank MG, 2012, BRAIN BEHAV IMMUN, V26, P337, DOI 10.1016/j.bbi.2011.10.005; Frasch MG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0567-x; Frenkel D, 2008, ANN NEUROL, V63, P591, DOI 10.1002/ana.21340; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Galli G, 2012, OBES SURG, V22, P1276, DOI 10.1007/s11695-012-0669-1; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Gomez-Gonzalez B, 2010, ACTA NEUROPATHOL, V119, P303, DOI 10.1007/s00401-009-0590-4; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gracia-Garcia P, 2015, AM J GERIAT PSYCHIAT, V23, P119, DOI 10.1016/j.jagp.2013.02.011; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802; Hayashi Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02744; Hechler C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40434-8; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Ho L, 2018, EXPERT REV NEUROTHER, V18, P83, DOI 10.1080/14737175.2018.1400909; Hoeijmakers L, 2018, NEUROBIOL STRESS, V8, P172, DOI 10.1016/j.ynstr.2018.02.003; Hoeijmakers L, 2017, BRAIN BEHAV IMMUN, V63, P160, DOI 10.1016/j.bbi.2016.12.023; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hori H, 2019, PSYCHIAT CLIN NEUROS, V73, P143, DOI 10.1111/pcn.12820; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jagust W, 2016, BRAIN, V139, P23, DOI 10.1093/brain/awv326; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Joers V, 2017, PROG NEUROBIOL, V155, P57, DOI 10.1016/j.pneurobio.2016.04.006; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Joshi YB, 2012, J ALZHEIMERS DIS, V31, P167, DOI 10.3233/JAD-2012-120328; Joutsa J, 2017, JAMA NEUROL, V74, P583, DOI 10.1001/jamaneurol.2016.6091; Kaczmarczyk R, 2018, J NEUROCHEM, V146, P76, DOI 10.1111/jnc.14284; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kaplan C, 2001, TRANSFUS CLIN BIOL, V8, P311, DOI 10.1016/S1246-7820(01)00114-8; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Katsumoto A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00978; Kelly Aine M, 2018, Brain Plast, V4, P81, DOI 10.3233/BPL-180074; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kohman RA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-114; Koloverou E, 2016, DIABETES-METAB RES, V32, P73, DOI 10.1002/dmrr.2672; Kosmidou M, 2017, J NEUROL, V264, P254, DOI 10.1007/s00415-016-8340-8; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Leal LG, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01307; Lee HD, 2015, J NEUROSCI, V35, P11034, DOI 10.1523/JNEUROSCI.1625-15.2015; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leem YH, 2011, BIOCHEM BIOPH RES CO, V406, P359, DOI 10.1016/j.bbrc.2011.02.046; Lehmann ML, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0672-x; LEVINE SZ, 1951, AMA AM J DIS CHILD, V82, P236; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin LY, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0107-2; Lineweaver TT, 2014, AM J PSYCHIAT, V171, P201, DOI 10.1176/appi.ajp.2013.12121590; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lund H, 2018, NAT IMMUNOL, V19, P435, DOI 10.1038/s41590-018-0091-5; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mailing LJ, 2019, EXERC SPORT SCI REV, V47, P75, DOI 10.1249/JES.0000000000000183; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Maurer M, 2003, AM J PHYSIOL-RENAL, V284, pF32, DOI 10.1152/ajprenal.00212.2002; Mazur-Bialy AI, 2017, J PHYSIOL PHARMACOL, V68, P243; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Meneses G, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0140-5; Merrill DA, 2011, NEUROBIOL AGING, V32, P151, DOI 10.1016/j.neurobiolaging.2009.01.014; Metz LM, 2017, NEW ENGL J MED, V377, P789, DOI 10.1056/NEJMc1708486; Meyer JS, 2014, ILAR J, V55, P347, DOI 10.1093/ilar/ilu023; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Miner B, 2017, SLEEP MED CLIN, V12, P31, DOI 10.1016/j.jsmc.2016.10.008; Minter MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11047-w; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Moser VA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0077-17.2017; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Musiek ES, 2018, JAMA NEUROL, V75, P582, DOI 10.1001/jamaneurol.2017.4719; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nelson AM, 2007, J ADV NURS, V60, P29, DOI 10.1111/j.1365-2648.2007.04373.x; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nguyen ND, 2013, SLEEP, V36, P1051, DOI 10.5665/sleep.2808; Nievase BGP, 2011, J NEUROCHEM, V116, P43, DOI 10.1111/j.1471-4159.2010.07083.x; Nimgampalle M, 2017, J CLIN DIAGN RES, V11, pKC1, DOI 10.7860/JCDR/2017/26106.10428; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Ortega E, 2016, J PHYSIOL BIOCHEM, V72, P361, DOI 10.1007/s13105-016-0478-4; Peavy GM, 2007, BIOL PSYCHIAT, V62, P472, DOI 10.1016/j.biopsych.2007.03.013; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Pes GM, 2013, NUTR METAB CARDIOVAS, V23, P212, DOI 10.1016/j.numecd.2011.05.004; Phan TX, 2019, NEUROBIOL STRESS, V10, DOI 10.1016/j.ynstr.2018.10.001; Pires GN, 2016, SLEEP MED, V23, P109, DOI 10.1016/j.sleep.2016.07.019; Pistollato F, 2018, PHARMACOL RES, V131, P32, DOI 10.1016/j.phrs.2018.03.012; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Lima MGP, 2018, P NATL ACAD SCI USA, V115, pE2403, DOI 10.1073/pnas.1718435115; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Procaccini C, 2016, METABOLISM, V65, P1376, DOI [10.1016/j.metabol.2016.05.018, 10.1016/j.metabol]; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Ramanan Vijay K, 2013, Am J Neurodegener Dis, V2, P145; Ramirez K, 2016, BRAIN BEHAV IMMUN, V51, P154, DOI 10.1016/j.bbi.2015.08.011; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; REDDY BS, 1975, J NUTR, V105, P878, DOI 10.1093/jn/105.7.878; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rietdijk CD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00037; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Roque A, 2016, BRAIN BEHAV IMMUN, V55, P39, DOI 10.1016/j.bbi.2015.09.017; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Rothman SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.005; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Rowin J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13443; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Smith GC, 2011, ANN NEUROL, V70, P541, DOI 10.1002/ana.22545; Smith TE, 1997, PHYSIOL BEHAV, V62, P225, DOI 10.1016/S0031-9384(97)00103-0; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Sprecher KE, 2015, NEUROBIOL AGING, V36, P2568, DOI 10.1016/j.neurobiolaging.2015.05.004; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Srivareerat M, 2009, BIOL PSYCHIAT, V65, P918, DOI 10.1016/j.biopsych.2008.08.021; Stein DJ, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00207; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun MF, 2018, BRAIN BEHAV IMMUN, V70, P48, DOI 10.1016/j.bbi.2018.02.005; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Svensson M, 2015, NEUROREHAB NEURAL RE, V29, P577, DOI 10.1177/1545968314562108; SWAAB DF, 1994, J NEUROENDOCRINOL, V6, P681, DOI 10.1111/j.1365-2826.1994.tb00635.x; Tabuchi M, 2015, CURR BIOL, V25, P702, DOI 10.1016/j.cub.2015.01.016; Takayama F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30006; Tan AH, 2014, PARKINSONISM RELAT D, V20, P535, DOI 10.1016/j.parkreldis.2014.02.019; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tankou SK, 2018, MULT SCLER J, V24, P58, DOI 10.1177/1352458517737390; Tapia-Rojas C, 2016, BRAIN PATHOL, V26, P62, DOI 10.1111/bpa.12255; Tay TL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0584-3; Tay TL, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00421; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Tilg H, 2015, GASTROENTEROLOGY, V148, P1107, DOI 10.1053/j.gastro.2014.12.036; Tong LJ, 2017, NEUROCHEM RES, V42, P2698, DOI 10.1007/s11064-017-2270-4; Tremlett H, 2016, EUR J NEUROL, V23, P1308, DOI 10.1111/ene.13026; Tremlett H, 2018, MULT SCLER J, V24, P64, DOI 10.1177/1352458517737369; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Ulrich JD, 2016, ACS CHEM NEUROSCI, V7, P420, DOI 10.1021/acschemneuro.5b00313; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; van de Rest O, 2015, ADV NUTR, V6, P154, DOI 10.3945/an.114.007617; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Vaughn AC, 2017, ACTA NEUROBIOL EXP, V77, P18; Vogt NM, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0451-2; Vyas S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6391686; Wadhwa M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0998-z; Wadhwa M, 2017, J NEUROIMMUNOL, V312, P38, DOI 10.1016/j.jneuroim.2017.09.003; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu SP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12356; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu HX, 2016, J NEUROSCI, V36, P9041, DOI 10.1523/JNEUROSCI.1023-16.2016; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Zhang L, 2017, J ALZHEIMERS DIS, V60, P1241, DOI 10.3233/JAD-170020; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang YG, 2017, CLIN THER, V39, P322, DOI 10.1016/j.clinthera.2016.12.014; Zhou CN, 2019, J COMP NEUROL, V527, P1378, DOI 10.1002/cne.24616; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	294	104	111	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					222	240		10.1016/j.immuni.2019.12.003	http://dx.doi.org/10.1016/j.immuni.2019.12.003			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	KN8FZ	31924476	Bronze, Green Accepted			2022-12-18	WOS:000515082000008
J	Jain, R; Chen, Y; Kanno, Y; Joyce-Shaikh, B; Vahedi, G; Hirahara, K; Blumenschein, WM; Sukumar, S; Haines, CJ; Sadekova, S; McClanahan, TK; McGeachy, MJ; O'Shea, JJ; Cua, DJ				Jain, Renu; Chen, Yi; Kanno, Yuka; Joyce-Shaikh, Barbara; Vahedi, Golnaz; Hirahara, Kiyoshi; Blumenschein, Wendy M.; Sukumar, Selvakumar; Haines, Christopher J.; Sadekova, Svetlana; McClanahan, Terrill K.; McGeachy, Mandy J.; O'Shea, John J.; Cua, Daniel J.			Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells	IMMUNITY			English	Article							CYTOKINE GM-CSF; T(H)17 CELLS; TGF-BETA; TH17 CELLS; DIFFERENTIATION; GENERATION; RECEPTOR; IL-23; CONTRIBUTES; HOMEOSTASIS	Interleukin-23 (IL-23) is a pro-inflammatory cytokine required for the pathogenicity of T helper 17 (Th17) cells but the molecular mechanisms governing this process remain unclear. We identified the transcription factor Blimp-1 (Prdm1) as a key IL-23-induced factor that drove the inflammatory function of Th17 cells. In contrast to thymic deletion of Blimp-1, which causes T cell development defects and spontaneous autoimmunity, peripheral deletion of this transcription factor resulted in reduced Th17 activation and reduced severity of autoimmune encephalomyelitis. Furthermore, genome-wide occupancy and overexpression studies in Th17 cells revealed that Blimp-1 co-localized with transcription factors ROR gamma t, STAT-3, and p300 at the Il23r, Il17a/f, and Csf2 cytokine loci to enhance their expression. Blimp-1 also directly bound to and repressed cytokine loci Il2 and Bcl6. Taken together, our results demonstrate that Blimp-1 is an essential transcription factor downstream of IL-23 that acts in concert with RORgt to activate the Th17 inflammatory program.	[Jain, Renu; Chen, Yi; Joyce-Shaikh, Barbara; Blumenschein, Wendy M.; Sukumar, Selvakumar; Haines, Christopher J.; Sadekova, Svetlana; McClanahan, Terrill K.; McGeachy, Mandy J.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Kanno, Yuka; Vahedi, Golnaz; Hirahara, Kiyoshi; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Cua, DJ (corresponding author), Merck Res Labs, 901 Calif Ave, Palo Alto, CA 94304 USA.	daniel.cua@merck.com	Hirahara, Kiyoshi/E-2460-2017; Kanno, Yuka/B-5802-2013	Hirahara, Kiyoshi/0000-0002-9128-9449; Kanno, Yuka/0000-0001-5668-9319	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lin MH, 2013, DIABETOLOGIA, V56, P136, DOI 10.1007/s00125-012-2722-y; Lin MH, 2014, CLIN IMMUNOL, V151, P101, DOI 10.1016/j.clim.2014.02.006; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salehi S, 2012, J IMMUNOL, V189, P5682, DOI 10.4049/jimmunol.1201966; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319	36	104	110	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					131	142		10.1016/j.immuni.2015.11.009	http://dx.doi.org/10.1016/j.immuni.2015.11.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26750311	Bronze			2022-12-18	WOS:000368347000018
J	Ebert, A; McManus, S; Tagoh, H; Medvedovic, J; Salvagiotto, G; Novatchkova, M; Tamir, I; Sommer, A; Jaritz, M; Busslinger, M				Ebert, Anja; McManus, Shane; Tagoh, Hiromi; Medvedovic, Jasna; Salvagiotto, Giorgia; Novatchkova, Maria; Tamir, Ido; Sommer, Andreas; Jaritz, Markus; Busslinger, Meinrad			The Distal V-H Gene Cluster of the Igh Locus Contains Distinct Regulatory Elements with Pax5 Transcription Factor-Dependent Activity in Pro-B Cells	IMMUNITY			English	Article							HEAVY-CHAIN LOCUS; IMMUNOGLOBULIN LOCI; DJ RECOMBINATION; DNA-BINDING; CTCF; CHROMATIN; ACTIVATION; REGION; BSAP; REARRANGEMENTS	V-H-DJ(H) recombination of the immunoglobulin heavy chain (Igh) locus is temporally and spatially controlled during early B cell development, and yet no regulatory elements other than the V-H gene promoters have been identified throughout the entire VH gene cluster. Here, we discovered regulatory sequences that are interspersed in the distal VH gene region. These conserved repeat elements were characterized by the presence of Rax5 transcription factor-dependent active chromatin by binding of the regulators Pax5, E2A, CTCF, and Rad21, as well as by Pax5-dependent antisense transcription in pro-B cells. The Pax5-activated intergenic repeat (PAIR) elements were no longer bound by Pax5 in pre-B and B cells consistent with the loss of antisense transcription, whereas E2A and CTCF interacted with PAIR elements throughout early B cell development. The pro-B cell-specific and Pax5-dependent activity of the PAIR elements suggests that they are involved in the regulation of distal V-H-DJ(H) recombination at the Igh locus.	[Ebert, Anja; McManus, Shane; Tagoh, Hiromi; Medvedovic, Jasna; Salvagiotto, Giorgia; Novatchkova, Maria; Tamir, Ido; Sommer, Andreas; Jaritz, Markus; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Tagoh, Hiromi] Univ Leeds, Leeds Inst Mol Med, Sect Expt Haematol, Leeds LS9 7TF, W Yorkshire, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Leeds	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Busslinger, Meinrad J./J-1249-2016; Tagoh, Hiromi/B-2954-2009	Busslinger, Meinrad J./0000-0002-9111-9351; Sommer, Andreas/0000-0003-0456-1940; Jaritz, Markus/0000-0002-9326-2047; Medvedovic, Jasna/0000-0003-0483-4128; Tagoh, Hiromi/0000-0001-9905-6992	Boehringer Ingelheim; Bundesminsterium fur Bildung und Wissenschaf; European Union; Research Council UK; Yorkshire Cancer Research	Boehringer Ingelheim(Boehringer Ingelheim); Bundesminsterium fur Bildung und Wissenschaf; European Union(European Commission); Research Council UK(UK Research & Innovation (UKRI)); Yorkshire Cancer Research	We thank T. Jenuwein for providing the H3K27me3 antibody, M. Fuxa for the antisense V<INF>H</INF>J558 transcript analysis, and G. Stengl and G. SchmauB for FACS sorting. This research was supported by Boehringer Ingelheim, the Austrian GEN-AU initiative (financed by the Bundesminsterium fur Bildung und Wissenschaft), the European Union Sixth Framework Programme FP6 (funding the EuTRACC project), and grants from the Research Council UK and Yorkshire Cancer Research (to H.T.). A.E. was the recipient of a long-term EMBO fellowship.	ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tagoh H, 2006, METH MOL B, V325, P285; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	43	104	119	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					175	187		10.1016/j.immuni.2011.02.005	http://dx.doi.org/10.1016/j.immuni.2011.02.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349430	Bronze			2022-12-18	WOS:000287989500008
J	Elo, LL; Jarvenpaa, H; Tuomela, S; Raghav, S; Ahlfors, H; Laurila, K; Gupta, B; Lund, RJ; Tahvanainen, J; Hawkins, RD; Oresic, M; Lahdesmaki, H; Rasool, O; Rao, KV; Aittokallio, T; Lahesmaa, R				Elo, Laura L.; Jarvenpaa, Henna; Tuomela, Soile; Raghav, Sunil; Ahlfors, Helena; Laurila, Kirsti; Gupta, Bhawna; Lund, Riikka J.; Tahvanainen, Johanna; Hawkins, R. David; Oresic, Matej; Lahdesmaki, Harri; Rasool, Omid; Rao, Kanury V.; Aittokallio, Tero; Lahesmaa, Riitta			Genome-wide Profiling of Interleukin-4 and STAT6 Transcription Factor Regulation of Human Th2 Cell Programming	IMMUNITY			English	Article							IL-1 RECEPTOR ANTAGONIST; GENE-EXPRESSION; CUTTING EDGE; INDISPENSABLE ROLE; DIFFERENTIATION; PROTEIN; BINDING; IDENTIFICATION; ASSOCIATION; MECHANISMS	Dissecting the molecular mechanisms by which T helper (Th) cells differentiate to effector Th2 cells is important for understanding the pathogenesis of immune-mediated diseases, such as asthma and allergy. Because the STAT6 transcription factor is an upstream mediator required for interleukin-4 (IL-4)-induced Th2 cell differentiation, its targets include genes important for this process. Using primary human CD4(+) T cells, and by blocking STAT6 with RNAi, we identified a number of direct and indirect targets of STAT6 with ChIP sequencing. The integration of these data sets with detailed kinetics of IL-4-driven transcriptional changes showed that STAT6 was predominantly needed for the activation of transcription leading to the Th2 cell phenotype. This integrated genome-wide data on IL-4- and STAT6-mediated transcription provide a unique resource for studies on Th cell differentiation and, in particular, for designing interventions of human Th2 cell responses.	[Elo, Laura L.; Jarvenpaa, Henna; Tuomela, Soile; Raghav, Sunil; Ahlfors, Helena; Gupta, Bhawna; Lund, Riikka J.; Tahvanainen, Johanna; Rasool, Omid; Aittokallio, Tero; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FI-20521 Turku, Finland; [Elo, Laura L.; Jarvenpaa, Henna; Tuomela, Soile; Raghav, Sunil; Ahlfors, Helena; Gupta, Bhawna; Lund, Riikka J.; Tahvanainen, Johanna; Rasool, Omid; Aittokallio, Tero; Lahesmaa, Riitta] Abo Akad Univ, FI-20521 Turku, Finland; [Elo, Laura L.; Aittokallio, Tero] Univ Turku, Dept Math, Biomath Res Grp, FI-20014 Turku, Finland; [Jarvenpaa, Henna; Tuomela, Soile] Turku Grad Sch Biomed Sci, FI-20520 Turku, Finland; [Ahlfors, Helena] Abo Akad Univ, Natl Grad Sch Informat & Struct Biol, FI-20520 Turku, Finland; [Laurila, Kirsti; Lahdesmaki, Harri] Tampere Univ Technol, Dept Signal Proc, FI-33101 Tampere, Finland; [Lund, Riikka J.] Univ Sheffield, Dept Biol Sci, Sheffield S10 2TN, S Yorkshire, England; [Tahvanainen, Johanna] Univ Turku, Drug Discovery Grad Sch, FI-20014 Turku, Finland; [Hawkins, R. David] Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92037 USA; [Oresic, Matej] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, FI-02015 Helsinki, Finland; [Rao, Kanury V.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Lahesmaa, Riitta] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	University of Turku; Abo Akademi University; University of Turku; University of Turku; Abo Akademi University; Tampere University; University of Sheffield; University of Turku; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; VTT Technical Research Center Finland; Aalto University; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lahesmaa, R (corresponding author), Univ Turku, Turku Ctr Biotechnol, POB 123, FI-20521 Turku, Finland.	riitta.lahesmaa@btk.fi	Aittokallio, Tero/B-6583-2009; Lund, Riikka/AAW-7853-2020; Lund, Riikka J/F-7320-2014; Raghav, Sunil/AAL-1121-2021; Lund, Riikka/K-2441-2019; Oresic, Matej/K-7673-2016; Elo, Laura/A-9449-2015; Oresic, Matej/AAV-3978-2020	Aittokallio, Tero/0000-0002-0886-9769; Lund, Riikka/0000-0002-1068-5918; Oresic, Matej/0000-0002-2856-9165; Elo, Laura/0000-0001-5648-4532; Ahlfors, Helena/0000-0002-8183-0895	Academy of Finland [77773, 203725, 207490, 116639, 115939, 123864, 126063, 127575, 120569]; European Commission [EC-FP7-SYBILLA-201106, EC-FP7-NANOMMUNE-214281, EC-FP7-DIABIMMUNE-202063]; CIMO/Sitra; Sigrid Juselius Foundation; Department of Biotechnology, Government of India; Turku University Hospital	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); CIMO/Sitra; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Turku University Hospital	We thank the technical personnel for assistance; the staff of the Finnish Microarray and Sequencing Centre, Turku, Finland for microarray hybridizations; all voluntary blood donors; the personnel of Turku University Hospital Department of Obstetrics and Gynaecology, Maternity Ward (Hospital District of Southwest Finland) for the sample collection; and A. Rao for the critical reading of the manuscript. The work was supported by the Academy of Finland (grants 77773, 203725, 207490, 116639, 115939, 123864, 126063, 127575 [L.L.E.], and 120569 [TA.]), the European Commission Seventh Framework grants (EC-FP7-SYBILLA-201106, EC-FP7-NANOMMUNE-214281 and EC-FP7-DIABIMMUNE-202063), CIMO/Sitra grant (S.R. and R.L.), The Sigrid Juselius Foundation (R.L. and K.V.R.), The Department of Biotechnology, Government of India (K.V.R), and Turku University Hospital Grant.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Agrawal B, 2005, INT IMMUNOL, V17, P391, DOI 10.1093/intimm/dxh219; Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Buttner C, 2004, J CELL PHYSIOL, V198, P248, DOI 10.1002/jcp.10395; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Filen JJ, 2009, MOL CELL PROTEOMICS, V8, P32, DOI 10.1074/mcp.M800139-MCP200; Gabay C, 1999, BLOOD, V93, P1299, DOI 10.1182/blood.V93.4.1299.404k26_1299_1307; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Hamalainen H, 2001, GENOME BIOL, V2; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Kim SH, 2006, CLIN IMMUNOL, V118, P250, DOI 10.1016/j.clim.2003.10.002; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; McGaha TL, 2003, ARTHRITIS RHEUM-US, V48, P2275, DOI 10.1002/art.11089; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nagai S, 2001, INT IMMUNOL, V13, P367, DOI 10.1093/intimm/13.3.367; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Ohmori Y, 1996, J IMMUNOL, V157, P2058; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; Takatori H, 2005, J IMMUNOL, V174, P3734, DOI 10.4049/jimmunol.174.6.3734; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang SM, 2000, J IMMUNOL, V165, P10, DOI 10.4049/jimmunol.165.1.10; Zhao HR, 2005, J IMMUNOL, V174, P5288, DOI 10.4049/jimmunol.174.9.5288; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	70	104	104	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					852	862		10.1016/j.immuni.2010.06.011	http://dx.doi.org/10.1016/j.immuni.2010.06.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620947	Bronze			2022-12-18	WOS:000279365800015
J	Cemerski, S; Das, J; Giurisato, E; Markiewicz, MA; Allen, PM; Chakraborty, AK; Shaw, AS				Cemerski, Saso; Das, Jayajit; Giurisato, Emanuele; Markiewicz, Mary A.; Allen, Paul M.; Chakraborty, Arup K.; Shaw, Andrey S.			The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality	IMMUNITY			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTER; TRANSGENIC MICE; ZETA-PHOSPHORYLATION; TCR; LIGANDS; MICROCLUSTERS; STIMULATION; POTENCY; COMPLEX; NKG2D	The role of the center of the immunological synapse (the central supramolecular activation cluster or cSMAC) is controversial. One model suggests that the role of the cSMAC depends on antigen quality and can both enhance signaling and receptor downregulation, whereas a second model proposes that the sole function of the cSMAC is to downregulate signaling. An important distinction between the models is whether signaling occurs in the cSMAC. Here, we demonstrate that at early time points, signaling occurs outside the cSMAC, but occurs in the cSMAC at later time points. Additionally, we show that cSMAC formation enhances the stimulatory potency of weak agonists for the TCR. Combined with previous studies showing that cSMAC formation decreases the signaling by strong agonists, our data support a model proposing that signaling and receptor degradation both occur in the cSMAC and that the balance between signaling and degradation in the synapse is determined by antigen quality.	[Cemerski, Saso; Giurisato, Emanuele; Markiewicz, Mary A.; Allen, Paul M.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Das, Jayajit; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Div Biol Engn, Cambridge, MA 02139 USA; [Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	shaw@immunology.wustl.edu	GIURISATO, EMANUELE/I-4904-2017; Das, Jayajit/AAD-8502-2022; Das, Jayajit/E-2951-2011; GIURISATO, EMANUELE/AAO-2352-2020	GIURISATO, EMANUELE/0000-0003-0598-6449; Das, Jayajit/0000-0001-9649-4698; GIURISATO, EMANUELE/0000-0003-0598-6449; Markiewicz, Mary/0000-0001-5685-8573	National Institutes of Health [A1034094, A1057966, A1071195]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034094, R37AI057966, P01AI071195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Dustin and T. Saito for fruitful discussions. This research is supported by the National Institutes of Health (grants A1034094, A1057966, and A1071195)	Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Harrison Stephen A, 2002, Semin Gastrointest Dis, V13, P3; Hemmer B, 1998, J IMMUNOL, V160, P5807; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Itoh Y, 1999, J IMMUNOL, V162, P2073; Jang IK, 2003, CURR OPIN IMMUNOL, V15, P315, DOI 10.1016/S0952-7915(03)00048-7; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Kersh GJ, 1998, J IMMUNOL, V161, P585; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kupfer A, 2006, IMMUNITY, V25, P11, DOI 10.1016/j.immuni.2006.07.005; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; REAY PA, 1994, J IMMUNOL, V152, P3946; Schaefer BC, 2004, P NATL ACAD SCI USA, V101, P1004, DOI 10.1073/pnas.0307858100; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	44	104	106	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					414	422		10.1016/j.immuni.2008.06.014	http://dx.doi.org/10.1016/j.immuni.2008.06.014			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18760640	Green Accepted, Bronze			2022-12-18	WOS:000259708900012
J	Liu, LZ; Fuhlbrigge, RC; Karibian, K; Tian, T; Kupper, TS				Liu, Luzheng; Fuhlbrigge, Robert C.; Karibian, Kara; Tian, Tian; Kupper, Thomas S.			Dynamic programing of CD8(+) T cell trafficking after live viral immunization	IMMUNITY			English	Article							DENDRITIC CELLS; HOMING PHENOTYPES; IN-VIVO; MEMORY; TISSUE; MIGRATION; SKIN; EFFECTOR; CD4(+); ORGANS	After viral infection, activated T cells are present in multiple tissues regardless of the infection route. How these cells acquire pleiotropic homing ability is unclear. By using a cutaneous vaccinia virus infection model, we demonstrate that regulation of T cell trafficking is multiphasic. Upon completion of three cell divisions, CD8(+) T cells upregulated specific skin-homing molecules within draining lymph nodes (LN). By 60 hr after infection, some activated T cells reached the infected tissue, while others entered distant antigen-free LN. These latter cells continued to divide and acquire additional tissue-homing molecules in this new setting, independent of antigen presentation. After viral clearance, the initial skin-homing imprint became the predominant homing phenotype on memory cells and provided superior protection against secondary cutaneous challenge. These observations demonstrate a mechanism by which T cells provide both immediate tissue-specific immune control at the pathogen entry site and a more flexible systemic protection against pathogen dissemination.	Harvard Univ, Skin Dis Res Ctr, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med & Dent, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard School of Dental Medicine	Liu, LZ (corresponding author), Harvard Univ, Skin Dis Res Ctr, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA.	lzliu@rics.bwh.harvard.edu; tkupper@partners.org	Kupper, Thomas/O-4962-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707, U19AI057330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065807] Funding Source: NIH RePORTER; NIAID NIH HHS [1U19AI57330, R01 AI041707] Funding Source: Medline; NIAMS NIH HHS [R01 AR065807] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BASS DM, 1990, J VIROL, V64, P322, DOI 10.1128/JVI.64.1.322-330.1990; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; EARL PL, 1998, CURRENT PROTOCOLS MO, P16; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kassiotis G, 2004, J IMMUNOL, V173, P7292, DOI 10.4049/jimmunol.173.12.7292; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; LANE JM, 1977, JAMA-J AM MED ASSOC, V237, P2419; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; TASHIRO M, 1990, J VIROL, V64, P3627, DOI 10.1128/JVI.64.8.3627-3634.1990; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953	34	104	108	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					511	520		10.1016/j.immuni.2006.06.019	http://dx.doi.org/10.1016/j.immuni.2006.06.019			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973385	Bronze			2022-12-18	WOS:000240862200018
J	Legge, KL; Braciale, TJ				Legge, KL; Braciale, TJ			Lymph node dendritic cells control CD8(+) T cell responses through regulated FasL expression	IMMUNITY			English	Article							INFLUENZA-VIRUS INFECTION; IL-12 P40 HOMODIMER; ANTIGEN PRESENTATION; IN-VIVO; RECEPTOR SUBUNITS; INTERLEUKIN-12; LIGAND; MICE; PHOSPHORYLATION; CYTOTOXICITY	The lethal outcome of high-dose pulmonary virus infection is thought to reflect high-level, sustained virus replication and associated lung inflammation prior to development of an adaptive immune response. Herein, we demonstrate that the outcome of lethal/sublethal influenza infection instead correlates with the initial virus replication tempo. Furthermore, the magnitude of early lung antiviral CD8(+) T cell responses varies inversely with inoculum dose and is controlled by lymph-node-resident dendritic cells (LNDC) through IL-12p40-regulated FasL-dependent T cell apoptosis. These results suggest that the inoculum dose and replication rate of a pathogen entering the respiratory tract may regulate the strength of the adaptive immune response, and the subsequent outcome of infection and that LNDC may serve as regulators (gatekeepers) in the development of CD8(+) T cell responses.	Univ Virginia, Med Ctr, Carter Ctr Immunol, Dept Pathol, Charlottesville, VA 22908 USA; Univ Virginia, Med Ctr, Carter Ctr Immunol, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	University of Virginia; University of Virginia; University of Iowa	Braciale, TJ (corresponding author), Univ Virginia, Med Ctr, Carter Ctr Immunol, Dept Pathol, Charlottesville, VA 22908 USA.	tjb2r@virginia.edu	Legge, Kevin/B-1610-2009	Legge, Kevin/0000-0001-9800-6854	NHLBI NIH HHS [HL33391] Funding Source: Medline; NIAID NIH HHS [AI15608] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, R37AI015608] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bhardwaj N, 1996, J CLIN INVEST, V98, P715, DOI 10.1172/JCI118843; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Gavrilescu LC, 2003, INFECT IMMUN, V71, P2577, DOI 10.1128/IAI.71.5.2577-2583.2003; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Holschneider AM, 2002, EUR J PEDIATR SURG, V12, P1, DOI 10.1055/s-2002-25087; Juedes AE, 2003, ANN NY ACAD SCI, V1005, P128, DOI 10.1196/annals.1288.014; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kawashima T, 1998, CELL IMMUNOL, V186, P39, DOI 10.1006/cimm.1998.1294; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LOGAN AC, 1991, INFECT IMMUN, V59, P1024, DOI 10.1128/IAI.59.3.1024-1031.1991; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Lu LN, 1997, J IMMUNOL, V158, P5676; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Morgan DJ, 1996, J IMMUNOL, V157, P978; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Topham DJ, 1997, J IMMUNOL, V159, P5197; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Wolfe T, 2002, J IMMUNOL, V169, P4867, DOI 10.4049/jimmunol.169.9.4867; Wu B, 2001, J IMMUNOL, V166, P4773, DOI 10.4049/jimmunol.166.7.4773; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173; Zou J, 1997, J BIOL CHEM, V272, P6073, DOI 10.1074/jbc.272.9.6073	42	104	105	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					649	659		10.1016/j.immuni.2005.11.006	http://dx.doi.org/10.1016/j.immuni.2005.11.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356862	Bronze			2022-12-18	WOS:000234316900011
J	Dinarello, CA				Dinarello, CA			An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor	IMMUNITY			English	Editorial Material							T1/ST2	Activation of ST2, an orphan member of the IL-1 receptor family for 16 years, drives T helper type 2 (T(H)2) responses. The cytokine IL-33 is the specific ligand for ST2. IL-33 recapitulates much of the existing data that ST2 promotes T(H)2-type responses. The caspase-1 processing of precursor IL-33 provides a therapeutic target to control allergic diseases.	Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Dinarello, CA (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA.		Dinarello, Charles/C-8524-2013					Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; DEKONING HD, 2005, IN PRESS ANN RHEUM D; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019	13	104	117	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					461	462		10.1016/j.immuni.2005.10.004	http://dx.doi.org/10.1016/j.immuni.2005.10.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286013	Bronze			2022-12-18	WOS:000233660700002
J	Li, HM; Dai, MF; Zhuang, Y				Li, HM; Dai, MF; Zhuang, Y			A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome	IMMUNITY			English	Article							MICE LACKING; PROTEIN; AUTOANTIBODIES; SIALADENITIS; SPECIFICITY; LYMPHOCYTES; ANTIBODIES; RESPONSES; DISEASE; GROWTH	Sjogren's syndrome is an autoimmune disease with clinical hallmarks of keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth). The genetic basis of this autoimmune disease is poorly understood. Id3 is an immediate early-response gene in growth regulation and is involved in TCR-mediated T cell selection during T cell development. Here, we show that Id3-deficient mice develop many disease symptoms found in primary Sjogren's syndrome patients including dry eyes and mouth, lymphocyte infiltration in lachrymal and salivary glands, and development of anti-Ro and anti-La antibodies. Adoptive transfer experiment indicated a T cell intrinsic role for Id3 in the development of Sjogren's symptoms. Furthermore, genetic ablation of T cells or neonatal 3 day thymectomy in Id3-deficient mice showed a rescue of disease symptoms, suggesting a thymic origin of autoimmune T cells. Thus, this study establishes a critical connection between Id3-mediated T cell development and autoimmune diseases.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China	Duke University; Fudan University	Zhuang, Y (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	yzhuang@duke.edu		zhuang, yuan/0000-0002-2964-3654	NCI NIH HHS [R01 CA072433-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059638-04, R01 GM059638-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bagavant H, 2002, INT IMMUNOL, V14, P1397, DOI 10.1093/intimm/dxf105; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bolstad AI, 2002, ARTHRITIS RES, V4, P353, DOI 10.1186/ar599; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Fox RI, 2000, CURR OPIN RHEUMATOL, V12, P391, DOI 10.1097/00002281-200009000-00007; FOX RI, 1984, SEMIN ARTHRITIS RHEU, V14, P77, DOI 10.1016/0049-0172(84)90001-5; GOILLOT E, 1991, CLIN IMMUNOL IMMUNOP, V59, P462, DOI 10.1016/0090-1229(91)90041-8; Jonsson R, 2002, ORAL DIS, V8, P130, DOI 10.1034/j.1601-0825.2002.02846.x; Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Norton JD, 2000, J CELL SCI, V113, P3897; Pan LH, 2004, IMMUNOLOGY, V111, P147, DOI 10.1111/j.0019-2805.2003.01802.x; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Roper RJ, 2002, J IMMUNOL, V169, P1640, DOI 10.4049/jimmunol.169.3.1640; Skarstein K, 1995, AUTOIMMUNITY, V22, P9, DOI 10.3109/08916939508995294; St Clair E W, 1992, Concepts Immunopathol, V8, P161; STCLAIR EW, 1990, J IMMUNOL, V144, P3868; van Blokland SCA, 2002, CLIN IMMUNOL, V103, P111, DOI 10.1006/clim.2002.5189; WAHREN M, 1994, IMMUNOLOGY, V83, P9; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	26	104	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					551	560		10.1016/j.immuni.2004.08.013	http://dx.doi.org/10.1016/j.immuni.2004.08.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485632	Bronze			2022-12-18	WOS:000224744400011
J	Jabara, HH; Laouini, D; Tsitsikov, E; Mizoguchi, E; Bhan, AK; Castigli, E; Dedeoglu, F; Pivniouk, V; Brodeur, SR; Geha, RS				Jabara, HH; Laouini, D; Tsitsikov, E; Mizoguchi, E; Bhan, AK; Castigli, E; Dedeoglu, F; Pivniouk, V; Brodeur, SR; Geha, RS			The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching	IMMUNITY			English	Article							NF-KAPPA-B; RECEPTOR-ASSOCIATED FACTORS; TERMINAL KINASE; IMMUNE-RESPONSES; CD40 LIGAND; DEFECTIVE INTERLEUKIN-1; ECTODERMAL DYSPLASIA; CD40-DEFICIENT MICE; TARGETED DISRUPTION; GENE-EXPRESSION	To define the role of TRAF proteins in CD40-dependent isotype switching in B cells, we introduced wild-type (WT) and mutant CD40 transgenes that lacked the binding motifs for TRAF6 (CD40DeltaTRAF6), TRAF2 and TRAF3 (CD40DeltaTRAF2/3), or both (CD40DeltaTRAFs) into B cells of CD40(-/-) mice. The in vivo isotype switch defect in CD40(-/-) mice was fully corrected by WT and CD40Delta TRAF6, partially by CD40DeltaTRAF2/3, and not at all by CD40DeltaTRAFs transgenes. CD40-mediated isotype switching, proliferation, and activation of p38, JNK, and NFkappaB in B cells were normal in WT and CD40DeltaTRAF6 mice, severely impaired in CD40DeltaTRAF2/3, and absent in CD40DeltaTRAFs mice. These results suggest that binding to TRAF2 and/or TRAF3 but not TRAF6 is essential for CD40 isotype switching and activation in B cells.	Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Immunopathol Unit, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Geha, RS (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA.		Laouini, Dhafer/Q-6535-2019	Laouini, Dhafer/0000-0003-1222-4880	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031136] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31136] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aicher A, 1999, J IMMUNOL, V163, P5786; Bacharier LB, 1998, INT ARCH ALLERGY IMM, V115, P257, DOI 10.1159/000069456; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BERBERICH I, 1994, J IMMUNOL, V153, P4357; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Castigli E, 1996, INT IMMUNOL, V8, P405, DOI 10.1093/intimm/8.3.405; Chang T M, 1995, Biotechnol Annu Rev, V1, P267; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; Grammer AC, 1998, J IMMUNOL, V161, P1183; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Iciek LA, 1997, J IMMUNOL, V158, P4769; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jabara HH, 1998, BLOOD, V92, P2435, DOI 10.1182/blood.V92.7.2435.2435_2435_2440; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO;2-E; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Li YY, 1996, J IMMUNOL, V157, P1440; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagumo H, 1998, J IMMUNOL, V161, P6496; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Revy P, 1999, J IMMUNOL, V163, P787; Richards ML, 1997, J IMMUNOL, V158, P263; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Sutherland CL, 1999, J IMMUNOL, V162, P4720; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; Werneburg BG, 2001, J BIOL CHEM, V276, P43334, DOI 10.1074/jbc.M104994200; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; XU LX, 1994, INT IMMUNOL, V6, P515, DOI 10.1093/intimm/6.4.515; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto H, 1998, J IMMUNOL, V161, P4753; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	51	104	108	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					265	276		10.1016/S1074-7613(02)00394-1	http://dx.doi.org/10.1016/S1074-7613(02)00394-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354380	Bronze			2022-12-18	WOS:000178163100004
J	Stauffer, Y; Marguerat, S; Meylan, F; Ucla, C; Sutkowski, N; Huber, B; Pelet, T; Conrad, B				Stauffer, Y; Marguerat, S; Meylan, F; Ucla, C; Sutkowski, N; Huber, B; Pelet, T; Conrad, B			Interferon-alpha-induced endogenous superantigen: A model linking environment and autoimmunity	IMMUNITY			English	Article							DEPENDENT DIABETES-MELLITUS; T-CELLS; COXSACKIEVIRUS-B; TRANSGENIC MICE; BETA-CELLS; EXPRESSION; INFECTION; GENES; GAMMA; VIRUS	We earlier proposed that a human endogenous retroviral (HERV) superantigen (SAg) IDDMK(1,2)22 may cause type I diabetes by activating autoreactive T cells. Viral infections and induction of interferon-alpha (IFN-alpha) are tightly associated with the onset of autoimmunity. Here we establish a link between viral infections and IFN-alpha -regulated SAg expression of the polymorphic and defective HERV-K18 provirus. HERV-K18 has three alleles, IDDMK(1,2)22 and two full-length envelope genes, that all encode SAgs. Expression of HERV-K18 SAgs is inducible by IFN-alpha. and this is sufficient to stimulate V beta7 T cells to levels comparable to transfectants constitutively expressing HERV-K18 SAgs. Endogenous SAgs induced via IFN-alpha by viral infections is a novel mechanism through which environmental factors may cause disease in genetically susceptible individuals.	Univ Geneva, Sch Med, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland; Tufts Univ, Dept Pathol, Boston, MA 02111 USA	University of Geneva; Tufts University	Conrad, B (corresponding author), Univ Geneva, Sch Med, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland.		Marguerat, Samuel/AAY-3792-2020	Marguerat, Samuel/0000-0002-2402-3165				ACKRILL AM, 1991, NUCLEIC ACIDS RES, V19, P591, DOI 10.1093/nar/19.3.591; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Beales PE, 1999, DIABETOLOGIA, V42, P385; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Chehadeh T, 2000, J INFECT DIS, V181, P1929, DOI 10.1086/315516; Chehadeh W, 2000, J VIROL, V74, P10153, DOI 10.1128/JVI.74.21.10153-10164.2000; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; Conrad B, 1997, CELL, V90, P303, DOI 10.1016/S0092-8674(00)80338-4; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; FLEISCHER B, 1991, J IMMUNOL, V146, P11; FOULIS AK, 1987, LANCET, V2, P1423; Goff SP, 1996, CELL, V86, P691, DOI 10.1016/S0092-8674(00)80141-5; HAKEM R, 1991, J IMMUNOL, V147, P2384; HANNINEN A, 1992, J CLIN INVEST, V90, P1901, DOI 10.1172/JCI116067; Hasuike S, 1999, J HUM GENET, V44, P343, DOI 10.1007/s100380050173; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Le Page C, 2000, Rev Immunogenet, V2, P374; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; Luppi P, 2000, DIABETOLOGIA, V43, P1484, DOI 10.1007/s001250051559; MARRACK P, 1993, IMMUNOL REV, V131, P79, DOI 10.1111/j.1600-065X.1993.tb01531.x; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; Singh B, 1998, SEMIN IMMUNOL, V10, P79, DOI 10.1006/smim.1997.0107; SOMOZA N, 1994, J IMMUNOL, V153, P1360; STEINMAN L, 1995, CELL, V80, P7, DOI 10.1016/0092-8674(95)90443-3; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Stoye JP, 2000, NATURE, V403, P715, DOI 10.1038/35001700; SUBRAMANYAM M, 1993, J IMMUNOL, V151, P2538; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tissot C, 1997, J INTERF CYTOK RES, V17, P17, DOI 10.1089/jir.1997.17.17; Tonjes RR, 1999, J VIROL, V73, P9187; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219	37	104	114	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					591	601		10.1016/S1074-7613(01)00212-6	http://dx.doi.org/10.1016/S1074-7613(01)00212-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672541	Bronze			2022-12-18	WOS:000171757800010
J	Kim, HP; Kelly, J; Leonard, WJ				Kim, HP; Kelly, J; Leonard, WJ			The basis for IL-2-induced IL-2 receptor a chain gene regulation: Importance of two widely separated IL-2 response elements	IMMUNITY			English	Article							INTERLEUKIN-2 RECEPTOR; ALPHA-GENE; IMMUNOGLOBULIN-KAPPA; T-CELLS; HTLV-I; EXPRESSION; PROTEINS; BINDING; ENHANCER; HMG-I(Y)	The interleukin-2 receptor alpha (IL-2R alpha) chain is an essential component of high-affinity IL-2 receptors. Accordingly, lL-2R alpha expression helps to regulate T cell growth and other lymphoid functions. Lineage-restricted and activation-dependent IL-2R alpha transcription is controlled by three upstream positive regulatory regions (PRRs). We now describe an additional IL-2 response element, PRRIV, within intron 1, in humans and mice. PRRIV activity requires GAS motifs that bind Stat5 proteins and additional upstream HMG-I(Y) binding sites. Moreover, IL-2 induces the binding of HMG-I(Y), Stat5a, and Stat5b in vivo to PRRIV and PRRIII, which also functions as an IL-2 response element. Thus, the IL-2 inducibility of the lL-2Ra gene is unexpectedly mediated by two widely separated regulatory Stat5-dependent elements, located both upstream and downstream of the transcription initiation sites.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022	Kim, Hyoung-Pyo/0000-0003-1441-8822				Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Bucher P, 1997, IMMUNOBIOLOGY, V198, P136, DOI 10.1016/S0171-2985(97)80034-4; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CROSS SL, 1989, SCIENCE, V244, P466, DOI 10.1126/science.2497520; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; ENVER T, 1985, NATURE, V318, P680, DOI 10.1038/318680a0; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; John S, 1999, MOL CELL BIOL, V19, P1910; JOHN S, 1995, MOL CELL BIOL, V15, P1786; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LEHN DA, 1988, BIOCHEM INT, V16, P963; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LIN BB, 1990, MOL CELL BIOL, V10, P850, DOI 10.1128/MCB.10.2.850; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NISSEN MS, 1995, J BIOL CHEM, V270, P4355, DOI 10.1074/jbc.270.9.4355; PICARD D, 1984, NATURE, V307, P80, DOI 10.1038/307080a0; Reeves R, 1995, Prog Cell Cycle Res, V1, P339; REEVES R, 1993, J BIOL CHEM, V268, P21137; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SOLDAINI E, 1995, J BIOL CHEM, V270, P10733, DOI 10.1074/jbc.270.18.10733; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SPERISEN P, 1995, J BIOL CHEM, V270, P10743, DOI 10.1074/jbc.270.18.10743; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLEDANO MB, 1990, P NATL ACAD SCI USA, V87, P1830, DOI 10.1073/pnas.87.5.1830; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; [No title captured]	42	104	106	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					159	172		10.1016/S1074-7613(01)00167-4	http://dx.doi.org/10.1016/S1074-7613(01)00167-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485747	Bronze			2022-12-18	WOS:000170153300016
J	Scott, D; Addey, C; Ellis, P; James, E; Mitchell, MJ; Saut, N; Jurcevic, S; Simpson, E				Scott, D; Addey, C; Ellis, P; James, E; Mitchell, MJ; Saut, N; Jurcevic, S; Simpson, E			Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens	IMMUNITY			English	Article							CD4(+) T-CELLS; MOUSE Y-CHROMOSOME; MINOR HISTOCOMPATIBILITY ANTIGENS; VERSUS-HOST DISEASE; H-Y; INVARIANT CHAIN; HLA-DR; EXPRESSION CLONING; SURFACE EXPRESSION; APOPTOTIC CELLS	Minor or histocompatibility (H) antigens are recognized by CD4(+) and CD8(+) T lymphocytes as short polymorphic peptides associated with MHC molecules. They are the targets of graft versus host and graft versus leukemia responses following bone marrow transplantation between HLA-identical siblings. Several genes encoding class I-restricted minor H epitopes have been identified, but approaches used for these have proved difficult to adapt for cloning class II-restricted minor H genes. We have combined the unique antigen-presenting properties of dendritic cells and high levels of episomal expression following transfection of COS cells to identify a Y chromosome gene encoding two HY peptide epitopes, HYA(b) and HYEk.	Hammersmith Hosp, Imperial Coll Sch Med, Transplantat Biol Grp, MRC Clin Sci Ctr, London W12 0NN, England; Fac Med Marseille, INSERM, U406, F-13385 Marseille 5, France; Kings Coll London, Guys Kings & St Thomas Med Sch, Dept Nephrol & Transplantat, Guys Hosp, London SE1 9RT, England	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Simpson, E (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Transplantat Biol Grp, MRC Clin Sci Ctr, London W12 0NN, England.	elizabeth.simpson@csc.mrc.ac.uk	Kozina, Slavica/H-6076-2017; Addey, Caroline/N-8474-2013; Mitchell, Michael/I-3987-2016	Addey, Caroline/0000-0002-7154-094X; Mitchell, Michael/0000-0003-2052-7347; Simpson, Elizabeth/0000-0002-2118-3139				Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cobbold SP, 1996, IMMUNOL REV, V149, P5, DOI 10.1111/j.1600-065X.1996.tb00897.x; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; Davies JD, 1996, J IMMUNOL, V157, P529; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fujii S, 1998, HUM IMMUNOL, V59, P607, DOI 10.1016/S0198-8859(98)00058-5; Fuller-Pace Frances V., 1994, Trends in Cell Biology, V4, P271, DOI 10.1016/0962-8924(94)90210-0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; GEE SL, 1994, GENE, V140, P171, DOI 10.1016/0378-1119(94)90541-X; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; HARRIS DP, 1995, EUR J IMMUNOL, V25, P3173, DOI 10.1002/eji.1830251128; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Jurcevic S, 1996, INT IMMUNOL, V8, P1807, DOI 10.1093/intimm/8.11.1807; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KING TR, 1994, GENOMICS, V24, P159, DOI 10.1006/geno.1994.1593; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LONG EO, 1994, J IMMUNOL, V153, P1487; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Malcherek G, 1998, EUR J IMMUNOL, V28, P1524, DOI 10.1002/(SICI)1521-4141(199805)28:05<1524::AID-IMMU1524>3.0.CO;2-T; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; ROOPENIAN DC, 1992, IMMUNOL TODAY, V13, P7, DOI 10.1016/0167-5699(92)90197-F; ROOPENIAN DC, 1999, IN PRESS MINOR HISTO; ROTZSCHKE O, 1990, SCIENCE, V249, P283, DOI 10.1126/science.1695760; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; SCOTT DM, 1992, IMMUNOGENETICS, V36, P86, DOI 10.1007/BF00215284; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; Simpson E, 1997, CURR OPIN IMMUNOL, V9, P655, DOI 10.1016/S0952-7915(97)80045-3; SIMPSON E, 1989, IMMUNOLOGY, P42; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; SIMPSON E, 1997, HDB EXPT IMMUNOLOGY; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STOCKINGER B, 1993, EUR J IMMUNOL, V23, P6, DOI 10.1002/eji.1830230103; TING A, 1989, ORGAN TRANSPLANTATIO, P1; TOMONARI K, 1983, J IMMUNOL, V131, P1641; Topalian SL, 1996, J EXP MED, V183, P1965, DOI 10.1084/jem.183.5.1965; vanBergen J, 1997, P NATL ACAD SCI USA, V94, P7499, DOI 10.1073/pnas.94.14.7499; WALL KA, 1994, J IMMUNOL, V152, P4526; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wang RF, 1999, J EXP MED, V189, P1659, DOI 10.1084/jem.189.10.1659; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Warren EH, 2000, J IMMUNOL, V164, P2807, DOI 10.4049/jimmunol.164.5.2807; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; Zuberi AR, 1998, IMMUNITY, V9, P687, DOI 10.1016/S1074-7613(00)80666-4	73	104	110	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					711	720		10.1016/S1074-7613(00)80221-6	http://dx.doi.org/10.1016/S1074-7613(00)80221-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894170	Bronze			2022-12-18	WOS:000087937300012
J	Sykulev, Y; Vugmeyster, Y; Brunmark, A; Ploegh, HL; Eisen, HN				Sykulev, Y; Vugmeyster, Y; Brunmark, A; Ploegh, HL; Eisen, HN			Peptide antagonism and T cell receptor interactions with peptide-MHC complexes	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER CELLS; LYMPHOCYTES-T; ANTIGEN RECEPTOR; VIRAL PEPTIDE; AFFINITY; TCR; ACTIVATION; MOLECULE; LIGANDS; SPECIFICITY	We describe antagonist peptides that specifically inhibit cytolytic activity of T cell clones and lines that express the antigen-specific receptor of CD8(+) T lymphocyte clone 2C, which recognizes peptides in association with syngeneic (Kb) and allogeneic (Ld) MHC proteins. Addition of an antagonist peptide that can bind to K-b on 2C cells decreased the tyrosine phosphorylation of CD3 zeta chains elicited by prior exposure of the cells to an agonist peptide-K-b complex. Contrary to previous agonist-antagonist comparisons, the 2C T cell receptor had higher affinity for an antagonist peptide-K-b complex than for a weak agonist peptide-K-b complex. This difference is considered in light of evidence that antigen-specific receptor affinity values can be substantially higher when determined with the receptor on live cells than with the receptor in cell-free systems.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Scripps Research Institute	Eisen, HN (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	hneisen@mit.edu			NATIONAL CANCER INSTITUTE [R01CA060686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034247] Funding Source: NIH RePORTER; NCI NIH HHS [CA60686, CA09255] Funding Source: Medline; NIAID NIH HHS [AI34247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; CARBONE FR, 1992, INT IMMUNOL, V4, P861, DOI 10.1093/intimm/4.8.861; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; EISEN HN, 1997, ADV PROTEIN CHEM, V49, P1; EVAVOLD BD, 1994, P NATL ACAD SCI USA, V91, P2300, DOI 10.1073/pnas.91.6.2300; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Malarkannan S, 1996, J IMMUNOL, V157, P4464; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; Robinson RA, 1996, J IMMUNOL, V156, P4266; ROJO JM, 1988, J IMMUNOL, V140, P1081; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; SCHUMACHER TNM, 1991, NATURE, V350, P703, DOI 10.1038/350703a0; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; SU MWC, 1993, J IMMUNOL, V151, P658; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; SYKULEV Y, 1997, IMMUNOLOGY METHODS M, P489; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P14487; TALLQUIST MD, 1995, J IMMUNOL, V155, P2419; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Udaka K, 1996, J IMMUNOL, V157, P670; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VANBLEEK GM, 1990, NATURE, V348, P213; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; WU MX, 1995, J IMMUNOL, V154, P4495; YOON ST, 1994, IMMUNITY, V1, P563; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	49	104	105	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					475	483		10.1016/S1074-7613(00)80631-7	http://dx.doi.org/10.1016/S1074-7613(00)80631-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806634	Bronze			2022-12-18	WOS:000076680700006
J	Endres, R; Luz, A; Schulze, H; Neubauer, H; Futterer, A; Holland, SM; Wagner, H; Pfeffer, K				Endres, R; Luz, A; Schulze, H; Neubauer, H; Futterer, A; Holland, SM; Wagner, H; Pfeffer, K			Listeriosis in p47(phox-/-) and TRp55(-/-) mice: Protection despite absence of ROI and susceptibility despite presence of RNI	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA PRODUCTION; CELL-INDEPENDENT PATHWAY; NATURAL-KILLER-CELLS; IFN-GAMMA; MONOCYTOGENES INFECTION; MURINE LISTERIOSIS; NITRIC-OXIDE; MACROPHAGE ACTIVATION; TARGETED DISRUPTION	The significance of host defense mechanisms in primary listeriosis in vivo is incompletely understood. Here, we show that tumor necrosis factor receptor p55(-/-) (TRp55(-/-)) mice are susceptible to Listeria monocytogenes infection in the presence of leukocyte recruitment, inflammatory cytokine production (including IFN gamma), nitric oxide synthesis, and oxidative burst formation. Mice deficient for oxidative burst (p47(phox-/-) mice) are relatively resistant to listeriosis. Despite activation of these antibacterial effector systems, TRp55(-/-) phagocytes in vivo are incapable of confining and eradicating L. monocytogenes inside phagolysosomes. Bone marrow chimeras reveal that for eradication of L. monocytogenes, TRp55 is crucially required only on cells from hematopoietic origin. Unexpectedly, prior to death, exocrine pancreatic cells undergo apoptosis in TRp55(-/-) mice. Collectively, these data demonstrate that in vivo, TRp55 initiates a protective, listericidal mechanism in phagocytes that differs from nitric oxide production and oxidative burst formation and that uncontrolled listeriosis results in necrotizing pancreatitis in TRp55(-/-) mice.	TECH UNIV MUNICH,INST MED MICROBIOL IMMUNOL & HYG,D-81675 MUNICH,GERMANY; GSF,NAT RES CTR ENVIRONM & HLTH,INST PATHOL,D-85758 OBERSCHLEISSHEIM,GERMANY; NIAID,HOST DEF LAB,NIH,BETHESDA,MD 20892	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Neubauer, Hans/C-4467-2016	Neubauer, Hans/0000-0002-3467-4105; Futterer, Agnes/0000-0003-3980-8763; Pfeffer, Klaus/0000-0002-5652-6330				Akira S, 1995, IMMUNOL REV, V148, P221, DOI 10.1111/j.1600-065X.1995.tb00100.x; ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BECKERMAN KP, 1993, J IMMUNOL, V150, P888; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLATHAM WW, 1994, J LEUKOCYTE BIOL, V56, P654; CONLAN JW, 1991, J EXP MED, V174, P741, DOI 10.1084/jem.174.3.741; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; DING AH, 1988, J IMMUNOL, V141, P2407; Dramsi S, 1996, CURR TOP MICROBIOL, V209, P61; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOOSSENS PL, 1991, J IMMUNOL, V147, P3514; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREGORY SH, 1993, J IMMUNOL, V150, P2901; Harty JT, 1996, CURR OPIN IMMUNOL, V8, P526, DOI 10.1016/S0952-7915(96)80041-0; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HAVELL EA, 1989, J IMMUNOL, V143, P2894; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; LEENEN PJM, 1994, J IMMUNOL, V153, P5141; LEPAY DA, 1985, J EXP MED, V161, P1503, DOI 10.1084/jem.161.6.1503; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MANDEL TE, 1980, INFECT IMMUN, V30, P851; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; Neumann B, 1996, J IMMUNOL, V156, P1587; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; PECK R, 1989, J LEUKOCYTE BIOL, V46, P434, DOI 10.1002/jlb.46.5.434; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PORTNOY DA, 1992, CURR OPIN IMMUNOL, V4, P20, DOI 10.1016/0952-7915(92)90118-X; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; RACZ P, 1970, ACTA MICROBIOL HUNG, V17, P221; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Rogers HW, 1996, J IMMUNOL, V156, P679; ROSEN H, 1989, J EXP MED, V170, P27, DOI 10.1084/jem.170.1.27; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; STEINBERG W, 1994, NEW ENGL J MED, V330, P1198, DOI 10.1056/NEJM199404283301706; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TEIXEIRA HC, 1994, J IMMUNOL, V152, P1873; TRIPP CS, 1994, J IMMUNOL, V152, P1883; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WILSON C, 1988, INT J PANCREATOL, V3, P273; WYNN TA, 1991, J IMMUNOL, V147, P4384	57	104	107	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					419	432		10.1016/S1074-7613(00)80363-5	http://dx.doi.org/10.1016/S1074-7613(00)80363-5			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324362	Bronze			2022-12-18	WOS:A1997XY83000011
J	Denney, L; Byrne, AJ; Shea, TJ; Buckley, JS; Pease, JE; Herledan, GMF; Walker, SA; Gregory, LG; Lloyd, CM				Denney, Laura; Byrne, Adam J.; Shea, Thomas J.; Buckley, James S.; Pease, James E.; Herledan, Gaelle M. F.; Walker, Simone A.; Gregory, Lisa G.; Lloyd, Clare M.			Pulmonary Epithelial Cell-Derived Cytokine TGF-beta 1 Is a Critical Cofactor for Enhanced Innate Lymphoid Cell Function	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; TGF-BETA; AIRWAY INFLAMMATION; ASTHMA; EXPRESSION; MICE; HYPERREACTIVITY; ACTIVIN; T(H)2	Epithelial cells orchestrate pulmonary homeostasis and pathogen defense and play a crucial role in the initiation of allergic immune responses. Maintaining the balance between homeostasis and inappropriate immune activation and associated pathology is particularly complex at mucosal sites that are exposed to billions of potentially antigenic particles daily. We demonstrated that epithelial cell-derived cytokine TGF-beta had a central role in the generation of the pulmonary immune response. Mice that specifically lacked epithelial cell-derived TGF-beta 1 displayed a reduction in type 2 innate lymphoid cells ( ILCs), resulting in suppression of interleukin-13 and hallmark features of the allergic response including airway hyperreactivity. ILCs in the airway lumen were primed to respond to TGF-beta by expressing the receptor TGF-beta RII and ILC chemoactivity was enhanced by TGF-beta. These data demonstrate that resident epithelial cells instruct immune cells, highlighting the central role of the local environmental niche in defining the nature and magnitude of immune reactions.	[Denney, Laura; Byrne, Adam J.; Shea, Thomas J.; Buckley, James S.; Pease, James E.; Herledan, Gaelle M. F.; Walker, Simone A.; Gregory, Lisa G.; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inflammat Repair & Dev, London SW7 2AZ, England	Imperial College London	Lloyd, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inflammat Repair & Dev, London SW7 2AZ, England.	c.lloyd@imperial.ac.uk	Byrne, Adam/Q-4835-2019; Pease, James/X-4521-2018	Byrne, Adam/0000-0003-2736-8174; Pease, James/0000-0003-3749-0341; Buckley, James/0000-0001-9567-1621; Lloyd, Clare/0000-0001-8977-6726; Gregory, Lisa/0000-0003-2199-5417	Wellcome Trust [087618/Z/08/Z]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The authors thank Catherine Simpson and Jane Srivastava of the Imperial College Core Flow Cytometry facility for assistance with cell sorting, Lorraine Lawrence for histological sectioning, and staff of the Mary Lyon Centre (MLC) at Harwell for performing mouse re-derivation and animal husbandry support. We are grateful to Shiro Kanegasaki and Tomoko Tsuchiya of the YU-ECI Research Center for Medical Science, Yeungnam University, Republic of Korea, for their help and support with the use of the 12-channel TAXIScan system. This work was supported by the Wellcome Trust (grant 087618/Z/08/Z).	AVERY A, 1993, BRIT J CANCER, V68, P137, DOI 10.1038/bjc.1993.301; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Castriconi R, 2013, J IMMUNOL, V190, P5321, DOI 10.4049/jimmunol.1202693; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Gregory LG, 2013, ALLERGY, V68, P1579, DOI 10.1111/all.12271; Gregory LG, 2010, AM J RESP CRIT CARE, V182, P143, DOI 10.1164/rccm.200905-0725OC; Happel C, 2008, J LEUKOCYTE BIOL, V83, P956, DOI 10.1189/jlb.1007685; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kariyawasam HH, 2009, J ALLERGY CLIN IMMUN, V124, P454, DOI 10.1016/j.jaci.2009.06.022; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kim H, 2012, J ALLERGY CLIN IMMUN, V129, pAB6, DOI 10.1016/j.jaci.2011.12.881; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li HL, 2007, HUM GENET, V121, P529, DOI 10.1007/s00439-007-0337-z; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Van Stry M, 2011, NAT IMMUNOL, V12, P16, DOI 10.1038/ni0111-16; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Walker JA, 2012, EUR J IMMUNOL, V42, P1368, DOI 10.1002/eji.201242425; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043008; Winkelmann A, 2010, EUR RESPIR J, V36, P722, DOI 10.1183/09031936.00146609; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhou L, 2012, IMMUNITY, V37, P589, DOI 10.1016/j.immuni.2012.10.002; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	48	103	107	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					945	958		10.1016/j.immuni.2015.10.012	http://dx.doi.org/10.1016/j.immuni.2015.10.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588780	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000366846000015
J	Xia, M; Liu, J; Wu, XH; Liu, SX; Li, G; Han, CF; Song, LJ; Li, ZQ; Wang, QQ; Wang, JL; Xu, T; Cao, XT				Xia, Meng; Liu, Juan; Wu, Xiaohui; Liu, Shuxun; Li, Gang; Han, Chaofeng; Song, Lijun; Li, Zhiqing; Wang, Qingqing; Wang, Jianli; Xu, Tian; Cao, Xuetao			Histone Methyltransferase Ash1l Suppresses Interleukin-6 Production and Inflammatory Autoimmune Diseases by Inducing the Ubiquitin-Editing Enzyme A20	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; RHEUMATOID-ARTHRITIS; METHYLATION; ACTIVATION; INDUCTION; GENES; RESPONSES; TNFAIP3; GENOME	Histone modifications play important roles in multiple physiological processes by regulating gene expression. However, the roles of histone modifications in immunity remain poorly understood. Here we report that Ash1l, a H3K4 methyltransferase, suppressed interleukin-6 (IL-6), and tumor necrosis factor (TNF) production in Toll-like receptor (TLR)-triggered macrophages, protecting mice from sepsis. Ash1l-silenced mice were more susceptible to autoimmune disease as a result of enhanced IL-6 production. Ash1l enhanced A20 expression through induction of H3K4 modification at the Tnfaip3 promoter via H3K4 methyltransferase activity of Ash1l SET (Su[var]3-9, E[z] and trithorax) domain. Ash1l suppressed NF-kappa B, mitogen-activated protein kinase (MAPK) pathways, and subsequent IL-6 production via facilitating A20-mediated NF-kappa B signal modulator NEMO and transducer TRAF6 deubiquitination. Therefore, Ash1l-mediated H3K4 methylation at the Tnfaip3 promoter is required for controlling innate IL-6 production and suppressing inflammatory autoimmune diseases, providing mechanistic insight into epigenetic modulation of immune responses and inflammation.	[Xia, Meng; Li, Zhiqing; Wang, Qingqing; Wang, Jianli; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310057, Zhejiang, Peoples R China; [Xia, Meng; Liu, Juan; Liu, Shuxun; Han, Chaofeng; Song, Lijun; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Xia, Meng; Liu, Juan; Liu, Shuxun; Han, Chaofeng; Song, Lijun; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wu, Xiaohui; Li, Gang; Xu, Tian] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100730, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310057, Zhejiang, Peoples R China.	caoxt@immunol.org	Li, Gang/H-5714-2015; wang, jian/GVS-0711-2022; song, lijun/ABB-7049-2021	xia, meng/0000-0001-5223-7390	National Key Basic Research Program of China [2013CB530500]; National Natural Science Foundation of China [81172787, 81230074, 81123006]; National 125 Key Project [2012ZX10002-014, 2012AA020901]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project	We thank Bin Xie and Jinxia Jiang for the excellent technical assistance. This work is supported by grants from the National Key Basic Research Program of China (2013CB530500), National Natural Science Foundation of China (81172787, 81230074, 81123006), and National 125 Key Project (2012ZX10002-014, 2012AA020901).	Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Austenaa L, 2012, IMMUNITY, V36, P572, DOI 10.1016/j.immuni.2012.02.016; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Miao CG, 2013, CELL SIGNAL, V25, P875, DOI 10.1016/j.cellsig.2012.12.017; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SHEARN A, 1978, GENETICS, V89, P341; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka T, 2012, IMMUNOTHERAPY-UK, V4, P87, DOI [10.2217/IMT.11.147, 10.2217/imt.11.147]; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V365, P589, DOI 10.1016/j.bbrc.2007.10.159; Tanaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028171; Wang X, 2012, J CELL SCI, V125, P4058, DOI 10.1242/jcs.103531; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	39	103	113	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					470	481		10.1016/j.immuni.2013.08.016	http://dx.doi.org/10.1016/j.immuni.2013.08.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012418	Bronze			2022-12-18	WOS:000330949600011
J	Medvedovic, J; Ebert, A; Tagoh, H; Tamir, IM; Schwickert, TA; Novatchkova, M; Sun, Q; Veld, PJHI; Guo, CG; Yoon, HS; Denizot, Y; Holwerda, SJB; de Laat, W; Cogne, M; Shi, Y; Alt, FW; Busslinger, M				Medvedovic, Jasna; Ebert, Anja; Tagoh, Hiromi; Tamir, Ido M.; Schwickert, Tanja A.; Novatchkova, Maria; Sun, Qiong; in't Veld, Pim J. Huis; Guo, Chunguang; Yoon, Hye Suk; Denizot, Yves; Holwerda, Sjoerd J. B.; de Laat, Wouter; Cogne, Michel; Shi, Yang; Alt, Frederick W.; Busslinger, Meinrad			Flexible Long-Range Loops in the V-H Gene Region of the Igh Locus Facilitate the Generation of a Diverse Antibody Repertoire	IMMUNITY			English	Article							HEAVY-CHAIN LOCUS; PRO-B CELLS; INTRONIC ENHANCER; CHROMATIN ARCHITECTURE; SWITCH RECOMBINATION; GENOMIC INTERACTIONS; REGULATORY ELEMENTS; IMMUNOGLOBULIN LOCI; V(D)J RECOMBINATION; 3D STRUCTURE	The immunoglobulin heavy-chain (Igh) locus undergoes large-scale contraction in pro-B cells, which facilitates V-H-DJ(H) recombination by juxtaposing distal V-H genes next to the DJ(H)-rearranged gene segment in the 3' proximal Igh domain. By using high-resolution mapping of long-range interactions, we demonstrate that local interaction domains established the three-dimensional structure of the extended Igh locus in lymphoid progenitors. In proB cells, these local domains engaged in long-range interactions across the Igh locus, which depend on the regulators Pax5, YY1, and CTCF. The large VH gene cluster underwent flexible long-range interactions with the more rigidly structured proximal domain, which probably ensures similar participation of all V-H genes in V-H-DJ(H) recombination to generate a diverse antibody repertoire. These long-range interactions appear to be an intrinsic feature of the V-H gene cluster, because they are still generated upon mutation of the E mu enhancer, IGCR1 insulator, or 30 regulatory region in the proximal Igh domain.	[Medvedovic, Jasna; Ebert, Anja; Tagoh, Hiromi; Tamir, Ido M.; Schwickert, Tanja A.; Novatchkova, Maria; Sun, Qiong; in't Veld, Pim J. Huis; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Tamir, Ido M.] Campus Sci Support Facil, A-1030 Vienna, Austria; [Novatchkova, Maria] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Guo, Chunguang; Yoon, Hye Suk; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Denizot, Yves; Cogne, Michel] Univ Limoges, CNRS, UMR CNRS 7276, F-87025 Limoges, France; [Holwerda, Sjoerd J. B.; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Holwerda, Sjoerd J. B.; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Div Newborn Med,Childrens Hosp, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Veld, Pim J. Huis in 't/AAJ-9030-2020; Denizot, Yves/H-9769-2016; cogné, michel/D-7370-2015; Busslinger, Meinrad J./J-1249-2016; Tagoh, Hiromi/B-2954-2009	Veld, Pim J. Huis in 't/0000-0003-0234-6390; cogné, michel/0000-0002-8519-4427; Busslinger, Meinrad J./0000-0002-9111-9351; Medvedovic, Jasna/0000-0003-0483-4128; Tagoh, Hiromi/0000-0001-9905-6992; Schwickert, Tanja/0000-0002-3371-2376	Boehringer-Ingelheim; Vienna Science and Technology Fund (WWTF); ERC Advanced Grant from the European Community's Seventh Framework Program [291740-LymphoControl]; Austrian GEN-AU initiative; Bundesminsterium fur Bildung und Wissenschaft; EMBO fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER	Boehringer-Ingelheim(Boehringer Ingelheim); Vienna Science and Technology Fund (WWTF); ERC Advanced Grant from the European Community's Seventh Framework Program; Austrian GEN-AU initiative; Bundesminsterium fur Bildung und Wissenschaft; EMBO fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Sommer and P. Stolt-Berger at the Campus Science Support Facilities for deep sequencing and protein expression, E. Axelsson for RNA-seq analysis, W. van Ijcken and F. Grosveld for advice on 4C sequencing, J. Skok for help with DNA-FISH analysis, and J.-M. Peters for advice on CTCF purification. This research was supported by Boehringer-Ingelheim, the Vienna Science and Technology Fund (WWTF), an ERC Advanced Grant (291740-LymphoControl) from the European Community's Seventh Framework Program, the Austrian GEN-AU initiative (financed by the Bundesminsterium fur Bildung und Wissenschaft), and an EMBO fellowship (to T.S.).	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689	35	103	104	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					229	244		10.1016/j.immuni.2013.08.011	http://dx.doi.org/10.1016/j.immuni.2013.08.011			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973221	Bronze, Green Accepted			2022-12-18	WOS:000330948800007
J	Okuma, A; Hoshino, K; Ohba, T; Fukushi, S; Aiba, S; Akira, S; Ono, M; Kaisho, T; Muta, T				Okuma, Atsushi; Hoshino, Katsuaki; Ohba, Tomoyuki; Fukushi, Sawako; Aiba, Setsuya; Akira, Shizuo; Ono, Masao; Kaisho, Tsuneyasu; Muta, Tatsushi			Enhanced Apoptosis by Disruption of the STAT3-I kappa B-zeta Signaling Pathway in Epithelial Cells Induces Sjogren's Syndrome-like Autoimmune Disease	IMMUNITY			English	Article							KAPPA-B-ZETA; INDUCIBLE NUCLEAR-PROTEIN; PIG-A GENE; MOUSE MODEL; FAS LIGAND; TARGETED DISRUPTION; ANCHORED PROTEINS; SALIVARY-GLANDS; OCULAR SURFACE; ALPHA-FODRIN	Sjogren's syndrome (SS) is an autoimmune disease characterized by exocrinopathy that leads to dry eye and mouth. Although lymphocyte infiltration into exocrine glands and the generation of autoantibodies have been reported in SS, its pathogenic mechanism remains elusive. Here, we show that mice lacking the transcriptional regulator I kappa B-zeta developed SS-like inflammation characterized by lymphocyte-infiltrated dacryoadenitis and SS-associated autoantibodies. In particular, epithelial cells, but not hematopoietic cells, lacking I kappa B-zeta were essential for the development of inflammation. I kappa B-zeta-deficient epithelial cells in the lacrimal glands exhibited enhanced apoptosis even in the absence of lymphocytes. Administration of caspase inhibitors ameliorated the inflammation, indicating the critical role of caspase-mediated apoptosis. Furthermore, epithelial cell-specific STAT3-deficient mice developed SS-like inflammation with impaired I kappa B-zeta expression in the lacrimal glands. Thus, this study reveals a pathogenic mechanism of SS in which dysfunction of epithelial cells caused by disruption of STAT3-mediated I kappa B-zeta induction elicits the activation of self-reactive lymphocytes.	[Okuma, Atsushi; Ohba, Tomoyuki; Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Hoshino, Katsuaki; Kaisho, Tsuneyasu] RIKEN Res Ctr Allergy & Immunol, Host Def Lab, Yokohama, Kanagawa 2300045, Japan; [Hoshino, Katsuaki; Kaisho, Tsuneyasu] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Fukushi, Sawako; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808575, Japan; [Ono, Masao] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Muta, Tatsushi] Ctr Ecosyst Management Adapting Global Change, Global Ctr Excellence Program, Sendai, Miyagi 9808578, Japan	Tohoku University; RIKEN; Osaka University; Osaka University; Tohoku University; Tohoku University; Osaka University	Muta, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan.	tmuta@biology.tohoku.ac.jp	Okuma, Atsushi/V-4675-2019; Hoshino, Katsuaki/L-9162-2014; Hoshino, Katsuaki/AAE-2830-2022; Oba, Tomoyuki/ABT-2152-2022; Okuma, Atsushi/N-7583-2018	Okuma, Atsushi/0000-0002-9086-1781; Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Oba, Tomoyuki/0000-0002-6715-7892; Okuma, Atsushi/0000-0002-9086-1781	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Japan Society for the Promotion of Science [21390088, 24390076]; Takeda Science Foundation; Naito Foundation; Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology;  [24.4191]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology; 	We are grateful to K. Sekikawa (PrivenTec), K. Takeda (Osaka University), J.-i. Miyazaki (Osaka University), J. Takeda (Osaka University), I. Forster (University of Duesseldorf), M. Reth (Max-Planck-Institut fur Immunologie), N. Ishii (Tohoku University), K. Nakayama (Tohoku University), and A. Yoshimura (Keio University) for kindly providing mutant mice. We thank T. Kitamura (The University of Tokyo) for providing pMY-IRES-GFP and Plat-E cells. We also thank T. Maruyama (Tohoku University) for discussion and assistance and Y. Fukuda for technical assistance. This work was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas (21117004) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. M., Grant-in-Aid for Scientific Research (21390088 and 24390076) from the Japan Society for the Promotion of Science to T. M., Grant-in-Aid for JSPS Fellows (24.4191) to A.O., and grants to T. M. from Takeda Science Foundation, the Naito Foundation, the Asahi Grass Foundation, Suzuken Memorial Foundation, the Novartis Foundation for the Promotion of Science, and the Japan Foundation for Applied Enzymology.	Al-Hashimi I, 2001, J ORAL PATHOL MED, V30, P1, DOI 10.1034/j.1600-0714.2001.300101.x; Apostolou I, 2003, J EXP MED, V198, P1103, DOI 10.1084/jem.20030698; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dartt DA, 2004, EXP EYE RES, V78, P337, DOI 10.1016/S0014-4835(03)00202-1; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Higuchi A, 2006, BRIT J OPHTHALMOL, V90, P760, DOI 10.1136/bjo.2005.088203; Hijioka K, 2007, BIOCHEM BIOPH RES CO, V356, P476, DOI 10.1016/j.bbrc.2007.03.002; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Huang M, 2005, CLIN EXP IMMUNOL, V142, P148, DOI 10.1111/j.1365-2249.2005.02888.x; Ishimaru N, 1999, AM J PATHOL, V155, P173, DOI 10.1016/S0002-9440(10)65111-5; Ito MR, 1997, ARTHRITIS RHEUM, V40, P1054, DOI 10.1002/art.1780400610; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kong LP, 1997, ARTHRITIS RHEUM, V40, P87, DOI 10.1002/art.1780400113; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Manganelli P, 2003, SEMIN ARTHRITIS RHEU, V33, P49, DOI 10.1053/sarh.2003.50019; Manoussakis MN, 1999, ARTHRITIS RHEUM, V42, P229, DOI 10.1002/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X; Matsumura R, 1998, CLIN EXP RHEUMATOL, V16, P561; Mavragani CP, 2000, INT ARCH ALLERGY IMM, V123, P46, DOI 10.1159/000024423; Mitsias DI, 2006, ORAL DIS, V12, P523, DOI 10.1111/j.1601-0825.2006.01292.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; MOUTSOPOULOS HM, 1986, ANN RHEUM DIS, V45, P677, DOI 10.1136/ard.45.8.677; Nagaraju K, 2001, ARTHRITIS RHEUM, V44, P2376, DOI 10.1002/1529-0131(200110)44:10<2376::AID-ART402>3.0.CO;2-E; Nakamura H, 1998, CLIN EXP IMMUNOL, V114, P106; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Polihronis M, 1998, CLIN EXP IMMUNOL, V114, P485; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Saegusa K, 2002, J IMMUNOL, V169, P1050, DOI 10.4049/jimmunol.169.2.1050; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Taniguchi T, 1997, LAB INVEST, V77, P647; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Ueta M, 2005, INVEST OPHTH VIS SCI, V46, P579, DOI 10.1167/iovs.04-1055; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P3387, DOI 10.1167/iovs.08-1691; Vissink A, 2003, ARCH OTOLARYNGOL, V129, P966, DOI 10.1001/archotol.129.9.966; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Wu AJ, 1996, J CELL PHYSIOL, V167, P297, DOI 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5; Xiao XY, 2012, INVEST OPHTH VIS SCI, V53, P191, DOI 10.1167/iovs.11-8553; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200	58	103	105	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					450	460		10.1016/j.immuni.2012.11.016	http://dx.doi.org/10.1016/j.immuni.2012.11.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23453632	Bronze			2022-12-18	WOS:000330941500011
J	Bandukwala, HS; Wu, YQ; Feuerer, M; Chen, YH; Barboza, B; Ghosh, S; Stroud, JC; Benoist, C; Mathis, D; Rao, A; Chen, L				Bandukwala, Hozefa S.; Wu, Yongqing; Feuerer, Markus; Chen, Yongheng; Barboza, Bianca; Ghosh, Srimoyee; Stroud, James C.; Benoist, Christophe; Mathis, Diane; Rao, Anjana; Chen, Lin			Structure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T Cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; TUMOR-SUPPRESSOR P53; IMMUNE DYSREGULATION; CRYSTAL-STRUCTURE; TARGET GENES; ENTEROPATHY; NFAT; IPEX; POLYENDOCRINOPATHY; MUTATIONS	The transcription factor FOXP3 is essential for the suppressive function of regulatory T cells that are required for maintaining self-tolerance. We have solved the crystal structure of the FOXP3 forkhead domain as a ternary complex with the DNA-binding domain of the transcription factor NFAT1 and a DNA oligonucleotide from the interleukin-2 promoter. A striking feature of this structure is that FOXP3 forms a domain-swapped dimer that bridges two molecules of DNA. Structure-guided or autoimmune disease (IPEX)-associated mutations in the domain-swap interface diminished dimer formation by the FOXP3 forkhead domain without compromising FOXP3 DNA binding. These mutations also eliminated T cell-suppressive activity conferred by FOXP3, both in vitro and in a murine model of autoimmune diabetes in vivo. We conclude that FOXP3-mediated suppressor function requires dimerization through the forkhead domain and that mutations in the dimer interface can lead to the systemic autoimmunity observed in IPEX patients.	[Bandukwala, Hozefa S.; Barboza, Bianca; Ghosh, Srimoyee; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wu, Yongqing; Chen, Yongheng; Stroud, James C.; Chen, Lin] Univ So Calif, Norris Comprehens Canc Ctr, Dept Chem, Dept Biol Sci, Los Angeles, CA 90089 USA; [Bandukwala, Hozefa S.; Feuerer, Markus; Ghosh, Srimoyee; Benoist, Christophe; Mathis, Diane; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bandukwala, Hozefa S.; Barboza, Bianca; Ghosh, Srimoyee; Rao, Anjana] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Bandukwala, Hozefa S.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Southern California; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@liai.org; linchen@usc.edu	Stroud, James C/B-3230-2012; chen, Lin/A-3392-2008	Stroud, James C/0000-0003-0850-4812; chen, Lin/0000-0003-4798-6199	NIH [AI48213, AI44432, CA42471, AI40127, RO1 GM077320, GM064642, T32]; Juvenile Diabetes Research Foundation [17-2010-421, 16-2007-427]; Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI040127, R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279, R01DK070055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, R01GM077320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M.K. Levings and A.N. McMurchy for discussions and for sharing their findings regarding the IPEX mutations investigated in this study, the USC NanoBiophysics Core facility for the MALS study, ALS BCSB staff members C. Ralston, P. Zwart, and K. Royal for help with data collection, and N. Neamati for help with FRET studies. This work was supported by NIH grants AI48213, AI44432, CA42471, and AI40127 and Juvenile Diabetes Research Foundation grants 17-2010-421 and 16-2007-427 (to A.R.) and NIH grants RO1 GM077320 and GM064642 (to L.C.). H.S.B. was supported by a postdoctoral fellowship from the Lady Tata Memorial Trust and currently by a postdoctoral fellowship from the GlaxoSmithKline-Immune Disease Institute Alliance. S.G. is supported by an NIH postdoctoral training grant (T32).	Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bates DL, 2008, STRUCTURE, V16, P684, DOI 10.1016/j.str.2008.01.020; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2009, ENDOCRIN METAB CLIN, V38, P265, DOI 10.1016/j.ecl.2009.01.002; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Giffin MJ, 2003, NAT STRUCT BIOL, V10, P800, DOI 10.1038/nsb981; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jin L, 2003, NAT STRUCT BIOL, V10, P807, DOI 10.1038/nsb975; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Li B, 2007, CELL CYCLE, V6, P1432; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ochs HD, 2007, IMMUNOL RES, V38, P112, DOI 10.1007/s12026-007-0022-2; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Peng J, 2007, J AUTOIMMUN, V28, P188, DOI 10.1016/j.jaut.2007.02.015; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	48	103	107	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					479	491		10.1016/j.immuni.2011.02.017	http://dx.doi.org/10.1016/j.immuni.2011.02.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21458306	Green Accepted, Bronze			2022-12-18	WOS:000290367300008
J	Chen, K; Cerutti, A				Chen, Kang; Cerutti, Andrea			Vaccination Strategies to Promote Mucosal Antibody Responses	IMMUNITY			English	Review							REGULATORY T-CELLS; CLASS-SWITCH RECOMBINATION; SEGMENTED FILAMENTOUS BACTERIA; GROWTH-FACTOR-BETA; DIVISION-OF-LABOR; DENDRITIC CELLS; B-CELLS; EPITHELIAL-CELLS; TGF-BETA; IMMUNOLOGICAL PARALYSIS	There are great interest and demand for the development of vaccines to prevent and treat diverse microbial infections Mucosal vaccines elicit immune protection by stimulating the production of antibodies at mucosal surfaces and systemic districts Being positioned in close proximity to a large community of commensal microbes, the mucosal immune system deploys a heterogeneous population of cells and a complex regulatory network to maintain the balance between surveillance and tolerance A successful mucosa, vaccine relies on leveraging the functions of these immune cells and regulatory components We review the important cellular interactions and molecular pathways underlying the induction and regulation of mucosal antibody responses and discuss their implications on mucosal vaccination	[Chen, Kang; Cerutti, Andrea] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA; [Cerutti, Andrea] IMIM Hosp del Mar Barcelona, Catalan Inst Res & Adv Studies, Barcelona 08003, Spain	Icahn School of Medicine at Mount Sinai; ICREA; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Cerutti, A (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1 Gustave L Levy Pl, New York, NY 10029 USA.			Cerutti, Andrea/0000-0003-3026-4704	U S National Institutes of Health [R01 AI 05753, R01 AI 074378, ARRA AI 61093]; Hemsley Foundation for IBD research Ministerio de Ciencia e Innovacion [SAF 2008 02725]; Fundacio IMIM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057653, P01AI061093, R01AI074378] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	U S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hemsley Foundation for IBD research Ministerio de Ciencia e Innovacion; Fundacio IMIM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	Supported by U S National Institutes of Health grants R01 AI 05753 R01 AI 074378 ARRA AI 61093 funds from The Hemsley Foundation for IBD research Ministerio de Ciencia e Innovacion grant SAF 2008 02725 and funds from Fundacio IMIM (to AC)	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg Per, 2007, P221, DOI 10.1007/978-0-387-72232-0_10; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Casola S, 2006, CURR TOP MICROBIOL, V308, P155; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chadwick S, 2010, ADV DRUG DELIVER REV, V62, P394, DOI 10.1016/j.addr.2009.11.012; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gallichan WS, 1996, J EXP MED, V184, P1879, DOI 10.1084/jem.184.5.1879; Gebert A, 1999, SEMIN IMMUNOL, V11, P165, DOI 10.1006/smim.1999.0172; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; HALLIDAY WJ, 1971, BACTERIOL REV, V35, P267, DOI 10.1128/MMBR.35.3.267-289.1971; HAPFELMEIER S, 2010, SCIENCE, V329, P1646; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iwasaki A, 2007, CELL, V128, P435, DOI 10.1016/j.cell.2007.01.024; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Phipps PA, 2003, EUR J IMMUNOL, V33, P224, DOI 10.1002/immu.200390025; Pulendran B, 2006, NAT IMMUNOL, V7, P699, DOI 10.1038/ni0706-699; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SATOH TN, 2008, IMMUNITY, V29, P958; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sha ZY, 2005, VIROLOGY, V331, P387, DOI 10.1016/j.virol.2004.10.014; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; STEVENS SK, 1982, J IMMUNOL, V128, P844; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki K, 2009, MUCOSAL IMMUNOL, V2, P468, DOI 10.1038/mi.2009.107; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tamura S, 1997, VACCINE, V15, P225, DOI 10.1016/S0264-410X(96)00135-1; Tarkowski A, 1999, ARTHRITIS RHEUM, V42, P1628, DOI 10.1002/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; VIJAY KM, 2010, SCIENCE, V328, P228; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	146	103	106	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					479	491		10.1016/j.immuni.2010.09.013	http://dx.doi.org/10.1016/j.immuni.2010.09.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029959	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000284300200005
J	Deguine, J; Breart, B; Lemaitre, F; Di Santo, JP; Bousso, P				Deguine, Jacques; Breart, Beatrice; Lemaitre, Fabrice; Di Santo, James P.; Bousso, Philippe			Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8(+) T Cells during Tumor Regression	IMMUNITY			English	Article							ACTIVATING NKG2D RECEPTOR; NK CELLS; IN-VIVO; INHIBITORY RECEPTOR; IMMUNE-SYSTEM; TARGET-CELLS; IFN-GAMMA; LIGANDS; RECOGNITION; CYTOTOXICITY	Recognition of NKG2D ligands by natural killer (NK) cells plays an important role during antitumoral responses To address how NKG2D engagement affects intratumoral NK cell dynamics, we performed intravital microscopy in a Rae-1 beta-expressing solid tumor This NKG2D ligand drove NK cell accumulation, activation, and motility within the tumor NK cells established mainly dynamic contacts with their targets during tumor regression In sharp contrast, cytotoxic T lymphocytes (CTLs) formed stable contacts in tumors expressing their cognate antigen Similar behaviors were observed during effector functions in lymph nodes In vitro, contacts between NK cells and their targets were cytotoxic but did not elicit sustained calcium influx nor adhesion, whereas CTL contact stability was critically dependent on extracellular calcium entry Altogether, our results offer mechanistic insight into how NK cells and CTLs can exert cytotoxic activity with remarkably different contact dynamics	[Deguine, Jacques; Breart, Beatrice; Lemaitre, Fabrice; Bousso, Philippe] Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France; [Deguine, Jacques; Breart, Beatrice; Lemaitre, Fabrice; Bousso, Philippe] INSERM, U668, Equipe Avenir, F-75015 Paris, France; [Di Santo, James P.] Inst Pasteur, INSERM, U668, Innate Immun Unit, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Deguine, J (corresponding author), Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France.		Di Santo, James P/M-4298-2014; BOUSSO, Philippe/M-6547-2014; Breart, Beatrice/M-7123-2014	Di Santo, James P/0000-0002-7146-1862; BOUSSO, Philippe/0000-0002-6362-561X; Deguine, Jacques/0000-0001-9218-3040	Center for Human Immunology at Institut Pasteur; Institut Pasteur INSERM Maine de Paris; Marie Curie Excellence grant	Center for Human Immunology at Institut Pasteur; Institut Pasteur INSERM Maine de Paris; Marie Curie Excellence grant(European Commission)	We thank D Raulet for providing tumor cell lines and plasmids E Robey and members of the Bousso lab for helpful comments on the manuscript and Plate forme de Cytometrie Institut Pasteur We acknowledge M Hasan and the Center for Human Immunology at Institut Pasteur for support in conducting this study This work was supported by Institut Pasteur INSERM Maine de Paris and by a Marie Curie Excellence grant J D BB and P B designed the research J D BB and F L performed the research J P D provided critical reagents J D analyzed data and J D and P B wrote the paper	Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Burgess SJ, 2008, IMMUNOL RES, V40, P18, DOI 10.1007/s12026-007-0060-9; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Caramalho I, 2009, J CELL MOL MED, V13, P3834, DOI 10.1111/j.1582-4934.2008.00586.x; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Colucci F, 1999, J IMMUNOL, V162, P2761; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eriksson M, 1999, J EXP MED, V190, P1005, DOI 10.1084/jem.190.7.1005; Garrod KR, 2010, J IMMUNOL, V184, P2329, DOI 10.4049/jimmunol.0902748; Garrod KR, 2007, P NATL ACAD SCI USA, V104, P12081, DOI 10.1073/pnas.0702867104; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; PORES FAT, 2009, IMMUNOL REV, V231, P160; PORES FAT, 2009, CELL IMMUNOL, V254, P105; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	46	103	107	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 29	2010	33	4					632	644		10.1016/j.immuni.2010.09.016	http://dx.doi.org/10.1016/j.immuni.2010.09.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	20951068	Bronze			2022-12-18	WOS:000284300200019
J	Kaufmann, T; Jost, PJ; Pellegrini, M; Puthalakath, H; Gugasyan, R; Gerondakis, S; Cretney, E; Smyth, MJ; Silke, J; Hakem, R; Bouillet, P; Mak, TW; Dixit, VM; Strasser, A				Kaufmann, Thomas; Jost, Philipp J.; Pellegrini, Marc; Puthalakath, Hamsa; Gugasyan, Raffi; Gerondakis, Steve; Cretney, Erika; Smyth, Mark J.; Silke, John; Hakem, Razq; Bouillet, Philippe; Mak, Tak W.; Dixit, Vishva M.; Strasser, Andreas			Fatal Hepatitis Mediated by Tumor Necrosis Factor TNF alpha Requires Caspase-8 and Involves the BH3-Only Proteins Bid and Bim	IMMUNITY			English	Article							INDUCED APOPTOSIS; IN-VIVO; T-CELLS; ACTIVATION; BCL-2; DEFICIENT; FAMILY; DEATH; JNK; BAX	Apoptotic death of hepatocytes, a contributor to many chronic and acute liver diseases, can be a consequence of overactivation of the immune system and is often mediated by TNF alpha. Injection with lipopolysaccharide (LPS) plus the transcriptional inhibitor D(+)-galactosamine (GaIN) or mitogenic T cell activation causes fatal hepatocyte apoptosis in mice, which is mediated by TNF alpha, but the effector mechanisms remain unclear. Our analysis of gene-targeted mice showed that caspase-8 is essential for hepatocyte killing in both settings. Loss of Bid, the proapoptotic BH3-only protein activated by caspase-8 and essential for Fas ligand-induced hepatocyte killing, resulted only in a minor reduction of liver damage. However, combined loss of Bid and another BH3-only protein, Bim, activated by c-Jun N-terminal kinase (JNK), protected mice from LPS+GaIN-induced hepatitis. These observations identify caspase-8 and the BH3-only proteins Bid and Bim as potential therapeutic targets for treatment of inflammatory liver diseases.	[Kaufmann, Thomas; Jost, Philipp J.; Puthalakath, Hamsa; Gugasyan, Raffi; Gerondakis, Steve; Bouillet, Philippe; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Pellegrini, Marc; Hakem, Razq; Mak, Tak W.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Cretney, Erika; Smyth, Mark J.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Silke, John] La Trobe Univ, Bundoora, Vic 3086, Australia; [Dixit, Vishva M.] Genentech Inc, San Francisco, CA 94080 USA	Walter & Eliza Hall Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Peter Maccallum Cancer Center; La Trobe University; Roche Holding; Genentech	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	strasser@wehi.edu.au	Smyth, Mark J/H-8709-2014; Bouillet, Philippe/E-1241-2013; dixit, vishva m/A-4496-2012; Jost, Philipp J./S-4962-2016; Strasser, Andreas/C-7581-2013; Puthalakath, Hamsa/B-8541-2011; Pellegrini, Marc/F-7670-2014; Silke, John/B-7622-2008	Smyth, Mark J/0000-0001-7098-7240; Bouillet, Philippe/0000-0002-9012-6058; dixit, vishva m/0000-0001-6983-0326; Jost, Philipp J./0000-0003-2454-0362; Strasser, Andreas/0000-0002-5020-4891; Silke, John/0000-0002-7611-5774; Pellegrini, Marc/0000-0003-3627-3126; Hakem, Razqallah/0000-0001-5948-7931; Kaufmann, Thomas/0000-0001-9906-874X	NHMRG; NCI [#CA 80188, #CA 43540]; Leukemia and Lymphoma Society of America [#7015]; JDRF/NHMRC; Swiss National Science Foundation; Roche Research Foundation; Novarlis Foundation; Mildred-Scheel Stiftung/Deutsche Krebshilfe;  [#257502]; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	NHMRG; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); JDRF/NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Novarlis Foundation; Mildred-Scheel Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Adams, S. Cory, D. Huang, K. Rajewski, H. Koerner, and Y. Lazebnik for gifts of gene-targeted mice or antibodies. We thank K. Vella, N. lannarella, and G. Siciliano for animal care, C. Young and D. Chau for excellent technical assistance, M. Robati and B. Helbert for genotyping, the Biochemistry Department of the Royal Melbourne Hospital for ALT and AST measurements, and J. Adams, S. Cory, D. Huang, D. Vaux, and L. O'Reilly for advice and critical comments on the manuscript. This work was supported by grants (program #257502) and fellowships from the NHMRG (Canberra), the NCI (NIH, USA; #CA 80188 and #CA 43540), the Leukemia and Lymphoma Society of America (SCOR grant #7015), the JDRF/NHMRC, the Swiss National Science Foundation, the Roche Research Foundation, the Novarlis Foundation (formerly Ciba-Geigy-Jubilaeumsstiftung; postdoctoral fellowships to T.K.) and the Mildred-Scheel Stiftung/Deutsche Krebshilfe (postdoctoral fellowship to P.J.J.). V.M.D. is an employee at Genentech, Inc.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2007, CELL DEATH DIFFER, V14, P637, DOI 10.1038/sj.cdd.4402061; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	40	103	105	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					56	66		10.1016/j.immuni.2008.10.017	http://dx.doi.org/10.1016/j.immuni.2008.10.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19119023	Bronze, Green Accepted			2022-12-18	WOS:000262769900010
J	Devadas, S; Das, J; Liu, C; Zhang, LY; Roberts, AI; Pan, Z; Moore, PA; Das, G; Shi, YF				Devadas, Satish; Das, Jyoti; Liu, Catherine; Zhang, Liying; Roberts, Arthur I.; Pan, Zui; Moore, Paul A.; Das, Gobardhan; Shi, Yufang			Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells	IMMUNITY			English	Article							ACTIVATION-INDUCED CELL; MEDIATED CYTOTOXICITY; DIFFERENTIAL ABILITY; FAS LIGAND; APOPTOSIS; TH2; LYMPHOCYTES; EXPRESSION; RESPONSES; SUBSETS	Although CD95L is required for T cell receptor (TCR)-induced cell death (TCR-ICD) in T helper 1 cells, the molecular mechanisms mediating TCR-ICD in Th2 cells are unknown. We found that death receptors were not involved in TCR-ICD of Th2 cells because blocking their cognate ligands had no effect on apoptosis of activated Th2 cells. Furthermore, we showed that caspases were not actively involved in TCR-ICD of Th2 cells. However, inhibition of granzyme B (GrB) activity abolished TCR-ICD in Th2 cells but not Th1 cells. Likewise, Th2 cells derived from GrB-deficient mice were resistant to TCR-ICD, and GrB deficiency or inhibition of GrB activity consequently enhanced the production of Th2 cytokines. GrB-deficient mice exhibited increased susceptibility to allergen-induced asthma. Thus, GrB plays a critical role in the TCR-ICD of Th2 cells.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; GlaxoSmithKline; Human Genome Sciences Inc	Shi, YF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 661 Hoes Lane, Piscataway, NJ 08854 USA.	shiyu@umdnj.edu	Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; Pan, Zui/0000-0003-4105-901X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043384, R01AI050222, R21AI043384, P01AI057596] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43384, AI50222, AI057596] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbar AN, 1997, IMMUNOL TODAY, V18, P72, DOI 10.1016/S0167-5699(97)01003-7; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Bidere N, 2002, J BIOL CHEM, V277, P32339, DOI 10.1074/jbc.M205153200; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Janssen O, 2000, CELL TISSUE RES, V301, P85, DOI 10.1007/s004419900155; Komoriya A, 2000, J EXP MED, V191, P1819, DOI 10.1084/jem.191.11.1819; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Levine BL, 1997, J IMMUNOL, V159, P5921; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Meade JL, 2006, BLOOD, V107, P3665, DOI 10.1182/blood-2005-03-1140; MERCEP M, 1988, J IMMUNOL, V140, P324; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; Oberg HH, 1997, CELL IMMUNOL, V181, P93, DOI 10.1006/cimm.1997.1200; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Raja SM, 2003, CURR OPIN IMMUNOL, V15, P528, DOI 10.1016/S0952-7915(03)00111-0; RAMSDELL F, 1994, INT IMMUNOL, V6, P1545, DOI 10.1093/intimm/6.10.1545; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Sehra S, 2005, J IMMUNOL, V174, P3440, DOI 10.4049/jimmunol.174.6.3440; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Takeda K, 2005, EUR RESPIR J, V26, P577, DOI 10.1183/09031936.05.00090304; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Watanabe N, 1997, EUR J IMMUNOL, V27, P1858, DOI 10.1002/eji.1830270807; Yamada M, 2003, FASEB J, V17, P1712, DOI 10.1096/fj.02-0116fje; Yates A, 2000, J THEOR BIOL, V206, P539, DOI 10.1006/jtbi.2000.2147; Zhang J, 2001, J IMMUNOL, V166, P4981, DOI 10.4049/jimmunol.166.8.4981; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	44	103	108	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					237	247		10.1016/j.immuni.2006.06.011	http://dx.doi.org/10.1016/j.immuni.2006.06.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16901729	Bronze			2022-12-18	WOS:000240047500010
J	Belyakov, IM; Berzofsky, JA				Belyakov, IM; Berzofsky, JA			Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; LYMPH-NODE IMMUNIZATION; CHEMOKINE RECEPTOR 9; DENDRITIC CELLS; PEYERS PATCH; CPG MOTIFS; TISSUE; TRANSMISSION; INDUCTION	Mucosal tissues are the primary site of natural HIV transmission and a major reservoir for HIV replication. Targeting immune responses to the mucosal entry site before viral dissemination could protect and also clear viral reservoirs. Recent understanding of mucosal HIV transmission and of chemokines and integrins in mucosal trafficking can aid design of new strategies to enhance AIDS vaccine efficacy.	NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Belyakov, IM (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	belyakov@mail.nih.gov			NATIONAL CANCER INSTITUTE [Z01SC004020, ZIASC004020] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlers JD, 2003, CURR MOL MED, V3, P285, DOI 10.2174/1566524033479843; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Belyakov IM, 2000, J IMMUNOL, V165, P6454, DOI 10.4049/jimmunol.165.11.6454; Belyakov IM, 1998, J VIROL, V72, P8264, DOI 10.1128/JVI.72.10.8264-8272.1998; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; Belyakov IM, 1998, P NATL ACAD SCI USA, V95, P1709, DOI 10.1073/pnas.95.4.1709; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; BELYAKOV IM, 2004, IN PRESS J CLIN INVE; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Campbell DJ, 2002, J CLIN INVEST, V110, P1079, DOI 10.1172/JCI200216946; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Cheng E, 1999, VACCINE, V18, P38, DOI 10.1016/S0264-410X(99)00168-1; Cromwell MA, 2000, J VIROL, V74, P8762, DOI 10.1128/JVI.74.18.8762-8766.2000; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Horner AA, 2001, J IMMUNOL, V167, P1584, DOI 10.4049/jimmunol.167.3.1584; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kaneko H, 2000, VIROLOGY, V267, P8, DOI 10.1006/viro.1999.0093; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Klavinskis LS, 1996, J IMMUNOL, V157, P2521; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kozlowski PA, 2003, CURR MOL MED, V3, P217, DOI 10.2174/1566524033479852; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; KUKEL EJ, 2003, J CLIN INVEST, V111, P1001; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lehner T, 1999, IMMUNOL REV, V170, P183, DOI 10.1111/j.1600-065X.1999.tb01338.x; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; Lehner T, 2002, TRENDS IMMUNOL, V23, P347, DOI 10.1016/S1471-4906(02)02252-4; Lehner T, 2000, EUR J IMMUNOL, V30, P2245, DOI 10.1002/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7; LOHMAN BL, 1995, J IMMUNOL, V155, P5855; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McMichael A, 2002, NAT REV IMMUNOL, V2, P283, DOI 10.1038/nri779; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Murphey-Corb M, 1999, J IMMUNOL, V162, P540; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Porgador A, 1997, J IMMUNOL, V158, P834; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Shata MT, 2001, VACCINE, V20, P623, DOI 10.1016/S0264-410X(01)00330-9; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	53	103	114	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					247	253		10.1016/S1074-7613(04)00053-6	http://dx.doi.org/10.1016/S1074-7613(04)00053-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030769	Bronze			2022-12-18	WOS:000221442600003
J	Swanson, BJ; Murakami, M; Mitchell, TC; Kappler, J; Marrack, P				Swanson, BJ; Murakami, M; Mitchell, TC; Kappler, J; Marrack, P			RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process	IMMUNITY			English	Article							TRANSLATIONAL REGULATION; MESSENGER-RNA; TNF-ALPHA; LYMPHOCYTES; IL-15; GENERATION; EXPRESSION; CHEMOKINES; LOCALIZATION; INDUCTION	An examination of differences in gene expression between memory and naive phenotype T cells revealed elevated levels of mRNA for several chemokines, especially RANTES, in memory phenotype T cells. Although RANTES mRNA is spliced and cytoplasmic, these cells do not contain or secrete significant amounts of RANTES protein without TCR stimulation. This secretion is independent of transcription, but requires translation. In vivo, CD8+ memory T cells proliferate continuously and slowly in response to IL-15; however, IL-15 does not stimulate RANTES secretion. These results show that memory phenotype CD8+ T cells use preexisting mRNA to produce and secrete RANTES rapidly following TCR stimulation. Such storage of preformed mRNAs for important inflammatory mediators may contribute to the speed of secondary immune responses.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.		Mitchell, Thomas C/B-4193-2013; Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, P01AI022295, R01AI018785, R37AI018785, R56AI017134, R56AI018785, R01AI017134, R01AI052225] Funding Source: NIH RePORTER; NCI NIH HHS [CA-46934] Funding Source: Medline; NIAID NIH HHS [AI-17134, AI-52225, AI-22295, AI-18785] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; DANOFF TM, 1994, J IMMUNOL, V152, P1182; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Gray D, 2000, NAT IMMUNOL, V1, P11, DOI 10.1038/76862; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HENTZE MW, 1995, CURR OPIN CELL BIOL, V7, P393, DOI 10.1016/0955-0674(95)80095-6; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Perera LP, 1999, J IMMUNOL, V162, P2606; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Sonenberg N, 2000, TRANSLATIONAL CONTRO; SOZZANI S, 1995, J IMMUNOL, V155, P3292; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Yang Y, 1998, J EXP MED, V188, P247, DOI 10.1084/jem.188.2.247; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	38	103	106	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					605	615		10.1016/S1074-7613(02)00456-9	http://dx.doi.org/10.1016/S1074-7613(02)00456-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433367	Bronze			2022-12-18	WOS:000179335100007
J	Doebele, RC; Busch, R; Scott, HM; Pashine, A; Mellins, ED				Doebele, RC; Busch, R; Scott, HM; Pashine, A; Mellins, ED			Determination of the HLA-DM interaction site on HLA-DR molecules	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INVARIANT CHAIN PEPTIDES; CLASS-II MOLECULES; ANTIGEN PRESENTATION; CONFORMATIONAL-CHANGES; LEUKOCYTE ANTIGEN; CRYSTAL-STRUCTURE; MHC MOLECULES; LYSOSOMAL PH; CELL LINE	HLA-DM removes CLIP and other loosely bound peptides from MHC class II molecules. The crystal structures of class II molecules and of HLA-DM have not permitted identification of their interaction sites. Here, we describe mutations in class II that impair interactions with DM. Libraries of randomly mutagenized DR3 alpha and beta chains were screened for their ability to cause cell surface accumulation of CLIP/DR3 complexes in EBV-B cells. Seven mutations were associated with impaired peptide loading in vivo, as detected by SDS stability assays. In vitro, these mutant DR3 molecules were resistant to DM-catalyzed CLIP release and showed reduced binding to DM. All mutations localize to a single lateral face of HLA-DR, which we propose interacts with DM during peptide exchange.	Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Stanford Univ, Med Ctr, Dept Pediat, Div Transplantat Biol & Immunol, Stanford, CA 94305 USA	University of Pennsylvania; Stanford University	Doebele, RC (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.		Doebele, Robert C./I-8230-2019	Doebele, Robert C./0000-0001-6728-6857; Busch, Robert/0000-0002-4132-0751; Mellins, Elizabeth/0000-0003-2577-139X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI028809, R01AI028809] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28809] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BODMER JG, 1995, HUM IMMUNOL, V43, P149, DOI 10.1016/0198-8859(95)00071-B; Busch R, 1998, J IMMUNOL, V160, P734; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; BUSCH R, 1995, EUR J IMMUNOL, V25, P48, DOI 10.1002/eji.1830250110; Clark E. A., 1984, LEUCOCYTE TYPING HUM, P339; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Guerra CB, 1998, J IMMUNOL, V160, P4289; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JOHNSON JP, 1982, J EXP MED, V156, P104, DOI 10.1084/jem.156.1.104; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; PIOUS D, 1985, J EXP MED, V162, P1193, DOI 10.1084/jem.162.4.1193; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Schafer PH, 1996, J IMMUNOL, V157, P5487; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Suh WK, 1999, J IMMUNOL, V162, P1530; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Vogt AB, 1997, IMMUNOL LETT, V57, P209, DOI 10.1016/S0165-2478(97)00061-8; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	46	103	103	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					517	527		10.1016/S1074-7613(00)00051-0	http://dx.doi.org/10.1016/S1074-7613(00)00051-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070170	Bronze			2022-12-18	WOS:000090079100011
J	Callard, R; George, AJT; Stark, J				Callard, R; George, AJT; Stark, J			Cytokines, chaos, and complexity	IMMUNITY			English	Review							POLYMORPHISMS; INTERLEUKIN-10; ASTHMA; ALPHA		UCL, Ctr Math & Phys Life Sci & Expt Biol, London WC1E 6BT, England; UCL, Ctr Nonlinear Dynam & Its Applicat, London WC1E 6BT, England; Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Hammersmith Hosp, Imperial Coll, Sch Med, Div Med,Dept Immunol, London W12 0NN, England	University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Callard, R (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, Gower St, London WC1E 6BT, England.	rcallard@ich.ucl.ac.uk	Callard, Robin E/C-5682-2008	George, Andrew/0000-0002-2866-0241				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Amiot F, 1997, EUR J IMMUNOL, V27, P1035, DOI 10.1002/eji.1830270434; Barnes KC, 1998, IMMUNOL TODAY, V19, P325, DOI 10.1016/S0167-5699(97)01241-3; CHAN CCW, 1999, IN PRESS P R SOC L B; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958, DOI 10.1164/ajrccm.158.6.9804011; Hurme M, 1998, ANN MED, V30, P469, DOI 10.3109/07853899809002488; Mullighan CG, 1997, J IMMUNOL, V159, P6236; Othmer H.G., 1997, CASE STUDIES MATH MO; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SHINBROT T, 1993, NATURE, V363, P411, DOI 10.1038/363411a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Turner D, 1997, TRANSPLANTATION, V64, P776, DOI 10.1097/00007890-199709150-00021; Woo P, 1997, RHEUM DIS CLIN N AM, V23, P491, DOI 10.1016/S0889-857X(05)70344-6	14	103	107	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					507	513		10.1016/S1074-7613(00)80125-9	http://dx.doi.org/10.1016/S1074-7613(00)80125-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591175	Bronze			2022-12-18	WOS:000083952200001
J	Swanson, PC; Desiderio, S				Swanson, PC; Desiderio, S			V(D)J recombination signal recognition: Distinct, overlapping DNA-protein contacts in complexes containing RAG1 with and without RAG2	IMMUNITY			English	Article							COLI RNA-POLYMERASE; HIN RECOMBINASE; STRUCTURE REQUIREMENTS; 2 STEPS; SEQUENCE; CLEAVAGE; PROMOTER; SPECIFICITY; INITIATION; MOLECULES	Protein interactions with V(D)J recombination signal sequences (RSSs) were mapped in complexes containing RAG1 with (M1/2) or without (M1) RAGS. In both complexes, RAG interactions with the DNA backbone are biased toward one side of the helix; nonamer contacts resemble those of Hin with hixL. In the M1 complex, DNA contacts are centered on the nonamer. In the M1/2 complex, protein-RSS interactions extend through the spacer and into the nonamer-proximal portion of the heptamer. Chemical modifications near the heptamer-coding junction are overrepresented in the M1/2 complex, providing evidence for perturbation of DNA structure in this region. Thus, while RAG1 alone can bind the nonamer, RAGS is required for heptamer occupancy.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.				NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [CA16519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; FRAPPIER L, 1992, J VIROL, V66, P1786, DOI 10.1128/JVI.66.3.1786-1790.1992; GLASGOW AC, 1989, J BIOL CHEM, V264, P10072; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; HUGHES KT, 1992, EMBO J, V11, P2695, DOI 10.1002/j.1460-2075.1992.tb05335.x; Kung HC, 1997, J BIOL CHEM, V272, P9227; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li WH, 1997, MOL CELL BIOL, V17, P6932, DOI 10.1128/MCB.17.12.6932; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Nagawa F, 1998, MOL CELL BIOL, V18, P655, DOI 10.1128/MCB.18.1.655; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OHLSEN KL, 1992, J BIOL CHEM, V267, P19813; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Roman CAJ, 1996, P NATL ACAD SCI USA, V93, P2333, DOI 10.1073/pnas.93.6.2333; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SADOFSKY MJ, 1995, GENE DEV, V9, P2193, DOI 10.1101/gad.9.17.2193; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SIGMAN DS, 1991, METHOD ENZYMOL, V208, P414; SLUKA JP, 1990, BIOCHEMISTRY-US, V29, P6551, DOI 10.1021/bi00480a002; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; TRUSS M, 1990, P NATL ACAD SCI USA, V87, P7180, DOI 10.1073/pnas.87.18.7180; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592	37	103	103	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					115	125		10.1016/S1074-7613(00)80593-2	http://dx.doi.org/10.1016/S1074-7613(00)80593-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697841	Bronze			2022-12-18	WOS:000075066600011
J	ten Boekel, E; Melchers, F; Rolink, AG				ten Boekel, E; Melchers, F; Rolink, AG			Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; MOUSE BONE-MARROW; IMMUNOGLOBULIN-MU; HEAVY-CHAIN; TARGETED DISRUPTION; MEMBRANE EXON; SINGLE CELLS; IG-BETA; GENE; REARRANGEMENTS	Within the pools of mu H chain-producing precursor and mature B cells from normal and lambda 5-defective mice, the frequency of cells in which both H chain alleles were productively V(H)DJ(H) rearranged was determined. An equally high percentage (2%-4%) of cells carrying two productively V(H)DJ(H)-rearranged H chain loci was found in precursor and mature B cell pools of both mouse strains. In all of these cells, one allele encodes a mu H chain incapable of forming a surface-expressed pre-B cell receptor. Hence, allelic exclusion is maintained at the level of pre-B cell receptor expression. The surprising conservation of H chain allelic exclusion in lambda 5-defective B cells suggests that an alternative form of pre-B cell receptor might function to ensure this allelic exclusion.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Melchers, F (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.							AIT F, 1984, EMBO J, V3, P1209; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; DECKER DJ, 1991, J IMMUNOL, V147, P1406; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HIRABAYASHI Y, 1995, J IMMUNOL, V155, P1218; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOBAT E, 1991, NIH PUBLICATION, P1335; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; NISHIMOTO N, 1991, P NATL ACAD SCI USA, V88, P6284, DOI 10.1073/pnas.88.14.6284; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; PICARELLA D, 1991, EUR J IMMUNOL, V21, P55, DOI 10.1002/eji.1830210110; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROLINK A, 1995, IMMUNOLOGIST, V3, P125; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; tenBoekel E, 1997, IMMUNITY, V7, P357; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; WABL M, 1982, P NATL ACAD SCI-BIOL, V79, P6976, DOI 10.1073/pnas.79.22.6976; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WEILER E, 1965, P NATL ACAD SCI USA, V54, P1765, DOI 10.1073/pnas.54.6.1765; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5	43	103	106	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					199	207						9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492001				2022-12-18	WOS:000072201800007
J	Pierre, P; Denzin, LK; Hammond, C; Drake, JR; Amigorena, S; Cresswell, P; Mellman, I				Pierre, P; Denzin, LK; Hammond, C; Drake, JR; Amigorena, S; Cresswell, P; Mellman, I			HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments	IMMUNITY			English	Article							INVARIANT CHAIN CONTAINS; SURFACE EXPRESSION; TRANSPORT; MOLECULES; ENDOSOMES; COMPLEX; GENES; ELECTROPHORESIS; LYSOSOMES; ANTIGENS	HLA-DM molecules remove invariant (ii) chain peptides from newly synthesized MHC class II complexes. Their localization may thus delineate compartments, e.g., MIIC, specialized for loading peptides onto class II molecules. In murine A20 B cells, however, DM is not restricted to specialized endosomal class II-containing vesicles (CIIV). Although DM was found in CIIV, it was also found throughout the endocytic pathway, principally in lysosomes devoid of class II molecules. In human lymphoblasts, HLA-DM was found in structures indistinguishable from late endosomes or lysosomes, although in these cells the lysosomes contained MHC class II molecules. Thus, the distribution of HLA-DM does not necessarily identify specialized class II compartments. Many ''MIIC'' may represent conventional lysosomes that accumulate MHC class II and HLA-DM in a number of cell types.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06520	Howard Hughes Medical Institute; Yale University	Pierre, P (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,NEW HAVEN,CT 06520, USA.		Mellman, Ira/ABG-5896-2020	Amigorena, Sebastian/0000-0001-8583-8416; pierre, philippe/0000-0003-0863-8255				AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BARNES KA, 1995, J EXP MED, V181, P1715, DOI 10.1084/jem.181.5.1715; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; CALAFAT J, 1994, J CELL BIOL, V126, P967, DOI 10.1083/jcb.126.4.967; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CHERVONSKY AV, 1994, INT IMMUNOL, V6, P973, DOI 10.1093/intimm/6.7.973; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; GRIFFITH IJ, 1988, J EXP MED, V167, P541, DOI 10.1084/jem.167.2.541; Holtzman E, 1989, LYSOSOMES; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAMB CA, 1992, J IMMUNOL, V148, P3478; LINDSTEDT R, 1995, IMMUNITY, V3, P561, DOI 10.1016/1074-7613(95)90127-2; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; MARZELLA L, 1987, LYSOSOMES THEIR ROLE; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MELLMAN I, 1995, CURR OPIN CELL BIOL, V7, P564, DOI 10.1016/0955-0674(95)80014-X; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PIETERS J, 1993, J CELL SCI, V106, P831; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; ROCHE PA, 1995, IMMUNITY, V3, P259, DOI 10.1016/1074-7613(95)90111-6; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SMILEY ST, 1996, IN PRESS P NATL ACAD; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	52	103	104	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					229	239		10.1016/S1074-7613(00)80431-8	http://dx.doi.org/10.1016/S1074-7613(00)80431-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624813	Bronze			2022-12-18	WOS:A1996UC01800004
J	Yang, XY; Cheng, XY; Tang, YT; Qiu, XH; Wang, YP; Kang, HX; Wu, JF; Wang, ZT; Liu, YK; Chen, FP; Xiao, XZ; Mackman, N; Billiar, TR; Han, JH; Lu, B				Yang, Xinyu; Cheng, Xiaoye; Tang, Yiting; Qiu, Xianhui; Wang, Yupeng; Kang, Haixia; Wu, Jianfeng; Wang, Zhongtai; Liu, Yukun; Chen, Fangping; Xiao, Xianzhong; Mackman, Nigel; Billiar, Timothy R.; Han, Jiahuai; Lu, Ben			Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure	IMMUNITY			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; NONCANONICAL INFLAMMASOME ACTIVATION; TISSUE FACTOR; PROCOAGULANT ACTIVITY; THROMBUS FORMATION; MONOCYTIC CELLS; CASPASE-11; PYROPTOSIS; PROTEIN; PORE	Excessive activation of the coagulation system leads to life-threatening disseminated intravascular coagulation (DIC). Here, we examined the mechanisms underlying the activation of coagulation by lipopolysaccharide (LPS), the major cell-wall component of Gram-negative bacteria. We found that caspase-11, a cytosolic LPS receptor, activated the coagulation cascade. Caspase-11 enhanced the activation of tissue factor (TF), an initiator of coagulation, through triggering the formation of gasdermin D (GSDMD) pores and subsequent phosphatidylserine exposure, in a manner independent of cell death. GSDMD pores mediated calcium influx, which induced phosphatidylserine exposure through transmembrane protein 16F, a calcium-dependent phospholipid scramblase. Deletion of Casp11, ablation of Gsdmd, or neutralization of phosphatidylserine or TF prevented LPS-induced DIC. In septic patients, plasma concentrations of interleukin (IL)-1 alpha and IL-1 beta, biomarkers of GSDMD activation, correlated with phosphatidylserine exposure in peripheral leukocytes and DIC scores. Our findings mechanistically link immune recognition of LPS to coagulation, with implications for the treatment of DIC.	[Yang, Xinyu; Cheng, Xiaoye; Qiu, Xianhui; Wang, Zhongtai; Liu, Yukun; Chen, Fangping; Lu, Ben] Cent S Univ, Xiangya Hosp 3, Dept Hematol & Crit Care Med, Changsha 410000, Hunan, Peoples R China; [Tang, Yiting] Cent S Univ, Sch Basic Med Sci, Dept Physiol, Changsha 410000, Hunan, Peoples R China; [Wang, Yupeng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kang, Haixia] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Immunol, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Wu, Jianfeng; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Xiao, Xianzhong; Lu, Ben] Cent S Univ, Sch Basic Med Sci, Dept Pathophysiol, Changsha 410000, Hunan, Peoples R China; [Xiao, Xianzhong; Lu, Ben] Cent S Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China; [Mackman, Nigel] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Med Ctr, 497 Scaife Hall, Pittsburgh, PA 15213 USA	Central South University; Central South University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Shanghai Jiao Tong University; Xiamen University; Central South University; Central South University; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, B (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Hematol & Crit Care Med, Changsha 410000, Hunan, Peoples R China.; Lu, B (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Pathophysiol, Changsha 410000, Hunan, Peoples R China.; Lu, B (corresponding author), Cent S Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China.	xybenlu@csu.edu.cn	Xiao, Xiao/GQP-7793-2022; Lu, Ben/AAN-1068-2021; xiao, xiang/GWU-6035-2022	Lu, Ben/0000-0002-8597-0406; Yang, Xinyu/0000-0001-6914-3526	National key scientific project [2015CB910700]; National Natural Science Foundation of China [81930059, 81470345, 81971893]; Innovation-driven scientific project of CSU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK120531] Funding Source: NIH RePORTER	National key scientific project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-driven scientific project of CSU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Xiangyu Wang for her excellent technical support. We thank Qian-qian Xue for managing mouse colonies and research assistance. We thank Professor Feng Shao for providing key cell lines. We thank Professor Dongsheng Cao for the principal component analysis. This study was supported by the National key scientific project 2015CB910700 (to B.L.), National Natural Science Foundation of China (81930059 and 81470345 to B.L. and 81971893 to Y.T.), and Innovation-driven scientific project of CSU (to B.L.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Cao MH, 2017, BLOOD, V129, P1855, DOI 10.1182/blood-2016-09-739334; Chen VMY, 2013, SEMIN THROMB HEMOST, V39, P40, DOI 10.1055/s-0032-1333311; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc12783; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; GREGORY SA, 1989, MOL CELL BIOL, V9, P2752, DOI 10.1128/MCB.9.6.2752; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Higgins SJ, 2018, J CLIN INVEST, V128, P1471, DOI 10.1172/JCI97488; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kirchhofer D, 2005, J THROMB HAEMOST, V3, P1098, DOI 10.1111/j.1538-7836.2005.01253.x; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Koyama K, 2014, CRIT CARE, V18, DOI 10.1186/cc13190; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Levi M, 2003, BLOOD, V101, P4823, DOI 10.1182/blood-2002-10-3254; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ousingsawat J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0373-8; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Parry GCN, 1998, TRENDS CARDIOVAS MED, V8, P138, DOI 10.1016/S1050-1738(98)00002-4; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Risom T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05729-w; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shah KG, 2012, INTENS CARE MED, V38, P128, DOI 10.1007/s00134-011-2353-7; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; van der Poll T, 2014, THROMB HAEMOSTASIS, V112, P640, DOI 10.1160/TH14-01-0053; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Watanabe R, 2018, P NATL ACAD SCI USA, V115, P3066, DOI 10.1073/pnas.1717956115; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; Yang ZT, 2018, NAT CELL BIOL, V20, P186, DOI 10.1038/s41556-017-0022-y; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang Y, 2016, SHOCK, V45, P299, DOI 10.1097/SHK.0000000000000509	68	102	103	11	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					983	+		10.1016/j.immuni.2019.11.005	http://dx.doi.org/10.1016/j.immuni.2019.11.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31836429	Bronze			2022-12-18	WOS:000503162900007
J	Magri, G; Comerma, L; Pybus, M; Sintes, J; Llige, D; Segura-Garzon, D; Bascones, S; Yeste, A; Grasset, EK; Gutzeit, C; Uzzan, M; Ramanujam, M; van Zelm, MC; Albero-Gonzalez, R; Vazquez, I; Iglesias, M; Serrano, S; Marquez, L; Mercade, E; Mehandru, S; Cerutti, A				Magri, Giuliana; Comerma, Laura; Pybus, Marc; Sintes, Jordi; Llige, David; Segura-Garzon, Daniel; Bascones, Sabrina; Yeste, Ada; Grasset, Emilie K.; Gutzeit, Cindy; Uzzan, Mathieu; Ramanujam, Meera; van Zelm, Menno C.; Albero-Gonzalez, Raquel; Vazquez, Ivonne; Iglesias, Mar; Serrano, Sergi; Marquez, Lucia; Mercade, Elena; Mehandru, Saurabh; Cerutti, Andrea			Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals	IMMUNITY			English	Article							LYMPHOID-TISSUE; SEQUENCING DATA; MICROBIOTA; GENERATION; RESPONSES; DIVERSIFICATION; REPERTOIRES; POPULATION; EXPRESSION; CAPACITIES	Secretory immunoglobulin A (SIgA) enhances host-microbiota symbiosis, whereas SIgM remains poorly understood. We found that gut IgM(+) plasma cells (PCs) were more abundant in humans than mice and clonally related to a large repertoire of memory IgM(+) B cells disseminated throughout the intestine but rare in systemic lymphoid organs. In addition to sharing a gut-specific gene signature with memory IgA(+) B cells, memory IgM(+) B cells were related to some IgA(+) clonotypes and switched to IgA in response to T cell-independent or T cell-dependent signals. These signals induced abundant IgM which, together with SIgM from clonally affiliated PCs, recognized mucus-embedded commensals. Bacteria recognized by human SIgM were dually coated by SIgA and showed increased richness and diversity compared to IgA-only-coated or uncoated bacteria. Thus, SIgM may emerge from pre-existing memory rather than newly activated naive IgM(+) B cells and could help SIgA to anchor highly diverse commensal communities to mucus.	[Magri, Giuliana; Comerma, Laura; Pybus, Marc; Sintes, Jordi; Llige, David; Segura-Garzon, Daniel; Bascones, Sabrina; Yeste, Ada; Cerutti, Andrea] Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona 08003, Spain; [Grasset, Emilie K.; Gutzeit, Cindy; Uzzan, Mathieu; Mehandru, Saurabh; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA; [Grasset, Emilie K.] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med, S-17176 Stockholm, Sweden; [Ramanujam, Meera] Boehringer Ingelheim Pharmaceut, Immunol & Resp Dis Res, Ridgefield, CT 06877 USA; [van Zelm, Menno C.] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia; [van Zelm, Menno C.] Alfred Hosp, Melbourne, Vic 3004, Australia; [Albero-Gonzalez, Raquel; Vazquez, Ivonne; Iglesias, Mar; Serrano, Sergi] Hosp Mar, Dept Pathol, Barcelona 08003, Spain; [Iglesias, Mar; Serrano, Sergi] Univ Autonoma Barcelona, Barcelona 08003, Spain; [Marquez, Lucia] Hosp Mar, Dept Gastroenterol, Barcelona 08003, Spain; [Mercade, Elena] Univ Barcelona, Dept Biol Hlth & Environm, E-08028 Barcelona, Spain; [Cerutti, Andrea] Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Icahn School of Medicine at Mount Sinai; Karolinska Institutet; Karolinska University Hospital; Boehringer Ingelheim; Monash University; Florey Institute of Neuroscience & Mental Health; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; ICREA	Magri, G; Cerutti, A (corresponding author), Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona 08003, Spain.; Cerutti, A (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA.; Cerutti, A (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain.	gmagri@imim.es; acerutti@imim.es	Blesa, Laura Comerma/AAQ-9455-2020; Marquez, Lucia/AAI-8215-2021; Magri, Giuliana/K-6552-2014; Mercade, Elena/L-5218-2014; van Zelm, Menno/O-4404-2015	Blesa, Laura Comerma/0000-0002-0249-4636; Magri, Giuliana/0000-0002-0163-3542; Vazquez, Ivonne/0000-0002-5305-1560; Albero, Raquel/0000-0001-9027-1426; MARQUEZ MOSQUERA, LUCIA/0000-0002-3182-9570; Llige, David/0000-0003-0786-6213; Pybus, Marc/0000-0002-6195-5738; Mercade, Elena/0000-0001-7828-2210; van Zelm, Menno/0000-0003-4161-1919; Cerutti, Andrea/0000-0003-3026-4704	European Advanced Grant [ERC-2011-ADG-20110310]; MINECO [SAF2014-52483-R]; AGAUR [2014 SGR 832]; US NIH [P01 AI61093, R01 AI57653, U01 AI95613]; Boeringher Ingelheim [134564-2]; NIH [R01 DK 112296-01]; Fondo de Investigacion Sanitaria ISCIII fellowships [CD14/00060, CM13/00136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057653, P01AI061093, U01AI095613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112296] Funding Source: NIH RePORTER	European Advanced Grant; MINECO(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boeringher Ingelheim; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria ISCIII fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Microarray Analysis Service from IMIM for global gene transcriptome analysis, the Genomic Core Facility from UPF and Christopher M. Tipton from Emory University for help with NGS, and the FACS Unit from UPF and CRG for help with cell sorting. Supported by European Advanced Grant (ERC-2011-ADG-20110310), MINECO (SAF2014-52483-R), AGAUR (2014 SGR 832), US NIH grants P01 AI61093, R01 AI57653, and U01 AI95613 (to A.C.), Boeringher Ingelheim grant 134564-2 (to A.C.), NIH grant R01 DK 112296-01 (to A.C. and S.M.), and Fondo de Investigacion Sanitaria ISCIII fellowships CD14/00060 and CM13/00136 (to G.M. and L.C., respectively).	Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Aranburu A, 2017, EUR J IMMUNOL, V47, P327, DOI 10.1002/eji.201646642; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Barak M, 2008, J IMMUNOL METHODS, V338, P67, DOI 10.1016/j.jim.2008.06.006; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kubinak JL, 2016, NAT REV IMMUNOL, V16, P767, DOI 10.1038/nri.2016.114; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Nair N, 2016, MUCOSAL IMMUNOL, V9, P68, DOI 10.1038/mi.2015.36; Narvaez CF, 2012, J VIROL, V86, P10829, DOI 10.1128/JVI.01466-12; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Rubtsov AV, 2015, J IMMUNOL, V195, P71, DOI 10.4049/jimmunol.1500055; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Sintes J, 2010, J LEUKOCYTE BIOL, V88, P687, DOI 10.1189/jlb.1109756; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	47	102	104	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					118	+		10.1016/j.immuni.2017.06.013	http://dx.doi.org/10.1016/j.immuni.2017.06.013			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28709802	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000405712800014
J	Zehner, M; Marschall, AL; Bos, E; Schloetel, JG; Kreer, C; Fehrenschild, D; Limmer, A; Ossendorp, F; Lang, T; Koster, AJ; Dubel, S; Burgdorf, S				Zehner, Matthias; Marschall, Andrea L.; Bos, Erik; Schloetel, Jan-Gero; Kreer, Christoph; Fehrenschild, Dagmar; Limmer, Andreas; Ossendorp, Ferry; Lang, Thorsten; Koster, Abraham J.; Duebel, Stefan; Burgdorf, Sven			The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8(+) T Cells	IMMUNITY			English	Article							DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; ER; DEGRADATION; CROSSPRESENTATION; COMPARTMENT; DISLOCATION; MECHANISMS; PROTEASOME; PHAGOSOMES	The molecular mechanisms regulating antigen translocation into the cytosol for cross-presentation are under controversial debate, mainly because direct data is lacking. Here, we have provided direct evidence that the activity of the endoplasmic reticulum (ER) translocon protein Sec61 is essential for endosome-to-cytosol translocation. We generated a Sec61-specific intrabody, a crucial tool that trapped Sec61 in the ER and prevented its recruitment into endosomes without influencing Sec61 activity and antigen presentation in the ER. Expression of this ER intrabody inhibited antigen translocation and cross-presentation, demonstrating that endosomal Sec61 indeed mediates antigen transport across endosomal membranes. Moreover, we showed that the recruitment of Sec61 toward endosomes, and hence antigen translocation and cross-presentation, is dependent on dendritic cell activation by Toll-like receptor (TLR) ligands. These data shed light on a long-lasting question regarding antigen cross-presentation and point out a role of the ER-associated degradation machinery in compartments distinct from the ER.	[Zehner, Matthias; Schloetel, Jan-Gero; Kreer, Christoph; Fehrenschild, Dagmar; Lang, Thorsten; Burgdorf, Sven] Univ Bonn, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany; [Marschall, Andrea L.; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Bos, Erik; Koster, Abraham J.] Leiden Univ Med Ctr LUMC, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands; [Limmer, Andreas] Univ Bonn, Dept Orthoped & Trauma Surg, D-53127 Bonn, Germany; [Ossendorp, Ferry] Leiden Univ Med Ctr LUMC, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands	University of Bonn; Braunschweig University of Technology; Leiden University; Leiden University Medical Center (LUMC); University of Bonn; Leiden University; Leiden University Medical Center (LUMC)	Burgdorf, S (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	burgdorf@uni-bonn.de	Zehner, Matthias/AAV-9709-2020; Marschall, Andrea L. J./AAU-2263-2020; Kreer, Christoph/ABG-7275-2021; Koster, Abraham/I-7665-2017	Zehner, Matthias/0000-0001-5745-0836; Marschall, Andrea L. J./0000-0002-9505-0427; Kreer, Christoph/0000-0002-9140-9850; Dubel, Stefan/0000-0001-8811-7390; Koster, Abraham/0000-0003-1717-2549	German Research Center [SFB645-C1]; EU	German Research Center; EU(European Commission)	We thank Peter Cresswell for 293T.FluERAD cells. This work was supported by the German Research Center (SFB645-C1) and the EU 7th framework (Affinomics). S.B. is a member of the Immunosensation Cluster of Excellence. We thank Saskia Helmsing, Michael Hust, Maarten Tuijtel, and Joop Wiegant for technical assistance.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Grotzke JE, 2013, P NATL ACAD SCI USA, V110, P3393, DOI 10.1073/pnas.1300328110; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kurts C, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00008; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Marschall AL, 2014, MABS-AUSTIN, V6, P1394, DOI 10.4161/mabs.34377; Meli G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4867; Nair-Gupta P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00401; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zehner M, 2012, EUR J IMMUNOL, V42, P2187, DOI 10.1002/eji.201142089; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108	32	102	107	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					850	863		10.1016/j.immuni.2015.04.008	http://dx.doi.org/10.1016/j.immuni.2015.04.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25979419	Bronze			2022-12-18	WOS:000354827400012
J	Deng, YC; Kerdiles, Y; Chu, JH; Yuan, SZ; Wang, YW; Chen, XL; Mao, HY; Zhang, LL; Zhang, JY; Hughes, T; Deng, YF; Zhang, Q; Wang, FJ; Zou, XH; Liu, CG; Freud, AG; Li, XH; Caligiuri, MA; Vivier, E; Yu, JH				Deng, Youcai; Kerdiles, Yann; Chu, Jianhong; Yuan, Shunzong; Wang, Youwei; Chen, Xilin; Mao, Hsiaoyin; Zhang, Lingling; Zhang, Jianying; Hughes, Tiffany; Deng, Yafei; Zhang, Qi; Wang, Fangjie; Zou, Xianghong; Liu, Chang-Gong; Freud, Aharon G.; Li, Xiaohui; Caligiuri, Michael A.; Vivier, Eric; Yu, Jianhua			Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function	IMMUNITY			English	Article							T-BET; NK-CELLS; TGF-BETA; GAMMA PRODUCTION; LYMPH-NODES; IFN-GAMMA; EXPRESSION; CD56(BRIGHT); HOMEOSTASIS; RESPONSES	Little is known about the role of negative regulators in controlling natural killer (NK) cell development and effector functions. Foxo1 is a multifunctional transcription factor of the forkhead family. Using a mouse model of conditional deletion in NK cells, we found that Foxo1 negatively controlled NK cell differentiation and function. Immature NK cells expressed abundant Foxo1 and little Tbx21 relative to mature NK cells, but these two transcription factors reversed their expression as NK cells proceeded through development. Foxo1 promoted NK cell homing to lymph nodes by upregulating CD62L expression and inhibited late-stage maturation and effector functions by repressing Tbx21 expression. Loss of Foxo1 rescued the defect in late-stage NK cell maturation in heterozygous Tbx21(+/-) mice. Collectively, our data reveal a regulatory pathway by which the negative regulator Foxo1 and the positive regulator Tbx21 play opposing roles in controlling NK cell development and effector functions.	[Deng, Youcai; Caligiuri, Michael A.; Yu, Jianhua] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Deng, Youcai; Deng, Yafei; Zhang, Qi; Wang, Fangjie; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing 400038, Peoples R China; [Deng, Youcai; Chu, Jianhong; Yuan, Shunzong; Wang, Youwei; Chen, Xilin; Mao, Hsiaoyin; Zhang, Lingling; Hughes, Tiffany; Zou, Xianghong; Freud, Aharon G.; Caligiuri, Michael A.; Yu, Jianhua] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kerdiles, Yann; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, INSERM,U1104,CNRS,UMR7280, F-13288 Marseille, France; [Yuan, Shunzong; Chen, Xilin] Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing 100071, Peoples R China; [Zhang, Jianying] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Caligiuri, Michael A.; Yu, Jianhua] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Vivier, Eric] Assistance Publ Hop Marseille, Serv Immunol, F-13385 Marseille, France	University System of Ohio; Ohio State University; Army Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Academy of Military Medical Sciences - China; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Caligiuri, MA (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu; jianhua.yu@osumc.edu	zhang, lingling/HDM-2189-2022; Wang, Youwei/M-4544-2019; kerdiles, yann/U-2190-2018; Vivier, Eric/F-8939-2010; Deng, Youcai/GZK-9548-2022; Yuan, Shunzong/AAO-3551-2020	kerdiles, yann/0000-0002-8605-1073; Vivier, Eric/0000-0001-7022-8287; Deng, Youcai/0000-0001-5488-8576; 	US National Institutes of Health [CA155521, OD018403, CA095426, CA163205, CA068458, CA185301]; National Blood Foundation Scientific Research Grant; American Cancer Society Research Scholar Grant [RSG-14-243-01-LIB]; Gabrielle's Angel Foundation for Cancer Research; Natural Science Foundation of China [81273507, 81370631]; European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee); INSERM; CNRS; Aix-Marseille University; Houston Methodist Research Institute; NATIONAL CANCER INSTITUTE [R37CA068458, R01CA185301, P01CA163205, T32CA090223, P01CA095426, R01CA068458, R01CA155521] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R41OD018403] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Blood Foundation Scientific Research Grant; American Cancer Society Research Scholar Grant(American Cancer Society); Gabrielle's Angel Foundation for Cancer Research; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Houston Methodist Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Ming O. Li (Memorial Sloan-Kettering Cancer Center) and Ronald A. DePinho (Dana Farber Cancer Institute, Harvard Medical School) for providing Foxo1<SUP>fl/fl</SUP> and Foxo3<SUP>fl/fl</SUP> mice. This project was supported in part by grants from US National Institutes of Health (CA155521 and OD018403 to J.Y., CA095426, CA163205, and CA068458 to M.A.C., and CA185301 to M.A. C and J.Y.). J.Y. was supported by a National Blood Foundation Scientific Research Grant, an American Cancer Society Research Scholar Grant (RSG-14-243-01-LIB), and a grant from by Gabrielle's Angel Foundation for Cancer Research. This project was also supported by a grant from the Natural Science Foundation of China (81273507 to X.L. and 81370631 to S.Y.). The E.V. laboratory is supported by the European Research Council (THINK Advanced Grant), the Ligue Nationale contre le Cancer (Equipe Labellisee) and by institutional grants from INSERM, CNRS, and Aix-Marseille University to CIML. E.V. is a scholar of the Institut Universitaire de France. The authors would like to sincerely thank Dr. Xian C. Li at Houston Methodist Research Institute for supporting the project and Dr. David M. Lucas at The Ohio State University for his critical reading of this manuscript. E.V. is the cofounder and a shareholder of Innate Pharma.	Allan DSJ, 2010, EUR J IMMUNOL, V40, P2289, DOI 10.1002/eji.200939910; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Araya N, 2014, J CLIN INVEST, V124, P3431, DOI 10.1172/JCI75250; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chow KT, 2013, J EXP MED, V210, P1621, DOI 10.1084/jem.20130498; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Deng YC, 2014, J IMMUNOL, V193, P2994, DOI 10.4049/jimmunol.1302600; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Huntington ND, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00014; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Liu JQ, 2012, P NATL ACAD SCI USA, V109, P16618, DOI 10.1073/pnas.1117610109; Luevano M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00319; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ramirez K, 2010, CURR OPIN IMMUNOL, V22, P193, DOI 10.1016/j.coi.2010.02.002; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Togher S, 2015, IMMUNOL CELL BIOL, V93, P120, DOI 10.1038/icb.2014.78; Tong Q, 2014, J IMMUNOL, V192, P5012, DOI 10.4049/jimmunol.1302943; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Werneck MBF, 2008, J IMMUNOL, V180, P8004, DOI 10.4049/jimmunol.180.12.8004; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu JH, 2007, EUR J IMMUNOL, V37, P2549, DOI 10.1002/eji.200737088; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Yun S, 2011, IMMUNOL LETT, V136, P29, DOI 10.1016/j.imlet.2010.11.008	47	102	108	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					457	470		10.1016/j.immuni.2015.02.006	http://dx.doi.org/10.1016/j.immuni.2015.02.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25769609	Green Accepted, Bronze			2022-12-18	WOS:000351301900011
J	Plumlee, CR; Sheridan, BS; Cicek, BB; Lefrancois, L				Plumlee, Courtney R.; Sheridan, Brian S.; Cicek, Basak B.; Lefrancois, Leo			Environmental Cues Dictate the Fate of Individual CD8(+) T Cells Responding to Infection	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES INFECTION; IL-7 RECEPTOR-ALPHA; IN-VIVO; VIRAL-INFECTION; MEMORY CELLS; DIFFERENTIATION; EFFECTOR; EXPRESSION; NAIVE; EXPANSION	Many studies have examined pathways controlling effector T cell differentiation, but less is known about the fate of individual CD8(+) T cells during infection. Here, we examine the antiviral and antibacterial responses of single CD8(+) T cells from the polyclonal repertoire. The progeny of naive clonal CD8(+) T cells displayed unique profiles of differentiation based on extrinsic pathogen-induced environmental cues, with some clones demonstrating extreme bias toward a single developmental pathway. Moreover, even within the same animal, a single naive CD8(+) T cell exhibited distinct fates that were controlled by tissue-specific events. However, memory CD8(+) T cells relied on intrinsic factors to control differentiation upon challenge. Our results demonstrate that stochastic and instructive events differentially contribute to shaping the primary and secondary CD8(+) T cell response and provide insight into the underlying forces that drive effector differentiation and protective memory formation.	[Plumlee, Courtney R.; Sheridan, Brian S.; Cicek, Basak B.; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA	University of Connecticut	Plumlee, CR (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA.	plumlee@uchc.edu; llefranc@neuron.uchc.edu			National Institutes of Health [RO1 A0I76457, RO1 A0I41576]; NERCE career development fellowship [U54 AI057159]; Crohn's and Colitis Foundation of America [2813]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076457, U54AI057159, R01AI041576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERCE career development fellowship; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Marc Jenkins (UMINN) for sharing unpublished data and for many insightful discussions. We thank Nancy Freitag, University of Illinois, Chicago, for construction of the LM-OVA internalin A recombinant and Evan Jellison and the UCHC Flow Cytometry Core for expert assistance. We thank Quynh-Mai Pham for exceptional technical support and Lynn Puddington and Sara Colpitts for critical review of the manuscript. This work was supported by the National Institutes of Health grant RO1 A0I76457 and RO1 A0I41576 (L.L.), U54 AI057159 NERCE career development fellowship (C.R.P.), and "Visualizing orally-induced T cell responses in the intestinal mucosa" reference number 2813 from the Crohn's and Colitis Foundation of America (B.S.S.).	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Alexander-Miller MA, 2005, IMMUNOL RES, V31, P13, DOI 10.1385/IR:31:1:13; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Bosc N, 2003, DEV COMP IMMUNOL, V27, P465, DOI 10.1016/S0145-305X(03)00027-2; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chao CC, 1997, J IMMUNOL, V159, P1686; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Martin MD, 2012, J IMMUNOL, V188, P1255, DOI 10.4049/jimmunol.1101579; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; TASWELL C, 1981, J IMMUNOL, V126, P1614; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	58	102	102	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					347	356		10.1016/j.immuni.2013.07.014	http://dx.doi.org/10.1016/j.immuni.2013.07.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23932571	Bronze, Green Accepted			2022-12-18	WOS:000330948800016
J	Sabatos, CA; Doh, J; Chakravarti, S; Friedman, RS; Pandurangi, PG; Tooley, AJ; Krummel, MF				Sabatos, Catherine A.; Doh, Junsang; Chakravarti, Sumone; Friedman, Rachel S.; Pandurangi, Priya G.; Tooley, Aaron J.; Krummel, Matthew F.			A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction	IMMUNITY			English	Article							LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; DENDRITIC CELLS; IN-VIVO; LYMPHOCYTES-T; ACTIVATION; RECEPTOR; DISTINCT; RESPONSES; DYNAMICS	T cells slow their motility, increase adherence, and arrest after encounters with antigen-presenting cells (APCs) bearing peptide-MHC complexes. Here, we analyzed the cell-cell communication among activating T cells. In vivo and in vitro, activating T cells associated in large clusters that collectively persisted for > 30 min, but they also engaged in more transient interactions, apparently distal to APCs. Homotypic aggregation was driven by LFA-1 integrin interactions. Ultrastructural analysis revealed that cell-cell contacts between activating T cells were organized as multifocal synapses, and T cells oriented both the microtubule-organizing complex and interleukin-2 (IL-2) secretion toward this synapse. T cells engaged in homotypic interactions more effectively captured IL-2 relative to free cells. T cells receiving paracrine synaptic IL-2 polarized their IL-2 signaling subunits into the synaptic region and more efficiently phosphorylated the transcription factor STAT5, likely through a synapse-associated signaling complex. Thus, synapse-mediated cytokine delivery accelerates responses in activating T cells.	[Sabatos, Catherine A.; Doh, Junsang; Chakravarti, Sumone; Friedman, Rachel S.; Pandurangi, Priya G.; Tooley, Aaron J.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Doh, Junsang] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Gyeongbuk, South Korea; [Doh, Junsang] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, Gyeongbuk, South Korea	University of California System; University of California San Francisco; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu			NIH [5T32AI007334]; National Multiple Sclerosis Society Postdoctoral Fellowship; HHMI Biomedical Research Support Program [5300246]; Juvenile Diabetes Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI052116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Postdoctoral Fellowship(National Multiple Sclerosis Society); HHMI Biomedical Research Support Program(Howard Hughes Medical Institute); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C.A.S. performed TPLSM imaging, immunocytochemistry experiments for LFA-1, CD25, pericentrin, p-STAT5, and IL-2, and data analysis and participated in experimental design and manuscript writing. J.D. performed TPLSM imaging, electron microscopy, immunocytochemistry experiments for p-STAT5, intracellular and capture IL-2 stains, LFA-deficient cluster experiments and analysis, and participated in experimental design and manuscript writing. S.C. performed clustering experiments and immunocytochemistry for LFA-1 and CD25 and participated in experimental design and data analysis. R.S.F. performed TPLSM for nonimmunized mice and assisted in manuscript writing. P.G.P. provided technical assistance for immunocytochemistry. A.J.T. established the initial TPLSM work and provided technical assistance. M.F.K. established the initial scientific questions, provided continuing intellectual guidance, and participated in experimental design, analysis, manuscript writing, and TPLSM imaging.; We would like to thank F. Siedenberg and L. Braun (Sutter Instruments) for technical assistance, I. Hsieh for assistance with electron microscopy, A. Hedges (University of Bristol) for assistance with statistics, and A. Ma and A. Abbas for helpful discussions. This work was supported by NIH training grant #5T32AI007334 (C.A.S.), a National Multiple Sclerosis Society Postdoctoral Fellowship (S.C.), startup funds from the HHMI Biomedical Research Support Program (grant #5300246), and the Juvenile Diabetes Foundation (M. F. K.).	Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Long MX, 2006, J IMMUNOL, V177, P4257, DOI 10.4049/jimmunol.177.7.4257; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	36	102	103	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					238	248		10.1016/j.immuni.2008.05.017	http://dx.doi.org/10.1016/j.immuni.2008.05.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18674934	Green Accepted, Bronze			2022-12-18	WOS:000258610800012
J	Zhang, H; Schaff, UY; Green, CE; Chen, H; Sarantos, MR; Hu, YM; Wara, D; Simon, SI; Lowell, CA				Zhang, Hong; Schaff, Ulrich Y.; Green, Chad E.; Chen, Hua; Sarantos, Melissa R.; Hu, Yongmei; Wara, Diane; Simon, Scott I.; Lowell, Clifford A.			Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils	IMMUNITY			English	Article							CELL-ACTIVATION; REGULATE NEUTROPHIL; L-SELECTIN; ADHESION; KINASES; LFA-1; WASP; SRC; TRANSMIGRATION; CHEMOTAXIS	Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency that manifests as increased susceptibility to many pathogens. Although the spectrum of infections suffered by WAS patients is consistent with defects in neutrophil (PMN) function, the consequences of WAS protein (WASp) deficiency on this innate immune cell have been unclear. We report that deficiency of WASp in both human and murine PMNs resulted in profound defects in clustering of beta 2 integrins, leading to defective adhesion and transendothelial migration under conditions of physiologic shear flow. Wild-type PMNs redistributed clustered beta 2 integrins to the uropod of the cell during active migration, whereas WASp-deficient cells remain unpolarized. The WASp-deficient PMNs also showed reduced integrin-dependent activation of degranulation and respiratory burst. PMNs from a WAS patient manifested similar defects in integrin clustering and signaling. These results suggest that impaired beta 2 integrin function in WASp-deficient PMNs may contribute substantially to the clinical immunodeficiency suffered by WAS patients.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	clifford.lowell@ucsf.edu			NHLBI NIH HHS [T32-HL07013-26, T32 HL007013] Funding Source: Medline; NIAID NIH HHS [AI65495, R01 AI065495, R01 AI068150, AI47294, R01 AI047294] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047294, R01AI068150, R01AI065495] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badolato R, 1998, J IMMUNOL, V161, P1026; Badour K, 2004, SEMIN IMMUNOL, V16, P395, DOI 10.1016/j.smim.2004.08.019; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; Ding ZM, 1999, J IMMUNOL, V163, P5029; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Green CE, 2006, BLOOD, V107, P2101, DOI 10.1182/blood-2005-06-2303; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; KOLLURI R, 1995, HUM MOL GENET, V4, P1119, DOI 10.1093/hmg/4.7.1119; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Tsang YTM, 1997, J IMMUNOL, V159, P4566; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	28	102	103	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					285	295		10.1016/j.immuni.2006.06.014	http://dx.doi.org/10.1016/j.immuni.2006.06.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16901726	Green Accepted, Bronze			2022-12-18	WOS:000240047500014
J	Duan, L; Reddi, AL; Ghosh, A; Dimri, M; Band, H				Duan, L; Reddi, AL; Ghosh, A; Dimri, M; Band, H			The Cbl family and other ubiquitin ligases: Destructive forces in control of antigen receptor signaling	IMMUNITY			English	Review							PHOSPHOTYROSINE-BINDING DOMAIN; T-CELL ANERGY; NEGATIVE REGULATION; C-CBL; TYROSINE KINASE; PROTOONCOGENE PRODUCT; MEDIATED UBIQUITINYLATION; PHOSPHORYLATION SITE; LYMPHOCYTE FUNCTION; GENE-TRANSCRIPTION	Regulation of tyrosine kinase-mediated cellular activation through antigen receptors is of great biological and practical significance. The evolutionarily conserved Cb1 family ubiquitin ligases have emerged as key negative regulators of activated tyrosine kinase-coupled receptors, and their impaired function switches a normal immune response into autoimmunity. Cb1 proteins facilitate the ubiquitinylation of activated tyrosine kinases and other signaling proteins and of the signaling chains of receptors themselves; monoubiquitin tag promotes sorting of activated receptors and associated proteins into internal vesicles of the multivesicular body, facilitating their lysosomal degradation, whereas polyubiquitin tag promotes proteasomal degradation. Notably, increased expression of Cb1 proteins and other ubiquitin ligases is a component of anergic signaling program in T cells. Thus, controlled destruction of the signaling apparatus has emerged as a key to fine-tuning antigen receptor signaling. Further studies of this pathway are likely to elucidate the pathogenesis of autoimmune diseases and offer new therapeutic targets.	Evanston Northwestern Healthcare Res Inst, Feinberg Sch Med, Dept Med, Div Mol Oncol, Evanston, IL 60201 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60201 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Band, H (corresponding author), Evanston Northwestern Healthcare Res Inst, Feinberg Sch Med, Dept Med, Div Mol Oncol, Evanston, IL 60201 USA.	h-band@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA099900, R01CA105489, R01CA087986, R01CA099163] Funding Source: NIH RePORTER; NCI NIH HHS [CA99163, CA 105489, CA 99900, CA87986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2003, NAT IMMUNOL, V4, P725, DOI 10.1038/ni0803-725; Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Davis M, 2004, NAT IMMUNOL, V5, P238, DOI 10.1038/ni0304-238; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Goodnow CC, 2001, ADV EXP MED BIOL, V490, P33; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; Itoh Y, 1999, J IMMUNOL, V162, P2073; Jang IK, 2003, CURR OPIN IMMUNOL, V15, P315, DOI 10.1016/S0952-7915(03)00048-7; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; KEANE MM, 1995, ONCOGENE, V10, P2367; KIM TJ, 1995, J BIOL CHEM, V270, P27504, DOI 10.1074/jbc.270.46.27504; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krawczyk C, 2001, TRENDS CELL BIOL, V11, P212, DOI 10.1016/S0962-8924(01)01981-X; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Love PE, 2003, CURR OPIN IMMUNOL, V15, P199, DOI 10.1016/S0952-7915(03)00002-5; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Magnan A, 2001, J EXP MED, V194, P491, DOI 10.1084/jem.194.4.491; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marengere LEM, 1997, J IMMUNOL, V159, P70; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sawasdikosol S, 2000, BBA-REV CANCER, V1471, pM1, DOI 10.1016/S0304-419X(00)00013-5; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shao Y, 2003, EMBO REP, V4, P425, DOI 10.1038/sj.embor.embor813; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Zhang WY, 2003, J BIOL CHEM, V278, P23978, DOI 10.1074/jbc.M212671200; Zhang ZH, 1999, CURR BIOL, V9, P203, DOI 10.1016/S0960-9822(99)80090-6; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	96	102	108	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					7	17		10.1016/j.immuni.2004.06.012	http://dx.doi.org/10.1016/j.immuni.2004.06.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345216	Bronze			2022-12-18	WOS:000222975500004
J	French, AR; Pingel, JT; Wagner, M; Bubic, I; Yang, LP; Kim, S; Koszinowski, U; Jonjic, S; Yokoyama, WM				French, AR; Pingel, JT; Wagner, M; Bubic, I; Yang, LP; Kim, S; Koszinowski, U; Jonjic, S; Yokoyama, WM			Escape of mutant double-stranded DNA virus from innate immune control	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MURINE CYTOMEGALOVIRUS REPLICATION; IN-VIVO; MOUSE CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; MONOCLONAL-ANTIBODY; GENETIC-LOCUS; INFECTION; RESISTANCE; EVASION	As innate immune system components, natural killer (NK) cells respond rapidly to infections and effectively control replication of pathogens, including murine cytomegalovirus (MCMV), a double-stranded DNA beta-herpesvirus. In the absence of NK cell control, MCMV infection results in early mortality due to uncontrolled viral replication. However, here we show that even in the face of initial NK cell control, there is late recrudescence of disease and mortality in immunodeficient mice due to the outgrowth of MCMV mutants that escape recognition by innate NK cells. These data suggest that viral infections in certain clinical settings also may be due to viral escape from innate immunity.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, Div Pediat Rheumatol, St Louis, MO 63110 USA; Max Von Pettenkofer Inst, D-8000 Munich, Germany; Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); University of Munich; University of Rijeka	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Med, St Louis, MO 63110 USA.	yokoyama@im.wustl.edu	Bubic, Ivan/GZL-2338-2022; Jonjic, Stipan/C-5657-2016	Jonjic, Stipan/0000-0001-5003-3108	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051345, R37AI034385] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI034385, R01 AI051345] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Ciurea A, 2001, NAT MED, V7, P795, DOI 10.1038/89915; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; DeFilippis VR, 2001, FIELDS VIROLOGY, P353; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FAUCI AS, 2001, HARRISONS PRINCIPLES, P1852; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hunziker L, 2003, P NATL ACAD SCI USA, V100, P6015, DOI 10.1073/pnas.1031671100; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Knipe D.M., 2001, FIELDS VIROLOGY; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Lee SH, 2003, J EXP MED, V197, P515, DOI 10.1084/jem.20021713; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Bueno A, 2003, J VIROL, V77, P2701, DOI 10.1128/JVI.77.4.2701-2708.2003; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; REDDEHASE MJ, 1987, J VIROL, V61, P3102, DOI 10.1128/JVI.61.10.3102-3108.1987; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Schrag SJ, 1999, J VIROL, V73, P51, DOI 10.1128/JVI.73.1.51-54.1999; Schwarz K, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P155; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; THALE R, 1995, J VIROL, V69, P6098; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Webb JR, 2002, GENES IMMUN, V3, P250, DOI 10.1038/sj.gene.6363876; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x	45	102	103	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					747	756		10.1016/j.immuni.2004.05.006	http://dx.doi.org/10.1016/j.immuni.2004.05.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189739	Bronze			2022-12-18	WOS:000222205300010
J	Wang, LH; Yang, XY; Zhang, XH; Huang, JQ; Hou, J; Li, J; Xiong, H; Mihalic, K; Zhu, HM; Xiao, WH; Farrar, WL				Wang, LH; Yang, XY; Zhang, XH; Huang, JQ; Hou, J; Li, J; Xiong, H; Mihalic, K; Zhu, HM; Xiao, WH; Farrar, WL			Transcriptional inactivation of STAT3 by PPAR gamma suppresses IL-6-responsive multiple myeloma cells	IMMUNITY			English	Article							ACTIVATED RECEPTOR-GAMMA; HUMAN T-LYMPHOCYTES; ESTROGEN-RECEPTOR; INDUCE APOPTOSIS; IL-2 PRODUCTION; GROWTH-FACTOR; CROSS-TALK; C-MYC; INTERLEUKIN-6; SURVIVAL	Multiple myeloma (MM) remains largely incurable despite conventional and high-dose therapies. Therefore, novel biologically based treatment approaches are urgently required. Here we demonstrate that expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in MM cells and its agonists 15-d-PGJ2 and troglitazone completely abolished IL-6-inducible MM cell proliferation and induced apoptosis through affecting expression of multiple cell cycle or apoptosis genes, whereas PPARgamma antagonist GW9662 and PPARalpha agonist WY14643 did not display this inhibitory effect. These PPARgamma agoinists significantly inhibited DNA binding and transactivation of STAT3 bound to the promoter of target genes in chromatin, but did not affect the expression of IL-6 receptor and phosphorylation of JAK/STAT3, MAPK, and PI3K/Akt. Interestingly, although inactivation of STAT3 by PPAR-y agonists is in a PPARgamma-dependent manner, the molecular mechanism by which two structurally distinct PPARgamma agonists suppress IL-6-activated STAT3 shows the divergent interactions between PPARgamma and STAT3 including direct or SMRT-mediated association.	Natl Canc Inst, Basic Res Program, SAIC Frederick, Frederick, MD 21702 USA; Natl Canc Inst, Cytoking Mol Mech Sect, Mol Immunoregulat Lab, Div Basic Sci, Frederick, MD 21702 USA; Second Mil Med Univ, Changzheng Hosp, Shanghai 200003, Peoples R China; Second Mil Med Univ, Xinhua Hosp, Shanghai 200003, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Naval Medical University; Naval Medical University	Wang, LH (corresponding author), Natl Canc Inst, Basic Res Program, SAIC Frederick, Frederick, MD 21702 USA.	lhwang@ncifcrf.gov; farrar@ncifcrf.gov	Huang, Jiaqiang/C-2375-2011; Xiao, Weihua/N-2775-2013	Huang, Jiaqiang/0000-0002-6610-8159; Xiao, Weihua/0000-0001-9102-6326	NATIONAL CANCER INSTITUTE [Z01BC010253] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CA-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson K, 1999, SEMIN ONCOL, V26, P10; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chung CD, 1997, J IMMUNOL, V159, P1758; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Ferlin M, 2000, BRIT J HAEMATOL, V111, P626, DOI 10.1046/j.1365-2141.2000.02364.x; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gado K, 2000, CELL BIOL INT, V24, P195, DOI 10.1006/cbir.2000.0497; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Glass CK, 2000, GENE DEV, V14, P121; Govind AP, 2001, J CELL BIOCHEM, V80, P571, DOI 10.1002/1097-4644(20010315)80:4<571::AID-JCB1011>3.0.CO;2-H; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HITZLER JK, 1991, BLOOD, V78, P1996, DOI 10.1182/blood.V78.8.1996.1996; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang JQ, 2001, J IMMUNOL, V167, P6073, DOI 10.4049/jimmunol.167.11.6073; Jourdan M, 2000, CELL DEATH DIFFER, V7, P1244, DOI 10.1038/sj.cdd.4400758; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Mitsiades CS, 2003, SEMIN ONCOL, V30, P309, DOI 10.1053/sonc.2003.50065; Nikitakis NG, 2002, BRIT J CANCER, V87, P1396, DOI 10.1038/sj.bjc.6600618; NILSSON UL, 1990, CLIN VISION SCI, V6, P3; Padilla J, 2002, CLIN IMMUNOL, V103, P22, DOI 10.1006/clim.2001.5181; Reece D E, 1998, Curr Opin Hematol, V5, P460, DOI 10.1097/00062752-199811000-00018; Schlezinger JJ, 2002, J IMMUNOL, V169, P6831, DOI 10.4049/jimmunol.169.12.6831; Setoguchi K, 2001, J CLIN INVEST, V108, P1667; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sjak-Shie NN, 2000, CURR OPIN HEMATOL, V7, P241, DOI 10.1097/00062752-200007000-00007; Smith MR, 1998, BRIT J HAEMATOL, V102, P1090, DOI 10.1046/j.1365-2141.1998.00850.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Treon SP, 1998, BLOOD, V92, P1749, DOI 10.1182/blood.V92.5.1749.417k38_1749_1757; Varterasian Mary L., 1999, Current Opinion in Oncology, V11, P3, DOI 10.1097/00001622-199901000-00002; Wang LH, 2001, J BIOL CHEM, V276, P31839, DOI 10.1074/jbc.M105185200; Wang LH, 2003, CANCER RES, V63, P2046; Wang LH, 1999, J IMMUNOL, V162, P3897; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xu FH, 1998, BLOOD, V92, P241, DOI 10.1182/blood.V92.1.241.413k28_241_251; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yang XY, 2002, J BIOL CHEM, V277, P3973, DOI 10.1074/jbc.M105619200; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	59	102	104	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					205	218		10.1016/S1074-7613(04)00030-5	http://dx.doi.org/10.1016/S1074-7613(04)00030-5			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975242	Bronze			2022-12-18	WOS:000221442400009
J	Li, YL; Li, HM; Dimasi, N; McCormick, JK; Martin, R; Schuck, P; Schlievert, PM; Mariuzza, RA				Li, YL; Li, HM; Dimasi, N; McCormick, JK; Martin, R; Schuck, P; Schlievert, PM; Mariuzza, RA			Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II	IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-A; TOXIC-SHOCK-SYNDROME; BINDING-SITES; COMPLEX; PEPTIDE; PROTEIN; MOLECULE; ANTIGEN; APOPTOSIS; CELLS	MHC class II molecules possess two binding sites for bacterial superantigens (SAGs): a low-affinity site on the cu chain and a high-affinity, zinc-dependent site on the beta chain. only the former has been defined crystallographically. We report the structure of streptococcal pyrogenic exotoxin C (SPE-C) complexed with HLA-DR2a (DRA*010l, DRB5*0101) bearing a self-peptide from myelin basic protein (MBP). SPE-C binds the beta chain through a zinc bridge that links the SAG and class II molecules. Surprisingly, SPE-C also makes extensive contacts with the MBP peptide, such that peptide accounts for one third of the surface area of the MHC molecule buried in the complex, similar to TCR-peptide/MHC complexes. Thus, SPE-C may optimize T cell responses by mimicking the peptide dependence of conventional antigen presentation and recognition.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; NIH, Div Bioengn & Phys Sci, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA	Mariuzza, RA (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA.	mariuzza@carb.nist.gov	McCormick, John/E-4232-2015; Schuck, Peter/AAA-6888-2020; Li, Hongmin/ABI-2439-2020	Schuck, Peter/0000-0002-8859-6966; Li, Hongmin/0000-0002-8684-5308; Schlievert, Patrick/0000-0001-8314-9369; McCormick, John/0000-0003-3742-7289	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD010485] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42937, AI36900] Funding Source: Medline; PHS HHS [36611] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHARDWAJ N, 1993, J EXP MED, V178, P633, DOI 10.1084/jem.178.2.633; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BOHACH GA, 1997, SUPERANTIGENS MOL BI, P167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CHINTAGUMPALA MM, 1991, J IMMUNOL, V147, P3876; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cockerill FR, 1998, CLIN INFECT DIS, V26, P1448, DOI 10.1086/516376; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; HILLERT J, 1994, J NEUROIMMUNOL, V50, P95, DOI 10.1016/0165-5728(94)90219-4; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Kotb M, 1998, CURR OPIN MICROBIOL, V1, P56, DOI 10.1016/S1369-5274(98)80143-4; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI [10.1007/s00249-009-0425-1, DOI 10.1007/S00249-009-0425-1]; Lavoie PM, 1997, P NATL ACAD SCI USA, V94, P6892, DOI 10.1073/pnas.94.13.6892; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; Lo Conte L, 1999, J MOL BIOL, V285, P2177; McCormick JK, 2000, GRAM-POSITIVE PATHOGENS, P43; McCormick JK, 2000, J IMMUNOL, V165, P2306, DOI 10.4049/jimmunol.165.4.2306; MEHINDATE K, 1995, J EXP MED, V182, P1573, DOI 10.1084/jem.182.5.1573; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oksenberg JR, 1996, BRAIN PATHOL, V6, P289, DOI 10.1111/j.1750-3639.1996.tb00856.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papageorgiou AC, 1997, STRUCTURE, V5, P991, DOI 10.1016/S0969-2126(97)00252-9; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913	48	102	110	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2001	14	1					93	103		10.1016/S1074-7613(01)00092-9	http://dx.doi.org/10.1016/S1074-7613(01)00092-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163233	Bronze			2022-12-18	WOS:000166513800009
J	Delon, J; Gregoire, C; Malissen, B; Darche, S; Lemaitre, F; Kourilsky, P; Abastado, JP; Trautmann, A				Delon, J; Gregoire, C; Malissen, B; Darche, S; Lemaitre, F; Kourilsky, P; Abastado, JP; Trautmann, A			CD8 expression allows T cell signaling by monomeric peptide-MHC complexes	IMMUNITY			English	Article							CLASS-I MOLECULES; LYMPHOCYTES-T; LIGAND INTERACTIONS; TARGET-CELL; RECEPTOR; ASSOCIATION; BINDING; OLIGOMERIZATION; TRANSDUCTION; ACTIVATION	Physiologically, TCR signaling is unlikely to result from the cross-linking of TCR-CD3 complexes, given the low density of specific peptide-MHC complexes on antigen-presenting cells. We therefore have tested directly an alternative model for antigen recognition. We show that monomers of soluble peptide-MHC trigger Ca2+ responses in CD8 alpha beta(+) T cells. This response is not observed in CD8(-) T cells and when either the CD8:MHC or CD8:Lck interactions are prevented. This demonstrates that an intact CD8 coreceptor is necessary for effective TCR signaling in response to monomeric peptide-MHC molecules. We propose that this heterodimerization of TCR and CD8 by peptide-MHC corresponds to the physiological event normally involved during antigen-specific signal transduction.	CERVI, Lab Immunol Cellulaire, CNRS, UMR 7627, F-75013 Paris, France; CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille 9, France; Inst Pasteur, Unite Biol Mol Gene, INSERM, U277, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Trautmann, A (corresponding author), CERVI, Lab Immunol Cellulaire, CNRS, UMR 7627, 83 Blvd Hop, F-75013 Paris, France.	trautman@wotan.ens.fr	; Malissen, Bernard/AAK-4659-2020	Delon, Jerome/0000-0003-0222-1192; Malissen, Bernard/0000-0003-1340-9342				ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; ABASTADO JP, 1993, J IMMUNOL, V151, P3569; ANDERSON P, 1987, J IMMUNOL, V139, P678; Arden B, 1998, CURR OPIN IMMUNOL, V10, P74, DOI 10.1016/S0952-7915(98)80035-6; BLANC D, 1988, EUR J IMMUNOL, V18, P613, DOI 10.1002/eji.1830180419; BRACIALE TJ, 1987, J EXP MED, V166, P678, DOI 10.1084/jem.166.3.678; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHALUPNY NJ, 1991, EMBO J, V10, P1201, DOI 10.1002/j.1460-2075.1991.tb08061.x; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; DELON J, 1998, IN PRESS J EXP MED, V188; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; GERMAIN RN, 1995, IMMUNOLOGIST, V3, P113; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Gregoire C, 1996, P NATL ACAD SCI USA, V93, P7184, DOI 10.1073/pnas.93.14.7184; HOEVELER A, 1993, MOL IMMUNOL, V30, P755, DOI 10.1016/0161-5890(93)90147-4; Irie HY, 1998, J IMMUNOL, V161, P183; Kessler B, 1997, J EXP MED, V186, P2033, DOI 10.1084/jem.186.12.2033; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; LETOURNEUR F, 1990, P NATL ACAD SCI USA, V87, P2339, DOI 10.1073/pnas.87.6.2339; Lim GEK, 1998, EUR J IMMUNOL, V28, P745, DOI 10.1002/(SICI)1521-4141(199802)28:02<745::AID-IMMU745>3.0.CO;2-6; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; METZGER H, 1992, J IMMUNOL, V149, P1477; Morgan DJ, 1996, J IMMUNOL, V157, P978; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Pardigon N, 1998, INT IMMUNOL, V10, P619, DOI 10.1093/intimm/10.5.619; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; RATCLIFFE MJH, 1992, J IMMUNOL, V148, P1643; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Renard V, 1996, EUR J IMMUNOL, V26, P2999, DOI 10.1002/eji.1830261227; ROSENSTEIN Y, 1989, J EXP MED, V169, P149, DOI 10.1084/jem.169.1.149; SAKIHAMA T, 1995, P NATL ACAD SCI USA, V92, P6444, DOI 10.1073/pnas.92.14.6444; SAKIHAMA T, 1995, IMMUNOL TODAY, V16, P581, DOI 10.1016/0167-5699(95)80081-6; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TOMONARI K, 1988, IMMUNOGENETICS, V28, P445, DOI 10.1007/BF00355377; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; WEIS RM, 1982, J BIOL CHEM, V257, P6440; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; WHITE J, 1989, J IMMUNOL, V143, P1822; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	56	102	103	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					467	473		10.1016/S1074-7613(00)80630-5	http://dx.doi.org/10.1016/S1074-7613(00)80630-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806633	Bronze			2022-12-18	WOS:000076680700005
J	Fowell, DJ; Magram, J; Turck, CW; Killeen, N; Locksley, RM				Fowell, DJ; Magram, J; Turck, CW; Killeen, N; Locksley, RM			Impaired Th2 subset development in the absence of CD4	IMMUNITY			English	Article							T-CELL DEVELOPMENT; HISTOCOMPATIBILITY COMPLEX BINDING; ANTIGEN RECEPTOR COMPLEX; HIGH-AFFINITY RECEPTOR; CLASS-II MHC; IN-VIVO; CD4-DEFICIENT MICE; LEISHMANIA-MAJOR; TRANSGENIC MICE; GAMMA-CHAIN	Prior studies in CD4-deficient mice established the capacity of T helper (Th) lineage cells to mature into Th1 cells. Unexpectedly, challenge of these mice with Nippostrongylus brasiliensis, a Th2-inducing stimulus, failed to result in the development of Th2 cells. Additional studies were performed using CD4(+) or CD4(-)CD8(-) (double-negative) T cell receptor (TCR) transgenic T cells reactive to LACK antigen of Leishmania major. Double-negative T cells were unable to develop into Th2 cells in vivo, and, unlike CD4(+) T cells, could not be primed for interleukin-4 production in vitro. Similarly, CD4(+) TCR transgenic T cells primed on antigen-presenting cells expressing mutant MHC class II molecules unable to bind CD4 did not differentiate into Th2 cells. These data suggest that interactions between the TCR, MHC II-peptide complex and CD4 may be involved in Th2 development.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT IMMUNOL & MICROBIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; HOFFMANN LA ROCHE INC,DEPT INFLAMMAT AUTOIMMUNE DIS,NUTLEY,NJ 07110	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Roche Holding					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BERENS RL, 1978, J PARASITOL, V64, P160, DOI 10.2307/3279633; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CAPONE M, 1995, J IMMUNOL, V154, P5165; CARBONE AM, 1988, SCIENCE, V242, P1174, DOI 10.1126/science.2460926; CHAN AC, 1994, J IMMUNOL, V152, P4758; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FLEURY S, 1991, CELL, V66, P1037, DOI 10.1016/0092-8674(91)90447-7; GAJEWSKI TF, 1991, J IMMUNOL, V146, P1750; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERMAIN RN, 1993, CURR BIOL, V3, P586, DOI 10.1016/0960-9822(93)90004-8; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guery JC, 1996, J EXP MED, V183, P485, DOI 10.1084/jem.183.2.485; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huang B, 1997, J IMMUNOL, V158, P216; IMAI T, 1995, J IMMUNOL, V155, P1229; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; KUMAR V, 1995, P NATL ACAD SCI USA, V92, P9510, DOI 10.1073/pnas.92.21.9510; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; MURRAY JS, 1989, J EXP MED, V170, P2135, DOI 10.1084/jem.170.6.2135; OHNO H, 1994, J EXP MED, V179, P365, DOI 10.1084/jem.179.1.365; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; QIAN DP, 1993, P NATL ACAD SCI USA, V90, P11875, DOI 10.1073/pnas.90.24.11875; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schountz T, 1996, J IMMUNOL, V157, P3893; SCOTT P, 1990, J IMMUNOL, V144, P1075; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Shen XL, 1996, J IMMUNOL, V157, P87; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; TITUS RG, 1987, EUR J IMMUNOL, V17, P1429, DOI 10.1002/eji.1830171007; URBAN JF, 1995, J IMMUNOL, V154, P4675; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; Wilson A, 1992, Dev Immunol, V2, P85, DOI 10.1155/1992/45150; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845	68	102	103	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					559	569		10.1016/S1074-7613(00)80344-1	http://dx.doi.org/10.1016/S1074-7613(00)80344-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175834	Bronze			2022-12-18	WOS:A1997XB81900007
J	Fang, W; Mueller, DL; Pennell, CA; Rivard, JJ; Li, YS; Hardy, RR; Schlissel, MS; Behrens, TW				Fang, W; Mueller, DL; Pennell, CA; Rivard, JJ; Li, YS; Hardy, RR; Schlissel, MS; Behrens, TW			Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-x(L) transgene	IMMUNITY			English	Article							D-MU PROTEIN; TARGETED DISRUPTION; ANTIBODY DIVERSITY; MEMBRANE EXON; BONE-MARROW; CHAIN GENE; EXPRESSION; MOUSE; BCL-2; LYMPHOCYTES	During B lymphocyte development, pro-B cells that fail to rearrange an immunoglobulin heavy (IgH) chain allele productively are thought to undergo developmental arrest and death, but because these cells are short-lived in vivo they are not well characterized. Transgenic mice expressing the apoptosis regulatory gene bcl-x(L) in the B lineage developed large expansions of pro-B cells in bone marrow. V(D)J rearrangements in the expanded population were nearly all nonproductive, and DJ(H) rearrangements were enriched for joints in D-H reading frame 2 and for aberrant joints with extensive D-H or J(H) deletions. Thus, the death of pro-B cells with failed immunoglobulin rearrangements occurs by apoptosis, and bcl-x(L) can deliver a strong survival signal at the pro-B stage. This analysis also demonstrates that immunoglobulin gene rearrangement is less precise than previously appreciated.	UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455; FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	University of Minnesota System; University of Minnesota Twin Cities; Fox Chase Cancer Center; Johns Hopkins University	Fang, W (corresponding author), UNIV MINNESOTA,SCH MED,CTR IMMUNOL,MINNEAPOLIS,MN 55455, USA.			Mueller, Daniel/0000-0003-1621-0419; Pennell, Christopher/0000-0002-2901-6554	NIAID NIH HHS [AI26782, AI31699, AI35296] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026782, P01AI035296] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BAKHSHI A, 1985, CELL, V41, P889; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Coligan JKA, 1991, CURRENT PROTOCOLS IM; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; FANG W, 1995, J IMMUNOL, V155, P66; FANG W, 1994, J IMMUNOL, V153, P4388; Feeney A J, 1994, Semin Immunol, V6, P155, DOI 10.1006/smim.1994.1021; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hogan BLM, 1994, MANIPULATING MOUSE E; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KORSMEYER SJ, 1992, CANCER SURV, V15, P105; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NAKAYAMA KI, 1995, J EXP MED, V182, P1101, DOI 10.1084/jem.182.4.1101; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; REED JC, 1992, LAB INVEST, V67, P443; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	45	102	103	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					291	299		10.1016/S1074-7613(00)80437-9	http://dx.doi.org/10.1016/S1074-7613(00)80437-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624819	hybrid			2022-12-18	WOS:A1996UC01800010
J	KOZONO, H; PARKER, D; WHITE, J; MARRACK, P; KAPPLER, J				KOZONO, H; PARKER, D; WHITE, J; MARRACK, P; KAPPLER, J			MULTIPLE BINDING-SITES FOR BACTERIAL SUPERANTIGENS ON SOLUBLE CLASS-II MHC MOLECULES	IMMUNITY			English	Article							STAPHYLOCOCCAL ENTEROTOXIN-A; T-CELL RECOGNITION; MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTOR BETA-CHAIN; HLA-DR; ANTIGEN; REGION; IDENTIFICATION; POLYMORPHISM; SPECIFICITY	We used surf ace plasmon resonance to study the binding of a set of soluble mouse I-E class II major histocompatibility molecules, each occupied by a different single peptide, to the staphylococcal enterotoxin superantigens, SEA and SEE. The rates of association and dissociation to SEA varied greatly depending on the I-E-bound peptide. By contrast, binding to SEE yielded fast association and dissociation rates, which were relatively peptide independent. The results also indicated nonoverlapping binding sites for SEE and SEA on class II and raised the possibility of enhanced SAg presentation to T cells by cross-linking of cell surface class II.	UNIV COLORADO, SCH MED, DEPT IMMUNOL, DENVER, CO 80206 USA; UNIV COLORADO, SCH MED, DEPT BIOPHYS BIOCHEM & GENET, DENVER, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	KOZONO, H (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED, HOWARD HUGHES MED INST, DENVER, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Parker, David/0000-0003-4456-2788; , Haruo/0000-0003-3352-0638	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018785, R01AI018785, R01AI017134, R56AI018785, P01AI022295, R37AI017134, R56AI017134] Funding Source: NIH RePORTER; NIAID NIH HHS [AI17134, AI22295, AI-18785] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARBER LD, 1991, J IMMUNOL, V147, P2346; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CAZENAVE PA, 1990, CELL, V63, P717, DOI 10.1016/0092-8674(90)90138-5; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOWD JE, 1995, J IMMUNOL, V154, P1024; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FRASER JD, 1992, P NATL ACAD SCI USA, V89, P5507, DOI 10.1073/pnas.89.12.5507; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GRIFFITH IJ, 1987, J IMMUNOL, V138, P4480; HARRIS TO, 1993, INFECT IMMUN, V61, P3175, DOI 10.1128/IAI.61.8.3175-3183.1993; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; HERRMANN T, 1989, EUR J IMMUNOL, V19, P2171, DOI 10.1002/eji.1830191131; HUDSON K, 1995, IN PRESS J EXP MED; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LEE JM, 1990, J IMMUNOL, V145, P3360; LERNER EA, 1980, J EXP MED, V152, P1085, DOI 10.1084/jem.152.4.1085; LORENZ RG, 1988, P NATL ACAD SCI USA, V85, P5220, DOI 10.1073/pnas.85.14.5220; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; MOLLICK JA, 1991, J IMMUNOL, V146, P463; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; OZATO K, 1980, J IMMUNOL, V124, P533; PULLEN AM, 1990, CELL, V61, P1365, DOI 10.1016/0092-8674(90)90700-O; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SCHOLL PR, 1990, J IMMUNOL, V144, P226; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; THIBODEAU J, 1994, SCIENCE, V266, P1874, DOI 10.1126/science.7997881; THIBODEAU J, 1994, J EXP MED, V179, P1029, DOI 10.1084/jem.179.3.1029; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; YAGI JJ, 1990, J IMMUNOL, V144, P892	49	102	105	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1995	3	2					187	196		10.1016/1074-7613(95)90088-8	http://dx.doi.org/10.1016/1074-7613(95)90088-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648392	Bronze			2022-12-18	WOS:A1995RR33900004
J	ZHU, CM; ROTH, DB				ZHU, CM; ROTH, DB			CHARACTERIZATION OF CODING ENDS IN THYMOCYTES OF SCID MICE - IMPLICATIONS FOR THE MECHANISM OF V(D)J RECOMBINATION	IMMUNITY			English	Article							SITE-SPECIFIC RECOMBINATION; BROKEN DNA-MOLECULES; MOUSE THYMOCYTES; REARRANGEMENTS; SEGMENTS; CHAIN; GENES; SEQUENCES; DIVERSITY; CLEAVAGE	We previously identified possible intermediates in V(D)J recombination at the TCR delta locus and characterized molecules with signal ends and with covalently sealed (hairpin) coding ends in thymocytes of scid mice by Southern blotting. Here, we use a sensitive ligation-mediated PCR assay to demonstrate that all coding ends detected in scid thymocytes are covalently sealed. Neither coding nor signal ends exhibit loss or addition of nucleotides. These data imply that hairpin formation is coupled to the initial cleavage at the signal/coding border, and that the cleavage step in V(D)J recombination is conservative. In scid/+ or wild-type thymocytes, hairpin coding ends are at least 1000-fold less abundant than signal ends. These results provide Insight into the mechanism of V(D)J recombination.	BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030	Baylor College of Medicine	ZHU, CM (corresponding author), BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030, USA.				NIAID NIH HHS [AI-36420] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036420] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BLACKWELL TK, 1989, EMBO J, V8, P735, DOI 10.1002/j.1460-2075.1989.tb03433.x; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CARROLL AM, 1991, GENE DEV, V5, P1357, DOI 10.1101/gad.5.8.1357; CARROLL AM, 1993, MOL CELL BIOL, V13, P3632, DOI 10.1128/MCB.13.6.3632; CARROLL AM, 1993, J IMMUNOL, V150, P2222; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; ELLIOTT JF, 1988, NATURE, V331, P627; FERRIER P, 1990, J EXP MED, V171, P1909, DOI 10.1084/jem.171.6.1909; FISH SM, 1994, MOL CELL BIOL, V14, P4455, DOI 10.1128/MCB.14.7.4455; KALLENBACH S, 1992, RES IMMUNOL, V143, P873, DOI 10.1016/0923-2494(92)80110-7; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Laskowski M Sr, 1980, Methods Enzymol, V65, P263; LEWIS S, 1985, SCIENCE, V228, P677, DOI 10.1126/science.3158075; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LEWIS SM, 1994, P NATL ACAD SCI USA, V91, P1332, DOI 10.1073/pnas.91.4.1332; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; Roth D B, 1992, Curr Top Microbiol Immunol, V182, P115; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SLACK JK, 1994, NUCLEIC ACIDS RES, V22, P1316; STAUNTON JE, 1994, MOL CELL BIOL, V14, P3876, DOI 10.1128/MCB.14.6.3876; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0	35	102	104	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					101	112		10.1016/1074-7613(95)90082-9	http://dx.doi.org/10.1016/1074-7613(95)90082-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600297	Bronze			2022-12-18	WOS:A1995QC59300009
J	Bonifacius, A; Tischer-Zimmermann, S; Dragon, AC; Gussarow, D; Vogel, A; Krettek, U; Godecke, N; Yilmaz, M; Kraft, ARM; Hoeper, MM; Pink, I; Schmidt, JJ; Li, Y; Welte, T; Maecker-Kolhoff, B; Martens, J; Berger, MM; Lobenwein, C; Stankov, MV; Cornberg, M; David, S; Behrens, GMN; Witzke, O; Blasczyk, R; Eiz-Vesper, B				Bonifacius, Agnes; Tischer-Zimmermann, Sabine; Dragon, Anna C.; Gussarow, Daniel; Vogel, Alexander; Krettek, Ulrike; Goedecke, Nina; Yilmaz, Mustafa; Kraft, Anke R. M.; Hoeper, Marius M.; Pink, Isabell; Schmidt, Julius J.; Li, Yang; Welte, Tobias; Maecker-Kolhoff, Britta; Martens, Joerg; Berger, Marc Moritz; Lobenwein, Corinna; Stankov, Metodi, V; Cornberg, Markus; David, Sascha; Behrens, Georg M. N.; Witzke, Oliver; Blasczyk, Rainer; Eiz-Vesper, Britta			COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses	IMMUNITY			English	Article							ASSAYS; MICE	Cellular and humoral immunity to SARS-CoV-2 is critical to control primary infection and correlates with severity of disease. The role of SARS-CoV-2-specific T cell immunity, its relationship to antibodies, and preexisting immunity against endemic coronaviruses (huCoV), which has been hypothesized to be protective, were investigated in 82 healthy donors (HDs), 204 recovered (RCs), and 92 active COVID-19 patients (ACs). ACs had high amounts of anti-SARS-CoV-2 nucleocapsid and spike IgG but lymphopenia and overall reduced antiviral T cell responses due to the inflammatory milieu, expression of inhibitory molecules (PD-1, Tim-3) as well as effector caspase-3, -7, and -8 activity in T cells. SARS-CoV-2-specific T cell immunity conferred by polyfunctional, mainly interferon-g-secreting CD4(+) T cells remained stable throughout convalescence, whereas humoral responses declined. Immune responses toward huCoV in RCs with mild disease and strong cellular SARS-CoV-2 T cell reactivity imply a protective role of pre-existing immunity against huCoV.	[Bonifacius, Agnes; Tischer-Zimmermann, Sabine; Dragon, Anna C.; Gussarow, Daniel; Vogel, Alexander; Krettek, Ulrike; Goedecke, Nina; Martens, Joerg; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med & Transplant Engn, Hannover, Germany; [Yilmaz, Mustafa] Publ Hlth Dept, Hannover, Germany; [Kraft, Anke R. M.; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Kraft, Anke R. M.; Stankov, Metodi, V; Cornberg, Markus; Behrens, Georg M. N.] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Kraft, Anke R. M.; Cornberg, Markus] Ctr Individualised Infect Med CiiM, Hannover, Germany; [Hoeper, Marius M.; Pink, Isabell; Welte, Tobias] Hannover Med Sch, Dept Pneumol, German Ctr Lung Res DZL, Hannover, Germany; [Schmidt, Julius J.; David, Sascha] Hannover Med Sch, Dept Kidney & Hypertens Dis, Hannover, Germany; [Li, Yang] Helmholtz Ctr Infect Res, Ctr Individualised Infect Med CiiM, Hannover Med Sch, Dept Computat Biol Individualised Med, Hannover, Germany; [Maecker-Kolhoff, Britta] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany; [Berger, Marc Moritz] Univ Hosp Essen, Dept Anesthesiol & Intens Care Med, Essen, Germany; [Lobenwein, Corinna; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, West German Ctr Infect Dis, Dept Infect Dis, Duisburg, Germany; [Stankov, Metodi, V; Behrens, Georg M. N.] Hannover Med Sch, Dept Rheumatol & Clin Immunol, Hannover, Germany; [David, Sascha] Univ Hosp Zurich, Inst Intens Care Med, Zurich, Switzerland	Hannover Medical School; Hannover Medical School; German Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; University of Duisburg Essen; University of Duisburg Essen; Hannover Medical School; University of Zurich; University Zurich Hospital	Eiz-Vesper, B (corresponding author), Hannover Med Sch, Inst Transfus Med & Transplant Engn, Hannover, Germany.	eiz-vesper.britta@mh-hannover.de	Li, Yang/HGT-8446-2022; Behrens, Georg MN/Q-4486-2016; David, Sascha/AAL-6909-2021; Maecker-Kolhoff, Britta/AFV-1492-2022; Cornberg, Markus/AAN-6939-2021	Li, Yang/0000-0003-4022-7341; Cornberg, Markus/0000-0002-9141-8001; Behrens, Georg/0000-0003-3111-621X; Berger, Marc Moritz/0000-0001-6771-3193; Stankov, Metodi/0000-0003-3001-2478	state of Lower Saxony [14-76103-184 CORONA-12/20]; Federal Ministry of Health [ZMVI12520COR804]; German Research Foundation (DFG) [2830, SFB 900/B11, 158989968]; Braukmann-Wittenberg Heart Foundation; DFG	state of Lower Saxony(European Commission); Federal Ministry of Health; German Research Foundation (DFG)(German Research Foundation (DFG)); Braukmann-Wittenberg Heart Foundation; DFG(German Research Foundation (DFG))	This research was funded in part by grants from the state of Lower Saxony (14-76103-184 CORONA-12/20), the Federal Ministry of Health (ZMVI12520COR804), and the German Research Foundation (DFG; Research Unit 2830 and SFB 900/B11 project ID 158989968). We are grateful to all study participants for providing samples and to the MVZ Laboratory Limbach Hannover GbR for RT-PCR analysis. Furthermore, we would like to thank Dorthe Rokitta, Nicole Neumann, Sarina Lukis, Elvira Schulde, Milena Stietzel, Juliane Ebersold, Sophie Meyer, Bach Uy Vu, Leona Schmaltz, and Marion Hitzigrath for technical support, as well as the team at the Cell Sorting Core Facility of Hannover Medical School, which was supported in part by the Braukmann-Wittenberg Heart Foundation and the DFG.	Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; AlFehaidi A, 2021, J INFECTION, V82, P422, DOI 10.1016/j.jinf.2020.10.019; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698; Behrens GMN, 2020, INFECT DIS THER, V9, P837, DOI 10.1007/s40121-020-00334-1; Bieling M, 2018, ONCOTARGET, V9, P4737, DOI 10.18632/oncotarget.23531; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Bunse CE, 2015, CLIN EXP IMMUNOL, V179, P265, DOI 10.1111/cei.12451; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449; Cornberg M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00475; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Ferreras C, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.620730; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang I, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00453-4; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Iwasaki A, 2021, LANCET INFECT DIS, V21, P3, DOI 10.1016/S1473-3099(20)30783-0; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Leung W., 2020, SUCCESFULL MANUFACTU, DOI [10.1101/2020.04.24.20077487, DOI 10.1101/2020.04.24.20077487]; Li HY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-019-0089-y; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Rudolf-Oliveira RCM, 2015, IMMUNOL LETT, V163, P96, DOI 10.1016/j.imlet.2014.11.003; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Odak I, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102885; Okamoto M, 2020, ANTIVIR RES, V182, DOI 10.1016/j.antiviral.2020.104902; Ong EZY, 2020, CELL HOST MICROBE, V27, P879, DOI 10.1016/j.chom.2020.03.021; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Priesner C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00393; Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3; Sariol A, 2020, IMMUNITY, V53, P248, DOI 10.1016/j.immuni.2020.07.005; Schogler A, 2016, J CYST FIBROS, V15, P332, DOI 10.1016/j.jcf.2015.10.013; Sekine T, 2020, AM J ROENTGENOL, V215, pW27, DOI 10.2214/AJR.20.23435; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Swadling L, 2020, NAT IMMUNOL, V21, P1307, DOI 10.1038/s41590-020-0798-y; Tischer S, 2014, J IMMUNOL METHODS, V408, P101, DOI 10.1016/j.jim.2014.05.011; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Ward H., 2020, DECLINING PREVALENCE; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; WHO, 2020, COVID 19 THER TRIAL; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Yasinska IM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01594; Yoshikawa N, 2009, J VIROL, V83, P5451, DOI 10.1128/JVI.02272-08; Zhang YG, 2020, CELL MOL IMMUNOL, V17, P878, DOI 10.1038/s41423-020-0484-x; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636; Zheng M, 2020, J BIOL CHEM, V295, P14040, DOI 10.1074/jbc.RA120.015036; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	60	101	101	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					340	+		10.1016/j.immuni.2021.01.008	http://dx.doi.org/10.1016/j.immuni.2021.01.008		FEB 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567252	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000627407700016
J	Hirota, K; Hashimoto, M; Ito, Y; Matsuura, M; Ito, H; Tanaka, M; Watanabe, H; Kondoh, G; Tanaka, A; Yasuda, K; Kopf, M; Potocnik, AJ; Stockinger, B; Sakaguchi, N; Sakaguchi, S				Hirota, Keiji; Hashimoto, Motomu; Ito, Yoshinaga; Matsuura, Mayumi; Ito, Hiromu; Tanaka, Masao; Watanabe, Hitomi; Kondoh, Gen; Tanaka, Atsushi; Yasuda, Keiko; Kopf, Manfred; Potocnik, Alexandre J.; Stockinger, Brigitta; Sakaguchi, Noriko; Sakaguchi, Shimon			Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; IL-17-PRODUCING T-CELLS; RHEUMATOID-ARTHRITIS; INFLAMMATORY RESPONSES; TNF-ALPHA; IN-VIVO; INDUCTION; RECEPTOR; DIFFERENTIATION; INTERLEUKIN-17	Despite the importance of Th17 cells in autoimmune diseases, it remains unclear how they control other inflammatory cells in autoimmune tissue damage. Using a model of spontaneous autoimmune arthritis, we showed that arthritogenic Th17 cells stimulated fibroblast-like synoviocytes via interleukin-17 (IL-17) to secrete the cytokine GMCSF and also expanded synovial-resident innate lymphoid cells (ILCs) in inflamed joints. Activated synovial ILCs, which expressed CD25, IL-33Ra, and TLR9, produced abundant GM-CSF upon stimulation by IL-2, IL-33, or CpG DNA. Loss of GM-CSF production by either ILCs or radio-resistant stromal cells prevented Th17 cell-mediated arthritis. GM-CSF production by Th17 cells augmented chronic inflammation but was dispensable for the initiation of arthritis. We showed that GM-CSF-producing ILCs were present in inflamed joints of rheumatoid arthritis patients. Thus, a cellular cascade of autoimmune Th17 cells, ILCs, and stromal cells, via IL-17 and GM-CSF, mediates chronic joint inflammation and can be a target for therapeutic intervention.	[Hirota, Keiji; Tanaka, Atsushi; Yasuda, Keiko; Sakaguchi, Noriko; Sakaguchi, Shimon] Osaka Univ, Dept Expt Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hashimoto, Motomu; Ito, Hiromu; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto 6068507, Japan; [Ito, Yoshinaga; Matsuura, Mayumi; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Expt Immunol, Kyoto 6068507, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto 6068507, Japan; [Hirota, Keiji; Watanabe, Hitomi; Kondoh, Gen] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Integrat Biol Sci, Kyoto 6068507, Japan; [Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Potocnik, Alexandre J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland; [Stockinger, Brigitta] Francis Crick Inst, AhR Immun Lab, London NW1 1AT, England	Osaka University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; Francis Crick Institute	Hirota, K; Sakaguchi, S (corresponding author), Osaka Univ, Dept Expt Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.; Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Lab Expt Immunol, Kyoto 6068507, Japan.; Hirota, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Lab Integrat Biol Sci, Kyoto 6068507, Japan.	hkeiji@infront.kyoto-u.ac.jp; shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Tanaka, Atsushi/U-6761-2019; Kopf, Manfred/B-6907-2009	Tanaka, Atsushi/0000-0003-1660-9892; Kopf, Manfred/0000-0002-0628-7140; Hirota, Keiji/0000-0002-4737-0661; Stockinger, Brigitta/0000-0001-8781-336X; Potocnik, Alexandre/0000-0002-4730-8593	Francis Crick Institute; Cancer Research UK [FC001159]; UK Medical Research Council [FC001159]; Wellcome Trust [FC001159]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16H06233, 17K19553, 16H06295]; Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency; Takeda Science Foundation	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001159), the UK Medical Research Council (FC001159), and the Wellcome Trust (FC001159). This work was also supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (16H06233 and 17K19553 to K.H. and 16H06295 to S.S.), the Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency (S.S.), and Takeda Science Foundation (K.H.). We would like to thank R. Ishii for technical assistance and the staff of the animal facility for breeding and maintenance of our mouse strains.	ALVAROGRACIA JM, 1989, J EXP MED, V170, P865, DOI 10.1084/jem.170.3.865; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Behrens F, 2015, ANN RHEUM DIS, V74, P1058, DOI 10.1136/annrheumdis-2013-204816; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015; Cho JH, 2015, NAT MED, V21, P730, DOI 10.1038/nm.3897; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ito Y, 2014, SCIENCE, V346, P363, DOI 10.1126/science.1259077; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Marafini I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126291; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Varas A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0710-6; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	49	101	109	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1220	+		10.1016/j.immuni.2018.04.009	http://dx.doi.org/10.1016/j.immuni.2018.04.009			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29802020	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000436456900020
J	Bournazos, S; Ravetch, JV				Bournazos, Stylianos; Ravetch, Jeffrey V.			Fc gamma Receptor Function and the Design of Vaccination Strategies	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELL MATURATION; HEPATITIS-B PATIENTS; IN-VIVO ACTIVITY; IMMUNE-COMPLEX; MONOCLONAL-ANTIBODY; HUMAN IGG1; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; NEUTRALIZING ANTIBODIES	Through specific interactions with distinct types of Fc gamma receptors (Fc gamma Rs), the Fc domain of immunoglobulin G (IgG) mediates a wide spectrum of immunological functions that influence both innate and adaptive responses. Recent studies indicate that IgG Fc-Fc gamma R interactions are dynamically regulated during an immune response through the control of the Fc-associated glycan structure and Ig subclass composition on the one hand and selective Fc gamma R expression on immune cells on the other, which together determine the capacity of IgG to interact in a cell-type-specific manner with specific members of the Fc gamma R family. Here, we present a framework that synthesizes the current understanding of the contribution of Fc gamma R pathways to the induction and regulation of antibody and T cell responses. Within this context, we discuss vaccination strategies to elicit broad and potent immune responses based on the immunomodulatory properties of Fc-Fc gamma R interactions.	[Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; 	Rockefeller University; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [P01AI100148, U19AI111825, U19AI109946]; National Cancer Institute [R35CA196620, P01CA190174]; Bill & Melinda Gates Foundation [OPP1124068]; NATIONAL CANCER INSTITUTE [P01CA190174, R35CA196620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111825, P01AI100148, U19AI109946] Funding Source: NIH RePORTER	Rockefeller University; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge support from the Rockefeller University. Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (P01AI100148, U19AI111825, and U19AI109946), the National Cancer Institute (R35CA196620 and P01CA190174), and the Bill & Melinda Gates Foundation (OPP1124068). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S.B. is an amfAR Mathilde Krim Fellow in Basic Biomedical Research (109519-60-RKVA).	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Albert H, 2008, P NATL ACAD SCI USA, V105, P15005, DOI 10.1073/pnas.0808248105; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Blank MC, 2005, HUM GENET, V117, P220, DOI 10.1007/s00439-005-1302-3; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Borthakur S, 2011, BIOCHEMISTRY-US, V50, P4608, DOI 10.1021/bi200019y; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; BOUIGE P, 1990, HYBRIDOMA, V9, P519, DOI 10.1089/hyb.1990.9.519; Bouige P, 1996, FEMS IMMUNOL MED MIC, V13, P71, DOI 10.1111/j.1574-695X.1996.tb00218.x; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Bournazos S, 2015, IMMUNOL REV, V268, P88, DOI 10.1111/imr.12343; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bournazos S, 2014, J CLIN INVEST, V124, P725, DOI 10.1172/JCI72676; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chan MA, 2010, CLIN IMMUNOL, V137, P330, DOI 10.1016/j.clim.2010.08.005; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; de Bono JS, 2004, ANN ONCOL, V15, P1825, DOI 10.1093/annonc/mdh472; de Man YA, 2014, CURR OPIN RHEUMATOL, V26, P329, DOI 10.1097/BOR.0000000000000045; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; DUCHEMIN AM, 1994, J BIOL CHEM, V269, P12111; Espy C, 2011, ARTHRITIS RHEUM-US, V63, P2105, DOI 10.1002/art.30362; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fiebiger BM, 2015, P NATL ACAD SCI USA, V112, pE2385, DOI 10.1073/pnas.1505292112; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Foss S, 2015, IMMUNOL REV, V268, P328, DOI 10.1111/imr.12363; Gerdes C.A., 2013, CLIN CANCER RES, V19, P1126; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Haddad EE, 1997, AVIAN DIS, V41, P882, DOI 10.2307/1592342; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hioe CE, 2009, VACCINE, V28, P352, DOI 10.1016/j.vaccine.2009.10.040; Hoffmann E, 2012, P NATL ACAD SCI USA, V109, P14556, DOI 10.1073/pnas.1203912109; Horton HM, 2008, CANCER RES, V68, P8049, DOI 10.1158/0008-5472.CAN-08-2268; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Kumar R, 2013, VACCINE, V31, P5413, DOI 10.1016/j.vaccine.2013.09.010; Kumar R, 2011, VACCINE, V29, P9064, DOI 10.1016/j.vaccine.2011.09.057; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; Liu SD, 2015, CANCER IMMUNOL RES, V3, P173, DOI 10.1158/2326-6066.CIR-14-0125; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lund J, 1996, J IMMUNOL, V157, P4963; Mueller M, 2013, AM J HUM GENET, V92, P28, DOI 10.1016/j.ajhg.2012.11.013; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; Ohmi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11205; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; POKRIC B, 1993, VACCINE, V11, P655, DOI 10.1016/0264-410X(93)90312-L; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110; Su KH, 2004, J IMMUNOL, V172, P7186, DOI 10.4049/jimmunol.172.11.7186; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; Theodoratou E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28098; Uciechowski P, 1998, EUR J IMMUNOL, V28, P2928, DOI 10.1002/(SICI)1521-4141(199809)28:09<2928::AID-IMMU2928>3.0.CO;2-8; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; VELDE AAT, 1992, J IMMUNOL, V149, P4048; Visciano Maria Luisa, 2008, Infect Agent Cancer, V3, P11, DOI 10.1186/1750-9378-3-11; von Behring E., 1892, Z HYG INFEKTIOSKRANK, V12, P10; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wen YM, 2016, EMBO MOL MED, V8, P1120, DOI 10.15252/emmm.201606593; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xu DZ, 2013, J HEPATOL, V59, P450, DOI 10.1016/j.jhep.2013.05.003; Xu DZ, 2005, VACCINE, V23, P2658, DOI 10.1016/j.vaccine.2004.10.040; Yao X, 2007, VACCINE, V25, P1771, DOI 10.1016/j.vaccine.2006.11.019; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	100	101	102	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					224	233		10.1016/j.immuni.2017.07.009	http://dx.doi.org/10.1016/j.immuni.2017.07.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813656	Green Accepted, Bronze			2022-12-18	WOS:000407788300010
J	MacLeod, DT; Choi, NM; Briney, B; Garces, F; Ver, LS; Landais, E; Murrell, B; Wrin, T; Kilembe, W; Liang, CH; Ramos, A; Bian, CB; Wickramasinghe, L; Kong, L; Eren, K; Wu, CY; Wong, CH; Pond, SLK; Wilson, IA; Burton, DR; Poignard, P				MacLeod, Daniel T.; Choi, Nancy M.; Briney, Bryan; Garces, Fernando; Ver, Lorena S.; Landais, Elise; Murrell, Ben; Wrin, Terri; Kilembe, William; Liang, Chi-Hui; Ramos, Alejandra; Bian, Chaoran B.; Wickramasinghe, Lalinda; Kong, Leopold; Eren, Kemal; Wu, Chung-Yi; Wong, Chi-Huey; Pond, Sergei L. Kosakovsky; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal		IAVI Protocol C Investigators; IAVI African Hiv Res Network	Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; VH4-21 GENE SEGMENT; B-CELLS; GLYCAN RECOGNITION; DEPENDENT EPITOPE; COLD AGGLUTININS; POTENT; VULNERABILITY; EVOLUTION; AUTOREACTIVITY	The high-mannose patch on HIV Env is a preferred target for broadly neutralizing antibodies (bnAbs), but to date, no vaccination regimen has elicited bnAbs against this region. Here, we present the development of a bnAb lineage targeting the high-mannose patch in an HIV-1 subtype-C-infected donor from sub-Saharan Africa. The Abs first acquired autologous neutralization, then gradually matured to achieve breadth. One Ab neutralized >47% of HIV-1 strains with only similar to 11% somatic hypermutation and no insertions or deletions. By sequencing autologous env, we determined key residues that triggered the lineage and participated in Ab-Env coevolution. Next-generation sequencing of the Ab repertoire showed an early expansive diversification of the lineage followed by independent maturation of individual limbs, several of them developing notable breadth and potency. Overall, the findings are encouraging from a vaccine standpoint and suggest immunization strategies mimicking the evolution of the entire high-mannose patch and promoting maturation of multiple diverse Ab pathways.	[MacLeod, Daniel T.; Choi, Nancy M.; Briney, Bryan; Garces, Fernando; Ver, Lorena S.; Landais, Elise; Ramos, Alejandra; Bian, Chaoran B.; Wickramasinghe, Lalinda; Kong, Leopold; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Briney, Bryan; Liang, Chi-Hui; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Garces, Fernando; Kong, Leopold; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Garces, Fernando; Kong, Leopold; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Briney, Bryan; Garces, Fernando; Kong, Leopold; Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Murrell, Ben; Eren, Kemal; Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA 94080 USA; [Kilembe, William] Zambia Emory HIV Res Project, Lusaka, Zambia; [Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [MacLeod, Daniel T.; Choi, Nancy M.; Ver, Lorena S.; Landais, Elise; Ramos, Alejandra; Bian, Chaoran B.; Wickramasinghe, Lalinda; Poignard, Pascal; IAVI African Hiv Res Network] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Poignard, Pascal] Univ Grenoble Alpes, CNRS, Inst Biol Struct, CEA, F-38044 Grenoble, France	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Academia Sinica - Taiwan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Poignard, P (corresponding author), Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Poignard, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Poignard, P (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10038 USA.; Poignard, P (corresponding author), Univ Grenoble Alpes, CNRS, Inst Biol Struct, CEA, F-38044 Grenoble, France.	poignard@scripps.edu	Wu, Chung-Yi/K-8334-2018; poignard, pascal/N-6678-2013; Pond, Sergei LK/G-9830-2012; Murrell, Ben/AAM-1188-2021; poignard, pascal/AAB-4613-2020	Pond, Sergei LK/0000-0003-4817-4029; Poignard, Pascal/0000-0002-0021-7192; Murrell, Ben/0000-0002-0393-4445; Kong, Leopold/0000-0001-7456-1773	IAVI; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development (USAID); National Institute of Allergy And Infectious Diseases [U19AI090970, UM1AI100663];  [U01GM110749];  [AI100665];  [K99AI120851];  [R01 AI084817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090970, R01AI084817, K99AI120851, UM1AI100663, T32AI007244, K24AI100665, R56AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110749, R01GM093939] Funding Source: NIH RePORTER	IAVI; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; World Bank(The World Bank India); Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by IAVI and made possible by the support of many donors, including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan in partnership with The World Bank, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation, the United Kingdom Department for International Development, and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. The contents of this manuscript are the responsibility of IAVI and do not necessarily reflect the views of USAID or the United States government. We would also like to thank all of the Protocol C clinical investigators, study participants, and research staff at each of the Protocol C clinical centers. This work was supported by grants U19AI090970 and UM1AI100663 from the National Institute of Allergy And Infectious Diseases. B.M. was supported by grants U01GM110749, AI100665, and K99AI120851 and I.A. by R01 AI084817. We thank Kay Limoli, Sam Jauregui, and Johnazen Perea at Monogram Biosciences for their contribution to this study and Olayinka Fagbayi for helping with the graphical summary. Finally, we are grateful to Shane Crotty (La Jolla Institute for Allergy and Immunology; LIAI), Colin Havenar-Daughton (LIAI), Devin Sok (IAVI), Matthias Pauthner (The Scripps Research Institute), and all researchers of the U19 group for generously providing reagents, thoughtful discussions, and technical help for this project.	Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; PASCUAL V, 1991, J IMMUNOL, V146, P4385; PASCUAL V, 1992, J IMMUNOL, V149, P2337; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI200112462; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	52	101	102	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1215	1226		10.1016/j.immuni.2016.04.016	http://dx.doi.org/10.1016/j.immuni.2016.04.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192579	Green Accepted, Bronze			2022-12-18	WOS:000376478500024
J	Haverkamp, JM; Smith, AM; Weinlich, R; Dillon, CP; Qualls, JE; Neale, G; Koss, B; Kim, Y; Bronte, V; Herold, MJ; Green, DR; Opferman, JT; Murray, PJ				Haverkamp, Jessica M.; Smith, Amber M.; Weinlich, Ricardo; Dillon, Christopher P.; Qualls, Joseph E.; Neale, Geoffrey; Koss, Brian; Kim, Young; Bronte, Vincenzo; Herold, Marco J.; Green, Douglas R.; Opferman, Joseph T.; Murray, Peter J.			Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways	IMMUNITY			English	Article							MACROPHAGE DIFFERENTIATION; CHRONIC INFLAMMATION; ANTIAPOPTOTIC MCL-1; HEMATOPOIETIC STEM; B-LYMPHOCYTES; CELLS; HOMEOSTASIS; SURVIVAL; MICE; EXPRESSION	Nonresolving inflammation expands a heterogeneous population of myeloid suppressor cells capable of inhibiting T cell function. This heterogeneity has confounded the functional dissection of individual myeloid subpopulations and presents an obstacle for antitumor immunity and immunotherapy. Using genetic manipulation of cell death pathways, we found the monocytic suppressor-cell subset, but not the granulocytic subset, requires continuous c-FLIP expression to prevent caspase-8-dependent, RIPK3-independent cell death. Development of the granulocyte subset requires MCL-1-mediated control of the intrinsic mitochondrial death pathway. Monocytic suppressors tolerate the absence of MCL-1 provided cytokines increase expression of the MCL-1-related protein A1. Monocytic suppressors mediate T cell suppression, whereas their granulocytic counterparts lack suppressive function. The loss of the granulocytic subset via conditional MCL-1 deletion did not alter tumor incidence implicating the monocytic compartment as the functionally immunosuppressive subset in vivo. Thus, death pathway modulation defines the development, survival, and function of myeloid suppressor cells.	[Haverkamp, Jessica M.; Smith, Amber M.; Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Haverkamp, Jessica M.; Smith, Amber M.; Weinlich, Ricardo; Dillon, Christopher P.; Qualls, Joseph E.; Green, Douglas R.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Koss, Brian; Opferman, Joseph T.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Kim, Young] Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD 21218 USA; [Bronte, Vincenzo] Verona Univ Hosp, I-37134 Verona, Italy; [Bronte, Vincenzo] Dept Pathol, I-37134 Verona, Italy; [Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Herold, Marco J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Johns Hopkins University; Johns Hopkins Medicine; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Walter & Eliza Hall Institute; University of Melbourne	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	peter.murray@stjude.org	Weinlich, Ricardo/S-7495-2016; Green, Douglas R/N-8083-2018; Opferman, Joseph T/M-5331-2018; Bronte, Vincenzo/K-7902-2016; Herold, Marco J/C-8039-2013; Weinlich, Ricardo/AAW-3154-2020; Murray, Peter J/K-4725-2018	Green, Douglas R/0000-0002-7332-1417; Opferman, Joseph T/0000-0002-1147-5621; Bronte, Vincenzo/0000-0002-3741-5141; Herold, Marco J/0000-0001-7539-7581; Weinlich, Ricardo/0000-0001-6822-7330; Murray, Peter J/0000-0001-6329-9802; Qualls, Joseph/0000-0002-0113-2166; Koss, Brian/0000-0003-0155-4809	NIH Cancer Center; Hartwell Foundation; Alex's Lemonade Stand Foundation; NHMRC [APP1049720]; NIH Cancer Center [P30 CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R21CA189990, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER	NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; Alex's Lemonade Stand Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Pope (Northwestern University) for the gift of the c-FLIP knockout mice and R. Cross and his team for cell sorting and J. Wu and S. Mao for the statistical analysis of tumor formation in TH-MYCN MCL-1 Delta M mice and B. Blazar for discussions. This work was supported by NIH Cancer Center developmental funds (P.J.M. and J.T.O.), The Hartwell Foundation Individual Biomedical Research Award (P.J.M.), Alex's Lemonade Stand Foundation (P.J.M.), NHMRC project grant APP1049720 (M.J.H.), NIH Cancer Center grant P30 CA21765, and the American Lebanese Syrian Associated Charities.	Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dolcetti L., 2010, CURR PROTOC IMMUNOL; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hu X, 2014, J IMMUNOL, V192, P1320, DOI 10.4049/jimmunol.1203195; Huang QQ, 2010, BLOOD, V116, P4968, DOI 10.1182/blood-2009-11-252841; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Ottina E, 2012, BLOOD, V119, P6032, DOI 10.1182/blood-2011-12-399089; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ryan SO, 2013, J IMMUNOL, V190, P5037, DOI 10.4049/jimmunol.1203404; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schouppe E, 2013, EUR J IMMUNOL, V43, P2930, DOI 10.1002/eji.201343349; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115	47	101	107	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					947	959		10.1016/j.immuni.2014.10.020	http://dx.doi.org/10.1016/j.immuni.2014.10.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25500368	Bronze, Green Accepted			2022-12-18	WOS:000346654100013
J	Skabytska, Y; Wolbing, F; Gunther, C; Koberle, M; Kaesler, S; Chen, KM; Guenova, E; Demircioglu, D; Kempf, WE; Volz, T; Rammensee, HG; Schaller, M; Rocken, M; Gotz, F; Biedermann, T				Skabytska, Yuliya; Woelbing, Florian; Guenther, Claudia; Koeberle, Martin; Kaesler, Susanne; Chen, Ko-Ming; Guenova, Emmanuella; Demircioglu, Doruk; Kempf, Wolfgang E.; Volz, Thomas; Rammensee, Hans-Georg; Schaller, Martin; Roecken, Martin; Goetz, Friedrich; Biedermann, Tilo			Cutaneous Innate Immune Sensing of Toll-like Receptor 2-6 Ligands Suppresses T Cell Immunity by Inducing Myeloid-Derived Suppressor Cells	IMMUNITY			English	Article							ATOPIC-DERMATITIS; CYTOKINE PRODUCTION; INFLAMMATION; SKIN; BACTERIA; LIPOPROTEINS; TLR2; ACCUMULATION; LIPOPEPTIDE; RECOGNITION	Skin is constantly exposed to bacteria and antigens, and cutaneous innate immune sensing orchestrates adaptive immune responses. In its absence, skin pathogens can expand, entering deeper tissues and leading to life-threatening infectious diseases. To characterize skin-driven immunity better, we applied living bacteria, defined lipopeptides, and antigens cutaneously. We found suppression of immune responses due to cutaneous infection with Gram-positive S. aureus, which was based on bacterial lipopeptides. Skin exposure to Toll-like receptor (TLR) 2-6-binding lipopeptides, but not TLR2-1-binding lipopeptides, potently suppressed immune responses through induction of Gr1(+)CD11b(+) myeloid-derived suppressor cells (MDSCs). Investigating human atopic dermatitis, in which Gram-positive bacteria accumulate, we detected high MDSC amounts in blood and skin. TLR2 activation in skin resident cells triggered interleukin-6 (IL-6), which induced suppressive MDSCs, which are then recruited to the skin suppressing T cell-mediated recall responses such as dermatitis. Thus, cutaneous bacteria can negatively regulate skin-driven immune responses by inducing MDSCs via TLR2-6 activation.	[Skabytska, Yuliya; Woelbing, Florian; Koeberle, Martin; Kaesler, Susanne; Chen, Ko-Ming; Guenova, Emmanuella; Kempf, Wolfgang E.; Volz, Thomas; Schaller, Martin; Roecken, Martin; Biedermann, Tilo] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Guenther, Claudia] Tech Univ Dresden, Dept Dermatol, D-01069 Dresden, Germany; [Koeberle, Martin; Kempf, Wolfgang E.; Volz, Thomas; Biedermann, Tilo] Tech Univ Munich, Dept Dermatol & Allergy, D-80802 Munich, Germany; [Guenova, Emmanuella] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Demircioglu, Doruk; Goetz, Friedrich] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany; [Rammensee, Hans-Georg] Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany; [Rammensee, Hans-Georg] Univ Tubingen, German Canc Consortium DKTK, German Canc Res Ctr DKFZ Partner Site Tubingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Technical University of Munich; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Biedermann, T (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeisterstr 25, D-72076 Tubingen, Germany.	tilo.biedermann@tum.de	Guenova, Emmanuella/G-7441-2017; Köberle, Martin/HCI-8264-2022; Günther, Claudia/AGG-8982-2022	Guenova, Emmanuella/0000-0001-5478-8735; Köberle, Martin/0000-0001-6825-2667; Rocken, Martin/0000-0003-3795-7001; Biedermann, Tilo/0000-0002-5352-5105	Baden-Wurttemberg Stiftung [P-LS-AL2/4, P-BWS-Glyko/21]; Deutsche Forschungsgemeinschaft (DFG) [BI 696/10-1, GU 1271/2-1, GO 371/9-1, 1394 BI 696/5-1, 1394 BI 696/5-2, KFO 249/GU1212/1-1, SFB 685, A6]; faculty of Medicine, Technical University Dresden	Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); faculty of Medicine, Technical University Dresden	We acknowledge the expert technical assistance of N. Zimmermann (Technical University Dresden), C. Grimmel (FACS core facility, Tubingen), and B. Fehrenbacher (electronmicroscopy laboratory, Tubingen). Wethank F. Eberle, K. Ghoreschi, C. Hunefeld, K. Belge, and S. Volc for cooperating in regard to the human samples. We appreciate B. Kraft, I. Wanke, J. Holstein, I. Kumbier, and C. Braunsdorf for the help with the keratinocyte culture. M. Kopf (Swiss Federal Institute of Technology, Switzerland) provided Il6<SUP>-/-</SUP> BALB/c mice, and C. Kirschning (Institute of Medical Microbiology, University Duisburg-Essen) provided Tlr2<SUP>-/-</SUP> mice. This work was supported by grants from the Baden-Wurttemberg Stiftung (P-LS-AL2/4 and P-BWS-Glyko/21), the Deutsche Forschungsgemeinschaft (DFG; BI 696/10-1, GU 1271/2-1 and GO 371/9-1, DFG Priority Program 1394 BI 696/5-1,/5-2, KFO 249/GU1212/1-1, and SFB 685; A6) and a MEDDRIVE-grant from the faculty of Medicine, Technical University Dresden.	Arora M, 2010, MUCOSAL IMMUNOL, V3, P578, DOI 10.1038/mi.2010.41; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Biedermann T, 2006, ACTA DERM-VENEREOL, V86, P99, DOI 10.2340/00015555-047; Biedermann T, 2002, EUR J IMMUNOL, V32, P3171, DOI 10.1002/1521-4141(200211)32:11<3171::AID-IMMU3171>3.0.CO;2-4; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Fedenko Elena S, 2011, Self Nonself, V2, P120; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Kurokawa K, 2012, J BACTERIOL, V194, P3299, DOI 10.1128/JB.00314-12; Kurokawa K, 2012, J BIOL CHEM, V287, P13170, DOI 10.1074/jbc.M111.292235; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mae M, 2007, FEMS IMMUNOL MED MIC, V49, P398, DOI 10.1111/j.1574-695X.2007.00218.x; Muller P, 2010, INFECT IMMUN, V78, P4243, DOI 10.1128/IAI.00538-10; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Navarini AA, 2011, J ALLERGY CLIN IMMUN, V128, P1128, DOI 10.1016/j.jaci.2011.09.009; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Saeed K, 2014, CURR OPIN INFECT DIS, V27, P130, DOI 10.1097/QCO.0000000000000046; Sasaki T, 2003, BRIT J DERMATOL, V148, P46, DOI 10.1046/j.1365-2133.2003.05017.x; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Takashima A, 1996, Semin Immunol, V8, P333, DOI 10.1006/smim.1996.0044; Travers JB, 2010, J ALLERGY CLIN IMMUN, V125, P146, DOI 10.1016/j.jaci.2009.09.052; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; Volz T, 2012, EXP DERMATOL, V21, P61, DOI 10.1111/j.1600-0625.2011.01393.x; Wanke I, 2013, EXP DERMATOL, V22, P153, DOI 10.1111/exd.12083; Wollenberg A, 2003, J AM ACAD DERMATOL, V49, P198, DOI 10.1067/S0190-9622(03)00896-X; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	50	101	101	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					762	775		10.1016/j.immuni.2014.10.009	http://dx.doi.org/10.1016/j.immuni.2014.10.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25456159	Bronze			2022-12-18	WOS:000345504900013
J	Yao, S; Zhu, YW; Zhu, GF; Augustine, M; Zheng, LH; Goode, DJ; Broadwater, M; Ruff, W; Flies, S; Xu, HY; Flies, D; Luo, LQ; Wang, SD; Chen, LP				Yao, Sheng; Zhu, Yuwen; Zhu, Gefeng; Augustine, Mathew; Zheng, Linghua; Goode, Diana J.; Broadwater, Megan; Ruff, William; Flies, Sarah; Xu, Haiying; Flies, Dallas; Luo, Liqun; Wang, Shengdian; Chen, Lieping			B7-H2 Is a Costimulatory Ligand for CD28 in Human	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; STRUCTURAL BASIS; ICOS DEFICIENCY; CO-STIMULATION; T-CELLS; CTLA-4; ACTIVATION; EXPRESSION; RECEPTOR; BINDING	CD28 and CTLA-4 are cell surface cosignaling molecules essential for the control of T cell activation upon the engagement of their ligands B7-1 and B7-2 from antigen-presenting cells. By employing a receptor array assay, we have demonstrated that B7-H2, best known as the ligand of inducible costimulator, was a ligand for CD28 and CTLA-4 in human, whereas these interactions were not conserved in mouse. B7-H2 and B7-1 or B7-2 interacted with CD28 through distinctive domains. B7-H2-CD28 interaction was essential for the costimulation of human T cells' primary responses to allogeneic antigens and memory recall responses. Similar to B7-1 and B7-2, B7-H2 costimulation via CD28 induced survival factor Bcl-xL, downregulated cell cycle inhibitor p27(kip1), and triggered signaling cascade of ERK and AKT kinase-dependent pathways. Our findings warrant re-evaluation of CD28 and CTLA-4's functions previously attributed exclusively to B7-1 and B7-2 and have important implications in therapeutic interventions against human diseases.	[Yao, Sheng; Zhu, Yuwen; Zhu, Gefeng; Zheng, Linghua; Flies, Dallas; Luo, Liqun; Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Augustine, Mathew; Goode, Diana J.; Broadwater, Megan; Ruff, William; Flies, Sarah; Xu, Haiying] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Wang, Shengdian] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100101, Peoples R China	Yale University; Johns Hopkins University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, LP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	lieping.chen@yale.edu	zhu, yuwen/C-9010-2011	Ruff, william/0000-0001-5828-6425	National Institutes of Health [CA97085, CA113341]; NATIONAL CANCER INSTITUTE [R01CA097085, U19CA113341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Xu and B. Cadugan for editing and P. Coulombe and B. Learn for their assistance with the BIAcore 3000 instrument. This work was partially supported by grants CA97085 and CA113341 from the National Institutes of Health.	Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chattopadhyay K, 2006, J IMMUNOL, V177, P3920, DOI 10.4049/jimmunol.177.6.3920; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; HARPER K, 1991, J IMMUNOL, V147, P1037; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang SD, 2000, BLOOD, V96, P2808; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	32	101	146	5	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					729	740		10.1016/j.immuni.2011.03.014	http://dx.doi.org/10.1016/j.immuni.2011.03.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21530327	Green Accepted, Bronze			2022-12-18	WOS:000291456500012
J	Letellier, E; Kumar, S; Sancho-Martinez, I; Krauth, S; Funke-Kaiser, A; Laudenklos, S; Konecki, K; Klussmann, S; Corsini, NS; Kleber, S; Drost, N; Neumann, A; Levi-Strauss, M; Brors, B; Gretz, N; Edler, L; Fischer, C; Hill, O; Thiemann, M; Biglari, B; Karray, S; Martin-Villalba, A				Letellier, Elisabeth; Kumar, Sachin; Sancho-Martinez, Ignacio; Krauth, Stefanie; Funke-Kaiser, Anne; Laudenklos, Sabrina; Konecki, Katrin; Klussmann, Stefan; Corsini, Nina S.; Kleber, Susanne; Drost, Natalia; Neumann, Andreas; Levi-Strauss, Matthieu; Brors, Benedikt; Gretz, Norbert; Edler, Lutz; Fischer, Carmen; Hill, Oliver; Thiemann, Meinolf; Biglari, Bahram; Karray, Saoussen; Martin-Villalba, Ana			CD95-Ligand on Peripheral Myeloid Cells Activates Syk Kinase to Trigger Their Recruitment to the Inflammatory Site	IMMUNITY			English	Article							SPINAL-CORD-INJURY; FAS-MEDIATED APOPTOSIS; CD95 LIGAND; FUNCTIONAL RECOVERY; IMMUNE PRIVILEGE; DEATH; TUMOR; GROWTH; MACROPHAGES; EXPRESSION	Injury to the central nervous system initiates an uncontrolled inflammatory response that results in both tissue repair and destruction. Here, we showed that, in rodents and humans, injury to the spinal cord triggered surface expression of CD95 ligand (CD95L, FasL) on peripheral blood myeloid cells. CD95L stimulation of CD95 on these cells activated phosphoinositide 3-kinase (PI3K) and metalloproteinase-9 (MMP-9) via recruitment and activation of Syk kinase, ultimately leading to increased migration. Exclusive CD95L deletion in myeloid cells greatly decreased the number of neutrophils and macrophages infiltrating the injured spinal cord or the inflamed peritoneum after thioglycollate injection. Importantly, deletion of myeloid CD95L, but not of CD95 on neural cells, led to functional recovery of spinal injured animals. Our results indicate that CD95L acts on peripheral myeloid cells to induce tissue damage. Thus, neutralization of CD95L should be considered as a means to create a controlled beneficial inflammatory response.	[Letellier, Elisabeth; Kumar, Sachin; Sancho-Martinez, Ignacio; Krauth, Stefanie; Funke-Kaiser, Anne; Laudenklos, Sabrina; Konecki, Katrin; Klussmann, Stefan; Corsini, Nina S.; Kleber, Susanne; Drost, Natalia; Neumann, Andreas; Martin-Villalba, Ana] German Canc Res Ctr, Mol Neurobiol Unit, D-69120 Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Theoret Bioinformat Unit, D-69120 Heidelberg, Germany; [Edler, Lutz] German Canc Res Ctr, Biostat Unit, D-69120 Heidelberg, Germany; [Fischer, Carmen; Hill, Oliver; Thiemann, Meinolf] Apogenix GmbH, D-69120 Heidelberg, Germany; [Levi-Strauss, Matthieu; Karray, Saoussen] Hop Necker Enfants Malad, INSERM, U580, F-75015 Paris, France; [Gretz, Norbert] Heidelberg Univ, Med Res Ctr, D-68167 Mannheim, Germany; [Biglari, Bahram] Berufsgenossenschaftliche Unfallklin Abt Orthopad, D-67071 Ludwigshafen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg	Martin-Villalba, A (corresponding author), German Canc Res Ctr, Mol Neurobiol Unit, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de	Brors, Benedikt/E-5620-2013; Letellier, Elisabeth/I-9515-2016	Brors, Benedikt/0000-0001-5940-3101; Letellier, Elisabeth/0000-0001-8242-9393; Karray, Saoussen/0000-0003-0107-4039; Martin-Villalba, Ana/0000-0002-9405-8910; Corsini, Nina/0000-0001-6731-3544; Sancho-Martinez, Ignacio/0000-0003-4348-1038	German Federal Ministry of Education and Research; Helmholtz Alliance on Systems Biology	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance on Systems Biology	We thank W. Tetzlaff for help in establishing the spinal cord crush injury model and N. Garbi and B. Becher for critical discussion of the data. We thank G. Schutz, K. Rajewsky, B. Arnold, and G. Hammerling for providing the NestinCre, Fas<SUP>flox/flox</SUP>, eGFp<SUP>Ubi</SUP>, and LckCre Mutant mouse lines, respectively. This work was supported by the German Federal Ministry of Education and Research (BMBF) and the Helmholtz Alliance on Systems Biology.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Allison J, 1997, P NATL ACAD SCI USA, V94, P3943, DOI 10.1073/pnas.94.8.3943; Altemeier WA, 2007, J LEUKOCYTE BIOL, V82, P721, DOI 10.1189/jlb.1006652; Atkinson EA, 1996, J BIOL CHEM, V271, P5968, DOI 10.1074/jbc.271.11.5968; Austin JW, 2008, J NEUROTRAUM, V25, P411, DOI 10.1089/neu.2007.0436; Baruzzi A, 2008, CELL MOL LIFE SCI, V65, P2175, DOI 10.1007/s00018-008-8005-6; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Brown SB, 1999, J IMMUNOL, V162, P480; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Frommhold D, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-31; Gonzalez R, 2007, REGEN MED, V2, P771, DOI 10.2217/17460751.2.5.771; GRESHAM HD, 1991, J IMMUNOL, V146, P3911; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HOANG TR, 2004, ARTHRITIS RES THER, V6, pR404; Hohlbaum AM, 2002, CLIN IMMUNOL, V103, P1, DOI 10.1006/clim.2001.5165; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kang SM, 1997, SCIENCE, V278, P1322, DOI 10.1126/science.278.5341.1322; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; KOZIOL JA, 1981, BIOMETRICS, V37, P383, DOI 10.2307/2530427; LOWRANCE JH, 1994, J EXP MED, V180, P1693, DOI 10.1084/jem.180.5.1693; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Park DR, 2003, J IMMUNOL, V170, P6209, DOI 10.4049/jimmunol.170.12.6209; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Sancho-Martinez I, 2009, CELL CYCLE, V8, P838, DOI 10.4161/cc.8.6.7906; Seino KI, 1997, NAT MED, V3, P165, DOI 10.1038/nm0297-165; Serrao KL, 2001, AM J PHYSIOL-LUNG C, V280, pL298, DOI 10.1152/ajplung.2001.280.2.L298; Shimizu M, 2005, INT J CANCER, V114, P926, DOI 10.1002/ijc.20836; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	52	101	104	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					240	252		10.1016/j.immuni.2010.01.011	http://dx.doi.org/10.1016/j.immuni.2010.01.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20153221	Green Submitted, Bronze			2022-12-18	WOS:000275346000013
J	Dullaers, M; Li, DP; Xue, YM; Ni, L; Gayet, I; Morita, R; Ueno, H; Palucka, KA; Banchereau, J; Oh, S				Dullaers, Melissa; Li, Dapeng; Xue, Yaming; Ni, Ling; Gayet, Ingrid; Morita, Rimpei; Ueno, Hideki; Palucka, Karolina Anna; Banchereau, Jacques; Oh, SangKon			A T Cell-Dependent Mechanism for the Induction of Human Mucosal Homing Immunoglobulin A-Secreting Plasmablasts	IMMUNITY			English	Article							HUMAN B-CELLS; FOLLICULAR-HELPER-CELLS; IGA-PRODUCING CELLS; IMMUNE-RESPONSES; DENDRITIC CELLS; GERMINAL CENTER; TRANSCRIPTIONAL REGULATION; COMMENSAL BACTERIA; CCR10 EXPRESSION; LAMINA PROPRIA	Mucosal immunoglobulin A (IgA) secreted by local plasma cells (PCs) is a critical component of mucosal immunity. Although IgA class switching can occur at mucosal sites, high-affinity PCs are optimally generated in germinal centers (GCs) in a T cell-dependent fashion. However, how CD4(+) helper T cells induce mucosal-homing IgA-PCs remains unclear. Here, we show that transforming growth factor beta 1 (TGF beta 1) and interleukin 21 (IL-21), produced by follicular helper T cells (Tfh), synergized to generate abundant IgA-plasmablasts (PBs). In the presence of IL-21, TGF beta 1 promoted naive B cell proliferation and differentiation and overrode IL-21-induced IgG class switching in favor of IgA. Furthermore, TGF beta 1 and IL-21 downregulated CXCR5 while upregulating CCR10 on plasmablasts, enabling their exit from GCs and migration toward local mucosa. This was supported by the presence of CCR10(+)IgA(+)PBs in tonsil GCs. These findings show that Tfh contribute to mucosal IgA. Thus, mucosal vaccines should aim to induce robust Tfh responses.	[Dullaers, Melissa; Li, Dapeng; Xue, Yaming; Ni, Ling; Gayet, Ingrid; Morita, Rimpei; Ueno, Hideki; Palucka, Karolina Anna; Banchereau, Jacques; Oh, SangKon] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Dullaers, Melissa; Li, Dapeng; Xue, Yaming; Ni, Ling; Gayet, Ingrid; Morita, Rimpei; Ueno, Hideki; Palucka, Karolina Anna; Banchereau, Jacques; Oh, SangKon] INSERM 899, Dallas, TX 75204 USA	Baylor Scott & White Health; Baylor University Medical Center	Oh, S (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu; sangkono@baylorhealth.edu	Li, Dapeng/HGE-1586-2022; ni, ling/D-5594-2011; Ueno, Hideki/L-1237-2016	Li, Dapeng/0000-0003-0571-5876; Ueno, Hideki/0000-0001-7747-0738; Dullaers, Melissa/0000-0003-0223-230X	pilot project [U19 AI057234]; BHCS Foundation; NATIONAL CANCER INSTITUTE [R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	pilot project; BHCS Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Kowalski and S. Coquery in the FACS Core at BIIR and D. Su in the Tissue Bank at Baylor hospital. We thank W. Leonard (NIH) and J. Skinner (BIIR) for critical reading of this manuscript. We also thank M. Ramsay and W. Duncan for supporting this study. This study was supported by a pilot project (S.O.) in U19 AI057234 (J.B.) and BHCS Foundation (S.O. and J.B.). M.D., J.6., and S.O. designed experiments and wrote the manuscript. M.D. performed experiments. YX and I.G. helped with experiments. D.L., L.N., and R.M. provided technical advice. H.U., K.A.P., J.B., and S.O. provided technical advice and conceptual guidance.	ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 1998, J IMMUNOL, V160, P2145; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; ISLAM KB, 1991, INT IMMUNOL, V3, P1099, DOI 10.1093/intimm/3.11.1099; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KEHRL JH, 1991, J IMMUNOL, V146, P4016; KETT K, 1986, J IMMUNOL, V136, P3631; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; LYCKE N, 1987, SCAND J IMMUNOL, V25, P413, DOI 10.1111/j.1365-3083.1987.tb02208.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Salmi M, 2005, IMMUNOL REV, V206, P100, DOI 10.1111/j.0105-2896.2005.00285.x; Shirakawa AK, 2008, J IMMUNOL, V180, P2786, DOI 10.4049/jimmunol.180.5.2786; Tangye SG, 2004, IMMUNOLOGY, V112, P509, DOI 10.1111/j.1365-2567.2004.01950.x; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200	47	101	110	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					120	129		10.1016/j.immuni.2008.11.008	http://dx.doi.org/10.1016/j.immuni.2008.11.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144318	Bronze, Green Accepted			2022-12-18	WOS:000262769900015
J	He, X; Park, KW; Wang, HT; He, X; Zhang, Y; Hua, XA; Li, Y; Kappes, DJ				He, Xi; Park, Kyewon; Wang, Haitao; He, Xiao; Zhang, Yi; Hua, Xiang; Li, Yi; Kappes, Dietmar J.			CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus	IMMUNITY			English	Article							T-CELL LINEAGE; SINGLE-POSITIVE CELLS; CD8 LINEAGE; THYMOCYTE DEVELOPMENT; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; INTERMEDIATE STEPS; RUNX PROTEINS; IN-VIVO; SELECTION	The transcription factor ThPOK is necessary and sufficient to trigger adoption of the CD4 lymphocyte fate. Here we investigate the regulation of ThPOK expression and its subsequent control of CD4(+) T cell commitment. Treatment of immature thymocytes with anti-TCR IT cell receptor) showed that TCR signals were important in ThPOK induction and that the CD4(+)8(lo) stage was the likely target of the inductive TCR signal. We identified at the ThPOK locus a key distal regulatory element (DRE) that mediated its differential expression in class I- versus II-restricted CD4(+)8(lo) thymocytes. The DRE was both necessary for suppression of ThPOK expression in class I-restricted thymocytes and sufficient for its induction in class II-restricted thymocytes. Mutagenesis analysis defined an essential 80bp core DRE sequence and its potential regulatory motifs. We propose a silencer-dependent model of lineage choice, whereby inactivation of the DRE silencer by a strong TCR signal leads to CD4 commitment, whereas continued silencer activity leads to CD8 commitment.	[He, Xi; Park, Kyewon; He, Xiao; Zhang, Yi; Hua, Xiang; Li, Yi; Kappes, Dietmar J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Park, Kyewon] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Wang, Haitao] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University; University of Pennsylvania	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dj_kappes@fccc.edu	Wang, Haitao/AAG-8784-2020; He, Xi/GXH-3286-2022	He, Xi/0000-0002-4383-0157; He, Xiao/0000-0002-9286-9859	NCI NIH HHS [CA06927] Funding Source: Medline; NIAID NIH HHS [AI42915] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042915] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barthlott T, 1997, EUR J IMMUNOL, V27, P2024, DOI 10.1002/eji.1830270829; Bommhardt U, 1999, J IMMUNOL, V163, P715; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ehlers M, 2003, J IMMUNOL, V171, P3594, DOI 10.4049/jimmunol.171.7.3594; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kappes DJ, 2006, IMMUNOL REV, V209, P237, DOI 10.1111/j.0105-2896.2006.00344.x; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KYDD R, 1995, J IMMUNOL, V155, P3806; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Nasreen M, 2003, J IMMUNOL, V171, P3394, DOI 10.4049/jimmunol.171.7.3394; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Singer A, 2004, ADV IMMUNOL, V83, P91; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	49	101	103	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					346	358		10.1016/j.immuni.2008.02.006	http://dx.doi.org/10.1016/j.immuni.2008.02.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342007	Bronze			2022-12-18	WOS:000254142500012
J	Rebholz, B; Haase, I; Eckelt, B; Paxian, S; Flaig, MJ; Ghoreschi, K; Nedospasov, SA; Mailhammer, R; Debey-Pascher, S; Schultze, JL; Weindl, G; Forster, I; Huss, R; Stratis, A; Ruzicka, T; Rocken, M; Pfeffer, K; Schmid, RM; Rupec, RA				Rebholz, Bernd; Haase, Ingo; Eckelt, Birgit; Paxian, Stephan; Flaig, Michael J.; Ghoreschi, Kamran; Nedospasov, Sergei A.; Mailhammer, Reinhard; Debey-Pascher, Svenja; Schultze, Joachim L.; Weindl, Guenther; Foerster, Irmgard; Huss, Ralf; Stratis, Athanasios; Ruzicka, Thomas; Roecken, Martin; Pfeffer, Klaus; Schmid, Roland M.; Rupec, Rudolf A.			Crosstalk between keratinocytes and adaptive immune cells in an I kappa B alpha protein-mediated inflammatory disease of the skin	IMMUNITY			English	Article							TRANSGENIC MICE; AUTOIMMUNE-DISEASE; ANIMAL-MODELS; TNF-ALPHA; T-CELLS; PSORIASIS; GENE; MECHANISMS; DEFICIENT; CYTOKINES	Inflammatory diseases at epithelial borders develop from aberrant interactions between resident cells of the tissue and invading immunocytes. Here, we unraveled basic functions of epithelial cells and immune cells and the sequence of their interactions in an inflammatory skin disease. Ubiquitous deficiency of the I kappa B alpha protein (lkba(Delta/Delta)) as well as concomitant deletion of lkba specifically in keratinocytes and T cells (lkba(K5 Delta/K5 Delta lck Delta/lCk Delta)) resulted in an inflammatory skin phenotype that involved the epithelial compartment and depended on the presence of lymphocytes as well as tumor necrosis factor and lymphotoxin signaling. In contrast, mice with selective ablation of lkba in keratinocytes or lymphocytes showed inflammation limited to the dermal compartment or a normal skin phenotype, respectively. Targeted deletion of ReIA from epidermal keratinocytes completely rescued the inflammatory skin phenotype of lkba(Delta/Delta) mice. This finding emphasizes the important role of aberrant NF-kappa B activation in both keratinocytes and lymphocytes in the development of the observed inflammatory skin changes.	Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50924 Cologne, Germany; Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; Tech Univ Munich, Dept Internal Med 2, D-81675 Munich, Germany; Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Inst Clin Mol Biol & Tumor Genet, Natl Res Ctr Environm & Hlth, GSF, D-81377 Munich, Germany; Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; Heinrich Heine Univ Dusseldorf gGmbH, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; Univ Munich, Dept Pathol, D-80337 Munich, Germany; Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany	University of Cologne; University of Cologne; University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Cologne; Heinrich Heine University Dusseldorf; University of Munich; Heinrich Heine University Dusseldorf	Haase, I (corresponding author), Univ Cologne, Dept Dermatol, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.	ingo.haase@uni-koeln.de; rudolf.rupec@med.uni-muenchen.de	Weindl, Günther/B-6161-2011; Schultze, Joachim L./ABA-8176-2020; Nedospasov, Sergei/J-5936-2013; Schultze, Joachim L/D-7794-2011; Nedospasov, Sergei/Q-7319-2016; Nedospasov, Sergei/L-1990-2015; Förster, Irmgard/P-8545-2016; Nedospasov, Sergei/C-3043-2018	Weindl, Günther/0000-0002-4493-7597; Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853; Förster, Irmgard/0000-0002-7644-5642; Pfeffer, Klaus/0000-0002-5652-6330; Rocken, Martin/0000-0003-3795-7001; Ghoreschi, Kamran/0000-0002-5526-7517				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Koo J, 2005, J DERMATOL SCI, V38, P75, DOI 10.1016/j.jdermsci.2005.01.011; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; LAWRENCE CM, 1992, J AM ACAD DERMATOL, V26, P138, DOI 10.1016/S0190-9622(08)80537-3; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nickoloff BJ, 1997, NAT MED, V3, P475, DOI 10.1038/nm0597-475b; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schon MP, 1999, J INVEST DERMATOL, V112, P405, DOI 10.1046/j.1523-1747.1999.00538.x; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	38	101	105	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					296	307		10.1016/j.immuni.2007.05.024	http://dx.doi.org/10.1016/j.immuni.2007.05.024			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17692539	Bronze			2022-12-18	WOS:000249056300015
J	Michael, N; Shen, HM; Longerich, S; Kim, N; Longacre, A; Storb, U				Michael, N; Shen, HM; Longerich, S; Kim, N; Longacre, A; Storb, U			The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription	IMMUNITY			English	Article							SINGLE-STRANDED-DNA; IMMUNOGLOBULIN GENES; HEAVY-CHAIN; B-CELLS; IG; E47; AID; ACTIVATION; BINDING; PROTEIN	The frequency of somatic hypermutations of an Ig kappa transgene with an artificial test insert, RS, is at least 4-fold higher than that of three related transgenes. The four transgenes differ only in the sequence of a 96 bp insert within the variable region. RS is hypermutable over the total 625 nucleotides of the variable/joining region. The RS insert contains two CAGGTG sequences, potential binding sites for basic helix-loop-helix proteins. Changing CAGGTG to AAGGTG reduces the mutability to that of the non-RS transgenes without altering the mutation pattern. The CAGGTG motif enhances somatic hypermutation without enhancing transcription. A DNA probe containing the two CAGGTG sites, but not AAGGTG, binds E47 and gives rise to two specific EMSA bands with nuclear extracts from mutating cells. Possible actions of this enhancer of somatic hypermutation are discussed.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Storb, U (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	stor@midway.uchicago.edu			NIAID NIH HHS [AI47380] Funding Source: Medline; NIGMS NIH HHS [GM07183] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047380, R56AI047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Dalla-Favera Riccardo, 1996, P139; DIAZ M, 2002, DNA REPAIR AMST, V131, P1; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; KIM N, 2000, THESIS U CHICAGO; Klotz EL, 1998, J IMMUNOL, V161, P782; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MICHAEL N, 1989, P NATL ACAD SCI USA, V86, P9808, DOI 10.1073/pnas.86.24.9808; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peng HZ, 1999, BLOOD, V93, P2167, DOI 10.1182/blood.V93.7.2167.407a35_2167_2172; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Shapiro GS, 1999, J IMMUNOL, V163, P259; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Storb U, 2001, PHILOS T ROY SOC B, V356, P13, DOI 10.1098/rstb.2000.0743; Storb U, 1998, IMMUNOL REV, V162, P153; Storb U, 1999, COLD SPRING HARB SYM, V64, P227, DOI 10.1101/sqb.1999.64.227; Winter DB, 1998, IMMUNOL REV, V162, P89, DOI 10.1111/j.1600-065X.1998.tb01432.x; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zan H, 1999, J IMMUNOL, V162, P3437	39	101	104	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					235	242		10.1016/S1074-7613(03)00204-8	http://dx.doi.org/10.1016/S1074-7613(03)00204-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932357	Bronze			2022-12-18	WOS:000184929000011
J	Brodeur, SR; Angelini, F; Bacharier, LB; Blom, AM; Mizoguchi, E; Fujiwara, H; Plebani, A; Notarangelo, LD; Dahlback, B; Tsitsikov, E; Geha, RS				Brodeur, SR; Angelini, F; Bacharier, LB; Blom, AM; Mizoguchi, E; Fujiwara, H; Plebani, A; Notarangelo, LD; Dahlback, B; Tsitsikov, E; Geha, RS			C4b-binding protein (C4BP) activates B cells through the CD40 receptor	IMMUNITY			English	Article							NF-KAPPA-B; CLASS-SWITCH RECOMBINATION; LINKED IMMUNOGLOBULIN DEFICIENCY; COMPLEMENT REGULATOR C4BP; AUTOSOMAL RECESSIVE FORM; CYTIDINE DEAMINASE AID; ELEVATED IGM HIGMX-1; AMYLOID-P COMPONENT; GENE-EXPRESSION; ALPHA-CHAIN	We demonstrate that the a. chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKgamma/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation.	Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Lund Univ, Dept Clin Chem, Malmo, Sweden; Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; Univ Brescia, Dept Pediat, Brescia, Italy; Univ Brescia, Inst Mol Med Angelo Nocivelli, Brescia, Italy; Univ Roma Tor Vergata, Dept Pediat, Rome, Italy; Washington Univ, Dept Pediat, St Louis, MO 63130 USA; Osaka Univ, Dept Med, Osaka, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Lund University; Harvard University; Massachusetts General Hospital; University of Brescia; University of Brescia; University of Rome Tor Vergata; Washington University (WUSTL); Osaka University	Geha, RS (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA.		Blom, Anna/B-9607-2009; Notarangelo, Luigi D/F-9718-2016; Plebani, Alessandro/C-8593-2011; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Notarangelo, Luigi D/0000-0002-8335-0262; Dahlback, Bjorn/0000-0003-1546-0328; Bacharier, Leonard/0000-0003-0432-2704	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, R01AI031451] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-31451, T32 AI-07512] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aicher A, 1999, J IMMUNOL, V163, P5786; BANCHEREAU J, 1994, STEM CELLS, V12, P278, DOI 10.1002/stem.5530120304; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Berggard K, 1997, INFECT IMMUN, V65, P3638; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J IMMUNOL, V166, P6764, DOI 10.4049/jimmunol.166.11.6764; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Brady K, 2001, BIOCHEM BIOPH RES CO, V289, P276, DOI 10.1006/bbrc.2001.5968; Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Challa A, 1999, ALLERGY, V54, P576, DOI 10.1034/j.1398-9995.1999.00092.x; CHU YW, 1995, J CLIN INVEST, V95, P1389, DOI 10.1172/JCI117791; CLEARY AM, 1995, J IMMUNOL, V155, P3329; COOPER ST, 1992, BIOCHEMISTRY-US, V31, P12328, DOI 10.1021/bi00164a006; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; GARCIA OC, 1995, J IMMUNOL, V155, P4037; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GOLAY J, 1992, J IMMUNOL, V149, P300; GRAMMER AC, 1995, J IMMUNOL, V154, P4996; HESSING M, 1990, J IMMUNOL, V144, P204; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; HILLARP A, 1988, J BIOL CHEM, V263, P12759; Iciek LA, 1997, J IMMUNOL, V158, P4769; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; JABARA HH, 1991, J IMMUNOL, V147, P1557; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jabara HH, 2001, J CLIN INVEST, V107, P371, DOI 10.1172/JCI10168; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Johnsson E, 1996, J IMMUNOL, V157, P3021; KASADAFUNAKOSHI M, 1991, BIOCHEM MED METAB B, V45, P350; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; LAPPIN DF, 1990, BIOCHEM J, V271, P767, DOI 10.1042/bj2710767; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mizoguchi E, 1997, LAB INVEST, V76, P385; MOFFAT GJ, 1992, BIOCHEMISTRY-US, V31, P12376, DOI 10.1021/bi00164a012; MORIO T, 1995, P NATL ACAD SCI USA, V92, P11633, DOI 10.1073/pnas.92.25.11633; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; OGATA RT, 1993, J IMMUNOL, V150, P2273; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; PARDOMANUEL F, 1990, P NATL ACAD SCI USA, V87, P4529, DOI 10.1073/pnas.87.12.4529; RAMESH N, 1994, IMMUNOL REV, V138, P87, DOI 10.1111/j.1600-065X.1994.tb00848.x; RAMESH N, 1993, INT IMMUNOL, V5, P769, DOI 10.1093/intimm/5.7.769; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richards ML, 1997, J IMMUNOL, V158, P263; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; SPERTINI F, 1992, J IMMUNOL, V149, P65; Sutherland CL, 1996, J IMMUNOL, V157, P3381; VYTHDREESE FA, 1995, EUR J IMMUNOL, V25, P3023, DOI 10.1002/eji.1830251106; Weckert HA, 2000, J IMMUNOL METHODS, V233, P141, DOI 10.1016/S0022-1759(99)00132-5; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Zhang K, 2002, J ALLERGY CLIN IMMUN, V110, P421, DOI 10.1067/mai.2002.126382	67	101	103	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					837	848		10.1016/S1074-7613(03)00149-3	http://dx.doi.org/10.1016/S1074-7613(03)00149-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818164	Bronze			2022-12-18	WOS:000183767700013
J	Perez, OD; Kinoshita, S; Hitoshi, Y; Payan, DG; Kitamura, T; Nolan, GP; Lorens, JB				Perez, OD; Kinoshita, S; Hitoshi, Y; Payan, DG; Kitamura, T; Nolan, GP; Lorens, JB			Activation of the PKB/AKT pathway by ICAM-2	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-2; CELL-SURVIVAL; CYTOPLASMIC DOMAIN; ERM PROTEINS; EXPRESSION; INTEGRINS; DEATH; BINDING; LIGAND; LFA-1	We identified intracellular adhesion molecule-2 (ICAM-2) in a genetic screen as an activator of the PI3K/AKT pathway leading to inhibition of apoptosis. ICAM-2 induced tyrosine phosphorylation of ezrin and PI3K kinase membrane translocation, resulting in phosphatidylinositol 3,4,5 production, PDK-1 and AKT activation, and subsequent phosphorylation of AKT targets BAD, GSK3, and FKHR. ICAM-2 clustering protected primary human CD19(+) cells from TNFalpha- and Fas-mediated apoptosis as determined by single-cell analysis. ICAM-2 engagement by CD19(+) cells of its natural receptor, LFA-1, on CD4(+) naive cells specifically induced AKT activity in the absence of an MHC-peptide interaction. These results attribute a novel signaling function to ICAM-2 that might suggest mechanisms by which ICAM-2 signals intracellular communication at various immunological synapses.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Rigel Inc, San Francisco, CA 94080 USA; Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1088639, Japan	Stanford University; Stanford University; Stanford University; University of Tokyo	Nolan, GP (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Lorens, James/B-9737-2017; Kitamura, Toshio/AAA-2071-2021	Lorens, James/0000-0002-6782-3349; Nolan, Garry/0000-0002-8862-9043	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR062227, R01AR044565] Funding Source: NIH RePORTER; NIAID NIH HHS [P01-AI39646] Funding Source: Medline; NIAMS NIH HHS [AR44565, N01-AR-6-2227, AR35304] Funding Source: Medline; NIH HHS [A1/GF41520-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; Dion F, 2000, ONCOGENE, V19, P1466, DOI 10.1038/sj.onc.1203463; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Fujii K, 2001, J IMMUNOL, V167, P1198, DOI 10.4049/jimmunol.167.3.1198; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gerwin N, 1999, IMMUNITY, V10, P9, DOI 10.1016/S1074-7613(00)80002-3; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Iyer SB, 1998, CYTOMETRY, V33, P206, DOI 10.1002/(SICI)1097-0320(19981001)33:2<206::AID-CYTO15>3.0.CO;2-Y; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Molica S, 1996, LEUKEMIA, V10, P907; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nixon JB, 1999, J IMMUNOL, V163, P4574; PEREZ OD, 2002, IN PRESS NAT BIOTECH; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RENKONEN R, 1992, AM J PATHOL, V140, P763; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; SANSOM D, 1991, GENOMICS, V11, P462, DOI 10.1016/0888-7543(91)90157-A; SIMMONS DL, 1995, CANCER SURV, V24, P141; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	34	101	109	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					51	65		10.1016/S1074-7613(02)00266-2	http://dx.doi.org/10.1016/S1074-7613(02)00266-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825565	Bronze			2022-12-18	WOS:000173575700006
J	Gartner, F; Alt, FW; Monroe, R; Chu, M; Sleckman, BP; Davidson, L; Swat, W				Gartner, F; Alt, FW; Monroe, R; Chu, M; Sleckman, BP; Davidson, L; Swat, W			Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion	IMMUNITY			English	Article							T-CELL-RECEPTOR; CHAIN GENE REARRANGEMENT; ADAPTER PROTEIN SLP-76; ALPHA-BETA; TCR-ALPHA; IMMUNOGLOBULIN-MU; TRANSGENIC MICE; DEFICIENT MICE; TYROSINE KINASES; ANTIGEN RECEPTOR	T cell receptor (TCR) beta chain allelic exclusion occurs at the thymocyte CD4(-)8(-) (double-negative, or DN) to CD4(+)8(+) (double-positive, or DP) transition, concurrently with differentiation and cellular expansion, and is imposed by a negative feedback loop in which a product of the first rearranged TCR allele arrests further recombination in the TCR beta locus. All of the major events associated with the development of DP cells can be induced by the introduction of TCR beta or activated Lck transgenes. Here, we present evidence that the signaling pathways that promote thymocyte differentiation and expansion of RAG-deficient DN cells but not those that suppress rearrangements of endogenous TCR beta genes in normal DN cells are engaged by activated Ras. We propose that TCR beta allelic exclusion is mediated by effector pathways downstream of Lck but independent of Ras.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-20047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Ardouin L, 1998, J EXP MED, V187, P105, DOI 10.1084/jem.187.1.105; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Henning SW, 1998, J EXP MED, V188, P931, DOI 10.1084/jem.188.5.931; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KRIMPENFORT P, 1989, NATURE, V341, P742, DOI 10.1038/341742a0; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VANMEERWIJK JPM, 1990, EMBO J, V9, P1057, DOI 10.1002/j.1460-2075.1990.tb08210.x; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WHITE J, 1989, J IMMUNOL, V143, P1822; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; Xu Y, 1996, P NATL ACAD SCI USA, V93, P2169, DOI 10.1073/pnas.93.5.2169; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	57	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					537	546		10.1016/S1074-7613(00)80053-9	http://dx.doi.org/10.1016/S1074-7613(00)80053-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367899	Bronze			2022-12-18	WOS:000080709400005
J	McMahan, CJ; Pink, PJ				McMahan, CJ; Pink, PJ			RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4(+) T cells	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; V(D)J RECOMBINATION; B-CELLS; ALLELIC EXCLUSION; IN-VIVO; EXPRESSION; TOLERANCE; SELECTION; MICE; LYMPHOCYTES	Under most circumstances, allelic exclusion at the T cell receptor (TCR)beta locus is tightly regulated. Here, we describe a system in which TCR beta allelic exclusion is overcome as a result of V(D)J recombination in peripheral CD4(+) T cells. In TCR beta chain transgenic mice, tolerogen-mediated chronic peripheral selection against cells expressing the transgene leads to surface expression of endogenous TCR beta chains. Peripheral CD4(+) T cells reexpress the recombination activating genes, RAG1 and RAG2, and contain signal end intermediates indicative of ongoing V(D)J recombination. The rescue from deletion of mature T cells expressing newly generated TCR beta chains suggests that receptor revision plays a role in the maintenance of peripheral T cell tolerance.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Pink, PJ (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	pfink@u.washington.edu			NATIONAL INSTITUTE ON AGING [R01AG013078] Funding Source: NIH RePORTER; NIA NIH HHS [AG13078] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEUTNER U, 1994, J EXP MED, V179, P1457, DOI 10.1084/jem.179.5.1457; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; DILLON SR, 1995, IMMUNITY, V3, P321, DOI 10.1016/1074-7613(95)90117-5; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FINK PJ, 1994, J IMMUNOL, V152, P4270; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; Hikida M, 1998, J EXP MED, V187, P795, DOI 10.1084/jem.187.5.795; Hikida M, 1996, SCIENCE, V274, P2092, DOI 10.1126/science.274.5295.2092; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LEFRANCOIS L, 1995, IMMUNOL TODAY, V16, P16, DOI 10.1016/0167-5699(95)80065-4; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Livak F, 1996, MOL CELL BIOL, V16, P609; Malissen B, 1996, CURR OPIN IMMUNOL, V8, P383, DOI 10.1016/S0952-7915(96)80129-4; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Przylepa J, 1998, CURR TOP MICROBIOL, V229, P85; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHERER MT, 1995, J EXP MED, V182, P1493, DOI 10.1084/jem.182.5.1493; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VANMEERWIJK JPM, 1990, EMBO J, V9, P1057, DOI 10.1002/j.1460-2075.1990.tb08210.x; Vella AT, 1996, P NATL ACAD SCI USA, V93, P951, DOI 10.1073/pnas.93.2.951; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; WOODLAND DL, 1991, J EXP MED, V174, P1255, DOI 10.1084/jem.174.5.1255; Zheng B, 1996, NATURE, V384, P263, DOI 10.1038/384263a0; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083	51	101	106	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					637	647		10.1016/S1074-7613(00)80661-5	http://dx.doi.org/10.1016/S1074-7613(00)80661-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846485	Bronze			2022-12-18	WOS:000077298300006
J	Ellmeier, W; Sunshine, MJ; Losos, K; Hatam, F; Littman, DR				Ellmeier, W; Sunshine, MJ; Losos, K; Hatam, F; Littman, DR			An enhancer that directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BETA-GLOBIN GENE; TRANSGENIC MICE; THYMIC SELECTION; HIGH-LEVEL; DIFFERENTIATION; COMMITMENT; MATURATION; IDENTIFICATION; LYMPHOCYTES	Positive selection of CD4(+)CD8(+) T cells to the CD4(+)CD8(-) helper and CD4(-)CD8(+) cytotoxic lineages is a multistep process that involves complex regulation of coreceptor gene expression. By analyzing expression of a reporter gene in transgenic mice, we have identified a DNA segment, located between the murine CD8 beta and CD8 alpha genes, that has enhancer activity restricted to CD8 lineage cells. Remarkably, this enhancer functions in thymocytes undergoing positive selection to the CD4(-)CD8(+) phenotype but not in immature double-positive thymocytes. The enhancer also functions in gut intraepithelial lymphocytes that express CD8 alpha but not CD8 beta, suggesting that it is specific for CD8 alpha expression. The tight correlation between activation of this enhancer and the final step in positive selection has important implications for understanding the mechanism of lineage commitment in thymocytes.	NYU,MED CTR,SKIRBALL INST BIOMOL MED,DIV MOL PATHOGENESIS,NEW YORK,NY 10016; NYU,MED CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10016	New York University; Howard Hughes Medical Institute; New York University				Ellmeier, Wilfried/0000-0001-8192-8481; Sunshine, Mary Jean/0000-0002-2188-7881				Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Benveniste P, 1996, EUR J IMMUNOL, V26, P461, DOI 10.1002/eji.1830260229; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROVES T, 1995, J IMMUNOL, V154, P5011; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; Hogan BLM, 1994, MANIPULATING MOUSE E; Hostert A, 1997, J IMMUNOL, V158, P4270; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; Kieffer LJ, 1996, INT IMMUNOL, V8, P1617, DOI 10.1093/intimm/8.10.1617; KIEFFER LJ, 1997, IN PRESS J IMMUNOL; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KISIELOW P, 1984, J IMMUNOL, V133, P1117; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; LEE WH, 1994, INT IMMUNOL, V6, P1307, DOI 10.1093/intimm/6.9.1307; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; NAKAUCHI H, 1987, NUCLEIC ACIDS RES, V15, P4337, DOI 10.1093/nar/15.10.4337; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Salmon P, 1996, J IMMUNOL, V156, P1873; Sambrook J, 1989, MOL CLONING LAB MANU; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCOLLAY R, 1985, J IMMUNOL, V134, P3632; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; WILKINSON MF, 1991, J EXP MED, V174, P269, DOI 10.1084/jem.174.1.269; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	56	101	101	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					537	547		10.1016/S1074-7613(00)80375-1	http://dx.doi.org/10.1016/S1074-7613(00)80375-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354474	hybrid			2022-12-18	WOS:A1997YD59300010
J	Ignatowicz, L; Rees, W; Pacholczyk, R; Ignatowicz, H; Kushnir, E; Kappler, J; Marrack, P				Ignatowicz, L; Rees, W; Pacholczyk, R; Ignatowicz, H; Kushnir, E; Kappler, J; Marrack, P			T cells can be activated by peptides that are unrelated in sequence to their selecting peptide	IMMUNITY			English	Article							CLASS-II MOLECULES; POSITIVE SELECTION; INVARIANT CHAIN; SINGLE PEPTIDE; THYMUS; MICE; RECOGNITION; REPERTOIRE; RECEPTOR; TRANSPORT	We tested the ability of CD4(+) T cells, selected in the thymus by reaction with class II protein bound to a single peptide, to react with the same class II protein bound to other peptide!;. The T cells reacted with all peptides tested, including one that was quite unlike the selecting peptide in T cell receptor binding residues. The receptors on class II/peptide-reactive T cells from class II/single peptide mice were similar but not identical to some of those from normal animals. Thus, class II bound to a single peptide selects a subset of T cells that is related to that selected by class II bound to many peptides.	UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT BIOPHYS,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT GENET,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262; MED COLL GEORGIA,INST MOL MED & GENET,AUGUSTA,GA 30912; PAN,IITD,WROCLAW,POLAND	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University System of Georgia; Augusta University; Polish Academy of Sciences	Ignatowicz, L (corresponding author), NATL JEWISH MED & RES CTR,DEPT MED,HOWARD HUGHES MED INST,DENVER,CO 80206, USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI 17134, AI-22295, AI-18785] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018785, R37AI017134, R01AI017134, P01AI022295, R01AI018785] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Arden Bernhard, 1995, Immunogenetics, V42, P501; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; FALK K, 1991, NATURE, V353, P622; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; ITOH Y, 1994, EUR J IMMUNOL, V24, P76, DOI 10.1002/eji.1830240113; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; LAMB CA, 1992, J IMMUNOL, V148, P3478; LO D, 1986, IMMUNOL RES, V5, P221, DOI 10.1007/BF02919203; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; OGASAWARA K, 1987, NATURE, V325, P450, DOI 10.1038/325450a0; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SCHERER MT, 1995, J EXP MED, V182, P1493, DOI 10.1084/jem.182.5.1493; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SUZUKI G, 1986, J IMMUNOL, V136, P230; WALL KA, 1994, J IMMUNOL, V152, P4526; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WHITE J, 1989, J IMMUNOL, V143, P1822; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	38	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					179	186		10.1016/S1074-7613(00)80521-X	http://dx.doi.org/10.1016/S1074-7613(00)80521-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285403	Bronze			2022-12-18	WOS:A1997XT49200002
J	Akasaka, T; Tsuji, K; Kawahira, H; Kanno, M; Harigaya, K; Hu, LN; Ebihara, Y; Nakahata, T; Tetsu, O; Taniguchi, M; Koseki, H				Akasaka, T; Tsuji, K; Kawahira, H; Kanno, M; Harigaya, K; Hu, LN; Ebihara, Y; Nakahata, T; Tetsu, O; Taniguchi, M; Koseki, H			The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors	IMMUNITY			English	Article							DROSOPHILA HOMEOTIC GENES; POSTERIOR SEX COMBS; MYC TRANSGENIC MICE; BMI-1 PROTOONCOGENE; TARGETED DELETION; TUMOR-SUPPRESSOR; ACUTE LEUKEMIAS; LACKING JAK3; CELL-CYCLE; EXPRESSION	mel-18 is a mammalian homolog of Drosophila melanogaster Polycomb group genes. Mice lacking the mel-18 gene show a posterior transformation of the axial skeleton, severe combined immunodeficiency, and a food-passing disturbance in the lower intestine due to hypertrophy of the smooth muscle layer. In this study, the severe combined immunodeficiency observed in mel-18 mutant mice is correlated with the impaired mitotic response of lymphocyte precursors upon interleukin-7 stimulation. Strikingly, the axial skeleton and lymphoid phenotypes are identical in both mel-18 and bmi-1 mutants, indicating that the Mel-18 and Bmi-1 gene products might act in the same genetic cascade. These results suggest that mammalian Polycomb group gene products are involved in cell cycle progression in the immune system.	CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOL IMMUNOL,CHIBA 260,JAPAN; CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV DEV GENET,CHIBA 260,JAPAN; UNIV TOKYO,INST MED SCI,DEPT CLIN ONCOL,TOKYO,JAPAN; CHIBA UNIV,SCH MED,CTR BIOMED SCI,DEPT PATHOL,CHIBA 260,JAPAN	Chiba University; Chiba University; University of Tokyo; Chiba University			Koseki, Haruhiko/I-3825-2014; Taniguchi, Masaru/N-7932-2015	Koseki, Haruhiko/0000-0001-8424-5854; Taniguchi, Masaru/0000-0001-7821-7179; Tetsu, Osamu/0000-0003-1820-7539; Kanno, masamoto/0000-0001-9169-3444				Akasaka T, 1996, DEVELOPMENT, V122, P1513; ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; BIENZ M, 1995, BIOESSAYS, V17, P775; Bornemann D, 1996, DEVELOPMENT, V122, P1621; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Core N, 1997, DEVELOPMENT, V124, P721; DiSanto JP, 1995, IMMUNOL REV, V148, P19; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DURA JM, 1988, DEVELOPMENT, V103, P733; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; GLICKSMAN MA, 1990, DEV BIOL, V142, P422, DOI 10.1016/0012-1606(90)90364-O; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HARDING K, 1988, EMBO J, V7, P205, DOI 10.1002/j.1460-2075.1988.tb02801.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; IRISH VF, 1989, EMBO J, V8, P1527, DOI 10.1002/j.1460-2075.1989.tb03537.x; ISHIDA A, 1993, GENE, V129, P294; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; KENNISON JA, 1993, TRENDS GENET, V9, P75, DOI 10.1016/0168-9525(93)90227-9; KIM DK, 1989, J IMMUNOL, V142, P616; KOIKE K, 1988, J EXP MED, V168, P879, DOI 10.1084/jem.168.3.879; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MARTIN EC, 1993, DEVELOPMENT, V117, P641; MULLER J, 1995, DEVELOPMENT, V121, P2847; NAKAHATA T, 1982, BLOOD, V60, P352; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; PEARCE JJH, 1992, DEVELOPMENT, V114, P921; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; QIAN S, 1991, EMBO J, V10, P1415, DOI 10.1002/j.1460-2075.1991.tb07662.x; RABINOVITCH PS, 1986, J IMMUNOL, V136, P2769; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; REINITZ J, 1990, DEV BIOL, V140, P57, DOI 10.1016/0012-1606(90)90053-L; SANTAMARIA P, 1995, MOL GEN GENET, V246, P282, DOI 10.1007/BF00288600; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; SHIMELL MJ, 1994, SCIENCE, V264, P968, DOI 10.1126/science.7909957; SIMON J, 1992, DEVELOPMENT, V114, P493; SUDA T, 1989, BLOOD, V74, P1936; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; TAGAWA M, 1990, J BIOL CHEM, V265, P20021; TERADA N, 1991, J IMMUNOL, V147, P698; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; WATSON JD, 1989, J IMMUNOL, V143, P1215; WHITE RAH, 1986, CELL, V47, P311, DOI 10.1016/0092-8674(86)90453-8; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	65	101	101	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					135	146		10.1016/S1074-7613(00)80516-6	http://dx.doi.org/10.1016/S1074-7613(00)80516-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252126	Bronze			2022-12-18	WOS:A1997XN69300012
J	Fukui, Y; Ishimoto, T; Utsuyama, M; Gyotoku, T; Koga, T; Nakao, K; Hirokawa, K; Katsuki, M; Sasazuki, T				Fukui, Y; Ishimoto, T; Utsuyama, M; Gyotoku, T; Koga, T; Nakao, K; Hirokawa, K; Katsuki, M; Sasazuki, T			Positive and negative CD4(+) thymocyte selection by a single MHC clas II peptide ligand affected by its expression level in the thymus	IMMUNITY			English	Article							T-CELL-RECEPTOR; TRANSGENIC MICE; ANTIGEN RECEPTOR; INVARIANT CHAIN; MEDULLARY EPITHELIUM; CLONAL DELETION; STROMAL CELL; RECOGNITION; MOLECULES; TOLERANCE	The central event in thymic selection of T cells bearing alpha beta TCRs is their interaction with self-peptides bound to self-MHC molecules. With the use of transgenic mouse lines expressing a single peptide/MHC class II complex, we show that CD4(+) T cells with the preferential usage of particular TCR V alpha s and V beta s were selected to mature on this complex in lines with the lower expression, whereas such CD4(+) T cells were eliminated in the thymus in a line with the relatively high expression. When a low expressing line was crossed with a high expressing line, the frequency of CD4(+) T cells selected by this complex markedly decreased. Thus, these results suggest that a single peptide/MHC class II complex, being affected by its cell surface density in the thymus, can serve as both positively and negatively selecting ligand in vivo.	TOKYO MED & DENT UNIV,DEPT PATHOL & IMMUNOL,TOKYO 113,JAPAN; KYUSHU UNIV,LAB EMBRYON & GENET ENGN,FUKUOKA 81282,JAPAN	Tokyo Medical & Dental University (TMDU); Kyushu University	Fukui, Y (corresponding author), KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,FUKUOKA 81282,JAPAN.			Fukui, Yoshinori/0000-0003-2335-8745; zhong wei, he gui/0000-0002-3066-3564				ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ARDEN B, 1995, IMMUNOGENETICS, V42, P601; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BURKLY LC, 1993, J IMMUNOL, V151, P3954; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GULDOS CJ, 1990, J EXP MED, V172, P835; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOGQUIST KA, 1993, J EXP MED, V177, P1464; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JACOBS H, 1990, EUR J IMMUNOL, V20, P2333, DOI 10.1002/eji.1830201024; JANEWAY C, 1992, Current Biology, V2, P26, DOI 10.1016/0960-9822(92)90419-B; JANEWAY CA, 1984, J IMMUNOL, V132, P662; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LORENZ RG, 1989, NATURE, V340, P557, DOI 10.1038/340557a0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MIZUOCHI T, 1992, J EXP MED, V175, P1601, DOI 10.1084/jem.175.6.1601; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAUJOKAS MF, 1995, IMMUNITY, V3, P359, DOI 10.1016/1074-7613(95)90120-5; NEEFJES JJ, 1992, IMMUNOL TODAY, V13, P179, DOI 10.1016/0167-5699(92)90123-O; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OGASAWARA K, 1990, INT IMMUNOL, V2, P219, DOI 10.1093/intimm/2.3.219; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SENMAJUMDAR A, 1992, J EXP MED, V176, P543, DOI 10.1084/jem.176.2.543; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; SPAIN LM, 1994, J IMMUNOL, V152, P1709; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; YAMAMOTO K, 1994, J EXP MED, V180, P165, DOI 10.1084/jem.180.1.165; YOON ST, 1994, IMMUNITY, V1, P563; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	59	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					401	410		10.1016/S1074-7613(00)80283-6	http://dx.doi.org/10.1016/S1074-7613(00)80283-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133419	Bronze			2022-12-18	WOS:A1997XC61900005
J	Gulden, PH; Fischer, P; Sherman, NE; Wang, W; Engelhard, VH; Shabanowitz, J; Hunt, DF; Pamer, EG				Gulden, PH; Fischer, P; Sherman, NE; Wang, W; Engelhard, VH; Shabanowitz, J; Hunt, DF; Pamer, EG			A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule	IMMUNITY			English	Article							PEPTIDE-BINDING; HISTOCOMPATIBILITY ANTIGEN; SPECIALIZED FUNCTIONS; MASS-SPECTROMETRY; CELLS; IDENTIFICATION; EPITOPE; IMMUNITY; PROTEIN; LENGTH	Polymorphism of MHC class Ia molecules severely constrains vaccine development against intracellular pathogens. Antigen presentation by MHC class Ib molecules, which are generally conserved between different individuals, may circumvent this obstacle. Herein, we use tandem mass spectrometry to identify a Listeria monocytogenes pentapeptide antigen that is presented to T lymphocytes by the H2-M3 MHC class Ib molecule. The peptide contains N-formyl methionine at the N terminus and exclusively hydrophobic amino acids. Mice of the H-2(d), H-2(b), and H-2(k) haplotypes respond to this peptide upon infection with Listeria monocytogenes. Identification of antigens presented by MHC class Ib molecules is feasible and may provide opportunities for relatively unrestricted vaccine development.	UNIV VIRGINIA, DEPT PATHOL, CHARLOTTESVILLE, VA 22901 USA; UNIV VIRGINIA, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22901 USA; UNIV VIRGINIA, BEIRNE CARTER CTR IMMUNOL RES, CHARLOTTESVILLE, VA 22901 USA; YALE UNIV, INFECT DIS SECT, NEW HAVEN, CT 06520 USA; YALE UNIV, IMMUNOBIOL SECT, NEW HAVEN, CT 06520 USA	University of Virginia; University of Virginia; University of Virginia; Yale University; Yale University	Gulden, PH (corresponding author), UNIV VIRGINIA, DEPT CHEM, CHARLOTTESVILLE, VA 22901 USA.		Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Engelhard, Victor/0000-0002-1741-0925; Sherman, Nicholas/0000-0003-3206-3113	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033993, R01AI033993, R29AI033143, R37AI020963, R01AI020963] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20963, AI33993, AI33143] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; BISHOP DK, 1987, J IMMUNOL, V139, P2005; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; HARTY JT, 1995, J IMMUNOL, V154, P4642; HENDERSON RA, 1993, P NATL ACAD SCI USA, V90, P10275, DOI 10.1073/pnas.90.21.10275; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; KAUFMANN SHE, 1988, J IMMUNOL, V140, P3173; KURLANDER RJ, 1992, SCIENCE, V257, P678, DOI 10.1126/science.1496381; LENZ LL, 1996, IN PRESS INT IMMUNOL, V151; LINDAHL KF, 1980, J EXP MED, V152, P1583; LINDAHL KF, 1989, COLD SH Q B, V54, P563; LINDAHL KF, 1991, ANNU REV IMMUNOL, V9, P351, DOI 10.1146/annurev.iy.09.040191.002031; LINDAHL KF, 1993, SEMIN IMMUNOL, V5, P117; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; LUKACS K, 1989, J IMMUNOL, V143, P3731; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MILLER JEW, 1994, J CELL BIOCHEM, P292; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nataraj C, 1996, INT IMMUNOL, V8, P367, DOI 10.1093/intimm/8.3.367; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Pamer Eric G., 1993, Trends in Microbiology, V1, P35, DOI 10.1016/0966-842X(93)90023-K; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHAWAR SM, 1991, J EXP MED, V174, P941, DOI 10.1084/jem.174.4.941; SHAWAR SM, 1990, J EXP MED, V171, P897, DOI 10.1084/jem.171.3.897; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sijts AJAM, 1996, J IMMUNOL, V156, P1497; Sijts AJAM, 1996, J IMMUNOL, V156, P685; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; STROYNOWSKI I, 1990, ANNU REV IMMUNOL, V8, P501, DOI 10.1146/annurev.iy.08.040190.002441; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; VYAS JM, 1995, J EXP MED, V181, P1817, DOI 10.1084/jem.181.5.1817; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WANG CR, 1991, CELL, V66, P335, DOI 10.1016/0092-8674(91)90623-7	51	101	102	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1996	5	1					73	79		10.1016/S1074-7613(00)80311-8	http://dx.doi.org/10.1016/S1074-7613(00)80311-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758896	hybrid			2022-12-18	WOS:A1996UZ45400008
J	Bourdely, P; Anselmi, G; Vaivode, K; Ramos, RN; Missolo-Koussou, Y; Hidalgo, S; Tosselo, J; Nunez, N; Richer, W; Vincent-Salomon, A; Saxena, A; Wood, K; Lladser, A; Piaggio, E; Helft, J; Guermonprez, P				Bourdely, Pierre; Anselmi, Giorgio; Vaivode, Kristine; Ramos, Rodrigo Nalio; Missolo-Koussou, Yoann; Hidalgo, Sofia; Tosselo, Jimena; Nunez, Nicolas; Richer, Wilfrid; Vincent-Salomon, Anne; Saxena, Alka; Wood, Kristie; Lladser, Alvaro; Piaggio, Eliane; Helft, Julie; Guermonprez, Pierre			Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; MONOCYTE DIFFERENTIATION; GENE-EXPRESSION; GROWTH-FACTOR; FLT3 LIGAND; PROGENITOR; RESIDENT; INTERLEUKIN-4; HETEROGENEITY; MACROPHAGES	Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88(-)CD1c(+)CD163(+) DCs (called DC3s) as immediate precursors of inflammatory CD88(-)CD14(+)CD1c(+) CD163(+)Fc epsilon RI+ DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8(+) T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor beta (TGF-beta) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8(+)CD103(+)CD69(+) tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.	[Bourdely, Pierre; Anselmi, Giorgio; Vaivode, Kristine; Guermonprez, Pierre] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, Ctr Inflammat Biol & Canc Immunol, London, England; [Bourdely, Pierre; Anselmi, Giorgio; Vaivode, Kristine; Guermonprez, Pierre] Kings Coll London, Canc Res UK Kings Hlth Partner Canc Ctr, London, England; [Ramos, Rodrigo Nalio; Missolo-Koussou, Yoann; Hidalgo, Sofia; Tosselo, Jimena; Nunez, Nicolas; Richer, Wilfrid; Piaggio, Eliane; Helft, Julie] PSL Res Univ, Inst Curie, Translat Immunotherapy Team, INSERM,Res Ctr,U392, Paris, France; [Hidalgo, Sofia; Lladser, Alvaro] Fdn Ciencia & Vida, Lab Immunooncol, Santiago, Chile; [Vincent-Salomon, Anne] PSL Res Univ, Inst Curie, Dept Biopathol, Paris, France; [Saxena, Alka; Wood, Kristie] Guys & St Thomas Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Saxena, Alka; Wood, Kristie] Kings Coll London, London, England; [Lladser, Alvaro] Univ San Sebastian, Fac Med & Ciencia, Santiago, Chile; [Guermonprez, Pierre] Univ Paris, CNRS, Ctr Inflammat Res, INSERM1149,ERL8252, Paris, France	University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Universidad San Sebastian; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Guermonprez, P (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, Ctr Inflammat Biol & Canc Immunol, London, England.; Guermonprez, P (corresponding author), Kings Coll London, Canc Res UK Kings Hlth Partner Canc Ctr, London, England.; Guermonprez, P (corresponding author), Univ Paris, CNRS, Ctr Inflammat Res, INSERM1149,ERL8252, Paris, France.	pierre.guermonprez@kcl.ac.uk	Guermonprez, Pierre/ABE-7718-2020; Helft, Julie/ABE-6179-2020; Ramos, Rodrigo N/K-3553-2012	Guermonprez, Pierre/0000-0001-5621-2262; Helft, Julie/0000-0002-2733-1972; Ramos, Rodrigo N/0000-0003-1249-4733; Tosello Boari, Jimena/0000-0003-1563-4420; Anselmi, Giorgio/0000-0002-8870-3354; Missolo-Koussou, Yoann-Lionel/0000-0002-3815-3980	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; BBSRC; CRUK; Rosetrees Trust; CRUK King's Health Partners Cancer Centre in United Kingdom; IDEX [ANR-18-IDEX-0001]; INCA (PL-BIO-ICR1); Institut Curie, Institut National de la Sante' et de la Recherche Medicale [ANR-10-IDEX-0001-02 PSL, ANR-11LABX0043]; Programa de Apoyo a Centros con Financiamiento Basal [AFB 170004]; FONDECYT in Chile [1171703]; NC3RS; Labex DCBIOL; BBSRC [BB/M029735/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); CRUK King's Health Partners Cancer Centre in United Kingdom; IDEX; INCA (PL-BIO-ICR1); Institut Curie, Institut National de la Sante' et de la Recherche Medicale; Programa de Apoyo a Centros con Financiamiento Basal; FONDECYT in Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NC3RS(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Labex DCBIOL; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	P.G. is a CNRS investigator. J.H. is an INSERM investigator. We thank the Anthony Nolan Cord Blood Bank and Cell Therapy Centre for providing the cord blood units used in this study, the flow core and NGS platform from Institut Curie, and Daniel Chung for technical help. This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The research was supported by the BBSRC, NC3RS, CRUK, Rosetrees Trust, CRUK King's Health Partners Cancer Centre in United Kingdom. The research was supported by IDEX (ANR-18-IDEX-0001) and INCA (PL-BIO-ICR1), Institut Curie, Institut National de la Sante ' et de la Recherche Me ' dicale, Labex DCBIOL (ANR-10-IDEX-0001-02 PSL), ANR-11LABX0043, SIRIC INCa-DGOS-INSERM_12554, in France and the Programa de Apoyo a Centros con Financiamiento Basal (AFB 170004), and FONDECYT 1171703 in Chile.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Anselmi G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15937-y; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bakdash G, 2016, CANCER RES, V76, P4332, DOI 10.1158/0008-5472.CAN-15-1695; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Durand M, 2016, METHODS MOL BIOL, V1423, P89, DOI 10.1007/978-1-4939-3606-9_6; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Guermonprez P, 2019, INT REV CEL MOL BIO, V349, P1, DOI 10.1016/bs.ircmb.2019.08.002; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Helft J, 2017, CELL REP, V20, P529, DOI 10.1016/j.celrep.2017.06.075; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kawamura S, 2017, IMMUNITY, V46, P835, DOI 10.1016/j.immuni.2017.04.019; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lee J, 2015, J IMMUNOL METHODS, V425, P21, DOI 10.1016/j.jim.2015.06.004; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Mach N, 2000, CANCER RES, V60, P3239; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Michea Paula, 2018, Nat Immunol, V19, P885, DOI 10.1038/s41590-018-0145-8; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Onai N, 2007, ANN NY ACAD SCI, V1106, P253, DOI 10.1196/annals.1392.015; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pulendran B, 1998, J EXP MED, V188, P2075, DOI 10.1084/jem.188.11.2075; Rihs S, 1996, AM J RESP CELL MOL, V15, P600, DOI 10.1165/ajrcmb.15.5.8918367; Rojas IML, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00971; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sander J, 2017, IMMUNITY, V47, P1051, DOI 10.1016/j.immuni.2017.11.024; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang ZQ, 2016, CLIN CANCER RES, V22, P6290, DOI 10.1158/1078-0432.CCR-16-0732; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Yin XY, 2017, J IMMUNOL, V198, P1553, DOI 10.4049/jimmunol.1600193; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	64	100	101	4	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					335	+		10.1016/j.immuni.2020.06.002	http://dx.doi.org/10.1016/j.immuni.2020.06.002			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32610077	Green Published, hybrid			2022-12-18	WOS:000561190600013
J	Shalapour, S; Karin, M				Shalapour, Shabnam; Karin, Michael			Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation	IMMUNITY			English	Review							REGULATORY B-CELLS; CD8(+) T-CELLS; NF-KAPPA-B; TGF-BETA; DENDRITIC CELLS; ER STRESS; IFN-GAMMA; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; LYMPHOID STRUCTURES	In many settings, tumor-associated inflammation, supported mainly by innate immune cells, contributes to tumor growth. Initial innate activation triggers secretion of inflammatory, regenerative, and anti-inflammatory cytokines, which in turn shape the adaptive immune response to the tumor. Here, we review the current understanding of the intricate dialog between cancer-associated inflammation and anti-tumor immunity. We discuss the changing nature of these interactions during tumor progression and the impact of the tissue environment on the anti-tumor immune response. In this context, we outline important gaps in current understanding by considering basic research and findings in the clinic. The future of cancer immunotherapy and its utility depend on improved understanding of these interactions and the ability to manipulate them in a predictable and beneficial manner.	[Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Karin, Michael] Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Karin, M (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Shalapour, Shabnam/0000-0002-4743-3706	PCF-Young Investigator Award; SCRC for ALPD & Cirrhosis - NIAAA [P50 AA011999]; NIH [R01 AI043477, R01 CA211794]; Tower Cancer Research Foundation; Padres Pedal the Cause C3 award [PTC2018];  [U01 AA027681];  [P01 CA128814]; NATIONAL CANCER INSTITUTE [R01CA211794, P01CA128814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043477, R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, U01AA027681] Funding Source: NIH RePORTER	PCF-Young Investigator Award; SCRC for ALPD & Cirrhosis - NIAAA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tower Cancer Research Foundation; Padres Pedal the Cause C3 award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank R.K. Ngu for illustration and figure preparation and C.R. Lichtenstern for manuscript assistance. S.S. was supported by PCF-Young Investigator Award and SCRC for ALPD & Cirrhosis funded by the NIAAA (P50 AA011999). Work in M.K. laboratory was supported by grants from the NIH (R01 AI043477, R01 CA211794) and Tower Cancer Research Foundation. Additional support came from U01 AA027681 to S.S. and M.K., P01 CA128814 to M.K. and Ze'ev Ronai, and Padres Pedal the Cause C3 award PTC2018.	Alspach E, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028480; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Barsoum IB, 2014, CANCER RES, V74, P7185, DOI 10.1158/0008-5472.CAN-14-2598; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bottcher JP, 2018, TRENDS CANCER, V4, P784, DOI 10.1016/j.trecan.2018.09.001; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21061-1; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Chou C, 2018, CANCER IMMUNOL RES, V6, P372, DOI 10.1158/2326-6066.CIR-17-0440; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diehl SA, 2012, IMMUNOL CELL BIOL, V90, P802, DOI 10.1038/icb.2012.17; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Dmitrieva-Posocco O, 2019, IMMUNITY, V50, P166, DOI 10.1016/j.immuni.2018.11.015; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dongre A, 2017, CANCER RES, V77, P3982, DOI 10.1158/0008-5472.CAN-16-3292; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; Fleming C, 2017, TRENDS CANCER, V3, P561, DOI 10.1016/j.trecan.2017.06.003; Fruton J. S., 1957, YALE J BIOL MED, V29, P628; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gajewski TF, 2017, ADV EXP MED BIOL, V1036, P19, DOI 10.1007/978-3-319-67577-0_2; Galdiero MR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028662; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Hashimoto M, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028464; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kammertoens T, 2017, NATURE, V545, P98, DOI 10.1038/nature22311; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kato T, 2018, CLIN CANCER RES, V24, P4820, DOI 10.1158/1078-0432.CCR-18-0205; Kepp O, 2015, SEMIN CANCER BIOL, V33, P86, DOI 10.1016/j.semcancer.2015.02.004; Kepp O, 2013, CYTOKINE GROWTH F R, V24, P311, DOI 10.1016/j.cytogfr.2013.05.001; Knochelmann HM, 2018, CELL MOL IMMUNOL, V15, P458, DOI 10.1038/s41423-018-0004-4; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lakins MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03347-0; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu Y, 2015, J HEPATOL, V63, P114, DOI 10.1016/j.jhep.2015.02.009; Lucas ED, 2018, J IMMUNOL, V201, P1735, DOI 10.4049/jimmunol.1800271; Lund AW, 2016, J CLIN INVEST, V126, P3389, DOI 10.1172/JCI79434; Luo XY, 2013, AM J PHYSIOL-GASTR L, V305, pG891, DOI 10.1152/ajpgi.00193.2013; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Mandai M, 2016, CLIN CANCER RES, V22, P2329, DOI 10.1158/1078-0432.CCR-16-0224; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Maurizi G, 2018, J CELL PHYSIOL, V233, P88, DOI 10.1002/jcp.25855; Medler TR, 2018, CANCER CELL, V34, P561, DOI 10.1016/j.ccell.2018.09.003; Mehta A, 2018, CANCER DISCOV, V8, P935, DOI 10.1158/2159-8290.CD-17-1178; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakajima A, 2018, J EXP MED, V215, P2019, DOI 10.1084/jem.20180427; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ogura K, 2018, CANCER IMMUNOL RES, V6, P348, DOI 10.1158/2326-6066.CIR-17-0204; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Pahl J, 2017, IMMUNOBIOLOGY, V222, P11, DOI 10.1016/j.imbio.2015.07.012; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Pylayeva-Gupta Y, 2016, CANCER DISCOV, V6, P247, DOI 10.1158/2159-8290.CD-15-0843; Ribatti D, 2017, ONCOTARGET, V8, P7175, DOI 10.18632/oncotarget.12739; Rojas OL, 2019, CELL, V176, P610, DOI 10.1016/j.cell.2018.11.035; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Smith LK, 2018, IMMUNITY, V48, P299, DOI 10.1016/j.immuni.2018.01.006; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tafani M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3907147; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vranova M., 2014, J CLIN CELL IMMUNOL, V5; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5; Ward JP, 2016, ADV IMMUNOL, V130, P25, DOI 10.1016/bs.ai.2016.01.001; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wilke CM, 2011, CANCER IMMUNOL IMMUN, V60, P1529, DOI 10.1007/s00262-011-1104-5; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Wu BG, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1500107; Wu L, 2012, ADV EXP MED BIOL, V946, P223, DOI 10.1007/978-1-4614-0106-3_13; Xiao S, 2015, J IMMUNOL, V194, P1602, DOI 10.4049/jimmunol.1402632; Yang R, 2016, J EXP MED, V213, P2281, DOI 10.1084/jem.20160417; Ye LS, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0451-6; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005; Zepp JA, 2017, J IMMUNOL, V199, P3849, DOI 10.4049/jimmunol.1601540; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120; Ziegler PK, 2018, CELL, V174, P88, DOI 10.1016/j.cell.2018.05.028; Zitti B, 2018, CYTOKINE GROWTH F R, V42, P37, DOI 10.1016/j.cytogfr.2018.08.001; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	163	100	100	5	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					15	26		10.1016/j.immuni.2019.06.021	http://dx.doi.org/10.1016/j.immuni.2019.06.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315033	Green Accepted, Bronze			2022-12-18	WOS:000475561000007
J	McGary, CS; Deleage, C; Harper, J; Micci, L; Ribeiro, SP; Paganini, S; Kuri-Cervantes, L; Benne, C; Ryan, ES; Balderas, R; Jean, S; Easley, K; Marconi, V; Silvestri, G; Estes, JD; Sekaly, RP; Paiardini, M				McGary, Colleen S.; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P.; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S.; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jacob D.; Sekaly, Rafick-Pierre; Paiardini, Mirko			CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques	IMMUNITY			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; FOLLICULAR HELPER-CELLS; CHRONIC HIV-INFECTION; TGF-BETA; IMMUNE ACTIVATION; REGULATORY CELLS; GENE-EXPRESSION; CTLA-4; REPLICATION; RESERVOIR	Antiretroviral therapy (ART) suppresses viral replication in HIV-infected individuals but does not eliminate the reservoir of latently infected cells. Recent work identified PD-1(+) follicular helper T (Tfh) cells as an important cellular compartment for viral persistence. Here, using ART-treated, SIV-infected rhesus macaques, we show that CTLA-4(+)PD-1(-) memory CD4(+) T cells, which share phenotypic markers with regulatory T cells, were enriched in SIV DNA in blood, lymph nodes (LN), spleen, and gut, and contained replication-competent and infectious virus. In contrast to PD-1(+) Tfh cells, SIV-enriched CTLA4 +PD-1(-) CD4(+) T cells were found outside the B cell follicle of the LN, predicted the size of the persistent viral reservoir during ART, and significantly increased their contribution to the SIV reservoir with prolonged ART-mediated viral suppression. We have shown that CTLA-4(+)PD-1(-) memory CD4+ T cells are a previously unrecognized component of the SIV and HIV reservoir that should be therapeutically targeted for a functional HIV-1 cure.	[McGary, Colleen S.; Harper, Justin; Micci, Luca; Paganini, Sara; Ryan, Emily S.; Jean, Sherrie; Marconi, Vincent; Silvestri, Guido; Paiardini, Mirko] Emory Univ, Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol, Atlanta, GA 30329 USA; [Deleage, Claire; Estes, Jacob D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Ribeiro, Susan P.; Kuri-Cervantes, Leticia; Benne, Clarisse; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Balderas, Robert] Becton Dickinson Immunosci, San Jose, CA 95131 USA; [Easley, Kirk] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30329 USA; [Marconi, Vincent; Silvestri, Guido; Paiardini, Mirko] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30329 USA	Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; Emory University; Rollins School Public Health; Emory University	Paiardini, M (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol, Atlanta, GA 30329 USA.; Paiardini, M (corresponding author), Emory Univ, Sch Med, Dept Med, Atlanta, GA 30329 USA.	mirko.paiardini@emory.edu	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Easley, Kirk A/K-6910-2015; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Easley, Kirk A/0000-0003-4419-2617; Marconi, Vincent/0000-0001-8409-4689; Harper, Justin/0000-0002-6948-3501	NIAID, NIH [104278, 116379, 116171, 110334]; amfAR [109354-59-RGRL]; ORIP/OD [P51OD011132, P30AI50409]; National Cancer Institute (NIH) [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116379, R33AI104278, R33AI116171, R01AI110334, P30AI050409] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); amfAR; ORIP/OD; National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephanie Ehnert, Christopher Souder, and all the animal care and veterinary staff at the YNPRC, as well as Barbara Cervasi at the Emory Flow Cytometry Core. We also thank David Favre and Shari Gordon at GSK and David Margolis at UNC Chapel Hill for helpful discussion; Mathias Lichterfeld and Sean Harrington of the Ragon Institute for technical assistance; and Romas Geleziunas (Gilead), Guenter Kraus (Johnson & Johnson), and Daria Hazuda (Merck) for supplying the antiretroviral drugs. The SIVmac251 used to infect the RMs was kindly provided by Chris Miller. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID: 174xCEM Cells from Dr. Peter Cresswell. M.P. is supported by the NIAID, NIH under award numbers 104278, 116379, 116171, and 110334 and by amfAR under award numbers 109354-59-RGRL. This work was also supported by ORIP/OD P51OD011132 (to the YNPRC), P30AI50409 (to the Emory CFAR), and in part with federal funds from the National Cancer Institute (NIH Contract HHSN261200800001E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Anderson A, 2008, AM J TRANSPLANT, V8, P2252, DOI 10.1111/j.1600-6143.2008.02376.x; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Baine I, 2013, J IMMUNOL, V190, P1008, DOI 10.4049/jimmunol.1200792; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cooper DA, 2008, LANCET, V372, P266, DOI 10.1016/S0140-6736(08)61086-7; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deleage Claire, 2016, Pathog Immun, V1, P68; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; El-Far M, 2015, J GEN VIROL, V96, P1463, DOI 10.1099/vir.0.000065; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gu J, 2017, CELL MOL IMMUNOL, V14, P521, DOI 10.1038/cmi.2016.30; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Havlir DV, 2001, J CLIN MICROBIOL, V39, P298, DOI 10.1128/JCM.39.1.298-303.2001; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jiao YM, 2015, INT J INFECT DIS, V37, P42, DOI 10.1016/j.ijid.2015.06.008; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann GR, 2000, AIDS, V14, P2643, DOI 10.1097/00002030-200012010-00003; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Micci L, 2015, J CLIN INVEST, V125, P4497, DOI 10.1172/JCI81400; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Paris RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144767; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Ross EM, 2014, EUR J IMMUNOL, V44, P2048, DOI 10.1002/eji.201343999; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sledzinska A, 2015, MOL ONCOL, V9, P1936, DOI 10.1016/j.molonc.2015.10.008; Soriano-Sarabia N, 2014, J VIROL, V88, P14070, DOI 10.1128/JVI.01900-14; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014	65	100	102	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					776	+		10.1016/j.immuni.2017.09.018	http://dx.doi.org/10.1016/j.immuni.2017.09.018			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045906	Green Accepted, Bronze			2022-12-18	WOS:000413091600020
J	Zanoni, I; Tan, YH; Di Gioia, M; Springstead, JR; Kagan, JC				Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Springstead, James R.; Kagan, Jonathan C.			By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation	IMMUNITY			English	Article							MURINE MACROPHAGES; INTRACELLULAR LPS; ENDOTOXIC-SHOCK; IMMUNE-SYSTEM; LIPOPOLYSACCHARIDE; MICE; ENDOCYTOSIS; ACTIVATION; BACTERIA; DANGER	A heterogeneous mixture of lipids called oxPAPC, derived from dying cells, can hyperactivate dendritic cells (DCs) but not macrophages. Hyperactive DCs are defined by their ability to release interleukin-1 (IL-1) while maintaining cell viability, endowing these cells with potent aptitude to stimulate adaptive immunity. Herein, we found that the bacterial lipopolysaccharide receptor CD14 captured extracellular oxPAPC and delivered these lipids into the cell to promote inflammasome-dependent DC hyperactivation. Notably, we identified two specific components within the oxPAPC mixture that hyperactivated macrophages, allowing these cells to release IL-1 for several days, by a CD14-dependent process. In murine models of sepsis, conditions that promoted cell hyperactivation resulted in inflammation but not lethality. Thus, multiple phagocytes are capable of hyperactivation in response to oxPAPC, with CD14 acting as the earliest regulator in this process, serving to capture and transport these lipids to promote inflammatory cell fate decisions.	[Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Kagan, Jonathan C.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Zanoni, Ivan] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Springstead, James R.] Western Michigan Univ, Dept Chem & Paper Engn, Kalamazoo, MI USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Milano-Bicocca; Western Michigan University	Zanoni, I; Kagan, JC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA.; Zanoni, I; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA.; Zanoni, I (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	ivan.zanoni@childrens.harvard.edu; jonathan.kagan@childrens.harvard.edu	Di Gioia, Marco/AAC-4192-2019	Di Gioia, Marco/0000-0001-9499-5771; Zanoni, Ivan/0000-0002-3423-7474	NIH [AI093589, AI116550, P30 DK34854, 1R01AI121066-01A1, 1R01DK115217, P30 DK034854, 1R15HL121770-01A1]; Burroughs Wellcome Fund; Harvard Medical School Milton Found; CCFA Senior Research Awards [412708]; Cariplo Foundation [2014-0859]; Jane Coffin Childs Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL121770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R01AI121066, R01AI116550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK115217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Medical School Milton Found; CCFA Senior Research Awards; Cariplo Foundation(Fondazione Cariplo); Jane Coffin Childs Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Kagan and Zanoni labs for helpful discussions. We thank L.R. Marek especially, for inspiring a critical stage of this project. J.C.K. is supported by NIH grants AI093589, AI116550, and P30 DK34854. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. I.Z. is supported by NIH grants 1R01AI121066-01A1, 1R01DK115217, and P30 DK034854, Harvard Medical School Milton Found, CCFA Senior Research Awards (412708), and the Cariplo Foundation (2014-0859). J.R.S. is supported by NIH grant 1R15HL121770-01A1. Y.T. is supported by a postdoctoral fellowship of the Jane Coffin Childs Fund (the Merck Fellow).	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Perera PY, 1997, J IMMUNOL, V158, P4422; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Pradeu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00287; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zanoni I, 2012, J CLIN INVEST, V122, P1747, DOI 10.1172/JCI60688; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	36	100	102	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					697	+		10.1016/j.immuni.2017.09.010	http://dx.doi.org/10.1016/j.immuni.2017.09.010			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045901	Bronze, Green Accepted			2022-12-18	WOS:000413091600014
J	Kang, K; Park, SH; Chen, J; Qiao, Y; Giannopoulou, E; Berg, K; Hanidu, A; Li, J; Nabozny, G; Kang, K; Park-Min, KH; Ivashkiv, LB				Kang, Kyuho; Park, Sung Ho; Chen, Janice; Qiao, Yu; Giannopoulou, Eugenia; Berg, Karen; Hanidu, Adedayo; Li, Jun; Nabozny, Gerald; Kang, Keunsoo; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.			Interferon-gamma Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF	IMMUNITY			English	Article							CELL-DIFFERENTIATION; C-MAF; SUPER-ENHANCERS; ACTIVATION; CHROMATIN; POLARIZATION; IDENTITY; PROGRAM; DISEASE; LOCALIZATION	Mechanisms by which interferon (IFN)-gamma activates genes to promote macrophage activation are well studied, but little is known about mechanisms and functions of IFN-gamma-mediated gene repression. We used an integrated transcriptomic and epigenomic approach to analyze chromatin accessibility, histone modifications, transcription-factor binding, and gene expression in IFN-gamma-primed human macrophages. IFN-gamma suppressed basal expression of genes corresponding to an "M2''-like homeostatic and reparative phenotype. IFN-gamma repressed genes by suppressing the function of enhancers enriched for binding by transcription factor MAF. Mechanistically, IFN-gamma disassembled a subset of enhancers by inducing coordinate suppression of binding by MAF, lineagedetermining transcription factors, and chromatin accessibility. Genes associated with MAF-binding enhancers were suppressed in macrophages isolated from rheumatoid-arthritis patients, revealing a disease-associated signature of IFN-gamma-mediated repression. These results identify enhancer inactivation and disassembly as a mechanism of IFN-gamma-mediated gene repression and reveal that MAF regulates the macrophage enhancer landscape and is suppressed by IFN-gamma to augment macrophage activation.	[Chen, Janice; Berg, Karen; Nabozny, Gerald; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Park, Sung Ho; Nabozny, Gerald] Hosp Special Surg, Arthrit & Tissue Degenerat Program & David Rosens, New York, NY 10021 USA; [Giannopoulou, Eugenia; Nabozny, Gerald] City Univ New York, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11201 USA; [Chen, Janice; Berg, Karen; Nabozny, Gerald] Dept Immunol & Resp Dis Res, Boehringer Ingelheim Pharmaceut, 900 Ridgebury Rd, Ridgefield, CT 06877 USA; [Park, Sung Ho; Hanidu, Adedayo; Kang, Keunsoo] Dept Immunol & Resp Dis Res, Boehringer Ingelheim Pharmaceut, 900 Ridgebury Rd, Ridgefield, CT 06877 USA; [Park, Sung Ho; Berg, Karen; Li, Jun] Dankook Univ, Dept Microbiol, Cheonan, Chungnam, South Korea	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; City University of New York (CUNY) System; Boehringer Ingelheim; Boehringer Ingelheim; Dankook University	Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA.	ivashkivl@hss.edu	Giannopoulou, Evgenia/K-9576-2019	Kang, Kyuho/0000-0003-3448-5336	N.I.H.; Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank A. Pernis and I. Rogatsky for helpful discussions and review of the manuscript. This work was supported by grants from the N.I.H. and by support for the Rosensweig Genomics Center from The Tow Foundation.	Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Cao SJ, 2002, J IMMUNOL, V169, P5715, DOI 10.4049/jimmunol.169.10.5715; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gorenshteyn D, 2015, IMMUNITY, V43, P605, DOI 10.1016/j.immuni.2015.08.014; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liddiard K, 2015, NAT MED, V21, P119, DOI 10.1038/nm.3798; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Witte S, 2015, TRENDS IMMUNOL, V36, P519, DOI 10.1016/j.it.2015.07.005; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	64	100	103	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					235	+		10.1016/j.immuni.2017.07.017	http://dx.doi.org/10.1016/j.immuni.2017.07.017			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813657	Bronze, Green Accepted			2022-12-18	WOS:000407788300011
J	Sierro, F; Evrard, M; Rizzetto, S; Melino, M; Mitchell, AJ; Florido, M; Beattie, L; Walters, SB; Tay, SS; Lu, B; Holz, LE; Roediger, B; Wong, YC; Warren, A; Ritchie, W; McGuffog, C; Weninger, W; Le Couteur, DG; Ginhoux, F; Britton, WJ; Heath, WR; Saunders, BM; McCaughan, GW; Luciani, F; MacDonald, KPA; Ng, LG; Bowen, DG; Bertolino, P				Sierro, Frederic; Evrard, Maximilien; Rizzetto, Simone; Melino, Michelle; Mitchell, Andrew J.; Florido, Manuela; Beattie, Lynette; Walters, Shaun B.; Tay, Szun Szun; Lu, Bo; Holz, Lauren E.; Roediger, Ben; Wong, Yik Chun; Warren, Alessandra; Ritchie, William; McGuffog, Claire; Weninger, Wolfgang; Le Couteur, David G.; Ginhoux, Florent; Britton, Warwick J.; Heath, William R.; Saunders, Bernadette M.; McCaughan, Geoffrey W.; Luciani, Fabio; MacDonald, Kelli P. A.; Ng, Lai Guan; Bowen, David G.; Bertolino, Patrick			A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment	IMMUNITY			English	Article							GREEN FLUORESCENT PROTEIN; MONONUCLEAR PHAGOCYTE SYSTEM; COLONY-STIMULATING FACTOR; DENDRITIC CELLS; CHEMOKINE RECEPTOR; BONE-MARROW; LANGERHANS CELLS; LYMPHOID ORGANS; KUPFFER CELLS; IN-VIVO	The liver is positioned at the interface between two routes traversed by pathogens in disseminating infection. Whereas blood-borne pathogens are efficiently cleared in hepatic sinusoids by Kupffer cells (KCs), it is unknown how the liver prevents dissemination of peritoneal pathogens accessing its outer membrane. We report here that the hepatic capsule harbors a contiguous cellular network of liver-resident macrophages phenotypically distinct from KCs. These liver capsular macrophages (LCMs) were replenished in the steady state from blood monocytes, unlike KCs that are embryonically derived and self-renewing. LCM numbers increased after weaning in a microbiota-dependent process. LCMs sensed peritoneal bacteria and promoted neutrophil recruitment to the capsule, and their specific ablation resulted in decreased neutrophil recruitment and increased intrahepatic bacterial burden. Thus, the liver contains two separate and non-overlapping niches occupied by distinct resident macrophage populations mediating immunosurveillance at these two pathogen entry points to the liver.	[Sierro, Frederic; Tay, Szun Szun; Lu, Bo; Wong, Yik Chun; McGuffog, Claire; McCaughan, Geoffrey W.; Bowen, David G.; Bertolino, Patrick] Univ Sydney, Centenary Inst, Sydney, NSW, Australia; [Sierro, Frederic; Tay, Szun Szun; Lu, Bo; Wong, Yik Chun; McGuffog, Claire; McCaughan, Geoffrey W.; Bowen, David G.; Bertolino, Patrick] Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia; [Sierro, Frederic; Tay, Szun Szun; Lu, Bo; Wong, Yik Chun; McGuffog, Claire; McCaughan, Geoffrey W.; Bowen, David G.; Bertolino, Patrick] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Evrard, Maximilien; Ginhoux, Florent; Ng, Lai Guan] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Rizzetto, Simone; Luciani, Fabio] UNSW, Kirby Inst, Viral Immunol Syst Program, Syst Immunol, Sydney, NSW, Australia; [Melino, Michelle; MacDonald, Kelli P. A.] QIMR Berghofer Med Res Inst, Antigen Presentat & Immunoregulat Lab, Brisbane, Qld, Australia; [Mitchell, Andrew J.] Univ Melbourne, Dept Chem & Biomol Engn, Mat Characterizat & Fabricat Platform, Melbourne, Vic, Australia; [Florido, Manuela; Walters, Shaun B.; Roediger, Ben; Ritchie, William; Weninger, Wolfgang; Britton, Warwick J.; Saunders, Bernadette M.] Centenary Inst, Newtown, NSW, Australia; [Florido, Manuela; Walters, Shaun B.; Roediger, Ben; Ritchie, William; Weninger, Wolfgang; Britton, Warwick J.; Saunders, Bernadette M.] Univ Sydney, Newtown, NSW, Australia; [Beattie, Lynette; Holz, Lauren E.; Heath, William R.] Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Beattie, Lynette; Holz, Lauren E.; Heath, William R.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Melbourne, Vic, Australia; [Lu, Bo] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia; [Warren, Alessandra; Le Couteur, David G.] Concord RG Hosp, CERA, Sydney, NSW, Australia; [Warren, Alessandra; Le Couteur, David G.] Concord RG Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Warren, Alessandra; Le Couteur, David G.] Univ Sydney, Sydney, NSW, Australia; [Saunders, Bernadette M.] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia; [Sierro, Frederic] Australian Nucl Sci & Technol Org, Human Hlth, Lucas Heights, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of New South Wales Sydney; Kirby Institute; QIMR Berghofer Medical Research Institute; University of Melbourne; University of Sydney; Centenary Institute; University of Sydney; University of Melbourne; St Vincent's Hospital Melbourne; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Technology Sydney; Australian Nuclear Science & Technology Organisation	Sierro, F; Bowen, DG; Bertolino, P (corresponding author), Univ Sydney, Centenary Inst, Sydney, NSW, Australia.; Sierro, F; Bowen, DG; Bertolino, P (corresponding author), Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia.; Sierro, F; Bowen, DG; Bertolino, P (corresponding author), Royal Prince Alfred Hosp, Sydney, NSW, Australia.; Sierro, F (corresponding author), Australian Nucl Sci & Technol Org, Human Hlth, Lucas Heights, NSW, Australia.	frederis@ansto.gov.au; d.bowen@centenary.org.au; p.bertolino@centenary.org.au	Rizzetto, Simone/T-6181-2019; MacDonald, Kelli/AAV-5365-2020; Ng, Lai Guan/E-5673-2011; MacDonald, Kelli PA/O-2722-2016; Sierro, Frederic/B-9742-2009; Research Institute, ANZAC/CAE-9030-2022; Evrard, Maximilien/L-3886-2019; Ng, Lai Guan/N-6980-2019; Rizzetto, Simone/O-6311-2015	Ng, Lai Guan/0000-0003-1905-3586; MacDonald, Kelli PA/0000-0003-3451-4221; Sierro, Frederic/0000-0001-5004-8414; Evrard, Maximilien/0000-0002-2105-1160; Ng, Lai Guan/0000-0003-1905-3586; Melino, Michelle/0000-0001-6962-9016; Bertolino, Patrick/0000-0001-8244-7057; Saunders, Bernadette/0000-0003-0540-4445; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Rizzetto, Simone/0000-0003-3881-8759; Mitchell, Andrew/0000-0003-4454-853X; Beattie, Lynette/0000-0002-5794-7233; Britton, Warwick/0000-0001-6721-9646; Heath, William/0000-0001-9670-259X; Bowen, David/0000-0002-7965-5581; Tay, Szun S/0000-0003-0186-8154; Holz, Lauren/0000-0003-4897-0981; Roediger, Ben/0000-0002-4593-091X	NHMRC Australia [APP1108565, APP1086451]; SIgN, AstarSTAR, Singapore	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); SIgN, AstarSTAR, Singapore(Agency for Science Technology & Research (A*STAR))	We would like to thank Prof. L. Guidotti and Dr. M. Iannacone for sharing their technical expertise in 2PM liver imaging, Prof. B. Malissen for Cd207-EGFP mice, Dr. Matthew Sweet for Mac-Blue mice, and Dr. H. Wu for TLR4- and MyD88-deficient mice. We would also like to thank the Centenary Institute Animal Facility and Advanced Cytometry Facility for technical support. This work was supported by the NHMRC Australia (project grants APP1108565 and APP1086451) and by SIgN, A<SUP>star</SUP>STAR, Singapore.	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BOUWENS L, 1984, HEPATOLOGY, V4, P213, DOI 10.1002/hep.1840040208; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; Capucha T, 2015, IMMUNITY, V43, P369, DOI 10.1016/j.immuni.2015.06.017; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; David BA, 2016, GASTROENTEROLOGY, V151, P1176, DOI 10.1053/j.gastro.2016.08.024; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Faust N, 2000, BLOOD, V96, P719; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gautier EL, 2014, IMMUNOL REV, V262, P85, DOI 10.1111/imr.12231; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guirat A, 2011, CLIN RES HEPATOL GAS, V35, P60, DOI 10.1016/j.gcb.2010.07.023; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Havell EA, 1999, IMMUNOBIOLOGY, V201, P164, DOI 10.1016/S0171-2985(99)80056-4; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; MULLERSCHOOP JW, 1978, BRIT MED J, V1, P1022, DOI 10.1136/bmj.1.6119.1022; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRICKETT TCR, 1988, TRANSPLANTATION, V46, P754, DOI 10.1097/00007890-198811000-00024; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	54	100	101	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					374	+		10.1016/j.immuni.2017.07.018	http://dx.doi.org/10.1016/j.immuni.2017.07.018			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813662	Bronze			2022-12-18	WOS:000407788300021
J	Krebs, CF; Paust, HJ; Krohn, S; Koyro, T; Brix, SR; Riedel, JH; Bartsch, P; Wiech, T; Meyer-Schwesinger, C; Huang, JB; Fischer, N; Busch, P; Mittrucker, HW; Steinhoff, U; Stockinger, B; Perez, LG; Wenzel, UO; Janneck, M; Steinmetz, OM; Gagliani, N; Stahl, RAK; Huber, S; Turner, JE; Panzer, U				Krebs, Christian F.; Paust, Hans-Joachim; Krohn, Sonja; Koyro, Tobias; Brix, Silke R.; Riedel, Jan-Hendrik; Bartsch, Patricia; Wiech, Thorsten; Meyer-Schwesinger, Catherine; Huang, Jiabin; Fischer, Nicole; Busch, Philipp; Mittruecker, Hans-Willi; Steinhoff, Ulrich; Stockinger, Brigitta; Perez, Laura Garcia; Wenzel, Ulrich O.; Janneck, Matthias; Steinmetz, Oliver M.; Gagliani, Nicola; Stahl, Rolf A. K.; Huber, Samuel; Turner, Jan-Eric; Panzer, Ulf			Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney	IMMUNITY			English	Article							REGULATORY T-CELLS; CRESCENTIC GLOMERULONEPHRITIS; T(H)17 CELLS; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; HELPER-CELLS; INTERLEUKIN-17; MICROBIOTA; INJURY; DIFFERENTIATION	Th17 cells are most abundant in the gut, where their presence depends on the intestinal microbiota. Here, we examined whether intestinal Th17 cells contribute to extra-intestinal Th17 responses in autoimmune kidney disease. We found high frequencies of Th17 cells in the kidneys of patients with antineutrophil cytoplasmatic antibody (ANCA)-associated glomerulonephritis. We utilized photoconversion of intestinal cells in Kaede mice to track intestinal T cell mobilization upon glomerulonephritis induction, and we found that Th17 cells egress from the gut in a S1P-receptor-1-dependent fashion and subsequently migrate to the kidney via the CCL20/ CCR6 axis. Depletion of intestinal Th17 cells in germ-free and antibiotic-treated mice ameliorated renal disease, whereas expansion of these cells upon Citrobacter rodentium infection exacerbated pathology. Thus, in some autoimmune settings, intestinal Th17 cells migrate into target organs, where they contribute to pathology. Targeting the intestinal Th17 cell "reservoir'' may present a therapeutic strategy for these autoimmune disorders.	[Krebs, Christian F.; Paust, Hans-Joachim; Krohn, Sonja; Koyro, Tobias; Brix, Silke R.; Riedel, Jan-Hendrik; Bartsch, Patricia; Meyer-Schwesinger, Catherine; Wenzel, Ulrich O.; Janneck, Matthias; Steinmetz, Oliver M.; Stahl, Rolf A. K.; Turner, Jan-Eric; Panzer, Ulf] Univ Klinikum Hamburg Eppendorf, Med Klin 3, D-20251 Hamburg, Germany; [Wiech, Thorsten] Univ Klinikum Hamburg Eppendorf, Inst Pathol, D-20251 Hamburg, Germany; [Huang, Jiabin; Fischer, Nicole] Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, D-20251 Hamburg, Germany; [Busch, Philipp; Gagliani, Nicola] Univ Klinikum Hamburg Eppendorf, Klin Allgemeinchirurg, D-20251 Hamburg, Germany; [Mittruecker, Hans-Willi] Univ Klinikum Hamburg Eppendorf, Inst Immunol, D-20251 Hamburg, Germany; [Steinhoff, Ulrich] Philipps Univ Marburg, Inst Med Mikrobiol, D-35043 Marburg, Germany; [Steinhoff, Ulrich] Krankenhaushygiene, D-35043 Marburg, Germany; [Stockinger, Brigitta] Francis Crick Inst, Midland Rd, London NW1 1AT, England; [Perez, Laura Garcia; Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Francis Crick Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Panzer, U (corresponding author), Univ Klinikum Hamburg Eppendorf, Med Klin 3, D-20251 Hamburg, Germany.	panzer@uke.de	Wiech, Thorsten/ABA-3632-2020; Turner, Jan-Eric/ABC-1214-2021; Perez, Laura Garcia/AAE-6964-2021	Wiech, Thorsten/0000-0003-4053-1474; Gagliani, Nicola/0000-0001-8514-1395; Garcia Perez, Laura/0000-0001-6339-6549; Steinhoff, Ulrich/0000-0003-2141-7756; Stockinger, Brigitta/0000-0001-8781-336X; Krebs, Christian F./0000-0003-2739-5578; Brix, Silke R/0000-0002-6002-6750; Huber, Samuel/0000-0001-9325-8227; Huang, Jiabin/0000-0002-3480-7115	Deutsche Forschungsgemeinschaft [SFB 1192]; Deutsche Nierenstiftung; Deutsche Gesellschaft fur Nephrologie; Werner-Otto-Foundation; The Francis Crick Institute [10159] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Nierenstiftung; Deutsche Gesellschaft fur Nephrologie; Werner-Otto-Foundation; The Francis Crick Institute	This study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 1192 to U.P. and C.F.K.) and grants from the Deutsche Nierenstiftung and Deutsche Gesellschaft fur Nephrologie to C.F.K. T.K. received a scholarship from the Werner-Otto-Foundation. FACS sorting was performed at the UKE FACS sorting core facility.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Annunziato F, 2013, SEMIN IMMUNOL, V25, P299, DOI 10.1016/j.smim.2013.10.011; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Baeyens A, 2015, TRENDS IMMUNOL, V36, P778, DOI 10.1016/j.it.2015.10.005; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Couser WG, 2012, J AM SOC NEPHROL, V23, P381, DOI 10.1681/ASN.2011030304; Disteldorf EM, 2015, J AM SOC NEPHROL, V26, P55, DOI 10.1681/ASN.2013101061; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gan PY, 2010, J AM SOC NEPHROL, V21, P925, DOI 10.1681/ASN.2009070763; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Hunemorder S, 2015, J PATHOL, V237, P62, DOI 10.1002/path.4559; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Krebs CF, 2013, J AM SOC NEPHROL, V24, P1955, DOI 10.1681/ASN.2013020130; Kursar M, 2008, EUR J IMMUNOL, V38, P127, DOI 10.1002/eji.200737142; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ooi JD, 2009, J AM SOC NEPHROL, V20, P980, DOI 10.1681/ASN.2008080891; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paust HJ, 2012, KIDNEY INT, V82, P72, DOI 10.1038/ki.2012.101; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Paust HJ, 2015, J AM SOC NEPHROL; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramani K, 2014, J LEUKOCYTE BIOL, V96, P463, DOI 10.1189/jlb.3A0414-184R; Riedel J. H., 2016, J AM SOC NEPHROL; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; Steinmetz OM, 2011, J AM SOC NEPHROL, V22, P472, DOI 10.1681/ASN.2010040435; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; Tulone C, 2011, AM J PATHOL, V179, P2683, DOI 10.1016/j.ajpath.2011.08.017; Turner JE, 2010, J AM SOC NEPHROL, V21, P974, DOI 10.1681/ASN.2009070741; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	57	100	105	3	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1078	1092		10.1016/j.immuni.2016.10.020	http://dx.doi.org/10.1016/j.immuni.2016.10.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851911	hybrid, Green Published			2022-12-18	WOS:000389473500018
J	Mitra, S; Ring, AM; Amarnath, S; Spangler, JB; Li, P; Ju, W; Fischer, S; Oh, J; Spolski, R; Weiskopf, K; Kohrt, H; Foley, JE; Rajagopalan, S; Long, EO; Fowler, DH; Waldmann, TA; Garcia, KC; Leonard, WJ				Mitra, Suman; Ring, Aaron M.; Amarnath, Shoba; Spangler, Jamie B.; Li, Peng; Ju, Wei; Fischer, Suzanne; Oh, Jangsuk; Spolski, Rosanne; Weiskopf, Kipp; Kohrt, Holbrook; Foley, Jason E.; Rajagopalan, Sumati; Long, Eric O.; Fowler, Daniel H.; Waldmann, Thomas A.; Garcia, K. Christopher; Leonard, Warren J.			Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps	IMMUNITY			English	Article							GAMMA-CHAIN; IL-2 RECEPTOR; BETA-CHAIN; CARDIAC TRANSPLANTATION; CYTOPLASMIC DOMAINS; MONOCLONAL-ANTIBODY; ALPHA-RECEPTOR; T-LYMPHOCYTES; HOST-DISEASE; CELLS	Interleukin-2 (IL-2) regulates lymphocyte function by signaling through heterodimerization of the IL-2R beta and gamma(c) receptor subunits. IL-2 is of considerable therapeutic interest, but harnessing its actions in a controllable manner remains a challenge. Previously, we have engineered an IL-2 "superkine'' with enhanced affinity for IL-2R beta. Here, we describe next-generation IL-2 variants that function as "receptor signaling clamps.'' They retained high affinity for IL-2R beta, inhibiting binding of endogenous IL-2, but their interaction with gamma(c) was weakened, attenuating IL-2R beta-gamma(c) heterodimerization. These IL-2 analogs acted as partial agonists and differentially affected lymphocytes poised at distinct activation thresholds. Moreover, one variant, H9-RETR, antagonized IL-2 and IL-15 better than blocking antibodies against IL-2R alpha or IL-2R beta. Furthermore, this mutein prolonged survival in a model of graft-versus-host disease and blocked spontaneous proliferation of smoldering adult T cell leukemia (ATL) T cells. This receptor-clamping approach might be a general mechanism-based strategy for engineering cytokine partial agonists for therapeutic immunomodulation.	[Mitra, Suman; Li, Peng; Oh, Jangsuk; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Mitra, Suman; Li, Peng; Oh, Jangsuk; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Ring, Aaron M.; Spangler, Jamie B.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Ring, Aaron M.; Spangler, Jamie B.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Ring, Aaron M.; Spangler, Jamie B.; Fischer, Suzanne; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Amarnath, Shoba; Foley, Jason E.; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ju, Wei; Waldmann, Thomas A.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA; [Weiskopf, Kipp; Kohrt, Holbrook] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA; [Rajagopalan, Sumati; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu; wjl@helix.nih.gov	amarnath, shoba/AAP-4391-2020; Leonard, Warren/AAA-1397-2022; Long, Eric O/G-5475-2011; Waldmann, Thomas/AAT-5972-2021	Long, Eric O/0000-0002-7793-3728; Waldmann, Thomas/0000-0003-4500-6660; Ring, Aaron/0000-0003-3699-2446; Spangler, Jamie/0000-0001-8187-3732	Divisions of Intramural Research, National Heart, Lung, and Blood Institute; National Cancer Institute; National Institute of Allergy and Infectious Diseases; Leukemia & Lymphoma Society;  [NIH-R0AI51321];  [NIH-F30DK094541]; NATIONAL CANCER INSTITUTE [ZIASC004002, ZIBBC010906] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL005401, ZICHL006058, ZIAHL005402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321, R01AI051321, ZIAAI000525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER	Divisions of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Divisions of Intramural Research, National Heart, Lung, and Blood Institute (S.M., P.L., J.O., R.S., and W.J.L.), National Cancer Institute (S.M., W.J., D.H.F., and T.A.W.), National Institute of Allergy and Infectious Diseases (S.R. and E.O.L), NIH-R0AI51321 (K.C.G.), and NIH-F30DK094541 (A.M.R.). K.C.G. is an investigator of the Howard Hughes Medical Institute. J.B.S. is the recipient of a Leukemia & Lymphoma Society Career Development Program fellowship. We thank Dr. Junji Yodoi, Kyoto University, for YT and YT-1 NK-like cells.	Beniaminovitz A, 2000, NEW ENGL J MED, V342, P613, DOI 10.1056/NEJM200003023420902; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Blaser BW, 2005, BLOOD, V105, P894, DOI 10.1182/blood-2004-05-1687; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; FERRARA JLM, 1986, J IMMUNOL, V137, P1874; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hershberger RE, 2005, NEW ENGL J MED, V352, P2705, DOI 10.1056/NEJMoa032953; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; KUZIEL WA, 1993, J IMMUNOL, V150, P3357; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Morris JC, 2006, P NATL ACAD SCI USA, V103, P401, DOI 10.1073/pnas.0509575103; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Riese DJ, 2011, EXPERT OPIN DRUG DIS, V6, P185, DOI 10.1517/17460441.2011.547468; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Strange PG, 2008, BRIT J PHARMACOL, V153, P1353, DOI 10.1038/sj.bjp.0707672; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thomas LM, 2013, J IMMUNOL, V191, P3981, DOI 10.4049/jimmunol.1301159; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; YODOI J, 1985, J IMMUNOL, V134, P1623; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	48	100	112	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					826	838		10.1016/j.immuni.2015.04.018	http://dx.doi.org/10.1016/j.immuni.2015.04.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992859	Bronze, Green Accepted			2022-12-18	WOS:000354827400010
J	Brown, CC; Esterhazy, D; Sarde, A; London, M; Pullabhatla, V; Osma-Garcia, I; al-Bader, R; Ortiz, C; Elgueta, R; Arno, M; de Rinaldis, E; Mucida, D; Lord, GM; Noelle, RJ				Brown, Chrysothemis C.; Esterhazy, Daria; Sarde, Aurelien; London, Mariya; Pullabhatla, Venu; Osma-Garcia, Ines; al-Bader, Raya; Ortiz, Carla; Elgueta, Raul; Arno, Matthew; de Rinaldis, Emanuele; Mucida, Daniel; Lord, Graham M.; Noelle, Randolph J.			Retinoic Acid Is Essential for Th1 Cell Lineage Stability and Prevents Transition to a Th17 Cell Program	IMMUNITY			English	Article							TRANSCRIPTIONAL ACTIVATION; INTERFERON-GAMMA; TGF-BETA; T-BET; DIFFERENTIATION; T(H)17; PLASTICITY; CHROMATIN; INCREASES; DISEASE	CD4(+) T cells differentiate into phenotypically distinct T helper cells upon antigenic stimulation. Regulation of plasticity between these CD4+ T-cell lineages is critical for immune homeostasis and prevention of autoimmune disease. However, the factors that regulate lineage stability are largely unknown. Here we investigate a role for retinoic acid (RA) in the regulation of lineage stability using T helper 1 (Th1) cells, traditionally considered the most phenotypically stable Th subset. We found that RA, through its receptor RAR alpha, sustains stable expression of Th1 lineage specifying genes, as well as repressing genes that instruct Th17-cell fate. RA signaling is essential for limiting Th1-cell conversion into Th17 effectors and for preventing pathogenic Th17 responses in vivo. Our study identifies RA-RAR alpha as a key component of the regulatory network governing maintenance and plasticity of Th1-cell fate and defines an additional pathway for the development of Th17 cells.	[Brown, Chrysothemis C.; Sarde, Aurelien; Osma-Garcia, Ines; al-Bader, Raya; Ortiz, Carla; Elgueta, Raul; Lord, Graham M.; Noelle, Randolph J.] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London SE1 9RT, England; [Esterhazy, Daria; London, Mariya; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Pullabhatla, Venu; de Rinaldis, Emanuele; Lord, Graham M.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London SE1 9RT, England; [Pullabhatla, Venu; de Rinaldis, Emanuele; Lord, Graham M.] Kings Coll London, London SE1 9RT, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London SE1 9NH, England; [de Rinaldis, Emanuele] Guys Hosp, Kings Coll London, Sch Med, Div Canc Studies, London SE1 9RT, England; [Noelle, Randolph J.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	University of London; King's College London; Rockefeller University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Dartmouth College	Brown, CC (corresponding author), Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London SE1 9RT, England.	chrysothemis.brown@kcl.ac.uk; rjn@dartmouth.edu	Abraham, Sabu/E-1144-2019	Abraham, Sabu/0000-0002-0916-5827; Brown, Chrysothemis/0000-0002-5834-926X; Ines Claire, OSMA GARCIA/0000-0002-3724-8371; Lord, Graham/0000-0003-2069-4743; Elgueta, Raul/0000-0002-7083-2430	Wellcome Trust; NIH [R01AT005382]; National Institute for Health Research (NIHR) Biomedical Research Centre; Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC [MR/J006742/1]; MRC [MR/M003493/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI119062, R01AI114059] Funding Source: NIH RePORTER; Medical Research Council [MR/M003493/1, MR/J006742/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to PJ Chana and H. Graves (BRC Flow Cytometry Core, Kings College) for cell sorting. We gratefully acknowledge the NIH Tetramer Core Facility for provision of I-A<SUP>b</SUP>:LLO<INF>190-201</INF> monomers and thank M. Jenkins (University of Minnesota) for providing us with Lm-2W. We thank K. Jones for critical reading of the manuscript and A. Hertweck for advice on experiments. This work was supported by a Wellcome Trust Research Training Fellowship to C.C.B. and a Wellcome Trust Principal Research Fellowship Award and NIH R01AT005382 award to R.J.N. Research was supported in part by the National Institute for Health Research (NIHR) Biomedical Research Centre, Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London and the Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC grant no. MR/J006742/1. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aoyama K, 2013, BLOOD, V122, P2125, DOI 10.1182/blood-2012-11-470252; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	37	100	106	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					499	511		10.1016/j.immuni.2015.02.003	http://dx.doi.org/10.1016/j.immuni.2015.02.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25769610	Green Published, hybrid			2022-12-18	WOS:000351301900014
J	Rajsbaum, R; Versteeg, GA; Schmid, S; Maestre, AM; Belicha-Villanueva, A; Martinez-Romero, C; Patel, JR; Morrison, J; Pisanelli, G; Miorin, L; Laurent-Rolle, M; Moulton, HM; Stein, DA; Fernandez-Sesma, A; tenOever, BR; Garcia-Sastre, A				Rajsbaum, Ricardo; Versteeg, Gijs A.; Schmid, Sonja; Maestre, Ana M.; Belicha-Villanueva, Alan; Martinez-Romero, Carles; Patel, Jenish R.; Morrison, Juliet; Pisanelli, Giuseppe; Miorin, Lisa; Laurent-Rolle, Maudry; Moulton, Hong M.; Stein, David A.; Fernandez-Sesma, Ana; tenOever, Benjamin R.; Garcia-Sastre, Adolfo			Unanchored K48-Linked Polyubiquitin Synthesized by the E3-Ubiquitin Ligase TRIM6 Stimulates the Interferon-IKK epsilon Kinase-Mediated Antiviral Response	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; UBIQUITIN-CHAIN SYNTHESIS; ADAPTIVE IMMUNITY; INNATE IMMUNITY; NS1 PROTEIN; DOMAIN; ACTIVATION; PATHWAY; FAMILY; ROLES	Type I interferons (IFN-I) are essential antiviral cytokines produced upon microbial infection. IFN-I elicits this activity through the upregulation of hundreds of IFN-I-stimulated genes (ISGs). The full breadth of ISG induction demands activation of a number of cellular factors including the I kappa B kinase epsilon (IKK epsilon). However, the mechanism of IKK epsilon activation upon IFN receptor signaling has remained elusive. Here we show that TRIM6, a member of the E3-ubiquitin ligase tripartite motif (TRIM) family of proteins, interacted with IKK epsilon and promoted induction of IKK epsilon-dependent ISGs. TRIM6 and the E2-ubiquitin conjugase UbE2K cooperated in the synthesis of unanchored K48-linked polyubiquitin chains, which activated IKK epsilon for subsequent STAT1 phosphorylation. Our work attributes a previously unrecognized activating role of K48-linked unanchored polyubiquitin chains in kinase activation and identifies the UbE2K-TRIM6-ubiquitin axis as critical for IFN signaling and antiviral response.	[Rajsbaum, Ricardo; Versteeg, Gijs A.; Schmid, Sonja; Maestre, Ana M.; Belicha-Villanueva, Alan; Martinez-Romero, Carles; Patel, Jenish R.; Morrison, Juliet; Pisanelli, Giuseppe; Miorin, Lisa; Laurent-Rolle, Maudry; Fernandez-Sesma, Ana; tenOever, Benjamin R.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Rajsbaum, Ricardo; Versteeg, Gijs A.; Belicha-Villanueva, Alan; Martinez-Romero, Carles; Patel, Jenish R.; Morrison, Juliet; Pisanelli, Giuseppe; Miorin, Lisa; Laurent-Rolle, Maudry; tenOever, Benjamin R.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Versteeg, Gijs A.] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Pisanelli, Giuseppe] Univ Naples Federico II, Dept Vet Med & Anim Prod, I-80137 Naples, Italy; [Moulton, Hong M.; Stein, David A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Naples Federico II; Oregon State University	Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, One Gustave L Levy Pl, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Rajsbaum, Ricardo/AAD-4775-2020; Merens, Ana Maestre/I-2445-2019	Merens, Ana Maestre/0000-0002-2494-0879; Patel, Jenish/0000-0001-5310-8160; Pisanelli, Giuseppe/0000-0002-8229-6882; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Morrison, Juliet/0000-0001-7387-6351; Fernandez-Sesma, Ana/0000-0002-3405-6702; tenOever, Benjamin/0000-0003-0324-3078; Schmid, Sonja/0000-0002-1946-5970; Versteeg, Gijs/0000-0002-6150-2165	NIH [R01AI080624, P01AI090935, U19 AI083025, U01AI095611, U19AI106754, HHSN272201000054C]; NIH/NIAID [1P01AI90935, 1R01AI073450]; DARPA [HR0011-11-C-0094]; NIAID funded CEIRS (Center of Excellence in Influenza Research and Surveillance [HHSN266200700010C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095611, R01AI080624, U19AI083025, R01AI073450, U19AI106754, P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIAID funded CEIRS (Center of Excellence in Influenza Research and Surveillance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Cadagan, O. Lizardo, and D. Bernal-Rubio for technical support. We thank C.F. Basler for kindly providing the IKK epsilon deletion plasmids. Confocal microscopy was performed at the Mount Sinai Microscopy Shared Resource Facility. This work was supported in part by NIH R01AI080624 (B.R.T.), P01AI090935, U19 AI083025, U01AI095611, U19AI106754, and HHSN272201000054C (A.G.-S.), NIH/NIAID 1P01AI90935, 1R01AI073450, and DARPA HR0011-11-C-0094 (A.F.-S.), and by NIAID funded CEIRS (Center of Excellence in Influenza Research and Surveillance, contract # HHSN266200700010C) (A.G.-S. and A.F.-S.).	Abes S, 2006, J CONTROL RELEASE, V116, P304, DOI 10.1016/j.jconrel.2006.09.011; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shin DY, 2011, FEBS LETT, V585, P3959, DOI 10.1016/j.febslet.2011.11.002; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wilson RC, 2011, BIOCHEM BIOPH RES CO, V405, P662, DOI 10.1016/j.bbrc.2011.01.089; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	34	100	107	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					880	895		10.1016/j.immuni.2014.04.018	http://dx.doi.org/10.1016/j.immuni.2014.04.018			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24882218	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000341440200011
J	Lefevre, L; Lugo-Villarino, G; Meunier, E; Valentin, A; Olagnier, D; Authier, H; Duval, C; Dardenne, C; Bernad, J; Lemesre, JL; Auwerx, J; Neyrolles, O; Pipy, B; Coste, A				Lefevre, Lise; Lugo-Villarino, Geanncarlo; Meunier, Etienne; Valentin, Alexis; Olagnier, David; Authier, Helene; Duval, Carine; Dardenne, Christophe; Bernad, Jose; Lemesre, Jean Loup; Auwerx, Johan; Neyrolles, Olivier; Pipy, Bernard; Coste, Agnes			The C-type Lectin Receptors Dectin-1, MR, and SIGNR3 Contribute Both Positively and Negatively to the Macrophage Response to Leishmania infantum	IMMUNITY			English	Article							NLRP3 INFLAMMASOME; HOST-DEFENSE; DC-SIGN; MANNOSE RECEPTOR; TYROSINE KINASE; B-CELLS; ACTIVATION	Macrophages act as the primary effector cells during Leishmania infection through production of reactive oxygen species (ROS) and interleukin-1 beta (IL-1 beta). However, how macrophage-killing mechanisms are activated during Leishmania-macrophage interactions is poorly understood. Here, we report that the macrophage response against Leishmania infantum in vivo is characterized by an M2b-like phenotype and C-type lectin receptors (CLRs) signature composed of Dectin-1, mannose receptor (MR), and the DC-SIGN homolog SIGNR3 expression. Dectin-1 and MR were crucial for the microbicidal response as indicated by the fact that they activated Syk-p47phox and arachidonic acid (AA)-NADPH oxidase signaling pathways, respectively, needed for ROS production and also triggered Syk-coupled signaling for caspase-1-induced IL-1 beta secretion. In contrast, SIGNR3 has divergent functions during Leishmania infantum pathogenesis; this CLR favored parasite resilience through inhibition of the LTB4-IL-1 beta axis. These pathways also operated during infection of primary human macrophages. Therefore, our study promotes CLRs as potential targets for treatment, diagnosis, and prevention of visceral leishmaniasis.	[Lefevre, Lise; Meunier, Etienne; Valentin, Alexis; Olagnier, David; Authier, Helene; Dardenne, Christophe; Bernad, Jose; Pipy, Bernard; Coste, Agnes] Univ Toulouse, UPS, UMR PHARMA DEV 152, F-31432 Toulouse, France; [Lefevre, Lise; Meunier, Etienne; Valentin, Alexis; Olagnier, David; Authier, Helene; Dardenne, Christophe; Bernad, Jose; Pipy, Bernard; Coste, Agnes] IRD, UMR 152, F-31432 Toulouse, France; [Lugo-Villarino, Geanncarlo; Duval, Carine; Neyrolles, Olivier] CNRS, IPBS, F-31077 Toulouse, France; [Lugo-Villarino, Geanncarlo; Duval, Carine; Neyrolles, Olivier] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Lemesre, Jean Loup] IRD Ctr CIRAD, F-34394 Montpellier, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CIRAD; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Coste, A (corresponding author), Univ Toulouse, UPS, UMR PHARMA DEV 152, F-31432 Toulouse, France.	agnes.coste@univ-tlse3.fr	Auwerx, Johan/ABE-9307-2021; Lugo, Geanncarlo/H-4674-2019; Agnès, Coste/AAK-9408-2020; Valentin, Alexis/I-6821-2015; Neyrolles, Olivier/AAG-3692-2019	Lugo, Geanncarlo/0000-0003-4620-8491; Valentin, Alexis/0000-0002-2133-112X; Neyrolles, Olivier/0000-0003-0047-5885; Olagnier, David/0000-0001-6912-0674; Coste, Agnes/0000-0001-7781-3323; authier, helene/0000-0002-5556-4570; Auwerx, Johan/0000-0002-5065-5393; Lefevre, Lise/0000-0003-0237-6696; Pipy, Bernard/0000-0001-8060-7029	Consortium for Functional Glycomics grant [GM62116]; Ministere de la recherche et de l'enseignement superieur; ERA-NET/ERASysBio grant TB-Host-Net; Fondation pour la Recherche Medicale	Consortium for Functional Glycomics grant; Ministere de la recherche et de l'enseignement superieur; ERA-NET/ERASysBio grant TB-Host-Net; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank P. Batigne for technical assistance and J.-P. Gangneux for helpful discussions. We also wish to acknowledge the Consortium for Functional Glycomics grant number GM62116 for providing the Cd209d<SUP>-/-</SUP> mice, and K. Inaba and K. Takahara for their kind gift of the anti-SIGNR3 (4A4). This work was supported by the Ministere de la recherche et de l'enseignement superieur (L. L., E. M.) and the ERA-NET/ERASysBio grant TB-Host-Net. G. L.-V. acknowledges fellowship funding from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilov OE, 2007, J LEUKOCYTE BIOL, V81, P1188, DOI 10.1189/jlb.0706439; Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Caparros E, 2005, IMMUNOBIOLOGY, V210, P185, DOI 10.1016/j.imbio.2005.05.013; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Koppel EA, 2008, MOL IMMUNOL, V45, P2881, DOI 10.1016/j.molimm.2008.01.032; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Nagaoka K, 2010, J LEUKOCYTE BIOL, V88, P913, DOI 10.1189/jlb.0510251; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wenzel A, 2009, AUTOIMMUNITY, V42, P331, DOI 10.1080/08916930902828239; Wethmar K, 2006, EUR J IMMUNOL, V36, P2781, DOI 10.1002/eji.200526311; WHO, 2010, WHO TECH REP SER, V949, P1; WILSON ME, 1988, INFECT IMMUN, V56, P363, DOI 10.1128/IAI.56.2.363-369.1988; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	40	100	103	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1038	1049		10.1016/j.immuni.2013.04.010	http://dx.doi.org/10.1016/j.immuni.2013.04.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23684988	Bronze			2022-12-18	WOS:000330942500020
J	Ramirez, K; Chandler, KJ; Spaulding, C; Zandi, S; Sigvardsson, M; Graves, BJ; Kee, BL				Ramirez, Kevin; Chandler, Katherine J.; Spaulding, Christina; Zandi, Sasan; Sigvardsson, Mikael; Graves, Barbara J.; Kee, Barbara L.			Gene Deregulation and Chronic Activation in Natural Killer Cells Deficient in the Transcription Factor ETS1	IMMUNITY			English	Article							NK CELLS; DNA-BINDING; IN-VITRO; T-BET; RECEPTOR; DIFFERENTIATION; IDENTIFICATION; PROTEINS; PROMOTER; FAMILY	Multiple transcription factors guide the development of mature functional natural killer (NK) cells, yet little is known about their function. We used global gene expression and genome-wide binding analyses combined with developmental and functional studies to unveil three roles for the ETS1 transcription factor in NK cells. ETS1 functions at the earliest stages of NK cell development to promote expression of critical transcriptional regulators including T-BET and ID2, NK cell receptors (NKRs) including NKp46, Ly49H, and Ly49D, and signaling molecules essential for NKR function. As a consequence, Ets(-/-) NK cells fail to degranulate after stimulation through activating NKRs. Nonetheless, these cells are hyperresponsive to cytokines and have characteristics of chronic stimulation including increased expression of inhibitory NKRs and multiple activation-associated genes. Therefore, ETS1 regulates a broad gene expression program in NK cells that promotes target cell recognition while limiting cytokine-driven activation.	[Ramirez, Kevin; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60615 USA; [Spaulding, Christina; Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Canc Biol, Chicago, IL 60615 USA; [Spaulding, Christina; Kee, Barbara L.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60615 USA; [Chandler, Katherine J.; Graves, Barbara J.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Ctr, Salt Lake City, UT 84112 USA; [Zandi, Sasan; Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Hematopoiesis Unit, S-58183 Linkoping, Sweden	University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Linkoping University	Kee, BL (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60615 USA.	bkee@bsd.uchicago.edu		Zandi, Sasan/0000-0002-8448-094X; Sigvardsson, Mikael/0000-0001-8527-7276	National Institutes of Health [CA099978, CA099978-S, GM38663, CA42014]; Leukemia and Lymphoma Society; Interdisciplinary Training Program in Immunology [T32A1007090]; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA099978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038663, R01GM038663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Interdisciplinary Training Program in Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Svensson and K. Barton for providing Ets1<SUP>-/-</SUP> mice. We are grateful to V. Kumar for helpful discussions and comments on this manuscript. This work was supported by the National Institutes of Health (CA099978 to B.L.K., CA099978-S to K.R., GM38663 to B.J.G., and CA42014 to the Huntsman Cancer Institute for support of core facilities). B.L.K. is supported by a scholar award from the Leukemia and Lymphoma Society. K.R. is supported by the Interdisciplinary Training Program in Immunology (T32A1007090).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barao I, 2011, BLOOD, V117, P7032, DOI 10.1182/blood-2010-11-316653; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Cowley DO, 2000, GENE DEV, V14, P366; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Eyquem S, 2004, EUR J IMMUNOL, V34, P3187, DOI 10.1002/eji.200425352; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GASTON K, 1995, NUCLEIC ACIDS RES, V23, P901, DOI 10.1093/nar/23.6.901; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; Grenningloh R, 2011, J IMMUNOL, V186, P969, DOI 10.4049/jimmunol.1002099; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; KARLHOFER FM, 1995, J EXP MED, V181, P1785, DOI 10.1084/jem.181.5.1785; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; SETH A, 1990, ONCOGENE, V5, P1761; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; YOKOMORI N, 1995, MOL CELL BIOL, V15, P5355; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x	58	100	105	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					921	932		10.1016/j.immuni.2012.04.006	http://dx.doi.org/10.1016/j.immuni.2012.04.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22608498	Green Accepted, Bronze			2022-12-18	WOS:000306097100011
J	Gross, O; Yazdi, AS; Thomas, CJ; Masin, M; Heinz, LX; Guarda, G; Quadroni, M; Drexler, SK; Tschopp, J				Gross, Olaf; Yazdi, Amir S.; Thomas, Christina J.; Masin, Mark; Heinz, Leonhard X.; Guarda, Greta; Quadroni, Manfredo; Drexler, Stefan K.; Tschopp, Jurg			Inflammasome Activators Induce Interleukin-1 alpha Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1	IMMUNITY			English	Article							NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; HOST-DEFENSE; CELL-DEATH; IL-1-ALPHA; IL-1-BETA; PRECURSOR; RECEPTOR; IL-1; IDENTIFICATION	Through their capacity to sense danger signals and to generate active interleukin-1 beta (IL-1 beta), inflammasomes occupy a central role in the inflammatory response. In contrast to IL-1 beta, little is known about how IL-1 alpha is regulated. We found that all inflammasome activators also induced the secretion of IL-1 alpha, leading to the cosecretion of both IL-1 cytokines. Depending on the type of inflammasome activator, release of IL-1 alpha was inflammasome dependent or independent. Calcium influx induced by the opening of cation channels was sufficient for the inflammasome-independent IL-1 alpha secretion. In both cases, IL-1 alpha was released primarily in a processed form, resulting from intracellular cleavage by calpain-like proteases. Inflammasome-caspase-1-dependent release of IL-1 alpha and IL-1 beta was independent of caspase-1 catalytic activity, defining a mode of action for caspase-1. Because inflammasomes contribute to the pathology of numerous chronic inflammatory diseases such as gout and diabetes, IL-1 alpha antagonists may be beneficial in the treatment of these disorders.	[Gross, Olaf; Yazdi, Amir S.; Thomas, Christina J.; Masin, Mark; Heinz, Leonhard X.; Guarda, Greta; Drexler, Stefan K.; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Quadroni, Manfredo] Univ Lausanne, Prot Anal Facil, CH-1066 Epalinges, Switzerland; [Gross, Olaf; Thomas, Christina J.] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany; [Yazdi, Amir S.] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany	University of Lausanne; University of Lausanne; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gross, O (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	ogross@lrz.tu-muenchen.de	Guarda, Greta/G-1921-2011; Gross, Olaf/E-4570-2010	Gross, Olaf/0000-0001-8660-3619; Guarda, Greta/0000-0001-9243-6116	Marie Curie RTN; DFG [YA182/2-1]; Swiss National Science Foundation; EU; Institute of Arthritis Research; Louis-Jeantet Foundation; NCCR Molecular Oncology; Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network	Marie Curie RTN(European Commission); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Institute of Arthritis Research; Louis-Jeantet Foundation; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network	We greatly appreciate the support of F. Martinon and N. Fasel in the time since Jurg Tschopp's passing. Many thanks to R. Castillo, A. Tardivel, and the staff at the Protein Analysis Facility for technical support, and H.R. MacDonald and E. Fiorini for help with the EL-4 thymoma cell line. This work is supported by an EMBO long-term fellowship to O.G. and NSERC postgraduate scholarships to C.J.T. A.S.Y. is supported by a Marie Curie RTN fellowship and by DFG grant YA182/2-1, and S.K.D is supported by a DFG fellowship. Studies in the laboratory of J.T. are funded by grants of the Swiss National Science Foundation, the EU Apo-Sys program, the Institute of Arthritis Research, the Louis-Jeantet Foundation, and NCCR Molecular Oncology. Work in O.G.'s laboratory is funded by the Bavarian Ministry of Sciences, Research and the Arts in the Framework of the Bavarian Molecular Biosystems Research Network. O.G., A.S.Y., and J.T. designed the research; O.G., A.S.Y., C.J.T., L.X.H., M.M., S.K.D., G.G., and M.Q. performed experiments; O.G. prepared the figures, and O.G., A.S.Y., C.J.T., and J.T. wrote the manuscript.	Beech DJ, 2004, J PHYSIOL-LONDON, V559, P685, DOI 10.1113/jphysiol.2004.068734; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; FUHLBRIGGE RC, 1988, J IMMUNOL, V141, P2643; GILBERT RJ, 1995, AM J PHYSIOL-GASTR L, V268, pG487, DOI 10.1152/ajpgi.1995.268.3.G487; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Joosten LAB, 2010, APMIS, V118, P1000, DOI 10.1111/j.1600-0463.2010.02684.x; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; LEMOAL MA, 1988, J IMMUNOL METHODS, V107, P23, DOI 10.1016/0022-1759(88)90004-X; Levine S, 2001, J APPL TOXICOL, V21, P303, DOI 10.1002/jat.759; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; So A, 2010, ARTHRITIS RHEUM-US, V62, P3064, DOI 10.1002/art.27600; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; WEWERS MD, 1993, J IMMUNOL METHODS, V165, P269, DOI 10.1016/0022-1759(93)90353-9; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107	43	100	101	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					388	400		10.1016/j.immuni.2012.01.018	http://dx.doi.org/10.1016/j.immuni.2012.01.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST		Bronze			2022-12-18	WOS:000302048400011
J	Nurieva, RI; Zheng, SL; Jin, W; Chung, Y; Zhang, YL; Martinez, GJ; Reynolds, JM; Wang, SL; Lin, X; Sun, SC; Lozano, G; Dong, C				Nurieva, Roza I.; Zheng, Shuling; Jin, Wei; Chung, Yeonseok; Zhang, Yongliang; Martinez, Gustavo J.; Reynolds, Joseph M.; Wang, Sung-Ling; Lin, Xin; Sun, Shao-Cong; Lozano, Guillermina; Dong, Chen			The E3 Ubiquitin Ligase GRAIL Regulates T Cell Tolerance and Regulatory T Cell Function by Mediating T Cell Receptor-CD3 Degradation	IMMUNITY			English	Article							CUTTING EDGE; TGF-BETA; TRANSCRIPTION; LYMPHOCYTES; ACTIVATION; EXPRESSION; ANERGY; MICE; INDUCTION; PROMOTER	T cell activation is tightly regulated to avoid autoimmunity. Gene related to anergy in lymphocytes (GRAIL, encoded by Rnf128) is an E3 ubiquitin ligase associated with T cell tolerance. Here, we generated and analyzed GRAIL-deficient mice and found they were resistant to immune tolerance induction and exhibited greater susceptibility to autoimmune diseases than wild-type mice. GRAIL-deficient naive T cells, after activation, exhibited increased proliferation and cytokine expression than controls and did not depend on costimulation for effector generation. Moreover, GRAIL-deficient regulatory T (Treg) cells displayed reduced suppressive function, associated with increased Th17 cell-related gene expression. GRAIL-deficient naive and Treg cells were less efficient in downregulating T cell receptor (TCR)-CD3 expression after activation and exhibited increased NFATc1 transcription factor expression; GRAIL expression promoted CD3 ubiquitinylation. Our results indicate that GRAIL, by mediating TCR-CD3 degradation, regulates naive T cell tolerance induction and Treg cell function.	[Nurieva, Roza I.; Jin, Wei; Chung, Yeonseok; Zhang, Yongliang; Martinez, Gustavo J.; Reynolds, Joseph M.; Sun, Shao-Cong; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Zheng, Shuling; Wang, Sung-Ling; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wang, Sung-Ling] Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Defense Medical Center	Nurieva, RI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Reynolds, Joseph/0000-0003-3490-0544; Martinez, Gustavo/0000-0003-0178-3329; Chung, Yeonseok/0000-0001-5780-4841	NIH; Leukemia and Lymphoma Society; American Heart Association; National Cancer Institute; Korea Science and Engineering Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050746, R01AI050761, R01AI054912, R01AI083761] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M.D. Anderson Cancer Center Genetic Engineered Mouse Facility for their assistance in generation of GRAIL-deficient mice, Dr. Gagea-Iurascu for help in pathology analysis, and the Dong lab members for their help. The work is supported by research grants from NIH (to G.L., C.D., and R.I.N.) and Leukemia and Lymphoma Society (to C.D.). R.I.N. was a recipient of a Scientist Development Grant from the American Heart Association, J.M.R. is a recipient of a T32 training grant from the National Cancer Institute, G.J.M. was a Schissler Foundation Fellow in cancer research, Y.C. is a recipient of postdoctoral fellowship program from the Korea Science and Engineering Foundation, and C.D. is a Leukemia and Lymphoma Society Scholar and a Trust Fellow of the M.D. Anderson Cancer Center.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HEISSMEYER V, 2004, SCI STKE, pPE29; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; Rangatia J, 2003, ONCOGENE, V22, P4760, DOI 10.1038/sj.onc.1206664; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Voice J, 2004, J IMMUNOL, V172, P7289, DOI 10.4049/jimmunol.172.12.7289; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Xia DY, 2001, TRANSPLANTATION, V72, P907, DOI 10.1097/00007890-200109150-00028; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	26	100	104	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					670	680		10.1016/j.immuni.2010.05.002	http://dx.doi.org/10.1016/j.immuni.2010.05.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20493730	Green Accepted, Bronze			2022-12-18	WOS:000278280500012
J	Kanaseki, T; Blanchard, N; Hammer, GE; Gonzalez, F; Shastri, N				Kanaseki, Takayuki; Blanchard, Nicolas; Hammer, Gianna Elena; Gonzalez, Federico; Shastri, Nilabh			ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum	IMMUNITY			English	Article							NATURALLY PROCESSED PEPTIDES; ER AMINOPEPTIDASE; TRIMS PRECURSORS; COMPLEX; GENERATION; ERAP1; DEGRADATION; PROTEASOME; SEQUENCE; PATHWAY	The major histocompatibility complex class 1 molecules display peptides (pMHC 1) on the cell surface for immune surveillance by CD8(+) T cells. These peptides are generated by proteolysis of intracellular polypeptides by the proteasome in the cytoplasm and then in the endoplasmic reticulum (ER) by the ER aminopeptidase associated with antigen processing (ERAAP). To define the unknown mechanism of ERAAP function in vivo, we analyzed naturally processed peptides in cells with or without appropriate MHC 1 and ERAAP. In the absence of MHC 1, ERAAP degraded the antigenic precursors in the ER. However, MHC 1 molecules could bind proteolytic intermediates and were essential for generation of the final peptide by ERAAP. Thus, ERAAP synergizes with MHC 1 to generate the final pMHC 1 repertoire.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@berkeley.edu	Blanchard, Nicolas/I-5255-2014; Blanchard, Nicolas/AAD-6601-2020	Blanchard, Nicolas/0000-0002-4924-2161; Blanchard, Nicolas/0000-0002-4924-2161; Hammer, Gianna/0000-0001-6959-858X; Kanaseki, Takayuki/0000-0001-7294-6880	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039548, R37AI060040, R01AI060040] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI060040, R01 AI060040-04, R01 AI060040, R01 AI039548, R01 AI060040-05, R01 AI039548-11, R01 AI039548-12] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; ELLIOTT T, 1990, NATURE, V348, P195, DOI 10.1038/348195a0; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Kageyama S, 2001, J IMMUNOL, V166, P3028, DOI 10.4049/jimmunol.166.5.3028; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KLEIN J, 1986, IMMUNOL TODAY, V7, P41, DOI 10.1016/0167-5699(86)90123-4; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 1998, CURR OPIN IMMUNOL, V10, P137, DOI 10.1016/S0952-7915(98)80241-0; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	34	100	103	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					795	806		10.1016/j.immuni.2006.09.012	http://dx.doi.org/10.1016/j.immuni.2006.09.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17088086	Green Accepted, Bronze			2022-12-18	WOS:000242063100012
J	Gleimer, M; Parham, P				Gleimer, M; Parham, P			Stress management: MHC class I and class I-like molecules as reporters of cellular stress	IMMUNITY			English	Review							DELTA T-CELLS; INDUCIBLE CDNA-CLONES; NKG2D RECEPTOR; CUTTING EDGE; IMMUNORECEPTOR NKG2D; MIC LIGANDS; F9 CELLS; NK CELLS; HLA-E; GAMMA	The evolutionarily ancient intracellular stress response protects cells from the effects of external and internal forces which perturb cellular metabolism. Members of the major histocompatibility complex (MHC) class I-like superfamily act as cell surface indicators of the intracellular stress response. Cellular immunity employs these indicators as a cue for elimination of damaged, infected, and malignant cells, promoting the health of the individual and the evolutionary success of the species.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	peropa@stanford.edu						ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beck S, 1999, IMMUNOL REV, V167, P201, DOI 10.1111/j.1600-065X.1999.tb01393.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cannon W.B., 1939, WISDOM BODY, DOI [10.1097/00000441-193907000-00031, DOI 10.1097/00000441-193907000-00031]; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cardoso CS, 2003, TISSUE ANTIGENS, V61, P263, DOI 10.1034/j.1399-0039.2003.00065.x; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2003, TISSUE ANTIGENS, V61, P335, DOI 10.1034/j.1399-0039.2003.00070.x; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Davies A, 2003, J IMMUNOL, V170, P5027, DOI 10.4049/jimmunol.170.10.5027; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doyle CK, 2003, J IMMUNOL, V171, P836, DOI 10.4049/jimmunol.171.2.836; Dutronc Y, 2002, TISSUE ANTIGENS, V60, P337, DOI 10.1034/j.1399-0039.2002.600501.x; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Herberts CA, 2003, HUM IMMUNOL, V64, P44, DOI 10.1016/S0198-8859(02)00707-3; Hickman HD, 2003, J IMMUNOL, V171, P22, DOI 10.4049/jimmunol.171.1.22; IMANI F, 1991, P NATL ACAD SCI USA, V88, P10475, DOI 10.1073/pnas.88.23.10475; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; Komatsu-Wakui M, 1999, IMMUNOGENETICS, V49, P620, DOI 10.1007/s002510050658; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Li ZH, 2000, IMMUNOGENETICS, V51, P246, DOI 10.1007/s002510050039; Malarkannan S, 1998, J IMMUNOL, V161, P3501; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; NOVER L., 1991, HEAT SHOCK RESPONSE; O'Callaghan CA, 1998, IMMUNOL REV, V163, P129, DOI 10.1111/j.1600-065X.1998.tb01192.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Sachs, 1864, FLORA, V47, P5; Sachs J, 1864, FLORA, V47, P33; SACHS J, 1864, FLORA, V47, P64; Sachs J, 1864, FLORA, V47, P24; Salaman MR, 2003, AUTOIMMUNITY, V36, P57, DOI 10.1080/0891693031000068637; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Veronese FD, 1996, J EXP MED, V183, P2509, DOI 10.1084/jem.183.6.2509; VIRET C, 1999, REV IMMUNOGENET, V1, P32; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Wilkinson KD, 1999, J NUTR, V129, P1933, DOI 10.1093/jn/129.11.1933; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; WU J, 1999, SCIENCE, V285, P645; Yim D, 2001, IMMUNOGENETICS, V53, P243, DOI 10.1007/s002510100321; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	80	100	107	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					469	477		10.1016/S1074-7613(03)00272-3	http://dx.doi.org/10.1016/S1074-7613(03)00272-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563312	Bronze			2022-12-18	WOS:000186051900004
J	Solymar, DC; Agarwal, S; Bassing, CH; Alt, FW; Rao, A				Solymar, DC; Agarwal, S; Bassing, CH; Alt, FW; Rao, A			A 3 ' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR NFAT1; HUMAN T-CELLS; COORDINATE REGULATOR; TRANSGENIC MICE; C-MAF; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-4; SEQUENCE; BINDING	Differentiation of naive T cells into mature Th2 cells is associated with the appearance of a complex pattern of DNase I hypersensitive (DH) sites within the IL-4/IL-13 cytokine gene cluster. We show here that targeted deletion of an inducible DH site, V-A, and the adjacent conserved DH site V (CNS-2) selectively compromises IL-4 gene transcription by differentiated Th2 cells and mast cells. In mast cells, the deletion abrogates IL-4 mRNA induction, an effect mimicked by deletion of the transcription factor NFAT1 (NFATc2), which binds DH site VA. In T cells, the deletion impairs a process of response maturation, defined by progressive increases in IL-4 levels as Th2 differentiation proceeds. These results identify an essential enhancer which regulates IL-4 gene expression in two important cell lineages in vivo.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.				NCI NIH HHS [CA42471] Funding Source: Medline; NIAID NIH HHS [AI35714, AI44432, AI20047] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R01AI044432, P01AI035714, R37AI020047] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Galli S J, 1994, Curr Opin Hematol, V1, P33; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; Glimcher LH, 2000, GENE DEV, V14, P1693; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; HENKEL G, 1992, J IMMUNOL, V149, P3239; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; HO AM, 1994, J BIOL CHEM, V269, P28181; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Sherman MA, 1999, J IMMUNOL, V163, P1733; Sherman MA, 1999, EUR J IMMUNOL, V29, P1235, DOI 10.1002/(SICI)1521-4141(199904)29:04<1235::AID-IMMU1235>3.3.CO;2-S; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Wardlaw AJ, 1995, ADV IMMUNOL, V60, P151, DOI 10.1016/S0065-2776(08)60586-6; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZON LI, 1991, J BIOL CHEM, V266, P22948; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; [No title captured]	53	100	101	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					41	50		10.1016/S1074-7613(02)00334-5	http://dx.doi.org/10.1016/S1074-7613(02)00334-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150890	Bronze			2022-12-18	WOS:000177187500005
J	Hayes, SM; Love, PE				Hayes, SM; Love, PE			Distinct structure and signaling potential of the gamma delta TCR complex	IMMUNITY			English	Article							T-CELL-RECEPTOR; EPSILON-RI-GAMMA; ALPHA-BETA; ANTIGEN RECEPTOR; POSITIVE SELECTION; MICE LACKING; ZETA-CHAIN; SURFACE EXPRESSION; LYMPHOCYTES-T; FC-RECEPTORS	alphabeta and gammadelta T cells are distinguished by the clonotypic subunits contained within their TCRs. Although the alphabetaTCR has been well characterized, much less is known about the gammadeltaTCR. Here, we report that, unlike alphabetaTCRs, most gammadeltaTCRs expressed on ex vivo gammadelta T cells lack CD38. Despite this structural difference, signal transduction by the gammadeltaTCR is superior to that of the alphabetaTCR, as measured by its ability to induce calcium mobilization, ERK activation, and cellular proliferation. Additionally, the TCR complexes expressed on primary gammadelta T cells contain only homodimers; however, following activation and expansion, Fcis an element ofR1 7 is expressed and is included in the gammadeltaTCR complex. These results reveal fundamental differences in the primary structure and signaling potential of the alphabeta- and gammadeltaTCR complexes.	NICHHD, Lab Mammalian Genet & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Love, PE (corresponding author), NICHHD, Lab Mammalian Genet & Dev, NIH, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; CRON RQ, 1988, J IMMUNOL, V141, P1074; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FERRICK DA, 1995, NATURE, V411, P820; Flamand V, 1996, J EXP MED, V184, P1725, DOI 10.1084/jem.184.5.1725; GROETTRUP M, 1993, CELL, V75, P282; GROSS JA, 1992, J IMMUNOL, V149, P380; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Heiken H, 1996, EUR J IMMUNOL, V26, P1935, DOI 10.1002/eji.1830260839; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Khattri R, 1996, J IMMUNOL, V157, P2320; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KORMAN AJ, 1988, J EXP MED, V168, P1021, DOI 10.1084/jem.168.3.1021; KOYASU S, 1994, J EXP MED, V179, P1957, DOI 10.1084/jem.179.6.1957; KRANGEL MS, 1987, P NATL ACAD SCI USA, V84, P3817, DOI 10.1073/pnas.84.11.3817; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; Liu CP, 1997, P NATL ACAD SCI USA, V94, P616, DOI 10.1073/pnas.94.2.616; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Nadler M J, 2000, Adv Immunol, V76, P325; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; PARDOLL DM, 1988, J IMMUNOL, V140, P4091; PARK SY, 1995, EUR J IMMUNOL, V25, P2107, DOI 10.1002/eji.1830250746; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; QIAN DP, 1993, P NATL ACAD SCI USA, V90, P11875, DOI 10.1073/pnas.90.24.11875; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; SAITO T, 1988, J EXP MED, V168, P1003, DOI 10.1084/jem.168.3.1003; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shores E, 1997, J IMMUNOL, V159, P222; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; SIM GK, 1995, J IMMUNOL, V154, P5821; Sommers CL, 1999, J EXP MED, V190, P1427, DOI 10.1084/jem.190.10.1427; VANNEERVEN J, 1990, EUR J IMMUNOL, V20, P2105, DOI 10.1002/eji.1830200932; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094	49	100	104	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					827	838		10.1016/S1074-7613(02)00320-5	http://dx.doi.org/10.1016/S1074-7613(02)00320-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121664	Bronze			2022-12-18	WOS:000176534000008
J	Jeannin, P; Magistrelli, G; Aubry, JP; Caron, G; Gauchat, JF; Renno, T; Herbault, N; Goetsch, L; Blaecke, A; Dietrich, PY; Bonnefoy, JY; Delneste, Y				Jeannin, P; Magistrelli, G; Aubry, JP; Caron, G; Gauchat, JF; Renno, T; Herbault, N; Goetsch, L; Blaecke, A; Dietrich, PY; Bonnefoy, JY; Delneste, Y			Soluble CD86 is a costimulatory molecule for human T lymphocytes	IMMUNITY			English	Article							ALTERNATIVELY SPLICED FORM; CELL ACTIVATION; CO-STIMULATION; B7-2 CD86; DIFFERENTIAL EXPRESSION; LANGERHANS CELLS; DENDRITIC CELLS; ANTIGEN; CD28; CTLA-4	CD86 is an important costimulatory molecule for the priming and activation of naive and memory T cells, respectively. Here, we show that soluble CD86 is detected in human serum. Soluble CD86 is produced by resting monocytes and results from an alternatively spliced transcript (CD86 Delta TM) characterized by deletion of the transmembrane domain. Recombinant CD86 Delta TM binds to CD28 and CTLA-4 and induces the activation of T cells after stimulation with anti-CDS mAb. CD86 Delta TM also induces IFN gamma production by virus-specific CD8(+) memory human T cells stimulated with the Flu M1 peptide. The concentrations of soluble CD86 found in human serum are sufficient to induce biological activity. Soluble CD86 molecule, therefore, appears to be a functional costimulatory molecule playing a potentially important role in immune surveillance.	Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France; Hop Cantonal Univ Geneva, Lab Immunol Tumeurs, CH-1124 Geneva, Switzerland	Centre d'Immunologie Pierre Fabre; University of Geneva	Bonnefoy, JY (corresponding author), Ctr Immunol Pierre Fabre, 5 Ave Napoleon III, F-74164 St Julien En Genevois, France.	jean.yves.bonnefoy@pierre-fabre.com	DELNESTE, Yves/K-7367-2015; Renno, Toufic/F-5564-2013; Delneste, Yves/O-3956-2016; JEANNIN, Pascale/K-8656-2015	DELNESTE, Yves/0000-0002-2142-596X; JEANNIN, Pascale/0000-0002-3666-3856				AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BAJORATH J, 1994, PROTEIN SCI, V3, P2148, DOI 10.1002/pro.5560031128; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; BORRIELLO F, 1995, J IMMUNOL, V155, P5490; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; CROFT M, 1994, CURR OPIN IMMUNOL, V6, P431, DOI 10.1016/0952-7915(94)90123-6; CROFTON J, 1992, AMORPHOUS CRYSTALLIN, V4, P176; Davis TA, 1996, INT IMMUNOL, V8, P1099, DOI 10.1093/intimm/8.7.1099; Dong HD, 1999, NAT MED, V5, P1365; ENGEL P, 1994, BLOOD, V84, P1402, DOI 10.1182/blood.V84.5.1402.bloodjournal8451402; Fleischer J, 1996, IMMUNOLOGY, V89, P592, DOI 10.1046/j.1365-2567.1996.d01-785.x; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; GUO Y, 1995, J EXP MED, V181, P1345, DOI 10.1084/jem.181.4.1345; Hakamada-Taguchi R, 1998, EUR J IMMUNOL, V28, P865, DOI 10.1002/(SICI)1521-4141(199803)28:03<865::AID-IMMU865>3.0.CO;2-T; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; INOBE M, 1994, BIOCHEM BIOPH RES CO, V200, P443, DOI 10.1006/bbrc.1994.1469; Inobe M, 1996, J IMMUNOL, V157, P582; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; Jeannin P, 1999, J IMMUNOL, V162, P2044; JELLIS CL, 1995, IMMUNOGENETICS, V42, P85; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; Klasen S, 1998, INT IMMUNOL, V10, P481, DOI 10.1093/intimm/10.4.481; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LIU Y, 1992, P NATL ACAD SCI USA, V89, P3845, DOI 10.1073/pnas.89.9.3845; Manickasingham SP, 1998, J IMMUNOL, V161, P3827; Matulonis U, 1996, J IMMUNOL, V156, P1126; MCLELLAN AD, 1995, EUR J IMMUNOL, V25, P2064, DOI 10.1002/eji.1830250739; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Rennert P, 1997, INT IMMUNOL, V9, P805, DOI 10.1093/intimm/9.6.805; Saito T, 1998, CURR OPIN IMMUNOL, V10, P313, DOI 10.1016/S0952-7915(98)80170-2; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; SYMINGTON FW, 1993, J IMMUNOL, V150, P1286; VAN DE VELDE H, 1993, INT IMMUNOL, V5, P1483; VYTHDREESE FA, 1995, EUR J IMMUNOL, V25, P3023, DOI 10.1002/eji.1830251106; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; YOKOCHI T, 1982, J IMMUNOL, V128, P823; Yokozeki H, 1996, J INVEST DERMATOL, V106, P147, DOI 10.1111/1523-1747.ep12329735; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang YQ, 1996, INT IMMUNOL, V8, P37, DOI 10.1093/intimm/8.1.37; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	56	100	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2000	13	3					303	312		10.1016/S1074-7613(00)00030-3	http://dx.doi.org/10.1016/S1074-7613(00)00030-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021528	Bronze			2022-12-18	WOS:000089616400003
J	Chvatchko, Y; Valera, S; Aubry, JP; Renno, T; Buell, G; Bonnefoy, JY				Chvatchko, Y; Valera, S; Aubry, JP; Renno, T; Buell, G; Bonnefoy, JY			The involvement of an ATP-gated ion channel, P-2X1, in thymocyte apoptosis	IMMUNITY			English	Article							PROGRAMMED CELL-DEATH; STAPHYLOCOCCAL ENTEROTOXIN-B; T-CELLS; IMMATURE THYMOCYTES; EXTRACELLULAR ATP; INVIVO INDUCTION; MOUSE THYMOCYTES; SENSORY NEURONS; TRANSGENIC MICE; RECEPTOR	In the immune system, apoptosis is involved in intrathymic elimination of self-reactive thymocytes and in peripheral T cell tolerance to exogenous antigens. Here, we describe the role in T cell apoptosis of P-2x1, a nonselective cation channel activated by ATP. P-2x1 molecules are up-regulated in thymocytes during dexamethasone-induced apoptosis, and antagonists to these receptors protect thymocytes from cell death. Moreover, P-2x1 mRNA and protein levels increase in thymocytes induced to die in vivo by the superantigen staphylococcal enterotoxin B. In contrast, T cells undergoing apoptosis in the periphery do not express P-2x1. The demonstration that P-2x1 ion channels play a role in the apoptosis of thymocytes but not peripheral T cells illustrates a novel mechanism contributing to thymocyte cell death and opens new possibilities for investigating clonal deletion in the thymus.	GENEVA BIOMED RES INST,DEPT MOL BIOL,CH-1228 GENEVA,SWITZERLAND; LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND	GlaxoSmithKline; University of Geneva; Ludwig Institute for Cancer Research	Chvatchko, Y (corresponding author), GENEVA BIOMED RES INST,DEPT IMMUNOL,14 CHEMIN AULX,CH-1228 GENEVA,SWITZERLAND.		Renno, Toufic/F-5564-2013					ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; ACHAORBEA H, 1985, EUR J IMMUNOL, V15, P31, DOI 10.1002/eji.1830150107; BEAN BP, 1992, TRENDS PHARMACOL SCI, V13, P87, DOI 10.1016/0165-6147(92)90032-2; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; BLASEY HD, 1995, CYTOTECHNOLOGY, V14, P1; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Buell G, 1996, BLOOD, V87, P2659, DOI 10.1182/blood.V87.7.2659.bloodjournal8772659; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P1; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; CHUSED TM, 1996, IN PRESS J IMMUNOL; COHEN JJ, 1984, J IMMUNOL, V132, P38; Collo G, 1996, J NEUROSCI, V16, P2495; CUSACK NJ, 1993, DRUG DEVELOP RES, V28, P244, DOI 10.1002/ddr.430280310; DENNERT G, 1980, CELL IMMUNOL, V53, P350, DOI 10.1016/0008-8749(80)90335-4; ETTINGER R, 1995, J IMMUNOL, V154, P4302; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; GRUBER J, 1994, EUR J IMMUNOL, V24, P1115, DOI 10.1002/eji.1830240516; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; Hoyle CH, 1991, ADENOSINE NERVOUS SY, P43; HUMPHREY PPA, 1995, ARCH PHAARM, V351, P1; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KASAKOV L, 1983, European Journal of Pharmacology, V86, P291; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; LEFF P, 1990, BRIT J PHARMACOL, V101, P645, DOI 10.1111/j.1476-5381.1990.tb14134.x; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; LIN YS, 1992, J IMMUNOL, V149, P1156; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MATKO J, 1993, BIOCHEM BIOPH RES CO, V191, P378, DOI 10.1006/bbrc.1993.1228; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; MCCONKEY DJ, 1989, FASEB J, V3, P1843, DOI 10.1096/fasebj.3.7.2497041; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; NICOTERA P, 1989, DRUG METAB REV, V20, P193, DOI 10.3109/03602538909103536; OWENS GP, 1991, MOL CELL BIOL, V11, P4177, DOI 10.1128/MCB.11.8.4177; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PIZZO P, 1991, BIOCHEM J, V274, P139, DOI 10.1042/bj2740139; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; SCHERMERHORN T, 1994, AM J VET RES, V55, P1602; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; Valera S, 1995, RECEPTOR CHANNEL, V3, P283; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; VULCHANOV AL, 1996, P NATL ACAD SCI USA, V93, P8063; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279; ZHIVOTOVSKY B, 1994, BIOCHEM BIOPH RES CO, V202, P120, DOI 10.1006/bbrc.1994.1901	51	100	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1996	5	3					275	283		10.1016/S1074-7613(00)80322-2	http://dx.doi.org/10.1016/S1074-7613(00)80322-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808682	Bronze			2022-12-18	WOS:A1996VJ79700009
J	Klinman, NR				Klinman, NR			The ''clonal selection hypothesis'' and current concepts of B cell tolerance	IMMUNITY			English	Review							REACTIVE LYMPHOCYTES-B; BALB-C MICE; IMMUNE-RESPONSE; GERMINAL-CENTER; IMMUNOLOGICAL-TOLERANCE; TRANSGENIC MICE; SPLEEN-CELLS; RECEPTOR ANTAGONISTS; ANTIBODY REPERTOIRE; DEPENDENT ANTIGEN				Klinman, NR (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.							Ada G L, 1970, Transplant Rev, V5, P105; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BOREL Y, 1974, P SOC EXP BIOL MED, V145, P470; Bregenholt S, 1996, J IMMUNOL, V157, P993; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; CAMBIER JC, 1976, J EXP MED, V144, P293, DOI 10.1084/jem.144.1.293; CANCRO MP, 1979, P NATL ACAD SCI USA, V76, P6577, DOI 10.1073/pnas.76.12.6577; CARLSSON L, 1992, EUR J IMMUNOL, V22, P71, DOI 10.1002/eji.1830220112; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CARSETTI R, 1993, EUR J IMMUNOL, V23, P168, DOI 10.1002/eji.1830230127; CHEN C, 1994, J IMMUNOL, V152, P1970; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; COICO RF, 1983, J IMMUNOL, V131, P2254; COOPER HM, 1989, EUR J IMMUNOL, V19, P315, DOI 10.1002/eji.1830190215; Coutinho A, 1992, Int Rev Immunol, V8, P173, DOI 10.3109/08830189209055572; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DECKER DJ, 1995, IMMUNITY, V2, P195, DOI 10.1016/S1074-7613(95)80092-1; DECKER DJ, 1995, J IMMUNOL, V154, P4924; DEFRANCO AL, 1982, B T CELL TUMORS BIOL, P445; DENIS KA, 1983, J EXP MED, V157, P1170, DOI 10.1084/jem.157.4.1170; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; ETLINGER HM, 1979, J IMMUNOL, V122, P2558; GERMAIN RN, 1995, IMMUNOLOGIST, V3, P113; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HAMILTON JA, 1974, EUR J IMMUNOL, V4, P268, DOI 10.1002/eji.1830040408; HARRIS DE, 1982, J EXP MED, V156, P567, DOI 10.1084/jem.156.2.567; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAVAS HF, 1969, IMMUNOLOGY, V17, P819; HOWARD JG, 1975, PROG ALLERGY, V18, P43; HUETZ F, 1993, EMBO J, V12, P1819, DOI 10.1002/j.1460-2075.1993.tb05830.x; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KATZ DH, 1971, J EXP MED, V134, P201, DOI 10.1084/jem.134.1.201; KENNY JJ, 1989, J IMMUNOL, V142, P4466; KLINMAN NR, 1976, ANN INST PASTEUR IMM, VC127, P489; KLINMAN NR, 1973, J EXP MED, V138, P1276, DOI 10.1084/jem.138.5.1276; Klinman NR, 1996, IMMUNOL REV, V150, P91, DOI 10.1111/j.1600-065X.1996.tb00697.x; KLINMAN NR, 1972, J EXP MED, V136, P241, DOI 10.1084/jem.136.2.241; KLINMAN NR, 1981, J IMMUNOL, V126, P1970; KLINMAN NR, 1975, J EXP MED, V141, P1133, DOI 10.1084/jem.141.5.1133; LANDRETH KS, 1983, J IMMUNOL, V131, P572; LAWRENCE DA, 1973, J EXP MED, V137, P470, DOI 10.1084/jem.137.2.470; LAWTON AR, 1972, J EXP MED, V135, P277, DOI 10.1084/jem.135.2.277; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; LINTON PJ, 1991, J IMMUNOL, V146, P4099; MALIPIERO UV, 1987, IMMUNOL REV, V96, P59, DOI 10.1111/j.1600-065X.1987.tb00509.x; MANSER T, 1987, IMMUNOL REV, V96, P141, DOI 10.1111/j.1600-065X.1987.tb00513.x; METCALF ES, 1977, J EXP MED, V145, P1382, DOI 10.1084/jem.145.5.1382; METCALF ES, 1977, J IMMUNOL, V118, P2111; METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327; METCALF ES, 1978, IMMUNOL REV, V43, P143; MOLLER G, 1976, J EXP MED, V143, P1429, DOI 10.1084/jem.143.6.1429; Monroe JG, 1996, J IMMUNOL, V156, P2657; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NIEUWENHUIS P, 1992, IMMUNOL REV, V126, P77, DOI 10.1111/j.1600-065X.1992.tb00632.x; NORVELL A, 1995, J IMMUNOL, V154, P4404; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; OLTZ EM, 1992, EMBO J, V11, P2759, DOI 10.1002/j.1460-2075.1992.tb05341.x; PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013; PRESS JL, 1974, EUR J IMMUNOL, V4, P155, DOI 10.1002/eji.1830040302; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RADIC MZ, 1989, COLD SPRING HARB SYM, V54, P933; RILEY RL, 1986, J IMMUNOL, V136, P3147; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SCOTT DW, 1993, ADV IMMUNOL, V54, P393, DOI 10.1016/S0065-2776(08)60539-8; SCOTT DW, 1978, IMMUNOL REV, V43, P241; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SIGAL NH, 1976, NATURE, V259, P51, DOI 10.1038/259051a0; STOCKER JW, 1977, IMMUNOLOGY, V32, P283; STOCKINGER B, 1988, EUR J IMMUNOL, V18, P249, DOI 10.1002/eji.1830180211; SZEWCZUK MR, 1977, J EXP MED, V145, P1590, DOI 10.1084/jem.145.6.1590; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; Taylor R B, 1969, Transplant Rev, V1, P114; TEALE JM, 1979, J EXP MED, V150, P205, DOI 10.1084/jem.150.2.205; TEALE JM, 1984, J IMMUNOL, V133, P1811; TEALE JM, 1980, NATURE, V288, P385, DOI 10.1038/288385a0; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; WECHSLER RJ, 1995, J IMMUNOL, V154, P1919; Weigle W O, 1980, Adv Immunol, V30, P159; WEIGLE WO, 1974, PROGR IMMUNOLOGY, V3, P187; YELLEN AJ, 1991, J IMMUNOL, V146, P1446; ZHARHARY D, 1984, ANN INST PASTEUR IMM, VD135, P199, DOI 10.1016/S0769-2625(84)81113-7	97	100	100	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1996	5	3					189	195		10.1016/S1074-7613(00)80314-3	http://dx.doi.org/10.1016/S1074-7613(00)80314-3			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808674	Bronze			2022-12-18	WOS:A1996VJ79700001
J	CORCORAN, LM; KARVELAS, M				CORCORAN, LM; KARVELAS, M			OCT-2 IS REQUIRED EARLY IN T-CELL-INDEPENDENT B-CELL ACTIVATION FOR G1 PROGRESSION AND FOR PROLIFERATION	IMMUNITY			English	Article							REMOTE ENHANCER POSITION; OCTAMER DNA MOTIF; TRANSCRIPTION FACTOR; PROTEIN-BINDING; LYMPHOCYTES-B; IMMUNOGLOBULIN PROMOTERS; SURFACE-IMMUNOGLOBULIN; TRANSGENIC MICE; GENE; EXPRESSION	Oct-2, a POU homeodomain protein expressed primarily in B cells, is a powerful transcriptional activator that binds to DNA at sites appropriately placed for major effects on immunoglobulin gene expression. Our examination of B cell development and function in Oct-2 null mice did not support an essential role for Oct-2 early in B cell development. Rather, Oct-2 was required later, when B cells were induced to differentiate to antibody-secreting cells. We show here that Oct-2 is not required for normal immunoglobulin production by mature B lymphocytes. Instead, it is essential for a normal proliferative response to polyclonal mitogens. Responses to signals from activated T cells are unaffected. The requirement for Oct-2 maps to an early activation step in G1, during which B cells make the commitment to progress through the cell cycle and to divide.			CORCORAN, LM (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,POST OFF,MELBOURNE,VIC 3050,AUSTRALIA.		Corcoran, Lynn M/C-9316-2013					ANDERSSON J, 1977, CELL, V10, P27, DOI 10.1016/0092-8674(77)90136-2; ANNWEILER A, 1993, J BIOL CHEM, V268, P2525; ANNWEILER A, 1992, NUCLEIC ACIDS RES, V20, P1503, DOI 10.1093/nar/20.7.1503; ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; ARNOSTI DN, 1993, EMBO J, V12, P157, DOI 10.1002/j.1460-2075.1993.tb05641.x; BERGMAN Y, 1990, EMBO J, V9, P849, DOI 10.1002/j.1460-2075.1990.tb08182.x; BHARGAVA AK, 1993, P NATL ACAD SCI USA, V90, P10260, DOI 10.1073/pnas.90.21.10260; BIJSTERBOSCH MK, 1986, BIOCHEM BIOPH RES CO, V137, P500, DOI 10.1016/0006-291X(86)91238-6; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTENSEN SM, 1992, J IMMUNOL, V148, P3610; COCKERILL PN, 1990, MOL CELL BIOL, V10, P1293, DOI 10.1128/MCB.10.3.1293; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; COOPER MD, 1986, NATURE, V321, P616, DOI 10.1038/321616a0; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; CZERKINSKY C, 1988, J IMMUNOL METHODS, V115, P31, DOI 10.1016/0022-1759(88)90306-7; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DEFRANCO AL, 1985, J IMMUNOL, V135, P87; ERIS JM, 1994, P NATL ACAD SCI USA, V91, P4392, DOI 10.1073/pnas.91.10.4392; FELDHAUS AL, 1993, EMBO J, V12, P2763, DOI 10.1002/j.1460-2075.1993.tb05937.x; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HERMANSON GG, 1989, P NATL ACAD SCI USA, V86, P7341, DOI 10.1073/pnas.86.19.7341; HODGKIN PD, 1991, J IMMUNOL, V147, P3696; HODGKIN PD, 1990, J IMMUNOL, V145, P2025; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; JOHNSON DG, 1990, MOL CELL BIOL, V10, P982, DOI 10.1128/MCB.10.3.982; JUNKER S, 1990, CELL, V61, P467, DOI 10.1016/0092-8674(90)90528-M; KANG SM, 1992, MOL CELL BIOL, V12, P3149, DOI 10.1128/MCB.12.7.3149; KARVELAS M, 1992, P NATL ACAD SCI USA, V89, P3150, DOI 10.1073/pnas.89.7.3150; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KLAUS GGB, 1985, IMMUNOLOGY, V55, P411; KOSSAKOWSKA AE, 1991, IMMUNOLOGY, V74, P37; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MCHEYZERWILLIAMS MG, 1989, EUR J IMMUNOL, V19, P2025, DOI 10.1002/eji.1830191109; MILLER CL, 1991, MOL CELL BIOL, V11, P4885, DOI 10.1128/MCB.11.10.4885; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; NOSSAL GJV, 1976, IMMUNOLOGY, V30, P189; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; PFISTERER P, 1994, EMBO J, V13, P1654, DOI 10.1002/j.1460-2075.1994.tb06429.x; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; PORTOLES P, 1989, J MOL CELL IMMUNOL, V4, P129; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P2081, DOI 10.1002/eji.1830191117; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; SCHULTZ CL, 1991, INT IMMUNOL, V3, P109, DOI 10.1093/intimm/3.2.109; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SULTZER BM, 1993, IMMUNOBIOLOGY, V187, P3; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; THEVENIN C, 1993, J BIOL CHEM, V268, P5949; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TONY HP, 1985, J EXP MED, V162, P1695, DOI 10.1084/jem.162.5.1695; VONBOEHMER H, 1973, J IMMUNOL METHODS, V2, P293, DOI 10.1016/0022-1759(73)90055-0; WETZEL GD, 1984, J IMMUNOL, V133, P2327; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; ZWILLING S, 1994, NUCLEIC ACIDS RES, V22, P1655, DOI 10.1093/nar/22.9.1655	63	100	101	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					635	645		10.1016/1074-7613(94)90035-3	http://dx.doi.org/10.1016/1074-7613(94)90035-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600291				2022-12-18	WOS:A1994PT93000002
J	Shan, L; Deng, K; Gao, HB; Xing, SF; Capoferri, AA; Durand, CM; Rabi, SA; Laird, GM; Kim, M; Hosmane, NN; Yang, HC; Zhang, H; Margolick, JB; Li, LH; Cai, WP; Ke, RA; Flavell, RA; Siliciano, JD; Siliciano, RF				Shan, Liang; Deng, Kai; Gao, Hongbo; Xing, Sifei; Capoferri, Adam A.; Durand, Christine M.; Rabi, S. Alireza; Laird, Gregory M.; Kim, Michelle; Hosmane, Nina N.; Yang, Hung-Chih; Zhang, Hao; Margolick, Joseph B.; Li, Linghua; Cai, Weiping; Ke, Ruian; Flavell, Richard A.; Siliciano, Janet D.; Siliciano, Robert F.			Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4(+) T Cells Permissive for Latent HIV-1 Infection	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; NF-KAPPA-B; VIRAL RESERVOIR; IN-VIVO; LYMPHOCYTES; ACTIVATION; REPLICATION; EXPRESSION; PERSISTENCE	The latent reservoir for HIV-1 in resting memory CD4(+) T cells is the major barrier to curing HIV-1 infection. Studies of HIV-1 latency have focused on regulation of viral gene expression in cells in which latent infection is established. However, it remains unclear how infection initially becomes latent. Here we described a unique set of properties of CD4(+) T cells undergoing effector-to-memory transition including temporary upregulation of CCR5 expression and rapid downregulation of cellular gene transcription. These cells allowed completion of steps in the HIV-1 life cycle through integration but suppressed HIV-1 gene transcription, thus allowing the establishment of latency. CD4(+) T cells in this stage were substantially more permissive for HIV-1 latent infection than other CD4(+) T cells. Establishment of latent HIV-1 infection in CD4(+) T could be inhibited by viral-specific CD8(+) T cells, a result with implications for elimination of latent HIV-1 infection by T cell-based vaccines.	[Shan, Liang; Deng, Kai; Xing, Sifei; Capoferri, Adam A.; Durand, Christine M.; Rabi, S. Alireza; Laird, Gregory M.; Kim, Michelle; Hosmane, Nina N.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shan, Liang; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Deng, Kai; Gao, Hongbo] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Yang, Hung-Chih] Natl Taiwan Univ Hosp, Taipei 100, Taiwan; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Li, Linghua; Cai, Weiping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou 510060, Guangdong, Peoples R China; [Ke, Ruian] North Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Shan, Liang] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Shan, Liang] Washington Univ, Andrew M & Jane M Bursky Ctr, Human Immunol & Immunotherapy Programs, Sch Med, St Louis, MO 63110 USA	Johns Hopkins University; Yale University; Sun Yat Sen University; National Taiwan University; National Taiwan University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Guangzhou Medical University; University of North Carolina; North Carolina State University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL)	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Siliciano, RF (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	Shan, Liang/ABB-9210-2021; Capoferri, Adam/AAM-9484-2021; Gao, Hongbo/AHE-9262-2022; Deng, Kai/AAK-4404-2020	Deng, Kai/0000-0002-9973-8130; Capoferri, Adam/0000-0002-6048-2115; Durand, Christine M./0000-0003-2605-9257; YANG, HUNG-CHIH/0000-0003-3864-9895	NIH Martin Delaney I4C [UM1 AI126603]; Beat-HIV [UM1 AI126620]; DARE [UM1 AI12661]; NIH [43222, 1K99AI125065-01]; Mathilde Krim Fellowship, amfAR; National Natural Science Foundation of China [81672024]; Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06S638]; Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou [201508020256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126603, UM1AI126611, K99AI125065, UM1AI126620, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752, T32GM007309] Funding Source: NIH RePORTER	NIH Martin Delaney I4C(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beat-HIV; DARE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathilde Krim Fellowship, amfAR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all study participants for making this research possible. R.F.S. was supported by the NIH Martin Delaney I4C (UM1 AI126603), Beat-HIV (UM1 AI126620), and DARE (UM1 AI12661). Collaboratories by the Johns Hopkins Center for AIDS Research (P30AI094189), by NIH grant 43222, and by the Howard Hughes Medical Institute and the Bill and Melinda Gates Foundation (OPP1115715). L.S. is supported by NIH 1K99AI125065-01 and Mathilde Krim Fellowship, amfAR. K.D. is supported by National Natural Science Foundation of China (81672024), by Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S638), and by Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou (201508020256).	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Laird GM, 2016, METHODS MOL BIOL, V1354, P239, DOI 10.1007/978-1-4939-3046-3_16; Lapenta C, 1999, EUR J IMMUNOL, V29, P1202, DOI 10.1002/(SICI)1521-4141(199904)29:04<1202::AID-IMMU1202>3.0.CO;2-O; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Puertas MC, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0282-9; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rouzine IM, 2015, CELL, V160, P1002, DOI 10.1016/j.cell.2015.02.017; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Vatakis DN, 2009, J VIROL, V83, P6222, DOI 10.1128/JVI.00356-09; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	56	99	100	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					766	+		10.1016/j.immuni.2017.09.014	http://dx.doi.org/10.1016/j.immuni.2017.09.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045905	Bronze, Green Accepted			2022-12-18	WOS:000413091600019
J	Kloverpris, HN; Kazer, SW; Mjosberg, J; Mabuka, JM; Wellmann, A; Ndhlovu, Z; Yadon, MC; Nhamoyebonde, S; Muenchhoff, M; Simoni, Y; Andersson, F; Kuhn, W; Garrett, N; Burgers, WA; Kamya, P; Pretorius, K; Dong, K; Moodley, A; Newell, EW; Kasprowicz, V; Karim, SSA; Goulder, P; Shalek, AK; Walker, BD; Ndung'u, T; Leslie, A				Kloverpris, Henrik N.; Kazer, Samuel W.; Mjosberg, Jenny; Mabuka, Jenniffer M.; Wellmann, Amanda; Ndhlovu, Zaza; Yadon, Marisa C.; Nhamoyebonde, Shepherd; Muenchhoff, Maximilian; Simoni, Yannick; Andersson, Frank; Kuhn, Warren; Garrett, Nigel; Burgers, Wendy A.; Kamya, Philomena; Pretorius, Karyn; Dong, Krista; Moodley, Amber; Newell, Evan W.; Kasprowicz, Victoria; Karim, Salim S. Abdool; Goulder, Philip; Shalek, Alex K.; Walker, Bruce D.; Ndung'u, Thumbi; Leslie, Alasdair			Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression	IMMUNITY			English	Article							SIV INFECTION; GASTROINTESTINAL-TRACT; T-CELLS; INFLAMMATION; IMMUNITY; VIRUS; ACTIVATION; FIBROSIS; DISEASE; TISSUES	Innate lymphoid cells (ILCs) play a central role in the response to infection by secreting cytokines crucial for immune regulation, tissue homeostasis, and repair. Although dysregulation of these systems is central to pathology, the impact of HIV-1 on ILCs remains unknown. We found that human blood ILCs were severely depleted during acute viremic HIV-1 infection and that ILC numbers did not recover after resolution of peak viremia. ILC numbers were preserved by antiretroviral therapy (ART), but only if initiated during acute infection. Transcriptional profiling during the acute phase revealed upregulation of genes associated with cell death, temporally linked with a strong IFN acute-phase response and evidence of gut barrier breakdown. We found no evidence of tissue redistribution in chronic disease and remaining circulating ILCs were activated but not apoptotic. These data provide a potential mechanistic link between acute HIV-1 infection, lymphoid tissue breakdown, and persistent immune dysfunction.	[Kloverpris, Henrik N.; Mabuka, Jenniffer M.; Wellmann, Amanda; Yadon, Marisa C.; Nhamoyebonde, Shepherd; Kasprowicz, Victoria; Ndung'u, Thumbi; Leslie, Alasdair] Univ KwaZulu Natal UKZN, KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa; [Kloverpris, Henrik N.] Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Kazer, Samuel W.; Kamya, Philomena; Dong, Krista; Moodley, Amber; Shalek, Alex K.; Walker, Bruce D.; Ndung'u, Thumbi; Leslie, Alasdair] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Mjosberg, Jenny] Karolinska Inst, Ctr Infect Med, S-17176 Stockholm, Sweden; [Ndhlovu, Zaza; Muenchhoff, Maximilian; Kamya, Philomena; Pretorius, Karyn; Goulder, Philip; Walker, Bruce D.; Ndung'u, Thumbi] UKZN, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4001 Durban, South Africa; [Muenchhoff, Maximilian; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Simoni, Yannick; Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore 138632, Singapore; [Andersson, Frank] Inkosi Albert Luthuli Hosp, Dept Surg, ZA-4058 Durban, South Africa; [Kuhn, Warren] Stanger Hosp, ENT Dept, ZA-4450 Durban, South Africa; [Garrett, Nigel] UKZN, Dept Infect Dis, ZA-4001 Durban, South Africa; [Garrett, Nigel; Karim, Salim S. Abdool] CAPRISA, ZA-4001 Durban, South Africa; [Burgers, Wendy A.] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Burgers, Wendy A.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [Shalek, Alex K.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, D-10117 Berlin, Germany	University of Kwazulu Natal; University of Copenhagen; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of Kwazulu Natal; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Kwazulu Natal; University of Cape Town; University of Cape Town; Columbia University; Harvard University; Howard Hughes Medical Institute; Max Planck Society	Kloverpris, HN (corresponding author), Univ KwaZulu Natal UKZN, KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa.; Kloverpris, HN (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark.	henrik.kloverpris@k-rith.org	Ndhlovu, Zaza/W-2437-2019; Karim, Salim Abdool/AAE-7118-2019; Newell, Evan W/F-9711-2012; Shalek, Alex/Y-2434-2019; Karim, Salim Abdool/P-3117-2019	Ndhlovu, Zaza/0000-0002-2708-3315; Newell, Evan W/0000-0002-2889-243X; Shalek, Alex/0000-0001-5670-8778; Karim, Salim Abdool/0000-0002-4986-2133; leslie, alasdair/0000-0003-2538-6467; SIMONI, Yannick/0000-0002-9086-3680; Burgers, Wendy/0000-0003-3396-9398; Ndung'u, Thumbi/0000-0003-2962-3992; Kazer, Samuel/0000-0002-7380-9594; Muenchhoff, Maximilian/0000-0001-7016-0470; Kloverpris, Henrik/0000-0002-2165-3313; Mjosberg, Jenny/0000-0002-1119-0976	Danish Agency for Science, Technology and Innovation [12-132295]; Lundbeck Foundation [R151-2013-14624]; MAERSK Foundation; Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH [AI067073]; Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI) [UKZNRSA1001]; NIAID [R37AI067073]; International Early Career Scientist Award from the Howard Hughes Medical Institute; Victor Daitz Foundation; National Science Foundation Graduate Research Fellowship Program (NSF GRFP); Searle Scholars Program; South African Research Chairs Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067073] Funding Source: NIH RePORTER	Danish Agency for Science, Technology and Innovation; Lundbeck Foundation(Lundbeckfonden); MAERSK Foundation; Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Early Career Scientist Award from the Howard Hughes Medical Institute; Victor Daitz Foundation; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Searle Scholars Program; South African Research Chairs Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by The Danish Agency for Science, Technology and Innovation (grant #12-132295), Lundbeck Foundation (grant #R151-2013-14624), and MAERSK Foundation (all to H.N.K.); by the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation and NIH grant AI067073 (both to B.D.W.); by partial support from the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative (IAVI) (UKZNRSA1001), and the NIAID (R37AI067073); by The South African Research Chairs Initiative, an International Early Career Scientist Award from the Howard Hughes Medical Institute, and the Victor Daitz Foundation (all to T.N.); by The National Science Foundation Graduate Research Fellowship Program (NSF GRFP) (to S.W.K.); and by The Searle Scholars Program(A.K.S.). We thank Dr. HollisShen for extensive support during cell sorting; all "iThimba," "Gateway,'' "CAPRISA002/004,'' and "FRESH'' Acute Infection Study participants; the supportive role of the CAPRISA002/004 studies; Carly G.K. Ziegler and Travis K. Hughes (from the A.K.S. lab) for help on analysis of the RNA-seq data; and NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH, for alpha 4 beta 7 monoclonal antibody (cat# 11718) from Dr. A.A. Ansari.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Boyd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108649; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Diefenbach A, 2013, EUR J MICROBIOL IMMU, V3, P143, DOI 10.1556/EuJMI.3.2013.3.1; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Hodge JN, 2011, BLOOD, V118, P3244, DOI 10.1182/blood-2010-12-323600; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Li HY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004551; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Petrovas C, 2004, J IMMUNOL, V172, P4444, DOI 10.4049/jimmunol.172.7.4444; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sanchez JL, 2015, J INFECT DIS, V211, P1068, DOI 10.1093/infdis/jiu586; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; TROMBETTA JJ, 2014, CURR PROTOC MOL BIOL, V107, P1, DOI DOI 10.1002/0471142727.MB0422S107; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Xu HB, 2015, FASEB J, V29, P5072, DOI 10.1096/fj.15-276477; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zhang Z, 2015, J CLIN INVEST, V125, P3692, DOI 10.1172/JCI82124	39	99	102	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					391	405		10.1016/j.immuni.2016.01.006	http://dx.doi.org/10.1016/j.immuni.2016.01.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26850658	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-18	WOS:000370294000020
J	Ichiyama, K; Sekiya, T; Inoue, N; Tamiya, T; Kashiwagi, I; Kimura, A; Morita, R; Muto, G; Shichita, T; Takahashi, R; Yoshimura, A				Ichiyama, Kenji; Sekiya, Takashi; Inoue, Naoko; Tamiya, Taiga; Kashiwagi, Ikko; Kimura, Akihiro; Morita, Rimpei; Muto, Go; Shichita, Takashi; Takahashi, Reiko; Yoshimura, Akihiko			Transcription Factor Smad-Independent T Helper 17 Cell Induction by Transforming-Growth Factor-beta Is Mediated by Suppression of Eomesodermin	IMMUNITY			English	Article							ROR-GAMMA-T; TGF-BETA; T(H)17 DIFFERENTIATION; AUTOIMMUNE INFLAMMATION; TH17 DIFFERENTIATION; NUCLEAR RECEPTORS; MOLECULAR-BASIS; GENE; ACTIVATION; LINEAGE	Transforming growth factor-beta (TGF-beta) has been shown to be required for Th17 cell differentiation via Smad-independent mechanisms. The molecular mechanism underlying this pathway remains to be clarified, however. We searched for genes regulated by TGF-beta through the Smad-independent pathway by using Smad2 and Smad3 double-deficient T cells and identified the transcription factor Eomesodermin (Eomes), whose expression was suppressed by TGF-beta via the c-Jun N-terminal kinase (JNK)-c-Jun signaling pathway. Inhibition of JNK strongly suppressed disease in an in vivo EAE model as well as in vitro Th17 cell induction. Overexpression of Eomes substantially suppressed Th17 cell differentiation, whereas ablation of Eomes expression could substitute for TGF-beta in Th17 cell induction in primary T cells. Eomes suppressed Rorc and II17a promoters by directly binding to the proximal region of these promoters. In conclusion, the suppression of Eomes by TGF-beta via the JNK pathway is an important mechanism for Smad-independent Th17 cell differentiation.	[Ichiyama, Kenji; Sekiya, Takashi; Inoue, Naoko; Tamiya, Taiga; Kashiwagi, Ikko; Kimura, Akihiro; Morita, Rimpei; Muto, Go; Shichita, Takashi; Takahashi, Reiko; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Ichiyama, Kenji; Sekiya, Takashi; Inoue, Naoko; Tamiya, Taiga; Kashiwagi, Ikko; Kimura, Akihiro; Morita, Rimpei; Muto, Go; Shichita, Takashi; Takahashi, Reiko; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Keio University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Kimura, Akihiro/0000-0001-5614-8547; KASHIWAGI, IKKOH/0000-0001-5386-5719; Ichiyama, Kenji/0000-0002-3340-9799; Tamiya, Taiga/0000-0002-8021-4628	Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [10J05327, 22249009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Yasutomo for providing the Eomes cDNA construct. We also thank M. Asakawa, K. Fukuse, and N. Shiino for technical assistance. This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO), The Mitsubishi Pharma Research Foundation, Kanae Foundation for the Promotion of Medical Science, The Mochida Memorial Foundation, and the Takeda Science Foundation.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Flavell RA, 1999, IMMUNOL RES, V19, P159, DOI 10.1007/BF02786484; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ichiyama K, 2009, INT IMMUNOL, V21, P881, DOI 10.1093/intimm/dxp054; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kottke T, 2007, CANCER RES, V67, P11970, DOI 10.1158/0008-5472.CAN-07-2259; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Macindoe I, 2009, J MOL BIOL, V389, P606, DOI 10.1016/j.jmb.2009.04.056; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mao CA, 2008, DEVELOPMENT, V135, P271, DOI 10.1242/dev.009688; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Matsumura Y, 2007, J IMMUNOL, V179, P2170, DOI 10.4049/jimmunol.179.4.2170; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shin T, 2003, J NEUROIMMUNOL, V140, P118, DOI 10.1016/S0165-5728(03)00174-7; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Tao J, 2007, EUR J IMMUNOL, V37, P818, DOI 10.1002/eji.200636726; Tran EH, 2006, P NATL ACAD SCI USA, V103, P13451, DOI 10.1073/pnas.0601155103; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Yi CH, 1999, GENOMICS, V55, P10, DOI 10.1006/geno.1998.5632; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	63	99	101	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					741	754		10.1016/j.immuni.2011.02.021	http://dx.doi.org/10.1016/j.immuni.2011.02.021			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21600798	Bronze			2022-12-18	WOS:000291456500013
J	Luo, XR; Herold, KC; Miller, SD				Luo, Xunrong; Herold, Kevan C.; Miller, Stephen D.			Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?	IMMUNITY			English	Review							BETA-CELL FUNCTION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTI-CD3 MONOCLONAL-ANTIBODY; HEAT-SHOCK-PROTEIN; REGULATORY T-CELLS; RANDOMIZED CONTROLLED-TRIAL; GLUTAMIC-ACID DECARBOXYLASE; B-LYMPHOCYTE DEPLETION; NOD MOUSE MODEL; BLIND PHASE-II	Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by destruction of insulin-producing pancreatic beta cells. Many broad-based immunosuppressive and antigen-specific immunoregulatory therapies have been and are currently being evaluated for their utility in the prevention and treatment of T1D. Looking forward, this review discusses the potential therapeutic use of antigen-specific tolerance strategies, including tolerance induced by "tolerogenic" antigen-presenting cells pulsed with diabetogenic antigens and transfer of induced or expanded regulatory T cells, which have demonstrated efficacy in nonobese diabetic (NOD) mice. Depending on the time of therapeutic intervention in the T1D disease process, antigen-specific immunoregulatory strategies may be employed as monotherapies, or in combination with short-term tolerance-promoting immunoregulatory drugs and/or drugs promoting differentiation of insulin-producing 13 cells from endogenous progenitors.	[Luo, Xunrong; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Luo, Xunrong] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Herold, Kevan C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Yale University	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.				National Institutes of Health (NIH) [1K08DK070029]; Type 1 Diabetes Pathfinder Award [DP2DK083099]; Juvenile Diabetes Research Foundation [1-2007-1005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083099, K08DK070029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048411, R01NS026543, R01NS062365] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Type 1 Diabetes Pathfinder Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health (NIH) Career Award 1K08DK070029 (X L), the Type 1 Diabetes Pathfinder Award DP2DK083099 (X L). and the Juvenile Diabetes Research Foundation Regular Research Grant 1-2007-1005 (S D M and X L)	Achenbach Peter, 2005, Curr Diab Rep, V5, P98, DOI 10.1007/s11892-005-0035-y; Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; ASSAN R, 1994, CLIN NEPHROL, V41, P41; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; BONIFACIO E, 2008, NOVART FDN SYMP, V292, P199; BONIFACIO E, 2008, NOVART FDN SYMP, V292, P202; Bonifacio Ezio, 2008, Novartis Found Symp, V292, P187; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; BOUGNERES PF, 1990, DIABETES, V39, P1264, DOI 10.2337/diabetes.39.10.1264; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; Chung DT, 2007, INT IMMUNOL, V19, P1003, DOI 10.1093/intimm/dxm078; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; COUN CE, 2009, JAMA-J AM MED ASSOC, V301, P1573; Daniel D, 1996, ANN NY ACAD SCI, V778, P371, DOI 10.1111/j.1749-6632.1996.tb21146.x; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; EISENBARTH GS, 1985, DIABETES RES CLIN EX, V2, P271; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Elias D, 1997, DIABETES, V46, P758, DOI 10.2337/diabetes.46.5.758; ELIAS D, 1995, DIABETES, V44, P1132, DOI 10.2337/diabetes.44.9.1132; Every AL, 2006, J IMMUNOL, V176, P4608, DOI 10.4049/jimmunol.176.8.4608; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; FEUTREN G, 1986, LANCET, V2, P119; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fousteri Georgia, 2007, Curr Diab Rep, V7, P91, DOI 10.1007/s11892-007-0017-3; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Harrison LC, 2004, DIABETES CARE, V27, P2348, DOI 10.2337/diacare.27.10.2348; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2003, J CLIN INVEST, V111, P409, DOI 10.1172/JCI200316090; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Huurman VAL, 2007, DIABETES-METAB RES, V23, P269, DOI 10.1002/dmrr.691; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Jin L, 2008, J IMMUNOL, V180, P58, DOI 10.4049/jimmunol.180.1.58; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KENNEDY MK, 1990, J IMMUNOL, V144, P909; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kohm AP, 2005, J IMMUNOL, V174, P4525, DOI 10.4049/jimmunol.174.8.4525; Kolb H, 1999, DIABETES CARE, V22, pB16; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; LAUPACIS A, 1983, LANCET, V1, P10; Lazar L, 2007, DIABETES-METAB RES, V23, P286, DOI 10.1002/dmrr.711; Leslie RDG, 1999, DIABETOLOGIA, V42, P3, DOI 10.1007/s001250051105; Lo J, 2006, ANN NY ACAD SCI, V1079, P153, DOI 10.1196/annals.1375.023; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Martinez NR, 2003, J CLIN INVEST, V111, P1365, DOI 10.1172/JCI200317166; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; MILLER BJ, 1988, J IMMUNOL, V140, P52; MILLER SD, 1979, J EXP MED, V149, P758, DOI 10.1084/jem.149.3.758; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; MORI Y, 1986, DIABETOLOGIA, V29, P244, DOI 10.1007/BF00454884; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nussbaum G, 2006, INT IMMUNOL, V18, P1413, DOI 10.1093/intimm/dxl074; O'Brien BA, 2000, J PATHOL, V191, P86; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Orban T, 2010, J AUTOIMMUN, V34, P408, DOI 10.1016/j.jaut.2009.10.005; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; RABINOVITCH A, 1990, J CLIN ENDOCR METAB, V71, P152, DOI 10.1210/jcem-71-1-152; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; SANTAMANA P, 2008, NOVART FDN SYMP, V292, P202; SANTAMANA P, 2008, NOVART FDN SYMP, V292, P136; Santamaria Pere, 2008, Novartis Found Symp, V292, P130; Saudek Frantisek, 2004, Rev Diabet Stud, V1, P80, DOI 10.1900/RDS.2004.1.80; Schloot NC, 2007, DIABETES-METAB RES, V23, P276, DOI 10.1002/dmrr.707; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Seyfert-Margolis V, 2006, DIABETES, V55, P2588, DOI 10.2337/db05-1378; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; Sherr J, 2008, NAT CLIN PRACT ENDOC, V4, P334, DOI 10.1038/ncpendmet0832; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; SIBLEY RK, 1985, LAB INVEST, V53, P132; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Smith CE, 2006, J AUTOIMMUN, V27, P218, DOI 10.1016/j.jaut.2006.12.002; Smith JA, 1998, J IMMUNOL, V160, P4841; Smith JA, 1997, J EXP MED, V185, P1413, DOI 10.1084/jem.185.8.1413; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; Sosenko JM, 2004, DIABETES, V53, pA425; STILLER CR, 1984, SCIENCE, V223, P1362, DOI 10.1126/science.6367043; TAN LJ, 1992, J IMMUNOL, V148, P2748; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thomas HE, 2004, DIABETES, V53, P113, DOI 10.2337/diabetes.53.1.113; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Turley DM, 2007, J IMMUNOL, V178, P2212, DOI 10.4049/jimmunol.178.4.2212; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; von Herrath M, 2009, NATURE, V459, P518, DOI 10.1038/459518a; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; YAMADA K, 1982, DIABETES, V31, P749, DOI 10.2337/diabetes.31.9.749; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	128	99	101	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					488	499		10.1016/j.immuni.2010.04.002	http://dx.doi.org/10.1016/j.immuni.2010.04.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412759	Bronze, Green Accepted			2022-12-18	WOS:000277171900006
J	Fischer, A				Fischer, Alain			Human primary immunodeficiency diseases	IMMUNITY			English	Review							ALDRICH-SYNDROME PROTEIN; NKT CELL-DEVELOPMENT; T-CELLS; LYMPHOPROLIFERATIVE SYNDROME; NEUTROPHIL ELASTASE; IMMUNE-DEFICIENCY; GENETIC-DISORDERS; OMENN-SYNDROME; CRAC CHANNEL; MUTATIONS	Primary immunodeficiency diseases (PID) provide invaluable insight into immune system, notably in vivo immune responses to microorganisms as based on the variable vulnerability to pathogens and opportunistic agents. PID are also very informative in defining key checkpoints controlling immunity to self. Despite a Mendelian inheritance of most PID, mutations of a given gene can lead to a vast array of phenotypes as a function of the type of mutations, environmental factors, the occurrence of additional somatic mutations, or regulatory factors, which add considerable but hitherto underestimated complexity. Understanding the molecular pathophysiology of PID is not only contributing to a better knowledge of the immune system but may also favor new therapeutic approaches.	[Fischer, Alain] INSERM, U768, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, F-75015 Paris, France; [Fischer, Alain] Univ Paris 05, F-75006 Paris, France; [Fischer, Alain] Assistance Publ, Unit Immunol & Hematol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Fischer, A (corresponding author), INSERM, U768, F-75015 Paris, France.	fischer@necker.fr						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bernard F, 2004, PEDIATRICS, V113, P136, DOI 10.1542/peds.113.1.136; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cavadini P, 2005, J CLIN INVEST, V115, P728, DOI 10.1172/JCI200523087; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Eidenschenk C, 2006, AM J HUM GENET, V78, P721, DOI 10.1086/503269; Eidenschenk C, 2006, J IMMUNOL, V177, P8835, DOI 10.4049/jimmunol.177.12.8835; Etzioni A, 2005, J PEDIATR-US, V146, P423, DOI 10.1016/j.jpeds.2004.11.022; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; Fischer A, 2004, NAT IMMUNOL, V5, P23, DOI 10.1038/ni1023; FISCHER A, 2003, IMMUNOLOGIC DISORDER, P447; Fischer A, 2007, CURR OPIN IMMUNOL, V19, P348, DOI 10.1016/j.coi.2007.04.006; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; Gits J, 2006, LEUKEMIA, V20, P2111, DOI 10.1038/sj.leu.2404448; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Khiong K, 2007, J CLIN INVEST, V117, P1270, DOI 10.1172/JCI30513; KLEIN I, 2007, BLOOD, V39, P86; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lai CH, 2004, P NATL ACAD SCI USA, V101, P15676, DOI 10.1073/pnas.0405155101; Lau YL, 1998, CLIN INFECT DIS, V26, P226, DOI 10.1086/517036; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Levy O, 2003, J INFECT DIS, V188, P948, DOI 10.1086/378503; Lilic D, 2002, CURR OPIN INFECT DIS, V15, P143, DOI 10.1097/00001432-200204000-00007; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Milner JD, 2007, P NATL ACAD SCI USA, V104, P576, DOI 10.1073/pnas.0610289104; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Notarangelo LD, 2006, ADV IMMUNOL, V89, P321, DOI 10.1016/S0065-2776(05)89008-X; Notarangelo LD, 2006, J PEDIATR-US, V148, P563, DOI 10.1016/j.jpeds.2005.06.028; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Vogt G, 2007, CURR OPIN GENET DEV, V17, P245, DOI 10.1016/j.gde.2007.04.008; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Watford WT, 2006, IMMUNITY, V25, P695, DOI 10.1016/j.immuni.2006.10.007; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	90	99	106	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					835	845		10.1016/j.immuni.2007.11.012	http://dx.doi.org/10.1016/j.immuni.2007.11.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093537	Bronze			2022-12-18	WOS:000251907300005
J	Zwart, W; Griekspoor, A; Kuijl, C; Marsman, M; van Rheenen, J; Janssen, H; Calafat, J; van Ham, M; Janssen, L; van Lith, M; Jalink, K; Neefjes, J				Zwart, W; Griekspoor, A; Kuijl, C; Marsman, M; van Rheenen, J; Janssen, H; Calafat, J; van Ham, M; Janssen, L; van Lith, M; Jalink, K; Neefjes, J			Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape	IMMUNITY			English	Article							CLASS-II MOLECULES; COMPLEX CLASS-II; GREEN FLUORESCENT PROTEIN; ANTIGEN PRESENTATION; MULTIVESICULAR-BODY; MYCOBACTERIUM-TUBERCULOSIS; SURFACE EXPRESSION; INVARIANT CHAIN; LYSOSOMAL PH; MHC	Major Histocompatibility Complex (MHC) class II molecules, including Human Leukocyte Antigen (HLA)-DR, present peptide fragments from proteins degraded in the endocytic pathway. HLA-DR is targeted to late-endocytic structures named MHC class II-containing Compartments (MIIC), where it interacts with HLA-DM. This chaperone stabilizes HLA-DR during peptide exchange and is critical for successful peptide loading. To follow this process in living cells, we have generated cells containing HLA-DR3/Cyan Fluorescent Protein (CFP), HLA-DM/Yellow Fluorescent Protein (YFP), and invariant chain. HLA-DR/DM interactions were observed by Fluorescence Resonance Energy Transfer (FRET). These interactions were pH insensitive, yet occurred only in internal structures and not at the limiting membrane of MIIC. In a cellular model of infection, phagosomes formed a limiting membrane surrounding internalized Salmonella. HLA-DR and HLA-DM did not interact in Salmonella-induced vacuoles, and HLA-DR was not loaded with antigens. The absence of HLA-DR/DM interactions at the limiting membrane prevents local loading of MHC class II molecules in phagosomes. This may allow these bacteria to successfully evade the immune system.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	van Rheenen, Jacco/G-3655-2014; Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Griekspoor, Alexander/0000-0003-0144-4335; Van Lith, Marcel/0000-0003-0225-5501; Jalink, Kees/0000-0001-7019-3440; Janssen, Lennert/0000-0001-9705-0204; Zwart, Wilbert/0000-0002-9823-7289; Kuijl, Coen/0000-0003-4378-1428				ALLEN PM, 1984, AM J ANAT, V170, P483, DOI 10.1002/aja.1001700319; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Bryant PW, 2002, ADV IMMUNOL, V80, P71, DOI 10.1016/S0065-2776(02)80013-X; CALAFAT J, 1994, J CELL BIOL, V126, P967, DOI 10.1083/jcb.126.4.967; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gruenberg J, 2003, CURR OPIN CELL BIOL, V15, P382, DOI 10.1016/S0955-0674(03)00078-4; Hammond C, 1998, J IMMUNOL, V161, P3282; Harding CV, 2003, CURR OPIN IMMUNOL, V15, P112, DOI 10.1016/S0952-7915(02)00008-0; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ullrich HJ, 2000, J IMMUNOL, V165, P6073, DOI 10.4049/jimmunol.165.11.6073; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; van Lith M, 2001, J IMMUNOL, V167, P884, DOI 10.4049/jimmunol.167.2.884; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; vanHam SM, 1997, CURR BIOL, V7, P950, DOI 10.1016/S0960-9822(06)00414-3; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Vermeer JEM, 2004, J MICROSC-OXFORD, V214, P190, DOI 10.1111/j.0022-2720.2004.01318.x; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Vogt AB, 1999, SEMIN IMMUNOL, V11, P391, DOI 10.1006/smim.1999.0197; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zur Lage S, 2003, IMMUNOLOGY, V108, P62, DOI 10.1046/j.1365-2567.2003.01564.x	56	99	107	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					221	233		10.1016/j.immuni.2005.01.006	http://dx.doi.org/10.1016/j.immuni.2005.01.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723810	Bronze			2022-12-18	WOS:000227509600008
J	Chowdhury, D; Sen, R				Chowdhury, D; Sen, R			Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements	IMMUNITY			English	Article							B-CELL DEVELOPMENT; MOUSE BONE-MARROW; ALLELIC EXCLUSION; V(D)J RECOMBINATION; TRANSGENIC MICE; PRO-B; RECEPTOR EXPRESSION; SURFACE EXPRESSION; IL-7 RECEPTOR; T-CELLS	Production of immunoglobulin heavy chain (IgH) protein feeds back to terminate further V-H gene recombination, a phenomenon also referred to as allelic exclusion. Here we provide evidence to support the proposition that allelic exclusion is the consequence of terminating signals that activate V-H genes for recombination. For the largest V(H)J558 family of genes, this occurs by attenuating IL-7/IL-7R signals in pre-B cells. Loss of these signals reverts the V-H locus to a chromatin state that is associated with hypoacetylated histories and is less accessible to nucleases. Furthermore, hyperacetylation and accessibility of unrearranged V-H genes can be restored in allelically excluded splenic B cells by activating this pathway. Thus, transient signals mediate V-H gene activation and inactivation during development.	Brandeis Univ, Rosenstiel Basic Med Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Sen, R (corresponding author), Brandeis Univ, Rosenstiel Basic Med Res Ctr, Waltham, MA 02454 USA.				NIGMS NIH HHS [GM38925] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038925, R29GM038925] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Banerjee A, 1998, J IMMUNOL, V161, P4611; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; BORN W, 1988, J IMMUNOL, V140, P3228; Chang Y, 1999, J EXP MED, V189, P1295, DOI 10.1084/jem.189.8.1295; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; DEMEEUS A, 1992, MAMM GENOME, V3, P637, DOI 10.1007/BF00352481; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; ERIKSON J, 1986, J IMMUNOL, V136, P3137; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Haines BB, 1998, EUR J IMMUNOL, V28, P4228, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;4228::AID-IMMU4228&gt;3.0.CO;2-H; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hikida M, 1998, J EXP MED, V188, P365, DOI 10.1084/jem.188.2.365; IACOMINI J, 1991, INT IMMUNOL, V3, P185; JEONG HD, 1989, J IMMUNOL, V143, P2752; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; Magari M, 2002, EUR J IMMUNOL, V32, P957, DOI 10.1002/1521-4141(200204)32:4<957::AID-IMMU957>3.3.CO;2-1; Mainville CA, 1996, J IMMUNOL, V156, P1038; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Marshall AJ, 1998, J IMMUNOL, V161, P6038; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Melchers F, 1999, SEMIN IMMUNOL, V11, P307, DOI 10.1006/smim.1999.0187; MEO T, 1980, P NATL ACAD SCI-BIOL, V77, P550, DOI 10.1073/pnas.77.1.550; Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x; Smart FM, 2000, J EXP MED, V191, P737, DOI 10.1084/jem.191.4.737; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; tenBoekel E, 1997, IMMUNITY, V7, P357; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; Wei CJ, 2000, J IMMUNOL, V164, P1961, DOI 10.4049/jimmunol.164.4.1961; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7	58	99	100	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					229	241		10.1016/S1074-7613(03)00030-X	http://dx.doi.org/10.1016/S1074-7613(03)00030-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594950	Bronze			2022-12-18	WOS:000181138100007
J	Jabri, B; Selby, JM; Negulescu, H; Lee, L; Roberts, AI; Beavis, A; Lopez-Botet, M; Ebert, EC; Winchester, RJ				Jabri, B; Selby, JM; Negulescu, H; Lee, L; Roberts, AI; Beavis, A; Lopez-Botet, M; Ebert, EC; Winchester, RJ			TCR specificity dictates CD94/NKG2A expression by human CTL	IMMUNITY			English	Article							T-CELL RECEPTOR; MHC CLASS-I; INTRAEPITHELIAL LYMPHOCYTES; INHIBITORY RECEPTORS; HLA-E; ANTIGEN-DRIVEN; NK CELLS; MOLECULES; ACTIVATION; REPERTOIRE	Activating and inhibitory CD94/NKG2 receptors regulate CTL responses by altering TCR signaling, thus modifying antigen activation thresholds set during thymic selection. To determine whether their expression was linked to TCR specificity, we examined the TCR repertoire of oligoclonal CTL expansions found in human blood and tissues. High-resolution TCR repertoire analysis revealed that commitment to inhibitory NKG2A expression was a clonal attribute developmentally acquired after TCR expression and during antigen encounter, whereas actual surface expression depended on recent TCR engagement. Further, CTL clones expressing sequence-related TCR, and therefore sharing the same antigen specificity, invariably shared the same NKG2A commitment. These findings suggest that TCR antigenic specificity dictates NKG2A commitment, which critically regulates subsequent activation of CTL.	Columbia Univ Coll Phys & Surg, Div Autoimmune & Mol Dis, New York, NY 10032 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Med & Dent New Jersey, Dept Med, New Brunswick, NJ 08903 USA; Univ Pompeu Fabra, CEXS Immunol, Barcelona 08003, Spain	Columbia University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Pompeu Fabra University	Jabri, B (corresponding author), Columbia Univ Coll Phys & Surg, Div Autoimmune & Mol Dis, 630 W 168th St, New York, NY 10032 USA.		Lopez-Botet, Miguel/I-5434-2014	Lopez-Botet, Miguel/0000-0003-4882-065X	NIAID NIH HHS [U19 AI46132] Funding Source: Medline; NIDDK NIH HHS [R01 DK 58727-01A1, DK 42166-11] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042166, R01DK058727] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arden Bernhard, 1995, Immunogenetics, V42, P455; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bellon T, 1999, J IMMUNOL, V162, P3996; BLOOM S, 1995, CLIN EXP IMMUNOL, V101, P157; BLUMBERG RS, 1993, J IMMUNOL, V150, P5144; Bourcier KD, 2001, J VIROL, V75, P9836, DOI 10.1128/JVI.75.20.9836-9843.2001; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; Colonna M, 2000, IMMUNOL TODAY, V21, P428, DOI 10.1016/S0167-5699(00)01697-2; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Costello PJ, 2001, J IMMUNOL, V166, P2878, DOI 10.4049/jimmunol.166.4.2878; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Lopez-Botet M, 2000, SEMIN IMMUNOL, V12, P109, DOI 10.1006/smim.2000.0213; MACKENSEN A, 1994, J CLIN INVEST, V93, P1397, DOI 10.1172/JCI117116; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Moretta A, 1997, CURR OPIN IMMUNOL, V9, P694, DOI 10.1016/S0952-7915(97)80051-9; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Namekawa T, 2000, J IMMUNOL, V165, P1138, DOI 10.4049/jimmunol.165.2.1138; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; Perkins D, 1996, J IMMUNOL, V156, P4154; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Schatzle JD, 1999, P NATL ACAD SCI USA, V96, P3870, DOI 10.1073/pnas.96.7.3870; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; TAUNK J, 1992, GASTROENTEROLOGY, V102, P69, DOI 10.1016/0016-5085(92)91785-3; Ugolini S, 2001, NAT IMMUNOL, V2, P198, DOI 10.1038/85246; Uhrberg M, 2001, J IMMUNOL, V166, P3923, DOI 10.4049/jimmunol.166.6.3923; VANKERCKHOVE C, 1992, J EXP MED, V175, P57, DOI 10.1084/jem.175.1.57; Vely F, 2001, J IMMUNOL, V166, P2487, DOI 10.4049/jimmunol.166.4.2487; VIE H, 1989, BLOOD, V74, P285; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Zajac AJ, 1999, J IMMUNOL, V163, P5526	46	99	104	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					487	499		10.1016/S1074-7613(02)00427-2	http://dx.doi.org/10.1016/S1074-7613(02)00427-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387742	Bronze			2022-12-18	WOS:000178667100009
J	Fang, W; Weintraub, BC; Dunlap, B; Garside, P; Pape, KA; Jenkins, MK; Goodnow, CC; Mueller, DL; Behrens, TW				Fang, W; Weintraub, BC; Dunlap, B; Garside, P; Pape, KA; Jenkins, MK; Goodnow, CC; Mueller, DL; Behrens, TW			Self-reactive B lymphocytes overexpressing Bcl-x(L) escape negative selection and are tolerized by clonal anergy and receptor editing	IMMUNITY			English	Article							CELL-DEATH; BCL-X; TRANSGENIC MICE; REGULATED EXPRESSION; AUTOIMMUNE-DISEASE; BONE-MARROW; ANTIBODY; ACTIVATION; APOPTOSIS; TOLERANCE	Self-reactive B cells Tg for both a bcl-x(L) death inhibitory gene and an Ig receptor recognizing hen egg lysozyme (HEL-Ig) efficiently escaped developmental arrest and deletion in mice expressing membrane-bound self-antigen (mHEL). In response to the same antigen, Tg HEL-Ig B cells not expressing bcl-x(L) were deleted, while cells expressing bcl-2 were arrested at the immature B stage. Bcl-x(L) Tg B cells escaping negative selection were anergic in both in vitro and in vivo assays and showed some evidence for receptor editing. These studies suggest that Bcl-x may have a distinct role in controlling survival at the immature stage of B cell development and demonstrate that tolerance is preserved when self-reactive B cells escape central deletion.	Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Australian National University; John Curtin School of Medical Research	Behrens, TW (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	behre001@maroon.tc.umn.edu	Garside, Paul/A-4227-2009; Jenkins, Marc K/G-1063-2012; Goodnow, Christopher C/V-8108-2018	Jenkins, Marc K/0000-0001-8009-7655; Goodnow, Christopher C/0000-0001-5296-6155; Mueller, Daniel/0000-0003-1621-0419				AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Behrens TW, 1997, IMMUNOL RES, V16, P149, DOI 10.1007/BF02786359; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BROOKS A, 1991, P NATL ACAD SCI USA, V88, P3290, DOI 10.1073/pnas.88.8.3290; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Conrad D H, 1991, Monogr Allergy, V29, P9; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DECKER DJ, 1995, J IMMUNOL, V154, P4924; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; FANG W, 1995, J IMMUNOL, V155, P66; FANG W, 1994, J IMMUNOL, V153, P4388; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1994, INT IMMUNOL, V6, P1417, DOI 10.1093/intimm/6.9.1417; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HE XW, 1993, ARTHRITIS RHEUM, V36, P1061, DOI 10.1002/art.1780360806; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; HUETZ F, 1993, EMBO J, V12, P1819, DOI 10.1002/j.1460-2075.1993.tb05830.x; JACOBS MJM, 1993, IMMUNOLOGY, V80, P511; KAMESAKI H, 1994, J IMMUNOL, V152, P3294; KLINMAN DM, 1987, J EXP MED, V165, P1755, DOI 10.1084/jem.165.6.1755; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MERINO R, 1995, J IMMUNOL, V155, P3830; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OBrien DP, 1997, MOL CELL BIOL, V17, P3477, DOI 10.1128/MCB.17.7.3477; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; PISETSKY DS, 1990, J CLIN INVEST, V85, P899, DOI 10.1172/JCI114517; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RUSSELL D, 1997, J EXP MED, V186, P1513; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SMITHGILL SJ, 1987, J MOL BIOL, V194, P713, DOI 10.1016/0022-2836(87)90249-X; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; tenBoekel E, 1997, IMMUNITY, V7, P357; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M	57	99	100	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					35	45		10.1016/S1074-7613(00)80586-5	http://dx.doi.org/10.1016/S1074-7613(00)80586-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697834	Bronze			2022-12-18	WOS:000075066600004
J	Passoni, L; Hoffman, ES; Kim, S; Crompton, T; Pao, W; Dong, MQ; Owen, MJ; Hayday, AC				Passoni, L; Hoffman, ES; Kim, S; Crompton, T; Pao, W; Dong, MQ; Owen, MJ; Hayday, AC			Intrathymic delta selection events in gamma delta cell development	IMMUNITY			English	Article							RECEPTOR-BETA-CHAIN; DEFICIENT MUTANT MICE; ADULT MURINE THYMUS; T-CELLS; ALPHA-BETA; THYMOCYTE DEVELOPMENT; IMMATURE THYMOCYTES; BONE-MARROW; INTERLEUKIN-2 RECEPTOR; POSITIVE SELECTION	The major pathway of gamma delta cell development is shown to be regulated by in-frame rearrangements at the T cell receptor (TCR) delta locus. Such ''delta selection'' occurs at or around the same point in thymocyte development as selection for in-frame rearrangements at the TCR beta locus. However, there are at least two major differences with beta selection: first, delta selection commonly involves selection on the cognate TCR chain, gamma, suggesting that there is no ''preT gamma'' chain of major biological significance; second, most gamma delta-selected thymocytes differentiate rather than proliferate. Nonetheless, some delta selection events seemingly facilitate thymocyte expansion, similar to alpha beta T cell development. In these cases, TCR gamma selection is less obvious. Furthermore, the capacity of individual gamma chains to facilitate gamma delta selection is shown to vary with developmental age. The results further clarify early T cell development at the beta selection/delta selection stage and place clear constraints on models of cell fate determination.	YALE UNIV,IMMUNOBIOL SECT,NEW HAVEN,CT 06511; YALE UNIV,DEPT BIOCHEM & MOL BIOPHYS,NEW HAVEN,CT 06511; IMPERIAL CANC RES FUND,LONDON WC2 3PX,ENGLAND	Yale University; Yale University; Cancer Research UK	Passoni, L (corresponding author), YALE UNIV,DEPT BIOL,POB 6666,NEW HAVEN,CT 06511, USA.			passoni, lorena/0000-0002-9468-2166; Crompton, Tessa/0000-0002-8973-4021	NIGMS NIH HHS [GM37759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BOGUE M, 1993, EUR J IMMUNOL, V23, P1185, DOI 10.1002/eji.1830230533; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CARDING SR, 1990, GENE DEV, V4, P1304, DOI 10.1101/gad.4.8.1304; Cheng LR, 1996, J IMMUNOL, V156, P3591; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; CRISSMAN HA, 1976, J HISTOCHEM CYTOCHEM, V24, P64, DOI 10.1177/24.1.56392; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; EGERTON M, 1990, INT IMMUNOL, V2, P501, DOI 10.1093/intimm/2.6.501; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; EWING T, 1988, EUR J IMMUNOL, V18, P261, DOI 10.1002/eji.1830180213; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAYDAY AC, 1997, IN PRESS ENCY IMMUNO; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KELLY KA, 1993, INT IMMUNOL, V5, P331, DOI 10.1093/intimm/5.4.331; KERSH GJ, 1995, J IMMUNOL, V154, P5706; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LECLERCQ G, 1993, J EXP MED, V178, P309, DOI 10.1084/jem.178.1.309; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; LYNCH F, 1993, INT IMMUNOL, V5, P991, DOI 10.1093/intimm/5.8.991; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; MATSUZAKI G, 1993, EUR J IMMUNOL, V23, P3345, DOI 10.1002/eji.1830231242; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1994, INT IMMUNOL, V6, P1061, DOI 10.1093/intimm/6.7.1061; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P649, DOI 10.1002/eji.1830190412; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PENIT C, 1995, J IMMUNOL, V154, P5103; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCOLLAY R, 1985, J IMMUNOL, V134, P3632; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHORES EW, 1990, EUR J IMMUNOL, V20, P69, DOI 10.1002/eji.1830200111; SHUTTER J, 1995, MOL CELL BIOL, V15, P7022; TATSUMI Y, 1993, J IMMUNOL, V151, P3030; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305; WILSON A, 1988, J IMMUNOL, V140, P1461; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; ZHANG Y, 1995, IMMUNITY, V3, P439, DOI 10.1016/1074-7613(95)90173-6; ZORBAS M, 1993, EUR J IMMUNOL, V23, P1655, DOI 10.1002/eji.1830230739	71	99	99	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					83	95		10.1016/S1074-7613(00)80512-9	http://dx.doi.org/10.1016/S1074-7613(00)80512-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252122	hybrid			2022-12-18	WOS:A1997XN69300008
J	Himes, SR; Coles, LS; Reeves, R; Shannon, MF				Himes, SR; Coles, LS; Reeves, R; Shannon, MF			High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters	IMMUNITY			English	Article							NF-KAPPA-B; ACCESSORY MOLECULE CD28; T-CELL ACTIVATION; TRANSCRIPTION FACTOR; DNA-BINDING; INTERLEUKIN-2 PROMOTER; CHROMOSOMAL-PROTEINS; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; LYMPHOCYTES-T	CD28 response elements (CD28REs) within cytokine promoters are variant NF-kappa B-binding sites and are essential for transcription in response to CD28 receptor activation in T cells. We show that the CK-1 element (CD28RE) within the GM-CSF promoter binds the RelA and c-Rel transcription factors in response to CD28 activation. We further show that the high mobility group protein HMG I(Y) can bind to the CD28REs of both GM-CSF and IL-2 and that this binding is critical for c-Rel, but not RelA, binding. A second NF-kappa B site in the GM-CSF promoter that binds p50 and RelA, but neither c-Rel nor HMG I(Y), failed to respond to CD28 activation. Expression of HMG I or c-Rel antisense RNA inhibited CD28 activation of the IL-2 and GM-CSF promoters, implying that HMG I(Y) enhancement of c-Rel binding plays an important role in the activity of the CD28REs.	INST MED & VET SCI,DIV HUMAN IMMUNOL,HANSON CTR CANC RES,ADELAIDE,SA 5000,AUSTRALIA; WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164	Institute Medical & Veterinary Science Australia; Washington State University								ABDULKADIR SA, 1995, J EXP MED, V182, P487, DOI 10.1084/jem.182.2.487; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; DU W, 1994, P NATL ACAD SCI USA, V91, P11318, DOI 10.1073/pnas.91.24.11318; DUNN SM, 1994, BLOOD, V83, P2469, DOI 10.1182/blood.V83.9.2469.2469; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Ghosh P, 1996, J BIOL CHEM, V271, P7700, DOI 10.1074/jbc.271.13.7700; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Harlow E., 1988, ANTIBODIES LABORATOR, P511; HIMES SR, 1993, ONCOGENE, V8, P3189; Himes SR, 1996, J VIROL, V70, P4001, DOI 10.1128/JVI.70.6.4001-4008.1996; Hughes CCW, 1996, J BIOL CHEM, V271, P5369, DOI 10.1074/jbc.271.10.5369; JOHN S, 1996, MOL CELL BIOL, V15, P1788; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KUCZEK ES, 1991, J IMMUNOL, V146, P2426; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAI JH, 1995, MOL CELL BIOL, V15, P4260; LEDERER JA, 1994, J IMMUNOL, V152, P77; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; LI M, 1993, MOL CELL BIOL, V13, P6490, DOI 10.1128/MCB.13.10.6490; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; REEVES R, 1990, J BIOL CHEM, V265, P8573; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; SHANNON MF, 1990, MOL CELL BIOL, V10, P2950, DOI 10.1128/MCB.10.6.2950; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weiss A, 1987, Adv Exp Med Biol, V213, P45; WOOD KV, 1991, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P543	54	99	102	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					479	489		10.1016/S1074-7613(00)80503-8	http://dx.doi.org/10.1016/S1074-7613(00)80503-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934574	Bronze			2022-12-18	WOS:A1996VV65800008
J	Rha, MS; Jeong, HW; Ko, JH; Choi, SJ; Seo, IH; Lee, JS; Sa, M; Kim, AR; Joo, EJ; Ahn, JY; Kim, JH; Song, KH; Kim, ES; Oh, DH; Ahn, MY; Choi, HK; Jeon, JH; Choi, JP; Kim, HB; Kim, YK; Park, SH; Choi, WS; Choi, JY; Peck, KR; Shin, EC				Rha, Min-Seok; Jeong, Hye Won; Ko, Jae-Hoon; Choi, Seong Jin; Seo, In-Ho; Lee, Jeong Seok; Sa, Moa; Kim, A. Reum; Joo, Eun-Jeong; Ahn, Jin Young; Kim, Jung Ho; Song, Kyoung-Ho; Kim, Eu Suk; Oh, Dong Hyun; Ahn, Mi Young; Choi, Hee Kyoung; Jeon, Ji Hoon; Choi, Jae-Phil; Kim, Hong Bin; Kim, Young Keun; Park, Su-Hyung; Choi, Won Suk; Choi, Jun Yong; Peck, Kyong Ran; Shin, Eui-Cheol			PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19	IMMUNITY			English	Article							DIFFERENTIATION; EFFECTOR	Memory T cell responses have been demonstrated in COVID-19 convalescents, but ex vivo phenotypes of SARS-CoV-2-specific T cells have been unclear. We detected SARS-CoV-2-specific CD8(+) T cells by MHC class I multimer staining and examined their phenotypes and functions in acute and convalescent COVID-19. Multimer(+) cells exhibited early differentiated effector-memory phenotypes in the early convalescent phase. The frequency of stem-like memory cells was increased among multimer cells in the late convalescent phase. Cytokine secretion assays combined with MHC class I multimer staining revealed that the proportion of interferon-gamma (IFN-gamma)-producing cells was significantly lower among SARS-CoV-2-specific CD8(+) T cells than those specific to influenza A virus. Importantly, the proportion of IFN-gamma-producing cells was higher in PD-1(+) cells than PD-1(-) cells among multimer cells, indicating that PD-1-expressing, SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional. Our current findings provide information for understanding of SARS-CoV-2-specific CD8(+) T cells elicited by infection or vaccination.	[Rha, Min-Seok; Choi, Seong Jin; Seo, In-Ho; Lee, Jeong Seok; Sa, Moa; Kim, A. Reum; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju 28644, South Korea; [Ko, Jae-Hoon; Peck, Kyong Ran] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Infect Dis,Sch Med, Seoul 06351, South Korea; [Lee, Jeong Seok] GENOME Insight Inc, Daejeon 34051, South Korea; [Sa, Moa; Park, Su-Hyung; Shin, Eui-Cheol] KAIST Inst, Ctr Epidem Preparedness, Daejeon 34141, South Korea; [Joo, Eun-Jeong] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Infect Dis,Sch Med, Seoul 03181, South Korea; [Ahn, Jin Young; Kim, Jung Ho; Choi, Jun Yong] Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul 03722, South Korea; [Song, Kyoung-Ho; Kim, Eu Suk; Kim, Hong Bin] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam 13620, South Korea; [Oh, Dong Hyun; Ahn, Mi Young; Choi, Jae-Phil] Seoul Med Ctr, Dept Internal Med, Seoul 02053, South Korea; [Choi, Hee Kyoung; Jeon, Ji Hoon; Choi, Won Suk] Korea Univ, Ansan Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Ansan 15355, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Severance Christian Hosp, Dept Internal Med, Wonju Coll Med, Wonju 26426, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungbuk National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul Medical Center; Korea University; Korea University Medicine (KU Medicine); Yonsei University	Shin, EC (corresponding author), Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.; Peck, KR (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Infect Dis,Sch Med, Seoul 06351, South Korea.; Shin, EC (corresponding author), KAIST Inst, Ctr Epidem Preparedness, Daejeon 34141, South Korea.; Choi, JY (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul 03722, South Korea.; Choi, WS (corresponding author), Korea Univ, Ansan Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Ansan 15355, South Korea.	cmcws@korea.ac.kr; seran@yuhs.ac; krpeck@skku.edu; ecshin@kaist.ac.kr	Park, Su-Hyung/N-3514-2014; Peck, Kyong Ran/AGV-5205-2022; Kim, Hong Bin/J-5452-2012; Choi, Won Suk/V-2730-2017	Park, Su-Hyung/0000-0001-6363-7736; Kim, Hong Bin/0000-0001-6262-372X; Song, Kyoung-Ho/0000-0002-4517-3840; Ahn, Jin Young/0000-0002-3740-2826; Seo, In-Ho/0000-0001-8280-7745; Choi, Jun Yong/0000-0002-2775-3315; Rha, Min-Seok/0000-0003-1426-7534; Kim, Jung Ho/0000-0002-5033-3482; Choi, Won Suk/0000-0001-5874-4764; Choi, Seong Jin/0000-0002-3842-0524	Samsung Science and Technology Foundation [SSTF-BA1402-51]	Samsung Science and Technology Foundation(Samsung)	This work was supported by the Samsung Science and Technology Foundation under Project Number SSTF-BA1402-51.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554, 10.1172/JCI138554.]; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; National Institutes of Health, 2020, COVID 19 TREATM GUID; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Shin EC, 2013, J VIROL, V87, P4772, DOI 10.1128/JVI.03122-12; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Song JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17240-2; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; World Health Organization, 2020, COR DIS COVID 19; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	28	98	99	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					44	+		10.1016/j.immuni.2020.12.002	http://dx.doi.org/10.1016/j.immuni.2020.12.002		JAN 2021	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33338412	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000607814000009
J	Karunakaran, MM; Willcox, CR; Salim, M; Paletta, D; Fichtner, AS; Noll, A; Starick, L; Nohren, A; Begley, CR; Berwick, KA; Chaleil, RAG; Pitard, V; Dechanet-Merville, J; Bates, PA; Kimmel, B; Knowles, TJ; Kunzmann, V; Walter, L; Jeeves, M; Mohammed, F; Willcox, BE; Herrmann, T				Karunakaran, Mohindar M.; Willcox, Carrie R.; Salim, Mahboob; Paletta, Daniel; Fichtner, Alina S.; Noll, Angela; Starick, Lisa; Noehren, Anna; Begley, Charlotte R.; Berwick, Katie A.; Chaleil, Raphael A. G.; Pitard, Vincent; Dechanet-Merville, Julie; Bates, Paul A.; Kimmel, Brigitte; Knowles, Timothy J.; Kunzmann, Volker; Walter, Lutz; Jeeves, Mark; Mohammed, Fiyaz; Willcox, Benjamin E.; Herrmann, Thomas			Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the V gamma 9V delta 2 TCR and Is Essential for Phosphoantigen Sensing	IMMUNITY			English	Article							DELTA T-CELLS; PHOSPHORYLATED ANTIGENS; RECEPTOR; RECOGNITION; MOLECULES; CYTOMEGALOVIRUS; STIMULATION; ACTIVATION; EXPRESSION; SYSTEM	V gamma 9V delta 2 T cells respond in a TCR-dependent fashion to both microbial and host-derived pyrophosphate compounds (phosphoantigens, or P-Ag). Butyrophilin-3A1 (BTN3A1), a protein structurally related to the B7 family of costimulatory molecules, is necessary but insufficient for this process. We performed radiation hybrid screens to uncover direct TCR ligands and cofactors that potentiate BTN3A1' s P-Ag sensing function. These experiments identified butyrophilin-2A1 (BTN2A1) as essential to V gamma 9V delta 2 T cell recognition. BTN2A1 synergised with BTN3A1 in sensitizing P-Ag-exposed cells for V gamma 9V delta 2 TCR-mediated responses. Surface plasmon resonance experiments established V gamma 9V delta 2 TCRs used germline-encoded V gamma 9 regions to directly bind the BTN2A1 CFG-IgV domain surface. Notably, somatically recombined CDR3 loops implicated in P-Ag recognition were uninvolved. Immunoprecipitations demonstrated close cell-surface BTN2A1-BTN3A1 association independent of P-Ag stimulation. Thus, BTN2A1 is a BTN3A1-linked co-factor critical to V gamma 9V delta 2 TCR recognition. Furthermore, these results suggest a composite-ligand model of P-Ag sensing wherein the V gamma 9V delta 2 TCR directly interacts with both BTN2A1 and an additional ligand recognized in a CDR3-dependent manner.	[Karunakaran, Mohindar M.; Paletta, Daniel; Fichtner, Alina S.; Starick, Lisa; Noehren, Anna; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Willcox, Carrie R.; Salim, Mahboob; Begley, Charlotte R.; Berwick, Katie A.; Mohammed, Fiyaz; Willcox, Benjamin E.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Willcox, Carrie R.; Salim, Mahboob; Begley, Charlotte R.; Berwick, Katie A.; Mohammed, Fiyaz; Willcox, Benjamin E.] Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England; [Noll, Angela; Walter, Lutz] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Chaleil, Raphael A. G.; Bates, Paul A.] Francis Crick Inst, Biomol Modelling Lab, London, England; [Pitard, Vincent; Dechanet-Merville, Julie] Bordeaux Univ, CNRS, ImmunoConcEpT Lab, Equipe Labellisee,LIGUE 2017,UMR 5164, F-33076 Bordeaux, France; [Pitard, Vincent; Dechanet-Merville, Julie] Bordeaux Univ, TransBioMed Core, Flow Cytometry Facil, CNRS,UMS 3427,INSERM,US05, F-33076 Bordeaux, France; [Kimmel, Brigitte; Kunzmann, Volker] Univ Wurzburg, Med Clin & Policlin 2, Wurzburg, Germany; [Knowles, Timothy J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Jeeves, Mark] Univ Birmingham, Inst Canc & Genom Sci, Henry Wellcome Bldg NMR, Birmingham, W Midlands, England	University of Wurzburg; University of Birmingham; University of Birmingham; Deutsches Primatenzentrum (DPZ); Francis Crick Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Wurzburg; University of Birmingham; University of Birmingham	Herrmann, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.; Willcox, BE (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Willcox, BE (corresponding author), Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England.	b.willcox@bham.ac.uk; herrmann-t@vim.uni-wuerzburg.de	Herrmann, Thomas/J-4943-2012; Walter, Lutz/I-2606-2017	Herrmann, Thomas/0000-0002-1093-0194; Walter, Lutz/0000-0001-9408-3131; Knowles, Tim/0000-0002-6632-0985; Jeeves, Mark/0000-0001-9736-0990; Fichtner, Alina Suzann/0000-0003-4772-9352	Wellcome Trust, United Kingdom [208400/Z/17/Z, 099266/Z/12/Z, 099266/Z/12/A]; Deutsche Krebshilfe, Germany [70112079, 70112081]; Wilhelm Sanderstiftung, Germany [2013.907.2]; Deutsche Forschungsgemeinschaft [HE2346/8-1]; SIRIC BRIO; Ligue Nationale contre le Cancer, France; University of Birmingham	Wellcome Trust, United Kingdom(Wellcome Trust); Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Wilhelm Sanderstiftung, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SIRIC BRIO; Ligue Nationale contre le Cancer, France(Ligue nationale contre le cancer); University of Birmingham	We thank the University of Birmingham Protein Expression Facility for use of their equipment and Aravindan Viswanathan for help with generation of BTN2A1 and BTN2A2 CRISPR cell lines. This work was supported by the Wellcome Trust, United Kingdom (grants 099266/Z/12/Z and 099266/Z/12/A to B.E.W. supporting C.R.W., M.S., F.M., and C.B.); Deutsche Krebshilfe, Germany to T.H. (grant 70112079) and V.K. (grant 70112081) supporting D.P. and M.M.K.; Wilhelm Sanderstiftung, Germany, grant 2013.907.2 to T.H. supporting M.M.K.; Deutsche Forschungsgemeinschaft grant HE2346/8-1 to T.H. supporting A.F., D.P., and M.M.K.; and SIRIC BRIO and the Ligue Nationale contre le Cancer, France (to J.D.-M. supporting V.P.). NMR studies were supported in part by the Wellcome Trust, United Kingdom (grant 208400/Z/17/Z to University of Birmingham), and we thank HWB-NMR staff at the University of Birmingham for providing open access to their Wellcome Trust-funded spectrometers. We gratefully acknowledge Adrian Hayday, Pierre Vantourout, and Fedor Berditchevski for useful discussions.	Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Davey MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04076-0; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DELFAU MH, 1992, EUR J IMMUNOL, V22, P2437, DOI 10.1002/eji.1830220937; Fichtner AS, 2020, P NATL ACAD SCI USA, V117, P6697, DOI 10.1073/pnas.1909474117; Fichtner AS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00265; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Karunakaran MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00648; Karunakaran MM, 2014, IMMUNOGENETICS, V66, P243, DOI 10.1007/s00251-014-0763-8; Kistowska M., 2007, THESIS, P202; Kunzmann V, 2000, BLOOD, V96, P384; Li J., 2010, MODULATING EXPRESSIO; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Nguyen K, 2017, FASEB J, V31, P4697, DOI 10.1096/fj.201601370RR; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Rhodes DA, 2016, ANNU REV IMMUNOL, V34, P151, DOI 10.1146/annurev-immunol-041015-055435; Riano F, 2014, EUR J IMMUNOL, V44, P2571, DOI 10.1002/eji.201444712; Rigau M, 2020, SCIENCE, V367, P642, DOI 10.1126/science.aay5516; Ross SR, 2001, MAMM GENOME, V12, P879, DOI 10.1007/s00335-001-4999-x; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot3825, 10.1101/pdb.prot4027, 10.1101/pdb.prot3723, 10.1101/pdb.prot3871, 10.1101/pdb.prot4044, 10.1101/pdb.prot4050, 10.1101/pdb.prot4453, 10.1101/pdb.prot3972, 10.1101/pdb.prot4455, 10.1101/pdb.prot4056, 10.1101/pdb.prot4022]; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Shen L, 2019, P NATL ACAD SCI USA, V116, P6371, DOI 10.1073/pnas.1811380116; Silva-Santos B, 2019, NAT REV CANCER, V19, P392, DOI 10.1038/s41568-019-0153-5; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Starick L, 2017, EUR J IMMUNOL, V47, P982, DOI 10.1002/eji.201646818; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang H, 2013, J IMMUNOL, V191, P1029, DOI 10.4049/jimmunol.1300658; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Willcox CR, 2019, IMMUNITY, V51, P813, DOI 10.1016/j.immuni.2019.09.006; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342	45	98	98	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					487	+		10.1016/j.immuni.2020.02.014	http://dx.doi.org/10.1016/j.immuni.2020.02.014			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32155411	Green Published			2022-12-18	WOS:000520600200011
J	Abelin, JG; Harjanto, D; Malloy, M; Suri, P; Colson, T; Goulding, SP; Creech, AL; Serrano, LR; Nasir, G; Nasrullah, Y; McGann, CD; Velez, D; Ting, YS; Poran, A; Rothenberg, DA; Chhangawala, S; Rubinsteyn, A; Hammerbacher, J; Gaynor, RB; Fritsch, EF; Greshock, J; Oslund, RC; Barthelme, D; Addona, TA; Arleta, CM; Rooney, MS				Abelin, Jennifer G.; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P.; Creech, Amanda L.; Serrano, Lia R.; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D.; Velez, Diana; Ting, Ying S.; Poran, Asaf; Rothenberg, Daniel A.; Chhangawala, Sagar; Rubinsteyn, Alex; Hammerbacher, Jeff; Gaynor, Richard B.; Fritsch, Edward F.; Greshock, Joel; Oslund, Rob C.; Barthelme, Dominik; Addona, Terri A.; Arleta, Christina M.; Rooney, Michael S.			Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction	IMMUNITY			English	Article							INVARIANT CHAIN; PEPTIDES; MELANOMA; MOLECULES; COMPLEX; CELLS; UBIQUITINATION; QUANTIFICATION; IMMUNOTHERAPY; DEGRADATION	Increasing evidence indicates CD4(+) T cells can recognize cancer-specific antigens and control tumor growth. However, it remains difficult to predict the antigens that will be presented by human leukocyte antigen class II molecules (HLA-II), hindering efforts to optimally target them therapeutically. Obstacles include inaccurate peptide-binding prediction and unsolved complexities of the HLA-II pathway. To address these challenges, we developed an improved technology for discovering HLA-II binding motifs and conducted a comprehensive analysis of tumor ligandomes to learn processing rules relevant in the tumor microenvironment. We profiled >40 HLA-II alleles and showed that binding motifs were highly sensitive to HLA-DM, a peptide-loading chaperone. We also revealed that intratumoral HLA-II presentation was dominated by professional antigen-presenting cells (APCs) rather than cancer cells. Integrating these observations, we developed algorithms that accurately predicted APC ligandomes, including peptides from phagocytosed cancer cells. These tools and biological insights will enable improved HLA-II-directed cancer therapies.	[Abelin, Jennifer G.; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P.; Creech, Amanda L.; Serrano, Lia R.; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D.; Velez, Diana; Ting, Ying S.; Poran, Asaf; Rothenberg, Daniel A.; Chhangawala, Sagar; Gaynor, Richard B.; Fritsch, Edward F.; Greshock, Joel; Oslund, Rob C.; Barthelme, Dominik; Addona, Terri A.; Arleta, Christina M.; Rooney, Michael S.] Neon Therapeut, Cambridge, MA 02139 USA; [Rubinsteyn, Alex; Hammerbacher, Jeff] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Rooney, MS (corresponding author), Neon Therapeut, Cambridge, MA 02139 USA.	mrooney@neontherapeutics.com		McGann, Chris/0000-0001-9379-1910; Goulding, Scott/0000-0002-2293-0335; Suri, Prerna/0000-0002-0949-8621; /0000-0002-8106-0640; Abelin, Jennifer/0000-0001-5262-7241				Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alvarez B, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700252; Alvaro-Benito M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00872; Andreatta M, 2017, NUCLEIC ACIDS RES, V45, pW458, DOI 10.1093/nar/gkx248; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; [Anonymous], 2015, ARXIV150203167V3; Archila LLD, 2017, METHODS MOL BIOL, V1592, P199, DOI 10.1007/978-1-4939-6925-8_16; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Barra C, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0594-6; Bassani-Sternberet M, 2016, J IMMUNOL, V197, P2492, DOI 10.4049/jimmunol.1600808; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Bergseng E, 2015, IMMUNOGENETICS, V67, P73, DOI 10.1007/s00251-014-0819-9; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Bulik-Sullivan B, 2019, NAT BIOTECHNOL, V37, P55, DOI 10.1038/nbt.4313; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chiang CLL, 2013, CLIN CANCER RES, V19, P4801, DOI 10.1158/1078-0432.CCR-13-1185; Chollet F., 2015, KERAS; Chong C, 2018, MOL CELL PROTEOMICS, V17, P533, DOI 10.1074/mcp.TIR117.000383; Clement CC, 2016, J BIOL CHEM, V291, P5576, DOI 10.1074/jbc.M115.655738; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029805; Deniger DC, 2018, CLIN CANCER RES, V24, P5562, DOI 10.1158/1078-0432.CCR-18-0573; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emens LA, 2015, CANCER IMMUNOL RES, V3, P436, DOI 10.1158/2326-6066.CIR-15-0064; Friedman KM, 2012, J IMMUNOTHER, V35, P400, DOI 10.1097/CJI.0b013e31825898c5; He K., 2015, ARXIV, P1; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heyder T, 2016, MOL CELL PROTEOMICS, V15, P3017, DOI 10.1074/mcp.M116.060764; Hoof I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002517; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Khodadoust MS, 2017, NATURE, V543, P723, DOI 10.1038/nature21433; Kim Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-394; Kingma D. P., 2015, P ICLR, P1; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Krutzik Peter O, 2011, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0631s55; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Loffler MW, 2018, CANCER RES, V78, P4627, DOI 10.1158/0008-5472.CAN-17-1745; Magnan CN, 2014, BIOINFORMATICS, V30, P2592, DOI 10.1093/bioinformatics/btu352; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Mommen GPM, 2016, MOL CELL PROTEOMICS, V15, P1412, DOI 10.1074/mcp.M115.055780; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nair V., 2010, ICML, P807; Nesbeth YC, 2010, J IMMUNOL, V184, P5654, DOI 10.4049/jimmunol.0903247; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pacis A, 2019, P NATL ACAD SCI USA, V116, P6938, DOI 10.1073/pnas.1814700116; Paul S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01795; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; R Development Core Team, 2014, R FDN STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Ritz D, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700246; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Rock KL, 2016, TRENDS IMMUNOL, V37, P724, DOI 10.1016/j.it.2016.08.010; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Saxena M, 2018, TRENDS CANCER, V4, P119, DOI 10.1016/j.trecan.2017.12.007; Schroder B, 2016, BBA-MOL CELL RES, V1863, P1269, DOI 10.1016/j.bbamcr.2016.03.026; Schuster H, 2017, P NATL ACAD SCI USA, V114, pE9942, DOI 10.1073/pnas.1707658114; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Shih AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206785; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; van Lith M, 2010, J BIOL CHEM, V285, P40800, DOI 10.1074/jbc.M110.148155; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Yadav N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.405; Yang JB, 2006, CLIN IMMUNOL, V120, P21, DOI 10.1016/j.clim.2006.03.008; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8	102	98	102	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					766	+		10.1016/j.immuni.2019.08.012	http://dx.doi.org/10.1016/j.immuni.2019.08.012			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31495665	Bronze			2022-12-18	WOS:000490141700020
J	Burzynski, LC; Humphry, M; Pyrillou, K; Wiggins, KA; Chan, JNE; Figg, N; Kitt, LL; Summers, C; Tatham, KC; Martin, PB; Bennett, MR; Clarke, MCH				Burzynski, Laura C.; Humphry, Melanie; Pyrillou, Katerina; Wiggins, Kimberley A.; Chan, Julie N. E.; Figg, Nichola; Kitt, Lauren L.; Summers, Charlotte; Tatham, Kate C.; Martin, Paul B.; Bennett, Martin R.; Clarke, Murray C. H.			The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1 alpha by Thrombin	IMMUNITY			English	Article							INFLAMMASOME ACTIVATION; CELLS; IL-1-ALPHA; CLEAVAGE; ATHEROSCLEROSIS; IDENTIFICATION; MEMBRANE; EXPOSURE	Ancient organisms have a combined coagulation and immune system, and although links between inflammation and hemostasis exist in mammals, they are indirect and slower to act. Here we investigated direct links between mammalian immune and coagulation systems by examining cytokine proproteins for potential thrombin protease consensus sites. We found that interleukin (IL)-1 alpha is directly activated by thrombin. Thrombin cleaved pro-IL-1 alpha at a site perfectly conserved across disparate species, indicating functional importance. Surface pro-IL-1 alpha on macrophages and activated platelets was cleaved and activated by thrombin, while tissue factor, a potent thrombin activator, colocalized with pro-IL1 alpha in the epidermis. Mice bearing a mutation in the IL-1 alpha thrombin cleavage site (R114Q) exhibited defects in efficient wound healing and rapid thrombopoiesis after acute platelet loss. Thrombin-cleaved IL-1 alpha was detected in humans during sepsis, pointing to the relevance of this pathway for normal physiology and the pathogenesis of inflammatory and thrombotic diseases.	[Burzynski, Laura C.; Humphry, Melanie; Pyrillou, Katerina; Wiggins, Kimberley A.; Chan, Julie N. E.; Figg, Nichola; Kitt, Lauren L.; Bennett, Martin R.; Clarke, Murray C. H.] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 0QQ, England; [Summers, Charlotte] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England; [Tatham, Kate C.] Imperial Coll London, Sect Anaesthet Pain Med & Intens Care, Dept Surg & Canc, Fac Med, London SW7 2AZ, England; [Martin, Paul B.] Univ Bristol, Sch Biochem, Biomed Sci, Bristol BS8 1TD, Avon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; University of Bristol	Clarke, MCH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 0QQ, England.	mchc2@cam.ac.uk	Tatham, Kate/AAB-5839-2020; Summers, Charlotte/A-6973-2012	Tatham, Kate/0000-0003-3080-8011; Bennett, Martin/0000-0002-2565-1825; Summers, Charlotte/0000-0002-7269-2873; Pyrillou, Katerina/0000-0003-0375-7810	British Heart Foundation [FS/09/005/26845, FS/13/3/30038, FS/18/19/33371, RG/16/8/32388, RG/13/14/30314]; BHF Cambridge Centre for Research Excellence [RE/13/6/30180]; Oxbridge BHF Regenerative Medicine Centre [RM/13/3/30159]; Cambridge NIHR Biomedical Research Centre	British Heart Foundation(British Heart Foundation); BHF Cambridge Centre for Research Excellence; Oxbridge BHF Regenerative Medicine Centre; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was funded by British Heart Foundation Grants FS/09/005/26845, FS/13/3/30038, FS/18/19/33371, and RG/16/8/32388 to M.C.H.C., RG/13/14/30314 to M.R.B., the BHF Cambridge Centre for Research Excellence RE/13/6/30180, the Oxbridge BHF Regenerative Medicine Centre RM/13/3/30159, and the Cambridge NIHR Biomedical Research Centre. We thank Richard Farndale for CRP, Nigel Mackman for discussions, and Stephen MacDonald for assistance with ROTEM.	Abraham E, 2000, AM J RESP CELL MOL, V22, P401, DOI 10.1165/ajrcmb.22.4.f184; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; ANTTILA HSI, 1990, J INVEST DERMATOL, V95, P31, DOI 10.1111/1523-1747.ep12873278; BECK G, 1986, P NATL ACAD SCI USA, V83, P7429, DOI 10.1073/pnas.83.19.7429; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Burzynski LC, 2015, J BIOL CHEM, V290, P25188, DOI 10.1074/jbc.M115.667915; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; HAWRYLOWICZ CM, 1989, J IMMUNOL, V143, P4015; HECHT P M, 1992, Trends in Cell Biology, V2, P197, DOI 10.1016/0962-8924(92)90246-J; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; Lee P, 2017, ELIFE, V6, DOI 10.7554/eLife.28875; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Rivers-Auty J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03362-1; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; SMITH EB, 1986, CLIN HAEMATOL, V15, P355; Thornton P, 2010, BLOOD, V115, P3632, DOI 10.1182/blood-2009-11-252643; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; Yates CM, 2011, J VASC SURG, V54, P497, DOI 10.1016/j.jvs.2011.02.061; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	36	98	101	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1033	+		10.1016/j.immuni.2019.03.003	http://dx.doi.org/10.1016/j.immuni.2019.03.003			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30926232	hybrid, Green Published			2022-12-18	WOS:000464660800020
J	Guo, CS; Chi, ZX; Jiang, DL; Xu, T; Yu, WW; Wang, Z; Chen, S; Zhang, L; Liu, QY; Guo, XC; Zhang, X; Li, WX; Lu, LR; Wu, YL; Song, BL; Wang, D				Guo, Chuansheng; Chi, Zhexu; Jiang, Danlu; Xu, Ting; Yu, Weiwei; Wang, Zhen; Chen, Sheng; Zhang, Li; Liu, Qianyun; Guo, Xingchen; Zhang, Xue; Li, Wenxin; Lu, Linrong; Wu, Yingliang; Song, Bao-Liang; Wang, Di			Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages	IMMUNITY			English	Article							METABOLIC PATHWAYS; DENDRITIC CELLS; SMALL-MOLECULE; PROTEIN SCAP; I INTERFERON; SREBP; TRANSPORT; CLEAVAGE; IMMUNITY; INNATE	Cholesterol metabolism has been linked to immune functions, but the mechanisms by which cholesterol biosynthetic signaling orchestrates inflammasome activation remain unclear. Here, we have shown that NLRP3 inflammasome activation is integrated with the maturation of cholesterol master transcription factor SREBP2. Importantly, SCAP-SREBP2 complex endoplasmic reticulum-to-Golgi translocation was required for optimal activation of the NLRP3 inflammasome both in vitro and in vivo. Enforced cholesterol biosynthetic signaling by sterol depletion or statins promoted NLPR3 inflammasome activation. However, this regulation did not predominantly depend on changes in cholesterol homeostasis controlled by the transcriptional activity of SREBP2, but relied on the escort activity of SCAP. Mechanistically, NLRP3 associated with SCAP-SREBP2 to form a ternary complex which translocated to the Golgi apparatus adjacent to a mitochondria! cluster for optimal inflammasome assembly. Our study reveals that, in addition to controlling cholesterol biosynthesis, SCAP-SREBP2 also serves as a signaling hub integrating cholesterol metabolism with inflammation in macrophages.	[Guo, Chuansheng; Chi, Zhexu; Jiang, Danlu; Xu, Ting; Wang, Zhen; Chen, Sheng; Zhang, Li; Lu, Linrong; Wang, Di] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Chuansheng; Chi, Zhexu; Jiang, Danlu; Xu, Ting; Wang, Zhen; Chen, Sheng; Zhang, Li; Zhang, Xue; Lu, Linrong; Wang, Di] Zhejiang Univ, Program Mol & Cellular Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xue] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Weiwei; Liu, Qianyun; Guo, Xingchen; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Song, Bao-Liang] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Wuhan University; Wuhan University	Wang, D (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, D (corresponding author), Zhejiang Univ, Program Mol & Cellular Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	diwang@zju.edu.cn	Yu, Wei/GZL-3831-2022	Song, Bao-Liang/0000-0002-6397-5935	National Natural Science Foundation of China [81730047, 31522020, 31670926]; National Key Research and Development Program of China [2018YFC1105203, 2016YFC1100204]; Fundamental Research Funds for the Central Universities [2015XZZX004-31]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Dr. Feng Shao (National Institute of Biological Sciences) for providing immortalized mouse macrophages and Dr. Tao Li (National Center of Biomedical Analysis) for providing plasmid of GST-NLRP3 Delta LRR. We thank Dr. I.C. Bruce for reading the manuscript. This work was supported by the National Natural Science Foundation of China (81730047, 31522020, 31670926), the National Key Research and Development Program of China (2018YFC1105203, 2016YFC1100204), and Fundamental Research Funds for the Central Universities (2015XZZX004-31).	Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo CS, 2016, IMMUNITY, V45, P944, DOI 10.1016/j.immuni.2016.10.009; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ito A, 2016, IMMUNITY, V45, P1311, DOI 10.1016/j.immuni.2016.11.008; Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Lorden G, 2017, J EXP MED, V214, P511, DOI 10.1084/jem.20161452; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Prochnicki T, 2017, CELL METAB, V26, P71, DOI 10.1016/j.cmet.2017.06.018; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Westerterp M, 2017, CELL METAB, V25, P1294, DOI 10.1016/j.cmet.2017.04.005; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Youm YH, 2012, CELL REP, V1, P56, DOI 10.1016/j.celrep.2011.11.005; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	98	104	8	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					842	+		10.1016/j.immuni.2018.08.021	http://dx.doi.org/10.1016/j.immuni.2018.08.021			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30366764	Bronze			2022-12-18	WOS:000450752200011
J	Baratin, M; Foray, C; Demaria, O; Habbeddine, M; Pollet, E; Maurizio, J; Verthuy, C; Davanture, S; Azukizawa, H; Flores-Langarica, A; Dalod, M; Lawrence, T				Baratin, Myriam; Foray, Chloe; Demaria, Olivier; Habbeddine, Mohamed; Pollet, Emeline; Maurizio, Julien; Verthuy, Christophe; Davanture, Suzel; Azukizawa, Hiroaki; Flores-Langarica, Adriana; Dalod, Marc; Lawrence, Toby			Homeostatic NF-kappa B Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance	IMMUNITY			English	Article							FUNCTIONAL SPECIALIZATION; MATURATION; BETA; ACTIVATION; EXPRESSION; ANTIGENS; IMMATURE; ALPHA	Migratory non-lymphoid tissue dendritic cells (NLT-DCs) transport antigens to lymph nodes (LNs) and are required for protective immune responses in the context of inflammation and to promote tolerance to self-antigens in steady-state. However, the molecular mechanisms that elicit steady-state NLT-DC maturation and migration are unknown. By comparing the transcriptome of NLT-DCs in the skin with their migratory counterparts in draining LNs, we have identified a novel NF-kappa B-regulated gene network specific to migratory DCs. We show that targeted deletion of IKK beta in DCs, a major activator of NF-kappa B, prevents NLT-DC accumulation in LNs and compromises regulatory T cell conversion in vivo. This was associated with impaired tolerance and autoimmunity. NF-kappa B is generally considered the prototypical pro-inflammatory transcription factor, but this study describes a role for NF-kappa B signaling in DCs for immune homeostasis and tolerance that could have implications in autoimmune diseases and immunity.	[Baratin, Myriam; Foray, Chloe; Demaria, Olivier; Habbeddine, Mohamed; Pollet, Emeline; Maurizio, Julien; Verthuy, Christophe; Davanture, Suzel; Dalod, Marc; Lawrence, Toby] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Baratin, Myriam; Foray, Chloe; Demaria, Olivier; Habbeddine, Mohamed; Pollet, Emeline; Maurizio, Julien; Verthuy, Christophe; Davanture, Suzel; Dalod, Marc; Lawrence, Toby] INSERM, U1104, F-13288 Marseille, France; [Baratin, Myriam; Foray, Chloe; Demaria, Olivier; Habbeddine, Mohamed; Pollet, Emeline; Maurizio, Julien; Verthuy, Christophe; Davanture, Suzel; Dalod, Marc; Lawrence, Toby] CNRS, UMR7280, F-13288 Marseille, France; [Azukizawa, Hiroaki] Osaka Univ, Osaka 5650871, Japan; [Flores-Langarica, Adriana] Univ Birmingham, Coll Med & Dent Sci, IBR MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Osaka University; University of Birmingham	Lawrence, T (corresponding author), Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.	lawrence@ciml.univ-mrs.fr	Lawrence, Toby/GLU-3895-2022; Dalod, Marc/AAK-6163-2020	Lawrence, Toby/0000-0003-0967-6122; Dalod, Marc/0000-0002-6436-7966; Flores-Langarica, Adriana/0000-0003-2183-4437	L'Agence Nationale de la Recherche (ANR) [ANR-09-MIEN-029-01, ANR-10-BLAN-1302-01]; European Research Council (FP7) [260753]; INSERM; CNRS; Aix-Marseille-Universite; Sanofi	L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Research Council (FP7); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille-Universite; Sanofi	We thank Boris Reizis (Columbia University) for supplying Tg(Itgax-Cre) mice, Jorge Caamano (University of Birmingham) for Tnfrsf1<SUP>-/-</SUP>Tnfrsf2<SUP>-/-</SUP> mice, Yang-Xin Fu (University of Chicago) for LTBR-Ig, Philippe Lesnik (UPMC) for Tg(Itgax-hBcl2) mice, and Michael Karin (University of California, San Diego) for Ikbkb<SUP>F/F</SUP> mice. We also thank our colleagues Bernard Malissen, Sandrine Henri, and Marc Bajenoff for helpful advice and for sharing unpublished observations. These studies were supported by grants to T.L. from L'Agence Nationale de la Recherche (ANR) (ANR-09-MIEN-029-01, ANR-10-BLAN-1302-01) and European Research Council (FP7/2007-2013 Grant agreement number 260753), and institutional funding from INSERM, CNRS, and Aix-Marseille-Universite. E.P. and M.D. received financial support from Sanofi during the course of these studies.	Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mancino A, 2013, EMBO J, V32, P816, DOI 10.1038/emboj.2013.28; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Uyttenhove C, 2011, J LEUKOCYTE BIOL, V89, P1001, DOI 10.1189/jlb.1210699; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Weinlich G, 1998, J INVEST DERMATOL, V110, P441, DOI 10.1046/j.1523-1747.1998.00161.x; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	35	98	102	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					627	639		10.1016/j.immuni.2015.03.003	http://dx.doi.org/10.1016/j.immuni.2015.03.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25862089	Green Published, Bronze			2022-12-18	WOS:000353347500010
J	Hasegawa, M; Yada, S; Liu, MZ; Kamada, N; Munoz-Planillo, R; Do, N; Nunez, G; Inohara, N				Hasegawa, Mizuho; Yada, Shoko; Liu, Meng Zhen; Kamada, Nobuhiko; Munoz-Planillo, Raul; Nhu Do; Nunez, Gabriel; Inohara, Naohiro			Interleukin-22 Regulates the Complement System to Promote Resistance against Pathobionts after Pathogen-Induced Intestinal Damage	IMMUNITY			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; FECAL MICROBIOTA TRANSPLANTATION; PROTECTIVE ROLE; GUT MICROBIOTA; HOST-DEFENSE; IL-22; IMMUNITY; CELLS; COLONIZATION; INFLAMMATION	Pathobionts play a critical role in disease development, but the immune mechanisms against pathobionts remain poorly understood. Here, we report a critical role for interleukin-22 (IL-22) in systemic protection against bacterial pathobionts that translocate into the circulation after infection with the pathogen Clostridium difficile. Infection with C. difficile induced IL-22, and infected Il22(-/-) mice harbored high numbers of pathobionts in extraintestinal organs despite comparable pathogen load and intestinal damage in mutant and wild-type mice. Pathobionts exhibited increased resistant against complement-mediated phagocytosis, and their intravenous administration resulted in high animal mortality. Selective removal of translocated commensals rescued Il22(-/-) mice, and IL-22 administration enhanced the elimination of pathobionts. Mechanistically, IL-22 augmented bacterial phagocytosis by increasing the expression and bacterial binding of complement C3. Our study demonstrates an unexpected role for IL-22 in controlling the elimination of pathobionts that enter the systemic circulation through the regulation of the complement system.	[Hasegawa, Mizuho; Yada, Shoko; Liu, Meng Zhen; Munoz-Planillo, Raul; Nhu Do; Nunez, Gabriel; Inohara, Naohiro] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Munoz-Planillo, Raul; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yada, Shoko] Yamaguchi Univ, Grad Sch Med, Student Med Acad Ctr, Ube, Yamaguchi 7558505, Japan; [Yada, Shoko] Yamaguchi Univ, Grad Sch Med, Dept Publ Hlth, Ube, Yamaguchi 7558505, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yamaguchi University; Yamaguchi University	Inohara, N (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	ino@umich.edu	Nuñez, Gabriel/A-7160-2014; Kamada, Nobuhiko/AAW-3299-2020	Kamada, Nobuhiko/0000-0002-1980-4178	NIH [R01 DE018503, R01 DK091191]; Michigan Gastrointestinal Peptide Research Center NIDDK [5P30DK034933]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK095782, P30DK034933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Gastrointestinal Peptide Research Center NIDDK; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Wenjun Ouyang (Genentech) for Il22<SUP>-/-</SUP> mice, Steffen Thiel (Aarhus University) for anti-MBL antibodies, Mohamed ElSayed (University of Michigan) for HepG2, and Melody Zeng, Jessica Werner, and Grace Chen (University of Michigan) for careful review and stimulating discussion of the manuscript. The work was supported by NIH grants R01 DE018503 (to N.I.) and R01 DK091191 (to G.N.) and the Crohn's and Colitis Foundation of America and Michigan Gastrointestinal Peptide Research Center NIDDK grant 5P30DK034933 (to N.K.).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; D'Auria KM, 2013, INFECT IMMUN, V81, P3814, DOI 10.1128/IAI.00869-13; Eaton SR, 2013, CRIT CARE CLIN, V29, P827, DOI 10.1016/j.ccc.2013.06.004; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Koenigsknecht MJ, 2013, CURR OPIN GASTROEN, V29, P628, DOI 10.1097/MOG.0b013e328365d326; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Lo Vecchio A, 2014, CURR OPIN GASTROEN, V30, P47, DOI 10.1097/MOG.0000000000000023; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Sunenshine RH, 2006, CLEV CLIN J MED, V73, P187, DOI 10.3949/ccjm.73.2.187; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	41	98	100	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					620	632		10.1016/j.immuni.2014.09.010	http://dx.doi.org/10.1016/j.immuni.2014.09.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367575	Green Accepted, Bronze			2022-12-18	WOS:000345504300015
J	Burton, OT; Rivas, MN; Zhou, JS; Logsdon, SL; Darling, AR; Koleoglou, KJ; Roers, A; Houshyar, H; Crackower, MA; Chatila, TA; Oettgen, HC				Burton, Oliver T.; Rivas, Magali Noval; Zhou, Joseph S.; Logsdon, Stephanie L.; Darling, Alanna R.; Koleoglou, Kyle J.; Roers, Axel; Houshyar, Hani; Crackower, Michael A.; Chatila, Talal A.; Oettgen, Hans C.			Immunoglobulin E Signal Inhibition during Allergen Ingestion Leads to Reversal of Established Food Allergy and Induction of Regulatory T Cells	IMMUNITY			English	Article							MAST-CELLS; CYTOKINE PRODUCTION; IGE; MICE; ANAPHYLAXIS; MODEL; DESENSITIZATION; INFLAMMATION; ENTEROPATHY; RECRUITMENT	Immunoglobulin E (IgE) antibodies are known for triggering immediate hypersensitivity reactions such as food anaphylaxis. In this study, we tested whether they might additionally function to amplify nascent antibody and T helper 2 (Th2) cell-mediated responses to ingested proteins and whether blocking IgE would modify sensitization. By using mice harboring a disinhibited form of the IL-4 receptor, we developed an adjuvant-free model of peanut allergy. Mast cells and IgE were required for induction of antibody and Th2-cell-mediated responses to peanut ingestion and they impaired regulatory T (Treg) cell induction. Mast-cell-targeted genetic deletion of the Fc epsilon RI signaling kinase Syk or Syk blockade also prevented peanut sensitization. In mice with established allergy, Syk blockade facilitated desensitization and induction of Treg cells, which suppressed allergy when transferred to naive recipients. Our study suggests a key role for IgE in driving Th2 cell and IgE responses while suppressing Treg cells in food allergy.	[Burton, Oliver T.; Rivas, Magali Noval; Zhou, Joseph S.; Logsdon, Stephanie L.; Darling, Alanna R.; Koleoglou, Kyle J.; Chatila, Talal A.; Oettgen, Hans C.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Burton, Oliver T.; Rivas, Magali Noval; Zhou, Joseph S.; Logsdon, Stephanie L.; Chatila, Talal A.; Oettgen, Hans C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Roers, Axel] Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany; [Houshyar, Hani; Crackower, Michael A.] Merck Res Labs, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Technische Universitat Dresden; Merck & Company	Oettgen, HC (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	hans.oettgen@childrens.harvard.edu	Noval Rivas, Magali/R-4987-2016	Noval Rivas, Magali/0000-0001-5570-8928; Chatila, Talal/0000-0001-7439-2762; Burton, Oliver/0000-0003-3884-7373; Oettgen, Hans/0000-0003-1199-1391	NIH NIAID [R01 AI085090, R56 AI100889, T32 AI007512, P30 DK034854]; Boston Children's Hospital Translational Research Program; Rao Chakravorti Family Fund; Bunning Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, R01AI085090, R56AI100889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boston Children's Hospital Translational Research Program; Rao Chakravorti Family Fund; Bunning Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH NIAID grants R01 AI085090 (T.A.C.), R56 AI100889 (H.C.O.), T32 AI007512 (O.T.B., S.L.L.), and P30 DK034854, by the Boston Children's Hospital Translational Research Program (H.C.O.), by the Rao Chakravorti Family Fund (H.C.O.), and by the Bunning Foundation (H.C.O., T.A.C.). H.H. is an employee of Merck and Co. as was M.A.C. at the time the study was performed.	Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brown P, 2012, EUR FOOD RES TECHNOL, V235, P971, DOI 10.1007/s00217-012-1827-3; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Moy LY, 2013, AM J RESP CELL MOL, V49, P1085, DOI 10.1165/rcmb.2013-0200OC; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nadeau KC, 2011, J ALLERGY CLIN IMMUN, V127, P1622, DOI 10.1016/j.jaci.2011.04.009; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Narendran P, 2002, ANN NY ACAD SCI, V958, P170; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Schneider LC, 2013, J ALLERGY CLIN IMMUN, V132, P1368, DOI 10.1016/j.jaci.2013.09.046; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, pS161, DOI 10.1016/j.jaci.2009.12.981; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Vickery BP, 2010, CURR OPIN PEDIATR, V22, P765, DOI 10.1097/MOP.0b013e32833f5fc0; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108	37	98	99	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					141	151		10.1016/j.immuni.2014.05.017	http://dx.doi.org/10.1016/j.immuni.2014.05.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25017467	Green Accepted, Bronze			2022-12-18	WOS:000341444200017
J	Moy, RH; Gold, B; Molleston, JM; Schad, V; Yanger, K; Salzano, MV; Yagi, Y; Fitzgerald, KA; Stanger, BZ; Soldan, SS; Cherry, S				Moy, Ryan H.; Gold, Beth; Molleston, Jerome M.; Schad, Veronica; Yanger, Kilangsungla; Salzano, Mary-Virginia; Yagi, Yoshimasa; Fitzgerald, Katherine A.; Stanger, Ben Z.; Soldan, Samantha S.; Cherry, Sara			Antiviral Autophagy Restricts Rift Valley Fever Virus Infection and Is Conserved from Flies to Mammals	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; RIG-I; INTERFERON; KINASE; RECOGNITION; IMMUNITY; ACTIVATION; LISTERIA; COMPLEX; TARGET	Autophagy has been implicated as a component of host defense, but the significance of antimicrobial autophagy in vivo and the mechanism by which it is regulated during infection are poorly defined. Here we found that antiviral autophagy was conserved in flies and mammals during infection with Rift Valley fever virus (RVFV), a mosquito-borne virus that causes disease in humans and livestock. In Drosophila, Toll-7 limited RVFV replication and mortality through activation of autophagy. RVFV infection also elicited autophagy in mouse and human cells, and viral replication was increased in the absence of autophagy genes. The mammalian Toll-like receptor adaptor, MyD88, was required for anti-RVFV autophagy, revealing an evolutionarily conserved requirement for pattern-recognition receptors in antiviral autophagy. Pharmacologic activation of autophagy inhibited RVFV infection in mammalian cells, including primary hepatocytes and neurons. Thus, autophagy modulation might be an effective strategy for treating RVFV infection, which lacks approved vaccines and therapeutics.	[Moy, Ryan H.; Gold, Beth; Molleston, Jerome M.; Schad, Veronica; Cherry, Sara] Univ Penn, Dept Microbiol, Penn Genome Frontiers Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yanger, Kilangsungla; Stanger, Ben Z.] Univ Penn, Dept Microbiol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yanger, Kilangsungla; Stanger, Ben Z.] Univ Penn, Dept Microbiol, Perelman Sch Med, Div Gastroenterol,Dept Med, Philadelphia, PA 19104 USA; [Salzano, Mary-Virginia; Soldan, Samantha S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yagi, Yoshimasa] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Nagoya University; University of Massachusetts System; University of Massachusetts Worcester	Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Penn Genome Frontiers Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu	Fitzgerald, Katherine/ABE-6317-2020; Soldan, Samantha/AAS-3182-2020; Yanger, Kilang/N-2888-2015	Soldan, Samantha/0000-0001-6263-519X; Yanger, Kilang/0000-0002-1710-5306; Molleston, Jerome/0000-0003-3702-8317; Moy, Ryan/0000-0002-0507-8590; cherry, sara/0000-0003-3956-6610; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [R01AI074951, U54AI057168, R01AI095500, R01DK083355, T32-AI-007324]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324, R01AI095500, U54AI057168, R01AI074951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Coyne for mCherry-GFP-LC3 U2OS cells; R. Medzhitov for Myd88<SUP>-/-</SUP> MEFs; J. Kagan for Mavs<SUP>-/-</SUP> MEFs; T. Neufeld for Atg8-GFP flies; N. Silverman for Traf6 mutant flies; Mahoney Institute of Neurological Sciences Neuron Culture Service Center for neuroglial cell cultures; C. Lopez, A. Yasunaga, T. Nguyen, and D. Schieffer for technical help; Y. Choi and M. Walsh for TRAF6 antibody; and H. W. Virgin for reagents and advice throughout. This work was supported by grants from the National Institutes of Health to S.C. (R01AI074951, U54AI057168, and R01AI095500), B.Z.S. (R01DK083355), and R. H. M. (T32-AI-007324). S. C. is a recipient of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award.	Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003017; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ermler ME, 2013, J VIROL, V87, P4846, DOI 10.1128/JVI.01997-12; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Leib DA, 2009, J VIROL, V83, P12164, DOI 10.1128/JVI.01676-09; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mohankumar V, 2011, BIOCHEM BIOPH RES CO, V406, P262, DOI 10.1016/j.bbrc.2011.02.030; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ross TM, 2012, VIRUS RES, V163, P417, DOI 10.1016/j.virusres.2011.10.023; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shen BH, 2001, P NATL ACAD SCI USA, V98, P8596, DOI 10.1073/pnas.141235698; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yordy B, 2013, AUTOPHAGY, V9, P236, DOI 10.4161/auto.22506; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	64	98	100	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					51	65		10.1016/j.immuni.2013.10.020	http://dx.doi.org/10.1016/j.immuni.2013.10.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24374193	Bronze, Green Accepted			2022-12-18	WOS:000331476900009
J	Figueiredo, N; Chora, A; Raquel, H; Pejanovic, N; Pereira, P; Hartleben, B; Neves-Costa, A; Moita, C; Pedroso, D; Pinto, A; Marques, S; Faridi, H; Costa, P; Gozzelino, R; Zhao, JL; Soares, MP; Gama-Carvalho, M; Martinez, J; Zhang, QS; Doring, G; Grompe, M; Simas, JP; Huber, TB; Baltimore, D; Gupta, V; Green, DR; Ferreira, JA; Moita, LF				Figueiredo, Nuno; Chora, Angelo; Raquel, Helena; Pejanovic, Nadja; Pereira, Pedro; Hartleben, Bjoern; Neves-Costa, Ana; Moita, Catarina; Pedroso, Dora; Pinto, Andreia; Marques, Sofia; Faridi, Hafeez; Costa, Paulo; Gozzelino, Raffaella; Zhao, Jimmy L.; Soares, Miguel P.; Gama-Carvalho, Margarida; Martinez, Jennifer; Zhang, Qingshuo; Doering, Gerd; Grompe, Markus; Pedro Simas, J.; Huber, Tobias B.; Baltimore, David; Gupta, Vineet; Green, Douglas R.; Ferreira, Joao A.; Moita, Luis F.			Anthracyclines Induce DNA Damage Response-Mediated Protection against Severe Sepsis	IMMUNITY			English	Article							SEPTIC SHOCK; AUTOPHAGY; RESISTANCE; TOLERANCE; EPIDEMIOLOGY; NECROSIS; DOXORUBICIN; ACTIVATION; INFECTION; SURVIVAL	Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates and limited therapeutic options in addition to organ support measures. Here we show that the clinically approved group of anthracyclines acts therapeutically at a low dose regimen to confer robust protection against severe sepsis in mice. This salutary effect is strictly dependent on the activation of DNA damage response and autophagy pathways in the lung, as demonstrated by deletion of the ataxia telangiectasia mutated (Atm) or the autophagy-related protein 7 (Atg7) specifically in this organ. The protective effect of anthracyclines occurs irrespectively of pathogen burden, conferring disease tolerance to severe sepsis. These findings demonstrate that DNA damage responses, including the ATM and Fancony Anemia pathways, are important modulators of immune responses and might be exploited to confer protection to inflammation-driven conditions, including severe sepsis.	[Figueiredo, Nuno; Chora, Angelo; Raquel, Helena; Pejanovic, Nadja; Pereira, Pedro; Neves-Costa, Ana; Moita, Catarina; Pedroso, Dora; Pinto, Andreia; Marques, Sofia; Pedro Simas, J.; Ferreira, Joao A.; Moita, Luis F.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Figueiredo, Nuno; Costa, Paulo] Ctr Hosp Lisboa Norte, EPE, Clin Univ Cirurgia 1, P-1649028 Lisbon, Portugal; [Figueiredo, Nuno] Gulbenkian Programme Adv Med Educ, P-2780156 Oeiras, Portugal; [Figueiredo, Nuno] Champalimaud Fdn, P-1400038 Lisbon, Portugal; [Hartleben, Bjoern; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Faridi, Hafeez; Gupta, Vineet] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA; [Gozzelino, Raffaella; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Zhao, Jimmy L.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Gama-Carvalho, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Func & Integrat BioFIG, P-1749016 Lisbon, Portugal; [Martinez, Jennifer; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Zhang, Qingshuo; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Doering, Gerd] Univ Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany; [Moita, Luis F.] Lisbon Acad Med Ctr, Clin Res Ctr, P-1649028 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Fundacao Champalimaud; University of Freiburg; Rush University; Instituto Gulbenkian de Ciencia; California Institute of Technology; Universidade de Lisboa; St Jude Children's Research Hospital; Oregon Health & Science University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universidade de Lisboa	Moita, LF (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal.	lmoita@fm.ul.pt	Green, Douglas R/N-8083-2018; Gozzelino, Raffaella/AAS-8598-2021; Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013; Gozzelino, Raffaella/E-8147-2017; Carvalho, Margarida/GZA-4406-2022; Figueiredo, Nuno/I-8379-2019; da Costa, Paulo Matos/ABD-1573-2021; Simas, J Pedro/M-5157-2013; Martinez, Jennifer/C-3740-2019; Gama-Carvalho, Margarida/E-6180-2012; Neves-Costa, Ana/AAJ-7066-2021; Ferreira Chora, Angelo/AAZ-6503-2021	Green, Douglas R/0000-0002-7332-1417; Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Gozzelino, Raffaella/0000-0002-1195-8527; Figueiredo, Nuno/0000-0002-5582-0933; da Costa, Paulo Matos/0000-0002-7550-8285; Simas, J Pedro/0000-0001-6982-9253; Martinez, Jennifer/0000-0002-3060-2518; Gama-Carvalho, Margarida/0000-0002-0365-6916; Neves-Costa, Ana/0000-0001-6506-7829; Ferreira Chora, Angelo/0000-0002-7941-7196; Marques, Sofia/0000-0003-1467-1529; D N Pinto, Andreia L/0000-0002-0840-6844; Ferreira Moita, Catarina/0000-0002-9910-2343; Pedroso, Dora/0000-0002-5735-5094; Zhang, Qing-shuo/0000-0002-4407-6053; Ferreira, Joao/0000-0002-8044-8926; Raquel, Helena/0000-0001-6008-6852; Soares, Miguel/0000-0002-9314-4833; Huber, Tobias B./0000-0001-7175-5062; Grompe, Markus/0000-0002-6616-4345	FLAD; FCT [PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008]; Gulbenkian grant [96526/2009]; FCT fellow [SFRH/BD/45502/2008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL110691, P01HL048546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079243, R01AI040646, R01AI047891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	FLAD; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Gulbenkian grant; FCT fellow; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Vasco Barreto for Atm<SUP>-/-</SUP> and Frederick Alt for Atm<SUP>loxP/loxP</SUP> mice. We thank Mario Ramirez for bacterial strains to probe epirubicin protection in different models of sepsis. The authors greatly appreciate the critical contribution of Professor Gerd Doring, who sadly passed away before the publication of this manuscript. L. F. M. receives support from FLAD and FCT (grants PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008, and PTDC/SAU-IMU/110303/2009), A. C. receives support from FCT (PTDC/SAU-IMU/110303/2009), J.A.F. receives support from a Gulbenkian grant (96526/2009), and P. P. is an FCT fellow (SFRH/BD/45502/2008).	Alexander A, 2010, AUTOPHAGY, V6, P672, DOI 10.4161/auto.6.5.12509; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Chien WS, 2011, SHOCK, V35, P506, DOI 10.1097/SHK.0b013e31820b2f05; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Garrison SP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001240; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan AA, 2000, ANTIMICROB AGENTS CH, V44, P3169, DOI 10.1128/AAC.44.11.3169-3173.2000; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Krysko DV, 2011, CELL DEATH DIFFER, V18, P1316, DOI 10.1038/cdd.2011.4; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Lu JV, 2012, IMMUNOL REV, V249, P205, DOI 10.1111/j.1600-065X.2012.01147.x; Marques S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000177; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matsushita N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023324; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shen HM, 2012, EXP CELL RES, V318, P1304, DOI 10.1016/j.yexcr.2012.02.006; Siu WY, 2004, MOL CANCER THER, V3, P621; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Valentin-Vega YA, 2012, AUTOPHAGY, V8, P840, DOI 10.4161/auto.19693; Vanderwerf SM, 2009, BLOOD, V114, P5290, DOI 10.1182/blood-2009-05-222414; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020	53	98	100	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					874	884		10.1016/j.immuni.2013.08.039	http://dx.doi.org/10.1016/j.immuni.2013.08.039			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24184056	Green Accepted, Bronze			2022-12-18	WOS:000330950600010
J	Li, YS; Dalli, J; Chiang, N; Baron, RM; Quintana, C; Serhan, CN				Li, Yongsheng; Dalli, Jesmond; Chiang, Nan; Baron, Rebecca M.; Quintana, Carolina; Serhan, Charles N.			Plasticity of Leukocytic Exudates in Resolving Acute Inflammation Is Regulated by MicroRNA and Proresolving Mediators	IMMUNITY			English	Article							RESOLUTION-PHASE MACROPHAGES; NF-KAPPA-B; APOPTOTIC CELLS; GENE-EXPRESSION; ACTIVATION; PROTEIN; PHAGOCYTOSIS; RECOGNITION; TRANSLATION; CLEARANCE	The magnitude and duration of acute inflammation are controlled by active resolution programs involving specialized proresolving mediators (SPMs; resolvins and maresins) and microRNAs (miRNAs). Here, we report that miR-466l was temporally regulated in murine exudate-infiltrating leukocytes. Neutrophil miR-466l overexpression in vivo promoted initiation of inflammation that anteceded macrophage expression of this miRNA, which accelerated resolution when overexpressed. In macrophages, miR-466l overexpression increased prostanoids and SPMs (e. g., resolvin D1 [RvD1] and RvD5), which enhanced resolution. RvD1, RvD2, maresin 1 (MaR1), and apoptotic neutrophils reduced miR-466l expression within human macrophages, a feedback regulation that most likely prepares for homeostasis. miR-466l was upregulated in peripheral blood of sepsis patients, and its increase correlated with nonsurvival from sepsis. SPMs and miR-466l regulated transcription factors activator protein 1 and nuclear factor kappa B1 in miRNA biogenesis. These results demonstrate pivotal roles for SPMs and miR-466l in dynamic leukocyte plasticity during resolution of acute inflammatory responses.	[Li, Yongsheng; Dalli, Jesmond; Chiang, Nan; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Li, Yongsheng; Dalli, Jesmond; Chiang, Nan; Baron, Rebecca M.; Quintana, Carolina; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Baron, Rebecca M.; Quintana, Carolina] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Dalli, Jesmond/0000-0001-6328-3640; Li, Yongsheng/0000-0003-2175-9449	National Institutes of Health [R01-GM038765, R01-HL112747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112747, P01HL108801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Gabrielle Fredman for providing some of the murine exudates. We appreciate Mary H. Small for expert help in manuscript preparation. This work was supported by National Institutes of Health grants R01-GM038765 (C.N.S.) and R01-HL112747 (R. M. B.). The authors are grateful to the members of the BWH Registry of Critical Illness (A. M. Choi, A. F. Massaro, L. E. Fredenburgh, L. Gazourian, J.A. Englert, A. Rogers, and T. Dolinay) for their help with human subjects studies, and special thanks go to Anna Trtchounian for assistance with preparing the manuscript. C.N.S. is an inventor of patents (resolvins) assigned to BWH and licensed to Resolvyx Pharmaceuticals. C.N.S. was scientific founder of Resolvyx Pharmaceuticals and owns founder stock in the company. C.N.S.'s interests were reviewed and are managed by BWH and Partners HealthCare in accordance with their conflict-of-interest policies.	Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; GALLIN EK, 1977, J CELL BIOL, V75, P277, DOI 10.1083/jcb.75.1.277; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Jozsef L, 2002, P NATL ACAD SCI USA, V99, P13266, DOI 10.1073/pnas.202296999; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; MCCUSKER JH, 1994, GENETICS, V136, P1261; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pillai PS, 2012, INFLAMMATION, V35, P98, DOI 10.1007/s10753-011-9294-8; Rajakariar R, 2006, MOL INTERV, V6, P199, DOI 10.1124/mi.6.4.6; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Russell DG, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, pXIII; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038	45	98	103	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					885	898		10.1016/j.immuni.2013.10.011	http://dx.doi.org/10.1016/j.immuni.2013.10.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238341	Bronze, Green Accepted			2022-12-18	WOS:000330950600011
J	Gardner, JM; Metzger, TC; McMahon, EJ; Au-Yeung, BB; Krawisz, AK; Lu, W; Price, JD; Johannes, KP; Satpathy, AT; Murphy, KM; Tarbell, KV; Weiss, A; Anderson, MS				Gardner, James M.; Metzger, Todd C.; McMahon, Eileen J.; Au-Yeung, Byron B.; Krawisz, Anna K.; Lu, Wen; Price, Jeffrey D.; Johannes, Kellsey P.; Satpathy, Ansuman T.; Murphy, Kenneth M.; Tarbell, Kristin V.; Weiss, Arthur; Anderson, Mark S.			Extrathymic Aire-Expressing Cells Are a Distinct Bone Marrow-Derived Population that Induce Functional Inactivation of CD4(+) T Cells	IMMUNITY			English	Article							THYMIC EPITHELIAL-CELLS; DENDRITIC CELLS; PERIPHERAL TOLERANCE; STEADY-STATE; LYMPH-NODES; ANTIGEN; ACQUIRE; LIGANDS; ANERGY; STROMA	The autoimmune regulator (Aire) is essential for prevention of autoimmunity; its role is best understood in the thymus, where it promotes self-tolerance through tissue-specific antigen (TSA) expression. Recently, extrathymic Aire-expressing cells (eTACs) have been described in murine secondary lymphoid organs, but the identity of such cells and their role in immune tolerance remains unclear. Here we have shown that eTACs are a discrete major histocompatibility complex class II (MHC II)(hi), CD80(lo), CD86(lo), epithelial cell adhesion molecule (EpCAM)(hi), CD45(lo) bone marrow-derived peripheral antigen-presenting cell (APC) population. We also have demonstrated that eTACs can functionally inactivate CD4(+) T cells through a mechanism that does not require regulatory T cells (Treg) and is resistant to innate inflammatory stimuli. Together, these findings further define eTACs as a distinct tolerogenic cell population in secondary lymphoid organs.	[Gardner, James M.; Metzger, Todd C.; McMahon, Eileen J.; Krawisz, Anna K.; Lu, Wen; Johannes, Kellsey P.; Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gardner, James M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [McMahon, Eileen J.] Westmont Coll, Dept Biol, Santa Barbara, CA 93108 USA; [Au-Yeung, Byron B.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Microbiol & Immunol, Howard Hughes Med Inst,Dept Med, San Francisco, CA 94143 USA; [Price, Jeffrey D.] Natl Inst Diabet & Digest & Kidney Dis, Immune Tolerance Sect, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Satpathy, Ansuman T.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, Howard Hughes Med Inst, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Washington University (WUSTL)	Anderson, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu	; Tarbell, Kristin/E-6458-2016	Gardner, James/0000-0003-3470-9520; Satpathy, Ansuman/0000-0002-5167-537X; Krawisz, Anna/0000-0002-1462-3773; Au-Yeung, Byron/0000-0002-6446-9102; Tarbell, Kristin/0000-0003-3738-379X	Helmsley Charitable Trust; American Diabetes Association; UCSF Medical Scientist Training Program; UCSF Department of Surgery; National Institute of Diabetes and Digestive and Kidney Diseases, NIH; Network for Pancreatic Organ Donors with Diabetes (nPOD); Juvenile Diabetes Research Foundation International (JDRF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK059958, P30DK063720, ZIADK075065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	Helmsley Charitable Trust; American Diabetes Association(American Diabetes Association); UCSF Medical Scientist Training Program; UCSF Department of Surgery; National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Network for Pancreatic Organ Donors with Diabetes (nPOD); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cheng for critical reading of the manuscript; J. Esensten, J. Bluestone, Q. Tang, H. van Santen, P. Peterson, H. Scott, E. Unanue, D. Mathis, and C. Benoist for reagents and mice, and N. Killeen and the UCSF Transgenic Core for help generating transgenic mice. This work was supported by the US National Institutes of Health AI035297 (M. S. A), DK59958 and DK063720 for core support, the Helmsley Charitable Trust (M. S. A, T. C. M), the American Diabetes Association (J. M. G.), the UCSF Medical Scientist Training Program (J. M. G.), the UCSF Department of Surgery (J. M. G.), and the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH (J. D. P. and K. V. T.). This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project sponsored by the Juvenile Diabetes Research Foundation International (JDRF). Organ Procurement Organizations (OPO) partnering with nPOD to provide research resources are listed at www.jdrfnpod.org/our-partners.php.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Halonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P197, DOI 10.1177/002215540104900207; Hamilton-Williams EE, 2009, J IMMUNOL, V183, P1533, DOI 10.4049/jimmunol.0900428; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Lathrop SK, 2004, J IMMUNOL, V172, P6735, DOI 10.4049/jimmunol.172.11.6735; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Poliani PL, 2010, AM J PATHOL, V176, P1104, DOI 10.2353/ajpath.2010.090956; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Shum AK, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000284; Singh NJ, 2007, J IMMUNOL, V179, P7999, DOI 10.4049/jimmunol.179.12.7999; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	34	98	102	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					560	572		10.1016/j.immuni.2013.08.005	http://dx.doi.org/10.1016/j.immuni.2013.08.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	23993652	Bronze, Green Accepted			2022-12-18	WOS:000330949600018
J	Henrickson, SE; Perro, M; Loughhead, SM; Senman, B; Stutte, S; Quigley, M; Alexe, G; Iannacone, M; Flynn, MP; Omid, S; Jesneck, JL; Imam, S; Mempel, TR; Mazo, IB; Haining, WN; von Andrian, UH				Henrickson, Sarah E.; Perro, Mario; Loughhead, Scott M.; Senman, Balimkiz; Stutte, Susanne; Quigley, Michael; Alexe, Gabriela; Iannacone, Matteo; Flynn, Michael P.; Omid, Shaida; Jesneck, Jonathan L.; Imam, Sabrina; Mempel, Thorsten R.; Mazo, Irina B.; Haining, W. Nicholas; von Andrian, Ulrich H.			Antigen Availability Determines CD8(+) T Cell-Dendritic Cell Interaction Kinetics and Memory Fate Decisions	IMMUNITY			English	Article							LYMPH-NODES; IN-VIVO; TRANSCRIPTION FACTOR; STOP SIGNAL; EFFECTOR; DIFFERENTIATION; TOLERANCE; DYNAMICS; ACTIVATION; INDUCTION	T cells are activated by antigen (Ag)-bearing dendritic cells (DCs) in lymph nodes in three phases. The duration of the initial phase of transient, serial DC-T cell interactions is inversely correlated with Ag dose. The second phase, characterized by stable DC-T cell contacts, is believed to be necessary for full-fledged T cell activation. Here we have shown that this is not the case. CD8(+) T cells interacting with DCs presenting low-dose, short-lived Ag did not transition to phase 2, whereas higher Ag dose yielded phase 2 transition. Both antigenic constellations promoted T cell proliferation and effector differentiation but yielded different transcriptome signatures at 12 hr and 24 hr. T cells that experienced phase 2 developed long-lived memory, whereas conditions without stable contacts yielded immunological amnesia. Thus, T cells make fate decisions within hours after Ag exposure, resulting in long-term memory or abortive effector responses, correlating with T cell-DCs interaction kinetics.	[Henrickson, Sarah E.; Perro, Mario; Loughhead, Scott M.; Senman, Balimkiz; Stutte, Susanne; Iannacone, Matteo; Flynn, Michael P.; Omid, Shaida; Mazo, Irina B.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Quigley, Michael; Alexe, Gabriela; Jesneck, Jonathan L.; Imam, Sabrina; Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Quigley, Michael; Alexe, Gabriela; Jesneck, Jonathan L.; Imam, Sabrina; Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Perro, Mario/AAB-5554-2021; Iannacone, Matteo/I-8507-2018	Perro, Mario/0000-0003-1375-8155; Iannacone, Matteo/0000-0002-9370-2671; Henrickson, Sarah/0000-0001-5569-4132	NIH [AI069259, AI072252]; MSTP at Harvard Medical School; Osaka University Immunology Frontier Research Center (iFREC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072252, P01AI078897, R01AI111595, R01AI069259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP at Harvard Medical School; Osaka University Immunology Frontier Research Center (iFREC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Buschman for assistance with programming and G. Cheng and M. Perdue for technical and secretarial assistance, respectively. This work was supported by NIH grants AI069259 and AI072252 to U. H. v. A. and MSTP funding at Harvard Medical School and a Osaka University Immunology Frontier Research Center (iFREC) Postdoctoral Fellowship to S.E.H.	Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Hugues S, 2010, SEMIN IMMUNOPATHOL, V32, P227, DOI 10.1007/s00281-010-0211-2; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Manly B.F.J., 1997, RANDOMIZATION BOOTST, V2; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tkach K, 2013, CURR OPIN IMMUNOL, V25, P120, DOI 10.1016/j.coi.2012.12.001; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	58	98	101	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					496	507		10.1016/j.immuni.2013.08.034	http://dx.doi.org/10.1016/j.immuni.2013.08.034			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054328	Green Accepted, Bronze			2022-12-18	WOS:000330949600013
J	Suthar, MS; Ramos, HJ; Brassil, MM; Netland, J; Chappell, CP; Blahnik, G; McMillan, A; Diamond, MS; Clark, EA; Bevan, MJ; Gale, M				Suthar, Mehul S.; Ramos, Hilario J.; Brassil, Margaret M.; Netland, Jason; Chappell, Craig P.; Blahnik, Gabriele; McMillan, Aimee; Diamond, Michael S.; Clark, Edward A.; Bevan, Michael J.; Gale, Michael, Jr.			The RIG-I-like Receptor LGP2 Controls CD8(+) T Cell Survival and Fitness	IMMUNITY			English	Article							WEST-NILE-VIRUS; RNA HELICASE LGP2; CLONAL EXPANSION; INNATE IMMUNITY; MEMORY FORMATION; VIRAL-INFECTION; ANTIVIRAL RESPONSES; CUTTING EDGE; REPLICATION; INTERFERON	The RIG-I-like receptors (RLRs) signal innate immune defenses upon RNA virus infection, but their roles in adaptive immunity have not been clearly defined. Here, we showed that the RLR LGP2 was not essential for induction of innate immune defenses, but rather was required for controlling antigen-specific CD8(+) T cell survival and fitness during peripheral T cell-number expansion in response to virus infection. Adoptive transfer and biochemical studies demonstrated that T cell-receptor signaling induced LGP2 expression wherein LGP2 operated to regulate death-receptor signaling and imparted sensitivity to CD95-mediated cell death. Thus, LGP2 promotes an essential prosurvival signal in response to antigen stimulation to confer CD8(+) T cell-number expansion and effector functions against divergent RNA viruses, including West Nile virus and lymphocytic choriomeningitis virus.	[Suthar, Mehul S.; Ramos, Hilario J.; Brassil, Margaret M.; Netland, Jason; Chappell, Craig P.; Blahnik, Gabriele; McMillan, Aimee; Clark, Edward A.; Bevan, Michael J.; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Clark, Edward A.; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Bevan, Michael J.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gale, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	mgale@u.washington.edu	Suthar, Mehul/B-2015-2013; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Clark, Edward A/0000-0001-8061-5475; Gale, Michael/0000-0002-6332-7436	National Institutes of Health [1F32AI081490, R01AI074973, U19AI083019, U54AI081680]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680, U19AI083019, R01AI104002, F32AI081490, R01AI074973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Thomas and M. Kaja for helpful discussion. We thank B. Doehle and S. Homer for comments and manuscript revisions. Work was supported by National Institutes of Health grants 1F32AI081490, R01AI074973, U19AI083019, and U54AI081680.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P720; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107; Zhao Y, 2009, J IMMUNOL, V182, P6278, DOI 10.4049/jimmunol.0803682; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	45	98	100	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					235	248		10.1016/j.immuni.2012.07.004	http://dx.doi.org/10.1016/j.immuni.2012.07.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22841161	Bronze, Green Accepted			2022-12-18	WOS:000308261800009
J	Britten, CM; Janetzki, S; Butterfield, LH; Ferrari, G; Gouttefangeas, C; Huber, C; Kalos, M; Levitsky, HI; Maecker, HT; Melief, CJM; O'Donnell-Tormey, J; Odunsi, K; Old, LJ; Ottenhoff, THM; Ottensmeier, C; Pawelec, G; Roederer, M; Roep, BO; Romero, P; van der Burg, SH; Walter, S; Hoos, A; Davis, MM				Britten, C. M.; Janetzki, S.; Butterfield, L. H.; Ferrari, G.; Gouttefangeas, C.; Huber, C.; Kalos, M.; Levitsky, H. I.; Maecker, H. T.; Melief, C. J. M.; O'Donnell-Tormey, J.; Odunsi, K.; Old, L. J.; Ottenhoff, T. H. M.; Ottensmeier, C.; Pawelec, G.; Roederer, M.; Roep, B. O.; Romero, P.; van der Burg, S. H.; Walter, S.; Hoos, A.; Davis, M. M.			T Cell Assays and MIATA: The Essential Minimum for Maximum Impact	IMMUNITY			English	Letter									[Britten, C. M.] Johannes Gutenberg Univ Mainz gGmbH, Translat Oncol, D-55131 Mainz, Germany; [Janetzki, S.] ZellNet Consulting Inc, Ft Lee, NJ 07024 USA; [Butterfield, L. H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Ferrari, G.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA; [Gouttefangeas, C.] Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany; [Huber, C.] Assoc Canc Immunotherapy, D-55130 Mainz, Germany; [Kalos, M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Levitsky, H. I.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Maecker, H. T.] Stanford Univ, Med Ctr, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Melief, C. J. M.] Leiden Univ, Med Ctr, Dept Immunhematol & Blood Transfus, NL-2300 Leiden, Netherlands; [O'Donnell-Tormey, J.] Inst Canc Res, New York, NY 10006 USA; [Odunsi, K.] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Old, L. J.] MSKCC, Ludwig Inst Canc Res, Lab Human Canc Immunol, New York, NY 10017 USA; [Ottenhoff, T. H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 Leiden, Netherlands; [Ottensmeier, C.] Southampton Univ Hosp, Canc Sci Div, Southampton SO16 6YD, Hants, England; [Ottensmeier, C.] Southampton Univ Hosp, Dept Med Oncol, Southampton SO16 6YD, Hants, England; [Pawelec, G.] Univ Tubingen, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, D-72072 Tubingen, Germany; [Roederer, M.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Roep, B. O.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Natl Diabet Expert Ctr, NL-2300 Leiden, Netherlands; [Romero, P.] Univ Hosp CHUV, Lausanne Branch, Ludwig Inst Canc Res, Div Clin Oncoimmunol, CH-1005 Lausanne, Switzerland; [van der Burg, S. H.] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 Leiden, Netherlands; [Walter, S.] Immat Biotechnol GmbH, D-72076 Tubingen, Germany; [Hoos, A.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Davis, M. M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Johannes Gutenberg University of Mainz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Eberhard Karls University of Tubingen; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Roswell Park Cancer Institute; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Southampton; University of Southampton; Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Immatics Biotechnologies GmbH; GlaxoSmithKline; Howard Hughes Medical Institute; Stanford University	Britten, CM (corresponding author), Johannes Gutenberg Univ Mainz gGmbH, Translat Oncol, D-55131 Mainz, Germany.	cedrik.britten@tron-mainz.de	Roep, Bart/AAD-7609-2021; Butterfield, Lisa H./W-1564-2019; Ottensmeier, Christian H/E-8131-2012; Ottensmeier, Christian/ABE-9056-2020; Pawelec, Graham/H-2713-2019; van der Burg, Sjoerd H/T-1875-2017; Roederer, Mario/G-1887-2011; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015	Butterfield, Lisa H./0000-0002-3439-9844; Ottensmeier, Christian H/0000-0003-3619-1657; Ottensmeier, Christian/0000-0003-3619-1657; Pawelec, Graham/0000-0002-3600-0163; van der Burg, Sjoerd H/0000-0002-6556-0354; Ferrari, Guido/0000-0001-7747-3349; Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005101, ZIAAI005020] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Britten CM, 2011, CANCER IMMUNOL IMMUN, V60, P15, DOI 10.1007/s00262-010-0940-z; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Hoos A, 2011, NAT BIOTECHNOL, V29, P867, DOI 10.1038/nbt.2000; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Roep B, 2012, NAT MED, V18, P48, DOI 10.1038/nm.2626; Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; van der Burg SH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002785	9	98	101	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					1	2		10.1016/j.immuni.2012.07.010	http://dx.doi.org/10.1016/j.immuni.2012.07.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840835	hybrid			2022-12-18	WOS:000307133200001
J	Harada, Y; Tanaka, S; Motomura, Y; Harada, Y; Ohno, S; Ohno, S; Yanagi, Y; Inoue, H; Kubo, M				Harada, Yohsuke; Tanaka, Shinya; Motomura, Yasutaka; Harada, Yasuyo; Ohno, Shin-ichiro; Ohno, Shinji; Yanagi, Yusuke; Inoue, Hiromasa; Kubo, Masato			The 3 ' Enhancer CNS2 Is a Critical Regulator of Interleukin-4-Mediated Humoral Immunity in Follicular Helper T Cells	IMMUNITY			English	Article							CENTER B-CELL; CUTTING EDGE; MAST-CELLS; CYTOKINE PRODUCTION; SIGNALING PATHWAY; T(H)2 CELLS; DIFFERENTIATION; GENE; EXPRESSION; RESPONSES	A main role for interleukin-4 (IL-4) is in humoral immunity, and follicular helper CD4(+) T (Tfh) cells may be an intrinsic IL-4 source. Here we demonstrate that conserved noncoding sequence 2 (CNS2) is an essential enhancer element for IL-4 expression in Tfh cells but not in Th2 cells. Mice with a CNS2 deletion had a reduction in IgG1 and IgE production and in IL-4 expression in Tfh cells. Tracking of CNS2 activity via a GFP reporter mouse demonstrated that CNS2-active cells expressed several markers of Tfh cells: CXCR5, PD-1, and ICOS; the transcriptional master regulator Bcl6; and the cytokines IL-21 and IL-4. These CNS2-active cells were mainly localized in B cell follicles and germinal centers. The GFP(+) Tfh cells were derived from GFP(-) naive T cells after in vivo systemic immunization. These results indicate that CNS2 is an essential enhancer element required for IL-4 expression in Tfh cells controlling humoral immunity.	[Harada, Yohsuke; Motomura, Yasutaka; Harada, Yasuyo; Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Noda, Chiba 2780022, Japan; [Tanaka, Shinya] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Motomura, Yasutaka; Ohno, Shin-ichiro; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa 2300045, Japan; [Ohno, Shinji; Yanagi, Yusuke] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan; [Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 8908520, Japan	Tokyo University of Science; University of Texas System; UTMD Anderson Cancer Center; RIKEN; Kyushu University; Kagoshima University	Kubo, M (corresponding author), Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, 2669 Yamazaki, Noda, Chiba 2780022, Japan.	raysolfc@rcai.riken.jp	慎一郎, 大野/AAI-7736-2021; Kubo, Masato/A-5918-2016	Harada, Yohsuke/0000-0002-8023-1030; Yanagi, Yusuke/0000-0001-7815-1667	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Takeda foundation; Research Associate grant at TUS	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Takeda foundation; Research Associate grant at TUS	We thank H. Fujimoto, Y. Hachiman, Y. Suzuki, and K. Ikari for technical support and animal maintenance. We thank P. Burrows for helpful comments on the manuscript. This work was supported by a Grant-in-Aid-of-Scientific Research in Priority Areas of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Takeda foundation. Y.M. is a recipient of Research Associate grant at TUS.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; ESSER C, 1989, EMBO J, V8, P483, DOI 10.1002/j.1460-2075.1989.tb03401.x; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sofi MH, 2011, J IMMUNOL, V186, P2792, DOI 10.4049/jimmunol.1003353; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	98	99	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					188	200		10.1016/j.immuni.2012.02.002	http://dx.doi.org/10.1016/j.immuni.2012.02.002			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365664	Bronze			2022-12-18	WOS:000300812400008
J	Mercer, EM; Lin, YC; Benner, C; Jhunjhunwala, S; Dutkowski, J; Flores, M; Sigvardsson, M; Ideker, T; Glass, CK; Murre, C				Mercer, Elinore M.; Lin, Yin C.; Benner, Christopher; Jhunjhunwala, Suchit; Dutkowski, Janusz; Flores, Martha; Sigvardsson, Mikael; Ideker, Trey; Glass, Christopher K.; Murre, Cornelis			Multilineage Priming of Enhancer Repertoires Precedes Commitment to the B and Myeloid Cell Lineages in Hematopoietic Progenitors	IMMUNITY			English	Article							GENE-EXPRESSION; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; E2A PROTEINS; HUMAN GENOME; DNA-BINDING; STEM-CELLS; DIFFERENTIATION; IDENTIFICATION; CHROMATIN	Recent studies have documented genome-wide binding patterns of transcriptional regulators and their associated epigenetic marks in hematopoietic cell lineages. In order to determine how epigenetic marks are established and maintained during developmental progression, we have generated long-term cultures of hematopoietic progenitors by enforcing the expression of the E-protein antagonist Id2. Hematopoietic progenitors that express Id2 are multipotent and readily differentiate upon withdrawal of Id2 expression into committed B lineage cells, thus indicating a causative role for E2A (Tcf3) in promoting the B cell fate. Genome-wide analyses revealed that a substantial fraction of lymphoid and myeloid enhancers are premarked by the poised or active enhancer mark H3K4me1 in multipotent progenitors. Thus, in hematopoietic progenitors, multilineage priming of enhancer elements precedes commitment to the lymphoid or myeloid cell lineages.	[Mercer, Elinore M.; Lin, Yin C.; Jhunjhunwala, Suchit; Flores, Martha; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Benner, Christopher; Dutkowski, Janusz; Ideker, Trey; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Sigvardsson, Mikael] Linkoping Univ, Dept Clin & Expt Sci, S-58183 Linkoping, Sweden	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Linkoping University	Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu	Glass, Christopher/AAI-3933-2021; Jhunjhunwala, Suchit/GNH-2256-2022	Glass, Christopher/0000-0003-4344-3592; Jhunjhunwala, Suchit/0000-0003-3484-0588; Benner, Christopher/0000-0002-4618-0719; Ideker, Trey/0000-0002-1708-8454; Lin, Yin/0000-0003-4925-5453; Sigvardsson, Mikael/0000-0001-8527-7276	NIH [P01DK074868, CA52599, CA054198-20]; Ruth L. Kirschstein Research Service Award [1F32CA130276]; NSF [NSF IIS-0803937]; BIOGEM [DK063491]; NATIONAL CANCER INSTITUTE [R01CA052599, R01CA054198, R37CA054198, R01CA078384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, P30DK063491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BIOGEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Hardiman, C. Ludka, J. Sprague, M. Harabaglia, and Z. Ye for help with Solexa DNA Sequencing. We are grateful to J. Sprague for microarray analysis. We thank the members of the C.M. laboratory for comments on the manuscript. E.M.M. was supported by a training grant from the NIH. Y.C.L. was supported by the Ruth L. Kirschstein Research Service Award (1F32CA130276). The studies were supported by grants from the NSF (NSF IIS-0803937) to T.I. and from the NIH to C.B. (P01DK074868), C.K.G. (CA52599), and C.M. (CA054198-20) and BIOGEM DK063491 to the University of California, San Diego Core Facility.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rivera R, 2001, ONCOGENE, V20, P8308, DOI 10.1038/sj.onc.1205091; RIVERA RR, 1993, MOL CELL BIOL, V13, P7163, DOI 10.1128/MCB.13.11.7163; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031	41	98	100	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					413	425		10.1016/j.immuni.2011.06.013	http://dx.doi.org/10.1016/j.immuni.2011.06.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21903424	Green Accepted, Bronze			2022-12-18	WOS:000295748100012
J	Wun, KS; Cameron, G; Patel, O; Pang, SS; Pellicci, DG; Sullivan, LC; Keshipeddy, S; Young, MH; Uldrich, AP; Thakur, MS; Richardson, SK; Howell, AR; Illarionov, PA; Brooks, AG; Besra, GS; McCluskey, J; Gapin, L; Porcelli, SA; Godfrey, DI; Rossjohn, J				Wun, Kwok S.; Cameron, Garth; Patel, Onisha; Pang, Siew Siew; Pellicci, Daniel G.; Sullivan, Lucy C.; Keshipeddy, Santosh; Young, Mary H.; Uldrich, Adam P.; Thakur, Meena S.; Richardson, Stewart K.; Howell, Amy R.; Illarionov, Petr A.; Brooks, Andrew G.; Besra, Gurdyal S.; McCluskey, James; Gapin, Laurent; Porcelli, Steven A.; Godfrey, Dale I.; Rossjohn, Jamie			A Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T Cells	IMMUNITY			English	Article							NKT CELLS; RECOGNITION; RECEPTOR; TCR; ACTIVATION; KINETICS; LIGANDS; SELECTION; VARIANTS; AFFINITY	Natural killer T (NKT) cells respond to a variety of CD1d-restricted antigens (Ags), although the basis for Ag discrimination by the NKT cell receptor (TCR) is unclear. Here we have described NKT TCR fine specificity against several closely related Ags, termed altered glycolipid ligands (AGLs), which differentially stimulate NKT cells. The structures of five ternary complexes all revealed similar docking. Acyl chain modifications did not affect the interaction, but reduced NKT cell proliferation, indicating an affect on Ag processing or presentation. Conversely, truncation of the phytosphingosine chain caused an induced fit mode of TCR binding that affected TCR affinity. Modifications in the glycosyl head group had a direct impact on the TCR interaction and associated cellular response, with ligand potency reflecting the t(1/2) life of the interaction. Accordingly, we have provided a molecular basis for understanding how modifications in AGLs can result in striking alterations in the cellular response of NKT cells.	[Cameron, Garth; Pellicci, Daniel G.; Sullivan, Lucy C.; Uldrich, Adam P.; Brooks, Andrew G.; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Wun, Kwok S.; Patel, Onisha; Pang, Siew Siew; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Prot Crystallog Unit, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia; [Keshipeddy, Santosh; Thakur, Meena S.; Richardson, Stewart K.; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Young, Mary H.; Gapin, Laurent] Univ Colorado Denver, Dept Immunol, Denver, CO 80206 USA; [Young, Mary H.; Gapin, Laurent] Natl Jewish Hlth, Denver, CO 80206 USA; [Illarionov, Petr A.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	University of Melbourne; Monash University; University of Connecticut; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Birmingham; Yeshiva University; Albert Einstein College of Medicine	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Pellicci, Daniel/AAX-8539-2020; Uldrich, Adam/AAX-3785-2020	McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Patel, Onisha/0000-0001-6701-7139; Howell, Amy/0000-0003-1958-6411; Cameron, Garth/0000-0003-0778-3506; Godfrey, Dale/0000-0002-3009-5472; Sullivan, Lucy/0000-0003-2907-4989; Wun, Kwok/0000-0002-1908-4596; Pellicci, Daniel/0000-0001-5305-2398; ULDRICH, ADAM/0000-0002-6350-5976; Brooks, Andrew/0000-0002-4085-9683; keshipeddy, santosh/0000-0002-9375-2230; Besra, Gurdyal/0000-0002-5605-0395	Cancer Council of Victoria; National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; CRI; NIH [AI45889, R01GM087136, AI076463, AI078246, T32 AI07405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078246, R21AI076463, R01AI045889, T32AI007405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136] Funding Source: NIH RePORTER	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); CRI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Australian synchrotron for assistance with data collection. We also thank D. Taylor, S. Chakravarti, and K. Field for assistance. We are grateful to P. Savage for generously providing alpha-GalCer (PBS44) for CD1d tetramer loading. This work was supported by the Cancer Council of Victoria, the National Health and Medical Research Council of Australia (NHMRC), and the Australian Research Council. G.C. is supported by CRI predoctoral scholarship and L.C.S. by an NHMRC RD Wright Fellowship. SAP. was supported by NIH grant AI45889. A.R.H. was supported by NIH grant R01GM087136. L.G. is supported by NIH grants (AI076463 and AI078246) and M.H.Y. by NIH training grant T32 AI07405. D.I.G. is supported by an NHMRC Principal Research Fellowship; J.R. is supported by an ARC Federation Fellowship. S.A.P. has received payments as a consultant for Vaccinex, Inc. (Rochester, NY) for work related to the development of therapeutics based on CD1d-pretreated glycolipids.	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Jervis PJ, 2010, BIOORG MED CHEM LETT, V20, P3475, DOI 10.1016/j.bmcl.2010.05.010; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Raju R, 2009, BIOORG MED CHEM LETT, V19, P4122, DOI 10.1016/j.bmcl.2009.06.005; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; SLOANLANCASTER J, 2003, ANNU REV IMMUNOL, V14, P1; Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102	40	98	99	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					327	339		10.1016/j.immuni.2011.02.001	http://dx.doi.org/10.1016/j.immuni.2011.02.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21376639	Green Accepted, Bronze			2022-12-18	WOS:000289014500009
J	Hirahashi, J; Mekala, D; Van Ziffle, J; Xiao, L; Saffaripour, S; Wagner, DD; Shapiro, SD; Lowell, C; Mayadas, TN				Hirahashi, Junichi; Mekala, Divya; Van Ziffle, Jessica; Xiao, Ling; Saffaripour, Simin; Wagner, Denisa D.; Shapiro, Steven D.; Lowell, Clifford; Mayadas, Tanya N.			Mac-1 signaling via Src-farnily and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy	IMMUNITY			English	Article							FC-GAMMA RECEPTOR; FAMILY KINASES; LEUKOCYTE ADHESION; HUMAN NEUTROPHILS; POLYMORPHONUCLEAR LEUKOCYTES; COMPLEMENT ACTIVATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL ADHESION; SHWARTZMAN REACTION; CELL ACTIVATION	CD18 integrins promote neutrophil recruitment, and their engagement activates tyrosine kinases, leading to neutrophil activation. However, the significance of integrin-dependent leukocyte activation in vivo has been difficult to prove. Here, in a model of thrombo-hemorrhagic vasculitis, the CD18 integrin Mac-1 on neutrophils recognized complement C3 deposited within vessel walls and triggered a signaling pathway involving the Src-famlly kinase Hck and the Syk tyrosine kinase. This led to neutrophil elastase release, causing hemorrhage, fibrin deposition, and thrombosis. Mice genetically deficient in any of these components (C3, Mac-1, Hck, Syk, or elastase) were resistant to disease despite normal tissue neutrophil accumulation. Disease was restored in Mac-1-deficient mice infused with wild-type, but not kinase- or elastase-deficient, neutrophils. Elastase release in the inflamed tissue was reduced in Mac-1-deficient mice, and a deficiency of Mac-1 or the kinases blocked neutrophil elastase release in vitro. These data suggest that Mac-1 engagement of complement activates tyrosine kinases to promote elastase-dependent blood vessel injury in vivo.	Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Biomed Res Inst, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of California System; University of California San Francisco	Mayadas, TN (corresponding author), Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, 75 Francis St, Boston, MA 02115 USA.	tmayadas@rics.bwh.harvard.edu			NHLBI NIH HHS [R37 HL41002, T32HL07627, R01 HL54853, R01 HL041002] Funding Source: Medline; NIAID NIH HHS [R01 AI068150, AI065495] Funding Source: Medline; NIAMS NIH HHS [R01 AR050800] Funding Source: Medline; NIDDK NIH HHS [DK51643] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054853, R37HL041002, T32HL007627, R01HL041002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068150, R01AI065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051643] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786; Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4; ARGENBRIGHT LW, 1992, J CLIN INVEST, V89, P259, DOI 10.1172/JCI115570; ARNAOUT MA, 1990, BLOOD, V75, P1037; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bouchard BA, 2001, CURR OPIN HEMATOL, V8, P263, DOI 10.1097/00062752-200109000-00001; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BROZNA JP, 1990, SEMIN THROMB HEMOST, V16, P326, DOI 10.1055/s-2007-1002685; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Caveggion E, 2003, J CELL PHYSIOL, V195, P276, DOI 10.1002/jcp.10236; CHANG HR, 1993, J LEUKOCYTE BIOL, V53, P636, DOI 10.1002/jlb.53.6.636; Chen KR, 2002, BRIT J DERMATOL, V147, P905, DOI 10.1046/j.1365-2133.2002.04933.x; CHENOWETH DE, 1981, NEW ENGL J MED, V304, P497, DOI 10.1056/NEJM198102263040901; COLTEN HR, 1986, CIBA F SYMP, V118, P141, DOI 10.1002/9780470720998.ch10; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Danning Carol L., 1998, Current Opinion in Rheumatology, V10, P58; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; FONG JSC, 1971, J EXP MED, V134, P642, DOI 10.1084/jem.134.3.642; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Gasser O, 2005, EXP CELL RES, V307, P381, DOI 10.1016/j.yexcr.2005.03.011; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Kakkar AK, 2004, CURR OPIN PHARMACOL, V4, P154, DOI 10.1016/j.coph.2004.01.003; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Kawakami Y, 1997, CANCER LETT, V116, P21, DOI 10.1016/S0304-3835(97)04737-X; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; MARKS RM, 1989, NATURE, V339, P314, DOI 10.1038/339314a0; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; MOHN H, 1995, BIOCHEM J, V309, P657; MOVAT HZ, 1985, AM J PATHOL, V121, P404; Newbrough SA, 2003, IMMUNITY, V19, P759; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; PHILIPS MR, 1989, CLIN ASPECTS AUTOIMM, V3, P6; Prins M, 1996, BRIT J DERMATOL, V134, P915; Riedle B, 1997, AM J PATHOL, V151, P215; Riemekasten G, 2002, LUPUS, V11, P204, DOI 10.1191/0961203302lu193xx; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; SINCLAIR RA, 1981, J CLIN PATHOL, V34, P859, DOI 10.1136/jcp.34.8.859; SKLAR LA, 1982, J BIOL CHEM, V257, P5471; STETSON CA, 1951, J EXP MED, V93, P49, DOI 10.1084/jem.93.1.49; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; THORBECKE G. J., 1965, CIBA FOUND SYMP, P99, DOI 10.1002/9780470719381.ch5; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Vicentini L, 2002, J IMMUNOL, V168, P6446, DOI 10.4049/jimmunol.168.12.6446; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WRIGHT SD, 1984, NATURE, V309, P359, DOI 10.1038/309359a0; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Zhou JS, 2003, J EXP MED, V198, P1243, DOI 10.1084/jem.20030906	67	98	101	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					271	283		10.1016/j.immuni.2006.05.014	http://dx.doi.org/10.1016/j.immuni.2006.05.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16872848	Bronze			2022-12-18	WOS:000240047500013
J	Xiong, N; Kang, CL; Raulet, DH				Xiong, N; Kang, CL; Raulet, DH			Positive selection of dendritic epidermal gamma delta T cell precursors in the fetal thymus determines expression of skin-homing receptors	IMMUNITY			English	Article							CHEMOKINE RECEPTOR; CUTTING EDGE; JUNCTIONAL SEQUENCES; ANTIGEN RECEPTORS; LANGERHANS CELLS; MICE; REARRANGEMENT; MATURATION; GENES; REGION	The role of cellular selection in the development of gammadelta T cells remains unclear. Knockout mice lacking a subset of Vgamma genes, including Vgamma3, contain abundant gammadelta T cells but are devoid of dendritic epidermal gammadeltaT cells (DETCs), which normally express an invariant Vgamma3/Vdelta1 gammadelta TCR. A rearranged Vgamma2 transgene restored DETC development, but the restored DETCs selectively expressed a unique Vdelta gene other than Vdelta1, indicating that DETC development involves TCR-based selection. In both normal and transgenic/knockout mice, specific DETC precursors in the fetal thymus were activated and expressed the IL-15 receptor beta chain, skin-homing receptors, and thymic exiting receptors. In vitro activation of irrelevant precursors also led to upregulation of the skin-homing receptor, providing an explanation for how thymic selection is coordinated with development of epidermal gammadelta T cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 489 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu		Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031650] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI31650] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1993, CURR OPIN IMMUNOL, V5, P241, DOI 10.1016/0952-7915(93)90011-G; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Baker JE, 1998, IMMUNITY, V9, P159, DOI 10.1016/S1074-7613(00)80598-1; BONNEVILLE M, 1990, J EXP MED, V171, P1015, DOI 10.1084/jem.171.4.1015; Campbell JJ, 1999, J IMMUNOL, V163, P2353; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; Chu CL, 1999, J IMMUNOL, V162, P1896; Coligan JKA, 1991, CURRENT PROTOCOLS IM; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; Dieli F, 1997, EUR J IMMUNOL, V27, P206, DOI 10.1002/eji.1830270131; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; FERRI M, 1989, DIRITTO SOC, V1, P1; Fujise S, 1997, EUR J IMMUNOL, V27, P2549, DOI 10.1002/eji.1830271013; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hara H, 2000, J IMMUNOL, V165, P3695, DOI 10.4049/jimmunol.165.7.3695; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jarmin DI, 2000, J IMMUNOL, V164, P3460, DOI 10.4049/jimmunol.164.7.3460; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kawai K, 1998, J INVEST DERMATOL, V110, P961, DOI 10.1046/j.1523-1747.1998.00214.x; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Minagawa M, 2001, J DERMATOL SCI, V25, P150, DOI 10.1016/S0923-1811(00)00119-5; MIYAUCHI S, 1987, J INVEST DERMATOL, V88, P703, DOI 10.1111/1523-1747.ep12470379; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Pereira P, 2000, EUR J IMMUNOL, V30, P1988, DOI 10.1002/1521-4141(200007)30:7<1988::AID-IMMU1988>3.0.CO;2-W; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Sperling AI, 1997, J IMMUNOL, V159, P86; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Weigmann B, 1997, SCAND J IMMUNOL, V45, P308, DOI 10.1046/j.1365-3083.1997.d01-402.x; WELLS FB, 1993, J EXP MED, V177, P1061, DOI 10.1084/jem.177.4.1061; WELLS FB, 1991, SCIENCE, V253, P903, DOI 10.1126/science.1831565; Witherden DA, 2000, J IMMUNOL, V165, P1902, DOI 10.4049/jimmunol.165.4.1902; Xiong N, 2004, P NATL ACAD SCI USA, V101, P260, DOI 10.1073/pnas.0303738101; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; ZHANG Y, 1995, IMMUNITY, V3, P439, DOI 10.1016/1074-7613(95)90173-6	53	98	100	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					121	131		10.1016/j.immuni.2004.06.008	http://dx.doi.org/10.1016/j.immuni.2004.06.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345225	Bronze			2022-12-18	WOS:000222975500013
J	Sanui, T; Inayoshi, A; Noda, M; Iwata, E; Oike, M; Sasazuki, T; Fukui, Y				Sanui, T; Inayoshi, A; Noda, M; Iwata, E; Oike, M; Sasazuki, T; Fukui, Y			DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells	IMMUNITY			English	Article							EXCHANGE FACTOR VAV; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; RECEPTOR SIGNALS; MYOBLAST CITY; ACTIVATION; PROTEIN; THYMOCYTES; REORGANIZATION; COSTIMULATION	DOCK2 is a mammalian homolog of Caenorhabditis elegans CED-5 and Drosophila melanogaster Myoblast City which are known to regulate actin cytoskeleton. DOCK2 is critical for lymphocyte migration, yet the role of DOCK2 in TCR signaling remains unclear. We show here that DOCK2 is essential for TCR-mediated Rac activation and immunological synapse formation. In DOCK2-deficient T cells, antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, to the APC interface was severely impaired, resulting in a significant reduction of antigen-specific T cell proliferation. In addition, we found that the efficacy of both positive and negative selection was reduced in DOCK2-deficient mice. These results suggest that DOCK2 regulates T cell responsiveness through remodeling of actin cytoskeleton via Rac activation.	Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Pharmacol, Fukuoka 8128582, Japan; Int Med Ctr Japan, Tokyo 1628655, Japan	Kyushu University; Kyushu University; National Center for Global Health & Medicine - Japan	Fukui, Y (corresponding author), Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan.			Fukui, Yoshinori/0000-0003-2335-8745				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Kovacs B, 2002, P NATL ACAD SCI USA, V99, P15006, DOI 10.1073/pnas.232058599; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; SPAIN LM, 1994, J IMMUNOL, V152, P1709; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	56	98	100	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					119	129		10.1016/S1074-7613(03)00169-9	http://dx.doi.org/10.1016/S1074-7613(03)00169-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871644	Bronze			2022-12-18	WOS:000184260400013
J	Beutler, B				Beutler, B			Autoimmunity and apoptosis: The Crohn's connection	IMMUNITY			English	Review							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; RIP-LIKE KINASE; NF-KAPPA-B; DEATH DOMAIN; CONFERS RESPONSIVENESS; MONOCLONAL-ANTIBODY; DIABETES-MELLITUS; CD95 FAS/APO-1		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu						ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aksentijevich I, 1997, CELL, V90, P797; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Beutler B, 1998, BLOOD CELL MOL DIS, V24, P216, DOI 10.1006/bcmd.1998.0187; Bhan A K, 2000, Int Rev Immunol, V19, P123, DOI 10.3109/08830180009048393; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brown GR, 1998, DIABETOLOGIA, V41, P1502, DOI 10.1007/s001250051097; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; COUTINHO A, 1978, IMMUNOGENETICS, V7, P17, DOI 10.1007/BF01843983; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; DIAZLAVIADA I, 1991, HISTOCHEM J, V23, P221, DOI 10.1007/BF01462244; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; HEPPNER G, 1965, J BACTERIOL, V90, P696, DOI 10.1128/JB.90.3.696-703.1965; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; KRIEGSMANN J, 1993, CELL MOL BIOL, V39, P791; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; MUNICIO AM, 1990, ADV EXP MED BIOL, V256, P199; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POYET JL, 2001, J BIOL CHEM; RALPH P, 1977, J IMMUNOL, V119, P950; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; ROTHGEB CL, 1984, BEHAV SOC SCI LIBR, V3, P1, DOI 10.1300/J103v03n04_01; Schaible T F, 2000, Can J Gastroenterol, V14 Suppl C, p29C; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; VANKRUININGEN HJ, 1986, DIGEST DIS SCI, V31, P1351, DOI 10.1007/BF01299814; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang J, 1997, CURR OPIN IMMUNOL, V9, P818, DOI 10.1016/S0952-7915(97)80184-7; Wang Y, 1997, AM J PATHOL, V151, P1791; WARNER SJC, 1985, BIOCHEM J, V232, P379, DOI 10.1042/bj2320379; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEEL JFL, 1989, INFECT IMMUN, V57, P3395, DOI 10.1128/IAI.57.11.3395-3402.1989; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhou T, 1996, J IMMUNOL, V156, P2661; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	74	98	100	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					5	14		10.1016/S1074-7613(01)00176-5	http://dx.doi.org/10.1016/S1074-7613(01)00176-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485733	Bronze			2022-12-18	WOS:000170153300002
J	Lee, J; Desiderio, S				Lee, J; Desiderio, S			Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair	IMMUNITY			English	Article							STRAND BREAK REPAIR; B-PRECURSOR CELLS; DEPENDENT KINASES; RETINOBLASTOMA PROTEIN; GENE REARRANGEMENT; G(1) ARREST; S-PHASE; SIGNAL; RECEPTOR; COMPLEX	Accumulation of the V(D)J recombinase protein RAG-P is restricted to G0/G1 cells by phosphorylation-mediated degradation at the G1-S boundary. Here cyclin A/CDK2 is shown to oppose RAG-2 accumulation; conversely, RAG-2 is induced by p27(Kip1) and related CDK inhibitors. Coinduction of RAG-P and G1 delay by p27(Kip1) is accompanied by strong stimulation of V(D)J recombination. Unexpectedly, induction of RAG-2 accumulation in the absence of G1 delay has no effect on recombination frequency. p27(Kip1) may stimulate V(D)J recombination by coordinating accumulation of RAGE with prolongation of G1, when nonhomologous end joining is preferentially active. Consistent with this, enforced expression of RAG-2 throughout cell cycle is associated with accumulation of aberrant recombination products reminiscent of those formed in the absence of nonhomologous end joining.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.							BELMAAZA A, 1994, EMBO J, V13, P5355, DOI 10.1002/j.1460-2075.1994.tb06870.x; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CARROLL AM, 1993, MOL CELL BIOL, V13, P3632, DOI 10.1128/MCB.13.6.3632; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; ELDEIRY WS, 1994, CANCER RES, V54, P1169; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; HARPER JW, 1993, CELL, V75, P805; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Higashi H, 1996, EUR J BIOCHEM, V237, P460, DOI 10.1111/j.1432-1033.1996.0460k.x; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Itoh N, 1996, INT IMMUNOL, V8, P317, DOI 10.1093/intimm/8.3.317; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Umezu K, 1998, GENETICS, V148, P989; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; YASUNAGA M, 1995, J EXP MED, V182, P315, DOI 10.1084/jem.182.2.315; ZerfassThome K, 1997, MOL CELL BIOL, V17, P407, DOI 10.1128/MCB.17.1.407	55	98	99	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					771	781		10.1016/S1074-7613(00)80151-X	http://dx.doi.org/10.1016/S1074-7613(00)80151-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626899	Bronze			2022-12-18	WOS:000084612900013
J	Klinman, DM; Verthelyi, D; Takeshita, F; Ishii, KJ				Klinman, DM; Verthelyi, D; Takeshita, F; Ishii, KJ			Immune recognition of foreign DNA: A cure for bioterrorism?	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; CPG-CONTAINING OLIGODEOXYNUCLEOTIDES; INDUCE AUTOIMMUNE-DISEASE; CYTOKINE GENE-EXPRESSION; B SURFACE-ANTIGEN; BACTERIAL-DNA; IMMUNOSTIMULATORY DNA; PLASMID DNA; PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES; CUTTING EDGE		US FDA, Sect Retroviral Immunol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Klinman, DM (corresponding author), US FDA, Sect Retroviral Immunol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	klinman@CBER.FDA.GOV	Ishii, Ken J/B-1685-2012	Ishii, Ken J/0000-0002-6728-3872				ALTAS RM, 1998, CRIT REV MICROBIOL, V24, P157; Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; Ballas ZK, 1996, J IMMUNOL, V157, P1840; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Boyer JD, 1997, NAT MED, V3, P526, DOI 10.1038/nm0597-526; Branda RF, 1996, J LAB CLIN MED, V128, P329, DOI 10.1016/S0022-2143(96)90035-9; Calarota S, 1998, LANCET, V351, P1320, DOI 10.1016/S0140-6736(97)09440-3; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Cohen AD, 1998, FASEB J, V12, P1611, DOI 10.1096/fasebj.12.15.1611; Davis HL, 1997, SPRINGER SEMIN IMMUN, V19, P195, DOI 10.1007/BF00870268; Davis HL, 1998, J IMMUNOL, V160, P870; DAVIS HL, 1999, IN PRESS CURR TOP MI; EFFROS RB, 1983, IMMUNOLOGY, V49, P387; Elkins KL, 1999, J IMMUNOL, V162, P2291; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; Gilkeson GS, 1998, J IMMUNOL, V161, P3890; GILKESON GS, 1993, CLIN IMMUNOL IMMUNOP, V68, P283, DOI 10.1006/clin.1993.1129; Gu ML, 1999, VACCINE, V17, P340, DOI 10.1016/S0264-410X(98)00210-2; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; HADDEN JW, 1993, IMMUNOL TODAY, V14, P275, DOI 10.1016/0167-5699(93)90045-M; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Hartmann G, 1996, MOL MED, V2, P429, DOI 10.1007/BF03401902; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; HENGGE UR, 1995, NAT GENET, V10, P161, DOI 10.1038/ng0695-161; Horner AA, 1998, CELL IMMUNOL, V190, P77, DOI 10.1006/cimm.1998.1400; Ishii KJ, 1999, GENE THER, V6, P237, DOI 10.1038/sj.gt.3300799; Iwasaki A, 1997, J IMMUNOL, V158, P4591; Jakob T, 1998, J IMMUNOL, V161, P3042; Johnston SA, 1997, VACCINE, V15, P808, DOI 10.1016/S0264-410X(96)00276-9; KATSUMI A, 1994, HUM GENE THER, V5, P1335, DOI 10.1089/hum.1994.5.11-1335; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Klinman DM, 1998, ANTISENSE NUCLEIC A, V8, P181, DOI 10.1089/oli.1.1998.8.181; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Klinman DM, 1997, J IMMUNOL, V158, P3635; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Kovarik J, 1999, J IMMUNOL, V162, P1611; KRIEG AM, 1995, J CLIN IMMUNOL, V15, P284, DOI 10.1007/BF01541318; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Liang H, 1996, J CLIN INVEST, V98, P1119, DOI 10.1172/JCI118894; Lipford GB, 1997, EUR J IMMUNOL, V27, P2340, DOI 10.1002/eji.1830270931; Liu MA, 1998, ADV EXP MED BIOL, V452, P187; MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419; MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5; Martin T, 1999, HUM GENE THER, V10, P759, DOI 10.1089/10430349950018517; McCluskie MJ, 1998, J IMMUNOL, V161, P4463; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Moldoveanu Z, 1998, VACCINE, V16, P1216, DOI 10.1016/S0264-410X(98)80122-9; Monteith DK, 1997, ANTI-CANCER DRUG DES, V12, P421; Monteith DK, 1999, TOXICOL PATHOL, V27, P307, DOI 10.1177/019262339902700306; Mor G, 1997, HUM GENE THER, V8, P293, DOI 10.1089/hum.1997.8.3-293; Noll A, 1999, EUR J IMMUNOL, V29, P986, DOI 10.1002/(SICI)1521-4141(199903)29:03<986::AID-IMMU986>3.0.CO;2-9; Okada E, 1997, J IMMUNOL, V159, P3638; PAGANELLI R, 1994, AGING-CLIN EXP RES, V6, P143, DOI 10.1007/BF03324229; Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1; Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Seelos C, 1999, NATURE, V398, P187, DOI 10.1038/18292; Segal BM, 1997, J IMMUNOL, V158, P5087; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; SPRWASSER T, 1999, IN PRESS CURR TOP MI; Stacey KJ, 1996, J IMMUNOL, V157, P2116; STEIN CA, 1993, SCIENCE, V261, P1004, DOI 10.1126/science.8351515; STEINBERG AD, 1990, IMMUNOL REV, V118, P129, DOI 10.1111/j.1600-065X.1990.tb00815.x; Sun SQ, 1997, J IMMUNOL, V159, P3119; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1997, VACCINE, V15, P839, DOI 10.1016/S0264-410X(96)00256-3; Vanderzanden L, 1998, VIROLOGY, V246, P134, DOI 10.1006/viro.1998.9176; WAGNER H, 1999, IN PRESS ADV IMMUNOL; Wang B, 1995, AIDS, V9 Suppl A, pS159; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weeratna R, 1998, ANTISENSE NUCLEIC A, V8, P351, DOI 10.1089/oli.1.1998.8.351; Weiss WR, 1998, J IMMUNOL, V161, P2325; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; XIANG ZQ, 1995, VIROLOGY, V209, P569, DOI 10.1006/viro.1995.1289; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; Yi AK, 1996, J IMMUNOL, V157, P5394; Yi AK, 1996, J IMMUNOL, V157, P4918; Yi AK, 1998, J IMMUNOL, V161, P4493; Yi AK, 1998, J IMMUNOL, V160, P4755; Zimmermann S, 1998, J IMMUNOL, V160, P3627	90	98	120	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					123	129		10.1016/S1074-7613(00)80087-4	http://dx.doi.org/10.1016/S1074-7613(00)80087-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485647	Bronze			2022-12-18	WOS:000082383400001
J	Ardouin, L; Luche, H; Chelbi, R; Carpentier, S; Shawket, A; Sanchis, FM; Maria, CS; Grenot, P; Alexandre, Y; Gregoire, C; Fries, A; Manh, TPV; Tamoutounour, S; Crozat, K; Tomasello, E; Jorquera, A; Fossum, E; Bogen, B; Azukizawa, H; Bajenoff, M; Henri, S; Dalod, M; Malissen, B				Ardouin, Laurence; Luche, Herve; Chelbi, Rabie; Carpentier, Sabrina; Shawket, Alaa; Sanchis, Frederic Montanana; Maria, Camille Santa; Grenot, Pierre; Alexandre, Yannick; Gregoire, Claude; Fries, Anissa; Thien-Phong Vu Manh; Tamoutounour, Samira; Crozat, Karine; Tomasello, Elena; Jorquera, Audrey; Fossum, Even; Bogen, Bjarne; Azukizawa, Hiroaki; Bajenoff, Marc; Henri, Sandrine; Dalod, Marc; Malissen, Bernard			Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery	IMMUNITY			English	Article							REGULATORY T-CELLS; IMMUNE HOMEOSTASIS; LANGERHANS CELLS; LYMPH-NODES; IN-VIVO; ANTIGEN; MATURE; REPERTOIRE; EXPRESSION; INDUCTION	Dendritic cells (DCs) are instrumental in the initiationof T cell responses, but how thymic and peripheral tolerogenic DCs differ globally from Toll-like receptor (TLR)-induced immunogenic DCs remains unclear. Here, we show that thymic XCR1(+) DCs undergo a high rate of maturation, accompanied by profound gene-expression changes that are essential for central tolerance and also happen in germ-free mice. Those changes largely overlap those occurring during tolerogenic and, more unexpectedly, TLR-induced maturation of peripheral XCR1(+) DCs, arguing against the commonly held view that tolerogenic DCs undergo incomplete maturation. Interferon-stimulated gene (ISG) expression was among the few discriminators of immunogenic and tolerogenic XCR1(+) DCs. Tolerogenic XCR1(+) thymic DCs were, however, unique in expressing ISGs known to restrain virus replication. Therefore, a broad functional convergence characterizes tolerogenic and immunogenic XCR1(+) DC maturation in the thymus and periphery, maximizing antigen presentation and signal delivery to developing and to conventional and regulatory mature T cells.	[Ardouin, Laurence; Luche, Herve; Chelbi, Rabie; Shawket, Alaa; Sanchis, Frederic Montanana; Alexandre, Yannick; Gregoire, Claude; Fries, Anissa; Thien-Phong Vu Manh; Tamoutounour, Samira; Crozat, Karine; Tomasello, Elena; Jorquera, Audrey; Bajenoff, Marc; Henri, Sandrine; Dalod, Marc; Malissen, Bernard] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, F-13288 Marseille, France; [Luche, Herve; Maria, Camille Santa; Grenot, Pierre; Malissen, Bernard] Aix Marseille Univ, CNRS, Ctr Immunophen, INSERM, F-13288 Marseille, France; [Carpentier, Sabrina] Aix Marseille Univ, MI mAbs, F-13288 Marseille, France; [Fossum, Even; Bogen, Bjarne] Univ Oslo, Inst Immunol, N-0424 Oslo, Norway; [Fossum, Even; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, N-0424 Oslo, Norway; [Azukizawa, Hiroaki] Osaka Univ, Dept Dermatol, Osaka 5650871, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Oslo; University of Oslo; National Hospital Norway; Osaka University	Dalod, M; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, F-13288 Marseille, France.; Malissen, B (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunophen, INSERM, F-13288 Marseille, France.	dalod@ciml.univ-mrs.fr; bernardm@ciml.univ-mrs.fr	Dalod, Marc/AAK-6163-2020; Crozat, Karine/L-7297-2019; LUCHE, Herve/GLT-1401-2022; BATAILLE, Laurence/AAA-5535-2021; Fossum, Even/W-9136-2019; Henri, Sandrine/O-3045-2016; Malissen, Bernard/AAK-4659-2020	Dalod, Marc/0000-0002-6436-7966; Crozat, Karine/0000-0003-4761-3675; BATAILLE, Laurence/0000-0001-7770-2041; Fossum, Even/0000-0001-7064-0327; HENRI, Sandrine/0000-0002-8980-9193; Malissen, Bernard/0000-0003-1340-9342; Alexandre, Yannick/0000-0002-6634-4098; LUCHE, Herve/0000-0003-4309-8338; Vu Manh, Thien-Phong/0000-0002-0294-342X; GRENOT, PIERRE/0000-0003-3991-753X	CNRS; INSERM; PHENOMIN; European Research Council [281225, 322465]; DCBiol Labex [ANR-11-LA-BEX-0043, ANR-10-IDEX-0001-02]; A*MIDEX project [ANR-11-IDEX-0001-02]; I2HD CIML-SANOFI project; SYB-ILLA European collaborative project;  [ANR-11-DPBS-002]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHENOMIN; European Research Council(European Research Council (ERC)European Commission); DCBiol Labex; A*MIDEX project(French National Research Agency (ANR)); I2HD CIML-SANOFI project; SYB-ILLA European collaborative project; 	We thank R. Locksley, V. Zimmermann, and N. Taylor for mice and C. Thibault-Carpentier from Plateforme Biopuces. This work was supported by CNRS, INSERM, PHENOMIN, the European Research Council (FP7/2007-2013 grants 322465 to B.M and 281225 to M.D.), the DCBiol Labex (ANR-11-LA-BEX-0043, grant ANR-10-IDEX-0001-02 PSL), the A*MIDEX project (ANR-11-IDEX-0001-02), the I2HD CIML-SANOFI project, fellowships from the SYB-ILLA European collaborative project (H.L.) and the I2HD CIML-SANOFI project (A.S.), and grant ANR-11-DPBS-002 (S.C.). This work benefited from data assembled by the ImmGen consortium.	Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Baratin M, 2015, IMMUNITY, V42, P627, DOI 10.1016/j.immuni.2015.03.003; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Desch AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5674; Elpek KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023921; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Luche H, 2011, EUR J IMMUNOL, V41, P2165, DOI 10.1002/eji.201141728; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Perry JSA, 2016, IMMUNOL REV, V271, P141, DOI 10.1111/imr.12403; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Spidale NA, 2014, J IMMUNOL, V193, P21, DOI 10.4049/jimmunol.1400321; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Takamura S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003937; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Vega-Ramos J, 2014, J IMMUNOL, V193, P3851, DOI 10.4049/jimmunol.1303215; Wagner CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076801; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112	36	97	97	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					305	318		10.1016/j.immuni.2016.07.019	http://dx.doi.org/10.1016/j.immuni.2016.07.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533013	Bronze			2022-12-18	WOS:000382267300013
J	Tian, YJ; Kuo, CF; Akbari, O; Ou, JHJ				Tian, Yongjun; Kuo, Cheng-fu; Akbari, Omid; Ou, Jing-hsiung James			Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission	IMMUNITY			English	Article							PRECORE REGION; CORE ANTIGEN; MUTATIONS; TOLERANCE; CLEARANCE; PROMOTER; CELLS; DNA	In contrast to horizontal transmission of hepatitis B virus (HBV) between adults, which often leads to self-limited acute infection, vertical transmission of HBV from mother to child often leads to chronic infection. However, the mechanisms linking vertical transmission with chronic infection are not known. We developed a mouse model to study the effect of maternal HBV infection on HBV persistence in offspring and found that HBV carried by the mother impaired CD8(+) T cell responses to HBV in her offspring, resulting in HBV persistence. This impairment of CD8(+) T cell responses was mediated by hepatic macrophages, which were predisposed by maternal HBV e antigen (HBeAg) to support HBV persistence by upregulation of inhibitory ligand PD-L1 and altered polarization upon restimulation with HBeAg. Depletion of hepatic macrophages led to CD8(+) T cell activation and HBV clearance in the offspring, raising the possibility of targeting macrophages to treat chronic HBV patients.	[Tian, Yongjun; Kuo, Cheng-fu; Akbari, Omid; Ou, Jing-hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of Southern California	Ou, JHJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	jamesou@hsc.usc.edu		Kuo, Cheng-Fu/0000-0002-8933-0799	NIH [DK100257, CA177337]; L.K. Whittier Foundation; NATIONAL CANCER INSTITUTE [R01CA177337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L.K. Whittier Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to thank Dr. Frank Chisari for critical reading of this manuscript and for providing valuable comments. We also would like to thank the Non-parenchymal Liver Cell Core Facility of the USC Research Center for Alcoholic Liver and Pancreatic Diseases for help with the isolation of hepatic macrophages. This work was supported by NIH grants DK100257 and CA177337 and a grant from L.K. Whittier Foundation.	CARMAN WF, 1989, LANCET, V2, P588; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu CJ, 2004, J MED VIROL, V74, P237, DOI 10.1002/jmv.20176; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; MAGNIUS LO, 1972, J IMMUNOL, V109, P1017; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Ou JH, 1997, J GASTROEN HEPATOL, V12, pS178, DOI 10.1111/j.1440-1746.1997.tb00499.x; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; Publicover J, 2013, J CLIN INVEST, V123, P3728, DOI 10.1172/JCI68182; Publicover J, 2011, J CLIN INVEST, V121, P1154, DOI 10.1172/JCI44198; Reifenberg K, 1998, VIROLOGY, V243, P45, DOI 10.1006/viro.1998.9033; Scaglioni PP, 1997, VIROLOGY, V233, P374, DOI 10.1006/viro.1997.8594; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Tian YJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002159; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang JS, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90021-7; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; YEH CT, 1990, J VIROL, V64, P6141, DOI 10.1128/JVI.64.12.6141-6147.1990; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	32	97	99	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1204	1214		10.1016/j.immuni.2016.04.008	http://dx.doi.org/10.1016/j.immuni.2016.04.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27156385	Green Accepted, Bronze			2022-12-18	WOS:000376478500023
J	Lim, H; Kim, YU; Sun, H; Lee, JH; Reynolds, JM; Hanabuchi, S; Wu, HZ; Teng, BB; Chung, Y				Lim, Hoyong; Kim, Young Uk; Sun, Hua; Lee, Joyce H.; Reynolds, Joseph M.; Hanabuchi, Shino; Wu, Huaizhu; Teng, Ba-Bie; Chung, Yeonseok			Proatherogenic Conditions Promote Autoimmune T Helper 17 Cell Responses In Vivo	IMMUNITY			English	Article							LOW-DENSITY-LIPOPROTEIN; ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MACROPHAGE-GENE-EXPRESSION; E-DEFICIENT MICE; PPAR-GAMMA; RHEUMATOID-ARTHRITIS; LYMPHOPENIC HOSTS; INTERFERON-GAMMA; LIPID-METABOLISM	Patients with systemic autoimmune diseases show increased incidence of atherosclerosis. However, the contribution of proatherogenic factors to autoimmunity remains unclear. We found that atherogenic mice (herein referred to as LDb mice) exhibited increased serum interleukin-17, which was associated with increased numbers of T helper 17 (Th17) cells in secondary lymphoid organs. The environment within LDb mice was substantially favorable for Th17 cell polarization of autoreactive T cells during homeostatic proliferation, which was considerably inhibited by antibodies directed against oxidized low-density lipoprotein (oxLDL). Moreover, the uptake of oxLDL induced dendritic-cell-mediated Th17 cell polarization by triggering IL-6 production in a process dependent on TLR4, CD36, and MyD88. Furthermore, self-reactive CD4(+) T cells that expanded in the presence of oxLDL induced more profound experimental autoimmune encephalomyelitis. These findings demonstrate that proatherogenic factors promote the polarization and inflammatory function of autoimmune Th17 cells, which could be critical for the pathogenesis of atherosclerosis and other related autoimmune diseases.	[Lim, Hoyong; Kim, Young Uk; Lee, Joyce H.; Chung, Yeonseok] Univ Texas Hlth Sci Ctr Houston, Ctr Immunol & Autoimmune Dis, Houston, TX 77030 USA; [Sun, Hua; Teng, Ba-Bie] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Inst Mol Med, Houston, TX 77030 USA; [Kim, Young Uk; Teng, Ba-Bie; Chung, Yeonseok] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Reynolds, Joseph M.; Hanabuchi, Shino] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Wu, Huaizhu] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Chung, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Immunol & Autoimmune Dis, Houston, TX 77030 USA.	yeonseok.chung@uth.tmc.edu	Hanabuchi, Shino/AAI-8676-2021	Chung, Yeonseok/0000-0001-5780-4841; Reynolds, Joseph/0000-0003-3490-0544; Kim, Young Uk/0000-0002-2518-0189	American Heart Association [10SDG3860046]; Center for Clinical and Translational Sciences; National Institutes of Health Clinical and Translational Award [UL1 TR000371]; National Institutes of Health [HL084597]; Cancer Prevention and Research Institute of Texas [RP 110776]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084594, R01HL098839] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Center for Clinical and Translational Sciences; National Institutes of Health Clinical and Translational Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Dong, R. Wetsel, and G. Martinez for critical comments and suggestions on the manuscript, as well as A. Hazen for helping with cell sorting. The work was supported by research grants from the American Heart Association (10SDG3860046 to Y.C.), the Center for Clinical and Translational Sciences funded by the National Institutes of Health Clinical and Translational Award UL1 TR000371 (to Y.C.), and National Institutes of Health grant HL084597 (to B.B.T.). The Flow Cytometry Core Facility is supported in part by the shared instrumentation grant (RP 110776) from the Cancer Prevention and Research Institute of Texas.	Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta R, 2003, ATHEROSCLEROSIS, V169, P51, DOI 10.1016/S0021-9150(03)00133-3; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Goyal T., 2012, CURR ATHEROSCLER REP; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; Koenen RR, 2010, NAT REV DRUG DISCOV, V9, P141, DOI 10.1038/nrd3048; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; KRUEGER GG, 1994, J INVEST DERMATOL, V102, pS14, DOI 10.1111/1523-1747.ep12386079; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li Q, 2010, BIOCHEM BIOPH RES CO, V394, P836, DOI 10.1016/j.bbrc.2010.03.090; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391	48	97	103	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					153	165		10.1016/j.immuni.2013.11.021	http://dx.doi.org/10.1016/j.immuni.2013.11.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412615	Green Accepted, Bronze			2022-12-18	WOS:000331476900017
J	Richer, MJ; Nolz, JC; Harty, JT				Richer, Martin J.; Nolz, Jeffrey C.; Harty, John T.			Pathogen-Specific Inflammatory Milieux Tune the Antigen Sensitivity of CD8(+) T Cells by Enhancing T Cell Receptor Signaling	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES; AVIDITY MATURATION; FUNCTIONAL AVIDITY; MEMORY; THRESHOLD; IMMUNITY; DIFFERENTIATION; ACTIVATION; EXPRESSION; EXPANSION	CD8(+) T cells confer host protection through T-cell-receptor (TCR)-mediated recognition of foreign antigens presented by infected cells. Thus, generation of CD8(+) T cell populations with high antigen sensitivity is critical for efficient pathogen clearance. Besides selection of high-affinity TCRs, the molecular mechanisms regulating the antigen sensitivity of CD8(+) T cells remain poorly defined. Herein, we have demonstrated that the antigen sensitivity of effector and memory CD8(+) T cells is dynamically regulated and can be tuned by pathogen-induced inflammatory milieux independently of the selection of cells with higher TCR affinity. Mechanistically, we have demonstrated that the signal-transduction capacity of key TCR proximal molecules is enhanced by inflammatory cytokines, which reduced the antigen density required to trigger antimicrobial functions. Dynamic tuning of CD8(+) T cell antigen sensitivity by inflammatory cytokines most likely optimizes immunity to specific pathogens while minimizing the risk of immunopathology at steady state.	[Richer, Martin J.; Nolz, Jeffrey C.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Harty, John/0000-0001-7266-2802	National Institutes of Health [AI42767, AI50073, AI46653, AI085515, AI96850]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042767, R01AI042767, R01AI050073, R01AI046653, R21AI096850, R01AI085515, R37AI042767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Mescher for II12rb1<SUP>-/-</SUP> OT-I cells, Murali-Krishna Kaja for Ifnar1<SUP>-/-</SUP> P14 cells, S. Varga for Pichinde virus, and S. Bhaumik, L. Epping, and L. Hancox for assistance. We thank members of the Harty Lab, V. Badovinac, S. Condotta, and J. Houtman for comments and discussion. M.J.R. is supported by a Canadian Institutes of Health Research fellowship, and J.C.N. is supported by a Leukemia and Lymphoma Society career development award. The J.T.H. lab is supported by National Institutes of Health grants AI42767, AI50073, AI46653, AI085515, and AI96850. M.J.R. and J.C.N. designed the experiments, performed the work, analyzed the data, and wrote the manuscript. J.T.H. designed the experiments, analyzed the data, and wrote the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Amoah S, 2012, J IMMUNOL, V189, P638, DOI 10.4049/jimmunol.1102579; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; DUSTIN ML, 1989, COLD SPRING HARB SYM, V54, P753; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1987, EUR J IMMUNOL, V17, P159, DOI 10.1002/eji.1830170202; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2011, J IMMUNOL, V186, P5873, DOI 10.4049/jimmunol.1100194; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Walker LJ, 2010, CLIN EXP IMMUNOL, V159, P245, DOI 10.1111/j.1365-2249.2009.04047.x; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	48	97	100	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					140	152		10.1016/j.immuni.2012.09.017	http://dx.doi.org/10.1016/j.immuni.2012.09.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23260194	Green Accepted, Bronze			2022-12-18	WOS:000314195500016
J	Khounlotham, M; Kim, W; Peatman, E; Nava, P; Medina-Contreras, O; Addis, C; Koch, S; Fournier, B; Nusrat, A; Denning, TL; Parkos, CA				Khounlotham, Manirath; Kim, Wooki; Peatman, Eric; Nava, Porfirio; Medina-Contreras, Oscar; Addis, Caroline; Koch, Stefan; Fournier, Benedicte; Nusrat, Asma; Denning, Timothy L.; Parkos, Charles A.			Compromised Intestinal Epithelial Barrier Induces Adaptive Immune Compensation that Protects from Colitis	IMMUNITY			English	Article							JUNCTIONAL-ADHESION-MOLECULE; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; IMMUNOGLOBULIN-A; E-CADHERIN; EXPRESSION; RESPONSES; PERMEABILITY; INDUCTION	Mice lacking junctional adhesion molecule A (JAM-A, encoded by F11r) exhibit enhanced intestinal epithelial permeability, bacterial translocation, and elevated colonic lymphocyte numbers, yet do not develop colitis. To investigate the contribution of adaptive immune compensation in response to increased intestinal epithelial permeability, we examined the susceptibility of F11r(-/-)Rag1(-/-) mice to acute colitis. Although negligible contributions of adaptive immunity in F11r(+/+)Rag1(-/-) mice were observed, F11r(-/-)Rag1(-/-) mice exhibited increased microflora-dependent colitis. Elimination of T cell subsets and cytokine analyses revealed a protective role for TGF-beta-producing CD4(+) T cells in F11r(-/-) mice. Additionally, loss of JAM-A resulted in elevated mucosal and serum IgA that was dependent upon CD4(+) T cells and TGF-beta. Absence of IgA in F11r(+/+) Igha(-/-) mice did not affect disease, whereas F11r(-/-) Igha(-/-) mice displayed markedly increased susceptibility to acute injury-induced colitis. These data establish a role for adaptive immune-mediated protection from acute colitis under conditions of intestinal epithelial barrier compromise.	[Khounlotham, Manirath; Kim, Wooki; Peatman, Eric; Nava, Porfirio; Addis, Caroline; Koch, Stefan; Fournier, Benedicte; Nusrat, Asma; Denning, Timothy L.; Parkos, Charles A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA; [Medina-Contreras, Oscar; Denning, Timothy L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University	Denning, TL (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA.	tdennin@emory.edu; cparkos@emory.edu	Denning, Timothy/F-2271-2011; Nava, Porfirio/D-8306-2012; Medina-Contreras, Oscar/B-1956-2010	Nava, Porfirio/0000-0002-0506-1510; Medina-Contreras, Oscar/0000-0002-4432-7780; Koch, Stefan/0000-0003-3579-4229; Denning, Timothy/0000-0002-1072-7444	NIH [DK061379, DK72564, DK055679, DK59888, AA017870, AI083554]; Digestive Diseases Minicenter [DK 064399]; Emory Egleston Children's Research Center; Crohn's and Colitis Foundation of America; AGA Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055679, R29DK055679, R01DK072564, R01DK059888, R24DK064399, R01DK061379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Minicenter; Emory Egleston Children's Research Center; Crohn's and Colitis Foundation of America; AGA Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. L. Eckmann for providing Igha<SUP>-/-</SUP> mice, Dr. R. Ahmed and Dr. R.S. Mittler for providing GK1.5 and YTS169.4 antibodies, and Winston Lee and Christopher Capaldo for discussions. This work was supported by grants from the NIH (DK061379 and DK72564 to C.A.P., DK055679 and DK59888 to A.N., and AA017870 and AI083554 to T.L.D.), core support from a Digestive Diseases Minicenter grant (DK 064399), a Emory Egleston Children's Research Center seed grant to T.L.D., a Crohn's and Colitis Foundation of America Career Development Award and an AGA Foundation for Digestive Health and Nutrition Research Scholar Award to P.N., and Crohn's and Colitis Foundation of America Research Fellowship and senior research awards to M.K. and B.F., respectively.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; DOGAN A, 1995, J CLIN PATHOL, V48, P143, DOI 10.1136/jcp.48.2.143; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harriman GR, 1999, J IMMUNOL, V162, P2521; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Severson EA, 2008, MOL BIOL CELL, V19, P1862, DOI 10.1091/mbc.E07-09-0869; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Vetrano S, 2008, GASTROENTEROLOGY, V135, P173, DOI 10.1053/j.gastro.2008.04.002; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Welcker K, 2004, EUR J MED RES, V9, P456; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	46	97	102	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					563	573		10.1016/j.immuni.2012.06.017	http://dx.doi.org/10.1016/j.immuni.2012.06.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22981539	Green Accepted, Bronze			2022-12-18	WOS:000309199000019
J	van Gisbergen, KPJM; Klarenbeek, PL; Kragten, NAM; Unger, PPA; Nieuwenhuis, MBB; Wensveen, FM; ten Brinke, A; Tak, PP; Eldering, E; Nolte, MA; van Lier, RAW				van Gisbergen, Klaas P. J. M.; Klarenbeek, Paul L.; Kragten, Natasja A. M.; Unger, Peter-Paul A.; Nieuwenhuis, Marieke B. B.; Wensveen, Felix M.; ten Brinke, Anja; Tak, Paul P.; Eldering, Eric; Nolte, Martijn A.; van Lier, Rene A. W.			The Costimulatory Molecule CD27 Maintains Clonally Diverse CD8(+) T Cell Responses of Low Antigen Affinity to Protect against Viral Variants	IMMUNITY			English	Article							SELECTIVE EXPRESSION; MEMORY; EFFECTOR; ACTIVATION; EXPANSION; RECEPTOR; VIRUS; STIMULATION; MAINTENANCE; GENERATION	CD70 and CD27 are costimulatory molecules that provide essential signals for the expansion and differentiation of CD8(+) T cells. Here, we show that CD27-driven costimulation lowered the threshold of T cell receptor activation on CD8(+) T cells and enabled responses against low-affinity antigens. Using influenza infection to study in vivo consequences, we found that CD27-driven costimulation promoted a CD8(+) T cell response of overall low affinity. These qualitative effects of CD27 on T cell responses were maintained into the memory phase. On a clonal level, CD27-driven costimulation established a higher degree of variety in memory CD8(+) T cells. The benefit became apparent when mice were reinfected, given that CD27 improved CD8(+) T cell responses against reinfection with viral variants, but not with identical virus. We propose that CD27-driven costimulation is a strategy to generate memory clones that have potential reactivity to a wide array of mutable pathogens.	[van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Unger, Peter-Paul A.; Nieuwenhuis, Marieke B. B.; Wensveen, Felix M.; Eldering, Eric; Nolte, Martijn A.; van Lier, Rene A. W.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Klarenbeek, Paul L.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Nolte, Martijn A.; van Lier, Rene A. W.] Sanquin Res CLB & Landsteiner Lab, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands; [ten Brinke, Anja] Sanquin Res CLB & Landsteiner Lab, Dept Immunopathol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Gisbergen, KPJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.vangisbergen@sanquin.nl	Wensveen, Felix/O-3122-2018; Nolte, Martijn A./AAC-8092-2022	Wensveen, Felix/0000-0002-1333-8882; Nolte, Martijn A./0000-0002-5447-0839; van Lier, Rene/0000-0002-3201-7144; ten Brinke, Anja/0000-0002-0135-7496; Nieuwenhuis, Marieke/0000-0002-3163-7878; van Gisbergen, Klaas/0000-0003-3623-7555	Netherlands Organization of Scientific Research	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank A. de Bruin for technical assistance, B. Hooibrink for cell sorting, G. van Schijndel for tetramer production, B. van Schaik and A. van Kampen for statistical analysis, and the staff of the animal facility of the AMC for excellent animal care. We thank L. Boon, R. Bodewes, and G. Rimmelzwaan for kindly providing reagents. Finally, we thank J. Borst, N. de Vries, E. van Leeuwen, and M. Wolkers for critical reading of the manuscript and helpful discussion. This study was supported by an LSBR grant (NAMK), a VIDI Grant (MAN), and a VICI Grant (RAWvL) from The Netherlands Organization of Scientific Research.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Arens R, 2005, J IMMUNOL, V174, P5915, DOI 10.4049/jimmunol.174.10.5915; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Carr JM, 2006, P NATL ACAD SCI USA, V103, P19454, DOI 10.1073/pnas.0609706104; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kedzierska K, 2008, J IMMUNOL, V181, P2556, DOI 10.4049/jimmunol.181.4.2556; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Peperzak V, 2010, J CLIN INVEST, V120, P168, DOI 10.1172/JCI40178; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Posnett DN, 2005, J EXP MED, V201, P1881, DOI 10.1084/jem.20050928; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wensveen FM, 2010, IMMUNITY, V32, P754, DOI 10.1016/j.immuni.2010.06.005; Xiao YL, 2008, J IMMUNOL, V181, P1071, DOI 10.4049/jimmunol.181.2.1071; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	38	97	98	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					97	108		10.1016/j.immuni.2011.04.020	http://dx.doi.org/10.1016/j.immuni.2011.04.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21763160	Bronze			2022-12-18	WOS:000293107300013
J	Shaw, PJ; Barr, MJ; Lukens, JR; McGargill, MA; Chi, HB; Mak, TW; Kanneganti, TD				Shaw, Patrick J.; Barr, Maggie J.; Lukens, John R.; McGargill, Maureen A.; Chi, Hongbo; Mak, Tak W.; Kanneganti, Thirumala-Devi			Signaling via the RIP2 Adaptor Protein in Central Nervous System-Infiltrating Dendritic Cells Promotes Inflammation and Autoimmunity	IMMUNITY			English	Article							BACTERIAL PEPTIDOGLYCAN; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; RECEPTOR 2; INNATE; NOD2; INDUCTION; CNS; DIFFERENTIATION; RECOGNITION	Peripheral peptidolgycan (PGN) is present within antigen-presenting cells in the central nervous system (CNS) of multiple sclerosis (MS) patients, possibly playing a role in neuroinflammation. Accordingly, PGN is linked with disease progression in the animal model of MS, experimental autoimmune encephalomyelitis (EAE), but the role of specific PGN-sensing proteins is unknown. Here we report that the progression of EAE was dependent on the intracellular PGN sensors NOD1 and NOD2 and their common downstream adaptor molecule, receptor interacting protein 2 (RIP2; also known as RIPK2 and RICK). We found that RIP2, but not toll-like receptor 2 (TLR2), played a critical role in the activation of CNS-infiltrating dendritic cells. Our results suggest that PGN in the CNS is involved in the pathogenesis of EAE through the activation of infiltrating dendritic cells via NOD1-, NOD2-, and RIP2-mediated pathways.	[Shaw, Patrick J.; Barr, Maggie J.; Lukens, John R.; McGargill, Maureen A.; Chi, Hongbo; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38104 USA; [Mak, Tak W.] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38104 USA.	thirumala-devi.kanneganti@stjude.org	McGargill, Maureen/N-8131-2018; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Chi, Hongbo/M-9397-2018	McGargill, Maureen/0000-0002-0916-0372; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Chi, Hongbo/0000-0002-9997-2496; Lukens, John/0000-0002-6795-0866	National Institutes of Health [AR056296, AI088177]; American Lebanese and Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell (Yale University School of Medicine) and S. Akira (Osaka University) for the generous supply of mutant mice and D. Perera and G. Johnson for technical assistance. This work was supported by grants from the National Institutes of Health (AR056296 and AI088177) and the American Lebanese and Syrian Associated Charities to T.-D.K.	Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Buljevac D, 2003, ANN NEUROL, V54, P828, DOI 10.1002/ana.10759; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Du XG, 2010, MOL CELL BIOCHEM, V337, P277, DOI 10.1007/s11010-009-0309-9; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Fairhead T, 2008, AM J TRANSPLANT, V8, P1143, DOI 10.1111/j.1600-6143.2008.02236.x; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Inohara N, 2000, J BIOL CHEM, V275, P27823; Joosten LAB, 2008, P NATL ACAD SCI USA, V105, P9017, DOI 10.1073/pnas.0710445105; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Nembrini C, 2008, MICROBES INFECT, V10, P522, DOI 10.1016/j.micinf.2008.01.016; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; SIBLEY WA, 1985, LANCET, V1, P1313; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Visser L, 2005, J IMMUNOL, V174, P808, DOI 10.4049/jimmunol.174.2.808; Visser L, 2006, AM J PATHOL, V169, P1671, DOI 10.2353/ajpath.2006.060143; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235	36	97	105	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					75	84		10.1016/j.immuni.2010.12.015	http://dx.doi.org/10.1016/j.immuni.2010.12.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21236705	Green Accepted, Bronze			2022-12-18	WOS:000287336600011
J	Wendorff, AA; Koch, U; Wunderlich, FT; Wirth, S; Dubey, C; Bruning, JC; MacDonald, HR; Radtke, F				Wendorff, Agnieszka A.; Koch, Ute; Wunderlich, F. Thomas; Wirth, Silvia; Dubey, Christelle; Bruening, Jens C.; MacDonald, H. Robson; Radtke, Freddy			Hes1 Is a Critical but Context-Dependent Mediator of Canonical Notch Signaling in Lymphocyte Development and Transformation	IMMUNITY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BETA-SELECTION CHECKPOINT; HEMATOPOIETIC STEM-CELLS; ZONE B-CELLS; DELTA-LIKE 4; IN-VIVO; T-CELLS; THYMOCYTE DEVELOPMENT; LINEAGE COMMITMENT; ALPHA-BETA	Although canonical Notch signaling regulates multiple hematopoietic lineage decisions including T cell and marginal zone B cell fate specification, the downstream molecular mediators of Notch function are largely unknown. We showed here that conditional inactivation of Hes1, a well-characterized Notch target gene, in adult murine bone marrow (BM) cells severely impaired T cell development without affecting other Notch-dependent hematopoietic lineages such as marginal zone B cells. Competitive mixed BM chimeras, intrathymic transfer experiments, and in vitro culture of BM progenitors on Delta-like-expressing stromal cells further demonstrated that Hes1 is required for T cell lineage commitment, but dispensable for Notch-dependent thymocyte maturation through and beyond the beta selection checkpoint. Furthermore, our data strongly suggest that Hes1 is essential for the development and maintenance of Notch-induced T cell acute lymphoblastic leukemia. Collectively, our studies identify Hes1 as a critical but context-dependent mediator of canonical Notch signaling in the hematopoietic system.	[Wendorff, Agnieszka A.; Koch, Ute; Wirth, Silvia; Dubey, Christelle; Radtke, Freddy] Swiss Inst Expt Canc Res ISREC, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Wunderlich, F. Thomas; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, D-50674 Cologne, Germany; [MacDonald, H. Robson] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Cologne; Ludwig Institute for Cancer Research; University of Lausanne	Radtke, F (corresponding author), Swiss Inst Expt Canc Res ISREC, Ecole Polytech Fed Lausanne, Stn 19, CH-1015 Lausanne, Switzerland.	freddy.radtke@epfl.ch	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045; Koch, Ute/0000-0001-7914-7061	Swiss National Science Foundation; Swiss Cancer League; EuroSyStem; Marie Curie foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EuroSyStem(European Commission); Marie Curie foundation(European Commission)	This work was in part supported by the Swiss National Science Foundation, the Swiss Cancer League, EuroSyStem and the Marie Curie foundation. We thank O. Randin and A. Wilson for technical assistance and providing reagents and M. Garcia, S. Winkler and G. Tapia for cell sorting.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Issack PS, 1998, CELL GROWTH DIFFER, V9, P827; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Watanabe Y, 1997, CELL IMMUNOL, V177, P18, DOI 10.1006/cimm.1997.1094; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	46	97	100	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					671	684		10.1016/j.immuni.2010.11.014	http://dx.doi.org/10.1016/j.immuni.2010.11.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093323	Bronze			2022-12-18	WOS:000286082600007
J	Liu, WL; Meckel, T; Tolar, P; Sohn, HW; Pierce, SK				Liu, Wanli; Meckel, Tobias; Tolar, Pavel; Sohn, Hae Won; Pierce, Susan K.			Intrinsic Properties of immunoglobulin IgG1 Isotype-Switched B Cell Receptors Promote Microclustering and the Initiation of Signaling	IMMUNITY			English	Article							RESONANCE ENERGY-TRANSFER; RESPONSES IN-VIVO; ANTIGEN RECEPTOR; LIVING CELLS; AFFINITY MATURATION; PLASMA-CELL; MEMORY; ACTIVATION; TAIL; LEISHMANIASIS	Memory B cells express high-affinity, immunoglobulin GB cell receptors (IgG BCRs) that enhance B cell responses, giving rise to the rapid production of high-affinity, IgG antibodies. Despite the central role of IgG BCRs in memory responses, the mechanisms by which the IgG BCRs function to enhance B cell responses are not fully understood. Using high-resolution live-cell imaging, we showed that IgG1 BCRs dramatically enhanced the earliest BCR-intrinsic events that followed within seconds of B cells' encounter with membrane bound antigen, including BCR oligomerization and BCR microcluster growth, leading to Syk kinase recruitment and calcium responses. The enhancement of these early events was dependent on a membrane proximal region of the IgG1 cytoplasmic tail not previously appreciated to play a role in IgG1 BCR signaling. Thus, intrinsic properties of the IgG1 BCR enhance early antigen-driven events that ultimately translate into heightened signaling.	[Liu, Wanli; Sohn, Hae Won; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Meckel, Tobias] Tech Univ Darmstadt, Dept Biol Membrane Biophys, D-64287 Darmstadt, Germany; [Tolar, Pavel] Natl Inst Med Res, Ridgeway, London NW7 1AA, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Technical University of Darmstadt	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov	Meckel, Tobias/F-4372-2010; liu, wanli/H-5690-2011	Meckel, Tobias/0000-0003-0759-2072; liu, wanli/0000-0003-2624-6802; Tolar, Pavel/0000-0003-4693-7299; Liu, Wanli/0000-0003-0395-2800	National Institutes of Health, National Institute of Allergy and Infectious Diseases; Medical Research Council [MC_U117597138] Funding Source: researchfish; MRC [MC_U117597138] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000898] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Garnett Kelsoe, Duke University, Dr. Robert Brink, Garvan Institute of Medical Research of Australia, and Dr. Christopher C Goodnow, the Australian National University, for generously providing experimental materials, and as always, we thank Dr. Joseph Brzostowski for expert advice on imaging. We thank Bhaskar Upadhyaya for charactering the Ig alpha-YFP Tg C57BL/6 mice. This work has been supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Douglass AD, 2008, METHOD CELL BIOL, V85, P113, DOI 10.1016/S0091-679X(08)85006-6; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Tolar P, 2010, CURR TOP MICROBIOL, V340, P155, DOI 10.1007/978-3-642-03858-7_8; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; Tolar P, 2009, EMBO REP, V10, P331, DOI 10.1038/embor.2009.26; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963	36	97	100	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 25	2010	32	6					778	789		10.1016/j.immuni.2010.06.006	http://dx.doi.org/10.1016/j.immuni.2010.06.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620943	Bronze, Green Accepted			2022-12-18	WOS:000279365800009
J	Baran, K; Dunstone, M; Chia, J; Ciccone, A; Browne, KA; Clarke, CJP; Lukoyanova, N; Saibil, H; Whisstock, JC; Voskoboinik, I; Trapani, JA				Baran, Katherine; Dunstone, Michelle; Chia, Jenny; Ciccone, Annette; Browne, Kylie A.; Clarke, Christopher J. P.; Lukoyanova, Natalya; Saibil, Helen; Whisstock, James C.; Voskoboinik, Ilia; Trapani, Joseph A.			The Molecular Basis for Perforin Oligomerization and Transmembrane Pore Assembly	IMMUNITY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; FORMING PROTEIN PERFORIN-1; NATURAL-KILLER-CELLS; GRANZYME-B; 9TH COMPONENT; CYTOTOXIC LYMPHOCYTES; MEDIATED CYTOTOXICITY; IMMUNE HOMEOSTASIS; CYTOLYSIN PERFORIN; HUMAN-COMPLEMENT	Perforin, a pore-forming protein secreted by cytotoxic lymphocytes, is indispensable for destroying virus-infected cells and for maintaining immune homeostasis. Perforin polymerizes into transmembrane channels that inflict osmotic stress and facilitate target cell uptake of proapoptotic granzymes. Despite this, the mechanism through which perforin monomers self-associate remains unknown. Our current study establishes the molecular basis for perforin oligomerization and pore assembly. We show that after calcium-dependent membrane binding, direct ionic attraction between the opposite faces of adjacent perforin monomers was necessary for pore formation. By using mutagenesis, we identified the opposing charges on residues Arg213 (positive) and Glu343 (negative) to be critical for intermolecular interaction. Specifically, disrupting this interaction had no effect on perforin synthesis, folding, or trafficking in the killer cell, but caused a marked kinetic defect of oligomerization at the target cell membrane, severely disrupting lysis and granzyme B-induced apoptosis. Our study provides important insights into perforin's mechanism of action.	[Baran, Katherine; Chia, Jenny; Ciccone, Annette; Browne, Kylie A.; Clarke, Christopher J. P.; Voskoboinik, Ilia; Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Dunstone, Michelle; Whisstock, James C.; Trapani, Joseph A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Dunstone, Michelle] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Clarke, Christopher J. P.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Trapani, Joseph A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Lukoyanova, Natalya; Saibil, Helen] Birkbeck Coll, Inst Struct & Mol Biol, Dept Crystallog, London WC1E 7HX, England	Peter Maccallum Cancer Center; Monash University; Monash University; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; University of London; Birkbeck University London	Voskoboinik, I (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, St Andrews Pl, Melbourne, Vic 3002, Australia.	ilia.voskoboinik@petermac.org; joe.trapani@petermac.org	Dunstone, Michelle/I-2895-2014	Dunstone, Michelle/0000-0002-6026-648X; Whisstock, James/0000-0003-4200-5611; Lukoyanova, Natalya/0000-0002-2051-0812; Trapani, Joseph/0000-0003-0983-1532; Voskoboinik, Ilia/0000-0002-6410-009X	National Health and Medical Research Council (NHMRC) of Australia; NHMRC; Australian Research Council; Monash University Faculty of Medicine Strategic Grant Scheme Early Career Researcher award; Cancer Council Victoria, Australia; Biotechnology and Biological Sciences Research Council [BB/D008573/1] Funding Source: researchfish; BBSRC [BB/D008573/1] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash University Faculty of Medicine Strategic Grant Scheme Early Career Researcher award; Cancer Council Victoria, Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.A.T. and I.V. are supported by Fellowships, a project grant, and a Program Grant from the National Health and Medical Research Council (NHMRC) of Australia. J.C.W. is an Australian Research Council Federation Fellow and is supported by a program and project grant from the NHMRC as well as a Centre of Excellence/Discovery Project from the Australian Research Council. M.D. is an NHMRC Peter Doherty Training Fellow and recipient of a Monash University Faculty of Medicine Strategic Grant Scheme Early Career Researcher award. K.B. is supported by a postdoctoral fellowship from the Cancer Council Victoria, Australia. We thank C. House for expert assistance with gel filtration experiments.	Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Clementi R, 2005, BLOOD, V105, P4424, DOI 10.1182/blood-2004-04-1477; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishii E, 2005, BLOOD, V105, P3442, DOI 10.1182/blood-2004-08-3296; Kagi D, 1997, J EXP MED, V186, P989, DOI 10.1084/jem.186.7.989; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KWON BS, 1989, BIOCHEM BIOPH RES CO, V158, P1, DOI 10.1016/S0006-291X(89)80168-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MASSON D, 1985, J BIOL CHEM, V260, P9069; Mehta PA, 2006, LEUKEMIA, V20, P1539, DOI 10.1038/sj.leu.2404299; Myers MA, 2000, J IMMUNOL, V165, P3830, DOI 10.4049/jimmunol.165.7.3830; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; PERSECHINI PM, 1992, BIOCHEMISTRY-US, V31, P5017, DOI 10.1021/bi00136a015; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; PODACK ER, 1982, J BIOL CHEM, V257, P5204; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Trapani JA, 1998, INT REV CYTOL, V182, P111, DOI 10.1016/S0074-7696(08)62169-5; Trapani JA, 2003, J CELL BIOL, V160, P223, DOI 10.1083/jcb.200210150; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2004, J EXP MED, V200, P811, DOI 10.1084/jem.20040776; Voskoboinik I, 2007, BLOOD, V110, P1184, DOI 10.1182/blood-2007-02-072850; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Whisstock J, 1996, PROTEINS, V26, P288, DOI 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A; YOUNG JDE, 1986, J EXP MED, V164, P144, DOI 10.1084/jem.164.1.144; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	50	97	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					684	695		10.1016/j.immuni.2009.03.016	http://dx.doi.org/10.1016/j.immuni.2009.03.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19446473	Bronze			2022-12-18	WOS:000266356900011
J	Choi, YI; Duke-Cohan, JS; Ahmed, WB; Handley, MA; Mann, F; Epstein, JA; Clayton, LK; Reinherz, EL				Choi, Young I.; Duke-Cohan, Jonathan S.; Ahmed, Wesam B.; Handley, Maris A.; Mann, Fanny; Epstein, Jonathan A.; Clayton, Linda K.; Reinherz, Ellis L.			PlexinD1 Glycoprotein Controls Migration of Positively Selected Thymocytes into the Medulla	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; LYMPHOID ORGAN DEVELOPMENT; EPITHELIAL-CELLS; PROGENITOR LOCALIZATION; THYMIC MEDULLA; CROSS-LINKING; SEMAPHORIN 3E; CHEMOKINE; RECEPTOR; EXPRESSION	Precise intrathymic cell migration is important for thymocyte maturation and organ architecture. The orchestration of thymocyte trafficking, however, is not well understood at a molecular level. Here, we described highly regulated plexinD1 expression on CD4(+)CD8(+) double positive (DP) thymocytes. PlexinD1 expression was further affected by the engagement of T cell receptor complex. Activation of plexinD1 via the ligand, semaphorin 3E, repressed CCL25 chemokine signaling via its receptor CCR9 in CD69(+) thymocytes. In the absence of plexinD1, CD69(+) thymocytes remained in the cortex, maturing to form ectopic single positive (SP) thymocyte clusters in Plxnd1-deficient fetal liver cell-transplanted mice. As a consequence, the boundary between DID and SP thymocytes; at corticomedullary junctions was disrupted and medullary structures formed under the thymic capsule. These results demonstrate the importance of plexinD1 in directing migration of maturing thymocytes via modulation of biological responses to chemokine gradients.	[Choi, Young I.; Duke-Cohan, Jonathan S.; Ahmed, Wesam B.; Handley, Maris A.; Clayton, Linda K.; Reinherz, Ellis L.] Dana Farber Canc Inst, Dept Med Oncol, Immunobiol Lab, Boston, MA 02115 USA; [Choi, Young I.; Duke-Cohan, Jonathan S.; Clayton, Linda K.; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mann, Fanny] Univ Aix Marseille 2, CNRS, UMR 6216, Inst Marseille Luminy, F-13288 Marseille 09, France; [Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Clayton, Linda K.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Pennsylvania; University of Pennsylvania	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Immunobiol Lab, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Duke-Cohan, Jonathan/A-5812-2010; Mann, Fanny/G-2786-2016	Duke-Cohan, Jonathan/0000-0002-9478-9609; Mann, Fanny/0000-0003-4839-4347; Epstein, Jonathan/0000-0001-8637-4465	National Institutes of Health [AI19807, AI078340]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI019807, R01AI019807, R37AI019807, R21AI078340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the excellent pathology expertise of S. Signoretti and technical assistance of E. Witten. This work was supported, in part, by National Institutes of Health Grant AI19807 to E.L.R. and AI078340 to L.K.C.	Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Campbell JJ, 1999, J IMMUNOL, V163, P2353; DeKoning J, 1997, J IMMUNOL, V158, P2558; Elewaut D, 2007, TRENDS IMMUNOL, V28, P169, DOI 10.1016/j.it.2007.02.005; Ghendler Y, 1997, EUR J IMMUNOL, V27, P2279, DOI 10.1002/eji.1830270923; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Gunturi A, 2003, J IMMUNOL, V170, P1737, DOI 10.4049/jimmunol.170.4.1737; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kutlesa S, 2002, J CELL SCI, V115, P4505, DOI 10.1242/jcs.00142; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Lerner A, 1996, EMBO J, V15, P5876, DOI 10.1002/j.1460-2075.1996.tb00974.x; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; SHIBATA K, 1992, P NATL ACAD SCI USA, V89, P3135, DOI 10.1073/pnas.89.7.3135; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Swainson L, 2005, P NATL ACAD SCI USA, V102, P12867, DOI 10.1073/pnas.0503603102; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Watakabe A, 2006, J COMP NEUROL, V499, P258, DOI 10.1002/cne.21106; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yamamoto M, 2008, INT IMMUNOL, V20, P413, DOI 10.1093/intimm/dxn006	39	97	100	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					888	898		10.1016/j.immuni.2008.10.008	http://dx.doi.org/10.1016/j.immuni.2008.10.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19027330	Green Accepted, Bronze			2022-12-18	WOS:000262012400009
J	Kared, H; Adle-Biassette, H; Fois, E; Masson, A; Bach, JF; Chatenoud, L; Schneider, E; Zavala, F				Kared, Hassen; Adle-Biassette, Homa; Fois, Elena; Masson, Annie; Bach, Jean-Francois; Chatenoud, Lucienne; Schneider, Elke; Zavala, Flora			Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; ANTIGEN-PRESENTING CELLS; MOUSE BONE-MARROW; STEM-CELLS; DENDRITIC CELLS; NOD MICE; IN-VIVO; UP-REGULATION; LIGAND; EXPRESSION	Cellular interactions promoting the in vivo expansion of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells for maintenance of immune tolerance remain poorly defined. Here we report that mobilized Lin(-)Sca-1(+)c-kit(+) (LSK) hematopoletic progenitor cells (HPCs), unlike medullary hematopoietic stem cells (HSCs), selectively drove the direct, immediate expansion of functional host-derived Treg cells, thereby preventing the progression to overt spontaneous autoimmune diabetes in nonobese diabetic mice. Treg cell expansion required cell-to-cell contact and Notch3 signaling, which was mediated selectively through the Notch ligand Jagged2 expressed by the multipotent HPC subset, as assessed by small interfering RNA (siRNA) silencing. Conversely, notwithstanding their similar multilineage microchimerism, neither sorted Jagged2(-) HPCs nor Jagged2(lo) medullary HSCs were able to expand Treg cells. These data provide evidence for a productive Notch-mediated interaction between a unique subset of mobilized hematopoietic progenitors and Treg cells. They open therapeutic perspectives for autologous transplantation of Jagged2(+) LSK progenitors to promote Treg cell expansion in T cell-mediated diseases.	Univ Paris 05, Necker Inst, CNRS, UMR 8147, F-75743 Paris 15, France; Necker Inst, INSERM, U580, F-75743 Paris, France; Hop Bichat Claude Bernard, Pathol Lab, AP HP, F-78018 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Zavala, F (corresponding author), Univ Paris 05, Necker Inst, CNRS, UMR 8147, F-75743 Paris 15, France.	zavala@necker.fr	Adle-Biassette, Homa/AAG-2751-2019; ZAvALA, Flora/E-7973-2017; Kared, Hassen/AAD-7247-2020	ZAvALA, Flora/0000-0002-2338-6802; 				Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Beilhack GF, 2003, DIABETES, V52, P59, DOI 10.2337/diabetes.52.1.59; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Burt RK, 2002, BLOOD, V99, P768, DOI 10.1182/blood.V99.3.768; Chilton PM, 2004, DIABETES, V53, P1995, DOI 10.2337/diabetes.53.8.1995; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; Higano CS, 2004, CLIN CANCER RES, V10, P1219, DOI 10.1158/1078-0432.CCR-1404-02; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; MacDonald KPA, 2005, J IMMUNOL, V174, P1841, DOI 10.4049/jimmunol.174.4.1841; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; O'Keeffe M, 2005, INT IMMUNOL, V17, P307, DOI 10.1093/intimm/dxh210; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SERREZE DV, 1988, DIABETES, V37, P252, DOI 10.2337/diabetes.37.2.252; Steptoe RJ, 2005, DIABETES, V54, P434, DOI 10.2337/diabetes.54.2.434; Steptoe RJ, 2003, J CLIN INVEST, V111, P1357, DOI 10.1172/JCI200315995; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tsai S, 2000, BLOOD, V96, P950, DOI 10.1182/blood.V96.3.950.015k43_950_957; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422	44	97	102	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					823	834		10.1016/j.immuni.2006.09.008	http://dx.doi.org/10.1016/j.immuni.2006.09.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17081781	Bronze			2022-12-18	WOS:000242063100014
J	Nagaishi, T; Pao, L; Lin, SH; Iijima, H; Kaser, A; Qiao, SW; Chen, ZG; Glickman, J; Najjar, SM; Nakajima, A; Neel, BG; Blumberg, RS				Nagaishi, Takashi; Pao, Lily; Lin, Sue-Hwa; Iijima, Hideki; Kaser, Arthur; Qiao, Shuo-Wang; Chen, Zhangguo; Glickman, Jonathan; Najjar, Sonia M.; Nakajima, Atsushi; Neel, Benjamin G.; Blumberg, Richard S.			SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms	IMMUNITY			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; INFLAMMATORY-BOWEL-DISEASE; BILIARY GLYCOPROTEIN CD66A; N-TERMINAL DOMAIN; EXPERIMENTAL COLITIS; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; RECEPTOR; EXPRESSION; ACTIVATION	T cell activation through the T cell receptor (TCR) is subsequently modified by secondary signals that are either stimulatory or inhibitory. We show that CEACAM1 adhesion molecule isoforms containing a long cytoplasmic domain inhibited multiple T cell functions as a consequence of TCR ligation. Overexpression of CEACAM1 resulted in decreased proliferation, allogeneic reactivity, and cytokine production in vitro and delayed type hypersensitivity and inflammatory bowel disease in mouse models in vivo. Conditioned deletion of CEACAM1 in T cells caused increased TCR-CD3 complex signaling. This T cell regulation was dependent upon the presence of immunoreceptor tyrosine-based inhibition motifs (ITIM) within the cytoplasmic domain of CEACAM1 and the Src homology 2 domain-containing protein tyrosine-phosphatase 1 (SHP1) in the T cell. Thus, CEACAM1 overexpression or deletion in T cells resulted in T cell inhibition or activation, respectively, revealing a role for CEACAM1 as a class of inhibitory receptors potentially amenable to therapeutic manipulation.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Gastroenterol Div,Dept Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Hematol Oncol Div, Boston, MA 02115 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Med Univ Ohio, Toledo, OH 43614 USA; Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanagawa 2360004, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Yokohama City University	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Gastroenterol Div,Dept Med, Boston, MA 02115 USA.	rblumberg@partners.org	Chen, Zhangguo/AAW-2032-2021; Najjar, Sonia M/GXW-2217-2022; Qiao, Shuo-Wang/ABE-8148-2020	Qiao, Shuo-Wang/0000-0002-0935-8397; Chen, Zhangguo/0000-0002-2741-0080	NCI NIH HHS [T32CA81156, CA111479] Funding Source: Medline; NIDDK NIH HHS [DK51362, DK50693, DK44319, DK34854, DK53056, DK54254] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA081156, R01CA111479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, R37DK044319, R01DK051362, R01DK053056, R01DK050693, P30DK034854, R01DK054254] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Daeron M, 1999, CURR TOP MICROBIOL, V244, P1; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; DVEKSLER GS, 1993, P NATL ACAD SCI USA, V90, P1716, DOI 10.1073/pnas.90.5.1716; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; GAGNETEN S, 1995, J VIROL, V69, P889, DOI 10.1128/JVI.69.2.889-895.1995; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Isakov N, 1997, IMMUNOL RES, V16, P85, DOI 10.1007/BF02786325; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; KHAN WN, 1993, INT IMMUNOL, V5, P265, DOI 10.1093/intimm/5.3.265; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; Moller MJ, 1996, INT J CANCER, V65, P740, DOI 10.1002/(SICI)1097-0215(19960315)65:6<740::AID-IJC5>3.0.CO;2-Z; Morales VM, 1999, J IMMUNOL, V163, P1363; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OIKAWA S, 1992, BIOCHEM BIOPH RES CO, V186, P881, DOI 10.1016/0006-291X(92)90828-9; Ouyang J, 2004, CHINESE J CHEM ENG, V12, P27; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1991, RES IMMUNOL, V142, P54, DOI 10.1016/0923-2494(91)90013-9; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Stocks SC, 1996, EUR J IMMUNOL, V26, P2924, DOI 10.1002/eji.1830261218; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szczepanik M, 1996, J EXP MED, V184, P2129, DOI 10.1084/jem.184.6.2129; Takato-Kaji R, 2005, IMMUNOL LETT, V96, P39, DOI 10.1016/j.imlet.2004.05.017; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WATT SM, 1991, BLOOD, V78, P63; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; WATT SM, 1995, EXPRESSION FUNCTION; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	54	97	102	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					769	781		10.1016/j.immuni.2006.08.026	http://dx.doi.org/10.1016/j.immuni.2006.08.026			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17081782	Bronze			2022-12-18	WOS:000242063100010
J	De Libero, G; Moran, AP; Gober, HJ; Rossy, E; Shamshiev, A; Chelnokova, O; Mazorra, Z; Vendetti, S; Sacchi, A; Prendergast, MM; Sansano, S; Tonevitsky, A; Landmann, R; Mori, L				De Libero, G; Moran, AP; Gober, HJ; Rossy, E; Shamshiev, A; Chelnokova, O; Mazorra, Z; Vendetti, S; Sacchi, A; Prendergast, MM; Sansano, S; Tonevitsky, A; Landmann, R; Mori, L			Bacterial infections promote T cell recognition of self-glycolipids	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; CAMPYLOBACTER-JEJUNI; HELICOBACTER-PYLORI; MOLECULAR MIMICRY; AUTOIMMUNE-DISEASE; GLYCOSPHINGOLIPID METABOLISM; SPHINGOLIPID BIOSYNTHESIS; O-2 LIPOPOLYSACCHARIDE; CHEMICAL-STRUCTURE; INNATE IMMUNITY	Recognition of self is essential for repertoire selection, immune regulation, and autoimmunity and may be a consequence of infection. Self-induced recognition may represent the escape mechanism adopted by pathogens but may also incite autoimmune diseases. Here, we show that bacterial infection may promote activation of T cells reactive to self-glycosphingolipids (self-GSL). CD1(+) antigen-presenting cells (APCs) infected with bacteria (Escherichia coli, Bacillus subtilis, Staphylococcus aureus, or Mycobacterium bovis-Bacillus Calmette Guerin [BCG]) or treated with the bacterial components lipopolysaccharide, lipoteichoic acid, or Pam(3)CysSerLys(4) (P3CSK4) lipopeptide acquire the capacity to stimulate self-GSL-specific T cells to cytokine release. Immediately after infection, APCs increase the endogenous GSL synthesis and stimulate GSL-specific T cells in a CD1- and T cell receptor (TCR)-dependent manner. This stimulation may contribute to inflammatory responses during bacterial infections and may predispose individuals to autoimmune diseases.	Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Natl Univ Ireland Univ Coll Galway, Lab Mol Biochem, Galway, Ireland; Inst Genet Microorganisms, Moscow 113545, Russia; Ist Lazzaro Spallanzani, I-00149 Rome, Italy	University of Basel; Ollscoil na Gaillimhe-University of Galway; IRCCS Lazzaro Spallanzani	De Libero, G (corresponding author), Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.	gennaro.delibero@unibas.ch	VENDETTI, SILVIA/M-4369-2015; Tonevitsky, Alexander G/F-8640-2014; Sacchi, Alessandra/K-7782-2016; Tonevitsky, Alexander/R-5596-2019; De Libero, Gennaro/P-2694-2017	VENDETTI, SILVIA/0000-0002-8443-496X; Sacchi, Alessandra/0000-0003-4964-386X; De Libero, Gennaro/0000-0003-0853-7868; Tonevitsky, Alexander/0000-0002-7079-7145				Amedei A, 2003, J EXP MED, V198, P1147, DOI 10.1084/jem.20030530; Appelmelk BJ, 1997, TRENDS MICROBIOL, V5, P70, DOI 10.1016/S0966-842X(96)10084-6; ASPINALL GO, 1994, CARBOHYDR LETT, V0001; Aspinall GO, 1999, GLYCOBIOLOGY, V9, P1235; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Grogan JL, 1999, J IMMUNOL, V163, P3764; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; HAIMOVITZFRIEDMAN, 1997, J EXP MED, V186, P1831; Hanniffy OM, 2001, CARBOHYD RES, V330, P223, DOI 10.1016/S0008-6215(00)00281-0; Hardardottir Ingibjorg, 1994, Current Opinion in Lipidology, V5, P207, DOI 10.1097/00041433-199405030-00008; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P1, DOI 10.1146/annurev.immunol.20.080801.102422; Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726; KNIREL YA, 1994, BIOCHEMISTRY-MOSCOW+, V59, P1325; Knirel YA, 1999, EUR J BIOCHEM, V266, P123, DOI 10.1046/j.1432-1327.1999.00831.x; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Mattern T, 1999, J EXP MED, V189, P693, DOI 10.1084/jem.189.4.693; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Memon RA, 1999, J BIOL CHEM, V274, P19707, DOI 10.1074/jbc.274.28.19707; Memon RA, 2001, J LIPID RES, V42, P452; Memon RA, 1998, ARTERIOSCL THROM VAS, V18, P1257, DOI 10.1161/01.ATV.18.8.1257; Moody DB, 2001, CELL MOL LIFE SCI, V58, P1461, DOI 10.1007/PL00000789; MORAN AP, 1991, J BACTERIOL, V173, P618, DOI 10.1128/jb.173.2.618-626.1991; Moran AP, 2002, J NEUROL SCI, V196, P1, DOI 10.1016/S0022-510X(02)00036-9; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Moran AP, 2001, J AUTOIMMUN, V16, P241, DOI 10.1006/jaut.2000.0490; Muldoon J, 2002, CARBOHYD RES, V337, P2223, DOI 10.1016/S0008-6215(02)00182-9; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; RIETSCHEL ET, 1984, REV INFECT DIS, V6, P432; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Shi FD, 2001, TRENDS IMMUNOL, V22, P97, DOI 10.1016/S1471-4906(00)01821-4; WANG E, 1991, J BIOL CHEM, V266, P14486; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	45	97	99	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2005	22	6					763	772		10.1016/j.immuni.2005.04.013	http://dx.doi.org/10.1016/j.immuni.2005.04.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963790	Bronze			2022-12-18	WOS:000230180300013
J	Rathinam, C; Geffers, R; Yucel, R; Buer, J; Welte, K; Moroy, T; Klein, C				Rathinam, C; Geffers, R; Yucel, R; Buer, J; Welte, K; Moroy, T; Klein, C			The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function	IMMUNITY			English	Article							ZINC-FINGER PROTEIN; MONOCYTE DIFFERENTIATION; MICE LACKING; STAT3; MACROPHAGES; ACTIVATION; PROGENITORS; PRECURSORS; EXPRESSION; LINEAGE	The mechanisms controlling the differentiation of dendritic cells (DCs) remain largely unknown. Using a transcriptional profiling approach, we identified Gfi1 as a novel critical transcription factor in DC differentiation. Gfi1(-/-) mice showed a global reduction of myeloid and lymphoid DCs in all lymphoid organs whereas epidermal Langerhans cells were enhanced in number. In vivo, Gfi1(-/-) DCs showed striking phenotypic and functional alterations such as defective maturation and increased cytokine production. In vitro, Gfi1(-/-) hematopoietic progenitor cells were unable to develop into DCs. Instead, they differentiated into macrophages, suggesting that Gfi1 is a critical modulator of DC versus macrophage development. Analysis of hematopoietic chimeras and retrovirus-reconstituted hematopoietic progenitor cells established a cell autonomous and nonredundant role for Gfi1 in DC development. The developmental defect of Gfi1(-/-) progenitor cells was associated with decreased STAT3 activation. In conclusion, we have identified Gfi1 as a critical transcription factor that controls DC versus macrophage development and dissociates DC maturation and activation.	Hannover Med Sch, Dept Pediat Hematol Oncol, D-30625 Hannover, Germany; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; Univ Klinikum Essen, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; University of Duisburg Essen	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Moroy, Tarik/D-9923-2011	Buer, Jan/0000-0002-7602-1698				Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Jegalian AG, 2002, J BIOL CHEM, V277, P2345, DOI 10.1074/jbc.M105575200; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Schroeder T, 2000, BRIT J HAEMATOL, V111, P890; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; YUCEL R, 2004, J BIOL CHEM, V39, P40936; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	51	97	100	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					717	728		10.1016/j.immuni.2005.04.007	http://dx.doi.org/10.1016/j.immuni.2005.04.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963786	Bronze			2022-12-18	WOS:000230180300009
J	Taylor, PR; Gordon, S				Taylor, PR; Gordon, S			Monocyte heterogeneity and innate immunity	IMMUNITY			English	Article							DENDRITIC CELLS	Peripheral monocyte heterogeneity is widely acknowledged in humans but until now comparable heterogeneity has not been characterized in mice. In this issue, Geissmann et al. use chemokine receptors to define two monocyte subsets and Serbina et al. highlight the importance of selective monocyte recruitment in the innate immune response to Listeria.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Taylor, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.			Taylor, Philip/0000-0003-0163-1421				Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P62	9	97	103	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					2	4		10.1016/S1074-7613(03)00178-X	http://dx.doi.org/10.1016/S1074-7613(03)00178-X			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871633	Bronze			2022-12-18	WOS:000184260400002
J	Liou, J; Kiefer, F; Dang, A; Hashimoto, A; Cobb, MH; Kurosaki, T; Weiss, A				Liou, J; Kiefer, F; Dang, A; Hashimoto, A; Cobb, MH; Kurosaki, T; Weiss, A			HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1	IMMUNITY			English	Article							N-TERMINAL KINASE; GERMINAL CENTER KINASE; T-CELL RECEPTOR; HEMATOPOIETIC PROGENITOR KINASE-1; STE20-RELATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; TYROSINE KINASES; PHOSPHOLIPASE C-GAMMA-2; ADAPTER PROTEINS; MEDIATED ACTIVATION	The serine/threonine kinase HPK1 is a member of the germinal center kinase (GCK) family that has been implicated in the regulation of MAP kinase pathways. Here, we demonstrate the involvement of HPK1 in antigen receptor signaling. Engagement of the TCR or the BCR resulted in a marked induction of HPK1 catalytic activity. Subsequent analysis revealed that Src and Syk/ZAP-70 tyrosine kinases and the adaptor proteins LAT, SLP-76, BLNK, Grb2, and Grap are involved in HPK1 activation. Overexpression of HPK1 inhibited TCR activation of AP-1. and ERK2, whereas the kinase-inactive mutant of HPK1 potentiated these responses. Neither form of HPK1 affected PMA or v-Ras activation of AP-1 and ERK2. Thus, HPK1 is a negative regulator of the TCR-induced AP-1 response pathway.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Max Planck Inst Physiol & Clin Res, WG Kerckhoff Inst, D-61231 Bad Nauheim, Germany; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Kansai Med Univ, Dept Mol Genet, Inst Liver Res, Moriguchi, Osaka 5708506, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Kansai Medical University	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Cobb, Melanie/0000-0003-0833-5473; Kiefer, Friedemann/0000-0002-3002-8237	NCI NIH HHS [R01 CA72531] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072531] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Ling P, 1999, MOL CELL BIOL, V19, P1359; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	49	97	109	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2000	12	4					399	408		10.1016/S1074-7613(00)80192-2	http://dx.doi.org/10.1016/S1074-7613(00)80192-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795738	Bronze			2022-12-18	WOS:000086757300005
J	Steinhoff, U; Brinkmann, V; Klemm, U; Aichele, P; Seiler, P; Brandt, U; Bland, PW; Prinz, I; Zugel, U; Kaufmann, SHE				Steinhoff, U; Brinkmann, V; Klemm, U; Aichele, P; Seiler, P; Brandt, U; Bland, PW; Prinz, I; Zugel, U; Kaufmann, SHE			Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells	IMMUNITY			English	Article							INFLAMMATORY BOWEL-DISEASE; HEAT-SHOCK-PROTEIN; TUMOR-NECROSIS-FACTOR; COLITIC C3H/HEJBIR MICE; CROHNS-DISEASE; ULCERATIVE-COLITIS; SCID MICE; INTERLEUKIN-10-DEFICIENT MICE; EPITHELIAL-CELLS; LYMPHOCYTES	Due to their ubiquitous distribution and high degree of structural similarity, heat shock proteins (hsp) are potential target antigens in autoimmune diseases. Here, we describe induction of intestinal inflammation following transfer of hsp60-reactive CD8 T cells into mice. Inflammatory reactions were MHC class I dependent and developed primarily in the smalt intestine. IFN gamma and TNF alpha, as well as gut-derived hsp60, were elevated at sites of T cell infiltration. Intestinal lesions were drastically reduced in mice lacking receptors for TNF alpha. Pathology also developed in germ-free mice, indicating recognition of host-derived hsp60 by CD8 T cells. This report demonstrates that CD8 T cells with defined antigen specificity cause intestinal inflammation, emphasizing a link between infection and autoimmune disease.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Microscopy Unit, D-10117 Berlin, Germany; Free Univ Berlin, Inst Anim Welf Anim Behav & Lab Anim Sci, Div Vet Med, D-12207 Berlin, Germany; Univ Bristol, Dept Vet Clin Sci, Div Mol & Cellular Biol, Bristol BS40 5DU, Avon, England	Max Planck Society; Max Planck Society; Free University of Berlin; University of Bristol	Steinhoff, U (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany.	steinhoff@mpiib-berlin.mpg.de	Prinz, Immo/A-3026-2010; Brinkmann, Volker/A-6015-2009; Kaufmann, Stefan HE/I-5454-2014	Prinz, Immo/0000-0002-8789-9578; Steinhoff, Ulrich/0000-0003-2141-7756; Kaufmann, Stefan HE/0000-0001-9866-8268				Aichele P, 1996, IMMUNOL REV, V152, P21, DOI 10.1111/j.1600-065X.1996.tb00909.x; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; BLAND PW, 1986, IMMUNOLOGY, V58, P1; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; BRAEGGER CP, 1994, ANN ALLERGY, V72, P135; Brandwein SL, 1997, J IMMUNOL, V159, P44; CAPPELLO M, 1992, GUT, V33, P1214, DOI 10.1136/gut.33.9.1214; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Dianda L, 1997, AM J PATHOL, V150, P91; Duchmann R, 1996, SCAND J IMMUNOL, V44, P71, DOI 10.1046/j.1365-3083.1996.d01-273.x; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; ELSAGHIER A, 1992, CLIN EXP IMMUNOL, V89, P305, DOI 10.1111/j.1365-2249.1992.tb06950.x; EMOTO M, 1995, INT IMMUNOL, V7, P1729, DOI 10.1093/intimm/7.11.1729; Hanano R, 1996, INFECT IMMUN, V64, P3201, DOI 10.1128/IAI.64.8.3201-3209.1996; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; KOGA T, 1989, SCIENCE, V245, P1112, DOI 10.1126/science.2788923; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MACDONALD TT, 1990, CLIN EXP IMMUNOL, V81, P301; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; MOUDGIL KD, 1994, CLIN IMMUNOL IMMUNOP, V73, P283, DOI 10.1006/clin.1994.1200; MOWAT AM, 1989, IMMUNOLOGY, V68, P18; OTTENHOFF THM, 1990, CURR TOP MICROBIOL, V155, P111; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; REIMANN J, 1995, J MOL MED, V73, P133, DOI 10.1007/BF00198241; REIMANN J, 1993, EUR J IMMUNOL, V23, P350, DOI 10.1002/eji.1830230208; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; RUDOLPH U, 1995, J CLIN IMMUNOL, V15, pS101, DOI 10.1007/BF01540899; RUDOLPHI A, 1994, EUR J IMMUNOL, V24, P2803, DOI 10.1002/eji.1830241134; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Spahn TW, 1997, DIGESTION, V58, P469, DOI 10.1159/000201485; STEINHOFF U, 1994, P NATL ACAD SCI USA, V91, P5085, DOI 10.1073/pnas.91.11.5085; STEVENS TRJ, 1992, CLIN EXP IMMUNOL, V90, P271; STROBER W, 1986, J CLIN IMMUNOL, V6, P415, DOI 10.1007/BF00915248; SUNDBERG JP, 1994, GASTROENTEROLOGY, V112, P1876; TAUROG JD, 1993, J IMMUNOL, V150, P4168; THOMPSON SJ, 1990, EUR J IMMUNOL, V20, P2479, DOI 10.1002/eji.1830201118; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; ZUGEL U, 1995, EUR J IMMUNOL, V25, P451, DOI 10.1002/eji.1830250222; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	52	97	98	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1999	11	3					349	358		10.1016/S1074-7613(00)80110-7	http://dx.doi.org/10.1016/S1074-7613(00)80110-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514013	Bronze			2022-12-18	WOS:000082918500010
J	Shearer, GM				Shearer, GM			HIV-induced immunopathogenesis	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ACQUIRED IMMUNE-DEFICIENCY; T-CELLS; SEROPOSITIVE INDIVIDUALS; INFECTED INDIVIDUALS; CLASS-II; EXPRESSION; PATHOGENESIS; APOPTOSIS; AIDS		NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shearer, GM (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	Gene_Shearer@nih.gov						AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102; ASCHER MS, 1988, CLIN EXP IMMUNOL, V73, P165; Badley AD, 1998, J CLIN INVEST, V102, P79, DOI 10.1172/JCI2691; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Chougnet C, 1998, EUR J IMMUNOL, V28, P646, DOI 10.1002/(SICI)1521-4141(199802)28:02<646::AID-IMMU646>3.0.CO;2-6; Chougnet C, 1995, RES IMMUNOL, V146, P615, DOI 10.1016/0923-2494(96)83039-2; Clerici M, 1996, AIDS, V10, P603, DOI 10.1097/00002030-199606000-00005; CLERICI M, 1989, NATURE, V339, P383, DOI 10.1038/339383a0; Clerici M, 1996, AIDS RES HUM RETROV, V12, P1053, DOI 10.1089/aid.1996.12.1053; Clerici M, 1997, CELL DEATH DIFFER, V4, P699, DOI 10.1038/sj.cdd.4400314; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; CLERICI M, 1991, J IMMUNOL, V146, P2207; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Cottrez F, 1997, J CLIN INVEST, V99, P257, DOI 10.1172/JCI119154; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Dudhane A, 1996, AIDS RES HUM RETROV, V12, P885, DOI 10.1089/aid.1996.12.885; Dudhane A, 1996, AIDS RES HUM RETROV, V12, P893, DOI 10.1089/aid.1996.12.893; ENNEN J, 1990, EUR J IMMUNOL, V20, P2451, DOI 10.1002/eji.1830201114; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; GOTTLIEB MS, 1983, ANN INTERN MED, V99, P208, DOI 10.7326/0003-4819-99-2-208; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; HO HN, 1993, J IMMUNOL, V150, P3070; IMBERTI L, 1991, SCIENCE, V254, P860, DOI 10.1126/science.1948066; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Levy JA, 1998, HIV PATHOGENESIS AID; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; MEYAARD L, 1993, IMMUNOL TODAY, V14, P161, DOI 10.1016/0167-5699(93)90279-T; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; Mikovits JA, 1998, MOL CELL BIOL, V18, P5166, DOI 10.1128/MCB.18.9.5166; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OYAIZU N, 1995, J CLIN IMMUNOL, V15, P217, DOI 10.1007/BF01540879; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; Pericle F, 1998, J IMMUNOL, V160, P28; Polyak S, 1997, J IMMUNOL, V159, P2177; PRINCE HE, 1984, J IMMUNOL, V133, P1313; RAMSDELL F, 1994, INT IMMUNOL, V6, P1545, DOI 10.1093/intimm/6.10.1545; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; ROOK AH, 1983, J CLIN INVEST, V72, P398, DOI 10.1172/JCI110981; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rossio JL, 1995, AIDS RES HUM RETROV, V11, P1433, DOI 10.1089/aid.1995.11.1433; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; Shearer GM, 1996, IMMUNOL TODAY, V17, P21, DOI 10.1016/0167-5699(96)80564-0; SHEARER GM, 1996, IMMUNOLOGY HIV INFEC, P229; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; VYAKARNAM A, 1995, IMMUNOLOGY, V86, P85; Westby M, 1996, IMMUNOL TODAY, V17, P120, DOI 10.1016/0167-5699(96)80603-7; Yoo L, 1996, J IMMUNOL, V157, P1313; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1; ZWILLING BS, 1991, AIDS, V5, P1327, DOI 10.1097/00002030-199111000-00007	60	97	98	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					587	593		10.1016/S1074-7613(00)80656-1	http://dx.doi.org/10.1016/S1074-7613(00)80656-1			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846480	Bronze			2022-12-18	WOS:000077298300001
J	Gobin, SJP; Peijnenburg, A; van Eggermond, M; van Zutphen, N; van den Berg, R; van den Elsen, PJ				Gobin, SJP; Peijnenburg, A; van Eggermond, M; van Zutphen, N; van den Berg, R; van den Elsen, PJ			The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta(2)-microglobulin genes	IMMUNITY			English	Article							BARE-LYMPHOCYTE-SYNDROME; MAJOR HISTOCOMPATIBILITY COMPLEX; BOX-BINDING PROTEIN; REGULATORY FACTOR; X-BOX; TRANSCRIPTION FACTORS; KAPPA-B; HLA-A; NF-Y; EXPRESSION	In type III bare lymphocyte syndrome (BLS) patients, defects in the RFX protein complex result in a lack of MHC class II and reduced MHC class I cell surface expression. Using type III BLS cell lines, we demonstrate that the RFX subunits RFX5 and RFXAP are crucial for constitutive and CIITA-induced MHC class I and beta(2)m transactivation. Similar to MHC class II, the promoters of MHC class I and beta(2)m contain lan S-X-Y region of which the X1 box is crucial for constitutive and CIITA-induced MHC class I and beta(2)m transactivation. Thus, the RFX complex is part of a regulatory pathway linking the transactivation of MHC class I and II and their accessory genes.	Leiden Univ, Med Ctr, Dept Immunohematol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Blood Bank, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Elsen, PJ (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol, NL-2333 ZA Leiden, Netherlands.	pvdelsen@euronet.nl						Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037, DOI 10.1089/jir.1995.15.1037; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; FLAJNIK MF, 1991, IMMUNOGENETICS, V33, P295, DOI 10.1007/BF00216688; Fontes JD, 1997, J MOL BIOL, V270, P336, DOI 10.1006/jmbi.1997.1121; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; GAUR LK, 1992, IMMUNOGENETICS, V35, P136; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GIRDLESTONE J, 1993, P NATL ACAD SCI USA, V90, P11568, DOI 10.1073/pnas.90.24.11568; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; GUSSOW D, 1987, J IMMUNOL, V139, P3132; ISRAEL A, 1987, P NATL ACAD SCI USA, V84, P2653, DOI 10.1073/pnas.84.9.2653; JabraneFerrat N, 1996, MOL CELL BIOL, V16, P4683; JOHNSON DR, 1994, MOL CELL BIOL, V14, P1322, DOI 10.1128/MCB.14.2.1322; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KROEMER G, 1990, IMMUNOGENETICS, V31, P405, DOI 10.1007/BF02115020; LAMBERT M, 1991, RES IMMUNOL, V142, P789, DOI 10.1016/0923-2494(91)90124-2; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; LONERGAN M, 1993, MOL CELL BIOL, V13, P6629, DOI 10.1128/MCB.13.11.6629; LouisPlence P, 1997, J IMMUNOL, V159, P3899; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MANSKY P, 1994, J IMMUNOL, V153, P5082; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; MORENO CS, 1995, J IMMUNOL, V155, P4313; Moreno CS, 1997, J IMMUNOL, V158, P5841; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; PEIJNENBURG A, 1995, IMMUNOGENETICS, V41, P287, DOI 10.1007/BF00172153; Peijnenburg A, 1997, J IMMUNOL, V159, P2720; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; Riegert P, 1996, P NATL ACAD SCI USA, V93, P1243, DOI 10.1073/pnas.93.3.1243; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Sabatier C, 1996, CR ACAD SCI III-VIE, V319, P789; SALTERCID L, 1995, CRIT REV IMMUNOL, V15, P31, DOI 10.1615/CritRevImmunol.v15.i1.20; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Schoneich J, 1997, J IMMUNOL, V158, P4788; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; TOURAINE JL, 1985, EXP HEMATOL, V13, P86; VALLEJO AN, 1995, IMMUNOL REV, V143, P249, DOI 10.1111/j.1600-065X.1995.tb00678.x; Villard J, 1997, NEW ENGL J MED, V337, P748, DOI 10.1056/NEJM199709113371104; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; ZELEZNIKLE NJ, 1991, P NATL ACAD SCI USA, V88, P1873, DOI 10.1073/pnas.88.5.1873; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	51	97	100	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					531	541		10.1016/S1074-7613(00)80636-6	http://dx.doi.org/10.1016/S1074-7613(00)80636-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806639	Bronze			2022-12-18	WOS:000076680700011
J	Vales-Gomez, M; Reyburn, HT; Mandelboim, M; Strominger, JL				Vales-Gomez, M; Reyburn, HT; Mandelboim, M; Strominger, JL			Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors	IMMUNITY			English	Article							CLASS-I MOLECULES; MHC CLASS-I; DIRECT BINDING; LOW-AFFINITY; RECOGNITION; LYSIS; ADHESION; ANTIBODY; PEPTIDES; SPECIFICITY	The recognition of HLA-C molecules by specific inhibitory receptors is a crucial step in the regulation of natural killer (NK) cell function. Using soluble, recombinant HLA-C molecules and NK inhibitory receptors (NKIR, members of the immunoglobulin superfamily), we show that HLA-C binds to NKIR molecules with extremely fast association and dissociation rates, among the fastest of the immune system interactions so far studied. These kinetics may be essential for the biological function of NK cells, i.e., to facilitate the rapid immunosurveillance of cells for absent or diminished expression of class I MHC proteins.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Strominger, JL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jlstrom@fas.harvard.edu	Vales-Gomez, Mar/ABG-7808-2020; Reyburn, Hugh T/B-4338-2009; Valés-Gómez, Mar/F-5351-2012	Vales-Gomez, Mar/0000-0001-7424-3206; Reyburn, Hugh T/0000-0003-2855-1595; Valés-Gómez, Mar/0000-0001-7424-3206	NCI NIH HHS [CA-4774] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell C, 1996, J MAT CULT, V1, P93, DOI 10.1177/135918359600100105; CICCONE E, 1992, J EXP MED, V175, P709, DOI 10.1084/jem.175.3.709; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P7983, DOI 10.1073/pnas.89.17.7983; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; Dohring C, 1996, EUR J IMMUNOL, V26, P365, DOI 10.1002/eji.1830260215; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Gumperz JE, 1997, J IMMUNOL, V158, P5237; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; LopezBotet M, 1997, IMMUNOL REV, V155, P165, DOI 10.1111/j.1600-065X.1997.tb00949.x; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P4604, DOI 10.1073/pnas.94.9.4604; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Olcese L, 1996, J IMMUNOL, V156, P4531; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; ROGGENBUCK D, 1994, SCAND J IMMUNOL, V40, P64, DOI 10.1111/j.1365-3083.1994.tb03434.x; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Zappacosta F, 1997, P NATL ACAD SCI USA, V94, P6313, DOI 10.1073/pnas.94.12.6313	41	97	99	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					337	344		10.1016/S1074-7613(00)80616-0	http://dx.doi.org/10.1016/S1074-7613(00)80616-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768753	Bronze			2022-12-18	WOS:000076202300006
J	Nelms, K; Snow, AL; Hu-Li, J; Paul, WE				Nelms, K; Snow, AL; Hu-Li, J; Paul, WE			FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation	IMMUNITY			English	Article							IRS-1 PTB DOMAIN; INSULIN-RECEPTOR; IL-4 RECEPTOR; TYROSINE KINASES; SIGNAL-TRANSDUCTION; SHC PHOSPHORYLATION; STRUCTURAL BASIS; GROWTH-FACTOR; BINDING; ACTIVATION	The human IL-4 receptor contains a sequence (the I4R motif) centered on Y497 that, when phosphorylated, interacts with phosphotyrosine-binding (PTB) domain proteins. Here, we describe a PTB domain protein, FRIP, that is phosphorylated in response to cytokine stimulation. FRIP is related to the rasGAP-associated protein p62(dok) and is bound by the N-terminal SH2 domain of rasGAP. The frip gene maps to the hairless (hr) locus on mouse chromosome 14. hr/hr mice exhibit lymphadenopathy, and their lymph node T cells proliferate more vigorously to anti-CDS with IL-4 or IL-2 stimulation than +/hr T cells. FRIP expression is significantly reduced in T cells from hr/hr mice. FRIP may negatively regulate proliferation by acting as an adapter molecule between rasGAP and receptor complexes.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	wepaul@helix.nih.gov		Snow, Andrew/0000-0002-8728-6691				ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BURNS LA, 1993, J BIOL CHEM, V268, P17659; CANCHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CONRAD DH, 1987, J IMMUNOL, V139, P2290; Crowley MT, 1996, J BIOL CHEM, V271, P1145, DOI 10.1074/jbc.271.2.1145; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Downward J, 1996, CANCER SURV, V27, P87; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; EVANS GA, 1995, J BIOL CHEM, V270, P28858, DOI 10.1074/jbc.270.48.28858; GOLEMIS EA, 1992, MOL CELL BIOL, V12, P3006, DOI 10.1128/MCB.12.7.3006; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HEINIGER HJ, 1974, CANCER RES, V34, P201; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Huang H, 1997, J IMMUNOL, V159, P3731; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; HULI J, 1989, J IMMUNOL, V142, P800; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; MEIER H, 1969, P NATL ACAD SCI USA, V63, P759, DOI 10.1073/pnas.63.3.759; MORRISSEY PJ, 1980, J IMMUNOL, V125, P1558; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PERKINS GR, 1993, J EXP MED, V178, P1429, DOI 10.1084/jem.178.4.1429; RAVICHANDRAN KS, 1994, J BIOL CHEM, V269, P1599; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESKEKUNZ AB, 1979, J EXP MED, V149, P228, DOI 10.1084/jem.149.1.228; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; SALCINI AE, 1994, ONCOGENE, V9, P2827; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SHIBUYA H, 1992, CELL, V70, P57, DOI 10.1016/0092-8674(92)90533-I; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TRUB T, 1995, J BIOL CHEM, V270, P18205; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; WHITE MF, 1994, J BIOL CHEM, V269, P1; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; YAMANASHI Y, 1997, DOK CELL, V88, P205; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zamorano J, 1996, J IMMUNOL, V157, P4926; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	64	97	98	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					13	24		10.1016/S1074-7613(00)80584-1	http://dx.doi.org/10.1016/S1074-7613(00)80584-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697832	Bronze			2022-12-18	WOS:000075066600002
J	JACOBSON, BA; PANKA, DJ; NGUYEN, KA; ERIKSON, J; ABBAS, AK; MARSHAKROTHSTEIN, A				JACOBSON, BA; PANKA, DJ; NGUYEN, KA; ERIKSON, J; ABBAS, AK; MARSHAKROTHSTEIN, A			ANATOMY OF AUTOANTIBODY PRODUCTION - DOMINANT LOCALIZATION OF ANTIBODY-PRODUCING CELLS TO T-CELL ZONES IN FAS-DEFICIENT MICE	IMMUNITY			English	Article							LPR LPR MICE; SYSTEMIC LUPUS-ERYTHEMATOSUS; PRIMARY IMMUNE-RESPONSE; INDEPENDENT ANTIGENS; MONOCLONAL-ANTIBODY; CYTOLYTIC ACTIVITY; GERMINAL-CENTERS; SOMATIC MUTATION; AUTOIMMUNE MICE; LPR/LPR MICE	The goal of this study was to examine the in vivo site of autoantibody production in normal and autoimmune-prone mice. B cells were identified in tissue sections with IgM- and lgG2a-specific riboprobes that readily distinguished resting cells from antibody-forming cells (AFC). In normal mice, the few identifiable lgG2a-secreting cells were found in the red pulp. By contrast, in lpr mice exceedingly high numbers of IgG2a and autoantibody-producing cells were found deep within the T cell-rich periarteriolar lymphoid sheaths (PALS). This unusual anatomic location of autoantibody-secreting B cells is unique to Fas dysregulated strains, since IgG2a-producing cells in MRL/+ and (SWR x NZB)F1 mice were found predominantly in the red pulp or outer PALS, similar to normal mice, Furthermore, analysis of spleens from lpr and non-lpr anti-DNA immunoglobulin transgenic mice revealed dramatic accumulation of Tg(+) cells in the inner PALS only in lpr mice. These data suggest that in the absence of Fas, autoreactive B cells accumulate in T cell-rich zones, and this anatomic feature may contribute to autoantibody production.	WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA; HARVARD UNIV, CHILDRENS HOSP,SCH MED,DEPT PATHOL,DIV IMMUNOL RES, BOSTON, MA 02115 USA	The Wistar Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	JACOBSON, BA (corresponding author), BOSTON UNIV, SCH MED, DEPT MICROBIOL, BOSTON, MA 02118 USA.				NATIONAL CANCER INSTITUTE [T32CA064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035230] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA64070-01] Funding Source: Medline; NIAID NIH HHS [AI32531] Funding Source: Medline; NIAMS NIH HHS [AR35230] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BLOOM DD, 1993, J IMMUNOL, V150, P1591; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; BUDD RC, 1986, J IMMUNOL, V137, P3734; CHU YW, 1995, J CLIN INVEST, V95, P1389, DOI 10.1172/JCI117791; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CREIGHTON WD, 1979, J IMMUNOL, V123, P2627; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DAVIGNON JL, 1985, J IMMUNOL, V135, P2423; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; EISENBERG RA, 1982, J IMMUNOL, V129, P2146; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GIESE T, 1994, J IMMUNOL, V152, P2000; GIESE T, 1995, J IMMUNOL, V154, P4986; GODING JW, 1976, J IMMUNOL METHODS, V13, P215, DOI 10.1016/0022-1759(76)90068-5; HAMMOND DM, 1993, J EXP MED, V178, P2225, DOI 10.1084/jem.178.6.2225; HEITZMAN.H, 1974, P NATL ACAD SCI USA, V71, P3537, DOI 10.1073/pnas.71.9.3537; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JACOBSON BA, 1994, J IMMUNOL, V152, P4489; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KLINMAN DM, 1990, J CLIN INVEST, V86, P1249, DOI 10.1172/JCI114831; LIEBERUM B, 1988, CLIN IMMUNOL IMMUNOP, V46, P421, DOI 10.1016/0090-1229(88)90061-X; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1990, CURR TOP MICROBIOL, V159, P37; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; MIXTER PF, 1995, J IMMUNOL, V154, P2063; MORSE HC, 1982, J IMMUNOL, V129, P2612; MOUNTZ JD, 1987, J IMMUNOL, V138, P157; NEMAZEE D, 1991, J IMMUNOL, V147, P2536; PARK CL, 1983, J IMMUNOL, V130, P2161; PERKINS DL, 1990, J IMMUNOL, V145, P549; PRUDHOMME GJ, 1983, J EXP MED, V157, P730, DOI 10.1084/jem.157.2.730; RADIC MZ, 1991, J IMMUNOL, V146, P176; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; RUBIN RL, 1986, J IMMUNOL, V137, P2528; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SLACK JH, 1984, J IMMUNOL, V132, P1271; SOBEL ES, 1991, J EXP MED, V173, P1441, DOI 10.1084/jem.173.6.1441; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; VANDENEERTWEGH AJM, 1992, CRIT REV IMMUNOL, V11, P337; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; VANEWIJK W, 1977, CELL TISSUE RES, V183, P471, DOI 10.1007/BF00225661; VANROOIJEN N, 1986, IMMUNOL TODAY, V7, P193, DOI 10.1016/0167-5699(86)90100-3; VERY DL, 1993, IMMUNOLOGY, V80, P518; WALLACH J, 1992, INTERPRETATION DIAGN, P694; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WOLFOWICZ CB, 1988, CLIN IMMUNOL IMMUNOP, V46, P382, DOI 10.1016/0090-1229(88)90057-8; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	61	97	97	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1995	3	4					509	519		10.1016/1074-7613(95)90179-5	http://dx.doi.org/10.1016/1074-7613(95)90179-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584141	Bronze			2022-12-18	WOS:A1995TB60800011
J	He, WY; Holtkamp, S; Hergenhan, SM; Kraus, K; de Juan, A; Weber, J; Bradfield, P; Grenier, JMP; Pelletier, J; Druzd, D; Chen, CS; Ince, LM; Bierschenk, S; Pick, R; Sperandio, M; Aurrand-Lions, M; Scheiermann, C				He, Wenyan; Holtkamp, Stephan; Hergenhan, Sophia Martina; Kraus, Kerstin; de Juan, Alba; Weber, Jasmin; Bradfield, Paul; Grenier, Julien Martin Pierre; Pelletier, Jeoffrey; Druzd, David; Chen, Chien-Sin; Ince, Louise Madeleine; Bierschenk, Susanne; Pick, Robert; Sperandio, Markus; Aurrand-Lions, Michel; Scheiermann, Christoph			Circadian Expression of Migratory Factors Establishes Lineage-Specific Signatures that Guide the Homing of Leukocyte Subsets to Tissues	IMMUNITY			English	Article							CD8(+) T-CELLS; TRANSENDOTHELIAL MIGRATION; LYMPHOCYTE RECIRCULATION; ADHESION; TRAFFICKING; RECRUITMENT; EMIGRATION; CLOCKS; LIVER; CODE	The number of leukocytes present in circulation varies throughout the day, reflecting bone marrow output and emigration from blood into tissues. Using an organism-wide circadian screening approach, we detected oscillations in pro-migratory factors that were distinct for specific vascular beds and individual leukocyte subsets. This rhythmic molecular signature governed time-of-day-dependent homing behavior of leukocyte subsets to specific organs. Ablation of BMAL1, a transcription factor central to circadian clock function, in endothelial cells or leukocyte subsets demonstrated that rhythmic recruitment is dependent on both microenvironmental and cell-autonomous oscillations. These oscillatory patterns defined leukocyte trafficking in both homeostasis and inflammation and determined detectable tumor burden in blood cancer models. Rhythms in the expression of pro-migratory factors and migration capacities were preserved in human primary leukocytes. The definition of spatial and temporal expression profiles of pro-migratory factors guiding leukocyte migration patterns to organs provides a resource for the further study of the impact of circadian rhythms in immunity.	[He, Wenyan; Holtkamp, Stephan; Hergenhan, Sophia Martina; Kraus, Kerstin; de Juan, Alba; Weber, Jasmin; Druzd, David; Chen, Chien-Sin; Ince, Louise Madeleine; Bierschenk, Susanne; Pick, Robert; Sperandio, Markus; Scheiermann, Christoph] Ludwig Maximilians Univ Munchen, Univ Hosp, BioMed Ctr, Walter Brendel Ctr Expt Med, D-82152 Planegg Martinsried, Germany; [Bradfield, Paul] Fdn Eclos, Mesenflow Technol SARL, Geneva, Switzerland; [Grenier, Julien Martin Pierre; Pelletier, Jeoffrey; Aurrand-Lions, Michel] Aix Marseille Univ, INSERM, Ctr Rech Cancerol Marseille, Inst Paoli Calmettes,CNRS, Marseille, France; [Sperandio, Markus; Scheiermann, Christoph] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Ince, Louise Madeleine; Scheiermann, Christoph] Univ Geneva, Ctr Med Univ, Dept Pathol & Immunol, Geneva, Switzerland	University of Munich; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); German Centre for Cardiovascular Research; Munich Heart Alliance; University of Geneva	Scheiermann, C (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, BioMed Ctr, Walter Brendel Ctr Expt Med, D-82152 Planegg Martinsried, Germany.; Scheiermann, C (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany.; Scheiermann, C (corresponding author), Univ Geneva, Ctr Med Univ, Dept Pathol & Immunol, Geneva, Switzerland.	christoph.scheiermann@med.uni-muenchen.de	Chen, Chien-Sin/AAT-4242-2021; Ince, Louise/K-6149-2019; Aurrand-Lions, Michel/O-9953-2016; Scheiermann, Christoph/B-8261-2014	Chen, Chien-Sin/0000-0002-5847-1441; Ince, Louise/0000-0002-2093-0876; Aurrand-Lions, Michel/0000-0002-8361-3034; Scheiermann, Christoph/0000-0002-9212-0995; Sperandio, Markus/0000-0002-7689-3613; de Juan, Alba/0000-0003-0174-4389	German Research Foundation (DFG) [SCHE 1645/2-1, SFB914]; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF) [635872]; International Max Planck Research School; Integrated Cancer Research Site ofMarseille [Inca-Inserm-DGOS 6038]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); International Max Planck Research School; Integrated Cancer Research Site ofMarseille	This work was supported by the German Research Foundation (DFG) (Emmy-Noether grant SCHE 1645/2-1 and SFB914 projects B01, B09, and Z03), the German Centre for Cardiovascular Research (DZHK), and the German Ministry of Education and Research (BMBF), in addition to a European Research Council starting grant (635872, CIRCODE), the Integrated Cancer Research Site ofMarseille (Inca-Inserm-DGOS 6038), and funding from the International Max Planck Research School. Additional support came from the Core Facility for Animal Models of the Ludwig Maximilians University Biomedical Center and the animal facility of the Walter Brendel Centre of Experimental Medicine. We thank Ralf Adams (Munster) and Eloi Montanez (Munich) for providing animals.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; Born J, 1997, J IMMUNOL, V158, P4454; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doyle NA, 1997, J CLIN INVEST, V99, P526, DOI 10.1172/JCI119189; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gorlino CV, 2014, J IMMUNOL, V193, P1966, DOI 10.4049/jimmunol.1301791; Hampton HR, 2016, SEMIN IMMUNOL, V28, P129, DOI 10.1016/j.smim.2016.03.008; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Looney MR, 2014, ANNU REV PHYSIOL, V76, P431, DOI 10.1146/annurev-physiol-021113-170331; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Man K, 2016, SCIENCE, V354, P999, DOI 10.1126/science.aah4966; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nolte MA, 2002, IMMUNOLOGY, V106, P299, DOI 10.1046/j.1365-2567.2002.01443.x; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Rossaint J, 2013, J INNATE IMMUN, V5, P348, DOI 10.1159/000345943; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schnoor M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/946509; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Sutton CE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02111-0; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhao Y, 2017, BLOOD, V130, P1995, DOI 10.1182/blood-2017-04-778779	45	96	97	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1175	+		10.1016/j.immuni.2018.10.007	http://dx.doi.org/10.1016/j.immuni.2018.10.007			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30527911	Green Published, hybrid			2022-12-18	WOS:000453556500020
J	Kim, M; Galan, C; Hill, AA; Wu, WJ; Fehlner-Peach, H; Song, HW; Schady, D; Bettini, ML; Simpson, KW; Longman, RS; Littman, DR; Diehl, GE				Kim, Myunghoo; Galan, Carolina; Hill, Andrea A.; Wu, Wan-Jung; Fehlner-Peach, Hannah; Song, Hyo Won; Schady, Deborah; Bettini, Matthew L.; Simpson, Kenneth W.; Longman, Randy S.; Littman, Dan R.; Diehl, Gretchen E.			Critical Role for the Microbiota in CX(3)CR1(+) Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; CROHNS-DISEASE; INTERLEUKIN-10 RECEPTOR; IMMUNE-RESPONSES; GUT MICROBIOTA; IFN-GAMMA; IL-10; SALMONELLA; MICE	The intestinal barrier is vulnerable to damage by microbiota-induced inflammation that is normally restrained through mechanisms promoting homeostasis. Such disruptions contribute to autoimmune and inflammatory diseases including inflammatory bowel disease. We identified a regulatory loop whereby, in the presence of the normal microbiota, intestinal antigen-presenting cells (APCs) expressing the chemokine receptor CX(3)CR1 reduced expansion of intestinal microbe-specific T helper 1 (Th1) cells and promoted generation of regulatory T cells responsive to food antigens and the microbiota itself. We identified that disruption of the microbiota resulted in CX(3)CR1(+) APC-dependent inflammatory Th1 cell responses with increased pathology after pathogen infection. Colonization with microbes that can adhere to the epithelium was able to compensate for intestinal microbiota loss, indicating that although microbial interactions with the epithelium can be pathogenic, they can also activate homeostatic regulatory mechanisms. Our results identify a cellular mechanism by which the microbiota limits intestinal inflammation and promotes tissue homeostasis.	[Kim, Myunghoo; Hill, Andrea A.; Wu, Wan-Jung; Song, Hyo Won; Diehl, Gretchen E.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Kim, Myunghoo; Hill, Andrea A.; Wu, Wan-Jung; Song, Hyo Won; Diehl, Gretchen E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Galan, Carolina; Fehlner-Peach, Hannah; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Schady, Deborah] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Bettini, Matthew L.] Texas Childrens Hosp, Baylor Coll Med, Sect Diabet & Endocrinol, Dept Pediat, Houston, TX 77030 USA; [Bettini, Matthew L.; Diehl, Gretchen E.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Longman, Randy S.] Weill Cornell Med, Jill Roberts Ctr IBD Res, New York, NY 10021 USA; [Longman, Randy S.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Littman, Dan R.] Howard Hughes Med Inst, New York, NY 10016 USA; [Galan, Carolina] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Baylor College of Medicine; Baylor College of Medicine; New York University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Diehl, GE (corresponding author), Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA.; Diehl, GE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Diehl, GE (corresponding author), Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA.	gdiehl@bcm.edu		Diehl, Gretchen/0000-0002-1841-2842; McAlester, Andrea/0000-0002-7405-5915	Curtis Hankamer Basic Research Fund at Baylor College of Medicine; NIH [AI123945, AI125264, DK114252, P30 AI036211, P30 CA125123, S10 RR024574]; NRSA [T32AI053831_Corry]; AAI Careers in Immunology Fellowship; Howard Hughes Medical Institute; Colton Center for Autoimmunity; Texas Medical Center Digestive Disease Center Cellular and Molecular Morphology Core and Pilot Fund [NIH P30DK056338]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH tetramer core facility for provision of MHC-peptide complexes; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125264, P30AI036211, T32AI053831, R21AI123945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114252, P30DK056338] Funding Source: NIH RePORTER	Curtis Hankamer Basic Research Fund at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAI Careers in Immunology Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Colton Center for Autoimmunity; Texas Medical Center Digestive Disease Center Cellular and Molecular Morphology Core and Pilot Fund; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH tetramer core facility for provision of MHC-peptide complexes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Curtis Hankamer Basic Research Fund at Baylor College of Medicine (G.E.D.), NIH AI123945 (G.E.D.), NIH AI125264 (G.E.D.), institutional NRSA T32AI053831_Corry (A.A.H.), AAI Careers in Immunology Fellowship (M.K.), the Howard Hughes Medical Institute (D.R.L.), the Colton Center for Autoimmunity (D.R.L.), NIH DK114252 (R.S.L.), the Texas Medical Center Digestive Disease Center Cellular and Molecular Morphology Core and Pilot Fund (G.E.D) (NIH P30DK056338), the Cytometry and Cell Sorting Core at Baylor College of Medicine with expert assistance of Jole M. Sederstrom and funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574), and the NIH tetramer core facility for provision of MHC-peptide complexes.	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Baumler AJ, 1996, INFECT IMMUN, V64, P1862; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Dolowschiak T, 2016, CELL HOST MICROBE, V20, P238, DOI 10.1016/j.chom.2016.06.008; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Sartor RB, 2007, J CLIN GASTROENTEROL, V41, pS37, DOI 10.1097/MCG.0b013e31802db364; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Zhou ZJ, 2016, CLIN IMMUNOL, V173, P81, DOI 10.1016/j.clim.2016.09.005; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	46	96	102	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					151	+		10.1016/j.immuni.2018.05.009	http://dx.doi.org/10.1016/j.immuni.2018.05.009			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29980437	Green Accepted, Bronze			2022-12-18	WOS:000438949100018
J	Cherrier, DE; Serafini, N; Di Santo, JP				Cherrier, Dylan E.; Serafini, Nicolas; Di Santo, James P.			Innate Lymphoid Cell Development: A T Cell Perspective	IMMUNITY			English	Review							ROR-GAMMA-T; TRANSCRIPTION FACTOR BCL11B; NATURAL-KILLER-CELLS; FUNCTIONAL PLASTICITY; FACTOR GATA-3; LINEAGE; NK; BET; DIFFERENTIATION; SUBSETS	Innate lymphoid cells (ILCs) and natural killer (NK) cells have garnered considerable interest due to their unique functional properties in immune defense and tissue homeostasis. Our current understanding of how these cells develop has been greatly facilitated by knowledge of T cell biology. Models of T cell differentiation provided the basis for a conceptual classification of these innate effectors and inspired a scheme of their activation and regulation. In this review, we discuss NK cell and ILC development from a "T cell standpoint'' in an attempt to extend the analogy between adaptive T cells and their innate ILC and NK cell counterparts.	[Cherrier, Dylan E.; Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Cherrier, Dylan E.; Serafini, Nicolas; Di Santo, James P.] INSERM, U1223, F-75015 Paris, France; [Cherrier, Dylan E.] Univ Paris Diderot, F-75013 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, F-75015 Paris, France.; Di Santo, JP (corresponding author), INSERM, U1223, F-75015 Paris, France.	james.di-santo@pasteur.fr	SERAFINI, nicolas/S-5675-2019; Di Santo, James P/M-4298-2014	SERAFINI, nicolas/0000-0002-7440-4353; Di Santo, James P/0000-0002-7146-1862; Cherrier, Dylan E./0000-0002-9324-8763	French Ministry of Higher Education, Research and Innovation; Institut National de la Sante et de la Recherche Medicale (INSERM); Institut Pasteur; Agence National pour le Recherche (ANR); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [695467 - ILC_REACTIVITY]	French Ministry of Higher Education, Research and Innovation; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Agence National pour le Recherche (ANR)(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC))	The authors would like to thank members of the Di Santo laboratory for helpful discussions. D.E.C. is supported by the French Ministry of Higher Education, Research and Innovation. The Di Santo laboratory is supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Pasteur, the Agence National pour le Recherche (ANR), and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (695467 - ILC_REACTIVITY).	Antignano F, 2016, J EXP MED, V213, P1153, DOI 10.1084/jem.20151646; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burrack KS, 2018, IMMUNITY, V48, P760, DOI 10.1016/j.immuni.2018.03.012; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/368427; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cording S, 2014, FEBS LETT, V588, P4176, DOI 10.1016/j.febslet.2014.03.034; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Di Santo JP, 2017, ONCOTARGET, V8, P81729, DOI 10.18632/oncotarget.21046; Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Emgard J, 2018, IMMUNITY, V48, P120, DOI 10.1016/j.immuni.2017.11.020; Etzensperger R, 2017, NAT IMMUNOL, V18, P1218, DOI 10.1038/ni.3847; Fang DF, 2018, J EXP MED, V215, P1449, DOI 10.1084/jem.20171127; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kim S.-H, 2017, SCI REP, V7, P3980; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koga S, 2018, J EXP MED, V9, P9; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mowel WK, 2017, IMMUNITY, V47, P435, DOI 10.1016/j.immuni.2017.08.012; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sciume G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01579; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tang YJ, 2012, BLOOD, V120, P63, DOI 10.1182/blood-2011-02-337980; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Verrier T, 2016, J IMMUNOL, V196, P4731, DOI 10.4049/jimmunol.1502673; Verykokakis M, 2014, IMMUNOL REV, V261, P177, DOI 10.1111/imr.12203; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vivier E, 2016, NAT IMMUNOL, V17, P790, DOI 10.1038/ni.3459; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang J, 2018, J EXP MED, V215, P1069, DOI 10.1084/jem.20170518; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zook EC, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2139; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	143	96	98	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1091	1103		10.1016/j.immuni.2018.05.010	http://dx.doi.org/10.1016/j.immuni.2018.05.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924975	Bronze, Green Submitted			2022-12-18	WOS:000436456900010
J	Liu, Q; Jin, WN; Liu, Y; Shi, KB; Sun, HR; Zhang, F; Zhang, C; Gonzales, RJ; Sheth, KN; La Cava, A; Shi, FD				Liu, Qiang; Jin, Wei-Na; Liu, Yaou; Shi, Kaibin; Sun, Haoran; Zhang, Fang; Zhang, Chao; Gonzales, Rayna J.; Sheth, Kevin N.; La Cava, Antonio; Shi, Fu-Dong			Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; ADAPTIVE IMMUNITY; INNATE IMMUNITY; NK CELLS; T-CELLS; SYSTEM; RESPONSES; STROKE; ACTIVATION; RUNX3	Brain ischemia inhibits immune function systemically, with resulting infectious complications. Whether in stroke different immune alterations occur in brain and periphery and whether analogous mechanisms operate in these compartments remains unclear. Here we show that in patients with ischemic stroke and in mice subjected to middle cerebral artery occlusion, natural killer (NK) cells display remarkably distinct temporal and transcriptome profiles in the brain as compared to the periphery. The activation of catecholaminergic and hypothalamic-pituitary-adrenal axis leads to splenic atrophy and contraction of NKcell numbers in the periphery through a modulated expression of SOCS3, whereas cholinergic innervation-mediated suppression of NK cell responses in the brain involves RUNX3. Importantly, pharmacological or genetic ablation of innervation preserved NK cell function and restrained post-stroke infection. Thus, brain ischemia compromises NK cell-mediated immune defenses through mechanisms that differ in the brain versus the periphery, and targeted inhibition of neurogenic innervation limits post-stroke infection.	[Liu, Qiang; Jin, Wei-Na; Liu, Yaou; Shi, Kaibin; Sun, Haoran; Zhang, Fang; Zhang, Chao; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 300052, Peoples R China; [Liu, Qiang; Jin, Wei-Na; Liu, Yaou; Shi, Kaibin; Sun, Haoran; Zhang, Fang; Zhang, Chao; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Radiol, Tianjin 300052, Peoples R China; [Liu, Qiang; Jin, Wei-Na; Shi, Kaibin; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Gonzales, Rayna J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [La Cava, Antonio] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	Tianjin Medical University; Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Yale University; University of California System; University of California Los Angeles	Liu, Q; Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 300052, Peoples R China.; Liu, Q; Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Radiol, Tianjin 300052, Peoples R China.; Liu, Q; Shi, FD (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	qliu.asu@gmail.com; fshi@tmu.edu.cn	/AAG-9576-2020	/0000-0002-8839-0933	National Basic Research Program of China [2013CB966900]; National Science Foundation of China [91642205, 81230028, 81471220, 81471535]; US NIH [R01NS092713]; American Heart Association [16SDG27250236]; National Multiple Sclerosis Society [RG-1507-05318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the National Basic Research Program of China grant 2013CB966900; National Science Foundation of China grants 91642205, 81230028, 81471220, and 81471535; US NIH grant R01NS092713; American Heart Association grant 16SDG27250236; and National Multiple Sclerosis Society grant RG-1507-05318.	Aktas O., 2010, J EXP MED, V6, P373; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Braunschweig A, 2011, AM J REPROD IMMUNOL, V66, P329, DOI 10.1111/j.1600-0897.2011.00989.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P450, DOI 10.1038/jcbfm.2013.217; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hao JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057495; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; Mracsko E, 2014, J NEUROSCI, V34, P16784, DOI 10.1523/JNEUROSCI.1867-14.2014; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Toka FN, 2009, CLIN VACCINE IMMUNOL, V16, P1738, DOI 10.1128/CVI.00280-09; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waisman A, 2015, LANCET NEUROL, V14, P945, DOI 10.1016/S1474-4422(15)00141-6; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041869; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhang Y., 2014, MEDIAT INFLAMM, V2014, P11, DOI DOI 10.3171/2014.11.JNS14770	53	96	102	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					474	487		10.1016/j.immuni.2017.02.015	http://dx.doi.org/10.1016/j.immuni.2017.02.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28314594	Bronze			2022-12-18	WOS:000396818100018
J	Spath, S; Komuczki, J; Hermann, M; Pelczar, P; Mair, F; Schreiner, B; Becher, B				Spath, Sabine; Komuczki, Juliana; Hermann, Mario; Pelczar, Pawel; Mair, Florian; Schreiner, Bettina; Becher, Burkhard			Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; T-CELLS; MONOCYTES; MACROPHAGES; EXPRESSION; HISTIOCYTOSIS; ARTHRITIS; TARGET	Chronic inflammatory diseases are influenced by dysregulation of cytokines. Among them, granulocyte macrophage colony stimulating factor (GMCSF) is crucial for the pathogenic function of T cells in preclinical models of autoimmunity. To study the impact of dysregulated GM-CSF expression in vivo, we generated a transgenic mouse line allowing the induction of GM-CSF expression in mature, peripheral helper T (Th) cells. Antigen-independent GM-CSF release led to the invasion of inflammatory myeloid cells into the central nervous system (CNS), which was accompanied by the spontaneous development of severe neurological deficits. CNS-invading phagocytes produced reactive oxygen species and exhibited a distinct genetic signature compared to myeloid cells invading other organs. We propose that the CNS is particularly vulnerable to the attack of monocyte-derived phagocytes and that the effector functions of GM-CSF-expanded myeloid cells are in turn guided by the tissue microenvironment.	[Spath, Sabine; Komuczki, Juliana; Mair, Florian; Schreiner, Bettina; Becher, Burkhard] Univ Zurich, Inflammat Res, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Hermann, Mario; Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; [Hermann, Mario] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Schreiner, Bettina] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Hermann, Mario] Biogen, Cambridge, MA 02142 USA; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, CH-3350 Basel, Switzerland	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Biogen; University of Basel	Schreiner, B; Becher, B (corresponding author), Univ Zurich, Inflammat Res, Inst Expt Immunol, CH-8057 Zurich, Switzerland.; Schreiner, B (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	schreiner@immunology.uzh.ch; becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Spath, Sabine/0000-0002-2689-1951; Mair, Florian/0000-0001-6732-5449	Swiss National Science Foundation [316030_150768, 310030_146130, CRSII3_136203]; European Union [279017, 316722, 602239]; Swiss Multiple Sclerosis Society; University of Zurich [54311803]; Koetser Foundation; Austrian Academy of Science	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Swiss Multiple Sclerosis Society; University of Zurich; Koetser Foundation; Austrian Academy of Science	This study was supported by grants from the Swiss National Science Foundation (316030_150768, 310030_146130, and CRSII3_136203 to B.B.), European Union FP7 project TargetBraIn 279017, NeuroKine 316722, and ATECT 602239 (to B.B.), and the Swiss Multiple Sclerosis Society (to B.B.). S.S. was supported by a fellowship (Forschungskredit, 54311803) from the University of Zurich and the Koetser Foundation. J.K. was funded by the DOC fellowship from the Austrian Academy of Science. We thank Sabrina Nemetz, Jennifer Jaberg, and Sandra Konieczka for technical assistance, Andrew Croxford for providing Il17a<SUP>IND</SUP> mice, reading the manuscript, and providing critical discussions, and Melissa Vrohlings for help with the multiplex immunoassay. Furthermore we thank Hans Lassmann for critical input and Lennart Opitz and Jelena Kuhn-Georgijevic from the FGCZ for NGS and bioinformatics support.	Al-Homaidhi A, 1998, BONE MARROW TRANSPL, V21, P209, DOI 10.1038/sj.bmt.1701036; Aouba A, 2010, BLOOD, V116, P4070, DOI 10.1182/blood-2010-04-279240; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Campbell IK, 1998, J IMMUNOL, V161, P3639; Carrieri PB, 1998, IMMUNOPHARM IMMUNOT, V20, P373, DOI 10.3109/08923979809034820; Cives M, 2015, CRIT REV ONCOL HEMAT, V95, P1, DOI 10.1016/j.critrevonc.2015.02.004; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Greer JM, 1996, J IMMUNOL, V156, P371; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; Kuhlmann T, 2008, ACTA NEUROPATHOL, V115, P275, DOI 10.1007/s00401-007-0320-8; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Ronchi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11541; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; van Nieuwenhuijze AE, 2014, AM J PATHOL, V184, P184, DOI 10.1016/j.ajpath.2013.09.014; Vladimirova O, 1999, INFLAMM RES, V48, P412, DOI 10.1007/s000110050480; Wilejto M, 2012, CURR OPIN RHEUMATOL, V24, P90, DOI 10.1097/BOR.0b013e32834db53e; XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	44	96	99	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					245	260		10.1016/j.immuni.2017.01.007	http://dx.doi.org/10.1016/j.immuni.2017.01.007			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228281	Bronze			2022-12-18	WOS:000396410900013
J	Broughton, SE; Petersen, J; Theodossis, A; Scally, SW; Loh, KL; Thompson, A; van Bergen, J; Kooy-Winkelaar, Y; Henderson, KN; Beddoe, T; Tye-Din, JA; Mannering, SI; Purcell, AW; McCluskey, J; Anderson, RP; Koning, F; Reid, HH; Rossjohn, J				Broughton, Sophie E.; Petersen, Jan; Theodossis, Alex; Scally, Stephen W.; Loh, Khai Lee; Thompson, Allan; van Bergen, Jeroen; Kooy-Winkelaar, Yvonne; Henderson, Kate N.; Beddoe, Travis; Tye-Din, Jason A.; Mannering, Stuart I.; Purcell, Anthony W.; McCluskey, James; Anderson, Robert P.; Koning, Frits; Reid, Hugh H.; Rossjohn, Jamie			Biased T Cell Receptor Usage Directed against Human Leukocyte Antigen DQ8-Restricted Gliadin Peptides Is Associated with Celiac Disease	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TISSUE TRANSGLUTAMINASE; STRUCTURAL BASIS; IMMUNE-RESPONSES; CEREAL TOXICITY; SPECIFICITY; RECOGNITION; EPITOPES; TCR; DEAMIDATION	Celiac disease is a human leukocyte antigen (HLA)-DQ2- and/or DQ8-associated T cell-mediated disorder that is induced by dietary gluten. Although it is established how gluten peptides bind HLA-DQ8 and HLA-DQ2, it is unclear how such peptide-HLA complexes are engaged by the T cell receptor (TCR), a recognition event that triggers disease pathology. We show that biased TCR usage (TRBV9*01) underpins the recognition of HLA-DQ8-alpha-I-gliadin. The structure of a prototypical TRBV9*01-TCR-HLA-DQ8-alpha-I-gliadin complex shows that the TCR docks centrally above HLADQ8-alpha-I-gliadin, in which all complementarity-determining region-beta (CDR beta) loops interact with the gliadin peptide. Mutagenesis at the TRBV9*01-TCR-HLA-DQ8-alpha-I-gliadin interface provides an energetic basis for the V beta bias. Moreover, CDR3 diversity accounts for TRBV9*01(+) TCRs exhibiting differing reactivities toward the gliadin epitopes at various deamidation states. Accordingly, biased TCR usage is an important factor in the pathogenesis of DQ8-mediated celiac disease.	[Broughton, Sophie E.; Petersen, Jan; Theodossis, Alex; Scally, Stephen W.; Loh, Khai Lee; Henderson, Kate N.; Beddoe, Travis; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Thompson, Allan; van Bergen, Jeroen; Kooy-Winkelaar, Yvonne; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Tye-Din, Jason A.; Anderson, Robert P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Mannering, Stuart I.] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Mannering, Stuart I.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Walter & Eliza Hall Institute; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	jamie.rossjohn@monash.edu	Tye-Din, Jason A./A-6109-2019; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Broughton, Sophie/M-2662-2019; Beddoe, Travis/F-3415-2014; Purcell, Anthony/AAH-1942-2019	Tye-Din, Jason A./0000-0001-7687-9654; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Purcell, Anthony/0000-0003-0532-8331; Scally, Stephen/0000-0002-4264-7772; Loh, Khai Lee/0000-0002-2211-2404; Broughton, Sophie/0000-0003-1358-5063; Koning, Frits/0000-0002-4007-5715; Anderson, Robert/0000-0002-0764-7267	National Health and Medical Research Council; Australian Research Council; NHMRC Independent Research Institutes Infrastructure Support Scheme [361646]; Victorian State Government Operational Infrastructure Support; Celiac Disease Consortium; Innovative Cluster approved by The Netherlands Genomics Initiative; Dutch government [BSIK03009]; Pfizer Australian Research fellowship; NHMRC Australian Research Training Fellowship; NHMRC PhD scholarship; NHMRC SRF; Australia Fellowship from the NHMRC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Celiac Disease Consortium; Innovative Cluster approved by The Netherlands Genomics Initiative; Dutch government; Pfizer Australian Research fellowship; NHMRC Australian Research Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC PhD scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC SRF(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council, the Australian Research Council, an NHMRC Independent Research Institutes Infrastructure Support Scheme grant #361646, Victorian State Government Operational Infrastructure Support, the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative, and the Dutch government (grant BSIK03009). We thank the staff at the MX1 beamline of the Australian Synchrotron, Victoria, Australia for assistance with data collection. We thank J. Dromey for assistance. T.B. is supported by Pfizer Australian Research fellowship; J.A.T.-D. is supported by a NHMRC Australian Research Training Fellowship; S.E.B. is supported by an NHMRC PhD scholarship; A.W.P. is supported by an NHMRC SRF; and J.R. is supported by an Australia Fellowship from the NHMRC. J.A.T.-D. and R.P.A. are coinventors of patents pertaining to the use of gluten peptides in therapeutics, diagnostics, and nontoxic gluten. R.P.A. and J.A.T.-D. are shareholders in Nexpep Pty Ltd and R.P.A. is a shareholder in ImmusanT Inc. R.P.A. is Chief Scientific Officer of and J.A.T.-D. is a consultant to ImmusanT, Inc., a company developing a peptide-based therapy and diagnostic suitable for celiac disease.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Anderson RP, 2005, GUT, V54, P1217, DOI 10.1136/gut.2004.059998; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Henderson KN, 2007, ACTA CRYSTALLOGR F, V63, P1021, DOI 10.1107/S1744309107051408; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hovhannisyan Z, 2008, NATURE, V456, P534, DOI 10.1038/nature07524; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kooy-Winkelaar Y, 2011, J IMMUNOL, V187, P5123, DOI 10.4049/jimmunol.1101179; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Turner SJ, 2011, IMMUNITY, V35, P660, DOI 10.1016/j.immuni.2011.11.002; Tye-Din Jason, 2008, Curr Gastroenterol Rep, V10, P458, DOI 10.1007/s11894-008-0085-9; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21; Yoshida K, 2010, J CLIN INVEST, V120, P1578, DOI 10.1172/JCI41502	56	96	98	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					611	621		10.1016/j.immuni.2012.07.013	http://dx.doi.org/10.1016/j.immuni.2012.07.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23063329	Bronze			2022-12-18	WOS:000310185400007
J	Verykokakis, M; Boos, MD; Bendelac, A; Kee, BL				Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Kee, Barbara L.			SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8(+) T Cells with Innate Lymphocyte Characteristics	IMMUNITY			English	Article							CUTTING EDGE; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; SIGNALING PATHWAY; MICE LACKING; ZINC-FINGER; EFFECTOR; LINEAGE; PLZF; RECEPTOR	CD8(+) T cells are selected via low-affinity interaction with MHC class I molecules on thymic epithelial cells (TECs). However, compromised T cell receptor signaling was proposed to force CD8(+) T cell selection on hematopoietic cells through a SLAM-associated protein (SAP)-dependent mechanism similar to NKT cells. The outcome is an unconventional CD8(+) T cell with phenotypic and functional characteristics of innate lymphocytes. Here we showed that Id3(-/-) CD8(+) T cells had an innate-like phenotype and required SAP for their development. However, like conventional CD8(+) T cells, Id3(-/-) CD8(+) thymocytes were selected on TECs. The requirement for SAP and the innate-like phenotype was not intrinsic to Id3(-/-) CD8(+) thymocytes. Rather, an expanded population of NKT-like cells induced the innate phenotype on CD8(+) T cells through production of interleukin-4. Our findings reveal that accumulation of NKT-like cells promotes conventional CD8(+) thymocytes to acquire innate lymphocyte characteristics.	[Verykokakis, Mihalis; Bendelac, Albert; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu			NIH [R01 CA99978]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the B.L.K. and A.B. labs for helpful discussions, C. Spaulding for excellent technical help, and C. Terhorst for generously providing the Sh2d1a<SUP>-/-</SUP> mice. We also thank K. Hogquist for communicating data prior to publication. This work was supported by the NIH (R01 CA99978) and a Leukemia and Lymphoma Society Scholar award to B.L.K.	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carnaud C, 1999, J IMMUNOL, V163, P4647; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Dai HH, 2010, J IMMUNOL, V185, P803, DOI 10.4049/jimmunol.1000661; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; GREEN MC, 1961, J HERED, V52, P297, DOI 10.1093/oxfordjournals.jhered.a107103; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Li W, 2005, IMMUNITY, V23, P375, DOI 10.1016/j.immuni.2005.09.002; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Li W, 2007, J EXP MED, V204, P2145, DOI 10.1084/jem.20070321; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu GH, 2006, BIOCHEM BIOPH RES CO, V342, P1291, DOI 10.1016/j.bbrc.2006.02.065; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Park SH, 1998, J IMMUNOL, V160, P3128; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rifa'i M, 2008, INT IMMUNOL, V20, P937, DOI 10.1093/intimm/dxn052; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Ueda-Hayakawa I, 2009, J IMMUNOL, V182, P5306, DOI 10.4049/jimmunol.0804249; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; WEINREICH MA, 2010, NAT IMMUNOL IN PRESS	51	96	97	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					203	215		10.1016/j.immuni.2010.07.013	http://dx.doi.org/10.1016/j.immuni.2010.07.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20674402	Green Accepted, Bronze			2022-12-18	WOS:000281654900010
J	Chalifour, A; Scarpellino, L; Back, J; Brodin, P; Devevre, E; Gros, F; Levy, F; Leclercq, G; Hoglund, P; Beermann, F; Held, W				Chalifour, Anick; Scarpellino, Leonardo; Back, Jonathan; Brodin, Petter; Devevre, Estelle; Gros, Frederic; Levy, Frederic; Leclercq, Georges; Hoglund, Petter; Beermann, Friedrich; Held, Werner			A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHIC Class I for Natural Killer Cell Education	IMMUNITY			English	Article							HEMATOPOIETIC-CELLS; SELF-TOLERANCE; LIGAND-BINDING; MISSING SELF; MHC; ACTIVATION; EXPRESSION; MICE; CD22; RECOGNITION	Natural killer (NK) cells show enhanced functional competence when they express inhibitory receptors specific for inherited major histocompatibility complex class I (MHC-I) molecules. Current models imply that NK cell education requires an interaction of inhibitory receptors with MHC-I expressed on other cells. However, the inhibitory Ly49A receptor can also bind MHC-I ligand on the NK cell itself (in cis). Here we describe a Ly49A variant, which can engage MHC-I expressed on other cells but not in cis. Even though this variant inhibited NK cell effector function, it failed to educate NK cells. The association with MHC-I in cis sequestered wild-type Ly49A, and this was found to relieve NK cells from a suppressive effect of unengaged Ly49A. These data explain how inhibitory MHC-I receptors can facilitate NK cell activation. They dissociate classical inhibitory from educating functions of Ly49A and suggest that cis interaction of Ly49A is necessary for NK cell education.	[Chalifour, Anick; Scarpellino, Leonardo; Back, Jonathan; Devevre, Estelle; Gros, Frederic; Levy, Frederic; Held, Werner] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Brodin, Petter; Hoglund, Petter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, MTC, S-17177 Stockholm, Sweden; [Leclercq, Georges] Ghent Univ Hosp, State Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Beermann, Friedrich] Swiss Inst Expt Canc Res, EPFL, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Karolinska Institutet; Ghent University; Ghent University Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Held, W (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, Ch Boveresses 155, CH-1066 Epalinges, Switzerland.	werner.held@licr.unil.ch	GROS, Frédéric/G-6332-2013; Leclercq, Georges/H-9659-2017; Höglund, Petter/AAV-7443-2021; Brodin, Petter/C-3317-2011	GROS, Frédéric/0000-0002-6252-4323; Leclercq, Georges/0000-0002-1691-5294; Brodin, Petter/0000-0002-8103-0046	Swiss National Science Foundatio; Oncosuisse	Swiss National Science Foundatio(Swiss National Science Foundation (SNSF)); Oncosuisse	We are grateful to P. Guillaume (Ludwig Institute) for preparing tetramers, N. Rufer (University of Lausanne) for rIL-2, and J. Kang (University of Massachusetts, Worcester) for critical reading of the manuscript. This work was supported in part by grants from the Swiss National Science Foundation and Oncosuisse (to W.H).	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; BEAVIL AJ, 1992, P NATL ACAD SCI USA, V89, P753, DOI 10.1073/pnas.89.2.753; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Dorfman JR, 1996, EUR J IMMUNOL, V26, P151, DOI 10.1002/eji.1830260123; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 2003, CURR OPIN IMMUNOL, V15, P233, DOI 10.1016/S0952-7915(02)00031-6; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Johansson MH, 2004, SCAND J IMMUNOL, V59, P71, DOI 10.1111/j.0300-9475.2004.01363.x; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Mehta IK, 2001, IMMUNOGENETICS, V53, P572, DOI 10.1007/s002510100355; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vyas YM, 2004, J IMMUNOL, V173, P1571, DOI 10.4049/jimmunol.173.3.1571; Wu MF, 1997, J IMMUNOL, V158, P1628; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	42	96	97	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					337	347		10.1016/j.immuni.2008.12.019	http://dx.doi.org/10.1016/j.immuni.2008.12.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19249231	Bronze			2022-12-18	WOS:000264405500007
J	Kunisawa, J; Shastri, N				Kunisawa, Jun; Shastri, Nilabh			Hsp90 alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway	IMMUNITY			English	Article							HEAT-SHOCK PROTEINS; CROSS-PRESENTATION; T-CELLS; PEPTIDES; MOLECULES; HSP90; COMPLEX; GENERATION; DEGRADATION; PROTEASOME	Intracellular proteins are degraded in the antigen processing pathway to generate peptide-loaded MHC I complexes (pMHC I) for immune surveillance. The characteristics of the final pMHC I are clear but those of their precursors and their potential binding partners remain poorly defined. By using a unique method to biochemically detect preprocessed ovalbumin-derived antigenic peptides, we find that cells generate large, C-terminally extended proteolytic intermediates that are associated with the alpha isotype of hsp90 chaperone. Knockdown of hsp90 alpha expression by siRNA resulted in the loss of these intermediates and decreased presentation of the final pMHC I on the cell surface. Generation of pMHC I was also inhibited by knockdown of the cochaperone CHIP that interacts with heat shock proteins, ubiquitinates their clients, and delivers them to the proteasome. Thus, hsp90 alpha can serve as a chaperone for precursors of pMHC I at an early stage in the antigen processing pathway.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu						Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FALK K, 1993, CELL IMMUNOL, V150, P447, DOI 10.1006/cimm.1993.1212; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Ishii T, 1999, J IMMUNOL, V162, P1303; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MOORE SK, 1989, J BIOL CHEM, V264, P5343; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; REBBE NF, 1987, GENE, V53, P235, DOI 10.1016/0378-1119(87)90012-6; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROTZSCHKE O, 1990, SCIENCE, V249, P283, DOI 10.1126/science.1695760; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 1999, J IMMUNOL, V162, P4712; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Voss AK, 2000, DEVELOPMENT, V127, P1; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	46	96	101	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					523	534		10.1016/j.immuni.2006.03.015	http://dx.doi.org/10.1016/j.immuni.2006.03.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713971	Bronze			2022-12-18	WOS:000237970100010
J	Riedemann, NC; Guo, RF; Bernacki, KD; Reuben, JS; Laudes, IJ; Neff, TA; Gao, HW; Speyer, C; Sarma, VJ; Zetoune, FS; Ward, PA				Riedemann, NC; Guo, RF; Bernacki, KD; Reuben, JS; Laudes, IJ; Neff, TA; Gao, HW; Speyer, C; Sarma, VJ; Zetoune, FS; Ward, PA			Regulation by C5a of neutrophil activation during sepsis	IMMUNITY			English	Article							COMPLEMENT; LIPOPOLYSACCHARIDE; CACHECTIN; SHOCK; GRANULOCYTES; EXPRESSION; ANTIBODIES; COMPONENT; MORTALITY; INHIBITOR	In sepsis, there is evidence that excessive C5a generation leads to compromised innate immune functions, being associated with poor outcome. We now report that in vitro exposure of neutrophils to C5a causes increased levels Of IkappaBalpha, decreased NF-kappaB-dependent gene transcription of TNFalpha, and decreased lipopolysaccharide (LPS)-induced TNFalpha production. Similar findings were obtained with neutrophils from cecal ligation/puncture (CLP)-induced septic rats. Such changes were reversed by antibody-induced in vivo blockade of C5a. In contrast, in vitro exposure of alveolar macrophages to C5a and LPS resulted in enhanced production of TNFalpha and no increase in IkappaBalpha. These data suggest that CLP-induced sepsis causes a C5a-dependent dysfunction of neutrophils, which is characterized by altered signaling associated with NF-kappaB activation.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Riedemann, Niels C/C-1633-2010; Reuben, Jayne/GWQ-6664-2022					BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; DEBOER JP, 1993, INFECT IMMUN, V61, P4293, DOI 10.1128/IAI.61.10.4293-4301.1993; DUBRAVEC DB, 1990, P NATL ACAD SCI USA, V87, P6758, DOI 10.1073/pnas.87.17.6758; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huber-Lang MS, 2001, FASEB J, V15, P568; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Matsumoto T, 1997, FEMS IMMUNOL MED MIC, V17, P171, DOI 10.1016/S0928-8244(97)00005-9; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; McDonald PP, 1998, BIOCHEMISTRY-US, V37, P13165, DOI 10.1021/bi972539o; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Newcomb D, 1998, SHOCK, V10, P110, DOI 10.1097/00024382-199808000-00005; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Pan ZXK, 1998, BBA-GENE STRUCT EXPR, V1443, P90, DOI 10.1016/S0167-4781(98)00198-5; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Riedemann NC, 2002, FASEB J, V16, P887, DOI 10.1096/fj.02-0033fje; SACKS T, 1978, J CLIN INVEST, V61, P1161, DOI 10.1172/JCI109031; SCHUMACHER WA, 1991, AGENTS ACTIONS, V34, P345, DOI 10.1007/BF01988727; SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361; SMEDEGARD G, 1989, AM J PATHOL, V135, P489; SOLOMKIN JS, 1981, SURGERY, V90, P319; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; WILKINSON BJ, 1979, INFECT IMMUN, V26, P1159, DOI 10.1128/IAI.26.3.1159-1163.1979	31	96	103	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					193	202		10.1016/S1074-7613(03)00206-1	http://dx.doi.org/10.1016/S1074-7613(03)00206-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932353	Bronze			2022-12-18	WOS:000184929000007
J	Kimura, M; Koseki, Y; Yamashita, M; Watanabe, N; Shimizu, C; Katsumoto, T; Kitamura, T; Taniguchi, M; Koseki, H; Nakayama, T				Kimura, M; Koseki, Y; Yamashita, M; Watanabe, N; Shimizu, C; Katsumoto, T; Kitamura, T; Taniguchi, M; Koseki, H; Nakayama, T			Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; GERMINAL-CENTER FORMATION; T-CELLS; TH2-SPECIFIC EXPRESSION; CYTOKINE EXPRESSION; CUTTING EDGE; C-MAF; INTERLEUKIN-4; RECEPTOR; PROLIFERATION	Polycomb group (PcG) gene products regulate homeobox gene expression in Drosophila and vertebrates and also cell cycle progression of immature lymphocytes. In a gene-disrupted mouse for polycomb group gene mel-18, mature peripheral T cells exhibited normal anti-TCR-induced proliferation; however, the production of Th2 cytokines (IL-4, IL-5, and IL-13) was significantly reduced, whereas production of IFN gamma was modestly enhanced. Th2 cell differentiation was impaired, and the defect was associated with decreased levels in demethylation of the IL-4 gene. Significantly, reduced GATA3 induction was demonstrated. In vivo antigen-induced IgG1 production and Nippostrongylus brasiliensis-induced eosinophilia were significantly affected, reflecting the deficit in Th2 cell differentiation. Thus, the PcG gene products play a critical role in the control of Th2 cell differentiation and Th2-dependent immune responses.	Chiba Univ, Grad Sch Med, Dept Med Immunol, Chiba, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba, Japan; Chiba Univ, Grad Sch Med, Dept Mol Embryol, Chiba, Japan; Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo, Japan	Chiba University; Chiba University; Chiba University; University of Tokyo	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Med Immunol, 1-8-1 Inohana, Chiba, Japan.		Kitamura, Toshio/AAA-2071-2021; Taniguchi, Masaru/N-7932-2015; Koseki, Haruhiko/I-3825-2014; Nakayama, Toshinori/E-1067-2017	Taniguchi, Masaru/0000-0001-7821-7179; Koseki, Haruhiko/0000-0001-8424-5854; Nakayama, Toshinori/0000-0002-1434-2007				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Core N, 1997, DEVELOPMENT, V124, P721; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; GAJEWSKI TF, 1989, IMMUNOL REV, V111, P79, DOI 10.1111/j.1600-065X.1989.tb00543.x; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee HJ, 1998, J IMMUNOL, V160, P2343; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Satijn DPE, 1999, BBA-GENE STRUCT EXPR, V1447, P1, DOI 10.1016/S0167-4781(99)00130-X; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; van Lohuizen M, 1999, CURR OPIN GENET DEV, V9, P355, DOI 10.1016/S0959-437X(99)80053-7; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	68	96	98	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					275	287		10.1016/S1074-7613(01)00182-0	http://dx.doi.org/10.1016/S1074-7613(01)00182-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520462	Bronze			2022-12-18	WOS:000170717200009
J	Stockton, BM; Cheng, GY; Manjunath, N; Ardman, B; von Andrian, UH				Stockton, BM; Cheng, GY; Manjunath, N; Ardman, B; von Andrian, UH			Negative regulation of T cell homing by CD43	IMMUNITY			English	Article							L-SELECTIN; VASCULAR ADDRESSIN; LYMPHOCYTE; ADHESION; RECEPTOR; LEUKOSIALIN; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	We report that the cell surface mucin CD43 acts as an anti-adhesin on T lymphocytes. CD43-deficient murine lymphocytes homed significantly more frequently to secondary lymphoid organs than wild-type cells. Intravital microscopy of peripheral lymph node venules revealed that CD43-deficient lymphocytes were twice as likely to tether, roll, and stick than wild-type cells. This effect was due to CD43 interference with the homing receptor, L-selectin, and was most pronounced in venules with low L-selectin ligand density. In vitro, CD43-deficient cells tethered to L-selectin ligands more efficiently and rolled more slowly than wild-type lymphocytes. Thus, CD43 exerts a negative regulatory effect on T cell trafficking by counterbalancing L-selectin-mediated adhesion.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; New England Med Ctr Hosp, Tupper Res Inst, Dept Med, Boston, MA 02111 USA; Tufts Univ, Dept Pathol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Tufts Medical Center; Tufts University	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.		von Andrian, Ulrich H/A-5775-2008		NHLBI NIH HHS [HL54936, HL56949] Funding Source: Medline; NIAID NIH HHS [AI40225] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040225] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; AXELSSON B, 1988, J IMMUNOL, V141, P2912; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; DESMET W, 1993, IMMUNOLOGY, V79, P46; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; GULLEY ML, 1988, J IMMUNOL, V140, P3751; JONES AT, 1994, J IMMUNOL, V153, P3426; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; MANJUNATH N, 1993, J IMMUNOL, V151, P1528; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; McEvoy LM, 1997, J EXP MED, V185, P1493, DOI 10.1084/jem.185.8.1493; MENTZER SJ, 1987, J EXP MED, V165, P1383, DOI 10.1084/jem.165.5.1383; PILLER F, 1988, J BIOL CHEM, V263, P15146; PRIES AR, 1988, INT J MICROCIRC, V7, P327; REMOLD-O'DONNELL E, 1990, Immunodeficiency Reviews, V2, P151; REMOLDODONNELL E, 1994, J IMMUNOL, V152, P3595; SANCHEZMATEOS P, 1995, BLOOD, V86, P2228, DOI 10.1182/blood.V86.6.2228.bloodjournal8662228; SCHMIDSCHONBEIN GW, 1980, MICROVASC RES, V19, P45, DOI 10.1016/0026-2862(80)90083-7; Soler M, 1997, J LEUKOCYTE BIOL, V61, P609, DOI 10.1002/jlb.61.5.609; SPERLING AI, 1995, J EXP MED, V182, P139, DOI 10.1084/jem.182.1.139; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STANDRING R, 1978, NATURE, V289, P456; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; VONADRIAN UH, 1996, MICROCIRCULATION, V3, P387; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725; YONEMURA S, 1993, J CELL BIOL, V120, P437, DOI 10.1083/jcb.120.2.437	36	96	98	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					373	381		10.1016/S1074-7613(00)80542-7	http://dx.doi.org/10.1016/S1074-7613(00)80542-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529154	Bronze			2022-12-18	WOS:000072705300010
J	Hellerstein, MK; McCune, JM				Hellerstein, MK; McCune, JM			T cell turnover in HIV-1 disease	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW TRANSPLANTATION; IMMUNE-DEFICIENCY SYNDROME; DYNAMICS IN-VIVO; SCID-HU MOUSE; LIFE-SPAN; POPULATION-DYNAMICS; LYMPHOCYTES-T; INFECTION; THYMUS		UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, GLADSTONE INST VIROL & IMMUNOL, SAN FRANCISCO, CA 94110 USA; UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT MED, DIV AIDS, SAN FRANCISCO, CA 94110 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA; UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT MED, DIV ENDOCRINOL & METAB, SAN FRANCISCO, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco								ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; BASKIN GB, 1991, LAB INVEST, V65, P400; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; BURKE AP, 1995, ARCH PATHOL LAB MED, V119, P36; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; DIMITROV DS, 1995, NATURE, V375, P194, DOI 10.1038/375194b0; DUA N, 1994, VET IMMUNOL IMMUNOP, V43, P337, DOI 10.1016/0165-2427(94)90156-2; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; GOROCHOV G, 1994, BLOOD, V83, P587; GOWDA SD, 1989, J IMMUNOL, V142, P773; GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85; Heitger A, 1997, BLOOD, V90, P850, DOI 10.1182/blood.V90.2.850.850_850_857; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Joag SV, 1996, J VIROL, V70, P3189, DOI 10.1128/JVI.70.5.3189-3197.1996; JOSHI VV, 1985, ARCH PATHOL LAB MED, V109, P142; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; LEINO L, 1991, BONE MARROW TRANSPL, V8, P339; LI J, 1992, J ACQ IMMUN DEF SYND, V5, P639; Liu ZY, 1996, CYTOMETRY, V26, P1; Livingstone WJ, 1996, LANCET, V348, P649, DOI 10.1016/S0140-6736(96)02091-0; MACALLAN D, 1997, IN PRESS P NATL ACAD; MACKALL CL, 1994, BLOOD, V84, P2221; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Mackall CL, 1997, IMMUNOL TODAY, V18, P245, DOI 10.1016/S0167-5699(97)81664-7; MCCUNE JM, 1991, CELL, V64, P351, DOI 10.1016/0092-8674(91)90644-E; MCCUNE JM, 1995, HUMAN HEMATOPOIESIS, P129; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MEYAARD L, 1994, J CLIN INVEST, V94, P1947, DOI 10.1172/JCI117545; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; MILLER RA, 1984, J IMMUNOL, V133, P2925; MOSLER DE, 1995, NATURE, V375, P193, DOI 10.1038/375193b0; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; REBAI N, 1994, P NATL ACAD SCI USA, V91, P1529, DOI 10.1073/pnas.91.4.1529; ROCHA B, 1983, J IMMUNOL, V131, P2158; ROCHA BB, 1987, J IMMUNOL, V139, P365; ROEDERER M, 1995, NAT MED, V1, P621, DOI 10.1038/nm0795-621; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SAVINO W, 1986, AM J PATHOL, V122, P302; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; SCHUURMAN HJ, 1989, AM J PATHOL, V134, P1329; SEEMAYER TA, 1984, HUM PATHOL, V15, P469, DOI 10.1016/S0046-8177(84)80082-9; SPRENT J, 1995, NATURE, V375, P194, DOI 10.1038/375194a0; STANLEY SK, 1993, J EXP MED, V178, P1151, DOI 10.1084/jem.178.4.1151; SU L, 1995, IMMUNITY, V2, P25, DOI 10.1016/1074-7613(95)90076-4; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; TOUGH DF, 1995, STEM CELLS, V13, P242, DOI 10.1002/stem.5530130305; WAINHOBSON S, 1995, NATURE, V373, P102, DOI 10.1038/373102a0; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Woods TC, 1997, BLOOD, V89, P1635, DOI 10.1182/blood.V89.5.1635.1635_1635_1641	65	96	106	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1997	7	5					583	589		10.1016/S1074-7613(00)80379-9	http://dx.doi.org/10.1016/S1074-7613(00)80379-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390682	Bronze			2022-12-18	WOS:A1997YH55400001
J	Hampl, J; Chien, YH; Davis, MM				Hampl, J; Chien, YH; Davis, MM			CD4 augments the response of a T cell to agonist but not to antagonist ligands	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTOR ANTAGONISTS; MHC COMPLEXES; BINDING-SITE; PEPTIDE; ANTIGEN; RECOGNITION; ACTIVATION; AFFINITY; SPECIFICITY	The recognition of peptide variants by the T cell receptor (TCR) has revealed a wide range of possible responses. Here, using a series of CD4(+) and CD4(-) variants of the same T cell hybridoma, we find that while the expression of CD4 converts weak agonists into full agonists, none of the antagonist peptides are efficiently recognized as agonists. Furthermore, in antagonist assays, little difference can be seen in the response of CD4(+) and CD4(-) T cells. Together with previous work showing a marked difference in stability between TCR binding to agonist versus antagonist ligands, these data suggest that CD4 engagement occurs after a TCR-peptide/MHC complex has formed and that it requires a certain minimal half-life of the ternary complex to be fully engaged in signaling.	STANFORD UNIV, SCH MED, DEPT IMMUNOL & MICROBIOL, STANFORD, CA 94305 USA	Stanford University	Hampl, J (corresponding author), STANFORD UNIV, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Brady RL, 1996, CURR TOP MICROBIOL, V205, P1; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; Konig R, 1996, CURR TOP MICROBIOL, V205, P19; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MANNIE MD, 1995, J IMMUNOL, V154, P2642; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PORTOLES P, 1989, J IMMUNOL, V142, P4169; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; REAY PA, 1994, J IMMUNOL, V152, P3946; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SPAIN LM, 1994, J IMMUNOL, V152, P1709; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0	36	96	97	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1997	7	3					379	385		10.1016/S1074-7613(00)80359-3	http://dx.doi.org/10.1016/S1074-7613(00)80359-3			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324358	Bronze			2022-12-18	WOS:A1997XY83000007
J	Shubinsky, G; Schlesinger, M				Shubinsky, G; Schlesinger, M			The CD38 lymphocyte differentiation marker: New insight into its ectoenzymatic activity and its role as a signal transducer	IMMUNITY			English	Review							CYCLIC ADP-RIBOSE; SURFACE ANTIGEN CD38; PROTEIN-TYROSINE PHOSPHORYLATION; C-CBL PROTOONCOGENE; HUMAN BONE-MARROW; B-CELL SUBSETS; RETINOIC ACID; PHOSPHATIDYLINOSITOL 3-KINASE; MONOCLONAL-ANTIBODY; CYCLASE ACTIVITY		HEBREW UNIV JERUSALEM, HADASSAH MED SCH, HUBERT H HUMPHREY CTR EXPT MED & CANC RES, IL-91120 JERUSALEM, ISRAEL	Hebrew University of Jerusalem								Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ALESSIO M, 1990, J IMMUNOL, V145, P878; AUSIELLO CM, 1995, EUR J IMMUNOL, V25, P1477, DOI 10.1002/eji.1830250554; BANCHEREAU J, 1992, ADV IMMUNOL, V52, P125, DOI 10.1016/S0065-2776(08)60876-7; BEAN AGD, 1995, INT IMMUNOL, V7, P213, DOI 10.1093/intimm/7.2.213; BEERS KW, 1995, J CLIN INVEST, V95, P2385, DOI 10.1172/JCI117932; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Deaglio S, 1996, J IMMUNOL, V156, P727; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; DECREMOUX P, 1991, BIOCHEM PHARMACOL, V42, P2141, DOI 10.1016/0006-2952(91)90349-A; Deterre P, 1996, J IMMUNOL, V157, P1381; DIANZANI U, 1995, CRIT REV IMMUNOL, V15, P167, DOI 10.1615/CritRevImmunol.v15.i2.40; DRACH J, 1994, CANCER RES, V54, P1746; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FUNARO A, 1993, EUR J IMMUNOL, V23, P2407, DOI 10.1002/eji.1830231005; FURUYA Y, 1995, GENE, V165, P329, DOI 10.1016/0378-1119(95)00540-M; Galibert L, 1996, J EXP MED, V183, P77, DOI 10.1084/jem.183.1.77; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; HERCEND T, 1981, HUM IMMUNOL, V3, P247, DOI 10.1016/0198-8859(81)90021-5; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HO JL, 1994, J EXP MED, V180, P1457, DOI 10.1084/jem.180.4.1457; Hoshino S, 1997, J IMMUNOL, V158, P741; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Ikizawa K, 1996, CELL IMMUNOL, V170, P134, DOI 10.1006/cimm.1996.0143; ITOH M, 1994, BIOCHEM BIOPH RES CO, V203, P1309, DOI 10.1006/bbrc.1994.2325; JACKSON DG, 1990, J IMMUNOL, V144, P2811; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; KIKUCHI Y, 1995, P NATL ACAD SCI USA, V92, P11814, DOI 10.1073/pnas.92.25.11814; KIM KM, 1993, IMMUNOL REV, V132, P125, DOI 10.1111/j.1600-065X.1993.tb00840.x; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; KIRKHAM PA, 1994, IMMUNOLOGY, V83, P513; Kitanaka A, 1996, BLOOD, V88, P590, DOI 10.1182/blood.V88.2.590.bloodjournal882590; KOCHNOLTE F, 1995, INT IMMUNOL, V7, P883, DOI 10.1093/intimm/7.5.883; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; Kontani K, 1996, J BIOL CHEM, V271, P1534; Kontani K, 1996, BIOCHEM BIOPH RES CO, V222, P466, DOI 10.1006/bbrc.1996.0767; KRAMER G, 1995, J UROLOGY, V154, P1636, DOI 10.1016/S0022-5347(01)66733-8; Kukimoto I, 1996, EUR J BIOCHEM, V239, P177, DOI 10.1111/j.1432-1033.1996.0177u.x; KUMAGAI MA, 1995, J EXP MED, V181, P1101, DOI 10.1084/jem.181.3.1101; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; KUMAR R, 1994, CARCINOGENESIS, V15, P701, DOI 10.1093/carcin/15.4.701; LAGRESLE C, 1993, INT IMMUNOL, V5, P1259, DOI 10.1093/intimm/5.10.1259; LAGRESLE C, 1995, J IMMUNOL, V154, P5746; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LIEW FM, 1992, EXP CELL RES, V202, P310, DOI 10.1016/0014-4827(92)90080-R; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; LUND FE, 1995, EUR J IMMUNOL, V25, P1338, DOI 10.1002/eji.1830250531; Lund FE, 1996, J IMMUNOL, V157, P1455; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MALAVASI F, 1994, IMMUNOL TODAY, V15, P95, DOI 10.1016/0167-5699(94)90148-1; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; MIZUGUCHI M, 1995, BRAIN RES, V697, P235, DOI 10.1016/0006-8993(95)00885-T; MUSZYNSKI KW, 1995, J EXP MED, V181, P2189, DOI 10.1084/jem.181.6.2189; NAKAGAWARA K, 1995, CYTOGENET CELL GENET, V69, P38, DOI 10.1159/000133933; NISHINA H, 1994, BIOCHEM BIOPH RES CO, V203, P1318, DOI 10.1006/bbrc.1994.2326; Oertel J, 1996, ANN HEMATOL, V72, P125, DOI 10.1007/s002770050149; Okazaki IJ, 1996, REV PHYSIOL BIOCH P, V129, P51; Oliver AM, 1997, J IMMUNOL, V158, P1108; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; PERNIS A, 1995, P NATL ACAD SCI USA, V92, P7971, DOI 10.1073/pnas.92.17.7971; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; PRINCE HE, 1992, CELL IMMUNOL, V145, P254, DOI 10.1016/0008-8749(92)90329-N; Ramaschi G, 1996, BLOOD, V87, P2308, DOI 10.1182/blood.V87.6.2308.bloodjournal8762308; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; SANTOSARGUMEDO L, 1995, INT IMMUNOL, V7, P163, DOI 10.1093/intimm/7.2.163; SANTOSARGUMEDO L, 1993, J IMMUNOL, V151, P3119; Satterthwaite A, 1996, ANNU REV IMMUNOL, V14, P131, DOI 10.1146/annurev.immunol.14.1.131; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Shubinsky G, 1996, CELL IMMUNOL, V173, P87, DOI 10.1006/cimm.1996.0254; SHUBINSKY G, 1994, CELL PROLIFERAT, V27, P489, DOI 10.1111/j.1365-2184.1994.tb01478.x; Silvennoinen O, 1996, J IMMUNOL, V156, P100; STASHENKO P, 1981, P NATL ACAD SCI-BIOL, V78, P3848, DOI 10.1073/pnas.78.6.3848; TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642; TAKAHASHI K, 1995, FEBS LETT, V371, P204, DOI 10.1016/0014-5793(95)00914-U; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Umar S, 1996, J BIOL CHEM, V271, P15922, DOI 10.1074/jbc.271.27.15922; Vicari AP, 1996, INT IMMUNOL, V8, P183, DOI 10.1093/intimm/8.2.183; VONBOEHMER H, 1992, IMMUNOL TODAY, V13, P454, DOI 10.1016/0167-5699(92)90075-I; Waite DJ, 1996, AM J PATHOL, V148, P2043; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wang J, 1996, J IMMUNOL, V156, P2819; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAMASHITA Y, 1995, IMMUNOLOGY, V85, P248; YOKOYAMA HM, 1996, J BIOL CHEM, V271, P12951; ZHANG LX, 1995, J BIOL CHEM, V270, P6022, DOI 10.1074/jbc.270.11.6022; ZOCCHI E, 1995, FEBS LETT, V359, P35, DOI 10.1016/0014-5793(95)00005-T; ZUPO S, 1994, EUR J IMMUNOL, V24, P1218, DOI 10.1002/eji.1830240532; ZUPO S, 1994, EUR J IMMUNOL, V24, P1426, DOI 10.1002/eji.1830240628	99	96	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1997	7	3					315	324		10.1016/S1074-7613(00)80353-2	http://dx.doi.org/10.1016/S1074-7613(00)80353-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324352	Bronze			2022-12-18	WOS:A1997XY83000001
J	Cibotti, R; Punt, JA; Dash, KS; Sharrow, SO; Singer, A				Cibotti, R; Punt, JA; Dash, KS; Sharrow, SO; Singer, A			Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals	IMMUNITY			English	Article							POSITIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; MONOCLONAL-ANTIBODY; RECEPTOR EXPRESSION; NEGATIVE SELECTION; MURINE; MICE; MATURATION; PROTEIN; MHC	Differentiation of immature double positive (DP) CD4(+) CD8(+). thymocytes into single positive (SP) CD4(+) and CD8(+) T cells is referred to as positive selection and requires physical contact with thymic cortical epithelium. We now have identified ''coinducer'' molecules on DP thymocytes that, together with TCR, signal DP thymocytes to differentiate into SP T cells in vitro in the absence of thymic epithelium. A remarkable number of different molecules on DP thymocytes possessed ''coinducing'' activity, including CD2, CD5, CD24, CD28, CD49d, CD81, and TSA-1. Interestingly, in vitro differentiation occurred in the absence of lineage-specific signals, yet resulted in the selective generation of CD4(+)CD8(-) T cells. Thus, the present study has identified surface molecules that can signal DP thymocytes to differentiate into SP T cells in the absence of thymic epithelium and has characterized a default pathway for CD4(+) T cell differentiation.	NCI,EXPT IMMUNOL BRANCH,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Benveniste P, 1996, EUR J IMMUNOL, V26, P461, DOI 10.1002/eji.1830260229; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; DELASSUS S, 1994, J IMMUNOL, V152, P2411; DESAI DM, 1994, EMBO J, V13, P4002, DOI 10.1002/j.1460-2075.1994.tb06716.x; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; GROVES T, 1995, J IMMUNOL, V154, P5011; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; INNIS MA, 1990, PCR PROTOCOLS; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; KAYE J, 1992, CELL, V71, P423, DOI 10.1016/0092-8674(92)90512-B; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KOTEWICZ ML, 1985, GENE, V35, P249, DOI 10.1016/0378-1119(85)90003-4; KUBO RT, 1989, J IMMUNOL, V142, P2736; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LYONS AB, 1992, CYTOMETRY, V13, P809; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SINGER KH, 1987, HUM IMMUNOL, V20, P127, DOI 10.1016/0198-8859(87)90027-9; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	46	96	98	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					245	255		10.1016/S1074-7613(00)80327-1	http://dx.doi.org/10.1016/S1074-7613(00)80327-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075925	Bronze			2022-12-18	WOS:A1997XC61800004
J	DIAZ, P; CADO, D; WINOTO, A				DIAZ, P; CADO, D; WINOTO, A			A LOCUS-CONTROL REGION IN THE T-CELL RECEPTOR ALPHA/DELTA LOCUS	IMMUNITY			English	Article							DOMINANT CONTROL REGION; BETA-GLOBIN LOCUS; INDEPENDENT GENE-EXPRESSION; CHAIN INTRON ENHANCER; TRANSGENIC MICE; TRANSCRIPTION FACTOR; ALPHA-GENE; ANTIGEN RECEPTOR; BINDING PROTEIN; HIGH-LEVEL	A locus control region (LCR) is a set of cis-acting elements that regulate chromatin accessibility of a gene locus. In the T cell receptor (TCR) alpha/delta locus, an LCR might regulate the differential tissue and developmental expression and the rearrangement of TCR alpha and delta genes. We have localized a region 3' of the TCR alpha/delta locus containing eight T cell-specific nuclease hypersensitive domains (HS-1 to HS-8), which fit the characteristics of an LCR. In transgenic mice, a TCR alpha gene linked to this region is expressed at a high level, independent of the site of integration and correlates with gene copy number. The transgene is expressed in the alpha beta but not the gamma delta T cell subset and is activated at the right time during development. Proper LCR function requires the region containing HS-2 to HS-6. We propose a model of LCR competition to explain the differential regulation of TCR alpha versus delta genes during development.	UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	DIAZ, P (corresponding author), UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA.							ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BERG LJ, 1988, MOL CELL BIOL, V8, P5459, DOI 10.1128/MCB.8.12.5459; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONIFER C, 1990, EMBO J, V9, P2843, DOI 10.1002/j.1460-2075.1990.tb07473.x; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FONDELL JD, 1992, MOL CELL BIOL, V12, P1480, DOI 10.1128/MCB.12.4.1480; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GILL LL, 1991, EUR J IMMUNOL, V21, P807, DOI 10.1002/eji.1830210339; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; HANSCOMBE O, 1989, GENE DEV, V3, P1572, DOI 10.1101/gad.3.10.1572; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; JAMESON SC, 1991, J IMMUNOL, V147, P3185; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; MARINE J, 1991, P NATL ACAD SCI USA, V88, P7284, DOI 10.1073/pnas.88.16.7284; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PETERS LL, 1993, NATURE, V362, P768, DOI 10.1038/362768a0; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PRUZINA S, 1991, NUCLEIC ACIDS RES, V19, P1413, DOI 10.1093/nar/19.7.1413; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; REITMAN M, 1993, MOL CELL BIOL, V13, P3990, DOI 10.1128/MCB.13.7.3990; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VANASSENDELFT GB, 1989, CELL, V56, P969, DOI 10.1016/0092-8674(89)90630-2; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGROSVELD F, 1987, CELL, V51, P975; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650	67	96	97	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1994	1	3					207	217		10.1016/1074-7613(94)90099-X	http://dx.doi.org/10.1016/1074-7613(94)90099-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889409				2022-12-18	WOS:A1994PK16500005
J	Shomuradova, AS; Vagida, MS; Sheetikov, SA; Zornikova, KV; Kiryukhin, D; Titov, A; Peshkova, IO; Khmelevskaya, A; Dianov, DV; Malasheva, M; Shmelev, A; Serdyuk, Y; Bagaev, DV; Pivnyuk, A; Shcherbinin, DS; Maleeva, AV; Shakirova, NT; Pilunov, A; Malko, DB; Khamaganova, EG; Biderman, B; Ivanov, A; Shugay, M; Efimov, GA				Shomuradova, Alina S.; Vagida, Murad S.; Sheetikov, Savely A.; Zornikova, Ksenia, V; Kiryukhin, Dmitry; Titov, Aleksei; Peshkova, Iuliia O.; Khmelevskaya, Alexandra; Dianov, Dmitry, V; Malasheva, Maria; Shmelev, Anton; Serdyuk, Yana; Bagaev, Dmitry, V; Pivnyuk, Anastasia; Shcherbinin, Dmitrii S.; Maleeva, Alexandra, V; Shakirova, Naina T.; Pilunov, Artem; Malko, Dmitry B.; Khamaganova, Ekaterina G.; Biderman, Bella; Ivanov, Alexander; Shugay, Mikhail; Efimov, Grigory A.			SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors	IMMUNITY			English	Article							SARS CORONAVIRUS; IMPROVED PREDICTIONS; IMMUNE-RESPONSES; PROTECTION; ANTIGEN; BIAS; IDENTIFICATION; GENERATION; PATTERNS; SEQUENCE	Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-19 patients and healthy donors sampled both prior to and during the pandemic. Healthy donors examined during the pandemic exhibited increased numbers of SARS-CoV-2-specific T cells, but no humoral response. Their probable exposure to the virus resulted in either asymptomatic infection without antibody secretion or activation of preexisting immunity. In convalescent patients, we observed a public and diverse T cell response to SARS-CoV-2 epitopes, revealing T cell receptor (TCR) motifs with germline-encoded features. Bulk CD4(+) and CD8(+) T cell responses to the spike protein were mediated by groups of homologous TCRs, some of them shared across multiple donors. Overall, our results demonstrate that the T cell response to SARS-CoV-2, including the identified set of TCRs, can serve as a useful biomarker for surveying antiviral immunity.	[Shomuradova, Alina S.; Vagida, Murad S.; Sheetikov, Savely A.; Zornikova, Ksenia, V; Kiryukhin, Dmitry; Titov, Aleksei; Peshkova, Iuliia O.; Khmelevskaya, Alexandra; Dianov, Dmitry, V; Malasheva, Maria; Shmelev, Anton; Serdyuk, Yana; Maleeva, Alexandra, V; Shakirova, Naina T.; Pilunov, Artem; Malko, Dmitry B.; Khamaganova, Ekaterina G.; Biderman, Bella; Efimov, Grigory A.] Natl Res Ctr Hematol, Moscow, Russia; [Shomuradova, Alina S.; Sheetikov, Savely A.; Zornikova, Ksenia, V; Khmelevskaya, Alexandra; Dianov, Dmitry, V; Malasheva, Maria; Pilunov, Artem] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Bagaev, Dmitry, V] Eindhoven Univ Technol, Eindhoven, Netherlands; [Pivnyuk, Anastasia; Shugay, Mikhail] Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia; [Shcherbinin, Dmitrii S.; Shugay, Mikhail] Pirogov Russian Med State Univ, Moscow, Russia; [Shcherbinin, Dmitrii S.; Shugay, Mikhail] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Ivanov, Alexander] Russian Acad Sci, Ctr Precis Genome Editing & Genet Technol Biomed, Engelhardt Inst Mol Biol, Moscow, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Lomonosov Moscow State University; Eindhoven University of Technology; Skolkovo Institute of Science & Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Efimov, GA (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.; Shugay, M (corresponding author), Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia.; Shugay, M (corresponding author), Pirogov Russian Med State Univ, Moscow, Russia.; Shugay, M (corresponding author), Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	mikhail.shugay@gmail.com; efimov.g@blood.ru	Dianov, Dmitry/AAH-6718-2021; Maleeva, Alexandra/AAI-3406-2021; Shcherbinin, Dmitrii S/F-3502-2017; Ivanov, Alexander/A-7700-2012; Serdyuk, Yana/AAH-6487-2021; Vagida, Murad/L-1243-2015; Kiryukhin, Dmitry/AAI-2334-2021; Zornikova, Ksenia/AAH-6849-2021; Sheetikov, Savely/R-3161-2017; Shomuradova, Alina/GQH-1341-2022; Efimov, Grigory/AAH-4502-2021; Shomuradova, Alina/AAZ-8917-2020; Khmelevskaya, Alexandra/AAH-6721-2021; Pilunov, Artem/AAH-6701-2021; Malko, Dmitry/B-9285-2016	Shcherbinin, Dmitrii S/0000-0002-4676-0916; Ivanov, Alexander/0000-0002-5659-9679; Vagida, Murad/0000-0001-7408-3994; Kiryukhin, Dmitry/0000-0001-6962-2236; Sheetikov, Savely/0000-0002-0975-0938; Shomuradova, Alina/0000-0002-3446-7587; Khmelevskaya, Alexandra/0000-0001-8399-4124; Shakirova, Naina/0000-0002-1917-5295; Khmelevskaya, Alexandra/0000-0003-2773-5608; Efimov, Grigory/0000-0001-7129-6062; Zornikova, Ksenia/0000-0002-9568-2109; Serdyuk, Yana/0000-0003-1573-7614; Titov, Aleksei/0000-0003-4077-3924; Malko, Dmitry/0000-0002-3278-3930; Dianov, Dmitry/0000-0002-2687-8482	Russian Science Foundation [20-15-00395]; Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1789, 075-15-2019-1660]; Russian Foundation for Basic Research (RFBR) [19-34-70011]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Higher Education of the Russian Federation; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	We would like to express our gratitude to all donors who volunteered for our study; to the nurses who performed the venipuncture (Yulia Fadeeva, Anastasya Nisanova, Valentyna Mirponova, and Lubov Piskunova); and to our colleagues Anastasia Minervina, Mikhail Pogorelyy, Vasily Lazarev, Maria Lagarkova, Ivan Zvyagin, Igor Fabrichny, Anastassia Semikhina, Alexey Panov, Ekaterina Avilova, Artem Demidenko, Alexander Veretennikov, Fedor Rozov, Elena Osipova, Nikolay Mugue, Igor Fabrichny, Yuri Lebedin, and Ekaterina Morozova, for their kind help with experiments and reagents and their most valuable advice. We thank Michael Eisenstein for careful and thoughtful manuscript editing. Wet lab experiments (Figures 1, 2, and S1-S4) were supported by Russian Science Foundation grant 20-15-00395 (G.A.E.). The bioinformatic work of D.V.B., A. Pivnyuk, D.S.S., and M.S. (Figures 3, 4, and S5) was supported by a grant from the Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1789) and by Russian Foundation for Basic Research (RFBR) grant 19-34-70011 (M.S.). A.I. was supported by the Ministry of Science and Higher Education of the Russian Federation (agreement 075-15-2019-1660).	Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Bagaev DV, 2020, NUCLEIC ACIDS RES, V48, pD1057, DOI 10.1093/nar/gkz874; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698; Bovay A, 2018, EUR J IMMUNOL, V48, P258, DOI 10.1002/eji.201747082; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9; Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850; Danilova L, 2018, CANCER IMMUNOL RES, V6, P888, DOI 10.1158/2326-6066.CIR-18-0129; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Fan YY, 2009, ARCH VIROL, V154, P1093, DOI 10.1007/s00705-009-0409-6; Gallais F., 2020, INTRAFAMILIAL EXPOSU, DOI [10.1101/2020.06.21.20132449, DOI 10.1101/2020.06.21.20132449]; Gangaev A., 2020, PROFOUND CD8 T CELL; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]; Ishizuka J, 2009, J IMMUNOL, V183, P4337, DOI 10.4049/jimmunol.0901607; Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227; Lee Chloe H, 2020, F1000Res, V9, P145, DOI 10.12688/f1000research.22507.2; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Li TS, 2004, J INFECT DIS, V189, P648, DOI 10.1086/381535; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lillie PJ, 2020, J INFECTION, V80, P600, DOI 10.1016/j.jinf.2020.02.020; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lv YB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-61; Mamedov IZ, 2020, LONGITUDINAL HIGH TH, DOI DOI 10.1101/2020.05.18.100545; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Miles JJ, 2011, J IMMUNOL, V186, P901, DOI 10.4049/jimmunol.1003167; Minervina AA, 2020, ELIFE, V9, DOI 10.7554/eLife.53704; Nelde A., 2020, SARS COV 2 T CELL EP; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Nguyen A, 2020, J VIROL, V94, DOI 10.1128/JVI.00510-20; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Phan I.Q., 2020, SILICO DETECTION SAR, DOI [10.1101/2020.05.22.111526, DOI 10.1101/2020.05.22.111526]; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pogorelyy MV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02159; Pogorelyy MV, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0577-7; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Ritvo PG, 2018, P NATL ACAD SCI USA, V115, P9604, DOI 10.1073/pnas.1808594115; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Romero-Lopez JP, 2020, PREDICTION SARS COV2; Rubelt F, 2017, NAT IMMUNOL, V18, P1274, DOI 10.1038/ni.3873; Schultheiss C, 2020, IMMUNITY, V53, P442, DOI 10.1016/j.immuni.2020.06.024; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Shanmugaraj B, 2020, ASIAN PAC J ALLERGY, V38, P10, DOI 10.12932/AP-200220-0773; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Wang BM, 2004, BLOOD, V104, P200, DOI 10.1182/blood-2003-11-4072; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Wang YD, 2004, J VIROL, V78, P5612, DOI 10.1128/JVI.78.11.5612-5618.2004; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wong V. W. S., 2003, Hong Kong Medical Journal, V9, P199; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang LT, 2006, CLIN IMMUNOL, V120, P171, DOI 10.1016/j.clim.2006.05.002; Yang LT, 2007, J GEN VIROL, V88, P2740, DOI 10.1099/vir.0.82839-0; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zvyagin IV, 2017, LEUKEMIA, V31, P1145, DOI 10.1038/leu.2016.321	72	95	99	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1245	+		10.1016/j.immuni.2020.11.004	http://dx.doi.org/10.1016/j.immuni.2020.11.004			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326767	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000599363300013
J	Huang, LS; Hong, ZG; Wu, W; Xiong, SQ; Zhong, M; Gao, XP; Rehman, J; Malik, AB				Huang, Long Shuang; Hong, Zhigang; Wu, Wei; Xiong, Shiqin; Zhong, Ming; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.			mtDNA Activates cGAS Signaling and Suppresses the YAP-Mediated Endothelial Cell Proliferation Program to Promote Inflammatory Injury	IMMUNITY			English	Article							GASDERMIN D; HIPPO PATHWAY; REGENERATION; MECHANISMS; PYROPTOSIS; CASPASE-11; UNDERLIES; UPSTREAM	Cytosolic DNA acts as a universal danger-associated molecular pattern (DAMP) signal; however, the mechanisms of self-DNA release into the cytosol and its role in inflammatory tissue injury are not well understood. We found that the internalized bacterial endotoxin lipopolysaccharide (LPS) activated the pore-forming protein Gasdermin D, which formed mitochondrial pores and induced mitochondrial DNA (mtDNA) release into the cytosol of endothelial cells. mtDNA was recognized by the DNA sensor cGAS and generated the second messenger cGAMP, which suppressed endothelial cell proliferation by downregulating YAP1 signaling. This indicated that the surviving endothelial cells in the penumbrium of the inflammatory injury were compromised in their regenerative capacity. In an experimental model of inflammatory lung injury, deletion of cGas in mice restored endothelial regeneration. The results suggest that targeting the endothelial Gasdermin D activated cGAS-YAP signaling pathway could serve as a potential strategy for restoring endothelial function after inflammatory injury.	[Huang, Long Shuang; Hong, Zhigang; Wu, Wei; Xiong, Shiqin; Zhong, Ming; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Huang, Long Shuang; Hong, Zhigang; Wu, Wei; Xiong, Shiqin; Zhong, Ming; Gao, Xiaopei; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA; [Wu, Wei; Zhong, Ming] Fudan Univ, Zhongshan Hosp, Dept Crit Care Med, Shanghai 200433, Peoples R China; [Rehman, Jalees] Univ Illinois, Div Cardiol, Dept Med, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fudan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rehman, J; Malik, AB (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA.; Rehman, J; Malik, AB (corresponding author), Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA.; Rehman, J (corresponding author), Univ Illinois, Div Cardiol, Dept Med, Coll Med, Chicago, IL 60612 USA.	jalees@uic.edu; abmalik@uic.edu	Huang, Longshuang/H-9553-2016; Rehman, Jalees/GVU-1981-2022	Rehman, Jalees/0000-0002-2787-9292; Malik, Asrar/0000-0002-8205-7128	NIH [R01-HL045638, P01HL060678, T32-HL007829, R01-HL118068, R01-HL090152]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The studies were supported by NIH grants R01-HL045638 (to A.B.M.), P01HL060678 (to A.B.M. and J.R.), T32-HL007829 (to L.S.H., S.X., and A.B.M.), R01-HL118068 (to J.R. and A.B.M.), and R01-HL090152 (to J.R. and A.B.M.). Cdh5-CreERT2 mice were provided by Dr. Ralf Adams.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Broz P, 2015, NATURE, V526, P642, DOI 10.1038/nature15632; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Castellon X, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0803; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Cochi SE, 2016, ANN AM THORAC SOC, V13, P1742, DOI 10.1513/AnnalsATS.201512-841OC; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; He JL, 2018, CIRC RES, V122, P591, DOI 10.1161/CIRCRESAHA.117.311950; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; LaCanna R, 2019, J CLIN INVEST, V129, P2107, DOI 10.1172/JCI125014; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lim S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09597-w; Liu ML, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10134-y; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Manda P, 2018, IMMUNITY, V49, P42, DOI 10.1016/j.immuni.2018.06.011; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Park C, 2016, ARTERIOSCL THROM VAS, V36, P86, DOI 10.1161/ATVBAHA.115.306430; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Rathinam VAK, 2019, NAT IMMUNOL, V20, P527, DOI 10.1038/s41590-019-0368-3; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sun SG, 2016, TRENDS CELL BIOL, V26, P694, DOI 10.1016/j.tcb.2016.05.003; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9; Wang S, 2017, NAT IMMUNOL, V18, P733, DOI 10.1038/ni.3744; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114	50	95	103	10	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					475	+		10.1016/j.immuni.2020.02.002	http://dx.doi.org/10.1016/j.immuni.2020.02.002			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32164878	Green Accepted, Bronze			2022-12-18	WOS:000520600200010
J	Liu, C; Chikina, M; Deshpande, R; Menk, AV; Wang, T; Tabib, T; Brunazzi, EA; Vignali, KM; Sun, M; Stolz, DB; Lafyatis, RA; Chen, W; Delgoffe, GM; Workman, CJ; Wendell, SG; Vignali, DAA				Liu, Chang; Chikina, Maria; Deshpande, Rahul; Menk, Ashley, V; Wang, Ting; Tabib, Tracy; Brunazzi, Erin A.; Vignali, Kate M.; Sun, Ming; Stolz, Donna B.; Lafyatis, Robert A.; Chen, Wei; Delgoffe, Greg M.; Workman, Creg J.; Wendell, Stacy G.; Vignali, Dario A. A.			Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8(+) T Cell-Derived Interferon-gamma	IMMUNITY			English	Article							ALTERNATIVE ACTIVATION; SUPPRESSOR-CELLS; CANCER; IMMUNITY; DIFFERENTIATION; RESISTANCE; INDUCTION; DEPLETION; THERAPY; INNATE	Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME). Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME. Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types. Treg cells suppressed CD8(+) T cell secretion of interferon-gamma (IFN gamma), which would otherwise block the activation of sterol regulatory element-binding protein 1 (SREBP1)mediated fatty acid synthesis in immunosuppressive (M2-like) tumor-associated macrophages (TAMs). Thus, Treg cells indirectly but selectively sustained M2-like TAM metabolic fitness, mitochondria! integrity, and survival. SREBP1 inhibition augmented the efficacy of immune checkpoint blockade, suggesting that targeting Treg cells or their modulation of lipid metabolism in M2-like TAMs could improve cancer immunotherapy.	[Liu, Chang; Menk, Ashley, V; Brunazzi, Erin A.; Vignali, Kate M.; Delgoffe, Greg M.; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Chikina, Maria] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA; [Deshpande, Rahul; Wendell, Stacy G.] Univ Pittsburgh, Hlth Sci Metabol & Lipid Core, Pittsburgh, PA 15261 USA; [Wang, Ting; Chen, Wei] Univ Pittsburgh, Dept Pediat, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15224 USA; [Tabib, Tracy; Lafyatis, Robert A.] Univ Pittsburgh, Sch Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA; [Sun, Ming; Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Menk, Ashley, V; Delgoffe, Greg M.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Wendell, Stacy G.] Univ Pittsburgh, Clin Translat Sci Inst, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Ting] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	Delgoffe, Greg M./HCH-2805-2022; Wang, Ting/L-8427-2017	Delgoffe, Greg M./0000-0002-2957-8135; Wang, Ting/0000-0003-4712-6658; Chen, Wei/0000-0001-7196-8703	NIH [CA203689]; NCI Comprehensive Cancer Center Support CORE grant [CA047904]; UPSOM Unified Flow Core [1S10 ERR019142 01]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA203689, P30CA047904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant; UPSOM Unified Flow Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank A. Rudensky and D. Cheresh for mice; A. McIntyre, D. Falkner, and H. Shen from the Immunology Flow Core for cell sorting; S. Gingras and the transgenic and gene targeting (TGT) core for generating the Ifng<SUP>L/L</SUP> mice; and the staff of the Division of Laboratory Animal Services for the animal husbandry. We also thank Dr. Jeremy Tilstra for helpful discussions, and David Finkelstein (St. Jude Children's Research Hospital) for initial Affymetrix data analysis. This work was supported by the NIH (CA203689 to D.A.A.V.) and NCI Comprehensive Cancer Center Support CORE grant (CA047904 to D.A.A.V.). Part of this project used the UPSOM Unified Flow Core (1S10 ERR019142 01).	Arina A, 2015, CURR OPIN IMMUNOL, V33, P120, DOI 10.1016/j.coi.2015.02.006; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Bu X, 2016, TRENDS MOL MED, V22, P448, DOI 10.1016/j.molmed.2016.04.008; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guerriero JL, 2018, TRENDS MOL MED, V24, P472, DOI 10.1016/j.molmed.2018.03.006; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Li XN, 2011, ANAL CHEM, V83, P3192, DOI 10.1021/ac103093w; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu C, 2016, FEBS J, V283, P2731, DOI 10.1111/febs.13656; Marigo I, 2016, CANCER CELL, V30, P377, DOI 10.1016/j.ccell.2016.08.004; Melo RCN, 2016, EXP CELL RES, V340, P193, DOI 10.1016/j.yexcr.2015.10.028; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Nystrom SN, 2014, EUR J IMMUNOL, V44, P3621, DOI 10.1002/eji.201344432; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sawant DV, 2019, NAT IMMUNOL, V20, P724, DOI 10.1038/s41590-019-0346-9; Sawant DV, 2014, J IMMUNOL, V192, P2904, DOI 10.4049/jimmunol.1202502; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Topalian SL, 2015, CELL, V161, P185; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	41	95	96	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					381	+		10.1016/j.immuni.2019.06.017	http://dx.doi.org/10.1016/j.immuni.2019.06.017			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31350177	Green Accepted, Bronze			2022-12-18	WOS:000482088500019
J	Komuczki, J; Tuzlak, S; Friebel, E; Hartwig, T; Spath, S; Rosenstiel, P; Waisman, A; Opitz, L; Oukka, M; Schreiner, B; Pelczar, P; Becher, B				Komuczki, Juliana; Tuzlak, Selma; Friebel, Ekaterina; Hartwig, Tom; Spath, Sabine; Rosenstiel, Philip; Waisman, Ari; Opitz, Lennart; Oukka, Mohammed; Schreiner, Bettina; Pelczar, Pawel; Becher, Burkhard			Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1 beta	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; COLLAGEN-INDUCED ARTHRITIS; EFFECTOR PHASE; TH17 CELLS; MULTIPLE-SCLEROSIS; FETAL MONOCYTES; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; RECEPTOR	Pathogenic lymphocytes initiate the development of chronic inflammatory diseases. The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) (encoded by Csf2) is a key communicator between pathogenic lymphocytes and tissue-invading inflammatory phagocytes. However, the molecular properties of GM-CSF-producing cells and the mode of Csf2 regulation in vivo remain unclear. To systematically study and manipulate GM-CSF+ cells and their progeny in vivo, we generated a fate-map and reporter of GM-CSF expression mouse strain (FROG). We mapped the phenotypic and functional profile of auto-aggressive T helper (Th) cells during neuroinflammation and identified the signature and pathogenic memory of a discrete encephalitogenic Th subset. These cells required interleukin-23 receptor (IL-23R) and IL-1R but not IL-6R signaling for their maintenance and pathogenicity. Specific ablation of this subset interrupted the inflammatory cascade, despite the unperturbed tissue accumulation of other Th subsets (e.g., Th1 and Th17), high-lighting that GM-CSF expression not only marks pathogenic Th cells, but that this subset mediates immunopathology and tissue destruction.	[Komuczki, Juliana; Tuzlak, Selma; Friebel, Ekaterina; Hartwig, Tom; Spath, Sabine; Schreiner, Bettina; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Basel, Switzerland; [Schreiner, Bettina] Univ Hosp Zurich, Neurol Clin, Zurich, Switzerland; [Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rosenstiel, Philip] Univ Hosp Schleswig Holstein, Kiel, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Oukka, Mohammed] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Opitz, Lennart] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Spath, Sabine] Benaroya Res Inst, Seattle, WA USA	University of Zurich; University of Basel; University of Zurich; University Zurich Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Johannes Gutenberg University of Mainz; Seattle Children's Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Benaroya Research Institute	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Friebel, Ekaterina/ABF-1308-2021; Rosenstiel, Philip/A-5137-2009; Becher, Burkhard/ABE-4225-2020	Friebel, Ekaterina/0000-0003-1419-2376; Rosenstiel, Philip/0000-0002-9692-8828; Becher, Burkhard/0000-0002-1541-7867; Spath, Sabine/0000-0002-2689-1951	Swiss National Science Foundation, Switzerland [316030_150768, 310030_146130]; European Community FP7 [602239 ATECT]; University Research Priority Program (URPP) for Translational Cancer Research; DOC fellowship from the Austrian Academy of Science; DFG Cluster of Excellence Inflammation at Interfaces; EU H2020 grant SYSCID [733100]; DFG [CRC/TR 128]; Hertie Stiftung, Germany	Swiss National Science Foundation, Switzerland(Swiss National Science Foundation (SNSF)); European Community FP7; University Research Priority Program (URPP) for Translational Cancer Research; DOC fellowship from the Austrian Academy of Science; DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); EU H2020 grant SYSCID; DFG(German Research Foundation (DFG)); Hertie Stiftung, Germany	This study was supported by grants from the Swiss National Science Foundation, Switzerland (316030_150768 and 310030_146130), a European Community FP7 (602239 ATECT), and the University Research Priority Program (URPP) for Translational Cancer Research to B.B. J.K. was funded by the DOC fellowship from the Austrian Academy of Science. P.R. is supported by the DFG Cluster of Excellence Inflammation at Interfaces and the EU H2020 grant SYSCID (#733100). A.W. received funds from the DFG via CRC/TR 128 and from the Hertie Stiftung, Germany. We thank Mirjam Lutz, Heide Oller, and Anto Pavlovic for technical assistance. We thank Marija Banovic for performing real-time PCR analysis. We also thank Insight Editing London for assistance with preparation and critical evaluation of the manuscript.	Aden K, 2016, CELL REP, V16, P2208, DOI 10.1016/j.celrep.2016.07.054; Babon JJ, 2014, SEMIN IMMUNOL, V26, P13, DOI 10.1016/j.smim.2013.12.004; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Behrens F, 2015, ANN RHEUM DIS, V74, P1058, DOI 10.1136/annrheumdis-2013-204816; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Campbell IK, 1998, J IMMUNOL, V161, P3639; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Eberl G, 2018, TRENDS IMMUNOL, V39, P261, DOI 10.1016/j.it.2017.11.004; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fotiadou C, 2018, PSORIASIS-TARGETS TH, V8, P1, DOI 10.2147/PTT.S98893; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; GRIFFIN JD, 1990, INT J CELL CLONING, V8, P35, DOI 10.1002/stem.5530080705; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Hartwig T, 2015, EUR J IMMUNOL, V45, P3022, DOI 10.1002/eji.201545883; Hatakeyama M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1104-8; Hatfield JK, 2015, CELL IMMUNOL, V297, P69, DOI 10.1016/j.cellimm.2015.06.006; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hirota K, 2018, IMMUNITY, V48, P1220, DOI 10.1016/j.immuni.2018.04.009; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Liao Y., 2019, NUCLEIC ACIDS RES; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marini F., 2018, BIORXIV, DOI [10.1101/493551, DOI 10.1101/493551]; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McGinley AM, 2018, J AUTOIMMUN, V87, P97, DOI 10.1016/j.jaut.2018.01.001; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; MOMBAERTS IM, 1991, AM J OPHTHALMOL, V112, P96, DOI 10.1016/S0002-9394(14)76225-7; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; Mufazalov IA, 2017, EMBO J, V36, P102, DOI 10.15252/embj.201694615; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Pare A, 2018, P NATL ACAD SCI USA, V115, pE1194, DOI 10.1073/pnas.1714948115; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Shaw OM, 2014, ARTHRITIS RHEUMATOL, V66, P2423, DOI 10.1002/art.38730; Sheih A, 2017, MUCOSAL IMMUNOL, V10, P705, DOI 10.1038/mi.2016.90; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Spath S, 2013, EUR J IMMUNOL, V43, P2810, DOI 10.1002/eji.201344109; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2016, CYTOM PART A, V89A, P22, DOI 10.1002/cyto.a.22734; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4_9, DOI 10.1007/978-3-319-24277-4]; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; 2008, LANCET NEUROL, V7, P796, DOI DOI 10.1016/S1474-4422(08)70173-X; 1999, J NEUROIMMUNOL, V101, P188; 2015, EUR J IMMUNOL, V45, P2780, DOI DOI 10.1002/EJI.201545800	96	95	96	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1289	+		10.1016/j.immuni.2019.04.006	http://dx.doi.org/10.1016/j.immuni.2019.04.006			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31079916	Bronze			2022-12-18	WOS:000468429500018
J	Datta, M; Staszewski, O; Raschi, E; Frosch, M; Hagemeyer, N; Tay, TL; Blank, T; Kreutzfeldt, M; Merkler, D; Ziegler-Waldkirch, S; Matthias, P; Meyer-Luehmann, M; Prinz, M				Datta, Moumita; Staszewski, Ori; Raschi, Elena; Frosch, Maximilian; Hagemeyer, Nora; Tay, Tuan Leng; Blank, Thomas; Kreutzfeldt, Mario; Merkler, Doron; Ziegler-Waldkirch, Stephanie; Matthias, Patrick; Meyer-Luehmann, Melanie; Prinz, Marco			Histone Deacetylases 1 and 2 Regulate Microglia Function during Development, Homeostasis, and Neurodegeneration in a Context-Dependent Manner	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; MACROPHAGES; HDAC2; REVEALS; FATE; CELL; CNS; PRECURSORS; MONOCYTES; VARIANTS	Microglia as tissue macrophages contribute to the defense and maintenance of central nervous system (CNS) homeostasis. Little is known about the epigenetic signals controlling microglia function in vivo. We employed constitutive and inducible mutagenesis in microglia to delete two class I histone deacetylases, Hdac1 and Hdac2. Prenatal ablation of Hdac1 and Hdac2 impaired microglial development. Mechanistically, the promoters of pro-apoptotic and cell cycle genes were hyperacetylated in absence of Hdac1 and Hdac2, leading to increased apoptosis and reduced survival. In contrast, Hdac1 and Hdac2 were not required for adult microglia survival during homeostasis. In a mouse model of Alzheimer's disease, deletion of Hdac1 and Hdac2 in microglia, but not in neuroectodermal cells, resulted in a decrease in amyloid load and improved cognitive impairment by enhancing microglial amyloid phagocytosis. Collectively, we report a role for epigenetic factors that differentially affect microglia development, homeostasis, and disease that could potentially be utilized therapeutically.	[Datta, Moumita; Staszewski, Ori; Frosch, Maximilian; Hagemeyer, Nora; Tay, Tuan Leng; Blank, Thomas; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Fac Med, D-79106 Freiburg, Germany; [Raschi, Elena] Alma Mater Studiorum Univ Bologna, Sch Med, Dept Expt Diagnost & Special Med, I-40126 Bologna, Italy; [Kreutzfeldt, Mario; Merkler, Doron] Geneva Fac Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Ziegler-Waldkirch, Stephanie; Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Fac Med, D-79106 Freiburg, Germany; [Matthias, Patrick] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Datta, Moumita] Univ Ulm, Inst Immunol, Fac Med, D-89081 Ulm, Germany	University of Freiburg; University of Bologna; University of Geneva; University of Freiburg; Friedrich Miescher Institute for Biomedical Research; University of Freiburg; Ulm University	Datta, M; Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Fac Med, D-79106 Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.; Datta, M (corresponding author), Univ Ulm, Inst Immunol, Fac Med, D-89081 Ulm, Germany.	moumita.datta@uni-ulm.de; marco.prinz@uniklinik-freiburg.de	Merkler, Doron/N-9157-2016; Datta, Moumita/AAU-8006-2021	Merkler, Doron/0000-0002-0247-2007; Frosch, Maximilian/0000-0002-5418-0962; Tay, Tuan Leng/0000-0002-3507-6502; Kreutzfeldt, Mario/0000-0003-0335-2733; Staszewski, Ori/0000-0002-0579-6701; Blank, Thomas/0000-0002-3969-405X	BMBF [01GI1303B]; Sobek-Foundation; DFG [SFB 992, SFB1160, SFB/TRR167]; Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation")	BMBF(Federal Ministry of Education & Research (BMBF)); Sobek-Foundation; DFG(German Research Foundation (DFG)); Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation")	The authors thank K. Seidel, M. Oberle, and M. Ditter for excellent technical support; M. Follo and team at lighthouse fluorescence technologies core Facility, University Medical Center, Freiburg for cell sorting; CEMT, University of Freiburg for excellent animal care; and KFB, Center of Excellence for Fluorescent Bioanalytics, Regensburg for Microarray and RNA-Seq analysis. The authors also thank Prof. Dr. Hassan Jumaa from Institute for Immunology, Ulm University for his support. M.P. is supported by the BMBF-funded competence network of multiple sclerosis (KKNMS) (Forderkennzeichen 01GI1303B), the Sobek-Foundation, the DFG (SFB 992, SFB1160, SFB/TRR167, Reinhart-Koselleck-Grant), and the Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation").	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Das Gupta K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.46; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Heideman MR, 2013, BLOOD, V121, P2038, DOI 10.1182/blood-2012-08-450916; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2017, J CLIN INVEST, V127, P3201, DOI [10.1172/JCI90602, 10.1172/jci90602]; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Meyer-Luehmann M, 2015, TRENDS NEUROSCI, V38, P659, DOI 10.1016/j.tins.2015.08.011; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sellner S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0374-8; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Spowart-Manning L, 2004, BEHAV BRAIN RES, V151, P37, DOI 10.1016/j.bbr.2003.08.004; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Varol D, 2017, IMMUNITY, V46, P1030, DOI 10.1016/j.immuni.2017.05.003; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16	55	95	99	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					514	+		10.1016/j.immuni.2018.02.016	http://dx.doi.org/10.1016/j.immuni.2018.02.016			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29548672	Bronze			2022-12-18	WOS:000427916900012
J	Emgard, J; Kammoun, H; Garcia-Cassani, B; Chesne, J; Parigi, SM; Jacob, JM; Cheng, HW; Evren, E; Das, S; Czarnewski, P; Sleiers, N; Melo-Gonzalez, F; Kvedaraite, E; Svensson, M; Scandella, E; Hepworth, MR; Huber, S; Ludewig, B; Peduto, L; Villablanca, EJ; Veiga-Fernandes, H; Pereira, JOP; Flavell, RA; Willinger, T				Emgard, Johanna; Kammoun, Hana; Garcia-Cassani, Bethania; Chesne, Julie; Parigi, Sara M.; Jacob, Jean-Marie; Cheng, Hung-Wei; Evren, Elza; Das, Srustidhar; Czarnewski, Paulo; Sleiers, Natalie; Melo-Gonzalez, Felipe; Kvedaraite, Egle; Svensson, Mattias; Scandella, Elke; Hepworth, Matthew R.; Huber, Samuel; Ludewig, Burkhard; Peduto, Lucie; Villablanca, Eduardo J.; Veiga-Fernandes, Henrique; Pereira, Joa O. P.; Flavell, Richard A.; Willinger, Tim			Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation	IMMUNITY			English	Article							ROR-GAMMA-T; MUCOSAL; IDENTIFICATION; GENERATION; LIGANDS; DIFFERENTIATION; INITIATION; EXPRESSION; MIGRATION; FATE	Group 3 innate lymphoid cells (ILC3s) sense environmental signals and are critical for tissue integrity in the intestine. Yet, which signals are sensed and what receptors control ILC3 function remain poorly understood. Here, we show that ILC3s with a lymphoid-tissue-inducer (LTi) phenotype expressed G-protein-coupled receptor 183 (GPR183) and migrated to its oxysterol ligand 7 alpha, 25-hydroxycholesterol (7 alpha, 25-OHC). In mice lacking Gpr183 or 7 alpha, 25-OHC, ILC3s failed to localize to cryptopatches (CPs) and isolated lymphoid follicles (ILFs). Gpr183 deficiency in ILC3s caused a defect in CP and ILF formation in the colon, but not in the small intestine. Localized oxysterol production by fibroblastic stromal cells provided an essential signal for colonic lymphoid tissue development, and inflammation-induced increased oxysterol production caused colitis through GPR183-mediated cell recruitment. Our findings show that GPR183 promotes lymphoid organ development and indicate that oxysterol-GPR183- dependent positioning within tissues controls ILC3 activity and intestinal homeostasis.	[Emgard, Johanna; Kammoun, Hana; Evren, Elza; Sleiers, Natalie; Kvedaraite, Egle; Svensson, Mattias; Willinger, Tim] Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden; [Garcia-Cassani, Bethania; Chesne, Julie] Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal; [Parigi, Sara M.; Das, Srustidhar; Czarnewski, Paulo; Villablanca, Eduardo J.] Karolinska Inst, Dept Med, Immunol & Allergy Unit, S-17176 Stockholm, Sweden; [Jacob, Jean-Marie; Peduto, Lucie] Inst Pasteur, Unite Stroma Inflammat & Tissue Repair, F-75724 Paris, France; [Jacob, Jean-Marie; Peduto, Lucie] INSERM U1224, F-75724 Paris, France; [Cheng, Hung-Wei; Scandella, Elke; Ludewig, Burkhard] Kantonsspital, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Melo-Gonzalez, Felipe; Hepworth, Matthew R.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9PL, Lancs, England; [Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 1, D-20246 Hamburg, Germany; [Pereira, Joa O. P.; Flavell, Richard A.; Willinger, Tim] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Karolinska Institutet; Fundacao Champalimaud; Karolinska Institutet; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Manchester; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; Howard Hughes Medical Institute	Willinger, T (corresponding author), Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden.; Flavell, RA; Willinger, T (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	richard.flavell@yale.edu; tim.willinger@ki.se	Das, Srustidhar/GVU-1044-2022; Kvedaraite, Egle/AAA-5257-2021; Villablanca, Eduardo/E-1380-2016	Melo-Gonzalez, Felipe/0000-0002-3711-2407; Evren, Elza/0000-0002-5656-4417; Peduto, Lucie/0000-0003-2414-4407; Huber, Samuel/0000-0001-9325-8227; Czarnewski, Paulo/0000-0001-8150-4021; Pereira, Joao/0000-0002-5694-4938; Hepworth, Matthew/0000-0002-9613-7858; Willinger, TIM/0000-0002-8720-7199; Villablanca, Eduardo/0000-0001-9522-9729	Sir Henry Dale Wellcome Trust Fellowship [105644/Z/14/Z]; NIH [RO1AI113040]; Swiss National Science Foundation grant [159188]; Center for Innovative Medicine at the Karolinska Institutet; Ake Wiberg Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113040] Funding Source: NIH RePORTER	Sir Henry Dale Wellcome Trust Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Center for Innovative Medicine at the Karolinska Institutet; Ake Wiberg Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Rongvaux, L. Evangelisti, J. Stein, C. Hughes, and L. Borelli for help with generating Gpr183 <SUP>/</SUP> mice. We also thank L. Zenewicz for providing cDNA and G. Eberl (Pasteur Institute) for providing Rorc(gamma t)<SUP>GFP</SUP> transgenic mice. R.A.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by a Sir Henry Dale Wellcome Trust Fellowship (105644/Z/14/Z) to M.R.H., NIH grant RO1AI113040 to J.P.P., Swiss National Science Foundation grant 159188 to B.L., and a Junior Investigator Research Grant from the Center for Innovative Medicine at the Karolinska Institutet and a grant from the Ake Wiberg Foundation to T.W.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Buettner M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00342; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kvedaraite E, 2016, GUT, V65, P1632, DOI 10.1136/gutjnl-2014-309014; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lu E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5237; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Randall TD, 2014, MUCOSAL IMMUNOL, V7, P455, DOI 10.1038/mi.2014.11; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	51	95	96	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					120	+		10.1016/j.immuni.2017.11.020	http://dx.doi.org/10.1016/j.immuni.2017.11.020			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343433	Green Published, hybrid			2022-12-18	WOS:000422751600015
J	Roquilly, A; McWilliam, HEG; Jacqueline, C; Tian, ZH; Cinotti, R; Rimbert, M; Wakim, L; Caminschi, I; Lahoud, MH; Belz, GT; Kallies, A; Mintern, JD; Asehnoune, K; Villadangos, JA				Roquilly, Antoine; McWilliam, Hamish E. G.; Jacqueline, Cedric; Tian, Zehua; Cinotti, Raphael; Rimbert, Marie; Wakim, Linda; Caminschi, Irina; Lahoud, Mireille H.; Belz, Gabrielle T.; Kallies, Axel; Mintern, Justine D.; Asehnoune, Karim; Villadangos, Jose A.			Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections	IMMUNITY			English	Article							REGULATORY T-CELLS; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; DENDRITIC CELLS; TGF-BETA; CROSS-PRESENTATION; IN-VIVO; MICE; MACROPHAGES; EXPRESSION	Lung infections cause prolonged immune alterations and elevated susceptibility to secondary pneumonia. We found that, after resolution of primary viral or bacterial pneumonia, dendritic cells (DC), and macrophages exhibited poor antigen-presentation capacity and secretion of immunogenic cytokines. Development of these "paralyzed'' DCs and macrophages depended on the immunosuppressive microenvironment established upon resolution of primary infection, which involved regulatory T (Treg) cells and the cytokine TGF-beta. Paralyzed DCs secreted TGF-beta and induced local Treg cell accumulation. They also expressed lower amounts of IRF4, a transcription factor associated with increased antigen-presentation capacity, and higher amounts of Blimp1, a transcription factor associated with tolerogenic functions, than DCs present during primary infection. Blimp1 expression in DC of humans suffering sepsis or trauma correlated with severity and complicated outcomes. Our findings describe mechanisms underlying sepsis-and trauma-induced immunosuppression, reveal prognostic markers of susceptibility to secondary infections and identify potential targets for therapeutic intervention.	[Roquilly, Antoine; McWilliam, Hamish E. G.; Tian, Zehua; Wakim, Linda; Villadangos, Jose A.] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Roquilly, Antoine; Jacqueline, Cedric; Cinotti, Raphael; Asehnoune, Karim] Med Univ Nantes, Inst Rech Sante Nantes Biotech 2, Therapeut Antiinfect EA3826, F-44000 Nantes, France; [Roquilly, Antoine; Cinotti, Raphael; Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu, Surg Intens Care Unit, F-44093 Nantes, France; [Rimbert, Marie] CHU Nantes, Immunol Lab, CIMNA, Nantes, France; [Caminschi, Irina; Lahoud, Mireille H.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Caminschi, Irina; Lahoud, Mireille H.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Belz, Gabrielle T.; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Belz, Gabrielle T.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Mintern, Justine D.; Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne; Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Monash University; Monash University; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Villadangos, JA (corresponding author), Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Villadangos, JA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	j.villadangos@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020; Roquilly, Antoine/P-9826-2017; Belz, Gabrielle T/C-9350-2013; Jacqueline, Cédric/G-5650-2010; McWilliam, Hamish EG/AAM-8665-2021; Lahoud, Mireille/F-1299-2013	Villadangos, Jose A/0000-0001-6771-8891; Belz, Gabrielle T/0000-0002-9660-9587; Jacqueline, Cédric/0000-0001-9606-5930; McWilliam, Hamish EG/0000-0003-3479-3419; Mintern, Justine/0000-0002-3797-8577; Lahoud, Mireille/0000-0001-8472-6201; Wakim, Linda/0000-0003-1752-9579; Kallies, Axel/0000-0002-6312-6968; Roquilly, Antoine/0000-0002-1029-6242; Caminschi, Irina/0000-0002-9027-2098	National Health and Medical Research Council of Australia (NHMRC); Sylvia and Charles Viertel Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme; Societe Francaise d'Anesthesie Reanimation; Fondation des Gueules Cassees	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia); Societe Francaise d'Anesthesie Reanimation; Fondation des Gueules Cassees	We thank the Biological Resource Centre for biobanking (CHU Nantes, Hotel Dieu, Centre de ressources biologiques [CRB], Nantes, F-44093, France [BRIF: BB-0033-00040]) and the Cytometry Facilty "Cytocell," University of Nantes. Funding: This work was funded with grants from the National Health and Medical Research Council of Australia (NHMRC) to J.A.V., the Sylvia and Charles Viertel Foundation (Senior Medical Research Fellowship to A.K.), the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme. A.R. received grants from the Societe Francaise d'Anesthesie Reanimation and the Fondation des Gueules Cassees. Data and materials availability: Data can be accessed upon request from the server of the University of Melbourne.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Asehnoune K, 2012, ANESTHESIOLOGY, V117, P411, DOI 10.1097/ALN.0b013e31825f018d; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Broquet A, 2014, CRIT CARE MED, V42, pE441, DOI 10.1097/CCM.0000000000000311; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kashiwagi I, 2015, IMMUNITY, V43, P65, DOI 10.1016/j.immuni.2015.06.010; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Roquilly A, 2016, EUR RESPIR J, V47, P1219, DOI 10.1183/13993003.01314-2015; Roquilly A, 2015, MOL IMMUNOL, V68, P120, DOI 10.1016/j.molimm.2015.06.030; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Roquilly A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071639; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Thompson LJ, 2016, NAT IMMUNOL, V17, P297, DOI 10.1038/ni.3329; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; van Vught LA, 2016, AM J RESP CRIT CARE, V194, P1366, DOI 10.1164/rccm.201602-0368OC; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vega-Ramos J, 2014, J IMMUNOL, V193, P3851, DOI 10.4049/jimmunol.1303215; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Worthington JJ, 2011, GASTROENTEROLOGY, V141, P1802, DOI 10.1053/j.gastro.2011.06.057	60	95	101	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					135	+		10.1016/j.immuni.2017.06.021	http://dx.doi.org/10.1016/j.immuni.2017.06.021			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723546	Bronze			2022-12-18	WOS:000405712800015
J	Dalli, J; Colas, RA; Arnardottir, H; Serhan, CN				Dalli, Jesmond; Colas, Romain A.; Arnardottir, Hildur; Serhan, Charles N.			Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution	IMMUNITY			English	Article							PRO-RESOLVING MEDIATORS; LIPID MEDIATORS; VAGUS NERVE; ACUTE-INFLAMMATION; TISSUE; DISEASE; PROFILES; PATHWAYS; INCREASE; IMMUNITY	Uncovering mechanisms that control immune responses in the resolution of bacterial infections is critical for the development of new therapeutic strategies that resolve infectious inflammation without unwanted side effects. We found that disruption of the vagal system in mice delayed resolution of Escherichia coli infection. Dissection of the right vagus decreased peritoneal group 3 innate lymphoid cell (ILC3) numbers and altered peritoneal macrophage responses. Vagotomy resulted in an inflammatory peritoneal lipid mediator profile characterized by reduced concentrations of pro-resolving mediators, including the protective immunoresolvent PCTR1, along with elevated inflammation-initiating eicosanoids. We found that acetylcholine upregulated the PCTR biosynthetic pathway in ILC3s. Administration of PCTR1 or ILC3s to vagotomized mice restored tissue resolution tone and host responses to E. coli infections. Together these findings elucidate a host protective mechanism mediated by ILC3-derived pro-resolving circuit, including PCTR1, that is controlled by local neuronal output to regulate tissue resolution tone and myeloid cell responses.	[Dalli, Jesmond; Colas, Romain A.; Arnardottir, Hildur; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Dalli, Jesmond; Colas, Romain A.; Arnardottir, Hildur; Serhan, Charles N.] Harvard Med Sch, Boston, MA 02115 USA; [Dalli, Jesmond; Colas, Romain A.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Biochem Pharmacol,Lipid Mediator Unit, London EC1M 6BQ, England; [Arnardottir, Hildur] Karolinska Univ Sjukhuset, Solna MedS, Dept Med, Grp G Hansson,Cmm, K2,L8 03, S-17176 Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of London; Queen Mary University London	Dalli, J; Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA.; Dalli, J; Serhan, CN (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Dalli, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Biochem Pharmacol,Lipid Mediator Unit, London EC1M 6BQ, England.	j.dalli@qmul.ac.uk; cnserhan@zeus.bwh.harvard.edu		Arnardottir, Hildur/0000-0002-5163-3946; Dalli, Jesmond/0000-0001-6328-3640	NIH [P01GM095467, GM38765]; European Research Council (ERC) under the European Union [677542]; Sir Henry Dale Fellowship - Wellcome Trust [107613/Z/15/Z]; Sir Henry Dale Fellowship - Royal Society [107613/Z/15/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765, R37GM038765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC) under the European Union(European Research Council (ERC)); Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (P01GM095467 and GM38765 to C.N.S.). J.D. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 677542). J.D. is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 107613/Z/15/Z).	Ahmed AMM, 2014, J CLIN EXP HEPATOL, V4, P279, DOI 10.1016/j.jceh.2014.08.003; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dahdah A, 2014, J CLIN INVEST, V124, P4577, DOI 10.1172/JCI75212; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2015, AM J RESP CELL MOL, V53, P314, DOI 10.1165/rcmb.2014-0299OC; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Flannigan KL, 2014, P NATL ACAD SCI USA, V111, P13559, DOI 10.1073/pnas.1413390111; Fukatsu K, 1996, J AM COLL SURGEONS, V183, P450; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hellmann J, 2015, PROSTAG OTH LIPID M, V116, P49, DOI 10.1016/j.prostaglandins.2015.01.001; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Lee CR, 2015, NEW ENGL J MED, V373, P2183, DOI 10.1056/NEJMcibr1511280; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Leslie M, 2015, SCIENCE, V349, P18, DOI [10.1126/science.349.6243.18, 10.1126/science.347.6217.18]; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Ramon S, 2016, AM J PATHOL, V186, P962, DOI 10.1016/j.ajpath.2015.12.012; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Swanson L.W., 2015, NEUROANATOMICAL TERM; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Vartiainen A, 1934, J PHYSIOL-LONDON, V82, P282, DOI 10.1113/jphysiol.1934.sp003181; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375	35	95	99	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					92	105		10.1016/j.immuni.2016.12.009	http://dx.doi.org/10.1016/j.immuni.2016.12.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28065837	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000392918300013
J	Zhang, LJ; Sen, GL; Ward, NL; Johnston, A; Chun, K; Chen, YF; Adase, C; Sanford, JA; Gao, NN; Chensee, M; Sato, E; Fritz, Y; Baliwag, J; Williams, MR; Hata, T; Gallo, RL				Zhang, Ling-juan; Sen, George L.; Ward, Nicole L.; Johnston, Andrew; Chun, Kimberly; Chen, Yifang; Adase, Christopher; Sanford, James A.; Gao, Nina; Chensee, Melanie; Sato, Emi; Fritz, Yi; Baliwag, Jaymie; Williams, Michael R.; Hata, Tissa; Gallo, Richard L.			Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-beta Production by Epidermal Keratinocytes during Skin Injury	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; PSORIASIS SUSCEPTIBILITY; DENDRITIC CELLS; DISEASE; ALPHA; INFLAMMATION; REPAIR; VIRUS; MICE	Type 1 interferons (IFNs) promote inflammation in the skin but the mechanisms responsible for inducing these cytokines are not well understood. We found that IFN-beta was abundantly produced by epidermal keratinocytes (KCs) in psoriasis and during wound repair. KC IFN-beta production depended on stimulation of mitochondrial antiviral-signaling protein (MAVS) by the antimicrobial peptide LL37 and double stranded-RNA released from necrotic cells. MAVS activated downstream TBK1 (TANK-Binding Kinase 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3) signaling cascade leading to IFN-beta production and then promoted maturation of dendritic cells. In mice, the production of epidermal IFN-beta by LL37 required MAVS, and human wounded and/or psoriatic skin showed activation of MAVS-associated IRF3 and induction of MAVS and IFN-beta gene signatures. These findings show that KCs are an important source of IFN-beta and MAVS is critical to this function, and demonstrates how the epidermis triggers unwanted skin inflammation under disease conditions.	[Zhang, Ling-juan; Sen, George L.; Chun, Kimberly; Chen, Yifang; Adase, Christopher; Sanford, James A.; Gao, Nina; Chensee, Melanie; Sato, Emi; Williams, Michael R.; Hata, Tissa; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Sen, George L.; Chen, Yifang] Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ward, Nicole L.; Fritz, Yi] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA; [Johnston, Andrew; Baliwag, Jaymie] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; Case Western Reserve University; University of Michigan System; University of Michigan	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Zhang, Ling-juan/V-6141-2019; Zhang, Lingjuan/K-3080-2017; Ward, Nicole Leanne/L-2642-2019	Gallo, Richard L/0000-0002-1401-7861; Zhang, Ling-juan/0000-0001-6937-4578; Zhang, Lingjuan/0000-0001-6937-4578; Ward, Nicole Leanne/0000-0003-1907-2621; Sanford, James/0000-0001-7901-5579; Sato, Emi/0000-0001-9394-653X	NIH [RO1 AI052453, AR064781, AI116576, T32 AR062496, K01 AR064765]; National Psoriasis Foundation;  [P30 AR39750];  [RO1 AR063437];  [RO1 AR062546];  [R21 AR063852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116576, R01AI052453, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062546, P30AR039750, T32AR062496, R01AR064781, R01AR069653, R01AR063437, K01AR064765, R21AR063852] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants RO1 AI052453, AR064781, AI116576, and T32 AR062496 to R.L.G. N.L.W. is supported by P30 AR39750, RO1 AR063437, RO1 AR062546, R21 AR063852, and the National Psoriasis Foundation. A.J. is supported by NIH grant K01 AR064765.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bijlmakers MJ, 2011, HUM MOL GENET, V20, P3129, DOI 10.1093/hmg/ddr215; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Deng WW, 2008, J BIOL CHEM, V283, P35590, DOI 10.1074/jbc.M805775200; Erkek E, 2000, DERMATOLOGY, V201, P179, DOI 10.1159/000018447; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goutagny N, 2006, NAT IMMUNOL, V7, P555, DOI 10.1038/ni0606-555; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Mistry DS, 2014, STEM CELLS, V32, P3209, DOI 10.1002/stem.1809; Mistry DS, 2012, CELL STEM CELL, V11, P127, DOI 10.1016/j.stem.2012.04.022; MORHENN VB, 1988, IMMUNOL TODAY, V9, P104, DOI 10.1016/0167-5699(88)91278-9; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Ruano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148450; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; SCHMID P, 1994, J INTERFERON RES, V14, P229, DOI 10.1089/jir.1994.14.229; Sweeney CM, 2011, ARCH DERMATOL RES, V303, P691, DOI 10.1007/s00403-011-1169-1; Toussirot Eric, 2014, Case Rep Rheumatol, V2014, P949317, DOI 10.1155/2014/949317; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Weiss G, 2002, J EUR ACAD DERMATOL, V16, P241, DOI 10.1046/j.1473-2165.2002.00406.x; Wen CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041687; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Yamamoto T, 1995, ACTA DERM-VENEREOL, V75, P482; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017; Zhang LJ, 2012, J CELL SCI, V125, P5733, DOI 10.1242/jcs.108969	46	95	101	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					119	130		10.1016/j.immuni.2016.06.021	http://dx.doi.org/10.1016/j.immuni.2016.06.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438769	Bronze, Green Accepted			2022-12-18	WOS:000380749000015
J	Zhang, CY; Xin, H; Zhang, W; Yazaki, PJ; Zhang, ZF; Le, K; Li, WZ; Lee, H; Kwak, L; Forman, S; Jove, R; Yu, H				Zhang, Chunyan; Xin, Hong; Zhang, Wang; Yazaki, Paul J.; Zhang, Zhifang; Le, Keith; Li, Wenzhao; Lee, Heehyoung; Kwak, Larry; Forman, Stephen; Jove, Richard; Yu, Hua			CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer	IMMUNITY			English	Article							TUMOR MICROENVIRONMENT; CHRONIC INFLAMMATION; PROSTATE-CANCER; EXPRESSION; IL-6; ACTIVATION; IMMUNITY; PATHWAY; MICE; AUTOIMMUNITY	The participation of a specific subset of B cells and how they are regulated in cancer is unclear. Here, we demonstrate that the proportion of CD5(+) relative to interleukin-6 receptor alpha (IL-6R alpha)-expressing B cells was greatly increased in tumors. CD5(+) B cells responded to IL-6 in the absence of IL-6R alpha. IL-6 directly bound to CD5, leading to activation of the transcription factor STAT3 via gp130 and its downstream kinase JAK2. STAT3 upregulated CD5 expression, thereby forming a feed-forward loop in the B cells. In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. CD5(+) B cells also showed activation of STAT3 in multiple types of human tumor tissues. Thus, our findings demonstrate a critical role of CD5(+) B cells in promoting cancer.	[Zhang, Chunyan; Xin, Hong; Zhang, Wang; Li, Wenzhao; Lee, Heehyoung; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Zhang, Chunyan; Xin, Hong; Zhang, Wang; Yazaki, Paul J.; Zhang, Zhifang; Le, Keith; Li, Wenzhao; Lee, Heehyoung; Yu, Hua] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Yazaki, Paul J.; Zhang, Zhifang; Le, Keith] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; [Kwak, Larry; Forman, Stephen] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Jove, Richard] Nova SE Univ, Cell Therapy Inst, Ft Lauderdale, FL 33314 USA; [Yu, Hua] Ctr Translat Med, Zhangjiang Hitech Pk,Pudong New Area, Shanghai 201203, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Nova Southeastern University	Zhang, CY; Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.; Zhang, CY; Yu, H (corresponding author), City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA.; Yu, H (corresponding author), Ctr Translat Med, Zhangjiang Hitech Pk,Pudong New Area, Shanghai 201203, Peoples R China.	czhang@coh.org; hyu@coh.org		Kwak, Larry/0000-0002-1884-5349; YU, Hua/0000-0003-0931-1000	V Foundation Translational Research Grant; National Cancer Institute of the NIH [P30CA033572];  [R01CA122976];  [R01CA146092];  [P50 CA107399]; NATIONAL CANCER INSTITUTE [R01CA140692, P50CA107399, P30CA033572, R01CA122976] Funding Source: NIH RePORTER	V Foundation Translational Research Grant; National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the dedication of staff members at the flow cytometry core, pathology core, and light microscopy core at the Beckman Research Institute at City of Hope Comprehensive Cancer Center for their technical assistance. We also acknowledge the contribution of staff members at the animal facilities at City of Hope. This work is funded in part by R01CA122976, R01CA146092, P50 CA107399, and V Foundation Translational Research Grant. Research reported in this publication was supported by the National Cancer Institute of the NIH under grant number P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; de Wit J, 2011, BLOOD, V118, P6107, DOI 10.1182/blood-2011-05-352682; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Dong HY, 2003, AM J CLIN PATHOL, V119, P218, DOI 10.1309/U98ADVKUC26R2RJA; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrmann A, 2014, CANCER RES, V74, P5218, DOI 10.1158/0008-5472.CAN-14-1151; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lamprecht B, 2008, BLOOD, V112, P3339, DOI 10.1182/blood-2008-01-134783; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li Q, 2009, J IMMUNOL, V183, P3195, DOI 10.4049/jimmunol.0803773; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; NISHIMOTO N, 1994, J EXP MED, V179, P1343, DOI 10.1084/jem.179.4.1343; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Rose-John S, 2004, IMMUNITY, V20, P2, DOI 10.1016/S1074-7613(04)00003-2; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Vera J, 2009, P NATL ACAD SCI USA, V106, P1506, DOI 10.1073/pnas.0805846106; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Woo JR, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-30; Xin H, 2013, J BIOL CHEM, V288, P13842, DOI 10.1074/jbc.M113.450049; Xing C, 2015, J LEUKOCYTE BIOL, V97, P547, DOI 10.1189/jlb.3A0414-213RR; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064159; Yang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054029; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711	54	95	97	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					913	923		10.1016/j.immuni.2016.04.003	http://dx.doi.org/10.1016/j.immuni.2016.04.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096320	Green Accepted, Bronze			2022-12-18	WOS:000374444300021
J	Tan, YH; Zanoni, I; Cullen, TW; Goodman, AL; Kagan, JC				Tan, Yunhao; Zanoni, Ivan; Cullen, Thomas W.; Goodman, Andrew L.; Kagan, Jonathan C.			Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION; MURINE MACROPHAGES; CRYSTAL-STRUCTURE; LIPOPOLYSACCHARIDE; CD14; MD-2; ENDOTOXIN; COMPLEX; TLR4; RESPONSIVENESS	Microbe-induced receptor trafficking has emerged as an essential means to promote innate immune signal transduction. Upon detection of bacterial lipopolysaccharides (LPS), CD14 induces an inflammatory endocytosis pathway that delivers Toll-like receptor 4 (TLR4) to endosomes. Although several regulators of CD14-dependent TLR4 endocytosis have been identified, the cargo-selection mechanism during this process remains unknown. We reveal that, in contrast to classic cytosolic interactions that promoted the endocytosis of transmembrane receptors, TLR4 was selected as cargo for inflammatory endocytosis entirely through extracellular interactions. Mechanistically, the extracellular protein MD-2 bound to and dimerized TLR4 in order to promote this endocytic event. Our analysis of LPS variants from human pathogens and gut commensals revealed a common mechanism by which bacteria prevent inflammatory endocytosis. We suggest that evasion of CD14-dependent endocytosis is an attribute that transcends the concept of pathogenesis and might be a fundamental feature of bacteria that inhabit eukaryotic hosts.	[Tan, Yunhao; Zanoni, Ivan; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tan, Yunhao; Zanoni, Ivan; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Zanoni, Ivan] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Zanoni, Ivan] Humanitas Clin & Res Ctr, Unit Cell Signalling & Innate Immun, I-20089 Rozzano, Italy; [Cullen, Thomas W.; Goodman, Andrew L.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Cullen, Thomas W.; Goodman, Andrew L.] Yale Univ, Sch Med, Microbial Sci Inst, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Milano-Bicocca; IRCCS Humanitas Research Hospital; Yale University; Yale University	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu	Tan, Yunhao/K-7442-2016	Tan, Yunhao/0000-0002-5516-4980; Zanoni, Ivan/0000-0002-3423-7474	NIH [AI093589, AI113141, GM103574, GM105456]; Burroughs Wellcome Fund; Jane Coffin Childs Memorial Fund for Medical Research (Merck Fellowship); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI103082, R56AI113141, R01AI093589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105456, R01GM103574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Jane Coffin Childs Memorial Fund for Medical Research (Merck Fellowship); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the J.C.K. lab for helpful discussions. We also appreciate Noreen Francis from the BCH IDDRC - Flow Cytometry Facility for FACS assistance and Stefanie Vogel for providing purified F. tularensis LVS LPS. This work was supported by NIH grants AI093589 and AI113141 and an unrestricted gift from Mead Johnson & Company to J.C.K. and by NIH grants GM103574 and GM105456 to A.L.G. J.C.K. and A.L.G. hold Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund. Y.T. is supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research (the Merck Fellowship).	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; BERLIN RD, 1978, CELL, V15, P327, DOI 10.1016/0092-8674(78)90002-8; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016253; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Perera PY, 1997, J IMMUNOL, V158, P4422; Saitoh S, 2004, J ENDOTOXIN RES, V10, P257, DOI 10.1179/096805104225005904; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; STRITTMATTER W, 1983, J BACTERIOL, V155, P153, DOI 10.1128/JB.155.1.153-158.1983; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	45	95	97	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					909	922		10.1016/j.immuni.2015.10.008	http://dx.doi.org/10.1016/j.immuni.2015.10.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26546281	Bronze, Green Accepted			2022-12-18	WOS:000366846000012
J	Hossain, DMS; Panda, AK; Manna, A; Mohanty, S; Bhattacharjee, P; Bhattacharyya, S; Saha, T; Chakraborty, S; Kar, RK; Das, T; Chatterjee, S; Sa, G				Hossain, Dewan Md Sakib; Panda, Abir K.; Manna, Argha; Mohanty, Suchismita; Bhattacharjee, Pushpak; Bhattacharyya, Sankar; Saha, Taniya; Chakraborty, Sreeparna; Kar, Rajiv K.; Das, Tanya; Chatterjee, Subhrangsu; Sa, Gaurisankar			RETRACTED: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells (Retracted article. See vol. 54, pg. 2167, 2021)	IMMUNITY			English	Article; Retracted Publication							TARGET GENES; TRANSCRIPTION; ACETYLTRANSFERASE; RESPONSES; INHIBITION; ACTIVATION; OCCUPANCY; CARCINOMA; KEY	FoxP3, a lineage-specification factor, executes its multiple activities mostly through transcriptional regulation of target genes. We identified an interleukin-10 (IL-10)-producing FoxP3(+) T regulatory cell population that contributes to IL-10-dependent type 2 cytokine bias in breast-cancer patients. Although genetic ablation of FOXP3 inhibited IL10 transcription, genome-wide analysis ruled out its role as a transcription factor for IL10. In-depth analysis revealed that histone acetyl transterase-1, in association with FoxP3, modified the IL10 promoter epigenetically, making a space for docking STAT3-FoxP3 complexes. A predictive docking module with target-receptor specificity, along with exon-deletion and site-directed mutagenesis studies, showed that STAT3 binds through its N-terminal floppy domain to the exon 2 beta sheet region of FoxP3 to form STAT3-FoxP3 complexes. Such cotranscriptional activity of FoxP3 extended to other STAT3-target genes that lack FoxP3-binding sites. These results suggest a function of FoxP3, where, failing to achieve direct promoter occupancy, FoxP3 promotes transcription in association with the locus-specific transcription factor STAT3.	[Hossain, Dewan Md Sakib; Panda, Abir K.; Manna, Argha; Mohanty, Suchismita; Bhattacharjee, Pushpak; Bhattacharyya, Sankar; Saha, Taniya; Chakraborty, Sreeparna; Das, Tanya; Sa, Gaurisankar] Bose Inst, Div Mol Med, Kolkata 700054, India; [Kar, Rajiv K.; Chatterjee, Subhrangsu] Bose Inst, Dept Biophys, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Sa, G (corresponding author), Bose Inst, Div Mol Med, P 1-12,CIT Scheme 7 M, Kolkata 700054, India.	gauri@jcbose.ac.in	PANDA, ABIR K/D-6320-2016; Bhattacharyya, Sankar/AAK-2204-2020	PANDA, ABIR K/0000-0002-1865-1683; 	Department of Biotechnology; Council for Scientific and Industrial Research, Government of India	Department of Biotechnology; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to D. Das of Presidency College (Kolkata) for helpful advice during the preparation and to R. Sarkar for editorial assistance of the manuscript. We are grateful to A. Rao of Harvard Medical School (Boston), S. Hori of RIKEN Research Center for Allergy and Immunology (Japan) for FoxP3 clones, and L. Cheng of The Johns Hopkins University School of Medicine (Baltimore) for STAT3 clones. This work was supported by grants from the Department of Biotechnology and Council for Scientific and Industrial Research, Government of India.	Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Groux H, 2003, TRANSPLANTATION, V75, p8S, DOI 10.1097/01.TP.0000067944.90241.BD; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lathers DMR, 2003, HUM IMMUNOL, V64, P1160, DOI 10.1016/j.humimm.2003.08.024; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	42	95	102	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1057	1069		10.1016/j.immuni.2013.11.005	http://dx.doi.org/10.1016/j.immuni.2013.11.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24315995	Bronze			2022-12-18	WOS:000330951000012
J	Chen, E; Staudt, LM; Green, AR				Chen, Edwin; Staudt, Louis M.; Green, Anthony R.			Janus Kinase Deregulation in Leukemia and Lymphoma	IMMUNITY			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL LYMPHOMA; JAK2 V617F MUTATION; ACUTE MEGAKARYOBLASTIC LEUKEMIA; HEMATOPOIETIC STEM-CELL; CHRONIC MYELOPROLIFERATIVE DISORDERS; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; OF-FUNCTION MUTATIONS; POLYCYTHEMIA-VERA	Genetic alterations affecting members of the Janus kinase (JAK) family have been discovered in a wide array of cancers and are particularly prominent in hematological malignancies. In this review, we focus on the role of such lesions in both myeloid and lymphoid tumors. Oncogenic JAK molecules can activate a myriad of canonical downstream signaling pathways as well as directly interact with chromatin in noncanonical processes, the interplay of which results in a plethora of diverse biological consequences. Deciphering these complexities is shedding unexpected light on fundamental cellular mechanisms and will also be important for improved diagnosis, identification of new therapeutic targets, and the development of stratified approaches to therapy.	[Staudt, Louis M.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Chen, Edwin; Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0XY, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Staudt, LM (corresponding author), NCI, Metab Branch, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov; arg1000@cam.ac.uk	Staudt, Louis/AAC-5324-2019	Green, Anthony/0000-0002-9795-0218; Chen, Edwin/0000-0003-0742-9734	Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Biomedical Cambridge Research Centre; Leukemia and Lymphoma Society of America; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011008] Funding Source: NIH RePORTER; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Biomedical Cambridge Research Centre; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in the authors' laboratories is supported by the Leukemia and Lymphoma Research, the Kay Kendall Leukaemia Fund, the NIHR Biomedical Cambridge Research Centre and the Leukemia and Lymphoma Society of America (A.R.G.), and the National Institutes of Health (L.M.S.).	Aboudola S, 2007, AM J SURG PATHOL, V31, P233, DOI 10.1097/01.pas.0000213338.25111.d3; Asnafi V, 2010, BRIT J HAEMATOL, V148, P179, DOI 10.1111/j.1365-2141.2009.07912.x; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; Beer PA, 2009, BRIT J HAEMATOL, V144, P904, DOI 10.1111/j.1365-2141.2008.07560.x; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Chen GL, 2007, BLOOD, V110, P1410, DOI 10.1182/blood-2006-09-018655; Dai CH, 2005, EXP HEMATOL, V33, P152, DOI 10.1016/j.exphem.2004.10.017; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Dusa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011157; Elliott NE, 2011, BLOOD, V118, P3911, DOI 10.1182/blood-2010-12-319467; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ishii T, 2007, EXP HEMATOL, V35, P1633, DOI 10.1016/j.exphem.2007.07.005; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Joos S, 2000, CANCER RES, V60, P549; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kamishimoto J, 2011, CELL SIGNAL, V23, P849, DOI 10.1016/j.cellsig.2011.01.009; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Khwaja A, 2006, BRIT J HAEMATOL, V134, P366, DOI 10.1111/j.1365-2141.2006.06206.x; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lelievre H, 2006, LEUKEMIA, V20, P1885, DOI 10.1038/sj.leu.2404361; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Li J, 2011, DIS MODEL MECH, V4, P311, DOI 10.1242/dmm.006817; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Ma WL, 2009, J MOL DIAGN, V11, P49, DOI 10.2353/jmoldx.2009.080114; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mark HFL, 2006, EXP MOL PATHOL, V81, P217, DOI 10.1016/j.yexmp.2006.07.004; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; McMullin MF, 2007, BRIT J HAEMATOL, V138, P821, DOI 10.1111/j.1365-2141.2007.06741.x; Mesa RA, 2006, LEUKEMIA, V20, P1800, DOI 10.1038/sj.leu.2404338; Monte-Mor BDR, 2009, LEUKEMIA, V23, P144, DOI 10.1038/leu.2008.275; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Perez B, 2010, BRIT J HAEMATOL, V151, P460, DOI 10.1111/j.1365-2141.2010.08393.x; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sato T, 2008, BRIT J HAEMATOL, V141, P681, DOI 10.1111/j.1365-2141.2008.07081.x; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Schaub FX, 2009, BLOOD, V113, P2022, DOI 10.1182/blood-2008-07-167056; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Scuto A, 2011, CANCER RES, V71, P3182, DOI 10.1158/0008-5472.CAN-10-2380; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Van Pelt K, 2008, BLOOD, V112, P921, DOI 10.1182/blood-2008-04-154708; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Walz C., 2012, BLOOD, P10; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xiang ZF, 2008, BLOOD, V111, P4809, DOI 10.1182/blood-2007-05-090308; Yan D., 2011, BLOOD, P5; Yan Y., 2011, HAEMATOLOGI IN PRESS, DOI [10.3324/haemato1.2011.054080, DOI 10.3324/HAEMATOL.2011.054080]; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	119	95	109	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					529	541		10.1016/j.immuni.2012.03.017	http://dx.doi.org/10.1016/j.immuni.2012.03.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520846	Green Accepted, Bronze			2022-12-18	WOS:000303223900003
J	Mahabeleshwar, GH; Kawanami, D; Sharma, N; Takami, Y; Zhou, GJ; Shi, H; Nayak, L; Jeyaraj, D; Grealy, R; White, M; McManus, R; Ryan, T; Leahy, P; Lin, ZY; Haldar, SM; Atkins, GB; Wong, HR; Lingrel, JB; Jain, MK				Mahabeleshwar, Ganapati H.; Kawanami, Daiji; Sharma, Nikunj; Takami, Yoichi; Zhou, Guangjin; Shi, Hong; Nayak, Lalitha; Jeyaraj, Darwin; Grealy, Robert; White, Mary; McManus, Ross; Ryan, Thomas; Leahy, Patrick; Lin, Zhiyong; Haldar, Saptarsi M.; Atkins, G. Brandon; Wong, Hector R.; Lingrel, Jerry B.; Jain, Mukesh K.			The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock	IMMUNITY			English	Article							NF-KAPPA-B; INDUCIBLE FACTOR 1-ALPHA; PROINFLAMMATORY ACTIVATION; ALTERNATIVE ACTIVATION; SEVERE SEPSIS; SEPTIC SHOCK; EXPRESSION; ENDOTHELIUM; HIF-1-ALPHA; MACROPHAGES	Precise control of myeloid cell activation is required for optimal host defense. However, this activation process must be under exquisite control to prevent uncontrolled inflammation. Herein, we identify the Kruppel-like transcription factor 2 (KLF2) as a potent regulator of myeloid cell activation in vivo. Exposure of myeloid cells to hypoxia and/or bacterial products reduced KLF2 expression while inducing hypoxia inducible factor-1 alpha (HIF-1 alpha), findings that were recapitulated in human septic patients. Myeloid KLF2 was found to be a potent inhibitor of nuclear factor-kappaB (NF-kappa B)-dependent HIF-1 alpha. transcription and, consequently, a critical determinant of outcome in models of polymicrobial infection and endotoxemia. Collectively, these observations identify KLF2 as a tonic repressor of myeloid cell activation in vivo and an essential regulator of the innate immune system.	[Mahabeleshwar, Ganapati H.; Kawanami, Daiji; Sharma, Nikunj; Takami, Yoichi; Zhou, Guangjin; Shi, Hong; Nayak, Lalitha; Jeyaraj, Darwin; Lin, Zhiyong; Haldar, Saptarsi M.; Atkins, G. Brandon; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr,Case Cardiovasc Res Inst, Harrington McLaughlin Heart & Vasc Inst,Dept Med, Cleveland, OH 44106 USA; [Grealy, Robert; White, Mary; McManus, Ross; Ryan, Thomas] Trinity Coll Dublin, Inst Mol Med, Dept Anesthesia, Dublin 8, Ireland; [Leahy, Patrick] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wong, Hector R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Res Fdn, Div Crit Care Med, Cincinnati, OH 45267 USA; [Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Case Western Reserve University; Case Western Reserve University Hospital; Trinity College Dublin; Case Western Reserve University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jain, MK (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr,Case Cardiovasc Res Inst, Harrington McLaughlin Heart & Vasc Inst,Dept Med, Cleveland, OH 44106 USA.	mukesh.jain2@case.edu	McManus, Ross/AAE-9236-2020; Ryan, Thomas/S-6978-2019	Ryan, Thomas/0000-0002-3556-5592; Grealy, Robert/0000-0002-4725-0619; McManus, Ross/0000-0002-0529-9617; Takami, Yoichi/0000-0001-9018-6707; Wong, Hector/0000-0001-7989-1173	National Institutes of Health [HL72952, HL75427, HL76754, HL086548, HL084154, P01 HL048743, HL097023, HL078806, HL087595, HL088740, HL086614, HL094660, GM064619, HL100474]; Robert Wood Johnson/Harold Amos Medical Faculty Development grant; Dominic Visconsi Scholar Award; American Heart Association [0725297B, 09POST2060203]; Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119195, RC1HL100474, R00HL097023, P01HL048743, R01HL072952, K08HL086614, R01HL086548, R01HL076754, K99HL087595, R01HL075427, K08HL094660, R01HL097593, K01HL088740, R00HL087595, R01HL084154, R01HL078806, K99HL097023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson/Harold Amos Medical Faculty Development grant; Dominic Visconsi Scholar Award; American Heart Association(American Heart Association); Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72952, HL75427, HL76754, HL086548, HL084154, and P01 HL048743 (M.K.J.); HL097023 (G.H.M.); HL078806 (J.B.L.); HL087595 (Z.L.); HL088740 (G.B.A.); HL086614 (S.M.H.); HL094660 (D.J.); and GM064619 and HL100474 (H.R.W.); a Robert Wood Johnson/Harold Amos Medical Faculty Development grant (G.B.A.), a Dominic Visconsi Scholar Award (S.M.H., G.B.A.), American Heart Association Grants 0725297B (D.K.) and 09POST2060203 (N.S.), Sankyo Foundation of Life Science grants (Y.T.), and a Kanae Foundation for the Promotion of Medical Science grant (Y.T. and D.K.).	Ahmad N, 2005, BIOCHEMISTRY-US, V44, P6276, DOI 10.1021/bi050018s; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Bista P, 2008, MOL IMMUNOL, V45, P3618, DOI 10.1016/j.molimm.2008.05.001; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Gill SE, 2010, AM J PATHOL, V176, P64, DOI 10.2353/ajpath.2010.090158; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Kellam P, 2006, CELL, V124, P695, DOI 10.1016/j.cell.2006.02.003; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serbina NV, 2008, IMMUNITY, V29, P672, DOI 10.1016/j.immuni.2008.10.003; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34	44	95	98	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					715	728		10.1016/j.immuni.2011.04.014	http://dx.doi.org/10.1016/j.immuni.2011.04.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21565532	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000291456500011
J	Kim, HS; Das, A; Gross, CC; Bryceson, YT; Long, EO				Kim, Hun Sik; Das, Asmita; Gross, Catharina C.; Bryceson, Yenan T.; Long, Eric O.			Synergistic Signals for Natural Cytotoxicity Are Required to Overcome Inhibition by c-Cbl Ubiquitin Ligase	IMMUNITY			English	Article							NK-CELL CYTOTOXICITY; KILLER-CELLS; T-CELLS; NEGATIVE REGULATION; RECEPTOR SIGNALS; VAV PROTEINS; ACTIVATION; NKG2D; PATHWAYS; POLARIZATION	Natural killer (NK) cell cytotoxicity toward target cells depends on synergistic coactivation by NK cell receptors such as NKG2D and 2B4. How synergy occurs is not known. Synergistic phosphorylation of phospholipase PLC-gamma 2, Ca2+, mobilization, and degranulation triggered by NKG2D and 2B4 coengagement were blocked by Vav1 siRNA knockdown, but enhanced by knockdown of c-CbI. c-CbI inhibited Vav1-dependent signals, given that c-CbI knockdown did not rescue the Vav1 defect. Moreover, c-CbI knockdown and Vav1 overexpression each circumvented the necessity for synergy because NKG2D or 2134 alone became sufficient for activation. Thus, synergy requires not strict complementation but, rather, strong Vav1 signals to overcome inhibition by c-CbI. Inhibition of NK cell cytotoxicity by CD94NKG2A binding to HLA-E on target cells was dominant over synergistic activation, even after c-CbI knockdown. Therefore, NK cell activation by synergizing receptors is regulated at the level of Vav1 by a hierarchy of inhibitory mechanisms.	[Kim, Hun Sik; Das, Asmita; Gross, Catharina C.; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Bryceson, Yenan T.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, S-14186 Huddinge, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Karolinska University Hospital	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	elong@nih.gov	Bryceson, Yenan T/D-2121-2018; Long, Eric O/G-5475-2011	Bryceson, Yenan T/0000-0002-7783-9934; Long, Eric O/0000-0002-7793-3728; Gross, Catharina/0000-0002-4872-9189; Das, Asmita/0000-0001-9846-1005	National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525, ZIAAI001117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. March for useful discussions; G. Cohen, D. Geraghty, J. Gumperz, P. Parham, H.G. Klingemann, J. Kornbluth, and M. Robertson for cell lines; and L. Samelson and D. Bohman for plasmids. This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Chiang YJ, 2009, J BIOL CHEM, V284, P4429, DOI 10.1074/jbc.M808679200; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee N, 1998, J IMMUNOL, V160, P4951; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Tassawar H, 2007, INT J PLANT PROD, V1, P1; Tassi I, 2006, IMMUNOL REV, V214, P92, DOI 10.1111/j.1600-065X.2006.00463.x; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200	50	95	98	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					175	186		10.1016/j.immuni.2010.02.004	http://dx.doi.org/10.1016/j.immuni.2010.02.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189481	Bronze, Green Accepted			2022-12-18	WOS:000275346000008
J	Victoratos, P; Lagnel, J; Tzima, S; Alimzhanov, MB; Rajewsky, K; Pasparakis, M; Kollias, G				Victoratos, P; Lagnel, J; Tzima, S; Alimzhanov, MB; Rajewsky, K; Pasparakis, M; Kollias, G			FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; NF-KAPPA-B; PEYERS PATCH ORGANOGENESIS; LYMPHOID ORGAN DEVELOPMENT; LYMPHOTOXIN-BETA-RECEPTOR; GERMINAL-CENTER FORMATION; CYTIDINE DEAMINASE AID; TNF RECEPTOR; MICE LACKING	The FDC-specific molecular signals required in the formation of FDC networks, B cell follicles, and germinal centers (GCs) have remained poorly understood. We used FDC-specific gene targeting to investigate the function of p55TNFR and IKK2 in lymphoid organ structure and function. Here we show that FDC-specific expression of p55TNFR is necessary and sufficient to promote FDC network and B cell follicle formation, restore the expression of CXCL13 and VCAM-1/ICAM-1 in FDCs, and lead to productive GCs. Notably, FDC-specific disruption of IKK2 does not affect formation of FDC networks. Yet, after antigen engagement or immune complex (IC) deposition, FDCs lacking IKK2 fail to upregulate VCAM-1 and ICAM-1, and GCs remain sterile. These findings demonstrate that IKK2-independent function of p55TNFR on FDCs is sufficient to support the development of FDC networks and GCs, while FDC-specific IKK2 is indispensable for the generation of efficient humoral immune responses.	Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari 16672, Greece; Univ Cologne, Genet Inst, D-50931 Cologne, Germany; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Italy	Alexander Fleming Biomedical Sciences Research Center; University of Cologne; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Kollias, G (corresponding author), FORTH HELLAS, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece.	g.kollias@fleming.gr	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Kollias, George/A-7079-2012	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Kollias, George/0000-0003-1867-3150; Rajewsky, Klaus/0000-0002-6633-6370				Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; AYDAR Y, 1925, J IMMUNOL, V174, P5358; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Douni Eleni, 2004, Methods Mol Med, V98, P137; Drayton DL, 2004, J IMMUNOL, V173, P6161, DOI 10.4049/jimmunol.173.10.6161; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; FREEDMAN AS, 1990, SCIENCE, V249, P1030, DOI 10.1126/science.1697696; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Koopman G, 1997, EUR J IMMUNOL, V27, P1, DOI 10.1002/eji.1830270102; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LINDHOUT E, 1993, CLIN EXP IMMUNOL, V91, P330; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Matsumoto M, 1997, J EXP MED, V186, P1997, DOI 10.1084/jem.186.12.1997; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Park CS, 2004, J IMMUNOL, V173, P6676, DOI 10.4049/jimmunol.173.11.6676; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasparakis Manolis, 1996, Cytokine and Growth Factor Reviews, V7, P223, DOI 10.1016/S1359-6101(96)00031-7; Poljak L, 1999, J IMMUNOL, V163, P6581; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; Tkachuk M, 1998, J EXP MED, V187, P469, DOI 10.1084/jem.187.4.469; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang JL, 2001, J UNIV SCI TECHNOL B, V8, P167	58	95	98	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					65	77		10.1016/j.immuni.2005.11.013	http://dx.doi.org/10.1016/j.immuni.2005.11.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413924	Bronze			2022-12-18	WOS:000234850200011
J	Lazarevic, V; Myers, AJ; Scanga, CA; Flynn, JL				Lazarevic, V; Myers, AJ; Scanga, CA; Flynn, JL			CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M-tuberculosis infection	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; DENDRITIC CELLS; MEDIATED-IMMUNITY; LEISHMANIA-MAJOR; CD40-CD40 LIGAND; CD8(+) CTL; MICE; ACTIVATION; STIMULATION; HEAT-SHOCK-PROTEIN-70	CD40(-/-) mice succumbed to low-dose aerosol infection with M. tuberculosis due to deficient IL-12 production leading to impaired priming of lFN-gamma T cell responses. In contrast, CD40L(-/-) mice were resistant to M. tuberculosis. This asymmetry in outcome of infection between the two knockout strains is likely due to the existence of an alternative ligand for CD40. Both in vitro M. tuberculosis infection and recombinant M. tuberculosis Hsp70 elicited IL-12 production from WT dendritic cells. This response was absent in both CD40(-/-) dendritic cells and CD40(-/-) mice, suggesting that M. tuberculosis Hsp70 serves as an alternative ligand for CD40 in vivo.	Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; NIAID, Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Flynn, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA.	joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020; Lazarevic, Vanja/B-1160-2009	Lazarevic, Vanja/0000-0002-5783-7130; Scanga, Charles/0000-0003-3654-5603	NIAID NIH HHS [R01 AI37859, N01 AI-75320] Funding Source: Medline; PHS HHS [A50732] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037859, N01AI075320] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; Caruso AM, 1999, J IMMUNOL, V162, P5407; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; CHALUPNY NJ, 1992, P NATL ACAD SCI USA, V89, P10360, DOI 10.1073/pnas.89.21.10360; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chaussabel D, 1999, INFECT IMMUN, V67, P1929; Compos-Neto A, 1998, J IMMUNOL, V160, P2037; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Grewal IS, 1997, CURR OPIN IMMUNOL, V9, P491, DOI 10.1016/S0952-7915(97)80100-8; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Henderson RA, 1997, J IMMUNOL, V159, P635; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mackey MF, 1998, J LEUKOCYTE BIOL, V63, P418, DOI 10.1002/jlb.63.4.418; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Serbina NV, 2000, J IMMUNOL, V165, P353, DOI 10.4049/jimmunol.165.1.353; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; Thomsen AR, 1998, J IMMUNOL, V161, P4583; VanKooten C, 1996, ADV IMMUNOL, V61, P1; Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996	32	95	99	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					823	835		10.1016/S1074-7613(03)00324-8	http://dx.doi.org/10.1016/S1074-7613(03)00324-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670300	Bronze			2022-12-18	WOS:000187230700008
J	O'Callaghan, CA; Cerwenka, A; Willcox, BE; Lanier, LL; Bjorkman, PJ				O'Callaghan, CA; Cerwenka, A; Willcox, BE; Lanier, LL; Bjorkman, PJ			Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60	IMMUNITY			English	Article							PLASMON RESONANCE BIOSENSORS; CELL-SURFACE PROTEINS; INDUCIBLE CDNA CLONES; NATURAL-KILLER-CELLS; DELTA T-CELLS; MHC MOLECULES; HLA-E; PHOSPHATIDYLINOSITOL 3-KINASE; ESCHERICHIA-COLI; KINETIC-ANALYSIS	NKG2D is a potent activating receptor on natural killer cells, T cells, and macrophages. Mouse NKG2D interacts with two cell surface ligands related to class I MHC molecules: RAE1 and H60. We used soluble versions of NKG2D, RAE1, and H60 to characterize their interactions. RAE1 and H60 each bind NKG2D with nanomolar affinities, indicating tighter binding than most cell surface immune interactions, but NKG2D binds to H60 with similar to 25-fold higher affinity than to RAE1. RAE1 and H60 compete directly for occupancy of NKG2D, and, thus, NKG2D can be occupied by only one ligand at a time. The NKG2D-H60 interaction is more temperature dependent and makes greater use of electrostatic interactions than the NKG2D-RAE1 interaction. The distinct thermodynamic profiles provide insights into the different molecular mechanisms of the binding interactions.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bjorkman, PJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.		Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Cerwenka, Adelheid/0000-0001-6977-3536	NCI NIH HHS [CA 89189] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alape-Giron A, 2000, EUR J BIOCHEM, V267, P5191, DOI 10.1046/j.1432-1327.2000.01588.x; ANDREWS NW, 1988, J EXP MED, V167, P300, DOI 10.1084/jem.167.2.300; BAHRAM S, 1994, P NATL ACAD SCI USA, V96, P6879; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Leder L, 1995, BIOCHEMISTRY-US, V34, P16509, DOI 10.1021/bi00050a035; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; O'Callaghan CA, 1998, PROTEIN SCI, V7, P1264, DOI 10.1002/pro.5560070525; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; O'Callaghan CA, 1998, IMMUNOL REV, V163, P129, DOI 10.1111/j.1600-065X.1998.tb01192.x; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; QUINONEZ G, 1988, ULTRASTRUCT PATHOL, V12, P389, DOI 10.3109/01913128809064209; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VONHIPPE.PH, 1965, J BIOL CHEM, V240, P3909; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	53	95	99	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					201	211		10.1016/S1074-7613(01)00187-X	http://dx.doi.org/10.1016/S1074-7613(01)00187-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520456	Bronze			2022-12-18	WOS:000170717200003
J	Panoutsakopoulou, V; Sanchirico, ME; Huster, KM; Jansson, M; Granucci, F; Shim, DJ; Wucherpfennig, KW; Cantor, H				Panoutsakopoulou, V; Sanchirico, ME; Huster, KM; Jansson, M; Granucci, F; Shim, DJ; Wucherpfennig, KW; Cantor, H			Analysis of the relationship between viral infection and autoimmune disease	IMMUNITY			English	Article							SIMPLEX-VIRUS TYPE-1; T-CELLS; MOLECULAR MIMICRY; TRANSGENIC MICE; BYSTANDER ACTIVATION; ENCEPHALOMYELITIS; DEMYELINATION; INDUCTION; IDENTIFICATION; TOLERANCE	The clinical association between viral infection and onset or exacerbation of autoimmune disorders remains poorly understood. Here, we examine the relative roles of molecular mimicry and nonspecific inflammatory stimuli in progression from infection to autoimmune disease. Murine herpes virus 1 (HSV-1 KOS) infection triggers T cell-dependent autoimmune reactions to corneal tissue. We generated an HSV-1 KOS point mutant containing a single amino acid exchange within the putative mimicry epitope as well as mice expressing a TOR transgene specific for the self-peptide mimic to allow dissection of two pathogenic mechanisms in disease induction. These experiments indicate that viral mimicry is essential for disease induction after low-level viral infection of animals containing limited numbers of autoreactive T cells, while innate immune mechanisms become sufficient to provoke disease in animals containing relatively high numbers of autoreactive T cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu	GRANUCCI, Francesca/K-6150-2019	granucci, francesca/0000-0002-7046-4914; Panoutsakopoulou, Vily/0000-0002-1569-1508	NATIONAL EYE INSTITUTE [F32EY007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048125, R37AI012184, R01AI012184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039096] Funding Source: NIH RePORTER; NEI NIH HHS [F32EY07032] Funding Source: Medline; NIAID NIH HHS [AI12184, AI48125, AI37562] Funding Source: Medline; NINDS NIH HHS [NS 39096] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 1997, J IMMUNOL, V158, P438; ALTMANN DM, 1985, J GEN VIROL, V66, P1297, DOI 10.1099/0022-1317-66-6-1297; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; AVERY AC, 1995, NATURE, V376, P431, DOI 10.1038/376431a0; Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Cantor H, 2000, ADV IMMUNOL, V75, P209, DOI 10.1016/S0065-2776(00)75005-X; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Daheshia M, 1997, J IMMUNOL, V159, P1945; DALCANTO MC, 1982, ANN NEUROL, V11, P109, DOI 10.1002/ana.410110202; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; FOSTER CS, 1986, CLIN IMMUNOL IMMUNOP, V40, P313, DOI 10.1016/0090-1229(86)90036-X; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GAMBLE DR, 1973, BRIT MED J, V1, P289, DOI 10.1136/bmj.1.5848.289-a; GAMBLE DR, 1980, BRIT MED J, V281, P99, DOI 10.1136/bmj.281.6233.99; Gangappa S, 2000, INVEST OPHTH VIS SCI, V41, P453; Gangappa S, 1998, J IMMUNOL, V161, P4289; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; HENDRICKS RL, 1990, INVEST OPHTH VIS SCI, V31, P1929; Hogan B., 1986, MANIPULATING MOUSE E; Horwitz MS, 1999, IMMUNOL REV, V169, P241, DOI 10.1111/j.1600-065X.1999.tb01319.x; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Ludewig B, 1999, IMMUNOL REV, V169, P45, DOI 10.1111/j.1600-065X.1999.tb01305.x; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; MILLER M, 1990, EUR HEART J, V11, P9, DOI 10.1093/eurheartj/11.suppl_H.9; MILLER SD, 1995, IMMUNOL REV, V144, P225, DOI 10.1111/j.1600-065X.1995.tb00071.x; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; MUNOZ JJ, 1984, CELL IMMUNOL, V83, P92, DOI 10.1016/0008-8749(84)90228-4; NAGATA M, 1992, DIABETES, V41, P998, DOI 10.2337/diabetes.41.8.998; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Oxenius A, 1998, ADV IMMUNOL, V70, P313, DOI 10.1016/S0065-2776(08)60390-9; Patel AH, 1996, VIROLOGY, V217, P111, DOI 10.1006/viro.1996.0098; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; SANDSTROM IK, 1986, CLIN IMMUNOL IMMUNOP, V40, P326, DOI 10.1016/0090-1229(86)90037-1; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Sevilla N, 2000, J VIROL, V74, P3284, DOI 10.1128/JVI.74.7.3284-3292.2000; SIBLEY WA, 1985, LANCET, V1, P1313; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; SU YH, 1990, J VIROL, V64, P2187, DOI 10.1128/JVI.64.5.2187-2192.1990; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Thomas J, 1997, J IMMUNOL, V158, P1383; Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4; Vanderlugt CL, 1998, IMMUNOL REV, V164, P63, DOI 10.1111/j.1600-065X.1998.tb01208.x; vonHerrath MG, 1996, CURR OPIN IMMUNOL, V8, P878, DOI 10.1016/S0952-7915(96)80019-7; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344	56	95	100	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					137	147		10.1016/S1074-7613(01)00172-8	http://dx.doi.org/10.1016/S1074-7613(01)00172-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485745	Bronze			2022-12-18	WOS:000170153300014
J	Speir, JA; Stevens, J; Joly, E; Butcher, GW; Wilson, IA				Speir, JA; Stevens, J; Joly, E; Butcher, GW; Wilson, IA			Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-A(a)	IMMUNITY			English	Article							2.4 ANGSTROM RESOLUTION; ANTIGEN-BINDING SITE; T-CELL; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN-STRUCTURE; VIRAL PEPTIDES; COMPLEX; RECOGNITION; TRANSPORTERS	The rat MHC class la molecule RT1-A(a) has the unusual capacity to bind long peptides ending in arginine, such as MTF-E, a thirteen-residue, maternally transmitted minor histocompatibility antigen. The antigenic structure of MTF-E was unpredictable due to its extraordinary length and two arginines that could serve as potential anchor residues. The crystal structure of RT1-A(a)-MTF-E at 2.55 Angstrom shows that both peptide termini are anchored, as in other class I molecules, but the central residues in two independent pMHC complexes adopt completely different bulged conformations based on local environment. The MTF-E epitope is fully exposed within the putative T cell receptor (TCR) footprint. The flexibility demonstrated by the MTF-E structures illustrates how different TCRs may be raised against chemically identical, but structurally dissimilar, pMHC complexes.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Babraham Inst, Mol Immunol Programme, Cambridge CB2 4AT, England	Scripps Research Institute; Scripps Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Butcher, GW (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	geoff.butcher@bbsrc.ac.uk; wilson@scripps.edu	Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681	NCI NIH HHS [CA58896] Funding Source: Medline; NIMH NIH HHS [MH19185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Achour A, 1998, IMMUNITY, V9, P199, DOI 10.1016/S1074-7613(00)80602-0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhuyan PK, 1997, J IMMUNOL, V158, P3753; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DAVIES JD, 1991, J EXP MED, V173, P823, DOI 10.1084/jem.173.4.823; Dedier S, 2000, J BIOL CHEM, V275, P27055; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Horig H, 1999, J IMMUNOL, V163, P4434; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Joly E, 1998, CURR BIOL, V8, P169, DOI 10.1016/S0960-9822(98)70065-X; Joly E, 1998, IMMUNOL TODAY, V19, P580, DOI 10.1016/S0167-5699(98)01348-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li HM, 1998, J MOL BIOL, V283, P179, DOI 10.1006/jmbi.1998.2091; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; ROGNAN D, 1994, BIOCHEMISTRY-US, V33, P11476, DOI 10.1021/bi00204a009; Saito NG, 1999, J IMMUNOL, V162, P5998; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stevens J, 1998, EUR J IMMUNOL, V28, P1272, DOI 10.1002/(SICI)1521-4141(199804)28:04<1272::AID-IMMU1272>3.0.CO;2-E; Stevens J, 1998, J BIOL CHEM, V273, P2874, DOI 10.1074/jbc.273.5.2874; Stevens J, 2000, INT IMMUNOL, V12, P83, DOI 10.1093/intimm/12.1.83; Stevens J, 2000, J BIOL CHEM, V275, P29217, DOI 10.1074/jbc.M002565200; THORPE CJ, 1995, IMMUNOGENETICS, V41, P329; Viner NJ, 1996, J IMMUNOL, V156, P2365; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	74	95	102	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2001	14	1					81	92		10.1016/S1074-7613(01)00091-7	http://dx.doi.org/10.1016/S1074-7613(01)00091-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163232	Bronze			2022-12-18	WOS:000166513800008
J	Jose, ES; Borroto, A; Niedergang, F; Alcover, A; Alarcon, B				Jose, ES; Borroto, A; Niedergang, F; Alcover, A; Alarcon, B			Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism	IMMUNITY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; DOWN-REGULATION; ZETA-CHAIN; CYTOPLASMIC TAIL; ACTIVATION; TYROSINE; REQUIREMENTS; SENSITIVITY; RECOGNITION	Downregulation of the TCR complex is believed to be intimately tied to T cell activation, allowing serial triggering of receptors and desensitization of stimulated cells. We studied transfected and transgenic T cells expressing CD3 xi chimeras to demonstrate that ligand engagement of the TCR or chimeras causes comodulation of nonengaged receptors. Comodulation required protein tyrosine kinase activity but not trans-phosphorylation of nonengaged receptors. The TCR appears to be downregulated by at least two mechanisms. One mechanism requires direct engagement, independent of signaling. The second requires signaling and downregulates nontriggered receptors. These results shed new light on the process of TCR downregulation and indicate that the number of downregulated TCRs cannot be assumed to equal the number of engaged receptors.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Inst Pasteur, Unite Biol Interact Cellulaires, F-75724 Paris 15, France	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Alarcon, B (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	balarcon@cbm.uam.es	Alarcon, Balbino/N-9648-2016	Alarcon, Balbino/0000-0001-7820-1070; Niedergang, Florence/0000-0002-7064-830X; San Jose, Esther/0000-0002-5707-628X; Alcover, Andres/0000-0002-9507-3450				AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; Andre P, 1997, J IMMUNOL, V159, P5253; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; FRANK SJ, 1990, SCIENCE, V249, P174, DOI 10.1126/science.2371564; GELGER TL, 1999, J IMMUNOL, V162, P5931; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; Jose ES, 1997, VIROLOGY, V239, P303, DOI 10.1006/viro.1997.8872; Jose ES, 1998, EUR J IMMUNOL, V28, P12; LECHLER RI, 1988, J IMMUNOL, V141, P3003; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; LUTON F, 1994, J IMMUNOL, V153, P63; Luton F, 1997, J IMMUNOL, V158, P3140; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; Martin S, 1998, EUR J IMMUNOL, V28, P2991, DOI 10.1002/(SICI)1521-4141(199810)28:10<2991::AID-IMMU2991>3.3.CO;2-2; Niedergang F, 1998, J IMMUNOL, V161, P6054; Niedergang F, 1997, J IMMUNOL, V159, P1703; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rothenberg EV, 1996, SCIENCE, V273, P78, DOI 10.1126/science.273.5271.78; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Salio M, 1997, EUR J IMMUNOL, V27, P1769, DOI 10.1002/eji.1830270726; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; SHINKAI Y, 1995, IMMUNITY, V2, P401; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Valitutti S, 1996, EUR J IMMUNOL, V26, P2012, DOI 10.1002/eji.1830260907; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; ZANDERS ED, 1983, NATURE, V303, P625, DOI 10.1038/303625a0	41	95	97	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2000	12	2					161	170		10.1016/S1074-7613(00)80169-7	http://dx.doi.org/10.1016/S1074-7613(00)80169-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714682	Bronze			2022-12-18	WOS:000085621400006
J	Marguet, D; Spiliotis, ET; Pentcheva, T; Lebowitz, M; Schneck, J; Edidin, M				Marguet, D; Spiliotis, ET; Pentcheva, T; Lebowitz, M; Schneck, J; Edidin, M			Lateral diffusion of GFP-tagged H2L(d) molecules and of GFP-TAP1 reports on the assembly and retention of those molecules in the endoplasmic reticulum	IMMUNITY			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RECEPTORS; SURFACE EXPRESSION; QUALITY-CONTROL; TAP COMPLEXES; LYMPHOCYTES-T; ANTIGEN; PEPTIDE; CALNEXIN	Lateral diffusion of GFP-tagged H2L(d) molecules in the ER membrane reports on their interaction with the TAP complex during synthesis and peptide loading. Peptide-loaded H2L(d) molecules diffuse rapidly, near the theoretical limit for proteins in a bilayer. However, these molecules are retained in the ER for some time after assembly. H2L(d) molecules, associated with the TAP complex, diffuse slowly, as does GFP-tagged TAP1. This implies that the association of H2L(d) molecules with the TAP complex is stable for at least several minutes. It also suggests that the TAP complex is very large, perhaps containing hundreds of proteins.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Edidin, M (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.		Marguet, Didier/B-9946-2008; Marguet, Didier/AGO-5421-2022	Marguet, Didier/0000-0003-3198-5095	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014584, R01AI029575, R01AI014584] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29575, AI14584] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bai AL, 1997, J IMMUNOL, V159, P2139; BECK JC, 1986, J IMMUNOL, V137, P916; BIKOFF EK, 1991, NATURE, V354, P235, DOI 10.1038/354235a0; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; EDIDIN M, 1994, LEGACY CELL FUSION, P101; ELSON EL, 1979, J SUPRAMOL STR CELL, V12, P481, DOI 10.1002/jss.400120408; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harris MR, 1998, J IMMUNOL, V160, P5404; HOWARD JC, 1995, CURR OPIN IMMUNOL, V7, P69, DOI 10.1016/0952-7915(95)80031-X; HUGHES BD, 1982, BIOPHYS J, V37, P673; Joyce S, 1997, J MOL BIOL, V266, P993, DOI 10.1006/jmbi.1996.0822; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li Y, 1998, J BIOL CHEM, V273, P29830, DOI 10.1074/jbc.273.45.29830; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Marusina K, 1997, J IMMUNOL, V158, P5251; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; OZATO K, 1980, J IMMUNOL, V125, P2473; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SHIROISHI T, 1985, J IMMUNOL, V134, P623; SILVERMAN T, 1988, J IMMUNOL, V140, P4378; Solheim JC, 1997, J IMMUNOL, V158, P2236; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VanLeeuwen JEM, 1996, P NATL ACAD SCI USA, V93, P13997, DOI 10.1073/pnas.93.24.13997; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5	48	95	95	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					231	240		10.1016/S1074-7613(00)80098-9	http://dx.doi.org/10.1016/S1074-7613(00)80098-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485658	Bronze			2022-12-18	WOS:000082383400012
J	Benedict, CL; Kearney, JF				Benedict, CL; Kearney, JF			Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice	IMMUNITY			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; N-REGION DIVERSITY; V(D)J RECOMBINATION; PHOSPHOCHOLINE ANTIBODIES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; GENE-EXPRESSION; DEVELOPMENTAL SWITCH; LYMPHOCYTES-B; CHAIN GENES	Fetal Igs are less diverse than adult Igs, largely because of the lack of N addition in the absence of Tdt. To test whether the absence of Tdt is essential, we generated Tg mice that express Tdt and add N regions in fetal B cells. When challenged as adults with PC-containing Streptococcus pneumoniae, these mice fail to make the hallmark T15 anti-PC Ab encoded by canonical rearrangements of Ig H and L chain genes. The anti-PC Abs from these mice are altered by premature N addition and do not protect against death from virulent pneumococcal infection. These results show that maintenance of lower Ig diversity in early life is essential for the acquisition of a complete functional adult repertoire.	Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kearney, JF (corresponding author), Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.		Kearney, John/GOV-3123-2022	Benedict, Cindy/0000-0001-8380-161X	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, T32AI007051] Funding Source: NIH RePORTER; NCI NIH HHS [CA13148] Funding Source: Medline; NIAID NIH HHS [T32 AI007051, AI07051, R01 AI014782] Funding Source: Medline; PHS HHS [AL14782] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Bentolila LA, 1997, J IMMUNOL, V158, P715; BOUDINOT P, 1994, J IMMUNOL, V152, P2248; BRILES DE, 1989, INFECT IMMUN, V57, P1457, DOI 10.1128/IAI.57.5.1457-1464.1989; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; CARLSSON L, 1992, EUR J IMMUNOL, V22, P71, DOI 10.1002/eji.1830220112; CARLSSON L, 1990, INT IMMUNOL, V2, P639, DOI 10.1093/intimm/2.7.639; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; CLAFLIN JL, 1985, J IMMUNOL, V134, P2536; CLAFLIN JL, 1987, J IMMUNOL, V138, P3060; CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2; DESAYMARD C, 1984, MOL IMMUNOL, V21, P961, DOI 10.1016/0161-5890(84)90154-8; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Feeney A J, 1992, Int Rev Immunol, V8, P113, DOI 10.3109/08830189209055567; FEENEY AJ, 1991, J IMMUNOL, V147, P4343; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; FEENEY AJ, 1993, IMMUNOGENETICS, V37, P217; Gauss GH, 1996, MOL CELL BIOL, V16, P258; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GILFILLAN S, 1995, EUR J IMMUNOL, V25, P3115, DOI 10.1002/eji.1830251119; GREGOIRE KE, 1979, J IMMUNOL, V123, P1347; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Guo WX, 1997, INT IMMUNOL, V9, P665, DOI 10.1093/intimm/9.5.665; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HUETZ F, 1993, EMBO J, V12, P1819, DOI 10.1002/j.1460-2075.1993.tb05830.x; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KALLENBACH S, 1992, P NATL ACAD SCI USA, V89, P2799, DOI 10.1073/pnas.89.7.2799; KEARNEY JF, 1981, EUR J IMMUNOL, V11, P877, DOI 10.1002/eji.1830111106; KEARNEY JF, 1975, J IMMUNOL, V115, P671; KEARNEY JF, 1983, ANN NY ACAD SCI, V418, P151, DOI 10.1111/j.1749-6632.1983.tb18063.x; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KENNY JJ, 1992, J EXP MED, V176, P1637, DOI 10.1084/jem.176.6.1637; KENTER AL, 1991, MOL CELL BIOL, V11, P4398, DOI 10.1128/MCB.11.9.4398; Kepler TB, 1996, J IMMUNOL, V157, P4451; KIMURA H, 1989, EUR J IMMUNOL, V19, P1741, DOI 10.1002/eji.1830190932; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Martin F, 1997, INT IMMUNOL, V9, P493, DOI 10.1093/intimm/9.4.493; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; MCDANIEL LS, 1987, J EXP MED, V165, P381, DOI 10.1084/jem.165.2.381; MEEK K, 1990, SCIENCE, V250, P820, DOI 10.1126/science.2237433; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; MIMS CA, 1987, POTHOGENESIS INFECT; MITCHELL GF, 1991, IMMUNOPARASITOL TOD, pA2; NADEL B, 1995, J IMMUNOL, V154, P6430; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; POLLOK BA, 1984, NATURE, V311, P376, DOI 10.1038/311376a0; RAMSDEN DA, 1994, J IMMUNOL, V153, P1150; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Schroeder HW, 1995, ANN NY ACAD SCI, V764, P242; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SIGAL NH, 1977, J EXP MED, V146, P933, DOI 10.1084/jem.146.4.933; STOHRER R, 1984, J IMMUNOL, V133, P2323; STROHAL R, 1989, IMMUNOGENETICS, V30, P475, DOI 10.1007/BF02421180; VAKIL M, 1986, EUR J IMMUNOL, V16, P1159, DOI 10.1002/eji.1830160921; YOUNG D, 1995, INT IMMUNOL, V7, P807, DOI 10.1093/intimm/7.5.807; ZINKERNAGEL RM, 1985, BRIT MED BULL, V41, P92, DOI 10.1093/oxfordjournals.bmb.a072033	64	95	98	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					607	617		10.1016/S1074-7613(00)80060-6	http://dx.doi.org/10.1016/S1074-7613(00)80060-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367906	Bronze			2022-12-18	WOS:000080709400012
J	Ellmeier, W; Sunshine, MJ; Losos, K; Littman, DR				Ellmeier, W; Sunshine, MJ; Losos, K; Littman, DR			Multiple developmental stage-specific enhancers regulate CD8 expression in developing thymocytes and in thymus-independent T cells	IMMUNITY			English	Article							POSITIVE SELECTION; LINEAGE COMMITMENT; TRANSGENIC MICE; ALPHA-BETA; GENE; LYMPHOCYTE; INSTRUCTION; EPITHELIUM; MATURATION; REGION	We and others have recently identified a CD8 locus enhancer (E8(l)) that directs expression in mature CD8 single-positive thymocytes and peripheral CD8(+) T cells and in extrathymically derived intestinal intraepithelial lymphocytes (IEL). in this study, we show that deletion of E8(l) by homologous recombination results in reduced CD8 alpha alpha homodimer expression on IEL. Since CD8 expression on thymus-derived T cells was normal, other enhancers regulate CD8 expression in these cells. By exploiting a transgenic reporter expression assay, we identified three additional enhancers that directed expression in diverse thymocyte subsets and mature T cells but not in CD8 alpha alpha(+) IEL. The results suggest that CD8 alpha expression is primarily regulated by E8(l) in IEL and by the novel enhancers in the thymus-dependent lineages.	Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Ellmeier, W (corresponding author), Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA.	ellmeier@saturn.med.nyu.edu		Ellmeier, Wilfried/0000-0001-8192-8481; Sunshine, Mary Jean/0000-0002-2188-7881				BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hogan BLM, 1994, MANIPULATING MOUSE E; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; Kieffer LJ, 1997, J IMMUNOL, V159, P4907; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Klein JR, 1996, J EXP MED, V184, P1203, DOI 10.1084/jem.184.4.1203; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; LI XL, 1994, EMBO J, V13, P400, DOI 10.1002/j.1460-2075.1994.tb06274.x; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Merli C, 1996, GENE DEV, V10, P1260, DOI 10.1101/gad.10.10.1260; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Nakata T, 1989, Ann Nucl Med, V3, P1; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROCHA B, 1995, CURR OPIN IMMUNOL, V7, P235, DOI 10.1016/0952-7915(95)80008-5; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	39	95	99	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					485	496		10.1016/S1074-7613(00)80632-9	http://dx.doi.org/10.1016/S1074-7613(00)80632-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806635	Bronze			2022-12-18	WOS:000076680700007
J	Lissy, NA; Van Dyk, LF; Becker-Hapak, M; Vocero-Akbani, A; Mendler, JH; Dowdy, SF				Lissy, NA; Van Dyk, LF; Becker-Hapak, M; Vocero-Akbani, A; Mendler, JH; Dowdy, SF			TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point	IMMUNITY			English	Article							HUMAN PAPILLOMAVIRUS-E7 PROTEIN; T-CELLS; RETINOBLASTOMA PROTEIN; RESTRICTION POINT; DEPENDENT KINASES; INDUCED APOPTOSIS; GENE-PRODUCT; ACTIVATION; LYMPHOCYTES; HYBRIDOMAS	Deletion of antigen-activated T cells after an immune response and during peripheral negative selection after strong T cell receptor (TCR) engagement of cycling T cells occurs by an apoptotic process termed TCR antigen-induced cell death (AID). By analyzing the timing of death, cell cycle markers, BrdU-labeled S phase cells, and phase-specific centrifugally elutriated cultures from stimulated Jurkat T cells and peripheral blood lymphocytes, we found that AID occurs from a late G1 check point prior to activation of cyclin E:Cdk2 complexes. T cells stimulated to undergo ARD can be rescued by effecting an early G1 block by direct transduction of pi 6(INK4a) tumor suppressor protein or by inactivation of the retinoblastoma tumor suppressor protein (pRb) by transduced HPV E7 protein. These results suggest that AID occurs from a late G1 death check point in a pRb-dependent fashion.	Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Mol Oncol, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Mol Oncol, Dept Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dowdy, SF (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.			Mendler, Jason/0000-0001-5605-5324; van Dyk, Linda/0000-0003-2662-5554				AMOROSO K, 1990, J IMMUNOL, V145, P3155; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; COTTER TG, 1992, ANTICANCER RES, V12, P773; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1795, DOI 10.1073/pnas.89.5.1795; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DOU QP, 1993, CANCER RES, V53, P1493; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DOWDY SF, 1997, HUMAN GENOME METHODS, P121; DYSON N, 1992, J VIROL, V63, P2650; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; EXHEVSKY SA, 1996, MOL BIOL CELL, V7, P553; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; FOTEDAR R, 1995, MOL CELL BIOL, V15, P932; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GREEN DR, 1994, CURR OPIN IMMUNOL, V6, P476, DOI 10.1016/0952-7915(94)90130-9; JENKINSON EJ, 1989, EUR J IMMUNOL, V19, P2175, DOI 10.1002/eji.1830191132; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; JU ST, 1994, P NATL ACAD SCI USA, V91, P4185, DOI 10.1073/pnas.91.10.4185; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lenardo M J, 1995, Int Rev Immunol, V13, P115, DOI 10.3109/08830189509061742; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; MUNGER K, 1993, BIOCHIM BIOPHYS ACTA, V1155, P111, DOI 10.1016/0304-419X(93)90025-8; OKADA C, 1990, J IMMUNOL, V144, P2096; PAGANO M, 1992, ONCOGENE, V7, P1681; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Radvanyi LG, 1996, CELL IMMUNOL, V170, P260, DOI 10.1006/cimm.1996.0160; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SCOTT DW, 1987, IMMUNOL REV, V99, P153, DOI 10.1111/j.1600-065X.1987.tb01176.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SHI YF, 1990, J IMMUNOL, V144, P3326; SHI YF, 1991, J IMMUNOL, V146, P3340; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; ZHU LQ, 1995, J IMMUNOL, V154, P192	44	95	100	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					57	65		10.1016/S1074-7613(00)80458-6	http://dx.doi.org/10.1016/S1074-7613(00)80458-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462511	Bronze			2022-12-18	WOS:000071765700006
J	Oosterwegel, MA; Haks, MC; Jeffry, U; Murray, R; Kruisbeek, AM				Oosterwegel, MA; Haks, MC; Jeffry, U; Murray, R; Kruisbeek, AM			Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class II expressing thymic stromal cells	IMMUNITY			English	Article							DELTA T-CELLS; POLYMERASE CHAIN-REACTION; RECEPTOR-ALPHA-GENE; MONOCLONAL-ANTIBODIES; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; EPITHELIAL-CELLS; BETA-GENE; C-KIT; MICE	The embryonic thymic microenvironment provides the necessary elements for T cell lineage commitment, but the precise role of individual stromal cell components remains to be determined. Here we address the question of which stromal cell types are required for initiation of V-DJ rearrangements of the TCR-beta and TCR-delta locus in CD117(+)CD45(+) uncommitted fetal liver progenitors. We show that fetal thymic stroma alone is necessary and sufficient for induction of TCR-beta and TCR-delta rearrangements. Furthermore, the ability to induce this T cell commitment step is confined to a subset of MHC class Ii-positive epithelial cells. Thymic stroma derived from mice with a targeted deletion in the IL-7 gene, however, lacks this ability. These findings set the stage for a further definition of the nature of the thymic stromal cell support in the regulation of T cell commitment.	NETHERLANDS CANC INST,ANTONI VAN LEEUWENHOEK HUIS,DIV IMMUNOL,NL-1066 CX AMSTERDAM,NETHERLANDS; DNAX RES INST MOL & CELLULAR BIOL INC,PALO ALTO,CA 94304	Netherlands Cancer Institute; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.								ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; APPASAMY PM, 1993, J EXP MED, V178, P2201, DOI 10.1084/jem.178.6.2201; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BOEHM T, 1995, IMMUNOL TODAY, V16, P555, DOI 10.1016/0167-5699(95)80074-3; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; DADAMIO L, 1992, J IMMUNOL, V149, P3550; deWit TFR, 1996, INT IMMUNOL, V8, P1787; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1994, J IMMUNOL, V152, P4783; HAAS W, 1992, CURR OPIN IMMUNOL, V4, P147, DOI 10.1016/0952-7915(92)90004-X; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; IZON DJ, 1994, INT IMMUNOL, V6, P31, DOI 10.1093/intimm/6.1.31; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KINGSTON R, 1984, EUR J IMMUNOL, V14, P1052, DOI 10.1002/eji.1830141117; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; LEENEN PJM, 1990, EUR J IMMUNOL, V20, P27, DOI 10.1002/eji.1830200105; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; MALISSEN M, 1995, EMBO J, V14, P4841; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; MUEGGE K, 1993, SCIENCE, V261, P93, DOI 10.1126/science.7686307; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RAMSDELL F, 1992, CURRENT PROTOCOLS IM, P1; RITTER MA, 1993, IMMUNOL TODAY, V14, P482; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WATSON JD, 1989, J IMMUNOL, V143, P1215; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	63	95	96	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					351	360		10.1016/S1074-7613(00)80337-4	http://dx.doi.org/10.1016/S1074-7613(00)80337-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075935	Bronze			2022-12-18	WOS:A1997XC61800014
J	Spanopoulou, E; Cortes, P; Shih, C; Huang, CM; Silver, DP; Svec, P; Baltimore, D				Spanopoulou, E; Cortes, P; Shih, C; Huang, CM; Silver, DP; Svec, P; Baltimore, D			Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2	IMMUNITY			English	Article							NUCLEAR TARGETING SEQUENCES; RAY SENSITIVE MUTANTS; STRAND BREAK REPAIR; NUCLEOLAR LOCALIZATION; EXPRESSION VECTOR; SCID MUTATION; DNA-REPAIR; VIRAL-RNA; MICE; LYMPHOCYTES	The RAG1 and RAGS gene products are indispensable for activating somatic rearrangement of antigen receptor gene segments. The two proteins form a stable complex in primary thymocytes as well as when expressed in adherent cells. In both cell types, most cells localize RAG proteins at the periphery of the nucleus. However, when overexpressed in fibroblast cells, RAG1 is found largely in the nucleolus. Nucleolar localization of RAG1 is mediated by several domains containing stretches of basic amino acids, indicating that RAG1 has affinity for RNA or ssDNA. The RAG1 interacting proteins SRP1 and Rch1 directly bind to the nuclear localization signals of RAG1, which mediate the nuclear and nucleolar translocation of the protein. RAG1 appears to have a binary structure, each half containing multiple regions that can act as NLSs, binding sites for the SRP1/Rch1 family, and RNA binding domains.	ROCKEFELLER UNIV,NEW YORK,NY 10021; MIT,CAMBRIDGE,MA 02139; PHARMINGEN,SAN DIEGO,CA 92121	Rockefeller University; Massachusetts Institute of Technology (MIT)			Silver, Daniel/P-3443-2019		NCI NIH HHS [CA54162] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI Y, 1994, EMBO J, V13, P4153, DOI 10.1002/j.1460-2075.1994.tb06733.x; ADAM SA, 1995, TRENDS CELL BIOL, V5, P189, DOI 10.1016/S0962-8924(00)88991-6; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BONVEN BJ, 1985, CELL, V41, P541, DOI 10.1016/S0092-8674(85)80027-1; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; FERGUSON SE, 1994, MOL CELL BIOL, V14, P7298, DOI 10.1128/MCB.14.11.7298; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; FRIEDBERG EC, 1992, TRENDS BIOCHEM SCI, V17, P347, DOI 10.1016/0968-0004(92)90312-W; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOLDBERG IH, 1971, ANNU REV BIOCHEM, V40, P775, DOI 10.1146/annurev.bi.40.070171.004015; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HIGASHIURA M, 1992, EXP CELL RES, V201, P444, DOI 10.1016/0014-4827(92)90293-H; HSU T, 1993, P NATL ACAD SCI USA, V90, P6488, DOI 10.1073/pnas.90.14.6488; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; JONG AYS, 1987, MOL CELL BIOL, V7, P2947, DOI 10.1128/MCB.7.8.2947; KALLAND KH, 1994, J VIROL, V68, P1475, DOI 10.1128/JVI.68.3.1475-1485.1994; KEMP LM, 1984, MUTAT RES, V132, P189, DOI 10.1016/0167-8817(84)90037-3; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; MEIER UT, 1992, CELL, V70, P127; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; PERRY RP, 1962, P NATL ACAD SCI USA, V48, P2179, DOI 10.1073/pnas.48.12.2179; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; RUBEN S, 1989, J VIROL, V63, P1; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHIRAKATA M, 1991, MOL CELL BIOL, V11, P4528, DOI 10.1128/MCB.11.9.4528; SILVER DP, 1992, THESIS MIT CAMBRIDGE; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6110; SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANGENT DC, 1995, CELL, V81, P825; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	74	95	95	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					715	726		10.1016/1074-7613(95)90061-6	http://dx.doi.org/10.1016/1074-7613(95)90061-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777717	Bronze			2022-12-18	WOS:A1995TM02300006
J	Li, XV; Leonardi, I; Iliev, ID				Li, Xin V.; Leonardi, Irina; Iliev, Iliyan D.			Gut Mycobiota in Immunity and Inflammatory Disease	IMMUNITY			English	Review							REGULATORY T-CELLS; ANTI-SACCHAROMYCES-CEREVISIAE; ARYL-HYDROCARBON RECEPTOR; CANDIDA-ALBICANS MORPHOGENESIS; COMMENSAL FUNGI; INTESTINAL MICROBIOME; RESPIRATORY-TRACT; ANTIBODIES ASCA; CROHNS-DISEASE; HOST	The mammalian intestine is colonized by a wealth of microorganisms-including bacteria, viruses, protozoa, and fungi-that are all integrated into a functional trans-kingdom community. Characterization of the composition of the fungal community-the mycobiota-has advanced further than the much-needed mechanistic studies. Recent findings have revealed roles for the gut mycobiota in the regulation of host immunity and in the development and progression of human diseases of inflammatory origin. We review these findings here while placing them in the context of the current understanding of the pathways and cellular networks that induce local and systemic immune responses to fungi in the gastrointestinal tract. We discuss gaps in knowledge and argue for the importance of considering bacteria-fungal interactions as we aim to define the roles of mycobiota in immune homeostasis and immune-associated pathologies.	[Li, Xin V.; Leonardi, Irina; Iliev, Iliyan D.] Cornell Univ, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Li, Xin V.; Leonardi, Irina; Iliev, Iliyan D.] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Iliev, Iliyan D.] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA; [Iliev, Iliyan D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, Weill Cornell Med, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Iliev, ID (corresponding author), Cornell Univ, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Iliev, ID (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.; Iliev, ID (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA.; Iliev, ID (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, Weill Cornell Med, New York, NY 10065 USA.	iliev@med.cornell.edu	Leonardi, Irina/AAW-7480-2020; Li, Xin V./ABA-4321-2021; Li, Xin/AAH-2983-2019	Leonardi, Irina/0000-0002-0369-7371; Li, Xin V./0000-0002-9444-8214; 	US National Institutes of Health [DK113136, AI137157, AI146957]; Crohn's and Colitis Foundation Senior Research Award; Kenneth Rainin Foundation; Irma T. Hirschl Career Scientist awards; Crohn's and Colitis Foundation research fellowship; Jill Roberts Institute for Research in IBD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI146957, R56AI137157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113136] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation Senior Research Award; Kenneth Rainin Foundation; Irma T. Hirschl Career Scientist awards; Crohn's and Colitis Foundation research fellowship; Jill Roberts Institute for Research in IBD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Iliev laboratory and members of the New York Host-Mycobiota group for helpful discussions and suggestions. This work was funded by the US National Institutes of Health (grants DK113136, AI137157, and AI146957), a Crohn's and Colitis Foundation Senior Research Award, Kenneth Rainin Foundation and Irma T. Hirschl Career Scientist awards to I.D.I., a Crohn's and Colitis Foundation research fellowship to I.L., and the Jill Roberts Institute for Research in IBD.	Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Allaire JM, 2018, TRENDS IMMUNOL, V39, P677, DOI 10.1016/j.it.2018.04.002; Allert S, 2018, MBIO, V9, DOI 10.1128/mBio.00915-18; [Anonymous], [No title captured]; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Auchtung TA, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00092-18, 10.1128/msphere.00092-18]; Bacher P, 2014, MUCOSAL IMMUNOL, V7, P916, DOI 10.1038/mi.2013.107; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bandara HMHN, 2009, J MED MICROBIOL, V58, P1623, DOI 10.1099/jmm.0.012989-0; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bulgasem BY, 2016, MYCOBIOLOGY, V44, P302, DOI 10.5941/MYCO.2016.44.4.302; Cai WF, 2017, BEST PRACT RES CL GA, V31, P669, DOI 10.1016/j.bpg.2017.09.013; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chehoud C, 2015, INFLAMM BOWEL DIS, V21, P1948, DOI 10.1097/MIB.0000000000000454; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chiaro TR, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9044; Collar AL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95417; Conti HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/jimmunol.1500909; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; De Luca A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003486; Doron I, 2019, FUNGAL GENET BIOL, V127, P45, DOI 10.1016/j.fgb.2019.03.001; EISEMAN B, 1958, SURGERY, V44, P854; El-Azizi MA, 2004, J APPL MICROBIOL, V96, P1067, DOI 10.1111/j.1365-2672.2004.02213.x; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Ene LV, 2018, P NATL ACAD SCI USA, V115, pE8688, DOI 10.1073/pnas.1806002115; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Fan D, 2015, NAT MED, V21, P808, DOI 10.1038/nm.3871; Fanucchi S, 2019, NAT GENET, V51, P138, DOI 10.1038/s41588-018-0298-2; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gunsalus KTW, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00020-15; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hoarau G, 2016, MBIO, V7, DOI [10.1128/mBio.01250-16, 10.1128/mbio.01250-16]; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Iliev ID, 2015, CELL HOST MICROBE, V18, P139, DOI 10.1016/j.chom.2015.07.010; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Iwanaga N, 2019, IMMUNOLOGY, V156, P3, DOI 10.1111/imm.13006; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Kim SH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005308; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Krohn S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197319; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Lewis JD, 2017, GASTROENTEROLOGY, V152, P398, DOI 10.1053/j.gastro.2016.10.019; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Li X, 2018, CELL HOST MICROBE, V24, P847, DOI 10.1016/j.chom.2018.11.003; Liguori G, 2016, J CROHNS COLITIS, V10, P296, DOI 10.1093/ecco-jcc/jjv209; Limon JJ, 2019, CELL HOST MICROBE, V25, P377, DOI 10.1016/j.chom.2019.01.007; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Lionakis MS, 2018, ANNU REV IMMUNOL, V36, P157, DOI 10.1146/annurev-immunol-042617-053318; Lionakis MS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93156; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Nguyen LN, 2011, J ANTIMICROB CHEMOTH, V66, P2573, DOI 10.1093/jac/dkr358; Mar JS, 2016, MBIO, V7, DOI 10.1128/mBio.01072-16; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Maraki S, 1999, J CHEMOTHERAPY, V11, P363, DOI 10.1179/joc.1999.11.5.363; Martinez-Lopez M, 2019, IMMUNITY, V50, P446, DOI 10.1016/j.immuni.2018.12.020; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McAleer JP, 2016, J IMMUNOL, V197, P97, DOI 10.4049/jimmunol.1502566; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Morita N, 2019, NATURE, V566, P110, DOI 10.1038/s41586-019-0884-1; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188; Muratori P, 2003, CLIN EXP IMMUNOL, V132, P473, DOI 10.1046/j.1365-2249.2003.02166.x; Muthig M, 2010, MED MYCOL, V48, P56, DOI 10.3109/13693780802716532; Naglik JR, 2017, CURR OPIN MICROBIOL, V40, P104, DOI 10.1016/j.mib.2017.10.030; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Panpetch W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210798; Papp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012957; Paramsothy S, 2019, GASTROENTEROLOGY, V156, P1440, DOI 10.1053/j.gastro.2018.12.001; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Peng XG, 2015, J IMMUNOL, V195, P2797, DOI 10.4049/jimmunol.1403209; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10416; Raponi G, 2014, CLIN INFECT DIS, V59, P1648, DOI 10.1093/cid/ciu637; Richard ML, 2019, NAT REV GASTRO HEPAT, V16, P331, DOI 10.1038/s41575-019-0121-2; Richardson JP, 2018, J FUNGI, V4, DOI 10.3390/jof4010022; Richardson JP, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00645-17; Rizzetto L, 2016, J BIOL CHEM, V291, P7961, DOI 10.1074/jbc.M115.699645; Roman E, 2018, FUTURE MICROBIOL, V13, P857, DOI 10.2217/fmb-2018-0012; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salazar F, 2018, J INNATE IMMUN, V10, P373, DOI 10.1159/000488539; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; Schaffer T, 2007, INFLAMM BOWEL DIS, V13, P1339, DOI 10.1002/ibd.20228; Sendid B, 2018, VIRULENCE, V9, P1224, DOI 10.1080/21505594.2018.1496779; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Skalski JH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007260; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Sovran B, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0538-9; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Standaert-Vitse A, 2009, AM J GASTROENTEROL, V104, P1745, DOI 10.1038/ajg.2009.225; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Suhr MJ, 2016, LETT APPL MICROBIOL, V62, P209, DOI 10.1111/lam.12539; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Tipton L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0393-0; Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537; van Leeuwen PT, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00187-16; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; VARGAS SL, 1993, INFECT IMMUN, V61, P619, DOI 10.1128/IAI.61.2.619-626.1993; Verma AH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8834; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; Wang TT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005662; Wang YH, 2018, NAT MED, V24, P1804, DOI 10.1038/s41591-018-0238-9; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Whibley N, 2014, EUR J IMMUNOL, V44, P1069, DOI 10.1002/eji.201343604; Witchley JN, 2019, CELL HOST MICROBE, V25, P432, DOI 10.1016/j.chom.2019.02.008; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041; Zuo T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06103-6	157	94	102	6	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1365	1379		10.1016/j.immuni.2019.05.023	http://dx.doi.org/10.1016/j.immuni.2019.05.023			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216461	Green Accepted, Bronze			2022-12-18	WOS:000471876100009
J	Yudanin, NA; Schmitz, F; Flamar, AL; Thome, JJC; Wojno, ET; Moeller, JB; Schirmer, M; Latorre, IJ; Xavier, RJ; Farber, DL; Monticelli, LA; Artis, D				Yudanin, Naomi A.; Schmitz, Frederike; Flamar, Anne-Laure; Thome, Joseph J. C.; Wojno, Elia Tait; Moeller, Jesper B.; Schirmer, Melanie; Latorre, Isabel J.; Xavier, Ramnik J.; Farber, Donna L.; Monticelli, Laurel A.; Artis, David			Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity	IMMUNITY			English	Article							INDUCER-LIKE CELLS; EXPRESSION; INFLAMMATION; HOMEOSTASIS; PRECURSORS; DIVERSITY; CYTOKINES; IMMUNITY; PROGRAM; CRTH2	Innate lymphoid cells (ILC) play critical roles in regulating immunity, inflammation, and tissue homeostasis in mice. However, limited access to non-diseased human tissues has hindered efforts to profile anatomically-distinct ILCs in humans. Through flow cytometric and transcriptional analyses of lymphoid, mucosal, and metabolic tissues from previously healthy human organ donors, here we have provided a map of human ILC heterogeneity across multiple anatomical sites. In contrast to mice, human ILCs are less strictly compartmentalized and tissue localization selectively impacts ILC distribution in a sub-set-dependent manner. Tissue-specific distinctions are particularly apparent for ILC1 populations, whose distribution was markedly altered in obesity or aging. Furthermore, the degree of ILC1 population heterogeneity differed substantially in lymphoid versus mucosal sites. Together, these analyses comprise a comprehensive characterization of the spatial and temporal dynamics regulating the anatomical distribution, subset heterogeneity, and functional potential of ILCs in non-diseased human tissues.	[Yudanin, Naomi A.; Schmitz, Frederike; Flamar, Anne-Laure; Wojno, Elia Tait; Moeller, Jesper B.; Monticelli, Laurel A.; Artis, David] Weill Cornell Med, Joan & Stanford I Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Thome, Joseph J. C.; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, Dept Surg, New York, NY 10032 USA; [Thome, Joseph J. C.; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Wojno, Elia Tait] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Baker Inst Anim Hlth, Ithaca, NY 14850 USA; [Schirmer, Melanie] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Schirmer, Melanie; Latorre, Isabel J.; Xavier, Ramnik J.] Broad Inst & MIT Harvard, Cambridge, MA USA; [Latorre, Isabel J.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Monticelli, Laurel A.] Cornell Univ, Weill Cornell Med, Div Pulm & Crit Care Med, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA	Cornell University; Columbia University; Columbia University; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Cornell University	Monticelli, LA; Artis, D (corresponding author), Weill Cornell Med, Joan & Stanford I Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.; Monticelli, LA (corresponding author), Cornell Univ, Weill Cornell Med, Div Pulm & Crit Care Med, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA.	lam2031@med.cornell.edu; dartis@med.cornell.edu	Schirmer, Melanie/HDN-5528-2022; Moeller, Jesper B/E-6377-2015; Yudanin, Naomi/U-2757-2019	Moeller, Jesper B/0000-0001-8786-8037; Yudanin, Naomi/0000-0002-5019-2851; Tait Wojno, Elia/0000-0003-2822-296X; Farber, Donna/0000-0001-8236-9183; Artis, David/0000-0002-1753-4100; Schmitz, Frederike/0000-0003-2303-9517; Latorre, Isabel/0000-0003-0638-1783; Schirmer, Melanie/0000-0001-6456-3679	National Institutes of Health [NIH P01AI06697, AI074878, AI095466, AI095608, AI102942, F32 DK109630, F32 AI134018-01]; NIAID Mucosal Immunology Studies Team (MIST); Burroughs Wellcome Fund; Crohn's & Colitis Foundation of America; Weill Cornell Medicine Pre-Career Award; Novo Nordic Foundation [14052]; Leona M. and Harry B. Helmsley Charitable Trust [2014PG-IBD016]; Cure for IBD; NIAID [K22 AI116729]; Rosanne H. Silberman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102942, P01AI106697, R01AI095466, R01AI074878, F32AI134018, R01AI130379, U01AI095608, K22AI116729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Mucosal Immunology Studies Team (MIST); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation of America; Weill Cornell Medicine Pre-Career Award; Novo Nordic Foundation(Novo Nordisk Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Cure for IBD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rosanne H. Silberman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge the generosity of the donor families and the outstanding efforts of Harvey Lerner, Dr. Amy Friedman, and the LiveOnNY staff for making this study possible. We also wish to thank members of the D. Artis and G.F. Sonnenberg laboratories for critical reading of this manuscript. This work was supported by the National Institutes of Health NIH P01AI06697 (D.L.F. and D.A.), AI074878, AI095466, AI095608, and AI102942 (D.A.), F32 DK109630 (N.A.Y.), F32 AI134018-01 (L.A.M.), and the NIAID Mucosal Immunology Studies Team (MIST) (L.A.M. and D.A.). Additional support provided by the Burroughs Wellcome Fund (D.A.), Crohn's & Colitis Foundation of America (D.A.), the Weill Cornell Medicine Pre-Career Award (L.A.M.), the Novo Nordic Foundation (14052; J.B.M.), the Leona M. and Harry B. Helmsley Charitable Trust (2014PG-IBD016, I.J.L.), Cure for IBD (D.A.) the NIAID (K22 AI116729 to E.T.W.), and the Rosanne H. Silberman Foundation (D.A.).	Almeida FF, 2016, MUCOSAL IMMUNOL, V9, P1103, DOI 10.1038/mi.2016.64; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cortez V. S., 2017, NAT IMMUNOL; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Diefenbach A, 2015, NAT IMMUNOL, V16, P222, DOI 10.1038/ni.3107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Forkel M., 2016, HETEROGENEITY HUMAN; Forkel M, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0652-3; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Izuhara K, 2017, ALLERGOL INT, V66, P367, DOI 10.1016/j.alit.2017.06.007; Kim CH, 2016, TRENDS IMMUNOL, V37, P68, DOI 10.1016/j.it.2015.11.003; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kramer B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006373; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Li N, 2018, J EXP MED, V215, P1383, DOI 10.1084/jem.20171934; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund SJ, 2017, J IMMUNOL, V199, P1096, DOI 10.4049/jimmunol.1601569; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Montaldo E, 2016, IMMUNOL LETT, V179, P2, DOI 10.1016/j.imlet.2016.01.007; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2011, CELL MOL LIFE SCI, V68, P3541, DOI 10.1007/s00018-011-0803-6; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Sullivan TE, 2017, J MOL BIOL, V429, P3577, DOI 10.1016/j.jmb.2017.08.014; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Saetang J, 2018, MOL MED REP, V17, P1403, DOI 10.3892/mmr.2017.8038; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schuijs MJ, 2018, ANN NY ACAD SCI, V1417, P87, DOI 10.1111/nyas.13604; Simoni Y, 2018, IMMUNOLOGY, V153, P297, DOI 10.1111/imm.12862; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Sonnenberg Gregory F, 2013, Immunity, V39, P622, DOI 10.1016/j.immuni.2013.08.021; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Stehle C, 2016, NAT IMMUNOL, V17, P43, DOI 10.1038/ni.3353; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zhou L, 2012, IMMUNITY, V37, P589, DOI 10.1016/j.immuni.2012.10.002	70	94	95	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					505	+		10.1016/j.immuni.2019.01.012	http://dx.doi.org/10.1016/j.immuni.2019.01.012			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30770247	Bronze, Green Accepted			2022-12-18	WOS:000459006700022
J	Grizotte-Lake, M; Zhong, G; Duncan, K; Kirkwood, J; Iyer, N; Smolenski, I; Isoherranen, N; Vaishnava, S				Grizotte-Lake, Mayara; Zhong, Guo; Duncan, Kellyanne; Kirkwood, Jay; Iyer, Namrata; Smolenski, Irina; Isoherranen, Nina; Vaishnava, Shipra			Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; GUT DENDRITIC CELLS; VITAMIN-A; ANTIMICROBIAL PEPTIDES; T-CELLS; HOST; IL-22; RECEPTOR; INFLAMMATION; HOMEOSTASIS	Retinoic acid (RA), a vitamin A metabolite, regulates transcriptional programs that drive protective or pathogenic immune responses in the intestine, in a manner dependent on RA concentration. Vitamin A is obtained from diet and is metabolized by intestinal epithelial cells (IECs), which operate in intimate association with microbes and immune cells. Here we found that commensal bacteria belonging to class Clostridia modulate RA concentration in the gut by suppressing the expression of retinol dehydrogenase 7 (Rdh7) in IECs. Rdh7 expression and associated RA amounts were lower in the intestinal tissue of conventional mice, as compared to germ-free mice. Deletion of Rdh7 in IECs diminished RA signaling in immune cells, reduced the IL-22-dependent antimicrobial response, and enhanced resistance to colonization by Salmonella Typhimurium. Our findings define a regulatory circuit wherein bacterial regulation of IEC-intrinsic RA synthesis protects microbial communities in the gut from excessive immune activity, achieving a balance that prevents colonization by enteric pathogens.	[Grizotte-Lake, Mayara; Duncan, Kellyanne; Iyer, Namrata; Smolenski, Irina; Vaishnava, Shipra] Brown Univ, Mol Microbiol & Immunol, Providence, RI 02912 USA; [Zhong, Guo; Kirkwood, Jay; Isoherranen, Nina] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	Brown University; University of Washington; University of Washington Seattle	Vaishnava, S (corresponding author), Brown Univ, Mol Microbiol & Immunol, Providence, RI 02912 USA.	shipra_vaishnava@brown.edu	Iyer, Namrata/GQO-7833-2022	Zhong, Guo/0000-0002-6056-9472; Iyer, Namrata/0000-0002-5263-7092	NIH [P20GM10903, 1R01DK113265, GM111772]; CCFA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111772, P20GM109035] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sohini Mukherjee and Felix Yarovinsky for their intellectual input. We thank Lora Hooper for providing anti-Reg3g antibody and UT Southwestern mouse transgenic core for help in developing Rdh7<SUP>fl/fl</SUP> mouse models. We thank Kevin Carlson for flow cytometry analysis. This work was supported by NIH (P20GM10903 and 1R01DK113265 to S.V. and GM111772 to N. Isoherranen) and CCFA career development award to S.V.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Belzer C, 2011, EUR J MICROBIOL IMMU, V1, P311, DOI 10.1556/EuJMI.1.2011.4.7; Bhattacharya N, 2016, IMMUNITY, V45, P641, DOI 10.1016/j.immuni.2016.08.008; Callahan B, 2016, BIOCOMPUT-PAC SYM, P183; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chelstowska S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110676; Costa MM, 2013, DEV COMP IMMUNOL, V41, P746, DOI 10.1016/j.dci.2013.08.021; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Erkelens MN, 2017, TRENDS IMMUNOL, V38, P168, DOI 10.1016/j.it.2016.12.006; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fransen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072739; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Goverse G, 2016, J IMMUNOL, V196, P5148, DOI 10.4049/jimmunol.1501106; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Ho S, 2013, CURR PHARM DESIGN, V19, P40; Hong K, 2014, IMMUNOL LETT, V162, P34, DOI 10.1016/j.imlet.2014.06.011; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hurst RJM, 2013, PARASITE IMMUNOL, V35, P229, DOI 10.1111/pim.12032; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Jason J, 2002, CLIN DIAGN LAB IMMUN, V9, P616, DOI 10.1128/CDLI.9.3.616-621.2002; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lampen A, 2000, J PHARMACOL EXP THER, V295, P979; Larange A, 2016, ANNU REV IMMUNOL, V34, P369, DOI 10.1146/annurev-immunol-041015-055427; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magnusson MK, 2016, MUCOSAL IMMUNOL, V9, P171, DOI 10.1038/mi.2015.48; McDonald KG, 2012, AM J PATHOL, V180, P984, DOI 10.1016/j.ajpath.2011.11.009; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Miki T, 2017, CELL HOST MICROBE, V21, P195, DOI 10.1016/j.chom.2016.12.008; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mullin GE, 2011, NUTR CLIN PRACT, V26, P495, DOI 10.1177/0884533611411583; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sirisinha S, 2015, ASIAN PAC J ALLERGY, V33, P71; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Tomita K, 2000, GENE, V251, P175, DOI 10.1016/S0378-1119(00)00194-3; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Velazquez EM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2296; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Yi FM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/710915; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	74	94	94	4	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1103	+		10.1016/j.immuni.2018.11.018	http://dx.doi.org/10.1016/j.immuni.2018.11.018			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566883	Bronze, Green Accepted			2022-12-18	WOS:000453556500015
J	Bhattacharya, N; Yuan, R; Prestwood, TR; Penny, HL; DiMaio, MA; Reticker-Flynn, NE; Krois, CR; Kenkel, JA; Pham, TD; Carmi, Y; Tolentino, L; Choi, O; Hulett, R; Wang, J; Winer, DA; Napoli, JL; Engleman, EG				Bhattacharya, Nupur; Yuan, Robert; Prestwood, Tyler R.; Penny, Hweixian Leong; DiMaio, Michael A.; Reticker-Flynn, Nathan E.; Krois, Charles R.; Kenkel, Justin A.; Pham, Tho D.; Carmi, Yaron; Tolentino, Lorna; Choi, Okmi; Hulett, Reyna; Wang, Jinshan; Winer, Daniel A.; Napoli, Joseph L.; Engleman, Edgar G.			Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer	IMMUNITY			English	Article							INTESTINAL INFLAMMATION; COLON-CANCER; ULCERATIVE-COLITIS; VITAMIN-A; IN-VIVO; DIFFERENTIATION; EXPRESSION; SURVIVAL; GROWTH; BIOSYNTHESIS	Although all-trans-retinoic acid (atRA) is a key regulator of intestinal immunity, its role in colorectal cancer (CRC) is unknown. We found that mice with colitis-associated CRC had a marked deficiency in colonic atRA due to alterations in atRA metabolism mediated by microbiota-induced intestinal inflammation. Human ulcerative colitis (UC), UC-associated CRC, and sporadic CRC specimens have similar alterations in atRA metabolic enzymes, consistent with reduced colonic atRA. Inhibition of atRA signaling promoted tumorigenesis, whereas atRA supplementation reduced tumor burden. The benefit of atRA treatment was mediated by cytotoxic CD8(+) T cells, which were activated due to MHCI upregulation on tumor cells. Consistent with these findings, increased colonic expression of the atRA-catabolizing enzyme, CYP26A1, correlated with reduced frequencies of tumoral cytotoxic CD8(+) T cells and with worse disease prognosis in human CRC. These results reveal a mechanism by which microbiota drive colon carcinogenesis and highlight atRA metabolism as a therapeutic target for CRC.	[Bhattacharya, Nupur; Yuan, Robert; Prestwood, Tyler R.; Penny, Hweixian Leong; Reticker-Flynn, Nathan E.; Kenkel, Justin A.; Pham, Tho D.; Carmi, Yaron; Tolentino, Lorna; Choi, Okmi; Hulett, Reyna; Engleman, Edgar G.] Stanford Univ, Sch Med, Dept Pathol, Ctr Blood, 3373 Hillview Ave, Palo Alto, CA 94304 USA; [Prestwood, Tyler R.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA; [DiMaio, Michael A.] Stanford Univ, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA; [Krois, Charles R.; Wang, Jinshan; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA; [Winer, Daniel A.] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2N2, Canada; [Winer, Daniel A.] Univ Toronto, Dept Lab Med, Toronto, ON M5G 2N2, Canada; [Winer, Daniel A.] Univ Toronto, Dept Pathobiol, Toronto, ON M5G 2N2, Canada; [Winer, Daniel A.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2N2, Canada	Stanford University; Stanford University; Stanford University; University of California System; University of California Berkeley; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Bhattacharya, N; Engleman, EG (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Ctr Blood, 3373 Hillview Ave, Palo Alto, CA 94304 USA.	nupur26@stanford.edu; edgareng@stanford.edu	Reticker-Flynn, Nathan/R-7226-2019	Reticker-Flynn, Nathan/0000-0002-9963-039X	NIH [5 U01 CA141468, 1 R01 CA163441]; NIH NRSA [F30CA196145, F32CA189408]; NATIONAL CANCER INSTITUTE [F32CA189408, R01CA163441, U01CA141468, F30CA196145, R01CA196657, U54CA209971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Professor Robert West for providing us with colon cancer specimens. We thank Raghav Kumar for technical assistance, Nancy Wu for flow cytometry assistance, and Philip Engleman and Shawn Winer for help with the pathological diagnoses of histology slides. We also wish to thank Matt Spitzer and Ian Linde for critical review of the manuscript. This work was supported by NIH grants 5 U01 CA141468 and 1 R01 CA163441. T.R.P. is supported by NIH NRSA F30CA196145. N.E.R.-F. is supported by NIH NRSA F32CA189408.	Allie SR, 2013, J IMMUNOL, V190, P2178, DOI 10.4049/jimmunol.1201945; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Bengtsson AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-336; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Biondi A, 2012, WORLD J GASTROENTERO, V18, P1861, DOI 10.3748/wjg.v18.i16.1861; Brown GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090776; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Germain P, 2009, CHEM BIOL, V16, P479, DOI 10.1016/j.chembiol.2009.03.008; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guo YX, 2014, J IMMUNOL, V192, P3336, DOI 10.4049/jimmunol.1301949; Guo YX, 2012, CANCER RES, V72, P5230, DOI 10.1158/0008-5472.CAN-12-1727; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Jansa P, 1996, NUCLEIC ACIDS RES, V24, P694, DOI 10.1093/nar/24.4.694; Jimenez-Lara AM, 2004, TRENDS MOL MED, V10, P508, DOI 10.1016/j.molmed.2004.08.006; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Koelzer VH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-81; Kropotova ES, 2014, PATHOL ONCOL RES, V20, P707, DOI 10.1007/s12253-014-9751-4; Lee MO, 2000, BIOCHEM PHARMACOL, V59, P485, DOI 10.1016/S0006-2952(99)00355-X; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; NAGATA T, 1992, P NATL ACAD SCI USA, V89, P937, DOI 10.1073/pnas.89.3.937; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Simpson JAD, 2010, GUT, V59, P926, DOI 10.1136/gut.2009.194472; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; VANWAUWE JP, 1990, J PHARMACOL EXP THER, V252, P365; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13	46	94	95	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					641	655		10.1016/j.immuni.2016.08.008	http://dx.doi.org/10.1016/j.immuni.2016.08.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27590114	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000388454300019
J	Scharping, NE; Menk, AV; Moreci, RS; Whetstone, RD; Dadey, RE; Watkins, SC; Ferris, RL; Delgoffe, GM				Scharping, Nicole E.; Menk, Ashley V.; Moreci, Rebecca S.; Whetstone, Ryan D.; Dadey, Rebekah E.; Watkins, Simon C.; Ferris, Robert L.; Delgoffe, Greg M.			The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction (vol 45, pg 374, 2016)	IMMUNITY			English	Correction												gdelgoffe@pitt.edu	Watkins, Simon/ABG-2590-2021; Delgoffe, Greg M./HCH-2805-2022	Watkins, Simon/0000-0003-4092-1552; Delgoffe, Greg M./0000-0002-2957-8135					0	94	95	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					701	703		10.1016/j.immuni.2016.08.009	http://dx.doi.org/10.1016/j.immuni.2016.08.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD		Bronze			2022-12-18	WOS:000388454300023
J	Sok, D; Pauthner, M; Briney, B; Lee, JH; Saye-Francisco, KL; Hsueh, J; Ramos, A; Le, KM; Jones, M; Jardine, JG; Bastidas, R; Sarkar, A; Liang, CH; Shivatare, SS; Wu, CY; Schief, WR; Wong, CH; Wilson, IA; Ward, AB; Zhu, J; Poignard, P; Burton, DR				Sok, Devin; Pauthner, Matthias; Briney, Bryan; Lee, Jeong Hyun; Saye-Francisco, Karen L.; Hsueh, Jessica; Ramos, Alejandra; Le, Khoa M.; Jones, Meaghan; Jardine, Joseph G.; Bastidas, Raiza; Sarkar, Anita; Liang, Chi-Hui; Shivatare, Sachin S.; Wu, Chung-Yi; Schief, William R.; Wong, Chi-Huey; Wilson, Ian A.; Ward, Andrew B.; Zhu, Jiang; Poignard, Pascal; Burton, Dennis R.			A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; HEPATITIS-C VIRUS; HUMAN MONOCLONAL-ANTIBODIES; CRYO-EM STRUCTURE; GP41-GP120 INTERFACE; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; VACCINE DESIGN; POTENT	The dense patch of high-mannose-type glycans surrounding the N332 glycan on the HIV envelope glycoprotein (Env) is targeted by multiple broadly neutralizing antibodies (bnAbs). This region is relatively conserved, implying functional importance, the origins of which are not well understood. Here we describe the isolation of new bnAbs targeting this region. Examination of these and previously described antibodies to Env revealed that four different bnAb families targeted the (324)GDIR(327) peptide stretch at the base of the gp120 V3 loop and its nearby glycans. We found that this peptide stretch constitutes part of the CCR5 co-receptor binding site, with the high-mannose patch glycans serving to camouflage it from most antibodies. GDIR-glycan bnAbs, in contrast, bound both (324)GDIR(327) peptide residues and high-mannose patch glycans, which enabled broad reactivity against diverse HIV isolates. Thus, as for the CD4 binding site, bnAb effectiveness relies on circumventing the defenses of a critical functional region on Env.	[Sok, Devin; Pauthner, Matthias; Briney, Bryan; Saye-Francisco, Karen L.; Hsueh, Jessica; Ramos, Alejandra; Le, Khoa M.; Jones, Meaghan; Jardine, Joseph G.; Bastidas, Raiza; Liang, Chi-Hui; Schief, William R.; Zhu, Jiang; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sok, Devin; Pauthner, Matthias; Briney, Bryan; Lee, Jeong Hyun; Saye-Francisco, Karen L.; Hsueh, Jessica; Ramos, Alejandra; Le, Khoa M.; Jones, Meaghan; Jardine, Joseph G.; Bastidas, Raiza; Sarkar, Anita; Liang, Chi-Hui; Schief, William R.; Wilson, Ian A.; Ward, Andrew B.; Zhu, Jiang; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Sok, Devin; Pauthner, Matthias; Briney, Bryan; Lee, Jeong Hyun; Saye-Francisco, Karen L.; Hsueh, Jessica; Ramos, Alejandra; Le, Khoa M.; Jones, Meaghan; Jardine, Joseph G.; Bastidas, Raiza; Sarkar, Anita; Liang, Chi-Hui; Schief, William R.; Wilson, Ian A.; Ward, Andrew B.; Zhu, Jiang; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Sok, Devin; Pauthner, Matthias; Briney, Bryan; Lee, Jeong Hyun; Saye-Francisco, Karen L.; Hsueh, Jessica; Ramos, Alejandra; Le, Khoa M.; Jones, Meaghan; Jardine, Joseph G.; Bastidas, Raiza; Sarkar, Anita; Liang, Chi-Hui; Schief, William R.; Wilson, Ian A.; Ward, Andrew B.; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Sok, Devin; Ramos, Alejandra; Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Shivatare, Sachin S.; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Lee, Jeong Hyun; Sarkar, Anita; Wilson, Ian A.; Ward, Andrew B.; Zhu, Jiang] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Schief, William R.; Burton, Dennis R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Schief, William R.; Burton, Dennis R.] Harvard Univ, Cambridge, MA 02139 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Academia Sinica - Taiwan; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA.; Burton, DR (corresponding author), Harvard Univ, Cambridge, MA 02139 USA.	burton@scripps.edu	Schief, William/ABF-3645-2020; poignard, pascal/AAB-4613-2020; Ward, Andrew/ABD-7728-2021; Wu, Chung-Yi/K-8334-2018; Shivatare, Sachin S/G-7264-2017; Ward, Andrew B/F-9203-2014; poignard, pascal/N-6678-2013	Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Shivatare, Sachin S/0000-0002-7512-752X; Ward, Andrew B/0000-0001-7153-3769; Pauthner, Matthias G./0000-0001-9212-4307; Poignard, Pascal/0000-0002-0021-7192; Sarkar, Anita/0000-0001-5602-8406; Lee, Jeong Hyun/0000-0001-7371-845X	International AIDS Vaccine Initiative Neutralizing Antibody Consortium through Collaboration for AIDS Vaccine Discovery grant [OPP1084519]; NIH [R01 AI033292]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant [UM1AI100663]; California HIV/AIDS Research Program Basic Biomedical Sciences Training Award [D13-SRI-391]; James and Jessie Minor Chair in Immunology; IAVI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, UM1AI100663, R01AI033292, R37AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Consortium through Collaboration for AIDS Vaccine Discovery grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant; California HIV/AIDS Research Program Basic Biomedical Sciences Training Award; James and Jessie Minor Chair in Immunology; IAVI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The CCR5 N-terminal peptide Fc constructs were kindly provided by Michael Farzan. This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grant OPP1084519 (D.R.B., I.A.W., A.B.W.), NIH grants R01 AI033292 (D.R.B.), and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 (D.R.B., I.A.W., A.B.W.). Funding was also provided by the California HIV/AIDS Research Program Basic Biomedical Sciences Training Award D13-SRI-391 (M.P.). D.R.B. acknowledges the support of the James and Jessie Minor Chair in Immunology. This work was funded in part by IAVI and made possible by the support of many donors, including: the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. The contents of this manuscript are the responsibility of IAVI and do not necessarily reflect the views of USAID or the US Government.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chiang JJ, 2012, J VIROL, V86, P12417, DOI 10.1128/JVI.00967-12; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dorfman T, 2006, J BIOL CHEM, V281, P28529, DOI 10.1074/jbc.M602732200; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; KUIKEN CL, 1992, J VIROL, V66, P4622, DOI 10.1128/JVI.66.7.4622-4627.1992; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lee PS, 2015, CURR TOP MICROBIOL, V386, P323, DOI 10.1007/82_2014_413; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nelson JEA, 2000, J VIROL, V74, P8494, DOI 10.1128/JVI.74.18.8494-8501.2000; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Sok D, 2013, CELL, V155, P728, DOI 10.1016/j.cell.2013.10.009; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Rij RP, 2000, J CLIN INVEST, V106, P1569, DOI 10.1172/JCI7953C1; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang WK, 1998, P NATL ACAD SCI USA, V95, P5740, DOI 10.1073/pnas.95.10.5740; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	94	95	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					31	45		10.1016/j.immuni.2016.06.026	http://dx.doi.org/10.1016/j.immuni.2016.06.026			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438765	Green Accepted, Bronze			2022-12-18	WOS:000380749000008
J	Blank, T; Detje, CN; Spiess, A; Hagemeyer, N; Brendecke, SM; Wolfart, J; Staszewski, O; Zoller, T; Papageorgiou, I; Schneider, J; Paricio-Montesinos, R; Eisel, ULM; Manahan-Vaughan, D; Jansen, S; Lienenklaus, S; Lu, B; Imai, Y; Muller, M; Goelz, SE; Baker, DP; Schwaninger, M; Kann, O; Heikenwalder, M; Kalinke, U; Prinz, M				Blank, Thomas; Detje, Claudia N.; Spiess, Alena; Hagemeyer, Nora; Brendecke, Stefanie M.; Wolfart, Jakob; Staszewski, Ori; Zoeller, Tanja; Papageorgiou, Ismini; Schneider, Justus; Paricio-Montesinos, Ricardo; Eisel, Ulrich L. M.; Manahan-Vaughan, Denise; Jansen, Stephan; Lienenklaus, Stefan; Lu, Bao; Imai, Yumiko; Mueller, Marcus; Goelz, Susan E.; Baker, Darren P.; Schwaninger, Markus; Kann, Oliver; Heikenwalder, Mathias; Kalinke, Ulrich; Prinz, Marco			Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRANDED-RNA; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MAJOR DEPRESSION; IN-VIVO; RIG-I; MICE; CELLS; INFLAMMATION	Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.	[Blank, Thomas; Spiess, Alena; Hagemeyer, Nora; Brendecke, Stefanie M.; Staszewski, Ori; Zoeller, Tanja; Paricio-Montesinos, Ricardo; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Detje, Claudia N.; Lienenklaus, Stefan; Kalinke, Ulrich] Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Infect Res, D-30625 Hannover, Germany; [Wolfart, Jakob] Univ Rostock, Oscar Langendorff Inst Physiol, D-18057 Rostock, Germany; [Papageorgiou, Ismini; Schneider, Justus; Kann, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Eisel, Ulrich L. M.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Mol Neurobiol, NL-9700 Groningen, Netherlands; [Eisel, Ulrich L. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 Groningen, Netherlands; [Manahan-Vaughan, Denise; Jansen, Stephan] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, D-44780 Bochum, Germany; [Lienenklaus, Stefan] Hannover Med Sch, Inst Lab Anim Sci, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Lu, Bao] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Imai, Yumiko] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Mueller, Marcus] Univ Klinikum Bonn, Dept Neurol, D-53105 Bonn, Germany; [Baker, Darren P.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Schwaninger, Markus] Med Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81756 Munich, Germany; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, D-69120 Heidelberg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Helmholtz Association; Helmholtz-Center for Infection Research; University of Rostock; Ruprecht Karls University Heidelberg; University of Groningen; University of Groningen; Ruhr University Bochum; Hannover Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Akita University; University of Bonn; Biogen; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Wolfart, Jakob/F-1698-2011; Papageorgiou, Ismini/AAI-7329-2020; Kann, Oliver/M-4302-2019; Heikenwalder, Mathias/AAA-2269-2020; Imai, Yumiko/GXW-1144-2022	Wolfart, Jakob/0000-0003-0594-2112; Papageorgiou, Ismini/0000-0001-5810-0483; Kann, Oliver/0000-0003-4365-8067; Eisel, Ulrich/0000-0003-4178-0384; Staszewski, Ori/0000-0002-0579-6701; Paricio-Montesinos, Ricardo/0000-0003-3325-9038; Kalinke, Ulrich/0000-0003-0503-9564; Manahan-Vaughan, Denise/0000-0002-9283-9609; Schwaninger, Markus/0000-0002-4510-9718; Blank, Thomas/0000-0002-3969-405X	BMBF; competence network of neurodegenerative disorders (KNDD); DFG [PR 577/8-1, BL 1153/1-1]; ERA-Net NEURON initiative "NEURO-IFN'; Gemeinnutzige Hertie Foundation (GHST); Marie Curie Integration Grant [248033-MBfUSEDIT]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; German Research Council [SFB 854 (TP B15)];  [SFB 874/B1]	BMBF(Federal Ministry of Education & Research (BMBF)); competence network of neurodegenerative disorders (KNDD); DFG(German Research Foundation (DFG)); ERA-Net NEURON initiative "NEURO-IFN'; Gemeinnutzige Hertie Foundation (GHST); Marie Curie Integration Grant; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; German Research Council(German Research Foundation (DFG)); 	We thank Maria Oberle, Margarethe Ditter, and Christine El Gaz for excellent technical assistance and Silke Dirken for animal care. M.P. was supported by the BMBF-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (KNDD), the DFG (PR 577/8-1, Reinhart-Koselleck grant), the ERA-Net NEURON initiative "NEURO-IFN,'' and the Gemeinnutzige Hertie Foundation (GHST). T.B. was supported by the Marie Curie Integration Grant project No 248033-MBfUSEDIT submitted under the Call FP7-PEOPLE-2009-RG and the DFG (BL 1153/1-1). D.M.-V. was supported by the SFB 874/B1. U.K. was supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany, and the SFB 854 (TP B15 to U.K.) of the German Research Council. Mouse IFN-beta was supplied by Biogen Inc. D.P.B. is an employee of Biogen and owns company stock.	Allison DJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0151-1; Bekisz J, 2013, J INTERF CYTOK RES, V33, P154, DOI 10.1089/jir.2012.0167; Ben Abdallah NMB, 2013, BEHAV BRAIN RES, V252, P275, DOI 10.1016/j.bbr.2013.05.034; Benveniste EN, 2001, NEUROCHEM INT, V39, P381, DOI 10.1016/S0197-0186(01)00045-6; BILLIAU A, 1981, ARCH VIROL, V68, P19, DOI 10.1007/BF01315163; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dyrna F, 2013, J NEUROIMMUNE PHARM, V8, P763, DOI 10.1007/s11481-013-9473-5; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KIMURATAKEUCHI M, 1992, J INFECT DIS, V166, P1266, DOI 10.1093/infdis/166.6.1266; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Leuschen MP, 2004, MULT SCLER J, V10, P636, DOI 10.1191/1352458504ms1114oa; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Machida M, 2014, BRAIN BEHAV IMMUN, V35, P125, DOI 10.1016/j.bbi.2013.09.006; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; Marrocco J, 2014, J NEUROSCI, V34, P2015, DOI 10.1523/JNEUROSCI.4131-13.2014; Mendoza-Fernandez V, 2000, BRAIN RES, V885, P14, DOI 10.1016/S0006-8993(00)02877-8; MULLER M, 1993, BRAIN RES, V619, P157, DOI 10.1016/0006-8993(93)91607-T; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; PLATASALAMAN CR, 1992, AM J PHYSIOL, V263, pR1222, DOI 10.1152/ajpregu.1992.263.6.R1222; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00067; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Schrott LM, 1996, BEHAV NEUROSCI, V110, P492; Vlkolinsky R, 2004, J NEUROIMMUNOL, V150, P37, DOI 10.1016/j.jneuroim.2004.01.011; Wang J, 2008, MOL PSYCHIATR, V13, P293, DOI 10.1038/sj.mp.4002013; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Zheng LS, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.015; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	94	94	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					901	912		10.1016/j.immuni.2016.04.005	http://dx.doi.org/10.1016/j.immuni.2016.04.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096319	Bronze, Green Published			2022-12-18	WOS:000374444300020
J	Donkor, MK; Sarkar, A; Savage, PA; Franklin, RA; Johnson, LK; Jungbluth, AA; Allison, JP; Li, MO				Donkor, Moses K.; Sarkar, Abira; Savage, Peter A.; Franklin, Ruth A.; Johnson, Linda K.; Jungbluth, Achim A.; Allison, James P.; Li, Ming O.			T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-beta 1 Cytokine	IMMUNITY			English	Article							CONGENIC NORMAL MICE; TGF-BETA; IMMUNE SURVEILLANCE; IN-VIVO; ESTABLISHED MELANOMA; TUMOR SURVEILLANCE; NUDE-MICE; TOLERANCE; DIFFERENTIATION; MECHANISMS	Tolerance induction in T cells takes place in most tumors and is thought to account for tumor evasion from immune eradication. Production of the cytokine TGF-beta is implicated in immunosuppression, but the cellular mechanism by which TGF-beta induces T cell dysfunction remains unclear. With a transgenic model of prostate cancer, we showed that tumor development was not suppressed by the adaptive immune system, which was associated with heightened TGF-beta signaling in T cells from the tumor-draining lymph nodes. Blockade of TGF-beta signaling in T cells enhanced tumor antigen-specific T cell responses and inhibited tumor development. Surprisingly, T cell- but not Treg cell-specific ablation of TGF-beta 1 was sufficient to augment T cell cytotoxic activity and blocked tumor growth and metastases. These findings reveal that T cell production of TGF-beta 1 is an essential requirement for tumors to evade immunosurveillance independent of TGF-beta produced by tumors.	[Donkor, Moses K.; Sarkar, Abira; Savage, Peter A.; Franklin, Ruth A.; Allison, James P.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Savage, Peter A.; Allison, James P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Johnson, Linda K.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10065 USA; [Jungbluth, Achim A.] Ludwig Inst Canc Res, New York Branch, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org	Franklin, Ruth/AFK-5723-2022; Franklin, Ruth/AAG-4161-2022; Johnson, Linda/B-1828-2014	Johnson, Linda/0000-0002-7574-7753; Allison, James/0000-0001-8980-5697; li, ming/0000-0002-1383-0535	NIAMS-NIH [AR060723, AR053595]; Arthritis Foundation; CRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053595, R01AR060723] Funding Source: NIH RePORTER	NIAMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; CRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell (Yale) for providing the DNR mouse strain, L. Old (Ludwig Institute for Cancer Research, New York), and the M.O.L. lab for discussions. This work was supported by an NIAMS-NIH RO1 grant (AR060723, M.O.L.), an NIAMS-NIH KO1 grant (AR053595, M.O.L.), an Arthritis Foundation Investigator Award (M.O.L.), and a CRI predoctoral fellowship (M.K.D.). M.O.L. is a Rita Allen Foundation Scholar.	Anderson MJ, 2007, J IMMUNOL, V178, P1268, DOI 10.4049/jimmunol.178.3.1268; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bai AL, 2008, P NATL ACAD SCI USA, V105, P13003, DOI 10.1073/pnas.0805599105; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Blankenstein T, 2007, SEMIN CANCER BIOL, V17, P267, DOI 10.1016/j.semcancer.2007.06.007; Boesen M, 2000, CLIN EXP IMMUNOL, V121, P210, DOI 10.1046/j.1365-2249.2000.01292.x; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hurwitz A. A., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im2005s45, DOI 10.1002/0471142735.IM2005S45]; Kao JY, 2003, J IMMUNOL, V170, P3806, DOI 10.4049/jimmunol.170.7.3806; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KLEIN G, 1977, P NATL ACAD SCI USA, V74, P2121, DOI 10.1073/pnas.74.5.2121; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pu H, 2009, CANCER RES, V69, P7366, DOI 10.1158/0008-5472.CAN-09-0758; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Svane IM, 1996, EUR J IMMUNOL, V26, P1844, DOI 10.1002/eji.1830260827; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yamaguchi T, 2006, SEMIN CANCER BIOL, V16, P115, DOI 10.1016/j.semcancer.2005.11.005; Zhang Q, 2005, CANCER RES, V65, P1761, DOI 10.1158/0008-5472.CAN-04-3169	56	94	101	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					123	134		10.1016/j.immuni.2011.04.019	http://dx.doi.org/10.1016/j.immuni.2011.04.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21757379	Bronze, Green Accepted			2022-12-18	WOS:000293107300015
J	Tan, JB; Xu, K; Cretegny, K; Visan, I; Yuan, JS; Egan, SE; Guidos, CJ				Tan, Joanne B.; Xu, Keli; Cretegny, Kira; Visan, Ioana; Yuan, Julie S.; Egan, Sean E.; Guidos, Cynthia J.			Lunatic and Manic Fringe Cooperatively Enhance Marginal Zone B Cell Precursor Competition for Delta-like 1 in Splenic Endothelial Niches	IMMUNITY			English	Article							MICROCIRCULATORY PATHWAYS; NOTCH1; DIFFERENTIATION; SEGMENTATION; RECEPTORS; LIGANDS; DELTA-LIKE-1; REQUIREMENT; LYMPHOCYTES; INHIBITION	Notch2 activation induced by Delta-like-1 (DL1) drives development of splenic marginal zone (MZ) B cells, an innate-like lineage that protects against sepsis. DL1 interacts with Notch2 weakly, but it is not known whether enhancement of DL1-induced Notch2 activation by Fringe glycosyltransferases is important for MZ B cell development. Furthermore, DL1-expressing cells that promote MZ B cell development have not been identified. We show that Lunatic Fringe (Lfng) and Manic Fringe (Mfng) cooperatively enhanced the DL1-Notch2 interaction to promote MZ B cell development. We also identified radio-resistant red pulp endothelial cells in the splenic MZ that express high amounts of DL1 and promoted MZ B generation. Finally, MZ B cell precursor competition for DL1 homeostatically regulated entry into the MZ B cell pool. Our study has revealed that the Fringe-Notch2 interaction has important functions in vivo and provides insights into mechanisms regulating MZ B cell development.	[Tan, Joanne B.; Xu, Keli; Cretegny, Kira; Visan, Ioana; Yuan, Julie S.; Egan, Sean E.; Guidos, Cynthia J.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Tan, Joanne B.; Cretegny, Kira; Visan, Ioana; Yuan, Julie S.; Guidos, Cynthia J.] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Egan, Sean E.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Guidos, CJ (corresponding author), Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	cynthia.guidos@sickkids.ca			Canadian Institutes of Health Research [FRN 81300]; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research with an operating grant awarded to C.J.G. (FRN 81300) and a postdoctoral fellowship to I.V. S.E.E.'s lab was supported by funds from the Canadian Cancer Society administered by the National Cancer Institute of Canada. We also acknowledge Hospital for Sick Children Restracom Studentships awarded to J.S.Y. and J.B.T, and thank J. Rossant for providing DII4<SUP>+/Lacz</SUP> mice.	Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Cancro MP, 2004, IMMUNOL REV, V202, P237, DOI 10.1111/j.0105-2896.2004.00212.x; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Koch U, 2003, SEMIN IMMUNOL, V15, P99, DOI 10.1016/S1044-5323(03)00006-X; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; McCright B, 2002, DEVELOPMENT, V129, P1075; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Oliver AM, 1999, J IMMUNOL, V162, P7198; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sheng Y, 2008, IMMUNOL LETT, V121, P33, DOI 10.1016/j.imlet.2008.08.001; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	53	94	99	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					254	263		10.1016/j.immuni.2008.12.016	http://dx.doi.org/10.1016/j.immuni.2008.12.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19217325	Bronze			2022-12-18	WOS:000263710500012
J	Aoshi, T; Zinselmeyer, BH; Konjufca, V; Lynch, JN; Zhang, X; Koide, Y; Miller, MJ				Aoshi, Taiki; Zinselmeyer, Bernd H.; Konjufca, Vjollca; Lynch, Jennifer N.; Zhang, Xin; Koide, Yukio; Miller, Mark J.			Bacterial entry to the splenic white pulp initiates antigen presentation to CD8(+) T cells	IMMUNITY			English	Article							IN-VIVO DEPLETION; CD8-ALPHA(+) DENDRITIC CELLS; MARGINAL ZONE MACROPHAGES; LISTERIA-MONOCYTOGENES; IMMUNE-RESPONSES; SPLEEN; INFECTION; CHEMOKINE; REQUIREMENTS; ACTIVATION	The spleen plays an important role in host-protective responses to bacteria. However, the cellular dynamics that lead to pathogen-specific immunity remain poorly understood. Here we examined Listeria monocytogenes (Lm) infection in the mouse spleen via in situ fluorescence microscopy. We found that the redistribution of Lm from the marginal zone (MZ) to the periarteriolar lymphoid sheath (PALS) was inhibited by pertussis toxin and required the presence of CD11c(+) cells. As early as 9 hr after infection, we detected infected dendritic cells in the peripheral regions of the PALS and clustering of Lm-specific T cells by two-photon microscopy. Pertussis toxin inhibited both Lm entry into the PALS and antigen presentation to CD8(+) T cells. Our study suggests that splenic dendritic cells rapidly deliver intracellular bacteria to the T cell areas of the white pulp to initiate CD8(+) T cell responses.	[Aoshi, Taiki; Zinselmeyer, Bernd H.; Konjufca, Vjollca; Lynch, Jennifer N.; Zhang, Xin; Miller, Mark J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Koide, Yukio] Hamamatsu Univ Sch Med, Dept Infect Dis, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Washington University (WUSTL); Hamamatsu University School of Medicine	Miller, MJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	miller@pathology.wustl.edu	Zinselmeyer, Bernd/X-4802-2018	Zinselmeyer, Bernd/0000-0003-4172-6767; Konjufca, Vjollca/0000-0002-7736-5097; Miller, Mark/0000-0001-5676-389X				Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; Ato M, 2004, J IMMUNOL, V173, P4815, DOI 10.4049/jimmunol.173.8.4815; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DIJKSTRA CD, 1985, IMMUNOLOGY, V55, P23; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dufner A, 2008, MOL CELL BIOL, V28, P1541, DOI 10.1128/MCB.01359-07; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; KRAAL G, 1986, IMMUNOLOGY, V58, P665; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; Wong P, 2003, IMMUNITY, V18, P499, DOI 10.1016/S1074-7613(03)00081-5; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	50	94	96	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					476	486		10.1016/j.immuni.2008.06.013	http://dx.doi.org/10.1016/j.immuni.2008.06.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18760639	Bronze			2022-12-18	WOS:000259708900017
J	Lyubchenko, TA; Wurth, GA; Zweifach, A				Lyubchenko, TA; Wurth, GA; Zweifach, A			Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MICROTUBULE-ORGANIZING CENTER; GOLGI-APPARATUS; MAST-CELLS; CA2+; ACTIVATION; BINDING; ANTIGEN; RELEASE; DEGRANULATION	One mechanism cytotoxic T lymphocytes use to kill targets is exocytosis of cytotoxic agents from lytic granules, a process that requires Ca2+ influx. We investigated the role of Ca2+ influx in granule exocytosis using TALL-104 human leukemic cytotoxic T cells triggered via a bispecific antibody containing an anti-CD3 F(ab') to kill Raji B lymphoma cells. Using a novel fluorescence method, we detected target-directed release of similar to 15% of lytic granules during killing. Consistent with previous work, we observed sustained CTL Ca2+ gradients during killing, but gradients reflect the behavior of Fura-2 in granules. Rapid imaging experiments suggest that Ca2+ channels are not polarized during killing, indicating that Ca2+ influx does not direct granule reorientation. Furthermore, we find that Ca2+ acts via a high-affinity interaction to promote granule exocytosis.	Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Zweifach, A (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, 4200 E 9th Ave, Denver, CO 80262 USA.				NIAID NIH HHS [R01 AI054839, AI42964] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054839, R01AI042964] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEREBI G, 1987, P NATL ACAD SCI USA, V84, P1364; BERKE G, 1994, ANNU REV IMMUNOL, V12, P736; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CESANO A, 1992, IN VITRO CELL DEV-AN, V28A, P648; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; DUPUIS M, 1993, J EXP MED, V177, P1, DOI 10.1084/jem.177.1.1; DUTZ JP, 1993, J IMMUNOL, V150, P2591; GRAY LS, 1988, J IMMUNOL, V141, P2424; Griffiths G M, 1995, Curr Top Microbiol Immunol, V198, P39; GRIFFITHS GM, 1995, CURR OPIN IMMUNOL, V7, P343, DOI 10.1016/0952-7915(95)80108-1; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; HESS SD, 1993, J IMMUNOL, V150, P2620; HIDE I, 1993, J CELL BIOL, V123, P585, DOI 10.1083/jcb.123.3.585; ISHIURA S, 1990, MOL IMMUNOL, V27, P803; KATAOKA T, 1994, J IMMUNOL, V153, P3938; Kim TD, 1997, J BIOL CHEM, V272, P31225, DOI 10.1074/jbc.272.50.31225; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1984, J IMMUNOL, V133, P2762; LANCKI DW, 1987, J IMMUNOL, V138, P3646; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Link BK, 1998, INT J CANCER, V77, P251, DOI 10.1002/(SICI)1097-0215(19980717)77:2<251::AID-IJC14>3.0.CO;2-E; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Neher E., 1986, EXPT BRAIN RES SERIE, P80; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; REED PW, 1972, J BIOL CHEM, V247, P6970; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; TSCHOPP J, 1987, MOL IMMUNOL, V24, P907, DOI 10.1016/0161-5890(87)90002-2; YANELLI JR, 1986, J IMMUNOL, V136, P377; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X; Zweifach A, 2000, J CELL BIOL, V148, P603, DOI 10.1083/jcb.148.3.603; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	39	94	96	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					847	859		10.1016/S1074-7613(01)00233-3	http://dx.doi.org/10.1016/S1074-7613(01)00233-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728345	Bronze			2022-12-18	WOS:000172528200016
J	Malherbe, L; Filippi, C; Julia, V; Foucras, G; Moro, M; Appel, H; Wucherpfennig, K; Guery, JC; Glaichenhaus, N				Malherbe, L; Filippi, C; Julia, V; Foucras, G; Moro, M; Appel, H; Wucherpfennig, K; Guery, JC; Glaichenhaus, N			Selective activation and expansion of high-affinity CD4(+) T cells in resistant mice upon infection with Leishmania major	IMMUNITY			English	Article							MURINE CUTANEOUS LEISHMANIASIS; IN-VIVO; SUSCEPTIBLE MICE; LYMPH-NODE; ANTIGEN; IMMUNITY; REPERTOIRE; RESPONSES; GAMMA; DIFFERENTIATION	Using multimers of MHC class II molecules linked to a peptide derived from the Leishmania LACK antigen, we have compared the fate of parasite-specific CD4(+) T cells in resistant and susceptible mice transgenic far the beta chain of a LACK-specific TCR. Activated T cells were readily detected in the draining lymph nodes of infected animals. Although the kinetics of activation and expansion were similar in both strains, T cells from susceptible and resistant mice expressed low- and high-affinity TCR, respectively. As T cells from resistant mice produced more IFN-gamma and less IL-4 than those from susceptible animals, our results suggest that differences in TCR usage between MHC-matched animals may influence the development of the antiparasite immune response.	Univ Nice, CNRS, F-06560 Valbonne, France; Hop Purpan, INSERM, Unite U28, F-31059 Toulouse, France; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Glaichenhaus, N (corresponding author), Univ Nice, CNRS, 660 Route Lucioles, F-06560 Valbonne, France.		GUERY, Jean-Charles/G-1452-2013; FOUCRAS, Gilles/A-3061-2014	GUERY, Jean-Charles/0000-0003-4499-3270; FOUCRAS, Gilles/0000-0002-0363-0337	NIAID NIH HHS [P01 AI45757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AEBISCHER T, 1993, INFECT IMMUN, V61, P220, DOI 10.1128/IAI.61.1.220-226.1993; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; Bix M, 1998, J EXP MED, V188, P2289, DOI 10.1084/jem.188.12.2289; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Brown DR, 1999, INFECT IMMUN, V67, P266, DOI 10.1128/IAI.67.1.266-270.1999; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huber M, 1998, INFECT IMMUN, V66, P3968, DOI 10.1128/IAI.66.8.3968-3970.1998; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; LOHOFF M, 1994, EUR J IMMUNOL, V24, P492, DOI 10.1002/eji.1830240236; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McMichael AJ, 1999, J CLIN INVEST, V104, P1669, DOI 10.1172/JCI8943; MOLL H, 1993, EUR J IMMUNOL, V23, P1595, DOI 10.1002/eji.1830230730; MORRIS L, 1992, J IMMUNOL, V149, P2715; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reiner SL, 1998, J IMMUNOL, V160, P884; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; Roberts LJ, 1997, J EXP MED, V185, P1705, DOI 10.1084/jem.185.9.1705; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; SCOTT P, 1990, J IMMUNOL, V144, P1075; SCOTT P, 1991, J IMMUNOL, V147, P3149; SHANKAR AH, 1995, J EXP MED, V181, P845, DOI 10.1084/jem.181.3.845; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; TITUS RG, 1991, EUR J IMMUNOL, V21, P559, DOI 10.1002/eji.1830210305; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547	40	94	99	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					771	782		10.1016/S1074-7613(00)00075-3	http://dx.doi.org/10.1016/S1074-7613(00)00075-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163193	Bronze			2022-12-18	WOS:000166142300003
J	Levesque, JP; Zannettino, ACW; Pudney, M; Niutta, S; Haylock, DN; Snapp, KR; Kansas, GS; Berndt, MC; Simmons, PJ				Levesque, JP; Zannettino, ACW; Pudney, M; Niutta, S; Haylock, DN; Snapp, KR; Kansas, GS; Berndt, MC; Simmons, PJ			PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis	IMMUNITY			English	Article							MARROW STROMAL CELLS; BLOOD CD34+ CELLS; BONE-MARROW; GLYCOPROTEIN LIGAND-1; STEM-CELLS; MOLECULE-1; NEUTROPHILS; EXPRESSION; RECEPTOR; PROTEIN	Cellular interactions are critical for the regulation of hematopoiesis. The sialomucin PSGL-1/CD162 mediates the attachment of mature leukocytes to P-selectin. We now show that PSGL-1 also functions as the sole receptor for P-selectin on primitive human CD34(+) hematopoietic progenitor cells (HPC). More importantly, ligation of PSGL-1 by immobilized or soluble ligand or anti-PSGL-1 antibody results in a profound suppression of HPC proliferation stimulated by potent combinations of early acting hematopoietic growth factors. These data demonstrate an unanticipated but extremely marked growth-inhibitory effect of P-selectin on hematopoiesis and provide direct evidence that PSGL-1, in addition to its well-documented role as an adhesion molecule on mature leukocytes, is a potent negative regulator of human hematopoietic progenitors.	Hanson Ctr Canc Res, Div Haematol, Matthew Roberts Lab, Adelaide, SA 5000, Australia; Baker Med Res Inst, Lab Vasc Biol, Prahran, Vic 3181, Australia; NW Med Sch, Dept Immunol Microbiol, Chicago, IL 60601 USA	Baker Heart and Diabetes Institute	Simmons, PJ (corresponding author), Hanson Ctr Canc Res, Div Haematol, Matthew Roberts Lab, Adelaide, SA 5000, Australia.	paul.simmons@imvs.sa.gov.au	Levesque, Jean-Pierre/C-5426-2011	Levesque, Jean-Pierre/0000-0002-7299-6025; Zannettino, Andrew/0000-0002-6646-6167	NHLBI NIH HHS [HL58710] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058710] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banu N., 1996, Blood, V88, p533A; BANU N, 1995, BLOOD S, V86, pA284; Bazil V, 1996, BLOOD, V87, P1272, DOI 10.1182/blood.V87.4.1272.bloodjournal8741272; BECKSTEAD JH, 1986, BLOOD, V67, P285; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; CarverMoore K, 1996, BLOOD, V88, P803; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; DELUCA M, 1995, J BIOL CHEM, V270, P26734, DOI 10.1074/jbc.270.45.26734; DEXTER TM, 1982, J CELL PHYSIOL, P87; DUNLOP LC, 1992, J EXP MED, V175, P1147, DOI 10.1084/jem.175.4.1147; FACKLER MJ, 1995, BLOOD, V85, P3040, DOI 10.1182/blood.V85.11.3040.bloodjournal85113040; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HATZFELD J, 1991, J EXP MED, V174, P925, DOI 10.1084/jem.174.4.925; Haylock DN, 1997, BLOOD, V90, P2260; HAYLOCK DN, 1992, BLOOD, V80, P1405; Homeister JW, 1998, BLOOD, V92, P2345, DOI 10.1182/blood.V92.7.2345.2345_2345_2352; Jacobsen K, 1996, BLOOD, V87, P73; Jones WM, 1997, J IMMUNOL, V159, P3574; KANSAS GS, 1996, BLOOD, V88, P3529; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; LOKEN MR, 1987, BLOOD, V70, P1316; Luens KM, 1998, BLOOD, V91, P1206, DOI 10.1182/blood.V91.4.1206; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Makino S, 1997, J HEMATOTHER, V6, P475; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; ROMO GM, 1999, IN PRESS J EXP MED; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Simmons PJ, 1997, BAILLIERE CLIN HAEM, V10, P485, DOI 10.1016/S0950-3536(97)80022-4; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Snapp KR, 1997, BLOOD, V89, P896, DOI 10.1182/blood.V89.3.896; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; TEDDER TF, 1990, J IMMUNOL, V144, P532; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Tracey JB, 1996, EXP HEMATOL, V24, P1494; VERFAILLIE C, 1990, J EXP MED, V172, P509, DOI 10.1084/jem.172.2.509; Verfaillie CM, 1998, BLOOD, V92, P2609, DOI 10.1182/blood.V92.8.2609; WOLF NS, 1979, CLIN HAEMATOL, V8, P469; ZANNETTINO ACW, 1995, BLOOD, V85, P3466, DOI 10.1182/blood.V85.12.3466.bloodjournal85123466; Zannettino ACW, 1998, BLOOD, V92, P2613, DOI 10.1182/blood.V92.8.2613.420k15_2613_2628; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	48	94	100	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1999	11	3					369	378		10.1016/S1074-7613(00)80112-0	http://dx.doi.org/10.1016/S1074-7613(00)80112-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514015	Bronze			2022-12-18	WOS:000082918500012
J	Deckert, M; Tartare-Deckert, S; Hernandez, J; Rottapel, R; Altman, A				Deckert, M; Tartare-Deckert, S; Hernandez, J; Rottapel, R; Altman, A			Adaptor function for the Syk kinases interacting protein 3BP2 in IL-2 gene activation	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; TYROSINE KINASE; SIGNAL-TRANSDUCTION; T-CELLS; NUCLEAR FACTOR; ZAP-70 KINASE; PHOSPHORYLATION; FAMILY; DOMAINS	Syk-family tyrosine kinases are essential for lymphocyte development and activation. Using a yeast two-hybrid screen to identify Syk kinases-interacting proteins (SKIPs), we isolated 3BP2, an Abl SHE-interacting protein of unknown function. 3BP2 was selectively expressed in hematopoietic/lymphoid tissues and bound via its SH2 domain activated Syk-family kinases in mammalian cells, including in antigen receptor-stimulated T cells. In addition to Zap-70, the 3BP2 SH2 domain associated in vitro with LAT, Grb2, PLC gamma 1, and Cbl from activated T cell lysates. Transient 3BP2 overexpression induced transcriptional activation of the IL-2 promoter and its NFAT or AP-1 elements. This activity was dependent on the SH2 and pleckstrin-homology domains of 3BP2, and required functional Syk kinases, Ras, and calcineurin. Thus, 3BP2 is an important adaptor that may couple activated Zap-70/ Syk to a LAT-containing signaling complex involved in TCR-mediated gene transcription.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Fac Med, INSERM, U145, F-06107 Nice 2, France; Wellesley Hosp, Res Inst, Toronto, ON M4Y 1J3, Canada	La Jolla Institute for Immunology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA.	amnon@liai.org	TARTARE-DECKERT, Sophie/P-6057-2015; Deckert, Marcel/T-3566-2019; Deckert, Marcel/M-4998-2016	TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Deckert, Marcel/0000-0003-2094-559X; Rottapel, Robert/0000-0002-6024-5558	NCI NIH HHS [CA35299] Funding Source: Medline; NIGMS NIH HHS [GM50819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050819] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chen L, 1997, J I ENERGY, V70, P2; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; COUTURIER MF, 1994, CAN J CHEM ENG, V72, P91, DOI 10.1002/cjce.5450720114; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Eischen CM, 1997, J IMMUNOL, V159, P1135; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Koretzky GA, 1997, IMMUNOL TODAY, V18, P401, DOI 10.1016/S0167-5699(97)01088-8; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Luo C, 1996, MOL CELL BIOL, V16, P3955; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ray RJ, 1996, EUR J IMMUNOL, V26, P1504, DOI 10.1002/eji.1830260715; RAZIN E, 1995, IMMUNOL TODAY, V16, P370, DOI 10.1016/0167-5699(95)80003-4; RIVERA VM, 1995, MOL CELL BIOL, V15, P1582; ROSNET O, 1991, ONCOGENE, V6, P1641; SloanLancaster J, 1997, J EXP MED, V186, P1713, DOI 10.1084/jem.186.10.1713; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; WOODROW MA, 1993, J IMMUNOL, V150, P3853; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	44	94	99	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					595	605		10.1016/S1074-7613(00)80657-3	http://dx.doi.org/10.1016/S1074-7613(00)80657-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846481	Bronze			2022-12-18	WOS:000077298300002
J	SantAngelo, DB; Waterbury, PG; Cohen, BE; Martin, WD; VanKaer, L; Hayday, AC; Janeway, CA				SantAngelo, DB; Waterbury, PG; Cohen, BE; Martin, WD; VanKaer, L; Hayday, AC; Janeway, CA			The imprint of intrathymic self-peptides on the mature T cell receptor repertoire	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; BETA-CHAIN; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; ANTIGEN PRESENTATION; MICE; RECOGNITION; TCR; SPECIFICITY; COMPLEXES	The analysis of T cell receptor alpha (TCR alpha) chains in mice transgenic for a TCR beta chain has allowed us to demonstrate a central role for self-peptides in the positive intrathymic selection of major histocompatibility complex (MHC) class II-restricted T cells. Analysis of specific V alpha-J alpha joins in mature CD4+ TCRhigh thymocytes and in peripheral CD4+ T cells revealed a limitation in amino-acid sequences. By analysis of immature thymocytes, we could show that this limited repertoire was selected from a more diverse repertoire. By analysis of the same beta chain-transgenic mice bred to H-2Ma-deficient mice that express one or a very limited number of peptides, we could demonstrate that the V alpha-J alpha join repertoire was now altered and much more limited. Together, these data provide molecular and genetic evidence that the intrathymic positive selection of the TCR repertoire is critically affected by self-peptides presented by MHC class II molecules, most likely on thymic cortical epithelial cells.	YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06510; VANDERBILT UNIV,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37232	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University			Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309	NIAID NIH HHS [AI-14579] Funding Source: Medline; NIGMS NIH HHS [GM-37759] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014579, R01AI014579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037759] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; DILLON SR, 1994, J IMMUNOL, V152, P1790; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; Hsu BL, 1996, J IMMUNOL, V157, P2291; HSU BL, 1995, J EXP MED, V181, P805, DOI 10.1084/jem.181.2.805; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MERKENSCHLAGER M, 1994, J IMMUNOL, V153, P3005; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MORI L, 1992, J EXP MED, V176, P381, DOI 10.1084/jem.176.2.381; MORKOWSKI S, 1995, J EXP MED, V182, P1403, DOI 10.1084/jem.182.5.1403; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	33	94	94	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					517	524		10.1016/S1074-7613(00)80373-8	http://dx.doi.org/10.1016/S1074-7613(00)80373-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354472	hybrid			2022-12-18	WOS:A1997YD59300008
J	BONNEROT, C; LANKAR, D; HANAU, D; SPEHNER, D; DAVOUST, J; SALAMERO, J; FRIDMAN, WH				BONNEROT, C; LANKAR, D; HANAU, D; SPEHNER, D; DAVOUST, J; SALAMERO, J; FRIDMAN, WH			ROLE OF B-CELL RECEPTOR IG-ALPHA AND IG-BETA SUBUNITS IN MHC CLASS II-RESTRICTED ANTIGEN PRESENTATION	IMMUNITY			English	Article							HUMAN BLOOD-PLATELETS; INTRACELLULAR-TRANSPORT; INVARIANT CHAIN; LYMPHOCYTES-B; COMPLEX; MOLECULES; ANTIBODY; INTERNALIZATION; ENDOCYTOSIS; ACTIVATION	The ability of the a cell antigen receptors (BCRs) to enhance MHC class II-restricted antigen presentation was ascribed to mlg-associated Ig alpha/Ig beta heterodimers. The relative role of Ig alpha and Ig beta subunits in antigen presentation was investigated by fusing their cytoplasmic tails to the extracellular and transmembrane domains of Fc receptors, Ig alpha and Ig beta chimera mediate antigen internalization and increase the efficiency of antigen presentation, but they drive antigens to different endosomal compartments, Furthermore, antigens internalized by either chimera are degraded and presented with different kinetics, The cytoplasmic tail of Iga targets antigen towards a major population of newly synthesized MHC class II located in class II-rich compartments, In contrast, Ig beta targets antigen towards a minor population of recycling MHC class II molecules, located in transferrin receptor-containing endosomes, Altogether, our data indicate that the composition of BCR could be therefore an important way to modulate the immune response.	CTR REG TRANSFUS SANGUINE,HISTOCOMPATIBIL LAB,F-67085 STRASBOURG,FRANCE; FAC MED STRASBOURG,INST NATL SANTE & RECH MED,INST VIROL,U74,STRASBOURG,FRANCE; CTR IMMUNOL,INST NATL SANTE & RECH MED,CNRS,MARSEILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	BONNEROT, C (corresponding author), INST CURIE,INST NATL SANTE & RECH MED,U255,PARIS,FRANCE.			Davoust, Jean/0000-0002-3098-7665; fridman, wolf herman/0000-0002-1332-0973; salamero, jean/0000-0002-2610-5826				ALDORINI L, 1990, NATURE, V346, P63; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ARNIGORENA S, 1992, SCIENCE, V256, P1808; BONNEROT C, 1992, EMBO J, V11, P2747, DOI 10.1002/j.1460-2075.1992.tb05340.x; Bonnerot C, 1994, Immunomethods, V4, P41, DOI 10.1006/immu.1994.1006; CAMPBELL KS, 1990, EMBO J, V9, P441, DOI 10.1002/j.1460-2075.1990.tb08129.x; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CASTEN LA, 1988, J EXP MED, V168, P171, DOI 10.1084/jem.168.1.171; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FRIEDRICH RJ, 1993, J IMMUNOL, V150, P2814; GACHET C, 1992, J INVEST DERMATOL, V99, pS27, DOI 10.1111/1523-1747.ep12668284; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; HANAU D, 1991, J INVEST DERMATOL, V97, P756, DOI 10.1111/1523-1747.ep12485023; HARDING CV, 1989, J IMMUNOL, V142, P12; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; ISHIHARA K, 1993, J IMMUNOL, V150, P2253; JONES B, 1986, J IMMUNOL, V136, P348; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; LICHTMAN AH, 1987, J IMMUNOL, V138, P2822; MANCA F, 1991, J EXP MED, V173, P37, DOI 10.1084/jem.173.1.37; NADIMI F, 1991, EUR J IMMUNOL, V21, P1255, DOI 10.1002/eji.1830210524; NEEFJES JJ, 1992, IMMUNOL TODAY, V13, P179, DOI 10.1016/0167-5699(92)90123-O; NUCHTERN JG, 1990, NATURE, V343, P74, DOI 10.1038/343074a0; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; PINET V, 1994, J IMMUNOL, V152, P4852; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; ROOSNEK E, 1988, J IMMUNOL, V140, P4079; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; SNIDER DP, 1987, J IMMUNOL, V139, P1609; STPIERRE Y, 1990, J IMMUNOL, V145, P812; TROWBRIDGE IS, 1994, ANN REV CELL BIOL, P129; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	45	94	95	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					335	347		10.1016/1074-7613(95)90118-3	http://dx.doi.org/10.1016/1074-7613(95)90118-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552998	Bronze			2022-12-18	WOS:A1995RX64500008
J	Muecksch, F; Weisblum, Y; Barnes, CO; Schmidt, F; Schaefer-Babajew, D; Wang, ZJ; Lorenzi, JCC; Flyak, AI; DeLaitsch, AT; Huey-Tubman, KE; Hou, SR; Schiffer, CA; Gaebler, C; Da Silva, J; Poston, D; Finkin, S; Cho, A; Cipolla, M; Oliveira, TY; Millard, KG; Ramos, V; Gazumyan, A; Rutkowska, M; Caskey, M; Nussenzweig, MC; Bjorkman, PJ; Hatziioannou, T; Bieniasz, PD				Muecksch, Frauke; Weisblum, Yiska; Barnes, Christopher O.; Schmidt, Fabian; Schaefer-Babajew, Dennis; Wang, Zijun; Lorenzi, Julio C. C.; Flyak, Andrew, I; DeLaitsch, Andrew T.; Huey-Tubman, Kathryn E.; Hou, Shurong; Schiffer, Celia A.; Gaebler, Christian; Da Silva, Justin; Poston, Daniel; Finkin, Shlomo; Cho, Alice; Cipolla, Melissa; Oliveira, Thiago Y.; Millard, Katrina G.; Ramos, Victor; Gazumyan, Anna; Rutkowska, Magdalena; Caskey, Marina; Nussenzweig, Michel C.; Bjorkman, Pamela J.; Hatziioannou, Theodora; Bieniasz, Paul D.			Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations	IMMUNITY			English	Article							CRYO-EM STRUCTURE; PROTEIN; MEMORY; SUITE; BROAD; SPIKE	Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from 5 individuals shortly after infection and later in convalescence to determine the impact of maturation over months. In addition to increased affinity and neutralization potency, antibody evolution changed the mutational pathways for the acquisition of viral resistance and restricted neutralization escape options. For some antibodies, maturation imposed a requirement for multiple substitutions to enable escape. For certain antibodies, affinity maturation enabled the neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.	[Muecksch, Frauke; Weisblum, Yiska; Schmidt, Fabian; Da Silva, Justin; Poston, Daniel; Rutkowska, Magdalena; Hatziioannou, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA; [Barnes, Christopher O.; Flyak, Andrew, I; DeLaitsch, Andrew T.; Huey-Tubman, Kathryn E.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Schaefer-Babajew, Dennis; Wang, Zijun; Lorenzi, Julio C. C.; Gaebler, Christian; Finkin, Shlomo; Cho, Alice; Cipolla, Melissa; Oliveira, Thiago Y.; Millard, Katrina G.; Ramos, Victor; Gazumyan, Anna; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Hou, Shurong; Schiffer, Celia A.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01655 USA; [Nussenzweig, Michel C.; Bieniasz, Paul D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; California Institute of Technology; Rockefeller University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Hatziioannou, T; Bieniasz, PD (corresponding author), Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA.; Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC; Bieniasz, PD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	nussen@mail.rockefeller.edu; bjorkman@caltech.edu; thatziio@rockefeller.edu; pbieniasz@rockefeller.edu	Wang, Zhiquan/HHS-6768-2022; Gaebler, Christian/GWZ-2628-2022; Oliveira, Thiago Y/HGA-3848-2022	Gaebler, Christian/0000-0001-7295-8128; Oliveira, Thiago Y/0000-0002-2654-0879; Poston, Daniel/0000-0001-9900-6717; DeLaitsch, Andrew/0000-0002-3458-3449; Rutkowska, Magdalena/0000-0002-8090-3503	Gordon and Betty Moore Foundation; Beckman Foundation; Molecular Observatory; SLAC National Accelerator Laboratory; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-c76SF00515]; SRL Structural Molecular Biology Program; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NIH grants [R37-AI64003, R01AI78788, P01-AI138938-S1, K99 AI153465, 2U19AI111825]; George Mason University Fast Grant - NSF [GRFP DGE-1745301]; Caltech Merkin Institute for Translational Research; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Postdoctoral Enrichment Program from the Burroughs Wellcome Fund; Bulgari Women & Science Fellowship in COVID-19 Research; Robert S. Wennett PostDoctoral Fellowship; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program) [UL1 TR001866]; Shapiro-Silverberg Fund for the Advancement of Translational Research	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Foundation; Molecular Observatory; SLAC National Accelerator Laboratory(Stanford UniversityUnited States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SRL Structural Molecular Biology Program; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Mason University Fast Grant - NSF; Caltech Merkin Institute for Translational Research; Hanna Gray Fellowship Program from the Howard Hughes Medical Institute; Postdoctoral Enrichment Program from the Burroughs Wellcome Fund; Bulgari Women & Science Fellowship in COVID-19 Research; Robert S. Wennett PostDoctoral Fellowship; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program); Shapiro-Silverberg Fund for the Advancement of Translational Research	We thank all of the study participants and clinical staff. We thank members of the Bjorkman, Nussenzweig, and Bieniasz laboratories for helpful discussions; and Dr. Jost Vielmetter, Pauline Hoffman, and the Protein Expression Center in the Beckman Institute at Caltech for expression assistance. Electron microscopy was performed in the Caltech Beckman Institute Resource Center for Transmission Electron Microscopy with assistance from Dr. Songye Chen. We thank the Gordon and Betty Moore Foundation and the Beckman Foundation for gifts to Caltech to support the Molecular Observatory (Dr. Jens Kaiser, director), and Drs. Silvia Russi, Aina Cohen, and Clyde Smith and the beamline staff at SSRL for data collection assistance. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-c76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P41GM103393). This work was supported by NIH grants R37-AI64003 (to P.D.B.), R01AI78788 (to T.H.), P01-AI138938-S1 (to P.J.B. and M.C.N.), K99 AI153465 (to A.I.F.), and 2U19AI111825 (to M.C.N.). This work was also supported by a George Mason University Fast Grant (to P.J.B.), NSF grant no. GRFP DGE-1745301 (to A.T.D.), and by the Caltech Merkin Institute for Translational Research (to P.J.B.). C.O.B was supported by the Hanna Gray Fellowship Program from the Howard Hughes Medical Institute and the Postdoctoral Enrichment Program from the Burroughs Wellcome Fund. F.M. was supported by the Bulgari Women & Science Fellowship in COVID-19 Research. C.G. was supported by the Robert S. Wennett PostDoctoral Fellowship, in part by the National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program, grant no. UL1 TR001866), and by the Shapiro-Silverberg Fund for the Advancement of Translational Research. M.C.N. and P.D.B. are Howard Hughes Medical Institute investigators. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NIAID, or NIH.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bjorkman PJ, 2021, BIORXIV, DOI [10.1101/2021.02.14.431043, DOI 10.1101/2021.02.14.431043, 10. 1101/2021.02.14.431043]; Bowers K.J., 2006, P 2006 ACM IEEE C SU, pUSA, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; DeWitt WS, 2018, MOL BIOL EVOL, V35, P1253, DOI 10.1093/molbev/msy020; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujino T, 2021, EMERG INFECT DIS, V27, P1243, DOI 10.3201/eid2704.210138; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gaebler C, 2019, J EXP MED, V216, P2253, DOI 10.1084/jem.20190896; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hsieh Ching-Lin, 2020, Science, V369, P1501, DOI [10.1101/2020.05.30.125484, 10.1126/science.abd0826]; Hurlburt Nicholas K, 2020, bioRxiv, DOI [10.1038/s41467-020-19231-9, 10.1101/2020.06.12.148692]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/B978-0-12-381270-4.00019-6, 10.1016/S0076-6879(11)87019-9]; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Luchsinger Larry L, 2020, medRxiv, DOI 10.1101/2020.06.08.20124792; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Muecksch F, 2021, J INFECT DIS, V223, P389, DOI 10.1093/infdis/jiaa659; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sakharkar M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6916; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sokal Aurelien, 2021, Cell, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Tan Timothy J C, 2021, bioRxiv, DOI 10.1101/2021.01.26.428356; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Terwilliger TC, 2018, NAT METHODS, V15, P905, DOI 10.1038/s41592-018-0173-1; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Volz E., 2020, PREPRINT MEDRXIV, DOI DOI 10.1101/2020.12.30.20249034; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	82	93	93	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1853	+		10.1016/j.immuni.2021.07.008	http://dx.doi.org/10.1016/j.immuni.2021.07.008		AUG 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34331873	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-18	WOS:000684589700020
J	Zhou, C; Chen, X; Planells-Cases, R; Chu, JC; Wang, L; Cao, LM; Li, ZH; Lopez-Cayuqueo, KI; Xie, YD; Ye, SW; Wang, X; Ullrich, F; Ma, SX; Fang, YY; Zhang, XM; Qian, ZK; Liang, XZ; Cai, SQ; Jiang, ZF; Zhou, DM; Leng, QB; Xiao, TS; Lan, K; Yang, JB; Li, HB; Peng, C; Qiu, ZZ; Jentsch, TJ; Xiao, H				Zhou, Chun; Chen, Xia; Planells-Cases, Rosa; Chu, Jiachen; Wang, Li; Cao, Limin; Li, Zhihong; Lopez-Cayuqueo, Karen, I; Xie, Yadong; Ye, Shiwei; Wang, Xiang; Ullrich, Florian; Ma, Shixin; Fang, Yiyuan; Zhang, Xiaoming; Qian, Zhikang; Liang, Xiaozheng; Cai, Shi-Qing; Jiang, Zhengfan; Zhou, Dongming; Leng, Qibin; Xiao, Tsan S.; Lan, Ke; Yang, Jinbo; Li, Huabin; Peng, Chao; Qiu, Zhaozhu; Jentsch, Thomas J.; Xiao, Hui			Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity	IMMUNITY			English	Article							LEUCINE-RICH REPEAT; CYCLIC GMP-AMP; ESSENTIAL COMPONENT; IFN RESPONSE; ACTIVATION; PROTEIN; 2ND-MESSENGER; PHYSIOLOGY; ADAPTER; KINASE	The enzyme cyclic GMP-AMP synthase (cGAS) senses cytosolic DNA in infected and malignant cells and catalyzes the formation of 2'3'cGMP-AMP (cGAMP), which in turn triggers interferon (IFN) production via the STING pathway. Here, we examined the contribution of anion channels to cGAMP transfer and anti-viral defense. A candidate screen revealed that inhibition of volume-regulated anion channels (VRACs) increased propagation of the DNA virus HSV-1 but not the RNA virus VSV. Chemical blockade or genetic ablation of LRRC8A/SWELL1, a VRAC subunit, resulted in defective IFN responses to HSV-1. Biochemical and electrophysiological analyses revealed that LRRC8A/LRRC8E-containing VRACs transport cGAMP and cyclic dinucleotides across the plasma membrane. Enhancing VRAC activity by hypotonic cell swelling, cisplatin, GTP gamma S, or the cytokines TNF or interleukin-1 increased STING-dependent IFN response to extracellular but not intracellular cGAMP. Lrrc8e(-/-) mice exhibited impaired IFN responses and compromised immunity to HSV-1. Our findings suggest that cell-to-cell transmission of cGAMP via LRRC8/VRAC channels is central to effective anti-viral immunity.	[Zhou, Chun; Chen, Xia; Wang, Li; Cao, Limin; Xie, Yadong; Ma, Shixin; Xiao, Hui] Chinese Acad Sci, Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Pasteur Shan, Ctr Microbes Dev & Hlth,CAS Key Lab Mol Virol & I, Shanghai 200031, Peoples R China; [Chen, Xia; Yang, Jinbo] Lanzhou Univ, Coliege Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Planells-Cases, Rosa; Lopez-Cayuqueo, Karen, I; Ullrich, Florian; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Planells-Cases, Rosa; Lopez-Cayuqueo, Karen, I; Ullrich, Florian; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Chu, Jiachen; Qiu, Zhaozhu] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Li, Zhihong; Peng, Chao] Chinese Acad Sci, Shanghai Adv Res Inst, Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China; [Li, Zhihong; Peng, Chao] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China; [Ye, Shiwei; Cai, Shi-Qing] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci, Shanghai 200031, Peoples R China; [Ye, Shiwei; Cai, Shi-Qing] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Wang, Xiang; Fang, Yiyuan; Zhang, Xiaoming; Qian, Zhikang; Liang, Xiaozheng; Zhou, Dongming] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Jiang, Zhengfan] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Leng, Qibin] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, State Key Lab Resp Dis, Guangzhou 510180, Guangdong, Peoples R China; [Xiao, Tsan S.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA; [Lan, Ke] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Li, Huabin] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Ctr Allerg & Inflammatory Dis, Shanghai 200031, Peoples R China; [Li, Huabin] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200031, Peoples R China; [Jentsch, Thomas J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johns Hopkins University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Peking University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Case Western Reserve University; Wuhan University; Fudan University; Fudan University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Xiao, H (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Pasteur Shan, Ctr Microbes Dev & Hlth,CAS Key Lab Mol Virol & I, Shanghai 200031, Peoples R China.; Jentsch, TJ (corresponding author), Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany.; Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.; Qiu, ZZ (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA.; Jentsch, TJ (corresponding author), Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany.	zhaozhu@jhmi.edu; jentsch@fmp-berlin.de; huixiao@ips.ac.cn	Ullrich, Florian/AAA-6043-2019; Lopez-Cayuqueo, Karen/ABA-1967-2020; Xiao, Tsan/I-7616-2013	Ullrich, Florian/0000-0002-1153-2040; Lopez-Cayuqueo, Karen/0000-0001-8409-7345; Jentsch, Thomas/0000-0002-3509-2553; Zhou, Chun/0000-0002-9091-3342; Zhou, Dongming/0000-0002-5989-7591; Xiao, Tsan/0000-0001-9688-475X; Xiao, Hui/0000-0001-5304-243X	Key Development and Research project of China [2016YFA0502100]; National Natural Science Foundation of China, China [81720108019, 81725004, 31700784]; Key Cooperation Program of International Partnership Program [153831KYSB20180003]; Chinese Academy of Sciences, China [XDB29030302, 153211KYSB20160001]; Shanghai Municipal Science and Technology Major Project, Shanghai, China [2019SHZDZX02]; State Key Laboratory ofMicrobial Metabolism, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, China [MMLKF16-11]; European Research Council [740537]; European Union; Klingenstein-Simons Fellowship in Neuroscience; Sloan Research Fellowship	Key Development and Research project of China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Key Cooperation Program of International Partnership Program; Chinese Academy of Sciences, China(Chinese Academy of Sciences); Shanghai Municipal Science and Technology Major Project, Shanghai, China; State Key Laboratory ofMicrobial Metabolism, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Klingenstein-Simons Fellowship in Neuroscience; Sloan Research Fellowship(Alfred P. Sloan Foundation)	This study was supported by the Key Development and Research project 2016YFA0502100 of China; the National Natural Science Foundation of China (81720108019, 81725004, and 31700784), China; the Key Cooperation Program of International Partnership Program (153831KYSB20180003), the Strategic Priority Research Program (XDB29030302), and the External Cooperation Program (153211KYSB20160001) of the Chinese Academy of Sciences, China; the Shanghai Municipal Science and Technology Major Project (2019SHZDZX02), Shanghai, China; the JointResearch grantwith State Key Laboratory ofMicrobial Metabolism, School of Life Science and Biotechnology, Shanghai Jiao Tong University (MMLKF16-11 to C.P.), Shanghai, China; the European Research Council Advanced Grant 740537 (VolSignal) to T.J.J., European Union; and the Klingenstein-Simons Fellowship in Neuroscience and the Sloan Research Fellowship to Z.Q., USA.	Ablasser A, 2020, NAT IMMUNOL, V21, P17, DOI 10.1038/s41590-019-0556-1; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Best L, 2010, ISLETS, V2, P59, DOI 10.4161/isl.2.2.11171; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; CALDWELL JH, 1986, J MEMBRANE BIOL, V89, P85, DOI 10.1007/BF01870898; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Christensen MH, 2016, EMBO J, V35, P1385, DOI 10.15252/embj.201593458; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Du M, 2015, J IMMUNOL, V194, P4477, DOI 10.4049/jimmunol.1402777; Friard J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00328; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gentili M, 2019, CELL REP, V26, P3474, DOI 10.1016/j.celrep.2019.03.049; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gradogna A, 2017, J PHYSIOL-LONDON, V595, P6719, DOI 10.1113/JP274795; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holmgren AM, 2017, CELL MOL IMMUNOL, V14, P14, DOI 10.1038/cmi.2016.36; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Li FM, 2015, CANCER CELL, V27, P698, DOI 10.1016/j.ccell.2015.04.001; Liu HP, 2019, EMBO REP, V20, DOI 10.15252/embr.201846293; Luck JC, 2018, J BIOL CHEM, V293, P11796, DOI 10.1074/jbc.RA118.003853; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Ma SX, 2017, J EXP MED, V214, P1471, DOI 10.1084/jem.20161149; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Nilius B, 1999, J PHYSIOL-LONDON, V516, P67, DOI 10.1111/j.1469-7793.1999.067aa.x; Osei-Owusu J, 2018, CURR TOP MEMBR, V81, P177, DOI 10.1016/bs.ctm.2018.07.005; Pan D, 2018, J VIROL, V92, DOI 10.1128/JVI.00675-18; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Platt CD, 2017, J ALLERGY CLIN IMMUN, V140, P1651, DOI 10.1016/j.jaci.2016.12.974; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Stempel M, 2019, EMBO J, V38, DOI 10.15252/embj.2018100983; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Voets T, 1998, J PHYSIOL-LONDON, V506, P341, DOI 10.1111/j.1469-7793.1998.341bw.x; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Wilson CS, 2019, J NEUROCHEM, V151, P255, DOI 10.1111/jnc.14711; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang JH, 2019, NEURON, V102, P813, DOI 10.1016/j.neuron.2019.03.029; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou Y, 2020, IMMUNITY, V52, P357, DOI 10.1016/j.immuni.2020.01.014	65	93	98	4	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					767	U305		10.1016/j.immuni.2020.03.016	http://dx.doi.org/10.1016/j.immuni.2020.03.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32277911	Green Accepted, Bronze			2022-12-18	WOS:000535371100011
J	Koyama, M; Mukhopadhyay, P; Schuster, IS; Henden, AS; Hulsdunker, J; Varelias, A; Vetizou, M; Kuns, RD; Robb, RJ; Zhang, P; Blazar, BR; Thomas, R; Begun, J; Waddell, N; Trinchieri, G; Zeiser, R; Clouston, AD; Degli-Esposti, MA; Hill, GR				Koyama, Motoko; Mukhopadhyay, Pamela; Schuster, Iona S.; Henden, Andrea S.; Huelsduenker, Jan; Varelias, Antiopi; Vetizou, Marie; Kuns, Rachel D.; Robb, Renee J.; Zhang, Ping; Blazar, Bruce R.; Thomas, Ranjeny; Begun, Jakob; Waddell, Nicola; Trinchieri, Giorgio; Zeiser, Robert; Clouston, Andrew D.; Degli-Esposti, Mariapia A.; Hill, Geoffrey R.			MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota	IMMUNITY			English	Article							IDIOPATHIC PNEUMONIA SYNDROME; DENDRITIC CELLS; T-CELLS; IN-VIVO; MARROW-TRANSPLANTATION; ACUTE GVHD; B-CELLS; PREVENTION; EXPRESSION; INDUCTION	Graft-versus-host disease (GVHD) in the gastrointestinal (GI) tract is the principal determinant of lethality following allogeneic bone marrow transplantation (BMT). Here, we examined the mechanisms that initiate GVHD, including the relevant antigen-presenting cells. MHC class II was expressed on intestinal epithelial cells (IECs) within the ileum at steady state but was absent from the IECs of germ-free mice. IEC-specific deletion ofMHC class II prevented the initiation of lethal GVHD in the GI tract. MHC class II expression on IECs was absent frommice deficient in the TLR adaptors MyD88 and TRIF and required IFN gamma secretion by lamina propria lymphocytes. IFN gamma responses are characteristically driven by IL-12 secretion from myeloid cells. Antibiotic-mediated depletion of the microbiota inhibited IL-12/23p40 production by ileal macrophages. IL-12/23p40 neutralization prevented MHC class II upregulation on IECs and initiation of lethal GVHD in the GI tract. Thus, MHCclass II expression by IECs in the ileum initiates lethal GVHD, and blockade of IL-12/23p40 may represent a readily translatable therapeutic strategy.	[Koyama, Motoko; Henden, Andrea S.; Varelias, Antiopi; Kuns, Rachel D.; Robb, Renee J.; Zhang, Ping; Hill, Geoffrey R.] QIMR Berghofer Med Res Inst, Bone Marrow Transplantat Lab, Dept Immunol, Brisbane, Qld 4006, Australia; [Mukhopadhyay, Pamela; Waddell, Nicola] QIMR Berghofer Med Res Inst, Med Genom Lab, Genet & Computat Biol Dept, Brisbane, Qld 4006, Australia; [Schuster, Iona S.; Degli-Esposti, Mariapia A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Crawley, WA 6009, Australia; [Schuster, Iona S.; Degli-Esposti, Mariapia A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; [Schuster, Iona S.; Degli-Esposti, Mariapia A.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Schuster, Iona S.; Degli-Esposti, Mariapia A.] Monash Univ, Biomed Discovery Inst, Dept Microbiol, Clayton, Vic 3800, Australia; [Henden, Andrea S.; Hill, Geoffrey R.] Royal Brisbane & Womens Hosp, Canc Care Serv, Dept Haematol & Bone Marrow Transplantat, Brisbane, Qld 4029, Australia; [Huelsduenker, Jan; Zeiser, Robert] Albert Ludwigs Univ Freiburg, Freiburg Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany; [Huelsduenker, Jan] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79085 Freiburg, Germany; [Huelsduenker, Jan] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Vetizou, Marie; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Thomas, Ranjeny] Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia; [Begun, Jakob] Univ Queensland, Translat Res Inst, Mater Res Inst, Brisbane, Qld 4102, Australia; [Clouston, Andrew D.] Envoi Specialist Pathologists, Brisbane, Qld 4006, Australia; [Koyama, Motoko; Hill, Geoffrey R.] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA; [Hill, Geoffrey R.] Univ Washington, Div Med Oncol, Seattle, WA 98109 USA	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Western Australia; Lions Eye Institute; University of Western Australia; Monash University; Monash University; Royal Brisbane & Women's Hospital; University of Freiburg; University of Freiburg; University of Freiburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; Mater Research; University of Queensland; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Koyama, M; Hill, GR (corresponding author), QIMR Berghofer Med Res Inst, Bone Marrow Transplantat Lab, Dept Immunol, Brisbane, Qld 4006, Australia.; Hill, GR (corresponding author), Royal Brisbane & Womens Hosp, Canc Care Serv, Dept Haematol & Bone Marrow Transplantat, Brisbane, Qld 4029, Australia.; Koyama, M; Hill, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA.; Hill, GR (corresponding author), Univ Washington, Div Med Oncol, Seattle, WA 98109 USA.	mkoyama@fredhutch.org; grhill@fredhutch.org	Waddell, Nicola/H-4929-2015; Henden, Andrea S/J-1487-2015; Varelias, Antiopi/A-6516-2015; Thomas, Ranjeny/B-4504-2013; Begun, Jakob/J-6793-2014; Hill, Geoffrey/O-2630-2016	Waddell, Nicola/0000-0002-3950-2476; Henden, Andrea S/0000-0003-2261-169X; Thomas, Ranjeny/0000-0002-0518-8386; Begun, Jakob/0000-0001-5256-7672; Zeiser, Robert/0000-0001-6565-3393; zhang, ping/0000-0002-0311-6725; Varelias, Antiopi/0000-0002-3437-9659; Hill, Geoffrey/0000-0003-2994-0429; Degli-Esposti, Mariapia/0000-0002-7808-5935	National Health and Medical Research Council (NHMRC), Australia [APP1086685]; National Heart, Lung, and Blood Institute of the NIH, United States [R01HL148164]; NIH [R37 AI34495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL148164] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart, Lung, and Blood Institute of the NIH, United States; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From QIMR Berghofer, we thank C. Winterford for expert preparation of histology samples; M. Rist, P. Hall, and G. Chojnowski for expert cell sorting; M. Flynn for expert generation of the graphics; and the animal facility for attentive animal care. We thank S. Robine (Institut Curie-CNRS, France) and R.S. Blumberg (Harvard Medical School, USA) for the VillinCre-ERT2 mice. This work was supported by research grants from the National Health and Medical Research Council (NHMRC), Australia (APP1086685) and the National Heart, Lung, and Blood Institute of the NIH (R01HL148164), United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. M.K. was a Leukaemia Foundation of Australia fellow. N.W. is a NHMRC senior research fellow. M.A.D.-E. is a NHMRC principal research fellow. G.R.H. was a NHMRC senior principal research fellow. R.Z. is a fellow of Deutsche Krebshilfe (111639), Germany. B.R.B. is supported in part by the NIH (R37 AI34495).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Andermann TM, 2018, BIOL BLOOD MARROW TR, V24, P1322, DOI 10.1016/j.bbmt.2018.02.009; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Braga RB, 2011, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON ADVANCED GEOGRAPHIC INFORMATION SYSTEMS, APPLICATIONS, AND SERVICES (GEOPROCESSING 2011), P17; Burman AC, 2007, BLOOD, V110, P1064, DOI 10.1182/blood-2006-12-063982; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hayase E, 2017, J EXP MED, V214, P3507, DOI 10.1084/jem.20170418; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hixon JA, 2002, BIOL BLOOD MARROW TR, V8, P316, DOI 10.1053/bbmt.2002.v8.pm12108917; Hulsdunker J, 2018, BLOOD, V131, P1858, DOI 10.1182/blood-2017-10-812891; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kennedy GA, 2014, LANCET ONCOL, V15, P1451, DOI 10.1016/S1470-2045(14)71017-4; Koyama M, 2016, BLOOD, V127, P2963, DOI 10.1182/blood-2016-02-697250; Koyama M, 2015, J EXP MED, V212, P1303, DOI 10.1084/jem.20150329; Koyama M, 2012, NAT MED, V18, P135, DOI 10.1038/nm.2597; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Li HM, 2012, J IMMUNOL, V188, P3804, DOI 10.4049/jimmunol.1102795; Li HM, 2011, J IMMUNOL, V186, P230, DOI 10.4049/jimmunol.1002965; LONDEI M, 1984, NATURE, V312, P639, DOI 10.1038/312639a0; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Markey KA, 2018, CLIN CANCER RES, V24, P1604, DOI 10.1158/1078-0432.CCR-17-2148; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; MCDONALD GB, 1987, J CLIN PATHOL, V40, P312, DOI 10.1136/jcp.40.3.312; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pidala J, 2018, HAEMATOLOGICA, V103, P531, DOI 10.3324/haematol.2017.171199; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; SKOSKIEWICZ MJ, 1985, J EXP MED, V162, P1645, DOI 10.1084/jem.162.5.1645; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stevanovic S, 2013, BLOOD, V122, P1963, DOI 10.1182/blood-2012-12-470872; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Toubai T, 2012, BLOOD, V119, P3844, DOI 10.1182/blood-2011-10-384057; Unanue ER, 2016, ANNU REV IMMUNOL, V34, P265, DOI 10.1146/annurev-immunol-041015-055420; Varelias A, 2017, BLOOD, V129, P2172, DOI 10.1182/blood-2016-08-732628; Varelias A, 2015, BLOOD, V125, P2435, DOI 10.1182/blood-2014-07-590232; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; VOSSEN JM, 1990, EUR J CLIN MICROBIOL, V9, P14, DOI 10.1007/BF01969527; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zeiser R, 2017, NEW ENGL J MED, V377, P2167, DOI 10.1056/NEJMra1609337; Zhang P, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7152	65	93	94	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					885	+		10.1016/j.immuni.2019.08.011	http://dx.doi.org/10.1016/j.immuni.2019.08.011			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31542340	Green Accepted, Bronze			2022-12-18	WOS:000497811300012
J	Martinez-Lopez, M; Iborra, S; Conde-Garrosa, R; Mastrangelo, A; Danne, C; Mann, ER; Reid, DM; Gaboriau-Routhiau, V; Chaparro, M; Lorenzo, MP; Minnerup, L; Saz-Leal, P; Slack, E; Kemp, B; Gisbert, JP; Dzionek, A; Robinson, MJ; Ruperez, FJ; Cerf-Bensussan, N; Brown, GD; Bernardo, D; LeibundGut-Landmann, S; Sancho, D				Martinez-Lopez, Maria; Iborra, Salvador; Conde-Garrosa, Ruth; Mastrangelo, Annalaura; Danne, Camille; Mann, Elizabeth R.; Reid, Delyth M.; Gaboriau-Routhiau, Valerie; Chaparro, Maria; Lorenzo, Maria P.; Minnerup, Lara; Saz-Leal, Paula; Slack, Emma; Kemp, Benjamin; Gisbert, Javier P.; Dzionek, Andrzej; Robinson, Matthew J.; Ruperez, Francisco J.; Cerf-Bensussan, Nadine; Brown, Gordon D.; Bernardo, David; LeibundGut-Landmann, Salome; Sancho, David			Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and-22 Production and Promotes Intestinal Barrier Integrity	IMMUNITY			English	Article							C-TYPE LECTIN; INNATE LYMPHOID-CELLS; ROR-GAMMA-T; COMMENSAL BACTERIA; ADAPTIVE IMMUNITY; PEYERS-PATCHES; T(H)17 CELLS; DIFFERENTIATION; IGA; INDUCTION	Production of interleukin-17 (IL-17) and IL-22 by T helper 17 (Th17) cells and group 3 innate lymphoid cells (ILC3s) in response to the gut microbiota ensures maintenance of intestinal barrier function. Here, we examined the mechanisms whereby the immune system detects microbiota in the steady state. A Syk-kinase-coupled signaling pathway in dendritic cells (DCs) was critical for commensal-dependent production of IL-17 and IL-22 by CD4(+) T cells. The Syk-coupled C-type lectin receptor Mincle detected mucosal-resident commensals in the Peyer's patches (PPs), triggered IL-6 and IL-23p19 expression, and thereby regulated function of intestinal Th17- and IL-17-secreting ILCs. Mice deficient in Mincle or with selective depletion of Syk in CD11c(+) cells had impaired production of intestinal RegIII gamma and IgA and increased systemic translocation of gut microbiota. Consequently, Mincle deficiency led to liver inflammation and deregulated lipid metabolism. Thus, sensing of commensals by Mincle and Syk signaling in CD11c(+) cells reinforces intestinal immune barrier and promotes host-microbiota mutualism, preventing systemic inflammation.	[Martinez-Lopez, Maria; Iborra, Salvador; Conde-Garrosa, Ruth; Mastrangelo, Annalaura; Saz-Leal, Paula; Sancho, David] Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Iborra, Salvador] Univ Complutense Madrid, Sch Med, Dept Immunol, 12 Octubre Hlth Res Inst Imas12, Madrid, Spain; [Danne, Camille] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Mann, Elizabeth R.] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester, Lancs, England; [Mann, Elizabeth R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England; [Reid, Delyth M.; Brown, Gordon D.] Univ Aberdeen, MRC, Ctr Med Mycol, Aberdeen Fungal Grp,Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland; [Gaboriau-Routhiau, Valerie] Univ Paris Saclay, INRA Micalis Inst, AgroParisTech, UMR1319, F-78350 Jouy En Josas, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Inst Imagine, Lab Intestinal Immun, INSERM UMR1163, F-75015 Paris, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Chaparro, Maria; Gisbert, Javier P.; Bernardo, David] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa IIS IP, CIBEREHD, Diego Leon 62, Madrid 28006, Spain; [Lorenzo, Maria P.; Ruperez, Francisco J.] Univ San Pablo CEU, Fac Farm, Ctr Metabol & Bioanal CEMBIO, Urbanizac Monteprincipe, Km 0,M501, Alcorcon 28925, Spain; [Minnerup, Lara; Dzionek, Andrzej] MiltenyiBiotec GmbH, Bergisch Gladbach, Germany; [Slack, Emma] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Kemp, Benjamin; Robinson, Matthew J.] Medimmune, Granta Pk, Cambridge CB21 6GH, England; [LeibundGut-Landmann, Salome] Univ Zurich, Vetsuisse Fac, Sect Immunol, Winterthurerstr 266a, CH-8057 Zurich, Switzerland	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; University of Oxford; University of Manchester; University of Manchester; University of Aberdeen; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital de La Princesa; San Pablo CEU University; Miltenyi Biotec; Swiss Federal Institutes of Technology Domain; ETH Zurich; AstraZeneca; Medimmune; University of Zurich	Iborra, S; Sancho, D (corresponding author), Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain.; Iborra, S (corresponding author), Univ Complutense Madrid, Sch Med, Dept Immunol, 12 Octubre Hlth Res Inst Imas12, Madrid, Spain.	siborra@ucm.es; dsancho@cnic.es	Gisbert, Javier P/ABB-7531-2021; Iborra, Salvador/J-2863-2015; Gisbert, Javier P/GRY-2719-2022; Rupérez, Francisco Javier/I-8360-2012; Cerf-Bensussan, nadine/H-9505-2017; Chaparro, María/I-2500-2016; Lorenzo García, Maria Paz/K-4497-2014; Sancho, David/D-3433-2009; Bernardo, David/GXH-8727-2022; Bernardo, David/AAG-8098-2019; Martinez Lopez, Maria/HGA-6834-2022; Slack, Emma/B-1612-2016	Gisbert, Javier P/0000-0003-2090-3445; Iborra, Salvador/0000-0002-1607-1749; Rupérez, Francisco Javier/0000-0001-6457-6234; Cerf-Bensussan, nadine/0000-0003-0665-1245; Chaparro, María/0000-0002-9275-4242; Lorenzo García, Maria Paz/0000-0001-7344-2051; Sancho, David/0000-0003-2890-3984; LeibundGut-Landmann, Salome/0000-0002-5724-4837; Martinez Lopez, Maria/0000-0002-1995-0642; Danne, Camille/0000-0003-0971-8310; Bernardo, David/0000-0002-2843-6696; Slack, Emma/0000-0002-2473-1145; Mastrangelo, Annalaura/0000-0003-2650-0444	Spanish Ministerio de Educacion [AP2010-5935]; Spanish Ministerio de Ciencia, Innovacion, y Universidades (MCIU) [SAF2015-74561-JIN]; Fondos Europeos de Desarrollo Regional (FEDER); Wellcome Trust; MRC Centre for Medical Mycology at the University of Aberdeen; Swiss National Science Foundation [PP00P3_150758]; CNIC; MCIU [SAF2016-79040-R, RD16/0015/0018-REEM]; Agencia Estatal de Investigacion [SAF2016-79040-R]; FEDER [SAF2016-79040-R, RD16/0015/0018-REEM]; Comunidad de Madrid [B2017/BMD-3733 Immunothercan-CM]; FIS-Instituto de Salud Carlos III [RD16/0015/0018-REEM]; Acteria Foundation; Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation [201723]; European Commission [635122-PROCROP H2020]; European Research Council (ERC-2016-Consolidator Grant) [725091]; Pro-CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]; MRC [MR/N006364/2, MR/N006364/1] Funding Source: UKRI	Spanish Ministerio de Educacion(Spanish Government); Spanish Ministerio de Ciencia, Innovacion, y Universidades (MCIU)(Spanish Government); Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Medical Mycology at the University of Aberdeen(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNIC; MCIU; Agencia Estatal de Investigacion; FEDER(European Commission); Comunidad de Madrid(Comunidad de Madrid); FIS-Instituto de Salud Carlos III(Instituto de Salud Carlos III); Acteria Foundation; Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC-2016-Consolidator Grant); Pro-CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the D.S. laboratory and Dr. E. Fernandez-Malave for discussions and critical reading of the manuscript. We appreciate the support of A. Tomas-Loba, G. Sabio, P. Martin, A. Tsilingiri, A.R. Ramiro, C.L. Abram, C.A. Lowell, J.M. Garcia-Lobo, M. Molina, and M.C. Rodriguez for providing reagents and support. We thank the staff at the Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) facilities for technical support. M.M.-L. received a Formacion de Personal Universitario (FPU) fellowship (AP2010-5935) from the Spanish Ministerio de Educacion. S.I. is funded by grant SAF2015-74561-JIN from the Spanish Ministerio de Ciencia, Innovacion, y Universidades (MCIU) and Fondos Europeos de Desarrollo Regional (FEDER). G.D.B and D.M.R. are supported by the Wellcome Trust and the MRC Centre for Medical Mycology at the University of Aberdeen. S.L.L. is supported by the Swiss National Science Foundation (PP00P3_150758). Work in the D.S. laboratory is funded by the CNIC and grant SAF2016-79040-R from MCIU, the Agencia Estatal de Investigacion, and FEDER; B2017/BMD-3733 Immunothercan-CM from Comunidad de Madrid; RD16/0015/0018-REEM from FIS-Instituto de Salud Carlos III, MCIU, and FEDER; the Acteria Foundation; the Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation (201723); the European Commission (635122-PROCROP H2020), and the European Research Council (ERC-2016-Consolidator Grant 725091). The CNIC is supported by the MCIU and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Allen JN, 2017, JOVE-J VIS EXP, DOI 10.3791/55445; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Behler F, 2015, INFECT IMMUN, V83, P184, DOI 10.1128/IAI.02500-14; Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bonnardel J, 2015, CELL REP, V11, P770, DOI 10.1016/j.celrep.2015.03.067; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; COHEN PS, 1995, METHOD ENZYMOL, V253, P309; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Da Silva C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01254; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Eriksson M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00196; Fung TC, 2014, IMMUNOL REV, V260, P35, DOI 10.1111/imr.12186; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geijtenbeek TBH, 2016, NAT REV IMMUNOL, V16, P433, DOI 10.1038/nri.2016.55; Gonzalez-Pena D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020267; Goodyear AW, 2014, J IMMUNOL METHODS, V405, P97, DOI 10.1016/j.jim.2014.01.014; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Iborra S, 2016, IMMUNITY, V45, P788, DOI 10.1016/j.immuni.2016.09.012; Iborra S, 2015, IMMUNOBIOLOGY, V220, P175, DOI 10.1016/j.imbio.2014.09.013; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Mastrangelo A, 2015, ANAL CHIM ACTA, V900, P21, DOI 10.1016/j.aca.2015.10.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Nakamoto N, 2017, CELL REP, V21, P1215, DOI 10.1016/j.celrep.2017.10.022; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pierantonelli I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17187-3; Plant L, 2001, CLIN DIAGN LAB IMMUN, V8, P320, DOI 10.1128/CDLI.8.2.320-324.2001; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; Shah S, 2016, CHEM COMMUN, V52, P10902, DOI 10.1039/c6cc05631h; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Veal DA, 2000, J IMMUNOL METHODS, V243, P191, DOI 10.1016/S0022-1759(00)00234-9; Weiss G, 2012, J IMMUNOL, V189, P2860, DOI 10.4049/jimmunol.1103491; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Whitney PG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004276; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	68	93	101	8	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					446	+		10.1016/j.immuni.2018.12.020	http://dx.doi.org/10.1016/j.immuni.2018.12.020			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709742	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000459006700018
J	Iatsenko, I; Boquete, JP; Lemaitre, B				Iatsenko, Igor; Boquete, Jean-Philippe; Lemaitre, Bruno			Microbiota-Derived Lactate Activates Production of Reactive Oxygen Species by the Intestinal NADPH Oxidase Nox and Shortens Drosophila Lifespan	IMMUNITY			English	Article							GUT MICROBIOTA; HOST-DEFENSE; BACTERIAL-INFECTION; IMMUNE HOMEOSTASIS; ORAL INFECTION; PGRP-SD; PEPTIDOGLYCAN; IMD; LACTOBACILLUS; DYSBIOSIS	Commensal microbes colonize the gut epithelia of virtually all animals and provide several benefits to their hosts. Changes in commensal populations can lead to dysbiosis, which is associated with numerous pathologies and decreased lifespan. Peptidoglycan recognition proteins (PGRPs) are important regulators of the commensal microbiota and intestinal homeostasis. Here, we found that a null mutation in Drosophila PGRP-SD was associated with over-growth of Lactobacillus plantarum in the fly gut and a shortened lifespan. L. plantarum-derived lactic acid triggered the activation of the intestinal NADPH oxidase Nox and the generation of reactive oxygen species (ROS). In turn, ROS production promoted intestinal damage, increased proliferation of intestinal stem cells, and dysplasia. Nox-mediated ROS production required lactate oxidation by the host intestinal lactate dehydrogenase, revealing a host-commensal metabolic crosstalk that is probably broadly conserved. Our findings outline a mechanism whereby host immune dysfunction leads to commensal dysbiosis that in turn promotes age-related pathologies.	[Iatsenko, Igor; Boquete, Jean-Philippe; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Iatsenko, I; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.	igor.iatsenko@epfl.ch; bruno.lemaitre@epfl.ch	Iatsenko, Igor/AAI-6699-2021; Lemaitre, Bruno/T-8146-2019	Iatsenko, Igor/0000-0002-9249-8998; Lemaitre, Bruno/0000-0001-7970-1667	SNSF [3100A0-12079/1]	SNSF(Swiss National Science Foundation (SNSF))	We thank the Bloomington Stock Centre and the Vienna Drosophila Resource Center for fly stocks and Won-Jae Lee and Pascal Hols for providing L. plantarum strains. We are grateful to Claudine Neyen for critical reading of the manuscript. This project was supported by the SNSF grant 3100A0-12079/1.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Capo F, 2016, DEV COMP IMMUNOL, V64, P11, DOI 10.1016/j.dci.2016.01.001; Charroux B, 2018, CELL HOST MICROBE, V23, P215, DOI 10.1016/j.chom.2017.12.007; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Cirstea M, 2018, CELL HOST MICROBE, V23, P10, DOI 10.1016/j.chom.2017.12.008; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Fink C, 2016, MUCOSAL IMMUNOL, V9, P927, DOI 10.1038/mi.2015.112; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gillis CC, 2018, CELL HOST MICROBE, V23, P54, DOI 10.1016/j.chom.2017.11.006; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iatsenko I, 2016, IMMUNITY, V45, P1013, DOI 10.1016/j.immuni.2016.10.029; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kleino A, 2017, IMMUNITY, V47, P635, DOI 10.1016/j.immuni.2017.09.011; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008; Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277; Luo ST, 2017, SCI REP-UK, V7, DOI 10.1038/srep38105; Martino ME, 2017, CURR OPIN MICROBIOL, V38, P165, DOI 10.1016/j.mib.2017.06.004; Monahan A, 2016, IMMUNITY, V45, P951, DOI 10.1016/j.immuni.2016.11.002; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Galardo MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088024; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Overend G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27242; Pais IS, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005710; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Sannino DR, 2018, MBIO, V9, DOI 10.1128/mBio.00155-18; Sekihara S, 2016, J BIOL CHEM, V291, P25077, DOI 10.1074/jbc.M116.761791; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Storelli G, 2018, CELL METAB, V27, P362, DOI 10.1016/j.cmet.2017.11.011; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Vitetta L, 2017, GUT MICROBES, V8, P311, DOI 10.1080/19490976.2017.1279379; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhai ZZ, 2018, IMMUNITY, V48, P897, DOI 10.1016/j.immuni.2018.04.010	70	93	100	6	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					929	+		10.1016/j.immuni.2018.09.017	http://dx.doi.org/10.1016/j.immuni.2018.09.017			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30446385	Bronze, Green Submitted			2022-12-18	WOS:000450752200017
J	Hu, GQ; Cui, KR; Fang, DF; Hirose, S; Wang, X; Wangsa, D; Jin, WF; Ried, T; Liu, PT; Zhu, JF; Rothenberg, EV; Zhao, KJ				Hu, Gangqing; Cui, Kairong; Fang, Difeng; Hirose, Satoshi; Wang, Xun; Wangsa, Darawalee; Jin, Wenfei; Ried, Thomas; Liu, Pentao; Zhu, Jinfang; Rothenberg, Ellen V.; Zhao, Keji			Transformation of Accessible Chromatin and 3D Nucleome Underlies Lineage Commitment of Early T Cells	IMMUNITY			English	Article							HI-C DATA; LONG-RANGE INTERACTIONS; TRANSCRIPTIONAL CONTROL; HUMAN GENOME; CHROMOSOME ORGANIZATION; TOPOLOGICAL DOMAINS; GERMINAL CENTER; SINGLE CELLS; STEM-CELL; RNA-SEQ	How chromatin reorganization coordinates differentiation and lineage commitment from hematopoietic stem and progenitor cells (HSPCs) to mature immune cells has not been well understood. Here, we carried out an integrative analysis of chromatin accessibility, topologically associating domains, AB compartments, and gene expression from HSPCs to CD4(+)CD8(+) T cells. We found that abrupt genome-wide changes at all three levels of chromatin organization occur during the transition from double-negative stage 2 (DN2) to DN3, accompanying the T lineage commitment. The transcription factor BCL11B, a critical regulator of T cell commitment, is associated with increased chromatin interaction, and Bcl11b deletion compromised chromatin interaction at its target genes. We propose that these large-scale and concerted changes in chromatin organization present an energy barrier to prevent the cell from reversing its fate to earlier stages or redirecting to alternatives and thus lock the cell fate into the T lineages.	[Hu, Gangqing; Cui, Kairong; Jin, Wenfei; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Fang, Difeng; Zhu, Jinfang] NIAID, Lab Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hirose, Satoshi; Wang, Xun; Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Wangsa, Darawalee; Ried, Thomas] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wellcome Trust Sanger Institute	Hu, GQ; Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.; Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	hug21@nhlbi.nih.gov; evroth@its.caltech.edu; zhaok@nhlbi.nih.gov	Hu, Gangqing/ABA-3507-2020; Hirose, Satoshi/CAF-1500-2022; Zhu, Jinfang/B-7574-2012; Jin, Wenfei/V-9944-2019; Jin, Wenfei/H-5330-2011; FANG, DIFENG/G-7796-2018; Hu, Gangqing/K-5849-2012	Hirose, Satoshi/0000-0001-7825-501X; Zhu, Jinfang/0000-0002-0117-4745; Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739; FANG, DIFENG/0000-0003-2105-6743; Hu, Gangqing/0000-0001-5453-6888; Rothenberg, Ellen/0000-0002-3901-347X	Division of Intramural Research of the National Cancer Institute; National Institute of Allergy and Infectious Diseases; NHLBI; NIH [R01 AI083514]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, R01AI083514] Funding Source: NIH RePORTER	Division of Intramural Research of the National Cancer Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the National Heart, Lung, and Blood Institute (NHLBI) DNA Sequencing and Genomics Core facility for sequencing, the NHLBI Systems Biology Center and the NIH Biowulf High Performance Computing systems for computing service, the NHLBI Flow Cytometry Core facility for cell sorting, Dr. X. Zheng and Dr. B. Stanton for constructive comments, Dr. D. Northrup for assistance with cell sorting, Dr. G. Ren and Dr. K. Placek for assistance with cell isolation, Dr. H. Shin and Prof. X.J. Zhou (University of California, Los Angeles) for sharing the code of TopDOM, Mr. Timothy Zhou for setting up a local WashU genome browser, and Dr. D. Li and Prof. T. Wang (Washington University in St. Louis) for hosting the online WashU Epigenome Browser session. The work was supported by the Division of Intramural Research of the National Cancer Institute (T.R.), National Institute of Allergy and Infectious Diseases (J.Z.), and NHLBI (K.Z.) and NIH grant R01 AI083514 (E.V.R.).	Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hu GQ, 2016, IMMUNITY, V45, P459, DOI 10.1016/j.immuni.2016.08.020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Krysinska H, 2007, MOL CELL BIOL, V27, P878, DOI 10.1128/MCB.01915-06; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Li WY, 2015, BIOINFORMATICS, V31, P960, DOI 10.1093/bioinformatics/btu747; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Marecki S, 2004, MOL IMMUNOL, V40, P723, DOI 10.1016/j.molimm.2003.08.007; Martin P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10069; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer EM, 2011, SEMIN IMMUNOL, V23, P317, DOI 10.1016/j.smim.2011.08.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Oravecz A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9823; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Placek K, 2017, NAT IMMUNOL, V18, P1035, DOI 10.1038/ni.3812; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren G, 2017, MOL CELL, V67, P1049, DOI 10.1016/j.molcel.2017.08.026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shin HJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1505; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stadhouders R., 2018, BIORXIV; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zheng XB, 2015, CELL REP, V13, P1505, DOI 10.1016/j.celrep.2015.10.004; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440	70	93	94	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					227	+		10.1016/j.immuni.2018.01.013	http://dx.doi.org/10.1016/j.immuni.2018.01.013			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466755	Green Accepted, Bronze			2022-12-18	WOS:000425507800010
J	Underhill, DM; Pearlman, E				Underhill, David M.; Pearlman, Eric			Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street	IMMUNITY			English	Review							C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; MANNOSE-BINDING LECTIN; NEUTROPHIL EXTRACELLULAR TRAPS; CANDIDA-ALBICANS COLONIZATION; CHAIN 3 PROTEIN; DELTA T-CELLS; HOST-DEFENSE; NLRP3 INFLAMMASOME; TH17 CELLS	We are exposed to a wide spectrum of fungi including innocuous environmental organisms, opportunistic pathogens, commensal organisms, and fungi that can actively and explicitly cause disease. Much less is understood about effective host immunity to fungi than is generally known about immunity to bacterial and viral pathogens. Innate and adaptive arms of the immune system are required for effective host defense against Candida, Aspergillus, Cryptococcus, and others, with specific elements of the host response regulating specific types of fungal infections (e.g., mucocutaneous versus systemic). Here we will review themes and controversies that are currently shaping investigation of antifungal immunity (primarily to Candida and Aspergillus) and will also examine the emerging field of the role of fungi in the gut microbiome.	[Underhill, David M.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Underhill, David M.] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Immunol, Los Angeles, CA 90048 USA; [Pearlman, Eric] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Pearlman, Eric] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Pearlman, Eric] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu; eric.pearlman@uci.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X	NATIONAL EYE INSTITUTE [R01EY018612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093426] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018612] Funding Source: Medline; NIDDK NIH HHS [R01 DK093426] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdel-Rahman SM, 2012, J DERMATOL SCI, V67, P147, DOI 10.1016/j.jdermsci.2012.05.003; Ahmad Dina S, 2013, Avicenna J Med, V3, P37, DOI 10.4103/2231-0770.114121; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Babula O, 2003, CLIN INFECT DIS, V37, P733, DOI 10.1086/377234; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Caffrey AK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004625; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Casadevall A, 2012, CELL HOST MICROBE, V11, P447, DOI 10.1016/j.chom.2012.04.004; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Clark H. L., 2016, J IMMUNOL IN PRESS; Conti HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/jimmunol.1500909; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crosdale DJ, 2001, J INFECT DIS, V184, P653, DOI 10.1086/322791; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; De Luca A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003486; Deepe GS, 2009, J INFECT DIS, V200, P142, DOI 10.1086/599333; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Dollive S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071806; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Drummond R.A., 2015, MUCOSAL IMMUNOL; Drummond RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003417; Dupuy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090899; Eddens T, 2015, J IMMUNOL, V195, P185, DOI 10.4049/jimmunol.1403162; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Espinosa V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003940; Falcone EL, 2012, CURR OPIN INFECT DIS, V25, P658, DOI 10.1097/QCO.0b013e328358b0a4; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Jhingran A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004589; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Karthikeyan RS, 2015, J INFECT DIS, V211, P130, DOI 10.1093/infdis/jiu381; Kashem SW, 2015, IMMUNITY, V42, P356, DOI 10.1016/j.immuni.2015.01.008; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Ketelut-Carneiro N, 2015, J IMMUNOL, V194, P4507, DOI 10.4049/jimmunol.1402321; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Lanternier F, 2013, CURR OPIN PEDIATR, V25, P736, DOI 10.1097/MOP.0000000000000031; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039; Li SS, 2013, CELL HOST MICROBE, V14, P387, DOI 10.1016/j.chom.2013.09.007; Liese J, 2000, J PEDIATR-US, V137, P687, DOI 10.1067/mpd.2000.109112; Lionakis MS, 2012, CURR FUNGAL INFECT R, V6, P11, DOI 10.1007/s12281-011-0076-4; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Lobato-Pascual A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057406; Loures FV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004643; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; MILLER ME, 1968, LANCET, V2, P60; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Miyake Y, 2015, J IMMUNOL, V194, P5366, DOI 10.4049/jimmunol.1402429; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Ngo LY, 2014, J INFECT DIS, V209, P109, DOI 10.1093/infdis/jit413; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Ouederni M, 2014, CLIN INFECT DIS, V58, P204, DOI 10.1093/cid/cit722; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Skevaki C, 2015, CLIN EXP IMMUNOL, V180, P165, DOI 10.1111/cei.12578; Smeekens SP, 2013, EMBO MOL MED, V5, P805, DOI 10.1002/emmm.201201678; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tam JM, 2014, J INFECT DIS, V210, P1844, DOI 10.1093/infdis/jiu290; Taylor PR, 2014, J IMMUNOL, V192, P3319, DOI 10.4049/jimmunol.1302235; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; de Sousa MDT, 2014, CLIN INFECT DIS, V58, P1734, DOI 10.1093/cid/ciu168; Thomas PA, 2013, CLIN MICROBIOL INFEC, V19, P210, DOI 10.1111/1469-0691.12126; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Trautwein-Weidner K, 2015, MUCOSAL IMMUNOL, V8, P221, DOI 10.1038/mi.2014.57; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van der Velden WJFM, 2013, BIOL BLOOD MARROW TR, V19, P329, DOI 10.1016/j.bbmt.2012.11.008; Vautier S, 2015, CELL MICROBIOL, V17, P445, DOI 10.1111/cmi.12388; Vautier S, 2012, INFECT IMMUN, V80, P4216, DOI 10.1128/IAI.00559-12; Viriyakosol S, 2014, INFECT IMMUN, V82, P1147, DOI 10.1128/IAI.01355-13; Viriyakosol S, 2013, MBIO, V4, DOI 10.1128/mBio.00597-12; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wevers BA, 2014, CELL HOST MICROBE, V15, P494, DOI 10.1016/j.chom.2014.03.008; Whitney PG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004276; Wu SY, 2013, J IMMUNOL, V190, P3427, DOI 10.4049/jimmunol.1202122; Wuthrich M, 2015, EUR J IMMUNOL, V45, P2542, DOI 10.1002/eji.201545591; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Zhang HB, 2013, EUR J IMMUNOL, V43, P2671, DOI 10.1002/eji.201242891; Zhao XQ, 2014, J BIOL CHEM, V289, P30052, DOI 10.1074/jbc.M114.588574; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	147	93	96	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					845	858		10.1016/j.immuni.2015.10.023	http://dx.doi.org/10.1016/j.immuni.2015.10.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588778	Bronze, Green Accepted			2022-12-18	WOS:000366846000007
J	Benezech, C; Mader, E; Desanti, G; Khan, M; Nakamura, K; White, A; Ware, CF; Anderson, G; Caamano, JH				Benezech, Cecile; Mader, Emma; Desanti, Guillaume; Khan, Mahmood; Nakamura, Kyoko; White, Andrea; Ware, Carl F.; Anderson, Graham; Caamano, Jorge H.			Lymphotoxin-beta Receptor Signaling through NF-kappa B2-RelB Pathway Reprograms Adipocyte Precursors as Lymph Node Stromal Cells	IMMUNITY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; NF-KAPPA-B; INDUCER CELLS; ORGAN DEVELOPMENT; IMMUNE-RESPONSE; PPAR-GAMMA; ALPHA-BETA; ROR-GAMMA; T-CELLS; IN-VIVO	Lymph node development during embryogenesis involves lymphotoxin-beta receptor engagement and subsequent differentiation of a poorly defined population of mesenchymal cells into lymphoid tissue organizer cells. Here, we showed that embryonic mesenchymal cells with characteristics of adipocyte precursors present in the microenvironment of lymph nodes gave rise to lymph node organizer cells. Signaling through the lymphotoxin-beta receptor controlled the fate of adipocyte precursor cells by blocking adipogenesis and instead promoting lymphoid tissue stromal cell differentiation. This effect involved activation of the NF-kappa B2-RelB signaling pathway and inhibition of the expression of the key adipogenic factors Ppar gamma and Cebp alpha. In vivo organogenesis assays show that embryonic and adult adipocyte precursor cells can migrate into newborn lymph nodes and differentiate into a variety of lymph node stromal cells. Thus, we propose that adipose tissues act as a source of lymphoid stroma for lymph nodes and other lymphoid structures associated with fat.	[Benezech, Cecile; Mader, Emma; Desanti, Guillaume; Khan, Mahmood; Nakamura, Kyoko; White, Andrea; Anderson, Graham; Caamano, Jorge H.] Univ Birmingham, Sch Immun & Infect, IBR MRC Ctr Immune Regulat, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	University of Birmingham; Sanford Burnham Prebys Medical Discovery Institute	Benezech, C (corresponding author), Univ Birmingham, Sch Immun & Infect, IBR MRC Ctr Immune Regulat, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	c.benezech@bham.ac.uk; j.caamano@bham.ac.uk	Nakamura, Kyoko/B-4184-2013; Desanti, Guillaume/ABA-6731-2020; Caamano, Jorge/I-6778-2012; Caamano, Jorge/O-7530-2019	Desanti, Guillaume/0000-0003-4902-1868; Caamano, Jorge/0000-0003-3530-7056; Caamano, Jorge/0000-0003-3530-7056; Benezech, Cecile/0000-0002-2613-1418; anderson, graham/0000-0002-2917-4085	National Institutes of Health [AI33068]; MRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R01AI067890, R01AI033068] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D018234/1] Funding Source: researchfish; Medical Research Council [G9818340B, G1000213] Funding Source: researchfish; BBSRC [BB/D018234/1] Funding Source: UKRI; MRC [G1000213] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the personnel of the Biomedical Services Unit of the University of Birmingham for taking care of our animal colonies and to R. Bird for cell sorting. We are indebted to K. Pfeffer, D. Kioussis, S. Srinivas, M. Pasparakis, and R. Reed for providing mouse strains, tissues, and reagents. We want to thank E. Jenkinson for continuous support. We are thankful to P. Lane, A. Rot, V. Bekiaris, A. Brendolan, M. Coles, T. Cupedo, J. Girdlestone, R. Golub,. K. Serre, and S. van de Pavert for comments on the manuscript. We are grateful to F. Weih for discussing data before publication. This work was supported by a Biotechnology and Biological Sciences Research Council project grant to J.H.C. and G.A., the European Union FP7 integrated project Inflammation and Cancer Research in Europe (INFLA-CARE) to J.C., and the College of Medical and Dental Sciences, University of Birmingham. The work in C.F.W.'s laboratory was supported by National Institutes of Health grant AI33068. E.M. was the recipient of an MRC doctoral training account postdoctoral studentship. Author contributions are as follows: C.B., G.A., and J.H.C. designed and performed the research and collected and analyzed the data. E.M., G.D., M.K., K.N., A.W., and C.F.W. facilitated the research. C.B., G.A., and J.H.C. wrote the manuscript.	Banks TA, 2005, J IMMUNOL, V174, P7217, DOI 10.4049/jimmunol.174.11.7217; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Billon N, 2012, STEM CELL REV REP, V8, P55, DOI 10.1007/s12015-011-9242-x; Buettner M, 2010, TRENDS IMMUNOL, V31, P80, DOI 10.1016/j.it.2009.11.003; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chae GN, 2003, EXP MOL MED, V35, P431, DOI 10.1038/emm.2003.56; Chappaz S, 2010, J IMMUNOL, V184, P3562, DOI 10.4049/jimmunol.0901647; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DIENER E, 1965, NATURE, V208, P950, DOI 10.1038/208950a0; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ganeff C, 2011, MOL CELL BIOL, V31, P4319, DOI 10.1128/MCB.05033-11; HAUSMAN GJ, 1990, INT J OBESITY, V14, P177; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Izumi M, 1997, AM J NEURORADIOL, V18, P951; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Pond CM, 2002, CYTOKINE, V17, P131, DOI 10.1006/cyto.2001.0999; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; White A, 2007, BLOOD, V110, P1950, DOI 10.1182/blood-2007-01-070003; WRIGHT JT, 1990, J ANIM SCI, V68, P1170, DOI 10.2527/1990.6841170x; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X	49	93	95	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					721	734		10.1016/j.immuni.2012.06.010	http://dx.doi.org/10.1016/j.immuni.2012.06.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	22940098	Green Accepted, Bronze			2022-12-18	WOS:000310185400016
J	Shi, M; Lin, TH; Appell, KC; Berg, LJ				Shi, Min; Lin, Tsung H.; Appell, Kenneth C.; Berg, Leslie J.			Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation	IMMUNITY			English	Article							T-CELLS; GENE-EXPRESSION; INTERFERON-GAMMA; HISTONE ACETYLATION; TRANSCRIPTION FACTOR; TH2 DIFFERENTIATION; BET; STAT5; ACTIVATION; CHAIN	Differentiation of naive CD4(+) T cells into T helper type 1 (Th1) effector cells requires both T cell receptor (TCR) signaling and cytokines such as interleukin-12 and interferon gamma (IFN-gamma). Here, we report that a third cytokine signal, mediated by the Janus family tyrosine kinase 3 (Jak3) and signal transducer and activator of transcription 5 (STAT5) pathway, is also required for Th1 cell differentiation. In the absence of Jak3-dependent signals, naive CD4(+) T cells proliferate robustly but produce little IFN-gamma after Th1 cell polarization in vitro. This defect is not due to reduced activation of STAT1 or STAT4 or to impaired upregulation of the transcription factor T-bet. Instead, we find that T-bet binding to the Ifng promoter is greatly diminished in the absence of Jak3-dependent signals, correlating with a decrease in Ifng promoter accessibility and histone acetylation. These data indicate that Jak3 regulates epigenetic modification and chromatin remodeling of the Ifng locus during Th1 cell differentiation.	[Shi, Min; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Lin, Tsung H.; Appell, Kenneth C.] Pharmacopeia, Princeton, NJ 08540 USA	University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	leslie.berg@umassmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037584, R01AI046564, R01AI084987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37584, R01 AI037584, R01 AI046564, R01 AI046564-07, R01 AI084987, AI46564, R01 AI046564-08, R01 AI046564-06A2] Funding Source: Medline; NIDDK NIH HHS [P30 DK032520, DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Gonsky R, 2004, J IMMUNOL, V173, P6241, DOI 10.4049/jimmunol.173.10.6241; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thomis DC, 1997, J IMMUNOL, V159, P4708; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145; Van de Wiele CJ, 2004, J INTERF CYTOK RES, V24, P169, DOI 10.1089/jir.2004.24.169; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	48	93	99	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					763	773		10.1016/j.immuni.2008.04.016	http://dx.doi.org/10.1016/j.immuni.2008.04.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549798	Green Accepted, Bronze			2022-12-18	WOS:000256760200008
J	Jones, ME; Zhuang, Y				Jones, Mary Elizabeth; Zhuang, Yuan			Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors	IMMUNITY			English	Article							ALPHA-BETA; ROR-GAMMA; POSITIVE SELECTION; THYMOCYTE; PROTEIN; GENE; CD4; DIFFERENTIATION; PROLIFERATION; REPERTOIRE	The T cell receptor (TCR) is required for positive selection and the subsequent transition from the CD4(+)CD8(+) double-positive (DIP) to the CD4(+) or CD8(+) single-positive (SP) stage of alpha beta T cell development. The molecular mechanism that maintains DID fate prior to the acquisition of a functional TCR is not clear. We have shown here that the structurally and functionally related transcription factors HEB and E2A work together to maintain DID fate and to control the DID to SP transition. Simultaneous deletion of HEB and E2A in DIP thymocytes was sufficient for DIP to SP transition independent of TCR. Loss of HEB and E2A allowed DP cells to bypass the requirement for TCR-mediated positive selection, downregulate DP-associated genes, and upregulate SP-specific genes. These results identify HEB and E2A as the gatekeepers that maintain cells at the DID stage of development until a functional alpha beta TCR is produced.	[Jones, Mary Elizabeth; Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Zhuang, Y (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27710 USA.	yzhuang@duke.edu		zhuang, yuan/0000-0002-2964-3654	NATIONAL CANCER INSTITUTE [R01CA072433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059638] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA072433, R01 CA072433-10] Funding Source: Medline; NIGMS NIH HHS [R01 GM059638, R01 GM059638-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliahmad P, 2006, IMMUNOL REV, V209, P253, DOI 10.1111/j.0105-2896.2006.00345.x; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt R, 1999, J IMMUNOL, V163, P3331; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Guo JH, 2002, ASIAN J ANDROL, V4, P3; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Kappes DJ, 2006, IMMUNOL REV, V209, P237, DOI 10.1111/j.0105-2896.2006.00344.x; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Lazorchak AS, 2006, J IMMUNOL, V177, P2495, DOI 10.4049/jimmunol.177.4.2495; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rudolph B, 2001, ONCOGENE, V20, P1164, DOI 10.1038/sj.onc.1204196; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Wolff U, 2001, IEEE SENS J, V1, P4, DOI 10.1109/JSEN.2001.923583; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	37	93	93	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					860	870		10.1016/j.immuni.2007.10.014	http://dx.doi.org/10.1016/j.immuni.2007.10.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093538	Bronze, Green Accepted			2022-12-18	WOS:000251907300007
J	Zhang, ML; Park, SM; Wang, Y; Shah, R; Liu, N; Murmann, AE; Wang, CR; Peter, ME; Ashton-Rickardt, PG				Zhang, ML; Park, SM; Wang, Y; Shah, R; Liu, N; Murmann, AE; Wang, CR; Peter, ME; Ashton-Rickardt, PG			Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules	IMMUNITY			English	Article							GRANZYME-B INHIBITOR; CHEDIAK-HIGASHI-SYNDROME; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PERFORIN-DEFICIENT MICE; MEDIATED CYTOTOXICITY; DENDRITIC CELLS; DNA FRAGMENTATION; VIRAL-INFECTION; EFFECTOR CELL; IN-VIVO	How cytotoxic T lymphocytes (CTLs) kill intracellular pathogens without killing themselves has been a recurring question ever since their discovery. By using mice deficient in Serine Protease Inhibitor 6 (Spi6), we show that by inhibiting granzyme B (GrB), Spi6 protects CTLs from self-inflicted injury. Infection with either Lymphocytic Choriomeningitis virus (LCMV) or Listeria monocytogenes (LM) revealed increased apoptosis and diminished survival of Spi6 knockout (KO) CTLs, which was cell autonomous and could be corrected by GrB deficiency. Spi6 KID mice in turn were impaired in their ability to clear LCMV infection. Spi6 KO CTLs revealed a breakdown in the integrity of cytotoxic granules, increased cytoplasmic GrB, and ensuing apoptosis. We conclude that Spi6 protects CTLs from suicide caused by GrB-mediated breakdown of cytotoxic granules.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Ashton-Rickardt, PG (corresponding author), Univ Chicago, Dept Pathol, 924 E 57th St, Chicago, IL 60637 USA.	pashtonr@midway.uchicago.edu		Peter, Marcus Ernst/0000-0003-3216-036X	NIAID NIH HHS [R01 AI040310, AI45108, R01 AI040310-09] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; BAETZ K, 1995, J IMMUNOL, V154, P6122; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; COLIGAN JE, 1995, CURRENT PROTCOLS IMM, V1; Gong BD, 1999, CELL GROWTH DIFFER, V10, P491; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kaiserman D, 2002, GENOMICS, V79, P349, DOI 10.1006/geno.2002.6716; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUPFER A, 1986, J EXP MED, V163, P489, DOI 10.1084/jem.163.3.489; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; McMichael A, 1998, CURR OPIN IMMUNOL, V10, P379, DOI 10.1016/S0952-7915(98)80107-6; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MILLARD PJ, 1984, J IMMUNOL, V132, P3197; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Opferman JT, 2001, INT IMMUNOL, V13, P411, DOI 10.1093/intimm/13.4.411; Perou CM, 1996, P NATL ACAD SCI USA, V93, P5905, DOI 10.1073/pnas.93.12.5905; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Phillips T, 2004, J IMMUNOL, V173, P3801, DOI 10.4049/jimmunol.173.6.3801; PIRCHER HP, 1990, NATURE, V346, P624; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Spaner D, 1998, J IMMUNOL, V160, P2655; Spaner D, 1999, J IMMUNOL, V162, P1192; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; Ward DM, 2000, TRAFFIC, V1, P816; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; ZAGURY D, 1975, EUR J IMMUNOL, V5, P812; Zajac AJ, 2003, VIROLOGY, V305, P1, DOI 10.1006/viro.2002.1754	61	93	98	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					451	461		10.1016/j.immuni.2006.02.002	http://dx.doi.org/10.1016/j.immuni.2006.02.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618603	Bronze			2022-12-18	WOS:000237153000014
J	Cariappa, A; Mazo, IB; Chase, C; Shi, HN; Liu, HY; Li, Q; Rose, H; Leung, H; Cherayil, BJ; Russell, P; von Andrian, U; Pillai, S				Cariappa, A; Mazo, IB; Chase, C; Shi, HN; Liu, HY; Li, Q; Rose, H; Leung, H; Cherayil, BJ; Russell, P; von Andrian, U; Pillai, S			Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes	IMMUNITY			English	Article							MARGINAL ZONE; GERMINAL-CENTERS; HEMATOPOIETIC STEM; B1B CELLS; MICE; ANTIGEN; EXPRESSION; ANTIBODY; MEMORY; SUBSETS	Mature recirculating B cells are generally assumed to exist in follicular niches in secondary lymphoid organs, and these cells mediate T-dependent humoral immune responses. We show here that a large proportion of mature B lymphocytes occupy an anatomically and functionally distinct perisinusoidal niche in the bone marrow. Perisinusoidal B cells circulate freely, as revealed by parablosis studies. However, unlike their counterparts in the follicular niche, these cells are capable of being activated in situ by blood-borne microbes in a T-independent manner to generate specific IgM antibodies. The bone marrow represents a unique type of secondary lymphoid organ in which mature B cells are strategically positioned in the path of circulating microbes.	Massachusetts Gen Hosp, Boston, MA 02129 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Pillai, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02129 USA.	pillai@helix.mgh.harvard.edu	von Andrian, Ulrich H/A-5775-2008		NCI NIH HHS [CA102793] Funding Source: Medline; NHLBI NIH HHS [HL43340, HL071932] Funding Source: Medline; NIAID NIH HHS [AI54917] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102793] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071932, R01HL043340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054917] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cariappa A, 2005, J IMMUNOL, V175, P2925, DOI 10.4049/jimmunol.175.5.2925; Cariappa A, 1999, J IMMUNOL, V162, P4417; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Claman H N, 1969, Transplant Rev, V1, P92; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Dammers PM, 2000, J IMMUNOL, V165, P6156, DOI 10.4049/jimmunol.165.11.6156; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Floyd H, 2000, IMMUNOLOGY, V101, P342, DOI 10.1046/j.1365-2567.2000.00103.x; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hormaeche CE, 1996, VACCINE, V14, P251, DOI 10.1016/0264-410X(95)00249-Z; KHAZAIE K, 1994, P NATL ACAD SCI USA, V91, P7430, DOI 10.1073/pnas.91.16.7430; KOCH G, 1982, J IMMUNOL, V128, P1497; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; Lentz VM, 2001, J IMMUNOL, V167, P15, DOI 10.4049/jimmunol.167.1.15; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Nunez C, 1996, J IMMUNOL, V156, P866; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; OSMOND DG, 1984, AM J ANAT, V170, P349, DOI 10.1002/aja.1001700310; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROLINK A, 1993, BLOOD, V81, P2290; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Szczepanik M, 2003, J IMMUNOL, V171, P6225, DOI 10.4049/jimmunol.171.11.6225; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tripp RA, 1997, J IMMUNOL, V158, P3716; WALDSCHMIDT TJ, 1988, J IMMUNOL, V140, P2148; WANG DN, 1994, P NATL ACAD SCI USA, V91, P2502, DOI 10.1073/pnas.91.7.2502; WELLS SM, 1994, J IMMUNOL, V153, P5503; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804	54	93	94	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					397	407		10.1016/j.immuni.2005.09.004	http://dx.doi.org/10.1016/j.immuni.2005.09.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226505	Bronze			2022-12-18	WOS:000232995800008
J	Li, W; Kim, MG; Gourley, TS; McCarthy, BP; Sant'Angelo, DB; Chang, CH				Li, W; Kim, MG; Gourley, TS; McCarthy, BP; Sant'Angelo, DB; Chang, CH			An alternate pathway for CD4 T cell development: Thymocyte-expressed MHC class II selects a distinct T cell population	IMMUNITY			English	Article							BONE-MARROW-TRANSPLANTATION; BLOOD CD34(+) CELLS; POSITIVE SELECTION; CIITA; THYMUS; RECONSTITUTION; DETERMINANTS; LYMPHOCYTES; DEFICIENCY; INDUCTION	Conventional understanding of CD4 T cell development is that the MHC class II molecules on cortical thymic epithelial cell are necessary for positive selection, as demonstrated in mouse models. Clinical data, however, show that hematopoietic stem cells reconstitute CD4 T cells in patients devoid of MHC class II. Additionally, CD4 T cells generated from human stem cells in immunocompromised mice were restricted to human, but not mouse, MHC class II. These studies suggest an alternative pathway for CD4 T cell development that does not normally exist in mice. MHC class II is expressed on developing human thymocytes, indicating a possible role of MHC II on thymocytes for CD4 T cell generation. Therefore, we created mice in which MHC class II is expressed only on T lineage cells. Remarkably, the CD4 compartment in such mice is efficiently reconstituted with unique specificity, demonstrating a novel thymocyte-driven pathway of CD4 T cell selection.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; NIAID, Thym Mol Dev Unit, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Mem Sloan Kettering Canc Ctr, Lab T Cell Immunobiol, Program Immunol, New York, NY 10021 USA	Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Memorial Sloan Kettering Cancer Center	Chang, CH (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	chechang@iupui.edu			NIAID NIH HHS [AI45811] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045811] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Brekelmans P, 1990, Semin Immunol, V2, P13; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Canelles M, 2003, NAT IMMUNOL, V4, P756, DOI 10.1038/ni953; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chen JC, 2003, J IMMUNOL METHODS, V279, P123, DOI 10.1016/S0022-1759(03)00236-9; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Choi EY, 1997, HUM IMMUNOL, V54, P15, DOI 10.1016/S0198-8859(97)00012-8; Cole DN, 2000, US FOR SERV RMRS-P, V1, P1; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; Ernst BB, 1996, J EXP MED, V183, P1235, DOI 10.1084/jem.183.3.1235; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GILHUS NE, 1983, ACTA PATH MICRO IM C, V91, P227; Godthelp BC, 2000, HUM IMMUNOL, V61, P898, DOI 10.1016/S0198-8859(00)00156-7; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; KLEIN C, 1995, BLOOD, V85, P580; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Marinova Ts., 2001, Archives of Physiology and Biochemistry, V109, P74, DOI 10.1076/apab.109.1.74.4281; MARKOWITZ JS, 1993, P NATL ACAD SCI USA, V90, P2779, DOI 10.1073/pnas.90.7.2779; Merkenschlager M, 1996, EUR J IMMUNOL, V26, P892, DOI 10.1002/eji.1830260426; PARK SH, 1992, HUM IMMUNOL, V33, P294; Patel DR, 2005, CELL IMMUNOL, V233, P30, DOI 10.1016/j.cellimm.2005.03.006; Patel DR, 2004, J IMMUNOL, V173, P5501, DOI 10.4049/jimmunol.173.9.5501; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Saito Y, 2002, INT IMMUNOL, V14, P1113, DOI 10.1093/intimm/dxf087; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Terra R, 2005, BLOOD, V106, P193, DOI 10.1182/blood-2004-12-4886; Thulesen S, 1999, EXP CLIN IMMUNOGENET, V16, P226, DOI 10.1159/000019114; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	56	93	93	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					375	386		10.1016/j.immuni.2005.09.002	http://dx.doi.org/10.1016/j.immuni.2005.09.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226503	Bronze			2022-12-18	WOS:000232995800006
J	Bynoe, MS; Evans, JT; Viret, C; Janeway, CA				Bynoe, MS; Evans, JT; Viret, C; Janeway, CA			Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR TRANSGENIC MICE; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; TH2 RESPONSES; ORAL ANTIGEN; IN-VIVO; TOLERANCE; COSTIMULATION; GENERATION	Information on how suppressor/regulatory T cells can be generated directly in vivo and prevent autoimmunity remains fragmentary. We show here that epicutaneous immunization (ECi) with the immunodominant peptide of myelin basic protein (MBP), Ac1-11, protects mice that are transgenic for an Ac1-11-specific T cell receptor against both the induced and spontaneous forms of experimental allergic encephalomyelitis (EAE). This protection was antigen specific and antigen dose dependent, and was mediated by CD4(+)/CD25(-) T cells whose suppressive activity required cell-cell contact and could transfer protection to naive recipients. These ECi-induced suppressor T cells controlled naive MBP-specific CD4 T cells by inhibiting both their activation and their capacity to secrete IFN-gamma. There was no CD4 T cell infiltration in the brain of protected mice. Finally, ECi with autoantigenic peptides protected two nontransgenic models from relapsing-remitting EAE in an antigen-specific and antigen dose-dependent manner.	Yale Univ, Sch Med, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Bynoe, MS (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	margaret.bynoe@yale.edu	VIRET, Christophe/M-4590-2014	VIRET, CHRISTOPHE/0000-0003-1874-3489	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14579] Funding Source: Medline; PHS HHS [P01A136529] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013; Brabb T, 2000, J EXP MED, V192, P871, DOI 10.1084/jem.192.6.871; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Chai JG, 1999, EUR J IMMUNOL, V29, P686, DOI 10.1002/(SICI)1521-4141(199902)29:02<686::AID-IMMU686>3.0.CO;2-N; Cumberbatch M, 2000, CLIN EXP DERMATOL, V25, P413, DOI 10.1046/j.1365-2230.2000.00678.x; Dittel BN, 2000, J AUTOIMMUN, V14, P311, DOI 10.1006/jaut.2000.0371; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Goverman J, 1996, LAB ANIM SCI, V46, P482; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; HU SK, 1983, P NATL ACAD SCI-BIOL, V80, P3779, DOI 10.1073/pnas.80.12.3779; Karandikar NJ, 1998, J IMMUNOL, V161, P192; King C, 1997, CURR OPIN IMMUNOL, V9, P863, DOI 10.1016/S0952-7915(97)80191-4; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lechler R, 2001, IMMUNOLOGY, V103, P262, DOI 10.1046/j.1365-2567.2001.01250.x; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Olivares-Villagomez D, 2000, J IMMUNOL, V164, P5499, DOI 10.4049/jimmunol.164.10.5499; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; PTAK W, 1983, J EXP MED, V158, P1822, DOI 10.1084/jem.158.6.1822; Ragazzo JL, 2001, P NATL ACAD SCI USA, V98, P241, DOI 10.1073/pnas.011397798; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Wang LF, 1996, J IMMUNOL, V156, P4079; Wang LF, 1999, CLIN EXP ALLERGY, V29, P271; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	36	93	94	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					317	328		10.1016/S1074-7613(03)00239-5	http://dx.doi.org/10.1016/S1074-7613(03)00239-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499108	Bronze			2022-12-18	WOS:000185499800004
J	Zhang, ZX; Zemlin, M; Wang, YH; Munfus, D; Huye, LE; Findley, HW; Bridges, SL; Roth, DB; Burrows, PD; Cooper, MD				Zhang, ZX; Zemlin, M; Wang, YH; Munfus, D; Huye, LE; Findley, HW; Bridges, SL; Roth, DB; Burrows, PD; Cooper, MD			Contribution of V-H gene replacement to the primary B cell repertoire	IMMUNITY			English	Article							RECOMBINATION-ACTIVATING GENE; VARIABLE REGION GENES; HEAVY-CHAIN GENE; V(D)J RECOMBINATION; RECEPTOR REVISION; SELF-TOLERANCE; RAG2 PROTEINS; IN-VITRO; 2 STEPS; MECHANISM	V-H replacement has been proposed as one way to modify unwanted antibody specificities, but analysis of this mechanism has been limited without a dynamic cellular model. We describe a human cell line that spontaneously undergoes serial V-H gene replacement mediated by cryptic recombination signal sequences (cRSS) located near the 3' end of V-H genes. Recombination-activating gene products, RAG-1 and RAG-2, bind and cleave the cRSS to generate DNA deletion circles during the V-H replacement process. A VH replacement contribution to normal repertoire development is revealed by the identification of V-H replacement "footprints" in IgH sequences and double-stranded DNA breaks at V-H cRSS sites in immature B cells. Surprisingly, the residual 3' sequences of replaced V-H genes contribute charged amino acids to the CDR3 region, a hallmark of autoreactive antibodies.	Univ Alabama, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Emory Univ, Sch Med, Div Pediat Hematol Oncol Bone Marrow Transplantat, Atlanta, GA 30322 USA; Free Univ Berlin, Dept Pediat, D-12200 Berlin, Germany; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Emory University; Free University of Berlin; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Cooper, MD (corresponding author), Univ Alabama, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.		Zemlin, Michael/AAB-5746-2020	Zemlin, Michael/0000-0001-9528-7419; Zhang, Zhixin/0000-0003-3924-1082	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039816, R37AI039816, R01AI048098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048592] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48098, AI39816] Funding Source: Medline; NIAMS NIH HHS [K01 AR48592] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Brandt VL, 2002, CURR OPIN IMMUNOL, V14, P224, DOI 10.1016/S0952-7915(02)00325-4; BURROWS P, 1979, NATURE, V280, P838, DOI 10.1038/280838a0; Burrows PD, 1997, CURR OPIN IMMUNOL, V9, P239, DOI 10.1016/S0952-7915(97)80142-2; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COVEY LR, 1990, INT IMMUNOL, V2, P579, DOI 10.1093/intimm/2.6.579; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Hikida M, 1998, J EXP MED, V187, P795, DOI 10.1084/jem.187.5.795; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Huye LE, 2000, NUCLEIC ACIDS RES, V28, P4903, DOI 10.1093/nar/28.24.4903; Itoh K, 2000, J EXP MED, V192, P1151, DOI 10.1084/jem.192.8.1151; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; King LB, 2001, SCIENCE, V291, P1503, DOI 10.1126/science.291.5508.1503; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nunez C, 1996, J IMMUNOL, V156, P866; Nussenzweig MC, 1998, CELL, V95, P875, DOI 10.1016/S0092-8674(00)81711-0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Steen SB, 1997, EMBO J, V16, P2656, DOI 10.1093/emboj/16.10.2656; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; ten Boekel E, 1998, IMMUNITY, V8, P199; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; USUDA S, 1992, EMBO J, V11, P611, DOI 10.1002/j.1460-2075.1992.tb05093.x; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; Wang YH, 2003, BLOOD, V101, P1030, DOI 10.1182/blood-2002-06-1828; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Zemlin M, 2001, BLOOD, V97, P1511, DOI 10.1182/blood.V97.5.1511; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	50	93	96	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					21	31		10.1016/S1074-7613(03)00170-5	http://dx.doi.org/10.1016/S1074-7613(03)00170-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871636	Bronze			2022-12-18	WOS:000184260400005
J	Vanhove, M; Usherwood, YK; Hendershot, LM				Vanhove, M; Usherwood, YK; Hendershot, LM			Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release	IMMUNITY			English	Article							B-CELL DEVELOPMENT; ENDOPLASMIC-RETICULUM; BINDING-PROTEIN; MOLECULAR CHAPERONES; QUALITY-CONTROL; ATPASE ACTIVITY; DNAJ HOMOLOG; IMMUNOGLOBULIN; HSP70; GRPE	Unassembled Ig heavy chains are retained in the ER via the binding of BiP to the C(H)1 domain, which remains unoxidized. Interestingly, this domain folds rapidly, albeit nonproductively, when heavy chains are released from BiP in vitro with ATP. The in vivo cycling of BiP from heavy chains was monitored using BiP ATPase mutants as kinetic traps. Our data suggest that BiP does not cycle from the CH1 domain of free heavy chains. However, heavy and light chain assembly occurs rapidly and requires the ATP-dependent release of BiP. We propose that BiP's ATPase cycle is stalled or nonproductive when it is bound to free heavy chains. The binding of light chains to the complex reactivates the cycle and releases BiP.	St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIGMS NIH HHS [GM54068] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amshoff C, 1999, BIOL CHEM, V380, P669, DOI 10.1515/BC.1999.083; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; BERNARD O, 1978, CELL, V15, P1133, DOI 10.1016/0092-8674(78)90041-7; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BRIGHTMAN SE, 1995, GENE, V153, P249, DOI 10.1016/0378-1119(94)00741-A; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; GELLERT M, 1992, TRENDS GENET, V8, P408, DOI 10.1016/0168-9525(92)90322-U; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOTO Y, 1979, J BIOCHEM, V85, P1427, DOI 10.1093/oxfordjournals.jbchem.a132470; Gross M, 1996, J BIOL CHEM, V271, P16833, DOI 10.1074/jbc.271.28.16833; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; HOHFELD J, 1995, CELL, V83, P589; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; KALOFF CR, 1995, IMMUNITY, V2, P629, DOI 10.1016/1074-7613(95)90007-1; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; KNITTLER MR, 1995, P NATL ACAD SCI USA, V92, P1764, DOI 10.1073/pnas.92.5.1764; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; LIU AY, 1987, GENE, V54, P33, DOI 10.1016/0378-1119(87)90344-1; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Pedrazzini E, 1997, PLANT CELL, V9, P1869, DOI 10.1105/tpc.9.10.1869; SCHARFF MD, 1970, J CELL PHYSIOL, V76, P331, DOI 10.1002/jcp.1040760311; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; WATKINS JD, 1993, J BIOL CHEM, V268, P5182; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	93	94	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					105	114		10.1016/S1074-7613(01)00163-7	http://dx.doi.org/10.1016/S1074-7613(01)00163-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485742	Bronze			2022-12-18	WOS:000170153300011
J	Smith, A; Wikstrom, ME; Fazekas de St Groth, B				Smith, A; Wikstrom, ME; Fazekas de St Groth, B			Visualizing T cell competition for peptide/MHC complexes: A specific mechanism to minimize the effect of precursor frequency	IMMUNITY			English	Article							IN-VIVO; ANTIGEN RECEPTOR; IMMUNE-RESPONSE; PERIPHERAL TOLERANCE; SELECTIVE EXPANSION; TRANSGENIC MICE; VIRAL-INFECTION; AFFINITY; DELETION; SUPERANTIGEN	In vivo antigenic competition of naive CD4(+) TCR transgenic T cells was visualized by tracking cell division. Competition reduced both recruitment into cell division and burst size per recruited precursor cell, minimizing the effect of differences in precursor frequency while maintaining the dose-response relationship with antigen. Competition was restricted to T cells of the same specificity, indicating that cells were competing for access to AS-MHC complexes rather than for Ag nonspecific factors. Moreover, the qualitative distinction between the responses to i.v. peptide and s.c. peptide/CFA was unaffected by precursor frequency. These data explain the paradoxical ability of the immune system to tailor responses to the type and dose of Ag even in individuals with large differences in initial precursor frequency.	Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia	University of Sydney; Centenary Institute	Fazekas de St Groth, B (corresponding author), Centenary Inst Canc Med & Cell Biol, Locked Bag 6, Newtown, NSW 2042, Australia.	b.fazekas@centenary.usyd.edu.au	de St Groth, Barbara Fazekas/O-3017-2017	de St Groth, Barbara Fazekas/0000-0001-6817-9690; Smith, Adrian/0000-0002-0505-0344; Smith, Adrian/0000-0002-7657-6191				AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Anderton SM, 1998, EUR J IMMUNOL, V28, P1251, DOI 10.1002/(SICI)1521-4141(199804)28:04<1251::AID-IMMU1251>3.0.CO;2-O; ASHWELL JD, 1987, FASEB J, V46, P183; ASHWELL JD, 1986, J IMMUNOL, V136, P757; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Cook MC, 1998, EUR J IMMUNOL, V28, P4037, DOI 10.1002/(SICI)1521-4141(199812)28:12<4037::AID-IMMU4037>3.3.CO;2-O; Fazekas de St Groth B, 1999, IMMUNOL CELL BIOL, V77, P530; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; FAZEKASDESTGROTH B, 1992, MOL MECH IMMUNOLOGIC, P123; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Girgis L, 1999, J EXP MED, V189, P265, DOI 10.1084/jem.189.2.265; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lake RA, 1999, IMMUNOL CELL BIOL, V77, P99, DOI 10.1046/j.1440-1711.1999.00794.x; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McHeyzerWilliams MG, 1996, IMMUNOL REV, V150, P5, DOI 10.1111/j.1600-065X.1996.tb00693.x; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MOSKOPHIDIS D, 1993, EUR J IMMUNOL, V23, P3306, DOI 10.1002/eji.1830231237; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; STAERZ UD, 1985, J IMMUNOL, V134, P3994; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0	34	93	94	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2000	13	6					783	794		10.1016/S1074-7613(00)00076-5	http://dx.doi.org/10.1016/S1074-7613(00)00076-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163194	Bronze			2022-12-18	WOS:000166142300004
J	Penninger, JM; Sirard, C; Mittrucker, HW; Chidgey, A; Kozieradzki, I; Nghiem, M; Hakem, A; Kimura, T; Timms, E; Boyd, R; Taniguchi, T; Matsuyama, T; Mak, TW				Penninger, JM; Sirard, C; Mittrucker, HW; Chidgey, A; Kozieradzki, I; Nghiem, M; Hakem, A; Kimura, T; Timms, E; Boyd, R; Taniguchi, T; Matsuyama, T; Mak, TW			The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8(+) thymocytes	IMMUNITY			English	Article							T-CELL-RECEPTOR; CLASS-I MOLECULES; LINEAGE COMMITMENT; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; TOLERANCE INDUCTION; CD4+8+ THYMOCYTES; MUTANT MICE; ANTIGEN; EXPRESSION	Little is known about the molecular mechanisms and transcriptional regulation that govern T cell selection processes and the differentiation of CD4(+) and CD8(+) T cells. Mice lacking the interferon regulatory transcription factor-1 (IRF-1) have reduced numbers of mature CD8(+) cells within the thymus and peripheral lymphatic organs. Here we show that positive and negative T cell selection of two MHC class I-restricted TCR alpha beta transgenes, H-Y and P14, are impaired in IRF-1(-/-) mice. The absence of IRF-1 resulted in decreased expression of LMP2, TAP1, and MHC class I on thymic stromal cells. Despite decreased MHC class I expression on IRF-1(-/-) thymic stromal cells, the defect in CD8(+) T cells development did not reside in the thymic environment, and IRF-1(-/-) stromal cells can fully support development of CD8(+) thymocytes in in vivo bone marrow chimeras and in vitro reaggregation cultures. Moreover, IRF-1(-/-) thymocytes displayed impaired TCR-mediated signal transduction, and the induction of negative selection in TCR Tg thymocytes from IRF-1(-/-) mice required a 1000-fold increase in selecting peptide. We also provide evidence that IRF-1 is mainly expressed in mature, but not immature, thymocytes and that expression of IRF-1 in immature thymocytes is induced after peptide-specific TCR activation. These results indicate that IRF-1 regulates gene expression in developing thymocytes required for lineage commitment and selection of CD8(+) thymocytes.	OSAKA UNIV,INST MOL & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN; MONASH UNIV SCH MED,DEPT PATHOL & IMMUNOL,MELBOURNE,VIC 3181,AUSTRALIA; UNIV TORONTO,AMGEN INST,ONTARIO CANC INST,DEPT IMMUNOL,TORONTO,ON M5G 2C1,CANADA	Osaka University; Monash University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Penninger, JM (corresponding author), UNIV TORONTO,AMGEN INST,ONTARIO CANC INST,DEPT MED BIOPHYS,TORONTO,ON M5G 2C1,CANADA.		Chidgey, Ann P/I-2737-2014; Penninger, Josef M/I-6860-2013	Chidgey, Ann P/0000-0001-7442-6125; Penninger, Josef M/0000-0002-8194-3777; Kimura, Tohru/0000-0001-9227-0996				ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; Benveniste P, 1996, EUR J IMMUNOL, V26, P461, DOI 10.1002/eji.1830260229; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHEN D, 1993, MOL CELL BIOL, V13, P228, DOI 10.1128/MCB.13.1.228; CHIDGEY A, 1997, IN PRESS DEV IMMUNOL; CLEVERS HC, 1993, IMMUNOL TODAY, V14, P591, DOI 10.1016/0167-5699(93)90198-T; CRISPE IN, 1987, J IMMUNOL, V138, P2013; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; HARADA H, 1989, CELL, V58, P7298; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; LAHOUD M, 1993, DEV IMMUNOL, V3, P103, DOI 10.1155/1993/43482; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHASHI PS, 1993, INT IMMUNOL, V5, P131, DOI 10.1093/intimm/5.2.131; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PIRCHER H, 1994, EUR J IMMUNOL, V24, P1982, DOI 10.1002/eji.1830240907; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; TANAKA N, 1992, ADV IMMUNOL, V52, P263, DOI 10.1016/S0065-2776(08)60877-9; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; Wallace VA, 1997, J IMMUNOL, V158, P3205; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WHITE LC, 1996, IMMUNITY, V5, P1; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	58	93	93	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					243	254		10.1016/S1074-7613(00)80527-0	http://dx.doi.org/10.1016/S1074-7613(00)80527-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285409	Bronze			2022-12-18	WOS:A1997XT49200008
J	Backstrom, BT; Milia, E; Peter, A; Jaureguiberry, B; Baldari, CT; Palmer, E				Backstrom, BT; Milia, E; Peter, A; Jaureguiberry, B; Baldari, CT; Palmer, E			A motif within the T cell receptor alpha chain constant region connecting peptide domain controls antigen responsiveness	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; SIGNAL-TRANSDUCTION; LYMPHOCYTES-T; MONOCLONAL-ANTIBODY; GENE-TRANSFER; RETROVIRAL VECTORS; PARTIAL AGONISTS; MAMMALIAN-CELLS; ACTIVATION; COMPLEX	Mutant alpha beta TCRs were generated by replacing domains of the alpha and beta chain constant regions with homologous domains from TCR delta and gamma chains, respectively. Chimeric TCRs in which the alpha chain contains TCR delta chain sequences within the connecting peptide domain are unresponsive to alloantigens and superantigens, and have defective interactions with the CD3/zeta complex. Although these antigen-unresponsive TCRs undergo zeta chain phosphorylation upon stimulation with super-antigen, they do not generate a full signal capable of producing IL-2. Mutant TCRs acquire signaling activity with a combination of superantigen and calcium ionophore, indicating a defect in calcium-mediated signaling. Finally, a conserved motif, FETDxNLN, present-in the alpha chain connecting peptide domain, is disrupted in all signaling-defective TCRs. This conserved alpha chain connecting peptide motif might mediate the transfer of signals from the alpha beta heterodimer to the CD3/zeta complex.	UNIV SIENA,DEPT EVOLUTIONARY BIOL,I-53100 SIENA,ITALY; VETERQUIM LTD,DEPT RES & DEV,LOS CERRILLOS,SANTIAGO,CHILE	University of Siena	Backstrom, BT (corresponding author), BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND.			Baldari, Cosima/0000-0002-4414-6744	Telethon [E.0207] Funding Source: Medline	Telethon(Fondazione Telethon)		ACCOLLA RS, 1984, J EXP MED, V159, P378, DOI 10.1084/jem.159.2.378; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; DEMARTIN R, 1993, GENE, V124, P137, DOI 10.1016/0378-1119(93)90776-Y; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; DIANZANI U, 1992, J IMMUNOL, V148, P678; DIGIUSTO DL, 1994, MOL IMMUNOL, V31, P693, DOI 10.1016/0161-5890(94)90179-1; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; GUNTER KC, 1987, NATURE, V326, P505, DOI 10.1038/326505a0; GUNTER KC, 1984, J EXP MED, V159, P716, DOI 10.1084/jem.159.3.716; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0; HAYDAY AC, 1985, NATURE, V316, P828, DOI 10.1038/316828a0; ISAKOV N, 1994, J LEUKOCYTE BIOL, V55, P265, DOI 10.1002/jlb.55.2.265; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; KRANGEL MS, 1987, P NATL ACAD SCI USA, V84, P3817, DOI 10.1073/pnas.84.11.3817; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MEIER T, 1992, ANAL BIOCHEM, V204, P220, DOI 10.1016/0003-2697(92)90165-4; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MULLEN CA, 1992, P NATL ACAD SCI USA, V89, P33, DOI 10.1073/pnas.89.1.33; NECKER A, 1991, EUR J IMMUNOL, V21, P3035, DOI 10.1002/eji.1830211220; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; QIAN DP, 1993, P NATL ACAD SCI USA, V90, P11875, DOI 10.1073/pnas.90.24.11875; RACIOPPI L, 1995, CHEM IMMUNOL, V60, P79; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; SAITO H, 1984, NATURE, V312, P36, DOI 10.1038/312036a0; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STAERZ UD, 1985, J IMMUNOL, V134, P3994; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; VANOERS NSC, 1994, J IMMUNOL METHODS, V170, P261, DOI 10.1016/0022-1759(94)90401-4; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1991, ANNU REV GENET, V25, P487, DOI 10.1146/annurev.ge.25.120191.002415; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WOLFF CHJ, 1993, J IMMUNOL, V151, P1337; ZENNER G, 1995, BIOESSAYS, V17, P967, DOI 10.1002/bies.950171110	60	93	94	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					437	447		10.1016/S1074-7613(00)80500-2	http://dx.doi.org/10.1016/S1074-7613(00)80500-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934571				2022-12-18	WOS:A1996VV65800005
J	Rinkenberger, JL; Wallin, JJ; Johnson, KW; Koshland, ME				Rinkenberger, JL; Wallin, JJ; Johnson, KW; Koshland, ME			An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BSAP; B-CELL DIFFERENTIATION; 3'ALPHA ENHANCER; RNA EXPRESSION; NF-HB; BINDING PROTEIN; PROMOTER; DNA; IGM; SEQUENCE	Cytokine regulation of B cell development was analyzed using interleukin-2 (IL-2)-induced transcription of the J chain gene as a model system. A nuclear target of the IL-2 signal was identified as the Pax5 transcription factor, BSAP, which recognizes a negative regulatory motif in the J chain promoter. Functional assays showed that BSAP mediates the silencing of the J chain gene during the early stages of B cell development, but repression is relieved during the antigen-driven stages in a concentration-dependent manner by an IL-2-induced down-regulation of BSAP RNA expression. At the low levels present in J chain-expressing plasma cells, BSAP repression could be overridden by positive-acting factors binding to downstream J chain promoter elements. Overexpression of BSAP in these cells reversed the positive regulation and inhibited J chain gene transcription. Thus, IL-2 regulation of BSAP concentration may provide a mechanism for controlling both repressor and activator functions of BSAP during a B cell immune response.	UNIV CALIF BERKELEY, DEPT MOL & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Wallin, Jeffrey/0000-0002-5952-3813	NIAID NIH HHS [AI07079] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI007079, R01AI007079] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BROOKS K, 1983, NATURE, V302, P825, DOI 10.1038/302825a0; BUSSLINGER M, 1995, CURR OPIN GENET DEV, V5, P595, DOI 10.1016/0959-437X(95)80028-X; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GOMEZCUADRADO A, 1992, EMBO J, V11, P1857, DOI 10.1002/j.1460-2075.1992.tb05237.x; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; INOSTROZA JA, 1992, CELL, V70, P477; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; KEHRL JH, 1994, IMMUNOL TODAY, V15, P432, DOI 10.1016/0167-5699(94)90273-9; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; LAMSON G, 1984, J EXP MED, V160, P877, DOI 10.1084/jem.160.3.877; LANSFORD RD, 1992, P NATL ACAD SCI USA, V89, P5966, DOI 10.1073/pnas.89.13.5966; LIAO F, 1994, J IMMUNOL, V152, P2904; MATSUI K, 1989, J IMMUNOL, V142, P2918; MCFADDEN HJ, 1991, P NATL ACAD SCI USA, V88, P11027, DOI 10.1073/pnas.88.24.11027; Michaelson JS, 1996, J IMMUNOL, V156, P2349; MINIE ME, 1986, MOL CELL BIOL, V6, P4031, DOI 10.1128/MCB.6.11.4031; NAKANISHI K, 1984, J EXP MED, V160, P1736, DOI 10.1084/jem.160.6.1736; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; NEURATH MF, 1995, IMMUNOL TODAY, V16, P564, DOI 10.1016/0167-5699(95)80078-6; NEURATH MF, 1994, J IMMUNOL, V153, P730; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; OKABE T, 1992, EUR J IMMUNOL, V22, P37, DOI 10.1002/eji.1830220107; PETERSON CL, 1986, MOL CELL BIOL, V6, P4168, DOI 10.1128/MCB.6.12.4168; RANDALL TD, 1992, J BIOL CHEM, V267, P18002; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; ROTH SY, 1992, GENE DEV, V6, P411, DOI 10.1101/gad.6.3.411; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WAKATSUKI Y, 1994, J EXP MED, V179, P1099, DOI 10.1084/jem.179.4.1099; YANG J, 1995, J IMMUNOL, V155, P2498; ZWOLLO P, 1994, J BIOL CHEM, V269, P15310	46	93	95	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1996	5	4					377	386		10.1016/S1074-7613(00)80263-0	http://dx.doi.org/10.1016/S1074-7613(00)80263-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885870	Bronze			2022-12-18	WOS:A1996VP44400009
J	JANEWAY, CA				JANEWAY, CA			THYMIC SELECTION - 2 PATHWAYS TO LIFE AND 2 TO DEATH	IMMUNITY			English	Article							T-CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; POSITIVE SELECTION; CLASS-II; ANTIGEN RECOGNITION; DUAL RECOGNITION; TRANSGENIC MICE; H-2 ANTIGENS; IN-VITRO; LYMPHOCYTES				JANEWAY, CA (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.							ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, IN PRESS CELL, V76; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1975, NATURE, V256, P419, DOI 10.1038/256419a0; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BLANDEN RV, 1978, SCAND J IMMUNOL, V7, P181, DOI 10.1111/j.1365-3083.1978.tb00442.x; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; DAVIES D R, 1992, Current Biology, V2, P254, DOI 10.1016/0960-9822(92)90369-L; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; ELLIOTT JI, 1993, IMMUNOL REV, V135, P227, DOI 10.1111/j.1600-065X.1993.tb00651.x; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JANEWAY C, 1992, Current Biology, V2, P26, DOI 10.1016/0960-9822(92)90419-B; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JANEWAY CA, 1989, COLD SH Q B, V54, P657; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JANEWAY CA, 1993, CURR BIOL, V3, P282, DOI 10.1016/0960-9822(93)90179-R; JANEWAY CA, 1976, SCAND J IMMUNOL, V5, P593, DOI 10.1111/j.1365-3083.1976.tb00315.x; JANEWAY CA, 1982, BEHRING I MITT, V70, P200; KATZ DH, 1973, J EXP MED, V138, P734, DOI 10.1084/jem.138.3.734; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MANNIE MD, 1991, J THEOR BIOL, V151, P169, DOI 10.1016/S0022-5193(05)80360-1; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MOLLER G, 1993, IMMUNOL REV, V135, P1; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; ROJO JM, 1988, J IMMUNOL, V140, P1081; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SHEVACH EM, 1973, J EXP MED, V138, P1213, DOI 10.1084/jem.138.5.1213; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; SYKULEV Y, 1994, IN PRESS IMMUNITY, V1; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	47	93	95	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					3	6		10.1016/1074-7613(94)90003-5	http://dx.doi.org/10.1016/1074-7613(94)90003-5			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889396				2022-12-18	WOS:A1994PK15400001
J	Luda, KM; Joeris, T; Persson, EK; Rivollier, A; Demiri, M; Sitnik, KM; Pool, L; Holm, JB; Melo-Gonzalez, F; Richter, L; Lambrecht, BN; Kristiansen, K; Travis, MA; Svensson-Frej, M; Kotarsky, K; Agace, WW				Luda, Katarzyna M.; Joeris, Thorsten; Persson, Emma K.; Rivollier, Aymeric; Demiri, Mimoza; Sitnik, Katarzyna M.; Pool, Lieneke; Holm, Jacob B.; Melo-Gonzalez, Felipe; Richter, Lisa; Lambrecht, Bart N.; Kristiansen, Karsten; Travis, Mark A.; Svensson-Frej, Marcus; Kotarsky, Knut; Agace, William W.			IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell Homeostasis	IMMUNITY			English	Article							SIGNALING CONTROLS; CD4(+); EXPRESSION; RECEPTOR; ACTIVATION; ICSBP; MICE; TH17; SPECIALIZATION; LYMPHOCYTES	The role of dendritic cells (DCs) in intestinal immune homeostasis remains incompletely defined. Here we show that mice lacking IRF8 transcription-factor-dependent DCs had reduced numbers of T cells in the small intestine (SI), but not large intestine (LI), including an almost complete absence of SI CD8 alpha beta(+) and CD4(+)CD8 alpha alpha(+) T cells; the latter requiring beta 8 integrin expression by migratory IRF8 dependent CD103(+)CD11b(-) DCs. SI homing receptor induction was impaired during T cell priming in mesenteric lymph nodes (MLN), which correlated with a reduction in aldehyde dehydrogenase activity by SI-derived MLN DCs, and inefficient T cell localization to the SI. These mice also lacked intestinal T helper 1 (Th1) cells, and failed to support Th1 cell differentiation in MLN and mount Th1 cell responses to Trichuris muris infection. Collectively these results highlight multiple non-redundant roles for IRF8 dependent DCs in the maintenance of intestinal T cell homeostasis.	[Luda, Katarzyna M.; Persson, Emma K.; Demiri, Mimoza; Svensson-Frej, Marcus; Kotarsky, Knut; Agace, William W.] Lund Univ, Immunol Sect, S-22184 Lund, Sweden; [Joeris, Thorsten; Rivollier, Aymeric; Sitnik, Katarzyna M.; Pool, Lieneke; Agace, William W.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Frederiksberg C, Denmark; [Holm, Jacob B.; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, DK-2100 Copenhagen, Denmark; [Melo-Gonzalez, Felipe; Travis, Mark A.] Univ Manchester, MCCIR, Manchester M13 9NT, Lancs, England; [Melo-Gonzalez, Felipe; Travis, Mark A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Melo-Gonzalez, Felipe; Travis, Mark A.] Univ Manchester, Fac Life Sci, Manchester Immunol Grp, Manchester M13 9PT, Lancs, England; [Richter, Lisa] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Richter, Lisa] Univ Oslo, Rikshosp, Dept Pathol, N-0027 Oslo, Norway; [Richter, Lisa] Univ Oslo, N-0027 Oslo, Norway; [Persson, Emma K.; Lambrecht, Bart N.] VIB UGent Dept, IRC, B-9052 Ghent, Belgium	Lund University; Technical University of Denmark; University of Copenhagen; University of Manchester; University of Manchester; University of Manchester; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Flanders Institute for Biotechnology (VIB); Ghent University	Agace, WW (corresponding author), Lund Univ, Immunol Sect, S-22184 Lund, Sweden.; Agace, WW (corresponding author), Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Frederiksberg C, Denmark.	william.agace@med.lu.se	Lambrecht, Bart N/K-2484-2014; Richter, Lisa/AAJ-8014-2021; Holm, Jacob Bak B/B-8677-2019; Holm, Jacob Bak/H-6899-2013	Lambrecht, Bart N/0000-0003-4376-6834; Richter, Lisa/0000-0002-0769-619X; Holm, Jacob Bak B/0000-0003-1756-0875; Holm, Jacob Bak/0000-0003-1756-0875; Svensson-Frej, Marcus/0000-0002-3934-464X; Sitnik, Katarzyna/0000-0002-6965-0322; Agace, william/0000-0003-3823-5772; Melo-Gonzalez, Felipe/0000-0002-3711-2407; Rivollier, Aymeric Marie Christian/0000-0001-8734-2916; Kotarsky, Knut/0000-0003-3785-0327	Sapere Aude III senior researcher grant from the Danish Research Council; Lundbeckfonden [R155-2014-4184]; Swedish Medical Research Council; Kocks; Osterlund foundation; Professor Nanna Svartz foundation; Richard and Ruth Julins foundation; IngaBritt and Arne Lundbergs foundation; Royal Physiographic Society; Swedish national health service; BBSRC [BB/G001103/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001103/1] Funding Source: researchfish	Sapere Aude III senior researcher grant from the Danish Research Council; Lundbeckfonden(Lundbeckfonden); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Kocks; Osterlund foundation; Professor Nanna Svartz foundation; Richard and Ruth Julins foundation; IngaBritt and Arne Lundbergs foundation; Royal Physiographic Society; Swedish national health service; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank Dr. A.M. Mowat (Glasgow University) for constructive comments during the preparation of this manuscript and for providing bone marrow from Ccr2<SUP>-/-</SUP>. CD45.1 mice, Dr. D. Holmberg and T.D. Hannibal (Copenhagen and Lund University) for providing Tcf4<SUP>fl/fl</SUP> and Itgax-cre. Tcf4<SUP>fl/fl</SUP> mice, Dr. R.J. Noelle (King's College London) for providing Cd4-cre and dnRar<SUP>\s\/WT</SUP> mice, Dr. J.E. Konkel (Manchester University) for help in IEL preparation at Manchester, Dr. C. Reis e Sousa (The Francis Crick Institute) for providing OVA expressing H2<SUP>bm1</SUP> MEFs, A.-C. Selberg for animal care and genotyping, and A.N. Hansen for microbial DNA extraction. This work was supported by a Sapere Aude III senior researcher grant from the Danish Research Council, the Lundbeckfonden (grant number R155-2014-4184), grants from the Swedish Medical Research Council, Kocks, Osterlund, Professor Nanna Svartz, Richard and Ruth Julins and the IngaBritt and Arne Lundbergs foundations, the Royal Physiographic Society, and a clinical grant from the Swedish national health service.	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BANCROFT AJ, 1994, EUR J IMMUNOL, V24, P3113, DOI 10.1002/eji.1830241230; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cheroutre H, 2004, NAT REV IMMUNOL, V4, P290, DOI 10.1038/nri1333; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cortez VS, 2014, J EXP MED, V211, P623, DOI 10.1084/jem.20130904; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Everts B, 2016, J EXP MED, V213, P35, DOI 10.1084/jem.20150235; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; REIMANN J, 1995, EUR J IMMUNOL, V25, P1580, DOI 10.1002/eji.1830250617; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	53	92	96	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					860	874		10.1016/j.immuni.2016.02.008	http://dx.doi.org/10.1016/j.immuni.2016.02.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27067057	Green Submitted, Bronze			2022-12-18	WOS:000374444300017
J	Fung, TC; Bessman, NJ; Hepworth, MR; Kumar, N; Shibata, N; Kobuley, D; Wang, K; Ziegler, CGK; Goc, J; Shima, T; Umesaki, Y; Sartor, RB; Sullivan, KV; Lawley, TD; Kunisawa, J; Kiyono, H; Sonnenberg, GF				Fung, Thomas C.; Bessman, Nicholas J.; Hepworth, Matthew R.; Kumar, Nitin; Shibata, Naoko; Kobuley, Dmytro; Wang, Kelvin; Ziegler, Carly G. K.; Goc, Jeremy; Shima, Tatsuichiro; Umesaki, Yoshinori; Sartor, R. Balfour; Sullivan, Kaede V.; Lawley, Trevor D.; Kunisawa, Jun; Kiyono, Hiroshi; Sonnenberg, Gregory F.			Lymphoid-Tissue-Resident Commensal Bacteria Promote Members of the IL-10 Cytokine Family to Establish Mutualism	IMMUNITY			English	Article							GUT MICROBIOTA; T-CELLS; INFLAMMATION; HOMEOSTASIS; RESPONSES; METABOLITES; CONTAINMENT; IMMUNITY; COLITIS	Physical separation between the mammalian immune system and commensal bacteria is necessary to limit chronic inflammation. However, selective species of commensal bacteria can reside within intestinal lymphoid tissues of healthy mammals. Here, we demonstrate that lymphoid-tissue-resident commensal bacteria (LRC) colonized murine dendritic cells and modulated their cytokine production. In germ-free and antibiotic-treated mice, LRCs colonized intestinal lymphoid tissues and induced multiple members of the IL-10 cytokine family, including dendritic-cell-derived IL-10 and group 3 innate lymphoid cell (ILC3)-derived IL-22. Notably, IL-10 limited the development of pro-inflammatory Th17 cell responses, and IL-22 production enhanced LRC colonization in the steady state. Furthermore, LRC colonization protected mice from lethal intestinal damage in an IL-10-IL-10R-dependent manner. Collectively, our data reveal a unique host-commensal-bacteria dialog whereby selective subsets of commensal bacteria interact with dendritic cells to facilitate tissue-specific responses that are mutually beneficial for both the host and the microbe.	[Fung, Thomas C.; Kobuley, Dmytro; Wang, Kelvin] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fung, Thomas C.; Bessman, Nicholas J.; Hepworth, Matthew R.; Goc, Jeremy; Sonnenberg, Gregory F.] Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA; [Fung, Thomas C.; Bessman, Nicholas J.; Hepworth, Matthew R.; Goc, Jeremy; Sonnenberg, Gregory F.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Fung, Thomas C.; Bessman, Nicholas J.; Hepworth, Matthew R.; Goc, Jeremy; Sonnenberg, Gregory F.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Kumar, Nitin; Lawley, Trevor D.] Wellcome Trust Sanger Inst, Host Microbiota Interact Lab, Hinxton CB10 1SA, Cambs, England; [Shibata, Naoko; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Shibata, Naoko; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, Dept Computat Biol & Immunol, 1275 York Ave, New York, NY 10021 USA; [Shima, Tatsuichiro; Umesaki, Yoshinori] Yakult Cent Inst, Tokyo 1868650, Japan; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Sullivan, Kaede V.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Osaka 5670085, Japan	University of Pennsylvania; Pennsylvania Medicine; Cornell University; Cornell University; Cornell University; Wellcome Trust Sanger Institute; University of Tokyo; Japan Science & Technology Agency (JST); Memorial Sloan Kettering Cancer Center; Yakult Honsha Company, Limited; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sonnenberg, GF (corresponding author), Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu	Kiyono, Hiroshi/AAC-6735-2022; Goc, Jeremy/O-7254-2018	Goc, Jeremy/0000-0002-4214-8877; Hepworth, Matthew/0000-0002-9613-7858; Ziegler, Carly/0000-0002-8279-7150	National Institutes of Health [DP5OD012116, R56AI114724, R01AI123368]; NIAID Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Crohn's and Colitis Foundation of America; Cancer Research Institute; Wellcome Trust [098051]; Medical Research Council UK [PF451]; Ministry of Education, Culture, Sports and Technology of Japan; Ministry of Health and Welfare of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology (CREST); National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK034987]; Office of the Director at the National Institutes of Health [5-P40-OD010995]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123368, R56AI114724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK094779, P30DK034987] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116, P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Crohn's and Colitis Foundation of America; Cancer Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director at the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Sonnenberg laboratory for discussions and critical reading of the manuscript. This research was supported by the National Institutes of Health (DP5OD012116, R56AI114724, and R01AI123368 to G.F.S.), and the NIAID Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity (to G.F.S.), the Crohn's and Colitis Foundation of America (to M.R.H.), the Cancer Research Institute Student Training and Research in Tumor Immunology grant (to T.C.F), the Wellcome Trust (098051) and Medical Research Council UK (PF451) (for library preparation, sequencing and genomic analysis), the Ministry of Education, Culture, Sports and Technology of Japan (Grants-in-Aid for Scientific Research B [J.K.] and for Scientific Research S [H.K.]), the Ministry of Health and Welfare of Japan (J.K. and H.K.), Japan Science and Technology Agency (J.S.T.), Core Research for Evolutional Science and Technology (CREST) (H.K.), the National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK034987 to R.B.S.) and the Office of the Director at the National Institutes of Health (5-P40-OD010995 to R.B.S.). We thank Sylvester S. Roundtree Jr. (Children's Hospital of Philadelphia) for providing clinical bacterial isolates and the National Gnotobiotic Rodent Resource Center for providing germ-free IL-10-deficient mice.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Chiu CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675786; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]; Fung TC, 2014, IMMUNOL REV, V260, P35, DOI 10.1111/imr.12186; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunisawa J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00065; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Liu B, 2011, GASTROENTEROLOGY, V141, P653, DOI 10.1053/j.gastro.2011.04.053; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403	38	92	94	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					634	646		10.1016/j.immuni.2016.02.019	http://dx.doi.org/10.1016/j.immuni.2016.02.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982365	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000372784200020
J	Garg, AV; Amatya, N; Chen, K; Cruz, JA; Grover, P; Whibley, N; Conti, HR; Mir, GH; Sirakova, T; Childs, EC; Smithgall, TE; Biswas, PS; Kolls, JK; McGeachy, MJ; Kolattukudy, PE; Gaffen, SL				Garg, Abhishek V.; Amatya, Nilesh; Chen, Kong; Cruz, J. Agustin; Grover, Prerna; Whibley, Natasha; Conti, Heather R.; Mir, Gerard Hernandez; Sirakova, Tatiana; Childs, Erin C.; Smithgall, Thomas E.; Biswas, Partha S.; Kolls, Jay K.; McGeachy, Mandy J.; Kolattukudy, Pappachan E.; Gaffen, Sarah L.			MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA STABILITY; IL-17 RECEPTOR; CANDIDA-ALBICANS; GENE-EXPRESSION; HOST-DEFENSE; TARGET GENES; C/EBP-BETA; T-CELL	Interleukin-17 (IL-17) induces pathology in autoimmunity and infections; therefore, constraint of this pathway is an essential component of its regulation. We demonstrate that the signaling intermediate MCPIP1 (also termed Regnase-1, encoded by Zc3h12a) is a feedback inhibitor of IL-17 receptor signal transduction. MCPIP1 knockdown enhanced IL-17-mediated signaling, requiring MCPIP1' s endoribonuclease but not deubiquitinase domain. MCPIP1 haploinsufficient mice showed enhanced resistance to disseminated Candida albicans infection, which was reversed in an Il17ra(-/-) background. Conversely, IL-17-dependent pathology in Zc3h12a(+/-) mice was exacerbated in both EAE and pulmonary inflammation. MCPIP1 degraded Il6 mRNA directly but only modestly downregulated the IL-6 promoter. However, MCPIP1 strongly inhibited the Lcn2 promoter by regulating the mRNA stability of Nfkbiz, encoding the IkB zeta transcription factor. Unexpectedly, MCPIP1degraded Il17ra and Il17rc mRNA, independently of the 30 UTR. The cumulative impact of MCPIP1 on IL-6, IkBz, and possibly IL-17R subunits results in a biologically relevant inhibition of IL-17 signaling.	[Garg, Abhishek V.; Amatya, Nilesh; Cruz, J. Agustin; Whibley, Natasha; Conti, Heather R.; Mir, Gerard Hernandez; Childs, Erin C.; Biswas, Partha S.; McGeachy, Mandy J.; Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA; [Chen, Kong; Kolls, Jay K.] Univ Pittsburgh, Sch Med, Richard King Mellon Inst Pediat Res, Dept Pediat & Immunol, Pittsburgh, PA 15224 USA; [Grover, Prerna; Smithgall, Thomas E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Sirakova, Tatiana; Kolattukudy, Pappachan E.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Central Florida	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA.	sarah.gaffen@pitt.edu	Kolls, Jay/AAH-1829-2019; Hernández Mir, Gerard/AAH-1971-2022; Hernández Mir, Gerard/AEP-4408-2022	Kolls, Jay/0000-0001-5151-6304; Hernández Mir, Gerard/0000-0002-8934-4875; Hernández Mir, Gerard/0000-0002-8934-4875; Amatya, Nilesh/0000-0002-7942-1742; Cruz, J. Agustin/0000-0002-4927-9140	NIH [AI107825, DE022550, DE023815, AI110822, HL079142, HL069458, F32-DE023293]; RAC grant from Children's Hospital of UPMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL069458, R01HL079142, R01HL069458, R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825, R01AI110822, R56AI110822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE023293, R01DE022550, R01DE023815] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RAC grant from Children's Hospital of UPMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support was provided by NIH: AI107825, DE022550, and DE023815 to S.L.G., AI110822 to M.J.M., HL079142 to J.K.K. and K.C., HL069458 to P.E.K., and F32-DE023293 to H.R.C. The content is solely the responsibility of the authors and does not represent the official views of the NIH. K.C. was supported by a RAC grant from Children's Hospital of UPMC. We thank L. Kane, S. Sarkar, S. Filler, and C. Coyne for helpful suggestions and B. Coleman for technical assistance.	Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Dhamija S, 2013, J BIOL CHEM, V288, P19250, DOI 10.1074/jbc.M113.452649; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Gewies A, 2014, CELL REP, V9, P1292, DOI 10.1016/j.celrep.2014.10.044; Hamilton T, 2010, CYTOKINE, V52, P116, DOI 10.1016/j.cyto.2010.04.003; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Huang SP, 2013, CELL SIGNAL, V25, P1228, DOI 10.1016/j.cellsig.2013.02.009; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Liang J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-182; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lin RJ, 2014, J IMMUNOL, V193, P4159, DOI 10.4049/jimmunol.1400337; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Lindemann MJ, 2008, J BIOL CHEM, V283, P14100, DOI 10.1074/jbc.M801357200; Liu GP, 2014, CLIN IMMUNOL, V154, P127, DOI 10.1016/j.clim.2014.07.006; Liu XM, 2014, J BIOL CHEM, V289, P28971, DOI 10.1074/jbc.M114.577429; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Somma D, 2015, J IMMUNOL, V194, P3286, DOI 10.4049/jimmunol.1401589; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tokuda H, 2004, J CELL BIOCHEM, V91, P1053, DOI 10.1002/jcb.20004; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wu G, 2013, TRANSPL IMMUNOL, V28, P138, DOI 10.1016/j.trim.2013.03.003; Xu JW, 2012, PROTEIN CELL, V3, P903, DOI 10.1007/s13238-012-2075-9; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zepp JA, 2012, J IMMUNOL, V189, P33, DOI 10.4049/jimmunol.1200470; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	60	92	98	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					475	487		10.1016/j.immuni.2015.07.021	http://dx.doi.org/10.1016/j.immuni.2015.07.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26320658	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000370965900001
J	Muller, AJ; Filipe-Santos, O; Eberl, G; Aebischer, T; Spath, GF; Bousso, P				Mueller, Andreas J.; Filipe-Santos, Orchidee; Eberl, Gerard; Aebischer, Toni; Spaeth, Gerald F.; Bousso, Philippe			CD4(+) T Cells Rely on a Cytokine Gradient to Control Intracellular Pathogens beyond Sites of Antigen Presentation	IMMUNITY			English	Article							LEISHMANIA-MAJOR INFECTION; INTERFERON-GAMMA; IN-VIVO; EFFECTOR FUNCTION; IMMUNE-RESPONSE; DENDRITIC CELLS; LYMPH-NODE; MICE; EXPRESSION; INNATE	Effector T cells are critical for clearance of pathogens from sites of infection. Like cytotoxic CD8(+) T cells, CD4(+) helper T cells have been shown to deliver effector molecules directionally toward the immunological synapse, suggesting that infected cells need to be engaged individually to receive effector signals. In contrast, we show here that CD4(+) T cells stably contacted a minority of infected cells, yet these interactions triggered intracellular defense mechanisms in bystander cells in vivo. By using a functional read-out, we provide evidence that this effector bystander activity extends via a gradient of IFN-gamma more than 80 mu m beyond the site of antigen presentation, promoting pathogen clearance in the absence of immunological synapse formation. Our results thus demonstrate that CD4(+) T cells can exert their protective activity by engaging a minority of infected cells.	[Mueller, Andreas J.; Filipe-Santos, Orchidee; Eberl, Gerard; Spaeth, Gerald F.; Bousso, Philippe] Inst Pasteur, F-75015 Paris, France; [Mueller, Andreas J.; Filipe-Santos, Orchidee; Bousso, Philippe] INSERM, U668, F-75015 Paris, France; [Eberl, Gerard] CNRS, URA 1961, F-75015 Paris, France; [Aebischer, Toni] Robert Koch Inst, Mycol & Parasitol FG16, D-13302 Berlin, Germany; [Spaeth, Gerald F.] CNRS, URA 2581, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Robert Koch Institute; Centre National de la Recherche Scientifique (CNRS)	Muller, AJ (corresponding author), Inst Pasteur, F-75015 Paris, France.	andreas.muller@pasteur.fr; philippe.bousso@pasteur.fr	Späth, Gerald/B-1393-2014; BOUSSO, Philippe/M-6547-2014; Eberl, Gerard/A-1160-2013	BOUSSO, Philippe/0000-0002-6362-561X; Muller, Andreas/0000-0002-0281-6383; Aebischer, Toni/0000-0002-4875-8457; Eberl, Gerard/0000-0002-1119-5638; Spaeth, Gerald/0000-0002-0256-2029	Institut Pasteur; Inserm; Fondation pour la Recherche Medicale; European Research Council; Pasteur-Roux fellowship	Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); Pasteur-Roux fellowship	The authors wish to thank C. Soudais and H. Saklani for providing mice, S. Aeschlimann and R. Olekhnovitch for help with experiments, and E.-M. Weiss and all members of the P.B. laboratory for helpful comments on the manuscript. This work was funded by Institut Pasteur, Inserm, Fondation pour la Recherche Medicale, and a European Research Council Starting Grant ("LymphocyteContacts"). A.J.M. is funded by a Pasteur-Roux fellowship.	Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoui S, 2010, J IMMUNOL, V184, P2237, DOI 10.4049/jimmunol.0902871; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Erb K, 1996, IMMUNOBIOLOGY, V195, P243, DOI 10.1016/S0171-2985(96)80043-X; EVANS TG, 1993, J IMMUNOL, V151, P907; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; LEAO SD, 1995, J CELL SCI, V108, P3219; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; ROSENBERG AS, 1988, P NATL ACAD SCI USA, V85, P7739, DOI 10.1073/pnas.85.20.7739; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Zarnbrano-Villa S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4	39	92	93	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					147	157		10.1016/j.immuni.2012.05.015	http://dx.doi.org/10.1016/j.immuni.2012.05.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22727490	Bronze			2022-12-18	WOS:000307133200017
J	Murthy, A; Shao, YW; Narala, SR; Molyneux, SD; Zuniga-Pflucker, JC; Khokha, R				Murthy, Aditya; Shao, Yang Washington; Narala, Swami R.; Molyneux, Sam D.; Zuniga-Pfluecker, Juan Carlos; Khokha, Rama			Notch Activation by the Metalloproteinase ADAM17 Regulates Myeloproliferation and Atopic Barrier Immunity by Suppressing Epithelial Cytokine Synthesis	IMMUNITY			English	Article							INCREASED EXPRESSION; INFLAMMATORY SKIN; TH17 CELLS; DISEASE; MICE; DERMATITIS; KERATINOCYTES; MECHANISMS; REPRESSION; PSORIASIS	Epithelial cells of mucosal tissues provide a barrier against environmental stress, and keratinocytes are key decision makers for immune cell function in the skin. Currently, epithelial signaling networks that instruct barrier immunity remain uncharacterized. Here we have shown that keratinocyte-specific deletion of a disintegrin and metalloproteinase 17 (Adam17) triggers T helper 2 and/or T helper 17 (Th2 and/or Th17) cell-driven atopic dermatitis and myeloproliferative disease. In vivo and in vitro deficiency of ADAM17 dampened Notch signaling, increasing production of the Th2 cell-polarizing cytokine TSLP and myeloid growth factor G-CSF. Ligand-independent Notch activation was identified as a regulator of AP-1 transcriptional activity, with Notch antagonizing c-Fos recruitment to the promoters of Tslp and Csf3 (G-CSF). Further, skin inflammation was rescued and myeloproliferation ameliorated by delivery of active Notch to Adam17(-/-) epidermis. Our findings uncover an essential role of ADAM17 in the adult epidermis, demonstrating a gatekeeper function of the ADAM17-Notch-c-Fos triad in barrier immunity.	[Murthy, Aditya; Shao, Yang Washington; Narala, Swami R.; Molyneux, Sam D.; Khokha, Rama] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Zuniga-Pfluecker, Juan Carlos] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Khokha, R (corresponding author), Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	molyneux, sam/0000-0002-6356-3703; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Khokha, Rama/0000-0002-6028-1524	Canadian Institutes of Health Research; Canada Research Chair in Developmental Immunology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Immunology(Canada Research Chairs)	The authors would like to thank C.P. Blobel for providing Adam17<SUP>fl/fl</SUP> mice and Adam17<SUP>-/-</SUP> MEFs, M. Di Grappa for technical assistance with the manuscript, P. Cheung and his group for advice on chromatin immunoprecipitation assays, P. Hu for assistance with microarray data analysis, and P. Waterhouse and A. Aiken for critical assessment of the manuscript. A.M. is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research, and this work is supported by funding to R.K. from the Canadian Institutes of Health Research. J.C.Z.-P. is the recipient of a Canada Research Chair in Developmental Immunology.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chu JL, 2004, J BIOL CHEM, V279, P12337, DOI 10.1074/jbc.M311510200; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Di Cesare A, 2008, J INVEST DERMATOL, V128, P2569, DOI 10.1038/jid.2008.283; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gibb DR, 2011, J IMMUNOL, V186, P4244, DOI 10.4049/jimmunol.1003318; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Goud A, 2011, CONTEMP CLIN DENT, V2, P138, DOI 10.4103/0976-237X.83072; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pastore S, 2000, J INVEST DERMATOL, V115, P1134, DOI 10.1046/j.1523-1747.2000.00149.x; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Song ZM, 1996, J IMMUNOL, V156, P424; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	61	92	93	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					105	119		10.1016/j.immuni.2012.01.005	http://dx.doi.org/10.1016/j.immuni.2012.01.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284418	Bronze			2022-12-18	WOS:000299766000014
J	Beal, AM; Anikeeva, N; Varma, R; Cameron, TO; Vasiliver-Shamis, G; Norris, PJ; Dustin, ML; Sykulev, Y				Beal, Allison M.; Anikeeva, Nadia; Varma, Rajat; Cameron, Thomas O.; Vasiliver-Shamis, Gaia; Norris, Philip J.; Dustin, Michael L.; Sykulev, Yuri			Kinetics of Early T Cell Receptor Signaling Regulate the Pathway of Lytic Granule Delivery to the Secretory Domain	IMMUNITY			English	Article							MICROTUBULE-ORGANIZING CENTER; SUPRAMOLECULAR ACTIVATION CLUSTERS; IMMUNOLOGICAL SYNAPSE; EFFECTOR FUNCTIONS; TARGET-CELL; CLASS-I; POLARIZATION; LYMPHOCYTES; RECRUITMENT; PROTEIN	Cytolytic granules mediate killing of virus-infected cells by cytotoxic T lymphocytes. We show here that the granules can take long or short paths to the secretory domain. Both paths utilized the same intracellular molecular events, which have different spatial and temporal arrangements and are regulated by the kinetics of Ca2+-mediated signaling. Rapid signaling caused swift granule concentration near the microtubule-organizing center (MTOC) and subsequent delivery by the polarized MTOC directly to the secretory domain-the shortest path. Indolent signaling led to late recruitment of granules that moved along microtubules to the periphery of the synapse and then moved tangentially to fuse at the outer edge of the secretory domain-a longer path. The short pathway is associated with faster granule release and more efficient killing than the long pathway. Thus, the kinetics of early signaling regulates the quality of the T cell cytolytic response.	[Beal, Allison M.; Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Beal, Allison M.; Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; [Varma, Rajat; Cameron, Thomas O.; Vasiliver-Shamis, Gaia; Dustin, Michael L.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Norris, Philip J.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA	Jefferson University; Jefferson University; New York University; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	ysykulev@mail.jci.tju.edu	Varma, Rajat/I-1209-2012; Dustin, Michael/AAM-4611-2020	Varma, Rajat/0000-0001-5131-0402; Dustin, Michael/0000-0003-4983-6389	NIH [AI52812, AI44931, AI067854]; NRSA [T32-CA 0983]; NATIONAL CANCER INSTITUTE [K08CA000983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931, R01AI044931, R01AI052812, ZIAAI001027, U01AI067854, U19AI067854, R56AI052812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants to Y.S. (AI52812), M.L.D. (AI44931; AI52812), and P.J.N (AI067854). We thank A. Zanin-Zhorov for purification of His<INF>6</INF>-tagged ICAM-1 and T. Mareeva for help with production and purification of anti-CD107 Fab fragments. We also thank S. Vardhana for help with TIRF imaging, the Burkhardt lab for help with conjugate imaging, and the Kimmel Cancer Institute Bioimaging Facility where some experiments were performed. J. Heitman is acknowledged for the advice regarding the CD4<SUP>+</SUP> CTL maintenance. We thank A. Weiss for suggesting the use of CD3-specific antibodies as a generic strong TCR stimulus. A.M.B. was supported in part by NRSA training grant T32-CA 0983.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brander C, 2006, CURR OPIN IMMUNOL, V18, P430, DOI 10.1016/j.coi.2006.05.012; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HAHN S, 1995, IMMUNOL REV, V146, P57, DOI 10.1111/j.1600-065X.1995.tb00684.x; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Norris PJ, 2001, J VIROL, V75, P9771, DOI 10.1128/JVI.75.20.9771-9779.2001; PASTERNACK MS, 1986, NATURE, V322, P740, DOI 10.1038/322740a0; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Ribeiro M, 2007, PIGM CELL RES, V20, P70, DOI 10.1111/j.1600-0749.2006.00347.x; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Spiliotis ET, 2003, CURR OPIN CELL BIOL, V15, P430, DOI 10.1016/S0955-0674(03)00074-7; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Suck G, 2006, INT IMMUNOL, V18, P1347, DOI 10.1093/intimm/dxl071; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	44	92	95	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					632	642		10.1016/j.immuni.2009.09.004	http://dx.doi.org/10.1016/j.immuni.2009.09.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833088	Green Accepted, Bronze			2022-12-18	WOS:000271403900014
J	Rivera, J; Tessarollo, L				Rivera, Juan; Tessarollo, Lino			Genetic background and the dilemma of translating mouse studies to humans	IMMUNITY			English	Editorial Material							EMBRYONIC STEM-CELLS; STRAIN BACKGROUNDS; EGF RECEPTOR; MICE; MODELS; CANCER; DEFICIENT; PHENOTYPE; RESPONSES; TUMORS	C57BL/6 genetically modified mouse models are the accepted gold standard in biological studies. However, an increasing failure of translating the findings to human (patho)physiology casts doubt on using a single strain to address many questions.	[Rivera, Juan] NIAMSD, Lab Immune Cell Signalling, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Canc Res Ctr, Mouse Canc Genet Program, Neural Dev Grp, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rivera, J (corresponding author), NIAMSD, Lab Immune Cell Signalling, NIH, Bethesda, MD 20892 USA.	juan_rivera@nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010391, ZICBC011198, ZIABC010391, ZIABC010390, Z01BC010390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041101, ZIAAR041101, ZIAAR041155, Z01AR041155] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evans MJ, 2001, NAT MED, V7, P1081, DOI 10.1038/nm1001-1081; Frankel WN, 1998, NEURON, V20, P183, DOI 10.1016/S0896-6273(00)80447-X; Herz U, 2004, METHODS, V32, P271, DOI 10.1016/j.ymeth.2003.08.013; Kallapur S, 1999, MOL REPROD DEV, V52, P341, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;341::AID-MRD2&gt;3.0.CO;2-N; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lozano G, 1998, SEMIN CANCER BIOL, V8, P337, DOI 10.1006/scbi.1998.0096; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Nagy A, 2006, METHOD ENZYMOL, V418, P3, DOI 10.1016/S0076-6879(06)18001-5; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ridgway WM, 2007, NAT IMMUNOL, V8, P669, DOI 10.1038/ni0707-669; Roberts RB, 2004, CANCER CELL, V5, P115, DOI 10.1016/S1535-6108(04)00032-7; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Valor LM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001303; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; You Y, 1998, MAMM GENOME, V9, P232, DOI 10.1007/s003359900731	25	92	102	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					1	4		10.1016/j.immuni.2007.12.008	http://dx.doi.org/10.1016/j.immuni.2007.12.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199409	Bronze			2022-12-18	WOS:000252627300001
J	McCoy, KD; Harris, NL; Diener, P; Hatak, S; Odermatt, B; Hangartner, L; Senn, BM; Marsland, BJ; Geuking, MB; Hengartner, H; Macpherson, AJS; Zinkernagel, RM				McCoy, KD; Harris, NL; Diener, P; Hatak, S; Odermatt, B; Hangartner, L; Senn, BM; Marsland, BJ; Geuking, MB; Hengartner, H; Macpherson, AJS; Zinkernagel, RM			Natural IgE production in the absence of MHC class II cognate help	IMMUNITY			English	Article							HUMAN B-CELLS; INTACT STREPTOCOCCUS-PNEUMONIAE; ANTIVIRAL IMMUNE-RESPONSES; SECONDARY LYMPHOID ORGANS; STIMULATORY FACTOR-I; T-CELLS; DEFICIENT MICE; MAST-CELLS; MONOCLONAL-ANTIBODY; MOLECULAR ANALYSIS	IgE induction by parasites and allergens is antigen driven and cognate T cell help dependent. We demonstrate that spontaneously produced IgE in T cell-deficient and germ-free wild-type (wt) mice is composed of natural specificities and induced by a mechanism independent of MHC class II (MHC II) cognate help. This does not require secondary lymphoid structures or germinal center formation, although some bystander T cell-derived IL-4 is necessary. The pathway of spontaneous IgE production is not inhibited by regulatory T cells and increases with age to constitute significant serum concentrations, even in naive animals.	Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Lab Special Techniques, Dept Pathol, CH-8091 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8952 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	McCoy, KD (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, Schmeizbergstr 12, CH-8091 Zurich, Switzerland.	mccoyk@pathol.unizh.ch; nharris@ethz.ch	harris, nicola/E-5342-2019; Hangartner, Lars/H-3503-2011; Hangartner, Lars/AAS-1320-2021; McCoy, Kathy/ABD-5814-2021	harris, nicola/0000-0003-2922-0210; Hangartner, Lars/0000-0002-3165-2058; 				Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Buckley RH, 2002, IMMUNOL REV, V185, P206, DOI 10.1034/j.1600-065X.2002.18517.x; Buckley RH, 2001, CLIN REV ALLERG IMMU, V20, P139, DOI 10.1385/CRIAI:20:1:139; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRABBE PA, 1970, LAB INVEST, V22, P448; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; ITO K, 1979, INT ARCH ALLER A IMM, V58, P474, DOI 10.1159/000232229; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Karrer U, 2000, EUR J IMMUNOL, V30, P2799, DOI 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Khan AQ, 2004, J IMMUNOL, V172, P532, DOI 10.4049/jimmunol.172.1.532; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Marshall JS, 2004, J ALLERGY CLIN IMMUN, V114, P21, DOI 10.1016/j.jaci.2004.04.045; Miyajima H, 1996, INT ARCH ALLERGY IMM, V111, P152, DOI 10.1159/000237360; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NANNO M, 1994, J IMMUNOL, V153, P2014; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ochs HD, 2001, CLIN REV ALLERG IMMU, V20, P61, DOI 10.1385/CRIAI:20:1:61; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ramesh N, 1999, TRENDS CELL BIOL, V9, P15, DOI 10.1016/S0962-8924(98)01411-1; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; SAVELKOUL HFJ, 1989, INT ARCH ALLER A IMM, V89, P113, DOI 10.1159/000234933; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; TADA T, 1975, INT ARCH ALLER A IMM, V48, P116, DOI 10.1159/000231297; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; VERCELLI D, 1989, J EXP MED, V169, P1295, DOI 10.1084/jem.169.4.1295; VERCELLI D, 1989, EUR J IMMUNOL, V19, P1419, DOI 10.1002/eji.1830190811; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; WEN L, 1994, NATURE, V369, P657; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wu ZQ, 2002, J IMMUNOL, V168, P5551, DOI 10.4049/jimmunol.168.11.5551; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; ZHANG K, 1991, J IMMUNOL, V146, P1836	62	92	92	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					329	339		10.1016/j.immuni.2006.01.013	http://dx.doi.org/10.1016/j.immuni.2006.01.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546101	Green Submitted, Bronze			2022-12-18	WOS:000236504500013
J	Choi, EY; Jung, KC; Park, HJ; Chung, DH; Song, JS; Yang, SD; Simpson, E; Park, SH				Choi, EY; Jung, KC; Park, HJ; Chung, DH; Song, JS; Yang, SD; Simpson, E; Park, SH			Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells	IMMUNITY			English	Article							II TRANSACTIVATOR CIITA; THYMIC EPITHELIAL-CELLS; BLOOD CD34(+) CELLS; REPERTOIRE SELECTION; NEGATIVE SELECTION; DENDRITIC CELLS; MHC; EXPRESSION; LYMPHOCYTES; MOLECULES	Despite numerous reports on MHC class II expression by T cells from a wide spectrum of mammalian species including humans, the biological relevance of this phenomenon has never been tested with appropriately designed animal models. To address this issue, we developed mouse models in which immature thymocytes are the only positively selecting antigen-presenting cells in the thymus. In these mice, CD4(+) T cells were generated with the appropriate maturation phenotype and showed a diverse repertoire of TCR V beta s. The CD4(+) T cells were functionally competent, mediating effective allogeneic responses that involved polyclonal TCR V beta s. These results suggest that the thymocyte-thymocyte (T-T) interaction operates as an independent pathway for CD4(+) T cell selection in the thymi of species with MHC II-positive thymocytes. This T-T interaction appears to be the basis for the generation of donor MHC-restricted CD4(+) T cells in xenogeneic hosts.	Seoul Natl Univ, Coll Med, Grad Program Immunol, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Ctr Anim Resource Dev, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; Korea Res Inst Chem Technol, Taejon 305600, South Korea; Univ London Imperial Coll Sci & Technol, Fac Med, MRC, Ctr Clin Sci, London W12 0NN, England	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT); Imperial College London	Park, SH (corresponding author), Seoul Natl Univ, Coll Med, Grad Program Immunol, Seoul 110799, South Korea.	pshoe@plaza.snu.ac.kr	Jung, Kyeong Choen/C-6068-2011; Park, Seong Hoe/C-7353-2011; Chung, Doo Hyun/J-2791-2012	Jung, Kyeong Choen/0000-0002-7741-7184; Choi, Eun Young/0000-0002-2441-3374; Park, Hyo Jin/0000-0002-2198-5211; Simpson, Elizabeth/0000-0002-2118-3139				ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; BURGER R, 1984, IMMUNOLOGY, V51, P93; Capone M, 2001, BLOOD, V97, P1336, DOI 10.1182/blood.V97.5.1336; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Choi EY, 1997, HUM IMMUNOL, V54, P15, DOI 10.1016/S0198-8859(97)00012-8; Choi EY, 2001, CELL MOL BIOL, V47, P135; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DUTIA BM, 1993, EUR J IMMUNOL, V23, P2882, DOI 10.1002/eji.1830231123; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; Laufer TM, 1999, J IMMUNOL, V162, P5078; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lohr J, 2004, J IMMUNOL, V173, P5028, DOI 10.4049/jimmunol.173.8.5028; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; LONGO DL, 1985, P NATL ACAD SCI USA, V82, P5900, DOI 10.1073/pnas.82.17.5900; Martinic MM, 2003, P NATL ACAD SCI USA, V100, P1861, DOI 10.1073/pnas.252641399; Otten LA, 2003, J IMMUNOL, V170, P1150, DOI 10.4049/jimmunol.170.3.1150; PARK SH, 1992, HUM IMMUNOL, V33, P294; Park WS, 2004, INT IMMUNOL, V16, P1355, DOI 10.1093/intimm/dxh132; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; REIZIS B, 1994, EUR J IMMUNOL, V24, P2796, DOI 10.1002/eji.1830241133; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; SMALL M, 1989, IMMUNOLOGY, V68, P371; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Undale AH, 2004, INT IMMUNOL, V16, P1523, DOI 10.1093/intimm/dxh154; van den Elsen PJ, 1999, MICROBES INFECT, V1, P887, DOI 10.1016/S1286-4579(99)80532-2; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; WENGER RH, 1993, J BIOL CHEM, V268, P23345; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Zinkernagel RM, 1999, P NATL ACAD SCI USA, V96, P8092, DOI 10.1073/pnas.96.14.8092	44	92	92	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					387	396		10.1016/j.immuni.2005.09.005	http://dx.doi.org/10.1016/j.immuni.2005.09.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226504	Bronze			2022-12-18	WOS:000232995800007
J	Fiorucci, S; Mencarelli, A; Palazzetti, B; Sprague, AG; Distrutti, E; Morelli, A; Novobrantseva, TI; Cirino, G; Koteliansky, VE; de Fougerolles, AR				Fiorucci, S; Mencarelli, A; Palazzetti, B; Sprague, AG; Distrutti, E; Morelli, A; Novobrantseva, TI; Cirino, G; Koteliansky, VE; de Fougerolles, AR			Importance of innate immunity and collagen binding integrin alpha 1 beta 1 in TNBS-induced colitis	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXTRACELLULAR-MATRIX; T-LYMPHOCYTES; VLA-1 INTEGRIN; LATE ANTIGEN-1; EXPRESSION; MICE; ARTHRITIS; MODELS; ACTIVATION	Inflammation occurs in the context of integrin-mediated adhesive interactions of cells with their extracellular matrix environment. We investigated the role of the collagen binding integrin alpha1beta1 in a model of colitis. alpha1beta1 was expressed on lamina propria T cells and monocytes during disease. Both alpha1 deficiency and anti-alpha1 mAb treatment (prophylactic and therapeutic) protected against colitis. In vivo alpha1beta1 blockade improved macroscopic and histologic scores, decreased inflammatory cytokine production, and profoundly affected the ability of lamina propria mononuclear cells to proliferate and produce IFN-gamma in vitro. Development and alpha1-mediated inhibition of colitis can be lymphocyte independent, suggesting that activated monocytes also represent a key alpha1beta1-expressing cell type involved in colitis. These results underscore the importance of innate immunity and, specifically, of leukocyte/matrix interactions in regulating local inflammatory responses.	Biogen Inc, Cambridge, MA 02142 USA; Univ Perugia, Clin Gastroenterol & Endoscopia Digest, Dipartimento Med Clin Patol, I-06122 Perugia, Italy; Univ Naples, Dipartimento Farmacol Sperimentale, Naples, Italy	Biogen; University of Perugia; University of Naples Federico II	de Fougerolles, AR (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.		Fiorucci, Stefano/I-1251-2012	Cirino, Giuseppe/0000-0003-3954-4083				BANK I, 1991, J CLIN IMMUNOL, V11, P29, DOI 10.1007/BF00918792; BELKIN VM, 1990, J CELL BIOL, V111, P2159, DOI 10.1083/jcb.111.5.2159; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Fiorucci S, 2002, P NATL ACAD SCI USA, V99, P15770, DOI 10.1073/pnas.232583599; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hoffmann JC, 2001, GUT, V48, P489, DOI 10.1136/gut.48.4.489; Ianaro A, 2000, LAB INVEST, V80, P73, DOI 10.1038/labinvest.3780010; MACDONALD TT, 1990, J CLIN PATHOL, V43, P313, DOI 10.1136/jcp.43.4.313; Meharra EJ, 2000, CELL IMMUNOL, V201, P1, DOI 10.1006/cimm.2000.1630; MIYAKE S, 1994, EUR J IMMUNOL, V24, P2000, DOI 10.1002/eji.1830240910; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Palmen MJHJ, 1998, DIGEST DIS SCI, V43, P2518, DOI 10.1023/A:1026606904531; Rao WH, 2000, J IMMUNOL, V165, P4935, DOI 10.4049/jimmunol.165.9.4935; RUBIO MA, 1995, EUR J IMMUNOL, V25, P2701, DOI 10.1002/eji.1830250945; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; Singh B, 2001, BRIT J SURG, V88, P1558, DOI 10.1046/j.0007-1323.2001.01909.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; TAKAHASHI H, 1992, EUR J IMMUNOL, V22, P2879, DOI 10.1002/eji.1830221119; TANAKA T, 1995, INT IMMUNOL, V7, P1183, DOI 10.1093/intimm/7.8.1183; VANDERHEIJDEN PJ, 1987, J IMMUNOL METHODS, V103, P161, DOI 10.1016/0022-1759(87)90285-7; Wallace JL, 1999, GASTROENTEROLOGY, V117, P557, DOI 10.1016/S0016-5085(99)70448-8	32	92	97	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					769	780		10.1016/S1074-7613(02)00476-4	http://dx.doi.org/10.1016/S1074-7613(02)00476-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479823	Bronze			2022-12-18	WOS:000179985500009
J	He, XL; Radu, C; Sidney, J; Sette, A; Ward, ES; Garcia, KC				He, XL; Radu, C; Sidney, J; Sette, A; Ward, ES; Garcia, KC			Structural snapshot of aberrant antigen presentation linked to autoimmunity: The immunodominant epitope of MBP complexed with I-A(u)	IMMUNITY			English	Article							T-CELL-RECEPTOR; MYELIN BASIC-PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II MOLECULE; CRYSTAL-STRUCTURE; PEPTIDE BINDING; HIGH-AFFINITY; SELF-PEPTIDE; MHC; ENCEPHALOMYELITIS	Murine experimental allergic encephalomyelitis (EAE) is a useful model for the demyelinating, autoimmune disease multiple sclerosis. In the EAE system, the immunodominant N-terminal epitope of myelin basic protein (MBP) is an unusually short, weakly binding peptide antigen which elicits highly biased TCR chain usage. In the 2.2 Angstrom crystal structure of I-A(u)/MBP1-11 complex, only MBP residues 1-7 are bound toward one end of the peptide binding cleft. The fourth residue of MBP1-11 is located in an incompatible p6 pocket of I-A(u), thus explaining the short half-life of I-A(u) complexed with Ac1-11. MBP peptides extended at the C terminus of Ac1-11 result in dramatic affinity increases, likely attributed to register shifting to a higher affinity cryptic epitope, which could potentially mask the presentation of the immunodominant MBP1-11 peptide during thymic education.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, Dallas, TX 75390 USA; Epimmune Inc, San Diego, CA 92121 USA	Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Sette, Alessandro/AFO-8916-2022; Radu, Caius/D-3936-2013	Radu, Caius/0000-0002-9338-5397; Ward, E. Sally/0000-0003-3232-7238	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042949, N01AI095362] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI/NS 42949, N01-AI-95362] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Anderton SM, 1998, J IMMUNOL, V161, P3357; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Fugger L, 1996, MOL MED, V2, P181, DOI 10.1007/BF03401615; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GAUTAM AM, 1992, J EXP MED, V176, P605, DOI 10.1084/jem.176.2.605; GAUTAM AM, 1994, P NATL ACAD SCI USA, V91, P767, DOI 10.1073/pnas.91.2.767; GAUTAM AM, 1992, J IMMUNOL, V148, P3049; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; Grogan JL, 1999, J IMMUNOL, V163, P3764; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; JANEWAY CA, 1984, J IMMUNOL, V132, P662; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee C, 1998, J EXP MED, V187, P1505, DOI 10.1084/jem.187.9.1505; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Loftus C, 1999, J IMMUNOL, V162, P6451; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MASON K, 1995, BIOCHEMISTRY-US, V34, P14874, DOI 10.1021/bi00045a031; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; Pearson CI, 1999, P NATL ACAD SCI USA, V96, P197, DOI 10.1073/pnas.96.1.197; Radu CG, 2000, INT IMMUNOL, V12, P1553, DOI 10.1093/intimm/12.11.1553; Radu CG, 1998, J IMMUNOL, V160, P5915; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SETTE A, 1990, J IMMUNOL, V145, P1809; SIDNEY J, 1998, CURR PROT IMMUNOL, V18; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; Thatte J, 1999, J EXP MED, V189, P509, DOI 10.1084/jem.189.3.509; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WRAITH DC, 1992, J IMMUNOL, V149, P3765; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m	64	92	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2002	17	1					83	94		10.1016/S1074-7613(02)00340-0	http://dx.doi.org/10.1016/S1074-7613(02)00340-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150894	Bronze			2022-12-18	WOS:000177187500009
J	Purton, JF; Boyd, RL; Cole, TJ; Godfrey, DI				Purton, JF; Boyd, RL; Cole, TJ; Godfrey, DI			Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling	IMMUNITY			English	Article							THYMIC EPITHELIAL-CELLS; THYMOCYTE SELECTION; POSITIVE SELECTION; TRANSGENIC MICE; NEGATIVE SELECTION; IN-VIVO; SUPERANTIGEN; DISRUPTION; MATURATION; ACTIVATION	Glucocorticoids are believed to play a role in T cell development and selection, although their precise function is controversial. Glucocorticoid receptor (GR)-deficient mice were used to directly investigate this problem. GR-deficient thymocytes were resistant to dexamethasone-mediated apoptosis, confirming the absence of glucocorticoid responsiveness. An absence of GR signaling had no impact on thymocyte development either in vivo or in vitro. T cell differentiation, including positive selection, was normal as assessed by normal development of CD4(+)CD8(+), alpha beta TCR(+)CD4(+), and alpha beta TCR(+)CD8(+) thymocytes. Negative selection, mediated by the superantigen staphylococcal enterotoxin B (SEB), or anti-CD3/CD28, was also normal in the absence of GR signaling. In contrast to earlier reports, these data demonstrate that GR signaling is not essential for intrathymic T cell development or selection.	Monash Univ, Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia; Baker Med Res Inst, Prahran, Vic 3181, Australia	Monash University; Baker Heart and Diabetes Institute	Godfrey, DI (corresponding author), Monash Univ, Sch Med, Dept Pathol & Immunol, Commercial Rd, Prahran, Vic 3181, Australia.			Godfrey, Dale/0000-0002-3009-5472				Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 1999, MOL CELL ENDOCRINOL, V154, P29, DOI 10.1016/S0303-7207(99)00105-7; GODFREY DI, 1994, J IMMUNOL, V152, P2729; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GONZALO JA, 1994, J IMMUNOL, V152, P1597; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUGO P, 1991, EUR J IMMUNOL, V21, P835, DOI 10.1002/eji.1830210346; JENKINSON EJ, 1990, EUR J IMMUNOL, V20, P2517, DOI 10.1002/eji.1830201125; Jenkinson EJ, 1999, J IMMUNOL, V163, P5781; JONDAL M, 1993, EUR J IMMUNOL, V23, P1246, DOI 10.1002/eji.1830230608; KING LB, 1995, IMMUNITY, V3, P647, DOI 10.1016/1074-7613(95)90135-3; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Miller AH, 1998, CELL IMMUNOL, V186, P45, DOI 10.1006/cimm.1998.1293; MORALE MC, 1995, ENDOCRINOLOGY, V136, P3949, DOI 10.1210/en.136.9.3949; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Sacedon R, 1999, BLOOD, V94, P2819, DOI 10.1182/blood.V94.8.2819.420k12_2819_2826; Sacedon R, 1999, J NEUROIMMUNOL, V98, P157, DOI 10.1016/S0165-5728(99)00091-0; SCOLLAY R, 1983, THYMUS, V5, P245; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Tibbetts TA, 1999, P NATL ACAD SCI USA, V96, P12021, DOI 10.1073/pnas.96.21.12021; Vacchio MS, 1997, J EXP MED, V185, P2033, DOI 10.1084/jem.185.11.2033; Vacchio MS, 1999, J IMMUNOL, V163, P1327; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; VANVLIET E, 1986, CELL IMMUNOL, V103, P229, DOI 10.1016/0008-8749(86)90086-9; Xue YT, 1996, EUR J IMMUNOL, V26, P428, DOI 10.1002/eji.1830260224	29	92	92	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					179	186		10.1016/S1074-7613(00)00018-2	http://dx.doi.org/10.1016/S1074-7613(00)00018-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981961	Bronze			2022-12-18	WOS:000089132100003
J	Forero, A; Ozarkar, S; Li, HC; Lee, CH; Hemann, EA; Nadjsombati, MS; Hendricks, MR; So, L; Green, R; Roy, CN; Sarkar, SN; von Moltke, J; Anderson, SK; Gale, M; Savan, R				Forero, Adriana; Ozarkar, Snehal; Li, Hongchuan; Lee, Chia Heng; Hemann, Emily A.; Nadjsombati, Marija S.; Hendricks, Matthew R.; So, Lomon; Green, Richard; Roy, Chandra N.; Sarkar, Saumendra N.; von Moltke, Jakob; Anderson, Stephen K.; Gale, Michael, Jr.; Savan, Ram			Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons	IMMUNITY			English	Article							NF-KAPPA-B; ALPHA-INTERFERON; IFN-GAMMA; ANTIVIRAL PROTECTION; GENETIC-VARIATION; STIMULATED GENES; VIRUS-INFECTION; LAMBDA; CELLS; IL28B	Type I and III interferons (IFNs) activate similar downstream signaling cascades, but unlike type I IFNs, type III IFNs (IFN lambda) do not elicit strong inflammatory responses in vivo. Here, we examined the molecular mechanisms underlying this disparity. Type I and III IFNs displayed kinetic differences in expression of IFN-stimulated genes and proinflammatory responses, with type I IFNs preferentially stimulating expression of the transcription factor IRF1. Type III IFNs failed to induce IRF1 expression because of low IFN lambda receptor abundance and insufficient STAT1 activation on epithelial cells and thus did not activate the IRF1 proinflammatory gene program. Rather, IFN lambda stimulation preferentially induced factors implicated in tissue repair. Our findings suggest that IFN receptor compartmentalization and abundance confer a spatiotemporal division of labor where type III IFNs control viral spread at the site of the infection while restricting tissue damage; the transient induction of inflammatory responses by type I IFNs recruits immune effectors to promote protective immunity.	[Forero, Adriana; Ozarkar, Snehal; Lee, Chia Heng; Hemann, Emily A.; Nadjsombati, Marija S.; Hendricks, Matthew R.; So, Lomon; Green, Richard; von Moltke, Jakob; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [Li, Hongchuan; Anderson, Stephen K.] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21702 USA; [Green, Richard; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA; [Roy, Chandra N.; Sarkar, Saumendra N.] Univ Pittsburgh, Canc Inst, Pittsburgh, PA 15232 USA; [Anderson, Stephen K.] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Savan, R (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.; Savan, R (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA.	savanram@uw.edu	Sarkar, Saumendra N/B-5038-2011	Sarkar, Saumendra N/0000-0002-2850-6121; Savan, Ram/0000-0002-3087-1355; Nadjsombati, Marija/0000-0001-6632-8381; Anderson, Stephen/0000-0002-7856-4266; Hemann, Emily/0000-0002-6398-3492; Roy, Chandra Nath/0000-0001-6667-1550; Green, Richard/0000-0001-8851-7204	Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; Frederick National Laboratory forCancer Research, NIH [HHSN261200800001E];  [R01AI108765];  [T32HL007312];  [T32AI007509];  [R01 AI104002];  [U19 AI100625];  [R01 AI118916];  [R01 AI127463];  [P51 OD010425];  [17POST33660907];  [R01 AI118896]; NATIONAL CANCER INSTITUTE [R01CA178766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118896, R01AI127463, DP2AI136596, R01AI104002, T32AI007509, R01AI118916, R01AI108765, U19AI100625] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; Frederick National Laboratory forCancer Research, NIH; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by R01AI108765 (to R.S.), T32HL007312 (to A.F.), T32AI007509 (to M.R.H.), R01 AI104002 (to M.G.), U19 AI100625 (to M.G.), R01 AI118916 (to M.G.), R01 AI127463 (to M.G.), P51 OD010425 (to M.G.), 17POST33660907 (to E.A.H.), R01 AI118896 (to S.N.S.) and federal funds fromthe Frederick National Laboratory forCancer Research, NIH under contract HHSN261200800001E. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research.	Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16; Bhushal S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00671; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Blumer T, 2017, J BIOL CHEM, V292, P17928, DOI 10.1074/jbc.M117.788877; Chiriac MT, 2017, GASTROENTEROLOGY, V153, P123, DOI 10.1053/j.gastro.2017.03.015; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cuevas RA, 2016, J IMMUNOL, V196, P3877, DOI 10.4049/jimmunol.1501359; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Enane FO, 2017, J CLIN INVEST, V127, P3527, DOI 10.1172/JCI93488; Forero A, 2016, J VIROL, V90, P2240, DOI 10.1128/JVI.02974-15; Forero A, 2014, J IMMUNOL, V192, P5933, DOI 10.4049/jimmunol.1303470; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Garibaldi A, 2017, METHODS MOL BIOL, V1648, P169, DOI 10.1007/978-1-4939-7204-3_13; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hong MA, 2016, J EXP MED, V213, P2539, DOI 10.1084/jem.20160437; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Jarret A, 2016, NAT MED, V22, P1475, DOI 10.1038/nm.4211; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kato N, 1998, J GEN VIROL, V79, P1859, DOI 10.1099/0022-1317-79-8-1859; Kim S, 2017, AM J RESP CELL MOL, V56, P202, DOI 10.1165/rcmb.2016-0174OC; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pervolaraki K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00459; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rodriguez JL, 2006, BIOCHEM J, V398, P431, DOI 10.1042/BJ20060380; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwerk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072700; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Soini T, 2018, TUMOR BIOL, V40; Speer SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11496; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	62	91	91	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					451	+		10.1016/j.immuni.2019.07.007	http://dx.doi.org/10.1016/j.immuni.2019.07.007			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31471108	Bronze, Green Accepted			2022-12-18	WOS:000486184600009
J	Tibbitt, CA; Stark, JM; Martens, L; Ma, JJ; Mold, JE; Deswarte, K; Oliynyk, G; Feng, XG; Lambrecht, BN; De Bleser, P; Nylen, S; Hammad, H; Henriksson, MA; Saeys, Y; Coquet, JM				Tibbitt, Christopher Andrew; Stark, Julian Mario; Martens, Liesbet; Ma, Junjie; Mold, Jeff Eron; Deswarte, Kim; Oliynyk, Ganna; Feng, Xiaogang; Lambrecht, Bart Norbert; De Bleser, Pieter; Nylen, Susanne; Hammad, Hamida; Henriksson, Marie Arsenian; Saeys, Yvan; Coquet, Jonathan Marie			Single-Cell RNA Sequencing of the T Helper Cell Response to House Dust Mites Defines a Distinct Gene Expression Signature in Airway Th2 Cells	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; CO-STIMULATION; PPAR-GAMMA; DIFFERENTIATION; ASTHMA; MECHANISMS; DEFICIENCY; ACTIVATION; IMMUNITY	Naive CD4(+) T cells differentiate into functionally diverse T helper (Th) cell subsets. Th2 cells play a pathogenic role in asthma, yet a clear picture of their transcriptional profile is lacking. We performed single-cell RNA sequencing (scRNA-seq) of T helper cells from lymph node, lung, and airways in the house dust mite (HDM) model of allergic airway disease. scRNA-seq resolved transcriptional profiles of naive CD4(+) T, Th1, Th2, regulatory T (Treg) cells, and a CD4(+) T cell population responsive to type I interferons. Th2 cells in the airways were enriched for transcription of many genes, including Cd200r1, Il6, Plac8, and Igfbp7, and their mRNA profile was supported by analysis of chromatin accessibility and flow cytometry. Pathways associated with lipid metabolism were enriched in Th2 cells, and experiments with inhibitors of key metabolic pathways supported roles for glucose and lipid metabolism. These findings provide insight into the differentiation of pathogenic Th2 cells in the context of allergy.	[Tibbitt, Christopher Andrew; Stark, Julian Mario; Ma, Junjie; Oliynyk, Ganna; Feng, Xiaogang; Nylen, Susanne; Henriksson, Marie Arsenian; Coquet, Jonathan Marie] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17165 Stockholm, Sweden; [Martens, Liesbet; De Bleser, Pieter; Saeys, Yvan] VIB UGent Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Martens, Liesbet; De Bleser, Pieter] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Mold, Jeff Eron] Karolinska Inst, Dept Cell & Mol Biol, S-17165 Stockholm, Sweden; [Deswarte, Kim; Lambrecht, Bart Norbert; Hammad, Hamida] Univ Ghent, VIB Inflammat Res Ctr IRC, B-9052 Zwijnaarde, Belgium; [Saeys, Yvan] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium	Karolinska Institutet; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Karolinska Institutet; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Coquet, JM (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17165 Stockholm, Sweden.	jonathan.coquet@ki.se	De Bleser, Pieter/AAB-2968-2021; Lambrecht, Bart N/K-2484-2014; Henriksson, Marie Arsenian/F-5010-2015; Saeys, Yvan/C-1311-2009; Coquet, Jonathan M/A-5551-2015; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Saeys, Yvan/0000-0002-0415-1506; Coquet, Jonathan M/0000-0002-5967-4857; Deswarte, Kim/0000-0002-9761-6973; Tibbitt, Chris/0000-0002-7730-7700; Hammad, Hamida/0000-0003-3762-8603; Martens, Liesbet/0000-0001-9180-7456; Arsenian Henriksson, Marie/0000-0001-6376-7792	Swedish Research Council [2014-02858]; Swedish Cancer Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Ake Wiberg Foundation	scRNA-seq was performed at the eukaryotic single-cell genomics facility at SciLife laboratories (Stockholm, Sweden). We thank Mats Wahlgren for supplying important resources. Histology was performed at the Morphological Phenotype Analysis Core Facility at Karolinska Institute. J.M.C. was supported by grants from the Swedish Research Council (2014-02858), the Swedish Cancer Foundation, and the Ake Wiberg Foundation.	Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Angela M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13683; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ballesteros-Tato A, 2016, IMMUNITY, V44, P259, DOI 10.1016/j.immuni.2015.11.017; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Blom LH, 2017, ALLERGY, V72, P1081, DOI 10.1111/all.13129; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cannoodt R., 2016, BIORXIV, DOI [10.1101/079509, DOI 10.1101/079509]; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5196; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Coquet JM, 2015, IMMUNOL CELL BIOL, V93, P780, DOI 10.1038/icb.2015.45; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Holt PG, 2002, J EXP MED, V196, P1271, DOI 10.1084/jem.20021572; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; James J, 2017, J IMMUNOL, V198, P1164, DOI 10.4049/jimmunol.1601213; Jin ZB, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2016-000202; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Khan A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1708-7; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Ledford JG, 2012, IMMUNOL CELL BIOL, V90, P733, DOI 10.1038/icb.2011.107; Lee SM, 2015, J BIOL CHEM, V290, P30573, DOI 10.1074/jbc.M115.693614; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nobs SP, 2017, J EXP MED, V214, P3015, DOI 10.1084/jem.20162069; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Proserpio V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0957-5; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Stubbington MJT, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0045-x; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Webb LM, 2017, EMBO J, V36, P2404, DOI 10.15252/embj.201695345; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wittke A, 2004, J IMMUNOL, V173, P3432, DOI 10.4049/jimmunol.173.5.3432; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	65	91	96	5	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					169	184		10.1016/j.immuni.2019.05.014	http://dx.doi.org/10.1016/j.immuni.2019.05.014			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31231035	Bronze			2022-12-18	WOS:000475561000019
J	Wesemann, DR; Nagler, CR				Wesemann, Duane R.; Nagler, Cathryn R.			The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease	IMMUNITY			English	Review							FILAGGRIN NULL MUTATIONS; FOXP3(+) T-CELLS; COMMENSAL BACTERIA; FOOD ALLERGY; EARLY-LIFE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ATOPIC-DERMATITIS; FECAL MICROBIOTA; PEANUT ALLERGY	Allergic disease affects millions. Despite many advances in our understanding of the immune systemin the past century, the physiologic underpinning for the existence of allergy remains largely mysterious. Food allergies, in particular, have increased dramatically in recent years, adding a new sense of urgency to unraveling this mystery. The concurrence of significant lifestyle changes in Western societies with increasing disease prevalence implies a causal link. Demographic variables that influence the composition and function of the commensal microbiota early in life seem to be most important. Identifying the evolutionary and physiologic foundations of allergic disease and defining what about our modern environment is responsible for its increased incidence will provide insights critical to the development of new approaches to prevention and treatment.	[Wesemann, Duane R.] Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Wesemann, Duane R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago	Wesemann, DR (corresponding author), Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Wesemann, DR (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Nagler, CR (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dwesemann@bwh.harvard.edu; cnagler@bsd.uchicago.edu		Wesemann, Duane/0000-0002-6690-944X	NIH [AI 106302, AI121394, AI113217]; Sunshine Foundation; UChicago Center for Translational Medicine; UChicago Digestive Diseases Research Core Center [DK42086]; F.A.R.E. (Food Allergy Research and Education); Burroughs Wellcome Fund; F.A.R.E.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113217, R01AI121394, R56AI113217, R01AI106302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sunshine Foundation; UChicago Center for Translational Medicine; UChicago Digestive Diseases Research Core Center; F.A.R.E. (Food Allergy Research and Education); Burroughs Wellcome Fund(Burroughs Wellcome Fund); F.A.R.E.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank T. Feehley, J. Hwang, J. Boyce, and A. Granato for critical review of this manuscript. The C.R.N. laboratory is supported by the NIH (AI 106302), the Sunshine Foundation, UChicago Center for Translational Medicine, UChicago Digestive Diseases Research Core Center (DK42086), and F.A.R.E. (Food Allergy Research and Education). The D.R.W. laboratory is supported by the NIH (AI121394, and AI113217). D.R.W. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and a New Investigator Award from F.A.R.E.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Alduraywish SA, 2016, ALLERGY, V71, P77, DOI 10.1111/all.12784; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Barile D, 2013, CURR OPIN BIOTECH, V24, P214, DOI 10.1016/j.copbio.2013.01.008; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Branum Amy M, 2008, NCHS Data Brief, P1; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brown SJ, 2008, J ALLERGY CLIN IMMUN, V121, P940, DOI 10.1016/j.jaci.2008.01.013; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Cao S, 2014, FEBS LETT, V588, P4258, DOI 10.1016/j.febslet.2014.04.026; Chai JN, 2014, FEBS LETT, V588, P4167, DOI 10.1016/j.febslet.2014.06.040; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25; Davani D, 2014, J IMMUNOL, V192, P3218, DOI 10.4049/jimmunol.1302395; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dominguez-Bello MG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2741; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Elazab N, 2013, PEDIATRICS, V132, pE666, DOI 10.1542/peds.2013-0246; Erwin EA, 2005, IMMUNOL ALLERGY CLIN, V25, P1, DOI 10.1016/j.iac.2004.09.008; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Feehley T, 2012, SEMIN IMMUNOPATHOL, V34, P671, DOI 10.1007/s00281-012-0337-5; Filipiak-Pittroff B, 2011, J ALLERGY CLIN IMMUN, V128, P1235, DOI 10.1016/j.jaci.2011.09.014; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Fitzsimmons CM, 2009, TRENDS PARASITOL, V25, P447, DOI 10.1016/j.pt.2009.07.004; Franco A, 2011, IN VIVO, V25, P829; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Golby S, 2002, J LEUKOCYTE BIOL, V72, P279; Gruchalla RS, 2015, NEW ENGL J MED, V372, P875, DOI 10.1056/NEJMe1500186; Guaraldi F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00094; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; Hefle SL, 1996, CRIT REV FOOD SCI, V36, pS69, DOI 10.1080/10408399609527760; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hoff S, 2015, CLIN IMMUNOL, V156, P128, DOI 10.1016/j.clim.2014.12.001; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Igea JM, 2013, ALLERGY, V68, P966, DOI 10.1111/all.12174; ISHIZAKA K, 1966, J ALLERGY, V37, P169, DOI 10.1016/0021-8707(66)90091-8; Iweala OI, 2006, IMMUNOL REV, V213, P82, DOI 10.1111/j.1600-065X.2006.00431.x; Jackson K. D., 2013, NCHS DATA BRIEF; Janzi M, 2009, CLIN IMMUNOL, V133, P78, DOI 10.1016/j.clim.2009.05.014; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; KANOK JM, 1978, ANN ALLERGY, V41, P220; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee J.B., 2015, J ALLERGY CLIN IMMUN; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096603; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2015, IMMUNITY, V43, P416, DOI 10.1016/j.immuni.2015.08.024; Macpherson AJ, 2015, TRENDS IMMUNOL, V36, P460, DOI 10.1016/j.it.2015.06.006; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Metsala J, 2013, EPIDEMIOLOGY, V24, P303, DOI 10.1097/EDE.0b013e31827f520f; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Mutwiri G, 1999, IMMUNOLOGY, V97, P455, DOI 10.1046/j.1365-2567.1999.00791.x; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakayama J, 2011, FEMS IMMUNOL MED MIC, V63, P397, DOI 10.1111/j.1574-695X.2011.00872.x; Nemazee D, 2000, Adv Immunol, V74, P89; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Paul WE., 2013, FUNDAMENTAL IMMUNOLO; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; PLEBANI A, 1987, INT ARCH ALLER A IMM, V82, P485, DOI 10.1159/000234261; Prausnitz C., 1921, CENT BAKTERIO, V86, P160; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shek LPC, 2005, ALLERGY, V60, P912, DOI 10.1111/j.1398-9995.2005.00705.x; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Thompson-Chagoyan OC, 2011, INT ARCH ALLERGY IMM, V156, P325, DOI 10.1159/000323893; Thompson-Chagoyan OC, 2010, PEDIAT ALLERG IMM-UK, V21, pE394, DOI 10.1111/j.1399-3038.2009.00961.x; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tong P, 2015, CURR TOP MICROBIOL, V388, P21, DOI 10.1007/978-3-319-13725-4_2; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Valenta R, 2015, GASTROENTEROLOGY, V148, P1120, DOI 10.1053/j.gastro.2015.02.006; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; WEILL JC, 1987, SCIENCE, V238, P1094, DOI 10.1126/science.3317827; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wood RA, 2014, J ALLER CL IMM-PRACT, V2, P97, DOI 10.1016/j.jaip.2013.11.010; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b	142	91	93	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					728	738		10.1016/j.immuni.2016.02.002	http://dx.doi.org/10.1016/j.immuni.2016.02.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096316	Green Accepted, Bronze			2022-12-18	WOS:000374444300007
J	Wang, S; Charbonnier, LM; Rivas, MN; Georgiev, P; Li, N; Gerber, G; Bry, L; Chatila, TA				Wang, Sen; Charbonnier, Louis-Marie; Rivas, Magali Noval; Georgiev, Peter; Li, Ning; Gerber, Georg; Bry, Lynn; Chatila, Talal A.			MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism	IMMUNITY			English	Article							TOLL-LIKE-RECEPTORS; SEGMENTED FILAMENTOUS BACTERIA; NF-KAPPA-B; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; RETINOIC-ACID; ENVIRONMENTAL INTERFACES; INTESTINAL MICROBIOTA; PEYERS-PATCHES; IGA RESPONSE	Commensal microbiota promote mucosal tolerance in part by engaging regulatory T (Treg) cells via Toll-like receptors (TLRs). We report that Treg-cell-specific deletion of the TLR adaptor MyD88 resulted in deficiency of intestinal Treg cells, a reciprocal increase in T helper 17 (Th17) cells and heightened interleukin-17 (IL-17)-dependent inflammation in experimental colitis. It also precipitated dysbiosis with overgrowth of segmented filamentous bacteria (SFB) and increased microbial loads in deep tissues. The Th17 cell dysregulation and bacterial dysbiosis were linked to impaired anti-microbial intestinal IgA responses, related to defective MyD88 adaptor-and Stat3 transcription factor-dependent T follicular regulatory and helper cell differentiation in the Peyer's patches. These findings establish an essential role for MyD88-dependent microbial sensing by Treg cells in enforcing mucosal tolerance and maintaining commensalism by promoting intestinal Treg cell formation and anti-commensal IgA responses.	[Wang, Sen; Charbonnier, Louis-Marie; Rivas, Magali Noval; Georgiev, Peter; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Wang, Sen; Charbonnier, Louis-Marie; Rivas, Magali Noval; Georgiev, Peter; Chatila, Talal A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Li, Ning; Gerber, Georg; Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Ctr Clin & Translat Metagen, Dept Pathol,Med Sch, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Noval Rivas, Magali/R-4987-2016; Young, Richard A/F-6495-2012	Noval Rivas, Magali/0000-0001-5570-8928; Young, Richard A/0000-0001-8855-8647; Georgiev, Peter/0000-0002-4613-1255; Charbonnier, Louis-Marie/0000-0002-4594-7893; Bry, Lynn/0000-0002-8792-8527; Chatila, Talal/0000-0001-7439-2762	NIH grants [R01AI085090, R01HD061916, P30DK034854]; Brigham and Women's Department of Pathology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Department of Pathology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01AI085090 (T.A.C.), R01HD061916 (L.-M.B.), and P30DK034854 (L.-M.B. and G.G.) and by the Brigham and Women's Department of Pathology (G.G.).	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rivas MN, 2012, J CLIN INVEST, V122, P1933, DOI 10.1172/JCI40591; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	56	91	94	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					289	303		10.1016/j.immuni.2015.06.014	http://dx.doi.org/10.1016/j.immuni.2015.06.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231118	Green Accepted, Bronze			2022-12-18	WOS:000360101200012
J	Hirahara, K; Onodera, A; Villarino, AV; Bonelli, M; Sciume, G; Laurence, A; Sun, HW; Brooks, SR; Vahedi, G; Shih, HY; Gutierrez-Cruz, G; Iwata, S; Suzuki, R; Mikami, Y; Okamoto, Y; Nakayama, T; Holland, SM; Hunter, CA; Kanno, Y; O'Shea, JJ				Hirahara, Kiyoshi; Onodera, Atsushi; Villarino, Alejandro V.; Bonelli, Michael; Sciume, Giuseppe; Laurence, Arian; Sun, Hong-Wei; Brooks, Stephen R.; Vahedi, Golnaz; Shih, Han-Yu; Gutierrez-Cruz, Gustavo; Iwata, Shigeru; Suzuki, Ryo; Mikami, Yohei; Okamoto, Yoshitaka; Nakayama, Toshinori; Holland, Steven M.; Hunter, Christopher A.; Kanno, Yuka; O'Shea, John J.			Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity	IMMUNITY			English	Article							CD4(+) T-CELLS; INTERFERON-GAMMA; CUTTING EDGE; TH17 CELLS; IL-27; INTERLEUKIN-27; ACTIVATION; RECEPTOR; DIFFERENTIATION; INDUCTION	Interleukin-6 (IL-6) and IL-27 signal through a shared receptor subunit and employ the same downstream STAT transcription proteins, but yet are ascribed unique and overlapping functions. To evaluate the specificity and redundancy for these cytokines, we quantified their global transcriptomic changes and determined the relative contributions of STAT1 and STAT3 using genetic models and chromatin immunoprecipitation- sequencing (ChIP-seq) approaches. We found an extensive overlap of the transcriptomes induced by IL-6 and IL-27 and few examples in which the cytokines acted in opposition. Using STAT-deficient cells and T cells from patients with gain-of-function STAT1 mutations, we demonstrated that STAT3 is responsible for the overall transcriptional output driven by both cytokines, whereas STAT1 is the principal driver of specificity. STAT1 cannot compensate in the absence of STAT3 and, in fact, much of STAT1 binding to chromatin is STAT3 dependent. Thus, STAT1 shapes the specific cytokine signature superimposed upon STAT3's action.	[Hirahara, Kiyoshi; Villarino, Alejandro V.; Bonelli, Michael; Sciume, Giuseppe; Laurence, Arian; Vahedi, Golnaz; Shih, Han-Yu; Iwata, Shigeru; Mikami, Yohei; Kanno, Yuka; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei; Brooks, Stephen R.] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Gutierrez-Cruz, Gustavo] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Suzuki, Ryo] NIAMS, Lab Mol Immunogenet, NIH, Bethesda, MD 20892 USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Hirahara, Kiyoshi] Chiba Univ, Grad Sch Med, Dept Adv Allergol Airway, Chiba 2608670, Japan; [Onodera, Atsushi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan; [Okamoto, Yoshitaka] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol, Chiba 2608670, Japan; [Nakayama, Toshinori] Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Chiba, Chiba 2608670, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Chiba University; Chiba University; Chiba University; Japan Science & Technology Agency (JST)	Kanno, Y (corresponding author), NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov; osheaj@arb.niams.nih.gov	Kanno, Yuka/B-5802-2013; Laurence, Arian/A-8770-2009; Onodera, Atsushi/E-3136-2017; Villarino, Alejandro/AAE-3517-2020; Nakayama, Toshinori/E-1067-2017; Hirahara, Kiyoshi/E-2460-2017; Sciume, Giuseppe/K-8985-2016; MIKAMI, YOHEI/GRJ-8133-2022	Kanno, Yuka/0000-0001-5668-9319; Laurence, Arian/0000-0003-0942-8292; Villarino, Alejandro/0000-0001-8068-2176; Nakayama, Toshinori/0000-0002-1434-2007; Hirahara, Kiyoshi/0000-0002-9128-9449; Sciume, Giuseppe/0000-0003-0131-512X; MIKAMI, YOHEI/0000-0001-5104-4415; Bonelli, Michael/0000-0002-6122-7482; Shih, Han-Yu/0000-0002-7525-5433	Intramural Research Programs of NIAMS; Ministry of Education, Culture, Sports, Science and Technology (Japan) [25893032]; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Osaka Foundation for Promotion of Fundamental Medical Research; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110201, ZIAAI000647, ZIAAI000646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041167, ZICAR041207, ZICAR041181, ZIHAR041173] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Osaka Foundation for Promotion of Fundamental Medical Research; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone, J. Lay (Flow Cytometry Section, NIAMS), and the NIAMS LACU staff for their excellent technical support. This study utilized the high-performance computational capabilities of the Helix Systems at the NIH. This work was supported by the Intramural Research Programs of NIAMS, grant from the Ministry of Education, Culture, Sports, Science and Technology (Japan; Grants-in-Aid for Research Activity start-up #25893032), The Astellas Foundation for Research on Metabolic Disorders, The Uehara Memorial Foundation, Osaka Foundation for Promotion of Fundamental Medical Research, Kanae Foundation for the Promotion of Medical Science, and Takeda Science Foundation (K.H.).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gorissen M, 2011, J ENDOCRINOL, V209, P175, DOI 10.1530/JOE-11-0033; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang N, 2008, DNA CELL BIOL, V27, P527, DOI 10.1089/dna.2007.0715; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liongue C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032777; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schiavone D, 2011, FEBS LETT, V585, P2455, DOI 10.1016/j.febslet.2011.06.020; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda K, 1998, J IMMUNOL, V161, P4652; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Young A, 2012, J IMMUNOL, V189, P2079, DOI 10.4049/jimmunol.1200131; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	91	91	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					877	889		10.1016/j.immuni.2015.04.014	http://dx.doi.org/10.1016/j.immuni.2015.04.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992861	Bronze			2022-12-18	WOS:000354827400014
J	Reynolds, JM; Lee, YH; Shi, Y; Wang, XH; Angkasekwinai, P; Nallaparaju, KC; Flaherty, S; Chang, SH; Watarai, H; Dong, C				Reynolds, Joseph M.; Lee, Young-Hee; Shi, Yun; Wang, Xiaohu; Angkasekwinai, Pompimon; Nallaparaju, Kalyan C.; Flaherty, Stephanie; Chang, Seon Hee; Watarai, Hiroshi; Dong, Chen			Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation	IMMUNITY			English	Article							EPITHELIAL-CELLS; ADAPTER PROTEIN; CUTTING EDGE; RECEPTOR; IL-25; IL-17; PROMOTES; COLITIS; IDENTIFICATION; EXPRESSION	The interleukin-17 (IL-17) family of cytokines has emerged as a critical player in inflammatory diseases. Among them, IL-25 has been shown to be important in allergic inflammation and protection against parasitic infection. Here we have demonstrated that IL-17B, a poorly understood cytokine, functions to inhibit IL-25-driven inflammation. IL-17B and IL-25, both binding to the interleukin-17 receptor B (IL-17RB), were upregulated in their expression after acute colonic inflammation. Individual inhibition of these cytokines revealed opposing functions in colon inflammation: IL-25 was pathogenic but IL-17B was protective. Similarly opposing phenotypes were observed in Citrobacter rodentium infection and allergic asthma. Moreover, IL-25 was found to promote IL-6 production from colon epithelial cells, which was inhibited by IL-17B. Therefore, our data demonstrate that IL-17B is an anti-inflammatory cytokine in the IL-17 family.	[Reynolds, Joseph M.; Flaherty, Stephanie] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, N Chicago, IL 60064 USA; [Lee, Young-Hee; Shi, Yun; Nallaparaju, Kalyan C.; Chang, Seon Hee] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Lee, Young-Hee; Shi, Yun; Nallaparaju, Kalyan C.; Chang, Seon Hee] MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA; [Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Angkasekwinai, Pompimon] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani 12120, Thailand; [Watarai, Hiroshi] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Minato Ku, Tokyo 1088639, Japan; [Watarai, Hiroshi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Chiyoda Ku, Tokyo 1020076, Japan	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Thammasat University; University of Tokyo; Japan Science & Technology Agency (JST)	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.	chendong@tsinghua.edu.cn	Shi, Yun/HGE-1294-2022; Angkasekwinai, Pornpimon/AAX-6124-2020; dong, chen/B-3181-2009; Chang, Seon Hee/AAQ-9521-2020	Shi, Yun/0000-0003-1925-4337; dong, chen/0000-0002-0084-9130; Chang, Seon Hee/0000-0002-9389-508X; Angkasekwinai, Pornpimon/0000-0003-0303-9544; Reynolds, Joseph/0000-0003-3490-0544	National Cancer Institute [T32CA009598]; MD Anderson Cancer Center [5 P50 CA142509 04]; Crohn's and Colitis Foundation of America Career Development Award [3633]; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE [P50CA142509, P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center; Crohn's and Colitis Foundation of America Career Development Award; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was in part supported by a National Cancer Institute training grant T32CA009598 (J.M.R.), a SPORE grant from MD Anderson Cancer Center (5 P50 CA142509 04 to Y.-H.L.), a Crohn's and Colitis Foundation of America Career Development Award (#3633 to S.H.C.), and the Cancer Prevention and Research Institute of Texas (to S.H.C. and C.D.). C.D. is a Bayer Chair Professor at Tsinghua University.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Buning C, 2003, EUR J IMMUNOGENET, V30, P329, DOI 10.1046/j.1365-2370.2003.00411.x; Camelo A, 2012, J GASTROENTEROL, V47, P1198, DOI 10.1007/s00535-012-0591-2; Caruso R, 2009, GASTROENTEROLOGY, V136, P2270, DOI 10.1053/j.gastro.2009.02.049; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gay J, 2006, NEUROIMMUNOMODULAT, V13, P114, DOI 10.1159/000096656; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang CK, 2014, ONCOGENE, V33, P2968, DOI 10.1038/onc.2013.268; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kokubu T, 2008, J HISTOCHEM CYTOCHEM, V56, P89, DOI 10.1369/jhc.7A7223.2007; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; Mchenga SSS, 2008, CELL MOL IMMUNOL, V5, P425, DOI 10.1038/cmi.2008.53; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanders AJ, 2010, J ONCOL, V2010, DOI 10.1155/2010/817375; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Su JL, 2013, INFLAMM BOWEL DIS, V19, P720, DOI 10.1097/MIB.0b013e3182802a76; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tian EM, 2000, ONCOGENE, V19, P2098, DOI 10.1038/sj.onc.1203577; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wong CK, 2005, AM J RESP CELL MOL, V33, P186, DOI 10.1165/rcmb.2005-0034OC; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; You ZB, 2005, BIOCHEM BIOPH RES CO, V326, P624, DOI 10.1016/j.bbrc.2004.11.087; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	56	91	94	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					692	703		10.1016/j.immuni.2015.03.008	http://dx.doi.org/10.1016/j.immuni.2015.03.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25888259	Bronze, Green Accepted			2022-12-18	WOS:000353347500015
J	Ferris, ST; Carrero, JA; Mohan, JF; Calderon, B; Murphy, KM; Unanue, ER				Ferris, Stephen T.; Carrero, Javier A.; Mohan, James F.; Calderon, Boris; Murphy, Kenneth M.; Unanue, Emil R.			A Minor Subset of Batf3-Dependent Antigen-Presenting Cells in Islets of Langerhans Is Essential for the Development of Autoimmune Diabetes	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; CD8(+) T-CELLS; PANCREATIC LYMPH-NODES; CUTTING EDGE; IN-VIVO; MICE; INSULIN; MOUSE; EXPRESSION; AUTOANTIGEN	Autoimmune diabetes is characterized by inflammatory infiltration; however, the initiating events are poorly understood. We found that the islets of Langerhans in young nonobese diabetic (NOD) mice contained two antigen-presenting cell (APC) populations: a major macrophage and a minor CD103(+) dendritic cell (DC) population. By 4 weeks of age, CD4(+) T cells entered islets coincident with an increase in CD103(+) DCs. In order to examine the role of the CD103(+) DCs in diabetes, we examined Batf3-deficient NOD mice that lacked the CD103(+) DCs in islets and pancreatic lymph nodes. This led to a lack of autoreactive T cells in islets and, importantly, no incidence of diabetes. Additional examination revealed that presentation of major histocompatibility complex (MHC) class I epitopes in the pancreatic lymph nodes was absent with a partial impairment of MHC class II presentation. Altogether, this study reveals that CD103(+) DCs are essential for autoimmune diabetes development.	[Ferris, Stephen T.; Carrero, Javier A.; Mohan, James F.; Calderon, Boris; Murphy, Kenneth M.; Unanue, Emil R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	unanue@wustl.edu		Ferris, Stephen/0000-0003-3340-2607; Calderon, Boris/0000-0003-1575-0739	National Institutes of Health [DK058177, DK020579]; Juvenile Diabetes Research Foundation (JDRF) [17-2012-141]; Kilo Diabetes and Vascular Disease Foundation (Kilo); Rheumatic Diseases Core Center for Speed Congenics; National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR048335]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK058177, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Kilo Diabetes and Vascular Disease Foundation (Kilo); Rheumatic Diseases Core Center for Speed Congenics; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the members of our laboratory for many helpful discussions and assistance, and in particular Katherine E. Frederick, Xiaoxiao Wan, Lindsay Moore, and Anthony N. Vomund. This research was supported by the National Institutes of Health grants DK058177 and DK020579, Juvenile Diabetes Research Foundation (JDRF) 17-2012-141, and the Kilo Diabetes and Vascular Disease Foundation (Kilo). Experimental support was provided by the Rheumatic Diseases Core Center for Speed Congenics and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR048335). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, JDRF, or the Kilo foundation.	Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bouma G, 2005, EUR J IMMUNOL, V35, P2386, DOI 10.1002/eji.200526251; Brezar V, 2011, ENDOCR REV, V32, P623, DOI 10.1210/er.2011-0010; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Calderon B, 2012, CURR OPIN IMMUNOL, V24, P119, DOI 10.1016/j.coi.2011.11.005; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; de Jersey J, 2007, P NATL ACAD SCI USA, V104, P1295, DOI 10.1073/pnas.0610057104; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Grainger JR, 2014, IMMUNOL REV, V259, P75, DOI 10.1111/imr.12167; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kay TWH, 1996, J IMMUNOL, V157, P3688; Krishnamurthy B, 2008, J IMMUNOL, V180, P4458, DOI 10.4049/jimmunol.180.7.4458; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Levisetti MG, 2004, DIABETES, V53, P3115, DOI 10.2337/diabetes.53.12.3115; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; MILLER BJ, 1988, J IMMUNOL, V140, P52; Mohan JF, 2013, J EXP MED, V210, P2403, DOI 10.1084/jem.20130582; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Serreze DV, 2004, J IMMUNOL, V172, P871, DOI 10.4049/jimmunol.172.2.871; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Unanue ER, 2014, ANNU REV IMMUNOL, V32, P579, DOI 10.1146/annurev-immunol-032712-095941; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855; Yamanouchi J, 2003, J IMMUNOL, V171, P6900, DOI 10.4049/jimmunol.171.12.6900; Yin N, 2012, J IMMUNOL, V188, P4921, DOI 10.4049/jimmunol.1103725; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	56	91	92	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					657	669		10.1016/j.immuni.2014.09.012	http://dx.doi.org/10.1016/j.immuni.2014.09.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367577	Green Accepted, Bronze			2022-12-18	WOS:000345504300018
J	Yoshida, Y; Yoshimi, R; Yoshii, H; Kim, D; Dey, A; Xiong, HB; Munasinghe, J; Yazawa, I; O'Donovan, MJ; Maximova, OA; Sharma, S; Zhu, JF; Wang, HS; Morse, HC; Ozato, K				Yoshida, Yuko; Yoshimi, Ryusuke; Yoshii, Hiroaki; Kim, Daniel; Dey, Anup; Xiong, Huabao; Munasinghe, Jeeva; Yazawa, Itaru; O'Donovan, Michael J.; Maximova, Olga A.; Sharma, Suveena; Zhu, Jinfang; Wang, Hongsheng; Morse, Herbert C., III; Ozato, Keiko			The Transcription Factor IRF8 Activates Integrin-Mediated TGF-beta Signaling and Promotes Neuroinflammation	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; INTERFERON REGULATORY FACTOR-8; CELL SUBSET DEVELOPMENT; T-HELPER-CELLS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; CHRONIC INFLAMMATION; FAMILY CYTOKINES; ROR-GAMMA	Recent epidemiological studies have identified interferon regulatory factor 8 (IRF8) as a susceptibility factor for multiple sclerosis (MS). However, how IRF8 influences the neuroinflammatory disease has remained unknown. By studying the role of IRF8 in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, we found that Irf8(-/-) mice are resistant to EAE. Furthermore, expression of IRF8 in antigen-presenting cells (APCs, such as macrophages, dendritic cells, and microglia), but not in T cells, facilitated disease onset and progression through multiple pathways. IRF8 enhanced alpha v beta 8 integrin expression in APCs and activated TGF-beta signaling leading to T helper 17 (Th17) cell differentiation. IRF8 induced a cytokine milieu that favored growth and maintenance of Th1 and Th17 cells, by stimulating interleukin-12 (IL-12) and IL-23 production, but inhibiting IL-27 during EAE. Finally, IRF8 activated microglia and exacerbated neuroinflammation. Together, this work provides mechanistic bases by which IRF8 contributes to the pathogenesis of MS.	[Yoshida, Yuko; Yoshimi, Ryusuke; Yoshii, Hiroaki; Kim, Daniel; Dey, Anup; Ozato, Keiko] NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Xiong, Huabao] Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA; [Munasinghe, Jeeva] NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Yazawa, Itaru; O'Donovan, Michael J.] NINDS, Lab Neural Control, NIH, Bethesda, MD 20892 USA; [Maximova, Olga A.] NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA; [Sharma, Suveena; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Wang, Hongsheng; Morse, Herbert C., III] NIAID, Immunogenet Lab, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ozato, K (corresponding author), NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	o'donovan, michael/A-2357-2015; Zhu, Jinfang/B-7574-2012; Yoshimi, Ryusuke/ABA-5462-2021	o'donovan, michael/0000-0003-2487-7547; Zhu, Jinfang/0000-0002-0117-4745; Yoshimi, Ryusuke/0000-0002-3945-307X; Morse, Herbert/0000-0002-9331-3705	NICHD; NIAID; NINDS, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, ZIAAI001057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003022] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Alan Koretsky (NINDS) for his support and critical reading of the manuscript, Takayuki Ito and Makoto Horiuchi (UC, Davis), Ulrich Siebenlist (NIAID) for useful advice on experiments and reagents, and Mehrnoosh Abshari for assistance in cell sorting and in vitro experiments. This work was supported by the Intramural Program of NICHD, NIAID, and NINDS, National Institutes of Health.	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Disanto G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032281; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Hambleton S, 2011, N ENGL J MED; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Horiuchi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-227; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Li YH, 2007, BRAIN, V130, P490, DOI 10.1093/brain/awl273; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Schellenberg AE, 2007, MAGN RESON MED, V58, P298, DOI 10.1002/mrm.21289; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818	49	91	96	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					187	198		10.1016/j.immuni.2013.11.022	http://dx.doi.org/10.1016/j.immuni.2013.11.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24485804	Green Accepted, Bronze			2022-12-18	WOS:000331637600007
J	Qi, XP; Hong, J; Chaves, L; Zhuang, YH; Chen, YH; Wang, DM; Chabon, J; Graham, B; Ohmori, K; Li, YP; Huang, H				Qi, Xiaopeng; Hong, Jessie; Chaves, Lee; Zhuang, Yonghua; Chen, Yuhong; Wang, Demin; Chabon, Jacob; Graham, Brian; Ohmori, Keitaro; Li, Yapeng; Huang, Hua			Antagonistic Regulation by the Transcription Factors C/EBP alpha and MITF Specifies Basophil and Mast Cell Fates	IMMUNITY			English	Article							HUMAN PERIPHERAL-BLOOD; PROGENITORS; IDENTIFICATION; EXPRESSION; PHENOTYPE; COLONIES; LINEAGE; MARROW; IGE	It remains unclear whether basophils and mast cells are derived from a common progenitor. Furthermore, how basophil versus mast cell fate is specified has not been investigated. Here, we have identified a population of granulocyte-macrophage progenitors (GMPs) that were highly enriched in the capacity to differentiate into basophils and mast cells while retaining a limited capacity to differentiate into myeloid cells. We have designated these progenitor cells "pre-basophil and mast cell progenitors" (preBMPs). STAT5 signaling was required for the differentiation of pre-BMPs into both basophils and mast cells and was critical for inducing two downstream molecules: C/EBP alpha and MITF. We have identified C/EBP alpha as the critical basophil transcription factor for specifying basophil cell fate and MITF as the crucial transcription factor for specifying mast cell fate. C/EBP alpha and MITF silenced each other's transcription in a directly antagonistic fashion. Our study reveals how basophil and mast cell fate is specified.	[Qi, Xiaopeng; Hong, Jessie; Chaves, Lee; Zhuang, Yonghua; Li, Yapeng; Huang, Hua] Natl Jewish Hlth, Div Allergy & Immunol, Dept Med, Denver, CO 80206 USA; [Huang, Hua] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA; [Chen, Yuhong; Wang, Demin] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Chabon, Jacob; Graham, Brian] Fitzsimons Army Med Ctr, Dept Med, Program Translat Lung Res, Aurora, CO 80045 USA; [Ohmori, Keitaro] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Versiti Blood Center of Wisconsin; Tokyo University of Agriculture & Technology	Huang, H (corresponding author), Natl Jewish Hlth, Div Allergy & Immunol, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	huangh@njhealth.org	OHMORI, Keitaro/G-1143-2013; Wang, Demin/AAX-4449-2020; Zhuang, Yonghua/A-2946-2013; Li, Yapeng/N-1042-2017	OHMORI, Keitaro/0000-0002-0582-4880; Wang, Demin/0000-0001-5549-3795; Zhuang, Yonghua/0000-0002-1822-2395; Li, Yapeng/0000-0002-5042-6881; Huang, Hua/0000-0001-7317-8983; Graham, Brian/0000-0001-7541-2585	National Institutes of Health [RO1AI083986, RO1 AI05917]; American Recovery and Reinvestment Act [3R01AI068083-04S1, R01 AI079087, PO1 HL44612, K08HL105536]; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105536, P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI068083, R01AI059170, R01AI083986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Moriggl for providing the plasmid of cS5<SUP>F</SUP>; D. Fisher of Harvard University for providing bone marrow cells of Mitf<SUP>wh/wh</SUP> mice; T. Ludwig of Columbia University for providing a breeding pair of Rosa<SUP>creERT2</SUP> mice; H. Goettle, D. Bohrer-Kunter, and J.D. Williams for technical assistance; H. Lei for the help of setting up the ChIP assay; M. Leyden for animal husbandry; S. Sobus and J. Looms for FACS analysis and cell sorting; H. Chu for assisting with microscopy; A. Gerber for sharing Luminomiter; and L. Lenz and W. Born for critical reading the manuscript. This study was supported by National Institutes of Health grants RO1AI083986 (H. H.), RO1 AI05917 (H. H.), American Recovery and Reinvestment Act 3R01AI068083-04S1 (H. H.), R01 AI079087 (D. W.), PO1 HL44612 (D. W.), K08HL105536 (B. G.), and Parker B. Francis Fellowship (B.G.).	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arinobu Yojiro, 2009, Allergology International, V58, P21, DOI 10.2332/allergolint.08-RAI-0067; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DENBURG JA, 1985, BLOOD, V66, P312; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, IMMUNITY, V28, P495, DOI 10.1016/j.immuni.2008.03.010; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kim DK, 1999, BLOOD, V93, P4179, DOI 10.1182/blood.V93.12.4179.412k04_4179_4186; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LEARY AG, 1984, BLOOD, V64, P78; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Marone Gianni, 2002, Trends in Immunology, V23, P425, DOI 10.1016/S1471-4906(02)02274-3; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mukai K, 2012, BLOOD, V120, P76, DOI 10.1182/blood-2011-12-399113; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Qi XP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213389; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Takemoto CM, 2008, BLOOD CELL MOL DIS, V41, P82, DOI 10.1016/j.bcmd.2008.02.005; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	34	91	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					97	110		10.1016/j.immuni.2013.06.012	http://dx.doi.org/10.1016/j.immuni.2013.06.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23871207	Green Accepted, Bronze			2022-12-18	WOS:000330948300011
J	Chan, TD; Wood, K; Hermes, JR; Butt, D; Jolly, CJ; Basten, A; Brink, R				Chan, Tyani D.; Wood, Katherine; Hermes, Jana R.; Butt, Danyal; Jolly, Christopher J.; Basten, Antony; Brink, Robert			Elimination of Germinal-Center-Derived Self-Reactive B Cells Is Governed by the Location and Concentration of Self-Antigen	IMMUNITY			English	Article							MOLECULAR MIMICRY; NEGATIVE SELECTION; SOMATIC MUTATION; PLASMA-CELL; AFFINITY; ANTIBODY; MICE; AUTOIMMUNITY; MUTAGENESIS; LYMPHOCYTES	Secondary diversification of the B cell repertoire by immunoglobulin gene somatic hypermutation in the germinal center (GC) is essential for providing the high-affinity antibody specificities required for long-term humoral immunity. While the risk to self-tolerance posed by inadvertent generation of self-reactive GC B cells has long been recognized, it has not previously been possible to identify such cells and study their fate. In the current study, self-reactive B cells generated de novo in the GC failed to survive when their target self-antigen was either expressed ubiquitously or specifically in cells proximal to the GC microenvironment. By contrast, GC B cells that recognized rare or tissue-specific self-antigens were not eliminated, and could instead undergo positive selection by cross-reactive foreign antigen and produce plasma cells secreting high-affinity autoantibodies. These findings demonstrate the incomplete nature of GC self-tolerance and may explain the frequent association of cross-reactive, organ-specific autoantibodies with postinfectious autoimmune disease.	[Chan, Tyani D.; Wood, Katherine; Hermes, Jana R.; Butt, Danyal; Basten, Antony; Brink, Robert] Garvan Inst Med Res, Immunol Res Program, Sydney, NSW 2010, Australia; [Basten, Antony; Brink, Robert] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Jolly, Christopher J.] Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Centenary Institute	Brink, R (corresponding author), Garvan Inst Med Res, Immunol Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	r.brink@garvan.org.au	Brink, Robert/B-7910-2010; Jolly, Christopher/G-5261-2011	Brink, Robert/0000-0002-9586-3655; Jolly, Christopher/0000-0002-9307-1056; Chan, Tyani/0000-0001-9276-8479	National Health and Medical Research Council of Australia [427620]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (Program Grant 427620). We thank L. Holzman (University of Michigan) for supplying NPHS2-cre Tg mice. We also thank T. Phan, N. Krautler, S. Tangye, and C. Goodnow for helpful discussions and advice; C. Brownlee and N. Ailing for single cell FACS sorting; D. Christ, R. Rouet, and P. Schofield for assistance with Biacore analysis; and the staff of Australian Bioresources (Moss Vale) and the Garvan Institute animal facilities. We also thank Ozgene (Bentley, West Australia) for production of mHEL<SUP>4X</SUP> Tg mice.	Ait-Azzouzene D, 2010, J IMMUNOL, V185, P1015, DOI 10.4049/jimmunol.1000698; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; CASSON LP, 1995, J EXP MED, V182, P743, DOI 10.1084/jem.182.3.743; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Cunha-Neto E, 2006, AUTOIMMUNITY, V39, P41, DOI 10.1080/08916930500485002; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Guay HM, 2004, J IMMUNOL, V173, P5485, DOI 10.4049/jimmunol.173.9.5485; Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; NEMAZEE D, 1993, CURR OPIN IMMUNOL, V5, P866, DOI 10.1016/0952-7915(93)90098-D; NOSSAL GJV, 1988, IMMUNOL CELL BIOL, V66, P105, DOI 10.1038/icb.1988.14; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Notidis E, 2002, IMMUNITY, V17, P317, DOI 10.1016/S1074-7613(02)00392-8; OLEE TW, 1992, J EXP MED, V175, P831, DOI 10.1084/jem.175.3.831; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Plotkin S., 2008, VACCINES-BASEL; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rojas M, 2001, J IMMUNOL, V166, P3194, DOI 10.4049/jimmunol.166.5.3194; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SRINIVASAPPA J, 1986, J VIROL, V57, P397, DOI 10.1128/JVI.57.1.397-401.1986; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zhang W, 2009, BLOOD, V113, P4086, DOI 10.1182/blood-2008-09-181073	47	91	91	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					893	904		10.1016/j.immuni.2012.07.017	http://dx.doi.org/10.1016/j.immuni.2012.07.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23142780	Bronze			2022-12-18	WOS:000311460000015
J	Darmoise, A; Teneberg, S; Bouzonville, L; Brady, RO; Beck, M; Kaufmann, SHE; Winau, F				Darmoise, Alexandre; Teneberg, Susann; Bouzonville, Lauriane; Brady, Roscoe O.; Beck, Michael; Kaufmann, Stefan H. E.; Winau, Florian			Lysosomal alpha-Galactosidase Controls the Generation of Self Lipid Antigens for Natural Killer T Cells	IMMUNITY			English	Article							INVARIANT NKT CELLS; ENZYME REPLACEMENT; IMMUNE-RESPONSE; CD1D TETRAMERS; ACTIVATION; RECOGNITION; MICE; MATURATION; RECEPTORS; MOLECULES	Natural Killer T (NKT) cells are lipid-reactive, CD1 drestricted T lymphocytes important in infection, cancer, and autoimmunity. In addition to foreign antigens, NKT cells react with endogenous self lipids. However, in the face of stimulating self antigen, it remains unclear how overstimulation of NKT cells is avoided. We hypothesized that constantly degraded endogenous antigen only accumulates upon inhibition of alpha-galactosidase A (alpha-Gal-A) in lysosomes. Here, we show that alpha-Gal-A deficiency caused vigorous activation of NKT cells. Moreover, microbes induced inhibition of alpha-Gal-A activity in antigen-presenting cells. This temporary enzyme block depended on Toll-like receptor (TLR) signaling and ultimately triggered lysosomal lipid accumulation. Thus, we present TLR-dependent negative regulation of alpha-Gal-A as a mechanistic link between pathogen recognition and self lipid antigen induction for NKT cells.	[Darmoise, Alexandre; Bouzonville, Lauriane; Winau, Florian] Harvard Univ, Sch Med, Dept Pathol,Immune Dis Inst, Childrens Hosp,Program Cellular & Mol Med, Boston, MA 02115 USA; [Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, S-40530 Gothenburg, Sweden; [Brady, Roscoe O.] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; [Beck, Michael] Johannes Gutenberg Univ Mainz, Childrens Hosp, D-55131 Mainz, Germany; [Darmoise, Alexandre; Kaufmann, Stefan H. E.; Winau, Florian] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johannes Gutenberg University of Mainz; Max Planck Society	Winau, F (corresponding author), Harvard Univ, Sch Med, Dept Pathol,Immune Dis Inst, Childrens Hosp,Program Cellular & Mol Med, Boston, MA 02115 USA.	winau@idi.harvard.edu	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268	European Union Marie Curie Actions [MEST-CT-2005-020311]; German Science Foundation [SFB 421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083426] Funding Source: NIH RePORTER	European Union Marie Curie Actions(European Commission); German Science Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Weber for expert technical assistance. We are grateful to Dr. S. Porcelli for sharing mAb K253 with us. We thank Dr. A. d'Azzo for providing us with beta-Gal-deficient mice. We thank the NIH Tetramer Facility for CD1d-tetramers. This work was supported in part by the European Union Marie Curie Actions (MEST-CT-2005-020311 to A.D.) and the German Science Foundation (SFB 421 to S.H.E.K. and F.W.).	Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Dhodapkar MV, 2009, FRONT BIOSCI-LANDMRK, V14, P796, DOI 10.2741/3278; Dimasi N, 2004, IMMUNOL RES, V30, P95, DOI 10.1385/IR:30:1:095; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Hayakawa Y, 2004, NAT IMMUNOL, V5, P590, DOI 10.1038/ni1069; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Li YS, 2008, GLYCOBIOLOGY, V18, P158, DOI 10.1093/glycob/cwm129; Li YS, 2009, J PROTEOME RES, V8, P2740, DOI 10.1021/pr801040h; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pina DG, 2007, BBA-BIOMEMBRANES, V1768, P628, DOI 10.1016/j.bbamem.2006.12.011; Plati T, 2009, EUR J IMMUNOL, V39, P2748, DOI 10.1002/eji.200939639; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schumann J, 2007, EUR J IMMUNOL, V37, P1431, DOI 10.1002/eji.200737160; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	46	91	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					216	228		10.1016/j.immuni.2010.08.003	http://dx.doi.org/10.1016/j.immuni.2010.08.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20727792	Green Accepted, Bronze			2022-12-18	WOS:000281654900011
J	Beddoe, T; Chen, ZJ; Clements, CS; Ely, LK; Bushell, SR; Vivian, JP; Kjer-Nielsen, L; Pang, SS; Dunstone, MA; Liu, YC; Macdonald, WA; Perugini, MA; Wilce, MCJ; Burrows, SR; Purcell, AW; Tiganis, T; Bottomley, SP; McCluskey, J; Rossjohn, J				Beddoe, Travis; Chen, Zhenjun; Clements, Craig S.; Ely, Lauren K.; Bushell, Simon R.; Vivian, Julian P.; Kjer-Nielsen, Lars; Pang, Siew Siew; Dunstone, Michelle A.; Liu, Yu Chih; Macdonald, Whitney A.; Perugini, Matthew A.; Wilce, Matthew C. J.; Burrows, Scott R.; Purcell, Anthony W.; Tiganis, Tony; Bottomley, Stephen P.; McCluskey, James; Rossjohn, Jamie			Antigen Ligation Triggers a Conformational Change within the Constant Domain of the alpha beta T Cell Receptor	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CD3-EPSILON-GAMMA HETERODIMER; FLUORESCENCE SPECTROSCOPY; ENDOPLASMIC-RETICULUM; COMPLEX; PEPTIDE; RECOGNITION; TCR; MEMBRANE	Ligation of the alpha beta T cell receptor (TCR) by a specific peptide-loaded major histocompatibility complex (pMHC) molecule initiates T cell signaling via the CD3 complex. However, the initial events that link antigen recognition to T cell signal transduction remain unclear. Here we show, via fluorescence-based experiments and structural analyses, that MHC-restricted antigen recognition by the alpha beta TCR results in a specific conformational change confined to the A-B loop within the alpha chain of the constant domain (Cot). The apparent affinity constant of this A-B loop movement mirrored that of alpha beta TCR-pMHC ligation and was observed in two alpha beta TCRs with distinct pMHC specificities. The Ag-induced A-B loop conformational change could be inhibited by fixing the juxtapositioning of the constant domains and was shown to be reversible upon pMHC disassociation. Notably, the loop movement within the C alpha domain, although specific for an agonist pMHC ligand, was not observed with a pMHC antagonist. Moreover, mutagenesis of residues within the A-B loop impaired T cell signaling in an in vitro system of antigen-specific TCR stimulation. Collectively, our findings provide a basis for the earliest molecular events that underlie Ag-induced T cell triggering.	[Chen, Zhenjun; Kjer-Nielsen, Lars; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Beddoe, Travis; Clements, Craig S.; Ely, Lauren K.; Bushell, Simon R.; Vivian, Julian P.; Pang, Siew Siew; Dunstone, Michelle A.; Liu, Yu Chih; Macdonald, Whitney A.; Wilce, Matthew C. J.; Tiganis, Tony; Bottomley, Stephen P.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Burrows, Scott R.] Queensland Inst Med Res, Div Infect Dis & Immunol, Brisbane, Qld 4029, Australia	University of Melbourne; Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Tiganis, Tony/AAV-3495-2020; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; Burrows, Scott/G-2050-2011; Beddoe, Travis/F-3415-2014; Dunstone, Michelle/I-2895-2014	Tiganis, Tony/0000-0002-8065-9942; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Burrows, Scott/0000-0002-1430-0472; Beddoe, Travis/0000-0003-4550-2277; Vivian, Julian/0000-0002-9400-4437; Dunstone, Michelle/0000-0002-6026-648X; Bushell, Simon/0000-0001-5477-6777	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); Roche Organ Transplantation Research Fund, Monash University	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Roche Organ Transplantation Research Fund, Monash University(Monash University)	We thank N. La Gruta and R. Tweten for useful discussions and D. Garboczi for the generous provision of the A6 TCR plasmids. The Australian Research Council (ARC), the National Health and Medical Research Council of Australia (NHMRC), the Roche Organ Transplantation Research Fund, Monash University Strategic grant, and ANZ trustees supported this research. T.B. is an NHMRC CDA fellow; W.A.M. and M.A.D. are supported by NHMRC Peter Doherty Fellowships; L.K.E. is supported by a NHMRC CJ Martin Fellowship; M.C.J.W., S.R. Burrows, and S.P.B. are supported by a NHMRC Senior Research Fellowship; C.S.C. is supported by an ARC QEII fellowship; and J.R. is supported by an ARC Federation Fellowship.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Ely LK, 2005, J IMMUNOL, V174, P5593, DOI 10.4049/jimmunol.174.9.5593; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Haugland R., 1996, HDB FLUORESCENT PROB; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kobilka BK, 2002, METHOD ENZYMOL, V343, P170; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wang JH, 2008, IMMUNITY, V28, P139, DOI 10.1016/j.immuni.2008.01.007	58	91	92	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					777	788		10.1016/j.immuni.2009.03.018	http://dx.doi.org/10.1016/j.immuni.2009.03.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19464197	Bronze			2022-12-18	WOS:000267270700007
J	Lopez-Bravo, M; Ardavin, C				Lopez-Bravo, Maria; Ardavin, Carlos			In vivo induction of immune responses to pathogens by conventional dendritic cells	IMMUNITY			English	Review							ANTIGEN-PRESENTING FUNCTIONS; T-CELL; LANGERHANS CELLS; STEADY-STATE; BACTERIAL-INFECTION; CROSS-PRESENTATION; LYMPH-NODES; CUTTING EDGE; CD40 LIGAND; CD8-ALPHA(+)	Specific defense mechanisms against pathogens are fulfilled by different subsets of nonmucosal conventional dendritic cells (DCs), including migratory Langerhans cells (LCs), dermal DCs, and resident CD8(+) and CD8(-) DCs found in lymphoid organs. Dermal DCs capture antigens in the skin and migrate to lymph nodes, where they can transfer the antigens to CD8(+) DCs and activate CD4(+) T cells. Differential antigen-processing machinery grants CD8(+) DCs a high efficiency in activating CD8(+) T cells through crosspresentation, whereas CD8(-) DCs preferentially trigger CD4(+) T cell responses. Recent findings have revealed the important role played by monocyte-derived DCs (mo-DCs), newly formed during infection, in activating CD4(+) and CD8(+) T cells, regulating immunoglobulin production, and killing pathogens. However, a number of controversial issues regarding the function of different DC subsets during viral, bacterial, and parasitic infections remain to be resolved.	[Lopez-Bravo, Maria; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Ardavin, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Campus Univ Autonoma, Madrid 28049, Spain.	ardavin@cnb.csic.es		Lopez-Bravo, Maria/0000-0002-1898-9465	Spanish Ministerio de Ciencia e Innovacion, Comunidad de Madrid; Instituto de Salud Carlos III	Spanish Ministerio de Ciencia e Innovacion, Comunidad de Madrid(Comunidad de MadridMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	We are grateful to Pilar Dominguez, Elena Liarte, and Patricia Leiriao for scientific discussion. We are supported by the Spanish Ministerio de Ciencia e Innovacion, Comunidad de Madrid and Instituto de Salud Carlos III.	Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Fallarino F, 2002, J IMMUNOL, V169, P1182, DOI 10.4049/jimmunol.169.3.1182; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fukunaga A, 2004, J IMMUNOL, V172, P4091, DOI 10.4049/jimmunol.172.7.4091; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kissenpfennig A, 2006, TRENDS IMMUNOL, V27, P132, DOI 10.1016/j.it.2006.01.003; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Leon B, 2008, IMMUNOL CELL BIOL, V86, P320, DOI 10.1038/icb.2008.14; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Maroof A, 2008, INFECT IMMUN, V76, P239, DOI 10.1128/IAI.00643-07; Martin P, 2002, BLOOD, V99, P1282, DOI 10.1182/blood.V99.4.1282; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Ravindran R, 2007, P NATL ACAD SCI USA, V104, P12075, DOI 10.1073/pnas.0701363104; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tagliani E, 2008, J IMMUNOL, V180, P3201, DOI 10.4049/jimmunol.180.5.3201; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yrlid U, 2002, J IMMUNOL, V169, P108, DOI 10.4049/jimmunol.169.1.108; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	71	91	92	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					343	351		10.1016/j.immuni.2008.08.008	http://dx.doi.org/10.1016/j.immuni.2008.08.008			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799142	Bronze			2022-12-18	WOS:000259708900003
J	Kitaura, Y; Jang, IK; Wang, Y; Han, YC; Inazu, T; Cadera, EJ; Schlissel, M; Hardy, RR; Gu, H				Kitaura, Yasuyuki; Jang, Ihn Kyung; Wang, Yan; Han, Yoon-Chi; Inazu, Tetsuya; Cadera, Emily J.; Schlissel, Mark; Hardy, Richard R.; Gu, Hua			Control of the B cell-intrinsic tolerance programs by ubiquitin ligases cbl and Cbl-b	IMMUNITY			English	Article							HEAT-STABLE ANTIGEN(HI); C-CBL; NEGATIVE REGULATION; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; RECEPTOR; ACTIVATION; LYMPHOCYTES; MATURATION; AUTOIMMUNITY	B cell receptor (BCR) signaling plays a critical role in B cell tolerance and activation. Here, we show that mice with B cell-specific ablation of both Cbl and Cbl-b (Cbl(-/-)Cblb(-/-)) manifested systemic lupus erythematosus (SLE)-like autoimmune disease. The Cbl double deficiency resulted in a substantial increase in marginal zone (MZ) and B1 B cells. The mutant B cells were not hyperresponsive in terms of proliferation and antibody production upon BCR stimulation; however, B cell anergy to protein antigen appeared to be impaired. Concomitantly, BCR-proximal signaling, including tyrosine phosphorylation of Syk tyrosine kinase, Phospholipase C-gamma 2 (PLC-gamma 2), and Rho-family GTP-GDP exchange factor Vav, and Ca2+ mobilization were enhanced, whereas tyrosine phosphorylation of adaptor protein BLNK was substantially attenuated in the mutant B cells. These results suggested that the loss of coordination between these pathways was responsible for the impaired B cell tolerance induction. Thus, Cbl proteins control B cell-intrinsic checkpoint of immune tolerance, possibly through coordinating multiple BCR-proximal signaling pathways during anergy induction.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Berkeley; Fox Chase Cancer Center	Gu, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 630 W 168th St, New York, NY 10032 USA.	hg2065@columbia.edu		Jang, Ihn Kyung/0000-0001-8899-7930	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062931] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL 48702, R01 HL048702] Funding Source: Medline; NIAID NIH HHS [R01 AI062931, R01 AI062931-01A2, AI 062931, R01 AI062931-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cancro MP, 2004, IMMUNOL REV, V197, P89, DOI 10.1111/j.0105-2896.2004.0099.x; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Liu YC, 2002, TRENDS IMMUNOL, V23, P140, DOI 10.1016/S1471-4906(01)02157-3; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Monroe JG, 2004, IMMUNOL REV, V197, P5, DOI 10.1111/j.0105-2896.2004.0113.x; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Peeva E, 2003, J CLIN INVEST, V111, P275, DOI 10.1172/JCI200316530; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saijo K, 2003, ANN NY ACAD SCI, V987, P125, DOI 10.1111/j.1749-6632.2003.tb06040.x; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Vilen BJ, 2002, J IMMUNOL, V168, P4344, DOI 10.4049/jimmunol.168.9.4344; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068	52	91	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					567	578		10.1016/j.immuni.2007.03.015	http://dx.doi.org/10.1016/j.immuni.2007.03.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17493844	Bronze, Green Accepted			2022-12-18	WOS:000246895900010
J	Boname, JM; de Lima, BD; Lehner, PJ; Stevenson, PG				Boname, JM; de Lima, BD; Lehner, PJ; Stevenson, PG			Viral degradation of the MHC class I peptide loading complex	IMMUNITY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; T-CELL RESPONSE; ANTIGEN PRESENTATION; MURINE GAMMAHERPESVIRUS-68; GAMMA-HERPESVIRUS; GENE-EXPRESSION; UBIQUITIN LIGASES; DOWN-REGULATION; RMA-S; MOLECULES	The murine gamma-herpesvirus-68 MK3 protein inhibits CD8(+) T cell recognition by ubiquitinating the cytoplasmic tails of classical MHC class I heavy chains. Here we show that MK3 also provides the first example of a protein that degrades tapasin and TAP. The degradation was MK3 RING finger dependent and primarily affected TAP. MK3 associated with TAP1 in the absence of tapasin or TAP2, suggesting that TAP1 was a primary binding partner in the peptide loading complex. TAP2 also played a major role in MK3 stability and function. By degrading TAP, therefore, MK3 limited its own expression. However, TAP degradation also broadened the MK3 inhibitory repertoire and achieved a remarkable resistance to MHC class I upregulation by interferon-gamma, suggesting that it represents a specific adaptation to immune evasion in lymphoid tissue.	Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Tennis Court Rd, Cambridge CB2 1QP, England.	pgs27@mole.bio.cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Lehner, Paul Joseph/0000-0001-9383-1054; Boname, Jessica/0000-0002-5149-5934	Medical Research Council [G9800943] Funding Source: Medline; MRC [G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Christensen JP, 1999, J VIROL, V73, P4279, DOI 10.1128/JVI.73.5.4279-4283.1999; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Das G, 2000, J EXP MED, V192, P1521, DOI 10.1084/jem.192.10.1521; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; HENGEL H, 1994, J VIROL, V68, P289, DOI 10.1128/JVI.68.1.289-297.1994; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; LJUNGGREN HG, 1986, J IMMUNOGENET, V13, P141; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Marusina K, 1997, J IMMUNOL, V158, P5251; Means RE, 2002, EMBO J, V21, P1638, DOI 10.1093/emboj/21.7.1638; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; OUDSHOORNSNOEK M, 1989, J IMMUNOGENET, V16, P263; PALMER E, 1998, ANNU REV IMMUNOL, V16, P323; Posavad CM, 1998, NAT MED, V4, P381, DOI 10.1038/nm0498-381; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Powis SJ, 1997, EUR J IMMUNOL, V27, P2744, DOI 10.1002/eji.1830271040; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rice J, 2002, EUR J IMMUNOL, V32, P3481, DOI 10.1002/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J; Rochford R, 2001, J VIROL, V75, P4955, DOI 10.1128/JVI.75.11.4955-4963.2001; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; SHARROW SO, 1989, J IMMUNOL, V142, P3495; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; STROYNOWSKI I, 1987, CELL, V50, P759, DOI 10.1016/0092-8674(87)90334-5; Tigges MA, 1996, J IMMUNOL, V156, P3901; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; Yu YYL, 2002, J VIROL, V76, P2796, DOI 10.1128/JVI.76.6.2796-2803.2002	46	91	96	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					305	317		10.1016/S1074-7613(04)00047-0	http://dx.doi.org/10.1016/S1074-7613(04)00047-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030774	Bronze			2022-12-18	WOS:000221442600008
J	Zheng, S; De, BP; Choudhary, S; Comhair, SAA; Goggans, T; Slee, R; Williams, BRG; Pilewski, J; Haque, SJ; Erzurum, SC				Zheng, S; De, BP; Choudhary, S; Comhair, SAA; Goggans, T; Slee, R; Williams, BRG; Pilewski, J; Haque, SJ; Erzurum, SC			Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN AIRWAY EPITHELIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR; ACTIVATED PROTEIN-KINASE; INTERFERON-GAMMA; IN-VIVO; VIRAL REPLICATION; GENE-EXPRESSION; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION	Viral infection is the primary cause of respiratory morbidity in cystic fibrosis (CF) infants. Here, we identify that host factors allow increased virus replication and cytokine production, providing a mechanism for understanding the severity of virus disease in CF. Increased virus is due to lack of nitric oxide synthase 2 (NOS2) and 2', 5' oligoadenylate synthetase (OAS) 1 induction in response to virus or IFNgamma. This can be attributed to impairment of activation of signal transducer and activator of transcription (STAT)1, a fundamental component to antiviral defense. NO donor or NOS2 overexpression provides protection from virus infection in CF, suggesting that NO is sufficient for antiviral host defense in the human airway and is one strategy for antiviral therapy in CF children.	Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Virol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Erzurum, SC (corresponding author), Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	erzurus@ccf.org	Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, R37HL060917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK056490] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60917] Funding Source: Medline; NIDDK NIH HHS [P50 DK56490] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Armstrong D, 1998, PEDIATR PULM, V26, P371, DOI 10.1002/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.3.CO;2-E; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Choudhary S, 2001, J VIROL, V75, P4823, DOI 10.1128/JVI.75.10.4823-4831.2001; CROEN KD, 1993, J CLIN INVEST, V91, P2446, DOI 10.1172/JCI116479; *CYST FIBR FDN, 2000, CYST FIBR FDN PAT RE, P1; DE BP, 1993, J BIOL CHEM, V268, P5703; De BP, 2000, J VIROL, V74, P5886, DOI 10.1128/JVI.74.13.5886-5895.2000; DE BP, 1995, P NATL ACAD SCI USA, V92, P5204, DOI 10.1073/pnas.92.11.5204; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Elphick HE, 2001, THORAX, V56, P151, DOI 10.1136/thorax.56.2.151; ERZURUM SC, 1993, J APPL PHYSIOL, V75, P1256, DOI 10.1152/jappl.1993.75.3.1256; ERZURUM SC, 1993, NUCLEIC ACIDS RES, V21, P1607, DOI 10.1093/nar/21.7.1607; Flodstrom M, 2001, VIROLOGY, V281, P205, DOI 10.1006/viro.2000.0801; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gao J, 1999, J VIROL, V73, P1411, DOI 10.1128/JVI.73.2.1411-1418.1999; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315; Guo FH, 1997, J CLIN INVEST, V100, P829, DOI 10.1172/JCI119598; GUO FH, 1995, P NATL ACAD SCI USA, V92, P7809, DOI 10.1073/pnas.92.17.7809; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Haque SJ, 1998, SEMIN ONCOL, V25, P14; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hiatt PW, 1999, PEDIATRICS, V103, P619, DOI 10.1542/peds.103.3.619; HORDVIK NL, 1989, PEDIATR PULM, V7, P217, DOI 10.1002/ppul.1950070406; Iordanov MS, 2001, MOL CELL BIOL, V21, P61, DOI 10.1128/MCB.21.1.61-72.2001; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; KARUPIAH G, 1995, J EXP MED, V181, P2171, DOI 10.1084/jem.181.6.2171; Karupiah G, 1998, J VIROL, V72, P7703, DOI 10.1128/JVI.72.9.7703-7706.1998; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kelley TJ, 2000, J CLIN INVEST, V106, P403, DOI 10.1172/JCI9560; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kosugi I, 2002, AM J PATHOL, V161, P919, DOI 10.1016/S0002-9440(10)64252-6; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Noda S, 2001, J IMMUNOL, V166, P3533, DOI 10.4049/jimmunol.166.5.3533; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PETERSEN NT, 1981, ACTA PAEDIATR SCAND, V70, P623, DOI 10.1111/j.1651-2227.1981.tb05757.x; Reiss CS, 1998, J VIROL, V72, P4547, DOI 10.1128/JVI.72.6.4547-4551.1998; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ronni T, 1997, J IMMUNOL, V158, P2363; Rosenfeld M, 1992, Semin Respir Infect, V7, P158; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Sanders SP, 1999, P SOC EXP BIOL MED, V220, P123, DOI 10.1046/j.1525-1373.1999.d01-19.x; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steagall WK, 2000, AM J RESP CELL MOL, V22, P45, DOI 10.1165/ajrcmb.22.1.3789; Uetani K, 2000, J IMMUNOL, V165, P988, DOI 10.4049/jimmunol.165.2.988; WANG EEL, 1984, NEW ENGL J MED, V311, P1653, DOI 10.1056/NEJM198412273112602; Widdicombe JH, 2000, AM J RESP CELL MOL, V22, P11, DOI 10.1165/ajrcmb.22.1.f177; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yang JC, 2000, CIRCULATION, V102, P3046; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240; Zaragoza C, 1997, J CLIN INVEST, V100, P1760, DOI 10.1172/JCI119702; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738; Zhu Z, 1996, J CLIN INVEST, V97, P421, DOI 10.1172/JCI118431	79	91	96	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2003	18	5					619	630		10.1016/S1074-7613(03)00114-6	http://dx.doi.org/10.1016/S1074-7613(03)00114-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753739	Bronze			2022-12-18	WOS:000182962200007
J	Badovinac, VP; Hamilton, SE; Harty, JT				Badovinac, VP; Hamilton, SE; Harty, JT			Viral infection results in massive CD8(+) T cell expansion and mortality in vaccinated perforin-deficient mice	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LISTERIA-MONOCYTOGENES; IN-VIVO; IFN-GAMMA; PROTECTIVE IMMUNITY; CYTOKINE PRODUCTION; CUTTING EDGE; ANTIGEN; MEMORY; NAIVE	Perforin-mediated cytotoxicity is essential for clearance of primary LCMV infection. BALB/c-perforin-deficient (PKO) mice survived LCMV infection by deleting NP118-specific CD8(+) T cells whereas vaccination of PKO mice with Listeria expressing NP118 generated a stable memory CD8(+) T cell population. However, >85% of vaccinated BALB/c-PKO mice died after LCMV infection. Mortality was associated with enormous expansion of NP118-specific CD8(+) T cells in both lymphoid and nonlymphoid tissues and aberrant CD8(+) T cell cytokine production. Depletion of CD8(+) T cells or treatment with anti-IFNgamma antibody rescued vaccinated mice from mortality. Thus, perforin was essential for resistance to secondary LCMV infection, and, in the absence of perforin, vaccination resulted in lethal disease mediated by dysregulated CD8(+) T cell expansion and cytokine production.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.		badovinac, Vladimir/O-7760-2015	Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439	NIAID NIH HHS [AI42767, AI07511, AI46653, AI50073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050073, R37AI042767, R01AI042767, R01AI046653, R21AI042767] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Badovinac VP, 2000, J IMMUNOL, V165, P5387, DOI 10.4049/jimmunol.165.10.5387; Badovinac VP, 2000, J IMMUNOL METHODS, V238, P107, DOI 10.1016/S0022-1759(00)00153-8; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Busch DH, 2000, J IMMUNOL, V164, P4063, DOI 10.4049/jimmunol.164.8.4063; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; de Saint Basile G, 2001, CURR OPIN IMMUNOL, V13, P549, DOI 10.1016/S0952-7915(00)00257-0; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Hamilton SE, 2002, J IMMUNOL, V169, P4936, DOI 10.4049/jimmunol.169.9.4936; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HARTY JT, 1995, J IMMUNOL, V154, P4642; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jensen ER, 1998, INFECT IMMUN, V66, P4143; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; OEHEN S, 1992, EUR J IMMUNOL, V22, P3149, DOI 10.1002/eji.1830221218; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Smelt SC, 2001, J VIROL, V75, P448, DOI 10.1128/JVI.75.1.448-457.2001; Spaner D, 1999, J IMMUNOL, V162, P1192; Spielman J, 1998, J IMMUNOL, V161, P7063; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; vanderMost RG, 1996, J IMMUNOL, V157, P5543; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; White DW, 2000, J IMMUNOL, V165, P5, DOI 10.4049/jimmunol.165.1.5; White DW, 1998, J IMMUNOL, V160, P898; White DW, 1999, J IMMUNOL, V162, P980; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	52	91	93	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					463	474		10.1016/S1074-7613(03)00079-7	http://dx.doi.org/10.1016/S1074-7613(03)00079-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705850	Bronze			2022-12-18	WOS:000182353900003
J	Erlich, HA; Opelz, G; Hansen, J				Erlich, HA; Opelz, G; Hansen, J			HLA DNA typing and transplantation	IMMUNITY			English	Review							PCR AMPLIFICATION; COLLABORATIVE TRANSPLANT; MARROW TRANSPLANTATION; OLIGONUCLEOTIDE PROBES; RECOGNITION; MHC; MOLECULES; MUTATION; DONORS		Roche Mol Syst, Alameda, CA 94501 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Inst Immunol, Abt Transplantat Immunol, D-69120 Heidelberg, Germany	Roche Holding; Fred Hutchinson Cancer Center	Erlich, HA (corresponding author), Roche Mol Syst, Alameda, CA 94501 USA.							ANASETTI C, 1989, NEW ENGL J MED, V320, P197, DOI 10.1056/NEJM198901263200401; Arguello JR, 1998, NAT GENET, V18, P192, DOI 10.1038/ng0298-192; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Beck S, 1999, IMMUNOL REV, V167, P201, DOI 10.1111/j.1600-065X.1999.tb01393.x; BEGOVICH AB, 1995, JAMA-J AM MED ASSOC, V273, P586, DOI 10.1001/jama.273.7.586; BUGAWAN TL, 1994, TISSUE ANTIGENS, V44, P137, DOI 10.1111/j.1399-0039.1994.tb02371.x; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P7983, DOI 10.1073/pnas.89.17.7983; DENNERT G, 1985, J IMMUNOL, V135, P3729; Dunn O. J., 1974, Applied statistics: analysis of variance and regression; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; ERLICH HA, 1991, IMMUNOL TODAY, V12, P411, DOI 10.1016/0167-5699(91)90143-H; Hansen JA, 1997, IMMUNOL REV, V157, P141, DOI 10.1111/j.1600-065X.1997.tb00979.x; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Marsh S. G. E., 2000, Tissue Antigens, V56, P103; Mytilineos J, 1997, TRANSPLANTATION, V63, P1351, DOI 10.1097/00007890-199705150-00025; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Opelz G, 1997, TRANSPLANTATION, V63, P57, DOI 10.1097/00007890-199701150-00011; PARHAM P, 1992, NATURE, V360, P300, DOI 10.1038/360300a0; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Valiante N M, 1997, Biol Blood Marrow Transplant, V3, P229; Winter CC, 1998, J IMMUNOL, V161, P571; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	24	91	112	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					347	356		10.1016/S1074-7613(01)00115-7	http://dx.doi.org/10.1016/S1074-7613(01)00115-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336680	Bronze			2022-12-18	WOS:000168246700002
J	Bosselut, R; Kubo, S; Guinter, T; Kopacz, JL; Altman, JD; Feigenbaum, L; Singer, A				Bosselut, R; Kubo, S; Guinter, T; Kopacz, JL; Altman, JD; Feigenbaum, L; Singer, A			Role of CD8 beta domains in CD8 coreceptor function: Importance for MHC I binding, signaling, and positive selection of CD8(+) T cells in the thymus	IMMUNITY			English	Article							COMPLEX CLASS-I; TYROSINE-PROTEIN-KINASE; BETA-CHAIN; TRANSGENIC MICE; NEGATIVE SELECTION; LYMPHOCYTES-T; INTRAEPITHELIAL LYMPHOCYTES; CD4(+)CD8(+) THYMOCYTES; CYTOPLASMIC DOMAINS; SURFACE EXPRESSION	The contribution of the CDB beta subunit to CD8 coreceptor function is poorly understood. We now demonstrate that the CD8 beta extracellular domain increases the avidity of CD8 binding to MHC I, and that the intracellular domain of CD8 beta enhances association with two intracellular molecules required for TCR signal transduction, Lck and LAT. By assessing CD8(+) T cell differentiation in CD8 beta-deficient mice reconstituted with various transgenic CD8 beta chimeric molecules, we also demonstrate that the intracellular and extracellular domains of CD8 beta can contribute independently to CD8(+) T cell development, but that both CD8 beta domains together are most efficient. Thus, this study identifies the molecular functions of the CD8 beta intracellular and extracellular domains and documents their contributions to CD8(+) T cell development.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Emory Univ, Vaccine Ctr Yerkes, Atlanta, GA 30329 USA; NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov			NATIONAL CANCER INSTITUTE [ZIABC009273, Z01BC009273] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BAUME DM, 1990, CELL IMMUNOL, V131, P352, DOI 10.1016/0008-8749(90)90260-X; BLANC D, 1988, EUR J IMMUNOL, V18, P613, DOI 10.1002/eji.1830180419; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CROOKS MEC, 1994, IMMUNITY, V1, P277; Das G, 1999, J EXP MED, V190, P881, DOI 10.1084/jem.190.6.881; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; INGOLD AL, 1991, NATURE, V352, P721, DOI 10.1038/352721a0; Irie HY, 1998, J IMMUNOL, V161, P183; IRIE HY, 1995, J EXP MED, V181, P1267, DOI 10.1084/jem.181.4.1267; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JANEWAY CA, 1989, IMMUNOL TODAY, V10, P234, DOI 10.1016/0167-5699(89)90260-0; KARAKI S, 1992, J IMMUNOL, V149, P1613; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LEDBETTER JA, 1981, J EXP MED, V153, P1503, DOI 10.1084/jem.153.6.1503; LIAW CW, 1986, J IMMUNOL, V137, P1037; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NAKAUCHI H, 1987, P NATL ACAD SCI USA, V84, P4210, DOI 10.1073/pnas.84.12.4210; NAKAYAMA K, 1989, J IMMUNOL, V142, P2540; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; PARNES JR, 1989, ADV IMMUNOL, V44, P265; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SALTER RD, 1989, NATURE, V338, P345, DOI 10.1038/338345a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Sun JR, 1997, J IMMUNOL, V159, P6077; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Thome M, 1996, EUR J IMMUNOL, V26, P2093, DOI 10.1002/eji.1830260920; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wheeler CJ, 1998, J IMMUNOL, V160, P4199; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; Whelan JA, 1999, J IMMUNOL, V163, P4342; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; Wilson CS, 1999, J IMMUNOL, V162, P3933; Witte T, 1999, CELL IMMUNOL, V191, P90, DOI 10.1006/cimm.1998.1412; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	69	91	93	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2000	12	4					409	418		10.1016/S1074-7613(00)80193-4	http://dx.doi.org/10.1016/S1074-7613(00)80193-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795739	Bronze			2022-12-18	WOS:000086757300006
J	Hara, T; Nakano, Y; Tanaka, M; Tamura, K; Sekiguchi, T; Minehata, K; Copeland, NG; Jenkins, NA; Okabe, M; Kogo, H; Mukouyama, Y; Miyajima, A				Hara, T; Nakano, Y; Tanaka, M; Tamura, K; Sekiguchi, T; Minehata, K; Copeland, NG; Jenkins, NA; Okabe, M; Kogo, H; Mukouyama, Y; Miyajima, A			Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; ENDOTHELIAL-CELLS; MOUSE EMBRYO; YOLK-SAC; PROGENITORS; LEUKEMIA; MICE; VASCULOGENESIS; EXPRESSION; SCL/TAL-1	Recent studies with avian embryos and murine embryonic stem cells have suggested that hematopoietic cells are derived from hemangioblasts, the common precursors of hematopoietic and endothelial cells. We molecularly cloned podocalyxin-like protein 1 (PCLP1) as a novel surface marker for endothelial-like cells in the aorta-gonad-mesonephros (AGM) region of mouse embryos, where long-term repopulating hematopoietic stem cells (LTR-HSCs) are known to arise. PCLP1(+) CD45(-) cells in the AGM region incorporated acetylated low-density lipoprotein and produced both hematopoietic and endothelial cells when cocultured with OP9 stromal cells. Moreover, multiple lineages of hematopoietic cells were generated in vivo when PCLP1(+)CD45(-) cells were injected into neonatal liver of busulfan-treated mice. Thus, PCLP1 can be used to separate hemangioblasts that give rise to LTR-HSCs.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130032, Japan; Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920355, Japan; NCI, Mammalian Genet Lab, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Tokyo University of Pharmacy & Life Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Osaka University	Hara, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		; Okabe, Masaru/B-6917-2015	Mukouyama, Yoh-suke/0000-0002-9084-4922; Okabe, Masaru/0000-0002-0803-9044				Choi K, 1998, DEVELOPMENT, V125, P725; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Hara T, 1998, DEV BIOL, V201, P144, DOI 10.1006/dbio.1998.8990; HARADA N, 1990, P NATL ACAD SCI USA, V87, P857, DOI 10.1073/pnas.87.3.857; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Ho HTB, 1999, EUR J BIOCHEM, V259, P726, DOI 10.1046/j.1432-1327.1999.00110.x; HOCKFIELD S, 1993, SELECTED METHODS ANT, V1; IMAKAWA K, 1995, ENDOCRINE, V3, P511, DOI 10.1007/BF02738826; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; KERSHAW DB, 1995, J BIOL CHEM, V270, P29439, DOI 10.1074/jbc.270.49.29439; KODAMA H, 1994, EXP HEMATOL, V22, P979; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Matsuyoshi N, 1997, P ASSOC AM PHYSICIAN, V109, P362; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; OGOROCHI T, 1992, BLOOD, V79, P895; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SIRACUSA LD, 1991, GENETICS, V127, P169; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; TAKETO M, 1992, MAMM GENOME, V2, P240, DOI 10.1007/BF00355433; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yoshida A, 1996, ASSIST REPROD REV, V67, P93	49	91	98	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					567	578		10.1016/S1074-7613(00)80132-6	http://dx.doi.org/10.1016/S1074-7613(00)80132-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591182	Bronze			2022-12-18	WOS:000083952200009
J	Peterson, DA; DiPaolo, RJ; Kanagawa, O; Unanue, ER				Peterson, DA; DiPaolo, RJ; Kanagawa, O; Unanue, ER			Quantitative analysis of the T cell repertoire that escapes negative selection	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EGG-WHITE LYSOZYME; CLASS-II MHC; ANTIGEN TRANSGENIC MICE; LOW AVIDITY RECOGNITION; NONOBESE DIABETIC MICE; SELF-PEPTIDE; TOLERANCE INDUCTION; MOLECULE I-A(K); CLONAL DELETION	Mice expressing hen egg-white lysozyme (HEL) as a transgene are unresponsive to immunization with the HEL protein. Profound tolerance was found even in situations where the amounts of I-A(k)-peptide complexes was 100 or less per APC. Among the few T cells that escaped tolerance, we did not observe differential responses to the different HEL epitopes, perhaps because of the very high sensitivity of the negative selection process. The same HEL transgenic mice that did not respond to HEL responded to immunization with the 46-61 peptide of HEL. These peptide-specific T cells that escaped negative selection belonged to a set that reacted with a particular conformer of the HEL peptide-I-A(k) (type B). The presence of type B reactive T cells should be considered in autoimmunity.	Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA.	unanue@pathbox.wustl.edu						Accapezzato D, 1998, J IMMUNOL, V160, P5262; ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; ADORINI L, 1988, J EXP MED, V168, P2091, DOI 10.1084/jem.168.6.2091; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; ALLEN PM, 1984, IMMUNOBIOLOGY, V168, P182, DOI 10.1016/S0171-2985(84)80109-6; Barlow AK, 1998, J EXP MED, V187, P1403, DOI 10.1084/jem.187.9.1403; CABANIOLS JP, 1994, EUR J IMMUNOL, V24, P1743, DOI 10.1002/eji.1830240804; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; CERASOLI DM, 1995, INT IMMUNOL, V7, P935, DOI 10.1093/intimm/7.6.935; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; FISCHMANN T, 1988, J MOL BIOL, V203, P527, DOI 10.1016/0022-2836(88)90022-8; GAMMON G, 1991, J EXP MED, V173, P609, DOI 10.1084/jem.173.3.609; GAMMON G, 1989, NATURE, V342, P183, DOI 10.1038/342183a0; Gapin L, 1997, CELL IMMUNOL, V177, P77, DOI 10.1006/cimm.1997.1097; GOOD MF, 1983, J IMMUNOL, V130, P2046; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gugasyan R, 1998, J IMMUNOL, V161, P6074; Gyotoku T, 1998, EUR J IMMUNOL, V28, P4050, DOI 10.1002/(SICI)1521-4141(199812)28:12<4050::AID-IMMU4050>3.3.CO;2-P; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; JOOSTEN I, 1994, INT IMMUNOL, V6, P751, DOI 10.1093/intimm/6.5.751; Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721; KANAGAWA O, 1988, J IMMUNOL METHODS, V110, P169; KANOST D, 1993, INT IMMUNOL, V5, P893, DOI 10.1093/intimm/5.8.893; KELSO A, 1984, J IMMUNOL, V132, P2924; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; LATEK RR, 1999, IN PRESS IMMUNOL REV, V171; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MAMULA MJ, 1993, J EXP MED, V177, P567, DOI 10.1084/jem.177.2.567; MILICH DR, 1991, P NATL ACAD SCI USA, V88, P4348, DOI 10.1073/pnas.88.10.4348; MILICH DR, 1989, J IMMUNOL, V143, P3141; MOUDGIL KD, 1993, J EXP MED, V178, P2131, DOI 10.1084/jem.178.6.2131; Nelson CA, 1996, J IMMUNOL, V157, P755; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Peterson DA, 1999, J IMMUNOL, V162, P3117; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Purcell AW, 1998, J IMMUNOL, V160, P1085; Rabinowitz JD, 1997, P NATL ACAD SCI USA, V94, P8702, DOI 10.1073/pnas.94.16.8702; Rider BJ, 1996, MOL IMMUNOL, V33, P625, DOI 10.1016/0161-5890(96)00022-3; SCHILD H, 1991, J EXP MED, V174, P1665, DOI 10.1084/jem.174.6.1665; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Shih FF, 1997, INT IMMUNOL, V9, P249, DOI 10.1093/intimm/9.2.249; TOUME S, 1999, EUR J IMMUNOL, V29, P394; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; Viner NJ, 1996, J IMMUNOL, V156, P2365; Wen L, 1998, J CLIN INVEST, V102, P947, DOI 10.1172/JCI2723; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; YULE TD, 1993, J IMMUNOL, V151, P3057	55	91	92	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					453	462		10.1016/S1074-7613(00)80120-X	http://dx.doi.org/10.1016/S1074-7613(00)80120-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549627	Bronze			2022-12-18	WOS:000083343100007
J	Mandelboim, O; Reyburn, HT; Sheu, EG; ValesGomez, M; Davis, DM; Pazmany, L; Strominger, JL				Mandelboim, O; Reyburn, HT; Sheu, EG; ValesGomez, M; Davis, DM; Pazmany, L; Strominger, JL			The binding site of NK receptors on HLA-C molecules	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; NEONATAL FC RECEPTOR; CRYSTAL-STRUCTURE; RECOGNITION; CLONES; ANTIGEN; LYSIS; P58; IDENTIFICATION; SUPERANTIGEN	The protection of cells expressing class I HLA molecules from NK lysis is mediated by natural killer cell inhibitory receptors (NKIR). Using site-directed mutagenesis, residues on HLA-C that determine the locus specificity (alpha Val-76), allotype group specificity (a dimorphism alpha Asn-80/Lys-80), and affinity of NKIR binding (a second pair of dimorphisms, alpha Ala-73, Asp-90 or alpha Thr-73, Ala-90) have been identified. Thus the ''footprint'' of the NKIR on the alpha 1 helix of the class I MHC molecule HLA-C and its associated beta strands are similar in position to the site occupied by superantigens on and behind the alpha 1 helix of the class II MHC molecule HLA-DR1, but further toward its C-terminus. The intermediate affinity binding of NKIR to HLA-C, determined by alpha 73 and alpha 90, has an essential role in preventing cross-reactivity and ensuring the availability of NK cells for immunosurveillance; low affinity and high affinity mutants are both physiologically impaired.			Mandelboim, O (corresponding author), HARVARD UNIV, DEPT MOL & CELLULAR BIOL, CAMBRIDGE, MA 01238 USA.		Reyburn, Hugh T/B-4338-2009; Valés-Gómez, Mar/F-5351-2012; Vales-Gomez, Mar/ABG-7808-2020; Sheu, Eric/U-2188-2019	Reyburn, Hugh T/0000-0003-2855-1595; Valés-Gómez, Mar/0000-0001-7424-3206; Vales-Gomez, Mar/0000-0001-7424-3206; Sheu, Eric/0000-0003-2707-1768; Davis, Daniel/0000-0002-9182-291X; Mandelboim, Ofer/0000-0002-9354-1855	NCI NIH HHS [CA-47554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; BIASSONI R, 1995, J EXP MED, V182, P605, DOI 10.1084/jem.182.2.605; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; DANDREA A, 1995, J IMMUNOL, V155, P2306; Dohring C, 1996, J IMMUNOL, V156, P3098; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Luque I, 1996, EUR J IMMUNOL, V26, P1974, DOI 10.1002/eji.1830260845; MAndelboim O, 1996, SCIENCE, V274, P2097, DOI 10.1126/science.274.5295.2097; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; OLCESE L, 1996, IMMUNOLOGY, V156, P4531; PARHAM P, 1994, TISSUE ANTIGENS, V43, P302, DOI 10.1111/j.1399-0039.1994.tb02344.x; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; Peruzzi M, 1996, J IMMUNOL, V157, P3350; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; VILCHES C, 1994, IMMUNOGENETICS, V40, P166, DOI 10.1007/BF00188185; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X	43	91	92	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1997	6	3					341	350		10.1016/S1074-7613(00)80336-2	http://dx.doi.org/10.1016/S1074-7613(00)80336-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075934	Bronze			2022-12-18	WOS:A1997XC61800013
J	Hou, YZ; Liang, H; Rao, EY; Zheng, WX; Huang, XN; Deng, LF; Zhang, Y; Yu, XS; Xu, M; Mauceri, H; Arina, A; Weichselbaum, RR; Fu, YX				Hou, Yuzhu; Liang, Hua; Rao, Enyu; Zheng, Wenxin; Huang, Xiaona; Deng, Liufu; Zhang, Yuan; Yu, Xinshuang; Xu, Meng; Mauceri, Helena; Arina, Ainhoa; Weichselbaum, Ralph R.; Fu, Yang-Xin			Non-canonical NF-kappa B Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy	IMMUNITY			English	Article							DENDRITIC CELL ACTIVATION; LOCAL RADIATION-THERAPY; PROSTATE-CANCER CELLS; CD8(+) T-CELLS; IONIZING-RADIATION; ANTITUMOR IMMUNITY; TUMOR-REGRESSION; I INTERFERONS; EXPRESSION; RELB	The NF-kappa B pathway plays a crucial role in supporting tumor initiation, progression, and radioresistance of tumor cells. However, the role of the NF-kappa B pathway in radiation-induced anti-tumor host immunity remains unclear. Here we demonstrated that inhibiting the canonical NF-kappa B pathway dampened the therapeutic effect of ionizing radiation (IR), whereas non-canonical NF-kappa B deficiency promoted IR- induced anti-tumor immunity. Mechanistic studies revealed that non-canonical NF-kappa B signaling in dendritic cells (DCs) was activated by the STING sensor-dependent DNA-sensing pathway. By suppressing recruitment of the transcription factor RelA onto the Ifnb promoter, activation of the non-canonical NF-kappa B pathway resulted in decreased type I IFN expression. Administration of a specific inhibitor of the non-canonical NF-kappa B pathway enhanced the anti-tumor effect of IR in murine models. These findings reveal the potentially interactive roles for canonical and noncanonical NF-kappa B pathways in IR-induced STING-FN production and provide an alternative strategy to improve cancer radiotherapy.	[Hou, Yuzhu; Liang, Hua; Rao, Enyu; Zheng, Wenxin; Huang, Xiaona; Deng, Liufu; Zhang, Yuan; Xu, Meng; Mauceri, Helena; Arina, Ainhoa; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Rao, Enyu] Xuzhou Med Univ, Inst Canc, Xuzhou, Jiangsu, Peoples R China; [Deng, Liufu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Deng, Liufu] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai, Peoples R China; [Yu, Xinshuang] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China; [Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA	University of Chicago; Xuzhou Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Weichselbaum, RR (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.; Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA.	rrw@radonc.uchicago.edu; yang-xin.fu@utsouthwestern.edu	Hou, Yuzhu/O-2035-2019; Deng, Liufu/AAG-7244-2021	Hou, Yuzhu/0000-0001-8274-027X; Deng, Liufu/0000-0002-1164-6777	NIH [NCI-R21 CA195075, CA134563]; Cancer Prevention and Research Institute of Texas grant [RR150072]; University of Chicago Cancer Center Support Grant [P30CA014599]; NATIONAL CANCER INSTITUTE [R21CA195075, R01CA134563, P30CA014599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas grant; University of Chicago Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Amy K. Huser for editing assistance and Rolando Torres for assistance in animal studies. This research was supported in part by Mr. & Mrs. Vincent Foglia, The Chicago Tumor Institute, an endowment from the Ludwig Cancer Research Foundation to R.R.W., and NIH grant NCI-R21 CA195075 to R.R.W. This work was in part supported by the NIH grant CA134563 to Y.-X.F. and by Cancer Prevention and Research Institute of Texas grant RR150072 to Y.-X.F. Flow cytometry cost was covered in part by University of Chicago Cancer Center Support Grant (P30CA014599).	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chen XF, 2002, CANCER RES, V62, P1213; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Erstad DJ, 2013, SURG ONCOL CLIN N AM, V22, P705, DOI 10.1016/j.soc.2013.06.011; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gardner A, 2016, TRENDS IMMUNOL, V37, P855, DOI 10.1016/j.it.2016.09.006; Gupta A, 2012, J IMMUNOL, V189, P558, DOI 10.4049/jimmunol.1200563; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hou YZ, 2014, J IMMUNOL, V193, P130, DOI 10.4049/jimmunol.1302700; Jin J, 2014, IMMUNITY, V40, P342, DOI 10.1016/j.immuni.2014.02.006; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01566-5; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Mineva ND, 2009, J CELL PHYSIOL, V220, P593, DOI 10.1002/jcp.21765; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Vallabhapurapu SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9428; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang WX, 1999, ONCOGENE, V18, P4554, DOI 10.1038/sj.onc.1202833; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Weichselbaum RR, 2017, NAT REV CLIN ONCOL, V14, P365, DOI 10.1038/nrclinonc.2016.211; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	41	90	92	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					490	+		10.1016/j.immuni.2018.07.008	http://dx.doi.org/10.1016/j.immuni.2018.07.008			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30170810	Bronze, Green Accepted			2022-12-18	WOS:000444909600016
J	Morimoto, Y; Hirahara, K; Kiuchi, M; Wada, T; Ichikawa, T; Kanno, T; Okano, M; Kokubo, K; Onodera, A; Sakurai, D; Okamoto, Y; Nakayama, T				Morimoto, Yuki; Hirahara, Kiyoshi; Kiuchi, Masahiro; Wada, Tomoko; Ichikawa, Tomomi; Kanno, Toshio; Okano, Mikiko; Kokubo, Kota; Onodera, Atsushi; Sakurai, Daiju; Okamoto, Yoshitaka; Nakayama, Toshinori			Amphiregulin-Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; GROWTH-FACTOR RECEPTOR; REGULATORY T-CELLS; CHRONIC RHINOSINUSITIS; NASAL POLYPS; GENE-EXPRESSION; FACTOR FAMILY; TH2 CELLS; ASTHMA; INFLAMMATION	Memory T cells provide long-lasting protective immunity, and distinct subpopulations of memory T cells drive chronic inflammatory diseases such as asthma. Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. The immunological mechanisms that induce airway fibrotic changes remain unknown. We found that interleukin-33 (IL-33) enhanced amphiregulin production by the IL-33 receptor, ST2(hi) memory T helper 2 (Th2) cells. Amphiregulin-epidermal growth factor receptor (EGFR)-mediated signaling directly reprogramed eosinophils to an inflammatory state with enhanced production of osteopontin, a key profibrotic immunomodulatory protein. IL-5-producing memory Th2 cells and amphiregulin-producing memory Th2 cells appeared to cooperate to establish lung fibrosis. The analysis of polyps from patients with eosinophilic chronic rhinosinusitis revealed fibrosis with accumulation of amphiregulin-producing CRTH2(hi) CD161(hi) CD45RO(+)CD4(+) Th2 cells and osteopontin-producing eosinophils. Thus, the IL-33-am-phiregulin-osteopontin axis directs fibrotic responses in eosinophilic airway inflammation and is a potential target for the treatment of fibrosis induced by chronic allergic disorders.	[Morimoto, Yuki; Hirahara, Kiyoshi; Kiuchi, Masahiro; Wada, Tomoko; Ichikawa, Tomomi; Kanno, Toshio; Okano, Mikiko; Kokubo, Kota; Onodera, Atsushi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Morimoto, Yuki; Sakurai, Daiju; Okamoto, Yoshitaka] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Hirahara, Kiyoshi] AMED PRIME, AMED, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Onodera, Atsushi] Chiba Univ, Inst Global Prominent Res, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Nakayama, Toshinori] AMED CREST, AMED, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.; Nakayama, T (corresponding author), AMED CREST, AMED, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Hirahara, Kiyoshi/E-2460-2017	Hirahara, Kiyoshi/0000-0002-9128-9449	Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [26221305, 17K08876, 18K07164, 18K16830]; AMED-CREST, AMED [JP16gm0410009]; AMEDPRIME, AMED [JP18gm6110005]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED [JP18ek0410030, JP18ek0410045]; Takeda Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST, AMED; AMEDPRIME, AMED; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	We are grateful for Drs. Mark Bix, Omid Akbari, and Yuka Kanno for their critical reading and providing valuable suggestions on the manuscript. We thank Toshihiro Ito, Kaoru Sugaya, and Miki Kato for their excellent technical assistance. This work was supported by the following grants: Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) Grants-in-Aid for Scientific Research (S) 26221305, (C) 17K08876 and 18K07164, and Young Scientists (B) 18K16830; AMED-CREST, AMED (no. JP16gm0410009); AMEDPRIME, AMED (no. JP18gm6110005); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED (no. JP18ek0410030, JP18ek0410045); Takeda Science Foundation; and the Naito Foundation.	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Ball SL, 2016, AM J PATHOL, V186, P225, DOI 10.1016/j.ajpath.2015.09.020; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Foster PS, 2017, IMMUNOL REV, V278, P20, DOI 10.1111/imr.12549; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Hamilos DL, 2015, J ALLERGY CLIN IMMUN, V136, P1454, DOI 10.1016/j.jaci.2015.10.011; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Ho J, 2015, CLIN EXP ALLERGY, V45, P394, DOI 10.1111/cea.12462; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kobayashi Y, 2015, J ASTHMA, V52, P1060, DOI 10.3109/02770903.2015.1054404; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Liu WL, 2015, CLIN EXP ALLERGY, V45, P414, DOI 10.1111/cea.12320; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mesnil C, 2016, J CLIN INVEST, V126, P3279, DOI 10.1172/JCI85664; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moyer JD, 1997, CANCER RES, V57, P4838; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Onodera A, 2015, MOL CELL BIOL, V35, P3841, DOI 10.1128/MCB.00677-15; Pawankar R, 2007, CURR ALLERGY ASTHM R, V7, P202, DOI 10.1007/s11882-007-0073-4; Puxeddu I, 2010, ALLERGY, V65, P168, DOI 10.1111/j.1398-9995.2009.02148.x; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sabo-Attwood T, 2011, AM J PATHOL, V178, P1975, DOI 10.1016/j.ajpath.2011.01.048; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Shinoda K, 2016, P NATL ACAD SCI USA, V113, pE2842, DOI 10.1073/pnas.1512600113; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Stoll S, 1997, J CLIN INVEST, V100, P1271, DOI 10.1172/JCI119641; Straumann A, 2013, ALLERGY, V68, P375, DOI 10.1111/all.12096; Valladao AC, 2016, J IMMUNOL, V197, P4541, DOI 10.4049/jimmunol.1600007; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Yamamoto H, 2007, ALLERGY, V62, P1451, DOI 10.1111/j.1398-9995.2007.01464.x; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	55	90	96	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					134	+		10.1016/j.immuni.2018.04.023	http://dx.doi.org/10.1016/j.immuni.2018.04.023			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958800	Bronze			2022-12-18	WOS:000438949100017
J	Sestan, M; Marinovic, S; Kavazovic, I; Cekinovic, D; Wueest, S; Wensveen, TT; Brizic, I; Jonjic, S; Konrad, D; Wensveen, FM; Polic, B				Sestan, Marko; Marinovic, Sonja; Kavazovic, Inga; Cekinovic, Durdica; Wueest, Stephan; Wensveen, Tamara Turk; Brizic, Ilija; Jonjic, Stipan; Konrad, Daniel; Wensveen, Felix M.; Polic, Bojan			Virus-Induced Interferon-gamma Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity	IMMUNITY			English	Article							GLUCOSE-TOLERANCE; CELL-FUNCTION; INFLAMMATION; LIVER; DISEASE; PATHOGENESIS; HOMEOSTASIS; METABOLISM; MECHANISMS; STRESS	Pro-inflammatory cytokines of a T helper-1-signature are known to promote insulin resistance (IR) in obesity, but the physiological role of this mechanism is unclear. It is also unknown whether and how viral infection induces loss of glycemic control in subjects at risk for developing diabetes mellitus type 2 (DM2). We have found in mice and humans that viral infection caused short-term systemic IR. Virally-induced interferon-gamma (IFN-gamma) directly targeted skeletal muscle to downregulate the insulin receptor but did not cause loss of glycemic control because of a compensatory increase of insulin production. Hyperinsulinemia enhanced antiviral immunity through direct stimulation of CD8(+) effector T cell function. In prediabetic mice with hepatic IR caused by diet-induced obesity, infection resulted in loss of glycemic control. Thus, upon pathogen encounter, the immune system transiently reduces insulin sensitivity of skeletal muscle to induce hyperinsulinemia and promote antiviral immunity, which derails to glucose intolerance in prediabetic obese subjects.	[Sestan, Marko; Marinovic, Sonja; Kavazovic, Inga; Jonjic, Stipan; Wensveen, Felix M.; Polic, Bojan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; [Cekinovic, Durdica] Clin Hosp Ctr Rijeka, Dept Infectol, Rijeka, Croatia; [Wueest, Stephan; Konrad, Daniel] Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Wueest, Stephan; Konrad, Daniel] Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland; [Wensveen, Tamara Turk] Clin Hosp Ctr Rijeka, Dept Endocrinol, Rijeka, Croatia; [Brizic, Ilija; Jonjic, Stipan] Univ Rijeka, Fac Med, Ctr Prote, Rijeka, Croatia	University of Rijeka; University of Rijeka; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Rijeka; University of Rijeka	Polic, B (corresponding author), Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia.	bojan.polic@medri.uniri.hr	Marinović, Sonja/S-2859-2018; Brizic, Ilija/N-4052-2015; Brizić, Ilija/O-4776-2018; Jonjic, Stipan/C-5657-2016; Wüest, Stephan/AAG-9706-2020; Polic, Bojan/B-8622-2014; Kavazovic, Inga/S-1098-2018; Cekinović Grbeša, Đurđica/R-5303-2018; Wensveen, Felix/O-3122-2018; Šestan, Marko/S-4142-2018; Šestan, Marko/S-1092-2018; Turk Wensveen, Tamara/R-9514-2018	Marinović, Sonja/0000-0002-4054-338X; Brizić, Ilija/0000-0001-8839-7839; Jonjic, Stipan/0000-0001-5003-3108; Wüest, Stephan/0000-0002-0176-8906; Polic, Bojan/0000-0003-3930-9630; Kavazovic, Inga/0000-0003-4704-6199; Cekinović Grbeša, Đurđica/0000-0002-3601-9200; Wensveen, Felix/0000-0002-1333-8882; Šestan, Marko/0000-0002-1473-6647; Šestan, Marko/0000-0002-1473-6647; Konrad, Daniel/0000-0001-9067-4356; Turk Wensveen, Tamara/0000-0003-3813-1535	University of Rijeka [865.10.2101, 803.10.1103]; Croatian Science Foundation [IP-2016-06-8027, IP-2016-06-9306]; European Social Fund for Croatia [IP-2016-06-9306]; Unity through Knowledge Fund [UKF 15/13]; European Regional Development Fund; Swiss National Science Foundation [310030-179344];  [KK.01.1.1.01.0006]	University of Rijeka; Croatian Science Foundation; European Social Fund for Croatia; Unity through Knowledge Fund; European Regional Development Fund(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 	We thank to B. Troselj-Vukic, I. Pavic, and L. Bilic-Zulle for their support to the clinical part of the study, A. Waisman for generous help with iDTR mice, and M. Golemac for histochemistry. We also thank to S. Slavic-Stupac, D. Rumora, K. Miklic, S. Malic, M. Samsa, E. Razic, E. Marinovic, and A. Mise for excellent technical assistance and animal care. This work was supported by the University of Rijeka (865.10.2101 to F.M.W. and 803.10.1103 to B.P.), the Croatian Science Foundation (IP-2016-06-8027 to F.M.W. and IP-2016-06-9306 to B.P.), the European Social Fund for Croatia (HR.3.2.01-0263 to B.P.), the Unity through Knowledge Fund (UKF 15/13 to B.P.), and the grant KK.01.1.1.01.0006, awarded to the Scientific Centre of Excellence for Virus Immunology and Vaccines and co-financed by the European Regional Development Fund to S.J. This work was also supported by grants from the Swiss National Science Foundation (#310030-179344 to D.K.).	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Boll M, 2001, Z NATURFORSCH C, V56, P649; Chen SJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-18; Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71; Cotrozzi G, 1997, Ann Ital Med Int, V12, P84; Custro N, 2001, DIABETES METAB, V27, P476; Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Durward M., 2010, J VIS EXP, V45, P2250; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Grzelkowska-Kowalczyk K, 2010, CELL BIOL INT, V34, P117, DOI 10.1042/CBI20090135; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hirche C, 2017, CELL REP, V19, P2345, DOI 10.1016/j.celrep.2017.05.063; Holstein A, 2002, J GASTROEN HEPATOL, V17, P677, DOI 10.1046/j.1440-1746.2002.02755.x; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim SY, 2010, NAT REV RHEUMATOL, V6, P165, DOI 10.1038/nrrheum.2009.279; KOIVISTO VA, 1989, DIABETES, V38, P641, DOI 10.2337/diabetes.38.5.641; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Leinonen M, 1999, AM HEART J, V138, pS504, DOI 10.1016/S0002-8703(99)70286-3; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Mossanen JC, 2015, LAB ANIM-UK, V49, P30, DOI 10.1177/0023677215570992; Munzberg H, 2015, METABOLISM, V64, P13, DOI 10.1016/j.metabol.2014.09.010; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI 10.1080/13813450802181047 ; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Picardi A, 2006, DIABETES-METAB RES, V22, P274, DOI 10.1002/dmrr.636; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Roberts BW, 2005, SOUTH MED J, V98, P686, DOI 10.1097/01.SMJ.0000163310.12516.2D; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shahbazian H, 2013, J RENAL INJ PREV, V2, P73, DOI 10.12861/jrip.2013.24; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Uysal KT, 1998, ENDOCRINOLOGY, V139, P4832, DOI 10.1210/en.139.12.4832; Wada T, 2011, AM J PHYSIOL-ENDOC M, V300, pE1112, DOI 10.1152/ajpendo.00370.2010; Wagner FM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003493; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Wu J, 2014, J VIROL, V88, P10421, DOI 10.1128/JVI.00996-14; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; YKIJARVINEN H, 1989, J CLIN ENDOCR METAB, V69, P317, DOI 10.1210/jcem-69-2-317	68	90	91	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					164	+		10.1016/j.immuni.2018.05.005	http://dx.doi.org/10.1016/j.immuni.2018.05.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958802	Green Accepted, Bronze			2022-12-18	WOS:000438949100019
J	Kernfeld, EM; Genga, RMJ; Neherin, K; Magaletta, ME; Xu, P; Maehr, R				Kernfeld, Eric M.; Genga, Ryan M. J.; Neherin, Kashfia; Magaletta, Margaret E.; Xu, Ping; Maehr, Rene			A Single-Cell Transcriptomic Atlas of Thymus Organogenesis Resolves Cell Types and Developmental Maturation	IMMUNITY			English	Article							DELTA-T-CELLS; EPITHELIAL-CELLS; GENE-EXPRESSION; AUTOIMMUNE REGULATOR; RNA-SEQ; LINEAGE; DIFFERENTIATION; GENERATION; REVEALS; MICE	Thymus development is critical to the adaptive immune system, yet a comprehensive transcriptional framework capturing thymus organogenesis at single-cell resolution is still needed. We applied single-cell RNA sequencing (RNA-seq) to capture 8 days of thymus development, perturbations of T cell receptor rearrangement, and in vitro organ cultures, producing profiles of 24,279 cells. We resolved transcriptional heterogeneity of developing lymphocytes, and genetic perturbation confirmed T cell identity of conventional and non-conventional lymphocytes. We characterized maturation dynamics of thymic epithelial cells in vivo, classified cell maturation state in a thymic organ culture, and revealed the intrinsic capacity of thymic epithelium to preserve transcriptional regularity despite exposure to exogenous retinoic acid. Finally, by integrating the cell atlas with human genome-wide association study (GWAS) data and autoimmune-disease-related genes, we implicated embryonic thymus-resident cells as possible participants in autoimmune disease etiologies. This resource provides a single-cell transcriptional framework for biological discovery and molecular analysis of thymus organogenesis.	[Kernfeld, Eric M.; Genga, Ryan M. J.; Neherin, Kashfia; Magaletta, Margaret E.; Xu, Ping; Maehr, Rene] Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Maehr, R (corresponding author), Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA.	rene.maehr@umassmed.edu		Magaletta, Margaret/0000-0003-2858-7432	NIH [1DP3DK111898, R01 AI132963, UC4 DK104218]; Leona M. and Harry B. Helmsley Charitable Trust [2015PG-T1D035]; Glass Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218, DP3DK111898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Glass Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A.J. Choi for technical help in setting up Drop-seq runs; M.J. Ziller and D. Fischer for helpful suggestions on bioinformatics; N. Kearns, A. Reboldi, and J. Kang for thoughtful comments on the manuscript; and the UMass Medical School FACS core for support with cell sorting. We are grateful to P. Zamore and J. Luban for sequencer access. This work was funded by NIH grants (1DP3DK111898, R01 AI132963, and UC4 DK104218), the Leona M. and Harry B. Helmsley Charitable Trust (2015PG-T1D035), and The Glass Charitable Foundation.	Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Akiyama N, 2016, J EXP MED, V213, P1441, DOI 10.1084/jem.20151780; Alves NL, 2016, EUR J IMMUNOL, V46, P829, DOI 10.1002/eji.201646329; ANDERSON P, 1989, NATURE, V341, P159, DOI 10.1038/341159a0; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; BRITZ JS, 1983, J IMMUNOL, V130, P1848; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fischer D. S, 2017, RNASEQ TIME SERIES, DOI [10.1101/219188, DOI 10.1101/219188]; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Kearns NA, 2013, STEM CELL RES, V11, P1003, DOI 10.1016/j.scr.2013.06.007; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Markert ML, 2009, IMMUNOL RES, V44, P61, DOI 10.1007/s12026-008-8082-5; Marrella V, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00259; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Michel C, 2017, J IMMUNOL, V199, P3488, DOI 10.4049/jimmunol.1700203; Miragaia RJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19100-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ohigashi I, 2016, IMMUNOL REV, V271, P10, DOI 10.1111/imr.12404; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Sekai M, 2014, IMMUNITY, V41, P753, DOI 10.1016/j.immuni.2014.10.011; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Streb JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018538; Takaba H, 2017, TRENDS IMMUNOL, V38, P805, DOI 10.1016/j.it.2017.07.010; Takahama Y, 2017, NAT REV IMMUNOL, V17, P295, DOI 10.1038/nri.2017.12; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Xiao SY, 2003, CELL RES, V13, P265, DOI 10.1038/sj.cr.7290171; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	64	90	90	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1258	+		10.1016/j.immuni.2018.04.015	http://dx.doi.org/10.1016/j.immuni.2018.04.015			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29884461	Green Accepted, Bronze			2022-12-18	WOS:000436456900023
J	Osbourn, M; Soares, DC; Vacca, F; Cohen, ES; Scott, IC; Gregory, WF; Smyth, DJ; Toivakka, M; Kemter, AM; Le Bihan, T; Wear, M; Hoving, D; Filbey, KJ; Hewitson, JP; Henderson, H; Gonzalez-Ciscar, A; Errington, C; Vermeren, S; Astier, AL; Wallace, WA; Schwarze, J; Ivens, AC; Maizels, RM; McSorley, HJ				Osbourn, Megan; Soares, Dinesh C.; Vacca, Francesco; Cohen, E. Suzanne; Scott, Ian C.; Gregory, William F.; Smyth, Danielle J.; Toivakka, Matilda; Kemter, Andrea M.; Le Bihan, Thierry; Wear, Martin; Hoving, Dennis; Filbey, Kara J.; Hewitson, James P.; Henderson, Holly; Gonzalez-Ciscar, Andrea; Errington, Claire; Vermeren, Sonja; Astier, Anne L.; Wallace, William A.; Schwarze, Jurgen; Ivens, Alasdair C.; Maizels, Rick M.; McSorley, Henry J.			HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; CCP MODULES; LARGE-SCALE; IL-33; INFLAMMATION; CYTOKINE; PRODUCTS; ASTHMA; DNA	Infection by helminth parasites is associated with amelioration of allergic reactivity, but mechanistic insights into this association are lacking. Products secreted by the mouse parasite Heligmosomoides polygyrus suppress type 2 (allergic) immune responses through interference in the interleukin-33 (IL-33) pathway. Here, we identified H. polygyrus Alar-min Release Inhibitor (HpARI), an IL-33-suppressive 26-kDa protein, containing three predicted complement control protein (CCP) modules. In vivo, recombinant HpARI abrogated IL-33, group 2 innate lymphoid cell (ILC2) and eosinophilic responses to Alternaria allergen administration, and diminished eosinophilic responses to Nippostrongylus brasiliensis, increasing parasite burden. HpARI bound directly to both mouse and human IL-33 (in the cytokine's activated state) and also to nuclear DNA via its N-terminal CCP module pair (CCP1/2), tethering active IL-33 within necrotic cells, preventing its release, and forestalling initiation of type 2 allergic responses. Thus, HpARI employs a novel molecular strategy to suppress type 2 immunity in both infection and allergy.	[Osbourn, Megan; Soares, Dinesh C.; Vacca, Francesco; Gregory, William F.; Toivakka, Matilda; Henderson, Holly; Gonzalez-Ciscar, Andrea; Errington, Claire; Vermeren, Sonja; Astier, Anne L.; Schwarze, Jurgen; McSorley, Henry J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Cohen, E. Suzanne; Scott, Ian C.] MedImmune Ltd, Dept Resp Inflammat & Autoimmun, Granta Pk, Cambridge CB21 6GH, England; [Smyth, Danielle J.; Toivakka, Matilda; Kemter, Andrea M.; Filbey, Kara J.; Hewitson, James P.; Gonzalez-Ciscar, Andrea; Ivens, Alasdair C.; Maizels, Rick M.; McSorley, Henry J.] Univ Edinburgh, Inst Immunol & Infect Res, West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland; [Smyth, Danielle J.; Toivakka, Matilda; Kemter, Andrea M.; Filbey, Kara J.; Hewitson, James P.; Gonzalez-Ciscar, Andrea; Ivens, Alasdair C.; Maizels, Rick M.; McSorley, Henry J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Ashworth Labs, West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland; [Smyth, Danielle J.; Kemter, Andrea M.; Hoving, Dennis; Maizels, Rick M.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Sir Graeme Davies Bldg,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Le Bihan, Thierry] Univ Edinburgh, SynthSys, Kings Bldgs, Edinburgh EH9 3BF, Midlothian, Scotland; [Wear, Martin] Univ Edinburgh, WTCCB, EPPF, Kings Bldgs,Mayfield Rd, Edinburgh EH9 3BF, Midlothian, Scotland; [Hewitson, James P.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Wallace, William A.] Royal Infirm Edinburgh NHS Trust, Lab Med, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; AstraZeneca; Medimmune; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh; University of York - UK; Royal Infirmary of Edinburgh; University of Edinburgh	McSorley, HJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.; Maizels, RM; McSorley, HJ (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.; Maizels, RM; McSorley, HJ (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Ashworth Labs, West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.; Maizels, RM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Sir Graeme Davies Bldg,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	rick.maizels@glasgow.ac.uk; henry.mcsorley@ed.ac.uk	Le Bihan, Thierry/AAN-2534-2020; Filbey, Kara/S-8686-2019; Vermeren, Sonja/AAK-7442-2020; Astier, Anne L/A-1641-2008; Schwarze, Jürgen/F-7396-2011; Soares, Dinesh/A-4425-2012	Filbey, Kara/0000-0001-5758-5730; Vermeren, Sonja/0000-0002-8460-0884; Astier, Anne L/0000-0002-0144-3431; Cohen, Suzanne/0000-0002-4470-1680; Smyth, Danielle/0000-0001-6080-2679; Hewitson, James/0000-0002-3265-6763; Soares, Dinesh/0000-0001-7557-0495; McSorley, Henry/0000-0003-1300-7407; Vacca, Francesco/0000-0001-6808-5221; Le Bihan, Thierry/0000-0003-0498-8063	Asthma UK Fellowship [SPD-2012-172]; Medical Research Council Confidence in Concept award [MRC/CIC4/03]; Wellcome Trust [106122, 104111, 101527/Z/13/Z]; Medical Research Council [MC_PC_15027, MR/L008394/1] Funding Source: researchfish; Asthma UK [SPD-2012-172] Funding Source: researchfish; MRC [MR/L008394/1, MC_PC_15027] Funding Source: UKRI	Asthma UK Fellowship; Medical Research Council Confidence in Concept award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	H.J.M. is supported by an Asthma UK Fellowship (SPD-2012-172) and a Medical Research Council Confidence in Concept award (MRC/CIC4/03), R.M.M. is supported by the Wellcome Trust through an Investigator Award (Ref 106122) and core funding to the Wellcome Centre for Molecular Parasitology (Ref 104111). The EPPF is supported by the Wellcome Trust Multi-User Equipment grant 101527/Z/13/Z. E.S.C. and I.C.S. are employees of the AstraZeneca Group and have stock/stock options in AstraZeneca. We thank the Lothian NRS Bioresource for supplying human lung material.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chen C.C., 2017, J ALLERGY CLIN IMMUN; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Coakley G, 2017, CELL REP, V19, P1545, DOI 10.1016/j.celrep.2017.05.001; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Salvo C, 2016, AM J PATHOL; Gautier V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34255; Hewitson JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003492; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Hristova M, 2016, J ALLERGY CLIN IMMUN, V137, P1545, DOI 10.1016/j.jaci.2015.10.003; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Johnston CJC, 2015, JOVE-J VIS EXP, DOI 10.3791/52412; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Maizels RM, 2012, EXP PARASITOL, V132, P76, DOI 10.1016/j.exppara.2011.08.011; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; McSorley HJ, 2015, EXP PARASITOL, V158, P8, DOI 10.1016/j.exppara.2015.02.009; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Simon D, 2015, ALLERGY, V70, P443, DOI 10.1111/all.12570; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433	61	90	93	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					739	+		10.1016/j.immuni.2017.09.015	http://dx.doi.org/10.1016/j.immuni.2017.09.015			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045903	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000413091600017
J	Klein, RS; Hunter, CA				Klein, Robyn S.; Hunter, Christopher A.			Protective and Pathological Immunity during Central Nervous System Infections	IMMUNITY			English	Review							WEST-NILE-VIRUS; HERPES-SIMPLEX ENCEPHALITIS; BLOOD-BRAIN-BARRIER; CD8 T-CELLS; MHC CLASS-I; MICROVASCULAR ENDOTHELIAL-CELLS; CHRONIC VIRAL-INFECTION; TOXOPLASMA-GONDII INFECTION; ANTIBODY-SECRETING CELLS; CRYPTOCOCCUS-NEOFORMANS	The concept of immune privilege of the central nervous system (CNS) has dominated the study of inflammatory processes in the brain. However, clinically relevant models have highlighted that innate pathways limit pathogen invasion of the CNS and adaptive immunity mediates control of many neural infections. As protective responses can result in bystander damage, there are regulatory mechanisms that balance protective and pathological inflammation, but these mechanisms might also allow microbial persistence. The focus of this review is to consider the host-pathogen interactions that influence neurotropic infections and to highlight advances in our understanding of innate and adaptive mechanisms of resistance as key determinants of the outcome of CNS infection. Advances in these areas have broadened our comprehension of how the immune system functions in the brain and can readily overcome immune privilege.	[Klein, Robyn S.] Washington Univ, Sch Med, Dept Med, Neurosci, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol, Neurosci, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Immunol, Neurosci, St Louis, MO 63110 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, Neurosci, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol, Neurosci, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Immunol, Neurosci, St Louis, MO 63110 USA.; Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	rklein@wustl.edu; chunter@vet.upenn.edu			National Institutes of Health [DTRA1-11-16-BRCWMD-BAA, NIH/NINDS P01 NS059560, NIH/NIAID U19 AI083019, NIH/NINDS R01NS052632]; NIAID [R01 AI110201, R01 AI 41158]; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041158, R01AI110201, U19AI083019, R01AI101400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, P01NS059560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to acknowledge Deb Argento for outstanding help with the figures. Grant support from the National Institutes of Health: DTRA1-11-16-BRCWMD-BAA, NIH/NINDS P01 NS059560, NIH/NIAID U19 AI083019, and NIH/NINDS R01NS052632 (all to R.S.K.). NIAID R01 AI110201, NIAID R01 AI 41158, Commonwealth of Pennsylvania (all to C.A.H.).	Ali M, 2005, AM J NEURORADIOL, V26, P289; Ali T, 2013, DRUG HEALTHC PATIENT, V5, P79, DOI 10.2147/DHPS.S28801; Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274; Anghelina D, 2009, VIROLOGY, V385, P358, DOI 10.1016/j.virol.2008.12.014; [Anonymous], 2008, J VIROL, V82, P7078; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631; Barratt J, 2016, PARASITOLOGY, V143, P1087, DOI 10.1017/S0031182016000652; Bauer A, 2014, J VIROL, V88, P14172, DOI 10.1128/JVI.02254-14; BEAMAN BL, 1993, INFECT IMMUN, V61, P955, DOI 10.1128/IAI.61.3.955-965.1993; Beiting DP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002200; Benevides L, 2008, AM J PATHOL, V173, P741, DOI 10.2353/ajpath.2008.080129; Bennett JL, 2007, VIRAL IMMUNOL, V20, P19, DOI 10.1089/vim.2006.0068; Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Bernard SC, 2014, NAT MED, V20, P725, DOI 10.1038/nm.3563; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Biswas A, 2015, J IMMUNOL, V194, P3223, DOI 10.4049/jimmunol.1402037; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Bleau C, 2015, J VIROL, V89, P9896, DOI 10.1128/JVI.01501-15; Boss IW, 2011, BBA-GENE REGUL MECH, V1809, P708, DOI 10.1016/j.bbagrm.2011.06.012; Bowen LN, 2016, NAT REV NEUROL, V12, P662, DOI 10.1038/nrneurol.2016.149; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Braun BJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-11; BRITT RH, 1981, ANN NEUROL, V9, P107, DOI 10.1002/ana.410090203; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447; Cain M.D., 2017, J NEUROIMMUNOL; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Castro R, 2016, J CLIN LAB ANAL, V30, P628, DOI 10.1002/jcla.21913; Cavanaugh SE, 2015, J NEUROIMMUNOL, V279, P11, DOI 10.1016/j.jneuroim.2014.12.012; Cekanaviciute E, 2014, J IMMUNOL, V193, P139, DOI 10.4049/jimmunol.1303284; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Chevalier G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002393; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Christensen JE, 2006, J IMMUNOL, V176, P4235, DOI 10.4049/jimmunol.176.7.4235; Church JS, 2016, J NEUROSCI, V36, P6352, DOI 10.1523/JNEUROSCI.0353-16.2016; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Cullheim S, 2010, NEUROSCIENTIST, V16, P600, DOI 10.1177/1073858410381534; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805; Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; de Aquino MTP, 2014, J IMMUNOL, V193, P285, DOI 10.4049/jimmunol.1400058; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; de Medeiros AKA, 2016, J CLIN IMMUNOL, V36, P204, DOI 10.1007/s10875-016-0255-8; Deckert-Schluter M, 1998, J IMMUNOL, V160, P3427; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Denkers EY, 1997, J IMMUNOL, V159, P1903; Dinner S, 2017, MICROBES INFECT, V19, P18, DOI 10.1016/j.micinf.2016.09.003; Do JS, 2016, MUCOSAL IMMUNOL, V9, P137, DOI 10.1038/mi.2015.45; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durrant DM, 2014, J IMMUNOL, V193, P4095, DOI 10.4049/jimmunol.1401192; Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Farmer JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058813; Frost EL, 2015, J IMMUNOL, V195, P3520, DOI 10.4049/jimmunol.1501521; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gallego-Delgado J, 2016, J CLIN INVEST, V126, P4016, DOI 10.1172/JCI87306; Gamino V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-39; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Gensel JC, 2015, J NEUROSCI, V35, P9966, DOI 10.1523/JNEUROSCI.0337-15.2015; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971; Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Halonen SK, 2000, INFECT IMMUN, V68, P3426, DOI 10.1128/IAI.68.6.3426-3430.2000; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; Herbst M, 2015, PEDIATR INFECT DIS J, V34, P999, DOI 10.1097/INF.0000000000000736; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Hidano S, 2016, MBIO, V7, DOI 10.1128/mBio.01881-16; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hoftberger R, 2013, CLIN NEUROPATHOL, V32, P251, DOI 10.5414/NP300666; Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5; Hosmane S, 2012, J NEUROSCI, V32, P7745, DOI 10.1523/JNEUROSCI.0203-12.2012; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Huggins MA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00985-16; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Iovino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068408; Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Jelcic I, 2015, J NEUROVIROL, V21, P614, DOI 10.1007/s13365-014-0294-y; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; John B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002246; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Joshi AY, 2009, MAYO CLIN PROC, V84, P16, DOI [10.4065/84.1.16, 10.1016/S0025-6196(11)60802-1]; Kelcher AMH, 2017, FASEB J, V31, P2267, DOI 10.1096/fj.201601055R; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim BJ, 2015, J CLIN INVEST, V125, P2473, DOI 10.1172/JCI74159; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Konradt C, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.1, 10.1038/NMICROBIOL.2016.1]; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kramer T, 2013, VIRUSES-BASEL, V5, P678, DOI 10.3390/v5020678; Kulcsar KA, 2014, P NATL ACAD SCI USA, V111, P16053, DOI 10.1073/pnas.1418966111; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Landrith TA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00335; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lewis LA, 2014, VIRULENCE, V5, P98, DOI 10.4161/viru.26515; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lundberg P., 2010, J VIROL, V84, P312; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mahamed DA, 2012, P NATL ACAD SCI USA, V109, P16312, DOI 10.1073/pnas.1205589109; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Maruvada R, 2012, CELL MICROBIOL, V14, P1544, DOI 10.1111/j.1462-5822.2012.01819.x; Marzal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097321; Matsuda T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7514; Matullo CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002462; Maximova OA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004980; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Melzer T, 2008, INFECT IMMUN, V76, P4883, DOI 10.1128/IAI.01288-07; Menendez CM, 2016, J IMMUNOL, V197, P1262, DOI 10.4049/jimmunol.1600207; Miller KD, 2016, NAT REV NEUROSCI, V17, P766, DOI 10.1038/nrn.2016.140; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; Molloy ES, 2009, NAT REV RHEUMATOL, V5, P418, DOI 10.1038/nrrheum.2009.142; Moraga A, 2014, FASEB J, V28, P4710, DOI 10.1096/fj.14-252452; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Nansen A, 1998, J NEUROIMMUNOL, V86, P202, DOI 10.1016/S0165-5728(98)00055-1; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nayak D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003395; Neal JW, 2013, J NEUROPATH EXP NEUR, V72, P370, DOI 10.1097/NEN.0b013e3182909f2f; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Niedelman W, 2013, INFECT IMMUN, V81, P4341, DOI 10.1128/IAI.00416-13; Nishimura Y, 2013, CELL TRANSPLANT, V22, P2187, DOI 10.3727/096368912X657882; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; O'Brien CA, 2017, J IMMUNOL, V198, P4054, DOI 10.4049/jimmunol.1601581; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Olias P, 2016, CELL HOST MICROBE, V20, P72, DOI 10.1016/j.chom.2016.06.006; Olsan AD, 2003, AM J ROENTGENOL, V181, P591, DOI 10.2214/ajr.181.2.1810591; Orr MT, 2007, CELL HOST MICROBE, V2, P172, DOI 10.1016/j.chom.2007.06.013; Pal P, 2016, MBIO, V7, DOI 10.1128/mBio.00617-16; Parida SK, 2015, CLIN INFECT DIS, V61, pS217, DOI 10.1093/cid/civ615; Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002; Pfefferkorn C, 2016, J VIROL, V90, P2031, DOI 10.1128/JVI.02979-15; Phares TW, 2013, J VIROL, V87, P3382, DOI 10.1128/JVI.03307-12; Phillips AT, 2016, J VIROL, V90, P5785, DOI 10.1128/JVI.03219-15; Pinschewer DD, 2010, BRAIN, V133, P1054, DOI 10.1093/brain/awq028; PLANZ O, 1995, J VIROL, V69, P896, DOI 10.1128/JVI.69.2.896-903.1995; Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738; Rajbhandari L, 2014, GLIA, V62, P1982, DOI 10.1002/glia.22719; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; Rambach G, 2008, MICROBES INFECT, V10, P1567, DOI 10.1016/j.micinf.2008.09.011; Reichmann G, 1999, J IMMUNOL, V163, P3354; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Reuter D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033989; Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Santiago-Tirado FH, 2017, MBIO, V8, DOI 10.1128/mBio.02183-16; SASSEVILLE VG, 1994, AM J PATHOL, V144, P27; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schwartz M, 2011, BRAIN BEHAV IMMUN, V25, P817, DOI 10.1016/j.bbi.2010.12.015; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Solomos AC, 2016, VIROLOGY, V499, P196, DOI 10.1016/j.virol.2016.09.013; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stenzel W, 2004, J NEUROPATH EXP NEUR, V63, P631, DOI 10.1093/jnen/63.6.631; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Subauste CS, 2006, PARASITE IMMUNOL, V28, P567, DOI 10.1111/j.1365-3024.2006.00890.x; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022; Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009; Tang AT, 2017, NATURE, V545, P305, DOI 10.1038/nature22075; Tirotta E, 2013, J NEUROIMMUNOL, V254, P110, DOI 10.1016/j.jneuroim.2012.10.005; Trabalza A, 2013, GENE THER, V20, P723, DOI 10.1038/gt.2012.85; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670; Tschen SI, 2006, EUR J IMMUNOL, V36, P603, DOI 10.1002/eji.200535123; Tseng HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045083; Tufail Y, 2017, NEURON, V93, P574, DOI 10.1016/j.neuron.2016.12.021; Van Grol J, 2013, INFECT IMMUN, V81, P2002, DOI 10.1128/IAI.01145-12; van Sorge NM, 2012, FUTURE MICROBIOL, V7, P383, DOI [10.2217/fmb.12.1, 10.2217/FMB.12.1]; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Vu K, 2013, INFECT IMMUN, V81, P3139, DOI 10.1128/IAI.00554-13; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Waknine-Grinberg JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072722; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Westman G, 2016, CLIN MICROBIOL INFEC, V22, P934, DOI 10.1016/j.cmi.2016.07.028; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Wu HS, 2000, INFECT IMMUN, V68, P2979, DOI 10.1128/IAI.68.5.2979-2984.2000; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Young A, 2012, J IMMUNOL, V189, P2079, DOI 10.4049/jimmunol.1200131; Zanon RG, 2010, NEUROPATH APPL NEURO, V36, P515, DOI 10.1111/j.1365-2990.2010.01095.x; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao JC, 2016, J VIROL, V90, P7098, DOI 10.1128/JVI.00707-16; Zhao JX, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004279	254	90	96	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					891	909		10.1016/j.immuni.2017.06.012	http://dx.doi.org/10.1016/j.immuni.2017.06.012			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636958	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000403665900001
J	Agace, WW; McCoy, KD				Agace, William W.; McCoy, Kathy D.			Regionalized Development and Maintenance of the Intestinal Adaptive Immune Landscape	IMMUNITY			English	Review							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; CD103(+) DENDRITIC CELLS; SEGMENTED FILAMENTOUS BACTERIA; ISOLATED LYMPHOID FOLLICLES; NONOBESE DIABETIC MICE; CHAIN FATTY-ACIDS; ROR-GAMMA-T; INTRAEPITHELIAL LYMPHOCYTES; EARLY-LIFE	The intestinal immune system has the daunting task of protecting us from pathogenic insults while limiting inflammatory responses against the resident commensal microbiota and providing tolerance to food antigens. This role is particularly impressive when one considers the vast mucosal surface and changing landscape that the intestinal immune system must monitor. In this review, we highlight regional differences in the development and composition of the adaptive immune landscape of the intestine and the impact of local intrinsic and environmental factors that shape this process. To conclude, we review the evidence for a critical window of opportunity for early-life exposures that affect immune development and alter disease susceptibility later in life.	[Agace, William W.] Tech Univ Denmark DTU, Natl Vet Inst, Div Immunol & Vaccinol, DK-2800 Lyngby, Denmark; [Agace, William W.] Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14,Solvegatan 19, S-22184 Lund, Sweden; [McCoy, Kathy D.] Univ Calgary, Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Dept Physiol & Pharmacol & Calvin, Calgary, AB T2N 4N1, Canada	Technical University of Denmark; Lund University; University of Calgary	Agace, WW (corresponding author), Tech Univ Denmark DTU, Natl Vet Inst, Div Immunol & Vaccinol, DK-2800 Lyngby, Denmark.; Agace, WW (corresponding author), Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14,Solvegatan 19, S-22184 Lund, Sweden.; McCoy, KD (corresponding author), Univ Calgary, Phoebe & Joan Snyder Inst Chron Dis, Cumming Sch Med, Dept Physiol & Pharmacol & Calvin, Calgary, AB T2N 4N1, Canada.	wiag@vet.dtu.dk; kathy.mccoy@ucalgary.ca	McCoy, Kathy/ABD-5814-2021	Agace, william/0000-0003-3823-5772	Lundbeck Foundation [R155-2014-4184] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; BOLL G, 1995, SCAND J IMMUNOL, V41, P103, DOI 10.1111/j.1365-3083.1995.tb03541.x; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brown CC, 2015, EUR J IMMUNOL, V45, P1287, DOI 10.1002/eji.201344398; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; CAMERINI V, 1993, J IMMUNOL, V151, P1765; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cella M, 2015, SEMIN IMMUNOL, V27, P310, DOI 10.1016/j.smim.2015.10.002; Cheroutre H, 2004, NAT REV IMMUNOL, V4, P290, DOI 10.1038/nri1333; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; CORNES JS, 1965, GUT, V6, P225, DOI 10.1136/gut.6.3.225; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; CRAGO SS, 1984, J IMMUNOL, V132, P16; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Donaldson DS, 2015, MUCOSAL IMMUNOL, V8, P582, DOI 10.1038/mi.2014.90; El Aidy S, 2013, GUT MICROBES, V4, P118, DOI 10.4161/gmic.23362; Ericsson A, 2004, ANN NY ACAD SCI, V1029, P334, DOI 10.1196/annals.1309.014; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fischer A, 2016, GUT, V65, P1642, DOI 10.1136/gutjnl-2015-310022; Fukuyama S, 2007, IMMUNITY, V26, P393, DOI 10.1016/j.immuni.2007.04.004; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Geem D, 2014, J IMMUNOL, V193, P431, DOI 10.4049/jimmunol.1303167; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Gustafson CE, 2014, MUCOSAL IMMUNOL, V7, P467, DOI 10.1038/mi.2013.64; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Herbrand H, 2008, CRIT REV IMMUNOL, V28, P1; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hoorweg K, 2008, SEMIN IMMUNOL, V20, P164, DOI 10.1016/j.smim.2008.02.003; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Hu YJ, 2016, J AUTOIMMUN, V72, P47, DOI 10.1016/j.jaut.2016.05.001; Hu YJ, 2015, J IMMUNOL, V195, P4176, DOI 10.4049/jimmunol.1500884; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; IBRAGHIMOV AR, 1994, J EXP MED, V180, P433, DOI 10.1084/jem.180.2.433; Iiyama R, 2003, SCAND J IMMUNOL, V58, P620, DOI 10.1111/j.1365-3083.2003.01346.x; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; KAWAGUCHI M, 1993, P NATL ACAD SCI USA, V90, P8591, DOI 10.1073/pnas.90.18.8591; KETT K, 1986, J IMMUNOL, V136, P3631; KETT K, 1995, GASTROENTEROLOGY, V109, P819, DOI 10.1016/0016-5085(95)90389-5; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Kinoshita M, 2012, J IMMUNOL, V189, P2869, DOI 10.4049/jimmunol.1200420; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knoop KA, 2011, AM J PATHOL, V179, P1861, DOI 10.1016/j.ajpath.2011.06.004; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Korn LL, 2014, CELL REP, V9, P1567, DOI 10.1016/j.celrep.2014.11.006; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kusu T, 2013, J IMMUNOL, V190, P774, DOI 10.4049/jimmunol.1103067; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Lin M, 2014, MUCOSAL IMMUNOL, V7, P511, DOI 10.1038/mi.2013.68; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Livanos AE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.140, 10.1038/nmicrobiol.2016.140]; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; LUNDQVIST C, 1995, INT IMMUNOL, V7, P1473, DOI 10.1093/intimm/7.9.1473; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Martel MJ, 2009, AM J EPIDEMIOL, V169, P195, DOI 10.1093/aje/kwn309; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McDonald KG, 2012, AM J PATHOL, V180, P984, DOI 10.1016/j.ajpath.2011.11.009; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; OLEARY AD, 1986, HISTOPATHOLOGY, V10, P267, DOI 10.1111/j.1365-2559.1986.tb02481.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Pabst O, 2016, TRENDS IMMUNOL, V37, P287, DOI 10.1016/j.it.2016.03.002; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Pantazi E, 2015, J IMMUNOL, V195, P1368, DOI 10.4049/jimmunol.1500989; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Paun A, 2017, J IMMUNOL, V198, P590, DOI 10.4049/jimmunol.1601519; PLAUT AG, 1974, J CLIN INVEST, V54, P1295, DOI 10.1172/JCI107875; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Qiu Y, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4281865; Raciborski F, 2012, INT J OCCUP MED ENV, V25, P470, DOI 10.2478/S13382-012-0056-0; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Stenstad H, 2007, P NATL ACAD SCI USA, V104, P10122, DOI 10.1073/pnas.0700269104; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki H, 2002, EXP MOL PATHOL, V72, P230, DOI 10.1006/exmp.2002.2433; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Tai NW, 2016, J EXP MED, V213, P2129, DOI 10.1084/jem.20160526; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; TARKOWSKI A, 1990, IMMUNOLOGY, V71, P335; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tormo-Badia N, 2014, SCAND J IMMUNOL, V80, P250, DOI 10.1111/sji.12205; Torow N, 2015, GENOM DATA, V5, P371, DOI 10.1016/j.gdata.2015.07.009; Torow N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8725; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Turfkruyer M, 2016, MUCOSAL IMMUNOL, V9, P479, DOI 10.1038/mi.2015.114; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Velaga S, 2009, J IMMUNOL, V182, P2610, DOI 10.4049/jimmunol.0801141; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Wang XM, 2014, J EXP MED, V211, P2351, DOI 10.1084/jem.20140646; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wu W., 2016, MUCOSAL IMMUNOL; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180	189	90	95	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					532	548		10.1016/j.immuni.2017.04.004	http://dx.doi.org/10.1016/j.immuni.2017.04.004			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423335	Green Published, Bronze			2022-12-18	WOS:000399451100008
J	Calippe, B; Augustin, S; Beguier, F; Charles-Messance, H; Poupel, L; Conart, JB; Hu, SLJ; Lavalette, S; Fauvet, A; Rayes, J; Levy, O; Raoul, W; Fitting, C; Denefle, T; Pickering, MC; Harris, C; Jorieux, S; Sullivan, PM; Sahel, JA; Karoyan, P; Sapieha, P; Guillonneau, X; Gautier, EL; Sennlaub, F				Calippe, Bertrand; Augustin, Sebastien; Beguier, Fanny; Charles-Messance, Hugo; Poupel, Lucie; Conart, Jean-Baptiste; Hu, Shulong J.; Lavalette, Sophie; Fauvet, Alexandre; Rayes, Julie; Levy, Olivier; Raoul, William; Fitting, Catherine; Denefle, Thomas; Pickering, Matthew C.; Harris, Claire; Jorieux, Sylvie; Sullivan, Patrick M.; Sahel, Jose -Alain; Karoyan, Philippe; Sapieha, Przemyslaw; Guillonneau, Xavier; Gautier, Emmanuel L.; Sennlaub, Florian			Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation	IMMUNITY			English	Article							MACULAR DEGENERATION; SUBRETINAL INFLAMMATION; GENE-EXPRESSION; UP-REGULATION; SPINAL-CORD; MICROGLIA; DISEASE; MACROPHAGES; ANGIOGENESIS; ACTIVATION	Variants of the CFH gene, encoding complement factor H (CFH), show strong association with age-related macular degeneration (AMD), a major cause of blindness. Here, we used murine models of AMD to examine the contribution of CFH to disease etiology. Cfh deletion protected the mice from the pathogenic subretinal accumulation of mononuclear phagocytes (MP) that characterize AMD and showed accelerated resolution of inflammation. MP persistence arose secondary to binding of CFH to CD11b, which obstructed the homeostatic elimination of MPs from the subretinal space mediated by thrombospsondin-1 (TSP-1) activation of CD47. The AMD-associated CFH(H402) variant markedly increased this inhibitory effect on microglial cells, supporting a causal link to disease etiology. This mechanism is not restricted to the eye, as similar results were observed in a model of acute sterile peritonitis. Pharmacological activation of CD47 accelerated resolution of both subretinal and peritoneal inflammation, with implications for the treatment of chronic inflammatory disease.	[Calippe, Bertrand; Augustin, Sebastien; Beguier, Fanny; Charles-Messance, Hugo; Conart, Jean-Baptiste; Hu, Shulong J.; Lavalette, Sophie; Fauvet, Alexandre; Levy, Olivier; Raoul, William; Sahel, Jose -Alain; Guillonneau, Xavier; Sennlaub, Florian] UPMC Univ Paris 06, Sorbonne Univ, Inst Vis, INSERM,CNRS, 17 Rue Moreau, F-75012 Paris, France; [Poupel, Lucie; Gautier, Emmanuel L.] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR S 1166,Fac Med Pitie Salpetriere, 91 Blvd Hop, F-75013 Paris, France; [Rayes, Julie] Univ Paris 05, Unite Mixte Rech Sante 872, Ctr Rech Cordeliers, F-75006 Paris, France; [Pickering, Matthew C.] Imperial Coll, Ctr Complement & Inflammat Res, Dept Med, London W12 0NN, England; [Harris, Claire] Cardiff Univ, Inst Infect & Immun, Cardiff CF10 3XQ, S Glam, Wales; [Jorieux, Sylvie] LFB Biotechnol, F-59000 Lille, France; [Sullivan, Patrick M.] Duke Univ, Dept Med, Ctr Aging, Durham, NC 27710 USA; [Sullivan, Patrick M.] Duke Univ, Dept Med, Ctr Geriatr Res Educ, Durham, NC 27710 USA; [Sullivan, Patrick M.] Duke Univ, Dept Med, Ctr Clin, Durham Veteran Affairs Med Ctr, Durham, NC 27710 USA; [Denefle, Thomas; Karoyan, Philippe] Univ Paris 06, Sorbonne Univ, Lab Biomol, UMR 7203, Paris, France; [Denefle, Thomas; Karoyan, Philippe] Univ Paris 06, Sorbonne Univ, FR 2769, Paris, France; [Denefle, Thomas; Karoyan, Philippe] CNRS, UMR 7203, Paris, France; [Denefle, Thomas; Karoyan, Philippe] Ecole Normale Super, Dept Chim, F-75005 Paris, France; [Sapieha, Przemyslaw] Univ Montreal, Dept Ophthalmol, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H3T 1J4, Canada; [Fitting, Catherine] Inst Pasteur, Dept Infect & Epidemiol, Unite Cytokines & Inflammat, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Imperial College London; Cardiff University; Duke University; Duke University; Geriatric Research Education & Clinical Center; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite de Montreal; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sennlaub, F (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Inst Vis, INSERM,CNRS, 17 Rue Moreau, F-75012 Paris, France.	florian.sennlaub@inserm.fr	Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021; Conart, Jean-Baptiste/AAD-8547-2019; Denèfle, Thomas/Q-3767-2017; Raoul, William/H-2118-2018; Gautier, Emmanuel L./E-2259-2017; Sennlaub, Florian/F-2756-2017; Sahel, Jose-Alain/F-3172-2017; Beguier, Fanny/AAY-8581-2020	Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; Denèfle, Thomas/0000-0003-1342-7997; Raoul, William/0000-0002-5040-3372; Gautier, Emmanuel L./0000-0003-2976-7566; Sennlaub, Florian/0000-0003-4412-1341; Sahel, Jose-Alain/0000-0002-4831-1153; Beguier, Fanny/0000-0002-6123-2978; Poupel, Lucie/0000-0001-7015-8450; Michaelides, Michel/0000-0002-1552-7046; CHARLES-MESSANCE, Hugo/0000-0002-6627-2098; Rayes, Julie/0000-0003-0499-6880	INSERM; ANR Geno [R09099DS]; ANR MACLEAR [ANR-15-CE14-0015-01]; LABEX LIFESENSES [ANR-10-LABX-65]; ANR (Investissements d'Avenir programme [ANR-11-IDEX-0004-02]; Carnot; ERC [ERC-2007 St. G. 210345]; Association de Prevoyance Sante de ALLIANZ	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR Geno(French National Research Agency (ANR)); ANR MACLEAR(French National Research Agency (ANR)); LABEX LIFESENSES; ANR (Investissements d'Avenir programme(French National Research Agency (ANR)); Carnot; ERC(European Research Council (ERC)European Commission); Association de Prevoyance Sante de ALLIANZ	This work was supported by grants from INSERM, ANR Geno 2009 (R09099DS), ANR MACLEAR (ANR-15-CE14-0015-01), LABEX LIFESENSES [ANR-10-LABX-65] supported by the ANR (Investissements d'Avenir programme [ANR-11-IDEX-0004-02]), Carnot, and ERC starting Grant (ERC-2007 St. G. 210345), the Association de Prevoyance Sante de ALLIANZ, and a generous donation by Doris and Michael Bunte.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Appelboom G, 2011, J CLIN NEUROSCI, V18, P1439, DOI 10.1016/j.jocn.2011.04.001; Chen M, 2012, AM J PATHOL, V180, P235, DOI 10.1016/j.ajpath.2011.09.020; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Clark SJ, 2010, J BIOL CHEM, V285, P30192, DOI 10.1074/jbc.M110.103986; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Denefle T, 2016, J MED CHEM, V59, P8412, DOI 10.1021/acs.jmedchem.6b00781; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kang YH, 2012, IMMUNOBIOLOGY, V217, P455, DOI 10.1016/j.imbio.2011.10.008; Khandhadia S, 2013, OPHTHALMOLOGY, V120, P1612, DOI 10.1016/j.ophtha.2013.01.004; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Lad EM, 2015, GRAEF ARCH CLIN EXP, V253, P1941, DOI 10.1007/s00417-015-3094-z; Levy O, 2015, J NEUROSCI, V35, P13568, DOI 10.1523/JNEUROSCI.2468-15.2015; Levy O, 2015, EMBO MOL MED, V7, P211, DOI 10.15252/emmm.201404524; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Losse J, 2010, J IMMUNOL, V184, P912, DOI 10.4049/jimmunol.0901702; Luo C, 2011, MOL VIS, V17, P1588; Manna PP, 2005, J BIOL CHEM, V280, P29637, DOI 10.1074/jbc.M500922200; Martin M, 2016, IMMUNOL REV, V274, P218, DOI 10.1111/imr.12462; Mastellos D, 2004, MOL IMMUNOL, V40, P1213, DOI 10.1016/j.molimm.2003.10.019; Matsui H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.479; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Ng TF, 2009, INVEST OPHTH VIS SCI, V50, P5472, DOI 10.1167/iovs.08-2877; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Rayes J, 2014, BLOOD, V123, P121, DOI 10.1182/blood-2013-04-495853; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Schlaf G, 2001, MOL IMMUNOL, V38, P231, DOI 10.1016/S0161-5890(01)00045-1; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Tedesco D, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/230386; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Wang SJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P615, DOI 10.1001/archopthalmol.2011.1892; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wilms H, 1999, J NEUROIMMUNOL, V98, P89, DOI 10.1016/S0165-5728(99)00066-1; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zhang Z, 2012, CANCER EPIDEMIOL, V36, pE111, DOI 10.1016/j.canep.2011.11.004	54	90	93	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					261	272		10.1016/j.immuni.2017.01.006	http://dx.doi.org/10.1016/j.immuni.2017.01.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228282	Bronze, Green Submitted			2022-12-18	WOS:000396410900014
J	Zhao, F; Cannons, JL; Dutta, M; Griffiths, GM; Schwartzberg, PL				Zhao, Fang; Cannons, Jennifer L.; Dutta, Mala; Griffiths, Gillian M.; Schwartzberg, Pamela L.			Positive and Negative Signaling through SLAM Receptors Regulate Synapse Organization and Thresholds of Cytolysis	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; NATURAL-KILLER-CELLS; PROTEIN-TYROSINE-PHOSPHATASE; T-CELL; IMMUNOLOGICAL SYNAPSE; IMMUNE SYNAPSE; CYTOKINE PRODUCTION; SECRETORY DOMAIN; INFECTED CELLS; ENCODING GENE	X-linked lymphoproliferative syndrome, characterized by fatal responses to Epstein-Barr virus infection, is caused by mutations affecting the adaptor SAP, which links SLAM family receptors to downstream signaling. Although cytotoxic defects in SAP-deficient T cells are documented, the mechanism remains unclear. We show that SAP-deficient murine CD8(+) T cells exhibited normal cytotoxicity against fibrosarcoma targets, yet had impaired adhesion to and killing of B cell and low-avidity T cell targets. SAP-deficient cytotoxic lymphocytes showed specific defects in immunological synapse organization with these targets, resulting in inefficient actin clearance. In the absence of SAP, signaling through the SLAM family members Ly108 and 2B4 resulted in increased recruitment of the SHP-1 phosphatase, associated with altered SHP-1 localization and decreased activation of Src kinases at the synapse. Hence, SAP and SLAM receptors regulate positive and negative signals required for organizing the T cell:B cell synapse and setting thresholds for cytotoxicity against distinct cellular targets.	[Zhao, Fang; Griffiths, Gillian M.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Zhao, Fang; Cannons, Jennifer L.; Dutta, Mala; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Griffiths, GM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 0XY, England.	gg305@cam.ac.uk; pams@mail.nih.gov		Griffiths, Gillian/0000-0003-0434-5842; Zhao, Fang/0000-0002-5059-0833	National Human Genome Research Institute; Wellcome Trust [085880]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank J. Reilley, R. Handon, S. Wincovitch, S. Anderson, and J. Fekecs for assistance. This work was funded in part by the intramural program of the National Human Genome Research Institute and by the Wellcome Trust (085880 to G.M.G.). F.Z. was a Scholar in the NIH-Oxford-Cambridge Scholars in Biomedical Research program.	Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hislop AD, 2010, BLOOD, V116, P3249, DOI 10.1182/blood-2009-09-238832; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Li CJ, 2003, J BIOL CHEM, V278, P3852, DOI 10.1074/jbc.M206649200; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pfirsch-Maisonnas S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001309; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; RYSER JE, 1982, J IMMUNOL, V128, P1159; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Smith C, 2012, AM J TRANSPLANT, V12, P15, DOI 10.1111/j.1600-6143.2011.03863.x; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tsun A, 2011, J CELL BIOL, V192, P663, DOI 10.1083/jcb.201008140; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vyas YM, 2002, J IMMUNOL, V168, P3150, DOI 10.4049/jimmunol.168.7.3150; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	56	90	90	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					1003	1016		10.1016/j.immuni.2012.05.017	http://dx.doi.org/10.1016/j.immuni.2012.05.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22683123	Bronze, Green Accepted			2022-12-18	WOS:000306097100017
J	Powolny-Budnicka, I; Riemann, M; Tanzer, S; Schmid, RM; Hehlgans, T; Weih, F				Powolny-Budnicka, Iwona; Riemann, Marc; Taenzer, Simone; Schmid, Roland M.; Hehlgans, Thomas; Weih, Falk			ReIA and ReIB Transcription Factors in Distinct Thymocyte Populations Control Lymphotoxin-Dependent Interleukin-17 Production in gamma delta T Cells	IMMUNITY			English	Article							ESCHERICHIA-COLI INFECTION; CUTTING EDGE; PROINFLAMMATORY IL-17(+); DIFFERENTIAL REGULATION; GENE-EXPRESSION; RECEPTOR; RELA; PATHWAY; MEMBER; ALPHA	The NF-kappa B transcription factor regulates numerous immune responses but its contribution to interleukin-17 (IL-17) production by T cells is largely unknown. Here, we report that IL-17, but not interferon-gamma (IFN-gamma), production by gamma delta T cells required the NF-kappa B family members RelA and ReIB as well as the lymphotoxin-beta-receptor (LT beta R). In contrast, LT beta R-NF-kappa B signaling was not involved in the differentiation of conventional alpha beta Th17 cells. Impaired IL-17 production in ReIA- or ReIB-deficient T cells resulted in a diminished innate immune response to Escherichia coli infection. RelA controlled the expression of LT ligands in accessory thymocytes whereas ReIB, acting downstream of LT beta R, was required for the expression of ROR gamma t and ROR alpha 4 transcription factors and the differentiation of thymic precursors into gamma delta T17 cells. Thus, RelA and ReIB within different thymocyte subpopulations cooperate in the regulation of IL-17 production by gamma delta T cells and contribute to the host's ability to fight bacterial infections.	[Powolny-Budnicka, Iwona; Riemann, Marc; Taenzer, Simone; Weih, Falk] Age Res Fritz Lipmann Inst FLI, Leibniz Inst, Immunol Grp, D-07745 Jena, Germany; [Schmid, Roland M.] Klinikum Rechts Der Isar, Dept Internal Med 2, D-81675 Munich, Germany; [Hehlgans, Thomas] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany; [Weih, Falk] Univ Jena, Fac Biol & Pharmacol, D-07743 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technical University of Munich; University of Regensburg; Friedrich Schiller University of Jena	Weih, F (corresponding author), Age Res Fritz Lipmann Inst FLI, Leibniz Inst, Immunol Grp, Beutenbergstr 11, D-07745 Jena, Germany.	fweih@fli-leibniz.de			Deutsche Forschungsgemeinschaft [SFB 604, C8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge E. Meier and A. Gompf for excellent technical assistance. We want to express our gratitude to A. Taubner, T. Kamradt, and K. Shibata for critical technical information and suggestions. We thank D. Weih for comments and H. Rosemann in the animal facility of the FLI. We are indebted to K. Pfeffer for Ltbr<SUP>-/-</SUP>, M. Lohoff for Irf4<SUP>-/-</SUP>, S. Rose-John for II6<SUP>-/-</SUP>, M. Leppkes from the laboratory of C. Becker for Rorc<SUP>-/-</SUP>, and H. Korner for Tnf<SUP>-/-</SUP>,Lta<SUP>-/-</SUP> mice as well as J.D. Marth for Lck-cre and C.B. Wilson for Cd4-cre transgenic mice. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (grant SFB 604, C8 to M.R. and F.W.).	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; King DP, 1999, J IMMUNOL, V162, P5033; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tagawa T, 2004, J IMMUNOL, V173, P5156, DOI 10.4049/jimmunol.173.8.5156; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vallabhapurapu S, 2008, EUR J IMMUNOL, V38, P3508, DOI 10.1002/eji.200737830; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weih F, 1996, ONCOGENE, V12, P445; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	49	90	90	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					364	374		10.1016/j.immuni.2011.02.019	http://dx.doi.org/10.1016/j.immuni.2011.02.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21419662	Bronze			2022-12-18	WOS:000289014500012
J	Fooksman, DR; Schwickert, TA; Victora, GD; Dustin, ML; Nussenzweig, MC; Skokos, D				Fooksman, David R.; Schwickert, Tanja A.; Victora, Gabriel D.; Dustin, Michael L.; Nussenzweig, Michel C.; Skokos, Dimitris			Development and Migration of Plasma Cells in the Mouse Lymph Node	IMMUNITY			English	Article							IN-VIVO; AFFINITY MATURATION; BLIMP-1 EXPRESSION; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; B-LYMPHOCYTES; BONE-MARROW; RESPONSIVENESS; MICROENVIRONMENTS; DIFFERENTIATION	In this study, we imaged the differentiation and migratory behavior of nascent plasma cells (PCs) in mouse lymph nodes by intravital microscopy. Pre-PCs exhibited a unique migration pattern characterized by long, linear paths that were randomly oriented. Although chemotaxis via G alpha i coupled-receptors has been implicated in PC migration, treatment with Pertussis toxin (Ptx), which ablates these signals, did not prevent movement of pre-PCs while it arrested other lymphocytes. In vitro, pre-PCs displayed processive amoeboid locomotion on surfaces coated with integrin ligand, whereas fully differentiated PCs moved slowly or were arrested. Both PC arrest and differentiation occurred in the medullary cords. Ptx treatment before PC differentiation blocked their accumulation in the medullary cords but pre-PCs still differentiated in other lymph node regions. Taken together, we suggest pre-PCs undergo a persistent random walk to find the medullary cords, where localized chemokines help retain these cells until they undergo differentiation and arrest in situ.	[Fooksman, David R.; Dustin, Michael L.] NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; [Fooksman, David R.; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, Skirball Inst Biomol Med, New York, NY 10016 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Skokos, Dimitris] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	New York University; New York University; Howard Hughes Medical Institute; Rockefeller University; Regeneron	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA.	michael.dustin@med.nyu.edu; nussen@mail.rockefeller.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019; Victora, Gabriel/C-5946-2011	Dustin, Michael/0000-0003-4983-6389; Schwickert, Tanja/0000-0002-3371-2376; Victora, Gabriel/0000-0001-8807-348X	National Institutes of Health [R01AI072529, R56AI44931, CA009161-34]; Schering fellowship; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072529, R56AI044931, R01AI055037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schering fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank E. Meffre for Blimp-1-YFP mice, T. Starr for making ICAM-1 reagents, and the EM facility at Rockefeller University for help preparing and imaging cells. This work was supported by National Institutes of Health grants R01AI072529 (M.C.N. and M.L.D.), R56AI44931 (M.L.D.), and CA009161-34 (D.R.F.) and a Schering fellowship (T.S.).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Friedrich BM, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026007; GEUZE HJ, 1980, AM J ANAT, V158, P161, DOI 10.1002/aja.1001580206; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nitta T, 2008, ADV IMMUNOL, V99, P59, DOI 10.1016/S0065-2776(08)00603-2; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pabst O, 2005, J IMMUNOL, V174, P7492, DOI 10.4049/jimmunol.174.12.7492; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wehrli N, 2001, EUR J IMMUNOL, V31, P609, DOI 10.1002/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9; Williams A, 2008, NUCLEIC ACIDS RES, V36, P2320, DOI 10.1093/nar/gkn085; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Zygourakis K, 1996, Tissue Eng, V2, P1, DOI 10.1089/ten.1996.2.1	39	90	91	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					118	127		10.1016/j.immuni.2010.06.015	http://dx.doi.org/10.1016/j.immuni.2010.06.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20619695	Green Accepted, Bronze			2022-12-18	WOS:000280418100015
J	Mingueneau, M; Roncagalli, R; Gregoire, C; Kissenpfennig, A; Miazek, A; Archambaud, C; Wang, Y; Perrin, P; Bertosio, E; Sansoni, A; Richelme, S; Locksley, RM; Aguado, E; Malissen, M; Malissen, B				Mingueneau, Michael; Roncagalli, Romain; Gregoire, Claude; Kissenpfennig, Adrien; Miazek, Arkadiusz; Archambaud, Cristel; Wang, Ying; Perrin, Pierre; Bertosio, Elodie; Sansoni, Amandine; Richelme, Sylvie; Locksley, Richard M.; Aguado, Enrique; Malissen, Marie; Malissen, Bernard			Loss of the LAT Adaptor Converts Antigen-Responsive T Cells into Pathogenic Effectors that Function Independently of the T Cell Receptor	IMMUNITY			English	Article							MEDIATED SIGNALING PATHWAYS; REDOX BALANCE ALTERATIONS; LYMPHOPROLIFERATIVE DISORDER; TYPE-2 IMMUNITY; IN-VIVO; MICE; ACTIVATION; MUTATION; ASSOCIATION; HOMEOSTASIS	Despite compromised T cell antigen receptor (TCR) signaling, mice in which tyrosine 136 of the adaptor linker for activation of T cells (LAT) was constitutively mutated (Lat(Y136F) mice) accumulate CD4(+) T cells that trigger autoimmunity and inflammation. Here we show that equipping postthymic CD4(+) T cells with LATY136F molecules or rendering them deficient in LAT molecules triggers a lymphoproliferative disorder dependent on prior TCR engagement. Therefore, such disorders required neither faulty thymic T cell maturation nor LATY136F molecules. Unexpectedly, in CD4(+) T cells recently deprived of LAT, the proximal triggering module of the TCR induced a spectrum of protein tyrosine phosphorylation that largely overlapped the one observed in the presence of LAT. The fact that such LAT-independent signals result in lymphoproliferative disorders with excessive cytokine production demonstrates that LAT constitutes a key negative regulator of the triggering module and of the LAT-independent branches of the TCR signaling cassette.	[Mingueneau, Michael; Roncagalli, Romain; Gregoire, Claude; Kissenpfennig, Adrien; Miazek, Arkadiusz; Archambaud, Cristel; Wang, Ying; Perrin, Pierre; Bertosio, Elodie; Sansoni, Amandine; Richelme, Sylvie; Aguado, Enrique; Malissen, Marie; Malissen, Bernard] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; [Mingueneau, Michael; Roncagalli, Romain; Gregoire, Claude; Kissenpfennig, Adrien; Miazek, Arkadiusz; Archambaud, Cristel; Wang, Ying; Perrin, Pierre; Bertosio, Elodie; Sansoni, Amandine; Richelme, Sylvie; Aguado, Enrique; Malissen, Marie; Malissen, Bernard] INSERM, U631, F-13288 Marseille 9, France; [Mingueneau, Michael; Roncagalli, Romain; Gregoire, Claude; Kissenpfennig, Adrien; Miazek, Arkadiusz; Archambaud, Cristel; Wang, Ying; Perrin, Pierre; Bertosio, Elodie; Sansoni, Amandine; Richelme, Sylvie; Aguado, Enrique; Malissen, Marie; Malissen, Bernard] CNRS, UMR6102, F-13288 Marseille 9, France; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malissen, B (corresponding author), Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Roncagalli, Romain/ABB-8786-2020; Aguado, Enrique/L-4908-2014; Archambaud, Cristel/AAZ-8966-2021; Mingueneau, Michael/O-5313-2019; Malissen, Bernard/AAK-4659-2020	Aguado, Enrique/0000-0002-7232-2661; Archambaud, Cristel/0000-0002-6237-0109; Mingueneau, Michael/0000-0002-3873-7329; Malissen, Marie/0000-0003-2331-1445; Kissenpfennig, Adrien/0000-0002-9633-3111; Miazek, Arkadiusz/0000-0002-7210-2706; Malissen, Bernard/0000-0003-1340-9342; Roncagalli, Romain/0000-0001-7554-0552	CNRS; INSERM; European Communities; ANR; ARC; FRM; Ecole Normale Superieure and ARC; EMBO	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Communities(European Commission); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Ecole Normale Superieure and ARC; EMBO(European Molecular Biology Organization (EMBO))	We thank H. Acha-Orbea, S. Chevrier, L. Ardouin, A.M. Schmitt-Verhulst, S. Yamasaki, J. Leibold, and L. Leserman for discussions, R. Perlmutter and T. Mak for mice, and P. Grenot, M. Barad, and A. Gillet for advice. Supported by CNRS, INSERM, European Communities (MASTERSWITCH and SYBILLA Integrating Projects, MUGEN Network of Excellence), ANR (Plate-forme Technologique du Vivant IBISA), ARC, FRM, and by doctoral fellowships from Ecole Normale Superieure and ARC (M. Mingueneau) and postdoctoral fellowships from FRM (C.A. and E.A.) and EMBO (R.R.).	ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Archambaud C, 2009, J IMMUNOL, V182, P2680, DOI 10.4049/jimmunol.0803257; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Genton C, 2006, J IMMUNOL, V177, P2285, DOI 10.4049/jimmunol.177.4.2285; Gringhuis SI, 2002, MOL CELL BIOL, V22, P400, DOI 10.1128/MCB.22.2.400-411.2002; Gringhuis SI, 2000, J IMMUNOL, V164, P2170, DOI 10.4049/jimmunol.164.4.2170; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Kabouridis PS, 2003, BIOCHEM J, V371, P907, DOI 10.1042/BJ20021578; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Martin B, 2004, J IMMUNOL, V172, P3391, DOI 10.4049/jimmunol.172.6.3391; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yamasaki S, 2003, MOL CELL BIOL, V23, P2515, DOI 10.1128/MCB.23.7.2515-2529.2003; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	42	90	92	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					197	208		10.1016/j.immuni.2009.05.013	http://dx.doi.org/10.1016/j.immuni.2009.05.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19682930	Bronze			2022-12-18	WOS:000269338600007
J	Coffey, F; Alabyev, B; Manser, T				Coffey, Francis; Alabyev, Boris; Manser, Tim			Initial Clonal Expansion of Germinal Center B Cells Takes Place at the Perimeter of Follicles	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; IN-SITU; (4-HYDROXY-3-NITROPHENYL)ACETYL; ACTIVATION; AFFINITY; ANTIGEN; REGION; VISUALIZATION; EXPRESSION; MIGRATION	Current models of the germinal center (GC) response propose that after stimulation at the edges of T cell zones, pre-GC B cells directly migrate to the center of follicles and proliferate to form GCs. We followed the interrelationship of proliferation, differentiation, and microenvironmental locale in populations of pre-GC B cells responding to antigen. In contrast to the predictions of current models, after accumulation at the T-B interface, these cells appeared at the perimeter of follicles adjacent to the marginal zone. There, they rapidly proliferated for several days but underwent no V gene hypermutation and little heavy-chain class switching. Their chemokine receptor expression pattern indicated that these cells were sessile, yet they had begun to acquire many phenotypic characteristics of GC B cells. The expanded clones were subsequently observed in the center of follicles, suggesting that GCs are created by coalescence of B cells from this follicular perimeter response.	[Coffey, Francis; Alabyev, Boris; Manser, Tim] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Manser, T (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	manser@mail.jci.tju.edu			National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038965, R01AI046806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Fenn for technical assistance and all members of the Manser laboratory for their indirect contributions to this work. We also thank W. Jankowski of the Kimmel Cancer Center Bioimaging Facility, the Kimmel Cancer Center Flow Cytometry Facility, and M. Curtis of the Department of Pathology at Thomas Jefferson University for technical assistance with microdissection. This study was supported by grants from the National Institutes of Health to T.M.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; CASSON LP, 1995, J EXP MED, V182, P743, DOI 10.1084/jem.182.3.743; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; CLARK EA, 1991, ANNU REV IMMUNOL, V9, P97; COHN M, 1972, CELL IMMUNOL, V5, P1, DOI 10.1016/0008-8749(72)90079-2; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Flenghi L, 1996, AM J PATHOL, V148, P1543; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Haynes NM, 2008, TISSUE ANTIGENS, V71, P97, DOI 10.1111/j.1399-0039.2007.00995.x; Heltemes-Harris L, 2004, J IMMUNOL, V172, P823, DOI 10.4049/jimmunol.172.2.823; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; Liu XH, 2007, J IMMUNOL, V178, P5035, DOI 10.4049/jimmunol.178.8.5035; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Notidis E, 2002, IMMUNITY, V17, P317, DOI 10.1016/S1074-7613(02)00392-8; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; ROTHSTEIN TL, 1983, MOL IMMUNOL, V20, P161, DOI 10.1016/0161-5890(83)90127-X; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shlomchik MJ, 1989, PROG IMMUNOL, VVII, P415; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; Vora KA, 1999, J IMMUNOL, V163, P4315; Vora KA, 1998, J IMMUNOL, V160, P728; Wiens GD, 1998, IMMUNOL REV, V162, P197, DOI 10.1111/j.1600-065X.1998.tb01442.x; Winter DB, 1998, IMMUNOL REV, V162, P89, DOI 10.1111/j.1600-065X.1998.tb01432.x; WYSOCKI LJ, 1981, EUR J IMMUNOL, V11, P832, DOI 10.1002/eji.1830111016	47	90	90	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					599	609		10.1016/j.immuni.2009.01.011	http://dx.doi.org/10.1016/j.immuni.2009.01.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19303334	Bronze, Green Accepted			2022-12-18	WOS:000265319000016
J	Koehler, F; Hug, E; Eschbach, C; Meixlsperger, S; Hobeika, E; Kofer, J; Wardemann, H; Jumaa, H				Koehler, Fabian; Hug, Eva; Eschbach, Cathrin; Meixlsperger, Sonja; Hobeika, Elias; Kofer, Juliane; Wardemann, Hedda; Jumaa, Hassan			Autoreactive B Cell Receptors Mimic Autonomous Pre-B Cell Receptor Signaling and Induce Proliferation of Early B Cells	IMMUNITY			English	Article							SURROGATE-LIGHT-CHAIN; ANTI-DNA ANTIBODIES; V-H REPLACEMENT; POSITIVE SELECTION; DEVELOPMENTAL-STAGE; TRANSGENIC MICE; SELF-ANTIGEN; IMMUNOGLOBULIN; TOLERANCE; GENE	The majority of early immature B cells express autoreactive B cell receptors (BCRs) that are, according to the current view, negatively selected to avoid the production of self-reactive antibodies. Here, we show that polyreactive BCRs, which recognize multiple self-antigens, induced autonomous signaling and selective expansion of B cell precursors in a manner comparable to the pre-BCR. We found that the pre-BCR was capable of recognizing multiple self-antigens and that a signaling-deficient pre-BCR lacking the non-Ig region of the surrogate-light-chain component lambda 5 was rescued by the complementarity-determining region 3 derived from heavy chains of polyreactive receptors. Importantly, bone marrow B cells from mice carrying Ig transgenes for an autoreactive BCR showed increased cell-cycle activity, which could not be detected in cells lacking the transgenic BCR. Together, the pre-BCR has evolved to ensure self-recognition because autoreactivity is required for positive selection of B cell precursors.	[Koehler, Fabian; Hug, Eva; Eschbach, Cathrin; Meixlsperger, Sonja; Hobeika, Elias; Jumaa, Hassan] Univ Freiburg, Dept Mol Immunol, Fac Biol, D-79108 Freiburg, Germany; [Koehler, Fabian; Hug, Eva; Eschbach, Cathrin; Meixlsperger, Sonja; Hobeika, Elias; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signalling Studies, D-79108 Freiburg, Germany; [Koehler, Fabian; Hug, Eva; Eschbach, Cathrin; Meixlsperger, Sonja; Hobeika, Elias; Jumaa, Hassan] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Kofer, Juliane; Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany	University of Freiburg; University of Freiburg; Max Planck Society; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Dept Mol Immunol, Fac Biol, D-79108 Freiburg, Germany.	jumaa@immunbio.mpg.de	hobeika, elias/AAV-6663-2021	Wardemann, Hedda/0000-0003-3921-5933	Deutsche Forschungsgemeinschaft [SFB620, SFB746]; Boehringer Ingelheim Fonds fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds fellowship(Boehringer Ingelheim)	We would like to thank M. Nussenzweig for providing materials; J. Kirberg for providing the S27 antibody; R. Pelanda and K. Rajewski for the 3-83Igl mice; I. Fidler for excellent technical assistance; and J. Wersing and A. Wuerch for help with cell sorting. This work was supported by the Deutsche Forschungsgemeinschaft (SFB620 and SFB746) and by a Boehringer Ingelheim Fonds fellowship to S.M.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CROUZIER R, 1995, J IMMUNOL, V154, P4526; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Jerne NK, 2004, EUR J IMMUNOL, V34, P1234, DOI 10.1002/eji.200425132; Julien S, 2002, J IMMUNOL, V169, P4198, DOI 10.4049/jimmunol.169.8.4198; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; King LB, 2000, IMMUNOL REV, V176, P86; Koenig-Marrony S, 2001, J IMMUNOL, V166, P1463, DOI 10.4049/jimmunol.166.3.1463; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nemazee D, 1996, J AUTOIMMUN, V9, P259, DOI 10.1006/jaut.1996.0032; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Oberdoerffer P, 2003, J EXP MED, V197, P1165, DOI 10.1084/jem.20030402; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Tze LE, 2000, J IMMUNOL, V165, P6796, DOI 10.4049/jimmunol.165.12.6796; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Wang HS, 2004, IMMUNOL REV, V197, P51, DOI 10.1111/j.0105-2896.2004.0098.x; Wang HS, 2003, J IMMUNOL, V171, P6381, DOI 10.4049/jimmunol.171.12.6381; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Zhang ZX, 2004, IMMUNOL REV, V197, P231, DOI 10.1111/j.0105-2896.2004.0107.x; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5	55	90	91	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					912	921		10.1016/j.immuni.2008.10.013	http://dx.doi.org/10.1016/j.immuni.2008.10.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19084434	Bronze			2022-12-18	WOS:000262012400011
J	Spitaler, M; Emslie, E; Wood, CD; Cantrell, D				Spitaler, M; Emslie, E; Wood, CD; Cantrell, D			Diacylglycerol and protein kinase D localization during T lymphocyte activation	IMMUNITY			English	Article							COUPLED RECEPTOR ACTIVATION; CYSTEINE-RICH DOMAIN/; TRANS-GOLGI NETWORK; IMMUNOLOGICAL SYNAPSE; PHOSPHOLIPASE-C; CELL-ACTIVATION; NUCLEAR EXPORT; D PKD; TRANSLOCATION; MEMBRANE	The serine kinase protein kinase D (PKD) has a cysteine-rich domain (CRD) that binds diacylglycerol (DAG) with high affinity. PKD is cytosolic in unstimulated T cells, but it rapidly polarizes to the immunological synapse in response to antigen/antigen presenting cells (APCs). PKD repositioning is determined by the accumulation of DAG at the immunological synapse and changes in DAG accessibility of the PKD-CRD. Unstimulated T cells are shown to have a uniform distribution of DAG at the plasma membrane, whereas after T cell activation, a gradient of DAG is created with a persistent focus of DAG at the center of the synapse. PKD is only transiently associated with the immune synapse, indicating a fine tuning of PKD responsiveness to DAG by additional regulatory mechanisms. These results reveal the immune synapse as a focal point for DAG and PKD as an immediate and dynamic DAG effector during T cell activation.	Univ Dundee, WTB, Dundee DD2 1BE, Scotland	University of Dundee	Spitaler, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, CISBIC Microscopy Facil, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	m.spitaler@imperial.ac.uk		Cantrell, Doreen/0000-0001-7525-3350; Wood, David/0000-0002-0758-0592; Spitaler, Martin/0000-0002-8833-638X				Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Diaz-Flores E, 2003, J BIOL CHEM, V278, P29208, DOI 10.1074/jbc.M303165200; Ebinu JO, 2000, BLOOD, V95, P3199; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Jones DR, 1999, J BIOL CHEM, V274, P16846, DOI 10.1074/jbc.274.24.16846; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Madani S, 2001, FASEB J, V15, P2595, DOI 10.1096/fj.01-0753int; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	49	90	93	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					535	546		10.1016/j.immuni.2006.02.013	http://dx.doi.org/10.1016/j.immuni.2006.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713972	Bronze			2022-12-18	WOS:000237970100011
J	Manoury, B; Mazzeo, D; Li, DTN; Billson, J; Loak, K; Benaroch, P; Watts, C				Manoury, B; Mazzeo, D; Li, DTN; Billson, J; Loak, K; Benaroch, P; Watts, C			Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone	IMMUNITY			English	Article							T-CELL SELECTION; CATHEPSIN-S; ANTIGEN PRESENTATION; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; CYSTEINE PROTEASES; PEPTIDE BINDING; COMPLEX; MOLECULES; PROTEOLYSIS	The invariant chain (li) chaperone for MHC class II molecules is crucial for their effective function. Equally important is its removal. Cathepsins S or L are known to be required for the final stages of li removal in different APCs, but the enzymes which initiate li processing have not been identified. Here we show that this step can be performed in B lymphocytes by asparagine endopeptidase (AEP), which targets different asparagine residues in the lumenal domain of human and mouse invariant chain. Inhibition of AEP activity slows invariant chain processing and hinders the expression of an antigenic peptide engineered to replace the groove binding region of li (CLIP). However, the initiation of li removal can also be performed by other proteases, reflecting the importance of this step.	Univ Dundee, Div Cell Biol & Immunol, Sch Life Sci, Dundee DD1 5EH, Scotland; Inst Curie, INSERM, U520, F-75005 Paris, France; Medivir UK Ltd, Cambridge CB1 9PT, England	University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Medivir	Manoury, B (corresponding author), Univ Dundee, Div Cell Biol & Immunol, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	b.manoury@dundee.ac.uk; c.watts@dundee.ac.uk		Watts, Colin/0000-0001-6183-2087; Manoury, Benedicte/0000-0001-7784-3389; Benaroch, Philippe/0000-0002-2655-0129				Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; Ashman JB, 1999, J IMMUNOL, V163, P2704; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DAVIDSON HW, 1990, J IMMUNOL, V144, P4101; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Knight AM, 1997, EMBO J, V16, P3842, DOI 10.1093/emboj/16.13.3842; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMB CA, 1992, J IMMUNOL, V148, P3478; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MORTON PA, 1995, J IMMUNOL, V154, P137; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NEWCOMB JR, 1993, J IMMUNOL, V151, P4153; NGUYEN QV, 1989, HUM IMMUNOL, V24, P153, DOI 10.1016/0198-8859(89)90056-6; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Pond L, 1999, J BIOL CHEM, V274, P18049, DOI 10.1074/jbc.274.25.18049; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; RIBERDY JM, 1994, J CELL BIOL, V125, P1225, DOI 10.1083/jcb.125.6.1225; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANT AJ, 1994, CURR OPIN IMMUNOL, V6, P57, DOI 10.1016/0952-7915(94)90034-5; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stumptner P, 1997, EMBO J, V16, P5807, DOI 10.1038/sj.emboj.7590555; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Vincent-Schneider H, 2001, J CELL SCI, V114, P323; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Xing RY, 1998, BIOCHEM J, V332, P499, DOI 10.1042/bj3320499; Zhong GM, 1996, J EXP MED, V184, P2061, DOI 10.1084/jem.184.5.2061	62	90	91	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2003	18	4					489	498		10.1016/S1074-7613(03)00085-2	http://dx.doi.org/10.1016/S1074-7613(03)00085-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705852	Bronze			2022-12-18	WOS:000182353900005
J	Green, EA; Flavell, RA				Green, EA; Flavell, RA			The temporal importance of TNF alpha expression in the development of diabetes	IMMUNITY			English	Article							INDUCIBLE GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; TRANSGENIC MICE; NOD MICE; NEONATAL TOLERANCE; CROSS-PRESENTATION; COSTIMULATOR B7-1; LOCAL EXPRESSION; TISSUE ANTIGENS	The inflammatory cytokine tumor necrosis factor alpha (TNF alpha) has been linked to the development of several autoimmune diseases. By adapting the tetracycline-regulated gene transcription system, we generated a murine model where islet-specific expression of TNF alpha could be repressed/derepressed within 48 hr following introduction/removal of tetracycline in the drinking water. Here we describe the temporal importance of TNF alpha in diabetes development in mice expressing islet-specific B7-1 and TNF alpha. We show that the duration of TNF alpha-mediated inflammation, not the putative maturity of the immune system at the time of TNF alpha expression, determines diabetes progression. Further, we have described an interval between 21 and 25 days following initiation of TNF alpha expression where the fate of islet-reactive T cells is decided.	Yale Univ, Sch Med, New Haven, CT 06520 USA; Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	fran.manzo@yale.edu			NIDDK NIH HHS [5 P30 DK47535, 1P01 DK53015, 1 R01 DK51665] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665, P01DK053015] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Balasa B, 1998, J IMMUNOL, V161, P4420; Balasa B, 1997, J IMMUNOL, V159, P4620; Bradley LM, 1999, J IMMUNOL, V162, P2511; BURKLY LC, 1990, SCIENCE, V248, P1364, DOI 10.1126/science.1694042; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; CARLOW DA, 1992, INT IMMUNOL, V4, P599, DOI 10.1093/intimm/4.5.599; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gallichan WS, 1999, J IMMUNOL, V163, P1696; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Green EA, 2000, J EXP MED, V191, P225, DOI 10.1084/jem.191.2.225; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; GUERDER S, 1994, IMMUNITY, V1, P155; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; Guerder S, 1998, J IMMUNOL, V161, P2128; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HERRATH MG, 1995, IMMUNITY, V3, P727; HERRERA PL, 1994, DIABETOLOGIA, V37, P1277; Herrera PL, 2000, P NATL ACAD SCI USA, V97, P279, DOI 10.1073/pnas.97.1.279; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Kurts C, 1999, NATURE, V398, P341, DOI 10.1038/18692; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tian J, 1998, IMMUNOL REV, V164, P119, DOI 10.1111/j.1600-065X.1998.tb01214.x; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	47	90	90	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					459	469		10.1016/S1074-7613(00)80198-3	http://dx.doi.org/10.1016/S1074-7613(00)80198-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843379	Bronze			2022-12-18	WOS:000087356400002
J	Saparov, A; Wagner, FH; Zheng, R; Oliver, JR; Maeda, H; Hockett, RD; Weaver, CT				Saparov, A; Wagner, FH; Zheng, R; Oliver, JR; Maeda, H; Hockett, RD; Weaver, CT			Interleukin-2 expression by a subpopulation of primary T cells is linked to enhanced memory/effector function	IMMUNITY			English	Article							CYTOKINE GENE-EXPRESSION; ALTERED PEPTIDE LIGANDS; INTERFERON-GAMMA; TRANSGENIC MICE; PHENOTYPE DEVELOPMENT; ANTIGEN RECEPTOR; IFN-GAMMA; IN-VIVO; ACTIVATION; HETEROGENEITY	Single cell studies have identified intraclonal heterogeneity of cytokine production by activated T cells. To investigate implications of cytokine heterogeneity for cell fate, an interleukin (IL)-2 promoter-green fluorescent protein (GFP) reporter transgenic model was developed to track IL-2(+) and IL-2(-) T cells during differentiation from naive precursors. Antigen-activated IL-2(+) and IL-2(-) cells had comparable proliferative capacities in primary responses. However, T cells that expressed IL-2 in primary responses demonstrated enhanced antigenic sensitivity and increased expression of effector cytokines in secondary responses in vitro and in vivo. Thus, heterogeneity of activation during a primary response translates into heterogeneous secondary responses, in which enhanced memory/effector function is linked to cells that previously exceeded an activation threshold associated with IL-2 gene transcription.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.			Saparov, Arman/0000-0002-4407-1236; Weaver, Casey/0000-0002-2180-1793	NCI NIH HHS [CA13148] Funding Source: Medline; NIAID NIH HHS [AI35783] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI035783, R01AI035783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BROMBACHER F, 1994, INT IMMUNOL, V6, P189, DOI 10.1093/intimm/6.2.189; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Grakoui A, 1999, J IMMUNOL, V162, P1923; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; LANG G, 1991, NUCLEIC ACIDS RES, V19, P5851, DOI 10.1093/nar/19.21.5851; MINASI LAE, 1993, J EXP MED, V177, P1451, DOI 10.1084/jem.177.5.1451; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakamura T, 1997, J IMMUNOL, V158, P1085; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rogers WO, 1997, J IMMUNOL, V158, P649; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Weaver CT, 1998, IMMUNOL RES, V17, P279, DOI 10.1007/BF02786452; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	47	90	95	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					271	280		10.1016/S1074-7613(00)80102-8	http://dx.doi.org/10.1016/S1074-7613(00)80102-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514005	Bronze			2022-12-18	WOS:000082918500002
J	Avots, A; Buttmann, M; Chuvpilo, S; Escher, C; Smola, U; Bannister, AJ; Rapp, UR; Kouzarides, T; Serfling, E				Avots, A; Buttmann, M; Chuvpilo, S; Escher, C; Smola, U; Bannister, AJ; Rapp, UR; Kouzarides, T; Serfling, E			CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation	IMMUNITY			English	Article							C-JUN; NUCLEAR FACTOR; HISTONE ACETYLTRANSFERASES; COACTIVATORS P300; PROTEIN-KINASE; DEFICIENT MICE; DNA-BINDING; MAP KINASES; CBP; DOMAIN	NF-ATc, an inducibly expressed transcription factor, controls gene expression in T lymphocytes and cardiomyocytes. We show here that the transcriptional coactivators CBP/p300 bind to and control the activity of the inducible N-terminal transactivation domain of NF-ATc, TAD-A. Similar to the N terminal transactivation domain of c-Jun, TAD-A is inducibly phosphorylated, but this phosphorylation is dispensable for the interaction with CBP/p300. Constitutive active versions of c-Raf and Rac synergistically enhance the CBP/p300-mediated increase of TAD-A activity, indicating the important role CBP/p300 plays in the integration of T cell activation signals. Since a mutation of CBP abolishing HAT activity is almost as active as wild-type CBP in T cells, functions of CBP/p300 other than histone acetylation appear to control the NF-AT-dependent transcription in T cells.	Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Med Radiat Res & Cell Biol, D-97080 Wurzburg, Germany; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England	University of Wurzburg; University of Wurzburg; University of Cambridge; University of Cambridge	Serfling, E (corresponding author), Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany.	path015@mail.uni-wuerzburg.de	Serfling, Edgar/X-7212-2019; Buttmann, Mathias/AAD-7488-2021; Buttmann, Mathias/R-7301-2019; Brunner, Cornelia/L-1291-2013; Chuvpilo, Sergey/AAD-3144-2019	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 1995, ONCOGENE, V11, P2509; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; BOWNELL JE, 1996, CELL, V84, P843; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Eckner R, 1996, BIOL CHEM, V377, P685; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hoffmeyer A, 1998, J BIOL CHEM, V273, P10112, DOI 10.1074/jbc.273.17.10112; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Janknecht R, 1996, ONCOGENE, V12, P1961; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEE CA, 1995, HAEMOPHILIA, V1, P1, DOI 10.1111/j.1365-2516.1995.tb00031.x; MARENGERE LEM, 1998, IMMUNITY, V8, P115; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; MartinezMartinez S, 1997, MOL CELL BIOL, V17, P6437, DOI 10.1128/MCB.17.11.6437; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PARK JC, 1995, J BIOL CHEM, V270, P20653, DOI 10.1074/jbc.270.35.20653; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SCHMITZ ML, 1994, BIOTECHNIQUES, V17, P714; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; WHITEHURST CE, 1995, J BIOL CHEM, V270, P5594, DOI 10.1074/jbc.270.10.5594; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	51	90	94	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1999	10	5					515	524		10.1016/S1074-7613(00)80051-5	http://dx.doi.org/10.1016/S1074-7613(00)80051-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367897	Bronze			2022-12-18	WOS:000080709400003
J	Ardouin, L; Boyer, C; Gillet, A; Trucy, J; Bernard, AM; Nunes, J; Delon, J; Trautmann, A; He, HT; Malissen, B; Malissen, M				Ardouin, L; Boyer, C; Gillet, A; Trucy, J; Bernard, AM; Nunes, J; Delon, J; Trautmann, A; He, HT; Malissen, B; Malissen, M			Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; TANDEM SH2 DOMAINS; EPSILON-RI-GAMMA; TCR ZETA-CHAIN; ANTIGEN RECEPTOR; ACTIVATION MOTIF; PLASMON RESONANCE; CYTOPLASMIC TAIL; MICE LACKING; ZAP-70	We evaluated the importance of CD3-zeta ITAMs in T cell responses by breeding the P14 transgenic TCR into mice in which CD3-zeta chains lacking all or part of their ITAMs were genetically substituted for wild-type CD3-zeta chains. In contrast to the H-Y TCR, the P14 ICR permitted the development of peripheral CD8(+) T cells harboring signaling-defective CD3-zeta subunits. The absence of functional CD3-zeta ITAMs did not reduce the spectrum of activation events and effector functions that constitute the normal attributes of mature CD8(+) T cells. The only detectable differences were quantitative and noted only when T cells were challenged with suboptimal peptide concentrations. Therefore, the ITAMs present in the CD3-gamma delta epsilon module are sufficient for qualitatively normal TCR signaling and those present in CD3-zeta have no exclusive role during T cell activation.	CNRS Marseille Luminy, Ctr Immunol, INSERM, F-13288 Marseille 9, France; CERVI, UMR CNRS 7627, Lab Immunol Cellulaire, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, M (corresponding author), CNRS Marseille Luminy, Ctr Immunol, INSERM, Case 906, F-13288 Marseille 9, France.	malissen@ciml.univ-mrs.fr	NUNES, Jacques A/F-4952-2013; HE, Hai-Tao/O-6551-2016; BATAILLE, Laurence/AAA-5535-2021; Malissen, Bernard/AAK-4659-2020	NUNES, Jacques A/0000-0003-4865-0400; HE, Hai-Tao/0000-0002-6594-290X; BATAILLE, Laurence/0000-0001-7770-2041; Malissen, Marie/0000-0003-2331-1445; Delon, Jerome/0000-0003-0222-1192; Malissen, Bernard/0000-0003-1340-9342				Bachmann MF, 1998, EUR J IMMUNOL, V28, P3110; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; deAos I, 1997, J BIOL CHEM, V272, P25310, DOI 10.1074/jbc.272.40.25310; DONNADIEU E, 1994, J BIOL CHEM, V269, P32828; HERMANS MHA, 1993, EUR J IMMUNOL, V23, P2257, DOI 10.1002/eji.1830230931; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Jensen WA, 1997, EUR J IMMUNOL, V27, P707, DOI 10.1002/eji.1830270320; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; KOYASU S, 1994, P NATL ACAD SCI USA, V91, P6693, DOI 10.1073/pnas.91.14.6693; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; Luton F, 1997, J IMMUNOL, V158, P3140; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MOINGEON P, 1992, P NATL ACAD SCI USA, V89, P1492, DOI 10.1073/pnas.89.4.1492; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; NEUMEISTER K, 1998, SCIENCE, V281, P572; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; She J, 1998, INT IMMUNOL, V10, P1733, DOI 10.1093/intimm/10.11.1733; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; Steeg C, 1997, EUR J IMMUNOL, V27, P2233, DOI 10.1002/eji.1830270917; SunderPlassmann R, 1997, EUR J IMMUNOL, V27, P2001, DOI 10.1002/eji.1830270826; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; van Oers NSC, 1998, J IMMUNOL, V160, P163; Vely F, 1997, EUR J IMMUNOL, V27, P3010, DOI 10.1002/eji.1830271138; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	46	90	91	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1999	10	4					409	420		10.1016/S1074-7613(00)80041-2	http://dx.doi.org/10.1016/S1074-7613(00)80041-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229184	Bronze			2022-12-18	WOS:000079989600002
J	Gerwin, N; Gonzalo, JA; Lloyd, C; Coyle, AJ; Reiss, Y; Banu, N; Wang, BP; Xu, H; Avraham, H; Engelhardt, B; Springer, TA; Gutierrez-Ramos, JC				Gerwin, N; Gonzalo, JA; Lloyd, C; Coyle, AJ; Reiss, Y; Banu, N; Wang, BP; Xu, H; Avraham, H; Engelhardt, B; Springer, TA; Gutierrez-Ramos, JC			Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2-deficient mice results in extended hyperresponsiveness	IMMUNITY			English	Article							ADHESION MOLECULE-1-DEFICIENT MICE; T-CELLS; BRONCHIAL HYPERREACTIVITY; RESPIRATORY EPITHELIUM; COUNTER-RECEPTOR; MURINE MODEL; GUINEA-PIGS; IN-VITRO; INFLAMMATION; LYMPHOCYTE	ICAM-2-deficient mice exhibit prolonged accumulation of eosinophils in lung interstitium concomitant with a delayed increase in eosinophil numbers in the airway lumen during the development of allergic lung inflammation. The ICAM-2-dependent increased and prolonged accumulation of eosinophils in lung interstitium results in prolonged, heightened airway hyperresponsiveness. These findings reveal an essential role for ICAM-2 in the development of the inflammatory and respiratory components of allergic lung disease. This phenotype is caused by the lack of ICAM-2 expression on non-hematopoietic cells. ICAM-2 deficiency on endothelial cells causes reduced eosinophil transmigration in vitro. ICAM-2 is not essential for lymphocyte homing or the development of leukocytes, with the exception of megakaryocyte progenitors, which are significantly reduced.	Millennium Biotherapeut, Cambridge, MA 02139 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Max Planck Inst Physiol & Clin Res, D-61231 Bad Nauheim, Germany; Harvard Univ, Sch Med, New England Deaconess Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Beth Israel Hosp, Div Immunol, Boston, MA 02215 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Max Planck Society; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Gerwin, N (corresponding author), Millennium Biotherapeut, Cambridge, MA 02139 USA.		Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846; Avraham, Hava/0000-0002-7545-3640; Lloyd, Clare/0000-0001-8977-6726	Wellcome Trust [087618] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNAOUT MA, 1990, BLOOD, V75, P1037; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BANU N, 1995, BLOOD, V86, P1331, DOI 10.1182/blood.V86.4.1331.bloodjournal8641331; BERNAD A, 1994, BRIT J HAEMATOL, V87, P6, DOI 10.1111/j.1365-2141.1994.tb04863.x; BOYCE JA, 1995, J EXP MED, V182, P49, DOI 10.1084/jem.182.1.49; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; Djukanovic R, 1996, J ALLERGY CLIN IMMUN, V98, pS41, DOI 10.1016/S0091-6749(96)80127-8; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gelfand EW, 1997, NAT MED, V3, P382, DOI 10.1038/nm0497-382; GLEICH GJ, 1988, J ALLERGY CLIN IMMUN, V81, P776, DOI 10.1016/0091-6749(88)90931-1; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719; HONG X, 1992, J IMMUNOL, V149, P2650; HOWARTH PH, 1994, AM J RESP CRIT CARE, V150, pS18, DOI 10.1164/ajrccm/150.5_Pt_2.S18; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lefort J, 1996, J CLIN INVEST, V97, P1117, DOI 10.1172/JCI118505; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MARTIN DR, 1989, J EXP MED, V170, P679, DOI 10.1084/jem.170.3.679; Mendelson J., 1995, Blood, V86, p674A; NGUYEN C, 1995, GENOMICS, V29, P207, DOI 10.1006/geno.1995.1233; RESNICK MB, 1993, AM J RESP CELL MOL, V8, P349, DOI 10.1165/ajrcmb/8.4.349; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; Schmitz H, 1997, PHILOS RUNDSCH, V44, P90; Soriano SG, 1996, ANN NEUROL, V39, P618, DOI 10.1002/ana.410390511; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95	42	90	92	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					9	19		10.1016/S1074-7613(00)80002-3	http://dx.doi.org/10.1016/S1074-7613(00)80002-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023766	Bronze			2022-12-18	WOS:000078428700002
J	Mueller, R; Bradley, LM; Krahl, T; Sarvetnick, N				Mueller, R; Bradley, LM; Krahl, T; Sarvetnick, N			Mechanism underlying counterregulation of autoimmune diabetes by IL-4	IMMUNITY			English	Article							GLUTAMIC-ACID DECARBOXYLASE; T-CELL TOLERANCE; NOD MICE; CLONAL ELIMINATION; CYCLOPHOSPHAMIDE; EXPRESSION; INSULITIS; RECEPTOR; INTERLEUKIN-4; ANTIBODY	Diabetes in nonobese diabetic (NOD) mice is an autoimmune disease characterized by the destruction of the beta cells in the pancreas. We have previously reported that transgenic expression of interleukin-4 (IL-4) counterregulates the disease process, completely protecting NOD mice from insulitis and diabetes. Here we demonstrate the presence of autoreactivity but lack of pathogenicity of the IL-4-regulated lymphocytes. the importance of T cell diversity for the protective effect of IL-4 is demonstrated through breeding with transgenic BDC2.5 mice, which have an almost exclusively monoclonal T cell repertoire. Limitation of T cell diversity abrogated the protection by IL-4. We suggest that ''immune deviation'' in NOD-IL-4 mice is mediated by the pancreatic tissue itself, which causes activation of distinct, nonpathogenic T cell specificities.	Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Scripps Research Institute					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029764] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 29764] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Fanger NA, 1997, J IMMUNOL, V158, P3090; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; HAYWARD AR, 1989, J IMMUNOL, V143, P1555; HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; MILLER BJ, 1988, J IMMUNOL, V140, P52; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Mueller R, 1997, LAB INVEST, V76, P117; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; PANKEWYCZ O, 1991, EUR J IMMUNOL, V21, P873, DOI 10.1002/eji.1830210403; PANKEWYCZ OG, 1992, EUR J IMMUNOL, V22, P2017, DOI 10.1002/eji.1830220810; PARISH NM, 1993, DIABETES, V42, P1601, DOI 10.2337/diabetes.42.11.1601; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; ROTHE H, 1994, DIABETOLOGIA, V37, P1154, DOI 10.1007/BF00418380; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TSICH R, 1996, CELL, V85, P291; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855	29	90	90	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					411	418		10.1016/S1074-7613(00)80362-3	http://dx.doi.org/10.1016/S1074-7613(00)80362-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324361	Bronze			2022-12-18	WOS:A1997XY83000010
J	BIKOFF, EK; GERMAIN, RN; ROBERTSON, EJ				BIKOFF, EK; GERMAIN, RN; ROBERTSON, EJ			ALLELIC DIFFERENCES AFFECTING INVARIANT CHAIN DEPENDENCY OF MHC CLASS-II SUBUNIT ASSEMBLY	IMMUNITY			English	Article							CELL-SURFACE EXPRESSION; ALPHA-BETA-HETERODIMERS; HLA-DR MOLECULES; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; PEPTIDE-BINDING; IA ANTIGENS; T-CELL; B-CELL; HISTOCOMPATIBILITY ANTIGENS	The conserved invariant chain associates with highly polymorphic alpha and beta subunits guiding class II transport through the secretory pathway. Early associations of these three polypeptides inside antigen-presenting cells are poorly understood. The present experiments provide a detailed picture of the structure and fate of class II alpha and beta subunits in invariant chain mutants possessing different MHC haplotypes. In the absence of invariant chain, A alpha(b)A beta(b) is predominantly expressed as free A alpha(b) and A beta(b) chains by both splenocytes and activated LPS/IL-4 blasts, confirming that A alpha(b)A beta(b) assembly is strongly dependent on invariant chain coexpression. A quite different situation exists with respect to other allelic products. In the absence of invariant chain, A alpha(a)A beta(b), E alpha(k)E beta(k), and A alpha(a)A beta(d) molecules assemble efficiently and are conformationally similar to mature wild-type heterodimers. The contribution of invariant chain to subunit assembly thus differs for allelic variants, suggesting that sequential associations of alpha, beta, and invariant chain may be affected by polymorphic differences.	NIAID,IMMUNOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	BIKOFF, EK (corresponding author), HARVARD UNIV,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138, USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019047, R37AI019047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-19047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; BAAKE O, 1990, CELL, V63, P707; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BIJLMAKERS MJE, 1993, EUR J IMMUNOL, V23, P1305, DOI 10.1002/eji.1830230618; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BIKOFF EK, 1992, J IMMUNOL, V149, P1; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; BRAUNSTEIN NS, 1990, J IMMUNOL, V145, P1635; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUERSTEDDE JM, 1988, J EXP MED, V168, P823, DOI 10.1084/jem.168.3.823; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; DORNMAIR K, 1990, P NATL ACAD SCI USA, V87, P4134, DOI 10.1073/pnas.87.11.4134; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GERMAIN RN, 1985, CELL, V43, P233, DOI 10.1016/0092-8674(85)90028-5; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; HEDLEY ML, 1994, P NATL ACAD SCI USA, V91, P10479, DOI 10.1073/pnas.91.22.10479; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JANEWAY CA, 1984, J IMMUNOL, V132, P662; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KARP DR, 1990, J EXP MED, V171, P615, DOI 10.1084/jem.171.3.615; KOCH N, 1982, EUR J IMMUNOL, V12, P909, DOI 10.1002/eji.1830121103; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMB CA, 1992, J IMMUNOL, V148, P3478; LANDAIS D, 1986, J IMMUNOL, V137, P3002; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LEMEUR M, 1989, J IMMUNOL, V142, P323; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MURPHY DB, 1992, J IMMUNOL, V148, P3483; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; NIJENHUIS M, 1994, EUR J IMMUNOL, V24, P247, DOI 10.1002/eji.1830240139; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1980, J IMMUNOL, V124, P533; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; PIERRES M, 1981, IMMUNOGENETICS, V14, P481, DOI 10.1007/BF00350120; POLLA BS, 1986, P NATL ACAD SCI USA, V83, P4878, DOI 10.1073/pnas.83.13.4878; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANT AJ, 1987, P NATL ACAD SCI USA, V84, P8065, DOI 10.1073/pnas.84.22.8065; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SANT AJ, 1989, CELL, V57, P797, DOI 10.1016/0092-8674(89)90794-0; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z	92	90	92	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1995	2	3					301	310		10.1016/1074-7613(95)90054-3	http://dx.doi.org/10.1016/1074-7613(95)90054-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7697546	Bronze			2022-12-18	WOS:A1995QP27600009
J	YOON, ST; DIANZANI, U; BOTTOMLY, K; JANEWAY, CA				YOON, ST; DIANZANI, U; BOTTOMLY, K; JANEWAY, CA			BOTH HIGH AND LOW AVIDITY ANTIBODIES TO THE T-CELL RECEPTOR CAN HAVE AGONIST OR ANTAGONIST ACTIVITY	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; MONOCLONAL-ANTIBODY; PHYSICAL ASSOCIATION; NEGATIVE SIGNAL; ACCESSORY CELLS; CROSS-LINKING; ACTIVATION; CD4; MHC; RECOGNITION	Anti-TCR antibodies can activate or block the activation of T cells. In the present experiments, we have shown that different monoclonal antibodies to the same TCR can have either agonist or antagonist activity, and we have examined the relationship between these functional effects and the avidity of the antibody for the TCR. We show here that it is not the avidity of an anti-TCR antibody that determines whether it acts as an agonist or an antagonist. Moreover, we show that monovalent Fab fragments of agonist antibodies produce detectable changes in T cell behavior. These data suggest that T cell activation may involve not just aggregation of the TCR but also some induced change in individual ligated receptors, and that agonists may produce this change while antagonists do not. We argue that similar effects may apply to peptide-MHC ligands as well.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; Yale University			Dianzani, Umberto/K-1952-2016	DIANZANI, Umberto/0000-0001-6723-3931	NIAID NIH HHS [AI-14579] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1993, J IMMUNOL, V150, P1; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BANK I, 1985, J EXP MED, V162, P1294, DOI 10.1084/jem.162.4.1294; BEKOFF M, 1985, J IMMUNOL, V134, P1337; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; DIANZANI U, 1992, J IMMUNOL, V148, P678; DIANZANI U, 1992, INT IMMUNOL, V4, P995, DOI 10.1093/intimm/4.9.995; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JANEWAY CA, 1989, COLD SH Q B, V54, P657; Janeway Charles A. Jr., 1992, Current Biology, V2, P591, DOI 10.1016/0960-9822(92)90163-5; KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9; KAYE J, 1984, J IMMUNOL, V133, P1339; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; MANNIE MD, 1991, J THEOR BIOL, V151, P169, DOI 10.1016/S0022-5193(05)80360-1; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; NAKAGAWA TY, 1991, EUR J IMMUNOL, V21, P2851, DOI 10.1002/eji.1830211129; PORTOLES P, 1989, J MOL CELL IMMUNOL, V4, P129; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; ROJO JM, 1988, J IMMUNOL, V140, P1081; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; ROJO JM, 1989, EUR J IMMUNOL, V19, P2061, DOI 10.1002/eji.1830191114; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; STAERZ UD, 1985, J IMMUNOL, V134, P3994; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; TITE JP, 1986, J MOL CELL IMMUNOL, V2, P179; WASSMER P, 1985, J IMMUNOL, V135, P2237; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WOLFF H, 1992, J IMMUNOL, V149, P2996	39	90	95	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					563	569						7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600285				2022-12-18	WOS:A1994PN12700005
J	Ni, J; Wang, X; Stojanovic, A; Zhang, Q; Wincher, M; Buhler, L; Arnold, A; Correia, MP; Winkler, M; Koch, PS; Sexl, V; Hofer, T; Cerwenka, A				Ni, Jing; Wang, Xi; Stojanovic, Ana; Zhang, Qin; Wincher, Marian; Buehler, Lea; Arnold, Annette; Correia, Margareta P.; Winkler, Manuel; Koch, Philipp-Sebastian; Sexl, Veronika; Hoefer, Thomas; Cerwenka, Adelheid			Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1 alpha Unleashes NK Cell Activity	IMMUNITY			English	Article							IFN-GAMMA; ACTIVATION; ACCUMULATION; RESISTANCE; INFLAMMATION; EXPRESSION; GROWTH	Enhancing immune cell functions in tumors remains a major challenge in cancer immunotherapy. Hypoxia is a common feature of solid tumors, and cells adapt by upregulating the transcription factor HIF-1 alpha. Here, we defined the transcriptional landscape of mouse tumor-infiltrating natural killer (NK) cells by using single-cell RNA sequencing. Conditional deletion of Hif1a in NK cells resulted in reduced tumor growth, elevated expression of activation markers, effector molecules, and an enriched NF-kappa B pathway in tumor-infiltrating NK cells. Interleukin-18 (IL-18) from myeloid cells was required for NF-kappa B activation and the enhanced anti-tumor activity of Hif1a(-/-) NK cells. Extended culture with an HIF-1 alpha inhibitor increased human NK cell responses. Low HIF1A expression was associated with high expression of IFNG in human tumor-infiltrating NK cells, and an enriched NK-IL18-IFNG signature in solid tumors correlated with increased overall patient survival. Thus, inhibition of HIF-1 alpha unleashes NK cell anti-tumor activity and could be exploited for cancer therapy.	[Ni, Jing; Stojanovic, Ana; Wincher, Marian; Correia, Margareta P.; Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Innate Immunosci MI3, Dept Immunobiochem, D-68167 Mannheim, Germany; [Ni, Jing; Stojanovic, Ana; Buehler, Lea; Arnold, Annette; Correia, Margareta P.; Cerwenka, Adelheid] German Canc Res Ctr, Innate Immun, D-69120 Heidelberg, Germany; [Wang, Xi; Zhang, Qin; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Winkler, Manuel; Koch, Philipp-Sebastian] Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venereol & Allergol, D-68167 Mannheim, Germany; [Winkler, Manuel; Koch, Philipp-Sebastian] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany; [Winkler, Manuel; Koch, Philipp-Sebastian] Ctr Excellence Dermatol, D-68167 Mannheim, Germany; [Sexl, Veronika] Univ Vet Med, Inst Pharmacol & Toxicol, Dept Biomed Sci, A-1210 Vienna, Austria; [Koch, Philipp-Sebastian; Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Veterinary Medicine Vienna; Ruprecht Karls University Heidelberg	Cerwenka, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Innate Immunosci MI3, Dept Immunobiochem, D-68167 Mannheim, Germany.; Cerwenka, A (corresponding author), German Canc Res Ctr, Innate Immun, D-69120 Heidelberg, Germany.; Cerwenka, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, D-68167 Mannheim, Germany.	adelheid.cerwenka@medma.uni-heidelberg.de	Winkler, Manuel/U-6698-2019; Correia, Margareta P./ABA-8530-2020; Wang, Xi/N-9527-2014; Höfer, Thomas/G-5665-2013	Winkler, Manuel/0000-0003-2415-9350; Wang, Xi/0000-0002-7572-6354; Höfer, Thomas/0000-0003-3560-8780; Correia, Margareta/0000-0003-4378-0820; Cerwenka, Adelheid/0000-0001-6977-3536; Stojanovic, Ana/0000-0001-9503-2256	German Research Foundation [SFB1366, 394046768-SFB 1366, SPP 1937 (CE 140/2-2), TRR179 (TP07), SFB-TRR156 (B10N), RTG 2099, 259332240-RTG2099]; European Commission [H2020-MSCA-MC-ITN-765104-MATURE-NK]; German Cancer Aid [70112233, 111455]	German Research Foundation(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); German Cancer Aid(Deutsche Krebshilfe)	We thank the Animal Laboratory Services of the German Cancer Research Center (DKFZ) and the Medical Faculty Mannheim, University of Heidelberg (UMM), for animal care; the DKFZ Flow Cytometry core facility and UMM cell sorting core facility for cell sorting; the DKFZ Genomics and Proteomics core facility for Illumina Hiseq 4000 service; Roche Diagnostics for kindly providing the anti-VEGFA mAb; Ralph Schulz and Martina Seiffert (DKFZ) for providing the Myd88<SUP>-/</SUP>-mice; Katrin Busch and Hans-Reimer Rodewald for providing Rag2<SUP>-/-</SUP> Il2rg<SUP>-/-</SUP> mice; Petra Bugert and Julia Mergenthaler for technical support; and Jens Pahl for critical reading of the manuscript. This project was supported by grants from the German Research Foundation: SFB1366 (project number 394046768-SFB 1366; C02 to A.C., B2 to P.-S.K.), SPP 1937 (CE 140/2-2 to A.S. and A.C.), TRR179 (TP07 to A.C.), SFB-TRR156 (B10N to A.C.), and RTG 2099 (project number 259332240-RTG2099; P9 to A.C., P5 to P.-S.K.); a network grant of the European Commission (H2020-MSCA-MC-ITN-765104-MATURE-NK); and by the German Cancer Aid (project 70112233 to A.C. and M.C. and project 111455 to A.C.).	Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Balsamo M, 2013, EUR J IMMUNOL, V43, P2756, DOI 10.1002/eji.201343448; Bandarra D, 2015, DIS MODEL MECH, V8, P169, DOI 10.1242/dmm.017285; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Boraschi D, 2018, IMMUNOL REV, V281, P197, DOI 10.1111/imr.12606; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cataldi M, 2015, VIROLOGY, V485, P340, DOI 10.1016/j.virol.2015.08.003; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Dupaul-Chicoine J, 2015, IMMUNITY, V43, P751, DOI 10.1016/j.immuni.2015.08.013; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Galani IE, 2010, INT J CANCER, V127, P1131, DOI 10.1002/ijc.25132; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Hasmim M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00482; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayashi Y, 2019, CANCER SCI, V110, P1510, DOI 10.1111/cas.13990; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kelly JM, 2002, J IMMUNOL, V168, P4472, DOI 10.4049/jimmunol.168.9.4472; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Krzywinska E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01599-w; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Markowitz GJ, 2016, CANCER RES, V76, P2394, DOI 10.1158/0008-5472.CAN-15-1548; MCCOY JL, 1967, CANCER RES, V27, P1743; Miyake T, 2010, P NATL ACAD SCI USA, V107, P17680, DOI 10.1073/pnas.1012977107; Nakamura K, 2018, CANCER CELL, V33, P634, DOI 10.1016/j.ccell.2018.02.007; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Palazon A, 2017, CANCER CELL, V32, P669, DOI 10.1016/j.ccell.2017.10.003; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Parodi M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02358; Raulet DH, 2017, IMMUNOL REV, V280, P93, DOI 10.1111/imr.12600; Rocca YS, 2013, INNATE IMMUN-LONDON, V19, P76, DOI 10.1177/1753425912453187; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Song QQ, 2019, CANCER MED-US, V8, P3072, DOI 10.1002/cam4.2113; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Velasquez SY, 2016, J BIOL CHEM, V291, P12960, DOI 10.1074/jbc.M116.721753; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Yang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11947-7; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0	58	89	91	5	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1075	+		10.1016/j.immuni.2020.05.001	http://dx.doi.org/10.1016/j.immuni.2020.05.001			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32445619	Bronze			2022-12-18	WOS:000541890000019
J	Pauthner, MG; Nkolola, JP; Havenar-Daughton, C; Murrell, B; Reiss, SM; Bastidas, R; Prevost, J; Nedellec, R; von Bredow, B; Abbink, P; Cottrell, CA; Kulp, DW; Tokatlian, T; Nogal, B; Bianchi, M; Li, H; Lee, JH; Butera, ST; Evans, DT; Hangartner, L; Finzi, A; Wilson, IA; Wyatt, RT; Irvine, DJ; Schief, WR; Ward, AB; Sanders, RW; Crotty, S; Shaw, GM; Barouch, DH; Burton, DR				Pauthner, Matthias G.; Nkolola, Joseph P.; Havenar-Daughton, Colin; Murrell, Ben; Reiss, Samantha M.; Bastidas, Raiza; Prevost, Jeremie; Nedellec, Rebecca; von Bredow, Benjamin; Abbink, Peter; Cottrell, Christopher A.; Kulp, Daniel W.; Tokatlian, Talar; Nogal, Bartek; Bianchi, Matteo; Li, Hui; Lee, Jeong Hyun; Butera, Salvatore T.; Evans, David T.; Hangartner, Lars; Finzi, Andres; Wilson, Ian A.; Wyatt, Richard T.; Irvine, Darrell J.; Schief, William R.; Ward, Andrew B.; Sanders, Rogier W.; Crotty, Shane; Shaw, George M.; Barouch, Dan H.; Burton, Dennis R.			Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-MEDIATED CYTOTOXICITY; HIV-1 ENVELOPE TRIMERS; RHESUS MACAQUES; T-CELLS; INFECTION; REPLICATION; TYPE-1; IMMUNIZATION; RESPONSES	Passive administration of HIV neutralizing antibodies (nAbs) can protect macaques from hard-to-neutralize (tier 2) chimeric simian-human immunodeficiency virus (SHIV) challenge. However, conditions for nAb-mediated protection after vaccination have not been established. Here, we selected groups of 6 rhesus macaques with either high or low serum nAb titers from a total of 78 animals immunized with recombinant native-like (SOSIP) Env trimers. Repeat intrarectal challenge with homologous tier 2 SHIVBG505 led to rapid infection in unimmunized and low-titer animals. High-titer animals, however, demonstrated protection that was gradually lost as nAb titers waned over time. An autologous serum ID50 nAb titer of similar to 1:500 afforded more than 90% protection from medium-dose SHIV infection. In contrast, antibody-dependent cellular cytotoxicity and T cell activity did not correlate with protection. Therefore, Env protein-based vaccination strategies can protect against hard-to-neutralize SHIV challenge in rhesus macaques by inducing tier 2 nAbs, provided appropriate neutralizing titers can be reached and maintained.	[Pauthner, Matthias G.; Bastidas, Raiza; Nedellec, Rebecca; Bianchi, Matteo; Butera, Salvatore T.; Hangartner, Lars; Wyatt, Richard T.; Schief, William R.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Pauthner, Matthias G.; Havenar-Daughton, Colin; Reiss, Samantha M.; Bastidas, Raiza; Nedellec, Rebecca; Cottrell, Christopher A.; Tokatlian, Talar; Nogal, Bartek; Bianchi, Matteo; Lee, Jeong Hyun; Butera, Salvatore T.; Hangartner, Lars; Wilson, Ian A.; Wyatt, Richard T.; Irvine, Darrell J.; Schief, William R.; Ward, Andrew B.; Crotty, Shane; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Pauthner, Matthias G.; Bastidas, Raiza; Nedellec, Rebecca; Cottrell, Christopher A.; Nogal, Bartek; Bianchi, Matteo; Hangartner, Lars; Wilson, Ian A.; Wyatt, Richard T.; Schief, William R.; Ward, Andrew B.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Pauthner, Matthias G.; Bastidas, Raiza; Nedellec, Rebecca; Cottrell, Christopher A.; Nogal, Bartek; Bianchi, Matteo; Hangartner, Lars; Wilson, Ian A.; Wyatt, Richard T.; Schief, William R.; Ward, Andrew B.; Burton, Dennis R.] Scripps Res Inst, CAVD, La Jolla, CA 92037 USA; [Nkolola, Joseph P.; Abbink, Peter; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Havenar-Daughton, Colin; Reiss, Samantha M.; Lee, Jeong Hyun; Crotty, Shane] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Murrell, Ben; Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA; [Prevost, Jeremie; Finzi, Andres] Ctr Rech CHUM, Montreal, PQ H2X 0A9, Canada; [Prevost, Jeremie; Finzi, Andres] Univ Montreal, Dept Microbiol Infect Dis & Immunol, Montreal, PQ H2X 0A9, Canada; [von Bredow, Benjamin; Evans, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Cottrell, Christopher A.; Nogal, Bartek; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Cottrell, Christopher A.; Nogal, Bartek; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kulp, Daniel W.] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, Philadelphia, PA 19104 USA; [Tokatlian, Talar; Irvine, Darrell J.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Li, Hui; Shaw, George M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Irvine, Darrell J.; Barouch, Dan H.; Burton, Dennis R.] Harvard Univ, Massachusetts Gen Hosp, MIT, Ragon Inst, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10065 USA	Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; La Jolla Institute for Immunology; University of California System; University of California San Diego; Universite de Montreal; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Scripps Research Institute; The Wistar Institute; University of Pennsylvania; McGill University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, CAVD, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, MIT, Ragon Inst, Cambridge, MA 02139 USA.	shane@lji.org; shawg@pennmedicine.upenn.edu; dbarouch@bidmc.harvard.edu; burton@scripps.edu	Ward, Andrew B/F-9203-2014; Barouch, Dan/Y-3918-2019; Cottrell, Christopher A/P-3514-2015; Murrell, Ben/AAM-1188-2021; Crotty, Shane/AAE-8446-2019; Hangartner, Lars/AAS-1320-2021; Schief, William/ABF-3645-2020; Ward, Andrew/ABD-7728-2021; Crotty, Shane/AAC-6703-2019	Ward, Andrew B/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Hangartner, Lars/0000-0002-3165-2058; Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Crotty, Shane/0000-0002-6484-6262; Prevost, Jeremie/0000-0002-5260-5154; Lee, Jeong Hyun/0000-0001-7371-845X; Bianchi, Matteo/0000-0003-0517-8599; Murrell, Ben/0000-0002-0393-4445; von Bredow, Benjamin/0000-0001-8924-2193; Pauthner, Matthias G./0000-0001-9212-4307; Finzi, Andres/0000-0002-4992-5288	NIAID [UM1AI100663]; Bill & Melinda Gates Foundation [OPP1084519, OPP1145046]; National Institutes of Health [AI121135, AI136621, AI124377, AI126603, AI128751, OD011106]; CIHR [352417]; Canada Research Chair on Retroviral Entry [RCHS0235]; National Institute of Allergy and Infectious Diseases [R00AI120851, UM1AI068618]; Translational Virology Core at the UC San Diego Center for AIDS Research [P30 AI036214]; IGM Genomics Center, University of California, San Diego, La Jolla, California; NIH [Al131873]; Achievement Rewards for College Scientists Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121135, UM1AI068618, UM1AI100663, R00AI120851, R01AI136621, F31AI131873, P30AI036214, UM1AI126603, U19AI128751, UM1AI124377, R01AI098485, R01AI131331, R01AI095098, P01AI131251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair on Retroviral Entry; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Translational Virology Core at the UC San Diego Center for AIDS Research; IGM Genomics Center, University of California, San Diego, La Jolla, California; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Laura Pruyn and Joan Allmaras for excellent administrative support. The funding for this study was provided by NIAID UM1AI100663 (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery). The Bill & Melinda Gates Foundation (OPP1084519) and the International AIDS Vaccine Initiative helped support the design of some immunogens used in this study. This work was further supported by the National Institutes of Health grants AI121135 (D.T.E.), AI136621 (A.B.W.), AI124377, AI126603, AI128751 (D.H.B.), and OD011106 (Wisconsin National Primate Research Center) and grant OPP1145046 from the Bill & Melinda Gates Foundation (G.M.S.). A.F.'s work was supported by CIHR foundation grant #352417. A.F. is the recipient of a Canada Research Chair on Retroviral Entry RCHS0235. J.P. is the recipient of a CIHR Fellowship Award. B.M. was supported by grants R00AI120851 and UM1AI068618 from the National Institute of Allergy and Infectious Diseases. PacBio SMRT sequencing was performed with the support of the Translational Virology Core at the UC San Diego Center for AIDS Research (P30 AI036214) and the IGM Genomics Center, University of California, San Diego, La Jolla, California. C.A.C. is supported by a NIH F31 Ruth L. Kirschstein Predoctoral Award Al131873 and by the Achievement Rewards for College Scientists Foundation.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Alpert MD, 2012, J VIROL, V86, P12039, DOI 10.1128/JVI.01650-12; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Bianchi M, 2018, IMMUNITY, V49, P288, DOI 10.1016/j.immuni.2018.07.009; Bukh I, 2014, J VIROL, V88, P8468, DOI 10.1128/JVI.03850-13; Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cohen YZ, 2018, J VIROL, V92, DOI 10.1128/JVI.01883-17; de la Pena AT, 2018, J VIROL, V92, DOI 10.1128/JVI.01957-17; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Del Prete GQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006572; Ding SL, 2016, J VIROL, V90, P2127, DOI 10.1128/JVI.02779-15; Eren K, 2017, FULL LENGTH ENVELOPE, DOI [10.1101/230474, DOI 10.1101/230474]; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Fenizia C, 2011, J VIROL, V85, P12399, DOI 10.1128/JVI.05707-11; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Haynes BF, 2017, SCIENCE, V355, P1129, DOI 10.1126/science.aan0662; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2018, EXPERT REV VACCINES, V17, P127, DOI 10.1080/14760584.2018.1425619; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Huang YD, 2016, J IMMUNOL, V197, P4603, DOI 10.4049/jimmunol.1601197; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Keele BF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15740; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Klasse PJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006913; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Kristensen AB, 2018, J VIROL, V92, DOI 10.1128/JVI.02146-17; Kulp DW, 2017, NAT COMMUN, V8; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Martins MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029504; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Panna D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23882-6; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; PEGU A, 2014, SCI TRANSL MED, V6; Provine NM, 2012, VIROLOGY, V427, P25, DOI 10.1016/j.virol.2012.02.001; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Richard J, 2018, MBIO, V9, DOI 10.1128/mBio.00358-18; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011; Sundling C, 2013, J INFECT DIS, V207, P426, DOI 10.1093/infdis/jis696; Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Veillette Maxime, 2014, J Vis Exp, P51995, DOI 10.3791/51995; von Bredow B, 2016, J VIROL, V90, P6127, DOI 10.1128/JVI.00347-16	61	89	91	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					241	+		10.1016/j.immuni.2018.11.011	http://dx.doi.org/10.1016/j.immuni.2018.11.011			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30552025	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000455661600023
J	Li, ZQ; Liu, SX; Xu, JF; Zhang, X; Han, D; Liu, J; Xia, M; Yi, L; Shen, QC; Xu, S; Lu, LR; Cao, XT				Li, Zhiqing; Liu, Shuxun; Xu, Junfang; Zhang, Xiang; Han, Dan; Liu, Juan; Xia, Meng; Yi, Lin; Shen, Qicong; Xu, Sheng; Lu, Linrong; Cao, Xuetao			Adult Connective Tissue-Resident Mast Cells Originate from Late Erythro-Myeloid Progenitors	IMMUNITY			English	Article							YOLK-SAC; MONOCYTES; FIBROBLASTS; MACROPHAGES; PRECURSORS; MICROGLIA; TRYPTASE; ONTOGENY; INCREASE; REVEALS	Tissue-resident mast cells are associated with many inflammatory and physiological processes. Although mast cells arise from the yolk sac, the exact ontogeny of adult mast cells remains unclear. Here we have investigated the hematopoietic origin of mast cells using fate-mapping systems. We have shown that early erythro-myeloid progenitors (EMPs), late EMPs, and definitive hematopoietic stem cells (HSCs) each gave rise to mast cells in succession via an intermediate integrin beta 7(+) progenitor. From late embryogenesis to adult, early EMP-derived mast cells were largely replaced by late EMP-derived cells in most connective tissues except adipose and pleural cavity. Thus, mast cells with distinct origin displayed tissue-location preferences: early EMP-derived cells were limited to adipose and pleural cavity and late EMP-derived cells dominated most connective tissues, while HSC-derived cells were a main group in mucosa. Therefore, embryonic origin shapes the heterogeneity of adult mast cells, with diverse functions in immunity and development.	[Li, Zhiqing; Xu, Junfang; Han, Dan; Xia, Meng; Lu, Linrong; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Zhiqing; Liu, Shuxun; Zhang, Xiang; Liu, Juan; Yi, Lin; Shen, Qicong; Xu, Sheng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Li, Zhiqing; Liu, Shuxun; Zhang, Xiang; Liu, Juan; Yi, Lin; Shen, Qicong; Xu, Sheng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing 100005, Peoples R China; [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nankai University	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	caoxt@immunol.org	shen, qicong/GYJ-2803-2022; Xu, Junfang/ABC-6562-2021	xia, meng/0000-0001-5223-7390; xu, sheng/0000-0002-9547-8052	National Natural Science Foundation of China [31870878, 31470858, 91542000, 91642000, 81788101]; National Key R&D Program of China [2018YFA0507403]; National Key Basic Research Program of China [2015CB964403]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Key Basic Research Program of China(National Basic Research Program of China); CAMS Innovation Fund for Medical Sciences	We thank Dr. Igor M. Samokhvalov from the Institute of Physical and Chemical Research (RIKEN) CDB Laboratory for kindly providing the Runx1<SUP>MercreMer/WT</SUP> mice. This work was supported by Grants from the National Natural Science Foundation of China (31870878, 31470858, 91542000, 91642000, 81788101), National Key R&D Program of China (2018YFA0507403), National Key Basic Research Program of China (2015CB964403) and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Ding YY, 2016, NAT IMMUNOL, V17, P1167, DOI 10.1038/ni.3535; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Giannou AD, 2015, J CLIN INVEST, V125, P2317, DOI 10.1172/JCI79840; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2017, PFLUG ARCH EUR J PHY, V469, P365, DOI 10.1007/s00424-017-1945-7; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KANAKURA Y, 1988, BLOOD, V71, P573; Kierdorf K, 2015, SEMIN IMMUNOL, V27, P369, DOI 10.1016/j.smim.2016.03.017; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Lilla JN, 2010, DEV BIOL, V337, P124, DOI 10.1016/j.ydbio.2009.10.021; Liu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17569; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McGrath KE, 2015, SEMIN IMMUNOL, V27, P379, DOI 10.1016/j.smim.2016.03.013; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Ngkelo A, 2016, J EXP MED, V213, P1353, DOI 10.1084/jem.20160081; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ribatti D, 2014, IMMUNOL LETT, V159, P11, DOI 10.1016/j.imlet.2014.02.003; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; SONODA T, 1983, DEV BIOL, V97, P89, DOI 10.1016/0012-1606(83)90066-0; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; THARP MD, 1985, J HISTOCHEM CYTOCHEM, V33, P27, DOI 10.1177/33.1.2578142; Wang D, 2014, J EXP MED, V211, P2635, DOI 10.1084/jem.20140470; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	40	89	92	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					640	+		10.1016/j.immuni.2018.09.023	http://dx.doi.org/10.1016/j.immuni.2018.09.023			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332630	Bronze			2022-12-18	WOS:000447386700011
J	Varga, T; Mounier, R; Patsalos, A; Gogolak, P; Peloquin, M; Horvath, A; Pap, A; Daniel, B; Nagy, G; Pintye, E; Poliska, S; Cuvellier, S; Ben Larbi, S; Sansbury, BE; Spite, M; Brown, CW; Chazaud, B; Nagy, L				Varga, Tamas; Mounier, Remi; Patsalos, Andreas; Gogolak, Peter; Peloquin, Matthew; Horvath, Attila; Pap, Attila; Daniel, Bence; Nagy, Gergely; Pintye, Eva; Poliska, Szilard; Cuvellier, Sylvain; Ben Larbi, Sabrina; Sansbury, Brian E.; Spite, Matthew; Brown, Chester W.; Chazaud, Bemedicte; Nagy, Laszlo			Macrophage PPAR gamma, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration	IMMUNITY			English	Article							FIBRO/ADIPOGENIC PROGENITORS; BMP INHIBITOR; TISSUE-REPAIR; CELLS; DISTINCT; INJURY; MICE; DIFFERENTIATION; INFLAMMATION; RESOLUTION	Tissue regeneration requires inflammatory and reparatory activity of macrophages. Macrophages detect and eliminate the damaged tissue and subsequently promote regeneration. This dichotomy requires the switch of effector functions of macrophages coordinated with other cell types inside the injured tissue. The gene regulatory events supporting the sensory and effector functions of macrophages involved in tissue repair are not well understood. Here we show that the lipid activated transcription factor, PPAR gamma, is required for proper skeletal muscle regeneration, acting in repair macrophages. PPAR gamma controls the expression of the transforming growth factor-beta (TGF-beta) family member, GDF3, which in turn regulates the restoration of skeletal muscle integrity by promoting muscle progenitor cell fusion. This work establishes PPAR gamma as a required metabolic sensor and transcriptional regulator of repair macrophages. Moreover, this work also establishes GDF3 as a secreted extrinsic effector protein acting on myoblasts and serving as an exclusively macrophagederived regeneration factor in tissue repair.	[Varga, Tamas; Patsalos, Andreas; Horvath, Attila; Pap, Attila; Daniel, Bence; Nagy, Gergely; Poliska, Szilard; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary; [Mounier, Remi; Ben Larbi, Sabrina; Chazaud, Bemedicte] Univ Claude Bernard Lyon 1, CNRS UMR5310, INSERM U1217, Inst NeuroMyogene,INMG, F-69100 Villeurbanne, France; [Gogolak, Peter] Univ Debrecen, Dept Immunol, H-4012 Debrecen, Hungary; [Peloquin, Matthew; Daniel, Bence] Sanford Burnham Prebys Med Discovery Inst Lake No, 6400 Sanger Rd, Orlando, FL 32827 USA; [Nagy, Gergely] Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, H-4012 Debrecen, Hungary; [Pintye, Eva] Univ Debrecen, Dept Radiat Therapy, H-4012 Debrecen, Hungary; [Cuvellier, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, INSERM U1016,CNRS,UMR8104, F-75014 Paris, France; [Sansbury, Brian E.; Spite, Matthew] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Brown, Chester W.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brown, Chester W.] Baylor Coll Med, Dept Pediat, One Baylor Plaza, Houston, TX 77030 USA; [Brown, Chester W.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Debrecen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Debrecen; Sanford Burnham Prebys Medical Discovery Institute; University of Debrecen; University of Debrecen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Nagy, L (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary.; Chazaud, B (corresponding author), Univ Claude Bernard Lyon 1, CNRS UMR5310, INSERM U1217, Inst NeuroMyogene,INMG, F-69100 Villeurbanne, France.	benedicte.chazaud@inserm.fr; lnagy@sbpdiscovery.org	Nagy, Gergely/F-7670-2017; Chazaud, Benedicte/N-9291-2017; Horvath, Attila/AAA-9075-2020; Patsalos, Andreas/GQY-7136-2022; Nagy, Laszlo/A-3814-2008; Patsalos, Andreas/L-8957-2019	Nagy, Gergely/0000-0002-3273-731X; Chazaud, Benedicte/0000-0002-1262-502X; Patsalos, Andreas/0000-0002-9022-4985; Nagy, Laszlo/0000-0001-6653-2155; Patsalos, Andreas/0000-0002-9022-4985; Horvath, Attila/0000-0002-6127-8925	University of Debrecen [RH/751/2015]; Hungarian Academy of Sciences; Hungarian Scientific Research Fund (OTKA) [K100196, K111941, K116855]; "NR-NET" ITN from the EU-FP7 PEOPLE program [PITN-GA-2013-606806]; CNRS/Hungarian Academy of Sciences [26119]; Campus France, Balaton [817297H]; Agence Nationale de la Recherche Genopat In-A-Fiba EU FP7 Endostem [241440]; Fondation pour la Recherche Medicale [Equipe FRM DEQ20140329495]; National Institutes of Health [HL106173, GM095467]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	University of Debrecen; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "NR-NET" ITN from the EU-FP7 PEOPLE program; CNRS/Hungarian Academy of Sciences; Campus France, Balaton; Agence Nationale de la Recherche Genopat In-A-Fiba EU FP7 Endostem(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the technical assistance of Ms. T. Cseh and Ms. M. Porcelanne and discussions and comments on the manuscript by Dr. E. Rajnavolgyi and members of the Nagy laboratory. T.V. is a recipient of the RH/751/2015 intramural grant from the University of Debrecen, and a Bolyai Fellowship from the Hungarian Academy of Sciences. L.N. is supported by grants from the Hungarian Scientific Research Fund (OTKA K100196, K111941 and K116855) and by "NR-NET" ITN PITN-GA-2013-606806 from the EU-FP7 PEOPLE-2013 program. L.N. and B.C. acknowledges funding by CNRS/Hungarian Academy of Sciences Cooperation #26119 and Campus France, Balaton program #817297H. B.C. is supported by Agence Nationale de la Recherche Genopat In-A-Fiba EU FP7 Endostem (241440) and Fondation pour la Recherche Medicale "Equipe FRM DEQ20140329495". M.S. acknowledges the support of National Institutes of Health grants HL106173 and GM095467.	Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jiang CH, 2016, DEV BIOL, V409, P16, DOI 10.1016/j.ydbio.2015.11.007; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2009, DEV BIOL, V325, P43, DOI 10.1016/j.ydbio.2008.09.006; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Varga T, 2016, J IMMUNOL, V196, P4771, DOI 10.4049/jimmunol.1502490; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100	28	89	90	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1038	1051		10.1016/j.immuni.2016.10.016	http://dx.doi.org/10.1016/j.immuni.2016.10.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27836432	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000389473500015
J	Gitlin, AD; von Boehmer, L; Gazumyan, A; Shulman, Z; Oliveira, TY; Nussenzweig, MC				Gitlin, Alexander D.; von Boehmer, Lotta; Gazumyan, Anna; Shulman, Ziv; Oliveira, Thiago Y.; Nussenzweig, Michel C.			Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory	IMMUNITY			English	Article							GERMINAL-CENTER; SOMATIC HYPERMUTATION; CUTTING EDGE; BONE-MARROW; NEUTRALIZING ANTIBODIES; CLONAL SELECTION; CELL MIGRATION; ANTIGEN; RECEPTOR; IGG	Somatic hypermutation (SHM) and class-switch recombination (CSR) increase the affinity and diversify the effector functions of antibodies during immune responses. Although SHM and CSR are fundamentally different, their independent roles in regulating B cell fate have been difficult to uncouple because a single enzyme, activation-induced cytidine deaminase (encoded by Aicda), initiates both reactions. Here, we used a combination of Aicda and antibody mutant alleles that separate the effects of CSR and SHM on polyclonal immune responses. We found that class-switching to IgG1 biased the fate choice made by B cells, favoring the plasma cell over memory cell fate without significantly affecting clonal expansion in the germinal center (GC). In contrast, SHM reduced the longevity of memory B cells by creating polyreactive specificities that were selected against over time. Our data define the independent contributions of SHM and CSR to the generation and persistence of memory in the antibody system.	[Gitlin, Alexander D.; von Boehmer, Lotta; Gazumyan, Anna; Shulman, Ziv; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Shulman, Ziv] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Weizmann Institute of Science	Gitlin, AD; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	agitlin@rockefeller.edu; nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/ABF-5186-2020; Oliveira, Thiago Y/HGA-3848-2022	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Gitlin, Alexander/0000-0002-9229-0919; von Boehmer, Lotta/0000-0001-8018-1814	NIH Medical Scientist Training Program [T32GM07739]; National Institute of Allergy and Infectious Diseases, NIH [1F30AI109903-01]; National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award program [UL1 TR000043]; NIH [AI037526-19, AI072529-06]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI072529, R01AI037526, F30AI109903, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Eisenreich and S. Hinklein for help with mouse colony management; S. Bournazos for reagents; M. K. Jenkins, J. J. Taylor, and K. A. Pape for generous advice; E. S. Gitlin, H. Mouquet, D. Mucida, G. D. Victora, and C. T. Mayer for discussion and advice; D. F. Robbiani, P. C. Rommel, A. Weiss, and J. Zikherman for mice; J. Golijanin, S. Ackerman, and K. Yao for technical help; B. Zhang and C. Zhao and the Rockefeller University Genomics Resource Center for assistance with high-throughput sequencing; K. Velinzon and N. Thomas for assistance with cell sorting; and all members of the Nussenzweig laboratory for discussion. Supported by NIH Medical Scientist Training Program grant T32GM07739 and National Institute of Allergy and Infectious Diseases, NIH, grant 1F30AI109903-01 (A. D. G.); grant UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award program (L.v.B.); NIH grants AI037526-19 and AI072529-06 (M. C. N.); and the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M. C. N). Z. S. is a Human Frontiers of Science Program fellow (reference LT000340/2011-L). M. C. N. is an HHMI investigator.	Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson SM, 2006, J IMMUNOL, V176, P4515, DOI 10.4049/jimmunol.176.8.4515; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; CEBRA JJ, 1966, J EXP MED, V123, P547, DOI 10.1084/jem.123.3.547; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Engels N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6456; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Good-Jacobson KL, 2015, J EXP MED, V212, P1001, DOI 10.1084/jem.20150191; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Ota T, 2011, J EXP MED, V208, P617, DOI 10.1084/jem.20102265; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; ROTH PE, 1993, J EXP MED, V178, P2007, DOI 10.1084/jem.178.6.2007; ROTH PE, 1995, J EXP MED, V181, P1059, DOI 10.1084/jem.181.3.1059; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Taylor JJ, 2012, TRENDS IMMUNOL, V33, P590, DOI 10.1016/j.it.2012.07.005; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	83	89	89	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					769	781		10.1016/j.immuni.2016.01.011	http://dx.doi.org/10.1016/j.immuni.2016.01.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	26944202	Green Accepted, Bronze			2022-12-18	WOS:000374444300010
J	Maltez, VI; Tubbs, AL; Cook, KD; Aachoui, Y; Falcone, EL; Holland, SM; Whitmire, JK; Miao, EA				Maltez, Vivien I.; Tubbs, Alan L.; Cook, Kevin D.; Aachoui, Youssef; Falcone, E. Liana; Holland, Steven M.; Whitmire, Jason K.; Miao, Edward A.			Inflammasomes Coordinate Pyroptosis and Natural Killer Cell Cytotoxicity to Clear Infection by a Ubiquitous Environmental Bacterium	IMMUNITY			English	Article							CHRONIC-GRANULOMATOUS-DISEASE; CHROMOBACTERIUM-VIOLACEUM INFECTION; III SECRETION APPARATUS; NK-CELLS; NLRC4 INFLAMMASOME; T-CELLS; LISTERIA INFECTION; INNATE IMMUNITY; ACTIVATION; CASPASE-1	Defective neutrophils in patients with chronic granulomatous disease (CGD) cause susceptibility to extracellular and intracellular infections. Microbes must first be ejected from intracellular niches to expose them to neutrophil attack, so we hypothesized that inflammasomes detect certain CGD pathogens upstream of neutrophil killing. Here, we identified one such ubiquitous environmental bacterium, Chromobacterium violaceum, whose extreme virulence was fully counteracted by the NLRC4 inflammasome. Caspase-1 protected via two parallel pathways that eliminated intracellular replication niches. Pyroptosis was the primary bacterial clearance mechanism in the spleen, but both pyroptosis and interleukin-18 (IL-18)-driven natural killer (NK) cell responses were required for liver defense. NK cells cleared hepatocyte replication niches via perforin-dependent cytotoxicity, whereas interferon-g was not required. These insights suggested a therapeutic approach: exogenous IL-18 restored perforin-dependent cytotoxicity during infection by the inflammasome-evasive bacterium Listeria monocytogenes. Therefore, inflammasomes can trigger complementary programmed cell death mechanisms, directing sterilizing immunity against intracellular bacterial pathogens.	[Maltez, Vivien I.; Tubbs, Alan L.; Aachoui, Youssef; Whitmire, Jason K.; Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Maltez, Vivien I.; Tubbs, Alan L.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Maltez, Vivien I.; Tubbs, Alan L.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cook, Kevin D.; Whitmire, Jason K.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Falcone, E. Liana; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miao, EA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	edmiao1@gmail.com	, UNC Flow Cytometry Core/AGU-9839-2022	Miao, Edward/0000-0001-7295-3490; Whitmire, Jason/0000-0003-2578-6073; Cook, Kevin/0000-0003-3079-4174; Tubbs, Alan/0000-0001-5780-7540; Maltez, Vivien/0000-0003-2330-7518	NIH [AI097518, AI057141, AI119073, AI097518-02S1, R56AI110682, R01AI074862, T32 AI7273-27]; NCI Center Core Support Grant [P30CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001216, U54AI057141, R01AI074862, R01AI097518, T32AI007273, R56AI110682, R01AI119073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank Vishva Dixit, Richard Flavell, Shizuo Akira, and David Chaplin for sharing mice. We also thank Dat Mao, Davis Trihn, and Taylor Atherton for upkeep of our mouse colony. This work was supported by the following NIH grants: AI097518, AI057141, and AI119073 (E.A.M.), AI097518-02S1 (V.I.M.), R56AI110682 and R01AI074862 (J.K.W.), and T32 AI7273-27 (K.D.C.). The UNC Flow Cytometry Core Facility is supported in part by an NCI Center Core Support Grant (P30CA016086) to the UNC Lineberger Comprehensive Cancer Center.	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Brito Cristiana F Alves de, 2004, Genet Mol Res, V3, P148; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Dao T, 1998, J IMMUNOL, V161, P2217; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Duran M, 2010, FOLIA MICROBIOL, V55, P535, DOI 10.1007/s12223-010-0088-4; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Friis-Moller A, 2004, J CLIN MICROBIOL, V42, P1840, DOI 10.1128/JCM.42.4.1840-1842.2004; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KATZ P, 1990, J CLIN IMMUNOL, V10, P71, DOI 10.1007/BF00917500; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Le-Barillec K, 2005, J IMMUNOL, V175, P1735, DOI 10.4049/jimmunol.175.3.1735; Lee PPW, 2013, ASIAN PAC J ALLERGY, V31, P217; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Lima-Bittencourt CI, 2011, ANTON LEEUW INT J G, V99, P355, DOI 10.1007/s10482-010-9501-x; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Mailman Timothy L, 2005, Can J Infect Dis Med Microbiol, V16, P245; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Segal BH, 2003, INFECT IMMUN, V71, P205, DOI 10.1128/IAI.71.1.205-210.2003; Shabani Z, 2014, ARCH VIROL, V159, P1555, DOI 10.1007/s00705-013-1965-3; Son YI, 2001, CANCER RES, V61, P884; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	48	89	93	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					987	997		10.1016/j.immuni.2015.10.010	http://dx.doi.org/10.1016/j.immuni.2015.10.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26572063	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000366846000018
J	Woodcock, KJ; Kierdorf, K; Pouchelon, CA; Vivancos, V; Dionne, MS; Geissmann, F				Woodcock, Katie J.; Kierdorf, Katrin; Pouchelon, Clara A.; Vivancos, Valerie; Dionne, Marc S.; Geissmann, Frederic			Macrophage-Derived upd3 Cytokine Causes Impaired Glucose Homeostasis and Reduced Lifespan in Drosophila Fed a Lipid-Rich Diet	IMMUNITY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; IKK-EPSILON; FOAM CELL; OBESITY; PHAGOCYTOSIS; GENE; FAT; RECEPTOR; PROTEIN	Long-term consumption of fatty foods is associated with obesity, macrophage activation and inflammation, metabolic imbalance, and a reduced lifespan. We took advantage of Drosophila genetics to investigate the role of macrophages and the pathway(s) that govern their response to dietary stress. Flies fed a lipid-rich diet presented with increased fat storage, systemic activation of JAK-STAT signaling, reduced insulin sensitivity, hyperglycemia, and a shorter lifespan. Drosophila macrophages produced the JAK-STAT-activating cytokine upd3, in a scavenger-receptor (crq) and JNK-dependent manner. Genetic depletion of macrophages or macrophage-specific silencing of upd3 decreased JAK-STAT activation and rescued insulin sensitivity and the lifespan of Drosophila, but did not decrease fat storage. NF-kappa B signaling made no contribution to the phenotype observed. These results identify an evolutionarily conserved "scavenger receptor-JNK-type 1 cytokine'' cassette in macrophages, which controls glucose metabolism and reduces lifespan in Drosophila maintained on a lipid-rich diet via activation of the JAK-STAT pathway.	[Woodcock, Katie J.; Kierdorf, Katrin; Pouchelon, Clara A.; Vivancos, Valerie; Dionne, Marc S.; Geissmann, Frederic] Kings Coll London, CMCBI, Div Immun Infect & Inflammatory Dis, London SE1 1UL, England	University of London; King's College London	Geissmann, F (corresponding author), Kings Coll London, CMCBI, Div Immun Infect & Inflammatory Dis, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Kierdorf, Katrin/AAO-6288-2021	Dionne, Marc/0000-0002-8283-1750; geissmann, frederic/0000-0001-5029-2468; Kierdorf, Katrin/0000-0002-9272-4780	DFG (German Research Foundation); Wellcome Trust [WT101853MA]; ERC Investigator award from the European Research Council [2010-StG-261299]; BBSRC [BB/L020122/1] Funding Source: UKRI; MRC [MR/L018802/1, MR/L018802/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L020122/1] Funding Source: researchfish; Medical Research Council [MR/L018802/1, MR/L018802/2] Funding Source: researchfish	DFG (German Research Foundation)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC Investigator award from the European Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Authors are indebted to Celine Trouillet and Marisol Gonzalez Melendez for help with cell sorting and maintaining the fly room; Dr. Claire Pean and Dr. Werner Wolfgang for help with experiments; Dr. Brian Stramer, Dr. Brigitte Senechal, and Andrew Page for critical reading of the manuscript and support; and Prof. Bruno Lemaitre, Dr. Nicolas Buchon, and Dr. James C. G. Hombria for helpful suggestions and the kind gift of upd3 null, mex1-Gal4 flies, and UAS-upd2 flies. K.J.W. was a PhD fellow of the MRC (Medical Research Council, UK). C. A. P. is a fellow of the Ecole de l'INSERM Liliane Bettencourt. K. K. was funded by a research fellowship by the DFG (German Research Foundation). This work was supported by a Wellcome Trust Senior Investigator award (WT101853MA) and ERC Investigator award (2010-StG-261299) from the European Research Council to F.G.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Al-Anzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012353; Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Betz A, 2008, P NATL ACAD SCI USA, V105, P13805, DOI 10.1073/pnas.0806291105; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Clark RI, 2013, CELL, V155, P435, DOI 10.1016/j.cell.2013.09.007; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; DRIVER CJI, 1979, EXP GERONTOL, V14, P95, DOI 10.1016/0531-5565(79)90023-8; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gold KS, 2014, EXP HEMATOL, V42, P717, DOI 10.1016/j.exphem.2014.06.002; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Heinrichsen ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042587; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Kroenke CH, 2013, JNCI-J NATL CANCER I, V105, P616, DOI 10.1093/jnci/djt027; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Osman D, 2012, J CELL SCI, V125, P5944, DOI 10.1242/jcs.113100; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Robertson HT, 2011, J GERONTOL A-BIOL, V66, P279, DOI 10.1093/gerona/glq190; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tanti JF., 2012, FRONT ENDOCRINOL, V3, P181, DOI [DOI 10.3389/FENDO.2012.00181, 10.3389/fendo.2012.00181]; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wagener A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.4; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	62	89	92	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					133	144		10.1016/j.immuni.2014.12.023	http://dx.doi.org/10.1016/j.immuni.2014.12.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25601202	hybrid, Green Published			2022-12-18	WOS:000348197500017
J	Santarlasci, V; Maggi, L; Capone, M; Querci, V; Beltrame, L; Cavalieri, D; D'Aiuto, E; Cimaz, R; Nebbioso, A; Liotta, F; De Palma, R; Maggi, E; Cosmi, L; Romagnani, S; Annunziato, F				Santarlasci, Veronica; Maggi, Laura; Capone, Manuela; Querci, Valentina; Beltrame, Luca; Cavalieri, Duccio; D'Aiuto, Elena; Cimaz, Rolando; Nebbioso, Angela; Liotta, Francesco; De Palma, Raffaele; Maggi, Enrico; Cosmi, Lorenzo; Romagnani, Sergio; Annunziato, Francesco			Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion	IMMUNITY			English	Article							HUMAN TH17 CELLS; TRANSCRIPTION FACTORS; AUTOIMMUNE INFLAMMATION; TRANSIENT NATURE; PHENOTYPE; IL4I1; IDENTIFICATION; PLASTICITY; CYTOKINE; DISTINCT	The reason why CD4(+) T helper 17 (Th17) cells, despite their well-known pathogenic role in chronic inflammatory disorders, are very rare in the inflammatory sites remains unclear. We demonstrate that human Th17 cells exhibit low ability to proliferate and to produce the T cell growth factor interleukin-2 (IL-2), in response to combined CD3 and CD28 stimulation. This was due to the upregulated expression of IL-4-induced gene 1 (IL4I1) mRNA, a secreted L-phenylalanine oxidase, which associated with a decrease in CD3 zeta chain expression and consequent abnormalities in the molecular pathway that allows IL-2 production and cell proliferation. High IL4I1 mRNA expression was detectable in Th17 cell precursors and was strictly dependent on Th17 cell master gene, the retinoid acid related orphan receptor (RORC). Th17 cells also exhibited RORC-dependent CD28 hyperexpression and the ability to produce IL-17A after CD28 stimulation without CD3 triggering. Our findings suggest that the rarity of human Th17 cells in inflamed tissues results from RORC-dependent mechanisms limiting their expansion.	[Santarlasci, Veronica; Maggi, Laura; Capone, Manuela; Querci, Valentina; Liotta, Francesco; Maggi, Enrico; Cosmi, Lorenzo; Romagnani, Sergio; Annunziato, Francesco] Univ Florence, Dept Internal Med, I-50134 Florence, Italy; [Santarlasci, Veronica; Maggi, Laura; Capone, Manuela; Querci, Valentina; Liotta, Francesco; Maggi, Enrico; Cosmi, Lorenzo; Romagnani, Sergio; Annunziato, Francesco] Univ Florence, DENOTHE Ctr, I-50134 Florence, Italy; [Cavalieri, Duccio] Univ Florence, Dept Pharmacol M Aiazzi Mancini, I-50134 Florence, Italy; [Beltrame, Luca] Mario Negri Inst Pharmacol Res, Dept Oncol, I-20156 Milan, Italy; [D'Aiuto, Elena; De Palma, Raffaele] Univ Naples 2, Dept Clin & Expt Med, I-80131 Naples, Italy; [Nebbioso, Angela] Univ Naples 2, Dept Gen Pathol, I-80131 Naples, Italy; [Cimaz, Rolando] Anna Meyer Childrens Hosp, Rheumatol Unit, Dept Pediat, I-50134 Florence, Italy	University of Florence; University of Florence; University of Florence; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Annunziato, F (corresponding author), Univ Florence, Dept Internal Med, I-50134 Florence, Italy.	f.annunziato@dmi.unifi.it	NEBBIOSO, ANGELA/GVS-1294-2022; Beltrame, Luca/AAB-1998-2020; CIMAZ, Rolando/AAA-9058-2019; Maggi, Enrico/AAA-8045-2019; MAGGI, Laura/B-6693-2013; NEBBIOSO, Angela/C-3566-2016; CAVALIERI, DUCCIO/T-3097-2017	Beltrame, Luca/0000-0003-3631-6544; CIMAZ, Rolando/0000-0002-3260-4226; Maggi, Enrico/0000-0002-1824-3583; MAGGI, Laura/0000-0003-2862-9591; NEBBIOSO, Angela/0000-0001-5374-3527; De Palma, Raffaele/0000-0001-9070-8878; CAVALIERI, DUCCIO/0000-0001-6426-5719; Annunziato, Francesco/0000-0001-8798-7589	Ministero dell'Istruzione, dell'Universita e della Ricerca; Italian Ministry of Health, Associazione ltaliana Ricerca sul Cancro (AIRC); Ente Cassa Risparmio di Firenze	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health, Associazione ltaliana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ente Cassa Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	We thank M.K. Leving (Department of Surgery, University of British Columbia, Vancouver, BC, Canada) for providing us the pCCL EF1 alpha NGFR and pCCL EF1 alpha. NGFR hRORC2 plasmid vectors; F. Bambi (Meyer Children's Hospital, Florence, Italy) for providing us healthy donors' buffy coats; M. Fambrini (Department of Gynecology, Perinatology and Human Reproduction, University of Florence, Italy) for providing us UCB; L. Altucci (Department of General Pathology, SUN, Napoli); and L. Formisano (Department of Neurosciences, Federico II University, Naples) for help in ChIP experiments. This study was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, the Italian Ministry of Health, Associazione ltaliana Ricerca sul Cancro (AIRC), and Ente Cassa Risparmio di Firenze.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2010, EUR J IMMUNOL, V40, P3312, DOI 10.1002/eji.201041145; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Julia A, 2007, GENOMICS, V90, P6, DOI 10.1016/j.ygeno.2007.03.011; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Marinari B, 2004, P NATL ACAD SCI USA, V101, P6098, DOI 10.1073/pnas.0308688101; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Santarlasci V, 2009, EUR J IMMUNOL, V39, P207, DOI 10.1002/eji.200838748; Tuosto L, 2011, IMMUNOL LETT, V135, P1, DOI 10.1016/j.imlet.2010.09.005; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Wiemann S, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-16	34	89	91	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					201	214		10.1016/j.immuni.2011.12.013	http://dx.doi.org/10.1016/j.immuni.2011.12.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22326581	Green Submitted, Bronze			2022-12-18	WOS:000300812400009
J	Veillette, A; Dong, Z; Latour, S				Veillette, Andre; Dong, Zhongjun; Latour, Sylvain			Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes	IMMUNITY			English	Review							LINKED LYMPHOPROLIFERATIVE-DISEASE; NATURAL-KILLER-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONTROLS T-CELL; MOLECULE-ASSOCIATED PROTEIN; HUMAN NK CELLS; CUTTING EDGE; DEFICIENT MICE; GENE-PRODUCT; HUMORAL IMMUNITY	Signaling lymphocytic activation molecule (SLAM) family receptors mediate important regulatory signals in immune cells, as a result of their exquisite ability to associate with members of the SLAM-associated protein (SAP) family of adaptors. As discussed herein, recent findings show that the SLAM and SAP families carry out pivotal functions in innate-like and conventional lymphocytes. They are critically needed for the development of innate-like lymphocytes such as NKT cells. In addition, they influence several of the functions of conventional lymphocytes, including the ability of CD4(+) T cells to secrete certain cytokines and mediate B cell help; CD8(+) T cell proliferation and cytokine production; NK cell-mediated cytotoxicity; and B cell antibody production. These unique functional properties appear to be facilitated by the ability of SLAM-related receptors to serve as self-ligands during homotypic interactions between immune cells. The importance of the SLAM-SAP pathway in normal immunity is highlighted by the finding that SAP is mutated in humans suffering from the immunodeficiency X-linked lymphoproliferative disease.	Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Med, Montreal, PQ H2W 1R7, Canada; McGill Univ, Dept Med, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca	Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391				Al-Alem U, 2005, BLOOD, V106, P2069, DOI 10.1182/blood-2004-07-2731; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen G, 2005, J IMMUNOL, V175, P2212, DOI 10.4049/jimmunol.175.4.2212; Chen G, 2007, EUR J IMMUNOL, V37, P663, DOI 10.1002/eji.200636417; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Eberl G, 1999, J IMMUNOL, V163, P4091; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Falco M, 2004, EUR J IMMUNOL, V34, P1663, DOI 10.1002/eji.200424886; Fischer A, 2007, CURR OPIN IMMUNOL, V19, P348, DOI 10.1016/j.coi.2007.04.006; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Kamperschroer C, 2006, J IMMUNOL, V177, P5317, DOI 10.4049/jimmunol.177.8.5317; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Komori H, 2006, J IMMUNOL, V176, P395, DOI 10.4049/jimmunol.176.1.395; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Kumaresan PR, 2002, MOL IMMUNOL, V39, P1, DOI 10.1016/S0161-5890(02)00094-9; Latchman Y, 1998, J IMMUNOL, V161, P5809; Latour S, 2003, IMMUNOL REV, V192, P212, DOI 10.1034/j.1600-065X.2003.00023.x; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Li WL, 2005, MICROSYST TECHNOL, V11, P23, DOI 10.1007/s00542-004-0462-8; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Utting O, 2001, J IMMUNOL, V166, P1540, DOI 10.4049/jimmunol.166.3.1540; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Veillette A, 2006, TRENDS IMMUNOL, V27, P228, DOI 10.1016/j.it.2006.03.003; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504	95	89	91	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					698	710		10.1016/j.immuni.2007.11.005	http://dx.doi.org/10.1016/j.immuni.2007.11.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031694	Bronze			2022-12-18	WOS:000251269000005
J	Xi, HK; Schwartz, R; Engel, I; Murre, C; Kersh, GJ				Xi, Hongkang; Schwartz, Ruth; Engel, Isaac; Murre, Cornelis; Kersh, Gilbert J.			Interplay between ROR gamma t, Egr3, and E proteins controls proliferation in response to pre-TCR signals	IMMUNITY			English	Article							ORPHAN NUCLEAR RECEPTOR; LYMPHOID ORGAN DEVELOPMENT; ELEMENT-BINDING PROTEIN; LOOP-HELIX PROTEIN; B1 MESSENGER-RNA; TRANSCRIPTION FACTORS; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; OOCYTE MATURATION; THYMOCYTE SURVIVAL	The response of thymocytes to pre-T cell receptor (pre-TCR) signaling includes proliferation and gene rearrangement, two cellular processes that are incompatible. The control of proliferation by pre-TCR signals depends on the activities of the transcription factors ROR gamma t, Egr3, E12, and E47. Here, we describe a regulatory network in which interplay between these factors ensures transient proliferation that is temporally distinct from gene rearrangement. ROR gamma t expression was elevated after pre-TCR signaling, and RORyt promoted gene rearrangement in CD4(+), CD8(+) cells by inhibiting cell division, promoting survival via Bcl-X-L, and inducing Rag2. Egr3 was transiently induced by pre-TCR signals and promoted a distinct proliferative phase by reducing E protein-dependent RORyt expression and interacting with RORyt to prevent induction of target genes. After Egr3 subsided, the expression and function of RORyt increased. Thus, transient induction of Egr3 delays the effects of RORyt and enables pre-TCR signaling to induce both proliferation and gene rearrangement.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92903 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	Emory University; University of California System; University of California San Diego; La Jolla Institute for Immunology	Kersh, GJ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 101 Woodruff Circle, Atlanta, GA 30322 USA.	gkersh@emory.edu						Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Bettini M, 2003, EUR J IMMUNOL, V33, P3109, DOI 10.1002/eji.200324067; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Guo JH, 2002, ASIAN J ANDROL, V4, P3; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; He YW, 2000, IMMUNOL RES, V22, P71, DOI 10.1385/IR:22:2-3:71; He YW, 2000, J IMMUNOL, V164, P5668, DOI 10.4049/jimmunol.164.11.5668; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Hooijberg E, 2000, J IMMUNOL, V165, P4239, DOI 10.4049/jimmunol.165.8.4239; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten AM, 2002, CELL DEATH DIFFER, V9, P1167, DOI 10.1038/sj.cdd.4401085; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Loveys DA, 1996, NUCLEIC ACIDS RES, V24, P2813, DOI 10.1093/nar/24.14.2813; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Sasayama T, 2005, GENES CELLS, V10, P627, DOI 10.1111/j.1365-2443.2005.00870.x; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2003, J IMMUNOL, V170, P315, DOI 10.4049/jimmunol.170.1.315; Yamagata K, 1994, Learn Mem, V1, P140	46	89	92	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					813	826		10.1016/j.immuni.2006.03.023	http://dx.doi.org/10.1016/j.immuni.2006.03.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782036	Bronze			2022-12-18	WOS:000238592200018
J	Czopik, AK; Bynoe, MS; Palm, N; Raine, CS; Medzhitov, R				Czopik, Agnieszka K.; Bynoe, Margaret S.; Palm, Noah; Raine, Cedric S.; Medzhitov, Ruslan			Semaphorin 7A is a negative regulator of T cell responses	IMMUNITY			English	Article							GROWTH CONE GUIDANCE; CBL-B; RECEPTOR; FAMILY; ACTIVATION; EXPRESSION; CD100; IV; PHOSPHORYLATION; TRANSMEMBRANE	Semaphorins play an essential role in axonal guidance, and emerging evidence points to diverse functions of several Semaphorin family members in the immune system. Semaphorin 7A (Sema7A) promotes axonal growth in the central nervous system. Here, we show that Sema7A also plays a critical role in negative regulation of T cell activation and function. T cells deficient in Sema7A exhibit enhanced homeostatic and antigen-induced proliferative response. Moreover, autoreactive Sema7A-deficient T cells mediate aggressive autoimmune disease. The deficiency in Sema7A leads to defective TCR downmodulation and T cell hyperres-ponsiveness. These results demonstrate an important role of Sema7A in limiting autoimmune responses and add to growing evidence of shared signaling pathways used by the immune and nervous systems.	Yale Univ, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Albert Einstein Coll Med, Dept Pathol, New York, NY 10461 USA; Albert Einstein Coll Med, Dept Neurol, New York, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yeshiva University; Yeshiva University; Yeshiva University	Medzhitov, R (corresponding author), Yale Univ, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Palm, Noah/0000-0001-7262-9455	NIAID NIH HHS [AI46688, AI055502] Funding Source: Medline; NINDS NIH HHS [NS08952, NS11920] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI055502, R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011920, P50NS011920] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelisova P, 1999, IMMUNOBIOLOGY, V200, P234, DOI 10.1016/S0171-2985(99)80073-4; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BISMUTH G, 2002, SCI STKE, pRE4; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Elhabazi A, 2003, CRIT REV IMMUNOL, V23, P65, DOI 10.1615/CritRevImmunol.v23.i12.40; Gallegos AM, 2004, CELL, V117, P149, DOI 10.1016/S0092-8674(04)00340-X; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hwa K, 2001, ADV EXP MED BIOL, V491, P207; Iwata S, 2000, J DERMATOL SCI, V23, P75, DOI 10.1016/S0923-1811(99)00096-1; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kumanogoh A, 2003, ADV IMMUNOL, V81, P173, DOI 10.1016/S0065-2776(03)81005-2; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magee T, 2002, BIOL RES, V35, P127, DOI 10.4067/S0716-97602002000200003; Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RAINE CS, 1997, TXB NEUROPATHOLOGY, P243; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Sato Y, 1998, BBA-GENE STRUCT EXPR, V1443, P419, DOI 10.1016/S0167-4781(98)00245-0; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Trautmann A, 2001, SCIENCE, V292, P1667, DOI 10.1126/science.1061542; Walzer T, 2005, INT IMMUNOL, V17, P943, DOI 10.1093/intimm/dxh274; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wong FS, 1999, IMMUNOL REV, V169, P93, DOI 10.1111/j.1600-065X.1999.tb01309.x; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428	50	89	96	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					591	600		10.1016/j.immuni.2006.03.013	http://dx.doi.org/10.1016/j.immuni.2006.03.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713976	Bronze			2022-12-18	WOS:000237970100015
J	Pillai, S				Pillai, S			The chosen few? Positive selection and the generation of naive B lymphocytes	IMMUNITY			English	Review							LYN-DEFICIENT MICE; X-LINKED AGAMMAGLOBULINEMIA; HUMORAL IMMUNE-RESPONSE; CELL ANTIGEN RECEPTOR; SURROGATE LIGHT CHAIN; SYK TYROSINE KINASE; NF-KAPPA-B; B-1 CELLS; BONE-MARROW; T-CELL		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA.							Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CAMBIER JC, 1993, IMMUNOL REV, V132, P85, DOI 10.1111/j.1600-065X.1993.tb00838.x; Cariappa A, 1999, J IMMUNOL, V162, P4417; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325; Cook MC, 1997, J EXP MED, V186, P631, DOI 10.1084/jem.186.5.631; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fulcher DA, 1997, EUR J IMMUNOL, V27, P1188, DOI 10.1002/eji.1830270521; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Humbert PO, 1997, J IMMUNOL, V159, P5273; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KEYNA U, 1995, J IMMUNOL, V155, P5536; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klaus GGB, 1997, EUR J IMMUNOL, V27, P2749, DOI 10.1002/eji.1830271102; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEITGES M, 1996, SCIENCE, V273, P988; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PILLAI S, 1991, INT REV CYTOL, V130, P1, DOI 10.1016/S0074-7696(08)61500-4; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; Snapper CM, 1996, J IMMUNOL, V156, P183; Solvason N, 1998, J EXP MED, V187, P1081, DOI 10.1084/jem.187.7.1081; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tarakhovsky A, 1997, J EXP MED, V185, P981, DOI 10.1084/jem.185.6.981; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; ten Boekel E, 1998, IMMUNITY, V8, P199; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; Wortis H H, 1992, Int Rev Immunol, V8, P235, DOI 10.3109/08830189209055576; Ye J, 1996, EMBO J, V15, P1524, DOI 10.1002/j.1460-2075.1996.tb00496.x; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003; YING-ZI C, 1991, International Immunology, V3, P467, DOI 10.1093/intimm/3.5.467; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	112	89	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					493	502		10.1016/S1074-7613(00)80049-7	http://dx.doi.org/10.1016/S1074-7613(00)80049-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367895	Bronze			2022-12-18	WOS:000080709400001
J	Okamura, K; Ototake, M; Nakanishi, T; Kurosawa, Y; Hashimoto, K				Okamura, K; Ototake, M; Nakanishi, T; Kurosawa, Y; Hashimoto, K			The most primitive vertebrates with jaws possess highly polymorphic MHC class I genes comparable to those of humans	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RECEPTOR; HLA-B ALLELES; ANTIGEN PRESENTATION; CARTILAGINOUS FISH; MOLECULAR ANALYSIS; NATURAL-SELECTION; ALPHA-3 DOMAIN; DIVERSITY; PEPTIDE	We report the isolation and extensive analysis of highly polymorphic MHC class I genes from sharks (Triakis scyllia), which belong to the most primitive vertebrate group with jaws, the cartilaginous fish. Predicted complete peptide-binding domains showed retention of the critical amino acid residues that would interact with antigenic peptide termini and revealed extensive allelic polymorphisms comparable to those of classic human MHC class I molecules. Mosaic structures were apparent in these domains, suggesting recombinational mechanisms to create allelic diversity. The present study demonstrates the establishment of the basic strategy for antigen-presentation employed by MHC class I molecules and documents complete divergence of two polymorphic MHC classes at a phylogenetically primitive stage of vertebrate evolution.	Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 47011, Japan; Natl Res Inst Aquaculture, Tamaki, Mie 51904, Japan	Fujita Health University; Japan Fisheries Research & Education Agency (FRA)	Hashimoto, K (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 47011, Japan.		Nakanishi, Teruyuki/AAR-3019-2020					BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; BARTL S, 1997, IN PRESS J IMMUNOL, V159; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BORYSENKO M, 1970, TRANSPLANTATION, V10, P545, DOI 10.1097/00007890-197012000-00012; DIXON B, 1995, DEV COMP IMMUNOL, V19, P109, DOI 10.1016/0145-305X(94)00056-L; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; HASHIMOTO K, 1992, P NATL ACAD SCI USA, V89, P2209, DOI 10.1073/pnas.89.6.2209; HASHIMOTO K, 1990, P NATL ACAD SCI USA, V87, P6863, DOI 10.1073/pnas.87.17.6863; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUNT HD, 1994, IMMUNOGENETICS, V40, P370, DOI 10.1007/BF01246678; ISHIZAWA M, 1991, NUCLEIC ACIDS RES, V19, P5792, DOI 10.1093/nar/19.20.5792; Kandil E, 1996, J IMMUNOL, V156, P4245; KASAHARA M, 1993, EUR J IMMUNOL, V23, P2160, DOI 10.1002/eji.1830230917; KASAHARA M, 1992, P NATL ACAD SCI USA, V89, P6688, DOI 10.1073/pnas.89.15.6688; KAUFMAN J, 1990, IMMUNOL REV, V113, P83, DOI 10.1111/j.1600-065X.1990.tb00038.x; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KROEMER G, 1990, IMMUNOGENETICS, V31, P405, DOI 10.1007/BF02115020; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MIKKO S, 1995, P NATL ACAD SCI USA, V92, P4259, DOI 10.1073/pnas.92.10.4259; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; PEREY DYE, 1968, LAB INVEST, V19, P591; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; PULLEN JK, 1992, J IMMUNOL, V148, P953; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Sambrook J, 1989, MOL CLONING LAB MANU; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SHE JX, 1991, P NATL ACAD SCI USA, V88, P453, DOI 10.1073/pnas.88.2.453; SUN JR, 1995, J EXP MED, V182, P1275, DOI 10.1084/jem.182.5.1275; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; vanErp SHM, 1996, IMMUNOGENETICS, V44, P49, DOI 10.1007/BF02602656; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YUHKI N, 1990, J EXP MED, V172, P621, DOI 10.1084/jem.172.2.621; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407; ZOOROB R, 1993, EUR J IMMUNOL, V23, P1139, DOI 10.1002/eji.1830230524	49	89	92	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					777	790		10.1016/S1074-7613(00)80396-9	http://dx.doi.org/10.1016/S1074-7613(00)80396-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430223	Bronze			2022-12-18	WOS:000071351300005
J	Candeias, S; Muegge, K; Durum, SK				Candeias, S; Muegge, K; Durum, SK			IL-7 receptor and VDJ recombination: Trophic versus mechanistic actions	IMMUNITY			English	Review							REGION GENE SEGMENTS; SEVERE COMBINED IMMUNODEFICIENCY; THYMOCYTES IN-VIVO; MICE LACKING JAK3; T-LINEAGE CELLS; PRE-B-CELLS; GAMMA-CHAIN; V(D)J RECOMBINATION; TRANSGENIC MICE; ALPHA-BETA		NCI,SAIC,FREDERICK CANC RES & DEV CTR,FREDERICK,MD 21702; NCI,MOL IMMUNOREGULAT LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Candeias, Serge/0000-0003-2257-5529; durum, scott/0000-0003-1307-9582				ALVAREZ JD, 1995, J IMMUNOL, V155, P1191; APPASAMY PM, 1993, J EXP MED, V178, P2201, DOI 10.1084/jem.178.6.2201; BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CANDEIAS S, 1994, EUR J IMMUNOL, V24, P3073, DOI 10.1002/eji.1830241224; Candeias S, 1996, J EXP MED, V184, P1919, DOI 10.1084/jem.184.5.1919; CANDELAS S, 1997, IN PRESS IMMUNOL LET; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Clegg CH, 1996, NATURE, V384, P261, DOI 10.1038/384261a0; CONLON PJ, 1989, BLOOD, V74, P1368; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Crompton T, 1997, EUR J IMMUNOL, V27, P100, DOI 10.1002/eji.1830270115; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FISHER AG, 1995, INT IMMUNOL, V7, P415, DOI 10.1093/intimm/7.3.415; FONDELL JD, 1992, MOL CELL BIOL, V12, P1480, DOI 10.1128/MCB.12.4.1480; FOXWELL BMJ, 1995, EUR J IMMUNOL, V25, P3041, DOI 10.1002/eji.1830251109; FRIEND SL, 1994, EXP HEMATOL, V22, P321; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOTLIEB WH, 1993, CELL IMMUNOL, V151, P345, DOI 10.1006/cimm.1993.1244; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; GRZEGORZEWSKI KJ, 1995, J EXP MED, V181, P369, DOI 10.1084/jem.181.1.369; GU Y, 1992, P NATL ACAD SCI USA, V89, P10464, DOI 10.1073/pnas.89.21.10464; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; HENDERSON AJ, 1992, J IMMUNOL, V149, P1973; HERNANDEZCASELLES T, 1995, HUM IMMUNOL, V43, P181, DOI 10.1016/0198-8859(94)00168-P; HSIANG YHH, 1995, J IMMUNOL, V154, P5195; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KENAI H, 1993, EUR J IMMUNOL, V23, P1818, DOI 10.1002/eji.1830230813; KOMSCHLIES KL, 1994, J IMMUNOL, V152, P5776; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; LAUSTER R, 1993, EMBO J, V12, P4615, DOI 10.1002/j.1460-2075.1993.tb06150.x; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Lee SH, 1996, ONCOGENE, V13, P2131; LeiteDeMoraes MD, 1997, INT IMMUNOL, V9, P73, DOI 10.1093/intimm/9.1.73; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Matsuzaki Y, 1997, BLOOD, V89, P853, DOI 10.1182/blood.V89.3.853; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore TA, 1996, J IMMUNOL, V157, P2366; MORRISSEY PJ, 1994, CELL IMMUNOL, V157, P118, DOI 10.1006/cimm.1994.1210; MUEGGE K, 1993, SCIENCE, V261, P93, DOI 10.1126/science.7686307; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; Oosterwegel MA, 1997, IMMUNITY, V6, P351, DOI 10.1016/S1074-7613(00)80337-4; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PESCHON JJ, 1997, CYTOKINE KNOCKOUTS; Pribyl JAR, 1996, P NATL ACAD SCI USA, V93, P10348, DOI 10.1073/pnas.93.19.10348; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; RICH BE, 1995, J EXP MED, V181, P1223, DOI 10.1084/jem.181.3.1223; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SERVE M, 1993, EMBO J, V12, P2321; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIM GK, 1995, J IMMUNOL, V154, P5821; SLEASMAN JW, 1994, J IMMUNOL, V153, P442; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SPENCER DM, 1991, P NATL ACAD SCI USA, V88, P800, DOI 10.1073/pnas.88.3.800; TAGOH H, 1996, BLOOD, V89, P4463; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; Takeda S, 1997, BLOOD, V89, P518, DOI 10.1182/blood.V89.2.518; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tsuda S, 1996, J IMMUNOL, V156, P3233; VALENZONA HE, 1996, EXP HEMATOL, V24, P1525; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VERNOOIJ BTM, 1993, GENOMICS, V17, P566, DOI 10.1006/geno.1993.1373; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; VONFREEDENJEFFR.U, 1997, CYTOKINE KNOCKOUTS; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WATSON JD, 1989, J IMMUNOL, V143, P1215; WEAVER DT, 1995, ADV IMMUNOL, V58, P29, DOI 10.1016/S0065-2776(08)60619-7; WEINSTEIN Y, 1989, J EXP MED, V169, P2059, DOI 10.1084/jem.169.6.2059; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	101	89	93	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					501	508		10.1016/S1074-7613(00)80338-6	http://dx.doi.org/10.1016/S1074-7613(00)80338-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175828	Bronze			2022-12-18	WOS:A1997XB81900001
J	Henderson, AJ; Connor, RI; Calame, KL				Henderson, AJ; Connor, RI; Calame, KL			C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; NF-KAPPA-B; NECROSIS FACTOR-ALPHA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PERIPHERAL-BLOOD; LEUCINE ZIPPER; MONONUCLEAR PHAGOCYTES; DNA RECOGNITION	Previous work has shown that C/EBP sites and C/EBP transcriptional activators are necessary for HIV-1 LTR activity in monocytes/macrophages. We have investigated the role that C/EBP proteins play in induction and replication of HIV-1. Ectopic expression of the dominant negative C/EBP protein LIP inhibited HIV-1 mRNA and virus production in activated U1 cells, demonstrating that C/EBP proteins are required for provirus induction. U1 lines overexpressing C/EBP activator NF-IL-6 produced more viral mRNA and virus particles following cellular activation than control lines, demonstrating that C/EBP proteins are limiting for virus transcription. HIV-1 harboring mutations within two C/EBP sites were crippled in their ability to replicate in U937 promonocytic cells, indicating that these sites are required for replication. These data identify C/EBP proteins as regulators of HIV-1 expression in monocytes/macrophages.	AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016		Henderson, AJ (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032, USA.			Henderson, Andrew/0000-0002-9299-5302	NIGMS NIH HHS [GM44300, GM29361] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029361] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BREEN EC, 1990, J IMMUNOL, V144, P480; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER C, 1992, J IMMUNOL, V149, P3225; COOPER CL, 1994, J IMMUNOL, V153, P5049; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FAUCI AS, 1988, SCIENCE, V239, P480; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1988, J IMMUNOL, V140, P1117; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRIFFIN GE, 1991, RES VIROLOGY, V142, P233, DOI 10.1016/0923-2516(91)90062-8; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; HARRICH D, 1989, J VIROL, V63, P2585, DOI 10.1128/JVI.63.6.2585-2591.1989; HEINZEL SS, 1988, J VIROL, V62, P3738, DOI 10.1128/JVI.62.10.3738-3746.1988; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; KIM JYH, 1993, J VIROL, V67, P1658, DOI 10.1128/JVI.67.3.1658-1662.1993; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; LU YC, 1989, J VIROL, V63, P4115, DOI 10.1128/JVI.63.9.4115-4119.1989; LUBBERT M, 1991, BLOOD, V77, P909; MCCUNE JM, 1995, CELL, V82, P183, DOI 10.1016/0092-8674(95)90305-4; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NATSUKA S, 1992, BLOOD, V79, P460; PARROTT C, 1991, J VIROL, V65, P1414, DOI 10.1128/JVI.65.3.1414-1419.1991; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; POLI G, 1994, P NATL ACAD SCI USA, V91, P108, DOI 10.1073/pnas.91.1.108; POLI G, 1994, RES IMMUNOL, V145, P578, DOI 10.1016/S0923-2494(05)80036-7; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; ROMAN C, 1990, GENE DEV, V4, P1404, DOI 10.1101/gad.4.8.1404; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; ROULSTON A, 1992, J EXP MED, V175, P751, DOI 10.1084/jem.175.3.751; SAKAGUCHI M, 1991, J VIROL, V65, P5448, DOI 10.1128/JVI.65.10.5448-5456.1991; SAKSELA K, 1993, J VIROL, V67, P7423, DOI 10.1128/JVI.67.12.7423-7427.1993; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SCREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; SUZAN M, 1991, J IMMUNOL, V146, P377; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; VANVOORHIS WC, 1983, J EXP MED, V158, P126, DOI 10.1084/jem.158.1.126; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553	64	89	89	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					91	101		10.1016/S1074-7613(00)80313-1	http://dx.doi.org/10.1016/S1074-7613(00)80313-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758898	Bronze			2022-12-18	WOS:A1996UZ45400010
J	HEEMELS, MT; PLOEGH, HL				HEEMELS, MT; PLOEGH, HL			SUBSTRATE-SPECIFICITY OF ALLELIC VARIANTS OF THE TAP PEPTIDE TRANSPORTER	IMMUNITY			English	Article							CLASS-I MOLECULE; ANTIGEN PRESENTATION; ENDOPLASMIC-RETICULUM; MICROSOMAL-MEMBRANES; MURINE MHC; COMPLEX; TRANSLOCATION; REGION; SEPARATION; PROTEINS	The transporter associated with antigen processing (TAP) translocates peptides from the cytosol into the lumen of the endoplasmic reticulum (ER). An important determinant for the specificity of translocation is the identity of the C-terminal residue of the peptide substrate. In the rat, a suitable C terminus is necessary but not always sufficient for a peptide to be selected for translocation. Here we show that sequence constraints within a peptide of optimal length (9 residues) may interfere with transport; that the transporter selectively translocates shorter derivatives of a 16-mer peptide rather than the 16-mer itself; and that the transporter cim(b) allele, which is most selective in the C termini it will tolerate, is more relaxed in peptide length preference than is the cim(a) variant.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT)	HEEMELS, MT (corresponding author), MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA.			Heemels, Marie Therese/0000-0002-4364-3116	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033456] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI3 3456-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; BIJLMAKERS MJE, 1993, EUR J IMMUNOL, V23, P1305, DOI 10.1002/eji.1830230618; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; DECAMPOSLIMA PO, 1994, J EXP MED, V179, P1297, DOI 10.1084/jem.179.4.1297; DERES K, 1992, EUR J IMMUNOL, V22, P1603, DOI 10.1002/eji.1830220638; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOPPELMAN B, 1992, P NATL ACAD SCI USA, V89, P3908, DOI 10.1073/pnas.89.9.3908; LAMBRACHT D, 1993, TRANSPL P, V25, P2756; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; POWIS SJ, 1991, J EXP MED, V173, P913, DOI 10.1084/jem.173.4.913; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Romisch Karin, 1994, Trends in Cell Biology, V4, P311, DOI 10.1016/0962-8924(94)90227-5; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SCHUMACHER TNM, 1994, IN PRESS P NATL ACAD; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SIJTS AJAM, 1994, J IMMUNOL, V152, P106; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5	41	89	90	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1994	1	9					775	784		10.1016/S1074-7613(94)80019-7	http://dx.doi.org/10.1016/S1074-7613(94)80019-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895166				2022-12-18	WOS:A1994PX64800007
J	Elsner, RA; Shlomchik, MJ				Elsner, Rebecca A.; Shlomchik, Mark J.			Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity	IMMUNITY			English	Review							CLASS SWITCH RECOMBINATION; COMMON VARIABLE IMMUNODEFICIENCY; FOLLICULAR-HELPER-CELLS; LYMPH-NODE ARCHITECTURE; NECROSIS-FACTOR FAMILY; CHRONIC HEPATITIS-C; LIVED PLASMA-CELLS; MEMORY B; AFFINITY MATURATION; SOMATIC HYPERMUTATION	Activated B cells participate in either extrafollicular (EF) or germinal center (GC) responses. Canonical responses are composed of a short wave of plasmablasts (PBs) arising from EF sites, followed by GC producing somatically mutated memory B cells (MBC) and long-lived plasma cells. However. somatic hypermutation (SHM) and affinity maturation can take place at both sites, and a substantial fraction of MBC are produced prior to GC formation. Infection responses range from GC responses that persist for months to persistent EF responses with dominant suppression of GCs. Here, we review the current understanding of the functional output of EF and GC responses and the molecular switches promoting them. We discuss the signals that regulate the magnitude and duration of these responses, and outline gaps in knowledge and important areas of inquiry. Understanding such molecular switches will be critical for vaccine development, interpretation of vaccine efficacy and the treatment for autoimmune diseases.	[Elsner, Rebecca A.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15216 USA.	mshlomch@pitt.edu			NIH [T32 AI060525, T32 AI089443, R01 AI105018, R01 AI043603]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants T32 AI060525, T32 AI089443, R01 AI105018, and R01 AI043603.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Allman D, 2019, IMMUNOL REV, V288, P128, DOI 10.1111/imr.12754; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Arkatkar T, 2017, J EXP MED, V214, P3207, DOI 10.1084/jem.20170580; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; Buchanan RM, 1998, J IMMUNOL, V161, P5525; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Clark MR, 2015, SEMIN NEPHROL, V35, P455, DOI 10.1016/j.semnephrol.2015.08.007; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; De Giovanni M, 2020, NAT IMMUNOL, V21, P321, DOI 10.1038/s41590-020-0596-6; de Ruiter PE, 2015, EUR J IMMUNOL, V45, P1570, DOI 10.1002/eji.201445389; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Elsner RA, 2019, CELL REP, V29, P2796, DOI 10.1016/j.celrep.2019.10.069; Elsner RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004976; Elsner RA, 2012, J VIROL, V86, P7146, DOI 10.1128/JVI.06904-11; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817; Faro J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02038; Fink K, 2007, J IMMUNOL, V179, P5877, DOI 10.4049/jimmunol.179.9.5877; Foote JB, 2012, J IMMUNOL, V188, P57, DOI 10.4049/jimmunol.1100783; FRENI MA, 1995, HEPATOLOGY, V22, P389, DOI 10.1002/hep.1840220203; Goenka R, 2014, CYTOKINE GROWTH F R, V25, P107, DOI 10.1016/j.cytogfr.2014.01.001; Goenka R, 2014, J EXP MED, V211, P45, DOI 10.1084/jem.20130505; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Haley SL, 2017, J VIROL, V91, DOI 10.1128/JVI.02435-16; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hardenberg G, 2008, IMMUNOL CELL BIOL, V86, P530, DOI 10.1038/icb.2008.17; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hastey CJ, 2014, INFECT IMMUN, V82, P1548, DOI 10.1128/IAI.00969-13; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; Ise W, 2019, IMMUNOL REV, V288, P64, DOI 10.1111/imr.12751; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kellam P, 2020, J GEN VIROL, V101, P791, DOI 10.1099/jgv.0.001439; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; Kleinstein SH, 2003, J IMMUNOL, V171, P4639, DOI 10.4049/jimmunol.171.9.4639; Koenig A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00646; Konigsberg M, 2013, REDOX BIOL, V1, P475, DOI 10.1016/j.redox.2013.09.004; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Kyttaris VC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/861028; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Li JSY, 2002, J IMMUNOL, V169, P1419, DOI 10.4049/jimmunol.169.3.1419; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu SM, 2013, J IMMUNOL, V191, P3501, DOI 10.4049/jimmunol.1301454; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Lu E, 2019, IMMUNOL REV, V289, P158, DOI 10.1111/imr.12743; Luo SS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02938; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MACLENNAN ICM, 1991, RES IMMUNOL, V142, P253, DOI 10.1016/0923-2494(91)90070-Y; Manne C, 2019, P NATL ACAD SCI USA, V116, P7425, DOI 10.1073/pnas.1818242116; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Nakajima A, 1997, J IMMUNOL, V158, P1466; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nanton MR, 2015, EUR J IMMUNOL, V45, P428, DOI 10.1002/eji.201444540; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Noroozi R, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155143; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Nzula S, 2003, CANCER RES, V63, P3275; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Papillion A, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw7636; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Popescu M, 2019, J IMMUNOL, V203, P2415, DOI 10.4049/jimmunol.1900484; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; RIECKMANN P, 1991, J IMMUNOL, V146, P3462; ROARK JH, 1995, J IMMUNOL, V154, P4444; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sakai J, 2017, CLIN MICROBIOL REV, V30, P991, DOI 10.1128/CMR.00046-17; Sallenave JM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01229; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sang A, 2014, J IMMUNOL, V193, P1609, DOI 10.4049/jimmunol.1303000; Sangster MY, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040167; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; Sheikh AA, 2019, CELL REP, V28, P1758, DOI 10.1016/j.celrep.2019.07.034; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Silva-Cayetano A, 2020, CURR OPIN IMMUNOL, V64, P26, DOI 10.1016/j.coi.2020.03.007; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Suhandynata RT, 2020, J APPL LAB MED, V5, P908, DOI 10.1093/jalm/jfaa079; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tian MJ, 2018, J IMMUNOL, V200, P937, DOI 10.4049/jimmunol.1701067; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Trivedi N, 2019, IMMUNITY, V51, P1088, DOI 10.1016/j.immuni.2019.10.004; van Vollenhoven RF, 2018, LANCET, V392, P1330, DOI 10.1016/S0140-6736(18)32167-6; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vijay R, 2020, NAT IMMUNOL, V21, P790, DOI 10.1038/s41590-020-0678-5; Vincent FB, 2013, CYTOKINE GROWTH F R, V24, P203, DOI 10.1016/j.cytogfr.2013.04.003; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Weinstein JS, 2008, J IMMUNOL, V181, P3259, DOI 10.4049/jimmunol.181.5.3259; Weinstein JS, 2018, J EXP MED, V215, P337, DOI 10.1084/jem.20170457; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; William J, 2005, J IMMUNOL, V174, P6872, DOI 10.4049/jimmunol.174.11.6872; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wilmore JR, 2013, J IMMUNOL, V191, P4731, DOI 10.4049/jimmunol.1301450; Wojno EDT, 2019, IMMUNITY, V50, P851, DOI 10.1016/j.immuni.2019.03.011; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; YOSHIZAKI K, 1984, J IMMUNOL, V132, P2948; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	206	88	89	5	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1136	1150		10.1016/j.immuni.2020.11.006	http://dx.doi.org/10.1016/j.immuni.2020.11.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326765	Green Accepted, Bronze			2022-12-18	WOS:000599363300006
J	Wallrapp, A; Burkett, PR; Riesenfeld, SJ; Kim, SJ; Christian, E; Abdulnour, REE; Thakore, PI; Schnell, A; Lambden, C; Herbst, RH; Khan, P; Tsujikawa, K; Xavier, RJ; Chiu, IM; Levy, BD; Regev, A; Kuchroo, VK				Wallrapp, Antonia; Burkett, Patrick R.; Riesenfeld, Samantha J.; Kim, Se-Jin; Christian, Elena; Abdulnour, Raja-Elie E.; Thakore, Pratiksha, I; Schnell, Alexandra; Lambden, Conner; Herbst, Rebecca H.; Khan, Pavana; Tsujikawa, Kazutake; Xavier, Ramnik J.; Chiu, Isaac M.; Levy, Bruce D.; Regev, Aviv; Kuchroo, Vijay K.			Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses	IMMUNITY			English	Article							NATURAL HELPER-CELLS; SENSORY NEURONS; AIRWAY SENSORS; T-CELLS; RNA-SEQ; INTERLEUKIN-33; ACTIVATION; GENERATION; RESOLUTION; DEFICIENT	Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo. CGRP induced marked changes in ILC2 expression programs in vivo and in vitro, attenuating alarmin-driven proliferative and effector responses. A distinct subset of ILCs scored highly for a CGRP-specific gene signature after in vivo alarmin stimulation, suggesting CGRP regulated this response. Finally, we observed increased ILC2 proliferation and type 2 cytokine production as well as exaggerated responses to alarmins in mice lacking the CGRP receptor. Together, these data indicate that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.	[Wallrapp, Antonia; Burkett, Patrick R.; Kim, Se-Jin; Christian, Elena; Schnell, Alexandra; Lambden, Conner; Kuchroo, Vijay K.] Harvard Med Sch, lEvergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Wallrapp, Antonia; Burkett, Patrick R.; Kim, Se-Jin; Christian, Elena; Schnell, Alexandra; Lambden, Conner; Kuchroo, Vijay K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Burkett, Patrick R.; Kim, Se-Jin; Abdulnour, Raja-Elie E.; Khan, Pavana; Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Riesenfeld, Samantha J.; Christian, Elena; Thakore, Pratiksha, I; Lambden, Conner; Herbst, Rebecca H.; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka 5650871, Japan; [Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Chiu, Isaac M.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Osaka University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kuchroo, VK (corresponding author), Harvard Med Sch, lEvergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Regev, A; Kuchroo, VK (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	aregev@broadinstitute.org; vkuchroo@evergrande.hms.harvard.edu		Schnell, Alexandra/0000-0003-3442-7750; Riesenfeld, Samantha/0000-0001-9144-021X; Khan, Pavana/0000-0002-2891-5101; Kim, Se-Jin/0000-0002-6704-4644; Christian, Elena/0000-0002-5593-0155; Wallrapp, Antonia/0000-0002-3176-1553	Boehringer Ingelheim Fonds PhD fellowship; NIH [1K08HL130540, F32AI138458, R01 HL122531, R01 AI130019, R01 AI139536, 1K08AI123516]; Howard Hughes Medical Institute; Food Allergy Scientific Initiative; Klarman Cell Observatory at the Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL130540, R01HL122531] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI123516, R01AI130019, R01AI139536, F32AI138458] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Food Allergy Scientific Initiative; Klarman Cell Observatory at the Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Junrong Xia, Guangli Zhu, Dan Dubinsky, Deneen Kozoriz, Helene Stroh, and the Dana Farber Cancer Institute Rodent Histopathology Core for technical assistance. Mark Zylka and Eric McCoy (University of North Carolina) originally generated the CGRP-GFP reporter mice. Felipe Pinho-Ribeiro bred the mice at Harvard Medical School. A.W. is a PhD student who is jointly supervised by V.K.K. and Hans-Martin Jack (Friedrich-Alexander University of Erlangen-Nurnberg, Erlangen, Germany) and has been supported by a Boehringer Ingelheim Fonds PhD fellowship. P.R.B. (1K08AI123516), R.E.A. (1K08HL130540), P.I.T. (F32AI138458), B.D.L. (R01 HL122531), I.M.C. (R01 AI130019), and V.K.K. (R01 AI139536) are supported by the NIH. A.R. is supported by the Howard Hughes Medical Institute. We also acknowledge the support of the Food Allergy Scientific Initiative (A.R. and V.K.K.) and the Klarman Cell Observatory (A.R.) at the Broad Institute. A.R. is an HHMI investigator.	Aoki-Nagase T, 2002, AM J PHYSIOL-LUNG C, V283, pL963, DOI 10.1152/ajplung.00130.2002; Baliu-Pique M, 2014, EUR J IMMUNOL, V44, P3708, DOI 10.1002/eji.201444553; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Collier GR, 2000, DIABETES, V49, P1766, DOI 10.2337/diabetes.49.11.1766; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Domnik NJ, 2011, CURR OPIN PHARMACOL, V11, P211, DOI 10.1016/j.coph.2011.04.003; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Hafemeister C., 2019, BIORXIV, DOI [10.1101/576827, DOI 10.1101/576827]; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Hoyer D, 2012, CHEM BIODIVERS, V9, P2367, DOI 10.1002/cbdv.201200288; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jusek G, 2012, IMMUNOBIOLOGY, V217, P761, DOI 10.1016/j.imbio.2012.04.009; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Li H, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01048; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majumdar ID, 2011, CURR OPIN ENDOCRINOL, V18, P68, DOI 10.1097/MED.0b013e328340ff93; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Powell JD, 1999, J IMMUNOL, V162, P2775; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raker VK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00123; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Roediger B, 2015, J ALLERGY CLIN IMMUN, V136, P1653, DOI 10.1016/j.jaci.2015.03.043; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Springer J, 2004, REGUL PEPTIDES, V118, P127, DOI 10.1016/j.regpep.2003.11.006; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; Wallrapp A, 2018, IMMUNOL REV, V286, P53, DOI 10.1111/imr.12702; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu S, 2014, J ALLERGY CLIN IMMUN, V133, P943, DOI 10.1016/j.jaci.2014.02.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	88	89	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					709	+		10.1016/j.immuni.2019.09.005	http://dx.doi.org/10.1016/j.immuni.2019.09.005			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31604686	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000490141700016
J	Leyva-Castillo, JM; Galand, C; Kam, C; Burton, O; Gurish, M; Musser, MA; Goldsmith, JD; Hait, E; Nurko, S; Brombacher, F; Dong, C; Finkelman, FD; Lee, RT; Ziegler, S; Chiu, I; Austen, KF; Geha, RS				Leyva-Castillo, Juan-Manuel; Galand, Claire; Kam, Christy; Burton, Oliver; Gurish, Michael; Musser, Melissa A.; Goldsmith, Jeffrey D.; Hait, Elizabeth; Nurko, Samuel; Brombacher, Frank; Dong, Chen; Finkelman, Fred D.; Lee, Richard T.; Ziegler, Steven; Chiu, Isaac; Austen, K. Frank; Geha, Raif S.			Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; BARRIER FUNCTION; IL-33 PROMOTES; DEFICIENT MICE; TUFT CELLS; ROR-ALPHA; IGE; PERMEABILITY; SENSITIZATION; INFLAMMATION	Mast cell (MC) mediator release after crosslinking of surface-bound IgE antibody by ingested antigen underlies food allergy. However, IgE antibodies are not uniformly associated with food allergy, and intestinal MC load is an important determinant. Atopic dermatitis (AD), characterized by pruritis and cutaneous sensitization to allergens, including foods, is strongly associated with food allergy. Tape stripping mouse skin, a surrogate for scratching, caused expansion and activation of small intestinal MCs, increased intestinal permeability, and promoted food anaphylaxis in sensitized mice. Tape stripping caused keratinocytes to systemically release interleukin-33 (IL-33), which synergized with intestinal tuft-cell-derived IL-25 to drive the expansion and activation of intestinal type-2 innate lymphoid cells (ILC2s). These provided IL-4, which targeted MCs to expand in the intestine. Duodenal MCs were expanded in AD. In addition to promoting cutaneous sensitization to foods, scratching may promote food anaphylaxis in AD by expanding and activating intestinal MCs.	[Leyva-Castillo, Juan-Manuel; Galand, Claire; Kam, Christy; Burton, Oliver; Geha, Raif S.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Gurish, Michael; Austen, K. Frank] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Musser, Melissa A.; Chiu, Isaac] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Goldsmith, Jeffrey D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Hait, Elizabeth; Nurko, Samuel] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Brombacher, Frank] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Rondebosch, South Africa; [Brombacher, Frank] South Africa Med Res Council, Pietermaritzburg, South Africa; [Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Dong, Chen] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Dept Internal Med, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ziegler, Steven] Benaroya Res Inst, Program Immunol, Seattle, WA USA; [Galand, Claire] Agenus Inc, 3 Forbes Rd, Lexington, MA 02421 USA; [Burton, Oliver] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Tsinghua University; Tsinghua University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Benaroya Research Institute; Agenus Inc; Flanders Institute for Biotechnology (VIB)	Geha, RS (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	dong, chen/B-3181-2009; Chiu, Isaac/R-3803-2016	dong, chen/0000-0002-0084-9130; Lee, Richard/0000-0003-4687-1381; Nurko, Samuel/0000-0003-0936-4807; Leyva Castillo, Juan Manuel/0000-0001-7394-4457; Kam, Christy/0000-0002-8834-4929; Chiu, Isaac/0000-0002-0723-4841	NIH [AI113294-01A1, U19 AI117673]; NIAID T32 training grant [5T32AI007512]; National Center for Complementary & Integrative Health [DP2AT009499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673, T32AI007512, R01AI113294, R01AI130019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID T32 training grant; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. T. Chatila for his gift of Mcpt5-cre<SUP>Tg/0</SUP> mice; Dr. Andrew N.J. McKenzie for his gift of Il1rl1<SUP>-/-</SUP> and Il17rb<SUP>-/-</SUP> mice; Dr. Dennis O'Leary for his gift of Rora<SUP>cre/cre</SUP> mice; Dr. Nicolas Severe for help in immunofluorescence imaging; and Drs. T. Chatila, H. Oettgen, and J. Chou for reading the manuscript and for useful discussions. This work was supported by NIH grants AI113294-01A1 and U19 AI117673. J.-M.L.-C. is supported by NIAID T32 training grant (5T32AI007512).	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Caffarelli C, 2001, ANN ALLERG ASTHMA IM, V86, P665, DOI 10.1016/S1081-1206(10)62296-X; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Fleischer DM, 2011, J PEDIATR-US, V158, P578, DOI 10.1016/j.jpeds.2010.09.027; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Galand C, 2016, J ALLERGY CLIN IMMUN, V138, P1356, DOI 10.1016/j.jaci.2016.03.056; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; KALIMO K, 1988, BRIT J DERMATOL, V119, P579, DOI 10.1111/j.1365-2133.1988.tb03468.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lee H, 2013, J NEUROGASTROENTEROL, V19, P244, DOI 10.5056/jnm.2013.19.2.244; Leisten S, 2013, J ALLERGY CLIN IMMUN, V131, P1247, DOI 10.1016/j.jaci.2012.12.1576; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li M, 2001, DEVELOPMENT, V128, P675; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mukai K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00053-17; Oettgen HC, 2015, ADV IMMUNOL, V127, P203, DOI 10.1016/bs.ai.2015.03.001; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; PIKE MG, 1986, J INVEST DERMATOL, V86, P101, DOI 10.1111/1523-1747.ep12284035; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Sicherer SH, 2009, ANNU REV MED, V60, P261, DOI 10.1146/annurev.med.60.042407.205711; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; Sugarman JL, 2003, ARCH DERMATOL, V139, P1417, DOI 10.1001/archderm.139.11.1417; Vaali K, 2012, NEUROGASTROENT MOTIL, V24, pe325, DOI 10.1111/j.1365-2982.2012.01941.x; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; J EXP MED, V191, P1069; 2012, J INVEST DERMATOL, V132, P1392, DOI DOI 10.1038/JID.2011.446	49	88	91	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1262	+		10.1016/j.immuni.2019.03.023	http://dx.doi.org/10.1016/j.immuni.2019.03.023			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31027995	Green Accepted, Bronze			2022-12-18	WOS:000468429500016
J	Bianchi, M; Turner, HL; Nogal, B; Cottrell, CA; Oyen, D; Pauthner, M; Bastidas, R; Nedellec, R; Mccoy, LE; Wilson, IA; Burton, DR; Ward, AB; Hangartner, L				Bianchi, Matteo; Turner, Hannah L.; Nogal, Bartek; Cottrell, Christopher A.; Oyen, David; Pauthner, Matthias; Bastidas, Raiza; Nedellec, Rebecca; Mccoy, Laura E.; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.; Hangartner, Lars			Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; GLYCOPROTEIN COMPLEX; DEPENDENT EPITOPE; V2 APEX; IDENTIFICATION; QUATERNARY; ELICITATION; IMMUNOGENICITY; PRECURSORS	Characterizing polyclonal antibody responses via currently available methods is inherently complex and difficult. Mapping epitopes in an immune response is typically incomplete, which creates a barrier to fully understanding the humoral response to antigens and hinders rational vaccine design efforts. Here, we describe a method of characterizing polyclonal responses by using electron microscopy, and we applied this method to the immunization of rabbits with an HIV-1 envelope glycoprotein vaccine candidate, BG505 SOSIP.664. We detected known epitopes within the polyclonal sera and revealed how antibody responses evolved during the prime-boosting strategy to ultimately result in a neutralizing antibody response. We uncovered previously unidentified epitopes, including an epitope proximal to one recognized by human broadly neutralizing antibodies as well as potentially distracting nonneutralizing epitopes. Our method provides an efficient and semiquantitative map of epitopes that are targeted in a polyclonal antibody response and should be of widespread utility in vaccine and infection studies.	[Bianchi, Matteo; Pauthner, Matthias; Bastidas, Raiza; Nedellec, Rebecca; Burton, Dennis R.; Hangartner, Lars] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Turner, Hannah L.; Nogal, Bartek; Cottrell, Christopher A.; Oyen, David; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mccoy, Laura E.] UCL, Div Infect & Immun, London WC1E 6BT, England; [Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.; Hangartner, Lars] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA; [Bianchi, Matteo] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland	Scripps Research Institute; Scripps Research Institute; University of London; University College London; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Zurich	Hangartner, L (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Ward, AB (corresponding author), Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA.; Ward, AB; Hangartner, L (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.	andrew@scripps.edu; lhangart@scripps.edu	Hangartner, Lars/AAS-1320-2021; Ward, Andrew/ABD-7728-2021; Cottrell, Christopher A/P-3514-2015; Ward, Andrew B/F-9203-2014	Hangartner, Lars/0000-0002-3165-2058; Ward, Andrew/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Ward, Andrew B/0000-0001-7153-3769; Bianchi, Matteo/0000-0003-0517-8599; McCoy, Laura/0000-0001-9503-7946; Pauthner, Matthias G./0000-0001-9212-4307	NIH [UM1 AI100663]; Bill and Melinda Gates Foundation [OPP1115782, OPP1084519]; Swiss National Science Foundation [PP00P3_146345, P300PB_160969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI131873, UM1AI100663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daniel W. Kulp and William R. Schief for the BG505 MD39 CPG9 protein. We also thank Aleksandar Antanasijevic for early work on the polyclonal mapping project and Charles Bowman and Gabriel Ozorowski for helpful discussions regarding data interpretation. This work was supported by NIH grant UM1 AI100663 (Scripps CHAVI-ID), Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery grants OPP1115782 and OPP1084519, and Swiss National Science Foundation grants PP00P3_146345 and P300PB_160969.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679; BRIGANTI G, 1979, INT J RADIAT ONCOL, V5, P1095, DOI 10.1016/0360-3016(79)90625-4; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de la Pena AT, 2018, J VIROL, V92, DOI 10.1128/JVI.01957-17; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006913; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kulp DW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01549-6; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy LE, 2017, CURR OPIN HIV AIDS, V12, P195, DOI 10.1097/COH.0000000000000361; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Rappuoli R, 2016, CURR OPIN IMMUNOL, V41, pV, DOI 10.1016/j.coi.2016.07.001; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; ROBINSON JE, 1990, AIDS RES HUM RETROV, V6, P567, DOI 10.1089/aid.1990.6.567; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Voss JE, 2017, CELL REP, V21, P222, DOI 10.1016/j.celrep.2017.09.024; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wine Y, 2015, CURR OPIN IMMUNOL, V35, P89, DOI 10.1016/j.coi.2015.06.009; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	68	88	90	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					288	+		10.1016/j.immuni.2018.07.009	http://dx.doi.org/10.1016/j.immuni.2018.07.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30097292	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000442354500014
J	Kim, J; Chang, DY; Lee, HW; Lee, H; Kim, JH; Sung, PS; Kim, KH; Hong, SH; Kang, W; Lee, J; Shin, SY; Yu, HT; You, S; Choi, YS; Oh, I; Lee, DH; Lee, DH; Jung, MK; Suh, KS; Hwang, S; Kim, W; Park, SH; Kim, HJ; Shin, EC				Kim, Jihye; Chang, Dong-Yeop; Lee, Hyun Woong; Lee, Hoyoung; Kim, Jong Hoon; Sung, Pil Soo; Kim, Kyung Hwan; Hong, Seon-Hui; Kang, Wonseok; Lee, Jino; Shin, So Youn; Yu, Hee Tae; You, Sooseong; Choi, Yoon Seok; Oh, Insoo; Lee, Dong Ho; Lee, Dong Hyeon; Jung, Min Kyung; Suh, Kyung-Suk; Hwang, Shin; Kim, Won; Park, Su-Hyung; Kim, Hyung Joon; Shin, Eui-Cheol			Innate-like Cytotoxic Function of Bystander-Activated CD8(+) T Cells Is Associated with Liver Injury in Acute Hepatitis A	IMMUNITY			English	Article							TRANSGENIC MOUSE MODEL; C-VIRUS-INFECTION; IN-VIVO; VIRAL-INFECTION; B-VIRUS; HETEROLOGOUS IMMUNITY; FULMINANT-HEPATITIS; IL-15; IMMUNOPATHOLOGY; DISEASE	Acute hepatitis A (AHA) involves severe CD8(+) T cell-mediated liver injury. Here we showed during AHA, CD8(+) T cells specific to unrelated viruses became activated. Hepatitis A virus (HAV)-infected cells produced IL-15 that induced T cell receptor (TCR)-independent activation of memory CD8(+) T cells. TCR-independent activation of non-HAV-specific CD8(+) T cells were detected in patients, as indicated by NKG2D upregulation, a marker of TCR-independent T cell activation by IL-15. CD8(+) T cells derived from AHA patients exerted innate-like cytotoxicity triggered by activating receptors NKG2D and NKp30 without TCR engagement. We demonstrated that the severity of liver injury in AHA patients correlated with the activation of HAV-unrelated virus-specific CD8(+) T cells and the innate-like cytolytic activity of CD8(+) T cells, but not the activation of HAV-specific T cells. Thus, host injury in AHA is associated with innate-like cytotoxicity of bystander-activated CD8(+) T cells, a result with implications for acute viral diseases.	[Kim, Jihye; Lee, Hoyoung; Hong, Seon-Hui; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon 34141, South Korea; [Chang, Dong-Yeop; Kim, Jong Hoon; Sung, Pil Soo; Kim, Kyung Hwan; Kang, Wonseok; Lee, Jino; Shin, So Youn; Yu, Hee Tae; You, Sooseong; Choi, Yoon Seok; Oh, Insoo; Jung, Min Kyung; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Lee, Hyun Woong; Kim, Hyung Joon] Chung Ang Univ Hosp, Dept Internal Med, Seoul 06973, South Korea; [Lee, Dong Ho] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Surg, Coll Med, Daejeon 34943, South Korea; [Lee, Dong Hyeon; Kim, Won] Seoul Metropolitan Govt Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul 07061, South Korea; [Suh, Kyung-Suk] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 03080, South Korea; [Hwang, Shin] Univ Ulsan, Coll Med, Dept Surg, Asan Med Ctr, Seoul 05505, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chung Ang University; Chung Ang University Hospital; Catholic University of Korea; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of Ulsan	Park, SH; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon 34141, South Korea.; Park, SH; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.; Kim, HJ (corresponding author), Chung Ang Univ Hosp, Dept Internal Med, Seoul 06973, South Korea.	park3@kaist.ac.kr; mdjoon@cau.ac.kr; ecshin@kaist.ac.kr	Kim, Jong Hoon/I-3135-2019; Kim, Won/H-6940-2019; Sung, Pil Soo/K-2072-2019; Sung, Pil Soo/AAD-6344-2021; Park, Su-Hyung/N-3514-2014; LEE, HYUN WOONG/ABC-6119-2021; Shin, Eui-Cheol/C-1690-2011	Kim, Jong Hoon/0000-0002-3385-8180; Kim, Won/0000-0002-2926-1007; Sung, Pil Soo/0000-0002-5780-9607; Park, Su-Hyung/0000-0001-6363-7736; Shin, Eui-Cheol/0000-0002-6308-9503; Kim, Jihye/0000-0001-6297-4562; Lee, Darrall/0000-0002-6990-4441; Lee, Hyun Woong/0000-0002-6958-3035	Samsung Science and Technology Foundation [SSTF-BA1402-18]	Samsung Science and Technology Foundation(Samsung)	We would like to thank M. Roggendorf for providing us with an HLA class I tetramer and Charles D. Surh and Hyun Park for critical discussion. We also thank the members of the Hyehwa Forum for helpful and stimulating discussion. This work was supported by Samsung Science and Technology Foundation under Project Number SSTF-BA1402-18.	ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; ANDO K, 1994, J IMMUNOL, V152, P3245; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Chen AM, 2005, J VIROL, V79, P4700, DOI 10.1128/JVI.79.8.4700-4708.2005; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Estripeaut D, 2008, J INFECT DIS, V198, P1435, DOI 10.1086/592714; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Haring JS, 2002, J IMMUNOL, V169, P1550, DOI 10.4049/jimmunol.169.3.1550; Ito H, 2009, J IMMUNOL, V182, P391, DOI 10.4049/jimmunol.182.1.391; Jacquelin B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004241; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Katz G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005221; Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; McCloskey TW, 1997, CLIN IMMUNOL IMMUNOP, V84, P46, DOI 10.1006/clin.1997.4370; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Rehermann B, 2005, J EXP MED, V201, P667, DOI 10.1084/jem.20050220; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Schulte I, 2011, J HEPATOL, V54, P201, DOI 10.1016/j.jhep.2010.07.010; Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014; Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69; SIEGL G, 1993, MICROB PATHOGENESIS, V14, P1, DOI 10.1006/mpat.1993.1001; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; Sung PS, 2015, P NATL ACAD SCI USA, V112, P10443, DOI 10.1073/pnas.1513341112; Tamang DL, 2006, CYTOKINE, V36, P148, DOI 10.1016/j.cyto.2006.11.008; Tough DF, 1996, IMMUNOL REV, V150, P129, DOI 10.1111/j.1600-065X.1996.tb00699.x; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walker CM, 2015, CURR OPIN VIROL, V11, P7, DOI 10.1016/j.coviro.2015.01.003; Weng NP, 2002, ANN NY ACAD SCI, V975, P46, DOI 10.1111/j.1749-6632.2002.tb05940.x; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906	48	88	89	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					161	+		10.1016/j.immuni.2017.11.025	http://dx.doi.org/10.1016/j.immuni.2017.11.025			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29305140	Bronze			2022-12-18	WOS:000422751600018
J	Dalmas, E; Lehmann, FM; Dror, E; Wueest, S; Thienel, C; Borsigova, M; Stawiski, M; Traunecker, E; Lucchini, FC; Dapito, DH; Kallert, SM; Guigas, B; Pattou, F; Kerr-Conte, J; Maechler, P; Girard, JP; Konrad, D; Wolfrum, C; Boni-Schnetzler, M; Finke, D; Donath, MY				Dalmas, Elise; Lehmann, Frank M.; Dror, Erez; Wueest, Stephan; Thienel, Constanze; Borsigova, Marcela; Stawiski, Marc; Traunecker, Emmanuel; Lucchini, Fabrizio C.; Dapito, Dianne H.; Kallert, Sandra M.; Guigas, Bruno; Pattou, Francois; Kerr-Conte, Julie; Maechler, Pierre; Girard, Jean-Philippe; Konrad, Daniel; Wolfrum, Christian; Boni-Schnetzler, Marianne; Finke, Daniela; Donath, Marc Y.			Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid Production	IMMUNITY			English	Article							VISCERAL ADIPOSE-TISSUE; VITAMIN-A-DEFICIENCY; DENDRITIC CELLS; GLYCEMIC CONTROL; GENE-EXPRESSION; MACROPHAGES; INFLAMMATION; OBESITY; IL-33; PROLIFERATION	Pancreatic-islet inflammation contributes to the failure of beta cell insulin secretion during obesity and type 2 diabetes. However, little is known about the nature and function of resident immune cells in this context or in homeostasis. Here we show that interleukin (IL)-33 was produced by islet mesenchymal cells and enhanced by a diabetes milieu (glucose, IL-1 beta, and palmitate). IL-33 promoted b cell function through islet-resident group 2 innate lymphoid cells (ILC2s) that elicited retinoic acid (RA)-producing capacities in macrophages and dendritic cells via the secretion of IL-13 and colony-stimulating factor 2. In turn, local RA signaled to the b cells to increase insulin secretion. This IL-33-ILC2 axis was activated after acute b cell stress but was defective during chronic obesity. Accordingly, IL-33 injections rescued islet function in obese mice. Our findings provide evidence that an immunometabolic crosstalk between isletderived IL-33, ILC2s, and myeloid cells fosters insulin secretion.	[Dalmas, Elise; Dror, Erez; Thienel, Constanze; Borsigova, Marcela; Stawiski, Marc; Boni-Schnetzler, Marianne; Donath, Marc Y.] Univ Hosp Basel, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland; [Dalmas, Elise; Lehmann, Frank M.; Dror, Erez; Thienel, Constanze; Borsigova, Marcela; Stawiski, Marc; Traunecker, Emmanuel; Kallert, Sandra M.; Boni-Schnetzler, Marianne; Finke, Daniela; Donath, Marc Y.] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland; [Lehmann, Frank M.; Finke, Daniela] Univ Basel, Childrens Hosp, CH-4056 Basel, Switzerland; [Wueest, Stephan; Lucchini, Fabrizio C.; Konrad, Daniel] Univ Childrens Hosp, Dept Pediat Endocrinol & Diabetol, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Wueest, Stephan; Lucchini, Fabrizio C.; Konrad, Daniel] Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Dapito, Dianne H.; Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schorenstr 16, CH-8603 Schwerzenbach, Switzerland; [Guigas, Bruno] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 Leiden, Netherlands; [Guigas, Bruno] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 Leiden, Netherlands; [Pattou, Francois; Kerr-Conte, Julie] Univ Lille, INSERM, CHU Lille,EGID, Translat Res Diabet U119,European Genom Inst Diab, F-59000 Lille, France; [Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, Geneva, Switzerland; [Maechler, Pierre] Univ Geneva, Med Ctr, Fac Diabet Ctr, Geneva, Switzerland; [Girard, Jean-Philippe] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, F-31077 Toulouse, France	University of Basel; University of Basel; University of Basel; University Children's Hospital Zurich; University Children's Hospital Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Geneva; University of Geneva; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Dalmas, E (corresponding author), Univ Hosp Basel, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland.	edalmas@hotmail.fr	Guigas, Bruno/M-2515-2015; GIRARD, Jean-Philippe/F-5229-2010; Pattou, Francois/O-6151-2017; Wüest, Stephan/AAG-9706-2020	Guigas, Bruno/0000-0002-8856-5799; GIRARD, Jean-Philippe/0000-0002-9154-1691; Pattou, Francois/0000-0001-8388-3766; Wüest, Stephan/0000-0002-0176-8906; Konrad, Daniel/0000-0001-9067-4356; Wolfrum, Christian/0000-0002-3862-6805; Maechler, Pierre/0000-0002-2005-1433; Dalmas, Elise/0000-0003-0959-5648; Boni-Schnetzler, Marianne/0000-0001-5569-5506; Lehmann, Frank Michael/0000-0002-0381-9033; Kerr-Conte, julie/0000-0002-7590-1896	University of Basel Research Fund; European Foundation; Swiss National Science Foundation [166519, 172973]; European Foundation for the Study of Diabetes [Lilly FS 2015_1] Funding Source: researchfish	University of Basel Research Fund; European Foundation(European Science Foundation (ESF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Foundation for the Study of Diabetes	We are grateful to our excellent technicians, Kaethi Dembinski and Stephanie Hauselmann; Daniel Pinschewer (University of Basel) for providing Il33<SUP>gfp/wt</SUP> mice; Angela Bosch and Nicole von Burg for helping with experiments; Friederike Schulze, Shuyang Traub, and Katharina Timper for helpful discussions; and the flow-cytometry, microscopy, and animal facilities of the Department of Biomedicine (University of Basel). E.Da. was financially supported by the University of Basel Research Fund for junior researchers and the European Foundation for the Study of Diabetes and Lilly Research Fellowship. The Swiss National Science Foundation provided support to M.Y.D. (166519) and D.F. (172973).	Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brun PJ, 2015, FASEB J, V29, P671, DOI 10.1096/fj.14-256743; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; Criscimanna A, 2014, GASTROENTEROLOGY, V147, P1106, DOI 10.1053/j.gastro.2014.08.008; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Masamune A, 2010, AM J PHYSIOL-GASTR L, V299, pG821, DOI 10.1152/ajpgi.00178.2010; Matthews KA, 2004, J NUTR, V134, P1958, DOI 10.1093/jn/134.8.1958; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Odegaard JI, 2015, CURR OPIN IMMUNOL, V36, P67, DOI 10.1016/j.coi.2015.07.003; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Riley KG, 2015, MOL METAB, V4, P584, DOI 10.1016/j.molmet.2015.05.002; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; WU TCJ, 1992, DIFFERENTIATION, V51, P219, DOI 10.1111/j.1432-0436.1992.tb00699.x; Wueest S, 2014, EMBO MOL MED, V6, P43, DOI 10.1002/emmm.201302962; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	48	88	95	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					928	+		10.1016/j.immuni.2017.10.015	http://dx.doi.org/10.1016/j.immuni.2017.10.015			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166590	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000416483700016
J	Qiu, Y; Xu, YP; Zhang, Y; Zhou, H; Deng, YQ; Li, XF; Miao, M; Zhang, Q; Zhong, B; Hu, YY; Zhang, FC; Wu, LG; Qin, CF; Zhou, X				Qiu, Yang; Xu, Yanpeng; Zhang, Yao; Zhou, Hui; Deng, Yong-Qiang; Li, Xiao-Feng; Miao, Meng; Zhang, Qiang; Zhong, Bo; Hu, Yuanyang; Zhang, Fu-Chun; Wu, Ligang; Qin, Cheng-Feng; Zhou, Xi			Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals	IMMUNITY			English	Article							INFLUENZA-A VIRUS; MOUSE OOCYTES; PROTEIN 3A; CELLS; INTERFERENCE; REPLICATION; SUPPRESSION; INHIBITION; INDUCTION; DICER	RNA interference (RNAi) functions as a potent antiviral immunity in plants and invertebrates; however, whether RNAi plays antiviral roles in mammals remains unclear. Here, using human enterovirus 71 (HEV71) as a model, we showed HEV71 3A protein as an authentic viral suppressor of RNAi during viral infection. When the 3A-mediated RNAi suppression was impaired, the mutant HEV71 readily triggered the production of abundant HEV71-derived small RNAs with canonical siRNA properties in cells and mice. These virus-derived siRNAs were produced from viral dsRNA replicative intermediates in a Dicer-dependent manner and loaded into AGO, and they were fully active in degrading cognate viral RNAs. Recombinant HEV71 deficient in 3A-mediated RNAi suppression was significantly restricted in human somatic cells and mice, whereas Dicer deficiency rescued HEV71 infection independently of type I interferon response. Thus, RNAi can function as an antiviral immunity, which is induced and suppressed by a human virus, in mammals.	[Qiu, Yang; Zhou, Hui; Miao, Meng; Zhang, Qiang; Zhong, Bo; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Qiu, Yang; Xu, Yanpeng; Deng, Yong-Qiang; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Qiu, Yang; Zhou, Hui; Miao, Meng; Zhou, Xi] Chinese Acad Sci, Wuhan Inst Virol, Lab RNA Virol, Wuhan 430071, Hubei, Peoples R China; [Zhang, Yao; Wu, Ligang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhang, Fu-Chun; Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China	Wuhan University; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Guangzhou Medical University	Zhou, X (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Lab RNA Virol, Wuhan 430071, Hubei, Peoples R China.; Qin, CF (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.	qincf@bmi.ac.cn; zhouxi@wh.iov.cn	Qin, Cheng-Feng/I-6839-2019; li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; Qiu, Yang/AAQ-4435-2020	Qin, Cheng-Feng/0000-0002-0632-2807; Qiu, Yang/0000-0001-5152-1242; Zhou, Xi/0000-0002-3846-5079	National Key Research and Development Project of China [2016YFD0500304]; NSFC Excellent Young Scientist Fund [81522025, 31522004]; National Basic Research Program of China [2014CB542603]; NSFC [31670161, 81661130162, 31761130075]; Newton Advanced Fellowship from UK Academy of Medical Sciences; Strategic Priority Research Program of Chinese Academy of Sciences [XDPB0301]; National High-Tech R&D Program of China [2015AA020939]; National Science and Technology Major Project of China [2017ZX09101005, 2017ZX10304402]; Open Research Fund of the State Key Laboratory of Pathogen and Biosafety of China [SKLPBS1445]; Academy of Medical Sciences (AMS) [NAF005\\1002] Funding Source: researchfish	National Key Research and Development Project of China; NSFC Excellent Young Scientist Fund; National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship from UK Academy of Medical Sciences; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Science and Technology Major Project of China; Open Research Fund of the State Key Laboratory of Pathogen and Biosafety of China; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	We thank Bryan R. Cullen (Durham, NC), Hong-Bing Shu (Wuhan, China), Qi-Bin Leng (Shanghai, China), and Shou-wei Ding (Riverside, CA) for reagents. We also thank Ms. Markeda Wade (Houston, TX) for professionally editing the manuscript. This work was supported by the National Key Research and Development Project of China (2016YFD0500304 to C.-F.Q.), the NSFC Excellent Young Scientist Fund (No. 81522025 to C.-F.Q. and No. 31522004 to X.Z.), the National Basic Research Program of China (2014CB542603 to X.Z.), the NSFC No. 31670161 (to X.Z.), the Newton Advanced Fellowship from the UK Academy of Medical Sciences and NSFC (81661130162 to C.-F.Q. and 31761130075 to X.Z.), the Strategic Priority Research Program of Chinese Academy of Sciences (No. XDPB0301 to X.Z.), the National High-Tech R&D Program of China (2015AA020939 to X.Z.), the National Science and Technology Major Project of China (2017ZX09101005 and 2017ZX10304402), and the Open Research Fund of the State Key Laboratory of Pathogen and Biosafety of China (No. SKLPBS1445).	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Gao QQ, 2015, ANTIMICROB AGENTS CH, V59, P2654, DOI 10.1128/AAC.05108-14; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Mesa RA, 2012, NAT REV DRUG DISCOV, V11, P103, DOI 10.1038/nrd3652; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Qi N, 2012, J VIROL, V86, P5763, DOI 10.1128/JVI.07229-11; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Teterina NL, 2011, J VIROL, V85, P4284, DOI 10.1128/JVI.02398-10; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weng KF, 2014, NUCLEIC ACIDS RES, V42, P12789, DOI 10.1093/nar/gku952; Wessels E, 2006, J BIOL CHEM, V281, P28232, DOI 10.1074/jbc.M601122200; Zhang M, 2016, CELL RES, V26, P1302, DOI 10.1038/cr.2016.125	36	88	90	5	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					992	+		10.1016/j.immuni.2017.05.006	http://dx.doi.org/10.1016/j.immuni.2017.05.006			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636969	Bronze, Green Published			2022-12-18	WOS:000403665900013
J	Pua, HH; Steiner, DF; Patel, S; Gonzalez, JR; Ortiz-Carpena, JF; Kageyama, R; Chiou, NT; Gallman, A; de Kouchkovsky, D; Jeker, LT; McManus, MT; Erle, DJ; Ansel, KM				Pua, Heather H.; Steiner, David F.; Patel, Sana; Gonzalez, Jeanmarie R.; Ortiz-Carpena, Jorge F.; Kageyama, Robin; Chiou, Ni-Ting; Gallman, Antonia; de Kouchkovsky, Dimitri; Jeker, Lukas T.; McManus, Michael T.; Erle, David J.; Ansel, K. Mark			MicroRNAs 24 and 27 Suppress Allergic Inflammation and Target a Network of Regulators of T Helper 2 Cell-Associated Cytokine Production	IMMUNITY			English	Article							HELPER T-CELLS; CYCLIN-K; DIFFERENTIATION; TRANSCRIPTION; RNA; ASTHMA; COMPLEXES; RESOURCE; DELETION; IMMUNITY	MicroRNAs (miRNAs) are important regulators of cell fate decisions in immune responses. They act by coordinate repression of multiple target genes, a property that we exploited to uncover regulatory networks that govern T helper-2 (Th2) cells. A functional screen of individual miRNAs in primary T cells uncovered multiple miRNAs that inhibited Th2 cell differentiation. Among these were miR-24 and miR-27, miRNAs coexpressed from two genomic clusters, which each functioned independently to limit interleukin-4 (IL-4) production. Mice lacking both clusters in T cells displayed increased Th2 cell responses and tissue pathology in a mouse model of asthma. Gene expression and pathway analyses placed miR-27 upstream of genes known to regulate Th2 cells. They also identified targets not previously associated with Th2 cell biology which regulated IL-4 production in unbiased functional testing. Thus, elucidating the biological function and target repertoire of miR-24 and miR-27 reveals regulators of Th2 cell biology.	[Pua, Heather H.; Jeker, Lukas T.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Steiner, David F.; Patel, Sana; Gonzalez, Jeanmarie R.; Ortiz-Carpena, Jorge F.; Kageyama, Robin; Chiou, Ni-Ting; Gallman, Antonia; McManus, Michael T.; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [de Kouchkovsky, Dimitri; Jeker, Lukas T.; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Erle, David J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Jeker, Lukas T.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Jeker, Lukas T.] Univ Basel, CH-4031 Basel, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Basel; University of Basel	Ansel, KM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Ansel, KM (corresponding author), Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	mark.ansel@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Jeker, Lukas/0000-0002-3359-8796; Erle, David/0000-0002-2171-0648; Ortiz-Carpena, Jorge F./0000-0002-7727-9674; de Kouchkovsky, Dimitri/0000-0002-9609-3226; Gonzalez, Jeanmarie/0000-0001-8998-7726	US National Institutes of Health [HL107202, HL109102, K08AI116949]; Sandler Asthma Basic Research Center; Leukemia & Lymphoma Society; W.M. Keck Foundation; UCSF Diabetes Center (NIH) [P30 DK063720]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, U01HL126493, R01HL109102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106923, K08AI116949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Asthma Basic Research Center; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); W.M. Keck Foundation(W.M. Keck Foundation); UCSF Diabetes Center (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andrea Barczak, Rebecca Barbeau, and Joshua Pollack from the UCSF SABRE Functional Genomics Core Facility for help with RNA sequencing, Megan Laurance for help with pathway analysis, Chong Park and the Gladstone Transgenic Gene Targeting Core for help with generating mice, Nirav Bhakta for statistical analysis, Hannah Happ for help running flow cytometry experiments, and Yelena Bronevetsky, Marisella Panduro, and Priti Singh for help with establishing and maintaining mutant mouse colonies. This work supported by the US National Institutes of Health (HL107202, HL109102, K08AI116949), the Sandler Asthma Basic Research Center, a Scholar Award (K.M.A.) and a Fellow Award (H.H.P.) from The Leukemia & Lymphoma Society, the W.M. Keck Foundation (M.T.M.) and the UCSF Diabetes Center (NIH P30 DK063720). An MTA with Genome Research Limited, Wellcome Trust Sanger Institute governs use of Ago1-deficient mice.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chu X, 2013, J MED GENET, V50, P479, DOI 10.1136/jmedgenet-2013-101595; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Guerau-de-Arellano M, 2011, BRAIN, V134, P3575, DOI 10.1093/brain/awr262; Guo YE, 2014, MOL CELL, V54, P67, DOI 10.1016/j.molcel.2014.03.025; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kuyper LM, 2003, AM J MED, V115, P6, DOI 10.1016/S0002-9343(03)00241-9; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Okoye IS, 2014, P NATL ACAD SCI USA, V111, pE3081, DOI 10.1073/pnas.1406322111; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Szymanski K, 2014, TISSUE ANTIGENS, V83, P41, DOI 10.1111/tan.12259; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	39	88	92	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					821	832		10.1016/j.immuni.2016.01.003	http://dx.doi.org/10.1016/j.immuni.2016.01.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	26850657	Green Accepted, Bronze			2022-12-18	WOS:000374444300014
J	Price, JV; Vance, RE				Price, Jordan V.; Vance, Russell E.			The Macrophage Paradox	IMMUNITY			English	Review							FRANCISELLA-TULARENSIS REPLICATION; HOST-CELL DEATH; LISTERIA-MONOCYTOGENES; INTERFERON-GAMMA; PPAR-GAMMA; SALMONELLA; AUTOPHAGY; SURVIVAL; RECOGNITION; ACTIVATION	Macrophages are a diverse population of phagocytic cells that reside in tissues throughout the body. At sites of infection, macrophages encounter and engulf invading microbes. Accordingly, macrophages possess specialized effector functions to kill or coordinate the elimination of their prey. Nevertheless, many intracellular bacterial pathogens preferentially replicate inside macrophages. Here we consider explanations for what we call "the macrophage paradox:" why do so many pathogenic bacteria replicate in the very cells equipped to destroy them? We ask whether replication in macrophages is an unavoidable fate that essentially defines a key requirement to be a pathogen. Conversely, we consider whether fundamental aspects of macrophage biology provide unique cellular or metabolic environments that pathogens can exploit. We conclude that resolution of the macrophage paradox requires acknowledgment of the richness and complexity of macrophages as a replicative niche.	[Price, Jordan V.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu						Abdullah Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037349; Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P1562, DOI 10.1128/AEM.71.3.1562-1569.2005; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gopinath S, 2012, TRENDS MICROBIOL, V20, P320, DOI 10.1016/j.tim.2012.04.004; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; La Scola B, 2001, CLIN MICROBIOL INFEC, V7, P75, DOI 10.1046/j.1469-0691.2001.00193.x; Lam GY, 2012, ADV IMMUNOL, V113, P7, DOI 10.1016/B978-0-12-394590-7.00008-7; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mercer J, 2013, TRENDS MICROBIOL, V21, P380, DOI 10.1016/j.tim.2013.06.001; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; Pollard KM, 2013, DISCOV MED, V16, P123; Rafiei A, 2006, J INFECTION, V53, P315, DOI 10.1016/j.jinf.2005.11.024; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rodriguez AR, 2011, MUCOSAL IMMUNOL, V4, P217, DOI 10.1038/mi.2010.59; Saeed A, 2009, ARCH MICROBIOL, V191, P83, DOI 10.1007/s00203-008-0422-2; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Sarantis H, 2012, CELL HOST MICROBE, V12, P419, DOI 10.1016/j.chom.2012.09.001; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schunder E, 2014, J BIOL CHEM, V289, P21040, DOI 10.1074/jbc.M114.570085; Schuppler M, 2014, APPL MICROBIOL BIOT, V98, P2907, DOI 10.1007/s00253-014-5546-5; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; WILSON BA, 1992, CURR TOP MICROBIOL, V175, P27; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	71	88	91	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					685	693		10.1016/j.immuni.2014.10.015	http://dx.doi.org/10.1016/j.immuni.2014.10.015			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517611	Bronze			2022-12-18	WOS:000345504900007
J	Mukherjee, P; Woods, TA; Moore, RA; Peterson, KE				Mukherjee, Piyali; Woods, Tyson A.; Moore, Roger A.; Peterson, Karin E.			Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death	IMMUNITY			English	Article							LA-CROSSE-VIRUS; TOLL-LIKE RECEPTOR-3; NEGATIVE REGULATOR; CELL-DEATH; INTERFERON SYSTEM; IMMUNE-RESPONSES; ATP SYNTHASE; MICE LACKING; APOPTOSIS; MITOCHONDRIA	La Crosse virus (LACV), a zoonotic Bunyavirus, is a major cause of pediatric viral encephalitis in the United States. A hallmark of neurological diseases caused by LACV and other encephalitic viruses is the induction of neuronal cell death. Innate immune responses have been implicated in neuronal damage, but no mechanism has been elucidated. By using in vitro studies in primary neurons and in vivo studies in mice, we have shown that LACV infection induced the RNA helicase, RIG-I, and mitochondrial antiviral signaling protein (MAVS) signaling pathway, resulting in upregulation of the sterile alpha and TIR-containing motif 1 (SARM1), an adaptor molecule that we found to be directly involved in neuronal damage. SARM1-mediated cell death was associated with induced oxidative stress response and mitochondrial damage. These studies provide an innate-immune signaling mechanism for virus-induced neuronal death and reveal potential targets for development of therapeutics to treat encephalitic viral infections.	[Mukherjee, Piyali; Woods, Tyson A.; Moore, Roger A.; Peterson, Karin E.] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peterson, KE (corresponding author), NIAID, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.	petersonka@niaid.nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249	Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001102] Funding Source: NIH RePORTER	Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Sonja Best and Vinod Nair for confocal microscopy assistance and David Dorward for transmission electron microscopy assistance. The authors also thank Austin Athman for graphics assistance and Sonja Best, Sue Priola, Byron Caughey, and Kim Hasenkrug for critical reading of the manuscript. The project was supported by the Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; Bennett RS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-41; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Comelli M, 1998, FREE RADICAL BIO MED, V24, P924, DOI 10.1016/S0891-5849(97)00373-0; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Du M, 2010, J VIROL, V84, P11076, DOI 10.1128/JVI.01022-10; Ferrer PE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002083; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Kalfayan B, 1983, Prog Clin Biol Res, V123, P179; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Ma Y, 2007, CELL CYCLE, V6, P2859, DOI 10.4161/cc.6.23.5018; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Moore RA, 2010, PROTEOMICS, V10, P2858, DOI 10.1002/pmic.201000104; Natera-Naranjo O, 2012, MOL CELL NEUROSCI, V49, P263, DOI 10.1016/j.mcn.2011.12.006; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pan J, 2009, NEUROCHEM INT, V54, P418, DOI 10.1016/j.neuint.2009.01.013; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Panneerselvam P, 2012, BIOCHEM J, V442, P263, DOI 10.1042/BJ20111653; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09; Yuan SC, 2010, J IMMUNOL, V184, P6874, DOI 10.4049/jimmunol.0903675	50	88	90	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					705	716		10.1016/j.immuni.2013.02.013	http://dx.doi.org/10.1016/j.immuni.2013.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23499490	Bronze, Green Accepted			2022-12-18	WOS:000330942100013
J	Valdez, PA; Vithayathil, PJ; Janelsins, BM; Shaffer, AL; Williamson, PR; Datta, SK				Valdez, Patricia A.; Vithayathil, Paul J.; Janelsins, Brian M.; Shaffer, Arthur L.; Williamson, Peter R.; Datta, Sandip K.			Prostaglandin E2 Suppresses Antifungal Immunity by Inhibiting Interferon Regulatory Factor 4 Function and Interleukin-17 Expression in T Cells	IMMUNITY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; CRYPTOCOCCUS-NEOFORMANS INFECTION; ARYL-HYDROCARBON RECEPTOR; HYPER-IGE SYNDROME; ROR-GAMMA-T; TH17 RESPONSES; HELPER-CELLS; HOST-DEFENSE; BETA-GLUCAN; CYCLIC-AMP	T helper 17 (Th17) cells play an important role in mucosal host defense through production of the signature cytokines IL-17 and IL-22. Prostaglandin E2 (PGE2) has been shown to enhance IL-17 production by mature Th17 cells. However, when present during Th17 cell differentiation, we found that PGE2 inhibited the transcription factor IRF4 and suppressed production of IL-17 but not IL-22. We show that IRF4 was required for IL-17 expression but inhibited IL-22 expression, highlighting the potential for discordant regulation of these two cytokines in Th17 cells. The pathogenic fungus Cryptococcus neoformans produces PGE2, and we found that it uses PGE2- and IRF4-dependent mechanisms to specifically inhibit induction of IL-17 during Th17 cell differentiation. Blockade of host PGE2 during infection led to increased IL-17 production from CD4(+) T cells and increased survival of mice. These findings suggest that host-or pathogen-derived PGE2 can act directly on Th17 cells during differentiation to inhibit IL-17-dependent antimicrobial responses.	[Valdez, Patricia A.; Vithayathil, Paul J.; Janelsins, Brian M.; Datta, Sandip K.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Shaffer, Arthur L.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Williamson, Peter R.] NIAID, Translat Mycol Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Datta, SK (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA.	dattas@niaid.nih.gov		Datta, Sandip/0000-0003-0243-7815	NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001123, ZIAAI001043] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Munford (NIAID) for discussion and comments on the manuscript and members of the J. O'Shea (NIAMS) and W. Leonard (NHLBI) laboratories for assistance in identifying ChIP binding regions. This work was supported by the Intramural Research Program of the NIH, NIAID.	BETZ M, 1991, J IMMUNOL, V146, P108; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Erb-Downward JR, 2008, MOL MICROBIOL, V68, P1428, DOI 10.1111/j.1365-2958.2008.06245.x; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Erb-Downward JR, 2007, EUKARYOT CELL, V6, P346, DOI 10.1128/EC.00336-06; Gagliardi MC, 2010, J LEUKOCYTE BIOL, V88, P947, DOI 10.1189/jlb.0310139; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Hardison SE, 2010, INFECT IMMUN, V78, P5341, DOI 10.1128/IAI.00845-10; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HASLER F, 1983, J IMMUNOL, V131, P768; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kleinschek MA, 2010, INT IMMUNOL, V22, P81, DOI 10.1093/intimm/dxp117; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zelante T, 2011, EUR J IMMUNOL, V41, P270, DOI 10.1002/eji.201041246; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	56	88	88	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					668	679		10.1016/j.immuni.2012.02.013	http://dx.doi.org/10.1016/j.immuni.2012.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22464170	Bronze, Green Accepted			2022-12-18	WOS:000303223900018
J	Zafirova, B; Mandaric, S; Antulov, R; Krmpotic, A; Jonsson, H; Yokoyama, WM; Jonjic, S; Polic, B				Zafirova, Biljana; Mandaric, Sanja; Antulov, Ronald; Krmpotic, Astrid; Jonsson, Helena; Yokoyama, Wayne M.; Jonjic, Stipan; Polic, Bojan			Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice	IMMUNITY			English	Article							NATURAL-KILLER-CELL; IFN-ALPHA-BETA; MURINE CYTOMEGALOVIRUS; NKG2D RECEPTOR; T-CELLS; IN-VIVO; ACTIVATION RECEPTOR; VIRAL-INFECTION; PIVOTAL ROLE; CYTOTOXICITY	NKG2D is a potent activating receptor on natural killer (NK) cells and acts as a molecular sensor for stressed cells expressing NKG2D ligands such as infected or tumor-transformed cells. Although NKG2D is expressed on NK cell precursors, its role in NK cell development is not known. We have generated NKG2D-deficient mice by targeting the Klrk1 locus. Here we provide evidence for an important regulatory role of NKG2D in the development of NK cells. The absence of NKG2D caused faster division of NK cells, perturbation in size of some NK cell subpopulations, and their augmented sensitivity to apoptosis. As expected, Klrkl(-/-) NK cells are less responsive to tumor targets expressing NKG2D ligands. Klrkl(-/-) mice, however, showed an enhanced NK cell-mediated resistance to mouse cytomegalovirus infection as a consequence of NK cell dysregulation. Altogether, these findings provide evidence for regulatory function of NKG2D in NK cell physiology.	[Zafirova, Biljana; Mandaric, Sanja; Antulov, Ronald; Krmpotic, Astrid; Jonjic, Stipan; Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, HR-51000 Rijeka, Croatia; [Jonsson, Helena; Yokoyama, Wayne M.] Washington Univ, Howard Hughes Med Inst, Div Rheumatol, Med Ctr, St Louis, MO 63110 USA	University of Rijeka; Howard Hughes Medical Institute; Washington University (WUSTL)	Polic, B (corresponding author), Univ Rijeka, Sch Med, Dept Histol & Embryol, B Branchetta 20, HR-51000 Rijeka, Croatia.	bojanp@medri.hr	Jonjic, Stipan/C-5657-2016; Polic, Bojan/B-8622-2014; Zivadinov, Robert/Q-2054-2019; Krmpotic, Astrid/U-6224-2017	Jonjic, Stipan/0000-0001-5003-3108; Polic, Bojan/0000-0003-3930-9630; Zivadinov, Robert/0000-0002-7799-1485; Krmpotic, Astrid/0000-0001-5470-5370; Jonsson, Anna Helena/0000-0002-9558-2474	Croatian Ministry of Science, Education and Sport [TP01/006201 (103), 0062005, 062-0621261-1271]; Croatian-Israeli grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034385, R01AI051345] Funding Source: NIH RePORTER	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Croatian-Israeli grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Steinle and A. Diefenbach for critical reading of the manuscript and comments as well as J. Arapovic for helpful discussions. We especially express our gratitude to S. Slavic Stupac for excellent technical assistance and to M. Samsa for animal care. We also thank C. Uthoff-Hachenberg and D. Rumora for technical advice and help. This work was supported by the Croatian Ministry of Science, Education and Sport (grants TP01/006201 (103), 0062005, and 062-0621261-1271, as well as a Croatian-Israeli grant to B.P.).	Arapovic J, 2009, J VIROL, V83, P8198, DOI 10.1128/JVI.02549-08; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brune W, 2001, CURRENT PROTOCOLS IM, P1; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; French AR, 2006, J IMMUNOL, V177, P4981, DOI 10.4049/jimmunol.177.8.4981; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jiang K, 2003, BLOOD, V101, P236, DOI 10.1182/blood-2002-04-1251; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MacFarlane AW, 2008, BLOOD, V112, P131, DOI 10.1182/blood-2007-08-107847; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ogasawara K, 2005, NAT IMMUNOL, V6, P938, DOI 10.1038/ni1236; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Orange JS, 1996, J IMMUNOL, V156, P4746; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Sjolin H, 2002, J EXP MED, V195, P825, DOI 10.1084/jem.20011427; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	55	88	90	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					270	282		10.1016/j.immuni.2009.06.017	http://dx.doi.org/10.1016/j.immuni.2009.06.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19631564	Green Accepted, Bronze			2022-12-18	WOS:000269338600013
J	Diana, J; Griseri, T; Lagaye, S; Beaudoin, L; Autrusseau, E; Gautron, AS; Tomkiewicz, C; Herbelin, A; Barouki, R; von Herrath, M; Dalod, M; Lehuen, A				Diana, Julien; Griseri, Thibault; Lagaye, Sylvie; Beaudoin, Lucie; Autrusseau, Elodie; Gautron, Anne-Sophie; Tomkiewicz, Celine; Herbelin, Andre; Barouki, Robert; von Herrath, Matthias; Dalod, Marc; Lehuen, Agnes			NKT Cell-Plasmacytoid Dendritic Cell Cooperation via OX40 Controls Viral Infection in a Tissue-Specific Manner	IMMUNITY			English	Article							KILLER T-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; DEPENDENT DIABETES-MELLITUS; NATURAL-KILLER; IMMUNE-RESPONSE; ACTIVATION; MICE; LIGAND; TYPE-1; BETA	Invariant natural killer T (iNKT) cells promote immune responses to various pathogens, but exactly how iNKT cells control antiviral responses is unclear. Here, we showed that iNKT cells induced tissue-specific antiviral effects in mice infected by lymphocytic choriomeningitis virus (LCMV). Indeed, iNKT cells inhibited viral replication in the pancreas and liver but not in the spleen. In the pancreas, iNKT cells expressed the OX40 molecule and promoted type I interferon (IFN) production by plasmacytoid dendritic cells (pDCs) through OX40-OX40 ligand interaction. Subsequently, this iNKT cell-pDC cooperation attenuated the antiviral adaptive immune response in the pancreas but not in the spleen. The dampening of pancreatic anti-LCMV CD8(+) T cell response prevented tissue damage in transgenic mice expressing LCMV protein in islet beta cells. Thus, this study identifies pDCs as an essential partner of iNKT cells for mounting an efficient, nondeleterious antiviral response in peripheral tissue.	[Diana, Julien; Griseri, Thibault; Lagaye, Sylvie; Beaudoin, Lucie; Autrusseau, Elodie; Gautron, Anne-Sophie; Lehuen, Agnes] Hop Cochin St Vincent Paul, INSERM, U561, F-75014 Paris, France; [Diana, Julien; Griseri, Thibault; Lagaye, Sylvie; Beaudoin, Lucie; Autrusseau, Elodie; Gautron, Anne-Sophie; Tomkiewicz, Celine; Herbelin, Andre; Barouki, Robert; Lehuen, Agnes] Univ Paris 05, F-75014 Paris, France; [Tomkiewicz, Celine; Barouki, Robert] INSERM, U747, F-75007 Paris, France; [Dalod, Marc] CNRS, UMR6102, F-13288 Marseille, France; [von Herrath, Matthias] La Jolla Inst Allergy & Immunol, San Diego, CA 92037 USA; [Herbelin, Andre] CNRS, UMR 8147, F-75015 Paris, France; [Dalod, Marc] INSERM, U631, F-13288 Marseille, France; [Dalod, Marc] Univ Mediterranee, CIML, F-13288 Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lehuen, A (corresponding author), Hop Cochin St Vincent Paul, INSERM, U561, F-75014 Paris, France.	agnes.lehuen@inserm.fr	Dalod, Marc/AAK-6163-2020; Herbelin, Andre/D-3096-2017; DIANA, Julien/A-2873-2014	Dalod, Marc/0000-0002-6436-7966; Herbelin, Andre/0000-0003-0193-7084; DIANA, Julien/0000-0001-7542-042X; Lehuen, Agnes/0000-0002-0450-3321	INSERM; CNRS; Ministere de la Recherche; Agence Nationale de la Recherche (ANR-COD); European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Novo Nordisk; Agence Nationale de la Recherche (ANR-MIME)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Agence Nationale de la Recherche (ANR-COD)(French National Research Agency (ANR)); European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Novo Nordisk(Novo NordiskJuvenile Diabetes Research Foundation); Agence Nationale de la Recherche (ANR-MIME)(French National Research Agency (ANR))	We thank the Kirin Brewery (Tokyo, Japan) for providing a-GalCer, the Schering-Plough Research Institute (San Diego, CA, USA) for 120G8 mAb, Genetech (San Francisco, CA, USA) for mouse OX40-1g, J.-P. Briand (IBMC, Strasbourg, France) for NP39B viral peptide, M. Kopf (Zurich, Switzerland) for OX40-deficient mice, D. Bellanger for histological work, and L. Breton and the staff of the mouse facility for animal care. We are grateful to R. Monteiro, R. Mallone, and R. Schwartz for critical reading of the manuscript. This work was supported by funds from INSERM, CNRS, Ministere de la Recherche, Agence Nationale de la Recherche (ANR-COD), and the European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Novo Nordisk to A.L. T.G. and A.-S.G. were supported by a doctoral fellowship from the Ministere de la Recherche. M.D. issupported bya grant from Agence Nationale de la Recherche (ANR-MIME).	Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Barchet W, 2005, IMMUNOL RES, V32, P75, DOI 10.1385/IR:32:1-3:075; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen YG, 2005, J IMMUNOL, V174, P1196, DOI 10.4049/jimmunol.174.3.1196; Curry AJ, 2004, TRANSPLANTATION, V78, P807, DOI 10.1097/01.TP.0000131670.99000.54; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Exley MA, 2003, IMMUNOLOGY, V110, P519, DOI 10.1111/j.1365-2567.2003.01779.x; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Ito T, 2004, J IMMUNOL, V172, P4253, DOI 10.4049/jimmunol.172.7.4253; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kotani A, 2002, IMMUNOL LETT, V84, P1, DOI 10.1016/S0165-2478(02)00082-2; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Laloux V, 2001, J IMMUNOL, V166, P3749, DOI 10.4049/jimmunol.166.6.3749; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Mars LT, 2004, TRENDS IMMUNOL, V25, P471, DOI 10.1016/j.it.2004.07.001; Marschner A, 2005, EUR J IMMUNOL, V35, P2347, DOI 10.1002/eji.200425721; Martinic MM, 2007, DIABETES, V56, P1059, DOI 10.2337/db05-0062; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Montoya CJ, 2006, J IMMUNOL, V177, P1028, DOI 10.4049/jimmunol.177.2.1028; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Novak J, 2007, J IMMUNOL, V178, P1332, DOI 10.4049/jimmunol.178.3.1332; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Ohshima Y, 1997, J IMMUNOL, V159, P3838; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Sjolin H, 2006, J IMMUNOL, V177, P2908, DOI 10.4049/jimmunol.177.5.2908; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Spence PM, 2001, IMMUNOLOGY, V104, P168, DOI 10.1046/j.1365-2567.2001.01302.x; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Zaini J, 2007, J CLIN INVEST, V117, P3330, DOI 10.1172/JCI32693; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhu R, 2007, J IMMUNOL, V178, P5435, DOI 10.4049/jimmunol.178.9.5435	56	88	89	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					289	299		10.1016/j.immuni.2008.12.017	http://dx.doi.org/10.1016/j.immuni.2008.12.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19217323	Bronze			2022-12-18	WOS:000263710500015
J	Sosinowski, T; Killeen, N; Weiss, A				Sosinowski, T; Killeen, N; Weiss, A			The Src-like adaptor protein downregulates the T cell receptor on CD4(+)CD8(+) thymocytes and regulates positive selection	IMMUNITY			English	Article							DIFFERENTIAL-AVIDITY MODEL; SEVERE COMBINED IMMUNODEFICIENCY; TYROSINE KINASE; NEGATIVE SELECTION; SURFACE EXPRESSION; ANTIGEN RECEPTOR; CD4+CD8+ THYMOCYTES; IMMATURE THYMOCYTES; CD4+8+ THYMOCYTES; THYMIC SELECTION	In this report, we show that the Src-like adaptor protein (SLAP) plays an important role in thymocyte development. SLAP expression is developmentally regulated; it is low in CD4(-)CD8(-) thymocytes, it peaks in the CD4(+)CD8(+) subset, and it decreases to low levels in more mature cells. Disruption of the SLAP gene leads to a marked upregulation of TCR and CD5 expression at the CD4(+)CD8(+) stage. The absence of SLAP was also developmentally significant because it enhanced positive selection in mice expressing the DO11.10 transgenic T cell receptor. Moreover, SLAP deletion at least partially rescued the development of ZAP-70-deficient thymocytes. These results demonstrate that SLAP participates in a novel mechanism of TCR downregulation at the CD4(+)CD8(+) stage and regulates positive selection.	Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI 45865] Funding Source: Medline; NIGMS NIH HHS [GM 39553] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bhandoola A, 1999, IMMUNITY, V10, P301, DOI 10.1016/S1074-7613(00)80030-8; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; BONIFACINO JS, 1990, NATURE, V344, P247, DOI 10.1038/344247a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chu DH, 1999, J IMMUNOL, V163, P2610; Cook JR, 1997, IMMUNITY, V7, P233, DOI 10.1016/S1074-7613(00)80526-9; CROMPTON T, 1993, P NATL ACAD SCI USA, V90, P8982, DOI 10.1073/pnas.90.19.8982; Delaney JR, 1998, P NATL ACAD SCI USA, V95, P5235, DOI 10.1073/pnas.95.9.5235; DOHERTY FJ, 1989, BIOCHEM J, V263, P47, DOI 10.1042/bj2630047; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Girao C, 1997, J IMMUNOL, V159, P4205; Gong Q, 1997, IMMUNITY, V7, P369, DOI 10.1016/S1074-7613(00)80358-1; GOSGROVE D, 1991, CELL, V66, P1051; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; Kersh GJ, 2000, J IMMUNOL, V164, P5675, DOI 10.4049/jimmunol.164.11.5675; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; LASZLO L, 1990, FEBS LETT, V261, P365, DOI 10.1016/0014-5793(90)80593-8; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; MAGUIRE JE, 1990, FASEB J, V4, P3131, DOI 10.1096/fasebj.4.13.1698681; Manes G, 2000, MOL CELL BIOL, V20, P3396, DOI 10.1128/MCB.20.10.3396-3406.2000; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; Roche S, 1998, CURR BIOL, V8, P975, DOI 10.1016/S0960-9822(98)70400-2; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Tang J, 1999, P NATL ACAD SCI USA, V96, P9775, DOI 10.1073/pnas.96.17.9775; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WEISS A, 1987, J IMMUNOL, V138, P2169; Wiest DL, 1999, SEMIN IMMUNOL, V11, P251, DOI 10.1006/smim.1999.0181; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Williams O, 1997, IMMUNOL TODAY, V18, P121, DOI 10.1016/S0167-5699(97)01029-3; Wilson A, 1992, Dev Immunol, V2, P85, DOI 10.1155/1992/45150; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	72	88	89	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		457	466		10.1016/S1074-7613(01)00195-9	http://dx.doi.org/10.1016/S1074-7613(01)00195-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567635	Bronze			2022-12-18	WOS:000171211800012
J	Dittel, BN; Stefanova, I; Germain, RN; Janeway, CA				Dittel, BN; Stefanova, I; Germain, RN; Janeway, CA			Cross-antagonism of a T cell clone expressing two distinct T cell receptors	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; PEPTIDE-MHC COMPLEXES; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; ZETA-PHOSPHORYLATION; PARTIAL AGONISTS; ACTIVATION; TCR; LIGANDS; ZAP-70	Inhibition of T cell activation can be mediated by analogs of the original antigenic peptide (TCR antagonists). Here, a T cell clone expressing two distinct TCR was used to investigate whether such inhibition involves an active mechanism by examining whether an antagonist for one TCR could influence responses stimulated by the other TCR engaging its agonist. Our results demonstrate functional cross-inhibition under these conditions involving the ability of antagonist: TCR interactions to diminish Lck enzymatic activity associated with the agonist-recognizing second TCR, apparently through enhancement of SHP-1 association with these receptors. Our findings reveal that inhibition of cellular responses by antagonists arises at least in part from active negative regulation of proximal TCR signaling and identify elements of the biochemical process.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Howard Hughes Med Inst, New Haven, CT 06510 USA; NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	Yale University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dittel, BN (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000403, P01AI036529] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/AR36529] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Daniels MA, 1999, J IMMUNOL, V162, P3761; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Dittel BN, 1997, J IMMUNOL, V158, P4065; ESOUSA CR, 1996, J EXP MED, V184, P149; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fugger L, 1996, MOL MED, V2, P181, DOI 10.1007/BF03401615; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Hemmer B, 1998, J IMMUNOL, V160, P5807; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; LaFace DM, 1997, J IMMUNOL, V158, P2057; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Plas DR, 1999, J IMMUNOL, V162, P5680; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; SAITO T, 1989, J IMMUNOL, V143, P3379; Sette A, 1996, Semin Immunol, V8, P103, DOI 10.1006/smim.1996.0012; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1997, EUR J IMMUNOL, V27, P3080, DOI 10.1002/eji.1830271146; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176	50	88	89	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					289	298		10.1016/S1074-7613(00)80104-1	http://dx.doi.org/10.1016/S1074-7613(00)80104-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514007	Bronze			2022-12-18	WOS:000082918500004
J	Fehling, HJ; Iritani, BM; Krotkova, A; Forbush, KA; Laplace, C; Perlmutter, RM; vonBoehmer, H				Fehling, HJ; Iritani, BM; Krotkova, A; Forbush, KA; Laplace, C; Perlmutter, RM; vonBoehmer, H			Restoration of thymopoiesis in pT alpha(-/-) mice by anti-CD3 epsilon antibody treatment or with transgenes encoding activated lck or tailless pT alpha	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; T-CELL-DEVELOPMENT; THYMOCYTE DEVELOPMENT; MUTANT MICE; BETA; EXPRESSION; SELECTION; ANTIGEN; P56LCK; CD3	Mice deficient for the pre-TCR alpha (pT alpha) chain cannot form a pre-T cell receptor (TCR) and exhibit a severe defect in early T cell development, characterized by lack of ''beta selection'' and impaired generation of double-positive (DP) thymocytes. Here, we demonstrate that intraperitoneal injection of CD3 epsilon-specific antibodies into pT alpha(-/-) x RAG(-/-) mice or introduction of an activated p56(lck) transgene in pT alpha(-/-) mice fully restores the number of DP thymocytes, and that expression of a transgenic pT alpha chain lacking its cytoplasmic portion can overcome all developmental defects associated with pT alpha deficiency. These results allow a better definition of the role of pT alpha in pre-TCR signal transduction and provide conclusive evidence that the cytoplasmic tail of pT alpha is not essential for pre-TCR signaling.	UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT COMPARAT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; HOP NECKER ENFANTS MALAD,INSERM 373,F-75730 PARIS 15,FRANCE	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fehling, HJ (corresponding author), BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.			Fehling, Hans Joerg/0000-0002-4580-1990; Iritani, Brian/0000-0003-1903-7850	NIAID NIH HHS [K08 AI001445-05, K08 AI001445-06, K08 AI001445-04] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001445] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; ANDERSON SJ, 1995, IMMUNOL TODAY, V16, P99, DOI 10.1016/0167-5699(95)80096-4; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; delPorto P, 1995, P NATL ACAD SCI USA, V92, P12105, DOI 10.1073/pnas.92.26.12105; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; FEHLING HJ, 1995, IMMUNOGENETICS, V42, P275, DOI 10.1007/BF00176445; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Malissen B, 1996, CURR OPIN IMMUNOL, V8, P383, DOI 10.1016/S0952-7915(96)80129-4; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PENIT C, 1995, J IMMUNOL, V154, P5103; RUEFFJUY D, 1990, INT IMMUNOL, V3, P683; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Veillette A, 1991, Semin Immunol, V3, P143; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x	40	88	88	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					703	714		10.1016/S1074-7613(00)80446-X	http://dx.doi.org/10.1016/S1074-7613(00)80446-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208843	Bronze			2022-12-18	WOS:A1997XG57900006
J	Kalinke, U; Bucher, EM; Ernst, B; Oxenius, A; Roost, HP; Geley, S; Kofler, R; Zinkernagel, RM; Hengartner, H				Kalinke, U; Bucher, EM; Ernst, B; Oxenius, A; Roost, HP; Geley, S; Kofler, R; Zinkernagel, RM; Hengartner, H			The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus	IMMUNITY			English	Article							VH GENE FAMILY; VARIABLE-REGION GENES; B-CELL REPERTOIRE; ANTIBODY-RESPONSE; GERMINAL-CENTERS; BALB/C MICE; STREPTOCOCCUS-PNEUMONIAE; IMMUNOLOGICAL MEMORY; HEMAGGLUTININ; DIVERSITY	During most clinically relevant infections with cytopathic viruses, neutralizing antibodies are generated early, i.e., within the first week of infection, As early as 4 days after immunization of mice with vesicular stomatitis virus (VSV), a cytopathic virus closely related to rabies virus, hybridomas could be isolated that secreted virus-neutralizing IgGs. Such antibodies were devoid of somatic mutations, showed high binding avidities (similar to 10(9) M(-1)), and used V gene fragments predominantly belonging to the V(H)Q52 and V(K)19-28 families. In contrast, most secondary and hyperimmune response IgGs isolated 12 and 150 days after infection used several additional V gene combinations. These, which used the V(H)Q52/V(K)19-28 combination of early IgGs, were point mutated but showed only marginally enhanced binding avidities. Since all V(H)Q52/V(K)19-28-positive IgGs bound to one subsite within the major antigenic site of VSV-G irrespective of the presence or absence of somatic point mutations, fine specificity diversification of secondary and hyperimmune responses was achieved by newly appearing V gene combinations.	UNIV INNSBRUCK, SCH MED, INST GEN & EXPT PATHOL, A-6020 INNSBRUCK, AUSTRIA	University of Innsbruck	Kalinke, U (corresponding author), UNIV ZURICH, INST EXPT IMMUNOL, STERNWARTSTR 2, CH-8091 ZURICH, SWITZERLAND.		Oxenius, Annette/G-7794-2015	Kalinke, Ulrich/0000-0003-0503-9564				ADDERSON EE, 1991, J IMMUNOL, V147, P1667; BACHMANN MF, 1994, J IMMUNOL, V152, P4235; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; BAER GM, 1990, VIROLOGY, P883; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P161, DOI 10.1016/0022-1759(87)90186-4; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BOS NA, 1989, EUR J IMMUNOL, V19, P1811, DOI 10.1002/eji.1830191008; BRILES DE, 1984, EUR J IMMUNOL, V14, P1027, DOI 10.1002/eji.1830141112; CASADEVALL A, 1991, J EXP MED, V174, P151, DOI 10.1084/jem.174.1.151; Caton AJ, 1996, J EXP MED, V183, P13, DOI 10.1084/jem.183.1.13; CATON AJ, 1986, EMBO J, V5, P1577, DOI 10.1002/j.1460-2075.1986.tb04399.x; CATON AJ, 1991, J IMMUNOL, V147, P1675; CHANG SP, 1982, J IMMUNOL, V128, P702; CHARAN S, 1986, J IMMUNOL, V136, P3057; CHEN C, 1995, EMBO J, V14, P2784, DOI 10.1002/j.1460-2075.1995.tb07278.x; CHEN C, 1994, J EXP MED, V180, P577, DOI 10.1084/jem.180.2.577; CHEN C, 1992, J EXP MED, V176, P855, DOI 10.1084/jem.176.3.855; CLAFLIN JL, 1988, J IMMUNOL, V141, P4012; CLARKE S, 1990, J IMMUNOL, V145, P2286; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439; DUCHOSAL MA, 1989, J IMMUNOL, V142, P1737; EMINI EA, 1983, J VIROL, V48, P547, DOI 10.1128/JVI.48.2.547-550.1983; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; GEARHART PJ, 1981, NATURE, V291, P29, DOI 10.1038/291029a0; GILFILLAN S, 1995, EUR J IMMUNOL, V25, P3115, DOI 10.1002/eji.1830251119; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; GRIGERA PR, 1992, J VIROL, V66, P3749, DOI 10.1128/JVI.66.6.3749-3757.1992; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; KAVALER J, 1990, J IMMUNOL, V145, P2312; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; KOFLER R, 1989, IMMUNOGENETICS, V29, P65, DOI 10.1007/BF00395853; KOFLER R, 1988, J IMMUNOL, V140, P4031; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; LAWLER AM, 1987, P NATL ACAD SCI USA, V84, P2454, DOI 10.1073/pnas.84.8.2454; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; LEFRANCOIS L, 1983, J IMMUNOL, V130, P394; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LOTSCHER M, 1992, J IMMUNOL, V148, P3631; LUO LZ, 1988, VIROLOGY, V163, P341, DOI 10.1016/0042-6822(88)90274-7; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAKELA O, 1977, IMMUNOL REV, V34, P119, DOI 10.1111/j.1600-065X.1977.tb00370.x; MCCAREN LC, 1959, J EXP MED, V109, P475; OGRA PL, 1980, REV INFECT DIS, V2, P352; PADLAN EA, 1985, ANN INST PASTEUR IMM, VC136, P271, DOI 10.1016/S0769-2625(85)80058-1; REININGER L, 1988, EUR J IMMUNOL, V18, P1521, DOI 10.1002/eji.1830181008; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; Roost HP, 1996, J IMMUNOL METHODS, V189, P233, DOI 10.1016/0022-1759(95)00252-9; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; SABIN AB, 1981, REV INFECT DIS, V3, P543; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; UBOL S, 1995, J VIROL, V69, P1990, DOI 10.1128/JVI.69.3.1990-1993.1995; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Wabl M, 1996, CURR OPIN IMMUNOL, V8, P89, DOI 10.1016/S0952-7915(96)80110-5; WAGNER RR, 1987, RHABDOVIRUSES; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847; ZINKERNAGEL RM, 1996, SCIENCE, V271, P73	72	88	92	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					639	652		10.1016/S1074-7613(00)80277-0	http://dx.doi.org/10.1016/S1074-7613(00)80277-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986722	Bronze			2022-12-18	WOS:A1996WA65100013
J	SUN, R; SHEPHERD, SE; GEIER, SS; THOMSON, CT; SHEIL, JM; NATHENSON, SG				SUN, R; SHEPHERD, SE; GEIER, SS; THOMSON, CT; SHEIL, JM; NATHENSON, SG			EVIDENCE THAT THE ANTIGEN RECEPTORS OF CYTOTOXIC T-LYMPHOCYTES INTERACT WITH A COMMON RECOGNITION PATTERN ON THE H-2K(B) MOLECULE	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SITE-DIRECTED MUTAGENESIS; SOMATIC-CELL VARIANTS; CLASS-I MOLECULES; VIRAL PEPTIDES; TRANSPLANTATION ANTIGENS; MHC MOLECULES; SPECIFICITY; MUTANTS; BINDING	Recognition of class I MHC antigens involves interaction between TCRs of cytotoxic T lymphocytes (CTL) and the two alpha helices of MHC molecules. Using a combined panel of H-2K(b) mutants selected by either a CTL clone or MAbs, we have shown evidence that the TCRs of 59 K-b-specific CTL clones shared a common binding pattern on the H-2K(b) molecule. Mutations of amino acid residues at the C-terminal regions, but not the N-terminal regions, of the a helices abrogated the recognition by the majority of the clones. The data suggests that TCRs predominantly recognize the class I MHC molecule with an orientation that is parallel to the beta-pleated strands and diagonal to the alpha helices.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MICROBIOL & IMMUNOL, BRONX, NY 10461 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT CELL BIOL, BRONX, NY 10461 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, BRONX, NY 10461 USA; W VIRGINIA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, MORGANTOWN, WV 26506 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; West Virginia University					NCI NIH HHS [CA13330] Funding Source: Medline; NIAID NIH HHS [AI33184, AI07289] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033184, R37AI007289, R01AI007289, R56AI007289] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AJITKUMAR P, 1988, CELL, V54, P47, DOI 10.1016/0092-8674(88)90178-X; ALLEN H, 1984, NATURE, V309, P279, DOI 10.1038/309279a0; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BARBER LD, 1991, J IMMUNOL, V147, P2346; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; BILL J, 1989, J EXP MED, V170, P739, DOI 10.1084/jem.170.3.739; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLUESTONE JA, 1986, J IMMUNOL, V137, P1244; BUERSTEDDE JM, 1989, J EXP MED, V169, P1645, DOI 10.1084/jem.169.5.1645; BUERSTEDDE JM, 1988, J EXP MED, V167, P473, DOI 10.1084/jem.167.2.473; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CLAVERIE JM, 1989, IMMUNOL TODAY, V10, P10, DOI 10.1016/0167-5699(89)90058-3; COHN LE, 1986, P NATL ACAD SCI USA, V83, P747, DOI 10.1073/pnas.83.3.747; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GEIER SS, 1986, J IMMUNOL, V137, P1239; GELIEBTER J, 1986, P NATL ACAD SCI USA, V83, P3371, DOI 10.1073/pnas.83.10.3371; GELIEBTER J, 1987, PROGR IMMUNOLOGY, V6, P186; GILMAN M, 1987, IMMUNOL TODAY, V8, P274; HEMMI S, 1988, J EXP MED, V168, P2319, DOI 10.1084/jem.168.6.2319; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; HUNT HD, 1990, J IMMUNOL, V145, P1456; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; JAULIN C, 1992, J IMMUNOL, V149, P3990; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; JOYCE S, 1991, ANTIGEN PROCESSING R, P109; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; Klein J., 1986, NATURAL HIST MAJOR H; KOELLER D, 1987, J EXP MED, V166, P744, DOI 10.1084/jem.166.3.744; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MANN DW, 1988, J EXP MED, V168, P307, DOI 10.1084/jem.168.1.307; MARYANSKI JL, 1987, NATURE, V330, P660, DOI 10.1038/330660a0; MARYANSKI JL, 1989, EUR J IMMUNOL, V19, P193, DOI 10.1002/eji.1830190131; MELIEF CJM, 1980, J EXP MED, V151, P993, DOI 10.1084/jem.151.5.993; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; NATHENSON SG, 1981, ANNU REV BIOCHEM, V50, P1025, DOI 10.1146/annurev.bi.50.070181.005113; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P742, DOI 10.1073/pnas.83.3.742; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SANTOSAGUADO J, 1989, P NATL ACAD SCI USA, V86, P8936, DOI 10.1073/pnas.86.22.8936; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHEIL JM, 1986, IMMUNOGENETICS, V23, P52, DOI 10.1007/BF00376522; SHEPHERD SE, 1992, EUR J IMMUNOL, V22, P647, DOI 10.1002/eji.1830220306; Snell GD, 1976, HISTOCOMPATIBILITY; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; VANBLEEK GM, 1990, NATURE, V348, P213; WABUKEBUNOTI MAN, 1983, J IMMUNOL, V130, P2386; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	59	88	89	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1995	3	5					573	582		10.1016/1074-7613(95)90128-0	http://dx.doi.org/10.1016/1074-7613(95)90128-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584147	Bronze			2022-12-18	WOS:A1995TG28100005
J	ROTHMAN, P; KREIDER, B; AZAM, M; LEVY, D; WEGENKA, U; EILERS, A; DECKER, T; HORN, F; KASHLEVA, H; IHLE, J; SCHINDLER, C				ROTHMAN, P; KREIDER, B; AZAM, M; LEVY, D; WEGENKA, U; EILERS, A; DECKER, T; HORN, F; KASHLEVA, H; IHLE, J; SCHINDLER, C			CYTOKINES AND GROWTH-FACTORS SIGNAL THROUGH TYROSINE PHOSPHORYLATION OF A FAMILY OF RELATED TRANSCRIPTION FACTORS	IMMUNITY			English	Article							RECEPTOR GAMMA-CHAIN; INTERFERON ACTIVATION FACTOR; DNA-BINDING PROTEINS; TRANSDUCTION PATHWAY; CELL-LINE; ERYTHROPOIETIN RECEPTOR; FUNCTIONAL COMPONENT; NUCLEAR FACTOR; CNTF RECEPTOR; KINASE	The ability of cytokines to activate distinct but overlapping sets of genes defines their characteristic biological response. We now show that IFN gamma, IL-3, IL-4, IL-6, erythropoietin, EGF, and CSF-1 activate differing members of a family of latent cytoplasmic transcription factors. Although these factors have distinct physical and functional properties and exhibit different patterns of expression, they share many important features, including recognition of a related set of enhancer elements, rapid activation, tyrosine phosphorylation, and cross-reactivity to antibodies against p91, a cytoplasmic signaling protein activated by IFN alpha, IFN gamma, and IL-6. These shared features point to either parallel or common patterns of signal transduction. A general model of cytokine signal transduction is presented, in which receptor-associated tyrosine kinases activate ligand-specific members of a family of signal-transducing factors. Once activated, these factors carry their signals to the nucleus, where they bind a family of related enhancer elements.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; NYU, SCH MED, DEPT PATHOL, NEW YORK, NY 10016 USA; NYU, KAPLAN COMPREHENS CANC CTR, NEW YORK, NY 10016 USA; RHEIN WESTFAL TH AACHEN, D-52057 AACHEN, GERMANY; UNIV VIENNA, INST MICROBIOL & GENET, DEPT CELL & MICROBIOL, A-1030 VIENNA, AUSTRIA	St Jude Children's Research Hospital; New York University; New York University; RWTH Aachen University; University of Vienna	ROTHMAN, P (corresponding author), COLUMBIA UNIV, COLL PHYS & SURG, DEPT MED, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 21006-17] Funding Source: Medline; NIAID NIH HHS [AI 33540-01] Funding Source: Medline; NIDDK NIH HHS [DK 42932] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; COOK JR, 1992, P NATL ACAD SCI USA, V89, P11317, DOI 10.1073/pnas.89.23.11317; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DUSANTERFOURT I, 1994, EMBO J, V13, P2583, DOI 10.1002/j.1460-2075.1994.tb06548.x; EILERS A, 1993, MOL CELL BIOL, V13, P3245, DOI 10.1128/MCB.13.6.3245; EILERS A, 1994, MOL CELL BIOL, V14, P1364, DOI 10.1128/MCB.14.2.1364; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; GLIMCHER LH, 1982, NATURE, V298, P283, DOI 10.1038/298283a0; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KONTANIDES H, 1993, SCIENCE, V262, P1265; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEHMANN J, 1994, IN PRESS J IMMUNOL; LOH JE, 1992, EMBO J, V11, P1351, DOI 10.1002/j.1460-2075.1992.tb05180.x; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MIGLIACCIO G, 1989, J CELL BIOL, V109, P833, DOI 10.1083/jcb.109.2.833; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; ROTHMAN P, 1991, MOL CELL BIOL, V11, P5551, DOI 10.1128/MCB.11.11.5551; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SIEGEL JP, 1990, J IMMUNOL METHODS, V132, P287, DOI 10.1016/0022-1759(90)90040-3; SILVA D, 1994, IN PRESS J BIOL CHEM; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STREHLOW I, 1993, J BIOL CHEM, V268, P16590; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAKAO H, 1992, J BIOL CHEM, V267, P16365; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YIN T, 1992, BLOOD S, V80, pA151; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657; YULEE LY, 1990, MOL CELL BIOL, V10, P3087, DOI 10.1128/MCB.10.6.3087; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	72	88	93	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1994	1	6					457	468		10.1016/1074-7613(94)90088-4	http://dx.doi.org/10.1016/1074-7613(94)90088-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7895157				2022-12-18	WOS:A1994PK17100003
J	MUSTELIN, T				MUSTELIN, T			T-CELL ANTIGEN RECEPTOR SIGNALING - 3 FAMILIES OF TYROSINE KINASES AND A PHOSPHATASE	IMMUNITY			English	Article							CD45 PHOSPHOTYROSINE PHOSPHATASE; LEUKOCYTE-COMMON ANTIGEN; HUMAN LYMPHOCYTES-T; PROTEIN-KINASE; CROSS-LINKING; INTERLEUKIN-2 PRODUCTION; NEGATIVE REGULATION; FUNCTIONAL COMPLEX; MICE LACKING; C ACTIVATION				MUSTELIN, T (corresponding author), LA JOLLA INST ALLERGY & IMMUNOL,DIV CELL BIOL,11149 N TORREY PINES RD,LA JOLLA,CA 92037, USA.			Mustelin, Tomas/0000-0001-5912-8840				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ALTMAN A, 1990, ADV IMMUNOL, V48, P277; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; AUTERO M, 1994, MOL CELL BIOL, V14, P1308, DOI 10.1128/MCB.14.2.1308; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; COUTURE C, 1994, IN PRESS MOL CELL BI; DANIELIAN S, 1992, EUR J IMMUNOL, V22, P2915, DOI 10.1002/eji.1830221124; DASILVA AJ, 1992, MOL IMMUNOL, V29, P1417, DOI 10.1016/0161-5890(92)90215-J; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; GASSMANN M, 1992, EUR J IMMUNOL, V22, P283, DOI 10.1002/eji.1830220142; GUTTINGER M, 1992, INT IMMUNOL, V4, P1325, DOI 10.1093/intimm/4.11.1325; HALL CG, 1993, SCIENCE, V261, P915, DOI 10.1126/science.8346442; HOVIS RR, 1993, SCIENCE, V260, P544, DOI 10.1126/science.8475387; HSI ED, 1989, J BIOL CHEM, V264, P10836; HURLEY TR, 1993, MOL CELL BIOL, V13, P1651, DOI 10.1128/MCB.13.3.1651; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JUNE CH, 1990, J IMMUNOL, V144, P1591; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; KIENER PA, 1993, J BIOL CHEM, V268, P24442; KIENER PA, 1989, J IMMUNOL, V143, P23; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KORETZKY GA, 1992, J IMMUNOL, V149, P1138; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LEDBETTER JA, 1988, P NATL ACAD SCI USA, V85, P8628, DOI 10.1073/pnas.85.22.8628; LIN JJ, 1992, J IMMUNOL, V149, P3182; LIU XQ, 1993, ONCOGENE, V8, P1119; LUO KX, 1992, MOL CELL BIOL, V12, P4724, DOI 10.1128/MCB.12.10.4724; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; MUSTELIN T, 1990, ONCOGENE, V5, P809; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; MUSTELIN T, 1994, UNPUB; MUSTELIN T, 1994, SRC FAMILY TYROSINE; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; OETKEN C, 1994, ONCOGENE, V9, P1625; OKADA M, 1991, J BIOL CHEM, V266, P24249; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PARTANEN J, 1991, ONCOGENE, V6, P2013; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STAHLS A, 1994, IN RESS EUR J IMMUNO; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STOVER DR, 1991, P NATL ACAD SCI USA, V88, P7704, DOI 10.1073/pnas.88.17.7704; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; TURKA LA, 1992, EUR J IMMUNOL, V22, P551, DOI 10.1002/eji.1830220238; VOLAREVIC S, 1993, SCIENCE, V260, P541, DOI 10.1126/science.8475386; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x	84	88	90	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					351	356		10.1016/1074-7613(94)90065-5	http://dx.doi.org/10.1016/1074-7613(94)90065-5			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882167				2022-12-18	WOS:A1994PK16800003
J	Schreurs, RRCE; Baumdick, ME; Sagebiel, AF; Kaufmann, M; Mokry, M; Klarenbeek, PL; Schaltenberg, N; Steinert, FL; van Rijn, JM; Drewniak, A; The, SMML; Bakx, R; Derikx, JPM; de Vries, N; Corpeleijn, WE; Pals, ST; Gagliani, N; Friese, MA; Middendorp, S; Nieuwenhuis, EES; Reinshagen, K; Geijtenbeek, TBH; van Goudoever, JB; Bunders, MJ				Schreurs, Renee R. C. E.; Baumdick, Martin E.; Sagebiel, Adrian F.; Kaufmann, Max; Mokry, Michal; Klarenbeek, Paul L.; Schaltenberg, Nicola; Steinert, Fenja L.; van Rijn, Jorik M.; Drewniak, Agata; The, Sarah-May M. L.; Bakx, Roel; Derikx, Joep P. M.; de Vries, Niek; Corpeleijn, Willemijn E.; Pals, Steven T.; Gagliani, Nicola; Friese, Manuel A.; Middendorp, Sabine; Nieuwenhuis, Edward E. S.; Reinshagen, Konrad; Geijtenbeek, Teunis B. H.; van Goudoever, Johannes B.; Bunders, Madeleine J.			Human Fetal TNF-alpha-Cytokine-Producing CD4(+) Effector Memory T Cells Promote Intestinal Development and Mediate Inflammation Early in Life	IMMUNITY			English	Article							RESPONSES; TRANSCRIPTION; APOPTOSIS; DESIGN; MICE; GUT	Although the fetal immune system is considered tolerogenic, preterm infants can suffer from severe intestinal inflammation, including necrotizing enterocolitis (NEC). Here, we demonstrate that human fetal intestines predominantly contain tumor necrosis factor-alpha (TNF-alpha)(+)CD4(+)CD69(+) T effector memory (Tem) cells. Single-cell RNA sequencing of fetal intestinal CD4(+) T cells showed a T helper 1 phenotype and expression of genes mediating epithelial growth and cell cycling. Organoid co-cultures revealed a dose-dependent, TNF-alpha-mediated effect of fetal intestinal CD4(+) T cells on intestinal stem cell (ISC) development, in which low T cell numbers supported epithelial development, whereas high numbers abrogated ISC proliferation. CD4(+) Tem cell frequencies were higher in inflamed intestines from preterm infants with NEC than in healthy infant intestines and showed enhanced TNF signaling. These findings reveal a distinct population of TNF-alpha-producing CD4(+) T cells that promote mucosal development in fetal intestines but can also mediate inflammation upon preterm birth.	[Schreurs, Renee R. C. E.; Klarenbeek, Paul L.; Drewniak, Agata; The, Sarah-May M. L.; de Vries, Niek; Geijtenbeek, Teunis B. H.; Bunders, Madeleine J.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Infect & Immun Inst, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Schreurs, Renee R. C. E.; Corpeleijn, Willemijn E.; van Goudoever, Johannes B.; Bunders, Madeleine J.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Baumdick, Martin E.; Sagebiel, Adrian F.; Steinert, Fenja L.; Bunders, Madeleine J.] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Kaufmann, Max; Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol Hamburg, Inst Neuroimmunol & Multiple Sklerose, D-20251 Hamburg, Germany; [Mokry, Michal; van Rijn, Jorik M.; Middendorp, Sabine; Nieuwenhuis, Edward E. S.] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Div Pediat,Dept Pediat Gastroenterol, NL-3584 EA Utrecht, Netherlands; [Mokry, Michal; van Rijn, Jorik M.; Middendorp, Sabine; Nieuwenhuis, Edward E. S.] Univ Utrecht, Med Ctr, Regenerat Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Klarenbeek, Paul L.; de Vries, Niek] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Infect & Immun Inst, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Klarenbeek, Paul L.; de Vries, Niek] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Rheumatol & Immunol Ctr, NL-1105 AZ Amsterdam, Netherlands; [Schaltenberg, Nicola; Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany; [Schaltenberg, Nicola; Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, D-20246 Hamburg, Germany; [Schaltenberg, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Drewniak, Agata] Kiadis Pharma BV, NL-1105 BV Amsterdam, Netherlands; [The, Sarah-May M. L.; Bakx, Roel; Derikx, Joep P. M.] Amsterdam Univ Med Ctr, Pediat Surg Ctr Amsterdam, Dept Pediat Surg, NL-1105 AZ Amsterdam, Netherlands; [Pals, Steven T.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Gagliani, Nicola] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, S-17176 Stockholm, Sweden; [Reinshagen, Konrad] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Surg, D-20246 Hamburg, Germany; [van Goudoever, Johannes B.] Vrije Univ, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1081 HV Amsterdam, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Utrecht University; Wilhelmina Kinderziekenhuis; Utrecht University; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vrije Universiteit Amsterdam; University of Amsterdam; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Emma Children's Hospital; University of Amsterdam; Vrije Universiteit Amsterdam	Bunders, MJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Infect & Immun Inst, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands.; Bunders, MJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands.; Bunders, MJ (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany.	madeleine.bunders@leibniz-hpi.de	Middendorp, Sabine/B-8357-2013; Mokry, Michal/AAN-3809-2021; Middendorp, Sabine/J-8205-2012; van Rijn, Jorik/ABF-4613-2020; Reinshagen, Konrad/P-2824-2019; de Vries, Niek/J-9348-2013	Middendorp, Sabine/0000-0002-0925-0095; Mokry, Michal/0000-0002-5298-4852; Middendorp, Sabine/0000-0002-0925-0095; van Rijn, Jorik/0000-0003-2865-4455; de Vries, Niek/0000-0002-6257-8604; Pals, Steven/0000-0002-1419-0939; The, Sarah-May/0000-0002-0731-3128; Gagliani, Nicola/0000-0001-8514-1395; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; derikx, joep/0000-0003-0694-7679; Geijtenbeek, Teunis/0000-0002-5710-2839; Friese, Manuel A./0000-0001-6380-2420; Bakx, Roel/0000-0001-5884-2997; Kaufmann, Max/0000-0002-1954-4425	University Medical Center Utrecht; Hubrecht Institute; Utrecht University; Dutch Digestive Fund (MLDS Project) [CDG 15-02]; Deutsche Forschungsgemeinschaft (DFG) [SFB841]; Stichting Steun Emma [WAR008-2015-03-002]; Daisy Huet Roell Foundation	University Medical Center Utrecht; Hubrecht Institute; Utrecht University; Dutch Digestive Fund (MLDS Project); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stichting Steun Emma; Daisy Huet Roell Foundation	The authors would like to thank Dr. Weijer, Dr. Voordouw, and the Bloemenhove clinic (Heemstede, the Netherlands) for collecting and providing fetal tissues; Dr. Remmerswaal, Dr. Hooijbrink, and Mr. Dusedau for assistance in flow-cytometric analyses; and Dr. Dijkstra-Muncan and Ms. Martins Garcia for assistance in organoid experiments. We thank the Utrecht Sequencing Facility for providing sequencing service. The Utrecht Sequencing Facility is subsidized by the University Medical Center Utrecht, Hubrecht Institute, and Utrecht University. This work was supported by the Dutch Digestive Fund (MLDS Project CDG 15-02), the Deutsche Forschungsgemeinschaft (DFG; SFB841), the Stichting Steun Emma (WAR008-2015-03-002), and the Daisy Huet Roell Foundation.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aronica MA, 1999, J IMMUNOL, V163, P5116; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Bunders MJ, 2012, BLOOD, V120, P4383, DOI 10.1182/blood-2012-06-437566; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; CHAO CC, 1995, DEV NEUROSCI-BASEL, V17, P97, DOI 10.1159/000111278; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gerner RR, 2018, GUT, V67, P1813, DOI 10.1136/gutjnl-2017-314241; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; He YM, 2018, NAT MED, V24, P224, DOI 10.1038/nm.4467; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kretzschmar K, 2017, DEV BIOL, V428, P273, DOI 10.1016/j.ydbio.2017.05.015; Kuprash DV, 2005, EUR J IMMUNOL, V35, P1592, DOI 10.1002/eji.200526119; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; MEIENHOFER MC, 1979, BLOOD, V54, P389; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Nusse YM, 2018, NATURE, V559, P109, DOI 10.1038/s41586-018-0257-1; OROSZ P, 1993, J EXP MED, V177, P1391, DOI 10.1084/jem.177.5.1391; Parekh S, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy059; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Sands BE, 2007, J CLIN PHARMACOL, V47, P930, DOI 10.1177/0091270007301623; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schoenberger SP, 2012, P NATL ACAD SCI USA, V109, P8358, DOI 10.1073/pnas.1204616109; Schreurs RRCE, 2017, J IMMUNOL METHODS, V445, P45, DOI 10.1016/j.jim.2017.03.006; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; STEFANINI M, 1972, AM J CLIN PATHOL, V58, P408; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; WEAVER LT, 1991, GUT, V32, P1321, DOI 10.1136/gut.32.11.1321; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748; ZOLTI M, 1991, FERTIL STERIL, V56, P265	63	87	90	6	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					462	+		10.1016/j.immuni.2018.12.010	http://dx.doi.org/10.1016/j.immuni.2018.12.010			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30770246	Bronze			2022-12-18	WOS:000459006700019
J	Sander, J; Schmidt, SV; Cirovic, B; McGovern, N; Papantonopoulou, O; Hardt, AL; Aschenbrenner, AC; Kreer, C; Quast, T; Xu, AM; Schmidleithner, LM; Theis, H; Huong, LDT; Bin Sumatoh, HR; Lauterbach, MAR; Schulte-Schrepping, J; Gunther, P; Xue, J; Bassler, K; Ulas, T; Klee, K; Katzmarski, N; Herresthal, S; Krebs, W; Martin, B; Latz, E; Handler, K; Kraut, M; Kolanus, W; Beyer, M; Falk, CS; Wiegmann, B; Burgdorf, S; Melosh, NA; Newell, EW; Ginhoux, F; Schlitzer, A; Schultze, JL				Sander, Jil; Schmidt, Susanne V.; Cirovic, Branko; McGovern, Naomi; Papantonopoulou, Olympia; Hardt, Anna-Lena; Aschenbrenner, Anna C.; Kreer, Christoph; Quast, Thomas; Xu, Alexander M.; Schmidleithner, Lisa M.; Theis, Heidi; Lan Do Thi Huong; Bin Sumatoh, Hermi Rizal; Lauterbach, Mario A. R.; Schulte-Schrepping, Jonas; Guenther, Patrick; Xue, Jia; Bassler, Kevin; Ulas, Thomas; Klee, Kathrin; Katzmarski, Natalie; Herresthal, Stefanie; Krebs, Wolfgang; Martin, Bianca; Latz, Eicke; Haendler, Kristian; Kraut, Michael; Kolanus, Waldemar; Beyer, Marc; Falk, Christine S.; Wiegmann, Bettina; Burgdorf, Sven; Melosh, Nicholas A.; Newell, Evan W.; Ginhoux, Florent; Schlitzer, Andreas; Schultze, Joachim L.			Cellular Differentiation of Human Monocytes Is Regulated by Time-Dependent Interleukin-4 Signaling and the Transcriptional Regulator NCOR2	IMMUNITY			English	Article							HUMAN DENDRITIC CELLS; IN-VITRO; BLOOD MONOCYTES; BONE-MARROW; PPAR-GAMMA; STEM-CELL; GM-CSF; MACROPHAGES; EXPRESSION; RECEPTOR	Human in vitro generated monocyte-derived dendritic cells (moDCs) and macrophages are used clinically, e.g., to induce immunity against cancer. However, their physiological counterparts, ontogeny, transcriptional regulation, and heterogeneity remains largely unknown, hampering their clinical use. High-dimensional techniques were used to elucidate transcriptional, phenotypic, and functional differences between human in vivo and in vitro generated mononuclear phagocytes to facilitate their full potential in the clinic. We demonstrate that monocytes differentiated by macrophage colony-stimulating factor (M-CSF) or granulocyte macrophage colony-stimulating factor (GM-CSF) resembled in vivo inflammatory macrophages, while moDCs resembled in vivo inflammatory DCs. Moreover, differentiated monocytes presented with profound transcriptomic, phenotypic, and functional differences. Monocytes integrated GM-CSF and IL-4 stimulation combinatorically and temporally, resulting in a mode-and time-dependent differentiation relying on NCOR2. Finally, moDCs are phenotypically heterogeneous and therefore necessitate the use of high-dimensional phenotyping to open new possibilities for better clinical tailoring of these cellular therapies.	[Sander, Jil; Papantonopoulou, Olympia; Hardt, Anna-Lena; Aschenbrenner, Anna C.; Schmidleithner, Lisa M.; Theis, Heidi; Lan Do Thi Huong; Schulte-Schrepping, Jonas; Guenther, Patrick; Xue, Jia; Bassler, Kevin; Ulas, Thomas; Klee, Kathrin; Herresthal, Stefanie; Krebs, Wolfgang; Haendler, Kristian; Kraut, Michael; Beyer, Marc; Schultze, Joachim L.] Univ Bonn, LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Schmidt, Susanne V.; Lauterbach, Mario A. R.; Martin, Bianca; Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Cirovic, Branko; Katzmarski, Natalie; Schlitzer, Andreas] Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany; [McGovern, Naomi; Bin Sumatoh, Hermi Rizal; Newell, Evan W.; Ginhoux, Florent; Schlitzer, Andreas] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [McGovern, Naomi] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [McGovern, Naomi] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 1QP, England; [Kreer, Christoph; Burgdorf, Sven] Univ Bonn, LIMES Inst, Cellular Immunol, D-53115 Bonn, Germany; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, LIMES Inst, Mol Immunol & Cell, D-53115 Bonn, Germany; [Xu, Alexander M.; Melosh, Nicholas A.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, D-53127 Bonn, Germany; [Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol, Sigmund Freud Str 27, D-53127 Bonn, Germany; [Falk, Christine S.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Inst Transplant Immunol, D-30625 Hannover, Germany; [Wiegmann, Bettina] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen PRECISE, D-53127 Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, D-53127 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Cambridge; University of Cambridge; University of Bonn; University of Bonn; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Hannover Medical School; Hannover Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Schlitzer, A (corresponding author), Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany.; Schlitzer, A (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	andreas.schlitzer@uni-bonn.de	Beyer, Marc/ABE-1408-2021; Xu, Alexander/J-6528-2012; Latz, Eicke/H-3951-2014; Kreer, Christoph/ABG-7275-2021; Newell, Evan W/F-9711-2012; Schmidt, Susanne/AAU-6827-2021; Schultze, Joachim L./ABA-8176-2020; Falk, Christine/Q-4143-2016	Beyer, Marc/0000-0001-9704-148X; Xu, Alexander/0000-0003-4877-4358; Latz, Eicke/0000-0003-1488-5666; Kreer, Christoph/0000-0002-9140-9850; Newell, Evan W/0000-0002-2889-243X; Schultze, Joachim L./0000-0003-2812-9853; Falk, Christine/0000-0003-1376-7318; Do, Thi Huong Lan/0000-0001-8058-4410; Aschenbrenner, Anna/0000-0002-9429-5457; Handler, Kristian/0000-0001-5273-5277; Cirovic, Branko/0000-0002-0754-0099; Klee, Kathrin/0000-0003-2408-1282; Gunther, Patrick/0000-0002-9135-7819	German Research Foundation [SFB 832, SFB 704, INST 217/577-1, SFB 738, SCHL2116/1-1]; Singapore Immunology Network; Singapore Immunology Network immune-monitoring platform funding; European Union under REA [317445]; Royal Society; Wellcome Trust [204464/Z/16/Z]	German Research Foundation(German Research Foundation (DFG)); Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Singapore Immunology Network immune-monitoring platform funding; European Union under REA; Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	We thank J. Oldenburg for buffy coats from healthy individuals and M. Ballmaier for cell sorting at MHH. This work was supported by the German Research Foundation (SFB 832, SFB 704, INST 217/577-1, and SFB 738 to C.S.F.), core grants of the Singapore Immunology Network (F.G., E.W.N.), and the Singapore Immunology Network immune-monitoring platform funding (E.W.N.). J.L.S., A.S., W. Kolanus, E.L., S.B., and M.B. are members of the Excellence Cluster ImmunoSensation. The research leading to these results received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2077-2013 under REA grant agreement no. 317445. A.S. is supported by an Emmy Noether fellowship of the German Research foundation (SCHL2116/1-1). N.McG. is supported by a Royal Society and Wellcome Trust grant (204464/Z/16/Z).	Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; Allam JP, 2004, J INVEST DERMATOL, V123, P676, DOI 10.1111/j.0022-202X.2004.23428.x; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Breton G., 2015, J EXP MED, V207, P1273; Brower V, 2005, NAT MED, V11, P360, DOI 10.1038/nm0405-360a; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; Czimmerer Z, 2012, IMMUNOBIOLOGY, V217, P1301, DOI 10.1016/j.imbio.2012.08.270; de Souza Jorge Estefano Santana, 2012, Cancer Immun, V12, P15; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Garg AD, 2017, TRENDS IMMUNOL, V38, P577, DOI 10.1016/j.it.2017.05.006; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00406; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Ruckerl D, 2014, IMMUNOL REV, V262, P113, DOI 10.1111/imr.12221; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Stellato C, 1997, J CLIN INVEST, V99, P926, DOI 10.1172/JCI119257; Toujas L, 1997, IMMUNOLOGY, V91, P635, DOI 10.1046/j.1365-2567.1997.00287.x; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117	50	87	89	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1051	+		10.1016/j.immuni.2017.11.024	http://dx.doi.org/10.1016/j.immuni.2017.11.024			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262348	Green Published, hybrid			2022-12-18	WOS:000418486500011
J	Jones, A; Bourque, J; Kuehm, L; Opejin, A; Teague, RM; Gross, C; Hawiger, D				Jones, Andrew; Bourque, Jessica; Kuehm, Lindsey; Opejin, Adeleye; Teague, Ryan M.; Gross, Cindy; Hawiger, Daniel			Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells	IMMUNITY			English	Article							ENTRY MEDIATOR TNFRSF14; VERSUS-HOST-DISEASE; TRANSCRIPTION-FACTOR; SELF-TOLERANCE; RETINOIC-ACID; CD5 EXPRESSION; STEADY-STATE; REG-CELLS; IN-VIVO; LYMPHOCYTE	Dendritic cells ( DCs) initiate immunity and also antigen-specific tolerance mediated by extrathymic regulatory T ( Treg) cells, yet it remains unclear how DCs regulate induction of such tolerance. Here, we report that efficient induction of Treg cells was instructed by BTLA(+)DEC205(+)CD8(+)CD11c(+)DCs and the immunomodulatory functions of BTLA. In contrast, T cell activation in steady state by total CD11c(+) DCs that include a majority of DCs that do not express BTLA did not induce Treg cells and had no lasting impact on subsequent immune responses. Engagement of HVEM, a receptor of BTLA, promoted Foxp3 expression in T cells through upregulation of CD5. In contrast, T cells activated in the absence of BTLA and HVEM-mediated functions remained CD5(lo) and therefore failed to resist the inhibition of Foxp3 expression in response to effector cell-differentiating cytokines. Thus, DCs require BTLA and CD5-dependent mechanisms to actively adjust tolerizing T cell responses under steady-state conditions.	[Jones, Andrew; Bourque, Jessica; Kuehm, Lindsey; Opejin, Adeleye; Teague, Ryan M.; Gross, Cindy; Hawiger, Daniel] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University	Hawiger, D (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	dhawiger@slu.edu		Opejin, Adeleye/0000-0002-0023-3192; Teague, Ryan/0000-0002-8426-2870; Bourque, Jessica/0000-0003-3643-759X	National Multiple Sclerosis Society [RG5019A]; National Institute of Allergy and Infectious Diseases of the NIH [R01AI113903]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113903] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Joy Eslick and Sherri L. Koehm (Saint Louis University) for expert help with flow cytometry and Ziva Misulovin (Saint Louis University) for help with immunoblots. This work was supported in part by grants from the National Multiple Sclerosis Society (RG5019A) and National Institute of Allergy and Infectious Diseases of the NIH (R01AI113903) (both to D.H.). This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.	Albring JC, 2010, J EXP MED, V207, P2551, DOI 10.1084/jem.20102017; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Castro FVV, 2008, EUR J IMMUNOL, V38, P2263, DOI 10.1002/eji.200838302; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Flynn R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077991; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gottschalk C, 2013, J AM SOC NEPHROL, V24, P543, DOI 10.1681/ASN.2012101022; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hawiger D, 2010, NAT IMMUNOL, V11, P962, DOI 10.1038/ni.1929; Henderson JG, 2015, IMMUNITY, V42, P471, DOI 10.1016/j.immuni.2015.02.010; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huarte E, 2016, J IMMUNOL, V196, P5036, DOI 10.4049/jimmunol.1501973; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jones A, 2015, J IMMUNOL, V195, P1489, DOI 10.4049/jimmunol.1500174; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Mellman I, 2013, CANCER IMMUNOL RES, V1, P145, DOI 10.1158/2326-6066.CIR-13-0102; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Page JL, 2004, J BIOL CHEM, V279, P30966, DOI 10.1074/jbc.M402224200; Palucka K, 2013, CURR OPIN IMMUNOL, V25, P396, DOI 10.1016/j.coi.2013.05.001; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Sharma S, 2014, MICROBES INFECT, V16, P648, DOI 10.1016/j.micinf.2014.06.005; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Shui JW, 2011, J LEUKOCYTE BIOL, V89, P517, DOI 10.1189/jlb.0910528; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Steinberg MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077992; Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yang Y, 2004, P NATL ACAD SCI USA, V101, P3898, DOI 10.1073/pnas.0308764101; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025	74	87	95	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1066	1077		10.1016/j.immuni.2016.10.008	http://dx.doi.org/10.1016/j.immuni.2016.10.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27793593	Green Accepted, Bronze			2022-12-18	WOS:000389473500017
J	Norris, BA; Uebelhoer, LS; Nakaya, HI; Price, AA; Grakoui, A; Pulendran, B				Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali			Chronic but Not Acute Virus Infection Induces Sustained Expansion of Myeloid Suppressor Cell Numbers that Inhibit Viral-Specific T Cell Immunity	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMACYTOID DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; PERSISTENCE IN-VIVO; SUBSETS; IMMUNOSUPPRESSION; CD8(+); MICE; MONOCYTES; SYSTEM	Resolution of acute and chronic viral infections requires activation of innate cells to initiate and maintain adaptive immune responses. Here we report that infection with acute Armstrong (ARM) or chronic Clone 13 (C13) strains of lymphocytic choriomeningitis virus (LCMV) led to two distinct phases of innate immune response. During the first 72 hr of infection, dendritic cells upregulated activation markers and stimulated antiviral CD8(+) T cells, independent of viral strain. Seven days after infection, there was an increase in Ly6C(hi) monocytic and Gr-1(hi) neutrophilic cells in lymphoid organs and blood. This expansion in cell numbers was enhanced and sustained in C13 infection, whereas it occurred only transiently with ARM infection. These cells resembled myeloid-derived suppressor cells and potently suppressed T cell proliferation. The reduction of monocytic cells in Ccr2(-/-) mice or after Gr-1 antibody depletion enhanced antiviral T cell function. Thus, innate cells have an important immunomodulatory role throughout chronic infection.	[Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA; [Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; [Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020	Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333	National Institutes of Health [U54AI057157, R37AI48638, R37DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025, U19AI090023]; Bill & Melinda Gates Foundation; Yerkes Research Center Base Grant [RR-00165]; Public Health Service [DK083356, AI070101]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050025, U19AI057266, R37AI048638, T32AI007610, U54AI057157, R01AI070101, U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356, R37DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Yerkes Research Center Base Grant; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge R. Ahmed for advice and discussion; B. Evavold, J. Jacob, and R. Napier for comments on the paper; B. Cervasi and K. Gill for outstanding help with myeloid cell sorting; and J. Connolly's core laboratory at the Baylor Institute (Dallas, TX) for luminex analysis. This work was supported by grants U54AI057157, R37AI48638, R37DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025, and U19AI090023 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Additional support was provided by the Yerkes Research Center Base Grant RR-00165 and Public Health Service DK083356 and AI070101 (A.G.).	AHMED R, 1988, J VIROL, V62, P3301, DOI 10.1128/JVI.62.9.3301-3308.1988; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; MELILLO G, 1994, J BIOL CHEM, V269, P8128; Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Smelt SC, 2001, J VIROL, V75, P448, DOI 10.1128/JVI.75.1.448-457.2001; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yang RC, 2006, CANCER RES, V66, P6807, DOI 10.1158/0008-5472.CAN-05-3755; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	50	87	90	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					309	321		10.1016/j.immuni.2012.10.022	http://dx.doi.org/10.1016/j.immuni.2012.10.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438822	Bronze, Green Accepted			2022-12-18	WOS:000330940800013
J	Darce, J; Rudra, D; Li, L; Nishio, J; Cipolletta, D; Rudensky, AY; Mathis, D; Benoist, C				Darce, Jaime; Rudra, Dipayan; Li, Li; Nishio, Junko; Cipolletta, Daniela; Rudensky, Alexander Y.; Mathis, Diane; Benoist, Christophe			An N-Terminal Mutation of the Foxp3 Transcription Factor Alleviates Arthritis but Exacerbates Diabetes	IMMUNITY			English	Article							REGULATORY T-CELLS; AUTOIMMUNE-DISEASE; GENE-EXPRESSION; TGF-BETA; MICE; DIFFERENTIATION; T(H)17; INTERLEUKIN-4; SUBPHENOTYPES; SPECIFICATION	Maintenance of lymphoid homeostasis in a number of immunological and inflammatory contexts is served by a variety of regulatory T (Treg) cell subtypes and depends on interaction of the transcription factor FoxP3 with specific transcriptional cofactors. We report that a commonly used insertional mutant of FoxP3 (GFP-Foxp3) modified its molecular interactions, blocking HIF-1 alpha but increasing IRF4 interactions. The transcriptional profile of these Treg cells was subtly altered, with an overrepresentation of IRF4-dependent transcripts. In keeping with IRF4-dependent function of Treg cells to preferentially suppress T cell help to B cells and Th2 and Th17 cell-type differentiation, GFP-FoxP3 mice showed a divergent susceptibility to autoimmune disease: protection against antibody-mediated arthritis in the K/BxN model, but greater susceptibility to diabetes on the NOD background. Thus, specific subfunctions of Treg cells and the immune diseases they regulate can be influenced by FoxP3's molecular interactions, which result in divergent immunoregulation.	[Darce, Jaime; Li, Li; Nishio, Junko; Cipolletta, Daniela; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Rudra, Dipayan; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Rudra, Dipayan; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Benoist, C (corresponding author), Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Rudra, Dipayan/AAZ-5426-2020	Rudra, Dipayan/0000-0002-9667-5891	NIH [AI051530, AI065858, DK092541]; Juvenile Diabetes Research Foundation (JDRF) [4-2007-1057]; Iacocca Foundation; NRSA [DFCI/NCI: T32 CA007386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530, P01AI065858, R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Iacocca Foundation; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Vignali and M. Bettini for discussing their observations with us prior to publication, V. Kuchroo for mice, K. Hattori and A. Ortiz-Lopez for help with mice, J. LaVecchio and G. Buruzula for flow cytometry, J. Ericson and S. Davis for help with microarray analyses and bioinformatics, and C. Laplace for help with the manuscript. This work was supported by grants from the NIH (AI051530, AI065858, and DK092541) and the Juvenile Diabetes Research Foundation (JDRF) (4-2007-1057) to D.M. and C.B. J.N. was supported by an Iacocca Foundation fellowship. J.D. was supported by an NRSA Fellowship, Postdoctoral Training Program in Cancer Immunology (DFCI/NCI: T32 CA007386).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hung JT, 2005, J AUTOIMMUN, V25, P181, DOI 10.1016/j.jaut.2005.08.010; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; Monach P.A., 2008, K BXN ARTHRITIS MODE; Nikoopour E, 2010, J IMMUNOL, V184, P4779, DOI 10.4049/jimmunol.0902822; Ohmura K, 2005, ARTHRITIS RHEUM-US, V52, P1866, DOI 10.1002/art.21104; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin YC, 2008, CANCER RES, V68, P1751, DOI 10.1158/0008-5472.CAN-07-2766; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tse HM, 2010, J IMMUNOL, V185, P5247, DOI 10.4049/jimmunol.1001472; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang B, 1998, DIABETES, V47, P1207, DOI 10.2337/diabetes.47.8.1207; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	48	87	94	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					731	741		10.1016/j.immuni.2012.04.007	http://dx.doi.org/10.1016/j.immuni.2012.04.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22579475	Green Accepted, Bronze			2022-12-18	WOS:000304976000008
J	de Almeida, CR; Stadhouders, R; de Bruijn, MJW; Bergen, IM; Thongjuea, S; Lenhard, B; van IJcken, W; Grosveld, F; Galjart, N; Soler, E; Hendriks, RW				de Almeida, Claudia Ribeiro; Stadhouders, Ralph; de Bruijn, Marjolein J. W.; Bergen, Ingrid M.; Thongjuea, Supat; Lenhard, Boris; van IJcken, Wilfred; Grosveld, Frank; Galjart, Niels; Soler, Eric; Hendriks, Rudi W.			The DNA-Binding Protein CTCF Limits Proximal V kappa Recombination and Restricts kappa Enhancer Interactions to the Immunoglobulin kappa Light Chain Locus	IMMUNITY			English	Article							MOUSE BONE-MARROW; B-CELL RECEPTOR; V(D)J RECOMBINATION; PRO-B; ANTISENSE TRANSCRIPTION; IGH LOCUS; GENE; DIFFERENTIATION; REARRANGEMENT; LINEAGE	Regulation of immunoglobulin (Ig) V(D)J gene rear-rangement is dependent on higher-order chromatin organization. Here, we studied the in vivo function of the DNA-binding zinc-finger protein CTCF, which regulates interactions between enhancers and promoters. By conditional deletion of the Ctcf gene in the B cell lineage, we demonstrate that loss of CTCF allowed Ig heavy chain recombination, but pre-B cell proliferation and differentiation was severely impaired. In the absence of CTCF, the Ig kappa light chain locus showed increased proximal and reduced distal V kappa usage. This was associated with enhanced proximal V kappa and reduced J kappa germline transcription. Chromosome conformation capture experiments demonstrated that CTCF limits interactions of the Ig kappa enhancers with the proximal V(kappa) gene region and prevents inappropriate interactions between these strong enhancers and elements outside the Ig kappa locus. Thus, although Ig gene recombination can occur in the absence of CTCF, it is a critical factor determining V kappa segment choice for recombination.	[de Almeida, Claudia Ribeiro; de Bruijn, Marjolein J. W.; Bergen, Ingrid M.; Hendriks, Rudi W.] Erasmus MC, Dept Pulm Med, NL-3000 CA Rotterdam, Netherlands; [Stadhouders, Ralph; Grosveld, Frank; Galjart, Niels; Soler, Eric] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [van IJcken, Wilfred] Erasmus MC, Ctr Biom, NL-3000 CA Rotterdam, Netherlands; [Grosveld, Frank; Soler, Eric] Erasmus MC, Canc Genom Ctr, NL-3000 CA Rotterdam, Netherlands; [Thongjuea, Supat; Lenhard, Boris] Univ Bergen, Computat Biol Unit, Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Thongjuea, Supat; Lenhard, Boris] Univ Bergen, Sars Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Lenhard, Boris] Univ Bergen, Dept Biol, N-5008 Bergen, Norway	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Bergen; University of Bergen; University of Bergen	Hendriks, RW (corresponding author), Erasmus MC, Dept Pulm Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.hendriks@erasmusmc.nl	Galjart, Niels/D-1146-2010; Stadhouders, Ralph/J-8663-2015; Soler, Eric/ABE-9723-2021; van ijcken, willem/N-9805-2018	Galjart, Niels/0000-0003-1964-3607; Stadhouders, Ralph/0000-0002-1060-5607; Soler, Eric/0000-0003-0521-7463; van ijcken, willem/0000-0002-0421-8301; Ribeiro de Almeida, Claudia/0000-0002-1462-5453; Lenhard, Boris/0000-0002-1114-1509; Thongjuea, Supat/0000-0002-9129-4694; Hendriks, Rudi/0000-0003-2291-0382	Fundacao para a Ciencia e a Tecnologia; Dutch Cancer Foundation (KWF); Royal Netherlands Academy of Arts and Sciences (KNAW); Center of Biomedical Genetics; EuTRACC Consortium	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding); Royal Netherlands Academy of Arts and Sciences (KNAW); Center of Biomedical Genetics; EuTRACC Consortium	We thank E. Hobeika and M. Reth (Max Planck Institute for Immunobiology, Freiburg, Germany) for kindly providing mb1-Cre mice, Z. Ozgur, C.E.M. Kockx (Biomics, Erasmus MC), and M. Pescatori (Bioinformatics, Erasmus MC) for assistance on Affymetrix microarray analysis and Illumina sequencing, T. Langerak (Immunology) for facilitating DNA sequencing, and the Erasmus MC animal care facility staff. This work was partly supported by Fundacao para a Ciencia e a Tecnologia (C. R. A.), Dutch Cancer Foundation (KWF, R.W.H.), Royal Netherlands Academy of Arts and Sciences (KNAW, R.S.), the Center of Biomedical Genetics and the EuTRACC Consortium (F.G., E.S. and R. S.).	de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Duber S, 2003, MOL IMMUNOL, V40, P509, DOI 10.1016/S0161-5890(03)00226-8; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.3.CO;2-8; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Grawunder U, 1995, INT IMMUNOL, V7, P1915, DOI 10.1093/intimm/7.12.1915; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Inlay MA, 2006, J EXP MED, V203, P1721, DOI 10.1084/jem.20052310; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Martin F, 1997, INT IMMUNOL, V9, P493, DOI 10.1093/intimm/9.4.493; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; tenBoekel E, 1997, IMMUNITY, V7, P357; Xiang YG, 2011, J IMMUNOL, V186, P5356, DOI 10.4049/jimmunol.1003794	39	87	90	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					501	513		10.1016/j.immuni.2011.07.014	http://dx.doi.org/10.1016/j.immuni.2011.07.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM		Bronze			2022-12-18	WOS:000296657700010
J	Brenchley, JM; Silvestri, G; Douek, DC				Brenchley, Jason M.; Silvestri, Guido; Douek, Daniel C.			Nonprogressive and Progressive Primate Immunodeficiency Lentivirus Infections	IMMUNITY			English	Article							T-CELL DEPLETION; AFRICAN-GREEN MONKEYS; VIRUS TYPE-1 INFECTION; SOOTY MANGABEYS; IMMUNE ACTIVATION; IN-VIVO; INTESTINAL INFLAMMATION; GENE-EXPRESSION; SIV INFECTION; HIV DISEASE	Natural hosts for simian immunodeficiency virus (Sly) can be, and are often naturally, infected with species-specific SIVs, but do not develop acquired immunodeficiency syndrome (AIDS). These natural hosts maintain high SIV viral loads, but avoid immunodeficiency. Elucidating the mechanisms that allow natural hosts to coexist with SIV without overt disease may provide crucial information for understanding AIDS pathogenesis. Over the past few years, several key features of natural SIV infections have been described in studies conducted predominantly in sooty mangabeys (SMs), African green monkeys (AGMs), and mandrills. Natural SIV hosts are able to avoid the chronic, generalized immune system activation that is associated with disease progression in HIV-infected individuals and are known to downmodulate the expression of the receptors for SIV. In this perspective we propose that a critical factor that differentiates nonprogressive from progressive HIV or SIV infection is the maintenance of T cell immune competence in the face of a virus that infects and kills CD4(+) T cells. Elucidation of the mechanisms underlying the preservation of immune function during and after the acute phase of natural SIV infection may lead to the design of novel preventive and therapeutic interventions for treatment of chronic HIV infection.	[Brenchley, Jason M.] NIAID, Immunopathogenesis Unit, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University	Brenchley, JM (corresponding author), NIAID, Immunopathogenesis Unit, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jbrenchl@mail.nih.gov; ddouek@mail.nih.gov	Brenchley, Jason/AAC-5085-2019	Brenchley, Jason/0000-0001-8357-2984	Intramural NIH HHS [Z01 AI005034-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001029, ZIAAI005033, ZIAAI005066, ZIAAI005031, ZIAAI005034] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Bjarnason I, 1996, AIDS, V10, P1385, DOI 10.1097/00002030-199610000-00011; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dunham R, 2006, BLOOD, V108, P209, DOI 10.1182/blood-2005-12-4897; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; FULTZ PN, 1989, AIDS RES HUM RETROV, V5, P397, DOI 10.1089/aid.1989.5.397; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goldstein S, 2005, J VIROL, V79, P5153, DOI 10.1128/JVI.79.8.5153-5162.2005; Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000; Goldstein S, 2006, J VIROL, V80, P4868, DOI 10.1128/JVI.80.10.4868-4877.2006; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; KAPEMBWA MS, 1991, CLIN SCI, V81, P327, DOI 10.1042/cs0810327; Kim N, 2007, J VIROL, V81, P7584, DOI 10.1128/JVI.02616-06; Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814; KOTLER DP, 1984, ANN INTERN MED, V101, P421, DOI 10.7326/0003-4819-101-4-421; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; Ling BH, 2004, J VIROL, V78, P8902, DOI 10.1128/JVI.78.16.8902-8908.2004; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Milush JM, 2007, J IMMUNOL, V179, P3047, DOI 10.4049/jimmunol.179.5.3047; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Pandrea I, 2003, VIROLOGY, V317, P119, DOI 10.1016/j.virol.2003.08.015; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2008, J VIROL, V82, P5501, DOI 10.1128/JVI.02555-07; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea I, 2006, J MED PRIMATOL, V35, P194, DOI 10.1111/j.1600-0684.2006.00168.x; Pandrea I, 2006, J VIROL, V80, P4858, DOI 10.1128/JVI.80.10.4858-4867.2006; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Silvestri G, 2005, J MED PRIMATOL, V34, P243, DOI 10.1111/j.1600-0684.2005.00122.x; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Watson A, 1997, J VIROL, V71, P284, DOI 10.1128/JVI.71.1.284-290.1997; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	62	87	92	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					737	742		10.1016/j.immuni.2010.06.004	http://dx.doi.org/10.1016/j.immuni.2010.06.004			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620940	Green Accepted, Bronze			2022-12-18	WOS:000279365800005
J	Daneman, R; Rescigno, M				Daneman, Richard; Rescigno, Maria			The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different?	IMMUNITY			English	Review							CENTRAL-NERVOUS-SYSTEM; MICROVASCULAR ENDOTHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLI K1 INVASION; CORTICOTROPIN-RELEASING-HORMONE; TIGHT JUNCTION PERMEABILITY; MUCOSAL MAST-CELLS; ROR-GAMMA-T; ESCHERICHIA-COLI	In order to protect itself from a diverse set of environmental pathogens and toxins, the body has developed a number of barrier mechanisms to limit the entry of potential hazards. Here, we compare two such barriers: the gut immune barrier, which is the primary barrier against pathogens and toxins ingested in food, and the blood-brain barrier, which protects the central nervous system from pathogens and toxins in the blood. Although each barrier provides defense in very different environments, there are many similarities in their mechanisms of action. In both cases, there is a physical barrier formed by a cellular layer that tightly regulates the movement of ions, molecules, and cells between two tissue spaces. These barrier cells interact with different cell types, which dynamically regulate their function, and with a different array of immune cells that survey the physical barrier and provide innate and adaptive immunity.	[Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	University of California System; University of California San Francisco; IRCCS European Institute of Oncology (IEO)	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	richard.daneman@ucsf.edu; maria.rescigno@ifom-ieo-campus.it	Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X	Crohn's and Colitis Foundation of America (CCFA); European Research Council (ERC); European Commission; Italian Association for Cancer Research (AIRC); Sandler Foundation; Myelin Repair Foundation	Crohn's and Colitis Foundation of America (CCFA); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Sandler Foundation; Myelin Repair Foundation	M.R. is supported by the Crohn's and Colitis Foundation of America (CCFA), by the European Research Council (ERC), by the European Commission (FP7: IBDase, MetaHIT), and by the Italian Association for Cancer Research (AIRC). R.D. is supported by the Sandler Foundation and the Myelin Repair Foundation.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Arques JL, 2009, GASTROENTEROLOGY, V137, P579, DOI 10.1053/j.gastro.2009.04.010; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Behling-Kelly E, 2006, INFECT IMMUN, V74, P5311, DOI 10.1128/IAI.00614-06; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Buckner CM, 2006, J NEUROIMMUNE PHARM, V1, P160, DOI 10.1007/s11481-006-9017-3; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; CHADWICK VS, 1988, SCAND J GASTROENTERO, V23, P121, DOI 10.3109/00365528809093861; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chung JW, 2003, J BIOL CHEM, V278, P16857, DOI 10.1074/jbc.M301028200; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; CROWTHER RS, 1987, BIOCHIM BIOPHYS ACTA, V924, P393, DOI 10.1016/0304-4165(87)90153-X; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; de Repentigny L, 2000, INFECT IMMUN, V68, P3172, DOI 10.1128/IAI.68.6.3172-3179.2000; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Di Santo JP, 2006, IMMUNOL REV, V214, P35, DOI 10.1111/j.1600-065X.2006.00461.x; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Ewaschuk Julia B, 2006, Curr Gastroenterol Rep, V8, P486, DOI 10.1007/s11894-006-0039-z; Farhadi A, 2007, WORLD J GASTROENTERO, V13, P3027, DOI 10.3748/wjg.v13.i22.3027; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Grab DJ, 2004, J PARASITOL, V90, P970, DOI 10.1645/GE-287R; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HANANI M, 1994, CELL TISSUE RES, V278, P153; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Henninger DD, 1997, J IMMUNOL, V158, P1825; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hirase T, 1997, J CELL SCI, V110, P1603; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; IBRAHIM MZM, 1980, ACTA ANAT, V108, P102; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; ILIEV ID, 2009, GUT IN PRESS; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Isobe I, 1996, NEUROCHEM INT, V28, P523, DOI 10.1016/0197-0186(95)00142-5; Iweala OI, 2006, IMMUNOL REV, V213, P82, DOI 10.1111/j.1600-065X.2006.00431.x; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Khan NA, 2007, CELL MICROBIOL, V9, P169, DOI 10.1111/j.1462-5822.2006.00779.x; KIM KS, 1992, J CLIN INVEST, V90, P897, DOI 10.1172/JCI115965; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kimura K, 2000, MAYO CLIN PROC, V75, P802, DOI 10.4065/75.8.802; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kunisawa J, 2007, IMMUNOL REV, V215, P136, DOI 10.1111/j.1600-065X.2006.00475.x; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee KJ, 2008, J GASTROEN HEPATOL, V23, P1689, DOI 10.1111/j.1440-1746.2008.05574.x; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Moncada D, 2000, ARCH MED RES, V31, pS224, DOI 10.1016/S0188-4409(00)00227-7; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Motomura Y, 2008, GUT, V57, P475, DOI 10.1136/gut.2007.129296; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Neunlist M, 2008, J INTERN MED, V263, P577, DOI 10.1111/j.1365-2796.2008.01963.x; Neunlist M, 2007, AM J PHYSIOL-GASTR L, V292, pG231, DOI 10.1152/ajpgi.00276.2005; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Reijerkerk A, 2008, J IMMUNOL, V181, P3567, DOI 10.4049/jimmunol.181.5.3567; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; STEFFEN BJ, 1994, AM J PATHOL, V145, P189; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stent G, 1997, J ACQ IMMUN DEF SYND, V15, P95, DOI 10.1097/00042560-199706010-00001; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Theoharides TC, 2008, TRENDS PHARMACOL SCI, V29, P375, DOI 10.1016/j.tips.2008.06.002; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; VASS K, 1993, LAB INVEST, V69, P275; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; WEINER ML, 1988, FOOD CHEM TOXICOL, V26, P867, DOI 10.1016/0278-6915(88)90028-2; Wilhelm M, 2005, EUR J NEUROSCI, V22, P2238, DOI 10.1111/j.1460-9568.2005.04429.x; WILLIAMS AE, 1990, NEUROPATH APPL NEURO, V16, P377, DOI 10.1111/j.1365-2990.1990.tb01274.x; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yamada T, 2003, AM J PHYSIOL-GASTR L, V284, pG782, DOI 10.1152/ajpgi.00376.2002; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x	188	87	92	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					722	735		10.1016/j.immuni.2009.09.012	http://dx.doi.org/10.1016/j.immuni.2009.09.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19836264	Bronze, Green Submitted			2022-12-18	WOS:000272097900008
J	Andrews, NL; Pfeiffer, JR; Martinez, AM; Haaland, DM; Davis, RW; Kawakami, T; Oliver, JM; Wilson, BS; Lidke, DS				Andrews, Nicholas L.; Pfeiffer, Janet R.; Martinez, A. Marina; Haaland, David M.; Davis, Ryan W.; Kawakami, Toshiaki; Oliver, Janet M.; Wilson, Bridget S.; Lidke, Diane S.			Small, Mobile Fc epsilon R1 Receptor Aggregates Are Signaling Competent	IMMUNITY			English	Article							FC-EPSILON-RI; T-CELL-RECEPTOR; BASOPHILIC LEUKEMIA-CELLS; IMMUNOGLOBULIN-E-RECEPTOR; RBL-2H3 MAST-CELLS; IGE-RECEPTORS; TYROSINE PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; ROTATIONAL-DYNAMICS; CROSS-LINKING	Crosslinking of IgE-bound Fc epsilon R1 triggers mast cell degranulation. Previous fluorescence recovery after photobleaching (FRAP) and phosphorescent anisotropy studies suggested that Fc epsilon R1 must immobilize to signal. Here, single quantum dot (QD) tracking and hyperspectral microscopy methods were used for defining the relationship between receptor mobility and signaling. QD-IgE-Fc epsilon R1 aggregates of at least three receptors remained highly mobile overextended times at low concentrations of antigen that induced Syk kinase activation and near-maximal secretion. Multivalent antigen, presented as DNP-QD, also remained mobile at low doses that supported secretion. Fc epsilon R1 immobilization was marked at intermediate and high antigen concentrations, correlating with increases in cluster size and rates of receptor internalization. The kinase inhibitor PP2 blocked secretion without affecting immobilization or internalization. We propose that immobility is a feature of highly crosslinked immunoreceptor aggregates and a trigger for receptor internalization, but is not required for tyrosine kinase activation leading to secretion.	[Andrews, Nicholas L.; Pfeiffer, Janet R.; Martinez, A. Marina; Oliver, Janet M.; Wilson, Bridget S.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Andrews, Nicholas L.; Pfeiffer, Janet R.; Martinez, A. Marina; Oliver, Janet M.; Wilson, Bridget S.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Haaland, David M.; Davis, Ryan W.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Kawakami, Toshiaki] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA	University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories; La Jolla Institute for Immunology	Lidke, DS (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	dlidke@salud.unm.edu	Kawakami, Toshiaki/O-1616-2015		NIH [R01 A1051575, R01 GM49814, P20 GM67594, S10 RR14668, S10 RR19287, S10 RR0116918, P20 RR111830, P30 CA118100, GM067594, S10 RR15734, RR022493]; Sandia SURP program; Human Frontier Science Program; U.S. Department of Energy [DE-AC04-94AL85000]; Microscale Immune Studies Laboratory Grand Challenge LDRD at Sandia National Laboratories; NSF [DGE-0549500, MCB9982161]; UNM-SOM MD/PhD Program; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016918, S10RR014668, P20RR011830, S10RR022493, S10RR019287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM067594, R01GM049814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandia SURP program; Human Frontier Science Program(Human Frontier Science Program); U.S. Department of Energy(United States Department of Energy (DOE)); Microscale Immune Studies Laboratory Grand Challenge LDRD at Sandia National Laboratories; NSF(National Science Foundation (NSF)); UNM-SOM MD/PhD Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 A1051575, R01 GM49814, and P20 GM67594, the Sandia SURP program, and the Human Frontier Science Program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the U.S. Department of Energy under contract DE-AC04-94AL85000. A portion of this work was supported by the Microscale Immune Studies Laboratory Grand Challenge LDRD at Sandia National Laboratories. N.L.A. was supported by NSF IGERT DGE-0549500 and the UNM-SOM MD/PhD Program. We thank S. Ryan and Y. Kawakami for cell culture assistance and M. Raymond-Stintz, S. Steinberg, and M. Wester for assistance with the quantification of EM data. Support for the UNM Cancer Center Fluorescence Microscopy and Flow Cytometry Facilities was from NIH grants S10 RR14668, S10 RR19287, S10 RR0116918, P20 RR111830, and P30 CA118100 and NSF grant MCB9982161; the UNM EM Facility received support from NIH GM067594, S10 RR15734, and RR022493.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; BARKER SA, 1995, MOL BIOL CELL, V6, P1145, DOI 10.1091/mbc.6.9.1145; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Haaland DM, 2009, APPL SPECTROSC, V63, P271, DOI 10.1366/000370209787598843; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Johansson SGO, 2006, ALLERGY, V61, P1216, DOI 10.1111/j.1398-9995.2006.01172.x; Jones HDT, 2008, J CHEMOMETR, V22, P482, DOI 10.1002/cem.1170; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kashiwakura J, 2008, J LEUKOCYTE BIOL, V84, P357, DOI 10.1189/jlb.1207841; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; LEE RJ, 1995, MOL BIOL CELL, V6, P825, DOI 10.1091/mbc.6.7.825; LIDKE DS, 2007, P SPIE, V6448; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1980, J IMMUNOL, V124, P2728; MAO SY, 1991, J IMMUNOL, V146, P958; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; MENON AK, 1986, J CELL BIOL, V102, P541, DOI 10.1083/jcb.102.2.541; MENON AK, 1986, J CELL BIOL, V102, P534, DOI 10.1083/jcb.102.2.534; MYERS JN, 1992, BIOCHEMISTRY-US, V31, P567, DOI 10.1021/bi00117a038; Nishizumi H, 1997, J IMMUNOL, V158, P2350; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; Paar JM, 2002, J IMMUNOL, V169, P856, DOI 10.4049/jimmunol.169.2.856; PECHT I, 1991, BIOCHEMISTRY-US, V30, P3450, DOI 10.1021/bi00228a015; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; Santini F, 1996, J CELL BIOL, V132, P1025, DOI 10.1083/jcb.132.6.1025; SCHLESSINGER J, 1976, NATURE, V264, P550, DOI 10.1038/264550a0; SEAGRAVE J, 1991, J CELL PHYSIOL, V148, P139, DOI 10.1002/jcp.1041480117; Sigalov AB, 2004, TRENDS IMMUNOL, V25, P583, DOI 10.1016/j.it.2004.08.009; Sinclair MB, 2006, APPL OPTICS, V45, P6283, DOI 10.1364/AO.45.006283; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tamir I, 1996, BIOCHEMISTRY-US, V35, P6872, DOI 10.1021/bi952556i; Thyagarajan R, 2003, J IMMUNOL, V170, P6099, DOI 10.4049/jimmunol.170.12.6099; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; WILSON BS, 1995, J BIOL CHEM, V270, P4013, DOI 10.1074/jbc.270.8.4013; Xu KL, 1998, J IMMUNOL, V160, P3225; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014; ZIDOVETZKI R, 1986, BIOCHEMISTRY-US, V25, P4397, DOI 10.1021/bi00363a033	54	87	88	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					469	479		10.1016/j.immuni.2009.06.026	http://dx.doi.org/10.1016/j.immuni.2009.06.026			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19747859	Green Accepted, Bronze			2022-12-18	WOS:000270525900014
J	Lamkanfi, M; Dixit, VM				Lamkanfi, Mohamed; Dixit, Vishva M.			IL-33 Raises Alarm	IMMUNITY			English	Editorial Material							RECEPTOR ACCESSORY PROTEIN; IL-1-LIKE CYTOKINE IL-33; IN-VIVO; ST2; CELLS	The interleukin-1 (IL-1)-like cytokine IL-33 is widely assumed to undergo proteolytic maturation by caspase-1. In this issue of Immunity, Luthi et al. (2009) show that IL-33 is not a caspase-1 substrate. IL-33 is inactivated by caspase-3 and -7 to prevent an inappropriate immune response during apoptosis, but not in necrosis.	[Lamkanfi, Mohamed; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Duriez, Patrick/0000-0003-1814-2552				Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200	10	87	96	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					5	7		10.1016/j.immuni.2009.06.011	http://dx.doi.org/10.1016/j.immuni.2009.06.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604486	Bronze			2022-12-18	WOS:000268219900004
J	Smith, DE; Lipsky, BP; Russell, C; Ketchem, RR; Kirchner, J; Hensley, K; Huang, Y; Friedman, WJ; Boissonneault, V; Plante, MM; Rivest, S; Sims, JE				Smith, Dirk E.; Lipsky, Brian P.; Russell, Chris; Ketchem, Randal R.; Kirchner, Jacqueline; Hensley, Kelly; Huang, Yangyang; Friedman, Wilma J.; Boissonneault, Vincent; Plante, Marie-Michele; Rivest, Serge; Sims, John E.			A Central Nervous System-Restricted Isoform of the Interleukin-1 Receptor Accessory Protein Modulates Neuronal Responses to Interleukin-1	IMMUNITY			English	Article							NF-KAPPA-B; IL-1 RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; MENTAL-RETARDATION; NEGATIVE REGULATOR; IL1RAPL1 GENE; MAP KINASE; ACTIVATION; COMPLEX; INHIBITION	Interleukin-1 (IL-1) has multiple functions in both the periphery and the central nervous system (CNS) and is regulated at many levels. We identified an isoform of the IL-1 receptor (IL-1R) accessory protein (termed AcPb) that is expressed exclusively in the CNS. AcPb interacted with IL-1 and the IL-1R but was unable to mediate canonical IL-1 responses. AcPb expression, however, modulated neuronal gene expression in response to IL-1 treatment in vitro. Animals lacking AcPb demonstrated an intact peripheral IL-1 response and developed experimental autoimmune encephalomyelitis (EAE) similarly to wild-type mice. AcPb-deficient mice were instead more vulnerable to local inflammatory challenge in the CNS and suffered enhanced neuronal degeneration as compared to AcP-deficient or wildtype mice. These findings implicate AcPb as an additional component of the highly regulated IL-1 system and suggest that it may play a role in modulating CNS responses to IL-1 and the interplay between inflammation and neuronal survival.	[Smith, Dirk E.; Lipsky, Brian P.; Kirchner, Jacqueline; Hensley, Kelly; Sims, John E.] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA; [Russell, Chris] Amgen Inc, Dept Mol Sci, Seattle, WA 98119 USA; [Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Huang, Yangyang; Friedman, Wilma J.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Boissonneault, Vincent; Plante, Marie-Michele; Rivest, Serge] CHUL Res Ctr, Mol Endocrinol Lab, Ste Foy, PQ G1V 4G2, Canada; [Boissonneault, Vincent; Plante, Marie-Michele; Rivest, Serge] Univ Laval, Ste Foy, PQ G1V 4G2, Canada	Amgen; Amgen; Amgen; Rutgers State University Newark; Rutgers State University New Brunswick; Laval University; Laval University	Smith, DE (corresponding author), Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA.	smithde@amgen.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682; Russell, Chris/0000-0002-0240-1815; Sims, John/0000-0002-5667-9185; Rivest, Serge/0000-0002-6082-770X	Canadian Institutes of Health Research; Canadian Research Chair in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076867] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	H. Arnett provided helpful advice and discussion, M. Wiley and K. Christensen helped with knockout mice generation, and J. Scholler and C. Strathclee provided important technical support with lentiviral generation. H. Chen provided technical support of cortical neuron gene expression studies. M. Timour and D. Prosser performed the microarray experiments and B. Buetow helped perform phenotypic analysis of knockout brains. We are grateful to E. Magal and M. Zhang for excellent technical assistance with cortical neuron cultures. Finally, we thank E. Pinteaux (University of Manchester) for many useful suggestions. D.E.S., B.P.L., C.R., R.R.K., J.K., K.H., and J.E.S. are employees and shareholders of Amgen, Inc. S.R. is supported by the Canadian Institutes of Health Research and a Canadian Research Chair in Neuroimmunology.	Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Alpert D, 1999, J BIOL CHEM, V274, P22176, DOI 10.1074/jbc.274.32.22176; Andre R, 2005, J NEUROCHEM, V95, P324, DOI 10.1111/j.1471-4159.2005.03364.x; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Bhat SS, 2008, CLIN GENET, V73, P94, DOI 10.1111/j.1399-0004.2007.00920.x; Blomer U, 1997, J VIROL, V71, P6641; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chen HM, 2008, J NEUROCHEM, V105, P1300, DOI 10.1111/j.1471-4159.2008.05226.x; Cullinan EB, 1998, J IMMUNOL, V161, P5614; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Furlan R, 2007, GENE THER, V14, P93, DOI 10.1038/sj.gt.3302805; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Gao XC, 2008, NEUROSCI LETT, V438, P163, DOI 10.1016/j.neulet.2008.03.084; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Lang D, 1998, J IMMUNOL, V161, P6871; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Lovenberg TW, 1996, J NEUROIMMUNOL, V70, P113, DOI 10.1016/S0165-5728(96)00047-1; Lu HL, 2008, MOL IMMUNOL, V45, P1374, DOI 10.1016/j.molimm.2007.09.002; Malinowsky D, 1998, FEBS LETT, V429, P299, DOI 10.1016/S0014-5793(98)00467-0; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Radons JR, 2003, J BIOL CHEM, V278, P49145, DOI 10.1074/jbc.M306077200; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; Sims JE, 2003, EUR CYTOKINE NETW, V14, P77; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Smeets RL, 2005, ARTHRITIS RHEUM-US, V52, P2202, DOI 10.1002/art.21108; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Song DY, 2008, EXP NEUROL, V209, P268, DOI 10.1016/j.expneurol.2007.09.033; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Su JM, 2007, MOL IMMUNOL, V44, P900, DOI 10.1016/j.molimm.2006.03.021; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tabolacci E, 2006, AM J MED GENET A, V140A, P482, DOI 10.1002/ajmg.a.31107; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Tsakiri N, 2008, BRIT J PHARMACOL, V153, P775, DOI 10.1038/sj.bjp.0707610; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	53	87	93	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 19	2009	30	6					817	831		10.1016/j.immuni.2009.03.020	http://dx.doi.org/10.1016/j.immuni.2009.03.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19481478	Bronze, Green Accepted			2022-12-18	WOS:000267270700010
J	Godfrey, DI; Rossjohn, J; McCluskey, J				Godfrey, Dale I.; Rossjohn, Jamie; McCluskey, James			The fidelity, occasional promiscuity, and versatility of T cell receptor recognition	IMMUNITY			English	Review							COMPLEX CLASS-I; COLLAGEN-INDUCED ARTHRITIS; V(ALPHA)14 NKT CELLS; V-BETA DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PEPTIDE-MHC; ANTIGEN PRESENTATION; SELF-PEPTIDE; MOLECULAR RECOGNITION		[Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Melbourne; Monash University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au; jamesml@unimelb.edu.au	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Godfrey, Dale/0000-0002-3009-5472				Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Coppieters K, 2007, J IMMUNOL, V179, P2300, DOI 10.4049/jimmunol.179.4.2300; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DASCHER CC, 2007, CURR TOP MICROBIAL I, V1, P314; De Libero G, 2006, TRENDS IMMUNOL, V27, P485, DOI 10.1016/j.it.2006.08.001; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Ely LK, 2005, J IMMUNOL, V174, P5593, DOI 10.4049/jimmunol.174.9.5593; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Forestier C, 2007, J IMMUNOL, V178, P1415, DOI 10.4049/jimmunol.178.3.1415; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gagnon SJ, 2005, J MOL BIOL, V353, P556, DOI 10.1016/j.jmb.2005.08.024; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Maruoka T, 2005, IMMUNOGENETICS, V57, P590, DOI 10.1007/s00251-005-0016-y; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Rossjohn J, 2007, CELL, V129, P19, DOI 10.1016/j.cell.2007.03.018; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Sullivan LC, 2006, TRENDS IMMUNOL, V27, P413, DOI 10.1016/j.it.2006.07.006; Teng MWL, 2007, CANCER RES, V67, P7495, DOI 10.1158/0008-5472.CAN-07-0941; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Ueno Y, 2005, INFLAMM BOWEL DIS, V11, P35, DOI 10.1097/00054725-200501000-00005; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; ZAJONC DM, 2007, IMMUNOLOGY, V314, P27; Zarling AL, 2006, P NATL ACAD SCI USA, V103, P14889, DOI 10.1073/pnas.0604045103; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	126	87	92	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					304	314		10.1016/j.immuni.2008.02.004	http://dx.doi.org/10.1016/j.immuni.2008.02.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342005	Bronze			2022-12-18	WOS:000254142500008
J	Ishizuka, J; Stewart-Jones, GBE; van der Merwe, A; Bell, JI; McMichael, AJ; Jones, EY				Ishizuka, Jeffrey; Stewart-Jones, Guillaume B. E.; van der Merwe, Anton; Bell, John I.; McMichael, Andrew J.; Jones, E. Yvonne			The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its v beta domain	IMMUNITY			English	Article							PEPTIDE-MHC COMPLEXES; ELECTRON-DENSITY MAPS; INFLUENZA-A; ANTIGEN RECOGNITION; TCR BINDING; CONFORMATIONAL-CHANGES; KINETIC BASIS; HLA-A2; LYMPHOCYTES; DOMINANT	Immunodominant and public T cell receptor (TCR) usage is relatively common in many viral diseases yet surprising in the context of the large naive TCR repertoire. We examined the highly conserved V beta 17:V alpha 10.2 JM22 T cell response to the influenza matrix peptide (58-66)-HLA-A*0201 (HLA-A2-flu) through extensive kinetic, thermodynamic, and structural analyses. We found several conformational adjustments that accompany JM22-HLA-A2-flu binding and identified a binding "hotspot" within the V beta domain of the TCR. Within this hotspot, key germ line-encoded CDR1 and CDR2 loop residues and a crucial but commonly coded residue in the hypervariable region of CDR3 provide the basis for the substantial bias in the selection of the germline-encoded V beta 17 domain. The chances of having a substantial number of T cells in the naive repertoire that have HLA-A2-flu-specific V beta 17 receptors may consequently be relatively high, thus explaining the immunodominant usage of this clonotype.	[Ishizuka, Jeffrey; Stewart-Jones, Guillaume B. E.; Bell, John I.; McMichael, Andrew J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England; [Stewart-Jones, Guillaume B. E.; Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [van der Merwe, Anton] Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	McMichael, AJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk; yvonne.jones@strubi.ox.ac.uk	Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019; Stewart-Jones, Guillaume/E-7013-2013; van der Merwe, P. Anton/F-8539-2011	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; 	MRC [MC_U137884178, MC_U137884177, G9900061, G9722488] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [G9722488, MC_U137884178, G9900061, MC_U137884177, G19/31] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; BORON WF, 2004, MED PHYSL CELLULAR M, V1; BOWNESS P, 1993, EUR J IMMUNOL, V23, P1417, DOI 10.1002/eji.1830230702; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; Davis MM, 2003, NAT IMMUNOL, V4, P649, DOI 10.1038/ni0703-649; DeLano W. L, 2002, PYMOL MOL GENETICS G; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gagnon SJ, 2005, J MOL BIOL, V353, P556, DOI 10.1016/j.jmb.2005.08.024; Gagnon SJ, 2003, J IMMUNOL, V171, P2233, DOI 10.4049/jimmunol.171.5.2233; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lawson TM, 2001, INT IMMUNOL, V13, P1373, DOI 10.1093/intimm/13.11.1373; Lawson TM, 2001, INT IMMUNOL, V13, P1383, DOI 10.1093/intimm/13.11.1383; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Venturi V, 2006, P NATL ACAD SCI USA, V103, P18691, DOI 10.1073/pnas.0608907103; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wriggers W, 1997, PROTEINS, V29, P1	48	87	91	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					171	182		10.1016/j.immuni.2007.12.018	http://dx.doi.org/10.1016/j.immuni.2007.12.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275829	Bronze			2022-12-18	WOS:000253275000008
J	Bousso, P; Robey, EA				Bousso, P; Robey, EA			Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy	IMMUNITY			English	Review							DENDRITIC CELLS; IN-VIVO; ANTIGEN PRESENTATION; SYNAPSE FORMATION; IMMUNOLOGICAL SYNAPSE; IMMUNE-RESPONSE; ACTIVATION; NODES; MOTILITY; SELECTION	The initial application of two-photon imaging to the study of lymphoid tissues has provided a dramatic glimpse into how cells of the immune system move and interact in their native environments. In this review we summarize what we have learned so far and point out areas for future investigation using this approach.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Inst Pasteur, Dept Immunol, F-75015 Paris, France	University of California System; University of California Berkeley; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 471 Life Sci Addit, Berkeley, CA 94720 USA.	erobey@uclink4.berkeley.edu	BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053039, R01AI032985] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053039, AI32985] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON G, 1994, J IMMUNOL, V153, P1915; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cyster JG, 2000, CURR BIOL, V10, pR30, DOI 10.1016/S0960-9822(99)00253-5; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Robey EA, 2003, IMMUNOL REV, V195, P51, DOI 10.1034/j.1600-065X.2003.00069.x; Saiki T, 2001, J LEUKOCYTE BIOL, V69, P705; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912	33	87	90	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2004	21	3					349	355		10.1016/j.immuni.2004.08.005	http://dx.doi.org/10.1016/j.immuni.2004.08.005			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357946	Bronze			2022-12-18	WOS:000224034900006
J	Myung, PS; Derimanov, GS; Jordan, MS; Punt, JA; Liu, QH; Judd, BA; Meyers, EE; Sigmund, CD; Freedman, BD; Koretzky, GA				Myung, PS; Derimanov, GS; Jordan, MS; Punt, JA; Liu, QH; Judd, BA; Meyers, EE; Sigmund, CD; Freedman, BD; Koretzky, GA			Differential requirement for SLP-76 domains in T cell development and function	IMMUNITY			English	Article							ADAPTER PROTEIN SLP-76; INTERLEUKIN-2 PRODUCTION; CD4(+)CD8(+) THYMOCYTES; PHOSPHOLIPASE C-GAMMA-2; HEMATOPOIETIC-CELLS; ALLELIC EXCLUSION; PROMOTER ACTIVITY; TYROSINE KINASES; GLYCOPROTEIN VI; TRANSGENIC MICE	The hematopoietic cell-specific adaptor protein, SLP-76, is critical for T cell development and mature T cell receptor (TCR) signaling; however, the structural requirements of SLP-76 for mediating thymopoiesis and mature T cell function remain largely unknown. In this study, transgenic mice were generated to examine the requirements for specific domains of SLP-76 in thymocytes and peripheral T cells in vivo. Examination of mice expressing various mutants of SLP-76 on the null background demonstrates a differential requirement for specific domains of SLP-76 in thymocytes and T cells and provides new insight into the molecular mechanisms underlying SLP-76 function.	Univ Penn, Sch Med, Leonard & Madlyn Abramson Family Canc Res Inst, Signal Transduct Program, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Grad Program Immunol, Philadelphia, PA 19104 USA; Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Haverford Coll, Dept Biol, Haverford, PA 19041 USA; Univ Iowa, Mol Biol Grad Program, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Haverford College; University of Iowa; University of Iowa	Koretzky, GA (corresponding author), Univ Penn, Sch Med, Leonard & Madlyn Abramson Family Canc Res Inst, Signal Transduct Program, Philadelphia, PA 19104 USA.		Sigmund, Curt D./W-1611-2019; Koretzky, Gary/AAU-5381-2021	Sigmund, Curt D./0000-0002-1453-0921; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060921] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060921] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 1999, J EXP MED, V190, P1093, DOI 10.1084/jem.190.8.1093; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Clements JL, 1998, J IMMUNOL, V161, P3880; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Ellis JH, 2000, J IMMUNOL, V164, P5805, DOI 10.4049/jimmunol.164.11.5805; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Fang N, 1996, J IMMUNOL, V157, P3769; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Gross BS, 1999, EUR J BIOCHEM, V263, P612, DOI 10.1046/j.1432-1327.1999.00560.x; GROVES T, 1995, J IMMUNOL, V154, P5011; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansal SA, 1998, J IMMUNOL, V161, P1063; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; Kikuchi K, 2001, INT IMMUNOL, V13, P777, DOI 10.1093/intimm/13.6.777; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Musci MA, 1997, J IMMUNOL, V159, P1639; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	61	87	89	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					1011	1026		10.1016/S1074-7613(01)00253-9	http://dx.doi.org/10.1016/S1074-7613(01)00253-9			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754821	Bronze			2022-12-18	WOS:000172961400014
J	Raab, M; Pfister, S; Rudd, CE				Raab, M; Pfister, S; Rudd, CE			CD28 signaling via VAV/SLP-76 adaptors: Regulation of cytokine transcription independent of TCR ligation	IMMUNITY			English	Article							T-CELL RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-CLONING; PROMOTER ACTIVITY; PROTEIN SLP-76; ACTIVATION; VAV; COSTIMULATION; PROLIFERATION; BINDING	Since CD28 provides cosignals in T cell responses, a key question is whether the coreceptor operates exclusively via TCR zeta /CD3 or also operates as an independent signaling unit. In this study, we show that CD28 can cooperate with VAV/SLP-76 adaptors to upregulate interleukin 2/4 transcription independently of TCR ligation. CD28 signaling is dependent on VAV/ SLP-76 complex formation and induces membrane localization of these complexes. CD28-VAV/SLP-76 also functions in nonlymphoid cells to promote nuclear entry of NFAT, indicating that these adaptors are the only lymphoid components needed for this pathway. Further downstream, CD28-VAV/SLP-76 synergizes with Rac1 and causes F-actin remodelling proximal to receptor. Autonomous CD28 signaling may account for the distinct nature of the second signal and in trans amplification of T cell responses.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Imperial College London	Rudd, CE (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	christopher_rudd@dfci.harvard.edu	Rudd, Christopher E/ABF-7259-2021; Pfister, Stefan M/F-6860-2013; Rudd, Christopher E/GOH-2021-2022	Pfister, Stefan M/0000-0002-5447-5322; Rudd, Christopher E/0000-0001-5295-9019	PHS HHS [A139021] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Cefai D, 1996, INT IMMUNOL, V8, P1609, DOI 10.1093/intimm/8.10.1609; Cefai D, 1998, J IMMUNOL, V160, P2223; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Fang N, 1996, J IMMUNOL, V157, P3769; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kaga S, 1998, J IMMUNOL, V160, P24; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; LEDBETTER JA, 1990, BLOOD, V75, P1531; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Samelson LE, 1999, PROG BIOPHYS MOL BIO, V71, P393, DOI 10.1016/S0079-6107(98)00050-9; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Siefken R, 1998, J IMMUNOL, V161, P1645; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TRUITT KE, 1995, J IMMUNOL, V155, P4702; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zell T, 1996, J IMMUNOL, V156, P883; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	60	87	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					921	933		10.1016/S1074-7613(01)00248-5	http://dx.doi.org/10.1016/S1074-7613(01)00248-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754814	Bronze			2022-12-18	WOS:000172961400007
J	Kosugi, A; Sakakura, J; Yasuda, K; Ogata, M; Hamaoka, T				Kosugi, A; Sakakura, J; Yasuda, K; Ogata, M; Hamaoka, T			Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts	IMMUNITY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; MEMBRANE DOMAINS; ADAPTER PROTEIN; PHOSPHORYLATION; ZAP-70; ACTIVATION; SLP-76; LAT; ZETA	To elucidate the process of TCR-mediated signaling pathways in lipid rafts, we constructed a chimeric molecule that localizes activated SHP-1 to rafts. Raft targeting of activated SHP-1 in Jurkat-derived transfectants completely inhibited the expression of CD69 and transcriptional factors after TCR cross-linking. Whereas the inducible tyrosine phosphorylation of TCR zeta and ZAP-70 and the kinase activity of Lck were intact, phosphorylated LAT was rapidly dephosphorylated by raft targeting of activated SHP-1, leading to defects in LAT activation and subsequent downstream signaling events. Intriguingly, recruitment of endogenous SHP-1 to rafts and its association with LAT were dramatically increased after TCR engagement, suggesting that SHP-1 is involved in raft-mediated T cell activation.	Osaka Univ, Fac Med, Sch Allied Hlth Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kosugi, A (corresponding author), Osaka Univ, Fac Med, Sch Allied Hlth Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kosugi@sahs.med.osaka-u.ac.jp	Yasuda, Koubun/GQA-7622-2022	Yasuda, Koubun/0000-0002-3533-1702				Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jin YJ, 1998, J IMMUNOL, V161, P1743; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; KonKozlowski M, 1996, J BIOL CHEM, V271, P3856; Kosugi A, 1999, INT IMMUNOL, V11, P1395, DOI 10.1093/intimm/11.9.1395; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; Ogata M, 1999, J BIOL CHEM, V274, P20717, DOI 10.1074/jbc.274.29.20717; Ohnishi H, 1996, J BIOL CHEM, V271, P25569, DOI 10.1074/jbc.271.41.25569; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; PUNT JA, 1991, J EXP MED, V174, P775, DOI 10.1084/jem.174.4.775; Raab M, 1996, BIOCHEM BIOPH RES CO, V222, P50, DOI 10.1006/bbrc.1996.0696; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	40	87	89	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					669	680		10.1016/S1074-7613(01)00146-7	http://dx.doi.org/10.1016/S1074-7613(01)00146-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420038	Bronze			2022-12-18	WOS:000169495100004
J	Malarkannan, S; Horng, T; Shih, PP; Schwab, S; Shastri, N				Malarkannan, S; Horng, T; Shih, PP; Schwab, S; Shastri, N			Presentation of out-of-frame peptide MHC class I complexes by a novel translation initiation mechanism	IMMUNITY			English	Article							CYTOTOXIC LYMPHOCYTE-T; ANTIGENIC PEPTIDES; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; READING FRAMES; CTL EPITOPES; EXPRESSION; MOLECULES; RECOGNITION; CODONS	Immune surveillance by CD8 T cells requires that peptides derived from intracellular proteins be presented by MHC class I molecules on the target cell surface. Interestingly, MHC molecules can also present peptides encoded in alternate translational reading frames, some even without conventional AUG initiation codons. Using T cells to measure expression of MHC bound peptides, we identified the non-AUG translation initiation codons and established that their activity was at the level of translational rather than DNA replication or transcription mechanisms. This translation mechanism decoded the CUG initiation codon not as the canonical methionine but as the leucine residue, and its activity was independent of upstream translation initiation events. Naturally processed peptide/MHC complexes can thus arise from "noncoding" mRNAs via a novel translation initiation mechanism.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@socrates.berkely	Malarkannan, Subra/AAQ-9617-2020; Malarkannan, Subramaniam/AAQ-3934-2020	Malarkannan, Subramaniam/0000-0002-7511-2731; Schwab, Susan/0000-0002-0834-0822				BOECK R, 1994, EMBO J, V13, P3608, DOI 10.1002/j.1460-2075.1994.tb06668.x; BOON T, 1989, IMMUNOGENETICS, V29, P75, DOI 10.1007/BF00395854; BOON T, 1989, COLD SH Q B, V54, P587; Bullock TNJ, 1996, J EXP MED, V184, P1319, DOI 10.1084/jem.184.4.1319; Bullock TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/jem.186.7.1051; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Drabkin HJ, 1998, MOL CELL BIOL, V18, P5140, DOI 10.1128/MCB.18.9.5140; Elliott T, 1996, EUR J IMMUNOL, V26, P1175, DOI 10.1002/eji.1830260532; ENGELBERGKULKA H, 1994, MOL MICROBIOL, V11, P3, DOI 10.1111/j.1365-2958.1994.tb00283.x; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FETTEN JV, 1991, J IMMUNOL, V147, P2697; GOODING L R, 1988, P87; HAHN YS, 1991, J EXP MED, V174, P733, DOI 10.1084/jem.174.3.733; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LINDAHL KF, 1991, IMMUNOGENETICS, V34, P1, DOI 10.1007/BF00212305; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; Mayrand SM, 1998, IMMUNOL TODAY, V19, P551, DOI 10.1016/S0167-5699(98)01342-5; Mayrand SM, 1998, J IMMUNOL, V160, P39; NEISIG A, 1995, J IMMUNOL, V154, P1273; NIRENBERG MW, 1964, SCIENCE, V145, P1399, DOI 10.1126/science.145.3639.1399; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Rajbhandary Uttam L., 1995, P511; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; ROTZSCHKE O, 1990, SCIENCE, V249, P283, DOI 10.1126/science.1695760; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHASTRI N, 1995, J BIOL CHEM, V270, P1088, DOI 10.1074/jbc.270.3.1088; Shichijo S, 1998, J EXP MED, V187, P277, DOI 10.1084/jem.187.3.277; SONENBERG N, 1990, CURR TOP MICROBIOL, V161, P23; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; UENAKA A, 1994, J EXP MED, V180, P1599, DOI 10.1084/jem.180.5.1599; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wang RF, 1998, J IMMUNOL, V161, P3596; Yewdell JW, 1996, J IMMUNOL, V157, P1823; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248	48	87	90	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					681	690		10.1016/S1074-7613(00)80067-9	http://dx.doi.org/10.1016/S1074-7613(00)80067-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403643	Bronze			2022-12-18	WOS:000081209600006
J	Santulli-Marotto, S; Retter, MW; Gee, R; Mamula, MJ; Clarke, SH				Santulli-Marotto, S; Retter, MW; Gee, R; Mamula, MJ; Clarke, SH			Autoreactive B cell regulation: Peripheral induction of developmental arrest by lupus-associated autoantigens	IMMUNITY			English	Article							ANTI-DNA ANTIBODIES; MRL/MP-LPR/LPR MICE; SM NUCLEAR ANTIGEN; LPR LPR MICE; LYMPHOCYTES-B; BACTERIAL-DNA; TOLERANCE-INDUCTION; TRANSGENIC MICE; SELF-TOLERANCE; NEGATIVE SELECTION	Anti-Sm and anti-ssDNA transgenic (Tg) mice were generated using the V-H-D-J(H) rearrangement of an anti-Sm hybridoma of MRL/Mp-lpr/lpr origin. B cells of each specificity account for 15%-35% of the splenic repertoire, but no circulating anti-Sm or anti-ssDNA antibodies are detected. Most autoreactive cells exhibit an immature B cell phenotype and have short half-lives equivalent to those of non-Tg immature B cells. However, at least some anti-Sm B cells are functional, because immunization with murine snRNPs induces anti-Sm secretion. We propose that anti-Sm and anti-ssDNA are eliminated during the transition to mature B cells and that this late stage of tolerance induction is consequential to their spontaneous activation in murine lupus.	Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA	University of North Carolina; University of North Carolina Chapel Hill; Yale University	Clarke, SH (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	shl@med.unc.edu			NIAMS NIH HHS [AR07416, AR42573, AR41032] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041032, R29AR041032, T32AR007416, P50AR042573] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687; ALARCONSEGOVIA D, 1988, PRIMER RHEUMATIC DIS, P96; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; BELL SE, 1994, EMBO J, V13, P816, DOI 10.1002/j.1460-2075.1994.tb06324.x; BENNETT RM, 1987, J EXP MED, V166, P850, DOI 10.1084/jem.166.4.850; BLOOM DD, 1993, J IMMUNOL, V150, P1579; BLOOM DD, 1994, EUR J IMMUNOL, V24, P1332, DOI 10.1002/eji.1830240614; BLOOM DD, 1993, J IMMUNOL, V150, P1591; BOCKENSTEDT LK, 1995, J IMMUNOL, V154, P3516; BOYER CM, 1985, ARTHRITIS RHEUM, V28, P294, DOI 10.1002/art.1780280309; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CARSETTI R, 1993, EUR J IMMUNOL, V23, P168, DOI 10.1002/eji.1830230127; CHANG TL, 1991, J IMMUNOL, V147, P750; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; COHEN PL, 1982, J IMMUNOL, V129, P2682; CONGER JD, 1987, P NATL ACAD SCI USA, V84, P2931, DOI 10.1073/pnas.84.9.2931; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; DREWS R, 1994, BIOTECHNIQUES, V17, P866; EISENBERG RA, 1987, J CLIN INVEST, V80, P691, DOI 10.1172/JCI113123; EISENBERG RA, 1990, J CLIN INVEST, V85, P86, DOI 10.1172/JCI114437; EISENBERG RA, 1982, J IMMUNOL, V129, P2146; EISENBERG RA, 1989, CLIN EXP RHEUMATOL, V7, pS35; EISENBERG RA, 1987, J IMMUNOL, V139, P728; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; ERIS JM, 1994, P NATL ACAD SCI USA, V91, P4392, DOI 10.1073/pnas.91.10.4392; FATENEJAD S, 1993, P NATL ACAD SCI USA, V90, P12010, DOI 10.1073/pnas.90.24.12010; FATENEJAD S, 1994, J IMMUNOL, V152, P5523; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GILKESON GS, 1990, EUR J IMMUNOL, V20, P1789, DOI 10.1002/eji.1830200825; GILKESON GS, 1989, J IMMUNOL, V142, P1482; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V51, P362, DOI 10.1016/0090-1229(89)90034-2; GILKESON GS, 1991, CLIN IMMUNOL IMMUNOP, V59, P288, DOI 10.1016/0090-1229(91)90025-6; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; HARTLEY SB, 1994, INT IMMUNOL, V6, P1417, DOI 10.1093/intimm/6.9.1417; HEFENEIDER SH, 1992, CLIN IMMUNOL IMMUNOP, V63, P245, DOI 10.1016/0090-1229(92)90229-H; HEFENEIDER SH, 1992, LUPUS, V1, P167, DOI 10.1177/096120339200100308; HEFENEIDER SH, 1993, AUTOIMMUNITY, V15, P187, DOI 10.3109/08916939309019926; KLINMAN NR, 1981, J IMMUNOL, V126, P1970; KOREN E, 1995, J IMMUNOL, V154, P4857; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MAMULA MJ, 1994, J IMMUNOL, V152, P1453; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; MARION TN, 1990, J IMMUNOL, V145, P2322; MESSINA JP, 1991, J IMMUNOL, V147, P1759; MISHELL BB, 1980, SELECTED METHODS CEL, P452; Monroe JG, 1996, J IMMUNOL, V156, P2657; NORVELL A, 1995, J IMMUNOL, V154, P4404; Norvell A, 1996, J IMMUNOL, V156, P1328; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; OFFEN D, 1992, P NATL ACAD SCI USA, V89, P8332, DOI 10.1073/pnas.89.17.8332; Pisetsky DS, 1996, J IMMUNOL, V156, P421; PISETSKY DS, 1982, CELL IMMUNOL, V72, P294, DOI 10.1016/0008-8749(82)90477-4; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; REAP EA, 1993, J EXP MED, V177, P69, DOI 10.1084/jem.177.1.69; Retter MW, 1996, J IMMUNOL, V156, P1296; RETTER MW, 1995, J IMMUNOL, V155, P2248; RILEY RL, 1986, J IMMUNOL, V136, P3147; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; Rubio CF, 1996, J IMMUNOL, V157, P65; SHAN H, 1994, J IMMUNOL, V153, P5104; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; SHORES EW, 1986, J IMMUNOL, V136, P3662; SHORES EW, 1988, IMMUNOLOGY, V65, P473; SNAPPER CM, 1993, J IMMUNOL, V150, P2737; STASHENKO P, 1980, J IMMUNOL, V125, P531; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761; TSAO BP, 1993, EUR J IMMUNOL, V23, P2332, DOI 10.1002/eji.1830230942; YAKUBOV LA, 1989, P NATL ACAD SCI USA, V86, P6454, DOI 10.1073/pnas.86.17.6454	84	87	88	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1998	8	2					209	219		10.1016/S1074-7613(00)80473-2	http://dx.doi.org/10.1016/S1074-7613(00)80473-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492002	Green Published, hybrid			2022-12-18	WOS:000072201800008
J	Schwabenland, M; Salie, H; Tanevski, J; Killmer, S; Lago, MS; Schlaak, AE; Mayer, L; Matschke, J; Puschel, K; Fitzek, A; Ondruschka, B; Mei, HE; Boettler, T; Neumann-Haefelin, C; Hofmann, M; Breithaupt, A; Genc, N; Stadelmann, C; Saez-Rodriguez, J; Bronsert, P; Knobeloch, KP; Blank, T; Thimme, R; Glatzel, M; Prinz, M; Bengsch, B				Schwabenland, Marius; Salie, Henrike; Tanevski, Jovan; Killmer, Saskia; Lago, Marilyn Salvat; Schlaak, Alexandra Emilia; Mayer, Lena; Matschke, Jakob; Puschel, Klaus; Fitzek, Antonia; Ondruschka, Benjamin; Mei, Henrik E.; Boettler, Tobias; Neumann-Haefelin, Christoph; Hofmann, Maike; Breithaupt, Angele; Genc, Nafiye; Stadelmann, Christine; Saez-Rodriguez, Julio; Bronsert, Peter; Knobeloch, Klaus-Peter; Blank, Thomas; Thimme, Robert; Glatzel, Markus; Prinz, Marco; Bengsch, Bertram			Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions	IMMUNITY			English	Article							PROGENITOR	COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the central nervous system with pronounced neuropathology (astrocytosis, axonal damage, and blood-brain-barrier leakage) and detected viral antigen in ACE2-receptor-positive cells enriched in the vascular compartment. Microglial nodules and the perivascular compartment represented COVID-19-specific, microanatomic-immune niches with context-specific cellular interactions enriched for activated CD8(+) T cells. Altered brain T-cell-microglial interactions were linked to clinical measures of systemic inflammation and disturbed hemostasis. This study identifies profound neuroinflammation with activation of innate and adaptive immune cells as correlates of COVID-19 neuropathology, with implications for potential therapeutic strategies.	[Schwabenland, Marius; Knobeloch, Klaus-Peter; Blank, Thomas; Prinz, Marco] Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany; [Schwabenland, Marius; Knobeloch, Klaus-Peter; Blank, Thomas; Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBas, Freiburg, Germany; [Salie, Henrike; Killmer, Saskia; Lago, Marilyn Salvat; Schlaak, Alexandra Emilia; Mayer, Lena; Boettler, Tobias; Neumann-Haefelin, Christoph; Hofmann, Maike; Thimme, Robert; Bengsch, Bertram] Univ Med Ctr Freiburg, Fac Med, Clin Internal Med Gastroenterol Hepatol Endocrino, Freiburg, Germany; [Tanevski, Jovan; Saez-Rodriguez, Julio] Heidelberg Univ, Fac Med, Inst Computat Biomed, Heidelberg, Germany; [Matschke, Jakob; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Puschel, Klaus; Fitzek, Antonia; Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Hamburg, Germany; [Mei, Henrik E.] German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany; [Breithaupt, Angele] Friedrich Loeffler Inst, Dept Expt Anim Facil & Bior Management, Greifswald, Germany; [Genc, Nafiye; Stadelmann, Christine] Univ Goettingen, Inst Neuropathol, Gottingen, Germany; [Bronsert, Peter] Univ Freiburg, Fac Med, Med Ctr, Inst Surg Pathol, Freiburg, Germany; [Prinz, Marco; Bengsch, Bertram] Univ Freiburg, Signalling Res Ctr BIOSS & CIBSS, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Rheuma-Forschungszentrum (DRFZ); Friedrich Loeffler Institute; University of Gottingen; University of Freiburg; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBas, Freiburg, Germany.; Bengsch, B (corresponding author), Univ Med Ctr Freiburg, Fac Med, Clin Internal Med Gastroenterol Hepatol Endocrino, Freiburg, Germany.; Prinz, M; Bengsch, B (corresponding author), Univ Freiburg, Signalling Res Ctr BIOSS & CIBSS, Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de; bertram.bengsch@uniklinik-freiburg.de	Breithaupt, Angele/GON-7227-2022; Neumann-Haefelin, Christoph/E-5550-2011; Boettler, Tobias/E-3331-2012; Saez-Rodriguez, Julio/H-7114-2019; Schwabenland, Marius/AAF-4348-2021; Bengsch, Bertram/ABF-2142-2020	Breithaupt, Angele/0000-0002-6373-5923; Neumann-Haefelin, Christoph/0000-0001-7351-1387; Boettler, Tobias/0000-0002-1195-055X; Saez-Rodriguez, Julio/0000-0002-8552-8976; Schwabenland, Marius/0000-0003-2205-5427; Bengsch, Bertram/0000-0003-2552-740X; Salie, Henrike/0000-0002-2993-3782; Schlaak, Alexandra Emilia/0000-0001-5892-9224; Blank, Thomas/0000-0002-3969-405X; Mayer, Lena Sophie/0000-0002-5158-7599	German Research Foundation (DFG) [SFB992, SFB1160, SFB/TRR167, SFB/TRR179, CIBSS-EXC-2189, 390939984, IMM-PACT 413517907, ME-3644/5-1, BE-5496/5-1]; Reinhart-Kosellek grant; Gottfried Wilhelm Leibniz prize; Ministry for Science, Research and Art of Baden-Wuerttemberg; Ernst-Jung Foundation; DEFEAT PANDEMIcs project by the German Federal Ministry of Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Reinhart-Kosellek grant; Gottfried Wilhelm Leibniz prize; Ministry for Science, Research and Art of Baden-Wuerttemberg; Ernst-Jung Foundation; DEFEAT PANDEMIcs project by the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was supported by the German Research Foundation (DFG) (SFB992, SFB1160, SFB/TRR167, SFB/TRR179, CIBSS-EXC-2189 project 390939984, IMM-PACT 413517907, ME-3644/5-1 to H.E.M., BE-5496/5-1 to B.B., and the Reinhart-Kosellek grant and Gottfried Wilhelm Leibniz prize to M.P.), research funds from the Ministry for Science, Research and Art of Baden-Wuerttemberg dedicated to ``COVID-19 research'' and ``neuroinflammation,'' and the Sobek prize to M.P. was further supported by the Ernst-Jung Foundation and the. DEFEAT PANDEMIcs project by the German Federal Ministry of Education and Research (BMBF). Graphical abstractions were created using BioRender.com. We thank M. Haeussler for help with informative RNA sequencing (RNA-seq) datasets. We thank E. Barleon, M. Ditter, and S. Hirner for excellent technical assistance.	Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Heming M, 2021, IMMUNITY, V54, P164, DOI 10.1016/j.immuni.2020.12.011; Kantonen J, 2020, BRAIN PATHOL, V30, P1012, DOI 10.1111/bpa.12889; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Perl DP, 2021, NEW ENGL J MED, V384, P481, DOI 10.1056/NEJMc2033369; Prinz M, 2021, ANNU REV IMMUNOL, V39, P251, DOI 10.1146/annurev-immunol-093019-110159; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2; Rha MS, 2021, IMMUNITY, V54, P44, DOI 10.1016/j.immuni.2020.12.002; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Schapiro D, 2017, NAT METHODS, V14, P873, DOI [10.1038/NMETH.4391, 10.1038/nmeth.4391]; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Song ER, 2021, J EXP MED, V218, DOI 10.1084/jem.20202135; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Troscher AR, 2019, ACTA NEUROPATHOL, V137, P619, DOI 10.1007/s00401-019-01958-5; VARATHARAJ A, 2020, LANCET PSYCHIAT, V7, P875, DOI [DOI 10.1016/S2215-0366(20)30287-X, 10.1016/S2215-0366(20)30287-X]; von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	33	86	86	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1594	+		10.1016/j.immuni.2021.06.002	http://dx.doi.org/10.1016/j.immuni.2021.06.002		JUL 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34174183	Bronze, Green Published			2022-12-18	WOS:000672812100020
J	Deretic, V				Deretic, Vojo			Autophagy in inflammation, infection, and immunometabolism	IMMUNITY			English	Review							VIRUS-INDUCED AUTOPHAGY; SELECTIVE AUTOPHAGY; MYCOBACTERIUM-TUBERCULOSIS; NONCANONICAL AUTOPHAGY; IL-1-BETA PRODUCTION; I INTERFERONS; CONTROL MTOR; T-CELLS; INNATE; TBK1	Autophagy is a quality-control, metabolic, and innate immunity process. Normative autophagy affects many cell types, including hematopoietic as well as non-hematopoietic, and promotes health in model organisms and humans. When autophagy is perturbed, this has repercussions on diseases with inflammatory components, including infections, autoimmunity and cancer, metabolic disorders, neurodegeneration, and cardiovascular and liver diseases. As a cytoplasmic degradative pathway, autophagy protects from exogenous hazards, including infection, and from endogenous sources of inflammation, including molecular aggregates and damaged organelles. The focus of this review is on the role of autophagy in inflammation, including type I interferon responses and inflammasome outputs, from molecules to immune cells. A special emphasis is given to the intersections of autophagy with innate immunity, immunometabolism, and functions of organelles such as mitochondria and lysosomes that act as innate immunity and immunometabolic signaling platforms.	[Deretic, Vojo] Univ New Mexico, Autophagy Inflammat & Metab AIM Ctr Biomed Res Ex, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Deretic, Vojo] Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Deretic, V (corresponding author), Univ New Mexico, Autophagy Inflammat & Metab AIM Ctr Biomed Res Ex, Hlth Sci Ctr, Albuquerque, NM 87131 USA.; Deretic, V (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu			NIH NIAID [R37AI042999, R01AI111935]; NIGMS center grant [P20GM121176]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS center grant	V.D. dedicates this work to the memory of Dr. Beth Levine. V.D. thanks Drs. Judy Cannon and Andrew Thorburn for comments. This work was supported by NIH NIAID grants R37AI042999 and R01AI111935 and NIGMS center grant P20GM121176.	Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Agudo-Canalejo J, 2021, NATURE, V591, P142, DOI 10.1038/s41586-020-2992-3; Ahmad L, 2016, TRENDS MOL MED, V22, P511, DOI 10.1016/j.molmed.2016.04.006; Ahn J, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0333-0; Ali S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00778; Alsaleh G, 2020, ELIFE, V9, DOI 10.7554/eLife.57950; An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Antonia RJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49707-8; Balka KR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.056; Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bender S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005264; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Botbol Y, 2015, METHODS MOL BIOL, V1343, P143, DOI 10.1007/978-1-4939-2963-4_12; Brady OA, 2018, AUTOPHAGY, V14, P181, DOI 10.1080/15548627.2017.1313943; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Burke TP, 2020, NAT MICROBIOL, V5, P688, DOI 10.1038/s41564-020-0673-5; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025; Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032; Choi SW, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01019-18, 10.1128/aac.01019-18]; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Clarke AJ, 2018, J EXP MED, V215, P399, DOI 10.1084/jem.20170771; Combes AJ, 2021, NATURE, V591, P124, DOI 10.1038/s41586-021-03234-7; Cottam EM, 2014, AUTOPHAGY, V10, P1426, DOI 10.4161/auto.29309; Cottam EM, 2011, AUTOPHAGY, V7, P1335, DOI 10.4161/auto.7.11.16642; Cunha LD, 2018, CELL, V175, P429, DOI 10.1016/j.cell.2018.08.061; Daussy CF, 2021, J VIROL, V95, DOI 10.1128/JVI.00826-20; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Deretic V, 2010, F1000 BIOL REP, V2, P45; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; DeVorkin L, 2019, CELL REP, V27, P502, DOI 10.1016/j.celrep.2019.03.037; Di Cara F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163877; Di Rienzo M, 2020, CELL DEATH DIFFER, V27, P887, DOI 10.1038/s41418-020-0495-2; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dong XN, 2021, NATURE, V589, P456, DOI 10.1038/s41586-020-03056-z; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Eren E, 2020, EMBO REP, V21, DOI 10.15252/embr.202050829; Ferreira AR, 2016, J CELL MOL MED, V20, P750, DOI 10.1111/jcmm.12801; Finethy R, 2020, EMBO REP, V21, DOI 10.15252/embr.202050830; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fletcher K, 2018, EMBO J, V37, DOI 10.15252/embj.201797840; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2016.11.002, 10.1016/j.chom.2017.08.005]; Galluzzi L, 2019, CELL, V177, P1682, DOI 10.1016/j.cell.2019.05.026; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gassen N., 2020, BIORXIV, DOI [10.1101/2020.04.15.997254, DOI 10.1101/2020.04.15.997254]; Gerbino V, 2020, NEURON, V106, P789, DOI 10.1016/j.neuron.2020.03.005; Gerstenmaier L, 2015, P NATL ACAD SCI USA, V112, pE687, DOI 10.1073/pnas.1423318112; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Gonzalez A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Guo HS, 2017, DEV CELL, V43, P716, DOI 10.1016/j.devcel.2017.11.018; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hasan M, 2016, PHARMACOL RES, V111, P336, DOI 10.1016/j.phrs.2016.04.008; Heckmann BL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9036; Heckmann BL, 2019, CELL, V178, P536, DOI 10.1016/j.cell.2019.05.056; Heckmann BL, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222984; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Herhaus L, 2020, EMBO REP, V21, DOI 10.15252/embr.201948317; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hoffmann AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35811-8; Hoffmann HH, 2021, CELL, V184, P133, DOI 10.1016/j.cell.2020.12.005; Inomata M, 2020, P NATL ACAD SCI USA, V117, P33561, DOI 10.1073/pnas.2015368117; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jena KK, 2020, EMBO REP, V21, DOI 10.15252/embr.202050051; Jia JY, 2020, AUTOPHAGY, V16, P1539, DOI 10.1080/15548627.2020.1779451; Jia JY, 2020, MOL CELL, V77, P951, DOI 10.1016/j.molcel.2019.12.028; Jia JY, 2020, DEV CELL, V52, P69, DOI 10.1016/j.devcel.2019.10.025; Jia JY, 2018, MOL CELL, V70, P120, DOI 10.1016/j.molcel.2018.03.009; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Karmakar M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16043-9; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller MD, 2020, NATURE, V579, P260, DOI 10.1038/s41586-020-2066-6; Keller MD, 2020, CELL DEATH DIFFER, V27, P872, DOI 10.1038/s41418-019-0481-8; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Kimura T, 2017, EMBO J, V36, P42, DOI 10.15252/embj.201695081; Kimura T, 2016, J CELL SCI, V129, P881, DOI 10.1242/jcs.163758; Kimura T, 2015, J CELL BIOL, V210, P973, DOI 10.1083/jcb.201503023; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kumar S, 2020, NAT CELL BIOL, V22, P973, DOI 10.1038/s41556-020-0549-1; Kumar S, 2019, DEV CELL, V49, P130, DOI 10.1016/j.devcel.2019.01.027; Labzin LI, 2016, J ALLERGY CLIN IMMUN, V138, P37, DOI 10.1016/j.jaci.2016.05.010; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee C, 2020, DEV CELL, V55, P289, DOI 10.1016/j.devcel.2020.08.008; Leidal AM, 2020, NAT CELL BIOL, V22, P187, DOI 10.1038/s41556-019-0450-y; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li WH, 2019, HEPATOLOGY, V69, P604, DOI 10.1002/hep.30191; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lim J, 2019, ELIFE, V8, DOI 10.7554/eLife.44452; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Lu Q, 2016, CELL HOST MICROBE, V19, P102, DOI 10.1016/j.chom.2015.12.011; Ludigs K, 2012, CELL MOL LIFE SCI, V69, P3395, DOI 10.1007/s00018-012-0989-2; Lystad AH, 2019, NAT CELL BIOL, V21, P372, DOI 10.1038/s41556-019-0274-9; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Macian F, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00213; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Marshall RS, 2019, CELL, V177, P766, DOI 10.1016/j.cell.2019.02.009; Martin PK, 2018, NAT MICROBIOL, V3, P1131, DOI 10.1038/s41564-018-0229-0; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matsuzawa-Ishimoto Y, 2020, BLOOD, V135, P2388, DOI 10.1182/blood.2019004116; Matsuzawa-Ishimoto Y, 2017, J EXP MED, V214, P3687, DOI 10.1084/jem.20170558; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; Mejlvang J, 2018, J CELL BIOL, V217, P3640, DOI 10.1083/jcb.201711002; Melia TJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002085; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774; Mocholi E, 2018, CELL REP, V24, P1136, DOI 10.1016/j.celrep.2018.06.065; Montespan C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006217; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Morishita H, 2019, ANNU REV CELL DEV BI, V35, P453, DOI 10.1146/annurev-cellbio-100818-125300; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura S, 2020, NAT CELL BIOL, V22, P1252, DOI 10.1038/s41556-020-00583-9; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Niida M, 2010, MOL IMMUNOL, V47, P2378, DOI 10.1016/j.molimm.2010.05.004; Noad J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.63; Noda NN, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202004062; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pahari S, 2020, AUTOPHAGY, V16, P1021, DOI 10.1080/15548627.2019.1658436; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Park S, 2016, CELL HOST MICROBE, V19, P91, DOI 10.1016/j.chom.2015.12.010; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Poillet-Perez L, 2020, NAT CANCER, V1, P923, DOI 10.1038/s43018-020-00110-7; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Radulovic M, 2018, EMBO J, V37, DOI 10.15252/embj.201899753; Rai P, 2021, NAT IMMUNOL, V22, P312, DOI 10.1038/s41590-020-00859-0; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Ravenhill BJ, 2019, MOL CELL, V74, P320, DOI 10.1016/j.molcel.2019.01.041; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Ribeiro CMS, 2016, NATURE, V540, P448, DOI 10.1038/nature20567; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Riffelmacher T, 2017, IMMUNITY, V47, P466, DOI 10.1016/j.immuni.2017.08.005; Riffelmacher T, 2018, AUTOPHAGY, V14, P199, DOI 10.1080/15548627.2017.1362525; Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956; Saha B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009017; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Salio M, 2014, P NATL ACAD SCI USA, V111, pE5678, DOI 10.1073/pnas.1413935112; Samie M, 2018, NAT IMMUNOL, V19, P246, DOI 10.1038/s41590-017-0042-6; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Saravia J, 2020, CELL RES, V30, P328, DOI 10.1038/s41422-020-0301-1; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Schuck S, 2020, J CELL SCI, V133, DOI 10.1242/jcs.246322; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Skowyra ML, 2018, SCIENCE, V360, P49, DOI 10.1126/science.aar5078; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032; Sumpter R, 2016, CELL, V165, P867, DOI 10.1016/j.cell.2016.04.006; Swadling L, 2020, CELL REP, V30, P687, DOI 10.1016/j.celrep.2019.12.050; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Towers CG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201909033; Turco E, 2019, MOL CELL, V74, P330, DOI 10.1016/j.molcel.2019.01.035; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003; van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555; Vargas JNS, 2019, MOL CELL, V74, P347, DOI 10.1016/j.molcel.2019.02.010; Velayutham TS, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00383-19; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wan JH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw8523; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yamamoto K, 2020, NATURE, V581, P100, DOI 10.1038/s41586-020-2229-5; Yamashiro LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17156-x; Yamazaki T, 2020, NAT IMMUNOL, V21, P1160, DOI 10.1038/s41590-020-0751-0; Yang Q, 2017, ENVIRON SCI POLLUT R, V24, P21311, DOI 10.1007/s11356-017-9773-z; Youle RJ, 2019, SCIENCE, V365, P655, DOI 10.1126/science.aaw9855; Zachari M, 2019, DEV CELL, V50, P627, DOI 10.1016/j.devcel.2019.06.016; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu LL, 2019, NAT CELL BIOL, V21, P1604, DOI 10.1038/s41556-019-0429-8; Zhu LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05097-5; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	240	86	87	40	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					437	453		10.1016/j.immuni.2021.01.018	http://dx.doi.org/10.1016/j.immuni.2021.01.018		MAR 2021	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691134	Bronze, Green Accepted			2022-12-18	WOS:000627409300012
J	Hoagland, DA; Moller, R; Uhl, SA; Oishi, K; Frere, J; Golynker, I; Horiuchi, S; Panis, M; Blanco-Melo, D; Sachs, D; Arkun, K; Lim, JK; tenOever, BR				Hoagland, Daisy A.; Moller, Rasmus; Uhl, Skyler A.; Oishi, Kohei; Frere, Justin; Golynker, Ilona; Horiuchi, Shu; Panis, Maryline; Blanco-Melo, Daniel; Sachs, David; Arkun, Knarik; Lim, Jean K.; tenOever, Benjamin R.			Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity	IMMUNITY			English	Article							VESICULAR-STOMATITIS-VIRUS; STIMULATED GENES; INFECTION	The emergence and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant global morbidity, mortality, and societal disruption. A better understanding of virus-host interactions may potentiate therapeutic insights toward limiting this infection. Here we investigated the dynamics of the systemic response to SARS-CoV-2 in hamsters by histological analysis and transcriptional profiling. Infection resulted in consistently high levels of virus in the upper and lower respiratory tracts and sporadic occurrence in other distal tissues. A longitudinal cohort revealed a wave of inflammation, including a type I interferon (IFN-I) response, that was evident in all tissues regardless of viral presence but was insufficient to prevent disease progression. Bolstering the antiviral response with intranasal administration of recombinant IFN-I reduced viral disease, prevented transmission, and lowered inflammation in vivo. This study defines the systemic host response to SARS-CoV-2 infection and supports use of intranasal IFN-I as an effective means of early treatment.	[Hoagland, Daisy A.; Moller, Rasmus; Uhl, Skyler A.; Oishi, Kohei; Frere, Justin; Golynker, Ilona; Horiuchi, Shu; Panis, Maryline; Blanco-Melo, Daniel; Lim, Jean K.; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genom Sci, New York, NY 10029 USA; [Arkun, Knarik] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA 02111 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Tufts Medical Center	tenOever, BR (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	benjamin.tenoever@mssm.edu	Horiuchi, Shu/GXH-4855-2022; Hoagland, Daisy/AAT-4774-2021; Hoagland, Daisy/ABC-4539-2021	Horiuchi, Shu/0000-0001-5982-0247; Hoagland, Daisy/0000-0002-6781-3079; Oishi, Kohei/0000-0002-2995-7856; Sachs, David/0000-0002-4445-2055; Golynker, Ilona/0000-0002-7671-606X; Blanco-Melo, Daniel/0000-0002-0256-5019; Moller, Rasmus/0000-0002-8452-0761; tenOever, Benjamin/0000-0003-0324-3078	Marc Haas Foundation; [DARPA's] PREPARE program [HR0011-20-2-0040]	Marc Haas Foundation; [DARPA's] PREPARE program	This work was funded by the Marc Haas Foundation and DARPA's] PREPARE program (HR0011-20-2-0040). The views, opinions, and/or findings expressed are those of the author and should not interpreted as representing the official views or policies of the Department of Defense or the U.S. government. D.B.M. is an Open Philanthropy Fellow of the Life Sciences Research Foundation. We would like to thank Carlos Franco and Lenny Martinez, supervisors of the ISMMS animal facility, for all of their help.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Boudewijns R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19684-y; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Carignan A, 2020, CAN MED ASSOC J, V192, pE702, DOI 10.1503/cmaj.200869; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15; Dieterle ME, 2020, CELL HOST MICROBE, V28, P486, DOI 10.1016/j.chom.2020.06.020; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Douangamath A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18709-w; Eisinger RW, 2018, EMERG INFECT DIS, V24, P413, DOI 10.3201/eid2403.171797; Guo ZX, 2019, NAT REV IMMUNOL, V19, P31, DOI 10.1038/s41577-018-0071-x; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Han YL, 2021, NATURE, V589, P270, DOI 10.1038/s41586-020-2901-9; Harcourt J, 2020, EMERG INFECT DIS, V26, P1266, DOI 10.3201/eid2606.200516; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Israelow B, 2020, J EXP MED, V217, DOI [10.1084/jem.20201241, 10.1101/2020.05.27.118893]; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Landini G., 2020, BIOINFORMATICS; Langlois RA, 2013, NAT BIOTECHNOL, V31, P844, DOI 10.1038/nbt.2666; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Liu Z, 2020, J VIROL, V94, DOI 10.1128/JVI.00790-20; Longlong Si HB, 2020, HUMAN ORGAN CHIP ENA, DOI DOI 10.1101/2020.04.13.039917; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Manson JJ, 2020, LANCET RHEUMATOL, V2, pE594, DOI 10.1016/S2665-9913(20)30275-7; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Mesev EV, 2019, NAT MICROBIOL, V4, P914, DOI 10.1038/s41564-019-0421-x; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374; Sorokina M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00652-6; Stark GR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028555; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tostanoski LH, 2020, NAT MED, V26, P1694, DOI 10.1038/s41591-020-1070-6; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Wang B, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.101300; Weerahandi H, 2021, J GEN INTERN MED, V36, P738, DOI 10.1007/s11606-020-06338-4; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234; Yang LJ, 2020, LANCET GASTROENTEROL, V5, P629, DOI 10.1016/S2468-1253(20)30132-1; Yao Changfu, 2020, medRxiv, DOI 10.1101/2020.07.23.20161182; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zheng M, 2020, J BIOL CHEM, V295, P14040, DOI 10.1074/jbc.RA120.015036; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	73	86	86	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					557	+		10.1016/j.immuni.2021.01.017	http://dx.doi.org/10.1016/j.immuni.2021.01.017		MAR 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33577760	Green Published, Bronze			2022-12-18	WOS:000627409300020
J	Wu, JJ; Dobbs, N; Yang, K; Yan, N				Wu, Jianjun; Dobbs, Nicole; Yang, Kun; Yan, Nan			Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion	IMMUNITY			English	Article							ACTIVATION; INFECTION; CELLS	Type I interferon (IFN) response is commonly recognized as the main signaling activity of STING. Here, we generate the Sting1(S365A/S365A) mutant mouse that precisely ablates IFN-dependent activities while preserving IFN-independent activities of STING. Sting(S365A/S365A) mice protect against HSV-1 infection, despite lacking the STING-mediated IFN response. This challenges the prevailing view and suggests that STING controls HSV-1 infection through IFN-independent activities. Transcriptomic analysis reveals widespread IFN-independent activities of STING in macrophages and T cells, and STING activities in T cells are predominantly IFN independent. In mouse tumor models, T cells in the tumor experience substantial cell death that is in part mediated by IFN-independent activities of STING. We found that the tumor induces STING-mediated cell death in T cells to evade immune control. Our data demonstrate that mammalian STING possesses widespread IFN-independent activities that are important for restricting HSV-1 infection, tumor immune evasion and likely also adaptive immunity.	[Wu, Jianjun; Dobbs, Nicole; Yang, Kun; Yan, Nan] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Yan, Nan] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yan, N (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Yan, N (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu	Yang, Kun/O-2172-2017	Yang, Kun/0000-0002-2011-7084; Wu, Jianjun/0000-0003-4518-8361	National Institutes of Health [AR067135, AI134877, AI151708]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180288]; Burroughs Wellcome Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We thank Glen Barber (University of Miami) for the Sting1<SUP>-/-</SUP> mice; David Leib (Dartmouth University) for the WT HSV-1 (strain 17); Bernard Moss (National Institutes of Health [NIH]) for the VACV (B5R-GFP); Ryan Huang, Robert Maples, and Gustavo Torres-Ramirez for mouse breeding; and the members of the Yan lab for helpful discussions. This work was supported by the National Institutes of Health (AR067135, AI134877 and AI151708 to N.Y.), the Cancer Prevention and Research Institute of Texas (CPRIT; RP180288), and the Burroughs Wellcome Fund (to N.Y.).	Bouis D, 2019, J ALLERGY CLIN IMMUN, V143, P712, DOI 10.1016/j.jaci.2018.04.034; Cerboni S, 2017, J EXP MED, V214, P1769, DOI 10.1084/jem.20161674; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Franz KM, 2018, P NATL ACAD SCI USA, V115, pE2058, DOI 10.1073/pnas.1716937115; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim S, 2017, BIORXIV, DOI [10.1101/145854, DOI 10.1101/145854]; Kurt-Jones EA, 2017, ADV ANAT EMBRYOL CEL, V223, P49, DOI 10.1007/978-3-319-53168-7_3; Lahey L.J., 2020, BIORXIV, DOI [10.1101/2002.02.13.948273, DOI 10.1101/2002.02.13.948273]; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luksch H, 2019, J ALLERGY CLIN IMMUN, V144, P254, DOI 10.1016/j.jaci.2019.01.044; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Motwani M, 2019, P NATL ACAD SCI USA, V116, P7941, DOI 10.1073/pnas.1818281116; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ranoa DRE, 2019, CANCER RES, V79, P1465, DOI 10.1158/0008-5472.CAN-18-1972; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Schadt L, 2019, CELL REP, V29, P1236, DOI 10.1016/j.celrep.2019.09.065; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Sivick KE, 2018, CELL REP, V25, P3074, DOI 10.1016/j.celrep.2018.11.047; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Van Dis E, 2018, CELL REP, V23, P1435, DOI 10.1016/j.celrep.2018.04.003; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhao QL, 2019, GUT, V68, P1827, DOI 10.1136/gutjnl-2018-317098	34	86	88	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					115	+		10.1016/j.immuni.2020.06.009	http://dx.doi.org/10.1016/j.immuni.2020.06.009			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32640258	Bronze, Green Accepted			2022-12-18	WOS:000551116800014
J	Schultz, BT; Teigler, JE; Pissani, F; Oster, AF; Kranias, G; Alter, G; Marovich, M; Eller, MA; Dittmer, U; Robb, ML; Kim, JH; Michael, NL; Bolton, D; Streeck, H				Schultz, Bruce T.; Teigler, Jeffrey E.; Pissani, Franco; Oster, Alexander F.; Kranias, Gregory; Alter, Galit; Marovich, Mary; Eller, Michael A.; Dittmer, Ulf; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Bolton, Diane; Streeck, Hendrik			Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions	IMMUNITY			English	Article							ANTIBODY-RESPONSES; DIFFERENTIATION; IL-21; PROLIFERATION; INDUCTION; INFECTION; CYTOKINE; DYNAMICS	A central effort in HIV vaccine development is to generate protective broadly neutralizing antibodies, a process dependent on T follicular helper (Tfh) cells. The feasibility of using peripheral blood counterparts of lymph node Tfh cells to assess the immune response and the influence of viral and vaccine antigens on their helper functions remain obscure. We assessed circulating HIV-specific IL-21(+) CD4(+) T cells and showed transcriptional and phenotypic similarities to lymphoid Tfh cells, and hence representing peripheral Tfh (pTfh) cells. pTfh cells were functionally active and B cell helper quality differed depending on antigen specificity. Furthermore, we found higher frequency of pTfh cells in peripheral blood mononuclear cell specimens from the ALVAC+AIDSVAX (RV144) HIV vaccine trial associated with protective antibody responses compared to the non-protective DNA+Ad5 vaccine trial. Together, we identify IL-21(+) CD4(+) T cells as pTfh cells, implicating them as key populations in the generation of vaccine-evoked antibody responses.	[Schultz, Bruce T.; Teigler, Jeffrey E.; Pissani, Franco; Oster, Alexander F.; Kranias, Gregory; Marovich, Mary; Eller, Michael A.; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Bolton, Diane; Streeck, Hendrik] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Schultz, Bruce T.; Teigler, Jeffrey E.; Pissani, Franco; Oster, Alexander F.; Kranias, Gregory; Marovich, Mary; Eller, Michael A.; Robb, Merlin L.; Bolton, Diane; Streeck, Hendrik] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Schultz, Bruce T.; Streeck, Hendrik] Univ Duisburg Essen, Univ Hosp Essen, Inst HIV Res, D-45147 Essen, Germany; [Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45147 Essen, Germany; [Kim, Jerome H.] Int Vaccine Inst, Seoul 151742, South Korea	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Duisburg Essen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Duisburg Essen; International Vaccine Institute	Streeck, H (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.	hendrik.streeck@uk-essen.de	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Schultz, Bruce/0000-0003-4492-9463	U.S. NIH [R01 AI091450-01, R01 AI094602-01]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DOD) [W81XWH-11-2-0174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091450, R01AI094602] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. Madelene Lindqvist and Dr. Jan van Lunzen for their help with the manuscript. This work was funded by the U.S. NIH (R01 AI091450-01 and R01 AI094602-01) and a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The reagents HIV-1 PTE Gag and Env Peptides were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH; human rIL-2 was from Dr. Maurice Gately, Hoffmann at La Roche Inc. The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense.	Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Claman H N, 1969, Transplant Rev, V1, P92; Cohen K, 2014, J VIROL, V88, P13310, DOI 10.1128/JVI.02186-14; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; GEHA RS, 1973, J EXP MED, V138, P1230, DOI 10.1084/jem.138.5.1230; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnson S, 2015, J VIROL, V89, P7494, DOI 10.1128/JVI.00438-15; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pallikkuth S, 2013, IMMUNOL RES, V57, P279, DOI 10.1007/s12026-013-8457-0; Pissani F, 2014, TRENDS IMMUNOL, V35, P278, DOI 10.1016/j.it.2014.02.010; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI [10.1586/erv.10.132, 10.1586/ERV.10.132]; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	86	88	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					167	178		10.1016/j.immuni.2015.12.011	http://dx.doi.org/10.1016/j.immuni.2015.12.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795249	Bronze			2022-12-18	WOS:000368347000021
J	Jaillon, S; Moalli, F; Ragnarsdottir, B; Bonavita, E; Puthia, M; Riva, F; Barbati, E; Nebuloni, M; Krajinovic, LC; Markotic, A; Valentino, S; Doni, A; Tartari, S; Graziani, G; Montanelli, A; Delneste, Y; Svanborg, C; Garlanda, C; Mantovani, A				Jaillon, Sebastien; Moalli, Federica; Ragnarsdottir, Bryndis; Bonavita, Eduardo; Puthia, Manoj; Riva, Federica; Barbati, Elisa; Nebuloni, Manuela; Krajinovic, Lidija Cvetko; Markotic, Alemka; Valentino, Sonia; Doni, Andrea; Tartari, Silvia; Graziani, Giorgio; Montanelli, Alessandro; Delneste, Yves; Svanborg, Catharina; Garlanda, Cecilia; Mantovani, Alberto			The Humoral Pattern Recognition Molecule PTX3 Is a Key Component of Innate Immunity against Urinary Tract Infection	IMMUNITY			English	Article							LONG PENTRAXIN PTX3; UROPATHOGENIC ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACUTE PYELONEPHRITIS; SUSCEPTIBILITY; RECEPTORS; DEFICIENCY; MECHANISMS; PATHOGEN; BLADDER	Immunity in the urinary tract has distinct and poorly understood pathophysiological characteristics and urinary tract infections (UTIs) are important causes of morbidity and mortality. We investigated the role of the soluble pattern recognition molecule pentraxin 3 (PTX3), a key component of the humoral arm of innate immunity, in UTIs. PTX3-deficient mice showed defective control of UTIs and exacerbated inflammation. Expression of PTX3 was induced in uroepithelial cells by uropathogenic Escherichia coli (UPEC) in a Toll-like receptor 4 (TLR4)- and MyD88-dependent manner. PTX3 enhanced UPEC phagocytosis and phagosome maturation by neutrophils. PTX3 was detected in urine of UTI patients and amounts correlated with disease severity. In cohorts of UTI-prone patients, PTX3 gene polymorphisms correlated with susceptibility to acute pyelonephritis and cystitis. These results suggest that PTX3 is an essential component of innate resistance against UTIs. Thus, the cellular and humoral arms of innate immunity exert complementary functions in mediating resistance against UTIs.	[Jaillon, Sebastien; Moalli, Federica; Bonavita, Eduardo; Barbati, Elisa; Valentino, Sonia; Doni, Andrea; Tartari, Silvia; Graziani, Giorgio; Montanelli, Alessandro; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin Res Ctr, I-20089 Milan, Italy; [Ragnarsdottir, Bryndis; Puthia, Manoj; Svanborg, Catharina] Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, S-22362 Lund, Sweden; [Riva, Federica] Univ Milan, Dept Vet Pathol Hyg & Publ Hlth, I-20133 Milan, Italy; [Nebuloni, Manuela] Univ Milan, L Sacco Dept Clin Sci, Pathol Unit, I-20157 Milan, Italy; [Krajinovic, Lidija Cvetko; Markotic, Alemka] Univ Hosp Infect Dis, Zagreb 10000, Croatia; [Delneste, Yves] Ctr Rech Cancerol Nantes Angers, Inst Natl Sante & Rech Med, U892, F-44933 Angers, France; [Mantovani, Alberto] Univ Milan, Dept Biotechnol & Translat Med, I-20089 Milan, Italy	Lund University; University of Milan; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Milan	Jaillon, S (corresponding author), Humanitas Clin Res Ctr, Via Manzoni 56, I-20089 Milan, Italy.	sebastien.jaillon@humanitasresearch.it; alberto.mantovani@humanitasresearch.it	Bonavita, Eduardo/AAE-3702-2020; Riva, Federica/B-9287-2013; DELNESTE, Yves/K-7367-2015; Garlanda, Cecilia/K-4601-2016; Bonavita, Eduardo/P-4370-2014; Moalli, Federica/I-8176-2018; Mantovani, Alberto/HCI-7449-2022; Delneste, Yves/O-3956-2016; Valentino, Sonia/AAB-4066-2020; JAILLON, Sebastien/A-7537-2015; NEBULONI, MANUELA/L-3969-2017	Bonavita, Eduardo/0000-0003-2335-5827; Riva, Federica/0000-0002-1270-1627; DELNESTE, Yves/0000-0002-2142-596X; Garlanda, Cecilia/0000-0002-1510-7703; Bonavita, Eduardo/0000-0003-2335-5827; Moalli, Federica/0000-0002-8426-2571; Mantovani, Alberto/0000-0001-5578-236X; Valentino, Sonia/0000-0001-8652-3168; JAILLON, Sebastien/0000-0002-5600-855X; Puthia, Manoj/0000-0001-6048-7234; Montanelli, Alessandro/0000-0002-4426-6906; Doni, Andrea/0000-0001-9203-5814; NEBULONI, MANUELA/0000-0002-2773-734X	European Commission (ERC project HIIS) [280873]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB RBLA039LSF]; Swedish Medical Research Council, Medical Faculty (Lund University); Soderberg Foundation; Osterlund Foundation; Inga-Britt and Arne Lundberg Foundation for Medical Research; HJ Forssman Foundation for Medical Research,; Agence Nationale pour la Recherche (ANR) (project Pentraximmune); Leem Recherche	European Commission (ERC project HIIS); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Swedish Medical Research Council, Medical Faculty (Lund University); Soderberg Foundation; Osterlund Foundation; Inga-Britt and Arne Lundberg Foundation for Medical Research; HJ Forssman Foundation for Medical Research,; Agence Nationale pour la Recherche (ANR) (project Pentraximmune)(French National Research Agency (ANR)); Leem Recherche	We thank B. Bottazzi (Humanitas Clinical Research Center) for human PTX3, F. Feruglio and N. Polentarutti (Humanitas Clinical Research Center) for their technical support, C. Fedeli (Humanitas Clinical Research Center), and B. Wullt (Lund University) and all the medical staff for urine sampling. The contribution of the European Commission (ERC project HIIS, FP7-HEALTH-2011-ADITEC-No280873), Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project FIRB RBLA039LSF), Swedish Medical Research Council, Medical Faculty (Lund University), Soderberg and Osterlund Foundations, Inga-Britt and Arne Lundberg and HJ Forssman Foundations for Medical Research, and Agence Nationale pour la Recherche (ANR) (project Pentraximmune) is gratefully acknowledged. S.J. was supported by Leem Recherche.	Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; Barbati E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053030; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Fischer H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001109; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Foxman B, 2002, AM J MED, V113, p5S; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Hang L, 1999, J IMMUNOL, V162, P3037; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Jack DL, 2005, J LEUKOCYTE BIOL, V77, P328, DOI 10.1189/jlb.0604342; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; JOHANSON IM, 1993, MICROB PATHOGENESIS, V15, P121, DOI 10.1006/mpat.1993.1062; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Klemm P, 2006, INFECT IMMUN, V74, P781, DOI 10.1128/IAI.74.1.781-785.2006; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Smithson A, 2007, CLIN VACCINE IMMUNOL, V14, P256, DOI 10.1128/CVI.00400-06; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Svensson M, 2008, KIDNEY INT, V74, P81, DOI 10.1038/ki.2008.105; Wullt B, 2000, MOL MICROBIOL, V38, P456, DOI 10.1046/j.1365-2958.2000.02165.x; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	51	86	91	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					621	632		10.1016/j.immuni.2014.02.015	http://dx.doi.org/10.1016/j.immuni.2014.02.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745336	Bronze			2022-12-18	WOS:000334849400018
J	Kirkland, D; Benson, A; Mirpuri, J; Pifer, R; Hou, BD; DeFranco, AL; Yarovinsky, F				Kirkland, Donna; Benson, Alicia; Mirpuri, Julie; Pifer, Reed; Hou, Baidong; DeFranco, Anthony L.; Yarovinsky, Felix			B Cell-Intrinsic MyD88 Signaling Prevents the Lethal Dissemination of Commensal Bacteria during Colonic Damage	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNITY; INTESTINAL EPITHELIUM; DENDRITIC CELLS; PROTECTS MICE; INNATE; IGA; HOMEOSTASIS; COLITIS; INFLAMMATION	The Toll-like receptor adaptor protein MyD88 is essential for the regulation of intestinal homeostasis in mammals. In this study, we determined that Myd88-deficient mice are susceptible to colonic damage that is induced by dextran sulfate sodium (DSS) administration resulting from uncontrolled dissemination of intestinal commensal bacteria. The DSS-induced mortality of Myd88-deficient mice was completely prevented by antibiotic treatment to deplete commensal bacteria. By using cell type-specific Myd88-deficient mice, we established that B cell-intrinsic MyD88 signaling plays a central role in the resistance to DSS-induced colonic damage via the production of IgM and complement-mediated control of intestinal bacteria. Our results indicate that the lack of intact MyD88 signaling in B cells, coupled with impaired epithelial integrity, enables commensal bacteria to function as highly pathogenic organisms, causing rapid host death.	[Kirkland, Donna; Benson, Alicia; Mirpuri, Julie; Pifer, Reed; Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hou, Baidong; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Yarovinsky, F (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	felix.yarovinsky@utsouthwestern.edu		Hou, Baidong/0000-0002-0892-0181; Mirpuri, Julie/0000-0003-4255-3474; Reed, Pifer/0000-0002-9648-450X; Yarovinsky, Felix/0000-0001-5825-8002	NIH [AI085263, P01AI078869]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085263, P01AI078869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH R01 AI085263 to F.Y. and P01AI078869 to A.L.D. We thank D. Rakheja and J. Shelton for their help with the histology and pathology scoring.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker K, 2010, MUCOSAL IMMUNOL, V3, P324, DOI 10.1038/mi.2010.15; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fagarasan S, 2004, CURR OPIN IMMUNOL, V16, P277, DOI 10.1016/j.coi.2004.03.005; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	53	86	92	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 24	2012	36	2					228	238		10.1016/j.immuni.2011.11.019	http://dx.doi.org/10.1016/j.immuni.2011.11.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22306056	Green Accepted, Bronze			2022-12-18	WOS:000300812400011
J	Haraldsson, MK; Louis-Dit-Sully, CA; Lawson, BR; Sternik, G; Santiago-Raber, ML; Gascoigne, NRJ; Theofilopoulos, AN; Kono, DH				Haraldsson, M. Katarina; Louis-Dit-Sully, Christine A.; Lawson, Brian R.; Sternik, Gabriel; Santiago-Raber, Marie-Laure; Gascoigne, Nicholas R. J.; Theofilopoulos, Argyrios N.; Kono, Dwight H.			The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation	IMMUNITY			English	Article							T-CELL PROLIFERATION; MURINE LUPUS; SUSCEPTIBILITY LOCUS; ARP2/3 COMPLEX; PRONE MICE; FAS-LIGAND; EXPRESSION; ACTIN; HOMEOSTASIS; ACTIVATION	Here, we show that a lupus-suppressing locus is caused by a nonsense mutation of the filamentous actin-inhibiting Coronin-1A gene. This mutation was associated with developmental and functional Alterations in T cells including reduced migration, survival, activation, and Ca2+ flux. T-dependent humoral responses were impaired, but no intrinsic B cell defects were detected. By transfer of T cells, it was shown that suppression of autoimmunity could be accounted for by the presence of the Coro1a(Lmb3) mutation in T cells. Our results demonstrate that Coronin-1A is required for the development of systemic lupus and identify actin-cytoskeleton regulatory proteins as potential targets for modulating autoimmune diseases.	[Haraldsson, M. Katarina; Louis-Dit-Sully, Christine A.; Lawson, Brian R.; Sternik, Gabriel; Gascoigne, Nicholas R. J.; Theofilopoulos, Argyrios N.; Kono, Dwight H.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Haraldsson, M. Katarina] Umea Univ, Div Immunol, Dept Clin Microbiol, CH-1211 Geneva, Switzerland; [Santiago-Raber, Marie-Laure] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	Scripps Research Institute; University of Geneva	Kono, DH (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dkono@scripps.edu			NIAID NIH HHS [AI051977] Funding Source: Medline; NIAMS NIH HHS [R01 AR042242, AR31203, R01 AR039555-13, R01 AR039555, AR42242, R37 AR039555, R01 AR031203, AR39555, R01 AR031203-24] Funding Source: Medline; NIGMS NIH HHS [GM65230, R01 GM065230] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031203, R01AR042242, R37AR039555, R01AR039555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Boackle SA, 2001, IMMUNITY, V15, P775, DOI 10.1016/S1074-7613(01)00228-X; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Dustin ML, 2006, SCIENCE, V313, P767, DOI 10.1126/science.1131714; Eck SC, 2006, J IMMUNOL, V176, P2229, DOI 10.4049/jimmunol.176.4.2229; Elliott JI, 2005, ARTHRITIS RES THER, V7, pR468, DOI 10.1186/ar1699; Feeney AJ, 2001, J IMMUNOL, V167, P3486, DOI 10.4049/jimmunol.167.6.3486; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Grogan A, 1997, J CELL SCI, V110, P3071; Harley JB, 2006, SPRINGER SEMIN IMMUN, V28, P119, DOI 10.1007/s00281-006-0040-5; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Khaidukov SV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P692, DOI 10.1007/s10541-005-0170-8; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; Kono DH, 2006, SPRINGER SEMIN IMMUN, V28, P83, DOI 10.1007/s00281-006-0030-7; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lawson BR, 2001, J IMMUNOL, V167, P2354, DOI 10.4049/jimmunol.167.4.2354; LEWIS RS, 2007, NATURE, V200, P1083; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Mary C, 2000, J IMMUNOL, V165, P2987, DOI 10.4049/jimmunol.165.6.2987; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Qu WM, 2000, EUR J IMMUNOL, V30, P2027, DOI 10.1002/1521-4141(200007)30:7<2027::AID-IMMU2027>3.0.CO;2-S; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Santiago-Raber ML, 2007, J IMMUNOL, V178, P8195, DOI 10.4049/jimmunol.178.12.8195; Schaerli P, 2005, IMMUNOL RES, V31, P57, DOI 10.1385/IR:31:1:57; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wong M, 2006, SPRINGER SEMIN IMMUN, V28, P97, DOI 10.1007/s00281-006-0031-6; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Zielinski CE, 2005, J IMMUNOL, V174, P5100, DOI 10.4049/jimmunol.174.8.5100	48	86	95	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					40	51		10.1016/j.immuni.2007.11.023	http://dx.doi.org/10.1016/j.immuni.2007.11.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199416	Bronze, Green Accepted			2022-12-18	WOS:000252627300009
J	Yachi, PP; Ampudia, J; Zal, T; Gascoigne, NRJ				Yachi, Pia P.; Ampudia, Jeanette; Zal, Tomasz; Gascoigne, Nicholas R. J.			Altered peptide Ligands induce delayed CD8-T cell receptor interaction - a role for CD8 in distinguishing antigen quality	IMMUNITY			English	Article							CLASS-I MOLECULES; POSITIVE SELECTION; T-CELLS; IMMUNOLOGICAL SYNAPSE; ANTAGONIST LIGANDS; CRYSTAL-STRUCTURE; THYMIC SELECTION; TCR; MHC; AGONIST	How T cells translate T cell receptor (TOR) recognition of almost identical pMHC ligands into distinct biological responses has remained enigmatic. Although differences in affinity or off rate are important, they offer at best an incomplete explanation. By using Forster resonance energy transfer (FRET), we have visualized the ligand-induced interaction between OT-I TOR and CD8. We found that both recruitment of TOR to the immunological synapse and the TCR-CD8 interaction induced by weak agonists (positive-selecting ligands) was delayed but not necessarily weaker than strong agonists (negative selectors). A delayed and perhaps longer lasting CD8-TCR interaction results in delayed phospho-ERK recruitment to the synapse. The kinetics of the TCR-CD8 interaction can reconcile previously anomalous data, where biological activity did not correlate with TCR-pMHC binding kinetics for certain ligands. Our findings indicate that the T cell translates antigen recognition into T cell responses by differential recruitment of CD8 to the TOR.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gascoigne@scripps.edu		Zal, Tomasz/0000-0002-3469-4261	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039476, R01GM065230] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI07290] Funding Source: Medline; NIGMS NIH HHS [R01GM065230, R01GM039476] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Chidgey AP, 1998, INT IMMUNOL, V10, P999, DOI 10.1093/intimm/10.7.999; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; GASCOIGNE NRJ, 2001, MOL MED         0212, P1; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; HOGQUIST KA, 1993, EUR J IMMUNOL, V23, P3028, DOI 10.1002/eji.1830231145; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmberg K, 2003, J IMMUNOL, V171, P2427, DOI 10.4049/jimmunol.171.5.2427; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Risueno RM, 2006, P NATL ACAD SCI USA, V103, P9625, DOI 10.1073/pnas.0601785103; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	34	86	90	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					203	211		10.1016/j.immuni.2006.05.015	http://dx.doi.org/10.1016/j.immuni.2006.05.015			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16872849	Bronze			2022-12-18	WOS:000240047500007
J	Sethi, DK; Agarwal, A; Manivel, V; Rao, KVS; Salunke, DM				Sethi, DK; Agarwal, A; Manivel, V; Rao, KVS; Salunke, DM			Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response	IMMUNITY			English	Article							CROSS-REACTIVITY; ANTIGEN; RECOGNITION; EVOLUTION; PEPTIDE; COMPLEX; BINDING; SITE; CRYSTALLOGRAPHY; MATURATION	Correlation between the promiscuity of the primary antibody response and conformational flexibility in a germline antibody was addressed by using germline antibody 36-65. Crystallographic analyses of the 36-65 Fab with three independent dodecapeptides provided mechanistic insights into the generation of antibody diversity. While four antigen-free Fab molecules provided a quantitative description of the conformational repertoire of the antibody CDRs, three Fab molecules bound to structurally diverse peptide epitopes exhibited a common paratope conformation. Each peptide revealed spatially different footprints within the antigen-combining site. However, a conformation-specific lock involving two shared residues, which were also associated with hapten binding, was discernible. Unlike the hapten, the peptides interacted with residues that undergo somatic mutations, suggesting a possible mechanism for excluding "nonspecific" antigens during affinity maturation. The observed multiple binding modes of diverse epitopes within a common paratope conformation of a germline antibody reveal a simple, yet elegant, mechanism for expanding the primary antibody repertoire.	Natl Inst Immunol, New Delhi 110067, India; Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Salunke, DM (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	dinakar@nii.res.in						BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Goel M, 2004, J IMMUNOL, V173, P7358, DOI 10.4049/jimmunol.173.12.7358; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Manivel V, 2002, J IMMUNOL, V169, P888, DOI 10.4049/jimmunol.169.2.888; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Nair DT, 2000, J IMMUNOL, V165, P6949, DOI 10.4049/jimmunol.165.12.6949; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARHAMISEREN B, 1993, J IMMUNOL, V150, P1829; Ramirez-Benitez MD, 2001, PROTEINS, V45, P199, DOI 10.1002/prot.1140; ROBERTSON SM, 1982, FED PROC, V41, P2502; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SHARON J, 1989, J IMMUNOL, V142, P596; SOMPURAM SR, 1993, J IMMUNOL, V150, P1822; STRONG RK, 1991, BIOCHEMISTRY-US, V30, P3739, DOI 10.1021/bi00229a022; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vora KA, 1998, J IMMUNOL, V160, P728; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yin J, 2001, BIOCHEMISTRY-US, V40, P10764, DOI 10.1021/bi010536c; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407	39	86	92	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					429	438		10.1016/j.immuni.2006.02.010	http://dx.doi.org/10.1016/j.immuni.2006.02.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618601	Bronze			2022-12-18	WOS:000237153000012
J	Zhang, H; Meng, FY; Chu, CL; Takai, T; Lowell, CA				Zhang, H; Meng, FY; Chu, CL; Takai, T; Lowell, CA			The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B	IMMUNITY			English	Article							TYROSINE-PHOSPHATASE SHP-1; PROTEIN-COUPLED RECEPTOR; MOTH-EATEN MICE; ACTIVATION; MIGRATION; RESPONSES; ADHESION; LYN; SYK; PHOSPHORYLATION	In classical descriptions of leukocyte chemokine signaling, Src family kinases are thought to function in a positive fashion by coupling receptor associated Galpha subunits to downstream mitogen activated protein (MAP) kinase activation. However, neutrophils derived from hck(-/-)fgr(-/-) mice and dendritic cells (DCs) from fgr(-/-) animals manifested significantly higher intracellular signaling (Ca2+ flux, MAP kinase activation, actin polymerization) and functional responses (chemotaxis in vitro and migration in vivo) to a number of different chemokines. These kinases may mediate their effect through the inhibitory receptor PIR-B since neutrophils and DCs from pir-b(-/-) mice were also hyperresponsive to chemokine stimulation. In wild-type (wt) cells dephosphorylation of PIR-B was associated with maximal chemokine signaling, whereas in hck(-/-)fgr(-/-) cells PIR-B was unphosphorylated. These data support a model in which the Src family kinases Hck and Fgr function as negative regulators of myeloid cell chemokine signaling by maintaining the tonic phosphorylation of PIR-B.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan	University of California System; University of California San Francisco; Tohoku University	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	clowell@cgl.ucsf.edu		Chu, Ching-Liang/0000-0002-8463-526X	NIDDK NIH HHS [DK58066] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058066] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bacon K, 2003, CYTOKINE, V21, P48, DOI 10.1016/S1043-4666(02)00493-3; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Berton G, 1999, Curr Opin Hematol, V6, P51, DOI 10.1097/00062752-199901000-00009; Chen CC, 2002, IMMUNOL RES, V26, P191, DOI 10.1385/IR:26:1-3:191; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; Dulphy N, 2002, INT IMMUNOL, V14, P471, DOI 10.1093/intimm/14.5.471; El-Shazly A, 1999, BIOCHEM BIOPH RES CO, V264, P163, DOI 10.1006/bbrc.1999.1379; Gresham HD, 2000, J EXP MED, V191, P515, DOI 10.1084/jem.191.3.515; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Kim CH, 1999, J EXP MED, V190, P681, DOI 10.1084/jem.190.5.681; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lowell CA, 1996, BLOOD, V87, P1780; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mach N, 2000, CANCER RES, V60, P3239; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Stein JV, 2003, BLOOD, V101, P38, DOI 10.1182/blood-2002-03-0841; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	44	86	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					235	246		10.1016/j.immuni.2005.01.004	http://dx.doi.org/10.1016/j.immuni.2005.01.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723811	Bronze			2022-12-18	WOS:000227509600009
J	Hedrick, SM				Hedrick, SM			The acquired immune system: A vantage from beneath	IMMUNITY			English	Editorial Material							ANTIGENIC VARIATION; T-CELLS; EVOLUTION; HOST; RESISTANCE; GAMMA; EPIDEMIOLOGY; VIRULENCE; DISEASES; GENES		Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				Bartl S, 2003, IMMUNOGENETICS, V55, P594, DOI 10.1007/s00251-003-0608-3; Bingle LEH, 2001, CURR OPIN MICROBIOL, V4, P194, DOI 10.1016/S1369-5274(00)00188-0; Bourke A. F. G., 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; Cambefort Y., 1991, DUNG BEETLE ECOLOGY; CAMPBELL A, 1983, CAN J FISH AQUAT SCI, V40, P1667, DOI 10.1139/f83-193; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Cargnelli LM, 1999, NMFSNE148 NOAA; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CARROL L, 1872, LOOKING GLASS; COOPER EL, 1992, SCAND J IMMUNOL, V35, P247, DOI 10.1111/j.1365-3083.1992.tb02857.x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cooper VS, 2002, P ROY SOC B-BIOL SCI, V269, P1161, DOI 10.1098/rspb.2002.1976; Day T, 2004, AM NAT, V163, pE40, DOI 10.1086/382548; Day T, 2003, TRENDS ECOL EVOL, V18, P113, DOI 10.1016/S0169-5347(02)00049-6; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Duffy MF, 2003, TRENDS PARASITOL, V19, P121, DOI 10.1016/S1471-4922(03)00003-5; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Ebert TA, 2003, FISH B-NOAA, V101, P915; ENNIS GP, 1986, NEWFOUDLAND CAN TECH, V1116, P1; ERLICH P, 1906, COLLECTED STUDIES IM; EWALD PW, 1995, J PARASITOL, V81, P659, DOI 10.2307/3283951; Ewald PW, 1999, EVOLUTIONARY MEDICI NE, P271; FISHER WS, 1978, AQUACULTURE, V14, P115, DOI 10.1016/0044-8486(78)90025-X; Fleeman LM, 2001, VET CLIN N AM-SMALL, V31, P855, DOI 10.1016/S0195-5616(01)50003-0; Fogarty M., 1995, BIOL LOBSTER HOMARUS, P111; Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hansson H, 1999, VET IMMUNOL IMMUNOP, V69, P225, DOI 10.1016/S0165-2427(99)00056-2; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hernandez O, 2000, MED VET ENTOMOL, V14, P458, DOI 10.1046/j.1365-2915.2000.00258.x; HERRICK FH, 1977, NATURAL HIST AM LOBS; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Keith I.R., 1992, Fish & Shellfish Immunology, V2, P109, DOI 10.1016/S1050-4648(05)80040-3; King NJC, 2003, IMMUNOL CELL BIOL, V81, P207, DOI 10.1046/j.1440-1711.2003.01167.x; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Kurane I, 1992, Semin Immunol, V4, P121; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Miller LK, 1998, VIRUSES, P91; Miracle AL, 2001, INT IMMUNOL, V13, P567, DOI 10.1093/intimm/13.4.567; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nam BH, 2003, J IMMUNOL, V170, P3081, DOI 10.4049/jimmunol.170.6.3081; Nash TE, 2002, MOL MICROBIOL, V45, P585, DOI 10.1046/j.1365-2958.2002.03029.x; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Olivry T, 2001, CLIN TECH SMALL AN P, V16, P225, DOI 10.1053/svms.2001.26999; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Price P W, 1980, Monogr Popul Biol, V15, P1; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; ROPES JW, 1985, NAUTILUS, V99, P53; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Smith JA, 1999, P ROY SOC B-BIOL SCI, V266, P1283, DOI 10.1098/rspb.1999.0776; Smith SA, 2002, CRIT REV MICROBIOL, V28, P149, DOI 10.1080/1040-840291046722; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorci G, 1997, TRENDS ECOL EVOL, V12, P196, DOI 10.1016/S0169-5347(97)01056-2; Steinert M, 2003, INT J MED MICROBIOL, V293, P321, DOI 10.1078/1438-4221-00275; Stewart J.E., 1980, P301; Suzuki Y, 1995, J PARASITOL, V81, P1032, DOI 10.2307/3284069; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; THOMAS JT, 1973, NMFSSSRF667 NOAA; Thompson JN, 1994, COEVOLUTIONARY PROCE; Trowsdale J, 2004, EUR J IMMUNOL, V34, P7, DOI 10.1002/eji.200324693; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Van Valen L, 1973, EVOL THEORY, V1, P1; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Weintraub BC, 1997, INFECT IMMUN, V65, P2306, DOI 10.1128/IAI.65.6.2306-2312.1997; WILLIAMS T, 1995, MOL ECOL, V4, P447, DOI 10.1111/j.1365-294X.1995.tb00238.x; Wilson E.O, 1971, INSECT SOC	80	86	91	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					607	615		10.1016/j.immuni.2004.08.020	http://dx.doi.org/10.1016/j.immuni.2004.08.020			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539148	Bronze			2022-12-18	WOS:000225365000003
J	Chen, H; Mocsai, A; Zhang, H; Ding, RX; Morisaki, JH; White, M; Rothfork, JM; Heiser, P; Colucci-Guyon, E; Lowell, CA; Gresham, HD; Allen, PM; Brown, EJ				Chen, H; Mocsai, A; Zhang, H; Ding, RX; Morisaki, JH; White, M; Rothfork, JM; Heiser, P; Colucci-Guyon, E; Lowell, CA; Gresham, HD; Allen, PM; Brown, EJ			Role for plastin in host defense distinguishes integrin signaling from cell adhesion and spreading	IMMUNITY			English	Article							TYROSINE PHOSPHORYLATION; HUMAN-NEUTROPHILS; STAPHYLOCOCCUS-AUREUS; RESPIRATORY BURST; ACTIVATION; PROTEIN; ACTIN; DEFICIENCY; RECEPTORS; ADHERENCE	Integrin ligation activates both cell adhesion and signal transduction, in part through reorganization of the actin cytoskeleton. Plastins (also known as fimbrins) are actin-crosslinking proteins of the cortical cytoskeleton present in all cells and conserved from yeast to mammals. Here we show that plastin-deficient polymorphonuclear neutrophils (PMN) are deficient in killing the bacterial pathogen Staphylococcus aureus in vivo and in vitro, despite normal phagocytosis. Like integrin beta2-deficient PMN, plastin-deficient PMN cannot generate an adhesion-dependent respiratory burst, because of markedly diminished integrin-dependent syk activation. Unlike beta2(-/-) PMN, plastin-deficient PMN adhere and spread normally. Deficiency of plastin thus separates the classical integrin receptor functions of adhesion and spreading from intracellular signal transduction.	Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Albuquerque VAMC, Res Serv, Albuquerque, NM 87108 USA; Inst Pasteur, URA 361 CNRS, Paris, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brown, EJ (corresponding author), Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA.	ebrown@medicine.ucsf.edu	Mocsai, Attila/B-2792-2008	Mocsai, Attila/0000-0002-0512-1157; Heiser, Patrick/0000-0002-8831-4973				ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; FUHLBRIGGE RC, 1987, J IMMUNOL, V138, P3799; FUORTES M, 1994, J CELL BIOL, V127, P1477, DOI 10.1083/jcb.127.5.1477; Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857; GRAHAM IL, 1993, J CELL BIOL, V120, P1509, DOI 10.1083/jcb.120.6.1509; GRAHAM IL, 1994, J CELL BIOL, V127, P1139, DOI 10.1083/jcb.127.4.1139; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Han HS, 2003, J EXP MED, V197, P63, DOI 10.1084/jem.20021638; HAWKINS HK, 1992, PEDIATR PATHOL, V12, P119, DOI 10.3109/15513819209023288; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hii CST, 1999, INFECT IMMUN, V67, P1297, DOI 10.1128/IAI.67.3.1297-1302.1999; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kucik DF, 2001, MOL BIOL CELL, V12, P1509, DOI 10.1091/mbc.12.5.1509; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; LIN CS, 1994, MOL CELL BIOL, V14, P2457, DOI 10.1128/MCB.14.4.2457; LIN CS, 1993, J BIOL CHEM, V268, P2781; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; LIN TH, 1994, J CELL BIOL, V126, P1585, DOI 10.1083/jcb.126.6.1585; LIN TH, 1995, J BIOL CHEM, V270, P16189, DOI 10.1074/jbc.270.27.16189; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; PACAUD M, 1993, BIOCHEMISTRY-US, V32, P3448, DOI 10.1021/bi00064a031; PACAUD M, 1987, J CELL SCI, V88, P81; PETTY HR, 1993, J LEUKOCYTE BIOL, V54, P492, DOI 10.1002/jlb.54.5.492; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; ROSALES C, 1994, P NATL ACAD SCI USA, V91, P3534, DOI 10.1073/pnas.91.9.3534; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Schnitzler N, 1999, NAT MED, V5, P231, DOI 10.1038/5597; SHERMAN MP, 1992, J INFECT DIS, V166, P818, DOI 10.1093/infdis/166.4.818; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; SVEUM RJ, 1986, J IMMUNOL METHODS, V90, P257, DOI 10.1016/0022-1759(86)90083-9; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; WOOD WB, 1960, BACTERIOL REV, V24, P41, DOI 10.1128/MMBR.24.1.41-49.1960; WOOD WB, 1947, SCIENCE, V106, P86, DOI 10.1126/science.106.2743.86; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691	55	86	89	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2003	19	1					95	104		10.1016/S1074-7613(03)00172-9	http://dx.doi.org/10.1016/S1074-7613(03)00172-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871642	Bronze			2022-12-18	WOS:000184260400011
J	Wang, Y; Brooks, SR; Li, XL; Anzelon, AN; Rickert, RC; Carter, RH				Wang, Y; Brooks, SR; Li, XL; Anzelon, AN; Rickert, RC; Carter, RH			The physiologic role of CD19 cytoplasmic tyrosines	IMMUNITY			English	Article							B-LYMPHOCYTE RESPONSES; MARGINAL ZONE; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-DEVELOPMENT; IMMUNE-RESPONSE; B1B CELLS; ACTIVATION; ANTIGEN; RECEPTOR	The physiologic role of eight CD19 tyrosines was examined in CD19-knockout mice expressing transgenic CD19 constructs. CD19 Y482 and Y513 were essential for normal B cell biology, including differentiation of 131 and marginal zone B cells and for T-dependent and -independent antibody responses. In immunized mice with mutations in CD19 Y482 and Y513, early germinal center B cells appeared normal in phenotype and number, but maturation in the germinal center was defective. This was associated with retarded progression through the cell cycle. Thus, Y482 and Y513 are essential for all functions of CD19 in vivo. Mutation of these reduces proliferation in germinal center B cells, providing a potential mechanism for the failure of maturation, which abrogates antibody responses.	Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Vet Adm Med Ctr, Birmingham, AL 35294 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Canc Ctr, La Jolla, CA 92093 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Carter, RH (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	rcarter@uab.edu			NIAID NIH HHS [R01 AI 46225] Funding Source: Medline; NIAMS NIH HHS [P30 AR48311] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brooks SR, 2000, J IMMUNOL, V164, P3123, DOI 10.4049/jimmunol.164.6.3123; Buhl AM, 1999, J IMMUNOL, V162, P4438; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; CHALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978, DOI 10.1002/eji.1830251040; Cherukuri A, 2001, IMMUNITY, V14, P169; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Fujimoto M, 1999, J IMMUNOL, V162, P7088; Fujimoto M, 2001, J BIOL CHEM, V276, P44820, DOI 10.1074/jbc.M107559200; Fujimoto M, 1998, SEMIN IMMUNOL, V10, P267, DOI 10.1006/smim.1998.9999; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Li XL, 1998, J IMMUNOL, V161, P5901; Li XL, 1997, J IMMUNOL, V158, P5649; Li XL, 2001, J IMMUNOL, V166, P3122, DOI 10.4049/jimmunol.166.5.3122; Li XL, 2000, EUR J IMMUNOL, V30, P1576, DOI 10.1002/1521-4141(200006)30:6<1576::AID-IMMU1576>3.0.CO;2-0; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Oliver AM, 1997, J IMMUNOL, V158, P1108; Oliver AM, 1999, J IMMUNOL, V162, P7198; Otero DC, 2001, J BIOL CHEM, V276, P1474, DOI 10.1074/jbc.M003918200; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sato S, 2000, J IMMUNOL, V165, P6635, DOI 10.4049/jimmunol.165.11.6635; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; TEDDER TF, 1989, J IMMUNOL, V143, P712; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160	44	86	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2002	17	4					501	514		10.1016/S1074-7613(02)00426-0	http://dx.doi.org/10.1016/S1074-7613(02)00426-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387743	Bronze			2022-12-18	WOS:000178667100010
J	van der Merwe, PA				van der Merwe, PA			The TCR triggering puzzle	IMMUNITY			English	Article							LIGAND-SPECIFIC OLIGOMERIZATION; CELL-RECEPTOR BINDING; PEPTIDE-MHC; ACTIVATION; RECOGNITION; COMPLEXES		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	anton.vandermerwe@path.ox.ac.uk						Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DAVIS SJ, 2001, IN PRESS CURR BIOL; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dustin ML, 1996, J IMMUNOL, V157, P2014; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 2001, ADV IMMUNOL, V77, P45, DOI 10.1016/S0065-2776(01)77014-9; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	26	86	87	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					665	668		10.1016/S1074-7613(01)00155-8	http://dx.doi.org/10.1016/S1074-7613(01)00155-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420037	Bronze			2022-12-18	WOS:000169495100003
J	Laouar, Y; Crispe, IN				Laouar, Y; Crispe, IN			Functional flexibility in T cells: Independent regulation of CD4(+) T cell proliferation and effector function in vivo	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATURE DENDRITIC CELLS; IN-VIVO; TRANSGENIC MICE; LYMPHOCYTES-T; EBI1-LIGAND CHEMOKINE; RECEPTOR EXPRESSION; CYCLE PROGRESSION; DNA-REPLICATION; FLT3 LIGAND	Proliferation and differentiation of CD4(+) T cells are often correlated, but it is not clear whether they are mechanistically linked. When antigen-specific T cells are present at high frequency in vivo, they all respond to antigenic peptide stimulation by expressing activation markers, but only a subset begins to proliferate. However, noncycling cells may synthesize the effector cytokine IFN gamma even though their cell cycle is blocked in G1. These data show that proliferation and effector function are not rigidly linked in T cells. Instead, CD4(+) T cells have the flexibility to engage in or bypass clonal expansion based on the integration of multiple signals, including the frequency of other responding T cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06522 USA	Yale University	Crispe, IN (corresponding author), Univ Rochester, Ctr Vaccine Biol & Immunol, 601 Elmwood Ave,Box 609, Rochester, NY 14642 USA.				NIAID NIH HHS [AI 37554] Funding Source: Medline; NIGMS NIH HHS [GM 56689] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056689] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BELL EB, 1987, J IMMUNOL, V139, P1379; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; BUDD RC, 1987, J IMMUNOL, V138, P3120; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Chen WJ, 1998, J IMMUNOL, V160, P1504; CONSTANT S, 1995, J IMMUNOL, V154, P4915; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; DOHLSTEN M, 1993, IMMUNOLOGY, V79, P520; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HARPER JW, 1993, CELL, V75, P805; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HUANG L, 1993, J IMMUNOL, V151, P1844; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KELSO A, 1995, EUR J IMMUNOL, V25, P1168, DOI 10.1002/eji.1830250506; Kim CH, 1999, J LEUKOCYTE BIOL, V66, P455, DOI 10.1002/jlb.66.3.455; Knight SC, 1998, EUR J IMMUNOL, V28, P1636; Li X, 1996, EXP CELL RES, V222, P28, DOI 10.1006/excr.1996.0004; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; PENIT C, 1993, CYTOMETRY, V14, P757, DOI 10.1002/cyto.990140708; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Pulendran B, 1998, J EXP MED, V188, P2075, DOI 10.1084/jem.188.11.2075; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shulman MJ, 1999, SEMIN IMMUNOL, V11, P369, DOI 10.1006/smim.1999.0193; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; TRIPP RA, 1995, J IMMUNOL, V154, P5870; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WEBB SR, 1994, CURR OPIN IMMUNOL, V6, P467, DOI 10.1016/0952-7915(94)90129-5; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; XIANG T, 1997, J IMMUNOL, V158, P4237; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Yoshida R, 1998, INT IMMUNOL, V10, P901, DOI 10.1093/intimm/10.7.901; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	63	86	86	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					291	301		10.1016/S1074-7613(00)00029-7	http://dx.doi.org/10.1016/S1074-7613(00)00029-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021527	Bronze			2022-12-18	WOS:000089616400002
J	Carlyle, JR; Zuniga-Pflucker, JC				Carlyle, JR; Zuniga-Pflucker, JC			Requirement for the thymus in alpha beta T lymphocyte lineage commitment	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; HEMATOPOIETIC STEM-CELLS; MURINE FETAL LIVER; FC-GAMMA-RII/III; C-KIT; TRANSCRIPTION FACTORS; GENE REARRANGEMENT; PROGENITOR CELLS; BONE-MARROW	We recently identified a fetal thymic developmental stage (NK1.1(+)/CD117(lo)) that characterizes committed T/NK progenitors. We now report the existence of phenotypically and functionally identical T/NK progenitors in mouse fetal blood and spleen but not in fetal liver. These precursors are indistinguishable from previously characterized fetal blood "prothymocytes" (CD90(+)/CD117(lo)), with the exception that they express NK1.1, lack markers associated with T lineage commitment, maintain a germline TCR beta locus, and can give rise to both T and NK cells. Moreover, NK1.1(+)/CD90(+)/CD117(lo) fetal blood precursors are present in athymic nude mice. These results suggest that the T/NK lineage commitment pathway is thymus-independent. In contrast, full commitment to the alpha beta T lineage does not precede thymus colonization.	Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	jo.zuniga.pflucker@utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012; Carlyle, James R/A-1224-2008	Carlyle, James/0000-0002-3579-0300; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				AMAGAI T, 1995, EUR J IMMUNOL, V25, P757, DOI 10.1002/eji.1830250320; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BELL SE, 1991, EUR J IMMUNOL, V21, P2931, DOI 10.1002/eji.1830211206; Blom B, 1997, J IMMUNOL, V158, P3571; BOEHM T, 1995, IMMUNOL TODAY, V16, P555, DOI 10.1016/0167-5699(95)80074-3; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Carlyle JR, 1998, J IMMUNOL, V160, P744; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hattori N, 1996, J EXP MED, V184, P1901, DOI 10.1084/jem.184.5.1901; Hozumi K, 1996, INT IMMUNOL, V8, P1473, DOI 10.1093/intimm/8.10.1473; HOZUMI K, 1994, EUR J IMMUNOL, V24, P1339, DOI 10.1002/eji.1830240615; Jenkinson E J, 1990, Semin Immunol, V2, P51; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kawamoto H, 1997, J IMMUNOL, V158, P3118; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Leclercq G, 1996, J EXP MED, V184, P325, DOI 10.1084/jem.184.2.325; Lefrancois L, 1997, J IMMUNOL, V159, P538; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore TA, 1996, J IMMUNOL, V157, P2366; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NIKOLICZUGIC J, 1991, IMMUNOL TODAY, V12, P65, DOI 10.1016/0167-5699(91)90160-U; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; Oosterwegel MA, 1997, IMMUNITY, V6, P351, DOI 10.1016/S1074-7613(00)80337-4; PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Reya T, 1996, BLOOD, V87, P190, DOI 10.1182/blood.V87.1.190.bloodjournal871190; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SOLOFF RS, 1995, J IMMUNOL, V154, P3888; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; STICKNEY DG, 1994, BLOOD, V84, P3034, DOI 10.1182/blood.V84.9.3034.bloodjournal8493034; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Taubenberger JK, 1996, CELL IMMUNOL, V171, P41, DOI 10.1006/cimm.1996.0170; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Wang BP, 1996, INT IMMUNOL, V8, P939, DOI 10.1093/intimm/8.6.939; WANG J, 1994, SCIENCE, V265, P1860, DOI 10.1126/science.8091211; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609	57	86	88	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					187	197		10.1016/S1074-7613(00)80601-9	http://dx.doi.org/10.1016/S1074-7613(00)80601-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729039	Bronze			2022-12-18	WOS:000075610300005
J	Naramura, M; Hu, RJ; Gu, H				Naramura, M; Hu, RJ; Gu, H			Mice with a fluorescent marker for interleukin 2 gene activation	IMMUNITY			English	Article							CD4(+) T-CELLS; TRANSGENIC MICE; EXPRESSION; RESPONSES; HETEROGENEITY; LYMPHOCYTES; T-HELPER-1; PATHWAY; NUCLEAR; ALPHA	Production of interleukin (IL)-2 by T lymphocytes is one of the earliest events during immune response. A mutant mouse strain was generated by replacing the IL-2 gene with a cDNA encoding green fluorescent protein (GFP). In this model, GFP fluorescence is readily detectable upon T cell activation and is mostly coexpressed with IL-2 at the single cell level. Thus, individual activated T cells can express the IL-2 gene biallelically. Upon stimulation through the T cell antigen receptor, CD4(+) cells separate into distinct GFP(+) and GFP(-) populations, both of which are capable of differentiating into either Th1 or Th2 effecters. These mice allow noninvasive detection of IL-2 production by single cells and analysis of the subsequent differentiative fate of these cells as an immune response develops.	National Institute Allergy & Infectious Diseases, Immunol Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gu, H (corresponding author), National Institute Allergy & Infectious Diseases, Immunol Lab, NIH, Rockville, MD 20852 USA.	hgu@pop.niaid.nih.gov		Naramura, Mayumi/0000-0003-3658-0767				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BROMBACHER F, 1994, INT IMMUNOL, V6, P189, DOI 10.1093/intimm/6.2.189; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carter LL, 1997, CURR OPIN IMMUNOL, V9, P177, DOI 10.1016/S0952-7915(97)80132-X; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MEUER SC, 1984, P NATL ACAD SCI-BIOL, V81, P1509, DOI 10.1073/pnas.81.5.1509; MINASI LAE, 1993, J EXP MED, V177, P1451, DOI 10.1084/jem.177.5.1451; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Swain SL, 1996, IMMUNOL REV, V150, P143, DOI 10.1111/j.1600-065X.1996.tb00700.x; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; SZALLASI Z, 1994, J BIOL CHEM, V269, P27159; TOMONARI K, 1993, IMMUNOL REV, V131, P131, DOI 10.1111/j.1600-065X.1993.tb01534.x; UMLAUF SW, 1995, MOL CELL BIOL, V15, P3197; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WATSON JV, 1992, FLOW CYTOMETRY DATA; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	37	86	88	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					209	216		10.1016/S1074-7613(00)80603-2	http://dx.doi.org/10.1016/S1074-7613(00)80603-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729041	Bronze			2022-12-18	WOS:000075610300007
J	Hande, S; Notidis, E; Manser, T				Hande, S; Notidis, E; Manser, T			Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; SYSTEMIC LUPUS-ERYTHEMATOSUS; SINGLE GERMLINE VH; GERMINAL-CENTERS; PARA-AZOPHENYLARSONATE; AUTOIMMUNE-DISEASE; SOMATIC MUTATION; VARIABLE REGIONS; DNA ANTIBODIES; SELF-TOLERANCE	We analyzed the participation of a predominant B cell clonotype in the anti-arsonate immune response of mice in which Bcl-2 expression was enforced in B cells. Many of the antibodies expressed by the arsonate-induced memory compartment of these mice were "dual-reactive," displaying increased affinity acquired via V region somatic hypermutation for both arsonate and the autoantigen DNA. The hypermutated antibodies expressed by the anti-arsonate memory B cell compartment of normal mice have increased affinity for arsonate but lack measurable affinity for DNA. Thus, interference with apoptotic pathways allows developing memory B cells that have acquired autoreactivity to bypass a peripheral tolerance checkpoint. These data demonstrate that both positive and negative selection, working in concert with V gene somatic hypermutation, result in the "specificity maturation" of the antibody response.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Inst, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Manser, T (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	manser@lac.jci.tju.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038965] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38965] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVRAMEAS S, 1993, MOL IMMUNOL, V30, P1133, DOI 10.1016/0161-5890(93)90160-D; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BLIER PR, 1988, IMMUNOL REV, V105, P27, DOI 10.1111/j.1600-065X.1988.tb00764.x; BORRETZEN M, 1994, P NATL ACAD SCI USA, V91, P12917, DOI 10.1073/pnas.91.26.12917; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; CASSON LP, 1995, J EXP MED, V182, P743, DOI 10.1084/jem.182.3.743; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; EILAT D, 1994, MOL IMMUNOL, V27, P203; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRABAR P, 1983, IMMUNOL TODAY, V4, P337, DOI 10.1016/0167-5699(83)90169-X; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HANDE S, 1998, IN PRESS MOL IMMUNOL; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; KRISHNAN MR, 1993, J IMMUNOL, V150, P4948; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; Linton P J, 1992, Semin Immunol, V4, P3; LINTON PJ, 1991, J IMMUNOL, V146, P4099; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MALIPIERO UV, 1987, IMMUNOL REV, V96, P59, DOI 10.1111/j.1600-065X.1987.tb00509.x; MANSER T, 1989, J EXP MED, V170, P1211, DOI 10.1084/jem.170.4.1211; MANSER T, 1987, J EXP MED, V166, P1456, DOI 10.1084/jem.166.5.1456; MANSER T, 1990, MOL IMMUNOL, V27, P503, DOI 10.1016/0161-5890(90)90069-C; MANSER T, 1987, IMMUNOL REV, V96, P141, DOI 10.1111/j.1600-065X.1987.tb00513.x; MANSER T, 1991, SOMATIC HYPERMUTATIO, P42; MARION TN, 1992, IMMUNOL REV, V128, P123, DOI 10.1111/j.1600-065X.1992.tb00835.x; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Minnerath JM, 1995, P NATL ACAD SCI USA, V92, P12379, DOI 10.1073/pnas.92.26.12379; Moens U, 1995, P NATL ACAD SCI USA, V92, P12393, DOI 10.1073/pnas.92.26.12393; NAPARSTEK Y, 1986, J EXP MED, V164, P614, DOI 10.1084/jem.164.2.614; NEMAZEE D, 1993, CURR OPIN IMMUNOL, V5, P866, DOI 10.1016/0952-7915(93)90098-D; NEWMAN MA, 1992, J IMMUNOL, V149, P3260; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; NUNEZ G, 1991, NATURE, V353, P71, DOI 10.1038/353071a0; ParhamiSeren B, 1996, J IMMUNOL, V157, P2066; PARKER DC, 1991, FASEB J, V5, P2777, DOI 10.1096/fasebj.5.13.1916102; Pulendran B, 1997, IMMUNOL TODAY, V18, P27, DOI 10.1016/S0167-5699(97)80011-4; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RATHBUN G, 1988, ADV IMMUNOL, V42, P95, DOI 10.1016/S0065-2776(08)60843-3; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; RICKERT RC, 1995, J IMMUNOL, V154, P2209; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; ROTHSTEIN TL, 1983, MOL IMMUNOL, V20, P161, DOI 10.1016/0161-5890(83)90127-X; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; SHARON J, 1989, J IMMUNOL, V142, P596; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; Shlomchik MJ, 1989, PROG IMMUNOL, VVII, P415; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; Vora KA, 1998, J IMMUNOL, V160, P728; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; WYSOCKI LJ, 1987, J EXP MED, V166, P1, DOI 10.1084/jem.166.1.1	64	86	87	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					189	198		10.1016/S1074-7613(00)80471-9	http://dx.doi.org/10.1016/S1074-7613(00)80471-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492000	Bronze			2022-12-18	WOS:000072201800006
J	Schodin, BA; Tsomides, TJ; Kranz, DM				Schodin, BA; Tsomides, TJ; Kranz, DM			Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity	IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; PEPTIDE-MHC COMPLEXES; CLASS-I MHC; CYTOTOXIC LYMPHOCYTES-T; BETA-CHAIN; 3-DIMENSIONAL STRUCTURE; ANTIGEN RECEPTOR; BINDING-AFFINITY; SUPERANTIGEN; ANTIBODY	The number of T cell receptors on CTL clone 2C that are required for recognition of various peptide-MHC or superantigen-MHC ligands were measured as a function of both the ligand density on target cells and the binding affinity of the TCR. Quantitative inverse correlations were determined between the number of TCRs required for recognition and the number of ligands on target cells, and the number of TCR required and the K-a of the TCR for the ligand. We propose and test predictive uses of these relationships to determine the number of endogenous peptide-MHC complexes on a target cell (when TCR affinity is known) or to determine the affinity of the TCR (when the number of ligands is known).	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Schodin, BA (corresponding author), UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035990] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35990] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHO BK, 1995, J BIOL CHEM, V270, P25819, DOI 10.1074/jbc.270.43.25819; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DECKHUT AM, 1994, J EXP MED, V180, P1931, DOI 10.1084/jem.180.5.1931; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; HOO WFS, 1992, P NATL ACAD SCI USA, V89, P4759, DOI 10.1073/pnas.89.10.4759; HOO WS, 1993, J IMMUNOL, V150, P4331; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; KARUSH F, 1970, ANN NY ACAD SCI, V169, P56, DOI 10.1111/j.1749-6632.1970.tb55970.x; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; LIPES MA, 1993, SCIENCE, V259, P1165, DOI 10.1126/science.8267690; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MESCHER MF, 1991, J IMMUNOL, V147, P36; MOLLICK JA, 1991, J IMMUNOL, V146, P463; OROURKE AM, 1993, IMMUNOL TODAY, V14, P183; ROJO JM, 1988, J IMMUNOL, V140, P1081; Schlueter CJ, 1996, J MOL BIOL, V256, P859, DOI 10.1006/jmbi.1996.0132; SCHNECK J, 1989, CELL, V56, P47, DOI 10.1016/0092-8674(89)90982-3; SCHODIN BA, 1993, J BIOL CHEM, V268, P25722; SCHOLL PR, 1989, J IMMUNOL, V143, P2583; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WOODLAND DL, 1993, J EXP MED, V177, P433, DOI 10.1084/jem.177.2.433; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; YOON ST, 1994, IMMUNITY, V1, P563	47	86	88	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					137	146		10.1016/S1074-7613(00)80490-2	http://dx.doi.org/10.1016/S1074-7613(00)80490-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769477	Bronze			2022-12-18	WOS:A1996VE58900004
J	LINDSTEDT, R; LILJEDAHL, M; PELERAUX, A; PETERSON, PA; KARLSSON, L				LINDSTEDT, R; LILJEDAHL, M; PELERAUX, A; PETERSON, PA; KARLSSON, L			THE MHC CLASS-II MOLECULE H2-M IS TARGETED TO AN ENDOSOMAL COMPARTMENT BY A TYROSINE-BASED TARGETING MOTIF	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ALPHA-BETA-HETERODIMERS; INVARIANT CHAIN; HLA-DR; SURFACE EXPRESSION; CYTOPLASMIC TAIL; TRANSPORT; ANTIGENS; PEPTIDE; SIGNALS	The nonpolymorphic human class II molecule HLA-DM (DM) has been found to play a key role in antigen presentation by MHC class II molecules, HLA-DM and its murine equivalent H2-M are located intracellularly and are absent from the cell surface, In transfected HeLa cells, H2-M was transported to an endosomal compartment in the absence of invariant chain, A tyrosine-based targeting motif in the cytoplasmic tail of HP-M beta was responsible for the endosomal location and, if this tyrosine was mutated, H2-M accumulated at the cell surface. In the presence of invariant chain the mutated H2-M was redistributed to endosomes. The targeting motif of H2-M appeared not to be crucial for efficient peptide loading of class II, but if the invariant chain targeting motif also was removed, peptide loading decreased drastically. Thus, the targeting motif of H2-M appears to be supplementary, rather than essential for class II-peptide association.			LINDSTEDT, R (corresponding author), SCRIPPS RES INST, RW JOHNSON PHARMACEUT RES INST, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.							AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BREMNES B, 1994, J CELL SCI, V107, P2021; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CEMAN S, 1992, J IMMUNOL, V149, P754; CHERVONSKY AV, 1994, INT IMMUNOL, V6, P973, DOI 10.1093/intimm/6.7.973; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; JENSEN PE, 1992, J EXP MED, V176, P793, DOI 10.1084/jem.176.3.793; JOHNSON JP, 1982, J EXP MED, V156, P104, DOI 10.1084/jem.156.1.104; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KARLSSON L, 1992, J EXP MED, V176, P477, DOI 10.1084/jem.176.2.477; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LEE JM, 1992, INT IMMUNOL, V4, P889, DOI 10.1093/intimm/4.8.889; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; LUZIO JP, 1993, TRENDS BIOCHEM SCI, V18, P395, DOI 10.1016/0968-0004(93)90097-7; MEILINS E, 1994, J EXP MED, V179, P541; MEILINS E, 1990, NATURE, V343, P71; MONJI T, 1994, J IMMUNOL, V153, P4468; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; OGATA S, 1994, J BIOL CHEM, V269, P5210; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PIETERS J, 1993, J CELL SCI, V106, P831; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RASK L, 1976, EUR J IMMUNOL, V6, P93, DOI 10.1002/eji.1830060205; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; WILSON DW, 1993, J BIOL CHEM, V268, P7465	56	86	87	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					561	572		10.1016/1074-7613(95)90127-2	http://dx.doi.org/10.1016/1074-7613(95)90127-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584146	Bronze			2022-12-18	WOS:A1995TG28100004
J	KONG, GH; BU, JY; KUROSAKI, T; SHAW, AS; CHAN, AC				KONG, GH; BU, JY; KUROSAKI, T; SHAW, AS; CHAN, AC			RECONSTITUTION OF SYK FUNCTION BY THE ZAP-70 PROTEIN-TYROSINE KINASE	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; T-CELLS; MICE LACKING; ACTIVATION; ASSOCIATION; PHOSPHORYLATION; IMMUNOGLOBULIN; INVOLVEMENT; PLATELETS; P72(SYK)	ZAP-70 and Syk are PTKs required for TCR and BCR function, respectively. Loss of the Syk PTK results in a nonfunctional BCR. We provide evidence here that ZAP-70 and Syk are functionally homologous in antigen receptor signaling by demonstrating that expression of ZAP-70 in Syk(-) B cells reconstitutes BCR function. Reconstitution required the presence of functional Src homology 2 (SH2) and catalytic domains of ZAP-70. Thus, drug targeting of a single SH2 domain within ZAP-70 should be sufficient to inhibit hematopoietic antigen receptor function. In addition, we demonstrate that both ZAP-70 and Syk can bind directly to the phosphorylated Ig alpha and Ig beta subunits with affinities comparable to their binding to the TCR CD3 epsilon subunit. These data suggest that ZAP-70 and Syk are comparable in their abilities to mediate hematopoietic antigen receptor signaling.	WASHINGTON UNIV,SCH MED,DIV RHEUMATOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110; AMER CYANAMID CO,LEDERLE LABS,DEPT CARDIOVASC MOLEC BIOL,PEARL RIVER,NY 10965	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	KONG, GH (corresponding author), WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,ST LOUIS,MO 63110, USA.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Shaw, Andrey/0000-0001-5685-0272	NIAMS NIH HHS [5 T32 AR07279] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AGARWAL A, 1993, J BIOL CHEM, V268, P15900; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARAPAIA E, 1994, CELL, V76, P947; BU JJ, 1995, IN PRESS P NATL ACAD; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; BURKHARDT AL, 1994, MOL CELL BIOL, V14, P1095, DOI 10.1128/MCB.14.2.1095; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; DANIELIAN S, 1992, EUR J IMMUNOL, V22, P2915, DOI 10.1002/eji.1830221124; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; IWASHIMA M, 1994, SCIENCE, V263, P1163; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; LAW CL, 1993, J BIOL CHEM, V269, P12310; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; OHTA S, 1992, BIOCHEM BIOPH RES CO, V185, P1128, DOI 10.1016/0006-291X(92)91743-A; PAWSON T, 1992, CELL, V21, P359; PERLMUTTER R, 1994, NATURE, V37, P249; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; WANGE RL, 1993, J BIOL CHEM, V268, P19757; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118	52	86	86	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					485	492		10.1016/1074-7613(95)90029-2	http://dx.doi.org/10.1016/1074-7613(95)90029-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7538440	Bronze			2022-12-18	WOS:A1995QZ43000006
J	HUANG, XJ; HULTGREN, B; DYBDAL, N; STEWART, TA				HUANG, XJ; HULTGREN, B; DYBDAL, N; STEWART, TA			ISLET EXPRESSION OF INTERFERON-ALPHA PRECEDES DIABETES IN BOTH THE BB RAT AND STREPTOZOTOCIN-TREATED MICE	IMMUNITY			English	Article							PANCREATIC BETA-CELLS; AUTOIMMUNE CHRONIC HEPATITIS; NECROSIS-FACTOR-ALPHA; CLASS-II MHC; TRANSGENIC MICE; IFN-ALPHA; GENE-EXPRESSION; MELLITUS; INSULITIS; THERAPY	The mechanism(s) leading to beta cell dysfunction in type I diabetes has not been defined. We have investigated whether islet expression of IFN alpha could be a cause of the lesions that are hallmarks of type I diabetes. Streptozotocin induces the expression of interferon-alpha by pancreatic islets prior to the diabetes induced by streptozotocin. Increased IFN alpha, induced by poly I/C or expressed from a transgene will exacerbate the diabetogenic effects of streptozotocin. In another rodent model of type I diabetes (the BB rat), islet expression of IFN alpha precedes lymphocytic infiltration and diabetes. As in the streptozotocin model, in the BB rats poly I/C will induce islet expression of IFN alpha and accelerate the onset of diabetes. These results are consistent with the hypothesis that islet expression of IFN alpha participates in causing type I diabetes.			HUANG, XJ (corresponding author), GENENTECH INC, DEPT ENDOCRINE RES, San Francisco, CA 94080 USA.							ABDI EA, 1986, JAMA-J AM MED ASSOC, V255, P1878, DOI 10.1001/jama.1986.03370140076016; ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; BARRETTCONNOR E, 1985, REV INFECT DIS, V7, P207; BENNETT RA, 1981, CANCER RES, V41, P2786; BILLARD C, 1990, J IMMUNOL, V145, P1713; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; BRAATHEN LR, 1989, BRIT MED J, V298, P1713, DOI 10.1136/bmj.298.6689.1713-b; BURMAN P, 1986, J CLIN ENDOCR METAB, V63, P1086, DOI 10.1210/jcem-63-5-1086; BUSCHARD K, 1977, ACTA PATH MICRO IM C, V85, P469; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CAVALLO MG, 1992, IMMUNOLOGY, V75, P664; CHEN BDM, 1987, CELL IMMUNOL, V106, P343, DOI 10.1016/0008-8749(87)90177-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5; CRAIGHEAD JE, 1978, NEW ENGL J MED, V299, P1439, DOI 10.1056/NEJM197812282992605; DEMAEYER E, 1988, INTERFERONS OTHER RE, P39; DUMONT FJ, 1986, CELL IMMUNOL, V101, P625, DOI 10.1016/0008-8749(86)90172-3; EVANS SS, 1987, J IMMUNOL, V138, P2451; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; FOULIS AK, 1987, LANCET, V2, P1423; FOULIS AK, 1991, J PATHOL, V165, P97, DOI 10.1002/path.1711650203; FRANCIS ML, 1993, J IMMUNOL, V151, P2208; Gamble D R, 1980, Epidemiol Rev, V2, P49; GENDELMAN HE, 1992, J IMMUNOL, V148, P422; GERLING IC, 1994, DIABETES, V43, P433, DOI 10.2337/diabetes.43.3.433; HAAKFRENDSCHO M, 1994, J IMMUNOL, V152, P1347; HANNINEN A, 1992, J CLIN INVEST, V90, P1901, DOI 10.1172/JCI116067; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; HIGUCHI Y, 1992, J EXP MED, V176, P1719, DOI 10.1084/jem.176.6.1719; JIANG Z, 1991, J IMMUNOL, V146, P2990; JOURDAN M, 1991, J IMMUNOL, V147, P4402; KASAIAN MT, 1990, J EXP MED, V171, P745, DOI 10.1084/jem.171.3.745; KATO T, 1981, J GEN VIROL, V54, P293, DOI 10.1099/0022-1317-54-2-293; KROMANN H, 1980, MED BIOL, V58, P322; KURSCHNER C, 1992, J IMMUNOL, V149, P4096; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LEE KU, 1988, DIABETES, V37, P1053, DOI 10.2337/diabetes.37.8.1053; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MAYET WJ, 1989, HEPATOLOGY, V10, P24, DOI 10.1002/hep.1840100106; MORANTE AJL, 1992, AM J GASTROENTEROL, V87, P809; MOSSMAN BT, 1986, DIABETOLOGIA, V29, P186, DOI 10.1007/BF02427091; MUIR A, 1992, ENDOCRIN METAB CLIN, V21, P199, DOI 10.1016/S0889-8529(18)30215-9; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1984, SCIENCE, V224, P1440, DOI 10.1126/science.6203172; ONO SJ, 1988, DIABETES, V37, P1411, DOI 10.2337/diabetes.37.10.1411; PAPO T, 1992, ANN INTERN MED, V116, P51, DOI 10.7326/0003-4819-116-1-51; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; RHODES J, 1986, EUR J IMMUNOL, V16, P370, DOI 10.1002/eji.1830160410; RIZVI RY, 1986, BIOSCIENCE REP, V6, P557, DOI 10.1007/BF01114952; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Rossini A.A., 1993, DIABETES REV ALEX, V1, P43; ROSSINI AA, 1991, AUTOIMMUNITY, V8, P221, DOI 10.3109/08916939108997110; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SARZOTTI M, 1989, NAT IMMUN CELL GROW, V8, P66; SATOH J, 1990, J IMMUNOL, V145, P1395; SEMENZATO G, 1986, BLOOD, V68, P293; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; TANIGUCHI Y, 1992, INTERNAL MED, V31, P373, DOI 10.2169/internalmedicine.31.373; THOMAS VA, 1991, DIABETES, V40, P255, DOI 10.2337/diabetes.40.2.255; VERHAGEN A, 1990, NAT IMMUN CELL GROW, V9, P325; WALKER R, 1988, DIABETES, V37, P1301, DOI 10.2337/diabetes.37.9.1301; WANDL UB, 1992, CLIN IMMUNOL IMMUNOP, V65, P70, DOI 10.1016/0090-1229(92)90250-R; WILSON K, 1990, ANNU REV MED, V41, P497; YOSHIDA R, 1988, J EXP MED, V167, P1171, DOI 10.1084/jem.167.3.1171	69	86	92	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1994	1	6					469	478		10.1016/1074-7613(94)90089-2	http://dx.doi.org/10.1016/1074-7613(94)90089-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7895158				2022-12-18	WOS:A1994PK17100004
J	ZAMOYSKA, R				ZAMOYSKA, R			THE CD8 CORECEPTOR REVISITED - ONE CHAIN GOOD, 2 CHAINS BETTER	IMMUNITY			English	Review											ZAMOYSKA, R (corresponding author), NATL INST MED RES, DIV MOLEC IMMUNOL, THE RIDGEWAY, LONDON NW7 1AA, ENGLAND.			Zamoyska, Rose/0000-0001-9816-2638				BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; BOURSIER JP, 1993, J BIOL CHEM, V268, P2013; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CASABO LG, 1994, J IMMUNOL, V152, P397; CHALUPNY NJ, 1991, EMBO J, V10, P1201, DOI 10.1002/j.1460-2075.1991.tb08061.x; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; COLLINS TL, 1992, J IMMUNOL, V148, P2159; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; CROOKS MEC, 1994, IMMUNITY, V1, P277; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; EICHMANN K, 1989, IMMUNOL REV, V109, P39, DOI 10.1111/j.1600-065X.1989.tb00019.x; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; FUNGLEUNG WP, 1994, IN PRESS J EXP MED; GIBLIN PA, 1994, P NATL ACAD SCI USA, V91, P1716, DOI 10.1073/pnas.91.5.1716; GILLILAND LK, 1991, J IMMUNOL, V146, P1759; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; HOEVELER A, 1994, IMMUNITY, V1; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JULIUS M, 1993, IMMUNOL TODAY, V14, P177; KARAKI S, 1992, J IMMUNOL, V149, P1613; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; LAMARRE D, 1989, SCIENCE, V245, P743, DOI 10.1126/science.2549633; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NAKAYAMA T, 1993, P NATL ACAD SCI USA, V90, P10534, DOI 10.1073/pnas.90.22.10534; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; VANOERS NSC, 1992, EUR J IMMUNOL, V22, P735, DOI 10.1002/eji.1830220317; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; ZAMOYSKA R, 1988, EMBO J, V7, P2359, DOI 10.1002/j.1460-2075.1988.tb03080.x; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	44	86	87	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1994	1	4					243	246		10.1016/1074-7613(94)90075-2	http://dx.doi.org/10.1016/1074-7613(94)90075-2			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889412				2022-12-18	WOS:A1994PK16600001
J	Fatkhullina, AR; Peshkova, IO; Dzutsev, A; Aghayev, T; McCulloch, JA; Thovarai, V; Badger, JH; Vats, R; Sundd, P; Tang, HY; Kossenkov, AV; Hazen, SL; Trinchieri, G; Grivennikov, SI; Koltsova, EK				Fatkhullina, Aliia R.; Peshkova, Iuliia O.; Dzutsev, Amiran; Aghayev, Turan; McCulloch, John A.; Thovarai, Vishal; Badger, Jonathan H.; Vats, Ravi; Sundd, Prithu; Tang, Hsin-Yao; Kossenkov, Andrew V.; Hazen, Stanley L.; Trinchieri, Giorgio; Grivennikov, Sergei I.; Koltsova, Ekaterina K.			An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis	IMMUNITY			English	Article							GUT MICROBIOTA; INFLAMMATION; IMMUNE; OSTEOPONTIN; METABOLISM; MECHANISMS; EXPRESSION; CYTOKINE; BARRIER	Although commensal flora is involved in the regulation of immunity, the interplay between cytokine signaling and microbiota in atherosclerosis remains unknown. We found that interleukin (IL)-23 and its downstream target IL-22 restricted atherosclerosis by repressing pro-atherogenic microbiota. Inactivation of IL-23-IL-22 signaling led to deterioration of the intestinal barrier, dysbiosis, and expansion of pathogenic bacteria with distinct biosynthetic and metabolic properties, causing systemic increase in pro-atherogenic metabolites such as lipopolysaccharide (LPS) and trimethylamine N-oxide (TMAO). Augmented disease in the absence of the IL-23-IL-22 pathway was mediated in part by pro-atherogenic osteopontin, controlled by microbial metabolites. Microbiota transfer from IL-23-deficient mice accelerated atherosclerosis, whereas microbial depletion or IL-22 supplementation reduced inflammation and ameliorated disease. Our work uncovers the IL-23-IL-22 signaling as a regulator of atherosclerosis that restrains expansion of pro-atherogenic microbiota and argues for informed use of cytokine blockers to avoid cardiovascular side effects driven by microbiota and inflammation.	[Fatkhullina, Aliia R.; Peshkova, Iuliia O.; Aghayev, Turan; Koltsova, Ekaterina K.] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Dzutsev, Amiran; McCulloch, John A.; Thovarai, Vishal; Badger, Jonathan H.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Thovarai, Vishal] NCI, Basic Sci Program, Frederick Natl Lab Canc Res, Bethesda, MD 20892 USA; [Vats, Ravi; Sundd, Prithu] Univ Pittsburgh, Sch Med, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15213 USA; [Tang, Hsin-Yao] Wistar Inst Anat & Biol, Prote & Metabol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.] Wistar Inst Anat & Biol, Bioinformat Facil, 3601 Spruce St, Philadelphia, PA 19104 USA; [Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; The Wistar Institute; The Wistar Institute; Cleveland Clinic Foundation; Fox Chase Cancer Center	Koltsova, EK (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	ekaterina.koltsova@fccc.edu	Grivennikov, Sergei/AAE-7365-2019; Aghayev, Turan/ABE-4859-2021; Peshkova, Iuliia/AAI-2105-2020; Trinchieri, Giorgio/F-9369-2015; Hazen, Stanley L/ABD-5845-2021	Grivennikov, Sergei/0000-0003-2987-0555; Trinchieri, Giorgio/0000-0001-5892-7464; Aghayev, Turan/0000-0003-2208-9918; Tang, Hsin-Yao/0000-0003-1838-018X	Pew Scholar Award; NCI P30 Cancer Center Grant; NCI [R21 CA202396]; NIH [R56 HL133669, R01 HL133669, R01HL103866]; Leducq Foundation Award; Federal funds from the Frederick National Laboratory for Cancer Research, NIH [HHSN 261200800001E]; NATIONAL CANCER INSTITUTE [P30CA006927, R21CA202396, R50CA221838] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133669, R01HL103866, R56HL133669, R01HL128297] Funding Source: NIH RePORTER	Pew Scholar Award; NCI P30 Cancer Center Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Award; Federal funds from the Frederick National Laboratory for Cancer Research, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank laboratory animal, flow cytometry, cell culture and microscopy facilities at FCCC and Genentech Inc. for providing Il23p19<SUP>-/-</SUP> and Il22<SUP>-/-</SUP> mice and rIL-22-Ig. We thank Dr. Klaus Ley (La Jolla Institute) for help at early stages of this work and Drs. Daniel Mucida (Rockefeller University), Siddharth Balachandran (FCCC), and Rachel E. Locke for critical comments. This work was supported by Pew Scholar Award to S.I.G., NCI P30 Cancer Center Grant to FCCC; NCI R21 CA202396, NIH R56 HL133669, and NIH R01 HL133669 to E.K.K., and NIH R01HL103866 to S.L.H. S.L.H. also reports being partially supported by a Leducq Foundation Award. This project was supported in whole or in part from Federal funds from the Frederick National Laboratory for Cancer Research, NIH under contract HHSN 261200800001E.	Abbas A, 2015, STROKE, V46, P793, DOI 10.1161/STROKEAHA.114.006516; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Engelbertsen D, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008257; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001; Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hornemann T, 2013, ATHEROSCLEROSIS, V226, P16, DOI 10.1016/j.atherosclerosis.2012.08.041; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Isoda K, 2003, CIRCULATION, V107, P679, DOI 10.1161/01.CIR.0000055739.13639.D7; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kelly TN, 2016, CIRC RES, V119, P956, DOI 10.1161/CIRCRESAHA.116.309219; Khojasteh-Fard M, 2012, DIS MARKERS, V33, P289, DOI [10.1155/2012/629814, 10.3233/DMA-2012-00933]; Khosravi A, 2013, CURR OPIN MICROBIOL, V16, P221, DOI 10.1016/j.mib.2013.03.009; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Namasivayam S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0286-2; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rattik S, 2015, ATHEROSCLEROSIS, V242, P506, DOI 10.1016/j.atherosclerosis.2015.08.006; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Savvatis K, 2014, CIRC-HEART FAIL, V7, P161, DOI 10.1161/CIRCHEARTFAILURE.113.000604; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Subramanian M, 2015, CIRC RES, V116, pE13, DOI 10.1161/CIRCRESAHA.116.304794; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Taleb S, 2010, CURR OPIN LIPIDOL, V21, P404, DOI 10.1097/MOL.0b013e32833dc7f9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yan QL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00381; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	55	85	89	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					943	+		10.1016/j.immuni.2018.09.011	http://dx.doi.org/10.1016/j.immuni.2018.09.011			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30389414	Green Accepted, Bronze			2022-12-18	WOS:000450752200018
J	Li, SY; Bostick, JW; Ye, J; Qiu, J; Zhang, B; Urban, JF; Avram, D; Zhou, L				Li, Shiyang; Bostick, John W.; Ye, Jian; Qiu, Ju; Zhang, Bin; Urban, Joseph F., Jr.; Avram, Dorina; Zhou, Liang			Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function	IMMUNITY			English	Article							READ ALIGNMENT; IL-33; DIFFERENTIATION; IMMUNITY; PROMOTES; COLITIS; HETEROGENEITY; INFLAMMATION; MAINTENANCE; LYMPHOCYTES	Innate lymphoid cells (ILCs) are important for mucosal immunity. The intestine harbors all ILC subsets, but how these cells are balanced to achieve immune homeostasis and mount appropriate responses during infection remains elusive. Here, we show that aryl hydrocarbon receptor (Ahr) expression in the gut regulates ILC balance. Among ILCs, Ahr is most highly expressed by gut ILC2s and controls chromatin accessibility at the Ahr locus via positive feedback. Ahr signaling suppresses Gfi1 transcription-factor-mediated expression of the interleukin-33 (IL-33) receptor ST2 in ILC2s and expression of ILC2 effector molecules IL-5, IL-13, and amphiregulin in a cell-intrinsic manner. Ablation of Ahr enhances anti-helminth immunity in the gut, whereas genetic or pharmacological activation of Ahr suppresses ILC2 function but enhances ILC3 maintenance to protect the host from Citrobacter rodentium infection. Thus, the host regulates the gut ILC2-ILC3 balance by engaging the Ahr pathway to mount appropriate immunity against various pathogens.	[Li, Shiyang; Bostick, John W.; Ye, Jian; Zhou, Liang] Univ Florida, Dept Infect Dis & Immunol, Coll Vet Med, Gainesville, FL 32608 USA; [Bostick, John W.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Qiu, Ju] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China; [Zhang, Bin] Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Urban, Joseph F., Jr.] USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Avram, Dorina] Univ Florida, Dept Med, Div Pulm Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Northwestern University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Northwestern University; Feinberg School of Medicine; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Zhou, L (corresponding author), Univ Florida, Dept Infect Dis & Immunol, Coll Vet Med, Gainesville, FL 32608 USA.	liangzhou497@ufl.edu	Ye, Jian/ABG-4873-2020; Qiu, Ju/AAW-7301-2021	Ye, Jian/0000-0002-7168-0117; Bostick, John/0000-0001-8925-2447; Urban, Joseph/0000-0002-1590-8869	NIH [AI132391, DK105562, 1S10 OD021676-01]; Pew Charitable Trusts; Investigator in the Pathogenesis of Infectious Disease; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132391, R01AI067846, R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; Investigator in the Pathogenesis of Infectious Disease; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the entire Zhou lab for help and suggestions, specifically Drs. Yetao Wang and Lifeng Xiong for studying ILC3 regulation and ILC2P, respectively. We thank Drs. Jakob von Moltke and Richard Locksley for sharing Il5<SUP>RFP-cre</SUP> mice. We thank the Flow Cytometry Facility at the University of Florida and the Genomics Facility at the University of Chicago for service and assistance. This work was supported by NIH grants AI132391 and DK105562 to L.Z. and NIH instrumentation grant 1S10 OD021676-01. L.Z. is a Pew Scholar in the Biomedical Sciences, supported by the Pew Charitable Trusts, and an Investigator in the Pathogenesis of Infectious Disease, supported by the Burroughs Wellcome Fund.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cella M, 2015, SEMIN IMMUNOL, V27, P310, DOI 10.1016/j.smim.2015.10.002; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SY, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01909; Li SY, 2016, IMMUNITY, V45, P185, DOI 10.1016/j.immuni.2016.06.027; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pelly VS, 2016, MUCOSAL IMMUNOL, V9, P1407, DOI 10.1038/mi.2016.4; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Simoni Y, 2018, IMMUNOLOGY, V153, P297, DOI 10.1111/imm.12862; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tordesillas L, 2017, IMMUNITY, V47, P32, DOI 10.1016/j.immuni.2017.07.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Xu J, 2012, CELL, V151, P929, DOI 10.1016/j.cell.2012.11.007; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Ye J, 2017, CELL REP, V21, P2277, DOI 10.1016/j.celrep.2017.10.114; Zhang LH, 2016, J EXP MED, V213, P2249, DOI 10.1084/jem.20151998; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zhou L, 2016, TRENDS IMMUNOL, V37, P17, DOI 10.1016/j.it.2015.11.007; Zhu JF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/913041	66	85	88	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					915	+		10.1016/j.immuni.2018.09.015	http://dx.doi.org/10.1016/j.immuni.2018.09.015			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30446384	Bronze, Green Accepted			2022-12-18	WOS:000450752200016
J	Malik, A; Sharma, D; Malireddi, RKS; Guy, CS; Chang, TC; Olsen, SR; Neale, G; Vogel, P; Kanneganti, TD				Malik, Ankit; Sharma, Deepika; Malireddi, R. K. Subbarao; Guy, Clifford S.; Chang, Ti-Cheng; Olsen, Scott R.; Neale, Geoffrey; Vogel, Peter; Kanneganti, Thirumala-Devi			SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer	IMMUNITY			English	Article							B-CELL DEVELOPMENT; CROHNS-DISEASE; ULCERATIVE-COLITIS; BOWEL-DISEASE; INTESTINAL INFLAMMATION; SUSCEPTIBILITY LOCI; NLRP3 INFLAMMASOME; CARD9; TUMORIGENESIS; INFECTION	Fungi represent a significant proportion of the gut microbiota. Aberrant immune responses to fungi are frequently observed in inflammatory bowel diseases (IBD) and colorectal cancer (CRC), and mutations in the fungal-sensing pathways are associated with the pathogenesis of IBD. Fungal recognition receptors trigger downstream signaling via the common adaptor protein CARD9 and the kinase SYK. Here we found that commensal gut fungi promoted inflammasome activation during AOM-DSS-induced colitis. Myeloid cell-specific deletion of Card9 or Syk reduced inflammasome activation and interleukin (IL)-18 maturation and increased susceptibility to colitis and CRC. IL-18 promoted epithelial barrier restitution and interferon-g production by intestinal CD8(+) T cells. Supplementation of IL-18 or transfer of wildtype myeloid cells reduced tumor burden in AOM-DSS-treated Card9(-/-) and Syk(fl/fl) LysM(Cre/+) mice, whereas treatment with anti-fungal agents exacerbated colitis and CRC. CARD9 deletion changes the gut microbial landscape, suggesting that SYK-CARD9 signaling maintains a microbial ecology that promotes inflammasome activation and thereby restrains colitis and colon tumorigenesis.	[Malik, Ankit; Sharma, Deepika; Malireddi, R. K. Subbarao; Guy, Clifford S.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chang, Ti-Cheng] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Olsen, Scott R.; Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Vogel, Peter/N-2490-2018; Malik, Ankit/I-1817-2019; Kanneganti, Thirumala-Devi/Y-2503-2019; Chang, Ti-Cheng/HHS-7370-2022; Malireddi, RKSubbarao/C-5804-2013	Vogel, Peter/0000-0002-7535-0545; Malik, Ankit/0000-0001-7175-6575; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447	US National Institutes of Health [AI101935, AI124346, AR056296, CA163507]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA163507, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935, R01AI124346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the US National Institutes of Health (AI101935, AI124346, AR056296, and CA163507 to T.-D.K.) and the American Lebanese Syrian Associated Charities (to T.-D.K.). We thank Amanda Burton and Vivekanudeep Karri for their generous help and would like to apologize to our colleagues whose work could not be cited due to space limitations.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bergmann H, 2017, EUR J IMMUNOL, V47, P1342, DOI 10.1002/eji.201646765; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hedl M, 2014, J IMMUNOL, V192, P5924, DOI 10.4049/jimmunol.1302727; Howlader N, 2015, SEER CANC STAT REV 1; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Karki R, 2017, CANCER IMMUNOL RES, V5, P94, DOI 10.1158/2326-6066.CIR-16-0269; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kohno K, 1997, J IMMUNOL, V158, P1541; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Luan CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep07980; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Mager LF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00096; Malik A, 2014, MUCOSAL IMMUNOL, V7, P802, DOI 10.1038/mi.2013.97; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; MCKENZIE H, 1990, GUT, V31, P536, DOI 10.1136/gut.31.5.536; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Nielsen OH, 2014, FRONT MED-LAUSANNE, V1, DOI 10.3389/fmed.2014.00003; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; Qiu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10416; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Sharma D, 2017, IMMUNOL REV, V280, P57, DOI 10.1111/imr.12602; Sharma D, 2017, AM J PATHOL, V187, P236, DOI 10.1016/j.ajpath.2016.10.015; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Sharma D, 2015, INFLAMM BOWEL DIS, V21, P2766, DOI 10.1097/MIB.0000000000000563; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Williams TM, 2015, J IMMUNOL, V194, P3369, DOI 10.4049/jimmunol.1402098; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	62	85	93	6	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					515	+		10.1016/j.immuni.2018.08.024	http://dx.doi.org/10.1016/j.immuni.2018.08.024			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231985	Bronze, Green Accepted			2022-12-18	WOS:000444909600018
J	Onder, L; Morbe, U; Pikor, N; Novkovic, M; Cheng, HW; Hehlgans, T; Pfeffer, K; Becher, B; Waisman, A; Rulicke, T; Gommerman, J; Mueller, CG; Sawa, S; Scandella, E; Ludewig, B				Onder, Lucas; Moerbe, Urs; Pikor, Natalia; Novkovic, Mario; Cheng, Hung-Wei; Hehlgans, Thomas; Pfeffer, Klaus; Becher, Burkhard; Waisman, Ari; Ruelicke, Thomas; Gommerman, Jennifer; Mueller, Christopher G.; Sawa, Shinichiro; Scandella, Elke; Ludewig, Burkhard			Lymphatic Endothelial Cells Control Initiation of Lymph Node Organogenesis	IMMUNITY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PEYERS PATCH ORGANOGENESIS; T-CELLS; STROMAL CELLS; ORGANS; MICE; TISSUES; MACROPHAGES	Lymph nodes (LNs) are strategically situated throughout the body at junctures of the blood vascular and lymphatic systems to direct immune responses against antigens draining from peripheral tissues. The current paradigm describes LN development as a programmed process that is governed through the interaction between mesenchymal lymphoid tissue organizer (LTo) cells and hematopoietic lymphoid tissue inducer (LTi) cells. Using cell-type-specific ablation of key molecules involved in lymphoid organogenesis, we found that initiation of LN development is dependent on LTi-cell-mediated activation of lymphatic endothelial cells (LECs) and that engagement of mesenchymal stromal cells is a succeeding event. LEC activation was mediated mainly by signaling through receptor activator of NF-kappa B (RANK) and the non-canonical NF-kappa B pathway and was steered by sphingosine-1-phosphate-receptor-dependent retention of LTi cells in the LN anlage. Finally, the finding that pharmacologically enforced interaction between LTi cells and LECs promotes ectopic LN formation underscores the central LTo function of LECs.	[Onder, Lucas; Moerbe, Urs; Pikor, Natalia; Novkovic, Mario; Cheng, Hung-Wei; Scandella, Elke; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Hehlgans, Thomas] Univ Regensburg, Dept Immunol, Regensburg, Germany; [Pfeffer, Klaus] Univ Duesseldorf, Inst Med Microbiol, Dusseldorf, Germany; [Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Gommerman, Jennifer] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Mueller, Christopher G.] Univ Strasbourg, CNRS, UPR 3572, Strasbourg, France; [Sawa, Shinichiro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan	Kantonsspital St. Gallen; University of Regensburg; University of Zurich; Johannes Gutenberg University of Mainz; University of Veterinary Medicine Vienna; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hokkaido University	Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland.	burkhard.ludewig@kssg.ch	Becher, Burkhard/ABE-4225-2020; Mörbe, Urs Michael/AAM-2757-2020; Mörbe, Urs/GPX-7383-2022	Becher, Burkhard/0000-0002-1541-7867; Mörbe, Urs Michael/0000-0001-8747-437X; Pikor, Natalia/0000-0002-6564-4232; Gommerman, Jennifer/0000-0003-4576-6168; Novkovic, Mario/0000-0001-7654-5777; Mueller, Christopher/0000-0002-4119-2729	Swiss National Science Foundation [146133, 141918]; Deutsche Forschungsgemeinschaft [HE3116/9-1, CRC 974/FOR 729]; Agence Nationale pour la Recherche [ANR-10-LABX-0034 MEDALIS, ANR-11-EQPX-022]; Human Frontiers Science Program [RGP0034/2016]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	We would like to thank Rita de Giuli and Sonja Caviezel-Firner for technical support. This study received financial support from the Swiss National Science Foundation grants (146133 and 141918 to B.L.), the Deutsche Forschungsgemeinschaft (HE3116/9-1 to T.H. and B.L. and CRC 974/FOR 729 to K.P.), the Agence Nationale pour la Recherche (ANR-10-LABX-0034 MEDALIS and ANR-11-EQPX-022) to C.G.M., and the Human Frontiers Science Program (RGP0034/2016 to B.L.).	Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Brendolan A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00381; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; De Trez C, 2008, CYTOKINE GROWTH F R, V19, P277, DOI 10.1016/j.cytogfr.2008.04.013; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Friedman M, 1999, LARYNGOSCOPE, V109, P368, DOI 10.1097/00005537-199903000-00005; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; Luettig B, 2001, AM J RESP CELL MOL, V25, P69, DOI 10.1165/ajrcmb.25.1.4414; Macpherson AJ, 2003, IMMUNOGENETICS, V54, P693, DOI 10.1007/s00251-002-0517-x; Mair F, 2015, ELIFE, V4, DOI 10.7554/eLife.10087; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mooster JL, 2015, J EXP MED, V212, P185, DOI 10.1084/jem.20140979; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Onder L, 2015, EUR J IMMUNOL, V45, P2218, DOI 10.1002/eji.201545677; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Remouchamps C, 2011, CYTOKINE GROWTH F R, V22, P301, DOI 10.1016/j.cytogfr.2011.11.007; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Troupis T, 2012, BREAST, V21, P615, DOI 10.1016/j.breast.2012.06.006; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Vondenhoff MF, 2009, DEVELOPMENT, V136, P29, DOI 10.1242/dev.028456; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Zhou P, 2003, AM J TRANSPLANT, V3, P259, DOI 10.1034/j.1600-6143.2003.00067.x	58	85	85	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					80	+		10.1016/j.immuni.2017.05.008	http://dx.doi.org/10.1016/j.immuni.2017.05.008			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28709801	Bronze			2022-12-18	WOS:000405712800011
J	Heaton, NS; Moshkina, N; Fenouil, R; Gardner, TJ; Aguirre, S; Shah, PS; Zhao, N; Manganaro, L; Hultquist, JF; Noel, J; Sachs, DH; Hamilton, J; Leon, PE; Chawdury, A; Tripathi, S; Melegari, C; Campisi, L; Hai, R; Metreveli, G; Gamarnik, AV; Garcia-Sastre, A; Greenbaum, B; Simon, V; Fernandez-Sesma, A; Krogan, NJ; Mulder, LCF; van Bakel, H; Tortorella, D; Taunton, J; Palese, P; Marazzi, I				Heaton, Nicholas S.; Moshkina, Natasha; Fenouil, Romain; Gardner, Thomas J.; Aguirre, Sebastian; Shah, Priya S.; Zhao, Nan; Manganaro, Lara; Hultquist, Judd F.; Noel, Justine; Sachs, David H.; Hamilton, Jennifer; Leon, Paul E.; Chawdury, Amit; Tripathi, Shashank; Melegari, Camilla; Campisi, Laura; Hai, Rong; Metreveli, Giorgi; Gamarnik, Andrea V.; Garcia-Sastre, Adolfo; Greenbaum, Benjamin; Simon, Viviana; Fernandez-Sesma, Ana; Krogan, Nevan J.; Mulder, Lubbertus C. F.; van Bakel, Harm; Tortorella, Domenico; Taunton, Jack; Palese, Peter; Marazzi, Ivan			Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection	IMMUNITY			English	Article							HUMAN PROTEIN COMPLEXES; RNA-POLYMERASE-II; N-LINKED GLYCANS; A VIRUS; ENVELOPE GLYCOPROTEIN; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SEC61 TRANSLOCON; NS1 PROTEIN; LIFE-CYCLE	Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies.	[Heaton, Nicholas S.; Moshkina, Natasha; Gardner, Thomas J.; Aguirre, Sebastian; Zhao, Nan; Manganaro, Lara; Noel, Justine; Hamilton, Jennifer; Leon, Paul E.; Tripathi, Shashank; Melegari, Camilla; Campisi, Laura; Hai, Rong; Metreveli, Giorgi; Garcia-Sastre, Adolfo; Simon, Viviana; Fernandez-Sesma, Ana; Mulder, Lubbertus C. F.; Tortorella, Domenico; Palese, Peter; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Moshkina, Natasha; Zhao, Nan; Noel, Justine; Melegari, Camilla; Campisi, Laura; Metreveli, Giorgi; Garcia-Sastre, Adolfo; Simon, Viviana; Fernandez-Sesma, Ana; Mulder, Lubbertus C. F.; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Fenouil, Romain; Sachs, David H.; van Bakel, Harm] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Shah, Priya S.; Hultquist, Judd F.; Krogan, Nevan J.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chawdury, Amit; Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Chawdury, Amit; Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Oncol, New York, NY 10029 USA; [Chawdury, Amit; Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Gamarnik, Andrea V.] Fdn Inst Leloir CONICET, RA-1405 Buenos Aires, DF, Argentina	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	ivan.marazzi@mssm.edu	van Bakel, Harm/N-9561-2017; simon, viviana/A-9131-2008; Manganaro, Lara/AAL-8632-2020; ZHAO, NAN/H-7633-2017; Campisi, Laura/AAL-2064-2021	van Bakel, Harm/0000-0002-1376-6916; simon, viviana/0000-0002-6416-5096; Manganaro, Lara/0000-0003-2743-2658; Campisi, Laura/0000-0003-4173-4521; Fernandez-Sesma, Ana/0000-0002-3405-6702; Aguirre, Sebastian/0000-0001-6079-5544; Hamilton, Jennifer R./0000-0002-7136-1757; Tortorella, Domenico/0000-0003-0961-3535; marazzi, ivan/0000-0003-3376-0922; Palese, Peter/0000-0002-0337-5823; Noel, Justine/0000-0002-0692-1412; Shah, Priya/0000-0001-7518-2839; Gardner, Thomas/0000-0003-0838-8751; Sachs, David/0000-0002-4445-2055; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Hultquist, Judd/0000-0001-6424-4280; Tripathi, Shashank/0000-0002-5702-9248	NIH-NIAID [R01 AI089246, P01 AI090935]; NIH [AI101820, U19AI106754, 1R01AN3663134, 1R56AI114770-01A1]; Center for Research on Influenza Pathogenesis (CRIP) [HHSN272201400008C]; NIAID; NIH-NIGMS [R01 GM113886]; Public Health Service Institutional Research Training Award [AI07647]; Department of Defense [W911NF-14-1-0353]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101820, F31AI120648, P30AI027763, T32AI060537, R01AI073450, U19AI106754, R56AI114770, R01AI113186, P01AI090935, R01AI089246, R01AI095175, U19AI118610, T32AI007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113886, R01GM085697] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Influenza Pathogenesis (CRIP); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Public Health Service Institutional Research Training Award; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Ryan Langlois, Megan Shaw, and Andres Finzi for their expertise and helpful discussions; Daria Brinzevich and Raymond Alvarez for their technical assistance; and Hector Delgado for his artwork in the graphical abstract. We would also like to thank the flow-cytometry shared resource facilitiy and the high-performance scientific computing facility at the Icahn School of Medicine at Mount Sinai and the proteomics facility at Rockefeller University. N.S.H. is a Merck fellow of the Life Sciences Research Foundation. V.S. is partially supported by the NIH-NIAID grants R01 AI089246 and P01 AI090935. D.T. is partially supported by NIH grant AI101820. P.P., A.G., G.M., H.v.B., and I.M. are partially supported by HHSN272201400008C from the Center for Research on Influenza Pathogenesis (CRIP), a NIAID-funded Center of Excellence for Influenza Research and Surveillance (CEIRS). L.C.F.M is supported by NIH-NIGMS grant R01 GM113886. N.M. is supported in part by a Public Health Service Institutional Research Training Award (AI07647). I.M. is supported in part by The Department of Defense W911NF-14-1-0353 (to I.M.) and by NIH grants U19AI106754 (to I.M. and A.G-S.), 1R01AN3663134 (to I.M and H.v.B.), and 1R56AI114770-01A1 (to I.M.)	Alsuwaidi AR, 2013, VIROLOGY, V446, P180, DOI 10.1016/j.virol.2013.07.034; Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CERIOTTI A, 1990, J CELL BIOL, V111, P409, DOI 10.1083/jcb.111.2.409; Chakrabarti LA, 2002, J VIROL, V76, P1588, DOI 10.1128/JVI.76.4.1588-1599.2002; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Fayadat L, 2003, MOL BIOL CELL, V14, P1268, DOI 10.1091/mbc.E02-06-0363; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; GARCIASASTRE A, 1993, ANNU REV MICROBIOL, V47, P765, DOI 10.1146/annurev.mi.47.100193.004001; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gorai T, 2012, P NATL ACAD SCI USA, V109, P4615, DOI 10.1073/pnas.1114728109; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Guan ZH, 2012, ACTA VIROL, V56, P199, DOI 10.4149/av_2012_03_199; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Halestrap AP, 2012, CELL METAB, V16, P141, DOI 10.1016/j.cmet.2012.07.013; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; HOGUE BG, 1992, VIROLOGY, V188, P510, DOI 10.1016/0042-6822(92)90505-J; Iwasa A, 2011, J INFECT DIS, V204, pS919, DOI 10.1093/infdis/jir324; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Kalies KU, 2015, TRAFFIC, V16, P1027, DOI 10.1111/tra.12308; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lue J, 2002, J VIROL, V76, P10299, DOI 10.1128/JVI.76.20.10299-10306.2002; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Miller MS, 2015, NAT IMMUNOL, V16, P485, DOI 10.1038/ni.3132; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Munier S, 2013, MOL CELL PROTEOMICS, V12, P2845, DOI 10.1074/mcp.M113.028688; Ngamurulert S, 2009, ACTA VIROL, V53, P153, DOI 10.4149/av_2009_03_153; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; Panda D, 2013, CELL REP, V5, P1737, DOI 10.1016/j.celrep.2013.11.028; Paterson D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003019; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; SAITO T, 1995, J VIROL, V69, P5011, DOI 10.1128/JVI.69.8.5011-5017.1995; Schneider-Schaulies J, 2015, BIOL CHEM, V396, P585, DOI 10.1515/hsz-2014-0273; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shaw ML., 2013, FIELDS VIROLOGY, V6th, P1151; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Zhao C, 2010, INFLUENZA: MOLECULAR VIROLOGY, P1	73	85	86	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					46	58		10.1016/j.immuni.2015.12.017	http://dx.doi.org/10.1016/j.immuni.2015.12.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789921	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000368347000012
J	Schenten, D; Nish, SA; Yu, S; Yan, XT; Lee, HK; Brodsky, I; Pasman, L; Yordy, B; Wunderlich, FT; Bruning, JC; Zhao, HY; Medzhitov, R				Schenten, Dominik; Nish, Simone A.; Yu, Shuang; Yan, Xiting; Lee, Heung Kyu; Brodsky, Igor; Pasman, Lesley; Yordy, Brian; Wunderlich, F. Thomas; Bruening, Jens C.; Zhao, Hongyu; Medzhitov, Ruslan			Signaling through the Adaptor Molecule MyD88 in CD4(+) T Cells Is Required to Overcome Suppression by Regulatory T Cells	IMMUNITY			English	Article							INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; MEDIATED SUPPRESSION; RESPONSE LATE; CUTTING EDGE; BURN INJURY; IL-1; EXPRESSION; EXPANSION; DIFFERENTIATION	Innate immune recognition controls adaptive immune responses through multiple mechanisms. The MyD88 signaling adaptor operates in many cell types downstream of Toll-like receptors (TLRs) and interleukin-1 (IL-1) receptor family members. Cell-type-specific functions of MyD88 signaling remain poorly characterized. Here, we have shown that the T cell-specific ablation of MyD88 in mice impairs not only T helper 17 (Th17) cell responses, but also Th1 cell responses. MyD88 relayed signals of TLR-induced IL-1, which became dispensable for Th1 cell responses in the absence of T regulatory (Treg) cells. Treg cell-specific ablation of MyD88 had no effect, suggesting that IL-1 acts on naive CD4(+) T cells instead of Treg cells themselves. Together, these findings demonstrate that IL-1 renders naive CD4(+) T cells refractory to Treg cell-mediated suppression in order to allow their differentiation into Th1 cells. In addition, IL-1 was also important for the generation of functional CD4(+) memory T cells.	[Schenten, Dominik; Nish, Simone A.; Yu, Shuang; Lee, Heung Kyu; Brodsky, Igor; Pasman, Lesley; Yordy, Brian; Medzhitov, Ruslan] Yale Univ, Dept Immunobiol, New Haven, CT 06519 USA; [Schenten, Dominik; Nish, Simone A.; Yu, Shuang; Lee, Heung Kyu; Brodsky, Igor; Pasman, Lesley; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Yan, Xiting; Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Wunderlich, F. Thomas; Bruening, Jens C.] Univ Cologne, Max Planck Inst Neurol Res, Excellence Cluster Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Wunderlich, F. Thomas; Bruening, Jens C.] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, CMMC, Inst Genet, D-50931 Cologne, Germany	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Max Planck Society; University of Cologne; University of Cologne	Schenten, D (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA.	dominik.schenten@yale.edu; ruslan.medzhitov@yale.edu	Lee, Heung Kyu/C-2073-2011	Lee, Heung Kyu/0000-0002-3977-1510	Howard Hughes Medical Institute; National Institutes of Health (NIH) [AI055502]; NIH; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Marc Jenkins for reagents, Alexander Rudensky and Richard Flavell for mouse strains, Jorge Henao-Mejia for technical advice, Sophie Cronin and Charles Annicelli for expert mouse work, Gouzel Tokmoulina for cell sorting, Scott Pope for bioinformatic expertise and discussion, and Noah Palm and Jelena Bezbradica for discussion and critical reading of the manuscript. This work was funded by the Howard Hughes Medical Institute and The National Institutes of Health (NIH) through grant AI055502. D.S. was supported by a training grant of the NIH and then by an Irvington Fellowship of the Cancer Research Institute. S.A.N. was a recipient of a NIH training grant.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Cairns B, 2006, J TRAUMA, V61, P293, DOI 10.1097/01.ta.0000228969.46633.bb; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hoshino K, 1999, J IMMUNOL, V162, P5041; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; LUQMAN M, 1992, EUR J IMMUNOL, V22, P95, DOI 10.1002/eji.1830220115; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Mozingo DW, 2006, J TRAUMA, V61, P298; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; TAYLORROBINSON AW, 1994, IMMUNOLOGY, V81, P216; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Tomita T, 2008, J IMMUNOL, V180, P5291, DOI 10.4049/jimmunol.180.8.5291; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	51	85	95	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					78	90		10.1016/j.immuni.2013.10.023	http://dx.doi.org/10.1016/j.immuni.2013.10.023			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439266	Bronze, Green Accepted			2022-12-18	WOS:000331476900011
J	Baker, K; Rath, T; Flak, MB; Arthur, JC; Chen, ZG; Glickman, JN; Zlobec, I; Karamitopoulou, E; Stachler, MD; Odze, RD; Lencer, WI; Jobin, C; Blumberg, RS				Baker, Kristi; Rath, Timo; Flak, Magdalena B.; Arthur, Janelle C.; Chen, Zhangguo; Glickman, Jonathan N.; Zlobec, Inti; Karamitopoulou, Eva; Stachler, Matthew D.; Odze, Robert D.; Lencer, Wayne I.; Jobin, Christian; Blumberg, Richard S.			Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERFERON-GAMMA; CROSS-TALK; T-CELLS; IGG; ANTIGEN; INTERLEUKIN-12; TRANSPORT; COLITIS; IDENTIFICATION	Cancers arising in mucosal tissues account for a disproportionately large fraction of malignancies. Immunoglobulin G (IgG) and the neonatal Fc receptor for IgG (FcRn) have an important function in the mucosal immune system that we have now shown extends to the induction of CD8(+) T cell-mediated antitumor immunity. We demonstrate that FcRn within dendritic cells (DCs) was critical for homeostatic activation of mucosal CD8(+) T cells that drove protection against the development of colorectal cancers and lung metastases. FcRn-mediated tumor protection was driven by DCs activation of endogenous tumor-reactive CD8(+) T cells via the cross-presentation of IgG complexed antigens (IgG IC), as well as the induction of cytotoxicity-promoting cytokine secretion, particularly interleukin-12, both of which were independently triggered by the FcRn-IgG IC interaction in murine and human DCs. FcRn thus has a primary role within mucosal tissues in activating local immune responses that are critical for priming efficient anti-tumor immunosurveillance.	[Baker, Kristi; Rath, Timo; Flak, Magdalena B.; Chen, Zhangguo; Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Gastroenterol Div,Dept Med, Boston, MA 02115 USA; [Arthur, Janelle C.] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA; [Glickman, Jonathan N.] Caris Life Sci, GI Pathol, Caris Diagnost, Newton, MA 02464 USA; [Zlobec, Inti; Karamitopoulou, Eva] Univ Bern, Inst Pathol, Translat Res Unit, CH-3010 Bern, Switzerland; [Stachler, Matthew D.; Odze, Robert D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lencer, Wayne I.; Blumberg, Richard S.] Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jobin, Christian] Univ Florida, Coll Med, Dept Med, Dept Infect Dis & Pathol,Div Gastroenterol Hepato, Gainesville, FL 32611 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Bern; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; State University System of Florida; University of Florida	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Gastroenterol Div,Dept Med, Boston, MA 02115 USA.	rblumberg@partners.org	Flak, Magdalena B/M-7106-2016; Chen, Zhangguo/AAW-2032-2021; Flak, Magdalena/AAG-5272-2020	Flak, Magdalena B/0000-0002-8238-9835; Flak, Magdalena/0000-0002-8238-9835; Chen, Zhangguo/0000-0002-2741-0080; Lencer, Wayne/0000-0001-7346-2730; Arthur, Janelle/0000-0002-4796-0207; Zlobec, Inti/0000-0001-6741-3000; Baker, Kristi/0000-0002-2993-3889; Karamitopoulou-Diamantis, Eva/0000-0002-4833-1373; Rath, Timo/0000-0002-7728-9338	Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft [RA 2040/1-1]; Crohn's & Colitis Foundation of America; High Pointe Foundation; National Institutes of Health [T32 DK007737, DK73338, DK47700, DK53056, DK053162, DK088199, DK044319]; Harvard Digestive Diseases Center NIH [P30DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R13DK053162, R37DK044319, P30DK034854, R01DK047700, R01DK053056, R01DK051362, R01DK088199, R01DK073338, R56DK047700, T32DK007737, R01DK044319] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Crohn's & Colitis Foundation of America; High Pointe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Jennifer Cusick and Michal Pyzik for expert editorial assistance as well as Son Huynh, Victoria Thiele, Samantha Torquato, Mario Sablon, and Victoria G. Aveson for excellent technical assistance. Fcgrt<SUP>Fl/Fl</SUP> mice were a kind gift of E. Sally Ward (University of Texas Southwestern Medical Center). OVA-expressing B16 melanoma cells (OVA-B16) were a generous gift of Kenneth Rock (University of Massachusetts Medical School). IL-12 neutralizing antibody was a kind gift of Giorgio Trinchieri (National Cancer Institute). This work was supported by the Canadian Institutes of Health Research (K. B.), the Deutsche Forschungsgemeinschaft (RA 2040/1-1) (T. R.), the Crohn's & Colitis Foundation of America (M. B. F.), the High Pointe Foundation (R. S. B.), the National Institutes of Health T32 DK007737 (J.C.A.), DK73338 and DK47700 (C.J.), DK53056, DK053162, DK088199, and DK044319 (R. S. B.), and the Harvard Digestive Diseases Center NIH P30DK034854 (W. I. L. and R.S.B.).	Antonios D, 2010, J IMMUNOL, V185, P89, DOI 10.4049/jimmunol.0901992; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; AUER IO, 1988, GUT, V29, P1639, DOI 10.1136/gut.29.12.1639; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Brichory F, 2001, CANCER RES, V61, P7908; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Coghill AE, 2011, CLIN CANCER RES, V17, P7139, DOI 10.1158/1078-0432.CCR-11-1134; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Karamitopoulou E, 2011, HUM PATHOL, V42, P1888, DOI 10.1016/j.humpath.2010.06.020; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Kijanka G, 2010, GUT, V59, P69, DOI 10.1136/gut.2009.178574; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Ma YT, 2011, CURR OPIN IMMUNOL, V23, P146, DOI 10.1016/j.coi.2010.09.008; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; MACSWEEN JM, 1980, BRIT J CANCER, V42, P503, DOI 10.1038/bjc.1980.272; Metzger DW, 2010, CYTOKINE, V52, P102, DOI 10.1016/j.cyto.2010.06.011; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Revaz V, 2005, CURR OPIN IMMUNOL, V17, P175, DOI 10.1016/j.coi.2005.01.001; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	54	85	90	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1095	1107		10.1016/j.immuni.2013.11.003	http://dx.doi.org/10.1016/j.immuni.2013.11.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24290911	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000330951000015
J	Schulthess, J; Meresse, B; Ramiro-Puig, E; Montcuquet, N; Darche, S; Begue, B; Ruemmele, F; Combadiere, C; Di Santo, JP; Buzoni-Gatel, D; Cerf-Bensussan, N				Schulthess, Julie; Meresse, Bertrand; Ramiro-Puig, Emma; Montcuquet, Nicolas; Darche, Sylvie; Begue, Bernadette; Ruemmele, Frank; Combadiere, Christophe; Di Santo, James P.; Buzoni-Gatel, Dominique; Cerf-Bensussan, Nadine			Interleukin-15-Dependent NKp46(+) Innate Lymphoid Cells Control Intestinal Inflammation by Recruiting Inflammatory Monocytes	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; TOXOPLASMA-GONDII; CELIAC-DISEASE; T-CELLS; CROHNS-DISEASE; INTRAEPITHELIAL LYMPHOCYTES; NK CELLS; MICE; IL-15; EXPRESSION	With the goal in mind to define how interleukin-15 (IL-15) contributes to acute intestinal inflammation, we have used a mouse model of ileitis induced by oral infection with Toxoplasma gondii. We observed that a crosstalk between IL-15 and interleukin-18 (IL-18) promoted intestinal recruitment of inflammatory monocytes, where these cells participated in parasite control but also in tissue damage. A stromal source of IL-15 controlled the development of lamina propria NKp46(+)NK1.1(+) cells, whereas IL-18 produced during T. gondii infection stimulated their production of the chemokine CCL3. In turn, CCL3 attracted inflammatory monocytes via their chemokine receptor CCR1, which was indispensable for their recruitment into the inflamed gut. Collectively, these results identify the IL-15-dependent subset of intestinal NKp46(+) cells as an important source of CCL3, which can amplify intestinal inflammation via the recruitment of CCR1(+) inflammatory monocytes. Preliminary evidence suggests that this pathway might operate in Crohn's disease.	[Schulthess, Julie; Meresse, Bertrand; Ramiro-Puig, Emma; Montcuquet, Nicolas; Begue, Bernadette; Ruemmele, Frank; Cerf-Bensussan, Nadine] INSERM, U989, F-75015 Paris, France; [Schulthess, Julie; Meresse, Bertrand; Ramiro-Puig, Emma; Montcuquet, Nicolas; Begue, Bernadette; Ruemmele, Frank; Cerf-Bensussan, Nadine] Univ Paris 05, F-75015 Paris Sorbonne Cite, Institut Imagin, France; [Darche, Sylvie; Di Santo, James P.] Inst Pasteur, Unite Immunite Innee, F-75015 Paris, France; [Darche, Sylvie; Di Santo, James P.] INSERM, U668, F-75015 Paris, France; [Ruemmele, Frank] Hop Necker Enfants Malad, AP HP, Dept Pediat Gastroenterol, F-75015 Paris, France; [Combadiere, Christophe] INSERM UMR S 945, F-75013 Paris, France; [Combadiere, Christophe] Univ Paris 06, F-75005 Paris, France; [Buzoni-Gatel, Dominique] INRA, U1282, IASP, F-37380 Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; INRAE	Cerf-Bensussan, N (corresponding author), INSERM, U989, F-75015 Paris, France.	nadine.cerf-bensussan@inserm.fr	Combadiere, Christophe/I-5639-2013; Cerf-Bensussan, nadine/H-9505-2017; Begue, Bernadette/I-2744-2017; Di Santo, James P/M-4298-2014; Meresse, Bertrand/N-6325-2017	Combadiere, Christophe/0000-0002-1755-4531; Cerf-Bensussan, nadine/0000-0003-0665-1245; Begue, Bernadette/0000-0002-1228-9978; Di Santo, James P/0000-0002-7146-1862; Meresse, Bertrand/0000-0002-8978-8636	INSERM; Fondation Pour la Recherche Medicale; Agence Nationale pour la Recherche (ANR); Association Francois Aupetit; Fondation Princesse Grace; MNERT PhD fellowship; Fundacion Espanola para la Ciencia y Tecnologia (FECYT); Fundacion Pedro I Pons; FRM; ANR	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association Francois Aupetit; Fondation Princesse Grace; MNERT PhD fellowship; Fundacion Espanola para la Ciencia y Tecnologia (FECYT)(Portuguese Foundation for Science and Technology); Fundacion Pedro I Pons; FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	The authors acknowledge funding from INSERM, Fondation Pour la Recherche Medicale, Agence Nationale pour la Recherche (ANR), Association Francois Aupetit, and Fondation Princesse Grace. J.S. was supported by a MNERT PhD fellowship. E.R.-P. and N.M. were supported by postdoctoral fellowships from Fundacion Espanola para la Ciencia y Tecnologia (FECYT), Fundacion Pedro I Pons, and from FRM and ANR, respectively. The authors are grateful to O. Cabaret and S. Bretagne (Hopital Henri Mondor, Creteil) for help in quantifying parasitic loads and to C. Ducourneau (Faculte de Pharmacie, Tours) for help in preparing STAg.	Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bouchaud G, 2010, GASTROENTEROLOGY, V138, P2378, DOI 10.1053/j.gastro.2010.02.044; CHARDES T, 1994, J IMMUNOL, V153, P4596; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Combe CL, 2006, P NATL ACAD SCI USA, V103, P6635, DOI 10.1073/pnas.0506180103; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Denkers EY, 1997, J IMMUNOL, V159, P1903; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hmida NB, 2012, AM J GASTROENTEROL, V107, P604, DOI 10.1038/ajg.2011.397; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khan IA, 2001, J IMMUNOL, V166, P1930, DOI 10.4049/jimmunol.166.3.1930; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Lieberman LA, 2004, INFECT IMMUN, V72, P6729, DOI 10.1128/IAI.72.11.6729-6732.2004; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Mennechet FJD, 2004, EUR J IMMUNOL, V34, P1059, DOI 10.1002/eji.200324416; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Monteleone G, 1999, J IMMUNOL, V163, P143; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ohta N, 2002, J IMMUNOL, V169, P460, DOI 10.4049/jimmunol.169.1.460; Ortaldo JR, 2001, J IMMUNOL, V166, P4994, DOI 10.4049/jimmunol.166.8.4994; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; SHER A, 1993, J IMMUNOL, V150, P3982; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104	47	85	86	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					108	121		10.1016/j.immuni.2012.05.013	http://dx.doi.org/10.1016/j.immuni.2012.05.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22705105	Bronze			2022-12-18	WOS:000307133200014
J	Hershko, AY; Suzuki, R; Charles, N; Alvarez-Errico, D; Sargent, JL; Laurence, A; Rivera, J				Hershko, Alon Y.; Suzuki, Ryo; Charles, Nicolas; Alvarez-Errico, Damiana; Sargent, Jennifer L.; Laurence, Arian; Rivera, Juan			Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis	IMMUNITY			English	Article							REGULATORY T-CELLS; ATOPIC-DERMATITIS; CONTACT HYPERSENSITIVITY; MURINE MODEL; IN-VIVO; IMMUNE-RESPONSES; ULTRAVIOLET-B; MICE; DISEASE; MOUSE	The incidence of chronic allergic dermatitis is rapidly increasing. Regulatory control of this disease has not been adequately explored. Here we report that mast cell-derived interleukin-2 (IL-2) contributes to the suppression of chronic allergic dermatitis. Mice deficient in IL-2 production, or deficient in mast cells (Kit(W-sh/W-sh)), showed exacerbated dermatitis upon repeated oxazolone challenge when compared to their wild-type counterparts. Adoptive transfer of wild-type, but not ll2(-/-), mast cells into Kit(W-sh/W-sh) mice dampened the inflammatory response. During the course of disease, mast cell expansion occurred at the site of inflammation and also in the spleen, where production of IL-2 by mast cells was markedly enhanced. In the absence of mast cell IL-2 production, the ratio of activated to regulatory T cells at the site of inflammation was increased. Thus, MC-derived IL-2 contributes to the maintenance of suppression in chronic allergic skin inflammation.	[Hershko, Alon Y.; Suzuki, Ryo; Charles, Nicolas; Alvarez-Errico, Damiana; Sargent, Jennifer L.; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Laurence, Arian] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Rivera, J (corresponding author), NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA.	juan_rivera@nih.gov	Alvarez, Damiana/AAU-4160-2020; Alvarez Errico, Damiana/R-5964-2018; Laurence, Arian/A-8770-2009; CHARLES, Nicolas/S-2214-2019; CHARLES, Nicolas/P-5430-2014	Laurence, Arian/0000-0003-0942-8292; CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; Alvarez_Errico, Damiana/0000-0002-7921-5164	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health; American Physician Fellowship; Legacy Heritage Fund - Israel Science Foundation; Laboratory Animal Care and Use Section, the Flow Cytometry Unit, and the Light Imaging Section of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041156] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Physician Fellowship; Legacy Heritage Fund - Israel Science Foundation; Laboratory Animal Care and Use Section, the Flow Cytometry Unit, and the Light Imaging Section of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health. A.Y.H. was also supported by the American Physician Fellowship and by the Legacy Heritage Fund - Israel Science Foundation. We also thank the Laboratory Animal Care and Use Section, the Flow Cytometry Unit, and the Light Imaging Section of NIAMS for support of this work.	Bachelet I, 2007, TRENDS IMMUNOL, V28, P360, DOI 10.1016/j.it.2007.06.007; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bryce P. J, 2005, NOVART FDN S, V271, P15, DOI [10.1002/9780470033449.ch3, DOI 10.1002/9780470033449.CH3]; Bryce Paul J, 2005, Novartis Found Symp, V271, P15; Bryce PJ, 2005, NOVART FDN SYMP, V271, P24; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; EVANS DP, 1971, BRIT J PHARMACOL, V43, P403; Ezeamuzie CI, 2009, INT IMMUNOPHARMACOL, V9, P1110, DOI 10.1016/j.intimp.2009.05.009; Friend DS, 2000, J IMMUNOL, V165, P344, DOI 10.4049/jimmunol.165.1.344; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; Hershko AY, 2010, IMMUNOL LETT, V128, P98, DOI 10.1016/j.imlet.2009.10.013; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kurashima Y, 2007, J IMMUNOL, V179, P1577, DOI 10.4049/jimmunol.179.3.1577; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; Leung Alexander K C, 2007, Adv Pediatr, V54, P241, DOI 10.1016/j.yapd.2007.03.013; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011; Matsui K, 2006, INT ARCH ALLERGY IMM, V139, P271, DOI 10.1159/000091598; Matsumoto K, 2004, SKIN RES TECHNOL, V10, P122, DOI 10.1111/j.1600-0846.2004.00062.x; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; PHANUPHAK P, 1974, J IMMUNOL, V112, P115; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; PRITCHARD H, 1972, CLIN EXP IMMUNOL, V10, P151; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Sugiura S, 2010, BRIT J DERMATOL, V162, P1286, DOI 10.1111/j.1365-2133.2010.09756.x; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zheng LJ, 2007, J IMMUNOL, V179, P8035, DOI 10.4049/jimmunol.179.12.8035	51	85	89	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					562	571		10.1016/j.immuni.2011.07.013	http://dx.doi.org/10.1016/j.immuni.2011.07.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	21982597	Green Accepted, Bronze			2022-12-18	WOS:000296657700015
J	Sullivan, BM; Locksley, RM				Sullivan, Brandon M.; Locksley, Richard M.			Basophils: A Nonredundant Contributor to Host Immunity	IMMUNITY			English	Review							SCHISTOSOMA-MANSONI EGGS; SPLENIC NON-B; NON-T CELLS; CHRONIC ALLERGIC INFLAMMATION; ANTIGEN-CAPTURING CELLS; MAST-CELLS; IN-VIVO; IL-4 PRODUCTION; BONE-MARROW; TYPE-2 IMMUNITY	The role of basophils, the rarest of blood granulocytes, in host immunity has been a mystery. Long considered the poor relative of mast cells, basophils have received much recent attention because of the availability of new reagents and models that reveal unique properties of these cells. Basophils are known to have distinct roles in allergic hypersensitivity reactions and in the immune response to intestinal helminthes. In this review, we highlight these advances and summarize our current understanding of the repertoire of functions attributed to these cells. Despite these recent insights, we are likely only beginning to gain a full understanding of how and where these cells lend effector functions to vertebrate immunity. Advances are likely to come only with the development of specific reagents that enable the finer study of basophil lineage and function. Although many fundamental aspects of basophil biology remain unanswered, the prospects remain bright for unmasking new contributions by these unusual cells.	[Sullivan, Brandon M.; Locksley, Richard M.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Sullivan, Brandon M.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Sch Med, 513 Parnassus Ave,S-1032B, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI026918] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; DVORAK AM, 1982, BLOOD, V59, P1279; DVORAK AM, 1994, AM J PATHOL, V144, P160; Falcone FH, 1996, EUR J IMMUNOL, V26, P1147, DOI 10.1002/eji.1830260528; Falcone FH, 2001, TRENDS PARASITOL, V17, P126, DOI 10.1016/S1471-4922(00)01846-8; Falcone FH, 2000, BLOOD, V96, P4028; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; GALLI SJ, 1982, NATURE, V298, P288, DOI 10.1038/298288a0; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gibbs BF, 2005, CLIN EXP MED, V5, P43, DOI 10.1007/s10238-005-0064-5; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Haisch K, 2001, PARASITE IMMUNOL, V23, P427, DOI 10.1046/j.1365-3024.2001.00392.x; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jankovic D, 1997, J IMMUNOL, V159, P1868; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kepley CL, 2001, AM J RESP CRIT CARE, V164, P1053, DOI 10.1164/ajrccm.164.6.2102025; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; KOSHINO T, 1993, CLIN EXP ALLERGY, V23, P919, DOI 10.1111/j.1365-2222.1993.tb00276.x; Lantz CS, 2008, LAB INVEST, V88, P1134, DOI 10.1038/labinvest.2008.88; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LEGROS G, 1990, J IMMUNOL, V145, P2500; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NAGAO K, 1981, SCIENCE, V212, P333, DOI 10.1126/science.7209531; Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; OHNMACHT C, 2008, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2008-05-154773; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1991, J IMMUNOL, V147, P903; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Tschopp CM, 2006, BLOOD, V108, P2290, DOI 10.1182/blood-2006-03-010348; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; VELLA AT, 1992, J IMMUNOL, V148, P2283; Voehringer D, 2004, J BIOL CHEM, V279, P54117, DOI 10.1074/jbc.M406997200; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; WILLIAMS ME, 1993, EUR J IMMUNOL, V23, P1910, DOI 10.1002/eji.1830230827; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Zhang SL, 2006, J LEUKOCYTE BIOL, V79, P363, DOI 10.1189/jlb.0705398; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zheng XY, 2002, IMMUNOLOGY, V107, P306, DOI 10.1046/j.1365-2567.2002.01517.x	86	85	88	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					12	20		10.1016/j.immuni.2008.12.006	http://dx.doi.org/10.1016/j.immuni.2008.12.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144314	Bronze			2022-12-18	WOS:000262769900006
J	Peterson, ME; Long, EO				Peterson, Mary E.; Long, Eric O.			Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CLASS-I MOLECULES; MHC CLASS-I; C-CBL; UBIQUITIN LIGASES; SELF-TOLERANCE; IMMUNE SYNAPSE; NK CELLS; ACTIVATION; COMPLEX	Many cellular responses, such as autoimmunity and cytotoxicity, are controlled by receptors with cytoplasmic immunoreceptor tyrosine-based inhibition motifs (ITIMs). Here, we showed that binding of inhibitory natural killer (NK) cell receptors to human leukocyte antigen (HLA) class I on target cells induced tyrosine phosphorylation of the adaptor Crk, concomitant with dephosphorylation of the guanine exchange factor Vav1. Furthermore, Crk dissociated from the guanine exchange factor C3G and bound to the tyrosine kinase c-Abl during inhibition. Membrane targeting of a tyrosine-mutated form of Crk could overcome inhibition of NK cell cytotoxicity, providing functional evidence that Crk phosphorylation contributes to inhibition. The specific phosphorylation of Crk and its dissociation from a signaling complex, observed here with two types of inhibitory receptors, expands the signaling potential of the large ITIM-receptor family and reveals an unsuspected component of the inhibitory mechanism.	[Peterson, Mary E.; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	elong@nih.gov	Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728	National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001117, Z01AI000525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. March and A. Shaw for useful discussions; G. Cohen, D. Geraghty, J. Gumperz, P. Parham, and M. Robertson for cell lines; and R. Klemke for a CrkII cDNA. This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Abassi YA, 2002, EMBO J, V21, P4571, DOI 10.1093/emboj/cdf446; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Buensuceso CS, 2000, J BIOL CHEM, V275, P13118, DOI 10.1074/jbc.275.17.13118; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Endt J, 2007, J IMMUNOL, V178, P5606, DOI 10.4049/jimmunol.178.9.5606; Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Guerra N, 2002, BLOOD, V100, P2874, DOI 10.1182/blood-2002-02-0643; Holcomb M, 2006, J BIOL CHEM, V281, P2430, DOI 10.1074/jbc.M508454200; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lee N, 1998, J IMMUNOL, V160, P4951; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Long EO, 2001, IMMUNOL REV, V181, P223, DOI 10.1034/j.1600-065X.2001.1810119.x; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Masilamani M, 2006, J IMMUNOL, V177, P3590, DOI 10.4049/jimmunol.177.6.3590; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Olcese L, 1996, J IMMUNOL, V156, P4531; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Scaife RM, 2000, J CELL SCI, V113, P215; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021	48	85	87	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					578	588		10.1016/j.immuni.2008.07.014	http://dx.doi.org/10.1016/j.immuni.2008.07.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18835194	Green Accepted, Bronze			2022-12-18	WOS:000260316700011
J	Sharma, P; Chakraborty, R; Wang, L; Min, B; Tremblay, ML; Kawahara, T; Lambeth, JD; Haque, SJ				Sharma, Pankaj; Chakraborty, Rikhia; Wang, Lu; Min, Booki; Tremblay, Michel L.; Kawahara, Tsukasa; Lambeth, J. David; Haque, S. Jaharul			Redox Regulation of Interleukin-4 Signaling	IMMUNITY			English	Article							TYROSINE-PHOSPHATASE 1B; PROTEIN-KINASE-C; REACTIVE OXYGEN GENERATION; B-CELL LINE; NADPH OXIDASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE-C; IN-VIVO; RECEPTOR; ACTIVATION	The physiologic control of cytokine receptor activation is primarily mediated by reciprocal activation of receptor-associated protein tyrosine kinases and protein tyrosine phosphatases (PTPs). Here, we show that immediately after ligand-dependent activation, interleukin (IL)-4 receptor generated reactive oxygen species (ROS) via phosphatidylinositol 3-kinase-dependent activation of NAD(P)H oxidase (NOX)1 and NOX5L. ROS, in turn, promoted IL-4 receptor activation by oxidatively inactivating PTP1 B that physically associated with and deactivated IL-4 receptor. However, ROS were not required for the initiation of IL-4 receptor activation. ROS generated by other cytokine receptors, including those for erythropoietin, tumor necrosis factor-alpha, or IL-3, also promoted IL-4 signaling. These data indicate that inactivation of receptor-associated PTP activity by cytokine-generated ROS is a physiologic mechanism for the amplification of cytokine receptor activation in both cis and trans, revealing a role for ROS in cytokine crosstalk.	[Sharma, Pankaj; Chakraborty, Rikhia; Haque, S. Jaharul] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Chakraborty, Rikhia] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Wang, Lu; Min, Booki] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Kawahara, Tsukasa; Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Tremblay, Michel L.] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Emory University; McGill University	Haque, SJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.	haquej@ccf.org	sharma, pankaj/HGE-4423-2022; Sharma, Pankaj/AAH-7468-2019	Sharma, Pankaj/0000-0001-7405-1706	National Institutes of Health [R01 GM060533, R01 CA095006]; NATIONAL CANCER INSTITUTE [R01CA095006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T.A. Hamilton, S. Datta, J. Dasgupta, C. Eng, O.I. Stenina, J. Kusari, A. Guha, and J.E. Dixon for sharing of reagents, J.A. Drazba for assistance in imaging, and T. Koeck and K.S. Aulak for technical assistance. We also thank J.A. Houghton, S.C. Erzurum, F.H. Hsieh, G.C. Sen, R.H. Silverman, and B. Raychaudhuri for comments. This work was supported by grants R01 GM060533 and R01 CA095006 from the National Institutes of Health to S.J.H.	Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Cool RH, 1998, BIOCHEM J, V332, P5, DOI 10.1042/bj3320005; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Duran A, 2004, EMBO J, V23, P4595, DOI 10.1038/sj.emboj.7600468; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Fukuchi K, 2000, BBA-MOL CELL RES, V1496, P207, DOI 10.1016/S0167-4889(00)00018-5; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Haque SJ, 2006, VITAM HORM, V74, P165, DOI 10.1016/S0083-6729(06)74007-9; Haque SJ, 1997, P NATL ACAD SCI USA, V94, P8563, DOI 10.1073/pnas.94.16.8563; Haque SJ, 2000, J BIOL CHEM, V275, P26500, DOI 10.1074/jbc.275.34.26500; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; HARKINS AB, 1993, BIOPHYS J, V65, P865, DOI 10.1016/S0006-3495(93)81112-3; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HO JL, 1994, J EXP MED, V180, P1457, DOI 10.1084/jem.180.4.1457; Ikizawa K, 2000, BIOCHEM BIOPH RES CO, V268, P54, DOI 10.1006/bbrc.2000.2080; IKIZAWA K, 1994, J ALLERGY CLIN IMMUN, V94, P620, DOI 10.1016/0091-6749(94)90138-4; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; JARVIS WD, 1994, CANCER RES, V54, P1707; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; LAMBETH JD, 2007, J BIOL CHEM, V273, P15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Murata T, 2004, AM J RESP CRIT CARE, V170, P647, DOI 10.1164/rccm.200309-1311OC; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; OHARA J, 1987, NATURE, V325, P537, DOI 10.1038/325537a0; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Reid K, 1997, J PHARMACOL EXP THER, V283, P993; Rhee S G, 2000, Sci STKE, V2000, ppe1; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; SEUWEN K, 1995, BRIT J PHARMACOL, V114, P1613, DOI 10.1111/j.1476-5381.1995.tb14947.x; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Yamada T, 2002, J BIOL CHEM, V277, P28830, DOI 10.1074/jbc.M201781200; Yuan Q, 1998, J IMMUNOL, V161, P5143; Zamorano J, 2003, J IMMUNOL, V171, P4203, DOI 10.4049/jimmunol.171.8.4203	55	85	86	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					551	564		10.1016/j.immuni.2008.07.019	http://dx.doi.org/10.1016/j.immuni.2008.07.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957266	Green Accepted, Bronze			2022-12-18	WOS:000260316700009
J	Jones, RG; Bui, T; White, C; Madesh, M; Krawczyk, CM; Lindsten, T; Hawkins, BJ; Kubek, S; Frauwirth, KA; Wang, YL; Conway, SJ; Roderick, HL; Bootman, MD; Shen, H; Foskett, JK; Thompson, CB				Jones, Russell G.; Bui, Thi; White, Carl; Madesh, Muniswamy; Krawczyk, Connie M.; Lindsten, Tullia; Hawkins, Brian J.; Kubek, Sara; Frauwirth, Kenneth A.; Wang, Y. Lynn; Conway, Stuart J.; Roderick, H. Llewelyn; Bootman, Martin D.; Shen, Hao; Foskett, J. Kevin; Thompson, Craig B.			The proapoptotic factors Bax and Bak regulate T cell proliferation through control of endoplasmic reticulum Ca2+ homeostasis	IMMUNITY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; MITOCHONDRIAL DYSFUNCTION; CYCLE PROGRESSION; BCL-2; CALCIUM; RECEPTOR; DEATH; ACTIVATION; APOPTOSIS; SUPEROXIDE	The Bcl-2-associated X protein (Bax) and Bcl-2-antagonist/killer (Bak) are essential regulators of lymphocyte apoptosis, but whether they play a role in viable T cell function remains unclear. Here, we report that T cells lacking both Bax and Bak display defects in antigen-specific proliferation because of Ca2+-signaling defects. Bax(-/-), Bak(-/-) T cells displayed defective T cell receptor (TCR)- and inositol-1,4,5-trisphosphate (IP3)-dependent Ca2+ mobilization because of altered endoplasmic reticulum (ER) Ca2+ regulation that was reversed by Bax's reintroduction. The ability of TCR-dependent Ca2+ signals to stimulate mitochondrial NADH production in excess of that utilized for ATIP synthesis was dependent on Bax and Bak. Blunting of Ca2+-induced mitochondrial NADH elevation in the absence of Bax and Bak resulted in decreased reactive-oxygen-species production, which was required for T cell proliferation. Together, the data establish that Bax and Bak play an essential role in the control of T cell proliferation by modulating ER Ca2+ release.	Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Immunol, Philadelphia, PA 19104 USA; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Inst Environm Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Babraham Inst, Lab Mol Signaling, Cambridge CB2 4AT, England	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University System of Maryland; University of Maryland College Park; Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Thompson, CB (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu	Jones, Russell/AAC-2861-2022; Conway, Stuart/AAP-3526-2020; Bootman, Martin/AAB-3330-2019; Jones, Russell Graham/ABD-5261-2021; Foskett, Kevin/R-2549-2019; Wang, Y. Lynn/GRF-6667-2022	Conway, Stuart/0000-0002-5148-117X; Bootman, Martin/0000-0002-6447-3451; Jones, Russell Graham/0000-0003-2250-4675; Wang, Y. Lynn/0000-0003-0773-1212; White, Carl/0000-0002-0535-6968; Roderick, Hywel/0000-0001-7065-3523; Foskett, J. Kevin/0000-0002-8854-0268	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H110, BBS/E/B/00001116, BBS/E/B/0000C116] Funding Source: Medline; NCI NIH HHS [R01 CA099179, R01 CA099179-06] Funding Source: Medline; NIGMS NIH HHS [R01 GM056328] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA099179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER; BBSRC [BBS/E/B/0000H110] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; CHAUDHRI G, 1986, J IMMUNOL, V137, P2646; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; SCHOLZ W, 1988, J BIOL CHEM, V263, P3626; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	45	85	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					268	280		10.1016/j.immuni.2007.05.023	http://dx.doi.org/10.1016/j.immuni.2007.05.023			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17692540	Green Accepted, Bronze			2022-12-18	WOS:000249056300013
J	Drew, E; Merzaban, JS; Seo, W; Ziltener, HJ; McNagny, KM				Drew, E; Merzaban, JS; Seo, W; Ziltener, HJ; McNagny, KM			CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; L-SELECTIN; REVERSIBLE EXPRESSION; MICE; DIFFERENTIATION; IDENTIFICATION; INTEGRIN; PROTEIN; LIGAND; IL-4	CD34 is a cell-surface sialomucin expressed by hematopoietic stem cells (HSC), mast cells, and vascular endothelia. Despite its popularity as an HSC marker, the function of CD34 on hematopoietic cells remains enigmatic. Here, we have addressed this issue by examining the behavior of mutant mast cells lacking CD34, the related sialomucin, CD43, or both molecules. Loss of these molecules leads to a gene-dose-dependent increase in mast cell homotypic aggregation with CD34/CD43KOs > CD43KO > CD34KO > wild-type. Importantly, reexpression of CD34 or CD43 in these cells caused reversal of this phenotype. Furthermore, we find that loss of these sialomucins prevents mast cell repopulation and hematopoietic precursor reconstitution in vivo. Our data provide clear-cut evidence for a hematopoietic function for CD34 and suggest that it acts as a negative regulator of cell adhesion.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	McNagny, KM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada.	kelly@brc.ubc.ca	McNagny, Kelly/P-5239-2014; Seo, Wooseok/G-1953-2017; Merzaban, Jasmeen/V-3147-2018	McNagny, Kelly/0000-0003-4737-3499; Seo, Wooseok/0000-0001-6279-166X; Merzaban, Jasmeen/0000-0002-7276-2907				ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; BAECHERALLAN CM, 1993, IMMUNOGENETICS, V37, P183; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Carlow DA, 2001, J IMMUNOL, V166, P256, DOI 10.4049/jimmunol.166.1.256; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; CRAPPER RM, 1983, J IMMUNOL, V131, P923; Dao MA, 2003, BLOOD, V101, P112, DOI 10.1182/blood-2002-01-0025; Dastych J, 1998, AM J PHYSIOL-CELL PH, V275, pC1291, DOI 10.1152/ajpcell.1998.275.5.C1291; DELIA D, 1993, BLOOD, V81, P1001; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Drew E, 2002, EXP HEMATOL, V30, P1211, DOI 10.1016/S0301-472X(02)00890-1; FACKLER MJ, 1995, BLOOD, V85, P3040, DOI 10.1182/blood.V85.11.3040.bloodjournal85113040; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2003, NAT IMMUNOL, V4, P1160, DOI 10.1038/ni1203-1160; Gratama JW, 2001, SEMIN HEMATOL, V38, P139, DOI 10.1053/shem.2001.21925; Gurish MF, 2002, CLIN REV ALLERG IMMU, V22, P107, DOI 10.1385/CRIAI:22:2:107; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hasumura M, 2003, EXP HEMATOL, V31, P1331, DOI 10.1016/j.exphem.2003.09.004; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; KANAKURA Y, 1988, BLOOD, V71, P573; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; MADDEN KB, 1991, J IMMUNOL, V147, P1387; MAJDIC O, 1994, BLOOD, V83, P1226; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Migliaccio AR, 1999, EXP HEMATOL, V27, P1655, DOI 10.1016/S0301-472X(99)00110-1; NAKAMURA Y, 1993, EXP HEMATOL, V21, P236; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nielsen JS, 2002, CELLS TISSUES ORGANS, V171, P44, DOI 10.1159/000057691; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ogawa M, 2002, EXP HEMATOL, V30, P3, DOI 10.1016/S0301-472X(01)00770-6; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Rosenkranz AR, 1998, J IMMUNOL, V161, P6463; Sassetti C, 2000, J BIOL CHEM, V275, P9001, DOI 10.1074/jbc.275.12.9001; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Smith TJ, 1996, IMMUNOL TODAY, V17, P60, DOI 10.1016/0167-5699(96)80580-9; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; VECCHINI F, 1993, BLOOD, V81, P1489; Walker J, 1999, J IMMUNOL, V162, P4109; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Zanjani ED, 2003, EXP HEMATOL, V31, P406, DOI 10.1016/S0301-472X(03)00051-1	55	85	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					43	57		10.1016/j.immuni.2004.11.014	http://dx.doi.org/10.1016/j.immuni.2004.11.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664158	Bronze			2022-12-18	WOS:000226682900006
J	Lee, SS; Tranchina, D; Ohta, Y; Flajnik, MF; Hsu, E				Lee, SS; Tranchina, D; Ohta, Y; Flajnik, MF; Hsu, E			Hypermutation in shark immunoglobulin light chain genes results in contiguous substitutions	IMMUNITY			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNE-RESPONSE; MISMATCH REPAIR; NURSE SHARK; SEQUENCES; EVOLUTION; DIVERSITY; MUTATION; REARRANGEMENT	Among 631 substitutions present in 90 nurse shark immunoglobulin light chain somatic mutants, 338 constitute 2-4 bp stretches of adjacent changes. An absence of mutations in perinatal sequences and the bias for one mutating V gene in adults suggest that the diversification is antigen dependent. The substitutions shared no patterns, and the absence of donor sequences, including from family members, supports the idea that most changes arose from nontemplated mutation. The tandem mutations as a group are distinguished by consistently fewer transition changes and an A bias. We suggest this is one of several pathways of hypermutation diversifying shark antigen-receptor genes-point mutations, tandem mutations, and mutations with a G-C preference-that coevolved with or preceded gene rearrangement.	SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; NYU, Dept Biol, New York, NY 10003 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; New York University; University System of Maryland; University of Maryland Baltimore	Hsu, E (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	hsue@hscbkiyn.edu		Flajnik, Martin Francis/0000-0002-2792-5084				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; ANDERSON MK, 1995, J EXP MED, V182, P109, DOI 10.1084/jem.182.1.109; Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; BERNARD O, 1978, CELL, V15, P1133, DOI 10.1016/0092-8674(78)90041-7; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; DAGGFELDT A, 1993, IMMUNOGENETICS, V38, P199; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Diaz M, 1999, INT IMMUNOL, V11, P825, DOI 10.1093/intimm/11.5.825; Diaz M, 1998, P NATL ACAD SCI USA, V95, P14343, DOI 10.1073/pnas.95.24.14343; Du Pasquier L, 1998, CURR TOP MICROBIOL, V229, P199; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; GEARHART PJ, 1981, NATURE, V291, P29, DOI 10.1038/291029a0; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GREENBERG AS, 1994, THESIS U MIAMI MIAMI; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; HINDS KR, 1986, NATURE, V320, P546, DOI 10.1038/320546a0; HINDSFREY KR, 1993, J EXP MED, V178, P815, DOI 10.1084/jem.178.3.815; HOHMAN VS, 1993, P NATL ACAD SCI USA, V90, P9882, DOI 10.1073/pnas.90.21.9882; JANEWAY CA, 1993, IMMUNOLOGIST, V1, P36; KOKUBU F, 1988, EMBO J, V7, P3413, DOI 10.1002/j.1460-2075.1988.tb03215.x; Kong QZ, 1998, J IMMUNOL, V161, P294; Kong QZ, 2001, GENETICS, V158, P369; LEE A, 1993, DEV IMMUNOL, V3, P211, DOI 10.1155/1993/17249; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Lewis SM, 2000, J EXP MED, V191, P1631, DOI 10.1084/jem.191.10.1631; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Lu YF, 2001, INT IMMUNOL, V13, P643, DOI 10.1093/intimm/13.5.643; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Manly B.F.J., 1997, RANDOMIZATION BOOTST, V2; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; RAST JP, 1994, IMMUNOGENETICS, V40, P83; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rosner K, 2001, J CLIN IMMUNOL, V21, P102, DOI 10.1023/A:1011003821798; Rumfelt LL, 2001, P NATL ACAD SCI USA, V98, P1775, DOI 10.1073/pnas.98.4.1775; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733, DOI 10.1002/j.1460-2075.1989.tb08549.x; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847; Zan H, 1999, J IMMUNOL, V162, P3437	58	85	88	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					571	582		10.1016/S1074-7613(02)00300-X	http://dx.doi.org/10.1016/S1074-7613(02)00300-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970880	Bronze			2022-12-18	WOS:000175109600008
J	Shreedhar, V; Moodycliffe, AM; Ullrich, SE; Bucana, C; Kripke, ML; Flores-Romo, L				Shreedhar, V; Moodycliffe, AM; Ullrich, SE; Bucana, C; Kripke, ML; Flores-Romo, L			Dendritic cells require T cells for functional maturation in vivo	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; B-CELL; CONTACT HYPERSENSITIVITY; ANTIGEN PRESENTATION; LANGERHANS CELLS; IMMUNE-RESPONSE; CD40 LIGATION; NULL MICE; ACTIVATION; TRANSPLANTATION	We examined dendritic cell (DC) status in SCID and RAG2(-/-) mice-to assess the influence of T cells on DC development and function in vivo. These mice have reduced numbers of DC in the epidermis and lymph nodes draining hapten-sensitized skin. Epidermal DC in these mice were defective in presenting antigen in vivo to adoptively transferred, hapten-sensitized T cells from normal mice. Likewise, draining lymph node DC were deficient in their capacity to stimulate naive T cells in vitro and in vivo. DC numbers as well as the impaired ability to present antigen in vivo, were corrected by reconstituting these animals with normal T lymphocytes, suggesting that T cells are crucial for normal DC maturation and function in vivo.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Flores-Romo, L (corresponding author), CINVESTAV, Dept Expt Pathol, Mexico City 07000, DF, Mexico.	lflores@mail.cinvestav.mx			NCI NIH HHS [CA 16672, CA52457] Funding Source: Medline; NIEHS NIH HHS [ES 07327] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007327] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; AUSTYN JM, 1990, TRANSPLANTATION, V49, P1, DOI 10.1097/00007890-199001000-00001; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bjorck P, 1997, INT IMMUNOL, V9, P365, DOI 10.1093/intimm/9.3.365; Borkowski TA, 1997, J CLIN INVEST, V100, P575, DOI 10.1172/JCI119567; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Brenner M, 1997, SCIENCE, V277, P332, DOI 10.1126/science.277.5324.332; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cohen Lisa M., 1997, P209; EDELSON RL, 1997, NEW ENGL J MED, V337, P504; FloresRomo L, 1997, J EXP MED, V185, P341, DOI 10.1084/jem.185.2.341; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GRABBE S, 1993, J IMMUNOL, V151, P3430; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jullien D, 1997, J CLIN INVEST, V99, P2071, DOI 10.1172/JCI119378; KAPASI ZF, 1993, J IMMUNOL, V150, P2648; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kitajima T, 1996, J IMMUNOL, V157, P2340; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; MACPHERSON GG, 1995, J IMMUNOL, V154, P1317; MAX EE, 1999, FUNDAMENTAL IMMUNOLO, P111; MOODYCLIFFE AM, 1995, HUMAN CYTOKINES THEI, P131; Muller H K, 1992, Semin Immunol, V4, P205; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rietschel RL, 1997, LANCET, V349, P1093, DOI 10.1016/S0140-6736(96)07216-9; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Schon MP, 1997, NAT MED, V3, P183, DOI 10.1038/nm0297-183; Shinde S, 1996, J IMMUNOL, V157, P2764; STEINMAN R, 1995, J INVEST DERMATOL, V105, pS2, DOI 10.1111/1523-1747.ep12315162; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Taube M, 1997, SCAND J IMMUNOL, V45, P515, DOI 10.1046/j.1365-3083.1997.d01-433.x; TOEWS GB, 1980, J IMMUNOL, V124, P445; Toussaint Sonia, 1997, P151; Volkmann A, 1996, EUR J IMMUNOL, V26, P2565, DOI 10.1002/eji.1830261105; Wang BH, 1997, J IMMUNOL, V159, P6148; WILSEM EJG, 1994, J INVEST DERMATOL, V103, P217; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903	52	85	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1999	11	5					625	636		10.1016/S1074-7613(00)80137-5	http://dx.doi.org/10.1016/S1074-7613(00)80137-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591187	Bronze			2022-12-18	WOS:000083952200014
J	Song, A; Chen, YF; Thamatrakoln, K; Storm, TA; Krensky, AM				Song, A; Chen, YF; Thamatrakoln, K; Storm, TA; Krensky, AM			RFLAT-1: A new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes	IMMUNITY			English	Article							DNA-BINDING PROTEINS; FACTOR-KAPPA-B; HUMAN EOSINOPHILS; ANTIGEN RECEPTOR; INTERFERON-GAMMA; MAMMALIAN-CELLS; CYTOKINE RANTES; CHEMOKINE GENE; FACTOR EKLF; IDENTIFICATION	RANTES (Regulated upon Activation, Normal T cell Expressed and Secreted) is a chemoattractant cytokine (chemokine) important in the generation of inflammatory infiltrate and human immunodeficiency virus entry into immune cells. RANTES is expressed late (3-5 days) after activation in T lymphocytes. Using expression cloning, we identified the first "late" T lymphocyte associated transcription factor and named it "RANTES Factor of Late Activated T Lymphocytes-1" (RFLAT-1). RFLAT-1 is a novel, phosphorylated, zinc finger transcription factor that is expressed in T cells 3 days after activation, coincident with RANTES expression. While Rel proteins play the dominant role in RANTES gene expression in fibroblasts, RFLAT-1 is a strong transactivator for RANTES in T cells.	Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Transplantat Biol, Stanford, CA 94305 USA	Stanford University	Krensky, AM (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Transplantat Biol, Stanford, CA 94305 USA.		Krensky, Alan/F-7956-2011	Thamatrakoln, Kimberlee/0000-0002-8029-5026	NIAID NIH HHS [AI-07290] Funding Source: Medline; NIDDK NIH HHS [DK35008] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035008, R37DK035008] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAM R, 1993, J IMMUNOL, V150, P3442; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; KIM TK, 1994, P NATL ACAD SCI USA, V91, P4170, DOI 10.1073/pnas.91.10.4170; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KUNA P, 1992, J IMMUNOL, V149, P636; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Moriuchi H, 1997, J IMMUNOL, V158, P3483; Nelson PJ, 1998, CURR OPIN IMMUNOL, V10, P265, DOI 10.1016/S0952-7915(98)80164-7; NELSON PJ, 1993, J IMMUNOL, V151, P2601; Nelson PJ, 1996, J IMMUNOL, V157, P1139; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ortiz BD, 1996, MOL CELL BIOL, V16, P202; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; ORTIZ BD, 1995, BIOL CHEMOKINE RANTE, P87; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Sambrook J, 1989, MOL CLONING LAB MANU; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schluger NW, 1997, CURR OPIN IMMUNOL, V9, P504, DOI 10.1016/S0952-7915(97)80102-1; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1521; TAUB DD, 1995, J IMMUNOL, V155, P3877; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026	50	85	88	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1999	10	1					93	103		10.1016/S1074-7613(00)80010-2	http://dx.doi.org/10.1016/S1074-7613(00)80010-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023774	Bronze			2022-12-18	WOS:000078428700010
J	SETHNA, MP; VANPARIJS, L; SHARPE, AH; ABBAS, AK; FREEMAN, GJ				SETHNA, MP; VANPARIJS, L; SHARPE, AH; ABBAS, AK; FREEMAN, GJ			A NEGATIVE REGULATORY FUNCTION OF B7 REVEALED IN B7-1 TRANSGENIC MICE	IMMUNITY			English	Article							T-CELL CLONES; CTLA-4 COUNTER-RECEPTOR; ACTIVATION ANTIGEN-B7; CD28; COSTIMULATION; PROLIFERATION; EXPRESSION; INDUCTION; ADHESION; PREVENTS	To analyze the functions of T cell costimulators in vivo, we have constructed a transgenic mouse strain that constitutively expresses murine B7-1 on mature B cells. Antibody responses to T-dependent hapten-protein conjugates and serum immunoglobulin levels are markedly depressed in B7-1 transgenic mice. This immune deficiency is not due to an intrinsic B cell defect, as antibody responses to T-independent hapten conjugates are normal. Furthermore, treatment with anti-B7-1 restores the capacity of transgenic mice to respond to hapten-protein conjugates, demonstrating that the deficient antibody responses are directly attributable to the expression of B7-1. These results suggest that the temporally regulated expression of costimulators such as B7-1 may contribute to either initiation or down-regulation (feedback inhibition) of T-dependent immune responses in vivo, and that the inhibitory function is dominant in transgenic mice that constitutively express high levels of this costimulator.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; DANA FARBER CANC INST,DEPT MED,DIV HEMATOL MALIGNANCIES,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	SETHNA, MP (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV IMMUNOL RES,75 FRANCIS ST,BOSTON,MA 02115, USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL CANCER INSTITUTE [R01CA040216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022802, P01AI035297] Funding Source: NIH RePORTER; NCI NIH HHS [CA40216] Funding Source: Medline; NIAID NIH HHS [R01AI22802, P01AI35297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BOOM WH, 1988, J EXP MED, V167, P1350, DOI 10.1084/jem.167.4.1350; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; BOUSSIOTIS VA, 1993, J EXP MED, V178, P1753, DOI 10.1084/jem.178.5.1753; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; CLAYBERGER C, 1984, J IMMUNOL, V132, P2237; DELPRETE GF, 1991, J EXP MED, V174, P809, DOI 10.1084/jem.174.4.809; FREEDMAN AS, 1987, J IMMUNOL, V139, P3260; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; GIMMI CD, 1993, P NATL ACAD SCI USA, V90, P6586, DOI 10.1073/pnas.90.14.6586; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HOGAN B, 1986, MANIPULATION MOUSE E; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LENSCHOW DJ, 1994, IN PRESS J IMMUNOL; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P2172; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; TITE JP, 1984, EUR J IMMUNOL, V14, P878, DOI 10.1002/eji.1830141004	27	85	85	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					415	421		10.1016/1074-7613(94)90072-8	http://dx.doi.org/10.1016/1074-7613(94)90072-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7533646				2022-12-18	WOS:A1994PK16800010
J	Mogilenko, DA; Shpynov, O; Andhey, PS; Arthur, L; Swain, A; Esaulova, E; Brioschi, S; Shchukina, I; Kerndl, M; Bambouskova, M; Yao, ZT; Laha, A; Zaitsev, K; Burdess, S; Gillfilan, S; Stewart, SA; Colonna, M; Artyomov, MN				Mogilenko, Denis A.; Shpynov, Oleg; Andhey, Prabhakar Sairam; Arthur, Laura; Swain, Amanda; Esaulova, Ekaterina; Brioschi, Simone; Shchukina, Irina; Kerndl, Martina; Bambouskova, Monika; Yao, Zhangting; Laha, Anwesha; Zaitsev, Konstantin; Burdess, Samantha; Gillfilan, Susan; Stewart, Sheila A.; Colonna, Marco; Artyomov, Maxim N.			Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK(+) CD8(+) T Cells as Conserved Hallmark of Inflammaging	IMMUNITY			English	Article							GRANZYME K; AGED MICE; HETEROGENEITY; VARIABILITY; RESPONSES; SUBSETS	Systematic understanding of immune aging on a whole-body scale is currently lacking. We characterized age-associated alterations in immune cells across multiple mouse organs using single-cell RNA and antigen receptor sequencing and flow cytometry-based validation. We defined organ-specific and common immune alterations and identified a subpopulation of age-associated granzyme K (GZMK)-expressing CD8(+) T (Taa) cells that are distinct from T effector memory (Tern) cells. Taa cells were highly clonal, had specific epigenetic and transcriptional signatures, developed in response to an aged host environment, and expressed markers of exhaustion and tissue homing. Activated Taa cells were the primary source of GZMK, which enhanced inflammatory functions of non-immune cells. In humans, proportions of the circulating GZMK(+) CDE3(+) T cell population that shares transcriptional and epigenetic signatures with mouse Taa cells increased during healthy aging. These results identify GZMK(+) Taa cells as a potential target to address age-associated dysfunctions of the immune system.	[Mogilenko, Denis A.; Shpynov, Oleg; Andhey, Prabhakar Sairam; Arthur, Laura; Swain, Amanda; Esaulova, Ekaterina; Brioschi, Simone; Shchukina, Irina; Kerndl, Martina; Bambouskova, Monika; Laha, Anwesha; Burdess, Samantha; Gillfilan, Susan; Colonna, Marco; Artyomov, Maxim N.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Shpynov, Oleg] JetBrains Res, St Petersburg 197374, Russia; [Kerndl, Martina] Ctr Physiol & Pharmacol, Inst Vasc Biol, A-1090 Vienna, Austria; [Kerndl, Martina] Christian Doppler Lab Arginine Metab Rheumatoid A, A-1090 Vienna, Austria; [Yao, Zhangting; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Dept Med, St Louis, MO 63110 USA; [Yao, Zhangting; Stewart, Sheila A.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg 197101, Russia	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); ITMO University	Artyomov, MN (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	martyomov@wustl.edu	Zaitsev, Konstantin/AAU-5733-2021; Mogilenko, Denis/ABE-9454-2021; Laha, Anwesha/AAJ-2768-2021; Mogilenko, Denis/H-4436-2013	Zaitsev, Konstantin/0000-0003-3749-0886; Stewart, Sheila/0000-0002-2260-9576; Mogilenko, Denis/0000-0001-5427-5243; Brioschi, Simone/0000-0002-3849-3926	Aging Biology Foundation (USA); NIH [CA217208-01A1, AG059244-01A1]	Aging Biology Foundation (USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grant from Aging Biology Foundation (USA) (M.N.A.) and NIH grants CA217208-01A1 and AG059244-01A1 (S.A.S.). We would like to thank Dr. Gwendalyn Randolph and Peter Wang for providing Cx3cr1-GFP reporter mice, Dr. Diane Bender for assistance with multiplex techniques, and Dorjan Brinja and Dr. Erica Lantelme for assistance with cell sorting.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; [Anonymous], **DATA OBJECT**, DOI DOI 10.18129/B9.BIOC.PHANTASUS; Baumgarth N, 2017, J IMMUNOL, V199, P3387, DOI 10.4049/jimmunol.1700943; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509; Clamby ET, 2008, P NATL ACAD SCI USA, V105, P12997, DOI 10.1073/pnas.0805465105; Corridoni D, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1003-4; Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dulken B, 2019, NATURE, V571, P205, DOI 10.1038/s41586-019-1362-5; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Elyahu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8330; Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hashimoto K, 2019, P NATL ACAD SCI USA, V116, P24242, DOI 10.1073/pnas.1907883116; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Joeckel LT, 2017, IMMUNOL CELL BIOL, V95, P676, DOI 10.1038/icb.2017.35; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kimmel JC, 2019, GENOME RES, V29, P2088, DOI 10.1101/gr.253880.119; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quinn KM, 2018, CELL REP, V23, P3512, DOI 10.1016/j.celrep.2018.05.057; Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y; Schuyler RP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02367; Shchukina I., 2020, BIORXIV, DOI [10.1101/2020.05.10.087023., DOI 10.1101/2020.05.10.087023]; Singh SP, 2017, ONCOTARGET, V8, P71981, DOI 10.18632/oncotarget.18234; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3; Young Matthew D, 2020, Gigascience, V9, DOI 10.1093/gigascience/giaa151; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	53	84	84	17	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					99	+		10.1016/j.immuni.2020.11.005	http://dx.doi.org/10.1016/j.immuni.2020.11.005		JAN 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33271118	Bronze			2022-12-18	WOS:000607814000013
J	Xu, HP; Ding, JR; Porter, CBM; Wallrapp, A; Tabaka, M; Ma, S; Fu, SJ; Guo, XX; Riesenfeld, SJ; Su, CEW; Dionne, D; Nguyen, LT; Lefkovith, A; Ashenberg, O; Burkett, PR; Shi, HN; Rozenblatt-Rosen, O; Graham, DB; Kuchroo, VK; Regev, A; Xavier, RJ				Xu, Heping; Ding, Jiarui; Porter, Caroline B. M.; Wallrapp, Antonia; Tabaka, Marcin; Ma, Sai; Fu, Shujie; Guo, Xuanxuan; Riesenfeld, Samantha J.; Su, Chienwen; Dionne, Danielle; Nguyen, Lan T.; Lefkovith, Ariel; Ashenberg, Orr; Burkett, Patrick R.; Shi, Hai Ning; Rozenblatt-Rosen, Orit; Graham, Daniel B.; Kuchroo, Vijay K.; Regev, Aviv; Xavier, Ramnik J.			Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide alpha-CGRP Modulates Group 2 Innate Lymphoid Cell Responses	IMMUNITY			English	Article							GENE-EXPRESSION; TYPE-2 IMMUNITY; NEUROMEDIN U; TUFT CELLS; ASTHMA; CAMP	Signaling abnormalities in immune responses in the small intestine can trigger chronic type 2 inflammation involving interaction of multiple immune cell types. To systematically characterize this response, we analyzed 58,067 immune cells from the mouse small intestine by single-cell RNA sequencing (scRNA-seq) at steady state and after induction of a type 2 inflammatory reaction to ovalbumin (OVA). Computational analysis revealed broad shifts in both cell-type composition and cell programs in response to the inflammation, especially in group 2 innate lymphoid cells (ILC2s). Inflammation induced the expression of exon 5 of Calca, which encodes the alpha-calcitonin gene-related peptide (alpha-CGRP), in intestinal KLRG1(+) ILC2s. alpha-CGRP antagonized KLRG1(+) ILC2s proliferation but promoted IL-5 expression. Genetic perturbation of alpha-CGRP increased the proportion of intestinal KLRG1(+) ILC2s. Our work highlights a model where alpha-CGRP-mediated neuronal signaling is critical for suppressing ILC2 expansion and maintaining homeostasis of the type 2 immune machinery.	[Xu, Heping; Ding, Jiarui; Porter, Caroline B. M.; Tabaka, Marcin; Ma, Sai; Riesenfeld, Samantha J.; Dionne, Danielle; Nguyen, Lan T.; Lefkovith, Ariel; Ashenberg, Orr; Rozenblatt-Rosen, Orit; Graham, Daniel B.; Kuchroo, Vijay K.; Regev, Aviv; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Xu, Heping; Fu, Shujie; Guo, Xuanxuan] Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China; [Xu, Heping; Fu, Shujie; Guo, Xuanxuan] Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou 310024, Zhejiang, Peoples R China; [Wallrapp, Antonia; Burkett, Patrick R.; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02114 USA; [Wallrapp, Antonia; Burkett, Patrick R.; Kuchroo, Vijay K.] Brigham & Womens Hosp, Boston, MA 02114 USA; [Su, Chienwen; Shi, Hai Ning] Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Su, Chienwen; Shi, Hai Ning] Harvard Med Sch, Charlestown, MA 02129 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Westlake University; Westlake University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Xu, HP; Regev, A; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Xu, HP (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China.; Xu, HP (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou 310024, Zhejiang, Peoples R China.; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02114 USA.; Regev, A (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	xuheping@westlake.edu.cn; aregev@broadinstitute.org; xavier@molbio.mgh.harvard.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022	Su, Chien-Wen/0000-0002-5457-9295; Xu, Heping/0000-0003-2149-7004; Wallrapp, Antonia/0000-0002-3176-1553; Riesenfeld, Samantha/0000-0001-9144-021X; Tabaka, Marcin/0000-0002-6166-2820	Food Allergy Science Initiative, NIH [DK 043351, DK114784]; Crohn's & Colitis Foundation; National Natural Science Foundation of China [31970842]; Westlake Education Foundation of Westlake University; Klarman Cell Observatory; HHMI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK114784, P30DK040561, P30DK043351] Funding Source: NIH RePORTER	Food Allergy Science Initiative, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Westlake Education Foundation of Westlake University; Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Leslie Gaffney and Anna Hupalowska for help with figures, Tim Tickle for help with the Single Cell Portal, Miao Xu and Chao Huang for help with tissue harvest, Yan Wang for help with qPCR, Hans Oettgen for discussions, Hiroki Kurihara for donating the B6.129S6-Calca < tm1Hku > strain to a publicly available repository, the Broad Flow Cytometry Facility, and the Flow Cytometry Core and Laboratory Animal Resources Center in Westlake University. Work was supported by the Food Allergy Science Initiative, NIH grant DK114784 (A.R. and R.J.X.), NIH grant DK 043351, the Crohn's & Colitis Foundation (R.J.X.), the National Natural Science Foundation of China (grant 31970842; H.X.), the Westlake Education Foundation of Westlake University (H.X.), and the Klarman Cell Observatory and HHMI (A.R.).	AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Bielecki P., 2018, BIORXIV, DOI [10.1101/461228, DOI 10.1101/461228]; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burton OT, 2018, CLIN EXP ALLERGY, V48, P288, DOI 10.1111/cea.13075; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; CHATTERJEE TK, 1993, MOL PHARMACOL, V43, P167; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Ding JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04368-5; Ding JR, 2016, BIOINFORMATICS, V32, P2567, DOI 10.1093/bioinformatics/btw227; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; duVerle,DA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1175-6; Edvinsson L, 2018, CELL, V175, P1719, DOI 10.1016/j.cell.2018.11.049; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Kloepfer KM, 2012, AM J RESP CRIT CARE, V185, P1275, DOI 10.1164/rccm.201109-1635OC; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Korsunsky I., 2018, BIORXIV, DOI 10.1101/461954; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lopez R, 2018, NAT METHODS, V15, P1053, DOI 10.1038/s41592-018-0229-2; Madamanchi Aasakiran, 2007, Mcgill J Med, V10, P99; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Rowe RK, 2015, IMMUNOL ALLERGY CLIN, V35, P115, DOI 10.1016/j.iac.2014.09.012; Rydyznski CE, 2018, CELL REP, V24, P3367, DOI 10.1016/j.celrep.2018.08.075; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; Tordesillas L, 2017, IMMUNITY, V47, P32, DOI 10.1016/j.immuni.2017.07.004; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Welch JD, 2019, CELL, V177, P1873, DOI 10.1016/j.cell.2019.05.006; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	79	84	86	7	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					696	+		10.1016/j.immuni.2019.09.004	http://dx.doi.org/10.1016/j.immuni.2019.09.004			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618654	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000490141700015
J	Chattopadhyay, S; Kuzmanovic, T; Zhang, Y; Wetzel, JL; Sen, GC				Chattopadhyay, Saurabh; Kuzmanovic, Teodora; Zhang, Ying; Wetzel, Jaime L.; Sen, Ganes C.			Ubiquitination of the Transcription Factor IRF-3 Activates RIPA, the Apoptotic Pathway that Protects Mice from Viral Pathogenesis	IMMUNITY			English	Article							INTERFERON REGULATORY FACTOR-3; BINDING KINASE 1; RIG-I; ANTIVIRAL RESPONSE; SENDAI-VIRUS; INFECTION; LIGASE; RNA; IDENTIFICATION; DEGRADATION	The transcription factor IRF-3 mediates cellular antiviral response by inducing the expression of interferon and other antiviral proteins. In RNA-virus infected cells, IRF-3's transcriptional activation is triggered primarily by RIG-I-like receptors (RLR), which can also activate the RLR-induced IRF-3-mediated pathway of apoptosis (RIPA). Here, we have reported that the pathway of IRF-3 activation in RIPA was independent of and distinct from the known pathway of transcriptional activation of IRF-3. It required linear polyubiquitination of two specific lysine residues of IRF-3 by LUBAC, the linear polyubiquitinating enzyme complex, which bound IRF-3 in signal-dependent fashion. To evaluate the role of RIPA in viral pathogenesis, we engineered a genetically targeted mouse, which expressed a mutant IRF-3 that was RIPA-competent but transcriptionally inert; this single-action IRF-3 could protect mice from lethal viral infection. Our observations indicated that IRF-3-mediated apoptosis of virus-infected cells could be an effective antiviral mechanism, without expression of the interferon-stimulated genes.	[Chattopadhyay, Saurabh; Kuzmanovic, Teodora; Zhang, Ying; Wetzel, Jaime L.; Sen, Ganes C.] Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA; [Chattopadhyay, Saurabh] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 3000 Arlington Ave,Mailstop 1021, Toledo, OH 43614 USA; [Sen, Ganes C.] Cleveland Clin, Dept Immunol, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University System of Ohio; University of Toledo; Cleveland Clinic Foundation	Chattopadhyay, S; Sen, GC (corresponding author), Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA.; Chattopadhyay, S (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 3000 Arlington Ave,Mailstop 1021, Toledo, OH 43614 USA.; Sen, GC (corresponding author), Cleveland Clin, Dept Immunol, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	saurabh.chattopadhyay@utoledo.edu; seng@ccf.org	Chattopadhyay, Saurabh/I-4091-2019	Chattopadhyay, Saurabh/0000-0002-2930-1523	American Heart Association Scientist Development Grant [15SDG25090212]; National Institutes of Health [AI073303, CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073303, R01AI073303] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Heart Association Scientist Development Grant 15SDG25090212 (S.C.) and the National Institutes of Health grants AI073303 (G.C.S.) and CA062220 (G.C.S.). We would like to thank Jae Jung (University of Southern California) for kindly providing the LUBAC expression plasmids and Genentech for the linear ubiquitin-specific antibody.	Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Chattopadhyay S., 2013, MBIO, V4; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, CELL CYCLE, V9, P2479, DOI 10.4161/cc.9.13.12237; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Maelfait J, 2012, MICROBIOL MOL BIOL R, V76, P33, DOI 10.1128/MMBR.05012-11; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Pauli EK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004577; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sze A, 2013, CELL HOST MICROBE, V14, P422, DOI 10.1016/j.chom.2013.09.009; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wetzel JL, 2014, J VIROL, V88, P13593, DOI 10.1128/JVI.02201-14; White CL, 2011, J VIROL, V85, P5224, DOI 10.1128/JVI.00053-11; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277	37	84	86	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1151	1161		10.1016/j.immuni.2016.04.009	http://dx.doi.org/10.1016/j.immuni.2016.04.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27178468	Green Accepted, Bronze			2022-12-18	WOS:000376478500019
J	Cao, ZF; Conway, KL; Heath, RJ; Rush, JS; Leshchiner, ES; Ramirez-Ortiz, ZG; Nedelsky, NB; Huang, HL; Ng, A; Gardet, A; Cheng, SC; Shamji, AF; Rioux, JD; Wijmenga, C; Netea, MG; Means, TK; Daly, MJ; Xavier, RJ				Cao, Zhifang; Conway, Kara L.; Heath, Robert J.; Rush, Jason S.; Leshchiner, Elizaveta S.; Ramirez-Ortiz, Zaida G.; Nedelsky, Natalia B.; Huang, Hailiang; Ng, Aylwin; Gardet, Agnes; Cheng, Shih-Chin; Shamji, Alykhan F.; Rioux, John D.; Wijmenga, Cisca; Netea, Mihai G.; Means, Terry K.; Daly, Mark J.; Xavier, Ramnik J.			Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation	IMMUNITY			English	Article							INHERITED CARD9 DEFICIENCY; INNATE IMMUNITY; SUSCEPTIBILITY LOCI; ANTIVIRAL RESPONSE; CROHNS-DISEASE; FAMILY; RECOGNITION; INFECTION; PROTEINS; CELLS	CARD9 is a central component of anti-fungal innate immune signaling via C-type lectin receptors, and several immune-related disorders are associated with CARD9 alterations. Here, we used a rare CARD9 variant that confers protection against inflammatory bowel disease as an entry point to investigating CARD9 regulation. We showed that the protective variant of CARD9, which is C-terminally truncated, acted in a dominant-negative manner for CARD9-mediated cytokine production, indicating an important role for the C terminus in CARD9 signaling. We identified TRIM62 as a CARD9 binding partner and showed that TRIM62 facilitated K27-linked poly-ubiquitination of CARD9. We identified K125 as the ubiquitinated residue on CARD9 and demonstrated that this ubiquitination was essential for CARD9 activity. Furthermore, we showed that similar to Card9-deficient mice, Trim62-deficient mice had increased susceptibility to fungal infection. In this study, we utilized a rare protective allele to uncover a TRIM62-mediated mechanism for regulation of CARD9 activation.	[Cao, Zhifang; Conway, Kara L.; Heath, Robert J.; Nedelsky, Natalia B.; Ng, Aylwin; Gardet, Agnes; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Cao, Zhifang; Conway, Kara L.; Heath, Robert J.; Nedelsky, Natalia B.; Ng, Aylwin; Gardet, Agnes; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Cao, Zhifang; Conway, Kara L.; Heath, Robert J.; Nedelsky, Natalia B.; Huang, Hailiang; Ng, Aylwin; Gardet, Agnes; Daly, Mark J.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Cao, Zhifang; Conway, Kara L.; Heath, Robert J.; Nedelsky, Natalia B.; Ng, Aylwin; Gardet, Agnes; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Conway, Kara L.; Heath, Robert J.; Rush, Jason S.; Leshchiner, Elizaveta S.; Huang, Hailiang; Ng, Aylwin; Shamji, Alykhan F.; Daly, Mark J.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ramirez-Ortiz, Zaida G.; Means, Terry K.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Ramirez-Ortiz, Zaida G.; Means, Terry K.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA; [Ramirez-Ortiz, Zaida G.; Means, Terry K.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Huang, Hailiang; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Cheng, Shih-Chin; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Cheng, Shih-Chin; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Universite de Montreal; Universite de Montreal; University of Groningen	Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	xavier@molbio.mgh.harvard.edu	Daly, Mark J/B-2453-2017; CHENG, SHIH-CHIN/M-3773-2019; Wijmenga, Cisca/D-2173-2009; Rioux, John D/A-9599-2015; Ng, Aylwin/AAQ-6478-2020; Cheng, Shih-Chin/H-4567-2015; Netea, Mihai/N-5155-2014; Wijmenga, Cisca/AAE-7719-2019	Daly, Mark J/0000-0002-0949-8752; CHENG, SHIH-CHIN/0000-0003-1251-8774; Rioux, John D/0000-0001-7560-8326; Cheng, Shih-Chin/0000-0003-1251-8774; Wijmenga, Cisca/0000-0002-5635-1614; Ramirez Ortiz, Zaida/0000-0002-0253-0473; Heath, Robert/0000-0001-6675-7573	Helmsley Trust; NIH [DK097485, DK062432, DK086502]; ERC [310372]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086502, U01DK062432, P30DK043351, R01DK097485] Funding Source: NIH RePORTER	Helmsley Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Hiromitsu Hara (Saga Medical School, Japan) for providing Card9<SUP>-/-</SUP> mice (Hara et al., 2007), Kara Lassen for guidance with manuscript preparation, and Petric Kuballa, Jakob Begun, and David Fei for assistance with experiments. This work was supported by funding from the Helmsley Trust and NIH grants DK097485, DK062432, and DK086502 to R.J.X. M.G.N. was supported by an ERC Consolidator Grant (no. 310372). T.K.M.	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Chehoud C, 2015, INFLAMM BOWEL DIS, V21, P1948, DOI 10.1097/MIB.0000000000000454; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; Gazendam RP, 2014, BLOOD, V124, P590, DOI 10.1182/blood-2014-01-551473; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Grumach AS, 2015, J CLIN IMMUNOL, V35, P486, DOI 10.1007/s10875-015-0170-4; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Herbst M, 2015, PEDIATR INFECT DIS J, V34, P999, DOI 10.1097/INF.0000000000000736; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jachiet M, 2015, JAMA DERMATOL, V151, P192, DOI 10.1001/jamadermatol.2014.2154; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Jia XM, 2014, J EXP MED, V211, P2307, DOI 10.1084/jem.20132349; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lanternier F, 2015, J INFECT DIS, V211, P1241, DOI 10.1093/infdis/jiu412; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mandell MA, 2014, AUTOPHAGY, V10, P2387, DOI 10.4161/15548627.2014.984278; Marakalala MJ, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/567571; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Richard ML, 2015, INFLAMM BOWEL DIS, V21, P656, DOI 10.1097/MIB.0000000000000261; Rieber N, 2015, CELL HOST MICROBE, V17, P507, DOI 10.1016/j.chom.2015.02.007; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shi MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5820; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wang XW, 2014, J ALLERGY CLIN IMMUN, V133, P905, DOI 10.1016/j.jaci.2013.09.033; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Yang B, 2013, J IMMUNOL, V190, P3613, DOI 10.4049/jimmunol.1202507; Yang CS, 2012, CELL HOST MICROBE, V11, P277, DOI 10.1016/j.chom.2012.01.019; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	69	84	89	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					715	726		10.1016/j.immuni.2015.10.005	http://dx.doi.org/10.1016/j.immuni.2015.10.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488816	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000363478700014
J	Mouchess, ML; Arpaia, N; Souza, G; Barbalat, R; Ewald, SE; Lau, L; Barton, GM				Mouchess, Maria L.; Arpaia, Nicholas; Souza, Gianne; Barbalat, Roman; Ewald, Sarah E.; Lau, Laura; Barton, Gregory M.			Transmembrane Mutations in Toll-like Receptor 9 Bypass the Requirement for Ectodomain Proteolysis and Induce Fatal Inflammation	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASE; APOPTOTIC CELLS; I INTERFERON; BONE-MARROW; SELF-DNA; TLR9; EXPRESSION; MICE; RECOGNITION	Recognition of nucleic acids as a signature of infection by Toll-like receptors (TLRs) 7 and 9 exposes the host to potential self-recognition and autoimmunity. It has been proposed that intracellular compartmentalization is largely responsible for reliable self versus nonself discrimination by these receptors. We have previously shown that TLR9 and TLR7 require processing prior to activation, which may further reinforce receptor compartmentalization and tolerance to self, yet this possibility remains untested. Here we report that residues within the TLR9 transmembrane (TM) region conferred the requirement for ectodomain proteolysis. TLR9 TM mutants responded to extracellular DNA, and mice expressing such receptors died from systemic inflammation and anemia. This inflammatory disease did not require lymphocytes and appeared to require recognition of self-DNA by dendritic cells. To our knowledge, these results provide the first demonstration that TLR-intrinsic mutations can lead to a break in tolerance.	[Mouchess, Maria L.; Arpaia, Nicholas; Souza, Gianne; Barbalat, Roman; Ewald, Sarah E.; Lau, Laura; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, 405 Life Sci Addit, Berkeley, CA 94720 USA.	barton@berkeley.edu	Ewald, Sarah/AAM-8918-2020; Arpaia, Nicholas/R-2549-2018	Ewald, Sarah/0000-0002-5327-7578; Barton, Gregory/0000-0002-3793-0100; Arpaia, Nicholas/0000-0002-0657-0528	NIH [AI072429]; Lupus Research Institute; Ruth L. Kirschstein NRSA Predoctoral Fellowship [F31AI083012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI083012, R01AI072429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Ruth L. Kirschstein NRSA Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vance and the G.M.B. and Vance labs for helpful discussions. Supported by grants from the NIH (AI072429) and the Lupus Research Institute to G.M.B. M.L.M. was supported by a Ruth L. Kirschstein NRSA Predoctoral Fellowship (F31AI083012).	Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; YAMADA G, 1991, P NATL ACAD SCI USA, V88, P532, DOI 10.1073/pnas.88.2.532; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; ZOUMBOS NC, 1985, P NATL ACAD SCI USA, V82, P188, DOI 10.1073/pnas.82.1.188	36	84	87	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					721	732		10.1016/j.immuni.2011.10.009	http://dx.doi.org/10.1016/j.immuni.2011.10.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22078797	Green Accepted, Bronze			2022-12-18	WOS:000297390800012
J	Reardon, C; Lechmann, M; Brustle, A; Gareau, MG; Shuman, N; Philpott, D; Ziegler, SF; Mak, TW				Reardon, Colin; Lechmann, Matthias; Bruestle, Anne; Gareau, Melanie G.; Shuman, Naomi; Philpott, Dana; Ziegler, Steven F.; Mak, Tak W.			Thymic Stromal Lymphopoetin-Induced Expression of the Endogenous Inhibitory Enzyme SLPI Mediates Recovery from Colonic Inflammation	IMMUNITY			English	Article							NF-KAPPA-B; SECRETORY LEUKOPROTEASE INHIBITOR; INTESTINAL IMMUNE HOMEOSTASIS; DENDRITIC CELLS; EPITHELIAL-CELLS; EXPERIMENTAL COLITIS; PRIMARY CULTURES; T-CELLS; TSLP; MICE	Thymic stromal lymphopoetin (TSLP) influences numerous immune functions, including those in the colonic mucosa. Here we report that TSLP-deficient (Tslp(-/-)) mice did not exhibit increased inflammation during dextran sodium sulfate (DSS)-induced colitis but failed to recover from disease, resulting in death. Increased localized neutrophil elastase (NE) activity during overt inflammation was observed in Tslp(-/-) mice and was paralleled by reduced expression of an endogenous inhibitor, secretory leukocyte peptidase inhibitor (SLPI). Pharmacological inhibition of NE or treatment with rSLPI reduced DSS-induced mortality in Tslp(-/-) mice. Signaling through TSLPR on nonhematopoietic cells was sufficient for recovery from DSS-induced colitis. Expression of the receptor occurred on intestinal epithelial cells (IEC), with stimulation inducing SLPI expression. Therefore, TSLP is critical in mediating mucosal healing after insult and functions in a nonredundant capacity that is independent of restraining T helper 1 (Th1) and Th17 cell cytokine production.	[Reardon, Colin; Lechmann, Matthias; Bruestle, Anne; Shuman, Naomi; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada; [Gareau, Melanie G.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Philpott, Dana] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Benaroya Research Institute; Virginia Mason Medical Center	Mak, TW (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca		Reardon, Colin/0000-0003-2204-8091; Bruestle, Anne/0000-0002-3842-5683	Canadian Institutes of Health Research; Cancer Research Institute/Irvington Institute; NIH [AR056113, AI068731]; German Research Foundation DFG; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056113] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Institute/Irvington Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an operating grant from the Canadian Institutes of Health Research (T.W.M.). C.R. is a recipient of a Cancer Research Institute/Irvington Institute Fellowship. M.L. is a recipient of IZKF Erlangen TP A46. Additional support was from AR056113 and AI068731 grants from the NIH (S.F.Z.). A.B. is supported by a German Research Foundation DFG fellowship.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Blazquez AB, 2010, GASTROENTEROLOGY, V139, P1301, DOI 10.1053/j.gastro.2010.06.055; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; EVANS GS, 1992, J CELL SCI, V101, P219; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Fruchtman S, 2005, AM J PHYSIOL-GASTR L, V289, pG342, DOI 10.1152/ajpgi.00413.2004; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kaniuk NA, 2010, METHODS MOL BIOL, V648, P175, DOI 10.1007/978-1-60761-756-3_11; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lee HC, 2008, J IMMUNOL, V181, P5189, DOI 10.4049/jimmunol.181.8.5189; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; LLIEV ID, 2009, MUCOSAL IMMUNOL, V2, P340; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; Okada E, 2005, AM J PHYSIOL-GASTR L, V288, pG745, DOI 10.1152/ajpgi.00276.2004; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Peterson AJ, 2010, REGUL PEPTIDES, V160, P9, DOI 10.1016/j.regpep.2009.12.001; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Reardon C, 2001, INFECT IMMUN, V69, P4417, DOI 10.1128/IAI.69.7.4417-4423.2001; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Samsom JN, 2007, J IMMUNOL, V179, P6588, DOI 10.4049/jimmunol.179.10.6588; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yip HC, 1999, J IMMUNOL, V162, P3942; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Zhu YK, 2001, AM J PHYSIOL-LUNG C, V281, pL868, DOI 10.1152/ajplung.2001.281.4.L868	49	84	91	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					223	235		10.1016/j.immuni.2011.05.015	http://dx.doi.org/10.1016/j.immuni.2011.05.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21820333	Green Accepted, Bronze			2022-12-18	WOS:000294387900012
J	Scharf, L; Li, NS; Hawk, AJ; Garzon, D; Zhang, TJ; Fox, LM; Kazen, AR; Shah, S; Haddadian, EJ; Gumperz, JE; Saghatelian, A; Faraldo-Gomez, JD; Meredith, SC; Piccirilli, JA; Adams, EJ				Scharf, Louie; Li, Nan-Sheng; Hawk, Andrew J.; Garzon, Diana; Zhang, Tejia; Fox, Lisa M.; Kazen, Allison R.; Shah, Sneha; Haddadian, Esmael J.; Gumperz, Jenny E.; Saghatelian, Alan; Faraldo-Gomez, Jose D.; Meredith, Stephen C.; Piccirilli, Joseph A.; Adams, Erin J.			The 2.5 angstrom Structure of CD1c in Complex with a Mycobacterial Lipid Reveals an Open Groove Ideally Suited for Diverse Antigen Presentation	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; T-CELLS; RECOGNITION; BINDING; MOUSE; GLYCOLIPIDS; RESOLUTION; RESPONSES; FOREIGN; PATHWAY	CD1 molecules function to present lipid-based antigens to T cells. Here we present the crystal structure of CD1 c at 2.5 angstrom resolution, in complex with the pathogenic Mycobacterium tuberculosis antigen mannosyl-beta 1-phosphomycoketide (MPM). CD1c accommodated MPM's methylated alkyl chain exclusively in the A' pocket, aided by a unique exit portal underneath the alpha 1 helix. Most striking was an open F' pocket architecture lacking the closed cavity structure of other CD1 molecules, reminiscent of peptide binding grooves of classical major histocompatibility complex molecules. This feature, combined with tryptophan-fluorescence quenching during loading of a dodecameric lipopeptide antigen, provides a compelling model by which both the lipid and peptide moieties of the lipopeptide are involved in CD1c presentation of lipopeptides.	[Scharf, Louie; Li, Nan-Sheng; Kazen, Allison R.; Shah, Sneha; Haddadian, Esmael J.; Meredith, Stephen C.; Piccirilli, Joseph A.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hawk, Andrew J.; Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Garzon, Diana; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-60438 Frankfurt, Germany; [Zhang, Tejia; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Fox, Lisa M.; Gumperz, Jenny E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Faraldo-Gomez, Jose D.] Goethe Univ Frankfurt, D-60438 Frankfurt, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Max Planck Society; Harvard University; University of Wisconsin System; University of Wisconsin Madison; Goethe University Frankfurt	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	ejadams@uchicago.edu	Faraldo-Gomez, Jose/H-7127-2016	Jain, Sneha/0000-0002-0592-1453	National Institutes of Health [R01AI073922, R01GM081642]; Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922, R01AI074940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the Advanced Proton Source at GM/CA-CAT (23ID) and LS-CAT (21ID) for their use and assistance with X-ray beamlines; R. Sanishvili and J. Brunzelle in particular for help and advice during data collection; E. Haddadian, K.F. Freed, and T.R. Sosnick for use of their torsion angle plus real space refinement algorithm; M. Brenner for the CD1c cDNA; and A. Bendelac for helpful discussions. This study was supported by National Institutes of Health grants R01AI073922 and R01GM081642 and the Kinship Foundation Searle Scholars Award to E.J.A.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERTSON DG, 1988, EMBO J, V7, P2801, DOI 10.1002/j.1460-2075.1988.tb03135.x; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Beckman EM, 1996, J IMMUNOL, V157, P2795; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2007, CURR TOP MICROBIOL, V314, P51; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Garzon D, 2009, MOL IMMUNOL, V47, P253, DOI 10.1016/j.molimm.2009.09.029; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sullivan BA, 2007, CURR TOP MICROBIOL, V314, P165; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480; van Summeren RP, 2006, J AM CHEM SOC, V128, P4546, DOI 10.1021/ja060499i; VERONESE FD, 1988, J VIROL, V62, P795, DOI 10.1128/JVI.62.3.795-801.1988; Willcox BE, 2007, CURR TOP MICROBIOL, V314, P73; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	49	84	86	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					853	862		10.1016/j.immuni.2010.11.026	http://dx.doi.org/10.1016/j.immuni.2010.11.026			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21167756	Green Accepted, Bronze			2022-12-18	WOS:000286293900007
J	Kasper, CA; Sorg, I; Schmutz, C; Tschon, T; Wischnewski, H; Kim, ML; Arrieumerlou, C				Kasper, Christoph Alexander; Sorg, Isabel; Schmutz, Christoph; Tschon, Therese; Wischnewski, Harry; Kim, Man Lyang; Arrieumerlou, Cecile			Cell-Cell Propagation of NF-kappa B Transcription Factor and MAP Kinase Activation Amplifies Innate Immunity against Bacterial Infection	IMMUNITY			English	Article							SHIGELLA-FLEXNERI; SIGNALING PATHWAYS; INTERLEUKIN-8; RESPONSES; TAK1; IDENTIFICATION; INVASION; PLASMID; SYSTEM; DOMAIN	The enteroinvasive bacterium Shigella flexneri uses multiple secreted effector proteins to downregulate interleukin-8 (IL-8) expression in infected epithelial cells. Yet, massive IL-8 secretion is observed in Shigellosis. Here we report a host mechanism of cell-cell communication that circumvents the effector proteins and strongly amplifies IL-8 expression during bacterial infection. By monitoring proinflammatory signals at the single-cell level, we found that the activation of the transcription factor NF-kappa B and the MAP kinases JNK, ERK, and p38 rapidly propagated from infected to uninfected adjacent cells, leading to IL-8 production by uninfected bystander cells. Bystander IL-8 production was also observed during Listeria monocyto genes and Salmonella typhimurium infection. This response could be triggered by recognition of peptidoglycan and is mediated by gap junctions. Thus, we have identified a mechanism of cell-cell communication that amplifies innate immunity against bacterial infection by rapidly spreading proinflammatory signals via gap junctions to yet uninfected cells.	[Kasper, Christoph Alexander; Sorg, Isabel; Schmutz, Christoph; Tschon, Therese; Wischnewski, Harry; Kim, Man Lyang; Arrieumerlou, Cecile] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Arrieumerlou, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	cecile.arrieumerlou@unibas.ch		ARRIEUMERLOU, Cecile/0000-0002-6463-2897	Swiss National Science Foundation [3100A0-113561]; SystemsX.ch.; Werner-Siemens Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch.; Werner-Siemens Foundation	We thank J. Neefjes (NKI, Amsterdam, Netherlands) and M. Kelliher (Massachusetts Medical School, Worcester, USA) for the generous gift of A431-Cx43 cells and Tnfr1<SUP>-/-</SUP> MEFs, respectively. We also thank G. Cornelis, U. Jenal, and C. Dehio for comments on the manuscript and M. Podvinec for help with research IT. This work was funded by the Swiss National Science Foundation (grant 3100A0-113561 to C.A.) and the InfectX project from SystemsX.ch. C.A.K. was supported by the Werner-Siemens Foundation.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Dehio C, 1997, J CELL SCI, V110, P2141; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	34	84	88	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					804	816		10.1016/j.immuni.2010.10.015	http://dx.doi.org/10.1016/j.immuni.2010.10.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093316	Bronze			2022-12-18	WOS:000286082600017
J	Matza, D; Badou, A; Kobayashi, KS; Goldsmith-Pestana, K; Masuda, Y; Komuro, A; McMahon-Pratt, D; Marchesi, VT; Flavell, RA				Matza, Didi; Badou, Abdallah; Kobayashi, Koichi S.; Goldsmith-Pestana, Karen; Masuda, Yutaka; Komuro, Akihiko; McMahon-Pratt, Diane; Marchesi, Vincent T.; Flavell, Richard A.			A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation	IMMUNITY			English	Article							KINASE-C; DESMOYOKIN/AHNAK PROTEIN; CA2+ CHANNELS; GENE AHNAK; MOLECULAR CHARACTERIZATION; IMMUNOLOGICAL SYNAPSE; LEISHMANIA-MAJOR; PLASMA-MEMBRANE; BETA-SUBUNITS; MICE	Engagement of the T cell antigen receptor (TCR) during antigen presentation initiates a coordinated action of a large number of signaling proteins and ion channels. AHNAK1 is a scaffold protein, highly expressed by CD4(+) T cells, and is a critical component for calcium signaling. We showed that AHNAK1-deficient mice were highly susceptible to Leishmania major infection. AHNAK1-deficient CD4(+) T cells responded poorly to TCR stimulation in vitro with low proliferation and low Interleukin-2 production. Furthermore, AHNAK1 deficiency resulted in a reduced calcium influx upon TCR crosslinking and subsequent poor activation of the transcription factor NFAT. AHNAK1 was required for plasma membrane expression of L-type calcium channels alpha 1S (Ca(v)1.1), probably through its interaction with the beta regulatory subunit. Thus, AHNAK1 plays an essential role in T cell Ca2+ signaling through Ca(v)1 channels, triggered via TCR activation; therefore, AHNAK1 is a potential target for therapeutic intervention.	[Matza, Didi; Badou, Abdallah; Kobayashi, Koichi S.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Goldsmith-Pestana, Karen; McMahon-Pratt, Diane] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Masuda, Yutaka; Komuro, Akihiko; Marchesi, Vincent T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Masuda, Yutaka; Komuro, Akihiko; Marchesi, Vincent T.] Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	richard.flavell@yale.edu		Kobayashi, Koichi/0000-0003-2930-0114; Badou, Abdallah/0000-0003-4849-9085	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027811, R21AI027811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R21 AI027811, R01 AI027811, R01 AI027811-16, AI27811] Funding Source: Medline; NIDDK NIH HHS [R01 DK074738-05, R01 DK074738] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Freise D, 1999, BIOL CHEM, V380, P897, DOI 10.1515/BC.1999.110; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gentil BJ, 2003, J HISTOCHEM CYTOCHEM, V51, P339, DOI 10.1177/002215540305100309; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haase H, 2007, CARDIOVASC RES, V73, P19, DOI 10.1016/j.cardiores.2006.09.001; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kane MM, 2000, CURR OPIN HEMATOL, V7, P26, DOI 10.1097/00062752-200001000-00006; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; KUDOH J, 1995, CYTOGENET CELL GENET, V70, P218, DOI 10.1159/000134037; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; MASUNAGA T, 1995, J INVEST DERMATOL, V104, P941, DOI 10.1111/1523-1747.ep12606213; Mintz E, 1997, BBA-BIOENERGETICS, V1318, P52, DOI 10.1016/S0005-2728(96)00132-6; Nie ZZ, 2000, J INVEST DERMATOL, V114, P1044, DOI 10.1046/j.1523-1747.2000.00949.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Savignac M, 2004, J IMMUNOL, V172, P5206, DOI 10.4049/jimmunol.172.9.5206; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; SOONG L, 1995, INFECT IMMUN, V63, P3559, DOI 10.1128/IAI.63.9.3559-3566.1995; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x	49	84	85	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					64	74		10.1016/j.immuni.2007.11.020	http://dx.doi.org/10.1016/j.immuni.2007.11.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18191595	Green Accepted, Bronze			2022-12-18	WOS:000252627300011
J	Kaufmann, SHE				Kaufmann, SHE			Tuberculosis: Back on the immunologists' agenda	IMMUNITY			English	Editorial Material							CD8 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; VACCINE; PROTEIN; RESPIRATION; BIOMARKERS; RESPONSES; EFFICACY; IMMUNITY; BCG	Although tuberculosis research was instrumental in the birth of immunology, the two disciplines soon separated. The time is ripe for a reunion. Immunology has much to offer for rational intervention measures toward tuberculosis control.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Schumannstr 21-22, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268				Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hogrefe WR, 2005, BIOMARKERS, V10, pS50, DOI 10.1080/13547500500216629; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaufmann SHE, 2005, NAT IMMUNOL, V6, P1063, DOI 10.1038/ni1105-1063; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Panhuys N, 2005, TRENDS IMMUNOL, V26, P242, DOI 10.1016/j.it.2005.03.005; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	28	84	95	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2006	24	4					351	357		10.1016/j.immuni.2006.04.003	http://dx.doi.org/10.1016/j.immuni.2006.04.003			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618591	Bronze			2022-12-18	WOS:000237153000002
J	Oestreich, KJ; Cobb, RM; Pierce, S; Chen, JZ; Ferrier, P; Oltz, EM				Oestreich, KJ; Cobb, RM; Pierce, S; Chen, JZ; Ferrier, P; Oltz, EM			Regulation of TCR beta gene assembly by a promoter/enhancer holocomplex	IMMUNITY			English	Article							T-CELL DEVELOPMENT; V(D)J RECOMBINATION; LYSINE-9 METHYLATION; HISTONE DEACETYLASE; CHROMATIN STRUCTURE; DOMINANT ROLE; PROMOTER; LOCUS; ENHANCER; ACCESSIBILITY	Antigen receptor gene assembly is governed by transcriptional promoters and enhancers that communicate over large distances and modulate chromatin accessibility to V(D)J recombinase. The precise role of these cis-acting elements in opening chromatin at recombinase targets and the mechanisms underlying their crosstalk remain unclear. We show that the TCRP enhancer (E beta) directs long-range chromatin opening over both D beta J beta clusters. Strikingly, chromatin associated with the D beta 1 gene segment is refractory to Eo-mediated opening. Accessibility at D beta 1 is accompanied by the formation of a stable holocomplex between a Do-proximal promoter and E beta. These findings indicate a stepwise process for D beta -> J beta recombination that relies on distinct aspects of E beta activity: an intrinsic function that directs general chromatin opening and a cooperative function that facilitates the assembly of a promoter/enhancer holocomplex, unmasks the Doll gene segment, and triggers TCRP gene assembly.	Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Mediterranee, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France	Vanderbilt University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Oltz, EM (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA.	eugene.oltz@vanderbilt.edu			NATIONAL CANCER INSTITUTE [P30CA068485, T32CA009385, R01CA100905] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, P01HL068744] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA68485, CA100905, T32 CA09385] Funding Source: Medline; NHLBI NIH HHS [T32 HL69765, P01 HL68744] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bogue MA, 1998, P NATL ACAD SCI USA, V95, P15559, DOI 10.1073/pnas.95.26.15559; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Chattopadhyay S, 1998, J IMMUNOL, V160, P1256; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 2003, NAT IMMUNOL, V4, P603, DOI 10.1038/ni0703-603; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Oltz EM, 2001, IMMUNOL RES, V23, P121, DOI 10.1385/IR:23:2-3:121; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; ROTH DB, 1995, CURR BIOL, V5, P496, DOI 10.1016/S0960-9822(95)00101-1; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 1998, J IMMUNOL, V161, P1399; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Sikes ML, 1999, J IMMUNOL METHODS, V224, P25, DOI 10.1016/S0022-1759(99)00003-4; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; TAKEDA K, 1990, CAMP ISIJ, V3, P10; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	51	84	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					381	391		10.1016/j.immuni.2006.02.009	http://dx.doi.org/10.1016/j.immuni.2006.02.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618597	Bronze			2022-12-18	WOS:000237153000008
J	Mao, CC; Jiang, LY; Melo-Jorge, M; Puthenveetil, M; Zhang, XL; Carroll, MC; Imanishi-Kari, T				Mao, CC; Jiang, LY; Melo-Jorge, M; Puthenveetil, M; Zhang, XL; Carroll, MC; Imanishi-Kari, T			T cell-independent somatic hypermutation in murine B cells with an immature phenotype	IMMUNITY			English	Article							CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; IMMUNOGLOBULIN GENES; AFFINITY MATURATION; BONE-MARROW; ANTIBODY; LAMBDA; DIVERSIFICATION; REPERTOIRE; SEQUENCES	Somatic hypermutation contributes to the generation of antibody diversity and is strongly associated with the maturation of antigen-specific immune responses. We asked whether somatic hypermutation also plays a role in the generation of the murine immunoglobulin repertoire during B cell development. To facilitate identification of somatic mutations, we examined mouse systems in which only antibodies expressing lambda1, lambda2, and lambdax light chains can be generated. Somatic mutations were found in cells, which, by surface markers, RAG expression, and rapid turnover, had the phenotype of immature B cells. In addition, expression of AID was detected in these cells. The mutations were limited to V regions and were localized in known hot-spots. Mutation frequency was not diminished in the absence of T cells. Our results support the idea that somatic hypermutation can occur in murine immature B cells and may represent a mechanism for enlarging the V gene repertoire.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Tufts University; Tufts University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Imanishi-Kari, T (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	thereza.imanishi-kari@tufts.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045104] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45104] Funding Source: Medline; NICHD NIH HHS [HD38749] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BLOMBERG B, 1981, P NATL ACAD SCI-BIOL, V78, P3765, DOI 10.1073/pnas.78.6.3765; BOERSCHSUPAN ME, 1985, J EXP MED, V161, P1272, DOI 10.1084/jem.161.6.1272; Brard F, 1999, J EXP MED, V190, P691, DOI 10.1084/jem.190.5.691; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Butler JE, 1996, VET IMMUNOL IMMUNOP, V54, P7, DOI 10.1016/S0165-2427(96)05680-2; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; Chen ZB, 2000, J IMMUNOL, V164, P4522, DOI 10.4049/jimmunol.164.9.4522; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; DILDROP R, 1987, EUR J IMMUNOL, V17, P731, DOI 10.1002/eji.1830170525; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; Dorner T, 2001, ARTHRITIS RES, V3, P368, DOI 10.1186/ar329; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fischer MB, 1996, J IMMUNOL, V157, P549; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; GONZALEZFERNANDEZ A, 1994, P NATL ACAD SCI USA, V91, P12614, DOI 10.1073/pnas.91.26.12614; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Klonowski KD, 1999, J IMMUNOL, V162, P1566; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lucier MR, 1998, J IMMUNOL, V161, P5438; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Monson NL, 2001, CLIN IMMUNOL, V100, P71, DOI 10.1006/clim.2001.5049; MOTOYAMA N, 1991, P NATL ACAD SCI USA, V88, P7933, DOI 10.1073/pnas.88.18.7933; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oprea M, 2001, J IMMUNOL, V166, P892, DOI 10.4049/jimmunol.166.2.892; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Parng CL, 1996, J IMMUNOL, V157, P5478; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Shapiro GS, 1999, J IMMUNOL, V163, P259; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; WEINSTEIN PD, 1994, IMMUNITY, V1, P647, DOI 10.1016/1074-7613(94)90036-1; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	68	84	87	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					133	144		10.1016/S1074-7613(04)00019-6	http://dx.doi.org/10.1016/S1074-7613(04)00019-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975236	Bronze			2022-12-18	WOS:000221442400003
